Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AACS "ACSF1, FLJ12389, SUR-5" ENSG00000081760 "Acetoacetyl-CoA synthetase" Q86V21 12 125065379-125143333 "Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 54.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058815 Approved Approved Vesicles NA NA Vesicles "HPA058815: AB_2683826" "unprognostic (1.28e-1)" "unprognostic (9.78e-2)" "unprognostic (1.86e-1)" "unprognostic (1.06e-1)" "unprognostic (1.98e-3)" "unprognostic (9.46e-3)" "unprognostic (6.60e-6)" "unprognostic (3.03e-2)" "unprognostic (3.32e-2)" "unprognostic (2.45e-2)" "unprognostic (2.38e-2)" "unprognostic (3.04e-1)" "unprognostic (2.69e-2)" "unprognostic (1.69e-1)" "unprognostic (3.73e-2)" "unprognostic (7.71e-2)" "unprognostic (6.80e-2)" 21.1 6.5 9.0 10.5 13.0 2.5 33.7 6.6 22.0 11.7 9.3 5.3 7.4 12.9 5.2 7.7 22.3 6.6 12.9 5.8 8.1 5.6 6.8 3.3 4.9 4.9 5.1 13.1 4.9 9.7 5.8 6.7 4.8 10.0 6.7 8.6 5.1 33.7 12.9 3.7 26.9 8.7 4.5 4.2 4.3 12.7 9.7 3.6 6.8 7.6 12.2 8.7 5.0 9.9 3.0 11.8 6.9 2.3 5.8 5.7 3.8 14.5 14.5 6.3 8.6 23.4 15.3 10.6 11.8 11.3 14.0 12.6 18.7 9.7 9.0 12.2 14.2 6.1 15.9 11.8 12.7 7.6 9.7 10.8 7.2 9.7 14.2 19.5 5.1 7.3 16.9 10.4 11.9 12.1 17.6 10.2 5.3 5.0 5.6 8.9 26.6 5.9 6.8 8.0 15.3 17.2 1.1 16.1 12.4 14.3 22.2 17.0 4.9 12.5 19.8 9.1 6.5 14.8 11.3 9.7 6.8 10.8 7.6 9.0 12.7 7.2 9.8 8.5 8.4 7.4 6.9 2.3 6.7 4.2 0.7 5.4 3.0 3.9 3.2 2.8 1.7 5.7 3.8 0.3 5.8 0.8 11.8 2.4 3.8 9.0 13.0 6.6 22.0 8.1 5.6 5.1 13.1 10.0 3.6 6.0 12.9 0.8 4.9 14.7 16.4 7.3 12.7 0.0 5.7 5.2 25.5 1.8 6.6 9.5 54.0 5.8 9.9 0.0 9.5 7.4 11.4 9.4 2.3 2.5 4.1 6.4 24.2 0.6 3.2 14.6 8.6 2.8 5.0 5.4 20.1 5.4 8.7 5.8 4.9 6.2 20.1 0.0 7.6 12.7 5.4 24.6 2.1 9.2 15.1 4.9 ABCB9 EST122234 ENSG00000150967 "ATP binding cassette subfamily B member 9" Q9NP78 12 122920951-122981649 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 18.3;Muller glia cells: 20.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 6.2" "Group enriched" "Detected in many" 5 "B-cells: 6.2;granulocytes: 4.1;T-cells: 1.9" "Cell line enhanced" "Detected in many" "GAMG: 19.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033052, HPA035113, HPA035114" Approved Supported Vesicles NA NA Vesicles "CAB033052: AB_2273463, HPA035113: AB_2674470, HPA035114: AB_10601329" "unprognostic (1.47e-2)" "unprognostic (6.46e-4)" "unprognostic (3.96e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (5.65e-4)" "unprognostic (1.46e-1)" "unprognostic (2.67e-2)" "unprognostic (2.35e-1)" "unprognostic (4.08e-2)" "unprognostic (6.07e-2)" "unprognostic (2.28e-1)" "unprognostic (1.24e-1)" "unprognostic (1.37e-2)" "unprognostic (6.97e-2)" "unprognostic (1.70e-1)" "unprognostic (3.58e-3)" "unprognostic (2.71e-2)" 3.6 4.2 9.5 3.0 13.1 5.3 3.8 19.7 17.0 2.9 4.0 5.8 2.3 5.0 4.2 9.7 4.7 4.7 4.6 4.6 9.0 11.5 3.3 2.7 3.4 3.1 10.8 10.9 4.7 4.3 6.6 9.9 3.5 9.8 3.5 4.1 3.0 7.7 5.6 3.4 6.0 6.1 3.9 7.5 4.0 4.0 21.3 6.4 2.5 3.6 2.0 3.7 2.9 2.7 6.2 0.4 4.1 0.7 0.5 1.9 1.8 3.4 6.4 3.6 3.4 1.5 3.0 1.7 2.2 3.2 3.9 2.5 2.7 3.9 3.9 2.6 2.2 19.9 3.2 2.6 5.4 1.5 0.8 5.2 16.8 5.3 4.3 1.8 0.8 6.8 4.2 2.2 5.7 1.8 9.6 4.3 3.8 3.3 2.9 2.1 7.7 1.2 1.6 1.1 3.7 6.3 4.7 1.0 3.6 1.9 2.3 3.8 1.2 1.1 8.3 8.0 1.4 9.4 1.1 1.9 2.8 9.7 8.7 6.4 9.4 5.2 1.1 4.9 1.9 15.2 4.1 0.7 0.7 0.8 0.4 1.9 6.2 0.8 0.7 0.4 1.2 1.5 1.4 1.7 0.5 0.3 0.3 0.5 1.8 9.5 13.1 19.7 17.0 9.0 11.5 10.8 10.9 9.8 6.4 6.0 5.8 0.0 2.6 2.9 7.9 2.0 0.0 0.0 3.4 3.5 13.7 4.2 0.0 3.3 7.5 2.5 2.1 0.0 1.3 1.5 2.6 1.6 2.3 0.6 0.9 6.4 1.2 1.8 0.0 18.3 2.6 0.9 5.0 0.0 1.6 20.0 1.9 0.0 2.5 0.9 5.2 6.5 3.1 6.5 3.1 2.8 1.1 2.6 2.2 1.4 ABCG8 GBD4 ENSG00000143921 "ATP binding cassette subfamily G member 8" Q9H221 2 43831942-43882987 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "intestine: 62.4;liver: 64.4" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 24.1" "Cancer enriched" "Detected in some" 30 "liver cancer: 21.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 47 "Hep G2: 14.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA019556 Uncertain Approved Vesicles NA NA Vesicles "HPA019556: AB_1844444" "unprognostic (1.99e-1)" "unprognostic (4.49e-1)" "unprognostic (3.22e-1)" "unprognostic (1.37e-1)" "unprognostic (3.09e-2)" "unprognostic (2.43e-1)" "unprognostic (1.99e-3)" "unprognostic (1.27e-1)" "unprognostic (6.28e-1)" "unprognostic (6.14e-3)" "unprognostic (4.69e-1)" "unprognostic (1.76e-1)" "unprognostic (2.68e-1)" "unprognostic (7.86e-3)" "unprognostic (5.03e-1)" "unprognostic (1.50e-1)" 0.1 0.1 0.2 0.0 0.3 0.0 0.1 0.1 0.4 0.1 21.2 0.0 0.0 24.0 0.1 0.1 0.1 0.1 1.7 0.1 0.2 0.3 0.2 64.4 0.1 0.0 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 62.4 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.7 0.6 2.1 0.3 0.5 0.8 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 14.7 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 2.1 0.3 0.4 0.7 0.3 0.5 0.5 0.6 0.5 0.1 0.7 0.8 0.7 1.7 0.5 0.3 0.6 0.3 0.2 0.2 0.3 0.1 0.4 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 5.1 0.0 1.2 1.8 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABHD14A "DKFZP564O243, DORZ1" ENSG00000248487 "Abhydrolase domain containing 14A" Q9BUJ0 3 51971426-51981199 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038153, HPA056913" Approved Enhanced Vesicles NA NA 260000 Vesicles "HPA038153: AB_2675868, HPA056913: AB_2683275" "unprognostic (4.15e-3)" "unprognostic (6.73e-2)" "unprognostic (1.98e-1)" "unprognostic (3.34e-2)" "unprognostic (2.71e-1)" "unprognostic (1.08e-2)" "unprognostic (8.92e-2)" "prognostic favorable (4.72e-4)" "unprognostic (3.96e-1)" "unprognostic (2.46e-2)" "unprognostic (5.52e-3)" "unprognostic (1.51e-2)" "unprognostic (1.97e-2)" "unprognostic (9.74e-2)" "unprognostic (2.17e-1)" "unprognostic (1.33e-1)" "unprognostic (1.30e-2)" 11.8 28.0 23.3 6.0 25.8 9.0 9.2 39.6 45.0 18.3 7.3 12.2 8.5 8.0 6.9 23.2 5.4 19.6 9.3 16.4 22.3 27.8 26.2 13.0 9.7 8.9 16.6 23.4 14.8 20.6 15.6 21.3 7.0 18.7 11.6 5.6 26.1 17.7 12.5 23.8 3.9 6.6 8.8 14.5 7.7 11.0 6.2 7.0 6.6 24.1 8.4 8.8 9.2 7.4 15.4 13.9 4.5 6.0 12.0 30.9 15.3 2.8 5.4 3.5 10.6 35.3 17.8 1.9 3.8 6.3 4.6 6.2 6.2 11.5 3.2 2.6 9.4 5.2 2.4 3.8 4.2 1.5 10.3 4.3 9.4 16.2 20.5 9.9 12.8 12.6 16.7 2.9 3.9 2.0 10.3 5.9 6.2 3.8 10.9 7.1 3.2 5.9 13.1 2.0 13.5 13.0 4.2 1.8 30.3 8.8 4.4 7.3 11.3 9.5 2.0 5.6 0.8 3.0 14.1 3.4 4.2 4.5 10.0 4.3 15.9 14.8 2.6 7.8 20.6 6.0 2.1 6.0 4.5 30.2 3.5 30.9 15.4 26.7 26.8 10.4 12.4 24.6 26.2 0.6 12.0 2.2 13.9 25.7 15.3 23.3 25.8 39.6 45.0 22.3 27.8 16.6 23.4 18.7 7.0 6.0 17.1 20.4 20.4 8.7 89.3 21.0 15.3 24.1 19.4 31.4 23.6 9.0 28.2 13.8 3.6 14.2 8.5 0.0 10.8 11.5 41.8 21.4 15.0 11.6 25.9 55.6 38.7 17.2 11.8 18.4 81.4 13.0 11.8 4.6 11.8 36.2 13.3 2.9 31.1 69.3 86.1 19.4 11.3 16.9 59.2 4.8 4.1 34.6 14.0 13.2 ABHD14A-ACY1 ENSG00000114786 "ABHD14A-ACY1 readthrough" 3 51974706-51989183 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 3.7;Club cells: 3.4;Collecting duct cells: 5.2;Distal tubular cells: 3.3;Proximal tubular cells: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 3.4;HUVEC TERT2: 4.2;SH-SY5Y: 3.4" "HPA036174, HPA036175, HPA038153" Approved Uncertain Vesicles NA NA Vesicles "HPA036174: AB_2674988, HPA036175: AB_2674989, HPA038153: AB_2675868" "unprognostic (8.40e-2)" "unprognostic (1.37e-1)" "unprognostic (4.90e-2)" "unprognostic (7.22e-3)" "unprognostic (3.83e-2)" "unprognostic (1.43e-1)" "unprognostic (1.82e-1)" "unprognostic (1.35e-1)" "unprognostic (6.23e-2)" "unprognostic (2.71e-1)" "unprognostic (1.10e-1)" "unprognostic (1.29e-2)" "unprognostic (9.02e-2)" "unprognostic (1.09e-1)" "unprognostic (1.40e-1)" "unprognostic (1.02e-1)" "unprognostic (7.11e-4)" 2.7 2.9 3.5 2.6 8.2 2.0 2.3 8.3 15.1 3.7 3.5 3.2 1.9 4.8 2.5 3.2 2.0 3.3 3.5 4.8 3.2 4.1 5.8 8.4 3.0 1.9 2.7 7.2 2.7 4.6 1.4 3.7 1.7 5.6 2.8 1.6 8.2 4.1 2.2 8.0 2.0 10.5 2.0 3.9 3.3 2.6 2.2 1.3 0.9 4.7 1.8 2.8 2.3 2.7 2.4 5.2 1.2 4.0 4.7 4.1 2.7 0.0 0.0 0.3 0.5 2.0 1.1 0.2 0.0 2.0 0.4 0.4 2.0 3.4 0.8 0.1 0.0 0.3 1.6 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.1 0.0 0.0 0.0 2.6 1.0 0.0 0.0 0.5 4.2 1.1 2.1 0.0 0.0 0.0 2.0 1.5 1.3 1.0 1.8 0.5 0.0 0.2 0.0 0.0 0.4 3.4 0.0 2.4 0.0 0.0 0.9 0.0 0.0 1.0 0.0 2.1 0.0 0.0 0.0 2.0 1.6 0.0 0.0 0.2 1.7 1.2 4.1 4.0 2.4 2.4 2.3 4.1 5.2 1.7 2.1 2.7 0.0 4.7 2.0 2.4 2.5 2.7 3.5 8.2 8.3 15.1 3.2 4.1 2.7 7.2 5.6 1.3 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 5.2 0.0 0.0 3.3 0.8 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.0 0.0 0.0 1.3 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ABT1 Esf2 ENSG00000146109 "Activator of basal transcription 1" Q9ULW3 6 26596952-26600744 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077039 Approved Vesicles NA NA Vesicles "HPA077039: AB_2732328" "unprognostic (1.32e-1)" "unprognostic (3.94e-2)" "unprognostic (3.05e-1)" "unprognostic (1.15e-3)" "unprognostic (1.77e-1)" "unprognostic (7.74e-2)" "unprognostic (2.55e-2)" "unprognostic (2.36e-2)" "unprognostic (1.85e-2)" "prognostic favorable (1.89e-4)" "unprognostic (2.30e-3)" "unprognostic (2.93e-2)" "unprognostic (7.25e-3)" "unprognostic (7.20e-2)" "unprognostic (9.57e-2)" "unprognostic (1.49e-1)" "prognostic favorable (3.80e-4)" 13.1 11.0 11.2 14.6 10.7 28.9 13.0 15.8 14.1 13.3 12.1 9.8 13.5 14.5 16.2 14.3 19.4 13.9 9.0 10.8 9.6 7.6 10.1 19.1 11.4 20.4 9.5 9.3 14.2 18.2 8.4 10.9 19.6 8.3 13.5 10.1 9.3 13.4 12.0 16.1 18.2 15.6 9.2 6.3 23.2 13.5 17.9 9.4 23.9 13.1 17.4 22.4 12.9 13.2 32.0 18.5 29.1 20.1 24.9 34.7 37.0 12.6 6.6 9.3 16.0 5.2 5.5 13.6 7.5 7.7 11.4 11.2 11.9 5.6 18.5 17.2 6.1 9.1 8.1 10.7 10.9 6.7 10.2 21.8 12.2 6.0 22.1 8.4 16.6 12.4 7.2 10.2 9.1 5.4 5.3 9.9 14.7 21.1 12.5 6.3 12.8 19.1 21.2 9.5 8.1 8.9 11.6 7.5 19.5 7.1 10.3 12.2 9.8 4.6 12.2 17.8 5.1 11.7 13.5 8.4 8.8 6.4 6.9 15.0 14.7 21.6 16.8 4.1 20.6 13.3 29.1 20.1 24.0 32.8 18.1 31.4 31.2 32.3 32.7 18.5 32.0 34.7 31.2 17.4 24.9 18.0 17.1 34.1 37.0 11.2 10.7 15.8 14.1 9.6 7.6 9.5 9.3 8.3 9.4 14.9 13.3 52.3 27.6 53.1 16.8 5.6 20.4 18.7 15.9 10.4 2.0 79.8 34.9 29.8 33.9 35.1 16.3 0.0 34.0 80.3 20.7 16.1 27.8 21.2 36.8 14.3 32.6 17.8 15.4 58.5 25.6 22.9 15.1 25.2 23.4 20.9 28.3 21.0 22.3 19.1 15.4 19.4 23.2 22.3 36.4 52.2 91.5 58.6 30.2 27.0 AC091057.5 ENSG00000284906 "Rho GTPase-activating protein 11B " Q3KRB8 15 30624548-30685606 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 7.1;lymphoid tissue: 14.4;testis: 5.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA064479 Uncertain Uncertain Vesicles NA Yes Vesicles "HPA064479: AB_2685272" 0.2 0.1 0.8 10.3 1.8 7.1 0.5 0.7 0.9 0.1 5.1 0.6 0.0 1.1 0.8 0.2 1.8 0.2 0.3 0.2 1.0 0.0 0.1 0.9 2.8 0.1 0.0 0.1 0.0 0.0 0.4 0.7 0.6 0.0 1.2 0.3 0.1 0.1 0.4 0.9 1.5 0.8 1.9 1.4 1.0 5.8 2.1 14.4 0.0 1.4 5.7 0.5 0.0 1.0 1.0 1.6 0.3 0.0 0.8 0.0 4.4 2.9 5.0 2.5 0.1 0.6 2.8 4.6 1.9 3.2 3.7 3.0 3.7 2.8 1.8 1.9 3.6 4.0 2.6 1.6 2.8 6.1 3.1 7.4 10.0 1.3 0.0 4.7 5.3 0.2 0.2 2.1 1.6 1.1 2.2 6.6 4.4 8.7 2.2 2.1 3.6 4.0 1.5 2.2 1.5 5.1 5.1 1.3 0.9 2.8 2.4 2.2 5.4 2.0 1.0 1.4 2.5 2.4 2.5 5.0 4.2 2.4 3.9 3.0 3.2 6.1 1.7 5.4 4.0 1.6 0.3 0.2 0.4 0.0 0.0 0.6 0.8 0.6 0.1 1.0 0.1 0.1 0.1 0.0 0.1 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092718.3 ENSG00000260643 16 81053587-81096296 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "Ciliated cells: 16.0;Club cells: 4.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA041368 Approved Approved Vesicles NA NA Vesicles "HPA041368: AB_10804001" "unprognostic (3.87e-2)" "unprognostic (1.79e-1)" "unprognostic (1.95e-1)" "unprognostic (2.12e-2)" "unprognostic (8.06e-2)" "unprognostic (1.08e-1)" "unprognostic (3.95e-2)" "unprognostic (8.11e-2)" "unprognostic (2.85e-1)" "unprognostic (2.42e-1)" "unprognostic (3.94e-2)" "unprognostic (3.19e-1)" "unprognostic (2.69e-2)" "unprognostic (2.11e-1)" "unprognostic (1.95e-1)" "unprognostic (9.56e-3)" "unprognostic (3.03e-1)" 5.1 2.7 4.4 1.6 6.3 1.0 2.6 2.6 10.3 1.8 1.3 5.9 5.5 0.8 3.4 7.6 1.3 7.0 1.9 3.4 5.0 6.1 6.0 1.8 1.6 6.8 6.2 2.9 3.6 5.0 2.2 4.0 7.6 2.9 1.3 3.7 3.3 2.6 8.4 1.8 1.1 2.3 5.3 1.4 2.0 5.8 7.2 2.0 15.0 1.6 0.9 1.5 0.0 4.5 5.1 1.5 1.3 3.9 3.6 2.1 4.2 3.4 5.3 3.7 12.2 4.5 5.6 2.3 1.0 2.0 0.3 0.4 5.1 0.8 4.7 1.0 4.5 3.6 3.2 1.4 2.9 1.6 5.7 0.9 1.7 3.2 4.3 3.1 2.9 5.3 6.4 3.1 2.8 5.7 2.0 6.5 3.9 0.4 2.7 4.7 4.3 14.0 2.7 3.5 1.8 12.4 1.1 2.2 7.8 1.7 4.2 4.2 2.6 1.1 4.2 5.9 1.2 5.0 2.4 0.9 2.0 2.5 1.8 3.1 3.4 5.7 2.6 2.3 2.2 1.5 1.1 1.0 3.6 0.8 3.5 4.5 2.3 1.3 2.9 3.5 3.3 2.4 0.9 3.9 1.3 5.1 0.6 2.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 16.0 4.5 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC092718.8 ENSG00000284512 16 81022316-81096284 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 20.6" "Cell type enriched" "Detected in single" 11 "Alveolar cells type 2: 1.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA041368 Uncertain Approved Vesicles NA NA Vesicles "HPA041368: AB_10804001" 1.4 1.9 3.2 2.1 4.7 4.0 1.7 1.8 6.9 1.4 1.3 4.4 4.0 1.4 2.0 4.2 1.3 1.7 1.6 2.4 3.7 2.5 4.2 1.4 1.9 5.1 4.7 2.2 2.5 3.6 1.4 1.7 5.7 4.0 1.3 2.6 2.3 1.7 3.2 1.9 1.6 1.3 3.9 1.5 1.7 20.6 5.4 1.2 4.5 0.9 1.2 1.7 0.0 1.9 2.8 2.3 1.0 1.7 2.1 0.9 1.3 0.7 1.9 1.6 0.3 0.0 1.6 2.4 0.2 0.5 0.1 1.2 1.9 1.8 1.0 0.6 0.9 2.8 0.1 0.1 0.5 0.3 1.1 1.1 2.5 1.8 0.2 1.8 3.4 0.6 0.2 0.4 0.0 1.0 0.0 2.2 1.0 3.3 0.0 3.7 1.6 4.0 1.9 0.7 1.1 1.6 1.3 0.5 0.2 0.8 2.8 0.8 1.8 1.2 0.4 1.0 1.2 0.5 0.3 1.7 2.0 1.3 1.1 1.6 0.8 3.4 0.6 0.8 0.8 1.9 1.0 0.6 1.2 0.6 1.0 1.1 0.9 2.1 0.6 1.9 1.2 1.5 2.3 1.7 0.9 2.8 1.8 0.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC118553.2 ENSG00000283761 1 99970011-100083321 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.6;Ciliated cells: 9.4;Club cells: 2.3" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA073681 Approved Vesicles NA NA Vesicles "HPA073681: AB_2686625" 2.5 1.9 1.9 6.5 2.0 3.0 6.3 2.3 4.0 3.1 8.2 1.4 6.3 3.3 3.1 3.9 5.9 3.1 4.6 2.1 1.4 3.8 6.1 7.1 3.9 2.1 1.8 4.2 5.2 3.0 2.8 4.4 3.3 3.5 4.2 1.6 5.8 8.9 2.2 1.5 17.6 5.9 2.1 1.8 2.8 4.6 1.5 10.2 2.9 2.5 3.1 3.5 3.8 4.4 8.7 9.1 7.8 9.1 8.6 6.7 0.9 1.2 1.6 0.5 0.0 1.1 1.5 2.4 1.0 2.4 5.0 0.8 3.5 0.2 6.0 3.6 5.0 3.9 4.7 1.7 3.1 1.6 2.4 3.9 6.9 0.2 0.5 0.8 0.8 0.0 1.6 4.6 4.1 1.3 2.9 0.7 3.1 2.2 1.4 2.1 3.9 0.2 0.1 3.6 2.0 0.9 3.8 1.7 1.4 1.9 1.1 1.4 1.9 1.2 1.0 1.6 1.0 0.1 0.9 1.5 2.6 1.4 2.6 1.3 5.0 0.7 1.9 1.9 0.6 9.1 7.5 5.0 6.9 7.8 7.9 4.4 7.2 8.2 8.7 2.9 6.9 5.9 1.1 9.1 4.5 6.7 8.6 6.7 6.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 9.4 2.3 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACE "ACE1, CD143, DCP1" ENSG00000159640 "Angiotensin I converting enzyme" P12821 17 63477061-63498380 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "intestine: 205.6" "Group enriched" "Detected in many" 25 "Early spermatids: 470.5;Late spermatids: 1015.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "memory B-cell: 3.7" "Group enriched" "Detected in many" 23 "B-cells: 3.7;monocytes: 2.0;T-cells: 1.9" "Group enriched" "Detected in some" 4 "ASC TERT1: 36.7;HUVEC TERT2: 18.7" "CAB002426, CAB002921, HPA029298, HPA069790" Enhanced Approved Vesicles "Secreted to blood" NA NA 104000000 92000000 Vesicles "CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: AB_2686197" "unprognostic (4.72e-2)" "unprognostic (4.16e-1)" "unprognostic (1.93e-3)" "unprognostic (6.06e-2)" "unprognostic (2.78e-1)" "unprognostic (1.35e-2)" "unprognostic (4.37e-1)" "unprognostic (1.54e-1)" "unprognostic (1.56e-1)" "unprognostic (1.25e-2)" "unprognostic (3.13e-2)" "unprognostic (2.38e-1)" "unprognostic (7.66e-2)" "unprognostic (9.07e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-1)" "unprognostic (2.76e-2)" 6.8 2.0 0.5 2.4 4.2 0.0 2.9 0.5 1.1 5.3 83.2 0.7 37.7 46.4 4.5 5.1 1.7 1.5 4.4 4.7 0.6 0.7 2.6 1.4 16.3 2.2 0.4 0.7 1.4 3.0 3.6 3.6 3.6 0.8 3.4 1.4 1.7 2.5 20.1 3.6 1.3 205.6 2.4 0.6 1.4 1.9 32.6 1.3 0.5 6.9 3.1 2.2 1.7 1.6 3.7 0.1 0.0 2.0 0.0 1.9 0.4 0.0 0.0 0.0 0.0 1.5 36.7 0.4 1.3 2.7 0.0 0.0 0.5 3.2 0.7 1.1 6.2 0.0 0.0 1.7 0.0 0.0 0.0 0.7 3.5 0.0 0.0 0.8 0.0 0.0 2.4 0.0 0.0 0.0 0.6 18.7 0.0 3.1 0.0 0.0 0.6 0.0 0.8 0.3 6.3 0.4 0.1 0.2 0.5 0.0 0.0 4.6 3.2 0.0 0.0 0.0 0.7 1.6 0.2 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.4 0.6 0.9 3.7 1.9 1.4 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.4 0.5 4.2 0.5 1.1 0.6 0.7 0.4 0.7 0.8 1.3 0.0 3.5 0.0 1.5 1.3 3.1 1.4 0.0 0.0 1.2 0.0 0.0 0.1 0.0 3.4 470.5 13.5 29.6 0.0 0.4 0.1 1.0 6.0 6.9 0.0 4.4 0.0 17.3 2.5 18.5 1015.1 4.0 5.1 3.3 0.0 8.7 1.9 0.7 10.2 2.5 10.7 1.0 0.0 0.9 8.1 3.4 0.1 0.1 0.9 8.6 2.1 ACSBG1 "BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352" ENSG00000103740 "Acyl-CoA synthetase bubblegum family member 1" Q96GR2 15 78167468-78245688 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 11.4;brain: 40.5;skin 1: 19.9" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 26.8;Spermatogonia: 7.7" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 8.1;SK-MEL-30: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041642, CAB045955, HPA058869" Approved Approved Vesicles NA NA Vesicles "CAB045955: AB_11124196, HPA041642: AB_2677593, HPA058869: AB_2683840" "unprognostic (1.28e-1)" "unprognostic (1.63e-2)" "unprognostic (1.29e-2)" "unprognostic (2.28e-1)" "unprognostic (2.29e-2)" "unprognostic (4.18e-2)" "unprognostic (1.32e-2)" "unprognostic (1.58e-2)" "unprognostic (1.86e-1)" "unprognostic (5.64e-2)" "unprognostic (2.02e-1)" "unprognostic (4.13e-1)" "unprognostic (1.05e-1)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (4.19e-2)" "unprognostic (1.42e-2)" 1.1 11.4 16.9 1.5 26.9 4.5 3.8 6.6 27.0 1.1 1.2 10.5 0.0 1.6 1.2 2.3 1.3 5.9 1.3 1.1 16.4 8.5 1.0 1.0 1.7 1.6 21.1 13.9 1.2 1.0 0.9 0.3 1.1 32.9 2.0 1.1 0.0 1.5 1.4 1.2 19.9 1.5 1.2 40.5 1.3 1.2 5.4 19.0 0.0 1.2 0.0 1.1 1.5 0.2 0.4 3.9 1.2 0.2 0.6 0.2 1.5 0.8 0.1 1.6 2.4 0.0 0.0 0.6 0.5 0.0 0.5 0.1 0.5 0.6 0.8 0.2 0.1 0.6 0.9 0.1 0.3 0.2 0.4 1.4 0.7 1.4 0.7 0.0 0.7 1.6 0.6 0.0 0.4 0.2 0.5 0.2 1.0 0.5 1.1 0.1 0.4 0.6 1.4 8.1 0.7 0.3 0.3 1.0 0.5 0.0 1.0 0.6 0.9 0.4 1.0 3.8 1.0 0.5 0.5 1.0 0.6 0.6 0.5 0.3 0.9 0.3 0.9 0.3 0.6 1.6 0.4 0.2 0.1 0.2 0.1 0.1 0.3 0.1 0.0 0.1 0.4 0.2 0.1 1.2 0.6 0.2 3.9 0.0 1.5 16.9 26.9 6.6 17.9 16.4 8.5 21.1 13.9 32.9 19.0 0.0 1.3 0.0 0.3 1.0 2.1 2.0 0.0 26.8 4.5 0.0 3.9 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 0.3 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.9 0.9 7.7 0.5 0.3 0.0 0.0 0.3 ACSM5 FLJ20581 ENSG00000183549 "Acyl-CoA synthetase medium chain family member 5" Q6NUN0 16 20409534-20441336 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "liver: 94.6" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 179.6" "Group enriched" "Detected in some" 7 "liver cancer: 20.5;renal cancer: 9.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "classical monocyte: 2.8;intermediate monocyte: 1.9;myeloid DC: 3.2;non-classical monocyte: 1.3" "Group enriched" "Detected in many" 8 "dendritic cells: 3.2;monocytes: 2.8" "Group enriched" "Detected in some" 5 "ASC diff: 5.8;ASC TERT1: 12.6;HSkMC: 15.0;U-87 MG: 9.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA041435 Uncertain Uncertain Vesicles NA NA Vesicles "HPA041435: AB_10961121" "unprognostic (1.01e-1)" "unprognostic (1.61e-3)" "unprognostic (3.73e-2)" "unprognostic (1.98e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-2)" "unprognostic (1.84e-2)" "unprognostic (4.64e-3)" "unprognostic (1.64e-1)" "unprognostic (2.01e-2)" "unprognostic (2.15e-2)" "unprognostic (2.33e-1)" "unprognostic (5.11e-3)" "unprognostic (2.09e-2)" "unprognostic (3.85e-2)" "unprognostic (2.78e-2)" "unprognostic (1.57e-1)" 11.1 1.1 1.9 0.7 2.1 0.4 3.2 1.3 1.6 1.0 1.0 2.9 0.0 0.5 0.3 2.8 0.5 0.6 1.0 0.9 3.0 1.9 8.9 94.6 0.9 1.6 2.9 2.1 0.4 1.4 0.4 0.1 0.7 2.0 0.4 0.6 0.5 0.5 0.5 4.4 0.6 0.6 0.5 2.9 1.7 0.9 1.0 3.0 0.1 1.7 0.6 0.4 0.5 0.7 0.3 3.2 0.3 2.8 0.0 0.3 0.5 0.0 0.0 0.1 0.1 5.8 12.6 0.0 0.1 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.2 0.0 15.0 0.0 0.8 0.1 0.3 0.0 0.0 0.1 0.6 1.7 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 9.2 0.1 0.0 0.3 2.8 0.1 0.1 1.9 0.1 0.1 0.3 0.2 3.2 0.3 0.2 0.3 0.1 0.0 1.3 0.1 0.0 0.5 1.9 2.1 1.3 1.6 3.0 1.9 2.9 2.1 2.0 3.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.7 0.3 0.0 179.6 3.3 0.0 0.0 6.7 8.8 0.2 8.6 1.2 0.0 1.8 0.0 1.1 0.0 0.0 5.6 31.5 0.0 0.0 0.1 0.0 0.2 0.5 0.0 0.0 0.0 0.1 ADAM15 MDC15 ENSG00000143537 "ADAM metallopeptidase domain 15" Q13444 1 155050566-155062775 "Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion, Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 139.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 17.2;intermediate monocyte: 12.0;myeloid DC: 28.7" "Group enriched" "Detected in many" 5 "dendritic cells: 28.7;monocytes: 17.2" "Cell line enhanced" "Detected in many" "PC-3: 64.1;RPMI-8226: 67.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011633, HPA072878" Uncertain Uncertain Vesicles NA NA 13000 Vesicles "HPA011633: AB_1844574, HPA072878: " "unprognostic (6.35e-3)" "unprognostic (1.51e-1)" "unprognostic (1.60e-1)" "unprognostic (7.60e-2)" "prognostic unfavorable (5.83e-5)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.49e-4)" "unprognostic (2.07e-2)" "unprognostic (1.09e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (5.64e-9)" "unprognostic (3.35e-2)" "unprognostic (6.20e-2)" "unprognostic (2.04e-2)" "unprognostic (7.40e-2)" 32.7 8.3 7.3 13.3 8.9 19.3 47.9 7.8 13.9 19.9 21.2 22.2 11.9 10.7 20.4 16.2 36.0 19.3 30.3 42.3 8.0 7.7 12.4 12.8 29.2 23.3 10.8 8.3 15.7 17.5 18.9 6.9 25.5 13.9 17.8 15.9 15.4 20.4 12.1 13.6 45.8 20.3 25.6 13.6 16.0 19.6 8.3 7.4 2.7 14.6 41.5 19.7 13.4 26.5 1.1 28.7 0.7 17.2 0.7 4.5 8.1 20.8 6.7 1.3 29.8 11.0 9.2 12.9 9.2 11.8 11.8 8.0 4.8 12.0 5.8 41.7 12.1 5.2 26.2 6.7 28.4 3.1 2.6 8.7 1.4 13.2 4.7 19.2 11.8 1.5 9.8 30.1 11.9 17.2 16.3 53.4 1.8 2.2 24.4 8.7 11.3 0.1 8.7 4.2 36.4 64.1 1.8 4.0 67.6 8.6 5.5 4.1 8.8 20.2 25.5 7.9 2.2 37.7 7.3 39.3 11.6 4.9 11.5 10.2 2.7 2.1 2.5 8.4 9.0 12.6 0.0 17.2 0.3 4.5 12.0 3.1 1.0 2.3 2.6 28.7 1.1 1.0 1.2 0.7 0.7 2.8 2.3 3.8 8.1 7.3 8.9 7.8 13.9 8.0 7.7 10.8 8.3 13.9 7.4 3.0 7.0 6.0 22.9 43.5 8.9 9.2 33.1 4.0 5.7 8.7 27.5 9.0 0.0 34.2 1.5 86.7 58.2 0.0 22.4 139.2 17.1 43.0 1.1 17.4 29.2 6.4 12.2 51.0 57.4 1.0 16.1 18.9 13.5 3.6 62.3 8.0 30.5 51.8 17.0 2.2 15.6 12.9 16.1 0.9 6.1 49.9 14.9 5.0 53.8 32.0 ADAM19 MLTNB ENSG00000135074 "ADAM metallopeptidase domain 19" Q9H013 5 157395534-157575775 "Plasma proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 49.4;smooth muscle: 46.1" "Cell type enhanced" "Detected in many" 13 "B-cells: 69.2;Cone photoreceptor cells: 58.9;Extravillous trophoblasts: 72.0;monocytes: 134.3;Rod photoreceptor cells: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 32.3;eosinophil: 37.5;memory B-cell: 14.1;naive B-cell: 15.8;neutrophil: 20.1;plasmacytoid DC: 18.5" "Group enriched" "Detected in many" 5 "B-cells: 15.8;dendritic cells: 18.5;granulocytes: 37.5" "Cell line enhanced" "Detected in many" "HDLM-2: 31.7;U-251 MG: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055537 Approved Vesicles NA NA Vesicles "HPA055537: AB_2797253" "unprognostic (4.71e-1)" "unprognostic (1.01e-1)" "unprognostic (1.77e-1)" "unprognostic (4.64e-2)" "unprognostic (1.81e-3)" "unprognostic (2.63e-1)" "unprognostic (2.16e-2)" "unprognostic (1.82e-2)" "unprognostic (1.76e-2)" "unprognostic (2.80e-1)" "unprognostic (1.42e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (3.90e-12)" "unprognostic (1.44e-1)" "unprognostic (4.38e-2)" "unprognostic (2.22e-1)" "unprognostic (1.11e-2)" 3.7 2.5 1.3 49.4 1.5 4.8 2.8 6.9 2.4 4.4 15.1 1.1 3.6 3.9 8.6 5.9 4.6 5.9 14.7 18.9 1.6 1.7 1.6 4.3 9.1 19.2 1.6 1.0 3.0 0.5 0.0 1.4 33.0 3.4 5.9 4.9 5.0 6.8 4.6 3.9 0.8 14.0 46.1 2.8 16.8 7.7 1.3 0.5 5.6 3.1 3.3 29.4 17.0 3.9 15.8 18.5 37.5 3.9 0.1 4.4 2.2 11.1 1.7 3.4 0.0 0.2 0.2 22.3 13.3 4.7 8.3 6.2 5.8 9.1 5.8 0.7 6.8 1.7 9.5 0.5 0.8 7.6 31.7 0.3 0.0 0.9 0.7 2.0 0.0 0.0 1.6 0.0 6.5 1.3 9.9 9.4 0.0 1.6 0.8 17.7 0.0 0.0 0.0 3.7 0.0 5.8 0.1 19.9 4.8 0.9 0.1 1.6 1.0 0.0 4.8 0.7 14.4 0.0 0.2 14.3 9.0 9.7 2.0 60.2 3.6 0.1 20.8 2.0 0.0 4.0 32.3 3.9 37.5 0.4 0.3 1.0 14.1 4.4 1.0 1.1 15.8 0.1 0.1 20.1 0.1 0.0 18.5 4.4 2.2 1.3 1.5 6.9 2.3 1.6 1.7 1.6 1.0 3.4 0.5 6.0 1.1 69.2 0.0 1.9 32.2 3.3 0.0 0.0 1.2 3.5 58.9 0.7 0.0 0.5 3.4 3.9 0.0 0.0 1.3 72.0 4.7 0.1 0.0 8.6 1.5 14.3 0.0 6.2 14.4 1.1 5.2 6.7 1.7 134.3 0.0 2.0 1.6 0.0 7.4 0.0 47.3 6.5 5.2 0.0 1.5 1.3 7.0 10.2 0.0 0.1 ADAMTS13 "C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP" ENSG00000160323 "ADAM metallopeptidase with thrombospondin type 1 motif 13" Q76LX8 9 133414358-133459402 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Hydrolase, Metalloprotease, Protease" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "liver: 53.7" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 7.6;Early spermatids: 20.6;Ito cells: 8.0;Late spermatids: 10.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "basophil: 2.3" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.3" "Cell line enhanced" "Detected in many" "SuSa: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA042014, HPA042844, HPA052077" Approved Approved Vesicles "Secreted to blood" NA NA 1300000000 38000000 Vesicles "HPA042014: AB_2677798, HPA042844: AB_2678200, HPA052077: " "unprognostic (1.09e-1)" "unprognostic (1.45e-1)" "unprognostic (8.75e-4)" "unprognostic (1.49e-2)" "unprognostic (1.83e-1)" "unprognostic (3.02e-1)" "unprognostic (4.76e-2)" "unprognostic (2.54e-1)" "unprognostic (2.33e-2)" "unprognostic (1.88e-1)" "unprognostic (4.52e-5)" "unprognostic (1.11e-1)" "unprognostic (9.91e-2)" "unprognostic (4.78e-2)" "unprognostic (3.57e-1)" "unprognostic (1.82e-2)" "unprognostic (2.30e-3)" 1.4 1.0 3.1 1.4 3.7 0.5 1.4 6.6 4.2 1.4 1.4 1.4 1.4 4.1 1.6 4.0 1.4 2.1 1.5 1.7 3.4 2.2 1.8 53.7 4.8 1.4 2.1 1.4 2.3 1.8 2.2 4.2 1.7 1.6 1.6 1.1 1.6 2.5 2.0 2.6 2.9 4.4 1.4 2.0 1.4 5.5 3.8 1.4 1.4 1.7 1.4 1.4 1.7 1.4 0.3 0.0 2.3 0.0 0.0 0.5 0.1 0.0 1.3 3.3 4.6 2.7 2.4 1.2 1.1 0.9 0.4 0.6 0.5 3.6 0.4 1.5 0.8 1.1 0.6 0.3 0.6 0.1 1.9 3.0 0.4 1.3 0.7 1.9 0.1 1.1 6.4 1.6 0.5 1.2 2.2 0.3 2.3 0.1 1.4 0.5 5.5 0.1 1.5 3.5 1.9 2.0 0.4 0.4 1.6 1.5 1.4 2.1 6.8 2.3 1.3 1.8 7.1 5.8 0.6 0.8 2.4 1.4 1.6 0.0 2.5 0.6 0.5 2.0 0.4 2.8 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 3.7 6.6 4.2 3.4 2.2 2.1 1.4 1.6 1.4 0.0 1.3 0.0 0.1 0.2 1.4 3.6 7.6 0.0 3.4 0.0 0.0 0.1 1.7 0.6 20.6 0.3 1.0 0.0 0.3 0.2 0.8 0.4 0.0 1.5 0.2 3.2 1.2 8.0 0.0 10.2 0.9 0.0 0.0 0.0 1.3 1.9 0.3 1.4 1.4 0.7 1.7 0.0 0.4 4.7 3.8 0.4 0.1 0.0 0.6 0.3 ADAMTS7 "ADAM-TS7, DKFZp434H204" ENSG00000136378 "ADAM metallopeptidase with thrombospondin type 1 motif 7" Q9UKP4 15 78759203-78811431 "Plasma proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 31.9" "Cell type enhanced" "Detected in some" 10 "Cardiomyocytes: 9.0;Early spermatids: 3.9;Endothelial cells: 4.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 9 "HMC-1: 77.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA045284, HPA048453" Uncertain Supported Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA045284: AB_2679285, HPA048453: AB_2680399" "unprognostic (5.94e-3)" "unprognostic (9.94e-3)" "unprognostic (2.76e-2)" "unprognostic (7.09e-2)" "unprognostic (3.38e-1)" "unprognostic (1.93e-1)" "unprognostic (5.88e-4)" "unprognostic (3.34e-3)" "unprognostic (2.89e-2)" "unprognostic (3.31e-2)" "unprognostic (1.83e-2)" "unprognostic (3.79e-1)" "unprognostic (1.34e-2)" "prognostic unfavorable (9.53e-4)" "unprognostic (1.59e-1)" "unprognostic (2.66e-2)" "unprognostic (8.86e-2)" 6.0 4.1 0.7 4.1 2.5 0.3 2.8 1.5 1.8 4.3 2.9 1.7 1.4 2.2 8.6 1.9 2.2 1.6 9.9 31.9 1.7 0.6 1.5 0.8 5.3 3.2 1.2 0.7 8.7 1.0 0.4 0.7 4.0 2.3 1.5 0.6 4.4 0.9 1.1 1.8 1.4 2.8 4.5 1.3 4.1 1.7 3.5 2.6 0.3 1.6 1.1 1.4 3.1 2.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.9 2.2 2.1 2.5 6.2 1.0 0.3 0.3 0.1 0.0 0.0 0.0 1.4 0.1 0.3 0.1 0.1 0.5 0.0 0.0 0.2 0.6 0.1 0.0 2.1 0.0 77.9 1.0 0.6 0.5 0.3 1.6 7.1 0.0 0.0 0.2 1.6 0.0 0.0 1.4 1.4 0.0 0.4 4.9 2.2 0.0 0.1 0.2 0.0 7.1 1.4 0.0 0.1 1.2 0.9 0.1 8.7 2.8 0.3 1.0 0.0 0.0 0.0 0.0 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 2.5 1.5 1.8 1.7 0.6 1.2 0.7 2.3 2.6 0.0 0.0 0.0 0.1 0.3 0.3 9.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 3.9 4.5 0.0 0.0 0.0 0.2 3.1 0.2 3.5 0.0 0.6 0.0 0.0 3.1 0.0 2.2 1.4 0.0 1.7 0.0 0.0 1.3 0.2 0.0 1.8 0.0 0.0 0.0 1.6 3.0 1.3 0.1 0.2 0.0 0.0 0.2 ADAMTSL1 "ADAMTSR1, C9orf94, FLJ35283" ENSG00000178031 "ADAMTS like 1" Q8N6G6 9 17906563-18910950 "Predicted intracellular proteins, Predicted secreted proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 50.7;retina: 39.3" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 4.5;Leydig cells: 4.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 35.1;HSkMC: 17.8;hTEC/SVTERT24-B: 18.4;LHCN-M2: 18.1;TIME: 57.9;U-138 MG: 28.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057437, HPA074973" Uncertain Approved Vesicles "Secreted in other tissues" NA NA 74000000 Vesicles "HPA057437: AB_2683440, HPA074973: " "unprognostic (4.64e-2)" "unprognostic (2.41e-1)" "unprognostic (3.95e-2)" "unprognostic (7.21e-2)" "unprognostic (2.45e-3)" "unprognostic (1.89e-1)" "unprognostic (1.52e-2)" "unprognostic (7.77e-2)" "unprognostic (2.01e-4)" "unprognostic (3.66e-2)" "unprognostic (1.21e-1)" "unprognostic (6.41e-2)" "unprognostic (7.29e-3)" "unprognostic (2.58e-2)" "unprognostic (1.87e-1)" "unprognostic (6.59e-2)" "unprognostic (1.50e-2)" 6.3 7.6 0.5 5.9 0.8 0.0 4.4 3.9 1.5 14.3 5.2 0.6 6.5 1.6 50.7 12.0 9.0 5.2 4.4 2.9 1.6 1.0 3.4 1.0 1.9 2.2 0.4 1.2 4.9 1.3 0.1 3.9 0.8 0.9 8.4 4.6 39.3 3.1 5.6 0.5 2.0 2.7 13.3 0.7 0.9 5.0 2.3 0.0 0.0 2.0 1.7 1.5 2.8 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.3 0.0 5.1 35.1 0.0 1.0 4.5 4.1 9.5 0.0 0.0 0.0 0.0 12.3 1.5 0.0 1.8 0.2 12.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 17.8 0.0 18.4 0.0 15.9 7.7 0.0 0.0 0.0 18.1 0.0 0.0 0.0 1.6 0.0 0.1 0.0 2.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.9 28.2 0.7 0.7 4.1 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 3.9 1.5 1.6 1.0 0.4 1.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 4.5 0.8 1.3 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.1 0.0 0.0 1.3 0.0 1.5 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.4 1.9 0.9 0.1 0.1 0.0 0.8 0.0 ADAMTSL2 KIAA0605 ENSG00000197859 "ADAMTS like 2" Q86TH1 9 133532164-133575519 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 30.4;heart muscle: 36.4" "Cell type enhanced" "Detected in some" 9 "Distal tubular cells: 5.0;Intestinal endocrine cells: 5.1;Ito cells: 8.0;Leydig cells: 4.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Hep G2: 5.9;RPMI-8226: 8.2;SH-SY5Y: 25.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA045634, HPA053812" Approved Approved Vesicles "Secreted in other tissues" NA NA 67000000 Vesicles "HPA045634: AB_2679399, HPA053812: AB_2682271" "unprognostic (5.10e-2)" "unprognostic (1.50e-2)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.35e-2)" "unprognostic (1.07e-1)" "unprognostic (5.50e-2)" "unprognostic (6.78e-3)" "unprognostic (1.31e-2)" "unprognostic (5.49e-2)" "unprognostic (1.35e-1)" "prognostic favorable (6.70e-4)" "unprognostic (5.17e-2)" "unprognostic (7.37e-2)" "unprognostic (1.56e-1)" "unprognostic (3.40e-1)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" 3.6 30.4 5.5 1.8 5.4 0.7 0.9 6.4 9.3 1.6 1.6 8.8 0.9 2.4 1.9 4.9 1.8 1.8 11.0 36.4 4.7 4.0 15.1 24.8 11.3 6.8 5.7 4.9 6.9 7.9 1.4 8.6 2.6 9.9 4.3 1.1 4.5 5.4 3.8 5.5 0.9 2.6 1.8 5.1 3.5 2.3 3.2 6.8 0.0 6.5 1.3 1.3 2.2 6.0 0.3 0.2 1.0 0.2 0.4 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.5 0.4 0.0 0.9 0.6 8.2 0.0 0.0 1.2 25.7 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.3 0.7 0.3 0.8 0.4 0.0 0.2 0.0 0.3 5.5 5.4 6.4 9.3 4.7 4.0 5.7 4.9 9.9 6.8 0.0 0.3 0.0 0.1 0.1 1.8 2.0 0.0 0.0 0.0 1.8 0.0 0.0 5.0 0.3 0.0 1.6 0.0 0.0 0.0 0.1 1.4 0.1 0.0 0.9 0.2 0.0 5.1 8.0 0.0 0.7 4.4 0.2 0.0 0.0 0.0 0.2 0.2 0.0 2.8 0.6 0.3 6.5 1.6 0.0 0.2 0.3 0.0 0.0 0.7 0.1 ADAMTSL3 "KIAA1233, punctin-2" ENSG00000156218 "ADAMTS like 3" P82987 15 83654086-84039842 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 131.0;Alveolar cells type 2: 92.7;Ciliated cells: 103.1;Club cells: 111.5;granulocytes: 58.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "EFO-21: 12.3;hTERT-RPE1: 3.7;RPTEC TERT1: 14.3;TIME: 13.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA034773, HPA034774" Uncertain Uncertain Vesicles "Secreted in other tissues" NA NA 110000 Vesicles "HPA034773: AB_10601965, HPA034774: AB_2674326" "unprognostic (2.20e-1)" "unprognostic (1.37e-1)" "unprognostic (2.98e-2)" "unprognostic (1.07e-2)" "unprognostic (1.56e-1)" "unprognostic (9.89e-2)" "unprognostic (4.07e-2)" "unprognostic (3.27e-1)" "unprognostic (9.18e-3)" "unprognostic (5.92e-2)" "unprognostic (9.97e-2)" "unprognostic (3.85e-1)" "unprognostic (8.59e-3)" "unprognostic (5.00e-3)" "unprognostic (4.62e-1)" "unprognostic (8.64e-2)" "unprognostic (3.95e-5)" 6.9 5.0 1.5 6.2 2.9 0.0 5.3 2.8 2.8 8.7 14.3 4.4 1.8 1.5 12.0 3.7 5.4 5.6 4.7 15.9 3.1 1.3 3.8 12.1 10.6 1.5 5.1 2.9 2.0 12.9 1.1 2.6 12.0 7.2 8.1 3.7 19.9 4.7 8.7 2.6 2.2 3.1 26.8 3.6 2.0 7.5 2.9 4.2 0.2 4.6 2.2 0.5 8.0 13.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.9 0.0 14.3 0.0 0.0 0.0 0.2 0.2 0.0 1.4 0.0 0.0 13.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.9 2.8 2.8 3.1 1.3 5.1 2.9 7.2 4.2 131.0 92.7 0.0 4.4 6.3 0.1 6.1 0.0 103.1 111.5 1.8 0.0 0.1 0.0 0.4 12.0 3.6 0.0 0.0 1.9 0.1 1.6 1.8 58.1 8.6 0.2 6.4 0.0 1.3 0.6 13.4 45.8 0.6 0.0 0.0 0.0 0.0 1.5 0.0 15.9 0.6 0.2 25.8 0.5 1.8 1.3 1.0 0.1 0.0 0.0 1.7 ADCYAP1R1 "PAC1, PAC1R, PACAPR" ENSG00000078549 "ADCYAP receptor type I" P41586 7 31052461-31111479 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.2;fallopian tube: 25.1" "Group enriched" "Detected in some" 5 "Leydig cells: 10.6;Peritubular cells: 5.3" "Cancer enriched" "Detected in some" 11 "glioma: 45.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 5.6;NTERA-2: 7.3;SCLC-21H: 6.2;SH-SY5Y: 11.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030739, HPA049877" Enhanced Enhanced Vesicles NA NA Vesicles "HPA030739: AB_2732461, HPA049877: AB_2680928" "unprognostic (5.43e-2)" "unprognostic (1.16e-1)" "unprognostic (2.16e-2)" "prognostic favorable (5.78e-4)" "unprognostic (2.17e-1)" "unprognostic (8.36e-2)" "unprognostic (4.93e-2)" "unprognostic (5.75e-2)" "unprognostic (3.50e-2)" "unprognostic (3.88e-1)" "unprognostic (1.58e-1)" "unprognostic (6.67e-3)" "unprognostic (6.43e-4)" "unprognostic (1.09e-3)" "unprognostic (9.55e-2)" "unprognostic (3.85e-2)" "unprognostic (2.75e-4)" 5.4 10.6 23.6 2.7 24.2 0.9 2.9 13.7 71.2 12.8 2.7 13.4 0.0 1.6 5.4 2.3 3.3 25.1 2.0 2.8 22.1 21.6 1.0 1.1 1.6 1.0 19.0 20.2 1.9 2.2 2.9 4.4 1.0 18.7 2.1 2.0 0.0 2.6 3.7 1.9 1.8 2.0 3.9 6.5 1.3 1.6 2.2 13.3 0.0 2.3 0.9 1.6 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 11.1 0.0 0.0 0.0 2.2 0.0 0.0 0.3 0.9 1.3 0.2 0.1 0.0 0.0 0.0 1.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.6 24.2 13.7 17.3 22.1 21.6 19.0 20.2 18.7 13.3 0.0 0.0 0.0 0.0 0.5 1.2 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.6 0.0 1.7 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.2 0.0 1.4 0.0 1.5 0.3 0.0 0.0 0.0 0.0 ADHFE1 "ADHFe1, FLJ32430" ENSG00000147576 "Alcohol dehydrogenase, iron containing 1" Q8IWW8 8 66430185-66471601 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 44.5" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 32.1;Syncytiotrophoblasts: 97.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 4.6;HHSteC: 3.0;HSkMC: 2.7;hTERT-RPE1: 2.9;RPTEC TERT1: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023062 Enhanced Approved Vesicles NA NA Vesicles "HPA023062: AB_1844611" "prognostic favorable (5.76e-5)" "unprognostic (8.69e-2)" "unprognostic (6.71e-2)" "unprognostic (2.70e-1)" "unprognostic (1.14e-1)" "unprognostic (1.22e-1)" "prognostic favorable (9.90e-5)" "unprognostic (7.76e-3)" "unprognostic (2.88e-1)" "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (9.43e-2)" "prognostic favorable (4.55e-5)" "unprognostic (1.37e-2)" "unprognostic (2.06e-1)" "unprognostic (4.66e-2)" "unprognostic (5.94e-3)" 12.5 3.2 10.3 2.2 9.7 1.8 4.3 2.2 10.7 5.9 3.8 10.9 4.8 2.7 4.2 8.6 3.1 5.9 5.0 34.6 6.9 5.4 11.8 44.5 3.6 2.3 8.6 7.5 5.2 8.3 11.6 9.8 3.7 6.9 7.3 3.1 10.7 6.6 10.5 35.7 2.4 2.4 6.9 4.8 2.8 8.6 3.2 7.3 0.0 4.5 12.9 2.5 6.2 1.9 1.3 0.4 3.4 1.1 2.2 2.6 0.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.5 0.4 0.3 0.0 0.0 1.7 0.0 0.0 0.7 0.3 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.6 0.0 3.0 0.0 0.2 2.7 0.0 0.0 1.3 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.2 0.9 0.0 0.5 1.2 1.4 2.0 0.0 0.0 0.3 0.2 0.0 0.0 1.2 0.1 0.1 0.8 0.0 0.3 3.4 1.1 0.0 2.6 0.0 2.4 1.3 0.5 2.2 0.4 0.8 0.7 2.2 0.1 2.2 0.0 0.3 0.0 0.6 10.3 9.7 2.2 7.8 6.9 5.4 8.6 7.5 6.9 7.3 8.9 12.4 2.7 3.8 0.9 1.4 32.1 15.3 20.1 13.6 8.7 9.8 7.1 10.0 1.1 0.3 1.6 2.0 0.0 0.6 0.8 2.7 4.3 8.1 23.7 2.1 0.0 3.5 7.4 1.0 1.0 22.2 1.4 0.0 0.0 1.5 6.7 0.8 5.8 25.5 10.9 7.6 0.0 3.3 0.2 0.2 0.9 97.4 8.7 1.8 2.0 AGFG1 "HRB, RAB, RIP" ENSG00000173744 "ArfGAP with FG repeats 1" P52594 2 227472152-227561214 "Predicted intracellular proteins" "Differentiation, mRNA transport, Spermatogenesis, Transport" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 126.0;Late spermatids: 243.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008741 Approved Supported Vesicles NA NA 28000 Vesicles "HPA008741: AB_1850752" "unprognostic (5.76e-2)" "prognostic unfavorable (7.13e-4)" "unprognostic (8.73e-3)" "unprognostic (6.31e-3)" "prognostic favorable (6.10e-4)" "unprognostic (9.30e-3)" "prognostic unfavorable (7.31e-6)" "prognostic unfavorable (1.85e-4)" "unprognostic (1.30e-1)" "prognostic unfavorable (3.43e-5)" "unprognostic (2.03e-2)" "unprognostic (5.78e-2)" "prognostic unfavorable (6.92e-4)" "unprognostic (1.25e-1)" "unprognostic (2.37e-1)" "unprognostic (1.98e-1)" "unprognostic (4.24e-3)" 43.2 26.4 19.9 27.7 26.5 80.1 34.4 18.1 31.3 16.7 26.2 31.5 15.7 25.6 18.1 16.8 29.3 18.2 23.6 28.2 22.6 19.7 22.7 24.7 35.0 33.0 25.4 20.4 20.9 20.9 25.3 13.8 44.0 24.6 14.0 20.5 18.2 19.7 15.3 21.2 22.8 29.1 23.4 39.2 32.2 19.7 51.5 20.8 26.4 21.0 17.3 30.4 23.5 19.8 5.3 5.2 9.0 8.4 1.6 5.5 2.5 18.4 30.6 16.2 15.8 27.8 20.5 61.5 24.7 23.6 29.6 26.3 24.0 21.3 13.1 18.8 27.0 39.9 19.6 27.8 31.9 38.5 22.1 15.5 29.0 26.6 44.4 29.9 19.6 18.4 12.5 34.2 37.4 35.5 22.7 29.6 13.6 30.3 35.7 35.4 26.3 23.5 17.7 25.3 24.8 16.0 21.7 26.8 9.3 29.4 25.4 15.1 11.8 20.1 26.3 23.4 29.5 11.2 22.4 29.0 25.6 20.4 36.7 21.6 20.7 13.9 18.6 27.7 16.8 29.2 5.4 8.4 2.7 2.6 6.8 5.5 3.0 3.1 2.6 5.2 5.3 2.6 4.7 9.0 1.6 6.4 3.6 3.6 2.5 19.9 26.5 18.1 31.3 22.6 19.7 25.4 20.4 24.6 20.8 23.8 23.4 14.3 21.9 29.5 37.6 18.2 12.7 10.7 19.4 21.0 23.6 25.4 13.3 16.6 126.0 22.9 26.2 23.3 18.3 13.6 22.0 36.7 12.7 18.1 20.8 41.3 32.7 24.5 94.2 243.6 14.4 38.0 18.6 16.2 16.9 42.9 29.4 17.5 11.0 21.9 32.2 19.4 12.3 29.6 16.8 28.1 33.2 15.8 17.2 42.4 AGMO "FLJ16237, TMEM195" ENSG00000187546 "Alkylglycerol monooxygenase" Q6ZNB7 7 15200318-15562015 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 41.9;liver: 57.9" "Cell type enriched" "Detected in some" 5 "Hepatocytes: 79.7" "Cancer enriched" "Detected in many" 5 "liver cancer: 15.7" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "basophil: 3.6;neutrophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.6" "Cell line enhanced" "Detected in some" "HSkMC: 4.1;Karpas-707: 8.7;NTERA-2: 3.9;SCLC-21H: 3.7;TIME: 4.4;WM-115: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA057900 Uncertain Vesicles NA NA Vesicles "HPA057900: " "unprognostic (2.82e-1)" "unprognostic (9.28e-2)" "unprognostic (5.60e-3)" "unprognostic (1.44e-4)" "unprognostic (7.52e-2)" "unprognostic (1.07e-2)" "unprognostic (3.61e-2)" "unprognostic (6.56e-2)" "unprognostic (3.31e-1)" "unprognostic (3.35e-1)" "unprognostic (4.18e-3)" "unprognostic (3.24e-1)" "unprognostic (1.64e-1)" "unprognostic (2.04e-2)" "unprognostic (3.45e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" 6.8 0.2 0.8 1.0 1.2 0.1 3.7 0.3 0.5 0.3 16.5 1.1 0.1 4.6 0.3 7.3 0.3 0.3 4.7 0.9 0.7 0.6 5.3 57.9 0.4 0.5 1.1 0.8 0.3 0.3 0.0 0.7 0.4 0.7 0.4 0.3 0.0 0.4 0.1 0.5 0.5 41.9 0.1 1.1 0.3 0.3 1.8 2.0 0.0 0.7 0.1 0.1 1.0 0.4 0.2 0.1 3.6 0.1 0.6 0.1 0.0 0.0 2.5 0.1 2.2 0.2 3.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.1 3.9 0.0 0.0 0.0 0.0 1.3 0.0 0.7 3.7 0.0 0.0 0.0 0.0 2.9 0.0 0.0 4.4 1.5 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.0 17.2 3.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.1 3.1 0.6 0.0 0.1 0.0 0.0 0.8 1.2 0.3 0.4 0.7 0.6 1.1 0.8 0.7 2.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 15.3 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.7 0.1 2.6 0.0 0.0 0.1 0.7 0.0 0.0 79.7 0.1 0.0 1.7 1.3 1.3 0.9 0.0 0.1 3.3 0.0 0.1 0.0 0.6 0.0 0.0 15.2 0.0 6.5 0.2 0.4 2.5 0.0 0.1 0.0 0.6 0.0 AGTR1 "AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R" ENSG00000144891 "Angiotensin II receptor type 1" P30556 3 148697784-148743008 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 29.6;placenta: 44.9" "Group enriched" "Detected in many" 5 "Leydig cells: 134.3;Sertoli cells: 142.3" "Group enriched" "Detected in many" 8 "breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 64.4;ASC TERT1: 9.0;BJ hTERT+ SV40 Large T+: 12.3;HBF TERT88: 19.4;HSkMC: 11.7" "Low region specificity" "Detected in many" HPA003596 Enhanced Uncertain Vesicles NA NA Vesicles "HPA003596: AB_1845163" "unprognostic (2.19e-1)" "unprognostic (1.17e-1)" "unprognostic (8.78e-2)" "unprognostic (2.48e-4)" "unprognostic (5.28e-3)" "unprognostic (1.55e-1)" "unprognostic (3.46e-1)" "unprognostic (1.28e-2)" "unprognostic (3.26e-2)" "unprognostic (3.08e-2)" "unprognostic (9.25e-3)" "unprognostic (4.11e-2)" "unprognostic (4.79e-2)" "unprognostic (3.21e-3)" "unprognostic (1.46e-1)" "unprognostic (2.54e-1)" "unprognostic (5.41e-3)" 18.8 11.6 0.0 0.1 0.0 0.0 10.8 0.0 0.0 0.8 5.5 0.0 0.6 0.5 0.5 2.2 1.6 3.1 0.0 0.1 5.7 29.6 2.6 0.0 0.9 0.8 0.6 0.6 0.8 44.9 1.3 1.0 1.0 1.0 2.9 4.4 0.7 1.1 0.0 2.3 1.7 0.2 4.1 0.0 4.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 64.4 9.0 0.0 0.0 1.3 12.3 7.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 1.1 0.6 0.3 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 3.1 0.0 5.7 5.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.2 0.0 0.0 6.6 0.2 13.7 1.2 0.0 26.8 0.6 0.0 22.7 29.4 0.8 0.2 134.3 0.0 1.7 0.0 0.0 4.5 0.8 0.0 7.1 0.0 0.0 142.3 15.5 0.0 0.4 1.5 0.2 0.0 0.0 0.0 AGXT "AGT, AGT1, AGXT1, PH1, SPAT, SPT" ENSG00000172482 "Alanine-glyoxylate aminotransferase" P21549 2 240868479-240880502 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Aminotransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 172 "liver: 247.3" "Cell type enriched" "Detected in many" 17 "Hepatocytes: 1878.6" "Cancer enriched" "Detected in some" 425 "liver cancer: 253.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "Hep G2: 13.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035370, HPA035371" Enhanced Supported Vesicles NA NA 5200000 Vesicles "HPA035370: AB_10673218, HPA035371: AB_2674593" "unprognostic (3.14e-2)" "unprognostic (2.58e-1)" "unprognostic (3.37e-4)" "unprognostic (1.04e-1)" "unprognostic (1.23e-2)" "unprognostic (9.56e-2)" "prognostic favorable (5.92e-5)" "unprognostic (8.28e-2)" "unprognostic (2.77e-1)" "unprognostic (5.39e-2)" "unprognostic (1.55e-1)" "unprognostic (7.57e-3)" "unprognostic (2.54e-1)" "unprognostic (9.22e-2)" "unprognostic (1.37e-1)" "unprognostic (3.26e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 247.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 13.4 0.0 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.1 0.0 0.8 2.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.8 28.1 0.0 0.0 7.0 0.0 0.5 19.9 0.0 0.0 0.0 2.6 46.7 1.6 22.7 0.0 0.5 0.0 1878.6 0.2 0.0 8.6 45.4 38.8 0.0 0.9 0.0 0.0 0.0 3.9 0.0 0.2 7.0 0.4 108.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 8.2 1.2 0.0 AKAP7 "AKAP15, AKAP18" ENSG00000118507 "A-kinase anchoring protein 7" "O43687, Q9P0M2" 6 131135666-131283535 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 39.4;pancreas: 37.5" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 124.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NTERA-2: 19.4;RPTEC TERT1: 17.0;RT4: 18.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027172, HPA027200, HPA028327" Approved Approved Vesicles NA NA Vesicles "HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353" "unprognostic (2.83e-2)" "unprognostic (2.70e-1)" "unprognostic (2.88e-2)" "unprognostic (1.45e-3)" "unprognostic (4.57e-2)" "unprognostic (1.24e-1)" "unprognostic (1.93e-1)" "unprognostic (2.70e-2)" "unprognostic (4.41e-1)" "unprognostic (1.18e-1)" "unprognostic (3.89e-1)" "unprognostic (1.54e-1)" "unprognostic (1.32e-3)" "unprognostic (2.52e-1)" "unprognostic (6.03e-3)" "unprognostic (2.53e-1)" "prognostic favorable (2.56e-4)" 5.7 39.4 16.1 6.2 11.2 6.3 4.7 16.6 15.4 6.0 12.9 4.9 4.1 19.9 4.5 4.1 3.0 4.9 6.8 4.4 12.0 9.9 5.6 15.7 6.2 11.6 8.1 11.7 7.2 37.5 3.1 3.5 2.8 7.2 10.0 13.3 2.9 3.4 4.8 9.8 2.3 12.4 5.2 6.2 6.2 3.7 5.8 6.4 18.9 4.2 2.1 5.5 8.6 4.3 4.4 1.8 9.5 3.4 3.2 14.9 5.0 0.8 1.5 5.6 2.7 3.1 6.7 3.9 2.3 3.8 4.0 5.3 1.9 1.5 0.1 4.4 4.0 3.0 0.0 1.6 2.5 2.9 0.0 2.3 5.6 1.8 8.3 4.5 0.2 1.8 5.7 1.8 2.5 3.3 3.7 4.1 3.3 0.9 8.1 3.8 1.5 2.4 1.4 19.4 0.5 2.1 5.0 3.7 0.1 17.0 18.8 0.1 2.0 3.2 0.3 7.6 3.4 1.3 11.7 1.4 1.9 2.6 5.3 5.8 7.6 0.0 1.3 4.5 5.7 4.2 9.5 1.5 0.2 6.8 2.9 10.5 2.6 9.4 9.1 1.8 4.4 14.9 9.3 0.4 3.2 3.4 0.1 3.2 5.0 16.1 11.2 16.6 15.4 12.0 9.9 8.1 11.7 7.2 6.4 17.9 7.8 10.9 7.0 5.6 20.9 9.0 124.9 1.4 2.3 5.2 15.7 6.4 16.6 21.9 3.9 4.8 14.7 23.3 3.6 8.3 5.9 6.7 10.4 34.7 7.7 7.9 1.2 8.0 11.0 1.3 7.8 9.3 1.7 0.0 14.4 37.6 2.7 31.5 5.3 15.2 11.5 0.0 6.9 3.5 9.1 3.6 3.9 17.5 16.6 3.7 ANAPC1 "APC1, MCPR, TSG24" ENSG00000153107 "Anaphase promoting complex subunit 1" Q9H1A4 2 111611639-111884690 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Cancer-related genes, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036329, HPA036330, HPA042998" Approved Approved Vesicles NA NA Vesicles "HPA036329: AB_10670714, HPA036330: AB_2675065, HPA042998: AB_2678263" "unprognostic (1.74e-1)" "unprognostic (5.04e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (1.34e-4)" "unprognostic (3.49e-1)" "unprognostic (2.15e-1)" "unprognostic (2.16e-4)" "unprognostic (1.23e-1)" "unprognostic (3.94e-2)" "unprognostic (2.59e-1)" "unprognostic (3.65e-2)" "unprognostic (1.23e-1)" "unprognostic (2.13e-2)" "unprognostic (1.94e-1)" "unprognostic (1.98e-1)" "unprognostic (1.15e-2)" "unprognostic (1.92e-1)" 4.9 4.4 3.2 6.1 4.4 4.3 5.8 6.0 4.6 4.9 6.0 5.6 5.6 2.5 6.5 5.2 3.4 4.5 3.5 3.2 3.8 4.0 4.1 7.5 3.0 6.7 5.3 8.7 4.1 4.8 4.1 7.3 4.7 3.7 7.5 5.2 5.5 4.8 2.9 6.0 4.5 6.5 3.9 8.4 5.4 4.9 6.3 5.6 0.7 3.0 6.4 8.7 4.5 18.4 13.1 14.8 10.3 6.2 8.3 14.5 11.2 8.0 13.8 12.1 26.2 11.9 31.3 9.1 10.0 16.5 15.8 22.2 12.2 17.5 14.0 12.6 33.6 12.6 14.1 6.4 36.5 12.1 5.7 5.8 20.3 19.1 6.9 12.5 15.6 31.5 13.8 9.3 7.7 21.1 9.2 22.3 7.5 11.3 22.1 17.2 17.9 7.5 17.7 12.1 7.1 11.4 10.1 9.6 10.3 6.5 12.4 8.8 11.4 13.0 9.7 11.5 10.7 21.3 28.7 9.6 15.4 9.8 0.0 2.7 0.7 5.9 3.0 8.7 6.3 5.3 5.0 5.6 4.2 8.6 7.3 0.5 6.4 2.4 2.2 2.3 4.5 3.0 8.0 19.3 15.5 12.7 10.9 6.9 7.6 6.7 3.4 3.5 13.7 10.4 5.0 5.4 5.0 8.8 5.2 0.0 5.1 11.0 8.0 13.2 8.1 11.4 7.8 19.1 10.9 8.0 8.9 6.3 9.5 9.1 6.8 5.4 11.1 7.1 5.8 3.5 8.9 7.7 15.3 12.9 10.3 18.1 19.4 17.7 5.6 13.8 13.8 18.6 ANKRD13B FLJ25555 ENSG00000198720 "Ankyrin repeat domain 13B" Q86YJ7 17 29589769-29614761 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.9" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 23.2;Horizontal cells: 15.9;Late spermatids: 30.2;Leydig cells: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.7;SH-SY5Y: 32.3;SK-BR-3: 24.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051886, HPA063748" Uncertain Supported Vesicles NA NA Vesicles "HPA051886: AB_2681652, HPA063748: AB_2685112" "unprognostic (1.61e-1)" "unprognostic (2.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.66e-2)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (3.10e-4)" "unprognostic (1.84e-1)" "unprognostic (1.84e-1)" "unprognostic (1.03e-2)" "prognostic favorable (7.58e-4)" "unprognostic (3.94e-2)" "prognostic unfavorable (5.92e-6)" "unprognostic (9.93e-2)" "unprognostic (1.18e-1)" "unprognostic (3.94e-2)" "unprognostic (5.36e-3)" 8.0 6.6 10.2 4.2 14.3 2.6 12.0 34.9 28.6 7.2 4.2 16.4 2.6 2.7 12.3 3.5 5.4 9.9 7.5 6.4 12.4 9.3 1.7 1.1 3.9 3.6 14.7 10.0 10.5 3.6 5.5 6.9 2.7 7.7 5.2 2.7 3.4 4.8 4.8 8.5 10.0 3.3 8.2 13.7 3.1 3.5 16.1 12.7 2.0 2.8 2.2 2.2 7.2 8.5 0.7 0.3 0.0 0.0 0.1 1.6 0.1 3.7 7.8 8.4 17.8 4.7 4.4 2.7 1.0 0.6 1.4 1.7 3.5 0.6 4.2 3.5 1.6 3.6 13.8 4.9 4.0 0.2 7.0 16.8 2.2 15.4 3.0 1.8 2.0 2.4 4.1 5.3 1.4 2.7 4.8 6.2 7.6 3.5 3.5 1.5 3.5 10.5 5.0 6.7 4.1 6.1 17.0 5.1 11.7 1.7 1.6 28.7 32.3 3.1 24.8 2.8 0.7 4.0 2.5 4.4 3.7 4.1 4.0 3.7 5.8 7.5 5.1 2.6 6.8 2.7 0.0 0.0 0.0 0.2 0.0 0.8 0.7 0.0 1.6 0.3 0.1 0.5 0.4 0.0 0.1 0.0 0.0 0.0 0.1 10.2 14.3 34.9 17.5 12.4 9.3 14.7 10.0 7.7 12.7 0.0 0.0 0.0 0.7 1.4 4.4 1.4 0.0 0.0 0.0 0.0 2.0 0.0 1.7 1.4 23.2 1.5 0.0 0.0 0.5 0.1 1.6 1.0 0.0 0.8 0.1 15.9 2.9 1.8 0.0 30.2 13.6 0.0 0.0 0.0 0.5 1.4 0.6 0.0 7.1 0.0 5.0 0.0 1.4 6.0 4.1 1.5 0.1 0.0 1.0 1.1 ANKRD2 ARPP ENSG00000165887 "Ankyrin repeat domain 2" Q9GZV1 10 97572499-97583884 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "skeletal muscle: 472.2" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 151.7" "Cancer enhanced" "Detected in many" "testis cancer: 5.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 18 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 18 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "A-431: 14.8;A549: 5.1;BJ hTERT+ SV40 Large T+: 5.5;HaCaT: 11.7;RPTEC TERT1: 13.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA040842, HPA040884" Enhanced Enhanced Vesicles NA NA Vesicles "HPA040842: AB_10963794, HPA040884: AB_10969453" "unprognostic (1.27e-2)" "unprognostic (9.99e-2)" "unprognostic (2.86e-1)" "unprognostic (1.39e-2)" "unprognostic (1.37e-1)" "unprognostic (1.61e-2)" "unprognostic (2.53e-1)" "unprognostic (5.60e-3)" "unprognostic (2.17e-1)" "unprognostic (3.12e-1)" "unprognostic (4.91e-2)" "unprognostic (2.22e-1)" "unprognostic (1.05e-2)" "unprognostic (3.69e-3)" "unprognostic (4.56e-2)" "unprognostic (1.39e-1)" "unprognostic (2.13e-1)" 2.3 0.2 0.1 0.0 0.2 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 1.2 2.7 0.0 0.1 47.2 0.0 0.1 1.6 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.1 0.3 472.2 0.4 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 3.0 1.2 1.1 0.3 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 14.8 5.1 0.0 0.0 0.2 0.0 0.4 0.7 0.0 5.5 3.6 0.2 4.6 0.0 0.6 0.1 0.3 11.7 0.0 4.0 3.7 0.1 0.2 0.0 0.2 0.0 0.4 0.0 0.0 0.6 1.7 3.3 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 13.1 0.7 0.0 0.0 0.0 3.8 0.0 0.3 1.8 0.3 0.0 0.1 1.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 151.7 0.0 0.0 0.0 3.5 0.0 0.2 26.6 1.2 0.4 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.6 0.0 1.8 2.2 0.0 0.0 0.0 2.2 3.2 0.3 0.2 0.0 0.0 0.1 ANKRD6 KIAA0957 ENSG00000135299 "Ankyrin repeat domain 6" Q9Y2G4 6 89433170-89633834 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.8" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 26.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 3.0;intermediate monocyte: 2.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 10.2;BEWO: 31.2;HAP1: 9.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB020693, HPA035694, HPA064642" Approved Enhanced Vesicles NA NA Vesicles "CAB020693: , HPA035694: AB_2674739, HPA064642: AB_2685310" "unprognostic (3.80e-1)" "unprognostic (3.16e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (1.36e-1)" "unprognostic (3.06e-2)" "unprognostic (2.91e-2)" "unprognostic (3.29e-2)" "unprognostic (4.95e-2)" "unprognostic (2.09e-1)" "unprognostic (7.84e-2)" "unprognostic (2.26e-1)" "unprognostic (1.81e-1)" "unprognostic (1.43e-3)" "unprognostic (2.28e-1)" "unprognostic (3.01e-1)" "unprognostic (2.10e-1)" 3.9 2.2 11.7 3.0 7.8 1.6 3.9 47.8 17.8 5.7 2.9 2.8 1.1 1.0 6.1 4.4 4.9 11.7 5.7 8.9 7.8 9.1 5.4 4.5 5.7 2.5 4.2 12.0 15.6 4.3 9.3 4.2 4.3 7.3 3.6 1.1 6.6 7.7 2.3 4.0 1.9 1.8 5.4 5.0 2.0 2.6 6.1 3.7 2.0 5.6 3.3 2.5 4.4 4.0 0.3 0.1 3.0 2.9 0.6 1.0 0.3 0.0 1.3 10.2 4.3 0.1 0.4 31.2 0.1 0.1 0.0 0.6 0.3 0.8 0.0 1.0 0.0 4.7 0.0 9.3 5.2 0.4 0.0 6.9 3.7 0.0 0.3 0.1 0.0 1.4 0.6 1.4 0.0 0.0 0.0 1.0 0.9 0.3 2.3 0.0 1.1 0.1 0.3 2.9 0.4 1.0 3.6 0.0 0.0 1.5 5.2 6.7 2.4 0.8 6.9 3.4 6.5 2.0 2.2 0.0 1.7 0.6 0.1 0.8 0.3 0.0 0.0 0.1 0.0 1.2 0.0 0.4 3.0 1.0 2.9 0.0 0.0 0.7 0.0 0.1 0.3 0.3 0.4 0.7 0.6 0.0 0.0 0.2 0.3 11.7 7.8 47.8 11.6 7.8 9.1 4.2 12.0 7.3 3.7 14.9 14.2 0.0 4.6 0.8 0.6 3.9 10.2 10.7 7.9 1.8 11.8 2.5 10.0 4.8 2.5 4.1 0.0 0.0 10.0 6.5 4.7 1.8 10.4 2.5 2.3 0.0 1.7 4.9 2.7 4.3 8.9 1.1 3.3 3.6 0.0 5.7 4.2 0.0 26.2 3.4 1.6 6.5 3.3 5.4 4.9 1.0 1.6 1.3 0.0 4.3 ANTXR1 "ATR, FLJ10601, FLJ21776, TEM8" ENSG00000169604 "Anthrax toxin receptor 1" Q9H6X2 2 69013178-69249327 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor Hypotrichosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Basal keratinocytes: 44.0;Fibroblasts: 78.7;Peritubular cells: 63.6;Smooth muscle cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 73.4;RH-30: 39.8;TIME: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054785 Uncertain Vesicles "Intracellular and membrane" NA NA 4100000 Vesicles "HPA054785: " "unprognostic (1.44e-1)" "prognostic unfavorable (5.76e-4)" "unprognostic (8.49e-2)" "unprognostic (4.77e-2)" "unprognostic (3.61e-1)" "unprognostic (4.34e-2)" "unprognostic (1.05e-1)" "unprognostic (6.93e-2)" "unprognostic (1.37e-1)" "unprognostic (4.15e-3)" "unprognostic (9.05e-3)" "unprognostic (1.15e-1)" "unprognostic (3.48e-3)" "unprognostic (2.26e-3)" "unprognostic (9.84e-2)" "prognostic unfavorable (1.22e-5)" "unprognostic (2.09e-2)" 27.5 25.8 10.0 10.1 14.9 0.1 21.1 11.0 9.6 33.4 14.2 23.6 8.5 4.9 35.7 13.5 14.0 20.7 51.5 18.8 17.0 10.1 6.1 3.1 20.1 4.4 19.4 6.5 45.5 3.1 30.5 10.4 32.3 23.6 21.7 8.8 37.2 13.8 23.0 12.4 17.9 8.9 30.4 21.4 11.7 7.4 6.6 16.7 2.6 17.5 10.4 6.7 29.1 24.5 0.0 0.1 0.1 0.0 0.2 0.4 0.0 6.9 8.7 7.7 4.8 35.8 17.5 0.1 11.4 23.2 12.1 9.7 0.0 0.6 0.0 6.7 30.0 7.3 6.6 5.3 6.8 11.4 0.0 4.3 1.8 19.4 2.2 15.8 1.5 1.0 28.4 2.7 12.0 7.5 30.3 3.3 4.0 1.1 0.0 73.4 3.1 4.2 0.1 7.3 0.0 5.7 0.0 39.8 0.1 3.0 6.1 4.4 19.6 22.1 0.1 7.8 4.5 2.3 0.4 49.9 15.4 12.9 15.4 12.0 0.0 0.0 0.0 7.9 1.3 6.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 10.0 14.9 11.0 9.0 17.0 10.1 19.4 6.5 23.6 16.7 6.0 21.2 0.0 16.2 44.0 0.7 5.1 0.0 5.3 7.9 0.0 0.0 0.7 0.0 1.2 30.7 2.9 0.0 0.0 2.3 0.7 78.7 8.7 1.1 0.0 3.4 0.0 0.0 4.9 0.3 28.8 39.4 2.7 23.6 1.0 0.0 12.0 1.2 0.0 63.6 0.0 0.4 19.4 53.6 5.4 2.0 20.6 1.1 0.0 0.0 8.1 AOAH ENSG00000136250 "Acyloxyacyl hydrolase" P28039 7 36512949-36724549 "Enzymes, Predicted secreted proteins" "Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.6;lymphoid tissue: 57.4" "Cell type enhanced" "Detected in many" 17 "Hofbauer cells: 31.1;Kupffer cells: 110.3;Macrophages: 54.2;T-cells: 51.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 54.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 4.1;NB-4: 21.3;THP-1: 16.3;U-937: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA021666, HPA026716" Approved Uncertain Vesicles "Secreted to blood" NA NA Vesicles "HPA021666: AB_2670799, HPA026716: AB_2671960" "unprognostic (3.55e-2)" "unprognostic (4.03e-3)" "unprognostic (4.45e-2)" "unprognostic (3.58e-1)" "unprognostic (6.06e-2)" "unprognostic (4.78e-2)" "unprognostic (2.40e-1)" "unprognostic (3.14e-3)" "unprognostic (5.42e-2)" "unprognostic (6.02e-2)" "unprognostic (3.36e-2)" "unprognostic (1.05e-1)" "unprognostic (1.46e-3)" "unprognostic (1.75e-1)" "unprognostic (1.92e-3)" "unprognostic (2.38e-1)" "unprognostic (1.35e-1)" 8.4 3.4 5.2 17.2 4.9 19.3 2.8 1.9 3.6 3.1 5.3 7.4 0.2 4.9 3.9 7.2 2.5 3.1 8.4 3.4 4.8 3.8 3.1 6.8 9.4 23.2 6.9 2.0 2.1 2.3 0.6 2.4 5.7 5.8 3.8 7.3 3.8 4.5 1.4 1.5 1.6 7.6 4.7 12.6 57.4 3.3 1.4 6.8 14.0 2.9 0.4 10.9 7.2 2.8 0.3 34.8 18.7 54.6 19.2 8.8 31.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.5 0.0 0.0 0.0 2.9 0.0 0.3 0.1 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.5 21.3 0.1 0.0 0.0 0.4 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 7.1 0.0 0.3 54.6 17.6 8.8 47.9 1.8 0.3 0.4 6.1 34.8 0.0 1.0 7.8 18.7 19.2 20.2 0.5 0.1 31.0 5.2 4.9 1.9 3.6 4.8 3.8 6.9 2.0 5.8 6.8 0.0 14.0 8.8 0.0 0.7 0.0 0.4 0.0 1.4 4.5 0.0 0.0 0.2 1.7 0.2 0.4 0.5 5.8 0.0 0.0 0.2 0.5 0.1 4.7 0.6 31.1 0.0 14.9 3.1 110.3 0.4 0.0 54.2 0.0 19.0 0.4 3.2 0.0 1.5 0.4 0.3 0.2 0.0 0.9 0.0 0.0 0.3 0.1 51.7 0.5 0.1 AP1M2 "AP1-mu2, HSMU1B, mu2" ENSG00000129354 "Adaptor related protein complex 1 mu 2 subunit" Q9Y6Q5 19 10572671-10587315 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Proximal tubular cells: 243.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "basophil: 5.6;neutrophil: 9.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 9.4" "Cell line enhanced" "Detected in many" "CACO-2: 35.0;Hep G2: 62.5;MCF7: 53.9;OE19: 31.5;RT4: 33.6;U-2 OS: 35.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA054999 Supported Vesicles NA NA Vesicles "HPA054999: AB_2682666" "unprognostic (8.31e-2)" "unprognostic (2.38e-1)" "unprognostic (1.87e-1)" "prognostic favorable (2.07e-4)" "unprognostic (2.07e-1)" "unprognostic (7.76e-2)" "unprognostic (2.11e-3)" "unprognostic (4.83e-2)" "unprognostic (1.93e-1)" "unprognostic (2.49e-2)" "unprognostic (2.65e-1)" "unprognostic (2.23e-2)" "prognostic favorable (3.73e-6)" "unprognostic (1.80e-2)" "unprognostic (8.10e-2)" "unprognostic (2.05e-2)" "unprognostic (1.06e-1)" 1.6 0.2 1.0 6.1 0.7 0.0 9.1 0.6 0.8 7.5 24.5 0.8 44.4 17.3 1.8 20.4 22.2 12.9 34.4 0.6 0.6 0.3 37.3 1.2 10.5 0.6 0.6 0.6 4.7 33.5 16.0 16.1 31.5 0.8 12.5 17.7 0.6 28.4 36.4 1.2 15.3 38.2 1.1 0.6 0.6 20.4 10.3 0.6 3.0 36.6 17.5 14.2 9.6 7.7 0.0 0.3 9.4 1.7 0.0 0.2 3.7 28.6 14.5 0.0 2.1 0.0 0.0 13.6 0.0 0.0 0.4 0.3 35.0 16.9 0.0 13.6 0.2 9.1 20.0 0.0 22.3 0.6 0.1 0.2 1.3 10.2 62.5 0.2 0.0 0.1 0.0 17.0 0.8 0.0 1.0 0.0 0.0 0.0 0.1 0.2 53.9 0.1 0.3 6.5 31.5 0.0 0.5 1.9 0.1 0.5 33.6 14.1 0.0 0.0 24.8 0.1 7.6 25.5 0.0 0.0 0.1 35.3 0.2 0.4 0.0 0.1 0.2 0.0 0.0 0.0 5.6 0.5 3.5 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 9.4 0.0 1.7 0.2 0.0 3.7 1.0 0.7 0.6 0.8 0.6 0.3 0.6 0.6 0.8 0.6 26.8 33.3 1.5 17.0 6.2 0.0 0.2 38.2 36.1 26.1 82.0 0.0 109.1 116.0 116.3 36.2 0.7 123.3 0.0 102.6 79.6 2.0 40.6 2.3 0.0 8.5 0.0 71.4 0.6 0.6 14.9 1.4 0.0 3.3 2.8 88.2 0.0 104.4 116.8 0.7 243.3 0.0 0.0 0.9 10.7 2.4 11.4 55.3 3.5 112.5 36.0 AP1S3 ENSG00000152056 "Adaptor related protein complex 1 sigma 3 subunit" Q96PC3 2 223751686-223838027 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "ductus deferens: 50.0;epididymis: 64.5;seminal vesicle: 39.6" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 60.9;Cytotrophoblasts: 43.1;Urothelial cells: 65.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 8.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 56.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066782 Approved Supported Vesicles NA NA Vesicles "HPA066782: AB_2685720" "unprognostic (9.45e-3)" "unprognostic (1.79e-1)" "unprognostic (7.52e-2)" "unprognostic (5.80e-2)" "unprognostic (4.37e-2)" "unprognostic (4.89e-1)" "unprognostic (1.65e-3)" "prognostic unfavorable (3.36e-5)" "unprognostic (1.81e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (2.08e-5)" "unprognostic (1.56e-1)" "unprognostic (2.33e-1)" "unprognostic (2.50e-2)" "unprognostic (1.90e-1)" "unprognostic (2.32e-2)" "unprognostic (4.61e-2)" 1.9 1.4 1.6 5.4 3.0 1.8 1.6 2.2 1.9 1.6 1.8 0.2 50.0 3.1 0.8 64.5 5.8 1.7 7.6 1.0 2.3 1.7 7.0 1.9 5.2 3.8 1.1 1.0 0.8 5.1 3.3 6.8 4.6 0.9 2.5 2.0 1.9 4.1 39.6 0.5 1.6 4.1 0.9 1.0 3.1 6.2 1.1 0.4 0.8 10.5 3.1 5.7 8.1 2.9 8.8 5.3 4.9 0.5 0.7 1.6 0.7 9.1 8.6 1.0 3.3 0.5 0.2 4.7 3.8 0.9 1.9 1.7 56.2 7.1 3.6 3.2 0.5 2.0 15.1 2.7 10.4 2.9 5.2 4.4 0.4 13.8 5.7 0.2 1.1 0.4 0.1 11.3 3.4 12.0 4.1 1.3 2.0 0.5 0.8 1.1 3.8 0.1 0.2 1.2 10.5 6.1 1.3 0.0 1.5 17.8 18.0 2.5 0.8 2.0 3.7 1.3 2.2 1.8 1.7 0.7 0.4 2.0 1.0 3.0 3.6 3.1 9.8 1.3 0.4 2.1 4.9 0.5 0.4 1.1 0.3 0.8 8.8 0.5 0.4 2.2 3.5 0.4 0.7 1.9 0.7 0.2 5.3 1.6 0.7 1.6 3.0 2.2 1.9 2.3 1.7 1.1 1.0 0.9 0.4 32.8 7.0 9.5 25.9 3.8 3.2 1.2 0.0 5.3 10.3 10.4 60.9 43.1 8.3 15.5 0.0 1.4 3.8 0.0 16.0 1.5 2.3 25.3 3.5 0.4 4.2 6.4 2.4 0.0 1.9 0.0 0.3 3.4 3.3 11.8 3.2 1.5 29.8 2.9 0.0 2.8 6.2 0.0 1.4 0.2 2.4 3.6 11.0 5.9 3.4 65.3 AP2A1 "ADTAA, CLAPA1" ENSG00000196961 "Adaptor related protein complex 2 alpha 1 subunit" O95782 19 49766968-49807113 "Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Syncytiotrophoblasts: 202.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 15.8" "Lineage enriched" "Detected in all" 4 "monocytes: 15.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004306 Approved Supported Vesicles NA NA 300000 Vesicles "CAB004306: AB_2274034" "unprognostic (4.33e-2)" "unprognostic (1.52e-1)" "unprognostic (4.61e-1)" "unprognostic (7.18e-2)" "unprognostic (1.88e-1)" "unprognostic (1.23e-1)" "unprognostic (1.92e-2)" "unprognostic (5.85e-3)" "unprognostic (4.84e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (2.82e-2)" "unprognostic (2.38e-2)" "prognostic unfavorable (2.83e-9)" "unprognostic (2.63e-1)" "unprognostic (1.45e-1)" "unprognostic (7.90e-2)" "unprognostic (1.72e-3)" 26.5 37.8 23.7 21.7 34.3 40.9 19.8 32.2 58.6 18.4 15.9 22.2 11.5 22.3 25.2 13.1 23.0 23.0 17.9 23.7 21.5 22.0 15.2 31.7 15.3 23.7 20.1 28.2 26.1 22.5 10.3 15.1 29.4 37.6 15.3 9.7 16.5 16.5 18.8 39.6 26.2 22.8 19.8 18.1 22.8 15.8 48.5 14.6 15.5 13.2 14.3 13.5 20.1 18.0 1.1 3.9 3.4 15.8 2.0 1.8 3.0 23.5 34.1 11.8 27.2 21.2 26.0 24.1 28.0 19.2 17.4 18.3 17.5 15.0 10.6 10.7 28.9 14.7 21.5 8.9 20.2 7.4 16.6 20.1 15.6 22.9 18.8 23.4 12.5 26.3 40.8 14.7 19.3 10.1 15.6 20.6 17.7 38.9 14.8 16.4 18.6 13.7 16.6 12.1 22.4 35.2 15.6 27.8 13.4 10.3 30.0 9.0 12.1 30.8 21.4 11.6 13.2 18.0 17.8 28.3 45.4 25.2 18.9 19.8 22.1 27.1 11.1 31.9 18.4 19.0 0.2 3.9 2.6 1.8 10.9 1.3 1.1 1.1 1.1 3.9 0.9 0.9 1.1 3.4 2.0 15.8 1.2 1.5 3.0 23.7 34.3 32.2 58.6 21.5 22.0 20.1 28.2 37.6 14.6 0.0 2.9 15.7 14.9 12.2 41.4 2.6 20.4 0.0 3.4 14.0 41.2 70.4 10.0 14.6 99.3 14.7 36.5 70.0 25.5 27.7 28.2 13.1 9.2 33.4 27.7 47.7 2.4 41.1 43.1 126.6 49.5 20.9 18.6 22.6 13.0 29.2 22.9 17.5 58.0 39.5 27.5 58.2 26.8 43.5 56.7 12.2 202.1 27.1 19.5 19.0 AP2B1 "ADTB2, CLAPB1" ENSG00000006125 "Adaptor related protein complex 2 beta 1 subunit" P63010 17 35578046-35726409 "Cancer-related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Early spermatids: 401.9;Late spermatids: 548.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017631, HPA056733, HPA067983" Approved Supported Vesicles NA NA 680000 Vesicles "CAB017631: AB_2058201, HPA056733: AB_2683219, HPA067983: AB_2732777" "unprognostic (1.49e-2)" "unprognostic (4.04e-3)" "unprognostic (2.15e-3)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (3.01e-2)" "unprognostic (1.51e-3)" "unprognostic (2.64e-2)" "unprognostic (1.06e-1)" "unprognostic (4.73e-2)" "unprognostic (2.58e-2)" "unprognostic (2.50e-1)" "prognostic favorable (2.62e-4)" "unprognostic (1.70e-1)" "unprognostic (1.10e-1)" "unprognostic (3.25e-2)" "unprognostic (1.57e-2)" 20.1 19.9 36.6 16.3 51.3 18.6 27.6 32.8 59.0 27.8 29.8 35.2 17.0 15.1 20.0 33.1 13.1 22.9 20.2 30.3 36.8 36.1 32.9 16.0 23.6 16.0 35.5 39.9 28.7 15.4 75.6 30.0 30.6 40.7 20.0 39.0 21.8 18.7 25.3 23.3 13.1 16.7 26.1 37.0 18.4 21.6 45.3 27.4 18.5 31.5 10.6 20.1 19.6 21.5 12.6 10.7 15.8 15.4 9.5 19.4 10.3 41.7 53.6 27.7 32.3 45.6 50.2 11.8 21.5 33.0 31.7 34.3 29.9 36.6 20.3 19.2 40.1 39.7 39.9 37.7 61.7 45.4 24.3 34.9 27.5 39.2 16.3 26.2 26.5 19.4 31.9 24.5 32.1 48.8 36.4 49.9 26.8 41.7 29.5 49.6 8.4 25.6 12.9 22.2 22.6 38.6 21.6 39.4 14.9 40.0 24.2 22.7 27.9 26.7 9.5 29.4 67.5 38.6 17.9 49.5 24.2 22.3 26.1 32.2 12.5 22.6 19.2 30.9 19.7 25.6 15.0 11.3 15.8 16.6 15.4 17.8 12.6 14.9 14.9 10.6 11.5 6.9 8.7 13.3 9.5 15.1 10.7 19.4 10.3 36.6 51.3 32.8 59.0 36.8 36.1 35.5 39.9 40.7 27.4 14.9 14.2 41.9 22.8 27.6 64.4 50.6 76.5 16.0 37.5 106.4 53.0 23.8 99.5 100.1 401.9 39.3 44.4 233.6 104.0 33.3 37.1 29.2 40.4 56.8 38.2 65.2 68.5 71.2 50.5 548.2 54.4 27.4 15.1 41.5 60.3 48.9 130.3 52.9 64.3 61.5 38.2 58.2 20.0 197.7 60.9 12.8 27.5 41.5 67.8 20.9 AP3S1 CLAPS3 ENSG00000177879 "Adaptor related protein complex 3 sigma 1 subunit" Q92572 5 115841481-115914081 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049270 Uncertain Approved Vesicles NA NA Vesicles "HPA049270: AB_2680696" "prognostic unfavorable (1.22e-4)" "unprognostic (2.54e-2)" "unprognostic (8.05e-2)" "unprognostic (1.68e-2)" "prognostic unfavorable (3.33e-4)" "unprognostic (2.60e-2)" "unprognostic (3.83e-3)" "unprognostic (4.42e-3)" "unprognostic (1.36e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (1.13e-5)" "unprognostic (1.73e-1)" "prognostic unfavorable (9.57e-8)" "unprognostic (2.73e-2)" "unprognostic (3.62e-2)" "unprognostic (2.75e-1)" "unprognostic (1.64e-1)" 22.0 13.8 28.6 15.0 28.6 33.0 26.1 21.7 30.8 30.8 22.5 10.4 60.4 17.6 20.6 27.6 23.4 16.7 17.0 17.0 30.7 21.1 11.7 23.8 12.7 18.3 23.7 19.4 23.3 34.8 9.1 20.9 20.9 19.8 15.3 20.8 9.7 26.8 64.1 8.5 15.7 28.9 28.7 20.6 11.5 12.8 26.9 13.2 12.1 19.0 12.7 20.1 21.6 19.7 20.1 23.8 39.8 21.9 11.8 17.1 15.4 19.9 5.1 16.8 8.4 43.4 71.3 11.0 23.4 32.6 20.7 36.7 9.8 18.7 15.2 13.2 29.1 18.4 5.8 9.2 38.9 31.0 45.1 15.9 6.7 6.8 14.7 24.8 9.5 13.2 31.5 31.1 16.4 15.6 21.7 20.9 23.5 7.1 11.7 26.9 4.1 11.5 12.0 10.3 9.6 9.7 14.2 24.0 26.6 19.8 5.8 5.9 8.2 33.4 6.4 19.2 15.1 11.2 10.8 14.4 28.0 17.1 20.9 15.5 8.7 9.3 18.0 23.0 22.0 10.3 17.6 18.5 39.8 10.9 21.9 17.0 20.1 13.8 14.8 15.4 13.0 12.3 12.4 26.7 11.8 19.0 23.8 17.1 15.4 28.6 28.6 21.7 30.8 30.7 21.1 23.7 19.4 19.8 13.2 20.8 21.6 70.7 83.1 180.3 35.7 21.5 43.3 18.7 17.0 43.6 23.6 67.6 59.7 84.5 93.7 65.3 174.5 23.3 74.6 264.6 188.4 82.3 80.9 77.3 136.0 25.4 73.1 62.0 99.6 164.9 160.2 110.4 109.6 87.4 103.7 14.1 98.1 98.2 104.7 120.7 71.2 32.3 148.2 104.4 86.7 199.2 107.7 106.5 61.3 84.5 AP3S2 sigma3b ENSG00000157823 "Adaptor related protein complex 3 sigma 2 subunit" P59780 15 89830599-89894638 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049270 Uncertain Approved Vesicles NA NA Vesicles "HPA049270: AB_2680696" "unprognostic (1.46e-1)" "unprognostic (1.60e-2)" "unprognostic (1.18e-2)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "unprognostic (2.68e-1)" "unprognostic (3.78e-2)" "unprognostic (5.27e-2)" "unprognostic (3.03e-1)" "unprognostic (7.59e-2)" "unprognostic (1.22e-1)" "unprognostic (4.31e-2)" "prognostic favorable (5.55e-16)" "unprognostic (7.97e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (8.67e-3)" 18.0 20.9 18.4 7.9 20.2 6.7 14.3 16.8 24.7 13.5 13.2 20.4 13.4 7.9 9.9 12.6 15.3 13.2 12.8 22.2 16.6 19.4 27.3 29.3 11.6 8.6 19.8 14.6 15.2 20.0 36.4 17.3 15.3 19.2 11.5 14.4 21.6 10.8 16.6 43.3 9.5 12.8 13.2 20.1 11.5 10.8 10.9 12.8 12.2 19.4 9.2 12.8 11.7 8.9 6.0 10.1 13.9 16.4 7.2 7.4 7.8 5.1 24.7 13.3 13.9 26.9 18.6 11.2 22.9 29.5 29.6 24.1 10.5 13.6 4.6 20.7 15.1 19.7 12.1 22.5 12.8 23.4 19.6 11.3 14.2 11.1 13.6 11.2 6.1 8.8 12.4 16.0 8.2 16.6 16.3 15.2 12.0 11.1 13.0 19.0 11.2 10.2 3.2 14.7 26.5 4.7 6.0 13.4 9.5 16.7 14.5 10.1 8.9 27.0 16.7 15.7 29.4 10.5 5.3 6.3 16.0 7.7 24.5 7.5 11.2 34.8 11.2 14.1 7.3 9.4 3.9 14.6 6.9 5.0 13.0 7.3 3.9 7.0 7.1 10.1 6.0 5.6 3.9 13.9 7.2 16.4 6.8 7.4 7.8 18.4 20.2 16.8 24.7 16.6 19.4 19.8 14.6 19.2 12.8 11.9 19.1 6.9 3.7 3.0 18.3 15.3 12.7 10.7 14.8 5.2 33.4 8.1 8.3 11.3 2.1 4.4 19.6 0.0 14.0 3.6 4.7 5.4 8.1 13.9 5.7 17.5 13.8 8.0 10.3 2.5 6.6 8.3 8.5 15.4 11.7 13.7 11.8 14.4 7.1 10.9 28.2 0.0 5.0 11.5 6.8 2.5 5.4 5.2 14.2 3.2 AP4B1 "BETA-4, SPG47" ENSG00000134262 "Adaptor related protein complex 4 beta 1 subunit" Q9Y6B7 1 113894748-113905201 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 40.3" "Low region specificity" "Detected in all" "HPA028162, HPA028652" Approved Approved Vesicles NA NA Vesicles "HPA028162: AB_10610976, HPA028652: AB_10601451" "unprognostic (8.90e-2)" "unprognostic (2.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.40e-2)" "unprognostic (1.53e-1)" "unprognostic (5.01e-2)" "prognostic unfavorable (8.60e-7)" "unprognostic (3.45e-2)" "unprognostic (1.54e-2)" "unprognostic (8.34e-3)" "unprognostic (1.55e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (3.73e-6)" "unprognostic (5.08e-3)" "unprognostic (7.88e-2)" "unprognostic (3.12e-1)" "unprognostic (1.55e-2)" 9.5 8.8 11.5 18.3 19.1 23.3 11.4 23.1 16.7 12.4 13.3 14.1 4.1 16.4 12.5 18.5 12.2 10.5 12.6 11.0 12.2 11.4 9.2 8.2 9.5 16.4 15.3 13.2 16.1 14.1 8.1 19.7 7.6 13.4 9.4 16.8 14.0 10.7 8.3 13.0 13.9 13.6 11.9 14.2 20.0 10.6 10.5 14.7 13.7 11.6 7.7 17.2 9.9 12.5 11.8 12.8 14.0 10.9 11.7 16.6 9.3 6.5 5.9 6.7 6.8 10.2 8.5 3.8 6.0 5.6 7.8 9.6 4.0 4.5 12.8 9.7 7.6 4.4 5.9 7.5 7.8 9.7 10.2 6.2 10.4 9.3 5.3 5.8 11.5 10.6 9.9 3.9 15.4 9.7 4.9 13.5 13.0 7.5 11.5 10.1 40.3 9.1 12.0 5.9 4.5 11.9 8.9 13.5 7.4 7.7 3.3 6.7 5.0 7.0 11.2 4.3 6.1 3.7 9.3 12.3 9.6 8.5 10.5 11.5 9.2 8.9 14.2 14.5 15.1 14.7 14.0 10.0 8.2 15.5 10.9 16.6 9.7 12.3 13.2 12.8 11.8 13.9 12.0 1.1 11.7 8.3 9.3 10.3 9.3 11.5 19.1 23.1 16.7 12.2 11.4 15.3 13.2 13.4 14.7 3.0 7.9 3.4 3.5 3.2 7.4 7.0 2.5 2.7 12.5 3.5 29.5 3.3 1.7 6.7 3.1 7.1 6.2 70.0 23.4 3.3 4.4 2.9 2.3 3.0 4.8 7.9 2.9 6.2 9.7 1.5 2.6 6.1 6.8 3.6 4.3 3.9 10.4 6.0 4.6 3.0 20.3 12.9 5.6 11.6 8.9 3.1 1.4 15.0 6.9 2.7 AP4S1 "AP47B, CLA20, SPG52" ENSG00000100478 "Adaptor related protein complex 4 sigma 1 subunit" Q9Y587 14 31025106-31096450 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 40.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039963 Approved Supported Vesicles NA NA Vesicles "HPA039963: AB_10795240" "unprognostic (4.03e-2)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (2.43e-1)" "unprognostic (1.14e-1)" "unprognostic (8.00e-3)" "unprognostic (1.03e-1)" "prognostic favorable (7.44e-4)" "unprognostic (3.79e-2)" "unprognostic (8.62e-3)" "unprognostic (1.15e-2)" "unprognostic (3.02e-1)" "prognostic favorable (2.87e-6)" "unprognostic (2.20e-3)" "unprognostic (5.44e-2)" "unprognostic (7.75e-2)" "unprognostic (5.59e-2)" 4.2 6.1 16.6 5.8 18.4 4.8 8.2 15.9 22.2 6.0 6.6 5.9 4.0 3.3 7.3 6.6 4.6 7.0 6.4 8.2 12.2 10.8 7.2 5.6 4.9 10.7 8.5 11.3 10.8 8.0 6.5 7.7 6.3 9.0 5.8 3.9 4.7 5.0 6.5 11.0 4.1 3.8 7.6 7.3 6.9 4.0 16.5 7.3 4.5 8.3 2.4 6.9 5.5 4.4 5.5 4.6 7.0 4.8 11.5 8.8 2.4 7.8 11.2 9.7 2.7 4.2 7.4 7.7 5.1 9.3 8.4 8.7 10.7 13.0 9.1 5.2 6.5 6.5 8.8 6.4 8.9 14.4 7.7 3.7 13.4 4.3 16.8 8.6 11.9 8.2 5.8 5.5 8.2 11.5 5.7 10.0 6.5 6.8 6.3 10.0 11.2 7.8 6.7 11.5 9.1 9.6 8.2 8.9 1.3 9.5 11.3 5.3 5.7 9.3 4.8 13.8 7.0 10.3 5.8 7.8 6.8 5.8 4.7 4.6 7.7 14.2 13.3 3.9 3.8 4.9 7.0 1.8 3.0 3.7 4.8 5.8 5.1 5.7 4.5 1.8 5.5 5.3 6.7 3.7 11.5 3.7 4.6 8.8 2.4 16.6 18.4 15.9 22.2 12.2 10.8 8.5 11.3 9.0 7.3 8.9 7.7 5.1 5.6 3.1 11.2 9.6 7.6 9.4 2.3 5.2 29.5 7.5 5.0 6.8 13.9 5.1 3.6 0.0 4.1 4.4 5.8 3.4 7.0 4.0 6.6 6.4 5.8 11.1 4.5 11.7 6.4 6.6 3.3 6.4 2.3 8.0 3.5 3.7 8.1 6.1 22.8 6.5 5.8 40.9 7.3 2.5 9.6 4.9 4.5 3.9 APBA3 "mint3, X11L2" ENSG00000011132 "Amyloid beta precursor protein binding family A member 3" O96018 19 3750819-3761699 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045577 Approved Approved Vesicles NA NA Vesicles "HPA045577: AB_10964881" "unprognostic (3.47e-2)" "unprognostic (3.58e-2)" "unprognostic (5.00e-2)" "prognostic favorable (5.97e-4)" "unprognostic (1.69e-1)" "prognostic favorable (4.91e-4)" "unprognostic (6.64e-2)" "unprognostic (7.60e-3)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "prognostic favorable (1.51e-4)" "unprognostic (5.58e-3)" "unprognostic (2.67e-3)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "unprognostic (6.12e-2)" "prognostic favorable (1.83e-4)" 10.2 7.8 5.4 12.7 8.3 6.3 7.6 8.6 7.2 7.8 8.6 10.5 11.9 11.7 9.0 4.0 8.0 6.9 7.8 7.1 5.1 4.3 8.8 14.2 7.0 12.9 11.9 7.3 10.7 10.3 4.6 10.0 7.2 7.1 8.0 3.0 6.7 16.8 9.6 20.5 8.6 11.7 8.5 6.1 14.1 11.7 6.0 9.1 13.2 11.5 7.2 11.8 8.0 7.1 13.0 8.1 10.8 7.1 6.5 18.8 8.2 7.4 5.7 1.2 2.2 2.5 1.9 6.1 4.8 3.0 2.5 3.7 5.2 2.4 5.0 4.3 1.9 6.2 3.4 1.4 4.1 0.6 18.5 4.3 2.9 3.9 3.8 7.9 1.9 11.0 3.7 5.0 3.4 2.1 2.2 3.6 5.1 4.7 8.2 1.1 4.1 5.7 7.1 3.5 2.5 8.2 5.9 2.6 8.3 1.8 4.8 4.5 4.7 3.0 4.4 6.9 0.9 1.9 4.2 5.8 4.6 4.3 7.7 6.1 17.0 6.2 4.7 4.1 5.7 4.5 8.7 7.1 10.8 13.8 5.5 12.8 10.2 13.6 13.5 8.1 13.0 9.0 10.5 10.4 6.5 4.6 7.7 18.8 8.2 5.4 8.3 8.6 7.2 5.1 4.3 11.9 7.3 7.1 9.1 6.0 6.4 11.8 5.6 3.8 4.1 4.2 5.1 1.4 3.4 7.0 7.9 8.8 6.6 13.6 0.6 5.8 8.8 0.0 8.0 8.3 6.9 8.3 2.3 7.3 7.9 3.2 4.6 7.4 4.7 0.0 5.8 4.6 5.0 23.4 7.8 3.8 10.6 5.8 2.8 9.1 6.4 6.5 5.2 1.9 6.6 6.6 12.8 13.1 5.9 5.8 APLP2 "APPH, APPL2" ENSG00000084234 "Amyloid beta precursor like protein 2" Q06481 11 130069837-130144811 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "DNA-binding, Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "classical monocyte: 52.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039319 Approved Approved Vesicles NA NA 480000 Vesicles "HPA039319: AB_10673141" "unprognostic (2.83e-2)" "unprognostic (1.29e-1)" "unprognostic (2.06e-1)" "unprognostic (3.18e-2)" "unprognostic (1.24e-2)" "unprognostic (1.10e-2)" "prognostic unfavorable (3.37e-4)" "unprognostic (3.86e-2)" "unprognostic (2.33e-1)" "unprognostic (2.70e-2)" "unprognostic (3.12e-3)" "unprognostic (7.44e-2)" "prognostic favorable (1.33e-9)" "unprognostic (3.20e-3)" "unprognostic (4.95e-2)" "prognostic favorable (2.90e-4)" "unprognostic (4.42e-2)" 72.4 32.9 41.4 29.8 48.5 35.2 43.9 106.0 61.4 39.8 44.9 29.0 31.8 56.6 48.7 42.4 36.2 37.9 51.1 55.6 35.6 49.7 79.2 73.8 82.2 27.3 39.7 43.0 42.0 28.4 76.9 22.3 67.6 48.2 63.4 39.0 105.5 35.4 65.9 17.3 27.3 52.1 46.0 40.9 24.3 33.2 18.2 26.0 12.5 128.7 21.0 17.0 51.0 46.7 12.3 26.0 36.5 52.5 3.6 4.7 25.8 17.6 14.9 26.8 24.0 112.3 74.0 33.5 50.4 61.5 25.2 21.4 110.4 129.2 8.8 132.4 122.7 27.7 45.7 20.6 48.0 14.4 13.7 17.1 15.1 10.9 42.3 17.3 45.5 30.9 49.6 31.4 22.2 42.4 132.3 77.4 2.8 14.4 18.9 41.5 17.5 2.2 20.4 15.6 21.4 25.0 5.8 6.2 8.5 67.2 49.3 9.4 20.5 60.8 32.2 7.8 47.8 49.2 42.2 133.2 27.2 18.5 42.3 24.3 2.9 4.1 20.6 30.7 41.8 19.3 8.7 52.5 14.3 4.5 28.8 3.4 3.4 3.3 4.2 26.0 12.3 2.5 3.3 36.5 3.6 20.8 2.4 4.7 25.8 41.4 48.5 106.0 61.4 35.6 49.7 39.7 43.0 48.2 26.0 875.4 416.5 72.9 138.7 94.7 779.6 197.0 290.4 250.3 447.0 383.8 665.6 678.4 44.7 245.4 11.2 182.9 301.3 46.7 94.3 90.9 217.7 184.7 96.4 435.7 560.4 227.2 89.2 98.8 296.4 9.1 155.1 309.8 91.1 100.0 141.0 413.6 188.5 171.4 201.5 224.3 490.3 187.5 202.8 102.7 283.4 95.7 775.5 52.3 119.9 201.2 APOA4 ENSG00000110244 "Apolipoprotein A4" P06727 11 116820700-116823306 "Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 593.6" "Cell type enriched" "Detected in single" 618 "Hepatocytes: 61.8" "Cancer enriched" "Detected in some" 29 "liver cancer: 291.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 8.1;CACO-2: 8.2;Hep G2: 7.7;NB-4: 7.5;RPMI-8226: 12.0;SH-SY5Y: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA001352, HPA002549, CAB068250, CAB068251, CAB068252" Enhanced Approved Vesicles "Secreted to blood" NA NA 61200000000 140000000000 Vesicles "CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: AB_2665658, HPA001352: AB_1078179, HPA002549: AB_1078177" "unprognostic (8.81e-2)" "unprognostic (2.12e-2)" "unprognostic (1.75e-2)" "unprognostic (7.91e-2)" 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 293.8 0.0 0.0 175.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 93.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 593.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 3.3 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 APOE AD2 ENSG00000130203 "Apolipoprotein E" P02649 19 44905754-44909393 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" Heparin-binding "Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Hyperlipidemia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 226.8;liver: 508.1" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 7873.9;Hofbauer cells: 6293.2;Muller glia cells: 7584.1;Peritubular cells: 4660.8;Proximal tubular cells: 5645.5" "Cancer enhanced" "Detected in all" "liver cancer: 3183.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 167.1;CACO-2: 39.6;Hep G2: 77.6;HSkMC: 122.5;SK-MEL-30: 155.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008363, HPA065539, HPA068768, CAB069921" Enhanced Approved Vesicles "Secreted to blood" NA NA 51800000000 63000000000 Vesicles "CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029" "unprognostic (8.98e-2)" "unprognostic (2.32e-2)" "unprognostic (2.49e-2)" "unprognostic (5.28e-2)" "unprognostic (3.77e-2)" "unprognostic (7.25e-2)" "unprognostic (5.22e-3)" "unprognostic (6.13e-2)" "unprognostic (5.06e-2)" "unprognostic (4.13e-1)" "unprognostic (5.78e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (7.76e-2)" "unprognostic (1.64e-1)" "unprognostic (1.12e-3)" "unprognostic (4.13e-2)" 76.8 226.8 78.4 14.6 106.8 9.7 12.8 26.6 109.8 13.6 15.1 40.3 0.8 7.7 9.4 10.9 2.6 4.3 17.1 6.9 41.4 57.9 121.8 508.1 21.5 46.0 104.0 34.5 23.5 5.2 2.7 4.9 17.2 54.1 6.6 5.2 11.2 8.5 3.4 5.7 33.0 10.2 3.6 35.1 89.2 13.4 12.6 33.9 4.9 6.0 1.3 8.6 11.8 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.8 0.2 167.1 6.8 6.0 0.1 0.3 0.7 0.1 39.6 0.2 0.1 0.8 0.0 0.8 0.5 1.1 0.1 0.0 0.1 0.3 0.2 0.1 77.6 17.2 0.5 0.2 122.5 0.2 1.3 0.1 1.3 0.0 0.0 10.2 0.2 0.1 0.2 0.1 0.2 20.9 0.2 0.1 0.2 0.7 0.1 0.2 0.0 0.4 0.2 0.3 0.1 155.3 12.1 14.3 4.4 0.2 1.1 0.2 0.1 0.1 0.5 0.6 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 78.4 106.8 26.6 53.4 41.4 57.9 104.0 34.5 54.1 33.9 0.0 10.9 128.8 14.4 830.7 52.9 1.6 384.7 0.0 5.7 216.3 39.3 36.4 578.6 1.8 57.6 21.1 0.3 163.5 0.6 28.5 329.7 3.9 179.1 7873.9 6293.2 36.5 0.0 191.5 425.6 179.9 2434.6 240.8 2353.4 122.6 0.3 7584.1 0.8 0.0 4660.8 5645.5 238.0 219.9 382.4 13.0 8.5 1472.8 62.1 122.2 1.2 4.2 APOL4 APOLIV ENSG00000100336 "Apolipoprotein L4" Q9BPW4 22 36189124-36204840 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 7.9;Intestinal endocrine cells: 14.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 4.3;intermediate monocyte: 2.3;myeloid DC: 3.8" "Group enriched" "Detected in many" 5 "dendritic cells: 3.8;monocytes: 4.3" "Cell line enhanced" "Detected in some" "BEWO: 8.3;HDLM-2: 46.5;HSkMC: 7.6;K-562: 9.9;SCLC-21H: 21.4" "HPA049797, HPA055435" Uncertain Supported Vesicles "Secreted to blood" NA NA Vesicles "HPA049797: AB_2680887, HPA055435: AB_2682816" "unprognostic (2.73e-2)" "unprognostic (1.09e-1)" "unprognostic (1.70e-1)" "unprognostic (1.51e-1)" "unprognostic (5.31e-1)" "unprognostic (3.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.55e-1)" "unprognostic (1.91e-1)" "prognostic favorable (3.45e-4)" "unprognostic (1.33e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (2.00e-5)" "unprognostic (4.26e-2)" "unprognostic (3.69e-1)" "unprognostic (4.18e-2)" "prognostic favorable (2.40e-6)" 2.3 0.8 1.1 2.7 1.3 0.0 2.3 0.9 1.0 2.4 1.2 0.7 0.7 2.2 2.0 0.7 2.4 3.1 3.2 2.8 0.8 1.0 10.3 1.1 7.3 1.7 1.0 0.7 4.2 0.9 0.0 1.9 3.0 1.2 9.0 1.5 1.8 2.9 1.6 1.0 1.6 5.4 2.1 2.3 1.1 2.3 0.7 1.2 7.1 1.1 0.7 2.3 7.4 1.4 0.4 3.8 0.6 4.3 0.8 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.9 8.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 46.5 0.0 2.5 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.3 0.0 9.9 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.4 21.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 4.3 0.0 0.0 2.3 0.0 0.4 0.0 0.0 3.8 0.3 0.0 0.0 0.2 0.8 0.2 0.0 0.0 1.2 1.1 1.3 0.9 1.0 0.8 1.0 1.0 0.7 1.2 1.2 0.0 7.9 0.0 0.9 1.1 0.2 1.1 2.5 4.0 3.4 0.0 0.0 0.4 3.3 0.1 0.0 3.8 0.0 0.0 0.6 0.6 6.3 1.2 2.3 0.0 2.4 1.6 14.3 1.3 4.5 0.0 2.6 5.3 0.0 1.8 0.3 0.0 0.2 0.0 0.4 0.3 0.0 0.0 1.4 0.0 0.0 1.0 5.1 0.0 0.1 1.4 ARHGAP1 "CDC42GAP, p50rhoGAP, RhoGAP" ENSG00000175220 "Rho GTPase activating protein 1" Q07960 11 46677080-46700615 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004689, HPA008285" Approved Approved Approved Vesicles NA NA 16000000 Vesicles "HPA004689: AB_1078194, HPA008285: AB_1078195" "unprognostic (1.06e-1)" "unprognostic (2.73e-1)" "unprognostic (2.05e-3)" "unprognostic (5.19e-2)" "unprognostic (2.48e-2)" "unprognostic (9.07e-2)" "prognostic unfavorable (2.14e-4)" "unprognostic (1.34e-3)" "unprognostic (1.24e-1)" "unprognostic (7.96e-2)" "unprognostic (1.35e-2)" "unprognostic (4.94e-1)" "unprognostic (4.79e-2)" "unprognostic (4.13e-2)" "unprognostic (3.49e-2)" "unprognostic (2.55e-1)" "unprognostic (9.24e-2)" 39.9 23.0 17.5 21.3 24.0 17.5 25.8 9.5 30.1 35.6 23.9 42.9 13.1 15.2 43.0 23.9 36.8 31.0 40.2 63.3 23.0 14.8 19.8 19.4 17.9 22.0 17.5 17.7 32.6 17.0 18.6 16.7 32.0 17.1 36.3 20.0 33.8 21.6 39.3 15.1 26.9 19.5 58.5 18.1 29.0 21.4 21.4 24.1 21.0 20.0 16.2 27.2 59.5 27.1 7.9 17.1 18.8 33.4 11.6 14.3 10.3 7.1 18.1 9.1 12.8 45.3 33.4 10.7 15.9 16.3 14.7 13.5 10.8 9.5 10.5 8.7 32.6 13.3 18.0 7.2 24.4 11.1 7.2 7.8 11.5 9.3 12.7 14.9 9.7 17.2 44.1 15.3 11.3 14.2 15.3 12.6 8.7 7.5 9.9 17.9 26.0 6.5 9.7 23.4 24.8 9.4 7.8 13.0 15.4 14.0 27.2 3.3 10.4 14.6 22.8 6.1 13.8 28.6 11.2 15.7 27.3 8.5 32.1 16.0 10.5 11.5 7.9 25.6 16.5 12.7 12.0 16.3 15.6 14.3 28.2 10.2 7.7 11.3 12.1 16.1 7.9 9.9 11.2 18.8 11.6 33.4 17.1 13.4 10.3 17.5 24.0 9.5 30.1 23.0 14.8 17.5 17.7 17.1 24.1 17.9 18.9 18.8 13.8 7.6 11.2 45.2 10.2 2.7 12.5 27.9 25.5 21.6 3.3 19.3 0.3 14.3 20.6 0.0 24.3 27.0 18.9 11.0 18.5 24.6 25.1 15.9 18.7 26.4 23.4 0.9 21.9 15.1 8.5 22.6 29.7 9.4 21.2 17.5 33.2 10.9 14.0 58.2 42.0 3.2 3.4 11.4 13.8 19.1 17.2 14.4 ARHGAP11B ENSG00000285077 "Rho GTPase activating protein 11B" Q3KRB8 15 30624494-30638805 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 2.6;intestine: 2.7;stomach 1: 1.9" "Cell type enriched" "Detected in many" 5 "Erythroid cells: 93.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 17.9" HPA064479 Uncertain Uncertain Vesicles NA NA Vesicles "HPA064479: AB_2685272" 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.1 1.1 0.0 0.0 2.6 0.1 0.0 0.0 0.0 0.1 0.1 1.6 0.0 0.0 0.0 1.0 0.0 2.7 0.0 0.0 0.0 0.3 0.1 0.0 0.3 1.9 0.4 0.0 0.9 0.3 1.0 0.8 0.0 0.0 0.0 1.3 0.0 2.9 0.4 0.0 1.8 0.6 0.6 1.6 0.2 1.0 1.3 0.5 4.6 3.1 0.0 1.4 1.0 1.8 5.3 4.2 0.1 2.5 4.1 0.4 0.0 17.9 1.4 0.4 0.9 0.2 0.4 0.1 0.5 1.1 0.9 1.5 0.0 1.3 7.8 3.9 0.2 2.4 0.6 0.9 1.4 0.3 0.9 1.8 1.2 1.3 4.6 2.7 1.0 1.1 1.3 0.6 0.7 1.5 3.3 1.3 4.8 2.7 0.1 3.0 3.0 2.1 1.4 1.1 3.7 5.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.3 0.9 0.8 1.0 0.3 0.6 0.0 0.0 0.0 0.3 0.2 0.0 0.0 1.0 11.2 1.0 1.8 3.4 0.7 0.0 1.4 0.0 1.8 5.9 0.0 0.0 0.4 20.2 0.5 1.7 93.5 0.5 0.0 0.9 0.9 1.1 0.8 0.0 3.2 0.0 4.3 5.7 12.8 2.0 2.9 0.0 3.6 4.0 13.2 0.4 3.4 1.1 0.3 2.4 0.0 1.0 13.6 10.0 1.3 0.0 5.3 2.9 0.9 ARHGAP30 FLJ00267 ENSG00000186517 "Rho GTPase activating protein 30" Q7Z6I6 1 161046946-161069970 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.1;lymphoid tissue: 45.9" "Cell type enhanced" "Detected in many" 9 "granulocytes: 64.9;Hofbauer cells: 51.2;Kupffer cells: 65.0;Macrophages: 65.9;monocytes: 85.6;T-cells: 106.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 31.5;HL-60: 24.3;HMC-1: 34.3;Karpas-707: 25.5;MOLT-4: 19.7;THP-1: 24.2;U-266/70: 38.3;U-266/84: 25.3;U-698: 26.9;U-937: 19.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA036300 Enhanced Supported Vesicles NA NA Vesicles "HPA036300: AB_10601117" "unprognostic (7.31e-2)" "unprognostic (8.83e-3)" "unprognostic (7.46e-3)" "unprognostic (1.77e-3)" "unprognostic (7.41e-2)" "unprognostic (1.68e-3)" "unprognostic (3.05e-1)" "unprognostic (6.78e-3)" "unprognostic (1.94e-2)" "unprognostic (3.89e-2)" "unprognostic (7.91e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (9.78e-4)" "unprognostic (1.18e-1)" "unprognostic (1.08e-2)" "unprognostic (6.64e-2)" "unprognostic (2.65e-2)" 6.1 3.0 2.6 23.3 3.9 20.4 3.1 0.6 2.4 2.2 3.9 3.5 1.4 3.5 2.0 3.7 8.0 3.3 5.9 4.1 1.9 1.7 3.0 3.3 11.3 27.9 4.3 0.7 1.8 1.8 0.3 1.5 2.5 3.4 2.3 3.2 2.6 6.1 1.8 0.9 11.2 13.7 2.9 4.3 45.9 4.1 1.4 4.5 38.1 2.0 2.4 33.2 5.6 3.8 8.3 12.3 27.1 24.0 10.2 19.7 14.7 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 31.5 0.1 0.0 0.0 0.6 0.0 0.0 0.0 14.6 0.0 10.5 0.0 0.0 0.0 24.3 34.3 0.0 0.3 0.0 0.0 0.0 0.0 15.3 0.1 25.5 0.0 0.2 19.7 5.6 0.0 0.2 0.0 12.4 0.1 0.4 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.1 24.2 0.2 0.0 0.1 0.0 0.1 38.3 25.3 26.9 0.1 19.5 0.0 3.3 15.5 17.6 19.7 18.3 15.1 7.1 13.2 16.1 12.3 8.3 11.0 14.7 27.1 10.2 24.0 8.4 13.2 14.7 2.6 3.9 0.6 2.4 1.9 1.7 4.3 0.7 3.4 4.5 3.0 25.1 39.8 2.9 4.9 0.2 1.2 5.1 9.4 11.4 0.0 3.9 0.5 0.0 2.2 2.1 2.1 0.0 0.0 5.3 1.2 0.9 3.8 64.9 1.5 51.2 0.0 0.0 7.4 65.0 0.4 0.3 65.9 5.0 85.6 0.3 0.2 7.6 0.0 0.0 0.5 3.0 0.0 1.4 0.0 0.1 21.5 3.8 106.6 0.3 13.6 ARHGEF25 "GEFT, p63RhoGEF" ENSG00000240771 "Rho guanine nucleotide exchange factor 25" Q86VW2 12 57610180-57619379 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 17.5;Leydig cells: 23.0;Peritubular cells: 43.2;Sertoli cells: 25.8;Smooth muscle cells: 30.9" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 4 "amygdala: 26.2;cerebellum: 54.2;cerebral cortex: 47.7;hippocampal formation: 59.8;olfactory region: 39.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 22.8;RH-30: 49.9;SH-SY5Y: 22.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052016 Approved Approved Vesicles NA NA Vesicles "HPA052016: AB_2681695" "unprognostic (8.43e-2)" "unprognostic (4.24e-3)" "unprognostic (2.13e-3)" "unprognostic (6.95e-3)" "unprognostic (8.12e-2)" "unprognostic (1.99e-2)" "unprognostic (1.38e-1)" "unprognostic (9.18e-2)" "unprognostic (2.45e-2)" "unprognostic (2.39e-2)" "unprognostic (4.63e-3)" "unprognostic (2.51e-1)" "prognostic unfavorable (4.20e-7)" "unprognostic (1.41e-2)" "unprognostic (2.03e-1)" "unprognostic (6.82e-3)" "unprognostic (3.22e-3)" 10.4 7.6 26.2 6.1 11.1 0.5 10.5 54.2 47.7 15.4 41.1 3.6 19.8 6.3 40.0 27.0 17.9 24.3 13.9 11.5 59.8 10.5 4.6 1.7 7.6 3.6 7.5 39.3 22.6 3.7 4.9 7.8 5.8 11.2 23.5 12.0 6.1 7.9 49.2 6.3 3.5 10.3 40.7 8.9 7.9 15.0 4.6 6.2 0.0 4.2 3.7 3.1 21.8 16.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 15.9 9.9 0.0 0.0 1.3 4.8 14.1 6.3 7.8 1.9 3.0 1.3 4.1 8.7 2.9 0.1 6.1 0.2 5.3 4.3 5.3 2.7 2.1 4.1 4.6 0.0 7.4 4.5 1.3 2.8 0.4 22.8 2.4 0.7 5.6 6.1 4.6 1.1 0.9 0.1 10.2 0.1 0.1 0.0 49.9 0.2 0.3 0.2 9.3 22.7 0.9 0.4 1.7 5.9 1.6 3.2 0.0 5.7 5.5 3.7 1.7 12.9 1.9 0.0 4.8 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.2 11.1 54.2 47.7 59.8 10.5 7.5 39.3 11.2 6.2 0.0 0.0 0.0 1.8 1.8 17.5 12.3 0.0 0.0 1.2 0.0 2.0 0.1 0.0 0.7 0.2 2.1 0.0 0.0 1.2 0.4 8.7 0.7 0.0 0.0 0.4 7.9 0.0 10.4 0.0 0.2 23.0 0.0 0.0 0.0 0.0 3.5 0.5 0.0 43.2 0.3 2.8 25.8 30.9 0.5 1.1 1.0 0.2 0.0 0.0 0.4 ARV1 ENSG00000173409 "ARV1 homolog, fatty acid homeostasis modulator" Q9H2C2 1 230978981-231000595 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 92.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035709 Approved Uncertain Vesicles NA NA Vesicles "HPA035709: AB_2674744" "unprognostic (2.32e-1)" "unprognostic (4.69e-2)" "prognostic favorable (1.33e-4)" "unprognostic (3.29e-1)" "unprognostic (1.42e-1)" "unprognostic (9.95e-2)" "unprognostic (5.66e-2)" "prognostic favorable (3.27e-5)" "unprognostic (1.37e-1)" "unprognostic (1.12e-2)" "unprognostic (9.57e-2)" "unprognostic (9.82e-2)" "unprognostic (2.31e-1)" "unprognostic (4.82e-1)" "unprognostic (5.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.12e-3)" 8.2 16.3 22.0 10.1 31.0 10.0 16.1 17.1 24.3 11.0 20.0 16.5 13.9 13.8 8.1 20.6 13.6 12.3 17.0 24.2 23.8 21.8 21.0 20.9 12.5 11.0 22.7 17.7 9.8 14.9 18.4 25.8 9.4 22.0 14.0 21.6 15.4 16.9 13.4 15.7 14.6 15.6 10.7 27.1 10.5 13.7 24.6 18.2 11.0 18.4 16.8 11.9 12.7 9.3 15.3 13.9 7.3 17.7 12.5 14.0 8.3 20.0 21.8 10.9 13.0 15.9 13.9 10.2 9.4 17.5 17.4 20.1 8.0 15.7 5.8 11.8 10.9 10.7 16.5 20.5 12.8 20.7 14.7 28.8 17.9 15.8 10.8 16.2 26.3 14.6 15.0 13.5 9.4 10.9 11.3 11.6 18.0 26.3 15.9 11.4 7.0 10.7 8.0 14.0 21.2 14.8 12.7 16.2 16.4 23.2 16.5 11.4 17.3 11.3 13.4 27.8 2.7 24.0 23.5 6.4 6.9 4.4 12.6 22.6 24.6 21.6 14.4 18.9 23.0 18.8 6.4 7.6 7.3 9.8 10.8 13.3 15.3 11.0 11.7 9.1 10.1 13.8 12.7 1.9 12.5 17.7 13.9 14.0 8.3 22.0 31.0 17.1 24.3 23.8 21.8 22.7 17.7 22.0 18.2 14.9 24.8 20.9 19.1 11.4 19.4 26.9 7.6 17.4 18.2 27.9 2.0 32.5 51.4 20.9 26.0 11.9 11.7 46.7 35.3 12.7 17.5 14.6 16.2 17.9 21.8 36.5 7.5 12.3 11.5 14.7 8.6 14.3 23.6 9.0 15.0 28.4 17.4 10.5 15.6 24.2 13.2 0.0 14.4 92.9 16.8 13.2 13.0 7.9 27.4 16.2 ASIP "AGTIL, ASP" ENSG00000101440 "Agouti signaling protein" P42127 20 34194569-34269344 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.7;epididymis: 18.4;ovary: 24.8" "Cell type enhanced" "Detected in many" 13 "Cardiomyocytes: 25.4;Hofbauer cells: 12.3;Leydig cells: 11.5;Peritubular cells: 9.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 6 "hippocampal formation: 5.4" "Cell type enriched" "Detected in single" 321 "plasmacytoid DC: 43.7" "Lineage enriched" "Detected in single" 321 "dendritic cells: 43.7" "Cell line enhanced" "Detected in some" "CACO-2: 6.6;HSkMC: 5.4;SK-MEL-30: 3.9;U-698: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA048636 Uncertain Supported Vesicles "Secreted to blood" NA NA Vesicles "HPA048636: AB_2680471" "unprognostic (4.81e-2)" "unprognostic (7.46e-2)" "unprognostic (1.97e-3)" "unprognostic (3.26e-2)" "unprognostic (2.24e-1)" "unprognostic (3.07e-2)" "unprognostic (5.13e-2)" "unprognostic (4.57e-2)" "unprognostic (4.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.62e-1)" "unprognostic (1.48e-1)" "unprognostic (5.53e-6)" "unprognostic (1.02e-1)" "unprognostic (3.09e-1)" "unprognostic (1.27e-1)" "unprognostic (1.33e-1)" 0.5 0.1 0.3 0.3 0.3 0.2 1.9 0.3 0.8 2.0 1.0 0.3 0.3 0.0 2.0 18.4 0.3 2.1 0.3 10.3 5.4 0.0 0.3 0.5 0.3 0.4 0.3 0.3 24.8 0.3 0.0 0.3 0.3 0.7 2.5 0.0 0.3 0.3 0.3 0.3 5.4 0.3 0.3 1.3 0.3 0.1 7.1 0.3 0.3 0.3 0.3 0.8 0.5 0.4 0.1 43.7 0.0 0.0 0.0 0.0 0.2 0.1 2.4 0.9 0.8 0.5 1.6 0.2 0.2 0.0 0.0 0.0 6.6 0.1 2.4 0.5 0.7 0.0 0.4 0.0 0.0 0.0 0.2 1.6 3.4 0.7 1.1 0.0 0.0 0.9 5.4 0.0 0.0 0.0 0.3 0.0 1.6 1.2 2.0 0.0 0.7 0.5 3.5 0.0 0.3 1.4 0.7 0.6 3.0 0.0 0.2 0.6 0.6 0.0 0.4 3.9 1.1 0.7 0.4 0.8 1.2 1.2 0.2 0.6 0.8 0.8 4.0 0.5 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 43.7 0.0 0.2 0.3 0.3 0.3 0.8 5.4 0.0 0.3 0.3 0.7 0.3 0.0 1.1 0.0 0.0 2.3 0.0 25.4 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.0 1.0 1.3 0.0 0.0 0.0 0.1 2.3 0.0 0.0 4.0 12.3 0.0 0.0 4.3 0.3 0.2 11.5 1.7 1.7 0.0 0.0 0.0 0.1 0.0 9.9 4.4 0.0 6.5 1.0 1.6 1.3 2.8 0.7 0.0 0.0 0.0 ATG9A "APG9L1, FLJ22169" ENSG00000198925 "Autophagy related 9A" Q7Z3C6 2 219219380-219229717 "Predicted membrane proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 59.5;Late spermatids: 76.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA059551 Uncertain Supported Vesicles NA NA Vesicles "HPA059551: AB_2684060" "unprognostic (1.53e-2)" "unprognostic (4.03e-1)" "unprognostic (1.46e-2)" "unprognostic (5.04e-2)" "unprognostic (4.80e-1)" "unprognostic (1.92e-1)" "prognostic unfavorable (2.18e-5)" "unprognostic (8.99e-3)" "unprognostic (2.07e-1)" "unprognostic (3.55e-3)" "unprognostic (4.67e-2)" "unprognostic (4.21e-1)" "unprognostic (2.23e-2)" "unprognostic (4.84e-2)" "unprognostic (3.15e-1)" "unprognostic (5.61e-2)" "unprognostic (1.95e-2)" 13.9 14.3 15.2 9.0 26.1 23.3 13.2 26.7 37.9 12.2 15.0 23.8 10.0 17.1 14.9 9.4 17.6 10.4 13.3 23.4 14.2 13.2 12.6 21.0 13.6 10.2 18.5 14.0 12.9 16.7 27.0 10.8 20.3 20.6 12.8 14.3 12.5 14.0 14.9 61.3 17.5 19.8 18.0 14.3 13.0 13.0 47.0 16.3 7.8 13.1 16.6 12.6 14.7 12.3 5.0 6.6 8.8 16.8 8.4 7.6 8.5 9.6 12.7 9.9 22.9 20.5 21.6 12.8 18.0 21.3 25.3 23.1 19.2 13.5 2.4 14.5 29.5 20.3 21.5 16.2 20.7 19.3 7.8 24.6 19.4 32.8 22.0 20.4 5.2 14.9 21.6 34.4 26.3 24.7 23.1 25.9 6.3 26.4 9.9 17.5 12.6 4.2 10.8 6.9 9.6 10.1 5.7 13.2 9.8 14.8 14.3 15.3 8.9 18.2 16.9 15.9 21.1 6.2 12.5 17.5 25.2 11.7 10.2 16.2 5.3 5.0 4.0 20.5 12.1 13.6 4.8 9.4 4.3 6.2 14.4 6.6 5.0 4.9 7.6 6.6 3.4 4.7 5.5 8.8 8.4 16.8 2.9 5.6 8.5 15.2 26.1 26.7 37.9 14.2 13.2 18.5 14.0 20.6 16.3 0.0 5.0 9.9 6.8 6.9 16.0 30.7 20.4 1.4 3.4 0.0 13.7 21.5 0.0 0.1 59.5 11.7 32.9 23.3 0.4 19.3 9.8 12.3 10.3 30.8 9.9 20.6 13.3 16.0 11.2 76.7 13.0 2.2 10.1 0.0 15.5 20.3 0.2 23.0 8.1 0.1 13.0 12.9 6.6 21.6 12.5 9.7 29.1 10.2 15.3 5.9 ATP11A "ATPIH, ATPIS, KIAA1021" ENSG00000068650 "ATPase phospholipid transporting 11A" P98196 13 112690329-112887168 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Alveolar cells type 1: 202.5;Alveolar cells type 2: 171.3;Cone photoreceptor cells: 221.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035583, HPA035584" Approved Enhanced Vesicles NA NA Vesicles "HPA035583: AB_10671106, HPA035584: AB_10672096" "unprognostic (1.67e-1)" "unprognostic (5.06e-3)" "unprognostic (1.58e-1)" "unprognostic (5.27e-2)" "unprognostic (6.58e-2)" "unprognostic (8.84e-2)" "unprognostic (5.87e-3)" "unprognostic (1.80e-2)" "unprognostic (6.97e-2)" "unprognostic (1.54e-3)" "unprognostic (3.93e-2)" "unprognostic (4.23e-1)" "prognostic favorable (7.44e-4)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.26e-2)" "unprognostic (7.40e-3)" 11.1 11.5 7.2 8.3 16.4 15.7 7.9 5.0 12.5 13.6 5.8 24.4 8.7 9.5 13.7 9.2 8.5 10.8 14.6 19.6 7.2 5.4 12.9 12.3 36.9 7.5 17.7 6.9 8.6 13.2 36.1 17.8 11.2 12.8 5.0 3.6 10.0 12.0 9.0 11.2 11.4 8.7 9.1 12.5 10.2 6.1 9.7 16.2 2.1 16.4 6.4 6.0 5.7 11.3 4.2 1.1 6.4 3.1 0.0 1.0 0.6 14.0 7.2 9.1 10.7 4.6 6.3 16.2 6.7 3.9 5.7 4.7 22.6 16.3 7.1 8.2 5.6 7.4 12.0 8.2 5.5 5.6 7.1 7.7 8.2 6.0 11.7 7.3 15.3 13.4 4.2 4.3 6.9 4.2 4.6 15.0 6.5 5.6 1.2 4.0 5.3 6.9 9.7 3.9 16.1 5.1 6.1 3.7 4.0 31.3 3.3 14.6 4.0 6.5 8.5 5.6 12.4 3.2 20.5 9.8 0.0 12.5 7.4 5.0 3.9 7.5 3.0 2.5 14.5 6.3 0.0 2.3 3.1 1.0 3.1 0.6 1.3 0.6 0.5 1.1 4.2 0.7 0.4 6.4 0.0 2.7 1.1 0.1 0.6 7.2 16.4 5.0 12.5 7.2 5.4 17.7 6.9 12.8 16.2 202.5 171.3 5.6 2.8 9.6 29.4 38.0 35.7 16.0 45.5 15.7 221.9 0.6 5.0 31.2 0.7 19.8 4.2 0.0 10.0 26.5 10.6 5.3 11.5 13.2 17.6 12.7 11.5 24.5 33.5 1.4 10.3 21.3 10.1 7.2 3.3 10.4 18.9 5.8 4.6 15.8 44.2 0.0 5.1 3.9 9.0 8.4 7.2 5.7 5.2 3.7 ATP13A1 "ATP13A, CGI-152, FLJ31858, KIAA1825" ENSG00000105726 "ATPase 13A1" Q9HD20 19 19645198-19663693 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031798, HPA049717" Approved Approved Vesicles NA NA Vesicles "HPA031798: AB_2674048, HPA049717: AB_2680858" "unprognostic (2.08e-1)" "unprognostic (4.92e-2)" "unprognostic (4.30e-2)" "unprognostic (7.29e-2)" "unprognostic (3.33e-1)" "unprognostic (4.40e-3)" "unprognostic (3.97e-3)" "unprognostic (1.73e-2)" "unprognostic (3.17e-1)" "unprognostic (2.60e-2)" "unprognostic (1.16e-2)" "unprognostic (9.43e-3)" "prognostic unfavorable (6.51e-4)" "unprognostic (2.26e-3)" "unprognostic (3.33e-2)" "unprognostic (1.14e-1)" "unprognostic (1.57e-1)" 13.7 20.8 18.6 22.6 20.4 16.0 15.4 19.9 22.4 16.6 15.3 18.9 11.7 20.5 19.1 13.3 17.5 17.4 15.8 11.4 14.4 11.5 17.6 22.9 15.6 23.9 21.6 14.5 24.6 23.4 38.1 21.0 15.4 15.7 16.8 15.0 18.4 18.9 16.8 13.5 17.0 23.2 13.2 16.1 29.9 18.1 16.7 20.7 24.7 23.1 11.0 22.2 15.4 15.6 3.1 8.1 4.1 10.8 1.8 4.5 2.6 12.3 17.4 9.6 20.7 15.4 10.3 26.1 11.2 15.7 9.7 9.9 16.6 21.1 17.1 19.3 13.2 5.5 6.9 14.5 14.3 5.3 6.2 30.1 9.3 17.4 13.0 15.9 17.6 27.8 14.8 13.5 10.5 12.7 10.8 7.0 12.5 16.0 38.3 9.6 20.4 11.8 12.7 17.5 15.4 21.4 9.4 6.8 38.0 10.3 17.2 13.3 22.5 10.3 16.7 11.6 4.7 10.5 19.3 11.1 20.6 3.1 23.3 13.4 31.2 18.6 10.2 14.4 22.7 15.4 0.0 4.2 4.1 3.9 7.4 4.2 3.1 4.5 4.1 8.1 2.7 3.0 3.7 0.1 1.8 10.8 6.3 3.7 2.6 18.6 20.4 19.9 22.4 14.4 11.5 21.6 14.5 15.7 20.7 8.9 8.0 20.4 6.7 5.3 10.5 4.7 10.2 2.7 3.4 14.0 17.7 16.5 1.7 16.9 8.1 6.8 26.2 0.0 15.7 15.4 8.2 10.0 5.7 12.1 18.3 4.8 17.9 11.1 12.1 3.6 13.0 9.2 6.8 11.8 19.8 12.0 14.5 20.4 9.2 6.2 10.7 6.5 5.4 12.1 14.3 5.4 12.8 7.5 17.7 5.5 ATP6V0D2 "ATP6D2, FLJ38708, VMA6" ENSG00000147614 "ATPase H+ transporting V0 subunit d2" Q8N8Y2 8 85987323-86154228 "Predicted intracellular proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "kidney: 56.8" "Cell type enriched" "Detected in some" 6 "Distal tubular cells: 177.4" "Cancer enriched" "Detected in many" 9 "renal cancer: 36.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "SK-MEL-30: 5.6;SuSa: 9.2;U-87 MG: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA055327, HPA058496" Enhanced Approved Vesicles NA NA Vesicles "HPA055327: AB_2682784, HPA058496: " "unprognostic (3.79e-2)" "unprognostic (1.59e-1)" "unprognostic (1.78e-1)" "unprognostic (1.22e-1)" "unprognostic (8.50e-2)" "unprognostic (8.43e-3)" "unprognostic (5.36e-5)" "unprognostic (4.02e-2)" "unprognostic (1.16e-1)" "unprognostic (7.75e-3)" "unprognostic (2.32e-2)" "unprognostic (1.61e-1)" "prognostic favorable (2.20e-6)" "unprognostic (8.58e-2)" "unprognostic (1.77e-2)" "unprognostic (3.67e-1)" "unprognostic (1.97e-2)" 6.6 0.3 0.2 1.3 0.3 0.8 0.3 0.2 0.2 0.2 1.5 0.0 11.9 0.7 0.2 1.0 0.2 0.2 0.1 0.2 0.3 0.3 56.8 0.3 12.2 1.2 0.5 0.0 0.8 0.2 0.3 0.2 0.2 0.0 0.8 2.0 5.7 1.1 1.2 0.2 0.9 1.0 0.0 0.3 0.4 0.3 0.2 0.0 1.0 0.4 0.3 0.6 0.3 0.2 2.2 1.7 4.6 1.0 2.0 1.5 0.3 0.5 1.2 0.6 0.7 0.0 0.5 2.3 0.0 0.0 1.0 0.3 0.3 0.4 0.3 0.2 0.0 1.6 2.5 0.7 1.6 0.4 0.4 0.1 0.8 1.7 0.1 0.0 0.7 1.4 0.6 0.1 0.9 0.7 1.9 0.4 0.3 0.4 0.7 0.5 0.9 0.0 0.7 0.2 0.3 0.2 0.2 0.2 0.3 0.0 1.1 3.4 0.3 0.1 0.8 5.6 9.2 1.8 0.1 0.3 0.6 0.8 0.7 0.5 0.4 0.2 0.6 8.6 0.6 0.7 2.6 1.0 0.8 1.1 0.5 0.8 1.2 1.0 0.9 0.5 2.2 1.5 1.3 4.6 2.0 1.0 1.7 0.9 0.3 0.2 0.3 0.2 0.2 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.4 0.0 0.0 0.0 7.0 29.5 0.0 177.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.5 10.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP6V1B2 "ATP6B2, HO57, VATB, Vma2, VPP3" ENSG00000147416 "ATPase H+ transporting V1 subunit B2" P21281 8 20197367-20226819 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Hydrogen ion transport, Ion transport, Transport" Hydrolase "Deafness, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 116.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 69.7;eosinophil: 47.6;intermediate monocyte: 62.5;myeloid DC: 34.5;neutrophil: 116.0;non-classical monocyte: 54.1" "Group enriched" "Detected in all" 10 "dendritic cells: 34.5;granulocytes: 116.0;monocytes: 69.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008147 Enhanced Supported Vesicles NA NA 240000 Vesicles "HPA008147: AB_1845195" "unprognostic (1.90e-1)" "unprognostic (7.24e-3)" "unprognostic (3.62e-2)" "unprognostic (2.57e-1)" "unprognostic (2.84e-2)" "unprognostic (5.59e-3)" "unprognostic (1.76e-2)" "unprognostic (3.78e-2)" "unprognostic (4.68e-2)" "unprognostic (4.23e-3)" "unprognostic (1.29e-2)" "unprognostic (1.34e-1)" "prognostic favorable (8.41e-4)" "unprognostic (2.41e-1)" "unprognostic (2.09e-2)" "unprognostic (2.47e-2)" "unprognostic (5.25e-2)" 17.1 29.9 31.7 25.8 45.0 14.4 13.2 39.2 72.9 12.2 13.9 15.9 5.5 16.2 10.6 12.2 15.3 10.3 14.8 13.9 33.8 47.8 53.9 18.0 22.8 17.5 46.9 47.1 10.9 12.2 18.8 23.6 18.5 64.2 11.0 16.5 17.3 12.8 10.9 18.2 18.2 21.1 15.0 19.2 20.9 10.7 24.0 12.7 10.3 12.7 9.3 17.5 14.3 12.4 4.9 34.5 116.0 69.7 4.8 7.1 51.1 10.8 18.2 22.7 7.4 31.0 19.2 20.4 24.5 15.7 31.6 32.7 20.5 6.4 19.3 10.0 23.3 32.2 9.3 17.9 16.3 33.7 8.1 12.0 13.4 8.2 15.7 36.4 9.5 28.0 17.1 14.9 19.6 18.1 34.9 19.7 25.8 19.9 18.7 33.7 6.1 27.8 11.3 16.8 16.0 8.0 11.5 29.2 10.0 29.2 17.2 17.6 25.4 11.8 16.0 77.9 19.6 20.9 17.5 20.8 15.9 12.2 26.2 19.5 7.6 10.2 22.7 22.0 22.8 40.3 15.9 69.7 47.6 5.7 62.5 6.2 4.9 5.9 6.1 34.5 4.3 6.1 6.0 116.0 4.8 54.1 8.4 7.1 51.1 31.7 45.0 39.2 69.0 33.8 47.8 46.9 47.1 64.2 12.7 23.8 20.2 30.3 24.8 51.5 100.1 14.0 12.7 12.0 11.4 27.9 96.2 100.2 68.0 38.5 22.5 24.8 23.6 46.7 33.2 46.1 30.0 15.5 21.9 30.6 167.3 179.6 71.4 28.3 171.7 15.9 18.1 165.7 99.5 87.4 19.6 39.2 37.2 20.4 26.5 193.9 117.5 12.9 37.6 83.9 46.7 62.6 104.2 27.7 20.0 18.2 ATP8A1 ATPIA ENSG00000124406 "ATPase phospholipid transporting 8A1" Q9Y2Q0 4 42408373-42657105 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 38.9" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 2: 61.4;Cone photoreceptor cells: 76.6;Horizontal cells: 58.8;Intestinal endocrine cells: 81.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 17.2;Daudi: 28.1;HEL: 9.9;REH: 9.7;SH-SY5Y: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052935 Enhanced Supported Vesicles NA NA 20000 Vesicles "HPA052935: AB_2681992" "unprognostic (8.63e-2)" "unprognostic (3.43e-2)" "unprognostic (1.16e-2)" "unprognostic (7.61e-2)" "unprognostic (6.59e-2)" "unprognostic (6.82e-3)" "unprognostic (7.69e-2)" "unprognostic (2.02e-3)" "unprognostic (3.99e-1)" "unprognostic (2.99e-3)" "unprognostic (4.39e-2)" "unprognostic (9.71e-2)" "prognostic favorable (5.54e-10)" "unprognostic (2.43e-1)" "unprognostic (3.25e-1)" "unprognostic (8.21e-2)" "unprognostic (2.25e-1)" 5.3 8.6 14.2 8.0 29.6 18.5 4.8 7.2 32.0 3.1 11.3 27.3 8.4 4.2 3.4 11.6 2.9 3.5 2.8 8.0 13.7 8.8 4.0 2.1 10.6 12.5 18.0 17.4 15.1 10.0 38.9 6.9 2.6 15.3 7.9 10.7 3.9 4.4 15.2 16.9 3.2 8.1 3.1 23.1 7.8 10.5 2.8 24.9 8.9 34.9 1.9 10.3 4.5 4.0 4.4 3.8 0.9 3.3 3.2 7.3 0.9 0.0 0.1 0.3 17.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.2 28.1 8.0 0.1 0.0 1.4 4.0 0.0 0.0 4.4 2.8 9.9 1.0 0.4 0.0 2.4 0.2 0.3 0.0 0.0 0.0 0.3 0.1 6.3 0.0 3.2 0.0 1.2 3.5 0.8 1.3 1.1 0.3 9.7 0.0 3.1 6.1 0.3 3.1 9.3 0.2 5.9 0.0 0.7 1.9 0.0 0.2 0.0 1.3 0.3 0.0 1.1 0.0 5.7 0.4 3.4 0.1 0.0 1.0 0.9 6.0 0.4 3.2 2.6 1.9 6.5 0.9 4.4 2.9 7.3 0.9 3.2 3.3 3.8 1.4 0.9 14.2 29.6 7.2 22.1 13.7 8.8 18.0 17.4 15.3 24.9 26.8 61.4 5.1 1.7 1.3 17.7 12.8 0.0 0.0 9.1 5.2 76.6 0.0 3.3 0.0 3.0 9.3 46.1 0.0 2.2 0.1 2.2 16.2 8.1 1.1 1.5 58.8 81.2 17.8 7.5 2.3 3.1 3.8 3.3 1.8 23.3 1.0 0.8 7.0 1.8 1.4 41.3 0.0 0.3 1.1 4.1 1.3 0.0 21.8 23.1 2.4 AZIN1 "OAZI, OAZIN, ODC1L" ENSG00000155096 "Antizyme inhibitor 1" O14977 8 102826357-102893864 "Predicted intracellular proteins" "Polyamine biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027948 Approved Approved Vesicles NA NA Vesicles "HPA027948: AB_10602391" "unprognostic (1.16e-2)" "unprognostic (4.81e-3)" "unprognostic (2.23e-1)" "unprognostic (1.41e-1)" "unprognostic (8.55e-2)" "unprognostic (3.41e-2)" "unprognostic (7.19e-2)" "unprognostic (1.51e-2)" "unprognostic (2.10e-1)" "unprognostic (2.24e-1)" "unprognostic (2.07e-3)" "unprognostic (4.33e-3)" "unprognostic (1.25e-2)" "unprognostic (1.08e-1)" "unprognostic (2.83e-1)" "unprognostic (3.08e-2)" "unprognostic (1.68e-1)" 29.4 31.4 42.1 30.5 33.3 62.5 43.8 35.1 56.7 30.3 33.7 23.0 22.4 33.3 23.2 19.8 27.5 33.2 22.5 25.8 42.0 36.0 20.5 38.4 39.3 46.0 36.5 37.2 22.5 94.0 21.0 42.1 90.2 45.9 27.6 27.8 16.5 27.3 32.1 23.8 18.9 43.8 29.9 62.6 20.2 25.9 17.6 14.4 23.9 34.9 21.4 29.6 31.8 50.0 24.4 28.9 35.6 32.9 19.8 25.6 28.8 67.0 17.8 28.6 20.2 27.6 18.9 17.1 31.8 36.6 22.9 23.7 18.6 47.8 31.4 25.8 25.8 14.3 25.9 24.8 24.5 36.9 53.7 12.5 31.5 7.0 15.1 34.9 16.8 26.8 13.1 29.9 15.9 40.5 20.5 15.7 18.6 23.6 27.2 36.0 19.5 41.9 11.8 31.8 51.2 27.0 19.1 30.0 17.8 23.6 31.6 46.0 72.7 10.6 21.6 30.5 48.6 28.7 17.9 18.4 18.6 19.0 30.1 25.4 27.1 22.9 45.3 22.1 25.5 25.5 32.7 28.7 33.8 17.3 32.9 20.3 24.4 22.6 16.4 28.9 15.6 18.8 17.8 35.6 19.8 31.3 22.9 25.6 28.8 42.1 33.3 35.1 56.7 42.0 36.0 36.5 37.2 45.9 14.4 56.6 23.0 51.4 125.4 83.3 26.6 44.4 28.1 108.4 43.3 40.1 35.3 122.5 44.7 32.5 50.5 24.3 61.7 46.7 42.9 44.4 71.0 91.5 68.0 61.0 48.4 22.3 81.5 33.2 74.6 80.6 46.1 50.3 60.8 43.3 68.9 45.8 61.4 37.4 30.4 35.8 38.6 19.4 62.8 31.0 33.6 72.0 219.0 45.7 58.2 100.9 AZU1 "AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC" ENSG00000172232 "Azurocidin 1" P20160 19 825097-832018 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Chemotaxis "Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "bone marrow: 238.2" "Group enriched" "Detected in some" 5 "Hofbauer cells: 3.3;Kupffer cells: 4.6" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "classical monocyte: 3.3;neutrophil: 7.6" "Group enriched" "Detected in many" 6 "granulocytes: 7.6;monocytes: 3.3" "Cell line enriched" "Detected in some" 7 "THP-1: 154.5" "Not detected" "Not detected" "HPA055851, HPA075964" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 290000 Vesicles "HPA055851: AB_2682943, HPA075964: " "unprognostic (1.12e-2)" "unprognostic (3.71e-2)" "unprognostic (4.44e-2)" "unprognostic (8.85e-3)" "unprognostic (1.62e-2)" "unprognostic (1.29e-1)" "unprognostic (1.39e-1)" "unprognostic (8.12e-2)" "unprognostic (3.32e-1)" "unprognostic (4.22e-3)" "unprognostic (2.58e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-6)" "unprognostic (1.11e-2)" "unprognostic (1.10e-1)" "unprognostic (2.46e-2)" "unprognostic (3.04e-2)" 0.3 0.2 0.4 0.2 0.5 238.2 0.6 0.0 0.6 0.2 0.2 1.0 0.0 0.2 0.2 0.2 0.2 0.8 0.2 34.6 0.4 0.5 0.2 1.5 15.3 0.2 0.2 0.0 0.5 0.1 0.1 0.9 3.8 0.2 0.2 0.2 0.2 0.6 0.2 1.0 0.4 0.2 0.2 0.1 18.6 0.2 1.2 0.0 20.6 1.3 0.0 0.2 0.1 0.4 0.0 0.8 7.6 3.3 0.0 0.3 4.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 154.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.5 0.0 0.0 3.3 0.2 0.3 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 7.6 0.0 0.5 0.0 0.0 4.1 0.4 0.5 0.0 0.6 0.4 0.5 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.2 3.3 0.0 0.0 0.0 4.6 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.8 0.0 B3GALNT1 "B3GALT3, beta3Gal-T3, galT3, GLOB, P1" ENSG00000169255 "Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)" O75752 3 161083883-161105384 "Blood group antigen proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 36.8" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 52.9;Cardiomyocytes: 51.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 4.9;NK-cell: 16.7" "Group enriched" "Detected in many" 7 "granulocytes: 4.9;NK-cells: 16.7" "Cell line enhanced" "Detected in many" "PC-3: 17.2;RT4: 52.6" "Low region specificity" "Detected in all" HPA041204 Approved Vesicles NA NA 290000 Vesicles "HPA041204: AB_10795585" "unprognostic (3.85e-2)" "unprognostic (5.11e-3)" "unprognostic (3.02e-1)" "unprognostic (1.06e-2)" "unprognostic (7.83e-2)" "unprognostic (4.07e-2)" "unprognostic (9.26e-5)" "unprognostic (1.49e-2)" "unprognostic (1.12e-2)" "unprognostic (1.88e-2)" "unprognostic (3.44e-2)" "unprognostic (3.24e-1)" "unprognostic (2.09e-3)" "unprognostic (1.32e-1)" "unprognostic (4.90e-2)" "unprognostic (3.66e-2)" "unprognostic (3.19e-3)" 3.8 5.4 14.0 3.0 24.5 3.1 7.4 17.2 24.7 15.5 2.3 5.5 2.6 1.5 8.3 6.9 5.4 10.4 7.1 36.8 15.4 21.6 14.3 1.0 10.8 3.5 11.3 16.2 13.8 7.8 6.5 8.5 10.0 17.7 8.9 2.0 7.5 14.8 6.7 1.1 2.2 1.9 7.2 7.6 4.2 7.5 6.2 5.0 1.1 19.5 2.3 3.9 10.5 4.7 1.4 1.4 4.9 0.2 16.7 0.7 0.5 6.7 0.2 3.1 0.1 0.3 1.0 0.1 3.7 3.3 8.2 2.8 4.4 5.1 0.0 15.1 3.1 4.9 1.5 0.0 6.6 2.7 0.1 0.0 3.7 2.8 0.0 4.8 0.1 0.1 10.1 2.0 2.2 0.5 6.4 12.1 0.0 0.0 0.0 3.3 10.9 0.0 0.0 7.5 0.1 17.2 0.1 0.0 0.1 3.9 52.6 6.3 0.0 9.5 3.5 2.7 1.4 14.5 5.5 0.0 0.1 6.6 0.2 0.1 1.5 0.0 0.0 5.8 0.0 0.0 4.9 0.2 0.0 0.4 0.1 0.4 1.4 0.2 0.4 1.4 0.3 0.5 0.7 0.4 16.7 0.0 1.0 0.0 0.5 14.0 24.5 17.2 24.7 15.4 21.6 11.3 16.2 17.7 5.0 17.9 2.1 3.4 4.2 4.4 52.9 51.9 0.0 2.7 10.3 14.0 11.8 18.5 10.0 3.0 0.6 6.8 0.0 0.0 7.4 10.2 16.9 4.9 10.3 0.0 8.4 6.4 1.7 6.7 1.3 1.7 6.6 4.6 10.1 7.2 0.0 10.8 7.2 0.0 4.9 13.6 7.2 0.0 13.3 3.7 16.8 2.3 4.2 1.8 0.4 4.1 B3GAT1 "CD57, GlcAT-P, HNK-1, LEU7, NK-1" ENSG00000109956 "Beta-1,3-glucuronyltransferase 1" Q9P2W7 11 134378504-134411918 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "brain: 76.0" "Cell type enhanced" "Detected in some" 30 "Bipolar cells: 34.2;Horizontal cells: 22.3;Muller glia cells: 119.7" "Group enriched" "Detected in some" 11 "glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.8;naive CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 39 "T-cells: 3.8" "Cell line enhanced" "Detected in some" "AF22: 17.4;HMC-1: 19.3;NTERA-2: 16.7;SH-SY5Y: 6.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002500, CAB010893, HPA069468, HPA074314" Enhanced Enhanced Vesicles "Secreted in brain" NA NA Vesicles "CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: " "unprognostic (6.72e-2)" "unprognostic (3.97e-4)" "unprognostic (2.13e-2)" "unprognostic (1.40e-3)" "unprognostic (5.52e-2)" "unprognostic (2.60e-3)" "unprognostic (6.30e-2)" "unprognostic (1.96e-2)" "unprognostic (8.74e-2)" "unprognostic (2.72e-1)" "unprognostic (1.57e-3)" "unprognostic (1.58e-1)" "unprognostic (9.34e-3)" "unprognostic (3.87e-3)" "unprognostic (2.42e-1)" "unprognostic (4.07e-2)" "unprognostic (2.26e-2)" 1.5 5.8 38.9 1.7 23.7 2.1 5.6 9.2 76.0 1.7 1.5 25.8 0.0 1.8 1.6 1.7 1.4 1.6 1.7 1.5 43.4 14.9 2.1 6.0 1.8 3.3 30.3 19.5 1.5 1.7 1.4 0.9 1.4 19.7 4.2 1.5 2.1 2.2 1.8 1.4 1.8 1.6 1.5 45.1 2.1 6.0 1.8 25.2 0.0 7.7 0.0 1.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.4 0.0 0.0 17.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 3.0 0.0 0.7 0.9 1.1 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 16.7 0.8 0.0 0.3 0.0 1.2 0.0 0.1 2.3 6.4 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.3 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.8 1.9 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.4 38.9 23.7 9.2 33.7 43.4 14.9 30.3 19.5 19.7 25.2 0.0 0.0 0.0 0.0 0.0 34.2 1.0 2.5 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.9 0.1 22.3 1.7 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 119.7 0.0 0.0 0.4 2.3 6.3 0.0 0.0 0.2 0.1 0.0 0.1 3.2 0.0 0.1 B3GNT2 "B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT" ENSG00000170340 "UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2" Q9NY97 2 62196113-62224731 "Enzymes, Plasma proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 43.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005997 Approved Approved Vesicles NA NA 43000000 Vesicles "HPA005997: AB_1845234" "unprognostic (1.38e-1)" "unprognostic (1.13e-1)" "unprognostic (1.28e-1)" "unprognostic (2.64e-2)" "unprognostic (1.23e-2)" "unprognostic (1.67e-1)" "unprognostic (1.51e-1)" "unprognostic (1.55e-2)" "unprognostic (2.13e-2)" "unprognostic (3.76e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (3.63e-1)" "unprognostic (1.11e-2)" "unprognostic (9.55e-2)" "unprognostic (3.05e-2)" "unprognostic (3.18e-1)" "unprognostic (1.25e-1)" 18.9 14.3 8.6 10.8 23.0 41.6 17.5 3.1 14.1 18.4 17.9 7.4 5.6 17.9 19.8 8.0 24.5 8.7 18.1 20.9 7.6 11.5 24.4 14.2 23.9 13.9 9.7 7.1 9.0 43.2 5.4 25.9 22.8 9.5 7.5 16.3 14.4 17.2 6.0 5.2 13.0 21.7 16.3 7.6 14.6 12.0 7.0 10.6 27.0 15.6 8.5 18.5 11.8 14.7 8.4 6.8 28.3 5.6 20.3 19.3 8.2 7.8 5.4 8.2 3.6 9.0 4.1 23.7 7.6 8.5 6.1 8.2 11.1 12.6 8.5 7.0 7.1 8.6 7.5 5.2 6.4 10.6 17.6 4.2 20.8 2.6 6.5 6.8 12.4 9.4 4.9 12.1 11.7 4.2 4.3 9.1 5.9 11.3 5.3 7.3 5.9 23.6 18.6 7.8 14.2 2.2 43.4 5.7 4.6 11.6 7.7 8.0 5.9 5.4 11.7 8.7 13.8 3.3 14.7 10.3 7.4 6.5 12.5 7.5 15.1 5.3 36.5 5.8 21.6 7.1 7.2 4.5 28.3 11.0 4.4 15.6 7.6 8.2 19.3 5.5 8.4 9.9 14.4 11.3 20.3 5.6 6.8 13.2 8.2 8.6 23.0 3.1 14.1 7.6 11.5 9.7 7.1 9.5 10.6 59.6 9.8 25.1 27.0 63.4 16.0 8.7 17.8 5.3 3.4 17.4 0.0 31.1 19.9 20.8 0.1 21.0 17.3 46.7 50.7 30.1 35.3 23.6 3.5 15.5 51.9 0.0 9.1 37.4 22.7 0.2 2.3 20.4 33.7 24.4 19.1 8.1 37.8 21.8 2.1 18.9 2.4 64.7 52.3 0.2 1.5 56.7 54.6 17.5 11.9 34.6 BAAT BAT ENSG00000136881 "Bile acid-CoA:amino acid N-acyltransferase" Q14032 9 101360417-101383519 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Hydrolase, Serine esterase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "liver: 128.4" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 745.7" "Cancer enriched" "Detected in many" 42 "liver cancer: 181.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.1;CACO-2: 3.4;Hep G2: 2.4;OE19: 2.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA021251, HPA021330" Enhanced Uncertain Vesicles NA NA 470000 Vesicles "HPA021251: AB_1845247, HPA021330: AB_2670674" "unprognostic (2.53e-2)" "unprognostic (1.81e-1)" "unprognostic (9.97e-2)" "unprognostic (9.33e-2)" "unprognostic (7.75e-3)" "unprognostic (4.68e-2)" "prognostic favorable (4.97e-4)" "unprognostic (2.14e-2)" "unprognostic (6.19e-2)" "unprognostic (4.43e-4)" "unprognostic (3.65e-1)" "unprognostic (2.15e-1)" "prognostic unfavorable (4.24e-7)" "unprognostic (1.74e-1)" "unprognostic (2.12e-1)" "unprognostic (2.17e-2)" "unprognostic (1.75e-1)" 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 22.8 0.0 0.1 0.1 0.2 128.4 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.2 0.0 0.7 0.1 0.1 6.1 0.4 0.3 0.0 0.0 0.0 0.3 0.1 0.1 0.3 3.4 0.1 0.6 0.2 0.0 0.3 0.3 0.1 0.2 0.5 0.3 0.1 0.5 0.2 2.4 0.0 0.9 0.3 0.0 1.0 0.1 0.0 0.1 0.0 0.8 0.7 0.4 0.5 0.1 0.2 0.3 1.0 2.6 0.7 0.2 1.1 0.2 0.6 0.2 0.3 0.4 0.4 0.2 0.5 0.2 0.0 0.2 0.1 0.6 0.6 0.2 0.4 0.4 0.6 0.5 0.5 0.2 0.6 0.3 0.2 0.0 0.7 0.1 0.1 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.8 0.4 89.2 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 745.7 0.0 0.0 0.0 11.1 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 BAG5 ENSG00000166170 "BCL2 associated athanogene 5" Q9UL15 14 103556544-103562831 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 69.8" "Group enriched" "Detected in many" 18 "Early spermatids: 1517.7;Late spermatids: 1363.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016429 Enhanced Approved Vesicles NA NA Vesicles "HPA016429: AB_1845261" "unprognostic (3.02e-2)" "unprognostic (2.98e-2)" "unprognostic (1.05e-2)" "unprognostic (6.26e-2)" "unprognostic (2.54e-1)" "unprognostic (5.22e-2)" "unprognostic (1.99e-3)" "unprognostic (2.78e-1)" "unprognostic (1.04e-1)" "unprognostic (4.77e-3)" "unprognostic (2.34e-1)" "unprognostic (3.80e-2)" "prognostic favorable (1.58e-8)" "unprognostic (2.51e-1)" "unprognostic (1.52e-1)" "unprognostic (3.69e-2)" "unprognostic (2.53e-1)" 16.0 6.7 8.4 8.1 9.4 13.2 10.6 14.8 10.6 11.5 10.1 10.6 9.5 7.0 11.7 9.5 13.6 9.3 7.4 7.3 8.9 8.4 13.5 8.5 8.8 9.3 8.7 7.6 11.4 7.0 9.0 13.2 16.1 10.3 10.3 8.4 8.2 10.4 11.2 9.3 13.1 11.5 10.7 9.7 11.9 8.4 69.8 8.6 11.1 17.0 10.7 11.8 11.7 9.4 10.1 15.3 22.8 21.2 14.7 14.2 12.7 14.8 13.5 16.1 14.4 14.9 15.2 18.1 17.0 11.9 12.2 11.4 11.1 17.5 26.2 15.1 16.6 11.3 21.4 12.8 18.0 19.5 12.0 9.6 17.3 15.8 8.3 9.5 22.6 17.7 10.7 23.3 12.8 16.0 11.2 12.6 18.1 13.8 19.3 16.4 17.8 21.0 10.1 9.6 22.4 16.5 21.5 20.3 11.1 19.9 37.9 18.7 12.5 19.9 16.2 12.9 11.3 21.0 12.2 16.9 13.3 11.6 20.8 17.3 13.3 20.8 30.8 15.1 11.8 16.6 22.8 14.1 12.8 11.6 15.7 13.9 8.3 12.8 10.8 15.3 10.1 14.2 12.9 10.7 14.7 21.2 7.2 11.3 12.7 8.4 9.4 14.8 10.6 8.9 8.4 8.7 7.6 10.3 8.6 41.7 22.4 14.7 37.9 61.2 33.1 19.9 10.2 44.2 52.4 33.2 25.5 21.0 56.3 22.2 1517.7 34.2 17.1 0.0 16.6 14.3 26.3 32.2 31.2 20.3 18.5 71.5 30.4 53.4 26.7 1363.6 46.1 24.1 30.4 10.8 21.9 45.7 20.5 15.3 62.9 24.8 33.8 32.3 19.8 36.3 41.3 78.4 34.1 26.6 20.0 58.6 BCAS1 "AIBC1, NABC1" ENSG00000064787 "Breast carcinoma amplified sequence 1" O75363 20 53936777-54070594 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 134.0;intestine: 40.3;stomach 1: 85.5" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 100.4;Enterocytes: 78.0;Mucus-secreting cells: 285.2;Paneth cells: 94.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "OE19: 20.6;RT4: 41.6;SK-BR-3: 87.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033558, HPA051816, HPA054745" Enhanced Approved Vesicles NA NA Vesicles "CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590" "unprognostic (6.41e-2)" "unprognostic (1.01e-2)" "unprognostic (6.20e-2)" "unprognostic (7.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.43e-2)" "unprognostic (5.54e-2)" "unprognostic (1.86e-1)" "unprognostic (3.80e-1)" "unprognostic (1.19e-1)" "unprognostic (5.25e-2)" "unprognostic (2.91e-2)" "unprognostic (4.70e-3)" "unprognostic (3.95e-1)" "unprognostic (1.77e-1)" "unprognostic (1.75e-1)" "unprognostic (7.77e-3)" 1.3 1.0 49.8 3.8 63.4 0.9 2.8 5.4 37.2 5.1 36.9 97.6 0.0 10.7 1.6 2.1 4.7 1.7 5.4 0.9 51.6 35.6 1.7 0.9 2.4 1.1 75.3 14.7 0.9 1.0 0.8 0.3 0.9 69.7 19.1 40.3 0.0 2.9 1.0 0.9 1.1 17.1 2.4 134.0 1.1 85.5 2.5 49.2 0.0 0.8 0.0 4.1 21.8 1.1 1.6 0.2 1.0 0.2 0.3 5.7 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.0 0.0 0.0 0.0 20.6 0.0 0.5 0.0 0.2 0.0 41.6 0.0 0.0 0.0 87.1 0.1 0.0 2.8 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.1 0.2 0.2 0.0 0.0 0.5 0.2 0.1 0.5 0.2 3.0 1.6 1.0 0.3 0.0 0.5 0.2 0.1 1.0 0.3 0.2 0.2 5.7 0.2 49.8 63.4 5.4 32.3 51.6 35.6 75.3 14.7 69.7 49.2 8.9 0.6 1.3 5.9 0.7 0.0 2.0 5.1 100.4 22.7 3.5 0.0 0.1 1.7 0.9 13.2 0.1 78.0 0.0 20.6 0.1 0.9 33.5 4.6 0.0 0.1 0.0 8.1 0.6 0.0 13.6 0.3 1.6 15.1 0.0 285.2 0.9 13.8 94.5 0.0 0.0 0.5 0.0 0.3 10.5 5.3 0.3 0.0 0.7 33.5 44.2 BCL6B "BAZF, ZBTB28, ZNF62" ENSG00000161940 "B cell CLL/lymphoma 6B" Q8N143 17 7023020-7030290 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Endothelial cells: 32.1;Ito cells: 23.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 7.8;HMC-1: 24.0;HUVEC TERT2: 42.7;TIME: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059147, HPA075112" Uncertain Approved Vesicles NA NA Vesicles "HPA059147: AB_2683928, HPA075112: AB_2732279" "unprognostic (5.61e-2)" "unprognostic (9.43e-3)" "unprognostic (2.33e-2)" "unprognostic (2.12e-1)" "unprognostic (1.40e-1)" "prognostic favorable (8.56e-5)" "unprognostic (2.81e-1)" "unprognostic (2.28e-2)" "unprognostic (4.81e-2)" "unprognostic (1.80e-1)" "unprognostic (6.10e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (4.04e-4)" "unprognostic (7.14e-2)" "unprognostic (1.11e-1)" "unprognostic (4.29e-2)" "unprognostic (4.26e-2)" 23.9 4.0 2.5 4.4 3.4 0.0 11.5 2.0 4.1 5.2 3.9 2.3 1.2 2.5 9.7 3.9 4.0 4.2 10.8 12.7 2.4 2.4 6.0 6.1 26.2 5.2 3.4 0.8 7.4 3.0 2.4 4.7 15.9 4.9 6.8 1.8 4.5 4.6 2.9 8.6 3.5 4.0 6.3 2.9 17.9 3.4 2.3 2.4 0.5 10.0 8.2 2.5 6.6 28.6 1.1 0.6 0.0 0.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.8 0.0 0.0 0.2 0.0 24.0 0.0 0.0 0.0 0.0 0.0 42.7 0.1 1.4 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 16.7 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.6 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.5 3.4 2.0 4.1 2.4 2.4 3.4 0.8 4.9 2.4 3.0 6.2 0.0 0.0 1.9 0.0 2.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 32.1 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.1 0.0 0.0 23.9 3.2 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.3 1.5 1.1 0.1 0.0 0.0 0.1 BICD1 ENSG00000151746 "BICD cargo adaptor 1" Q96G01 12 32106835-32383633 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 39.0" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 26.0;Cone photoreceptor cells: 35.3;Muller glia cells: 32.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NTERA-2: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041309 Approved Approved Vesicles NA NA Vesicles "HPA041309: AB_10804000" "unprognostic (1.40e-1)" "unprognostic (1.18e-2)" "unprognostic (1.73e-2)" "unprognostic (2.10e-1)" "unprognostic (2.06e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-6)" "unprognostic (5.93e-2)" "unprognostic (4.57e-1)" "unprognostic (3.64e-1)" "unprognostic (8.19e-2)" "unprognostic (9.66e-2)" "prognostic unfavorable (2.33e-7)" "unprognostic (1.72e-1)" "unprognostic (1.74e-1)" "unprognostic (5.37e-2)" "unprognostic (1.36e-1)" 6.2 5.3 11.7 8.3 10.6 4.1 5.3 39.0 13.7 19.9 4.4 9.2 1.9 3.3 13.8 10.4 3.1 14.8 7.7 6.0 10.7 7.6 6.7 1.9 6.6 8.6 6.6 10.9 29.0 2.5 12.6 9.9 12.1 8.3 6.5 4.5 5.6 3.7 4.1 4.6 2.9 4.5 8.2 8.3 10.4 4.0 4.4 8.0 8.8 9.5 1.9 7.4 6.2 4.9 5.4 6.3 0.1 0.9 2.8 4.7 1.6 8.3 6.7 4.4 2.7 4.1 4.6 4.2 9.8 4.2 9.8 6.6 6.2 5.0 13.2 7.4 8.9 10.3 3.3 18.5 7.7 14.1 8.3 5.4 13.6 5.1 3.3 4.8 11.0 8.3 3.1 3.6 10.8 8.8 13.0 9.4 11.6 7.0 22.2 4.2 3.3 11.9 4.1 37.5 3.1 6.0 9.2 13.3 7.7 11.3 4.5 17.4 10.4 6.5 0.4 6.1 27.0 5.3 2.9 10.4 13.8 13.1 9.2 13.3 7.5 10.6 21.3 9.2 5.7 16.1 0.0 0.9 0.0 3.5 0.3 4.7 5.4 3.2 2.2 1.5 5.2 3.6 2.8 0.1 2.8 0.0 6.3 4.1 1.6 11.7 10.6 39.0 13.7 10.7 7.6 6.6 10.9 8.3 8.0 14.9 0.6 11.7 4.6 0.3 26.0 7.8 0.0 2.7 11.4 8.7 35.3 0.4 1.7 7.4 0.5 14.6 0.5 0.0 4.2 0.4 5.0 5.5 0.0 0.4 5.4 22.3 6.3 14.1 1.0 0.7 3.7 2.5 8.5 3.6 0.0 32.7 5.7 0.0 4.2 1.9 17.8 0.0 6.6 2.1 9.8 2.0 0.2 5.0 2.3 3.1 BLOC1S5 "dJ303A1.3, MU, MUTED" ENSG00000188428 "Biogenesis of lysosomal organelles complex 1 subunit 5" Q8TDH9 6 8013567-8064414 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB025613, HPA077525" Uncertain Supported Vesicles NA NA Vesicles "CAB025613: , HPA077525: AB_2686843" "unprognostic (1.54e-1)" "unprognostic (8.21e-2)" "unprognostic (1.26e-2)" "unprognostic (1.24e-2)" "unprognostic (1.92e-1)" "unprognostic (5.06e-2)" "prognostic unfavorable (8.12e-4)" "unprognostic (4.24e-2)" "unprognostic (1.20e-2)" "unprognostic (1.47e-2)" "unprognostic (2.87e-2)" "unprognostic (1.00e-1)" "unprognostic (1.62e-3)" "unprognostic (1.83e-1)" "unprognostic (1.13e-1)" "unprognostic (6.16e-2)" "unprognostic (7.60e-3)" 12.2 13.9 10.1 11.0 11.1 4.8 14.1 8.8 8.9 12.0 9.7 9.0 6.4 5.9 14.3 10.5 10.7 9.2 8.2 9.7 7.6 7.0 23.2 14.7 8.0 11.8 10.3 6.0 14.2 8.8 17.2 8.6 9.2 7.4 12.0 7.8 10.6 9.6 13.6 11.3 10.3 10.0 13.4 12.4 12.0 9.2 8.2 9.2 24.1 14.6 7.2 13.8 12.1 10.4 15.7 14.8 16.9 11.2 15.1 15.2 11.4 3.7 3.9 8.7 11.2 9.6 12.0 5.9 4.0 5.6 5.8 5.7 8.1 3.5 12.7 27.4 5.0 6.5 3.4 6.4 3.1 8.2 12.6 6.9 7.6 3.0 14.7 8.6 13.0 8.8 5.3 8.1 5.8 8.7 8.9 10.2 10.4 15.5 2.3 8.1 4.0 15.1 8.6 4.7 8.7 5.6 12.5 10.0 20.0 10.8 3.2 8.2 4.3 4.1 6.2 12.3 16.5 7.8 6.8 4.4 9.1 6.6 5.3 3.4 10.3 20.6 11.5 3.7 10.7 9.3 13.6 9.0 16.9 11.5 11.2 14.8 15.7 14.8 14.6 14.8 14.8 15.2 15.1 2.1 15.1 6.1 6.0 13.0 11.4 10.1 11.1 8.8 8.9 7.6 7.0 10.3 6.0 7.4 9.2 11.9 5.8 5.2 7.4 5.4 6.7 6.3 0.0 9.4 7.9 24.4 2.0 9.5 29.9 8.0 7.3 10.6 4.2 0.0 7.5 8.4 6.9 7.4 16.1 0.0 6.9 6.4 1.7 0.0 0.0 5.7 8.9 8.4 3.3 7.2 7.5 10.9 7.8 2.9 11.7 28.5 8.3 0.0 6.2 6.1 12.8 6.6 6.9 6.1 6.8 5.7 BMP2 BMP2A ENSG00000125845 "Bone morphogenetic protein 2" P12643 20 6767664-6780280 "Cancer-related genes, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Cytokine, Developmental protein, Growth factor" "Cancer-related genes, Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 147.9;Basal keratinocytes: 148.5;Suprabasal keratinocytes: 104.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "NK-cell: 2.2" "Lineage enriched" "Detected in single" 7 "NK-cells: 2.2" "Cell line enhanced" "Detected in many" "CACO-2: 21.2;HeLa: 13.8;hTERT-HME1: 12.5;RT4: 16.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA058610, CAB078457" Enhanced Vesicles "Secreted to blood" NA NA 24400 Vesicles "CAB078457: AB_2532532, HPA058610: AB_2683777" "unprognostic (2.22e-2)" "unprognostic (9.32e-2)" "unprognostic (6.12e-2)" "unprognostic (3.56e-2)" "unprognostic (1.94e-2)" "unprognostic (2.48e-1)" "unprognostic (3.70e-3)" "unprognostic (3.12e-3)" "unprognostic (8.51e-2)" "unprognostic (8.46e-2)" "unprognostic (2.53e-3)" "unprognostic (5.39e-3)" "unprognostic (7.81e-2)" "unprognostic (3.76e-1)" "unprognostic (2.77e-1)" "unprognostic (3.01e-2)" "unprognostic (7.49e-2)" 11.1 1.1 1.6 10.5 3.1 0.6 5.3 1.8 7.5 3.7 13.1 2.6 1.9 4.2 3.4 6.7 3.7 3.7 15.6 3.9 2.4 1.6 3.6 3.8 12.8 1.3 2.9 1.3 3.1 9.2 4.7 2.3 7.6 2.7 8.8 9.5 18.3 2.0 1.2 2.6 9.1 13.4 3.4 1.4 8.0 13.8 1.1 2.7 0.3 13.2 6.2 3.1 14.1 9.1 0.0 0.0 0.3 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.0 0.5 2.3 0.0 0.0 21.2 0.0 0.0 0.3 0.7 0.0 7.1 4.2 1.8 0.0 0.0 3.8 0.0 13.8 0.0 1.0 0.0 0.6 0.1 6.4 0.0 12.5 2.7 4.3 0.0 0.0 0.0 0.1 0.0 0.0 4.0 0.5 2.5 0.5 4.1 0.0 0.3 1.6 16.8 0.8 1.1 5.0 0.0 0.0 4.0 0.0 4.4 1.0 1.2 1.9 0.0 0.6 0.2 0.5 0.0 2.1 1.1 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.0 0.0 1.6 3.1 1.8 3.3 2.4 1.6 2.9 1.3 2.7 2.7 74.5 147.9 4.5 34.3 148.5 0.4 4.6 53.5 0.0 13.6 1.8 0.0 0.1 0.0 19.3 0.3 9.7 64.5 0.0 8.3 0.1 15.5 30.2 8.1 2.4 2.7 0.0 10.9 46.1 3.7 0.0 5.5 1.9 8.5 1.0 18.4 4.8 23.9 17.3 0.0 0.7 0.2 19.4 38.9 0.0 0.1 104.4 0.1 0.0 15.1 24.3 BPIFB2 "BPIL1, C20orf184, dJ726C3.2, LPLUNC2" ENSG00000078898 "BPI fold containing family B member 2" Q8N4F0 20 33007600-33023709 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "lymphoid tissue: 218.0;salivary gland: 191.2" "Cell type enhanced" "Detected in some" 19 "Early spermatids: 2.8;Glandular cells: 6.1;Hepatocytes: 1.5;Late spermatids: 7.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 552 "Hep G2: 69.5" "Region enhanced" "Detected in single" "olfactory region: 0.5" "Not detected" "Not detected" "HPA049491, HPA060121" Enhanced Approved Vesicles "Intracellular and membrane" NA NA 68000 Vesicles "HPA049491: AB_2680792, HPA060121: AB_2684207" "unprognostic (1.94e-1)" "prognostic favorable (1.97e-5)" "unprognostic (2.24e-4)" "unprognostic (9.48e-2)" "unprognostic (9.81e-2)" "unprognostic (2.02e-3)" "unprognostic (1.72e-2)" "unprognostic (2.71e-1)" "unprognostic (9.28e-2)" "unprognostic (5.35e-1)" "unprognostic (8.19e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.5 0.0 0.0 191.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 25.6 218.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 69.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 7.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 BSG "CD147, EMMPRIN, OK" ENSG00000172270 "Basigin (Ok blood group)" P35613 19 571277-583493 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cytotrophoblasts: 1238.9;Syncytiotrophoblasts: 1384.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002427, HPA036048, HPA074870" Enhanced Approved Vesicles NA NA 3400000 Vesicles "CAB002427: AB_563501, HPA036048: AB_2674917, HPA074870: AB_2686719" "unprognostic (1.88e-1)" "unprognostic (4.85e-2)" "unprognostic (9.53e-3)" "prognostic favorable (2.59e-4)" "unprognostic (3.34e-1)" "unprognostic (1.38e-2)" "prognostic unfavorable (5.48e-6)" "unprognostic (1.54e-3)" "unprognostic (1.55e-1)" "unprognostic (9.46e-2)" "unprognostic (4.48e-3)" "unprognostic (2.61e-2)" "prognostic favorable (1.95e-6)" "unprognostic (1.22e-1)" "unprognostic (1.03e-1)" "unprognostic (7.30e-2)" "unprognostic (3.22e-1)" 53.0 74.8 60.0 33.3 73.0 86.3 42.3 36.2 103.0 41.7 93.4 57.8 37.3 50.1 56.0 62.2 35.1 48.8 52.0 205.8 58.5 45.9 78.5 39.1 36.1 22.6 57.6 44.0 51.3 64.2 28.2 48.2 96.2 57.9 49.5 39.6 109.4 44.0 48.4 97.4 38.1 45.5 52.9 34.9 28.3 63.9 76.8 30.4 31.8 61.9 45.9 31.2 48.5 31.5 22.0 43.8 89.4 58.7 30.9 44.5 65.5 63.3 85.6 40.8 91.7 121.6 52.3 86.8 52.8 66.0 63.7 55.5 68.2 68.7 22.7 61.3 47.7 17.4 103.5 41.4 64.1 22.1 47.7 88.7 15.6 72.4 92.2 76.9 37.7 73.6 54.4 65.1 36.6 40.9 76.8 45.7 21.3 73.5 107.6 37.4 113.8 27.4 72.3 95.8 41.1 43.8 55.2 33.4 74.9 75.3 47.6 63.4 57.6 109.6 44.2 78.3 38.1 46.4 116.6 50.2 61.2 38.9 101.3 79.6 69.4 69.8 21.6 116.0 52.3 75.7 32.0 58.7 62.0 44.5 45.2 39.5 22.0 30.2 42.6 39.9 18.3 23.1 29.1 89.4 30.9 48.3 43.8 35.1 65.5 60.0 73.0 36.2 103.0 58.5 45.9 57.6 44.0 57.9 30.4 20.8 26.9 96.8 148.3 185.3 141.6 73.6 104.4 61.6 43.3 272.2 192.4 1238.9 124.3 507.3 196.9 200.0 714.8 607.3 327.4 909.7 249.5 169.5 116.3 84.7 379.2 131.9 245.0 132.0 136.1 473.6 278.2 146.3 480.8 346.3 224.4 452.0 369.5 480.7 316.4 241.2 167.7 200.5 269.3 259.3 553.8 137.0 1384.0 132.0 328.6 155.8 BTBD3 "dJ742J24.1, KIAA0952" ENSG00000132640 "BTB domain containing 3" Q9Y2F9 20 11890723-11926609 "Predicted intracellular proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 74.6;Horizontal cells: 62.0;Rod photoreceptor cells: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 6.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 66.5;HeLa: 52.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041424, HPA042048" Uncertain Supported Vesicles NA NA Vesicles "HPA041424: AB_10794667, HPA042048: AB_10796469" "unprognostic (3.93e-2)" "unprognostic (2.25e-1)" "unprognostic (1.32e-1)" "unprognostic (3.56e-3)" "unprognostic (4.24e-3)" "unprognostic (8.45e-2)" "prognostic unfavorable (2.51e-5)" "prognostic unfavorable (6.94e-4)" "unprognostic (4.87e-2)" "unprognostic (2.95e-1)" "unprognostic (1.07e-2)" "unprognostic (7.05e-2)" "unprognostic (6.66e-2)" "unprognostic (7.68e-3)" "unprognostic (1.67e-1)" "unprognostic (6.29e-2)" "unprognostic (1.37e-2)" 8.9 18.5 32.9 5.5 25.2 8.7 10.4 53.8 40.7 12.2 17.1 32.4 3.8 8.7 15.8 10.1 8.3 12.9 11.1 11.1 56.8 19.8 9.8 6.2 10.0 3.0 25.6 21.2 9.0 10.6 10.5 6.7 33.6 20.9 13.0 14.7 8.4 10.9 9.3 11.5 16.7 8.7 13.8 24.3 6.0 21.2 11.7 22.5 4.1 9.6 5.0 2.5 13.8 7.3 0.3 2.9 0.6 6.3 1.4 0.7 1.1 1.8 5.3 14.5 66.5 3.0 3.2 3.9 5.9 3.8 6.7 4.3 3.0 2.9 0.5 5.0 8.6 2.7 4.9 7.4 4.2 11.0 0.0 6.6 1.9 52.5 6.4 3.1 3.0 1.1 5.7 5.2 6.0 4.9 3.7 3.8 3.3 3.3 5.1 6.7 1.3 3.6 2.8 6.9 7.7 1.5 4.9 2.9 1.8 6.1 9.2 6.3 11.2 16.6 6.8 14.3 8.1 4.0 3.1 2.9 3.7 9.4 3.4 6.5 1.9 2.5 0.0 2.4 0.8 24.0 0.0 2.2 0.2 0.0 3.4 0.0 0.1 0.0 0.0 2.9 0.3 0.7 0.0 0.6 1.4 6.3 2.0 0.0 1.1 32.9 25.2 53.8 40.7 56.8 19.8 25.6 21.2 20.9 22.5 14.9 5.9 2.2 9.5 14.7 12.7 15.9 5.1 26.8 10.3 5.2 74.6 15.7 3.3 8.2 6.5 18.0 15.7 0.0 7.3 3.3 12.0 11.8 2.3 6.6 7.2 62.0 20.1 31.9 4.7 8.8 15.3 5.6 13.5 1.0 9.1 16.3 8.1 21.0 8.1 5.4 54.4 6.5 8.6 6.7 14.0 15.1 18.2 0.0 11.5 8.4 BTN3A1 "BT3.1, BTF5, BTN3.1, CD277" ENSG00000026950 "Butyrophilin subfamily 3 member A1" O00481 6 26402237-26415216 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "granulocytes: 24.4;T-cells: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA012565 Approved Uncertain Vesicles NA NA Vesicles "HPA012565: AB_1845494" "unprognostic (2.82e-2)" "unprognostic (6.43e-2)" "unprognostic (1.45e-3)" "unprognostic (4.72e-3)" "unprognostic (1.41e-2)" "unprognostic (1.42e-1)" "unprognostic (3.10e-2)" "unprognostic (9.31e-2)" "unprognostic (9.81e-2)" "unprognostic (8.60e-3)" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "prognostic unfavorable (4.15e-5)" "unprognostic (2.45e-1)" "unprognostic (5.02e-2)" "unprognostic (3.26e-2)" "prognostic favorable (4.81e-4)" 11.3 14.3 6.7 33.5 5.4 10.3 10.2 10.7 5.9 18.5 14.9 10.0 10.1 11.5 22.3 14.1 13.1 9.6 16.5 9.0 5.3 6.1 9.7 11.4 29.9 24.1 7.1 5.4 15.5 9.4 5.6 11.2 8.5 7.8 17.9 12.1 12.3 16.7 10.0 4.8 9.7 20.6 10.2 9.0 45.2 12.5 4.9 6.7 16.5 8.5 9.8 32.9 11.6 12.9 9.8 4.4 17.4 5.9 18.4 23.4 12.1 3.7 3.2 4.7 4.8 13.6 14.5 0.5 3.0 12.0 6.9 20.3 0.1 8.1 9.7 10.6 5.5 10.8 2.5 1.5 4.8 4.0 9.5 3.3 5.1 3.9 2.2 6.1 4.7 4.7 7.8 2.7 6.0 2.7 10.5 9.7 15.7 1.2 12.7 2.8 0.3 8.5 2.9 0.5 1.6 1.0 11.8 2.1 22.0 4.2 4.7 2.5 5.0 1.7 3.6 6.8 0.7 3.3 1.9 2.4 5.3 1.3 1.5 2.9 21.7 22.1 3.5 8.1 10.6 4.0 17.4 5.3 13.5 23.4 5.7 20.9 9.8 14.6 21.7 4.4 5.3 12.7 16.8 11.9 18.4 5.9 2.1 16.9 12.1 6.7 5.4 10.7 5.9 5.3 6.1 7.1 5.4 7.8 6.7 14.9 6.2 15.4 3.5 3.8 4.3 3.5 7.6 5.3 11.4 5.2 0.0 4.5 0.0 5.4 0.1 11.3 9.1 0.0 2.9 3.6 6.6 5.3 24.4 3.4 6.9 0.0 4.6 10.4 11.8 0.4 3.4 8.3 1.7 2.8 14.6 2.9 2.4 7.0 2.5 1.2 0.4 0.0 3.3 0.0 0.1 2.9 1.3 37.4 6.8 4.2 BZW1 "BZAP45, KIAA0005" ENSG00000082153 "Basic leucine zipper and W2 domains 1" Q7L1Q6 2 200810594-200827338 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 858.8;Late spermatids: 3073.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047288, HPA053272" Uncertain Approved Vesicles NA NA Vesicles "HPA047288: , HPA053272: " "unprognostic (2.45e-2)" "prognostic unfavorable (4.28e-4)" "unprognostic (2.08e-3)" "unprognostic (1.56e-2)" "unprognostic (1.93e-1)" "unprognostic (3.31e-3)" "unprognostic (3.98e-3)" "prognostic unfavorable (5.10e-4)" "unprognostic (4.49e-3)" "unprognostic (7.93e-3)" "unprognostic (1.08e-3)" "unprognostic (8.97e-3)" "unprognostic (4.38e-2)" "unprognostic (3.04e-1)" "unprognostic (7.61e-2)" "unprognostic (8.03e-2)" "unprognostic (1.24e-1)" 55.7 43.2 23.5 29.2 26.8 60.1 35.2 19.4 36.1 26.1 30.3 26.4 18.5 20.1 25.4 25.4 49.1 24.8 30.5 31.1 23.3 20.9 39.5 108.5 29.5 33.9 30.5 19.2 40.5 20.5 22.9 23.5 55.4 37.0 33.1 29.9 22.2 29.7 21.3 45.5 20.2 32.0 25.9 28.1 31.2 23.7 55.2 24.6 68.0 32.0 43.2 35.4 39.6 28.1 27.7 43.9 50.1 48.3 56.4 59.5 65.7 44.4 35.5 48.5 29.1 48.9 57.5 34.6 65.6 78.1 44.4 39.0 55.2 30.3 21.4 23.0 52.1 29.4 24.6 44.2 79.1 83.2 23.1 23.6 56.1 76.1 42.3 39.5 62.5 31.4 33.1 36.8 58.8 63.6 38.8 76.9 20.4 48.5 36.6 58.9 35.7 57.5 29.7 61.2 18.1 89.7 44.2 52.6 22.4 40.4 66.7 29.4 34.3 50.2 18.8 33.7 42.2 19.8 32.4 85.4 66.4 38.6 39.9 41.9 45.0 62.0 57.8 54.3 31.7 48.4 50.1 37.2 44.2 51.1 46.2 59.5 27.7 36.9 47.9 43.9 23.4 33.4 46.1 31.7 56.4 48.3 20.4 45.0 65.7 23.5 26.8 19.4 36.1 23.3 20.9 30.5 19.2 37.0 24.6 80.4 99.2 100.6 276.2 176.3 36.6 15.7 71.4 115.1 211.5 85.5 17.7 99.6 117.7 199.3 858.8 125.8 79.3 46.7 201.4 137.6 138.9 237.1 190.7 239.1 102.8 55.6 92.8 93.3 86.7 3073.0 94.6 150.2 118.1 423.0 79.5 109.8 321.4 70.2 90.2 127.7 31.9 97.0 116.9 160.7 145.7 171.4 163.3 128.0 71.8 299.2 C10orf76 FLJ13114 ENSG00000120029 "Chromosome 10 open reading frame 76" Q5T2E6 10 101845599-102056193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050913, HPA053580" Approved Approved Vesicles NA NA Vesicles "HPA050913: AB_2681270, HPA053580: AB_2682198" "unprognostic (5.88e-2)" "unprognostic (1.33e-1)" "unprognostic (1.62e-1)" "unprognostic (3.41e-2)" "unprognostic (9.41e-2)" "unprognostic (9.55e-2)" "unprognostic (5.28e-2)" "unprognostic (1.92e-2)" "unprognostic (1.18e-1)" "unprognostic (6.03e-3)" "unprognostic (1.40e-3)" "unprognostic (2.76e-1)" "unprognostic (1.86e-2)" "unprognostic (1.16e-1)" "unprognostic (2.48e-1)" "unprognostic (3.85e-1)" "unprognostic (4.87e-2)" 16.8 16.3 16.0 16.2 19.5 25.0 15.7 25.5 19.3 17.7 16.7 18.3 19.5 16.3 19.5 14.0 20.9 14.3 14.1 21.2 12.0 12.9 13.2 15.1 18.1 15.0 13.9 14.2 16.0 13.2 22.8 21.0 14.3 16.1 14.8 17.6 17.7 17.3 14.6 27.2 19.3 18.5 17.2 14.4 16.9 14.4 18.0 14.9 18.9 14.2 16.6 20.1 20.6 20.7 7.6 8.5 16.4 10.8 5.2 7.4 4.9 16.0 13.2 11.8 14.4 10.1 13.6 10.0 13.4 18.1 15.1 12.9 8.9 13.6 11.6 9.6 17.0 11.1 12.9 15.3 16.6 14.1 11.8 13.7 19.9 11.7 10.3 11.9 14.4 19.1 12.4 13.5 17.1 15.3 17.9 11.4 11.3 0.6 12.1 12.5 10.2 11.4 9.9 6.3 13.8 8.0 11.3 20.2 8.0 12.5 13.5 5.5 9.0 10.9 8.2 15.7 12.7 21.5 9.1 10.5 8.0 12.9 7.3 10.4 11.0 11.0 12.5 12.9 17.0 6.0 16.4 8.1 7.9 7.0 9.5 6.5 7.1 7.4 5.3 8.5 7.6 5.8 5.9 2.2 5.2 10.8 8.4 6.3 4.9 16.0 19.5 25.5 19.3 12.0 12.9 13.9 14.2 16.1 14.9 11.9 24.0 0.8 6.9 6.8 10.1 0.0 10.2 4.0 3.4 0.0 49.1 9.4 0.0 0.0 4.5 6.4 12.3 0.0 0.0 10.6 6.1 6.5 16.2 12.2 11.2 7.9 2.4 11.1 16.3 3.1 4.4 10.1 3.3 0.0 7.6 6.8 0.0 11.5 7.1 0.0 13.6 0.0 5.1 10.0 11.0 7.8 13.6 8.7 7.4 7.6 C11orf91 ENSG00000205177 "Chromosome 11 open reading frame 91" Q3C1V1 11 33698261-33700801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 7.2;gallbladder: 7.2;testis: 16.6" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 10.1;Late spermatids: 2.3;Sertoli cells: 6.5;Spermatocytes: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 15.2;hTERT-HME1: 9.8;HUVEC TERT2: 7.8;TIME: 11.9;U-2197: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047064, HPA050487" Uncertain Supported Vesicles NA NA Vesicles "HPA047064: AB_2679920, HPA050487: AB_2681142" "unprognostic (9.22e-3)" "unprognostic (1.51e-2)" "unprognostic (1.76e-1)" "unprognostic (6.60e-2)" "unprognostic (1.62e-2)" "unprognostic (3.63e-2)" "unprognostic (2.31e-1)" "unprognostic (5.68e-3)" "unprognostic (7.41e-2)" "unprognostic (2.97e-2)" "unprognostic (1.99e-2)" "unprognostic (3.01e-1)" "unprognostic (8.33e-2)" "unprognostic (4.06e-2)" "unprognostic (3.95e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" 7.2 0.2 1.2 2.1 3.0 0.9 2.1 0.3 1.3 0.3 0.3 0.3 0.3 0.0 0.4 0.9 4.3 0.3 7.2 0.7 0.4 0.6 0.9 0.9 1.4 0.3 0.7 0.3 0.6 1.9 0.0 0.3 1.0 1.3 0.3 0.0 0.3 0.9 0.3 0.4 1.3 0.3 0.8 0.8 0.3 2.7 16.6 0.3 0.6 0.3 0.3 0.3 1.2 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 1.4 0.0 0.0 0.0 1.7 0.0 0.8 0.4 0.2 0.6 0.0 0.1 1.8 0.2 0.6 0.5 15.2 1.2 0.4 0.0 0.0 2.9 0.8 0.3 0.0 0.0 0.0 0.1 1.2 9.8 0.5 7.8 0.2 0.0 2.4 3.7 0.0 0.0 0.3 0.0 0.1 4.8 0.0 0.0 0.0 1.1 2.0 0.0 0.3 0.0 1.5 0.1 0.5 0.0 0.0 11.9 1.1 0.3 9.8 0.3 0.7 0.5 0.0 2.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.0 0.3 1.3 0.4 0.6 0.7 0.3 1.3 0.3 0.0 0.0 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 10.1 0.1 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.2 5.4 0.2 0.0 0.1 0.0 0.0 1.1 C12orf29 DKFZp434N2030 ENSG00000133641 "Chromosome 12 open reading frame 29" Q8N999 12 88033846-88050160 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039663 Uncertain Approved Vesicles NA NA Vesicles "HPA039663: AB_10795253" "unprognostic (8.66e-2)" "unprognostic (1.39e-1)" "unprognostic (7.80e-2)" "unprognostic (6.88e-2)" "unprognostic (2.51e-2)" "unprognostic (2.06e-2)" "unprognostic (1.75e-3)" "unprognostic (4.72e-3)" "unprognostic (1.07e-2)" "unprognostic (1.84e-1)" "unprognostic (8.81e-2)" "unprognostic (6.49e-2)" "prognostic unfavorable (3.44e-4)" "unprognostic (1.03e-1)" "unprognostic (9.29e-2)" "unprognostic (2.03e-2)" "unprognostic (2.42e-1)" 7.9 12.9 13.3 6.1 20.0 11.5 14.5 12.6 19.6 10.2 7.1 5.7 7.8 6.3 9.4 14.8 24.9 8.2 8.0 8.7 13.6 12.6 10.4 15.5 7.2 9.2 14.9 15.0 11.7 11.3 8.7 15.1 7.6 12.6 11.5 7.4 3.1 11.8 9.5 10.1 19.8 6.6 9.1 15.5 7.8 8.6 9.5 13.2 9.3 13.9 8.8 12.1 12.3 16.4 7.5 2.8 6.8 1.7 5.6 11.7 5.6 9.5 6.2 5.7 6.4 11.6 15.2 4.6 12.3 10.0 10.7 9.2 5.7 3.6 16.9 1.8 6.2 5.8 8.2 11.1 8.6 17.7 7.5 12.7 15.0 5.0 5.1 15.1 19.0 6.8 10.7 12.0 9.6 12.5 11.3 7.9 7.5 13.9 3.4 15.6 3.3 12.5 8.1 8.8 7.6 13.0 7.4 9.8 14.3 11.6 7.8 13.9 12.6 7.3 16.5 7.9 4.6 10.5 11.4 6.6 9.3 3.4 9.7 9.4 8.5 11.4 11.3 7.2 13.4 8.3 6.8 1.7 1.3 7.1 1.7 9.7 7.5 8.8 7.6 2.3 5.3 11.7 9.0 0.0 5.6 1.5 2.8 7.3 5.6 13.3 20.0 12.6 19.6 13.6 12.6 14.9 15.0 12.6 13.2 8.9 12.8 13.7 22.3 45.7 13.8 14.3 22.9 21.4 20.5 5.2 5.9 12.8 31.5 20.6 19.5 12.6 3.6 23.3 20.9 13.3 26.0 20.2 10.4 15.5 8.2 9.5 7.5 9.8 8.5 13.2 29.7 6.7 25.3 3.6 7.4 10.0 18.1 3.5 29.0 25.2 17.9 6.5 35.0 42.3 32.3 62.5 7.8 19.1 11.2 23.8 C12orf75 "AGD3, OCC-1, OCC1" ENSG00000235162 "Chromosome 12 open reading frame 75" Q8TAD7 12 105235290-105396097 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 97.7" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 712.9;Extravillous trophoblasts: 1087.5;Proximal tubular cells: 486.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 97.7" "Group enriched" "Detected in many" 6 "dendritic cells: 97.7;T-cells: 26.3" "Cell line enhanced" "Detected in many" "BJ: 120.7;BJ hTERT+: 67.7;fHDF/TERT166: 55.7;RPTEC TERT1: 55.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065311 Uncertain Approved Vesicles NA NA Vesicles "HPA065311: AB_2685463" "unprognostic (5.96e-2)" "unprognostic (3.85e-1)" "unprognostic (9.86e-2)" "unprognostic (1.02e-1)" "unprognostic (6.73e-2)" "unprognostic (8.58e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (8.61e-2)" "unprognostic (1.01e-1)" "unprognostic (2.60e-2)" "unprognostic (1.33e-1)" "unprognostic (7.00e-2)" "prognostic favorable (1.69e-5)" "unprognostic (1.80e-1)" "unprognostic (1.15e-1)" "unprognostic (1.00e-1)" "unprognostic (4.47e-3)" 7.1 3.4 5.5 17.1 5.3 4.2 14.3 3.4 3.3 22.3 10.9 4.9 57.0 4.1 12.8 9.5 5.7 9.7 48.8 3.6 3.5 6.4 37.5 1.4 8.1 6.0 5.4 2.5 7.7 26.8 15.2 2.5 15.0 4.6 19.6 10.2 1.3 3.4 54.9 16.8 5.7 7.7 3.1 4.7 5.7 22.4 28.4 3.7 13.5 2.0 6.5 8.7 4.7 18.1 2.7 97.7 4.3 0.2 9.6 26.3 11.3 5.3 8.6 2.2 1.9 8.3 16.0 3.9 120.7 67.7 25.8 14.7 17.2 0.4 1.5 48.4 55.7 4.3 9.0 4.7 6.5 28.7 29.1 8.9 5.0 2.4 3.3 1.1 3.7 5.2 6.7 1.6 8.8 9.7 15.2 3.3 9.6 0.2 8.0 25.2 1.8 15.6 33.8 5.1 2.0 19.5 2.7 5.8 1.4 55.8 0.5 9.8 2.3 4.7 1.0 1.9 6.2 3.0 0.9 5.8 26.9 10.1 10.4 15.0 4.6 7.3 7.4 6.1 1.2 7.3 4.3 0.1 0.1 25.9 0.0 12.4 2.7 11.2 26.3 3.4 1.7 3.2 16.2 0.5 9.6 0.2 97.7 20.5 11.3 5.5 5.3 3.4 3.3 3.5 6.4 5.4 2.5 4.6 3.7 3.0 3.2 69.2 50.0 89.1 3.6 0.6 236.9 100.4 25.0 177.9 3.9 20.0 712.9 456.1 123.1 11.9 114.3 0.0 196.9 1087.5 96.3 39.4 2.3 1.5 26.7 60.4 320.1 10.4 2.1 216.0 14.4 17.3 57.3 34.3 54.4 2.0 293.7 42.5 4.6 486.9 4.8 6.5 176.9 110.5 92.4 53.4 34.0 103.3 55.5 26.7 C15orf38-AP3S2 ENSG00000250021 "C15orf38-AP3S2 readthrough" 15 89834308-89912882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 1.7;Club cells: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040513, HPA047173, HPA049270, HPA052278" Uncertain Approved Vesicles NA NA Vesicles "HPA040513: AB_2677015, HPA047173: AB_2679969, HPA049270: AB_2680696, HPA052278: AB_2681783" "unprognostic (1.27e-1)" "unprognostic (8.88e-2)" "unprognostic (4.94e-2)" "unprognostic (1.04e-1)" "unprognostic (3.25e-2)" "unprognostic (3.44e-1)" "unprognostic (2.56e-1)" "unprognostic (1.80e-1)" "unprognostic (1.84e-1)" "unprognostic (2.19e-1)" "unprognostic (1.82e-1)" "unprognostic (1.42e-1)" "unprognostic (1.44e-2)" "unprognostic (1.27e-1)" "unprognostic (8.35e-2)" "unprognostic (2.29e-1)" "unprognostic (4.49e-2)" 15.1 13.5 13.3 12.0 14.4 7.1 20.3 11.4 16.4 17.4 22.2 16.7 11.4 13.3 15.3 20.1 17.0 12.3 16.4 20.7 13.1 17.1 13.9 23.5 13.1 10.0 16.5 11.5 17.9 52.9 14.8 10.9 11.6 12.9 19.9 19.7 14.5 12.5 15.4 21.1 9.7 23.7 14.4 17.5 9.8 9.7 11.7 9.1 2.5 14.3 12.0 9.9 15.4 13.5 5.2 14.8 13.9 19.8 7.5 7.1 11.1 6.8 14.7 11.7 15.6 17.4 8.0 8.4 12.0 13.9 15.4 15.5 4.9 15.9 3.6 12.7 10.2 12.9 8.7 9.6 10.6 10.6 7.6 9.0 5.3 7.0 10.7 10.4 2.6 4.2 9.6 9.0 9.1 9.8 8.7 13.7 4.7 4.9 8.8 11.8 9.6 4.0 4.2 12.3 17.3 3.7 3.0 5.1 2.8 14.8 8.0 4.0 6.2 21.5 21.4 16.4 16.0 14.0 5.3 7.0 13.8 10.3 19.3 7.7 3.3 7.9 4.1 12.0 3.7 10.2 7.1 19.8 8.4 5.5 16.3 7.1 5.2 6.7 5.9 14.8 4.9 5.0 5.0 13.9 7.5 11.9 6.2 6.7 11.1 13.3 14.4 11.4 16.4 13.1 17.1 16.5 11.5 12.9 9.1 3.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 C19orf84 ENSG00000262874 "Chromosome 19 open reading frame 84" I3L1E1 19 51388289-51390574 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 39.0" "Cell type enhanced" "Detected in some" 24 "Late spermatids: 1.8;Spermatogonia: 3.2" "Cancer enhanced" "Detected in some" "testis cancer: 3.5" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "gdT-cell: 1.5;plasmacytoid DC: 1.7" "Group enriched" "Detected in many" 6 "dendritic cells: 1.7;T-cells: 1.5" "Cell line enriched" "Detected in some" 8 "K-562: 12.3" "Low region specificity" "Detected in all" HPA068082 Uncertain Approved Vesicles NA NA Vesicles "HPA068082: AB_2685949" "unprognostic (5.94e-2)" "unprognostic (7.72e-2)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (2.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.13e-3)" "unprognostic (9.28e-4)" "unprognostic (1.31e-1)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (3.84e-1)" "unprognostic (2.61e-7)" "unprognostic (8.30e-3)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (3.99e-3)" 0.0 0.0 0.1 0.3 0.2 0.9 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.1 0.1 0.2 0.6 0.1 0.0 0.0 0.1 0.3 0.4 0.0 0.4 0.0 0.0 0.1 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.5 0.0 39.0 0.2 1.0 0.0 0.2 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.2 1.5 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.3 0.3 0.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 12.3 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.1 0.2 0.2 0.2 0.6 0.1 0.4 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 C1GALT1C1 "C1GALT2, COSMC" ENSG00000171155 "C1GALT1 specific chaperone 1" Q96EU7 X 120625793-120630150 "Disease related genes, Predicted membrane proteins" Chaperone "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 83.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 73.1" "Low region specificity" "Detected in all" "HPA010666, HPA015632" Approved Approved Vesicles NA NA Vesicles "HPA010666: , HPA015632: AB_1845625" "prognostic unfavorable (5.66e-4)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.98e-1)" "unprognostic (3.07e-2)" "unprognostic (5.26e-3)" "unprognostic (4.34e-2)" "unprognostic (2.50e-1)" "unprognostic (2.18e-2)" "unprognostic (8.10e-2)" "unprognostic (3.85e-2)" "unprognostic (3.07e-1)" "unprognostic (3.98e-2)" "unprognostic (4.48e-2)" "unprognostic (1.55e-1)" "unprognostic (6.05e-3)" "unprognostic (3.78e-2)" 16.5 28.0 8.4 11.1 9.2 3.0 21.1 9.0 9.9 19.2 16.7 10.8 16.5 12.7 13.0 23.1 15.0 15.1 11.6 17.7 9.0 10.9 25.9 35.2 12.4 12.9 11.0 7.5 13.2 18.8 18.7 83.5 13.3 11.5 14.1 19.4 10.9 19.4 15.5 7.4 5.8 20.6 12.4 12.0 16.5 14.6 9.6 10.6 16.3 19.8 12.3 12.4 13.9 12.3 17.2 23.0 31.3 22.3 15.1 23.8 16.2 8.5 8.3 4.6 7.9 73.1 13.9 7.3 15.7 22.2 8.3 15.8 5.4 27.6 5.6 7.9 31.6 16.0 12.1 9.0 7.6 13.3 9.4 10.9 3.6 7.7 7.9 11.4 6.2 5.7 12.1 6.9 10.3 3.5 20.9 26.1 2.8 2.2 6.6 9.7 11.6 2.1 5.9 5.2 28.9 8.4 0.9 3.6 15.2 16.8 5.8 5.1 4.8 14.9 10.2 7.8 8.8 8.9 6.1 23.9 3.8 4.7 15.3 14.6 2.8 4.2 4.4 14.0 12.4 8.4 13.3 17.7 27.0 17.6 22.3 19.4 17.2 22.9 19.0 20.1 10.6 23.8 18.9 31.3 15.1 17.5 23.0 21.0 16.2 8.4 9.2 9.0 9.9 9.0 10.9 11.0 7.5 11.5 10.6 6.0 7.2 13.4 18.7 6.1 8.1 14.1 12.7 26.8 18.2 36.6 2.0 47.7 13.3 34.2 2.5 22.5 15.3 0.0 39.1 41.4 29.1 13.7 2.3 19.2 21.2 19.1 13.3 20.3 15.1 4.4 21.0 19.0 28.7 23.4 19.1 19.0 25.0 17.6 18.0 16.1 8.2 6.5 20.3 4.4 7.9 6.4 16.7 13.8 18.9 20.6 C1QTNF12 "ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127" ENSG00000184163 "C1q and TNF related 12" Q5T7M4 1 1242446-1246722 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 11.0;skin 1: 7.8" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 10.0;Proximal tubular cells: 37.6" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.6;NK-cell: 2.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "EFO-21: 8.3;U-2 OS: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA024107 Uncertain Approved Vesicles "Secreted to blood" NA NA 38200000 Vesicles "HPA024107: AB_2101207" "unprognostic (1.10e-2)" "unprognostic (5.68e-3)" "unprognostic (3.45e-1)" "unprognostic (1.24e-2)" "unprognostic (6.60e-3)" "unprognostic (2.43e-1)" "unprognostic (2.67e-3)" "unprognostic (1.01e-2)" "unprognostic (2.58e-1)" "unprognostic (1.05e-2)" "unprognostic (8.02e-3)" "unprognostic (1.10e-2)" "unprognostic (9.68e-3)" "unprognostic (1.48e-1)" "unprognostic (2.47e-1)" "unprognostic (1.09e-1)" "unprognostic (1.20e-1)" 1.0 0.0 0.5 0.2 0.0 0.0 0.5 0.2 0.2 0.1 3.4 11.0 0.1 0.0 1.2 0.2 0.1 0.2 0.0 1.0 3.1 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 1.2 0.4 0.0 0.1 7.8 10.4 0.1 0.2 0.0 0.3 2.4 0.2 0.1 0.0 0.4 0.3 0.6 2.6 0.3 2.2 0.4 0.2 0.3 0.0 0.0 0.6 0.4 0.1 1.6 1.1 0.0 0.1 0.0 0.6 0.4 0.1 8.3 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.2 0.3 0.1 0.1 0.1 0.3 0.0 0.0 0.2 0.4 0.0 0.0 0.5 0.3 0.1 0.9 0.6 0.1 0.3 0.0 1.3 0.0 0.0 1.2 0.3 0.0 0.0 0.7 0.0 0.6 0.1 0.0 0.0 8.2 0.1 0.0 1.7 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.2 0.0 0.6 0.3 0.4 0.0 2.6 2.2 0.3 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.2 0.0 0.0 0.0 0.0 0.7 10.0 0.0 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.7 0.0 0.0 37.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 C1QTNF7 CTRP7 ENSG00000163145 "C1q and TNF related 7" Q9BXJ2 4 15339818-15446166 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 39.6" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 15.1;Fibroblasts: 10.3;Leydig cells: 21.0;Peritubular cells: 29.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 14 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 14 "granulocytes: 1.7" "Group enriched" "Detected in some" 5 "ASC diff: 9.2;ASC TERT1: 6.4;HSkMC: 3.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB007055, HPA051797, HPA055392" Uncertain Approved Vesicles "Secreted to blood" NA NA 238000000 Vesicles "CAB007055: , HPA051797: AB_2681614, HPA055392: AB_2732596" "unprognostic (6.61e-2)" "unprognostic (4.50e-2)" "unprognostic (6.16e-2)" "unprognostic (6.50e-4)" "unprognostic (1.24e-1)" "unprognostic (4.98e-3)" "unprognostic (2.31e-2)" "unprognostic (7.69e-3)" "unprognostic (7.61e-2)" "unprognostic (1.13e-1)" "unprognostic (2.41e-1)" "unprognostic (1.38e-1)" "unprognostic (2.97e-4)" "unprognostic (3.01e-3)" "unprognostic (8.31e-2)" "unprognostic (7.56e-3)" "unprognostic (7.28e-3)" 16.0 0.9 0.6 24.7 0.8 0.0 7.4 0.3 0.7 39.6 12.0 0.5 3.3 0.6 24.6 10.1 17.3 6.2 20.3 5.4 0.6 0.6 4.0 1.0 7.9 0.5 0.8 0.5 15.9 1.3 0.0 1.4 5.4 0.8 22.0 3.2 5.4 2.7 2.4 2.2 3.5 4.1 22.1 0.7 10.2 10.4 4.4 0.1 0.3 4.2 13.0 2.0 16.3 15.8 0.1 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 6.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 3.4 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.3 0.7 0.6 0.6 0.8 0.5 0.8 0.1 0.0 0.0 0.0 0.0 3.2 15.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.2 10.3 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 21.0 0.0 5.0 0.0 0.0 0.2 0.0 0.0 29.7 1.0 0.9 6.5 8.2 0.0 0.0 2.6 0.0 0.0 0.0 0.1 C2CD4C "FAM148C, KIAA1957, NLF3" ENSG00000183186 "C2 calcium dependent domain containing 4C" Q8TF44 19 405438-409170 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.4" "Group enriched" "Detected in some" 5 "Intestinal endocrine cells: 2.9;Ito cells: 3.1;Muller glia cells: 1.7;Rod photoreceptor cells: 6.6;Spermatogonia: 1.9" "Cancer enhanced" "Detected in many" "testis cancer: 7.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.4;MCF7: 5.1;NTERA-2: 7.5;SCLC-21H: 13.4;U-2 OS: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA055915 Uncertain Approved Vesicles NA NA Vesicles "HPA055915: AB_2682968" "unprognostic (1.29e-1)" "unprognostic (9.43e-2)" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "unprognostic (9.39e-3)" "unprognostic (2.14e-1)" "unprognostic (1.67e-1)" "unprognostic (9.81e-2)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (1.19e-1)" "unprognostic (1.35e-1)" "unprognostic (1.12e-2)" "unprognostic (1.43e-2)" "unprognostic (5.04e-2)" "unprognostic (5.09e-2)" "unprognostic (1.74e-1)" 6.9 2.1 15.8 1.7 7.4 0.8 5.4 1.0 19.4 2.2 1.3 0.7 0.0 2.0 2.4 0.9 1.2 1.6 8.6 2.2 7.1 13.5 1.6 1.0 1.5 1.2 4.7 10.8 0.9 1.1 0.9 1.7 2.0 6.5 1.1 1.0 2.2 1.1 1.0 3.1 2.4 1.8 1.3 3.0 1.2 1.6 1.9 3.0 0.0 6.7 0.0 0.9 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.8 1.5 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.1 2.4 0.0 0.7 0.0 0.9 2.8 2.8 0.2 0.1 7.4 1.6 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.3 0.0 0.5 0.2 0.0 0.1 5.1 0.0 0.0 7.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.4 3.9 1.2 0.0 0.0 0.7 0.2 0.0 0.0 0.1 8.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 7.4 1.0 18.2 7.1 13.5 4.7 10.8 6.5 3.0 0.0 0.0 0.0 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 6.6 0.0 0.0 0.7 1.9 0.3 0.0 0.0 0.0 0.0 C4orf47 LOC441054 ENSG00000205129 "Chromosome 4 open reading frame 47" A7E2U8 4 185426249-185449826 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.8;fallopian tube: 20.3;testis: 20.6" "Group enriched" "Detected in many" 7 "Ciliated cells: 125.8;Early spermatids: 125.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.1" "Lineage enriched" "Detected in single" 4 "granulocytes: 4.1" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.1;hTERT-RPE1: 8.3;U-87 MG: 10.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA043662, HPA063485" Enhanced Uncertain Vesicles NA NA Vesicles "HPA043662: AB_10964715, HPA063485: " "unprognostic (3.38e-2)" "unprognostic (2.66e-1)" "unprognostic (5.78e-3)" "unprognostic (2.84e-3)" "unprognostic (3.61e-3)" "unprognostic (1.31e-1)" "unprognostic (5.82e-5)" "unprognostic (3.72e-2)" "unprognostic (4.62e-2)" "unprognostic (2.84e-1)" "unprognostic (1.25e-1)" "unprognostic (8.71e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.05e-1)" "unprognostic (3.64e-2)" "unprognostic (9.88e-3)" "unprognostic (1.50e-1)" 0.9 0.5 4.4 0.7 13.3 0.8 3.7 1.7 4.0 1.8 0.7 3.6 0.8 0.6 2.2 12.3 0.7 20.3 1.8 1.2 3.8 3.8 2.4 1.0 3.3 0.5 2.4 2.9 3.0 1.3 1.0 7.1 0.7 20.8 1.2 0.7 2.1 1.0 1.4 0.6 1.9 0.7 1.0 4.7 0.8 0.5 20.6 5.5 0.0 7.3 0.0 0.6 1.0 0.6 0.1 0.7 4.1 0.6 0.9 0.6 0.2 3.9 0.0 0.4 2.1 0.8 4.1 1.2 0.1 0.3 0.3 0.5 0.6 2.4 0.1 0.8 0.1 0.4 0.3 0.5 0.6 0.9 0.8 0.7 0.0 0.1 0.6 1.0 0.0 0.3 0.9 0.9 1.0 0.4 8.3 0.0 0.9 0.5 0.2 3.0 0.5 0.0 0.0 0.5 0.0 1.5 0.1 0.0 0.3 1.1 0.1 2.2 1.0 0.7 0.1 2.4 0.8 0.2 0.6 1.2 0.6 0.3 0.0 0.1 1.7 0.0 0.0 10.0 0.0 0.2 0.0 0.6 0.6 0.2 0.1 0.4 0.0 0.6 0.6 0.2 0.1 0.1 0.2 4.1 0.9 0.2 0.7 0.0 0.2 4.4 13.3 1.7 4.0 3.8 3.8 2.4 2.9 20.8 5.5 3.0 1.0 0.0 0.5 0.6 0.6 0.5 0.0 125.8 17.0 3.5 9.8 0.1 1.7 1.2 125.8 0.6 0.0 0.0 0.5 1.2 0.8 1.2 0.0 0.0 0.2 1.6 0.0 1.3 0.3 7.5 0.6 0.4 1.7 0.0 0.0 1.6 1.4 0.0 0.7 3.2 14.2 0.0 1.0 3.5 4.3 0.5 0.2 0.0 0.0 0.3 C7orf61 IMAGE:4839025 ENSG00000185955 "Chromosome 7 open reading frame 61" Q8IZ16 7 100456615-100464271 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 80.4" "Group enriched" "Detected in many" 48 "Early spermatids: 438.3;Late spermatids: 271.6" "Cancer enhanced" "Detected in some" "glioma: 3.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 22.2;NB-4: 8.1;TIME: 13.0" HPA060395 Enhanced Approved Vesicles NA NA Vesicles "HPA060395: AB_2684274" "unprognostic (1.88e-1)" "unprognostic (5.02e-1)" "unprognostic (1.26e-2)" "unprognostic (7.70e-5)" "unprognostic (1.65e-1)" "unprognostic (2.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (4.26e-1)" "unprognostic (2.25e-1)" "unprognostic (4.43e-2)" "unprognostic (2.53e-1)" "unprognostic (6.39e-13)" "unprognostic (9.54e-2)" "unprognostic (2.93e-1)" "unprognostic (1.33e-2)" "unprognostic (1.24e-2)" 0.5 0.3 2.8 0.6 3.1 1.2 0.5 1.4 3.4 0.5 0.5 0.5 0.5 0.1 0.8 0.8 0.5 0.7 0.6 0.5 3.0 2.3 0.5 0.5 0.5 0.8 3.2 0.5 1.0 0.5 0.4 0.9 0.6 0.6 0.5 0.2 0.5 0.5 0.7 0.5 0.7 0.5 0.5 3.1 1.0 0.1 80.4 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.1 0.6 1.3 1.2 0.8 2.9 0.2 0.8 0.2 0.7 0.8 0.9 2.0 0.3 0.3 1.3 0.2 0.7 0.9 0.4 0.6 1.5 0.8 1.2 0.6 0.3 0.0 0.5 0.8 1.5 1.2 1.7 0.0 1.1 0.4 0.3 0.3 0.4 0.8 1.2 2.1 22.2 2.1 0.6 1.1 1.3 2.1 0.4 8.1 0.5 0.3 1.0 2.1 0.0 0.4 0.3 0.3 0.0 0.0 0.5 0.7 1.3 0.4 0.4 2.2 13.0 1.2 2.0 2.5 0.4 0.3 0.2 0.8 0.2 1.9 0.1 0.0 1.2 0.0 0.8 0.7 0.3 0.0 1.1 0.6 0.6 0.1 0.1 1.6 1.3 0.8 0.4 0.0 2.9 0.2 2.8 3.1 1.4 1.5 3.0 2.3 3.2 0.5 0.6 0.5 0.0 0.0 0.0 0.4 7.3 1.5 0.9 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 438.3 1.5 0.3 0.0 0.0 0.3 1.3 0.6 0.0 0.0 0.8 3.2 0.0 0.0 0.3 271.6 7.2 1.7 5.0 1.0 0.2 6.3 0.3 0.0 3.5 0.0 0.0 6.5 0.8 3.6 2.5 5.4 0.1 0.0 0.4 0.4 CA10 "CA-RPX, CARPX, HUCEP-15" ENSG00000154975 "Carbonic anhydrase 10" Q9NS85 17 51630313-52160017 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 59.5;cervix, uterine: 23.4" "Cell type enhanced" "Detected in some" 27 "Bipolar cells: 230.7;Early spermatids: 106.6;Late spermatids: 56.3" "Cancer enhanced" "Detected in some" "glioma: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPTEC TERT1: 2.2;RT4: 3.8;SCLC-21H: 11.7;SuSa: 1.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054825, HPA057837" Supported Approved Vesicles "Secreted in brain" NA NA Vesicles "HPA054825: AB_2682617, HPA057837: AB_2683542" "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (6.06e-2)" "unprognostic (2.10e-1)" "unprognostic (3.43e-1)" "unprognostic (8.22e-2)" "unprognostic (4.43e-3)" "unprognostic (1.02e-3)" "unprognostic (1.01e-1)" "unprognostic (5.91e-2)" "unprognostic (1.46e-1)" "unprognostic (7.21e-3)" "unprognostic (9.18e-5)" "unprognostic (1.60e-1)" "unprognostic (1.51e-1)" 0.5 3.8 14.4 0.5 6.3 0.5 0.5 59.5 36.7 23.4 0.8 1.7 0.0 0.8 0.7 0.5 0.6 0.7 0.6 0.5 8.0 12.4 7.8 0.5 0.5 0.5 7.0 5.0 2.5 0.8 0.5 1.8 14.2 18.3 0.5 0.7 2.9 1.5 0.5 0.5 0.5 1.1 0.6 4.2 0.5 0.6 6.0 1.3 0.0 0.5 0.0 0.5 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 2.2 3.8 11.7 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 6.3 59.5 17.9 8.0 12.4 7.0 5.0 18.3 1.3 0.0 0.0 0.0 0.0 0.0 230.7 0.3 0.0 0.0 0.0 3.5 3.9 0.0 13.3 0.0 106.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 56.3 1.1 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.7 0.0 9.7 0.0 0.0 0.9 1.0 0.0 0.1 0.0 0.0 0.0 CAAP1 "C9orf82, CAAP, FLJ13657" ENSG00000120159 "Caspase activity and apoptosis inhibitor 1" Q9H8G2 9 26840685-26892804 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020404, HPA024029, HPA024100" Uncertain Approved Vesicles NA NA Vesicles "HPA020404: AB_1845841, HPA024029: AB_1845842, HPA024100: AB_1845843" "unprognostic (1.07e-1)" "unprognostic (2.35e-1)" "unprognostic (1.73e-2)" "unprognostic (6.74e-2)" "unprognostic (8.83e-2)" "unprognostic (1.35e-2)" "unprognostic (4.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.11e-2)" "prognostic favorable (1.27e-5)" "unprognostic (1.46e-1)" "unprognostic (1.89e-1)" "prognostic favorable (7.94e-9)" "unprognostic (2.74e-2)" "unprognostic (7.57e-2)" "unprognostic (1.46e-1)" "unprognostic (1.43e-2)" 9.5 26.3 10.5 14.3 11.7 10.0 11.6 12.9 12.9 10.1 16.9 9.1 16.4 14.9 13.6 19.5 14.3 9.1 12.3 9.1 10.2 10.6 25.6 30.1 7.9 12.7 9.7 7.2 8.1 20.7 17.7 20.0 9.1 10.7 10.8 19.1 14.2 17.5 15.5 9.9 10.6 17.6 10.0 8.8 14.1 10.8 19.4 9.6 25.6 27.1 10.6 16.7 10.1 9.8 16.2 15.0 12.7 14.5 15.1 17.6 12.7 13.0 8.2 14.0 14.6 9.4 8.0 10.2 9.0 9.8 9.5 11.7 2.5 8.6 16.4 9.0 8.7 5.5 6.7 14.3 9.7 13.4 19.6 7.2 27.6 13.7 15.4 16.0 11.4 13.0 8.0 12.5 7.2 18.0 10.7 15.8 10.4 7.3 12.1 10.8 7.2 18.1 4.9 18.3 13.0 5.3 12.7 6.5 10.1 24.6 9.9 10.8 22.4 8.6 10.3 8.7 13.3 8.8 14.4 8.6 0.0 14.3 5.8 9.2 5.3 9.9 17.9 4.7 12.4 5.8 12.7 9.4 6.4 14.1 14.5 17.6 16.2 15.6 16.3 15.0 14.1 13.0 13.6 1.2 15.1 12.1 13.8 15.1 12.7 10.5 11.7 12.9 12.9 10.2 10.6 9.7 7.2 10.7 9.6 20.8 16.3 15.2 9.8 8.9 10.2 6.7 15.3 24.1 33.0 29.6 7.9 15.8 49.7 17.2 7.9 10.4 15.3 0.0 17.2 12.3 9.8 13.5 17.4 27.2 10.8 7.9 14.9 11.6 10.7 2.7 7.8 10.6 8.5 16.2 22.0 20.7 17.9 21.0 6.0 19.9 11.6 12.9 9.1 39.5 18.8 12.8 9.0 8.7 26.8 10.5 CAB39L "bA103J18.3, FLJ12577, MO2L" ENSG00000102547 "Calcium binding protein 39 like" Q9H9S4 13 49308650-49444126 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 123.2" "Cancer enhanced" "Detected in all" "prostate cancer: 28.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 24.4;RT4: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003686, HPA045954, HPA076632" Approved Approved Vesicles NA NA Vesicles "CAB003686: AB_426084, HPA045954: AB_2679512, HPA076632: " "unprognostic (3.90e-2)" "unprognostic (1.09e-1)" "unprognostic (4.13e-1)" "unprognostic (5.01e-1)" "unprognostic (3.29e-1)" "unprognostic (1.94e-1)" "unprognostic (2.82e-1)" "unprognostic (2.94e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (2.28e-4)" "unprognostic (3.08e-2)" "prognostic favorable (7.91e-4)" "prognostic favorable (1.94e-13)" "unprognostic (6.59e-2)" "unprognostic (8.31e-2)" "unprognostic (4.96e-2)" "unprognostic (8.05e-3)" 19.6 32.1 18.4 5.6 18.2 2.1 32.6 17.6 22.6 12.9 33.2 13.1 19.0 5.5 11.5 14.8 25.6 12.5 13.6 14.5 22.2 16.3 12.8 5.0 12.2 3.7 29.6 19.5 17.6 10.2 17.9 10.7 10.3 26.4 35.8 10.2 7.6 13.8 20.7 4.9 10.6 8.0 21.1 23.3 3.8 18.8 24.1 24.9 2.5 8.9 9.1 4.6 21.3 13.0 3.8 3.9 9.9 3.8 2.7 5.3 3.2 1.0 1.0 6.7 1.9 6.6 6.6 9.2 6.0 12.8 3.7 3.0 24.4 3.5 8.3 0.8 4.0 4.2 1.9 3.5 4.3 7.0 2.9 3.2 2.2 1.5 1.7 3.4 1.8 1.0 4.9 3.8 3.0 4.7 5.2 4.7 1.4 0.3 2.0 5.7 1.6 1.9 1.6 5.2 3.2 1.7 1.6 0.9 1.3 5.8 25.5 0.8 2.6 3.2 7.2 7.8 7.8 11.2 3.4 4.8 1.7 1.7 3.4 4.9 1.5 1.4 9.6 1.9 1.8 4.0 9.9 3.8 7.9 4.4 3.5 3.2 3.8 5.2 5.3 3.9 2.9 4.0 3.7 8.4 2.7 2.9 0.5 5.2 3.2 18.4 18.2 17.6 22.2 22.2 16.3 29.6 19.5 26.4 24.9 14.9 11.0 0.0 11.2 2.7 5.6 13.7 5.1 24.1 11.4 10.4 5.9 22.7 10.0 8.3 123.2 2.9 1.0 0.0 9.4 10.1 12.0 23.2 4.6 1.9 5.6 1.6 2.4 5.5 2.2 17.0 14.4 4.3 11.8 7.2 2.3 11.5 7.7 0.0 11.0 3.7 5.0 6.5 11.7 8.2 3.0 3.9 24.3 1.8 1.9 20.0 CACNA2D2 KIAA0558 ENSG00000007402 "Calcium voltage-gated channel auxiliary subunit alpha2delta 2" Q9NY47 3 50362799-50504244 "FDA approved drug targets, Predicted intracellular proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 86.1" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 71.5;Alveolar cells type 2: 145.9" "Cancer enhanced" "Detected in many" "testis cancer: 20.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 8 "SH-SY5Y: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034771, HPA071829" Enhanced Approved Vesicles NA NA 1000000 Vesicles "HPA034771: AB_10603555, HPA071829: AB_2686454" "unprognostic (2.06e-1)" "unprognostic (2.37e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (7.62e-5)" "unprognostic (6.59e-2)" "unprognostic (6.37e-2)" "unprognostic (6.91e-2)" "unprognostic (6.57e-3)" "unprognostic (4.39e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.21e-4)" "unprognostic (2.71e-2)" "unprognostic (1.57e-4)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (3.55e-1)" "unprognostic (4.22e-2)" 1.0 0.9 1.6 1.3 11.1 1.1 1.4 14.9 6.5 1.1 1.7 0.9 0.6 1.4 1.7 1.2 0.9 1.1 0.9 7.6 1.7 9.1 1.6 0.5 86.1 1.3 3.9 3.2 2.2 4.0 3.8 6.0 1.9 6.1 3.0 2.0 6.1 1.5 1.4 1.7 2.6 1.7 1.4 1.4 1.5 4.1 5.8 2.5 0.2 2.3 0.1 0.7 0.7 0.7 1.8 0.3 0.7 0.1 2.3 3.6 1.1 0.0 0.0 1.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 8.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.0 2.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 6.4 66.5 0.2 0.1 0.0 2.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 2.2 0.0 2.7 1.8 2.6 2.0 0.0 1.3 3.6 2.2 0.0 2.3 0.1 0.3 3.2 1.1 1.6 11.1 14.9 6.5 1.7 9.1 3.9 3.2 6.1 2.5 71.5 145.9 0.0 0.3 1.3 7.2 3.0 0.0 4.0 4.5 1.8 19.6 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.1 0.7 19.7 0.0 0.1 0.0 1.2 0.6 0.0 2.3 0.3 0.0 0.0 0.0 3.5 4.0 0.6 0.0 1.8 0.4 10.0 12.9 0.8 1.6 11.1 0.5 0.2 1.0 0.4 0.3 CADPS "CAPS, CAPS1, KIAA1121, UNC-31" ENSG00000163618 "Calcium dependent secretion activator" Q9ULU8 3 62398346-62875389 "Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.0" "Group enriched" "Detected in many" 7 "Bipolar cells: 784.0;Cone photoreceptor cells: 591.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "memory B-cell: 1.3" "Lineage enriched" "Detected in single" 11 "B-cells: 1.3" "Cell line enhanced" "Detected in some" "OE19: 9.2;SCLC-21H: 16.5;SK-MEL-30: 7.3;U-698: 10.5;U-87 MG: 17.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059328 Enhanced Approved Vesicles NA NA Vesicles "HPA059328: AB_2683982" "unprognostic (3.46e-3)" "unprognostic (1.40e-2)" "unprognostic (1.61e-2)" "unprognostic (3.87e-2)" "unprognostic (1.14e-1)" "unprognostic (1.61e-1)" "unprognostic (2.21e-1)" "unprognostic (3.12e-2)" "unprognostic (9.27e-2)" "unprognostic (5.73e-2)" "unprognostic (2.08e-3)" "unprognostic (3.21e-1)" "unprognostic (4.20e-3)" "unprognostic (1.90e-2)" "unprognostic (2.04e-1)" "unprognostic (7.91e-3)" "unprognostic (5.35e-3)" 1.2 17.2 18.2 2.8 16.0 1.0 1.6 22.4 58.0 4.0 3.5 2.4 0.0 3.9 1.5 3.4 1.1 1.1 3.2 11.6 21.9 24.7 1.1 1.1 1.6 1.4 33.7 18.4 2.8 13.5 0.9 19.6 1.1 43.6 4.5 3.3 5.3 1.3 3.8 1.0 2.2 4.0 1.7 7.1 1.4 4.1 3.2 2.7 0.0 1.1 0.0 1.6 1.2 0.6 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.9 9.2 0.0 0.1 0.0 0.0 0.0 0.0 16.5 1.2 0.0 0.0 7.3 0.3 0.0 0.0 0.0 1.4 0.1 2.7 0.7 0.0 1.4 10.5 17.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 18.2 16.0 22.4 32.0 21.9 24.7 33.7 18.4 43.6 2.7 0.0 3.4 0.0 0.2 1.1 784.0 16.5 5.1 0.0 0.0 0.0 591.0 0.1 0.0 2.1 0.9 0.1 0.3 0.0 0.3 0.0 2.6 0.3 41.5 0.0 0.0 44.5 92.0 0.0 0.0 0.9 14.1 0.0 8.5 0.0 1.9 16.8 1.2 0.2 2.5 0.0 60.9 0.0 1.2 0.2 0.2 0.1 0.0 0.0 0.4 0.3 CALB1 CALB ENSG00000104327 "Calbindin 1" P05937 8 90058608-90095475 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 15 "brain: 73.8;kidney: 121.9" "Cell type enhanced" "Detected in some" 16 "Collecting duct cells: 26.2;Cone photoreceptor cells: 86.4;Distal tubular cells: 26.6;Horizontal cells: 93.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 6.4" "Group enriched" "Detected in many" 7 "granulocytes: 6.4;monocytes: 2.5" "Cell line enhanced" "Detected in many" "A-431: 39.3;EFO-21: 59.6;NTERA-2: 19.4;SuSa: 25.6" "Region enhanced" "Detected in many" "cerebellum: 483.1" "Group enriched" "Detected in all" 4 "basal ganglia: 88.7;cerebellum: 312.3" "CAB002138, HPA023099, HPA056734" Enhanced Approved Vesicles NA NA Vesicles "CAB002138: AB_563448, HPA023099: AB_1845859, HPA056734: AB_2683220" "unprognostic (2.19e-1)" "unprognostic (2.28e-3)" "unprognostic (2.61e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.82e-1)" "unprognostic (5.39e-2)" "unprognostic (2.05e-1)" "unprognostic (1.27e-1)" "unprognostic (3.49e-2)" "unprognostic (1.37e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (9.01e-2)" "unprognostic (2.11e-1)" "unprognostic (7.88e-2)" "unprognostic (2.24e-1)" "unprognostic (1.42e-1)" 1.6 1.2 19.6 1.4 73.8 1.0 1.4 66.0 10.9 3.1 1.3 0.5 0.0 1.0 1.0 2.0 1.7 2.0 0.9 1.0 13.8 15.2 121.9 1.5 2.1 1.0 2.8 6.4 0.9 2.0 1.3 3.2 2.2 12.8 0.9 1.4 0.8 1.3 0.8 1.4 1.7 1.1 1.2 14.7 1.1 1.3 2.1 10.6 0.0 1.4 0.0 1.0 1.0 0.1 0.5 0.6 6.4 2.5 0.0 0.2 1.0 39.3 2.1 8.9 0.6 0.2 1.4 1.2 0.6 4.0 0.3 0.5 0.3 4.7 0.2 59.6 0.0 0.6 13.7 12.8 15.8 2.7 0.1 0.7 1.4 16.5 0.3 1.7 0.2 0.7 0.6 5.1 0.8 7.8 2.1 10.6 0.7 2.7 1.1 10.5 0.2 0.6 0.1 19.4 0.5 8.0 0.3 0.2 0.7 4.7 0.3 1.4 0.9 10.7 0.7 0.1 25.6 0.5 0.5 0.0 1.5 8.4 1.9 3.4 1.0 1.3 0.3 0.2 0.1 0.1 2.6 0.5 1.5 0.2 0.7 0.0 0.0 0.0 0.1 0.1 0.5 0.2 0.2 6.4 0.0 2.5 0.6 0.0 1.0 19.6 73.8 66.0 10.9 13.8 15.2 2.8 6.4 12.8 10.6 0.0 0.0 0.0 0.0 0.0 20.2 1.6 0.0 0.0 0.0 26.2 86.4 0.0 26.6 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 93.8 3.4 0.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 17.8 0.2 0.0 0.0 0.0 12.3 0.0 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 CALM1 "CALML2, CAMI, DD132, PHKD" ENSG00000198668 "Calmodulin 1" P0DP23 14 90396502-90408261 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 176.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB018558, HPA044999" Supported Approved Vesicles NA NA Vesicles "CAB018558: AB_2069454, HPA044999: AB_2679177" "unprognostic (5.35e-3)" "unprognostic (3.96e-1)" "unprognostic (4.99e-3)" "unprognostic (2.91e-2)" "unprognostic (1.07e-1)" "unprognostic (2.87e-2)" "unprognostic (1.99e-3)" "unprognostic (1.52e-1)" "unprognostic (6.44e-2)" "unprognostic (1.16e-3)" "prognostic favorable (5.62e-4)" "unprognostic (2.77e-1)" "prognostic favorable (6.49e-4)" "unprognostic (2.66e-1)" "unprognostic (2.68e-1)" "unprognostic (1.11e-2)" "prognostic unfavorable (2.38e-5)" 47.5 28.1 141.5 26.9 148.2 57.2 21.5 149.6 176.0 27.4 55.9 49.4 20.7 53.9 20.3 41.7 58.8 48.6 29.5 52.3 139.8 86.1 61.5 39.0 38.7 27.8 85.2 100.1 20.9 22.6 41.4 27.6 38.6 106.1 33.7 60.5 22.2 33.2 43.5 100.2 19.3 50.6 42.6 71.1 29.3 35.6 22.3 49.8 12.6 22.7 18.8 37.8 32.7 21.8 45.7 42.8 90.3 53.7 88.8 118.3 109.4 26.9 37.6 44.9 17.2 50.5 44.5 38.4 49.8 42.7 38.5 41.8 40.0 47.9 29.2 26.0 58.7 18.1 45.2 28.1 69.2 64.2 56.8 18.0 30.9 32.4 36.6 27.7 46.8 24.9 27.9 34.6 37.7 13.4 25.6 86.8 20.3 14.2 40.1 52.7 91.7 15.4 45.8 26.1 74.4 52.6 30.9 40.1 19.7 31.8 83.3 94.1 39.5 43.5 76.2 27.8 38.9 50.4 16.4 53.8 32.5 20.8 34.0 41.4 22.4 50.6 32.1 51.4 39.4 45.1 90.3 31.8 71.0 96.0 37.9 118.3 45.7 102.5 101.0 42.8 35.7 74.8 88.1 47.0 88.8 53.7 40.5 105.6 109.4 141.5 148.2 149.6 176.0 139.8 86.1 85.2 100.1 106.1 49.8 360.3 314.0 329.2 485.1 503.7 1352.9 743.7 341.4 1962.0 494.8 378.6 115.8 358.0 389.6 484.7 100.9 794.0 1033.1 23.3 391.9 774.4 358.4 298.0 468.8 297.5 680.0 570.5 576.0 585.0 268.2 58.5 195.1 732.5 595.5 1203.7 393.5 1076.8 427.8 540.1 470.2 1073.9 291.0 310.4 582.3 94.1 162.2 507.4 959.8 581.7 530.3 385.0 CAT ENSG00000121691 Catalase P04040 11 34438925-34472062 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Hydrogen peroxide" "Mitogen, Oxidoreductase, Peroxidase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 258.3;liver: 184.8" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 350.4;Hepatocytes: 400.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 13 "eosinophil: 258.3" "Lineage enriched" "Detected in all" 13 "granulocytes: 258.3" "Cell line enhanced" "Detected in many" "HL-60: 76.4;THP-1: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001515, HPA051282, HPA055838" Enhanced Enhanced Vesicles NA NA 960000000 Vesicles "CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937" "unprognostic (3.62e-2)" "unprognostic (2.72e-1)" "unprognostic (3.59e-3)" "unprognostic (5.43e-2)" "unprognostic (4.44e-2)" "unprognostic (5.80e-3)" "prognostic favorable (9.67e-4)" "unprognostic (9.95e-3)" "unprognostic (3.22e-1)" "unprognostic (7.23e-2)" "unprognostic (3.34e-2)" "unprognostic (9.77e-2)" "prognostic favorable (1.96e-8)" "unprognostic (1.01e-1)" "unprognostic (7.31e-2)" "unprognostic (4.77e-2)" "unprognostic (6.59e-3)" 70.0 33.0 9.4 10.1 9.6 54.2 36.1 3.1 7.7 15.3 26.6 18.6 15.7 22.2 13.5 9.5 14.8 14.2 19.0 22.4 10.7 5.2 50.4 184.8 26.1 21.3 14.5 6.0 11.0 24.7 7.1 5.0 16.4 10.2 23.2 11.3 11.4 14.5 13.2 27.8 19.7 29.2 11.6 11.3 17.9 15.9 6.2 11.6 23.4 41.7 14.9 11.5 20.4 24.9 7.6 19.9 258.3 17.5 5.5 5.0 17.8 6.2 6.9 5.1 8.0 49.2 21.4 10.8 8.0 10.1 8.9 9.8 3.9 6.3 15.4 7.7 15.7 13.2 14.9 8.5 8.6 9.9 13.5 7.8 13.0 7.4 22.2 5.8 76.4 6.5 11.5 6.0 2.7 1.1 12.6 10.8 9.4 26.9 6.4 11.2 5.9 15.6 13.6 0.0 29.4 16.8 11.1 24.2 12.6 24.5 23.7 2.6 4.1 8.9 14.4 11.8 0.0 20.7 63.8 7.6 5.4 5.2 13.4 4.7 5.2 2.9 3.3 10.6 52.6 3.9 12.5 17.5 258.3 3.2 14.7 3.8 7.6 3.8 3.6 19.9 6.8 3.8 4.0 17.1 5.5 15.5 13.4 5.0 17.8 9.4 9.6 3.1 7.7 10.7 5.2 14.5 6.0 10.2 11.6 211.4 229.6 40.9 69.6 25.6 11.8 38.0 73.9 89.7 77.3 69.8 25.5 60.5 190.6 26.7 2.1 31.6 91.9 350.4 23.0 26.6 50.3 53.0 22.1 400.0 121.0 0.0 46.1 49.7 114.9 3.8 72.5 85.2 25.3 295.8 48.0 21.2 16.4 52.6 72.9 233.4 17.7 77.6 65.1 4.1 9.6 23.7 33.9 35.5 72.9 69.8 CATSPERB "C14orf161, FLJ14298" ENSG00000133962 "Cation channel sperm associated auxiliary subunit beta" Q9H7T0 14 91580696-91780707 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 15.1" "Cell type enhanced" "Detected in some" 11 "Early spermatids: 11.1;Exocrine glandular cells: 9.3;Pancreatic endocrine cells: 11.1" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "CAPAN-2: 3.8;OE19: 4.0;U-937: 3.7" "Not detected" "Not detected" HPA035134 Uncertain Uncertain Vesicles NA NA Vesicles "HPA035134: AB_10671510" "unprognostic (2.69e-2)" "unprognostic (1.95e-1)" "unprognostic (1.16e-3)" "unprognostic (1.93e-1)" "unprognostic (7.04e-3)" "unprognostic (2.72e-5)" "unprognostic (1.81e-1)" "unprognostic (5.01e-3)" "unprognostic (1.81e-3)" "unprognostic (3.52e-3)" "unprognostic (2.30e-2)" "unprognostic (4.34e-1)" "unprognostic (8.99e-3)" "unprognostic (6.85e-2)" "unprognostic (8.31e-2)" "unprognostic (8.88e-2)" "unprognostic (2.71e-3)" 0.6 0.1 0.0 0.6 0.0 0.0 1.4 0.0 0.2 0.4 0.9 0.3 0.4 0.4 0.6 0.7 1.2 0.6 0.0 0.0 0.3 0.2 0.9 1.1 0.0 0.2 15.1 1.0 0.3 0.0 0.9 0.7 3.7 0.0 1.7 4.2 1.2 0.1 0.0 0.8 2.0 2.0 0.9 0.6 0.5 0.3 0.4 0.2 1.1 0.2 0.7 1.6 0.4 0.6 0.0 0.7 1.6 0.0 0.0 1.8 0.2 0.3 0.0 0.0 2.3 3.8 1.1 0.9 0.0 0.1 0.6 0.0 0.5 0.7 1.4 2.0 0.4 1.2 2.2 0.0 1.6 0.8 0.6 0.7 0.4 0.5 1.5 0.0 1.0 0.5 0.2 0.4 2.2 0.6 0.7 0.2 4.0 0.5 0.3 0.0 0.0 0.4 0.9 1.6 0.1 0.0 0.8 1.5 1.7 0.4 2.1 0.9 0.2 0.2 0.0 0.3 0.9 0.8 0.3 0.2 3.7 1.0 1.1 0.2 0.6 1.1 0.0 1.5 0.4 1.6 1.0 0.0 0.2 1.1 1.4 0.4 0.7 0.2 0.2 0.0 0.4 3.0 1.0 0.0 0.2 0.1 0.0 0.1 0.0 1.4 2.3 0.0 0.0 0.0 0.0 1.6 11.1 0.0 0.3 0.0 9.3 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 1.0 2.1 0.0 11.1 0.9 0.0 0.5 0.0 0.0 0.0 0.9 0.2 0.0 0.2 0.0 0.4 0.3 CAV2 CAV ENSG00000105971 "Caveolin 2" P51636 7 116287380-116508541 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 824.8;Basal keratinocytes: 429.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 82 "basophil: 31.8" "Lineage enriched" "Detected in single" 318 "granulocytes: 31.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 48.8;HBEC3-KT: 55.8;LHCN-M2: 60.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013488, HPA044810" Enhanced Approved Vesicles NA NA Vesicles "CAB013488: AB_2533493, HPA044810: AB_2679098" "unprognostic (4.76e-2)" "unprognostic (3.91e-3)" "unprognostic (4.56e-2)" "unprognostic (2.91e-1)" "unprognostic (5.09e-3)" "prognostic unfavorable (5.80e-5)" "unprognostic (3.66e-2)" "unprognostic (2.27e-2)" "unprognostic (3.81e-1)" "unprognostic (3.34e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (6.32e-2)" "unprognostic (3.44e-3)" "unprognostic (7.84e-3)" "unprognostic (2.88e-1)" "unprognostic (2.42e-1)" "unprognostic (6.34e-3)" 61.9 4.5 3.0 9.5 6.6 0.2 39.9 1.0 3.7 26.3 15.7 3.1 10.3 3.3 23.4 19.6 25.2 10.8 31.3 54.6 4.4 3.1 9.5 17.4 59.4 6.0 7.5 3.8 17.7 16.0 1.4 2.8 35.2 4.6 20.6 5.0 12.1 10.7 10.5 15.3 13.3 8.3 34.0 8.6 25.3 8.9 12.1 5.3 1.7 61.2 23.2 4.9 29.5 15.4 0.0 0.0 31.8 0.0 0.0 0.0 0.2 39.3 10.7 0.5 0.0 18.2 19.6 0.8 27.5 32.8 9.1 8.2 2.0 48.8 0.0 33.0 28.2 29.4 38.2 0.5 55.8 13.2 0.0 2.6 0.3 8.2 0.0 11.2 0.0 0.1 11.5 32.2 12.3 25.5 14.6 29.4 0.0 1.9 1.6 60.2 2.1 0.0 0.0 0.5 1.3 6.9 0.4 13.4 0.5 33.5 1.2 0.0 0.0 21.0 0.7 5.1 5.9 0.0 0.2 41.9 0.0 5.8 18.2 9.0 1.7 0.0 0.1 3.7 0.0 19.7 31.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 3.0 6.6 1.0 3.7 4.4 3.1 7.5 3.8 4.6 5.3 824.8 93.2 3.0 234.5 429.9 3.3 197.7 119.8 33.5 164.9 38.4 3.9 12.5 29.9 203.4 19.4 231.9 2.4 0.0 87.5 115.4 81.9 72.8 2.3 42.7 4.3 0.0 1.7 104.3 4.7 13.0 87.5 7.4 138.3 3.6 4.7 140.5 278.7 0.0 182.5 2.2 6.0 187.5 172.0 2.3 1.3 246.5 10.4 2.5 5.1 133.6 CCDC130 MGC10471 ENSG00000104957 "Coiled-coil domain containing 130" P13994 19 13731760-13763296 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056977 Approved Approved Vesicles NA NA Vesicles "HPA056977: AB_2683297" "unprognostic (6.54e-2)" "unprognostic (5.72e-3)" "unprognostic (2.13e-3)" "unprognostic (1.27e-3)" "unprognostic (2.71e-1)" "prognostic favorable (7.83e-5)" "unprognostic (7.04e-2)" "unprognostic (1.25e-2)" "unprognostic (2.47e-1)" "unprognostic (9.69e-2)" "prognostic favorable (2.34e-4)" "unprognostic (2.06e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.94e-1)" "prognostic favorable (1.82e-4)" 17.5 20.1 17.4 23.6 22.1 28.2 20.4 22.2 24.5 18.7 17.8 32.9 23.8 21.3 27.2 18.0 17.6 20.7 18.1 22.6 16.9 14.5 20.6 17.9 19.8 28.9 24.7 19.7 30.1 19.1 24.9 26.1 21.0 19.4 20.2 11.0 23.6 24.3 21.0 26.6 22.5 21.9 16.9 17.0 26.1 20.3 22.0 24.0 22.0 25.3 11.5 19.6 17.9 21.4 19.2 16.9 23.1 17.2 17.0 20.0 13.3 8.6 6.8 13.0 13.0 8.8 7.1 7.0 9.2 9.1 9.6 8.9 5.4 6.2 7.5 7.1 8.4 7.6 8.7 5.6 5.1 3.0 11.6 16.1 5.8 17.3 9.3 17.4 6.0 15.8 9.4 11.6 12.3 8.1 10.1 11.1 14.3 6.0 14.6 5.7 6.1 14.9 11.8 8.2 4.4 12.8 13.4 6.5 9.7 6.8 9.8 7.4 9.8 6.4 5.3 15.7 7.1 5.4 13.8 8.5 15.5 6.2 18.0 12.4 22.1 8.2 5.8 13.1 14.0 10.8 22.2 17.2 23.1 17.3 14.7 20.0 18.6 18.1 18.2 16.9 19.2 16.8 19.4 17.0 17.0 16.6 12.4 14.8 13.3 17.4 22.1 22.2 24.5 16.9 14.5 24.7 19.7 19.4 24.0 8.9 13.2 23.8 16.0 11.8 28.4 14.0 5.1 24.1 12.5 27.9 25.5 14.6 6.6 14.4 25.2 17.4 27.0 23.3 13.7 16.6 15.4 12.1 23.2 9.6 15.9 25.4 18.0 11.6 19.8 18.6 17.5 19.2 23.6 27.9 13.6 27.8 16.3 21.0 15.9 12.9 40.8 25.8 21.7 27.7 19.6 13.7 29.3 25.0 15.0 9.4 CCDC169-SOHLH2 C13orf38-SOHLH2 ENSG00000250709 "CCDC169-SOHLH2 readthrough" 13 36168794-36297842 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 5 "testis: 42.2" "Cell type enhanced" "Detected in single" 35 "Late spermatids: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.4;HEL: 2.3;HL-60: 6.2;LHCN-M2: 2.4;NB-4: 3.5;SuSa: 2.3;U-937: 5.0" HPA029182 Uncertain Vesicles NA NA Vesicles "HPA029182: AB_10602409" "unprognostic (5.56e-2)" "unprognostic (3.93e-1)" "unprognostic (3.60e-2)" "unprognostic (4.66e-1)" "unprognostic (2.17e-1)" "unprognostic (1.84e-2)" "unprognostic (6.12e-2)" "unprognostic (3.43e-2)" 0.4 0.5 0.5 0.2 1.8 0.2 0.4 0.4 1.4 0.5 0.8 0.3 4.9 0.2 1.0 2.0 0.3 0.4 0.3 1.1 0.5 0.6 0.7 0.3 0.3 0.2 0.5 1.3 0.4 0.4 0.3 0.3 3.3 1.1 0.6 0.3 0.5 0.4 9.1 0.5 0.3 0.4 3.0 1.0 0.3 0.6 42.2 0.0 0.0 0.4 0.0 0.2 1.6 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 3.4 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.3 2.3 0.0 0.0 0.3 6.2 0.0 0.1 0.0 0.8 0.0 0.3 0.8 0.0 0.1 0.0 2.4 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 1.7 0.0 0.1 0.0 2.3 0.1 1.1 0.6 0.0 0.3 0.1 0.7 0.0 0.0 0.0 0.1 5.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.8 0.4 1.4 0.5 0.6 0.5 1.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCDC190 "C1orf110, MGC48998" ENSG00000185860 "Coiled-coil domain containing 190" Q86UF4 1 162824458-162868815 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 8.3;lung: 7.2;tongue: 7.5" "Cell type enriched" "Detected in some" 27 "Ciliated cells: 48.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTEC/SVTERT24-B: 4.1;hTERT-RPE1: 5.1;HUVEC TERT2: 5.0;LHCN-M2: 7.6;TIME: 17.3;U-2197: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028579, HPA028584, HPA028592" Uncertain Approved Vesicles NA NA Vesicles "HPA028579: AB_10610978, HPA028584: AB_10599423, HPA028592: AB_10601001" "unprognostic (4.29e-1)" "unprognostic (8.37e-2)" "unprognostic (1.75e-1)" "unprognostic (5.47e-2)" "unprognostic (1.68e-2)" "unprognostic (8.33e-3)" "unprognostic (3.04e-2)" "unprognostic (3.09e-2)" "unprognostic (6.41e-2)" "unprognostic (7.41e-5)" "unprognostic (2.64e-1)" "unprognostic (1.52e-1)" "unprognostic (5.26e-1)" "unprognostic (1.70e-1)" 0.2 0.1 1.1 0.2 1.7 0.0 0.2 0.2 0.9 0.3 0.2 0.2 0.2 0.0 0.2 0.8 8.3 1.1 1.3 1.0 1.2 0.7 0.2 0.2 7.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.5 0.0 0.2 0.2 0.3 0.2 0.1 0.7 0.2 0.6 0.2 7.5 2.4 0.3 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 1.9 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.3 0.2 0.1 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 4.1 2.6 5.1 5.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.4 0.0 9.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.1 1.7 0.2 0.6 1.2 0.7 0.4 0.2 0.2 0.2 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 48.2 0.0 1.8 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 CCDC74A FLJ40345 ENSG00000163040 "Coiled-coil domain containing 74A" Q96AQ1 2 131527675-131533666 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.1;testis: 41.2" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 107.1;Early spermatids: 339.1;Late spermatids: 203.8;Spermatocytes: 157.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 3.3" "Lineage enhanced" "Detected in single" "dendritic cells: 3.3" "Cell line enhanced" "Detected in many" "NTERA-2: 19.3;SCLC-21H: 15.9" HPA060727 Uncertain Vesicles NA NA Vesicles "HPA060727: " "prognostic favorable (5.11e-4)" "unprognostic (2.89e-3)" "unprognostic (6.49e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (2.33e-4)" "unprognostic (1.91e-1)" "unprognostic (1.36e-2)" "unprognostic (2.18e-3)" "unprognostic (1.71e-1)" "unprognostic (2.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.25e-1)" "prognostic unfavorable (1.70e-7)" "unprognostic (7.28e-3)" "prognostic favorable (4.92e-4)" "unprognostic (5.96e-2)" "unprognostic (3.53e-2)" 1.3 12.8 5.8 2.7 6.5 0.2 6.8 1.1 4.4 5.6 1.9 3.2 4.7 0.9 7.1 7.1 1.9 26.1 5.1 2.2 5.1 6.8 3.0 0.5 3.0 0.9 2.2 4.1 7.1 1.5 13.3 14.1 0.9 13.6 5.2 1.3 2.4 1.8 5.1 0.9 3.5 0.8 5.9 3.0 1.0 1.0 41.2 1.9 2.2 2.6 0.9 1.2 4.5 2.7 0.0 3.3 0.0 0.1 0.0 0.8 0.2 0.0 3.9 4.0 0.2 5.8 14.1 0.3 3.4 5.6 3.1 2.3 0.1 6.0 1.5 2.1 5.2 5.3 3.0 1.7 1.0 1.3 3.9 7.5 0.0 3.8 0.1 0.7 0.1 0.3 4.6 0.4 3.1 0.0 6.2 1.2 8.5 2.2 4.4 2.8 2.4 8.5 2.3 19.3 1.5 2.6 4.1 0.0 1.8 7.9 0.0 15.9 11.5 0.4 0.6 0.6 1.6 5.5 0.8 1.3 0.9 3.0 12.2 2.5 0.9 0.7 0.5 13.1 0.4 5.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.4 3.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 5.8 6.5 1.1 4.4 5.1 6.8 2.2 4.1 13.6 1.9 0.0 0.3 0.0 8.2 4.5 0.4 0.4 2.5 107.1 11.4 7.0 0.0 0.3 6.6 6.5 339.1 0.5 0.0 0.0 0.6 0.3 12.3 7.9 0.0 0.0 0.3 0.0 7.5 1.8 0.0 203.8 34.2 1.8 1.7 0.0 0.3 7.7 2.1 0.0 64.3 2.4 0.9 0.0 3.1 157.3 16.4 5.3 0.2 0.0 1.5 4.8 CCDC74B DKFZp434E2321 ENSG00000152076 "Coiled-coil domain containing 74B" Q96LY2 2 130139287-130145134 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "fallopian tube: 12.4;testis: 22.7" "Cell type enhanced" "Detected in many" 21 "Ciliated cells: 66.9;Early spermatids: 268.8;Late spermatids: 93.0;Spermatocytes: 141.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SCLC-21H: 10.6;SH-SY5Y: 15.1" HPA060727 Uncertain Vesicles NA NA Vesicles "HPA060727: " "prognostic favorable (4.46e-4)" "unprognostic (4.75e-3)" "unprognostic (2.67e-1)" "unprognostic (2.76e-3)" "unprognostic (2.81e-1)" "unprognostic (1.73e-1)" "unprognostic (8.69e-3)" "unprognostic (9.43e-2)" "unprognostic (2.99e-1)" "unprognostic (2.10e-1)" "unprognostic (6.43e-3)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (2.43e-2)" "unprognostic (1.48e-4)" "unprognostic (8.31e-3)" "unprognostic (9.94e-3)" 0.0 1.4 2.8 0.1 2.4 0.0 0.4 0.0 2.2 8.3 0.1 0.0 3.5 0.6 0.1 12.4 1.1 0.1 3.0 4.0 1.0 0.0 1.0 0.1 0.9 2.1 0.2 7.5 7.7 0.0 2.7 0.0 0.2 2.5 0.0 0.1 0.0 1.0 1.4 0.0 0.0 22.7 3.7 0.0 0.4 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 1.9 2.9 0.1 2.7 5.8 0.6 2.2 1.2 0.3 0.5 0.8 0.7 0.1 3.6 2.0 3.4 1.0 0.2 0.3 0.4 2.0 5.5 0.0 6.9 0.1 0.3 0.1 0.2 1.2 0.0 0.9 0.0 3.6 0.2 1.4 0.1 1.7 0.8 2.0 0.0 0.0 5.9 0.5 6.0 4.5 0.0 3.2 1.7 0.0 10.6 15.1 1.6 0.1 0.3 0.7 6.0 0.7 0.4 1.1 5.0 6.1 0.5 0.1 0.2 0.0 6.6 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.0 0.3 0.0 2.0 0.5 0.4 0.4 2.5 66.9 3.4 5.2 0.0 0.1 3.3 1.1 268.8 0.1 0.0 0.0 0.2 0.7 2.4 3.9 0.0 0.0 0.3 3.2 10.9 0.0 0.0 93.0 9.5 0.2 0.0 0.0 0.0 3.5 0.0 0.0 11.7 0.3 0.0 0.0 2.1 141.1 14.6 1.0 0.1 0.0 0.0 0.3 CCZ1 "C7orf28A, CCZ1A, CGI-43" ENSG00000122674 "CCZ1 homolog, vacuolar protein trafficking and biogenesis associated" P86791 7 5898725-5926550 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045114, HPA050006" Uncertain Enhanced Vesicles NA NA Vesicles "HPA045114: AB_2679219, HPA050006: AB_2680989" "unprognostic (1.91e-1)" "unprognostic (2.97e-3)" "unprognostic (3.15e-2)" "unprognostic (1.25e-2)" "unprognostic (1.82e-1)" "unprognostic (5.35e-2)" "unprognostic (3.74e-3)" "unprognostic (4.10e-1)" "unprognostic (9.25e-3)" "unprognostic (7.66e-2)" "unprognostic (6.64e-2)" "unprognostic (2.67e-2)" "unprognostic (5.27e-3)" "unprognostic (3.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.74e-1)" "unprognostic (4.41e-1)" 17.2 33.0 19.0 16.5 22.6 25.7 27.9 19.5 28.2 15.5 15.7 15.4 10.5 16.5 18.9 15.8 23.2 15.2 16.7 23.3 19.1 17.0 15.9 21.2 17.1 32.3 17.8 23.5 13.5 39.1 25.7 17.2 15.7 19.4 15.6 19.9 13.7 28.9 13.9 33.3 19.3 18.5 16.7 18.6 18.4 16.0 36.1 12.6 19.4 17.7 23.9 20.3 19.7 15.8 3.7 7.1 10.2 10.4 9.2 16.6 2.8 46.1 18.1 24.9 31.9 25.8 23.8 17.4 18.5 22.1 18.4 19.6 8.7 23.7 28.4 10.6 27.5 51.9 25.0 17.1 19.6 20.1 12.7 26.3 14.2 22.3 15.9 26.1 28.7 16.7 24.2 24.3 13.7 13.3 25.7 33.3 27.6 33.1 21.9 26.5 27.7 18.9 37.8 46.6 22.5 24.5 27.2 24.8 23.1 14.8 27.8 23.7 42.5 17.9 35.7 18.6 39.7 26.3 36.6 25.0 18.6 48.5 21.9 29.1 16.7 28.3 33.9 12.6 38.6 40.5 10.2 4.9 8.6 5.5 7.6 5.5 3.7 7.2 7.1 7.1 2.7 4.6 5.4 4.7 9.2 10.4 4.3 16.6 2.8 19.0 22.6 19.5 28.2 19.1 17.0 17.8 23.5 19.4 12.6 3.0 19.7 29.9 21.3 40.2 53.8 9.8 17.8 32.1 14.8 29.6 58.9 32.6 26.6 54.9 4.1 35.3 31.1 0.0 62.4 30.8 31.5 20.9 15.1 16.3 31.7 22.3 28.7 78.0 32.1 1.1 35.1 38.3 43.9 83.8 30.6 36.4 60.1 32.0 33.9 19.2 52.4 77.6 50.9 36.5 31.8 47.3 29.2 43.6 30.3 26.8 CCZ1B "C7orf28B, DKFZP586I1023, H_NH0577018.2, MGC19819" ENSG00000146574 "CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated" P86790 7 6794134-6826770 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045114, HPA050006" Uncertain Enhanced Vesicles NA NA Vesicles "HPA045114: AB_2679219, HPA050006: AB_2680989" "unprognostic (8.06e-3)" "unprognostic (1.53e-1)" "unprognostic (2.94e-2)" "unprognostic (1.00e-1)" "unprognostic (4.94e-2)" "unprognostic (1.45e-2)" "unprognostic (1.88e-3)" "unprognostic (2.74e-1)" "unprognostic (9.14e-2)" "unprognostic (1.06e-1)" "unprognostic (2.15e-1)" "unprognostic (2.86e-1)" "unprognostic (2.96e-3)" "unprognostic (9.61e-2)" "unprognostic (1.27e-1)" "unprognostic (2.73e-2)" "unprognostic (1.24e-1)" 2.5 4.5 3.6 2.1 4.4 3.2 4.2 3.8 8.4 2.7 3.5 10.7 2.1 2.6 3.5 7.0 5.7 5.3 3.5 2.6 4.0 3.6 3.0 2.4 3.4 3.7 2.9 2.1 3.0 3.3 11.8 2.6 2.7 9.1 3.0 2.5 5.2 6.6 7.0 10.6 3.4 2.7 2.1 2.7 3.0 3.2 5.4 2.1 3.0 2.5 2.1 3.5 4.3 2.6 4.3 5.6 10.5 9.5 6.1 6.6 1.8 13.0 4.7 9.4 23.4 8.4 8.3 10.4 8.1 12.3 9.9 10.9 5.4 8.6 5.5 9.7 11.7 18.1 8.9 17.7 10.2 11.3 3.3 6.3 3.8 5.7 13.4 8.7 27.5 19.5 5.5 5.5 9.4 4.9 4.8 8.5 17.5 7.3 6.4 9.9 22.3 13.1 12.3 26.2 12.4 8.8 8.2 20.3 6.8 7.3 9.7 14.7 23.5 9.1 17.9 12.1 8.4 14.6 31.6 9.3 2.8 8.8 11.5 17.4 6.5 13.3 4.0 9.1 28.9 16.8 10.5 3.8 6.5 3.8 4.6 4.5 4.3 4.5 5.6 4.8 3.9 3.2 4.2 4.8 6.1 9.5 5.6 6.6 1.8 3.6 4.4 3.8 8.4 4.0 3.6 2.9 2.1 9.1 2.1 6.0 10.1 18.1 7.8 7.4 8.6 6.7 5.1 30.8 11.4 3.5 13.7 8.6 13.3 16.3 2.7 9.2 10.2 0.0 24.7 9.4 10.3 7.4 2.3 6.8 9.4 15.9 17.9 16.0 13.2 2.3 6.6 16.3 13.5 25.2 16.4 11.0 20.1 14.4 9.9 9.0 11.1 19.4 10.0 11.4 8.8 10.9 6.6 13.8 12.5 10.8 CD14 ENSG00000170458 "CD14 molecule" P08571 5 140631728-140633701 "Cancer-related genes, CD markers, Plasma proteins, Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 189.4;liver: 165.8" "Cell type enhanced" "Detected in many" 25 "Hofbauer cells: 2162.9;Ito cells: 448.7;Kupffer cells: 633.7;Macrophages: 438.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 189.4" "Group enriched" "Detected in many" 5 "granulocytes: 52.3;monocytes: 189.4" "Cell line enhanced" "Detected in many" "A549: 9.1;CACO-2: 13.9;SiHa: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001887, HPA002127, CAB033631, CAB072865, CAB072866" Enhanced Approved Vesicles "Secreted to blood" NA NA 2750000000 15000000000 Vesicles "CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440" "unprognostic (1.92e-1)" "unprognostic (1.68e-1)" "unprognostic (3.42e-3)" "unprognostic (3.89e-2)" "unprognostic (3.29e-2)" "unprognostic (1.54e-1)" "unprognostic (4.71e-3)" "unprognostic (4.88e-2)" "unprognostic (2.16e-1)" "unprognostic (1.06e-1)" "unprognostic (1.83e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (6.80e-5)" "unprognostic (1.20e-2)" "unprognostic (6.87e-3)" "unprognostic (8.12e-2)" "unprognostic (6.92e-2)" 27.9 44.1 9.0 42.7 25.2 9.8 11.7 3.5 8.9 5.6 10.0 6.0 1.8 5.4 5.6 24.0 4.5 12.0 14.6 18.9 11.7 7.4 12.7 165.8 23.8 34.7 21.6 2.9 14.2 5.3 4.3 10.1 37.3 18.9 8.5 9.2 14.6 28.5 5.8 10.2 3.5 12.1 21.4 18.2 35.5 6.6 6.5 17.3 2.2 7.9 5.8 6.6 15.9 3.8 0.5 23.6 52.3 189.4 0.2 0.4 124.2 0.1 9.1 0.1 0.6 1.3 0.3 0.5 0.9 4.2 1.3 1.6 13.9 2.2 0.4 0.7 5.0 1.1 3.9 0.0 1.7 0.2 0.1 0.9 0.3 0.5 1.8 4.9 1.0 0.4 4.0 0.2 0.2 1.3 0.4 0.0 0.2 0.2 0.2 1.3 0.3 0.0 0.6 0.2 0.2 0.3 0.3 0.4 1.1 0.2 0.0 2.4 1.0 16.7 0.4 0.5 0.2 0.3 1.7 0.6 0.2 0.3 1.5 1.3 0.7 0.9 0.5 0.4 0.4 0.1 0.4 189.4 1.0 0.3 36.6 0.4 0.5 0.2 0.2 23.6 0.1 0.3 0.2 52.3 0.2 4.8 1.3 0.1 124.2 9.0 25.2 3.5 8.9 11.7 7.4 21.6 2.9 18.9 17.3 8.9 44.2 23.9 3.1 4.5 9.5 2.5 28.1 6.7 6.8 1.8 0.0 15.3 1.7 3.3 1.3 13.8 7.9 0.0 1.6 12.6 12.3 2.2 8.1 323.7 2162.9 31.8 6.9 448.7 633.7 3.2 4.6 438.8 8.5 0.0 4.5 36.9 2.3 8.5 4.9 5.4 3.5 32.3 9.2 0.7 0.9 3.8 38.6 5.9 5.1 3.0 CD24 CD24A ENSG00000272398 "CD24 molecule" 6 106969831-106975627 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "kidney: 383.7" "Cell type enhanced" "Detected in many" 9 "Distal tubular cells: 1347.9;Exocrine glandular cells: 3019.5;Pancreatic endocrine cells: 1516.5" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 26 "eosinophil: 30.4;memory B-cell: 23.4;naive B-cell: 15.0" "Group enriched" "Detected in many" 202 "B-cells: 23.4;granulocytes: 30.4" "Cell line enhanced" "Detected in many" "NTERA-2: 66.4;RPTEC TERT1: 313.7;SK-BR-3: 91.2" "HPA045879, CAB078471" Approved Enhanced Vesicles "Intracellular and membrane" NA NA Vesicles "CAB078471: AB_10983158, HPA045879: AB_2732523" "prognostic unfavorable (2.44e-5)" "unprognostic (6.64e-2)" "prognostic favorable (3.29e-4)" "unprognostic (1.87e-1)" "unprognostic (1.41e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (7.58e-4)" "unprognostic (2.32e-1)" "unprognostic (2.74e-1)" "unprognostic (1.04e-1)" "unprognostic (2.28e-2)" "unprognostic (1.51e-1)" "unprognostic (5.10e-2)" "unprognostic (2.92e-1)" "unprognostic (1.16e-1)" "unprognostic (2.01e-1)" "unprognostic (3.13e-1)" 0.5 0.5 12.8 2.4 9.9 17.9 25.5 0.5 2.9 69.5 30.6 0.7 1.6 1.2 34.5 5.9 38.1 6.0 25.1 4.2 22.7 383.7 0.8 0.7 0.9 4.8 7.2 15.6 40.0 0.0 5.7 48.2 13.0 3.2 21.2 0.7 15.9 16.6 0.4 0.5 0.8 2.2 4.9 0.7 16.4 0.5 6.5 0.4 48.8 1.2 11.3 4.0 8.1 23.4 0.0 30.4 0.1 0.0 0.0 0.6 23.4 14.5 0.2 1.9 0.0 0.0 27.5 0.0 0.1 0.1 0.0 0.2 0.1 2.3 7.2 0.0 1.0 48.5 8.2 18.3 0.1 0.0 0.1 0.0 17.9 1.0 0.0 0.3 0.1 0.1 21.1 0.2 1.2 1.1 0.1 0.0 0.5 0.0 0.4 29.4 0.1 0.1 66.4 52.2 5.6 54.8 0.0 0.2 313.7 60.5 41.1 30.3 16.6 91.2 0.0 31.1 42.1 0.1 0.0 0.0 0.2 0.2 0.7 0.0 0.1 31.0 0.3 0.1 0.1 0.1 0.0 30.4 0.0 0.0 0.0 23.4 0.0 0.0 0.0 15.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.6 145.9 106.6 139.4 57.2 0.0 6.5 1.1 1003.8 691.9 180.9 1235.3 2.0 679.9 1347.9 1087.4 21.0 2.3 819.9 0.0 3019.5 709.4 9.3 444.2 10.4 3.8 61.3 0.0 552.5 53.4 8.9 32.3 9.5 11.8 0.0 55.9 391.5 1.1 1516.5 703.5 2.1 408.2 0.5 6.5 0.4 0.5 4.9 0.0 466.9 12.5 734.9 281.9 CD276 "B7-H3, B7H3, B7RP-2" ENSG00000103855 "CD276 molecule" Q5ZPR3 15 73683966-73714518 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 186.5;Hofbauer cells: 70.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "neutrophil: 4.0" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.0" "Cell line enhanced" "Detected in many" "HaCaT: 42.2;U-2197: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009285, HPA017139, CAB017826" Enhanced Approved Vesicles NA NA 8900000 Vesicles "CAB017826: , HPA009285: AB_1078258, HPA017139: AB_1845246" "unprognostic (1.05e-1)" "unprognostic (4.74e-3)" "unprognostic (4.57e-3)" "unprognostic (9.62e-2)" "unprognostic (1.26e-2)" "unprognostic (5.50e-3)" "prognostic unfavorable (9.81e-4)" "unprognostic (2.57e-3)" "unprognostic (1.89e-1)" "unprognostic (3.75e-2)" "unprognostic (1.54e-2)" "unprognostic (3.29e-2)" "prognostic unfavorable (6.31e-5)" "unprognostic (1.17e-1)" "unprognostic (9.22e-2)" "unprognostic (1.21e-1)" "unprognostic (1.34e-3)" 32.3 16.6 5.8 9.2 3.9 0.6 17.1 3.6 5.3 19.4 8.3 5.1 4.2 8.8 17.2 17.9 6.3 8.1 14.3 12.3 5.6 3.6 7.2 22.9 9.3 6.7 4.6 3.8 16.8 14.3 3.5 5.3 27.7 7.9 16.5 4.2 20.5 12.8 7.8 7.1 12.6 7.0 13.8 4.4 7.4 8.4 9.9 3.9 1.2 7.8 8.3 4.7 12.4 13.6 0.4 0.5 4.0 0.6 0.8 0.2 0.0 9.8 12.2 8.4 18.4 15.4 9.3 25.7 11.5 9.5 7.6 6.9 21.5 20.7 0.1 18.8 10.9 14.6 42.2 9.0 10.3 1.3 7.5 20.4 0.8 12.8 10.3 4.7 0.2 12.3 7.4 5.0 6.9 4.5 5.3 10.0 0.0 3.2 0.2 1.7 15.3 0.1 0.5 20.4 1.9 8.9 0.1 12.3 1.6 6.6 13.7 5.8 14.0 10.7 5.3 20.8 7.1 8.8 5.3 11.5 16.8 15.1 55.2 11.6 0.2 0.2 0.2 27.9 0.9 11.5 0.9 0.3 0.5 0.1 0.6 0.2 0.2 0.1 0.2 0.2 0.4 0.2 0.1 4.0 0.8 0.3 0.5 0.1 0.0 5.8 3.9 3.6 5.2 5.6 3.6 4.6 3.8 7.9 3.9 17.9 7.2 0.5 9.2 13.4 21.2 7.0 5.1 5.3 18.2 10.4 29.5 8.8 1.7 42.7 0.7 8.9 4.0 0.0 16.3 186.5 42.4 15.5 14.9 13.9 70.5 9.5 8.6 5.5 5.8 0.7 9.2 20.9 23.6 7.2 12.1 8.9 22.2 17.3 16.3 2.4 27.5 12.9 41.2 1.2 2.8 8.9 10.3 0.5 8.7 6.5 CD63 "ME491, MLA1, TSPAN30" ENSG00000135404 "CD63 molecule" P08962 12 55725323-55729707 "CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 276.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010088, CAB026356, HPA073506" Supported Supported Vesicles "Intracellular and membrane" NA NA Vesicles "CAB026356: AB_629864, HPA010088: AB_1846323, HPA073506: " "unprognostic (8.76e-3)" "unprognostic (8.81e-2)" "unprognostic (1.27e-1)" "unprognostic (1.28e-3)" "unprognostic (9.48e-2)" "unprognostic (3.66e-3)" "prognostic unfavorable (1.37e-4)" "unprognostic (1.11e-1)" "unprognostic (6.50e-2)" "unprognostic (1.08e-1)" "unprognostic (1.66e-2)" "unprognostic (3.10e-1)" "unprognostic (2.70e-2)" "unprognostic (4.82e-2)" "unprognostic (5.21e-2)" "unprognostic (1.85e-3)" "unprognostic (9.02e-2)" 115.3 88.2 42.5 44.9 37.2 67.4 106.3 13.7 33.1 80.6 84.7 34.4 71.5 39.9 99.7 177.9 70.9 60.4 102.7 154.4 36.9 39.0 106.6 92.5 109.6 113.8 49.8 27.2 93.8 187.1 33.3 49.3 176.9 50.8 82.9 81.8 102.1 105.0 83.7 92.7 38.5 72.4 88.2 43.6 107.7 74.8 52.1 30.5 17.6 108.1 50.7 47.4 96.3 82.2 9.6 40.3 147.4 50.8 58.4 29.8 56.6 22.2 38.8 21.3 20.7 276.2 173.2 28.1 90.7 166.3 53.7 58.5 43.3 44.9 6.4 28.9 134.9 38.3 20.7 15.4 37.5 69.1 18.1 14.5 35.0 30.3 23.9 109.9 15.5 83.4 127.4 37.4 59.6 54.7 111.7 59.1 3.2 19.7 44.8 170.8 35.6 3.1 21.1 19.4 49.2 45.2 7.0 46.8 16.0 90.8 75.9 8.3 21.3 24.8 18.8 162.9 32.5 26.5 51.9 43.9 34.8 25.4 47.9 30.3 18.4 11.3 4.4 99.6 10.0 63.4 89.6 50.8 147.4 29.8 38.5 21.8 9.6 11.9 23.7 40.3 6.5 5.3 18.1 55.7 58.4 26.1 27.0 10.0 56.6 42.5 37.2 13.7 33.1 36.9 39.0 49.8 27.2 50.8 30.5 476.4 590.3 176.4 1219.6 503.8 174.4 555.7 917.2 377.4 564.1 830.5 143.3 558.0 197.3 2170.1 13.3 768.7 766.8 0.0 3001.1 2390.1 1497.1 1539.2 986.0 374.3 3024.5 31.8 557.9 750.1 794.3 26.6 1599.3 1215.7 1891.2 756.6 1108.9 851.5 2709.4 1083.7 1087.6 631.9 181.5 1235.3 1556.4 33.0 71.8 350.0 2264.8 339.0 575.6 1313.8 CD82 "IA4, KAI1, R2, ST6, TSPAN27" ENSG00000085117 "CD82 molecule" P27701 11 44564427-44620363 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "granulocytes: 269.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 80.5" "Group enriched" "Detected in all" 6 "B-cells: 51.1;granulocytes: 80.5;T-cells: 25.6" "Cell line enhanced" "Detected in many" "HMC-1: 78.9;LHCN-M2: 46.6;U-87 MG: 55.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002508, HPA028900, HPA061418" Supported Approved Vesicles NA NA Vesicles "CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: AB_2684510" "unprognostic (5.31e-2)" "unprognostic (4.62e-1)" "unprognostic (2.38e-2)" "unprognostic (1.33e-1)" "unprognostic (2.79e-1)" "unprognostic (1.37e-2)" "unprognostic (1.78e-1)" "unprognostic (7.29e-2)" "unprognostic (3.48e-1)" "unprognostic (2.97e-1)" "unprognostic (2.58e-2)" "unprognostic (1.58e-1)" "unprognostic (3.48e-3)" "unprognostic (1.86e-3)" "unprognostic (2.33e-2)" "unprognostic (2.88e-2)" "unprognostic (6.30e-2)" 14.7 4.9 16.3 21.6 23.1 43.6 13.8 6.3 13.6 17.5 20.7 23.0 53.0 25.9 4.8 13.5 58.3 19.8 21.7 12.7 16.9 13.3 10.2 18.8 38.8 22.8 17.9 9.2 9.0 11.6 2.8 3.9 20.7 14.0 14.3 6.8 18.6 29.8 55.2 10.5 34.6 36.0 8.9 10.2 21.9 22.5 4.5 12.6 23.9 8.3 23.5 33.5 16.3 28.1 51.1 6.7 80.5 9.1 7.2 25.6 9.5 5.1 0.7 6.8 1.3 4.6 17.6 0.2 2.9 24.1 5.2 13.3 0.3 3.5 5.3 3.6 1.5 11.0 19.6 0.9 15.3 12.0 23.7 0.4 33.1 1.6 0.1 3.4 9.1 78.9 24.2 17.9 21.9 11.7 13.4 9.2 4.5 0.2 1.6 46.6 3.7 8.8 17.1 0.2 18.7 0.3 0.2 28.2 7.4 3.1 5.0 0.2 0.3 1.8 28.1 3.9 0.9 26.9 9.0 5.1 16.5 2.2 0.3 28.0 0.6 0.0 0.1 55.8 5.0 8.8 48.4 9.1 16.0 4.9 4.8 8.5 51.1 24.9 11.6 2.2 30.9 8.6 3.8 80.5 7.2 3.4 6.7 25.6 9.5 16.3 23.1 6.3 13.6 16.9 13.3 17.9 9.2 14.0 12.6 44.7 44.6 74.3 91.2 48.9 1.8 6.5 45.9 54.9 87.6 150.1 2.0 1.2 10.0 68.4 1.9 26.6 44.6 46.7 58.6 1.0 26.5 41.9 269.5 23.3 60.0 1.6 12.7 43.0 26.7 1.3 37.4 30.2 60.8 10.0 21.4 35.9 63.0 30.0 7.8 2.0 1.9 12.9 28.8 1.8 4.7 58.7 1.1 35.1 29.6 115.3 CDH12 "Br-cadherin, CDHB" ENSG00000154162 "Cadherin 12" P55289 5 21750673-22853622 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6" "Group enriched" "Detected in some" 12 "Bipolar cells: 17.4;Horizontal cells: 19.1;Rod photoreceptor cells: 55.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.5;PC-3: 5.3;SCLC-21H: 7.6;U-2 OS: 3.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029325 Uncertain Uncertain Vesicles NA NA Vesicles "HPA029325: AB_2672998" "unprognostic (2.38e-1)" "unprognostic (3.21e-1)" "unprognostic (4.95e-2)" "unprognostic (8.61e-2)" "unprognostic (3.31e-2)" "unprognostic (3.91e-1)" "unprognostic (2.72e-1)" "unprognostic (3.26e-2)" "unprognostic (1.34e-1)" "unprognostic (3.51e-2)" "unprognostic (3.25e-4)" "unprognostic (7.35e-2)" "unprognostic (3.48e-2)" "unprognostic (5.19e-2)" 0.5 5.2 5.8 0.3 17.7 0.4 1.7 2.0 13.8 9.3 0.5 0.0 0.0 0.5 1.3 1.0 0.4 6.7 0.3 0.5 6.3 3.4 0.7 0.5 0.8 0.3 1.4 4.8 0.5 0.5 0.6 8.6 0.7 4.2 0.5 0.6 1.4 3.1 0.9 0.5 2.5 0.4 0.9 2.5 0.3 0.4 2.9 0.5 0.0 0.4 0.0 0.5 1.5 0.2 0.1 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.3 0.0 1.1 0.4 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.7 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 5.3 0.2 0.0 0.1 0.0 0.1 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.3 0.1 0.0 5.8 17.7 2.0 13.8 6.3 3.4 1.4 4.8 4.2 0.5 0.0 0.0 0.0 0.0 0.1 17.4 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 55.7 0.0 0.0 2.2 1.2 0.0 0.1 0.0 0.0 0.0 CEP295NL "DDC8, KIAA1731NL" ENSG00000178404 "CEP295 N-terminal like" Q96MC4 17 78870910-78903217 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 37.7" "Group enriched" "Detected in some" 129 "Early spermatids: 285.7;Late spermatids: 373.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "neutrophil: 3.5" "Lineage enriched" "Detected in single" 7 "granulocytes: 3.5" "Cell line enhanced" "Detected in some" "BEWO: 4.0;Karpas-707: 3.2;TIME: 3.2;U-2 OS: 5.5" "HPA023609, HPA024619, HPA025717" Uncertain Approved Vesicles NA NA Vesicles "HPA023609: AB_10610974, HPA024619: AB_10602076, HPA025717: AB_10601900" "unprognostic (1.68e-3)" "unprognostic (4.56e-2)" "unprognostic (2.62e-1)" "unprognostic (5.04e-3)" "unprognostic (1.88e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-1)" "unprognostic (9.03e-2)" "unprognostic (8.16e-2)" "unprognostic (9.80e-2)" "unprognostic (2.08e-1)" "unprognostic (3.89e-3)" "unprognostic (3.65e-3)" "unprognostic (1.03e-1)" "unprognostic (2.09e-1)" "unprognostic (1.28e-1)" "unprognostic (6.75e-3)" 0.1 0.0 0.1 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.3 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 37.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.2 3.5 0.4 0.1 0.1 0.0 0.7 0.1 0.0 0.9 0.2 0.6 4.0 1.7 0.1 0.6 1.1 0.2 0.6 0.0 1.1 0.6 2.5 0.1 0.0 0.2 0.6 0.0 0.0 0.0 1.3 0.3 0.4 0.2 0.1 0.4 0.0 1.2 0.0 0.2 0.4 0.1 0.0 3.2 0.1 0.0 0.3 0.0 0.3 0.0 0.6 0.8 0.5 0.1 0.2 0.0 0.1 0.9 0.5 0.4 0.7 0.9 0.1 1.1 3.2 1.4 5.5 1.7 0.7 1.2 1.6 0.0 0.0 0.1 1.7 0.0 0.4 0.7 0.0 0.4 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.0 3.5 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 285.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.3 373.8 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.0 2.1 1.1 0.0 0.0 0.0 0.0 0.0 CERK "dA59H18.2, dA59H18.3, DKFZp434E0211, FLJ21430, FLJ23239, hCERK, KIAA1646, LK4" ENSG00000100422 "Ceramide kinase" Q8TCT0 22 46684411-46738261 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064699 Approved Vesicles NA NA Vesicles "HPA064699: AB_2685327" "unprognostic (2.93e-2)" "unprognostic (1.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (2.67e-2)" "unprognostic (1.49e-3)" "unprognostic (8.55e-2)" "unprognostic (3.60e-2)" "unprognostic (3.87e-1)" "unprognostic (1.35e-2)" "prognostic favorable (2.35e-4)" "unprognostic (2.26e-1)" "unprognostic (1.50e-3)" "unprognostic (1.27e-1)" "unprognostic (4.78e-1)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.58e-4)" 10.6 15.5 10.6 16.7 10.8 14.5 12.9 29.3 21.7 10.8 14.6 9.8 15.8 24.9 14.1 7.5 10.0 15.3 18.9 36.5 11.4 16.8 15.2 12.1 10.6 19.1 21.7 13.1 22.7 23.2 7.2 33.3 7.9 23.9 8.2 12.2 12.3 11.8 11.6 12.8 11.9 25.1 12.5 10.2 14.5 14.0 6.0 6.5 39.2 16.1 8.7 19.5 10.7 17.4 2.0 4.9 3.6 6.9 2.0 16.4 3.6 9.4 5.7 27.8 8.7 16.0 12.1 2.6 16.6 13.0 9.5 6.7 8.3 3.2 13.2 7.8 17.7 5.8 6.2 11.7 7.5 9.8 4.6 12.6 5.9 14.4 10.8 11.1 18.4 1.5 10.1 9.7 10.4 3.6 15.4 28.2 14.2 4.4 17.1 17.4 0.7 12.4 9.2 12.5 3.8 6.3 23.3 31.5 15.0 5.7 0.1 25.9 23.6 8.1 3.9 17.5 6.7 4.3 14.1 25.6 19.7 10.5 14.5 24.0 17.8 21.5 8.3 21.0 10.5 16.0 0.6 2.6 3.0 9.4 6.0 16.4 1.8 9.9 9.0 4.5 2.0 5.8 5.4 3.6 2.0 6.9 4.9 8.6 3.6 10.6 10.8 29.3 21.7 11.4 16.8 21.7 13.1 23.9 6.5 8.9 20.5 11.9 5.1 3.1 21.3 35.3 5.1 0.0 15.9 1.8 5.9 1.9 13.3 11.3 5.0 14.8 26.5 0.0 10.3 1.3 7.3 1.3 9.3 19.8 9.7 25.4 13.8 28.8 27.0 9.4 8.9 13.6 3.3 5.4 2.7 19.0 8.9 15.0 14.2 13.0 10.1 0.0 12.0 0.9 1.6 3.9 1.5 20.8 15.1 0.9 CFH "ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS" ENSG00000000971 "Complement factor H" P08603 1 196651878-196747504 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" "Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity" "Age-related macular degeneration, Cancer-related genes, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 295.2" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 1052.9" "Cancer enriched" "Detected in all" 9 "liver cancer: 151.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 16.5" "Lineage enriched" "Detected in single" 27 "T-cells: 16.5" "Cell line enhanced" "Detected in many" "HHSteC: 26.9;HSkMC: 26.3;hTERT-RPE1: 81.0;RT4: 47.7" "CAB016385, CAB016769, HPA038922, HPA049176, HPA053326" Supported Approved Vesicles "Secreted to blood" NA NA 396000000000 110000000000 Vesicles "CAB016385: AB_627572, CAB016769: , HPA038922: AB_2676271, HPA049176: AB_2680663, HPA053326: AB_2682113" "unprognostic (2.40e-1)" "unprognostic (9.86e-2)" "unprognostic (1.22e-1)" "unprognostic (8.39e-2)" "unprognostic (5.40e-3)" "unprognostic (1.80e-1)" "unprognostic (3.75e-3)" "unprognostic (7.40e-2)" "unprognostic (1.06e-1)" "unprognostic (1.04e-1)" "unprognostic (9.08e-2)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.92e-6)" "unprognostic (6.50e-3)" "unprognostic (4.49e-3)" "unprognostic (1.73e-1)" "unprognostic (1.37e-1)" 28.6 5.5 1.6 3.7 3.8 0.1 8.8 2.6 2.7 10.4 9.1 1.0 3.9 3.7 2.5 8.7 15.2 3.4 17.0 47.3 2.0 1.2 7.0 295.2 11.0 10.3 5.3 1.7 40.9 1.9 1.7 4.3 5.1 5.3 10.3 10.4 6.3 19.0 3.3 10.0 11.5 8.1 12.6 4.2 3.3 5.8 6.4 2.9 0.7 22.0 22.8 5.8 17.2 16.8 0.0 0.1 0.6 0.1 0.0 16.5 1.0 0.0 13.6 0.0 0.0 21.4 12.1 0.0 5.5 13.5 0.7 2.9 0.0 2.5 0.0 2.0 0.0 0.0 0.4 0.0 5.0 0.5 0.2 0.0 4.1 16.2 0.0 26.9 0.1 0.0 26.3 0.0 4.0 1.7 81.0 16.8 0.0 15.3 0.5 19.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 19.6 4.3 0.0 47.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 16.2 0.2 0.1 0.1 0.1 0.0 0.0 2.9 0.0 1.2 0.0 0.1 0.0 1.8 0.0 16.5 0.0 6.0 3.5 0.1 0.0 0.4 1.4 0.6 0.0 0.0 0.0 0.0 1.0 1.6 3.8 2.6 2.7 2.0 1.2 5.3 1.7 5.3 2.9 8.9 14.5 21.0 47.7 39.3 0.4 6.2 30.6 119.1 131.9 5.2 0.0 0.0 0.0 1.9 1.5 55.0 0.0 0.0 0.7 0.0 200.9 8.6 3.5 1052.9 0.9 0.0 0.0 57.1 34.9 3.6 262.9 6.0 42.2 0.0 0.0 0.3 6.4 0.0 130.4 0.0 1.4 6.5 36.8 0.7 0.6 33.4 0.1 10.2 0.0 49.2 CFHR1 "CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2" ENSG00000244414 "Complement factor H related 1" Q03591 1 196819757-196832189 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Cancer-related genes, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 174 "liver: 218.9" "Cell type enhanced" "Detected in some" 13 "Cholangiocytes: 7.6;Erythroid cells: 23.3;Hepatocytes: 8.9;Ito cells: 17.2;Kupffer cells: 14.9" "Cancer enriched" "Detected in single" 798 "liver cancer: 182.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 2.7;HeLa: 3.2;HL-60: 4.8;U-266/70: 6.3" "HPA038915, HPA038922, HPA040726" Supported Approved Vesicles "Secreted to blood" NA NA 15000000000 Vesicles "HPA038915: AB_2676269, HPA038922: AB_2676271, HPA040726: AB_2677101" "unprognostic (2.28e-1)" "unprognostic (3.18e-1)" "unprognostic (3.50e-2)" "unprognostic (1.88e-2)" "prognostic favorable (8.71e-6)" "unprognostic (3.02e-1)" "unprognostic (3.70e-1)" "unprognostic (2.50e-1)" "unprognostic (8.48e-2)" "unprognostic (7.21e-4)" "unprognostic (7.01e-4)" "unprognostic (1.13e-1)" "unprognostic (6.41e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 218.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.1 0.0 0.0 0.3 0.2 2.7 1.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.2 0.0 0.7 0.4 0.5 0.0 0.0 0.0 0.0 0.0 1.6 3.2 0.2 0.2 4.8 0.8 0.2 0.0 0.0 0.0 1.0 0.1 1.0 0.3 2.4 0.8 0.0 1.5 0.0 0.9 0.0 0.0 0.8 2.0 0.0 0.0 0.3 0.0 0.1 0.9 0.0 0.2 0.5 0.4 0.0 1.4 0.9 0.4 0.2 0.2 6.3 0.0 1.1 0.0 0.4 0.9 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 3.0 0.0 0.0 0.1 0.3 0.0 1.4 7.6 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 23.3 0.0 0.0 1.0 0.0 0.0 8.9 4.2 0.0 0.0 17.2 14.9 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.6 0.0 0.2 0.0 0.0 0.1 CFP PFC ENSG00000126759 "Complement factor properdin" P27918 X 47623172-47630305 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Complement alternate pathway, Immunity, Innate immunity" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 106.7;bone marrow: 39.4;lymphoid tissue: 41.3" "Group enriched" "Detected in many" 17 "Ito cells: 122.2;Kupffer cells: 303.6;Macrophages: 129.1;monocytes: 486.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 9 "classical monocyte: 102.4;intermediate monocyte: 106.7;myeloid DC: 86.2;neutrophil: 64.3;non-classical monocyte: 70.6" "Group enriched" "Detected in many" 40 "dendritic cells: 86.2;granulocytes: 64.3;monocytes: 106.7" "Cell line enhanced" "Detected in some" "EFO-21: 21.2;HEL: 4.6;HMC-1: 5.3;NB-4: 10.1;U-937: 7.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA072644 Approved Vesicles "Secreted to blood" NA NA 8500000000 Vesicles "HPA072644: " "unprognostic (2.77e-3)" "unprognostic (2.21e-3)" "unprognostic (1.00e-1)" "unprognostic (2.15e-2)" "unprognostic (4.15e-2)" "unprognostic (9.66e-5)" "unprognostic (9.90e-3)" "unprognostic (1.30e-2)" "unprognostic (5.37e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (2.70e-1)" "unprognostic (1.97e-2)" "unprognostic (2.58e-1)" "unprognostic (1.32e-1)" "unprognostic (4.62e-2)" "unprognostic (2.17e-1)" 3.3 1.0 0.7 10.3 0.9 39.4 1.6 0.7 0.6 0.6 2.0 0.2 0.6 0.5 0.7 3.1 1.8 2.5 2.1 4.3 0.6 0.6 1.3 21.6 8.7 41.3 0.4 0.0 0.7 0.4 0.0 0.7 1.6 0.3 0.8 0.4 1.2 3.1 0.6 1.4 1.0 2.1 2.6 0.4 39.3 1.1 0.8 0.0 6.0 0.9 1.3 5.6 2.1 0.9 0.4 86.2 64.3 106.7 1.1 2.1 70.7 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 21.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 4.6 0.1 0.0 0.1 1.1 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.2 0.0 10.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 3.2 0.9 0.0 0.0 0.5 0.1 0.4 0.3 0.1 0.1 7.0 0.0 9.0 102.4 3.2 0.2 106.7 0.2 0.4 1.4 0.1 86.2 0.1 2.1 0.7 64.3 1.1 70.6 2.7 1.1 70.7 0.7 0.9 0.7 0.6 0.6 0.6 0.4 0.0 0.3 0.0 0.0 14.5 8.5 0.1 3.5 3.2 0.8 2.5 4.0 4.5 0.0 0.0 0.3 0.0 0.2 0.1 1.0 0.0 0.0 0.6 0.4 1.6 0.2 1.1 1.7 15.7 1.6 0.0 122.2 303.6 0.0 0.9 129.1 5.0 486.9 0.0 0.2 0.4 0.0 1.1 0.4 1.7 0.0 0.9 0.0 0.2 2.6 0.3 3.3 0.6 0.0 CHGA ENSG00000100604 "Chromogranin A" P10645 14 92923080-92935293 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins" "Antibiotic, Antimicrobial, Fungicide" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "parathyroid gland: 577.6" "Cell type enriched" "Detected in many" 49 "Intestinal endocrine cells: 6314.9" "Cancer enhanced" "Detected in many" "pancreatic cancer: 114.8" "Region enhanced" "Detected in many" "cerebral cortex: 97.9" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 134 "SCLC-21H: 44.3;SH-SY5Y: 120.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000023, HPA017369, CAB040544, CAB055506, CAB058688" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 295000000 78000000 Vesicles "CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: AB_2665574, HPA017369: AB_1846698" "prognostic favorable (7.85e-5)" "unprognostic (4.89e-2)" "unprognostic (5.96e-2)" "unprognostic (1.17e-1)" "unprognostic (1.43e-2)" "unprognostic (5.95e-2)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.74e-1)" "unprognostic (2.23e-1)" "unprognostic (4.56e-2)" "prognostic favorable (4.07e-4)" "unprognostic (1.85e-1)" "unprognostic (8.81e-13)" "unprognostic (1.07e-2)" "unprognostic (1.77e-1)" "unprognostic (9.17e-2)" "prognostic unfavorable (3.99e-4)" 2.0 81.9 6.6 3.1 18.7 1.3 1.3 0.5 97.9 1.9 36.1 4.0 0.0 15.8 1.3 1.3 1.2 1.3 1.3 1.2 11.2 14.0 1.3 1.2 1.4 1.2 8.0 36.1 1.2 15.9 577.6 81.1 1.2 17.1 2.0 7.9 0.4 1.3 1.3 1.2 1.3 38.8 1.3 2.5 1.3 51.9 32.5 0.7 0.0 5.9 0.0 1.2 1.3 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 44.3 120.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.6 18.7 0.5 97.9 11.2 14.0 8.0 36.1 17.1 0.7 0.0 0.0 0.0 0.2 0.8 10.3 2.2 0.0 0.0 0.0 0.0 27.5 0.3 0.0 0.0 1.0 0.1 14.4 0.0 0.3 0.1 0.2 4.0 0.0 0.0 1.2 15.9 6314.9 0.0 0.0 3.6 36.8 0.0 6.8 3.6 28.7 3.2 76.4 23.0 129.0 0.0 11.3 0.0 0.3 4.9 2.2 0.0 0.2 0.0 9.0 0.1 CHGB "SCG1, SgI" ENSG00000089199 "Chromogranin B" P05060 20 5911430-5925361 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 424.9;pituitary gland: 177.5" "Cell type enriched" "Detected in many" 11 "Intestinal endocrine cells: 997.5" "Cancer enriched" "Detected in many" 6 "pancreatic cancer: 154.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 2.6;T-reg: 1.1" "Lineage enhanced" "Detected in single" "T-cells: 2.6" "Group enriched" "Detected in some" 23 "SCLC-21H: 66.7;SH-SY5Y: 102.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008759, CAB009403, HPA012602" Enhanced Supported Enhanced Vesicles "Intracellular and membrane" NA NA 24000000 Vesicles "CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706" "unprognostic (1.79e-3)" "unprognostic (7.72e-2)" "unprognostic (3.48e-1)" "unprognostic (2.90e-2)" "unprognostic (1.68e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (7.96e-3)" "unprognostic (2.86e-1)" "unprognostic (6.18e-3)" "unprognostic (7.93e-2)" "prognostic favorable (9.96e-4)" "unprognostic (8.56e-2)" "unprognostic (8.21e-2)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "unprognostic (2.73e-1)" "unprognostic (1.01e-2)" 3.4 424.9 8.2 1.4 10.2 0.8 1.0 82.5 16.4 0.8 3.0 2.1 1.2 7.7 0.9 1.3 0.8 2.5 0.8 7.6 20.7 15.4 1.7 0.7 1.0 1.1 7.2 9.1 3.0 17.0 0.8 177.5 0.8 51.8 5.6 2.5 0.7 0.9 1.2 2.1 0.9 4.4 0.9 2.3 0.8 19.7 2.4 0.8 0.0 1.9 0.4 0.9 0.8 0.1 0.0 0.6 0.0 0.0 0.0 2.6 0.2 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.7 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 3.6 0.2 0.0 0.0 0.0 0.0 0.1 0.0 66.7 102.1 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 0.6 0.0 0.1 0.4 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.1 0.2 8.2 10.2 82.5 16.4 20.7 15.4 7.2 9.1 51.8 0.8 3.0 3.7 0.0 8.2 3.8 86.9 51.2 0.0 8.1 1.2 66.3 19.6 0.0 1.7 0.4 6.1 3.4 1.7 0.0 0.3 0.0 2.3 2.3 0.0 0.0 0.1 71.5 997.5 0.0 0.3 6.0 0.9 1.5 6.8 1.8 2.8 9.3 37.4 5.8 0.4 0.1 49.6 12.9 1.4 50.2 27.7 3.1 0.2 0.0 1.4 3.0 CHP1 "CHP, p22, p24, Sid470p, SLC9A1BP" ENSG00000187446 "Calcineurin like EF-hand protein 1" Q99653 15 41230839-41281890 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Protein kinase inhibitor" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Distal tubular cells: 330.0;Enterocytes: 365.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006616 Approved Approved Vesicles NA NA Vesicles "HPA006616: AB_1857461" "unprognostic (2.06e-2)" "unprognostic (3.26e-1)" "unprognostic (2.84e-1)" "prognostic favorable (9.63e-4)" "unprognostic (7.29e-2)" "unprognostic (3.74e-1)" "prognostic favorable (4.07e-6)" "unprognostic (2.20e-1)" "unprognostic (7.46e-2)" "unprognostic (3.26e-2)" "unprognostic (1.26e-3)" "unprognostic (2.79e-1)" "prognostic favorable (2.79e-6)" "unprognostic (1.06e-1)" "unprognostic (1.49e-1)" "unprognostic (4.62e-3)" "unprognostic (2.04e-1)" 39.4 32.5 21.2 17.0 21.5 25.7 32.3 13.5 34.1 17.0 51.0 19.0 18.9 41.0 13.4 16.4 39.1 11.2 38.8 27.3 22.7 23.8 35.6 82.3 31.6 14.4 22.4 15.6 13.6 31.1 27.1 13.9 12.2 32.1 16.8 37.6 15.2 28.7 23.1 42.2 24.2 55.6 15.8 19.0 12.6 52.5 7.5 11.3 10.3 23.6 34.2 24.7 21.7 22.5 8.6 30.5 52.5 47.4 11.0 11.8 19.4 21.7 21.3 8.2 31.5 34.9 33.2 12.8 16.9 21.3 13.3 14.3 18.8 42.0 3.7 19.0 22.2 14.1 26.7 15.9 25.7 14.7 15.3 6.0 14.6 17.6 29.1 27.3 19.2 23.1 34.0 28.0 15.2 15.3 19.4 23.8 11.5 23.6 24.0 14.6 12.0 8.0 19.7 8.9 32.5 11.4 11.5 13.4 10.5 26.0 39.8 5.6 13.9 28.8 53.1 14.0 14.8 31.4 18.2 34.1 15.0 16.2 23.5 11.0 14.1 37.3 17.8 26.8 11.8 13.5 42.9 47.4 52.5 10.7 40.0 11.0 8.6 10.1 10.7 30.5 6.8 6.5 9.3 35.6 11.0 38.5 19.2 11.8 19.4 21.2 21.5 13.5 34.1 22.7 23.8 22.4 15.6 32.1 11.3 41.7 95.4 37.9 53.7 64.2 9.4 73.8 193.6 22.7 38.7 97.7 9.8 29.7 330.0 84.2 45.0 25.3 365.9 23.3 131.3 51.6 41.6 79.7 36.9 304.1 61.4 11.1 53.4 75.5 170.6 81.7 27.3 82.7 123.2 54.1 120.3 19.0 140.2 153.1 27.6 162.5 9.3 25.8 42.4 12.5 19.0 94.9 56.0 55.4 104.3 95.4 CHPT1 CPT1 ENSG00000111666 "Choline phosphotransferase 1" Q8WUD6 12 101696947-101744140 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 497.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 19.4;eosinophil: 9.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 19.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067643 Approved Supported Vesicles NA NA Vesicles "HPA067643: " "unprognostic (1.59e-3)" "unprognostic (1.02e-1)" "unprognostic (1.91e-1)" "unprognostic (9.48e-2)" "unprognostic (3.15e-1)" "unprognostic (9.17e-2)" "unprognostic (5.79e-2)" "unprognostic (4.83e-2)" "unprognostic (1.12e-1)" "unprognostic (4.70e-1)" "unprognostic (5.27e-2)" "unprognostic (1.16e-2)" "unprognostic (1.52e-2)" "unprognostic (3.35e-1)" "unprognostic (1.72e-1)" "prognostic favorable (7.41e-4)" "unprognostic (1.79e-1)" 18.0 21.6 19.3 14.3 20.4 21.4 76.7 12.8 16.7 22.2 40.0 11.0 15.8 36.5 9.3 25.0 10.9 14.7 17.1 71.4 18.5 14.5 30.6 64.6 20.2 30.5 17.8 14.5 11.3 14.2 12.6 7.6 9.6 12.8 16.3 21.0 14.0 53.1 22.8 18.5 13.5 42.9 16.7 17.4 13.0 23.1 28.3 12.6 3.3 26.0 7.4 8.7 17.7 38.7 3.0 2.5 19.4 1.5 3.3 0.8 0.4 3.5 16.5 4.4 9.5 35.8 12.0 12.8 12.9 14.9 13.0 8.4 6.1 2.4 5.4 7.3 17.5 17.9 5.4 27.1 4.5 12.4 8.1 22.9 22.0 8.9 35.7 20.0 10.8 4.4 11.3 1.3 5.8 10.7 19.5 6.4 11.7 31.8 14.0 12.8 8.7 6.4 37.5 11.9 17.1 21.9 5.0 8.8 3.9 5.9 14.0 4.4 3.4 11.9 17.2 32.0 7.3 17.5 7.5 4.7 11.9 6.2 9.3 12.5 8.0 2.4 6.6 9.4 12.6 17.3 19.4 1.5 9.7 0.4 1.2 0.4 3.0 0.8 0.7 2.0 2.0 0.3 0.4 2.2 3.3 1.4 2.5 0.4 0.4 19.3 20.4 12.8 16.7 18.5 14.5 17.8 14.5 12.8 12.6 44.7 22.2 63.5 276.5 33.3 14.2 43.5 114.7 4.0 12.5 61.1 27.5 102.9 59.7 7.2 284.8 18.8 76.4 0.0 11.8 43.5 56.0 122.8 10.4 175.9 50.0 33.4 20.3 18.4 79.5 497.4 79.1 37.8 138.3 1.0 51.0 47.9 10.2 114.8 83.8 145.6 15.2 19.4 33.5 169.9 29.8 37.8 50.5 22.4 79.9 235.4 CHRDL2 BNF1 ENSG00000054938 "Chordin like 2" Q6WN34 11 74696429-74731385 "Predicted intracellular proteins, Predicted secreted proteins" "Chondrogenesis, Differentiation, Osteogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 64.5;endometrium 1: 76.5;gallbladder: 109.2" "Group enriched" "Detected in some" 5 "Cholangiocytes: 22.9;Hepatocytes: 76.1" "Cancer enhanced" "Detected in many" "stomach cancer: 14.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 13 "neutrophil: 1.2" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 6.1;PC-3: 3.2;SiHa: 6.1;TIME: 2.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in some" "HPA021771, HPA076522" Uncertain Approved Vesicles "Secreted to extracellular matrix" NA NA 5600000 Vesicles "HPA021771: AB_1846689, HPA076522: " "unprognostic (2.38e-2)" "unprognostic (1.80e-1)" "unprognostic (7.24e-2)" "unprognostic (3.41e-3)" "unprognostic (9.45e-2)" "unprognostic (2.09e-1)" "unprognostic (4.08e-2)" "unprognostic (4.33e-2)" "unprognostic (6.64e-2)" "unprognostic (2.57e-1)" "unprognostic (1.86e-1)" "unprognostic (1.23e-1)" "unprognostic (7.58e-6)" "unprognostic (8.39e-2)" "unprognostic (1.32e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (6.08e-4)" 1.0 0.0 0.0 39.3 0.2 0.0 1.7 0.1 0.3 64.5 27.9 0.1 1.0 1.4 76.5 47.6 4.3 2.9 109.2 35.8 0.1 0.1 1.0 14.5 0.8 0.5 0.0 0.0 6.7 1.0 0.4 0.1 1.5 0.4 8.0 0.9 0.9 0.2 3.5 2.6 0.3 3.5 45.3 0.6 0.8 24.1 7.6 0.0 0.1 0.2 3.2 1.1 22.6 8.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.6 0.0 0.0 0.0 0.0 0.5 0.1 1.0 6.1 0.7 0.0 1.3 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.9 0.0 3.2 0.0 0.6 0.0 0.0 0.0 0.1 0.2 6.1 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.5 0.4 0.7 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.1 0.1 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.4 0.2 0.0 2.2 22.9 0.0 0.0 8.7 0.0 0.0 0.0 5.8 9.7 0.5 0.0 0.0 9.0 0.0 0.9 0.8 0.0 76.1 0.1 0.0 0.0 2.5 2.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.7 0.0 0.0 0.0 1.0 0.2 1.9 0.0 0.1 0.0 0.0 0.5 CITED4 ENSG00000179862 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4" Q96RK1 1 40861051-40862366 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 152.3;Cholangiocytes: 76.5;Urothelial cells: 122.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 25.8;THP-1: 74.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA056434 Approved Approved Vesicles NA NA Vesicles "HPA056434: AB_2683132" "unprognostic (5.39e-3)" "unprognostic (5.41e-2)" "unprognostic (1.53e-1)" "prognostic favorable (4.38e-5)" "unprognostic (3.43e-3)" "unprognostic (1.90e-2)" "unprognostic (3.44e-3)" "unprognostic (3.42e-2)" "unprognostic (2.67e-1)" "unprognostic (1.98e-3)" "unprognostic (2.25e-2)" "unprognostic (6.00e-2)" "unprognostic (2.29e-3)" "unprognostic (2.10e-1)" "unprognostic (2.11e-1)" "unprognostic (2.11e-1)" "unprognostic (6.13e-2)" 17.3 10.1 2.9 2.5 5.2 21.5 22.1 3.2 9.4 18.3 12.3 8.0 13.8 3.0 11.3 14.4 14.9 7.1 15.7 10.4 2.4 5.5 12.9 27.8 8.6 4.8 5.5 2.8 12.2 39.4 4.0 2.3 12.9 6.0 11.0 1.5 26.1 15.9 19.1 37.1 22.6 3.7 8.0 2.7 33.4 7.4 12.3 2.7 1.5 8.1 16.0 11.4 8.5 10.1 0.0 1.3 2.2 1.0 0.0 1.5 0.4 8.1 1.6 0.4 9.9 0.2 0.4 10.0 0.5 0.6 0.2 0.2 0.8 11.0 0.0 1.3 0.1 0.3 12.5 0.6 6.8 0.2 0.0 0.1 0.0 0.8 1.3 1.7 0.2 0.1 1.2 2.9 0.6 2.2 0.8 0.5 0.1 0.0 0.0 0.3 0.2 0.1 5.4 3.2 0.2 1.1 0.0 0.0 0.0 25.8 4.7 1.9 0.5 0.4 10.3 0.5 1.1 5.0 74.0 0.6 0.0 0.0 0.1 0.3 0.0 0.2 0.0 0.0 3.8 0.2 0.0 1.0 0.4 0.1 0.5 0.3 0.0 0.3 0.0 1.3 0.0 1.1 1.5 2.2 0.0 0.3 0.0 0.0 0.4 2.9 5.2 3.2 9.4 2.4 5.5 5.5 2.8 6.0 2.7 8.9 0.6 0.5 152.3 16.9 3.5 9.0 76.5 4.0 4.5 21.0 0.0 0.5 36.5 11.8 34.8 3.8 0.5 0.0 37.1 0.8 3.1 48.3 0.0 28.7 1.1 1.6 7.5 3.7 7.1 46.4 4.6 2.2 18.6 1.0 3.1 41.7 27.0 3.1 5.3 65.0 1.9 19.4 3.9 0.5 0.6 21.2 0.1 0.0 2.1 122.5 CKLF "C32, CKLF1, CKLF3, CKLF4, HSPC224, UCK-1" ENSG00000217555 "Chemokine like factor" Q9UBR5 16 66552563-66566251 "Predicted membrane proteins, Predicted secreted proteins" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 142.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 334.0;Macrophages: 289.2;Spermatocytes: 349.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 142.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA062779 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA062779: AB_2684867" "unprognostic (1.64e-2)" "unprognostic (2.17e-2)" "unprognostic (1.88e-1)" "unprognostic (4.97e-2)" "unprognostic (3.06e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (5.67e-5)" "unprognostic (2.72e-1)" "unprognostic (3.35e-1)" "unprognostic (1.79e-2)" "unprognostic (8.05e-3)" "unprognostic (1.48e-1)" "prognostic unfavorable (1.06e-9)" "unprognostic (2.36e-1)" "unprognostic (2.65e-1)" "prognostic favorable (2.22e-4)" "unprognostic (1.07e-1)" 18.8 21.1 16.1 27.7 16.9 29.9 18.8 19.0 14.9 14.8 20.6 11.0 9.1 15.7 14.8 15.2 12.5 16.4 22.8 11.0 14.9 13.4 15.0 14.6 28.9 41.2 23.1 11.0 14.5 12.0 11.4 13.5 14.6 15.0 14.6 22.0 10.9 13.0 9.7 6.8 9.0 26.5 16.9 20.8 44.4 12.2 42.5 18.6 40.2 12.3 11.7 24.6 17.6 13.0 9.4 32.2 142.0 39.6 17.7 25.6 34.2 35.7 31.9 6.7 19.3 18.1 14.8 4.9 17.9 13.6 19.6 29.3 29.7 43.9 14.1 22.7 15.3 20.5 19.3 13.3 10.7 27.6 17.4 6.7 10.3 28.4 36.3 10.9 32.0 27.8 10.1 8.7 24.4 8.7 23.5 23.3 43.6 16.4 40.7 24.4 11.9 30.9 31.8 2.2 21.1 51.8 53.1 35.4 39.2 65.4 19.9 9.4 11.4 54.8 3.6 16.6 4.7 10.6 21.7 14.2 28.4 25.7 9.8 21.0 19.3 39.7 71.8 23.9 28.2 22.9 64.6 39.6 74.8 20.6 19.8 25.6 9.4 19.2 20.0 32.2 8.8 10.2 14.1 142.0 17.7 18.6 16.3 22.9 34.2 16.1 16.9 19.0 14.9 14.9 13.4 23.1 11.0 15.0 18.6 17.9 66.2 46.2 20.8 24.3 8.2 0.8 101.9 65.6 35.2 54.1 0.0 40.5 14.9 120.7 24.7 44.8 58.0 23.3 113.2 92.3 41.3 13.1 334.0 34.2 227.1 1.6 31.7 66.9 154.7 20.5 45.8 289.2 38.8 30.7 61.5 19.0 153.7 40.3 28.3 75.1 6.4 32.3 33.5 349.8 69.4 20.1 14.5 215.8 65.0 23.3 CLCN3 "ClC-3, CLC3" ENSG00000109572 "Chloride voltage-gated channel 3" P51790 4 169612633-169723673 "Predicted intracellular proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044723 Approved Supported Vesicles NA NA Vesicles "HPA044723: AB_10959733" "unprognostic (1.92e-1)" "unprognostic (3.92e-2)" "unprognostic (1.95e-3)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (2.25e-1)" "unprognostic (3.32e-1)" "unprognostic (1.79e-1)" "unprognostic (5.40e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.10e-4)" "unprognostic (2.49e-2)" "unprognostic (2.49e-1)" "unprognostic (1.45e-1)" "unprognostic (6.38e-3)" 11.6 21.1 27.6 10.9 29.9 5.9 18.4 24.9 37.7 15.0 26.7 32.4 15.5 17.1 11.1 17.7 26.6 15.6 22.0 19.6 29.3 29.7 22.2 14.7 11.9 9.0 32.7 22.7 14.0 23.4 29.4 38.7 14.5 36.1 19.5 30.8 20.6 48.5 13.5 14.6 18.0 16.5 10.4 46.1 9.0 23.2 18.4 25.4 10.8 21.7 18.4 13.5 20.5 16.7 8.6 11.9 6.2 8.1 6.9 11.5 7.9 11.4 11.9 17.8 22.6 36.3 30.5 8.7 15.4 19.3 10.4 12.7 8.4 26.0 14.1 9.6 12.8 12.0 9.8 22.1 9.5 17.5 12.5 8.6 11.9 19.3 9.6 24.7 14.2 19.9 21.2 21.9 18.5 18.3 43.3 18.7 19.7 29.3 32.5 18.4 4.1 19.4 3.3 7.3 19.8 8.1 8.7 7.9 11.0 21.7 23.7 19.3 19.0 13.7 15.0 24.1 15.3 10.2 6.7 15.8 8.4 9.4 13.4 11.9 14.4 21.7 12.6 25.1 5.4 22.0 6.2 6.5 4.7 9.0 8.1 11.5 8.6 6.7 8.2 9.5 7.4 10.4 9.2 5.3 6.9 6.5 11.9 8.1 7.9 27.6 29.9 24.9 36.8 29.3 29.7 32.7 22.7 36.1 25.4 29.8 22.1 14.3 22.7 10.1 84.1 61.8 45.9 71.0 13.6 59.3 123.7 19.6 6.6 32.1 76.3 24.8 82.7 23.3 38.3 14.8 13.8 65.9 112.9 33.3 15.9 57.2 64.2 33.7 32.6 56.4 22.7 13.3 30.4 7.2 61.7 156.2 31.4 48.2 19.8 15.9 109.5 6.5 19.6 16.9 16.4 22.8 59.5 16.0 47.2 30.6 CLCN4 "ClC-4, CLC4" ENSG00000073464 "Chloride voltage-gated channel 4" P51793 X 10156945-10237660 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 75.3;Cone photoreceptor cells: 96.2;Horizontal cells: 49.3;Rod photoreceptor cells: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4" "Group enriched" "Detected in many" 9 "B-cells: 6.8;granulocytes: 4.4" "Cell line enhanced" "Detected in many" "GAMG: 17.5;HEL: 16.2;SCLC-21H: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031313, HPA063637" Enhanced Approved Approved Vesicles NA NA Vesicles "HPA031313: AB_10601358, HPA063637: AB_2685069" "unprognostic (1.01e-1)" "unprognostic (1.20e-2)" "unprognostic (5.07e-2)" "prognostic unfavorable (2.13e-5)" "unprognostic (2.96e-1)" "unprognostic (3.75e-1)" "unprognostic (1.04e-2)" "unprognostic (3.66e-1)" "unprognostic (1.75e-1)" "unprognostic (5.99e-2)" "prognostic favorable (9.55e-4)" "unprognostic (9.70e-2)" "unprognostic (9.78e-3)" "unprognostic (1.68e-1)" "unprognostic (1.49e-1)" "unprognostic (1.32e-1)" "unprognostic (1.74e-1)" 3.1 3.4 9.7 2.0 21.3 2.1 1.6 18.6 29.1 2.0 1.4 15.7 0.0 1.2 1.3 22.8 2.3 3.0 2.8 11.4 13.0 10.5 3.4 3.5 3.4 2.9 23.5 10.4 2.2 2.4 8.9 3.9 1.7 18.2 2.1 1.1 6.0 2.3 1.7 34.6 1.2 1.2 1.4 15.2 3.2 2.1 2.2 17.9 0.0 6.8 2.0 2.2 2.3 0.8 6.8 0.6 4.4 0.5 0.0 0.0 0.6 4.8 3.0 2.2 0.0 1.1 2.0 0.0 0.1 0.0 0.0 0.0 5.9 3.3 3.6 8.7 0.9 17.5 1.0 1.4 3.2 0.1 0.0 3.4 16.2 1.6 2.4 5.4 0.0 0.0 9.7 2.6 4.2 1.0 3.4 6.2 0.0 1.2 0.0 2.2 0.5 0.0 0.1 2.8 5.2 10.5 0.0 3.6 0.0 1.5 0.5 16.8 6.3 6.9 0.7 0.0 2.0 1.8 2.0 6.1 2.6 4.4 11.4 0.4 0.4 8.1 1.3 8.3 0.0 3.3 2.3 0.5 0.0 0.0 0.4 0.0 1.7 0.0 0.0 0.6 6.8 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.6 9.7 21.3 18.6 26.7 13.0 10.5 23.5 10.4 18.2 17.9 8.9 1.9 3.7 0.7 0.5 75.3 26.7 12.7 5.3 1.2 7.0 96.2 0.1 0.0 2.2 0.0 1.4 0.0 0.0 3.1 0.2 1.0 0.7 1.1 4.2 2.5 49.3 14.5 17.2 4.7 0.0 0.9 0.5 0.0 0.0 0.0 12.8 2.9 0.0 3.5 2.6 37.1 0.0 0.8 0.0 0.2 0.1 0.2 0.0 0.0 0.8 CLDN14 DFNB29 ENSG00000159261 "Claudin 14" O95500 21 36460621-36576569 "Disease related genes, Predicted membrane proteins" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "kidney: 7.4;liver: 25.0" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 7.6;Distal tubular cells: 16.6;Ductal cells: 10.3;Exocrine glandular cells: 7.3;Hepatocytes: 19.8;Pancreatic endocrine cells: 13.1" "Cancer enriched" "Detected in many" 6 "liver cancer: 7.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 2.1" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.1" "Cell line enriched" "Detected in some" 14 "HDLM-2: 70.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA054707 Uncertain Vesicles NA NA Vesicles "HPA054707: " "unprognostic (1.14e-1)" "unprognostic (2.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.43e-2)" "unprognostic (8.20e-3)" "unprognostic (5.54e-2)" "prognostic favorable (1.53e-4)" "unprognostic (3.50e-4)" "unprognostic (2.28e-1)" "unprognostic (2.30e-2)" "unprognostic (2.12e-2)" "unprognostic (4.87e-1)" "unprognostic (7.44e-4)" "unprognostic (2.77e-2)" "unprognostic (7.65e-2)" "unprognostic (2.45e-2)" "unprognostic (9.71e-2)" 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.4 0.1 0.3 0.0 7.4 25.0 0.0 0.0 0.0 0.0 0.3 0.9 0.0 0.0 1.8 0.1 0.2 0.1 0.0 0.2 0.0 0.3 0.2 0.4 0.0 0.5 1.4 0.1 0.1 0.0 0.0 0.2 0.0 0.6 0.2 0.0 0.2 0.2 2.1 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 70.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.8 5.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 2.3 1.4 0.0 0.2 0.1 1.9 3.7 0.0 0.3 0.1 0.0 0.7 0.2 2.1 0.0 0.1 0.2 0.1 0.2 0.0 0.0 0.2 0.2 0.2 1.0 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.0 1.0 0.3 0.0 0.8 7.6 0.0 0.0 1.8 0.0 0.1 16.6 10.3 0.4 0.0 0.0 0.0 7.3 0.9 0.0 0.7 0.0 19.8 0.1 0.0 0.0 0.6 0.0 0.2 0.0 0.0 3.3 1.0 0.0 0.0 13.1 0.0 0.4 0.0 0.0 0.0 0.2 0.5 0.0 0.3 0.7 0.0 0.0 1.4 CLIP4 "FLJ21069, RSNL2" ENSG00000115295 "CAP-Gly domain containing linker protein family member 4" Q8N3C7 2 29097705-29189643 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 177.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 30.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043366, HPA056246" Uncertain Enhanced Vesicles NA NA Vesicles "HPA043366: AB_10963051, HPA056246: AB_2683078" "unprognostic (1.97e-2)" "unprognostic (1.49e-2)" "unprognostic (2.14e-2)" "unprognostic (2.47e-3)" "unprognostic (3.64e-1)" "unprognostic (6.82e-2)" "unprognostic (1.15e-2)" "unprognostic (8.82e-3)" "unprognostic (3.62e-1)" "unprognostic (4.32e-2)" "unprognostic (2.73e-1)" "unprognostic (7.99e-2)" "prognostic unfavorable (1.83e-4)" "unprognostic (3.59e-3)" "unprognostic (6.35e-2)" "unprognostic (2.14e-1)" "unprognostic (1.99e-2)" 16.8 9.7 12.1 8.6 19.5 2.0 18.8 12.7 19.7 8.3 13.4 17.3 7.2 4.8 13.1 8.8 22.1 12.5 12.7 26.6 13.7 12.1 7.7 4.6 17.2 8.7 19.8 12.8 22.3 6.2 12.1 22.9 39.2 15.8 16.5 7.1 15.7 10.4 15.2 46.0 28.0 7.3 23.5 18.4 9.1 8.1 15.2 14.4 7.1 31.1 16.8 9.8 19.6 13.0 1.1 1.8 1.3 17.5 3.9 9.8 3.7 28.1 7.9 1.2 4.3 11.5 17.4 0.0 11.2 19.3 6.3 7.2 0.2 18.6 3.5 5.7 19.2 25.3 11.6 1.2 8.7 9.0 6.5 1.9 0.0 9.9 0.4 29.4 0.0 5.8 12.2 22.2 8.3 30.5 22.8 4.4 2.6 0.1 11.2 9.5 0.2 2.7 1.2 0.3 1.6 1.7 0.0 7.2 0.5 11.6 5.0 1.9 4.9 9.7 4.0 10.1 1.2 0.0 1.7 13.8 1.5 11.5 4.9 4.8 5.8 0.0 0.0 6.9 0.0 4.5 1.3 4.6 0.1 6.3 10.7 9.8 1.1 4.8 6.5 1.8 0.4 5.5 5.4 0.9 3.9 17.5 0.0 1.7 3.7 12.1 19.5 12.7 19.7 13.7 12.1 19.8 12.8 15.8 14.4 59.6 16.7 2.9 19.3 15.1 29.8 57.7 0.0 5.3 11.4 12.2 27.5 5.7 3.3 9.1 177.9 2.9 0.0 0.0 7.9 1.6 24.8 16.7 4.7 1.0 10.0 19.1 0.0 2.5 28.6 66.0 25.3 11.8 8.5 1.8 0.0 20.9 16.8 0.0 22.6 5.0 19.4 12.9 9.5 10.4 0.5 23.8 18.0 17.9 0.0 21.3 CLNK MIST ENSG00000109684 "Cytokine dependent hematopoietic cell linker" Q7Z7G1 4 10486395-10684865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 10.9;lymphoid tissue: 10.8" "Cell type enhanced" "Detected in some" 9 "Distal tubular cells: 11.6;granulocytes: 11.5" "Cancer enriched" "Detected in single" 13 "renal cancer: 3.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "HDLM-2: 9.2;U-937: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035671, HPA035672" Uncertain Uncertain Vesicles NA NA Vesicles "HPA035671: AB_10669673, HPA035672: AB_10669775" "unprognostic (2.47e-3)" "unprognostic (4.74e-4)" "unprognostic (1.99e-4)" "unprognostic (2.24e-3)" "unprognostic (1.17e-1)" "unprognostic (2.23e-6)" "unprognostic (2.05e-2)" "unprognostic (5.37e-4)" "unprognostic (9.87e-2)" "unprognostic (3.75e-2)" "unprognostic (2.55e-1)" "unprognostic (7.74e-3)" "unprognostic (1.55e-1)" "unprognostic (6.05e-3)" "unprognostic (6.65e-3)" "unprognostic (1.45e-1)" "unprognostic (2.99e-2)" 0.4 0.5 0.3 5.7 0.3 0.5 0.7 0.4 0.3 1.9 1.8 0.1 0.1 0.7 0.8 1.7 2.0 0.4 1.4 0.3 0.3 0.3 10.9 1.2 3.2 5.0 0.3 0.1 0.5 0.7 0.0 3.2 1.5 0.5 0.5 0.4 1.6 2.5 0.1 0.3 1.2 2.3 1.7 0.3 6.3 1.6 1.1 0.1 8.4 0.5 1.5 10.8 0.4 0.4 3.4 5.5 1.6 0.4 4.3 3.6 0.5 0.1 0.6 0.5 0.3 0.8 0.2 0.6 0.4 0.0 0.1 0.2 0.0 0.4 0.3 0.1 0.4 0.1 0.4 0.0 0.0 0.1 9.2 0.4 0.4 0.5 0.1 0.1 0.3 0.3 0.4 0.1 0.0 0.3 0.2 0.1 0.2 0.1 0.7 0.0 0.0 0.0 0.4 0.2 0.4 0.2 0.2 0.1 1.1 0.1 0.6 0.8 0.1 0.3 0.5 0.3 0.3 0.3 0.0 1.0 0.2 0.3 0.6 0.3 0.5 0.1 0.4 0.5 4.8 0.2 1.0 0.4 0.6 0.7 0.3 0.3 3.4 1.2 0.4 5.5 2.9 0.5 0.5 1.6 4.3 0.2 1.4 3.6 0.5 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.1 0.5 0.1 3.0 4.8 0.8 0.8 0.7 1.1 0.6 0.0 0.0 1.2 0.0 2.0 0.3 11.6 0.0 4.9 0.3 0.0 0.0 0.0 1.6 0.4 0.4 11.5 0.2 0.2 0.0 0.0 0.6 0.3 3.1 0.3 1.3 1.7 0.0 0.0 0.2 0.2 0.0 2.1 0.0 0.8 0.0 0.4 1.1 0.5 0.4 0.1 2.5 0.0 0.6 CLTCL1 "CHC22, CLH22, CLTCL, CLTD" ENSG00000070371 "Clathrin heavy chain like 1" P53675 22 19179473-19291716 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 53.0" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 11.2;Cone photoreceptor cells: 13.7;Early spermatids: 15.7;Late spermatids: 12.9;Spermatocytes: 13.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 3.3;neutrophil: 8.4" "Group enriched" "Detected in many" 15 "granulocytes: 8.4;monocytes: 3.3" "Cell line enhanced" "Detected in many" "HMC-1: 34.9;K-562: 16.3" "HPA075327, HPA075795" Enhanced Approved Vesicles NA NA Vesicles "HPA075327: , HPA075795: AB_2686764" "unprognostic (1.29e-2)" "unprognostic (3.13e-2)" "unprognostic (1.93e-2)" "unprognostic (3.16e-3)" "unprognostic (8.20e-2)" "unprognostic (6.93e-3)" "unprognostic (1.60e-1)" "unprognostic (3.28e-1)" "unprognostic (4.42e-2)" "unprognostic (2.93e-3)" "unprognostic (3.14e-1)" "unprognostic (1.02e-1)" "unprognostic (1.20e-1)" "unprognostic (8.71e-4)" "unprognostic (1.61e-1)" "unprognostic (2.10e-2)" "unprognostic (1.06e-1)" 2.9 3.3 1.1 0.9 2.0 9.7 1.6 3.4 1.8 1.3 1.0 3.7 1.2 0.4 2.3 3.1 2.2 1.4 0.9 5.6 1.3 1.7 1.0 1.7 1.2 0.6 2.7 1.4 1.4 0.9 2.1 14.9 1.1 4.1 1.8 0.8 4.2 1.5 1.1 53.0 2.1 0.9 2.4 3.6 0.9 1.0 17.2 1.2 1.3 2.7 10.4 0.7 1.2 1.3 0.2 0.3 8.4 3.3 0.0 0.3 0.6 2.3 2.4 1.6 2.6 5.9 3.2 0.7 1.6 1.7 2.3 3.4 0.8 0.7 0.9 0.2 3.6 1.7 0.8 2.5 4.6 1.9 0.1 2.4 0.1 2.2 2.7 3.0 3.3 34.9 13.9 3.7 4.2 5.9 6.7 1.4 1.3 16.3 0.9 5.3 1.8 0.4 11.6 2.0 9.4 2.0 1.2 13.3 0.0 1.8 0.9 3.8 0.6 3.5 2.2 0.2 2.0 4.7 14.1 0.4 4.1 8.7 2.3 2.7 1.8 4.2 0.4 2.4 9.0 0.8 0.0 3.3 0.3 0.1 0.7 0.0 0.0 0.1 0.3 0.3 0.2 0.3 0.0 8.4 0.0 0.0 0.1 0.0 0.6 1.1 2.0 3.4 1.8 1.3 1.7 2.7 1.4 4.1 1.2 3.0 0.3 0.0 0.5 0.6 1.6 11.2 2.5 0.0 2.3 0.0 13.7 0.3 0.0 0.7 15.7 0.4 0.0 0.0 0.0 0.1 0.9 1.4 0.0 1.5 0.3 0.0 0.0 1.3 1.5 12.9 2.3 0.0 0.0 0.0 1.2 1.7 1.0 0.0 3.9 0.6 2.1 0.0 2.1 13.4 5.3 0.6 0.9 0.0 0.9 0.0 CMTM6 "CKLFSF6, FLJ20396" ENSG00000091317 "CKLF like MARVEL transmembrane domain containing 6" Q9NX76 3 32481312-32503408 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 55.5" "Cell type enhanced" "Detected in many" 6 "monocytes: 520.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026980, HPA063491" Enhanced Supported Vesicles NA NA 390000 Vesicles "HPA026980: AB_10602801, HPA063491: " "unprognostic (1.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.34e-2)" "unprognostic (1.81e-2)" "unprognostic (7.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.95e-2)" "unprognostic (1.99e-1)" "unprognostic (2.44e-3)" "unprognostic (2.95e-1)" "unprognostic (1.04e-3)" "unprognostic (6.79e-2)" "unprognostic (2.27e-1)" "unprognostic (7.23e-2)" "unprognostic (6.58e-2)" "unprognostic (3.74e-2)" "unprognostic (1.55e-3)" 5.5 6.4 2.8 8.2 2.6 10.4 6.7 1.4 1.4 6.6 5.5 2.5 6.7 4.9 9.8 24.4 6.1 4.2 2.4 2.4 5.1 21.6 9.0 5.6 2.8 4.1 6.0 4.0 3.0 8.6 6.0 7.3 9.0 5.0 0.7 12.6 5.9 4.7 3.9 10.5 6.3 5.7 7.7 9.5 9.3 6.1 10.0 12.8 55.5 35.4 11.2 8.1 16.3 22.9 7.4 14.8 11.1 25.7 25.6 65.6 17.0 24.4 17.9 20.7 7.9 38.4 13.7 19.4 22.7 12.1 14.9 10.3 28.2 24.5 61.1 12.6 17.3 5.4 11.7 18.3 28.8 34.5 25.3 18.2 20.6 15.5 28.9 28.7 13.4 8.4 25.8 22.8 7.1 17.3 15.0 13.2 19.2 11.0 14.7 11.6 10.6 24.8 32.2 3.4 10.0 15.5 8.8 16.3 15.7 12.9 28.9 25.7 19.9 13.2 19.4 20.3 13.4 13.3 12.8 13.9 25.3 24.8 24.6 15.1 35.2 5.6 23.3 6.2 10.0 7.5 5.3 12.8 7.1 4.4 4.9 55.5 11.2 35.4 6.9 8.1 16.3 32.8 47.1 95.1 72.5 85.3 9.9 5.1 81.5 112.4 53.4 90.7 11.8 219.6 28.2 87.5 4.6 59.7 40.2 0.0 72.9 81.3 109.6 119.8 124.6 218.5 140.7 47.7 126.8 122.2 288.9 5.4 36.5 262.8 77.6 520.2 93.6 137.9 99.4 49.1 40.3 54.3 17.2 38.8 75.2 34.5 20.2 110.7 218.9 111.7 53.2 91.4 CNIH1 "CNIH, CNIL, TGAM77" ENSG00000100528 "Cornichon family AMPA receptor auxiliary protein 1" O95406 14 54423560-54441431 "Predicted membrane proteins, Transporters" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002544 Approved Uncertain Vesicles NA NA Vesicles "HPA002544: AB_2081856" "unprognostic (1.06e-1)" "unprognostic (1.18e-3)" "unprognostic (7.09e-2)" "unprognostic (5.06e-2)" "unprognostic (1.50e-1)" "unprognostic (8.93e-3)" "unprognostic (1.47e-1)" "unprognostic (2.71e-3)" "unprognostic (4.78e-2)" "unprognostic (4.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.79e-1)" "unprognostic (4.12e-2)" "unprognostic (1.28e-1)" "unprognostic (1.47e-1)" "unprognostic (1.71e-2)" "prognostic unfavorable (8.95e-4)" 32.2 32.3 24.3 19.9 24.9 11.7 27.7 20.6 28.0 23.5 31.0 18.9 22.5 35.8 25.4 20.3 28.7 25.2 27.5 31.0 21.6 22.9 29.4 83.6 26.1 36.2 23.5 18.9 22.0 26.3 12.3 31.2 21.0 20.5 26.9 35.8 23.2 20.5 23.2 25.1 14.3 32.1 46.2 25.5 17.1 20.7 16.7 16.2 26.3 24.1 27.3 27.8 40.6 20.0 23.6 31.7 7.6 31.2 15.6 30.7 31.6 41.6 25.5 21.5 24.1 58.1 74.4 20.0 50.7 65.1 44.0 50.5 15.1 58.8 52.6 33.8 38.4 26.9 41.8 38.8 36.9 55.0 20.1 22.7 20.1 16.4 27.4 58.4 24.3 17.0 60.5 46.1 40.9 58.0 45.2 41.2 21.8 19.6 17.9 48.9 23.0 26.9 18.5 15.8 48.4 51.8 20.7 36.1 17.5 49.7 31.2 18.0 20.0 29.6 23.8 56.1 20.8 36.6 26.5 26.4 37.0 36.9 31.0 30.5 11.2 24.2 25.5 44.9 20.9 32.7 1.9 31.2 3.8 12.9 23.7 21.5 23.6 22.8 18.4 31.7 18.9 30.7 20.5 7.6 15.6 18.2 17.8 23.2 31.6 24.3 24.9 20.6 28.0 21.6 22.9 23.5 18.9 20.5 16.2 32.8 55.8 74.2 72.9 93.9 41.9 74.4 43.3 65.6 43.3 43.6 19.6 81.2 76.3 83.7 21.1 62.1 85.5 46.7 54.2 106.7 92.0 77.1 194.9 125.6 106.1 63.5 100.2 65.1 100.9 13.8 55.5 72.8 79.2 77.5 75.5 42.1 62.6 89.2 61.9 125.2 36.3 45.3 68.4 49.2 77.8 96.1 59.3 59.7 96.4 71.6 CNNM2 ACDP2 ENSG00000148842 "Cyclin and CBS domain divalent metal cation transport mediator 2" Q9H8M5 10 102918293-103090221 "Disease related genes, Predicted membrane proteins" "Ion transport, Transport" "Disease mutation, Epilepsy, Mental retardation, Primary hypomagnesemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 35.6" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 30.2;Syncytiotrophoblasts: 33.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059954, HPA071631" Enhanced Vesicles NA NA Vesicles "HPA059954: AB_2684177, HPA071631: AB_2686427" "unprognostic (2.18e-1)" "unprognostic (6.46e-2)" "unprognostic (1.24e-1)" "unprognostic (2.65e-3)" "unprognostic (3.19e-1)" "unprognostic (2.44e-1)" "unprognostic (1.93e-1)" "unprognostic (4.80e-2)" "unprognostic (4.51e-3)" "unprognostic (3.75e-2)" "unprognostic (1.29e-2)" "unprognostic (2.39e-1)" "prognostic favorable (2.39e-8)" "unprognostic (2.44e-1)" "unprognostic (1.13e-1)" "unprognostic (2.65e-3)" "unprognostic (1.56e-1)" 5.7 19.8 9.5 6.6 13.8 13.3 5.0 16.8 15.1 6.0 11.8 12.5 8.0 6.9 6.6 5.8 3.3 8.9 9.4 4.1 7.8 10.9 15.6 7.9 6.4 4.1 10.4 8.6 8.8 6.8 35.6 10.6 14.3 9.6 5.0 11.2 7.7 5.2 7.1 3.0 7.2 7.7 6.9 9.3 4.1 5.4 8.0 12.7 3.3 10.0 1.9 3.0 6.2 5.4 1.3 1.3 2.8 0.8 4.5 1.1 0.4 4.7 7.8 3.1 8.2 7.9 3.2 8.4 2.3 9.4 3.1 3.8 5.5 4.2 1.8 3.5 3.3 5.9 6.3 6.6 4.4 2.3 3.1 11.6 2.6 4.3 11.1 4.6 1.8 3.6 4.2 6.4 3.1 10.5 7.8 1.9 5.4 4.5 10.6 1.7 8.0 2.1 2.1 4.9 4.6 4.9 5.2 3.9 2.2 2.4 2.8 4.4 5.7 5.6 1.4 5.9 9.3 10.1 3.5 1.5 4.2 6.3 2.9 4.0 11.6 12.8 3.3 7.4 6.3 1.7 1.9 0.8 0.7 1.0 0.8 0.8 1.3 0.7 0.5 0.6 0.7 0.8 0.7 2.8 4.5 0.4 1.3 1.1 0.4 9.5 13.8 16.8 15.1 7.8 10.9 10.4 8.6 9.6 12.7 6.0 6.7 7.5 2.1 2.2 15.8 3.5 0.0 8.1 7.9 5.2 11.8 13.9 1.7 1.8 8.4 3.8 24.6 0.0 4.8 2.7 2.9 2.2 3.5 5.4 3.3 30.2 6.4 3.1 1.5 10.4 3.1 2.7 6.8 1.0 4.2 6.5 2.7 11.5 3.2 4.4 15.7 12.9 7.8 15.0 5.4 3.6 33.3 3.1 7.4 1.8 CNPY4 "MGC40499, PRAT4B" ENSG00000166997 "Canopy FGF signaling regulator 4" Q8N129 7 100119613-100125511 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Leydig cells: 32.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014166, HPA025240" Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA014166: AB_1853895, HPA025240: AB_2082630" "unprognostic (9.64e-2)" "unprognostic (1.59e-2)" "unprognostic (4.09e-3)" "unprognostic (8.44e-2)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.71e-1)" "prognostic unfavorable (3.99e-4)" "unprognostic (2.86e-1)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (6.16e-3)" "unprognostic (1.07e-1)" "prognostic unfavorable (3.59e-5)" "unprognostic (6.92e-2)" "unprognostic (1.80e-1)" "unprognostic (1.88e-1)" "unprognostic (1.35e-2)" 12.9 18.3 10.9 13.4 9.9 5.5 11.6 16.5 13.1 22.8 13.0 14.8 8.8 6.1 23.5 15.8 6.3 16.2 20.3 13.6 9.9 9.1 11.0 6.7 9.2 15.5 9.5 9.9 26.1 7.2 17.6 17.8 20.8 10.4 14.0 10.3 18.0 6.5 17.0 4.7 8.3 9.5 21.7 11.4 14.0 8.4 9.1 13.7 16.4 11.1 9.6 9.5 13.0 16.2 2.8 5.2 8.8 9.3 8.3 15.2 4.7 3.3 5.8 14.6 26.1 34.4 16.6 7.3 12.6 13.6 6.6 12.4 3.1 3.0 7.3 14.6 22.5 4.8 3.4 5.7 6.1 6.9 6.8 5.8 3.0 9.6 4.4 9.8 5.1 5.7 15.1 1.7 6.0 2.7 14.5 22.8 3.6 2.5 4.9 9.4 9.6 10.7 6.7 7.5 2.1 8.4 3.1 11.0 3.9 6.7 0.8 3.6 7.4 12.0 9.7 6.4 9.9 4.9 2.8 18.4 21.2 12.8 8.8 5.6 4.2 6.7 6.6 12.4 7.9 8.6 8.8 3.7 5.7 11.8 8.0 15.2 2.8 12.1 14.7 5.2 2.4 9.9 14.9 1.7 8.3 9.3 3.3 9.6 4.7 10.9 9.9 16.5 13.1 9.9 9.1 9.5 9.9 10.4 13.7 6.0 1.6 0.0 2.0 3.2 6.6 3.2 5.1 4.0 4.5 12.2 2.0 29.6 1.7 5.4 0.4 11.7 2.3 23.3 2.2 8.4 26.6 0.6 9.2 0.9 11.9 7.9 2.4 19.6 1.6 0.9 32.5 3.6 15.1 5.4 1.8 25.5 2.7 2.9 29.7 2.3 13.7 12.9 12.3 1.0 3.8 3.3 15.3 6.5 1.9 0.7 CNST "C1orf71, FLJ32001, PPP1R64" ENSG00000162852 "Consortin, connexin sorting protein" Q6PJW8 1 246566444-246668584 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007225, HPA007226" Approved Supported Vesicles NA NA 4600000 Vesicles "HPA007225: AB_1848869, HPA007226: AB_2667782" "unprognostic (1.55e-2)" "unprognostic (9.75e-2)" "unprognostic (3.33e-2)" "unprognostic (9.76e-2)" "unprognostic (2.78e-1)" "unprognostic (4.28e-2)" "unprognostic (3.72e-2)" "unprognostic (7.28e-3)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (3.52e-2)" "unprognostic (3.47e-2)" "unprognostic (2.73e-3)" "unprognostic (6.17e-2)" "unprognostic (2.63e-1)" "unprognostic (8.77e-3)" "unprognostic (2.26e-1)" 15.5 21.7 10.2 13.7 22.3 21.8 12.8 25.1 22.4 10.6 14.6 8.1 10.2 11.0 14.7 9.4 18.6 10.0 9.7 11.1 9.5 17.6 9.9 25.1 12.4 16.4 11.2 14.1 12.1 11.0 15.2 17.4 11.9 13.7 9.7 13.4 11.6 9.4 9.6 35.5 11.6 15.5 18.4 7.6 12.3 9.6 17.2 9.3 24.6 15.4 10.2 18.6 14.9 11.0 21.1 6.6 21.6 11.1 7.8 19.3 9.0 4.3 5.7 4.2 3.7 6.9 8.1 8.5 14.1 13.9 14.3 10.9 5.5 5.7 12.6 6.3 13.9 4.2 4.5 6.5 4.8 19.5 7.0 2.2 14.8 5.2 4.1 10.1 7.3 28.7 7.6 4.6 13.8 14.8 7.1 4.4 6.8 18.7 5.6 8.0 3.1 8.0 3.4 13.8 6.0 5.0 7.9 7.6 10.3 5.4 12.6 9.7 11.6 6.0 3.5 17.4 5.1 6.5 6.5 6.2 17.8 4.3 7.3 9.5 17.1 21.7 12.8 4.4 11.0 17.1 21.6 4.7 12.9 8.8 5.0 9.6 19.4 15.0 8.1 4.6 21.1 19.3 10.3 6.2 7.8 11.1 6.6 18.1 9.0 10.2 22.3 25.1 22.4 9.5 17.6 11.2 14.1 13.7 9.3 11.9 15.0 6.5 13.5 22.0 28.1 10.4 7.6 32.1 25.0 3.5 13.7 3.1 6.6 5.9 36.0 31.6 39.9 0.0 5.2 5.0 12.2 17.4 38.3 18.1 8.5 15.9 14.5 28.3 13.3 30.0 8.9 11.1 13.5 7.2 16.1 12.2 7.1 17.5 7.4 4.1 21.8 12.9 18.4 12.1 11.9 23.5 7.8 18.4 10.1 17.0 CNTF HCNTF ENSG00000242689 "Ciliary neurotrophic factor" P26441 11 58622673-58625733 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 47.5" "Cell type enriched" "Detected in single" 5 "Melanocytes: 1.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "midbrain: 47.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-2197: 12.9" "Low region specificity" "Detected in many" HPA019654 Approved Approved Vesicles NA NA 69200 Vesicles "HPA019654: AB_1859050" "unprognostic (1.88e-1)" "unprognostic (2.64e-3)" "unprognostic (1.01e-2)" "unprognostic (4.37e-2)" "unprognostic (1.52e-1)" "unprognostic (5.91e-2)" "unprognostic (1.63e-1)" "unprognostic (9.24e-2)" "unprognostic (5.87e-2)" "unprognostic (1.63e-1)" "unprognostic (8.25e-4)" "unprognostic (5.42e-2)" "unprognostic (8.50e-2)" "unprognostic (1.02e-1)" "unprognostic (1.91e-1)" "unprognostic (9.50e-2)" "unprognostic (9.67e-2)" 2.0 0.7 1.4 0.9 4.8 10.0 0.8 1.2 1.6 0.3 0.9 2.5 1.1 1.4 0.3 1.4 0.9 8.3 0.8 2.5 1.8 1.6 0.9 0.9 0.8 0.6 47.5 0.9 0.3 0.5 1.2 0.5 0.6 9.3 0.6 1.3 3.1 1.3 0.4 3.7 0.9 0.9 0.6 22.8 0.6 0.5 0.7 1.2 0.2 1.0 3.7 0.6 0.6 0.3 0.4 0.0 0.0 0.3 0.0 0.7 0.2 2.1 0.8 3.4 3.6 1.1 0.3 1.7 1.6 2.2 1.6 1.2 3.0 3.0 4.4 1.2 2.2 1.8 3.9 3.7 3.9 3.3 3.1 2.1 2.3 4.4 1.6 0.4 3.4 4.3 1.0 1.4 5.3 1.7 0.7 1.7 3.1 3.4 1.0 2.0 0.9 3.3 3.2 2.1 1.5 1.6 2.2 2.4 3.0 1.9 2.5 1.6 4.3 2.3 2.4 5.9 2.6 3.0 2.5 1.2 2.5 2.0 12.9 4.0 2.4 5.0 3.8 6.7 1.7 2.9 0.0 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.4 4.8 1.2 1.4 1.8 1.6 47.5 0.9 9.3 1.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 COCH "COCH-5B2, DFNA31, DFNA9" ENSG00000100473 Cochlin O43405 14 30874514-30895065 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters" Hearing "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 63.0;pancreas: 136.8" "Cell type enhanced" "Detected in many" 12 "Exocrine glandular cells: 52.5;Horizontal cells: 79.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 8 "basal ganglia: 63.0" "Group enriched" "Detected in some" 13 "memory B-cell: 24.0;naive B-cell: 7.7" "Lineage enriched" "Detected in many" 20 "B-cells: 24.0" "Cell line enhanced" "Detected in many" "HEK 293: 30.6;Hep G2: 20.0;K-562: 39.4;NB-4: 32.7;SCLC-21H: 36.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6" HPA065086 Supported Vesicles "Secreted to extracellular matrix" NA NA 88000 Vesicles "HPA065086: " "unprognostic (8.36e-3)" "unprognostic (2.51e-2)" "unprognostic (8.61e-2)" "unprognostic (1.64e-2)" "unprognostic (6.48e-2)" "unprognostic (6.53e-2)" "unprognostic (9.61e-2)" "unprognostic (4.03e-1)" "unprognostic (2.11e-2)" "unprognostic (1.40e-1)" "unprognostic (1.27e-2)" "unprognostic (2.91e-3)" "unprognostic (5.42e-3)" "unprognostic (3.92e-2)" "unprognostic (2.80e-2)" "unprognostic (1.03e-1)" "unprognostic (1.72e-1)" 1.1 1.4 2.1 1.1 63.0 1.3 0.9 1.1 2.3 4.0 0.8 1.4 1.6 0.6 0.6 1.0 0.6 2.2 1.2 0.9 1.2 2.9 1.8 0.5 0.5 3.1 0.8 1.9 0.6 136.8 0.4 3.3 0.9 2.1 14.7 1.0 0.8 1.8 21.8 0.6 4.6 0.7 0.7 1.4 0.8 0.8 1.8 7.9 0.0 0.6 0.7 2.4 1.1 7.8 24.0 0.0 0.1 0.3 0.0 1.1 0.6 0.0 11.2 1.0 0.0 0.2 0.0 7.0 0.0 0.0 2.1 5.6 6.6 0.4 0.1 0.5 0.0 0.4 0.0 7.1 0.0 3.5 0.0 30.6 5.6 2.6 20.0 0.0 0.5 2.3 0.4 0.0 0.2 0.0 0.0 0.1 12.7 39.4 1.6 0.5 0.2 2.8 32.7 3.8 0.0 1.2 8.3 0.0 0.2 0.3 1.0 36.3 9.8 0.8 0.1 0.0 4.1 0.0 15.3 0.2 0.0 0.0 0.1 0.0 1.8 4.8 3.5 0.0 0.0 1.4 0.0 0.3 0.0 0.0 0.0 0.0 24.0 0.2 0.0 0.0 7.7 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.6 2.1 63.0 1.1 2.3 1.2 2.9 0.8 1.9 2.1 7.9 0.0 0.3 11.3 1.6 16.9 1.9 0.4 2.5 0.0 1.2 0.0 3.9 3.9 1.7 0.4 1.3 2.1 0.2 0.0 52.5 9.8 3.8 3.0 1.1 3.9 3.1 79.4 16.4 4.3 8.6 1.3 1.4 1.5 18.6 4.6 0.0 14.5 5.7 0.0 5.6 7.9 3.9 0.0 15.6 3.9 6.6 11.8 5.5 2.9 0.4 1.0 COL14A1 UND ENSG00000187955 "Collagen type XIV alpha 1 chain" Q05707 8 120059780-120372036 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 87.4" "Cell type enhanced" "Detected in many" 21 "Cytotrophoblasts: 32.7;Fibroblasts: 157.1;Smooth muscle cells: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 18.3;hTERT-RPE1: 9.3;RH-30: 48.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023781 Uncertain Approved Vesicles "Secreted to extracellular matrix" NA NA 2000000 Vesicles "HPA023781: AB_1847098" "unprognostic (1.10e-1)" "unprognostic (3.15e-1)" "unprognostic (1.41e-1)" "unprognostic (2.19e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-3)" "unprognostic (5.96e-2)" "unprognostic (4.29e-2)" "unprognostic (7.61e-2)" "unprognostic (3.77e-2)" "unprognostic (4.36e-1)" "unprognostic (5.07e-2)" "prognostic unfavorable (5.79e-5)" "unprognostic (1.07e-2)" "unprognostic (8.21e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.01e-4)" 20.0 3.3 0.8 20.8 0.9 0.0 21.6 0.7 0.9 87.4 13.9 1.0 9.6 1.3 64.6 39.2 20.0 15.6 38.6 27.8 0.8 1.0 8.3 5.0 8.8 4.5 1.1 1.1 62.1 4.4 1.1 1.8 30.8 3.0 41.7 10.5 4.2 21.8 5.8 7.6 5.4 12.2 45.2 6.5 15.4 10.1 13.3 0.4 1.1 15.7 32.5 9.9 30.4 35.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.9 18.3 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.6 2.7 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.7 0.0 5.3 0.1 0.0 4.7 0.1 1.0 0.0 9.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.5 0.0 0.0 0.0 48.7 0.1 2.1 0.0 0.2 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 0.1 0.1 1.1 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.9 0.7 0.9 0.8 1.0 1.1 1.1 3.0 0.4 0.0 1.4 0.0 0.2 10.1 0.0 7.8 0.0 0.0 7.9 1.8 0.0 32.7 0.0 0.0 0.8 2.9 0.0 0.0 0.0 2.9 157.1 0.4 3.5 0.0 5.4 0.0 0.0 25.8 0.0 0.4 13.6 0.8 5.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.2 0.0 54.7 3.5 2.9 8.4 21.2 0.0 0.0 0.4 COL26A1 "EMI6, EMID2, Emu2" ENSG00000160963 "Collagen type XXVI alpha 1 chain" Q96A83 7 101362820-101559024 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 11.4;brain: 18.3" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 5.2;Hepatocytes: 2.6;Late spermatids: 2.2;Spermatogonia: 2.2" "Group enriched" "Detected in many" 6 "endometrial cancer: 12.6;ovarian cancer: 5.7;prostate cancer: 4.6;testis cancer: 14.7" "Cell type enriched" "Detected in single" 63 "plasmacytoid DC: 11.4" "Lineage enriched" "Detected in single" 63 "dendritic cells: 11.4" "Cell line enhanced" "Detected in some" "AF22: 20.3;BEWO: 16.3;HAP1: 7.2;NTERA-2: 17.1;SuSa: 13.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027059 Approved Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA027059: AB_1848142" "unprognostic (5.94e-3)" "unprognostic (2.16e-2)" "unprognostic (2.19e-2)" "unprognostic (4.67e-2)" "unprognostic (1.66e-1)" "unprognostic (3.35e-1)" "prognostic favorable (2.32e-5)" "unprognostic (1.48e-1)" "unprognostic (1.16e-1)" "unprognostic (2.85e-2)" "unprognostic (1.26e-3)" "unprognostic (1.78e-1)" "unprognostic (4.24e-3)" "unprognostic (3.60e-1)" "unprognostic (1.50e-1)" "unprognostic (7.48e-4)" "unprognostic (2.83e-3)" 0.0 4.1 2.5 0.3 7.0 0.3 0.2 0.4 18.3 0.1 0.0 0.2 0.0 0.1 0.5 0.3 0.0 0.2 0.3 0.1 3.3 3.1 4.8 0.6 0.9 0.0 8.1 0.2 3.1 6.7 0.0 0.5 0.6 3.7 0.0 0.0 0.2 1.1 0.0 0.1 0.1 0.1 0.3 0.4 0.2 0.8 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 11.4 0.1 0.0 0.0 0.0 0.0 0.0 0.5 20.3 1.2 0.0 0.0 16.3 0.0 0.0 0.0 0.0 0.8 0.0 0.1 3.2 0.0 0.0 0.0 7.2 0.0 0.0 0.7 0.8 0.0 0.0 5.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 17.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.1 0.0 0.0 0.1 13.7 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.0 0.0 5.2 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.0 0.5 0.2 0.0 0.5 0.0 2.6 0.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.3 0.0 0.0 0.5 COL4A2 "DKFZp686I14213, FLJ22259" ENSG00000134871 "Collagen type IV alpha 2 chain" P08572 13 110305812-110513027 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 125.7" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 463.3;Peritubular cells: 165.5;Sertoli cells: 368.7;Smooth muscle cells: 174.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 145.1;WM-115: 61.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010751, HPA029118, HPA069337" Enhanced Supported Vesicles "Secreted to extracellular matrix" NA NA 1900000 Vesicles "CAB010751: AB_476828, HPA029118: , HPA069337: " "unprognostic (2.43e-1)" "unprognostic (4.13e-3)" "unprognostic (8.04e-2)" "unprognostic (6.03e-3)" "unprognostic (2.20e-1)" "unprognostic (2.64e-2)" "unprognostic (3.45e-2)" "unprognostic (1.15e-2)" "unprognostic (3.50e-2)" "unprognostic (1.78e-1)" "unprognostic (1.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (3.49e-5)" "unprognostic (1.33e-2)" "unprognostic (1.57e-2)" "unprognostic (6.95e-2)" "prognostic unfavorable (9.25e-4)" 87.2 9.5 4.6 26.1 3.3 0.1 50.1 2.0 3.0 37.2 53.1 1.9 30.3 7.6 48.4 25.5 23.0 26.3 52.4 26.6 3.6 1.4 18.4 5.7 35.9 17.5 3.8 1.7 25.7 8.3 7.3 3.8 125.7 5.0 26.9 5.5 12.2 7.6 29.3 26.3 9.2 16.9 84.1 2.8 58.5 23.4 11.0 1.9 4.2 16.0 8.0 5.7 65.3 20.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 11.6 6.6 30.1 0.0 39.2 16.3 47.4 40.8 14.8 24.3 11.4 0.7 0.0 0.0 145.1 9.5 10.7 11.4 0.0 12.2 4.7 1.5 6.3 0.0 11.2 0.3 28.9 0.0 0.1 7.3 0.7 17.0 11.7 31.1 25.4 0.0 0.0 0.1 4.0 0.2 0.0 1.0 4.7 0.2 2.3 0.0 12.4 0.0 26.8 0.2 0.9 4.9 0.0 0.1 12.8 13.5 0.0 0.5 43.7 13.4 34.1 0.3 22.1 0.0 0.2 0.6 0.3 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.6 3.3 2.0 3.0 3.6 1.4 3.8 1.7 5.0 1.9 77.4 8.0 1.4 6.5 8.5 2.0 27.9 25.5 2.7 2.3 50.6 0.0 67.8 1.7 25.5 1.6 98.7 13.4 0.0 3.7 463.3 94.4 2.1 1.1 1.6 26.8 0.0 0.0 139.3 5.4 1.5 56.1 5.8 37.1 3.6 5.1 9.5 2.8 0.0 165.5 16.1 0.2 368.7 174.9 0.2 8.1 6.0 56.2 0.0 3.7 1.2 COL5A1 ENSG00000130635 "Collagen type V alpha 1 chain" P20908 9 134641774-134844843 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Heparin-binding "Cancer-related genes, Disease mutation, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 110.7" "Cell type enhanced" "Detected in many" 15 "Fibroblasts: 127.8;Leydig cells: 56.7;Peritubular cells: 36.4;Sertoli cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "MAIT T-cell: 2.3" "Lineage enriched" "Detected in single" 23 "T-cells: 2.3" "Cell line enhanced" "Detected in many" "BJ: 72.5;fHDF/TERT166: 67.3;HeLa: 48.1;HHSteC: 45.8;SiHa: 47.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA030769 Approved Approved Vesicles "Secreted to extracellular matrix" No No 12000000 Vesicles "HPA030769: AB_2673603" "unprognostic (7.77e-2)" "unprognostic (4.55e-3)" "unprognostic (2.22e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (9.56e-4)" "unprognostic (8.07e-2)" "unprognostic (8.09e-2)" "unprognostic (2.38e-3)" "unprognostic (1.54e-2)" "unprognostic (5.03e-3)" "unprognostic (5.05e-2)" "unprognostic (1.40e-1)" "prognostic unfavorable (2.07e-12)" "unprognostic (2.02e-2)" "unprognostic (4.73e-2)" "unprognostic (1.65e-2)" "unprognostic (2.50e-3)" 11.5 4.2 1.5 13.7 1.4 0.0 9.5 3.0 1.2 110.7 20.9 1.4 11.8 3.6 42.1 24.1 12.3 20.5 31.8 12.2 1.8 0.9 4.3 3.4 13.4 7.8 3.0 1.3 19.5 3.7 3.7 2.6 53.8 2.2 23.3 4.7 9.1 5.1 9.9 5.0 6.9 8.7 26.7 1.5 6.5 12.5 9.5 1.1 2.7 4.1 10.1 4.0 21.8 22.9 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.1 2.7 2.1 3.4 32.6 35.1 1.3 72.5 14.6 12.4 13.3 0.0 0.0 0.0 16.1 67.3 6.6 0.9 0.0 0.0 3.5 0.0 0.1 0.0 48.1 0.0 45.8 0.0 0.4 34.4 0.0 11.9 0.9 0.0 14.7 0.0 0.0 0.2 6.5 0.6 0.0 0.1 1.2 0.0 1.4 2.5 8.4 0.3 0.0 0.0 0.9 0.4 47.8 0.3 0.0 30.7 0.1 0.0 25.1 26.0 10.8 31.9 15.1 0.0 0.0 0.0 20.6 0.0 4.4 0.0 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.4 3.0 1.2 1.8 0.9 3.0 1.3 2.2 1.1 0.0 2.6 0.0 3.4 12.9 0.3 5.6 0.0 0.0 0.0 1.8 2.0 4.0 1.7 1.3 5.2 6.8 0.0 0.0 0.0 10.7 127.8 0.4 0.0 0.0 8.0 0.0 0.0 32.5 0.3 11.4 56.7 0.5 6.8 0.0 0.0 6.9 1.9 0.0 36.4 0.1 0.6 51.8 23.2 0.5 0.6 6.8 8.7 0.0 0.0 0.3 COL8A1 "C3orf7, MGC9568" ENSG00000144810 "Collagen type VIII alpha 1 chain" P27658 3 99638475-99799226 "Plasma proteins, Predicted secreted proteins" "Angiogenesis, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 56.0" "Group enriched" "Detected in many" 7 "Alveolar cells type 1: 229.3;Ito cells: 85.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 36.3;fHDF/TERT166: 149.2;hTERT-RPE1: 63.4;LHCN-M2: 43.8;TIME: 64.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA053107 Enhanced Supported Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA053107: AB_2682046" "unprognostic (3.13e-2)" "unprognostic (2.92e-2)" "unprognostic (2.27e-2)" "unprognostic (1.37e-1)" "unprognostic (2.07e-3)" "unprognostic (2.49e-1)" "unprognostic (2.31e-2)" "unprognostic (4.83e-2)" "unprognostic (2.62e-2)" "unprognostic (4.79e-2)" "unprognostic (3.58e-2)" "unprognostic (3.71e-1)" "prognostic unfavorable (9.39e-8)" "unprognostic (2.98e-3)" "unprognostic (1.72e-1)" "unprognostic (1.38e-2)" "unprognostic (1.32e-3)" 20.5 4.7 1.0 6.1 3.0 0.1 7.5 2.4 0.9 5.8 16.9 1.8 11.8 0.6 5.9 16.8 15.3 6.4 6.8 26.7 1.2 1.4 9.4 1.9 36.5 0.5 1.8 2.1 7.7 0.9 32.3 9.4 5.5 2.9 13.1 4.8 38.7 5.2 8.8 5.0 2.3 2.7 18.8 3.0 0.9 4.2 6.4 0.6 0.0 56.0 6.4 0.8 21.3 12.1 0.4 0.1 0.9 0.2 0.3 0.4 0.1 0.0 0.0 0.4 0.0 22.0 36.3 0.0 8.9 5.8 9.0 18.1 0.0 0.0 0.0 0.8 149.2 0.2 0.0 0.0 11.6 23.4 0.0 0.0 0.0 1.2 0.0 4.0 0.0 0.0 20.7 0.4 7.0 11.8 63.4 17.4 0.0 0.0 0.0 43.8 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 64.9 4.2 3.3 0.2 4.7 0.0 0.0 0.0 8.2 0.0 32.0 0.9 0.2 0.2 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.4 0.4 0.4 0.7 0.3 0.1 0.1 0.1 0.1 1.0 3.0 2.4 0.9 1.2 1.4 1.8 2.1 2.9 0.6 229.3 23.2 0.0 0.4 0.7 0.4 4.2 0.0 1.4 6.8 8.7 0.0 0.1 0.0 0.2 0.7 1.5 0.0 0.0 0.0 0.2 2.4 0.1 4.7 0.8 0.1 0.0 0.0 85.3 1.9 0.4 2.0 0.9 1.7 0.0 0.0 0.5 0.1 0.0 8.9 0.8 0.5 0.0 8.3 0.3 0.2 0.5 0.3 1.0 0.0 0.2 COLGALT1 "FLJ22329, GLT25D1" ENSG00000130309 "Collagen beta(1-O)galactosyltransferase 1" Q8NBJ5 19 17555594-17583162 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 66.0;Hofbauer cells: 81.3;Kupffer cells: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047821 Approved Approved Vesicles "Intracellular and membrane" No No Vesicles "HPA047821: AB_2680168" "unprognostic (2.46e-1)" "unprognostic (1.16e-1)" "unprognostic (3.49e-1)" "unprognostic (1.85e-1)" "unprognostic (1.17e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.65e-5)" "unprognostic (2.92e-3)" "unprognostic (2.92e-1)" "unprognostic (1.66e-3)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.89e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.43e-2)" "unprognostic (1.09e-1)" "unprognostic (8.87e-2)" "prognostic unfavorable (3.83e-4)" 29.8 11.4 12.1 26.9 16.5 21.3 36.2 15.6 13.1 18.2 18.5 10.8 9.6 12.0 21.9 20.2 17.6 19.2 18.1 21.7 10.8 7.1 11.1 17.8 25.1 46.1 19.4 7.3 19.0 15.2 7.9 8.1 29.6 11.8 12.6 11.6 9.5 12.0 13.0 10.7 16.7 17.3 25.7 11.3 30.9 13.9 11.2 17.9 10.3 11.3 12.7 11.9 19.6 19.1 2.5 11.5 7.6 17.4 1.4 3.6 7.1 23.2 27.5 13.4 18.4 53.2 33.0 21.4 21.8 12.8 28.8 29.9 20.8 36.7 11.9 39.1 38.2 24.6 20.8 13.6 25.3 17.5 6.7 21.8 11.4 35.8 19.7 29.2 27.2 34.9 27.3 22.7 32.2 13.5 11.7 32.3 7.6 23.3 6.0 10.4 10.2 13.7 17.6 9.9 16.9 26.9 14.7 17.1 18.2 6.1 15.5 9.7 7.0 23.4 18.7 22.1 9.1 9.7 39.7 22.5 57.2 16.2 50.7 35.4 10.8 27.3 13.1 33.8 51.9 25.9 1.1 15.0 7.6 3.4 17.4 2.0 2.3 3.2 3.2 11.5 2.5 2.3 3.6 2.4 1.4 12.6 4.4 1.9 7.1 12.1 16.5 15.6 13.1 10.8 7.1 19.4 7.3 11.8 17.9 17.9 30.0 6.0 4.6 17.3 3.6 8.9 5.1 5.3 18.2 10.4 5.9 5.4 0.0 11.4 2.7 14.6 9.7 0.0 6.9 66.0 26.7 5.5 8.1 12.3 81.3 12.7 5.2 9.2 58.8 2.3 17.5 43.3 16.9 8.2 13.7 1.7 10.2 5.8 20.5 4.1 2.9 12.9 17.3 3.1 13.9 18.2 7.0 10.2 15.3 7.5 COMMD7 "C20orf92, dJ1085F17.3" ENSG00000149600 "COMM domain containing 7" Q86VX2 20 32702691-32743997 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 221.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-937: 82.7" HPA054119 Approved Vesicles NA NA Vesicles "HPA054119: AB_2682388" "unprognostic (1.27e-1)" "unprognostic (1.51e-1)" "unprognostic (1.65e-1)" "unprognostic (1.84e-1)" "unprognostic (9.90e-2)" "unprognostic (1.64e-2)" "prognostic unfavorable (1.46e-4)" "unprognostic (5.31e-2)" "unprognostic (8.92e-2)" "unprognostic (2.31e-1)" "unprognostic (6.57e-2)" "unprognostic (2.98e-1)" "unprognostic (2.90e-3)" "unprognostic (5.04e-2)" "unprognostic (8.28e-2)" "unprognostic (8.52e-2)" "prognostic favorable (3.53e-4)" 22.4 22.6 32.8 18.4 25.3 23.6 24.0 25.0 30.7 18.0 21.9 19.3 26.9 12.6 19.5 35.5 18.5 19.4 19.0 27.8 25.3 21.5 30.5 25.5 19.0 18.2 23.5 26.6 17.6 27.3 19.9 14.7 32.3 17.8 21.1 21.6 22.3 23.4 22.7 41.8 19.4 15.4 25.9 17.3 21.9 20.3 10.5 16.6 13.4 37.3 16.7 22.2 21.1 16.0 19.3 36.8 46.5 45.4 27.9 24.3 43.8 16.4 11.3 11.1 7.8 8.2 15.3 19.9 14.1 24.2 24.3 16.8 21.4 10.9 12.8 12.6 17.4 20.3 7.4 9.4 12.2 18.6 5.0 5.8 36.2 7.2 16.0 21.3 15.1 20.8 11.6 15.3 18.3 11.0 19.4 23.7 7.4 12.6 6.6 15.5 12.5 13.1 31.4 9.4 16.8 10.5 12.3 1.2 4.6 25.7 11.6 6.7 10.4 14.6 20.6 24.4 12.6 12.0 25.3 15.5 24.9 13.3 15.2 14.4 7.2 5.9 4.5 30.1 82.7 9.9 29.4 32.2 46.5 24.3 42.0 21.2 19.3 20.1 22.3 36.8 17.7 22.3 21.5 3.3 27.9 45.4 23.9 21.9 43.8 32.8 25.3 25.0 30.7 25.3 21.5 23.5 26.6 17.8 16.6 20.8 13.2 34.2 27.6 14.7 51.8 40.3 50.9 12.0 14.8 34.9 64.8 192.2 74.6 89.3 2.1 44.4 26.7 0.0 103.4 87.6 36.1 28.7 53.0 35.2 110.4 63.5 31.8 37.4 43.7 2.7 34.8 46.3 54.0 96.4 40.1 67.1 91.9 48.7 44.9 92.8 64.0 45.3 38.1 12.6 17.1 25.2 221.2 70.3 42.2 36.0 CPLX1 CPX-I ENSG00000168993 "Complexin 1" O14810 4 784957-826198 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Transport" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 98.8" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 30.5;Horizontal cells: 17.5;Intestinal endocrine cells: 20.6;Rod photoreceptor cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "SCLC-21H: 43.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles NA NA Vesicles "HPA071191: , HPA074390: " "unprognostic (9.21e-3)" "prognostic unfavorable (4.20e-4)" "unprognostic (3.45e-2)" "unprognostic (4.68e-2)" "unprognostic (1.16e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" "unprognostic (2.26e-2)" "unprognostic (9.52e-3)" "unprognostic (2.01e-2)" "prognostic favorable (5.05e-4)" "unprognostic (1.10e-3)" "unprognostic (3.32e-1)" "unprognostic (2.05e-2)" "unprognostic (1.12e-1)" "unprognostic (1.34e-1)" "unprognostic (7.77e-2)" 7.8 6.5 13.1 2.9 40.7 1.5 2.4 26.3 98.8 2.2 2.5 3.9 0.0 2.8 4.2 1.5 1.6 2.3 1.9 3.0 16.9 7.6 2.4 2.4 2.8 2.4 16.3 18.3 2.4 3.0 3.4 1.7 1.8 52.8 4.4 1.7 3.8 4.4 2.5 4.5 3.0 2.8 2.0 5.4 5.6 3.2 4.9 4.2 0.0 1.8 0.0 1.6 1.7 1.7 0.2 2.3 0.1 0.0 0.0 0.8 0.0 2.7 0.2 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 8.2 0.9 2.0 0.9 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.9 0.2 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.9 0.1 0.0 1.2 1.1 0.0 1.3 2.2 1.3 0.0 0.0 0.8 0.0 0.2 43.0 6.0 0.2 2.8 0.0 0.1 4.3 0.1 0.0 0.0 0.3 0.0 0.0 0.1 2.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 13.1 40.7 26.3 98.8 16.9 7.6 16.3 18.3 52.8 4.2 0.0 0.0 0.0 3.4 0.9 30.5 3.0 0.0 0.0 3.4 0.0 3.9 0.0 1.7 0.4 1.2 10.8 0.5 0.0 0.7 2.6 0.7 2.0 0.0 3.8 0.2 17.5 20.6 8.0 0.3 1.9 1.7 0.0 1.7 0.0 1.7 13.7 0.7 2.9 0.0 0.8 15.0 0.0 1.4 4.7 8.2 1.0 0.8 1.0 1.5 1.1 CPLX2 "CPX-2, DKFZp547D155" ENSG00000145920 "Complexin 2" Q6PUV4 5 175796310-175884020 "Predicted intracellular proteins" "Differentiation, Exocytosis, Mast cell degranulation, Neurogenesis, Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 95.3;epididymis: 80.1" "Cell type enhanced" "Detected in some" 29 "Horizontal cells: 90.6;Intestinal endocrine cells: 35.2;Late spermatids: 18.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Group enriched" "Detected in some" 22 "A549: 106.1;Hep G2: 64.0;SCLC-21H: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071191, HPA074390" Supported Uncertain Vesicles NA NA Vesicles "HPA071191: , HPA074390: " "unprognostic (1.36e-1)" "unprognostic (1.12e-1)" "unprognostic (2.81e-1)" "unprognostic (8.98e-2)" "unprognostic (1.23e-2)" "unprognostic (5.73e-2)" "unprognostic (5.16e-2)" "unprognostic (2.49e-3)" "unprognostic (6.22e-2)" "unprognostic (1.20e-2)" "unprognostic (2.06e-1)" "unprognostic (1.90e-5)" "unprognostic (6.88e-2)" "unprognostic (2.20e-1)" "unprognostic (7.32e-2)" "unprognostic (6.87e-2)" 1.7 23.3 72.6 2.0 32.7 1.4 1.3 79.0 95.3 1.3 2.6 2.6 0.3 2.7 1.3 80.1 1.4 1.4 1.4 1.3 68.3 16.3 1.4 1.3 2.1 1.3 37.2 26.3 1.3 7.9 1.3 11.3 1.3 17.9 1.4 2.2 0.2 1.3 1.4 1.3 1.4 2.5 1.6 4.0 1.3 5.1 3.1 3.7 0.0 1.4 0.0 1.3 1.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 106.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 64.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 2.6 0.0 0.0 0.0 0.1 0.0 0.0 45.2 3.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 72.6 32.7 79.0 66.6 68.3 16.3 37.2 26.3 17.9 3.7 0.0 0.0 0.0 0.0 0.0 3.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.6 35.2 0.0 0.0 18.1 0.9 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 3.8 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 CPM ENSG00000135678 "Carboxypeptidase M" P14384 12 68842197-68971570 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 56.1" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 333.5;Sertoli cells: 750.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "classical monocyte: 15.5;myeloid DC: 11.9" "Group enriched" "Detected in many" 5 "dendritic cells: 11.9;monocytes: 15.5" "Cell line enhanced" "Detected in many" "ASC diff: 29.5;ASC TERT1: 21.0;HSkMC: 37.8;SiHa: 27.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002657, HPA077243" Enhanced Uncertain Vesicles NA NA 5000000 Vesicles "HPA002657: AB_1078398, HPA077243: " "unprognostic (1.74e-1)" "unprognostic (3.11e-1)" "unprognostic (2.88e-3)" "prognostic favorable (1.00e-4)" "unprognostic (4.58e-2)" "unprognostic (8.61e-2)" "unprognostic (1.57e-2)" "unprognostic (2.01e-1)" "unprognostic (8.42e-2)" "unprognostic (1.40e-1)" "unprognostic (1.35e-1)" "unprognostic (1.42e-1)" "unprognostic (1.47e-3)" "unprognostic (8.58e-2)" "unprognostic (6.85e-2)" "unprognostic (2.59e-2)" "unprognostic (1.06e-1)" 56.1 6.6 3.8 5.4 7.0 1.1 37.2 1.2 4.9 6.5 12.9 13.2 0.9 1.6 10.7 6.1 4.1 6.4 6.5 2.9 5.3 3.0 22.1 11.6 24.1 13.0 10.9 4.3 7.5 7.8 3.2 1.0 27.9 5.5 6.2 10.8 2.7 3.2 1.7 8.2 13.0 3.7 2.5 6.7 11.4 5.9 5.8 9.3 1.1 5.1 3.5 4.5 4.4 4.4 2.8 11.9 1.3 15.5 0.3 1.3 4.7 0.0 1.5 0.0 0.0 29.5 21.0 0.3 3.9 0.4 0.7 0.9 1.2 1.6 0.2 3.9 0.5 1.7 0.0 0.5 1.0 1.7 0.0 1.0 0.0 6.4 0.1 0.1 0.4 0.7 37.8 0.2 0.4 0.8 3.5 0.0 0.1 0.0 0.0 3.0 0.6 0.0 0.2 0.6 0.0 2.1 1.2 0.2 0.0 2.9 2.3 0.1 0.0 27.7 4.3 3.3 2.3 0.4 10.3 0.1 0.5 3.2 0.2 0.0 0.1 0.1 5.1 1.7 5.2 2.3 0.3 15.5 0.1 0.1 10.2 0.0 1.4 1.2 0.0 11.9 2.8 0.7 0.1 1.3 0.3 4.7 0.8 1.3 4.7 3.8 7.0 1.2 4.9 5.3 3.0 10.9 4.3 5.5 9.3 333.5 253.0 5.4 2.5 11.0 2.5 1.6 147.7 26.8 114.9 48.8 0.0 22.1 24.9 48.5 13.5 7.1 69.0 0.0 179.6 47.4 3.8 40.7 105.6 33.4 132.7 0.0 10.4 90.2 236.7 12.1 97.2 57.6 10.1 10.8 28.4 65.4 68.6 50.7 74.3 67.7 4.3 750.3 107.2 0.5 1.9 8.7 144.2 7.9 29.3 2.4 CRB1 "LCA8, RP12" ENSG00000134376 "Crumbs 1, cell polarity complex component" P82279 1 197268204-197478455 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 155.1;Muller glia cells: 100.9;Rod photoreceptor cells: 136.0" "Cancer enriched" "Detected in single" 12 "glioma: 2.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "basophil: 9.4" "Lineage enriched" "Detected in single" 22 "granulocytes: 9.4" "Cell line enriched" "Detected in some" 8 "HeLa: 17.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA061250, HPA063127" Approved Uncertain Vesicles "Intracellular and membrane" NA NA Vesicles "HPA061250: AB_2684458, HPA063127: AB_2684944" "unprognostic (1.96e-1)" "unprognostic (5.38e-3)" "unprognostic (2.92e-3)" "unprognostic (1.50e-2)" "unprognostic (5.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.38e-1)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (1.48e-3)" "unprognostic (2.59e-1)" "unprognostic (2.01e-3)" "unprognostic (1.78e-3)" "unprognostic (1.56e-1)" "unprognostic (3.36e-2)" "unprognostic (2.96e-1)" 1.1 1.1 11.9 0.9 11.0 1.8 1.2 31.4 20.4 0.9 0.9 10.4 0.0 0.9 0.8 1.2 1.1 2.0 1.0 1.2 11.4 6.2 1.1 0.9 1.0 1.0 4.0 8.9 2.6 1.7 0.7 1.9 0.9 14.1 1.0 0.9 9.0 0.8 0.9 2.4 0.9 0.9 0.8 8.7 0.9 1.5 7.3 9.6 0.0 1.3 0.0 0.8 0.9 0.1 0.1 0.0 9.4 0.0 0.1 0.4 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 17.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.3 0.1 0.0 0.0 0.0 0.0 11.9 11.0 31.4 10.5 11.4 6.2 4.0 8.9 14.1 9.6 0.0 0.0 0.0 0.2 0.2 12.7 1.2 0.0 0.0 0.0 0.0 155.1 0.0 0.0 0.0 1.4 0.0 0.0 23.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.0 100.9 0.0 0.0 0.4 0.0 136.0 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 CROT COT ENSG00000005469 "Carnitine O-octanoyltransferase" Q9UKG9 7 87345681-87399795 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Transport" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 116.1;Rod photoreceptor cells: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 35.3;RT4: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA019052, HPA019364, HPA019365" Enhanced Approved Vesicles NA NA Vesicles "HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174" "unprognostic (2.80e-2)" "unprognostic (6.47e-2)" "unprognostic (1.75e-1)" "unprognostic (4.56e-2)" "unprognostic (1.70e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" "unprognostic (9.93e-3)" "unprognostic (2.13e-1)" "unprognostic (1.13e-1)" "unprognostic (9.84e-2)" "unprognostic (3.48e-1)" "prognostic favorable (2.55e-6)" "unprognostic (3.52e-2)" "unprognostic (1.34e-1)" "unprognostic (7.60e-3)" "prognostic favorable (4.02e-4)" 4.6 10.1 9.3 5.1 9.6 1.6 10.5 7.4 8.4 9.0 9.4 5.5 24.1 19.6 10.0 12.6 17.0 6.8 8.7 5.9 5.2 5.4 12.3 21.5 4.2 3.4 5.4 6.6 7.2 4.6 15.5 9.1 13.7 5.8 14.8 7.0 9.8 8.3 32.3 7.2 15.0 19.1 8.8 6.8 4.8 4.9 3.8 4.7 7.4 27.1 8.4 8.0 22.4 15.3 2.2 2.3 3.4 5.5 13.0 9.5 3.0 7.2 5.4 6.6 2.3 6.3 5.8 4.9 7.7 7.2 4.7 5.1 2.8 3.8 3.0 6.8 6.5 9.4 9.1 1.1 10.2 6.7 4.3 4.6 6.6 3.8 3.6 4.1 4.1 4.1 4.7 35.3 3.8 3.0 6.0 6.6 5.0 0.3 4.4 12.3 7.1 5.1 4.1 1.4 2.6 8.0 2.3 9.1 0.5 6.0 34.6 1.1 5.2 9.4 10.9 4.9 4.7 6.9 1.5 3.5 10.9 4.7 14.7 7.2 6.7 9.6 4.2 7.3 0.0 6.4 2.0 1.4 3.4 7.4 1.7 9.5 2.2 7.5 6.0 2.0 2.2 6.1 6.6 0.9 13.0 5.5 2.3 6.3 3.0 9.3 9.6 7.4 8.4 5.2 5.4 5.4 6.6 5.8 4.7 20.8 7.7 4.4 49.0 14.9 16.1 13.2 7.6 32.1 36.4 50.6 43.2 116.1 8.3 6.6 18.7 6.5 24.7 0.0 7.6 5.2 7.3 20.4 7.0 28.8 12.0 14.3 7.0 5.5 7.5 33.1 14.7 7.4 18.6 6.4 13.1 24.1 8.0 7.4 13.1 15.3 76.5 6.5 8.3 2.5 3.6 13.4 41.0 7.0 10.9 43.1 CSF2 "GM-CSF, GMCSF" ENSG00000164400 "Colony stimulating factor 2" P04141 5 132073790-132076170 "Cancer-related genes, Predicted secreted proteins" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 9.5;lung: 6.8;pancreas: 4.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 10.7;Ductal cells: 12.3;granulocytes: 5.7;Pancreatic endocrine cells: 14.6;T-cells: 4.9" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "NK-cell: 9.5" "Lineage enriched" "Detected in single" 11 "NK-cells: 9.5" "Cell line enriched" "Detected in some" 4 "BJ hTERT+: 45.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA057404, HPA062006" Enhanced Vesicles "Secreted to blood" NA NA 23900 Vesicles "HPA057404: AB_2683428, HPA062006: AB_2684654" "unprognostic (7.29e-2)" "unprognostic (2.49e-3)" "unprognostic (8.77e-2)" "unprognostic (2.09e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" "unprognostic (2.56e-1)" "unprognostic (1.47e-2)" "unprognostic (2.64e-1)" "unprognostic (3.68e-3)" "unprognostic (1.87e-8)" "unprognostic (4.81e-2)" "unprognostic (1.22e-1)" "unprognostic (9.07e-2)" "unprognostic (2.06e-2)" 0.2 0.1 0.1 3.9 0.1 1.1 0.1 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.7 0.0 1.5 0.1 1.1 0.2 0.1 0.1 0.3 0.9 6.8 0.3 0.1 0.0 0.1 4.5 0.0 0.1 0.5 0.0 0.2 0.7 0.0 1.9 0.0 0.1 0.4 1.0 0.6 0.1 1.0 0.2 0.2 0.0 0.4 0.2 0.0 1.8 2.3 0.1 0.0 0.0 0.0 0.0 9.5 0.8 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 45.1 0.0 2.6 0.0 3.6 0.0 0.7 0.0 2.7 0.1 0.0 3.3 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 10.4 7.0 1.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.1 1.8 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 3.0 10.7 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.5 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 4.9 0.0 1.3 CSMD1 "KIAA1890, PPP1R24" ENSG00000183117 "CUB and Sushi multiple domains 1" 8 2935353-4994972 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 6 "brain: 29.5;testis: 9.0" "Cell type enhanced" "Detected in some" 20 "Bipolar cells: 8.4;Ciliated cells: 17.4;Early spermatids: 38.6" "Cancer enhanced" "Detected in some" "testis cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "K-562: 9.0;U-2 OS: 4.4;U-266/70: 4.3;U-266/84: 3.9;U-698: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA074707 Approved Vesicles NA NA Vesicles "HPA074707: AB_2686707" "unprognostic (6.32e-2)" "unprognostic (4.23e-2)" "unprognostic (2.37e-1)" "unprognostic (1.67e-3)" "unprognostic (5.72e-2)" "unprognostic (4.26e-2)" "unprognostic (1.02e-2)" "unprognostic (4.66e-2)" "unprognostic (7.69e-2)" "unprognostic (3.30e-2)" "unprognostic (1.36e-1)" "unprognostic (7.90e-2)" "unprognostic (1.01e-1)" "unprognostic (2.74e-2)" "unprognostic (5.09e-2)" "unprognostic (1.26e-2)" "unprognostic (1.11e-1)" 1.0 1.1 20.4 0.8 21.1 0.8 1.4 6.3 29.5 2.5 0.8 1.7 0.0 1.0 1.2 0.9 0.8 3.2 0.8 0.7 12.9 4.5 2.7 0.7 1.4 0.9 3.9 18.2 0.9 0.9 0.7 0.7 2.8 3.4 1.1 0.8 0.0 0.7 1.5 1.1 1.0 1.0 1.7 2.4 2.8 0.8 9.0 2.4 0.0 1.1 0.0 0.9 1.1 0.5 0.0 0.9 0.0 1.2 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.3 1.7 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 4.4 0.0 0.0 4.3 3.9 3.7 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 20.4 21.1 6.3 29.5 12.9 4.5 3.9 18.2 3.4 2.4 0.0 0.3 0.0 0.0 0.2 8.4 1.6 0.0 17.4 1.2 1.8 0.0 2.4 0.0 0.0 38.6 0.4 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.6 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.7 0.5 0.0 0.0 7.1 5.4 0.1 3.0 0.0 0.0 0.0 CSNK1G2 CK1g2 ENSG00000133275 "Casein kinase 1 gamma 2" P78368 19 1941149-1981338 "Enzymes, Predicted intracellular proteins" "Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 8 "Early spermatids: 218.1;Late spermatids: 503.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034868, HPA056572" Uncertain Approved Vesicles NA NA Vesicles "HPA034868: AB_10671235, HPA056572: AB_2683178" "unprognostic (2.00e-1)" "unprognostic (2.15e-1)" "unprognostic (1.83e-1)" "unprognostic (2.42e-3)" "unprognostic (6.51e-3)" "unprognostic (2.27e-3)" "unprognostic (1.14e-3)" "unprognostic (2.00e-1)" "unprognostic (9.42e-2)" "unprognostic (5.78e-2)" "unprognostic (4.83e-3)" "unprognostic (4.09e-3)" "unprognostic (7.95e-2)" "unprognostic (4.65e-3)" "unprognostic (5.09e-1)" "unprognostic (2.01e-1)" "unprognostic (1.63e-2)" 18.7 22.2 24.8 34.9 19.5 38.1 16.7 30.8 28.9 14.1 19.0 18.2 18.9 27.0 16.5 19.0 22.1 16.9 20.4 16.0 23.3 18.3 19.3 17.9 21.8 35.1 17.3 21.2 18.6 27.0 11.4 24.4 16.7 18.7 18.7 8.7 19.7 26.6 16.0 29.0 23.3 22.1 15.1 12.7 39.1 24.1 58.5 17.4 20.6 16.5 18.1 32.2 17.1 17.1 4.0 5.9 11.2 14.1 3.5 4.9 2.3 23.3 12.6 17.5 27.5 6.2 11.6 14.7 14.5 9.6 11.1 13.6 10.3 12.8 14.7 12.2 9.2 6.1 16.9 9.4 17.7 4.9 13.3 20.4 10.4 20.5 17.4 9.9 16.5 26.4 11.5 11.7 11.5 7.4 8.5 13.1 18.4 21.7 50.6 7.3 13.6 32.8 21.8 31.8 6.5 14.2 28.6 11.1 23.8 8.3 24.6 28.3 23.2 11.0 18.1 16.0 6.9 11.5 27.3 15.6 14.0 11.0 29.3 16.8 32.7 17.3 18.0 14.2 15.7 14.6 2.8 4.0 5.0 4.9 6.2 3.5 3.9 3.6 4.2 3.9 4.0 2.9 4.1 11.2 3.5 14.1 5.9 2.5 2.3 24.8 19.5 30.8 28.9 23.3 18.3 17.3 21.2 18.7 17.4 14.9 17.0 12.0 15.7 19.5 44.1 10.1 7.6 13.4 14.8 10.4 39.3 9.9 8.3 15.1 218.1 19.9 22.5 0.0 25.3 17.2 15.8 22.1 29.9 14.0 12.9 23.8 29.2 14.1 17.0 503.0 19.0 20.5 13.5 5.4 20.2 21.3 24.4 16.5 17.7 12.6 37.2 12.9 14.4 15.6 13.1 22.1 15.2 27.3 18.0 28.5 CT55 "CXorf48, FLJ20527" ENSG00000169551 "Cancer/testis antigen 55" Q8WUE5 X 135156536-135171398 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 11 "testis: 9.2" "Group enriched" "Detected in some" 35 "Spermatocytes: 8.1;Spermatogonia: 23.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 14 "K-562: 12.8" HPA059575 Approved Vesicles "Secreted in male reproductive system" NA NA Vesicles "HPA059575: " "unprognostic (6.20e-2)" "unprognostic (1.39e-1)" "unprognostic (8.36e-2)" "unprognostic (5.86e-3)" "unprognostic (3.47e-1)" "unprognostic (2.67e-1)" "unprognostic (4.44e-2)" "unprognostic (1.49e-1)" 0.1 0.2 0.5 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 9.2 0.2 0.0 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.8 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.6 0.0 0.1 0.1 0.1 0.2 0.6 0.8 0.0 0.0 0.0 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.1 23.4 0.0 0.0 0.0 0.0 0.0 CTSA "GSL, PPGB" ENSG00000064601 "Cathepsin A" P10619 20 45890144-45898820 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 125.7" "Cell type enhanced" "Detected in many" 4 "Hofbauer cells: 279.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 113.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB024930, HPA031068, HPA072487" Enhanced Enhanced Vesicles "Intracellular and membrane" NA NA 18000000 Vesicles "CAB024930: , HPA031068: AB_10601205, HPA072487: " "unprognostic (8.61e-2)" "unprognostic (3.37e-1)" "unprognostic (4.30e-2)" "unprognostic (2.13e-1)" "unprognostic (6.42e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (6.33e-2)" "unprognostic (9.53e-3)" "unprognostic (7.19e-2)" "unprognostic (1.83e-1)" "unprognostic (6.85e-2)" "unprognostic (7.57e-2)" "unprognostic (1.09e-1)" "unprognostic (6.05e-2)" "unprognostic (1.71e-1)" "unprognostic (8.40e-2)" 29.0 125.7 12.0 22.8 19.5 22.1 35.3 11.4 30.0 14.1 50.6 17.4 16.2 29.4 18.2 19.3 20.7 12.7 28.0 32.6 11.5 11.6 88.2 43.8 28.4 38.9 12.3 16.1 23.9 19.2 28.3 16.5 47.7 15.7 18.2 50.5 30.1 20.5 15.1 19.3 28.2 40.6 19.6 11.9 38.8 19.7 14.3 11.2 8.0 18.1 24.9 22.4 23.3 18.7 7.0 16.6 81.1 46.1 12.0 31.2 50.0 14.1 14.5 2.7 12.4 113.6 58.9 6.3 20.3 54.2 22.3 29.1 27.3 38.1 3.0 23.6 38.1 84.2 22.6 7.3 13.7 14.0 5.9 6.8 8.0 10.2 47.5 25.3 12.7 33.2 46.7 16.5 14.4 3.2 55.8 24.2 3.9 7.9 46.7 24.1 29.1 3.2 11.8 2.8 21.6 34.6 5.1 14.1 16.8 17.8 12.5 5.5 5.2 33.9 59.3 56.7 7.3 14.5 18.3 22.3 44.8 10.5 25.3 15.9 23.1 29.1 2.1 80.6 16.9 18.4 60.6 46.1 81.1 7.5 26.6 31.2 7.0 12.9 13.2 16.6 3.6 4.7 6.9 24.7 12.0 17.7 6.6 23.9 50.0 12.0 19.5 11.4 30.0 11.5 11.6 12.3 16.1 15.7 11.2 32.8 24.6 40.4 31.0 21.5 54.2 10.9 58.6 22.7 26.1 68.0 56.9 86.8 33.2 172.8 2.3 41.6 257.8 0.0 146.8 91.1 44.1 21.0 9.2 53.3 279.4 44.5 51.9 105.0 166.6 3.6 30.5 81.3 106.3 136.1 70.2 92.8 127.7 92.2 25.8 168.1 30.9 25.8 46.4 6.2 32.4 19.9 120.5 54.2 85.6 31.9 CTSC "DPP1, PALS, PLS" ENSG00000109861 "Cathepsin C" P53634 11 88293592-88337787 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 218.6" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 362.7;Hofbauer cells: 897.2;Macrophages: 364.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BJ hTERT+: 111.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025364, HPA066610, HPA068434" Enhanced Supported Vesicles "Intracellular and membrane" No No 19000000 Vesicles "CAB025364: , HPA066610: AB_2685694, HPA068434: AB_2685989" "unprognostic (4.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.50e-1)" "unprognostic (1.10e-1)" "unprognostic (3.70e-2)" "unprognostic (1.45e-2)" "prognostic unfavorable (9.30e-5)" "unprognostic (1.62e-1)" "unprognostic (1.04e-1)" "unprognostic (1.56e-2)" "unprognostic (3.11e-2)" "unprognostic (3.35e-1)" "prognostic favorable (4.80e-4)" "unprognostic (2.93e-1)" "unprognostic (4.35e-2)" "unprognostic (8.10e-2)" "unprognostic (4.07e-2)" 40.7 20.5 6.7 44.5 10.6 12.0 35.3 1.5 5.6 14.0 25.3 7.1 6.2 20.4 16.1 24.0 21.8 16.7 36.6 53.3 6.8 6.5 62.7 18.1 110.1 218.6 12.5 3.6 11.0 24.8 3.8 17.3 43.4 9.4 13.8 33.1 27.0 35.1 5.8 10.0 11.7 28.5 14.2 14.6 86.6 13.5 10.8 9.2 19.5 17.7 25.3 30.0 30.2 16.9 8.5 75.9 52.5 92.6 34.7 42.4 31.2 11.1 11.5 4.5 9.4 12.1 32.9 30.1 76.8 111.7 43.9 31.7 31.1 51.7 17.4 40.9 41.7 10.1 18.1 7.0 32.5 35.0 30.7 12.7 22.7 31.8 35.0 16.2 28.9 15.4 45.8 23.0 33.8 69.4 37.0 43.1 16.9 20.6 21.1 5.3 2.1 13.0 39.9 23.5 75.5 35.6 17.0 4.7 30.9 56.4 18.8 1.2 9.4 12.9 17.1 10.0 27.9 3.8 19.8 20.9 3.0 27.2 20.9 48.8 8.9 12.8 17.7 7.9 60.9 16.6 12.5 32.5 52.5 42.4 69.3 36.5 8.5 19.5 37.8 35.1 4.6 9.9 23.8 37.2 34.7 92.6 75.9 28.4 31.2 6.7 10.6 1.5 5.6 6.8 6.5 12.5 3.6 9.4 9.2 20.8 83.9 64.9 5.0 26.8 1.0 2.5 56.0 80.3 93.3 38.4 0.0 362.7 24.9 14.0 1.2 41.8 29.0 0.0 79.6 130.7 85.3 3.1 72.8 14.0 897.2 0.0 10.9 24.5 290.2 4.0 183.8 364.2 45.5 139.7 15.7 0.6 35.1 69.1 24.1 150.6 0.6 58.2 183.3 3.0 11.5 23.7 190.1 167.5 36.3 14.2 CTSK "CTSO, CTSO2, PKND, PYCD" ENSG00000143387 "Cathepsin K" P43235 1 150796208-150808323 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 104.1" "Cell type enhanced" "Detected in many" 11 "Basal keratinocytes: 61.1;Leydig cells: 110.1;Melanocytes: 92.8;Peritubular cells: 140.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 6.7" "Lineage enriched" "Detected in many" 6 "monocytes: 6.7" "Group enriched" "Detected in some" 8 "ASC diff: 205.0;ASC TERT1: 75.1;BJ hTERT+: 165.6" "Low region specificity" "Detected in all" HPA050346 Supported Vesicles "Intracellular and membrane" NA NA Vesicles "HPA050346: AB_2681101" "unprognostic (1.48e-1)" "unprognostic (9.29e-2)" "unprognostic (1.21e-1)" "unprognostic (7.61e-3)" "unprognostic (5.08e-2)" "unprognostic (6.57e-2)" "unprognostic (1.02e-1)" "unprognostic (6.60e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.49e-1)" "unprognostic (3.54e-2)" "prognostic unfavorable (7.12e-5)" "unprognostic (6.07e-3)" "unprognostic (2.98e-2)" "unprognostic (5.93e-3)" "unprognostic (6.41e-2)" 104.1 2.4 1.2 6.5 1.6 1.3 79.3 2.4 2.3 70.6 23.6 2.2 10.1 2.7 72.5 25.9 26.5 12.5 53.4 14.7 1.1 1.1 3.4 1.8 8.7 10.4 1.1 1.7 25.4 2.9 0.3 3.0 30.6 2.6 24.2 11.5 56.0 10.9 6.8 19.9 44.0 11.0 26.9 2.0 5.6 8.6 24.1 0.9 1.1 7.1 13.2 10.7 38.0 48.2 0.1 1.0 1.0 6.7 0.5 1.2 1.8 0.1 0.1 0.4 0.3 205.0 75.1 0.2 5.8 165.6 0.4 0.9 0.0 0.1 0.1 0.2 11.4 0.0 0.2 0.0 0.1 0.2 0.1 0.1 0.3 0.1 0.0 1.1 0.1 0.4 14.9 0.5 4.6 0.1 13.1 0.6 0.1 0.0 0.5 0.4 0.3 0.0 0.7 1.1 0.2 0.1 0.0 0.1 0.0 0.4 0.1 0.1 0.7 0.3 0.0 3.1 0.9 0.2 0.2 0.4 0.2 0.1 0.2 0.3 0.7 0.5 1.1 17.4 0.0 1.0 0.0 6.7 1.0 0.7 3.4 0.2 0.0 0.6 0.2 0.4 0.1 0.3 0.5 0.6 0.5 2.0 1.0 1.2 1.8 1.2 1.6 2.4 2.3 1.1 1.1 1.1 1.7 2.6 0.9 3.0 5.8 0.0 0.5 61.1 8.4 1.2 2.5 2.7 5.7 3.5 3.9 1.0 0.0 1.1 0.8 5.2 1.1 0.0 0.2 1.9 31.5 0.9 0.0 0.0 19.2 3.2 1.2 9.8 3.7 1.7 110.1 6.6 92.8 2.8 1.9 2.4 1.3 0.6 140.7 0.0 7.8 12.9 47.6 1.4 0.7 51.7 0.8 0.0 0.9 0.5 CTSS ENSG00000163131 "Cathepsin S" P25774 1 150730196-150765957 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 171.4;lymphoid tissue: 111.4" "Cell type enhanced" "Detected in many" 13 "Hofbauer cells: 672.3;Kupffer cells: 1992.4;Macrophages: 1161.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "classical monocyte: 171.4;intermediate monocyte: 151.2;myeloid DC: 43.5;neutrophil: 94.5;non-classical monocyte: 138.5" "Group enriched" "Detected in all" 9 "dendritic cells: 43.5;granulocytes: 94.5;monocytes: 171.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 21.6;HMC-1: 51.4;U-698: 109.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000460, HPA002988" Supported Approved Vesicles "Intracellular and membrane" NA NA 19000000 Vesicles "CAB000460: , HPA002988: AB_1078409" "unprognostic (7.81e-2)" "unprognostic (9.04e-2)" "unprognostic (3.23e-2)" "unprognostic (3.93e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-2)" "unprognostic (1.11e-1)" "unprognostic (1.23e-1)" "unprognostic (1.59e-1)" "unprognostic (6.00e-3)" "unprognostic (1.46e-1)" "unprognostic (3.89e-1)" "unprognostic (6.24e-2)" "unprognostic (7.50e-2)" "unprognostic (4.14e-2)" "unprognostic (2.13e-1)" "unprognostic (2.47e-3)" 41.6 9.3 6.8 32.3 10.3 30.3 9.7 1.9 6.2 4.7 32.9 6.6 5.6 19.6 3.7 12.9 8.8 10.7 15.9 17.3 6.4 5.1 9.6 21.5 55.8 99.5 12.6 2.3 7.6 6.4 0.4 3.4 14.4 9.3 7.5 33.4 6.5 12.9 3.3 3.5 3.8 38.0 6.8 17.1 111.4 13.8 3.8 9.5 12.9 7.6 4.6 22.8 21.5 5.3 11.1 43.5 94.5 171.4 3.3 5.6 145.4 1.0 3.3 0.0 0.0 0.4 0.3 0.3 0.0 3.3 0.2 0.6 0.0 21.6 14.9 1.6 0.1 6.1 0.4 0.0 0.1 0.0 8.3 0.0 6.5 0.1 0.0 0.0 8.9 51.4 0.6 0.0 1.9 0.1 0.1 1.2 0.0 0.6 13.0 0.4 0.0 0.0 6.3 0.0 0.0 0.0 3.7 1.2 18.2 4.0 3.2 0.0 0.1 0.2 0.9 0.3 0.0 0.0 18.2 1.8 1.3 0.2 0.0 0.3 9.0 0.8 109.3 7.6 9.6 0.8 1.2 171.4 16.5 3.2 151.2 3.9 11.1 3.9 3.8 43.5 10.2 3.9 3.6 94.5 3.3 138.5 9.4 5.6 145.4 6.8 10.3 1.9 6.2 6.4 5.1 12.6 2.3 9.3 9.5 101.3 167.2 252.8 20.8 15.0 2.0 3.0 84.1 518.0 134.2 40.1 11.8 3.1 0.0 145.4 5.3 35.1 277.5 0.0 157.6 3.9 26.3 16.7 100.8 19.5 672.3 0.0 40.9 64.4 1992.4 1.7 4.9 1161.7 54.0 251.5 198.9 0.3 150.7 378.7 2.1 4.2 4.1 19.4 7.6 0.2 0.4 13.6 5.1 117.4 149.8 109.8 CTSZ CTSX ENSG00000101160 "Cathepsin Z" Q9UBR2 20 58995185-59007247 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Hofbauer cells: 945.4;Macrophages: 462.5;monocytes: 1072.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.2;intermediate monocyte: 2.7;memory B-cell: 1.0;myeloid DC: 3.9;naive B-cell: 1.9;neutrophil: 3.5;non-classical monocyte: 2.9;plasmacytoid DC: 2.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 119.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB025114, HPA049876, HPA053504" Supported Supported Vesicles "Intracellular and membrane" NA NA 85000000 Vesicles "CAB025114: , HPA049876: AB_2680927, HPA053504: AB_2682172" "unprognostic (7.30e-2)" "unprognostic (3.98e-2)" "unprognostic (4.07e-2)" "unprognostic (1.11e-3)" "unprognostic (8.25e-3)" "unprognostic (1.15e-1)" "unprognostic (4.12e-2)" "unprognostic (6.59e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-1)" "unprognostic (1.33e-1)" "unprognostic (5.33e-2)" "prognostic unfavorable (5.72e-5)" "unprognostic (1.96e-1)" "unprognostic (6.92e-2)" "unprognostic (1.19e-1)" "unprognostic (2.04e-1)" 70.7 27.9 12.4 40.8 20.4 20.7 51.2 14.6 13.5 25.4 52.8 16.0 19.9 40.8 20.6 25.5 20.1 20.7 22.3 50.1 9.8 13.3 34.9 83.7 54.3 61.2 18.8 10.5 29.7 29.0 30.6 27.6 38.6 19.2 28.8 37.8 31.5 40.3 17.7 20.7 12.9 63.6 26.4 22.1 56.5 19.2 13.8 14.9 18.4 42.4 17.5 35.8 29.8 21.5 1.9 3.9 3.5 3.2 0.3 0.6 0.8 27.6 21.5 0.0 0.0 25.4 29.2 15.2 45.5 50.4 34.9 31.2 41.5 46.5 15.2 30.2 119.6 0.0 22.1 13.7 43.1 23.9 48.6 1.8 13.9 34.8 0.0 26.6 1.6 48.4 24.8 26.0 15.2 18.2 11.6 55.2 0.0 10.0 7.7 23.3 0.0 0.1 15.0 1.7 12.1 21.5 0.3 0.1 18.2 25.5 6.5 0.4 0.3 35.4 41.0 0.1 14.2 18.9 23.6 60.6 0.0 23.6 30.7 0.2 36.7 22.3 2.9 0.4 33.5 0.0 0.0 3.2 0.3 0.6 2.7 0.0 1.0 0.4 0.1 3.9 1.9 0.4 0.1 3.5 0.3 2.9 2.2 0.2 0.8 12.4 20.4 14.6 13.5 9.8 13.3 18.8 10.5 19.2 14.9 14.9 4.0 130.0 51.2 44.8 4.6 17.5 53.5 8.1 5.7 68.0 0.0 34.5 19.9 168.0 2.8 62.8 285.7 23.3 37.2 91.0 58.0 41.9 10.4 307.7 945.4 11.1 26.0 44.2 260.7 3.3 12.0 462.5 96.2 1072.2 50.0 45.9 72.3 98.2 13.1 68.2 4.9 45.3 59.0 1.7 4.5 36.3 34.6 29.9 76.8 46.2 CYP27C1 FLJ16008 ENSG00000186684 "Cytochrome P450 family 27 subfamily C member 1" Q4G0S4 2 127184120-127220078 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 10.6" "Cell type enhanced" "Detected in some" 10 "Club cells: 7.9;Collecting duct cells: 3.5;Leydig cells: 6.9;Pancreatic endocrine cells: 4.4;Suprabasal keratinocytes: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 8.4;HDLM-2: 12.1;hTERT-RPE1: 12.8;TIME: 12.1;U-138 MG: 12.4;U-251 MG: 8.1" "Low region specificity" "Detected in many" "HPA062460, HPA068731" Enhanced Vesicles NA NA Vesicles "HPA062460: AB_2732683, HPA068731: AB_2686023" "unprognostic (1.90e-1)" "unprognostic (4.07e-2)" "unprognostic (1.15e-1)" "unprognostic (1.38e-2)" "unprognostic (3.03e-1)" "unprognostic (7.75e-3)" "unprognostic (3.48e-1)" "unprognostic (2.31e-3)" "unprognostic (4.38e-2)" "unprognostic (3.15e-1)" "unprognostic (1.81e-3)" "unprognostic (1.11e-1)" "unprognostic (6.29e-4)" "unprognostic (3.49e-4)" "unprognostic (1.83e-1)" "unprognostic (4.27e-2)" "unprognostic (8.64e-2)" 2.7 1.0 0.6 2.4 2.4 0.8 0.6 0.4 1.8 5.2 1.9 1.5 0.4 0.5 1.3 0.8 4.4 1.0 1.5 2.0 0.4 0.9 0.4 0.4 0.4 0.6 2.9 0.4 0.4 0.4 0.0 0.4 0.4 0.7 2.2 0.7 4.2 0.4 1.5 0.8 10.6 1.0 0.4 0.4 0.4 0.5 0.7 3.6 0.4 0.4 2.2 1.6 2.7 4.5 1.5 1.3 3.6 1.0 1.8 1.4 0.2 1.3 3.8 1.9 0.1 0.1 0.0 0.2 0.5 3.6 2.0 0.8 0.1 3.0 0.2 0.1 2.2 1.4 8.4 3.1 1.8 0.6 12.1 1.4 0.0 2.1 0.1 0.0 0.1 0.1 0.1 0.1 0.5 1.2 12.8 0.5 0.3 0.1 0.5 2.3 0.1 0.3 0.1 4.3 0.0 1.0 0.1 0.2 0.0 6.3 1.1 0.1 0.7 5.3 0.0 0.0 1.5 0.2 0.1 12.1 12.4 2.2 6.0 8.1 0.2 0.1 0.1 0.1 0.1 0.9 2.4 1.0 0.7 1.2 0.7 1.0 0.9 1.0 0.8 0.3 1.5 1.1 1.4 3.6 1.8 0.7 1.3 0.8 0.2 0.6 2.4 0.4 1.3 0.4 0.9 2.9 0.4 0.7 3.6 0.0 1.1 0.0 1.2 1.5 0.0 0.3 0.0 0.0 7.9 3.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 1.4 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.4 0.0 0.0 0.0 0.9 0.1 0.1 6.4 0.0 0.0 0.0 3.0 CYP4B1 ENSG00000142973 "Cytochrome P450 family 4 subfamily B member 1" P13584 1 46757838-46819413 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 92.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 1140.4;Ciliated cells: 602.3;Club cells: 304.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 56.9" "Region enhanced" "Detected in single" "midbrain: 1.7" "Cell type enriched" "Detected in single" 11 "memory CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enriched" "Detected in some" 8 "RT4: 81.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA004331 Approved Supported Vesicles NA NA Vesicles "HPA004331: AB_1078616" "unprognostic (2.29e-2)" "prognostic favorable (5.99e-4)" "unprognostic (7.01e-2)" "unprognostic (1.11e-1)" "unprognostic (2.28e-1)" "unprognostic (8.31e-2)" "unprognostic (1.16e-2)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "unprognostic (2.59e-1)" "unprognostic (6.12e-2)" "unprognostic (5.46e-2)" "unprognostic (7.33e-2)" "unprognostic (1.80e-1)" "unprognostic (1.15e-1)" "unprognostic (1.22e-3)" "unprognostic (6.69e-3)" 41.6 2.2 0.0 0.6 0.1 0.3 45.5 0.1 0.3 9.5 6.7 0.1 7.2 0.7 2.1 2.8 17.9 18.5 0.8 13.5 0.0 0.0 1.4 0.2 92.0 1.5 1.7 0.1 3.3 0.9 0.5 4.8 0.9 0.8 15.4 0.5 2.8 5.0 6.9 14.4 10.4 3.4 6.8 3.5 0.5 3.0 1.7 0.1 0.7 12.7 4.5 5.7 36.5 18.9 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.5 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 1.7 0.1 0.8 0.1 1140.4 70.0 0.0 114.6 0.5 0.0 4.8 0.0 602.3 304.8 0.0 0.0 0.9 0.0 0.0 0.5 2.1 0.0 0.0 0.0 0.2 4.7 3.9 5.8 0.0 0.6 0.0 0.0 2.5 0.0 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 3.6 0.7 0.0 0.0 142.5 DAB1 ENSG00000173406 "DAB1, reelin adaptor protein" O75553 1 56994778-58546734 "Disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4;intestine: 20.8" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 20.8;Early spermatids: 6.5;Horizontal cells: 20.6" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 31.4" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.5" "Group enriched" "Detected in many" 16 "granulocytes: 1.4;T-cells: 5.5" "Cell line enhanced" "Detected in some" "AF22: 6.0;fHDF/TERT166: 30.0;HeLa: 10.8;NTERA-2: 13.3;RT4: 17.7;WM-115: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032329, HPA052033, HPA067495" Enhanced Enhanced Vesicles NA NA Vesicles "CAB032329: AB_638973, HPA052033: AB_2681703, HPA067495: AB_2685852" "unprognostic (7.88e-2)" "unprognostic (1.02e-1)" "unprognostic (8.54e-2)" "unprognostic (2.09e-4)" "unprognostic (1.21e-1)" "unprognostic (1.18e-1)" "unprognostic (7.30e-4)" "unprognostic (3.90e-1)" "unprognostic (3.07e-2)" "unprognostic (1.47e-2)" "unprognostic (2.06e-3)" "unprognostic (1.27e-1)" "unprognostic (2.00e-3)" "unprognostic (1.78e-1)" "unprognostic (2.01e-1)" "unprognostic (1.44e-2)" "unprognostic (5.67e-2)" 1.8 1.7 5.8 0.3 3.8 0.0 0.7 31.4 6.2 1.7 1.0 1.8 0.5 15.0 1.0 1.0 0.6 1.6 0.8 1.8 5.3 1.4 0.7 7.5 0.8 0.2 1.1 4.2 1.2 0.7 0.0 0.7 0.0 2.0 4.0 0.3 2.9 5.2 10.2 0.6 0.6 20.8 0.3 1.1 0.6 1.0 0.9 0.7 0.0 0.8 0.0 0.1 1.9 1.0 0.0 0.0 1.4 0.0 0.2 5.5 0.1 0.0 0.0 6.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 0.0 0.0 0.0 0.0 1.1 0.0 13.3 0.0 0.0 3.2 0.0 0.1 0.0 17.7 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 15.0 0.0 0.0 1.4 0.5 0.0 5.5 0.0 2.0 0.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.1 5.8 3.8 31.4 6.2 5.3 1.4 1.1 4.2 2.0 0.7 0.0 0.0 0.0 0.0 0.0 20.8 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.1 20.6 0.0 1.3 0.0 4.3 3.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 2.5 0.1 0.3 0.0 0.0 0.0 0.4 0.0 0.6 0.7 0.0 0.0 DENND6A "AFI1A, FAM116A, FLJ34969" ENSG00000174839 "DENN domain containing 6A" Q8IWF6 3 57625457-57693089 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 13.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062618, HPA069725, HPA071711" Approved Supported Vesicles NA NA Vesicles "HPA062618: AB_2684809, HPA069725: AB_2686184, HPA071711: AB_2686435" "unprognostic (6.20e-2)" "unprognostic (3.86e-2)" "prognostic favorable (9.21e-4)" "unprognostic (1.76e-1)" "unprognostic (7.75e-2)" "unprognostic (3.17e-1)" "prognostic unfavorable (6.36e-4)" "unprognostic (7.16e-2)" "unprognostic (1.17e-2)" "unprognostic (2.28e-3)" "unprognostic (5.97e-3)" "unprognostic (1.12e-1)" "prognostic favorable (7.77e-6)" "unprognostic (3.06e-1)" "unprognostic (1.63e-1)" "unprognostic (3.61e-3)" "unprognostic (2.94e-1)" 18.6 12.0 8.6 16.7 12.4 15.0 18.1 18.6 12.8 19.8 16.9 15.3 15.3 9.7 23.7 16.8 16.1 16.3 13.7 11.4 9.3 9.7 14.6 10.5 15.1 20.9 10.7 10.6 29.8 10.5 16.1 17.2 16.0 12.1 15.3 13.0 21.4 14.8 17.2 22.0 14.2 16.9 22.3 12.2 21.8 13.8 11.3 9.6 23.0 19.6 11.3 19.8 18.2 17.4 1.7 1.5 13.5 1.6 2.4 4.4 1.0 12.1 9.9 13.4 8.2 7.2 8.1 7.7 6.3 8.1 7.9 6.2 6.4 13.6 14.4 2.7 6.5 7.0 6.4 10.6 13.4 6.7 3.6 9.6 11.3 10.8 4.9 6.9 8.6 6.7 8.7 9.7 5.4 14.2 8.0 11.2 15.6 7.6 15.8 5.6 5.3 18.5 10.7 7.6 7.7 6.9 7.8 8.0 10.5 9.7 20.5 4.7 16.6 12.5 10.4 9.0 6.1 6.8 10.6 12.2 9.7 5.2 10.2 16.4 11.8 15.1 15.0 11.2 14.5 14.0 13.5 1.2 1.6 3.2 1.3 3.6 1.1 2.9 3.0 1.5 1.7 4.4 3.2 2.0 2.4 1.6 1.2 1.5 1.0 8.6 12.4 18.6 12.8 9.3 9.7 10.7 10.6 12.1 9.6 17.9 10.9 6.5 10.0 11.4 16.2 21.9 20.4 4.0 9.1 5.2 7.9 5.3 3.3 6.8 21.3 11.3 4.1 0.0 9.3 3.8 10.2 5.5 2.3 7.8 9.4 9.5 2.9 21.5 26.7 10.5 10.9 10.0 3.3 10.0 4.5 9.4 14.2 2.9 13.4 7.9 14.6 6.5 11.8 11.6 4.1 9.4 1.9 16.0 4.7 11.6 DERL3 "C22orf14, derlin-3, FLJ43842, IZP6, MGC71803" ENSG00000099958 "Derlin 3" Q96Q80 22 23834503-23839128 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.7;pancreas: 80.8" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 88.6;Late spermatids: 121.3;Melanocytes: 212.6;Spermatocytes: 55.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 9 "plasmacytoid DC: 77.7" "Lineage enriched" "Detected in many" 9 "dendritic cells: 77.7" "Cell line enhanced" "Detected in some" "Karpas-707: 33.9;RPMI-8226: 19.9;U-266/70: 36.4;U-698: 8.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB037234, HPA049306" Approved Uncertain Vesicles NA NA Vesicles "CAB037234: AB_1840802, HPA049306: " "unprognostic (2.01e-3)" "prognostic favorable (8.70e-5)" "unprognostic (9.72e-3)" "unprognostic (7.47e-2)" "unprognostic (9.77e-3)" "prognostic favorable (8.01e-4)" "unprognostic (2.23e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-1)" "unprognostic (8.66e-3)" "unprognostic (4.74e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.76e-13)" "unprognostic (1.53e-2)" "unprognostic (4.08e-1)" "unprognostic (1.65e-1)" "unprognostic (1.95e-1)" 1.3 1.8 1.2 27.3 2.1 4.1 2.8 1.7 1.6 3.7 21.5 1.1 20.2 18.7 1.9 2.9 4.1 3.4 5.7 3.9 1.2 1.9 2.9 4.7 7.2 25.5 1.3 1.2 1.1 80.8 0.6 4.0 7.9 2.4 1.6 6.9 1.9 44.8 29.3 1.3 0.4 14.9 0.3 1.0 28.5 21.8 12.6 1.6 1.0 9.5 3.4 36.1 15.5 1.2 8.4 77.7 0.1 0.0 0.0 0.1 1.3 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 3.1 3.5 0.6 0.0 0.6 0.0 0.3 0.6 0.0 0.7 1.8 0.1 2.0 0.0 0.4 3.8 0.9 0.0 0.1 0.2 0.0 0.1 0.1 0.2 0.5 33.9 0.0 0.0 0.5 2.0 0.5 1.4 0.1 2.6 0.0 19.9 0.7 0.1 0.3 0.0 0.1 0.0 0.2 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.0 36.4 4.4 8.6 0.4 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 8.4 0.0 0.0 0.0 6.1 0.0 0.0 0.1 0.0 0.0 77.7 0.0 1.3 1.2 2.1 1.7 1.6 1.2 1.9 1.3 1.2 2.4 1.6 0.0 1.4 39.4 1.5 1.5 1.1 2.8 2.5 14.7 3.4 0.0 2.0 0.7 0.0 0.3 88.6 0.5 1.3 0.0 5.0 4.3 1.1 2.3 2.3 3.2 2.9 0.0 1.7 6.7 2.4 121.3 2.3 1.7 212.6 0.0 4.0 0.8 1.6 0.0 3.9 0.3 0.5 0.0 1.2 55.6 36.8 1.8 12.9 5.7 4.3 0.9 DESI2 "C1orf121, CGI-146, FAM152A, FLJ21998, PNAS-4, PPPDE1" ENSG00000121644 "Desumoylating isopeptidase 2" Q9BSY9 1 244652935-244709033 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Spermatocytes: 160.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049950 Approved Vesicles NA NA Vesicles "HPA049950: AB_2680969" "unprognostic (1.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.05e-1)" "unprognostic (3.09e-1)" "unprognostic (1.96e-1)" "unprognostic (5.40e-2)" "unprognostic (1.95e-2)" "unprognostic (7.62e-2)" "unprognostic (1.38e-3)" "unprognostic (1.51e-1)" "unprognostic (4.47e-3)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (4.52e-2)" "unprognostic (8.27e-2)" "unprognostic (2.27e-2)" "unprognostic (9.49e-2)" 16.4 13.3 6.4 16.1 12.9 10.5 19.9 17.4 6.5 18.5 19.4 7.6 14.6 10.9 27.7 12.8 14.7 12.4 12.7 27.6 6.5 5.8 9.6 13.5 28.4 11.5 7.7 3.2 16.3 10.0 14.8 11.8 20.4 6.9 14.9 13.1 17.8 12.1 14.8 16.2 11.6 17.5 23.2 6.6 14.3 14.9 49.2 7.4 16.8 25.8 14.5 14.7 16.8 14.4 8.0 4.8 9.1 4.0 3.9 5.6 1.2 24.5 9.2 18.1 15.6 20.8 21.8 22.7 14.3 25.0 14.3 13.2 16.3 11.7 43.8 19.6 17.8 8.3 10.8 22.1 16.2 19.7 14.9 16.2 11.1 6.9 12.2 18.2 19.0 13.4 15.1 22.1 19.0 24.0 13.8 20.0 19.9 16.7 24.4 21.4 4.3 17.4 10.2 41.0 23.3 22.4 12.4 27.4 16.6 10.9 10.3 16.0 21.5 20.3 10.1 17.8 15.2 10.5 14.5 21.7 16.3 17.0 22.0 24.8 24.8 31.9 25.8 13.1 20.6 29.6 4.6 3.0 9.1 4.0 3.9 4.2 8.0 4.2 5.6 4.8 4.7 5.5 5.4 2.5 3.9 4.0 4.2 5.2 1.2 6.4 12.9 17.4 6.5 6.5 5.8 7.7 3.2 6.9 7.4 80.4 41.8 24.3 26.4 49.1 34.2 21.2 28.1 13.4 25.0 17.4 19.6 25.5 18.3 18.2 124.1 27.0 18.6 0.0 29.2 33.3 29.2 39.4 6.9 20.2 21.2 38.1 15.0 23.4 25.4 74.9 32.2 17.4 15.1 26.2 17.8 21.8 26.3 25.9 48.8 13.5 25.0 38.8 32.4 160.4 90.2 36.1 36.2 20.2 25.5 51.9 DHRS13 "MGC23280, SDR7C5" ENSG00000167536 "Dehydrogenase/reductase 13" Q6UX07 17 28897781-28903071 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 29.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 29.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA022991 Uncertain Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA022991: AB_1853865" "unprognostic (8.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.91e-1)" "unprognostic (2.35e-1)" "unprognostic (1.21e-2)" "unprognostic (6.37e-2)" "prognostic unfavorable (3.39e-6)" "unprognostic (2.38e-1)" "unprognostic (4.74e-2)" "unprognostic (5.65e-2)" "unprognostic (1.20e-2)" "unprognostic (7.57e-2)" "unprognostic (1.73e-2)" "unprognostic (3.72e-2)" "unprognostic (2.63e-1)" "unprognostic (7.22e-3)" "unprognostic (2.55e-1)" 2.3 6.0 5.9 5.1 7.9 31.7 5.9 24.9 5.7 6.4 4.5 6.4 9.0 4.1 2.6 6.5 6.7 4.0 3.0 2.7 5.3 10.9 6.9 27.0 4.1 8.6 6.7 5.4 3.6 9.5 8.5 5.3 9.5 9.9 14.9 3.5 5.0 11.8 10.9 1.1 6.8 3.0 3.2 5.6 8.0 5.5 2.8 3.6 4.4 5.5 1.2 8.1 9.2 5.1 4.0 3.1 29.7 3.5 4.6 6.3 3.1 5.6 3.6 8.5 10.8 1.3 1.9 8.3 3.1 4.0 5.7 8.8 11.2 3.4 15.6 5.3 0.6 6.6 5.1 12.0 3.4 2.4 15.7 11.6 8.8 6.7 6.1 3.2 4.4 1.0 1.4 3.1 3.6 3.8 4.0 1.7 11.0 19.7 5.4 1.1 10.2 9.7 7.4 5.2 14.9 0.5 15.5 8.1 12.0 10.5 9.6 12.3 10.3 4.9 34.0 6.6 4.7 22.6 7.2 0.5 1.8 5.6 4.4 4.2 12.6 11.8 9.7 5.4 5.6 4.5 0.4 2.3 1.6 4.8 3.5 5.9 3.6 6.1 6.0 3.1 4.0 6.3 4.6 29.7 4.6 3.3 1.7 5.7 3.1 5.9 7.9 24.9 5.7 5.3 10.9 6.7 5.4 9.9 3.6 3.0 3.4 3.0 11.5 1.3 5.4 0.4 2.5 0.0 3.4 7.0 2.0 21.6 8.3 7.8 10.7 2.9 2.4 46.7 2.4 18.2 1.9 9.4 1.1 3.8 5.2 4.8 2.9 6.7 0.8 3.8 1.1 2.7 5.0 24.4 2.7 6.9 3.2 2.9 0.4 2.9 5.0 6.5 1.4 1.5 12.6 1.5 11.3 5.3 5.7 4.3 DIO3 TXDI3 ENSG00000197406 "Iodothyronine deiodinase 3" P55073 14 101561351-101563452 "Enzymes, FDA approved drug targets, Predicted membrane proteins" "Thyroid hormones biosynthesis" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 40.9;placenta: 17.6" "Group enriched" "Detected in some" 4 "Fibroblasts: 8.0;Leydig cells: 10.0;Muller glia cells: 6.6;Peritubular cells: 7.1;Syncytiotrophoblasts: 23.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "basal ganglia: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "AF22: 35.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA073684 Supported Vesicles NA NA Vesicles "HPA073684: " "unprognostic (4.52e-3)" "unprognostic (1.80e-1)" "unprognostic (3.04e-3)" "unprognostic (3.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.50e-1)" "unprognostic (4.24e-2)" "unprognostic (8.11e-2)" "unprognostic (2.58e-1)" "unprognostic (6.24e-2)" "unprognostic (2.34e-1)" "unprognostic (2.52e-1)" "unprognostic (7.46e-5)" "unprognostic (4.82e-3)" "unprognostic (2.43e-1)" "unprognostic (1.11e-4)" "unprognostic (9.80e-3)" 4.5 0.2 0.2 1.7 1.8 0.0 3.5 0.1 0.8 40.9 1.6 0.1 1.0 0.0 3.4 2.2 1.9 3.5 2.9 1.6 0.7 0.0 0.9 2.7 1.4 7.1 0.1 0.1 9.2 4.1 0.0 0.6 17.6 0.3 1.6 0.4 12.6 0.8 2.5 2.2 1.9 0.7 0.9 0.1 2.5 0.7 1.0 0.1 0.1 3.6 1.1 0.4 6.9 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 35.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.6 0.9 0.5 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.8 0.1 0.6 0.7 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.1 0.0 0.9 0.0 0.0 2.1 8.0 0.3 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 1.0 0.0 6.6 0.6 0.0 7.1 0.0 0.1 0.0 1.2 0.0 0.0 0.1 23.7 0.0 0.0 0.1 DIRC2 "FLJ14784, RCC4" ENSG00000138463 "Disrupted in renal carcinoma 2" Q96SL1 3 122794795-122881139 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 14 "Syncytiotrophoblasts: 189.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "neutrophil: 4.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072579 Supported Vesicles NA NA Vesicles "HPA072579: AB_2686536" "unprognostic (1.40e-1)" "unprognostic (8.53e-3)" "unprognostic (1.20e-1)" "unprognostic (1.09e-1)" "unprognostic (1.16e-1)" "unprognostic (5.36e-2)" "prognostic unfavorable (7.48e-4)" "unprognostic (9.74e-2)" "unprognostic (2.58e-1)" "unprognostic (3.95e-2)" "prognostic unfavorable (5.81e-5)" "unprognostic (1.87e-1)" "prognostic favorable (8.81e-11)" "unprognostic (2.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.73e-1)" "unprognostic (7.13e-2)" 7.6 7.8 6.5 4.0 7.7 7.9 6.8 5.2 8.8 5.0 6.2 10.0 4.4 3.0 4.2 6.1 8.8 5.0 5.9 9.9 6.4 6.3 7.5 9.2 8.0 6.9 7.5 4.5 4.9 12.9 18.4 7.6 34.8 6.7 7.8 6.9 11.9 7.7 6.0 27.0 9.7 6.1 6.7 7.8 5.8 5.9 4.2 3.8 3.1 8.0 11.2 7.4 7.4 5.4 0.6 0.3 4.2 0.8 0.0 0.5 0.1 5.6 4.7 4.7 2.6 6.1 5.0 15.7 2.4 5.3 3.9 4.0 11.1 6.4 0.8 3.1 2.7 8.8 8.3 3.4 4.4 3.8 1.2 2.5 0.9 2.6 4.7 4.5 0.5 0.6 4.1 12.0 2.8 4.8 6.1 4.4 1.6 0.5 1.0 5.0 2.5 0.7 0.6 4.2 1.9 7.8 1.5 10.6 1.2 5.6 6.6 4.9 3.8 7.1 3.3 6.3 3.1 3.8 1.2 6.2 6.1 2.3 3.7 2.0 1.1 0.9 0.3 3.1 1.0 3.3 0.0 0.7 0.1 0.5 0.8 0.0 0.1 0.0 0.0 0.3 0.6 0.5 0.3 4.2 0.0 0.7 0.0 0.1 0.1 6.5 7.7 5.2 8.8 6.4 6.3 7.5 4.5 6.7 3.8 11.9 5.9 2.7 17.9 9.4 4.8 11.8 7.6 6.7 7.9 14.0 3.9 38.7 1.7 19.4 2.9 3.9 4.4 0.0 22.2 50.7 5.1 13.3 2.3 3.9 11.3 1.6 14.3 4.3 12.7 1.0 3.1 12.2 8.5 21.6 5.6 20.3 18.6 6.8 4.2 5.7 5.4 6.5 3.8 4.7 4.1 10.2 189.5 1.8 4.7 14.5 DKKL1 "CT34, SGY-1" ENSG00000104901 "Dickkopf like acrosomal protein 1" Q9UK85 19 49361783-49375116 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "testis: 91.5" "Group enriched" "Detected in some" 39 "Early spermatids: 1802.9;Late spermatids: 1817.6" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 4 "memory B-cell: 4.1" "Lineage enriched" "Detected in single" 42 "B-cells: 4.1" "Cell line enhanced" "Detected in many" "AF22: 7.3;AN3-CA: 13.8" "Group enriched" "Detected in many" 17 "amygdala: 27.1;basal ganglia: 15.6;cerebral cortex: 50.1;hippocampal formation: 25.1;olfactory region: 20.8" "Low region specificity" "Detected in all" "CAB025410, HPA047194" Enhanced Approved Vesicles "Secreted in male reproductive system" NA NA Vesicles "CAB025410: , HPA047194: AB_2679979" "unprognostic (1.64e-1)" "unprognostic (5.30e-1)" "unprognostic (5.39e-4)" "unprognostic (1.85e-4)" "unprognostic (3.79e-2)" "unprognostic (4.30e-2)" "unprognostic (5.52e-4)" "unprognostic (1.00e-1)" "unprognostic (6.76e-2)" "unprognostic (4.08e-1)" "unprognostic (1.90e-1)" "unprognostic (5.65e-2)" "unprognostic (2.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.13e-1)" "unprognostic (1.18e-1)" "unprognostic (5.57e-2)" 0.2 0.1 0.0 0.1 0.1 0.0 0.4 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.4 0.5 0.3 0.4 0.2 0.3 0.1 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.4 0.4 0.0 0.0 0.2 0.1 0.3 0.0 0.3 0.3 0.1 0.0 0.0 0.3 0.4 0.0 0.1 0.0 91.5 0.0 0.0 0.0 0.2 0.1 0.3 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 7.3 13.8 0.1 0.5 0.6 1.4 0.0 0.2 0.4 0.0 0.6 0.0 1.0 0.3 0.5 0.1 0.2 0.0 0.0 0.0 2.6 0.0 3.5 0.3 0.0 0.0 1.2 1.0 0.4 0.2 0.5 1.3 1.2 0.0 1.4 0.6 0.1 0.6 0.0 0.1 2.9 0.7 1.5 0.1 0.1 0.1 0.0 0.0 0.0 3.0 1.2 0.0 0.7 1.5 1.4 2.7 1.7 1.6 0.9 1.0 0.0 0.6 0.8 0.3 0.0 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.3 1802.9 1.0 0.0 0.0 0.5 0.1 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1817.6 15.5 0.0 1.7 0.0 0.1 2.2 0.4 0.0 11.3 0.0 0.1 6.5 0.3 46.8 10.9 0.0 0.0 0.0 0.0 0.1 DMRTA1 ENSG00000176399 "DMRT like family A1" Q5VZB9 9 22446841-22455740 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 12.2;salivary gland: 16.3" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 13.3;Hepatocytes: 25.3;Proximal tubular cells: 21.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.0;hTERT-RPE1: 11.0;LHCN-M2: 4.2;RPTEC TERT1: 4.3" "Not detected" "Not detected" "Region enhanced" "Detected in many" "midbrain: 2.5" "HPA044764, HPA062253" Uncertain Approved Vesicles NA NA Vesicles "HPA044764: AB_10959788, HPA062253: AB_2684726" "unprognostic (1.47e-1)" "unprognostic (2.48e-2)" "unprognostic (2.86e-1)" "unprognostic (7.74e-4)" "unprognostic (3.81e-2)" "unprognostic (2.67e-3)" "unprognostic (4.36e-2)" "unprognostic (2.36e-2)" "unprognostic (1.28e-1)" "unprognostic (9.64e-2)" "unprognostic (3.65e-3)" "unprognostic (2.92e-1)" "prognostic favorable (1.14e-6)" "unprognostic (8.58e-2)" "unprognostic (1.13e-1)" "unprognostic (1.61e-1)" "unprognostic (8.53e-3)" 2.1 0.2 0.7 1.4 0.7 0.0 5.6 0.8 0.7 2.4 1.0 0.7 1.1 0.7 1.2 1.8 5.5 0.3 1.2 0.6 0.6 0.5 5.5 12.2 1.1 1.4 0.8 0.4 0.6 2.7 6.1 2.9 0.0 0.9 2.4 0.4 1.9 16.3 0.5 0.9 0.5 0.8 0.7 0.7 0.4 2.8 0.6 0.0 1.1 5.0 0.6 2.0 0.9 1.7 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.5 0.1 0.0 0.4 0.1 0.2 0.0 9.0 0.3 0.3 0.1 0.1 0.0 2.0 0.0 0.2 0.3 1.8 2.4 0.3 0.0 0.6 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.6 1.7 11.0 0.6 0.0 0.0 3.3 4.2 0.9 0.0 0.0 1.8 0.4 3.0 0.0 0.2 1.2 4.3 0.0 0.1 0.0 1.1 0.7 2.0 2.2 0.0 0.0 3.1 0.0 3.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.7 0.8 0.7 0.6 0.5 0.8 0.4 0.9 0.0 0.0 2.4 0.0 4.7 0.0 0.5 1.1 2.5 4.0 4.5 5.2 0.0 0.0 13.3 5.4 0.0 0.0 2.6 0.0 6.0 0.0 1.3 5.6 0.0 25.3 0.3 0.0 2.4 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.3 4.8 5.6 0.0 0.0 21.4 0.0 0.0 0.4 0.0 0.6 0.4 0.1 0.0 1.9 6.2 DNAJC16 KIAA0962 ENSG00000116138 "DnaJ heat shock protein family (Hsp40) member C16" Q9Y2G8 1 15526813-15592379 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043643 Approved Approved Vesicles NA NA Vesicles "HPA043643: AB_10796794" "unprognostic (1.77e-1)" "unprognostic (4.95e-2)" "prognostic favorable (6.77e-4)" "unprognostic (4.52e-2)" "unprognostic (5.51e-2)" "unprognostic (2.05e-2)" "unprognostic (1.91e-2)" "unprognostic (2.15e-1)" "unprognostic (1.29e-1)" "unprognostic (4.28e-2)" "unprognostic (2.35e-2)" "unprognostic (3.74e-2)" "prognostic favorable (7.24e-4)" "unprognostic (3.67e-2)" "unprognostic (3.74e-1)" "unprognostic (5.38e-2)" "unprognostic (4.70e-2)" 9.6 11.5 9.8 9.5 18.7 3.9 12.3 13.2 24.3 10.2 10.9 18.4 14.2 12.0 12.9 14.7 11.5 13.0 11.2 9.1 11.0 10.8 22.1 20.0 8.9 10.5 11.1 10.8 13.1 13.4 20.1 20.3 13.9 17.2 10.8 11.2 12.0 12.1 10.8 19.2 10.2 11.2 11.9 10.7 11.3 9.9 11.1 11.0 11.4 13.9 8.9 12.5 10.3 9.4 6.9 4.1 3.8 4.1 3.2 8.0 3.6 7.5 7.2 6.0 10.9 16.4 13.3 5.6 9.0 9.2 9.1 9.8 6.2 11.1 6.5 6.1 9.0 11.9 9.4 7.3 8.0 12.9 7.7 3.4 6.7 8.3 10.7 16.3 10.3 7.8 9.6 9.5 14.7 8.2 11.4 10.1 5.5 14.1 6.0 10.4 3.0 5.2 5.3 5.7 6.8 5.1 6.2 7.7 7.3 11.2 5.2 6.7 6.3 9.3 8.9 7.6 9.0 5.6 4.2 13.7 16.1 5.8 14.8 4.9 8.2 11.5 5.9 10.0 6.0 7.6 3.8 4.1 3.0 5.6 4.0 8.0 6.8 5.8 5.0 4.1 6.9 7.4 6.3 2.3 3.2 2.9 3.7 5.3 3.6 9.8 18.7 13.2 24.3 11.0 10.8 11.1 10.8 17.2 11.0 0.0 8.3 11.2 4.1 4.5 13.4 12.0 20.4 21.4 11.4 24.4 21.6 10.5 1.7 8.1 7.1 8.7 8.6 0.0 6.0 6.3 8.6 10.7 8.1 15.3 9.4 17.5 11.1 16.5 19.9 5.4 11.5 5.8 6.8 5.4 11.3 12.4 8.2 7.0 10.6 13.8 15.0 6.5 4.6 22.7 14.5 5.1 18.4 4.3 11.5 5.2 DNAJC22 "FLJ13236, wus" ENSG00000178401 "DnaJ heat shock protein family (Hsp40) member C22" Q8N4W6 12 49346917-49357546 "Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 10.0;intestine: 10.0;liver: 18.9" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 40.8;Enterocytes: 38.0;Exocrine glandular cells: 37.8;Hepatocytes: 39.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CACO-2: 15.7;EFO-21: 16.9;MCF7: 13.8;OE19: 28.8;T-47d: 12.5" "Region enhanced" "Detected in single" "midbrain: 1.4" "Not detected" "Not detected" HPA039953 Approved Vesicles NA NA Vesicles "HPA039953: AB_2676770" "unprognostic (5.23e-2)" "unprognostic (1.24e-1)" "unprognostic (9.01e-2)" "prognostic favorable (4.56e-5)" "unprognostic (4.77e-3)" "unprognostic (2.74e-1)" "unprognostic (1.28e-1)" "unprognostic (4.05e-2)" "prognostic unfavorable (7.54e-4)" "unprognostic (6.14e-2)" "unprognostic (1.23e-2)" "unprognostic (2.49e-1)" "unprognostic (1.49e-2)" "unprognostic (3.18e-2)" "unprognostic (9.35e-2)" "unprognostic (1.58e-1)" "unprognostic (3.83e-2)" 1.1 0.3 0.5 0.4 1.0 0.0 0.4 0.4 2.2 1.5 5.4 0.8 0.4 10.0 2.2 1.3 0.4 0.8 10.0 0.4 0.7 0.5 5.2 18.9 0.4 0.4 1.0 1.2 0.4 5.2 2.7 0.4 0.9 4.6 0.4 5.2 0.8 1.2 0.4 0.4 0.2 8.3 0.4 0.8 0.4 4.4 0.6 0.4 0.4 6.6 0.4 0.4 0.4 0.7 0.7 0.8 2.7 0.5 0.5 0.5 0.4 1.4 9.4 0.0 10.0 0.0 0.0 3.3 0.3 3.0 1.0 2.2 15.7 9.9 0.0 16.9 0.3 0.9 0.1 1.4 0.0 1.7 0.1 2.3 0.3 0.2 7.8 2.4 0.0 1.7 0.1 0.0 1.5 0.3 4.0 1.4 0.0 0.1 0.3 0.7 13.8 0.0 0.0 0.0 28.8 4.8 0.0 4.8 0.0 0.2 0.0 1.6 0.8 0.3 0.5 3.1 0.2 12.5 0.2 0.2 1.0 3.1 0.1 1.3 0.0 0.0 0.0 2.3 0.0 2.0 2.3 0.5 0.5 0.5 0.3 0.3 0.4 0.4 0.3 0.1 0.7 0.3 0.3 2.7 0.5 0.4 0.8 0.2 0.4 0.5 1.0 0.4 2.2 0.7 0.5 1.0 1.2 4.6 0.4 0.0 0.6 0.0 1.8 0.6 0.1 0.3 40.8 8.1 1.2 1.8 0.0 0.1 0.0 13.9 3.9 0.3 38.0 0.0 37.8 0.2 1.3 0.5 1.1 39.4 0.1 3.2 20.2 1.3 0.3 1.3 0.0 0.0 3.3 1.0 24.6 0.6 20.2 23.0 0.7 18.0 0.3 0.0 0.3 0.0 0.4 0.3 0.3 0.0 23.4 0.1 DNASE1 DNL1 ENSG00000213918 "Deoxyribonuclease 1" P24855 16 3611728-3680143 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Apoptosis "Actin-binding, Endonuclease, Hydrolase, Nuclease" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 26.7" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA010703 Enhanced Supported Vesicles "Secreted in other tissues" NA NA 160000 Vesicles "HPA010703: AB_10600806" "unprognostic (5.18e-2)" "unprognostic (1.78e-2)" "unprognostic (1.16e-1)" "unprognostic (1.74e-1)" "unprognostic (2.38e-1)" "unprognostic (1.90e-2)" "unprognostic (3.73e-2)" "unprognostic (3.82e-1)" "unprognostic (3.20e-1)" "unprognostic (9.91e-2)" "unprognostic (1.69e-3)" "unprognostic (5.37e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-1)" "unprognostic (1.74e-1)" "unprognostic (1.45e-1)" "prognostic favorable (1.14e-4)" 1.5 1.4 1.5 2.6 1.6 1.7 1.5 3.8 2.5 2.2 12.2 1.8 1.5 14.9 1.5 2.2 3.4 1.2 2.5 1.5 1.5 1.2 11.4 1.5 1.5 4.4 1.5 1.5 2.0 13.7 1.6 12.2 1.9 3.1 5.1 2.1 1.5 3.3 1.5 1.5 3.9 26.7 1.5 1.5 2.3 6.0 2.7 1.5 1.5 1.6 2.6 3.8 1.9 2.3 4.5 2.2 9.2 2.0 1.9 3.4 1.0 2.5 5.8 10.2 5.3 3.0 2.6 4.8 4.0 0.7 3.3 4.8 6.9 6.1 10.7 3.3 0.6 7.0 4.2 3.6 1.1 3.5 4.6 5.6 3.7 8.6 4.5 1.5 2.6 8.7 2.1 4.3 4.4 1.1 5.2 2.2 9.0 9.3 4.7 2.8 10.4 5.3 11.5 6.2 7.4 3.1 12.6 4.6 5.2 2.8 2.2 7.2 6.7 3.0 9.2 1.7 5.3 9.1 6.6 3.0 6.1 4.5 3.8 2.3 4.3 6.1 18.5 1.7 4.9 5.8 4.3 2.0 5.3 3.0 1.3 1.9 2.5 2.3 2.4 1.0 4.5 2.7 3.4 9.2 1.9 1.2 2.2 2.4 1.0 1.5 1.6 3.8 2.5 1.5 1.2 1.5 1.5 3.1 1.5 8.9 10.1 2.4 8.5 2.4 27.4 4.8 5.1 9.4 11.4 15.7 21.6 6.6 48.0 4.5 16.1 4.5 12.7 0.0 9.7 3.3 5.1 9.8 2.3 1.5 3.2 23.8 13.7 4.9 2.7 34.9 7.8 3.8 1.7 11.8 11.3 12.8 4.3 11.2 7.4 1.4 18.3 0.0 4.2 15.1 17.5 3.3 5.1 10.5 15.3 5.3 DPT ENSG00000143196 Dermatopontin Q07507 1 168695459-168729264 "Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 128.1" "Group enriched" "Detected in some" 4 "Fibroblasts: 155.7;Leydig cells: 214.6;Peritubular cells: 116.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "ASC diff: 55.3;fHDF/TERT166: 21.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA065548 Approved Vesicles "Secreted to extracellular matrix" NA NA 25000 Vesicles "HPA065548: AB_2685511" "unprognostic (1.49e-1)" "unprognostic (7.62e-2)" "unprognostic (5.66e-2)" "unprognostic (4.39e-2)" "unprognostic (4.64e-2)" "unprognostic (3.78e-3)" "unprognostic (4.09e-2)" "unprognostic (2.57e-1)" "unprognostic (1.48e-1)" "unprognostic (1.03e-2)" "unprognostic (8.88e-2)" "unprognostic (2.16e-2)" "prognostic unfavorable (4.74e-5)" "unprognostic (2.12e-3)" "unprognostic (2.89e-2)" "unprognostic (1.09e-1)" "unprognostic (8.98e-3)" 128.1 6.1 0.8 22.6 0.8 0.0 99.3 0.8 2.4 51.0 81.7 0.9 19.8 2.4 20.4 38.8 33.1 23.0 52.3 48.8 0.8 0.3 2.4 6.0 9.6 7.7 0.8 0.8 12.8 13.4 0.0 0.9 7.8 0.9 24.0 9.4 1.8 14.4 10.2 13.0 8.6 23.1 76.1 0.8 1.0 23.6 8.7 0.8 2.3 16.3 55.7 22.8 48.7 39.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.3 0.2 0.0 0.0 2.4 2.7 2.8 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.8 2.4 0.8 0.3 0.8 0.8 0.9 0.8 3.0 1.7 0.0 0.1 28.3 0.0 5.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 0.6 0.4 0.0 0.0 0.2 0.3 155.7 0.2 0.0 0.0 0.6 0.0 0.0 12.9 0.0 0.7 214.6 0.0 37.1 0.0 0.0 0.0 0.3 0.0 116.3 0.0 0.0 0.0 15.0 0.3 0.3 28.0 0.3 0.0 0.0 0.5 DPY19L1 KIAA0877 ENSG00000173852 "Dpy-19 like C-mannosyltransferase 1" Q2PZI1 7 34928876-35038271 "Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 183.8;Late spermatids: 52.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059139 Uncertain Approved Vesicles NA NA Vesicles "HPA059139: AB_2683921" "unprognostic (4.66e-2)" "unprognostic (1.11e-3)" "unprognostic (8.53e-3)" "unprognostic (2.47e-3)" "unprognostic (2.50e-2)" "unprognostic (3.80e-3)" "unprognostic (2.02e-3)" "unprognostic (3.57e-2)" "unprognostic (1.14e-1)" "unprognostic (4.84e-2)" "prognostic unfavorable (2.99e-4)" "unprognostic (3.21e-1)" "unprognostic (1.88e-2)" "unprognostic (3.99e-1)" "unprognostic (2.69e-2)" "unprognostic (1.37e-1)" "unprognostic (4.12e-2)" 9.7 12.2 11.0 10.2 13.0 9.0 13.7 16.9 27.0 15.6 9.3 13.5 4.5 4.8 17.7 4.3 7.1 10.3 13.8 18.1 11.8 13.4 7.2 25.2 13.0 9.9 16.3 12.0 8.6 6.7 5.0 11.2 19.0 23.6 8.6 11.3 10.3 6.4 8.4 4.0 4.5 6.8 17.5 38.1 14.1 9.0 31.7 5.8 2.3 10.4 3.6 8.4 11.5 11.3 1.6 1.6 2.8 2.3 1.6 4.1 1.0 5.3 21.0 12.0 15.2 23.7 18.9 2.5 11.9 10.8 7.4 10.6 5.0 14.0 7.7 17.5 12.3 30.8 9.5 9.1 6.5 16.8 4.0 7.3 11.3 13.3 8.2 8.6 10.5 10.5 9.7 5.4 10.1 6.7 21.3 30.6 3.8 8.4 31.6 26.0 3.0 0.1 10.5 7.7 12.5 9.5 7.8 15.8 11.0 28.2 18.5 5.5 14.5 10.6 1.5 6.1 19.7 10.7 12.7 35.3 14.9 18.0 10.2 16.0 14.3 30.8 8.7 18.4 9.8 41.3 2.8 1.7 0.1 3.9 2.3 4.1 1.3 1.7 3.1 1.5 1.6 0.6 1.8 0.3 1.6 0.8 1.6 1.0 1.0 11.0 13.0 16.9 27.0 11.8 13.4 16.3 12.0 23.6 5.8 26.8 16.0 1.9 5.0 6.4 7.2 12.0 5.1 10.7 14.8 7.0 17.7 10.8 0.0 6.4 183.8 10.5 4.5 0.0 14.0 3.5 8.7 7.7 26.5 13.9 7.4 11.1 14.3 21.5 8.2 52.5 8.6 4.0 5.0 0.0 5.0 7.2 16.9 5.8 9.6 1.5 13.3 0.0 6.6 8.3 3.4 4.3 17.7 5.3 6.3 9.5 DTD2 "C14orf126, MGC9912" ENSG00000129480 "D-tyrosyl-tRNA deacylase 2 (putative)" Q96FN9 14 31446036-31457510 "Enzymes, Predicted intracellular proteins" "Hydrolase, RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA001117 Approved Approved Vesicles NA NA Vesicles "HPA001117: AB_2666204" "unprognostic (2.56e-3)" "unprognostic (9.38e-2)" "unprognostic (1.27e-3)" "unprognostic (3.24e-2)" "unprognostic (8.45e-2)" "prognostic unfavorable (9.33e-4)" "unprognostic (3.04e-2)" "unprognostic (1.64e-1)" "unprognostic (8.74e-3)" "unprognostic (2.91e-1)" "unprognostic (5.28e-2)" "unprognostic (6.96e-2)" "unprognostic (1.24e-1)" "unprognostic (2.32e-1)" "unprognostic (3.06e-2)" "unprognostic (1.22e-2)" "prognostic unfavorable (5.74e-6)" 11.9 11.0 12.4 6.8 16.0 2.9 13.1 9.1 19.6 6.7 6.8 15.2 3.8 5.6 8.0 7.7 9.9 7.5 6.9 6.0 13.2 11.0 8.6 11.6 10.0 8.0 13.6 8.9 8.6 9.9 8.3 9.6 6.2 13.3 8.8 8.2 7.1 10.3 6.1 2.3 8.2 5.3 8.3 10.9 6.7 5.7 14.6 9.9 12.3 9.4 2.8 7.8 7.5 6.5 6.4 6.6 3.5 4.8 6.9 9.1 4.8 8.4 7.2 6.3 8.2 11.6 9.9 4.3 7.8 7.7 6.2 5.5 3.9 8.2 16.2 5.4 8.9 6.7 8.2 9.9 8.8 10.7 8.7 4.4 4.6 5.2 21.7 12.5 9.3 5.7 11.1 10.0 5.5 12.5 5.2 9.1 9.8 9.0 7.8 8.2 10.2 13.4 8.4 8.5 14.7 7.5 9.1 4.6 8.4 11.6 7.4 9.4 6.2 12.8 16.7 9.0 5.6 15.3 4.9 6.5 6.9 6.0 5.5 6.7 9.6 17.9 15.8 3.0 8.6 11.0 3.5 4.8 1.7 4.0 4.1 5.6 4.9 5.9 4.3 6.6 6.4 9.1 6.0 3.0 6.9 2.0 4.0 2.9 4.8 12.4 16.0 9.1 19.6 13.2 11.0 13.6 8.9 13.3 9.9 8.9 7.0 5.2 5.4 4.6 4.3 3.6 7.6 5.3 4.5 3.5 7.9 7.4 3.3 4.8 3.3 3.5 2.7 0.0 5.4 5.3 5.8 4.4 1.1 11.1 4.5 4.8 2.9 1.3 6.4 5.1 6.9 2.9 3.3 2.8 5.9 9.5 4.9 3.5 7.8 6.8 8.3 0.0 6.7 8.1 2.5 4.6 2.3 2.9 7.5 3.8 DTX4 "KIAA0937, RNF155" ENSG00000110042 "Deltex E3 ubiquitin ligase 4" Q9Y2E6 11 59171430-59208587 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.8" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 33.1;Muller glia cells: 28.1" "Cancer enhanced" "Detected in all" "thyroid cancer: 63.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 6.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 27.3;CACO-2: 14.8;CAPAN-2: 15.7;OE19: 15.1;RT4: 41.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056760, HPA059294" Approved Approved Vesicles NA NA Vesicles "HPA056760: AB_2683228, HPA059294: AB_2683969" "unprognostic (3.23e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-2)" "unprognostic (4.98e-2)" "unprognostic (4.97e-2)" "unprognostic (5.03e-1)" "unprognostic (2.92e-1)" "unprognostic (1.06e-1)" "unprognostic (3.75e-1)" "unprognostic (1.14e-1)" "unprognostic (5.69e-2)" "unprognostic (3.04e-1)" "prognostic unfavorable (8.94e-4)" "unprognostic (5.51e-2)" "unprognostic (2.51e-1)" "prognostic favorable (5.81e-4)" "unprognostic (2.57e-3)" 7.0 2.2 8.9 7.6 12.8 8.2 7.9 14.0 16.5 8.9 17.7 29.8 1.4 16.7 4.3 2.3 3.7 6.5 9.5 2.1 10.7 10.9 6.5 23.9 17.7 5.2 15.3 8.8 16.3 5.9 1.7 3.3 15.3 24.8 5.6 18.4 7.7 16.0 3.7 1.5 4.2 14.3 3.6 42.8 5.0 12.2 1.9 9.1 0.8 12.4 2.3 6.7 19.8 14.7 3.3 6.1 3.1 1.0 0.1 0.1 0.2 2.0 2.3 13.5 0.2 3.8 0.2 27.3 0.2 1.1 0.1 0.1 14.8 15.7 4.8 0.9 0.3 0.5 7.0 4.1 5.1 0.0 0.3 0.2 0.0 2.7 4.7 1.0 0.4 0.9 0.6 8.5 0.0 0.2 0.9 0.0 0.9 0.0 0.5 0.6 1.1 0.2 0.0 6.9 15.1 0.6 1.6 11.9 0.5 1.1 41.0 0.0 0.0 10.4 2.7 0.3 3.6 2.0 0.2 0.1 0.0 2.1 0.0 0.0 0.1 0.0 0.5 0.1 1.2 1.1 1.5 1.0 0.7 0.1 1.0 0.0 2.2 0.1 0.0 1.4 3.3 0.0 0.0 3.1 0.1 0.5 6.1 0.0 0.2 8.9 12.8 14.0 16.5 10.7 10.9 15.3 8.8 24.8 9.1 17.9 15.6 2.4 2.4 1.4 1.4 1.1 33.1 12.0 18.2 7.0 0.0 12.2 0.0 6.5 0.3 2.0 19.7 0.0 4.4 16.4 5.2 2.1 1.1 17.4 3.2 0.0 4.7 3.7 2.6 0.0 3.7 1.6 5.0 1.0 10.0 28.1 8.4 17.3 3.2 9.1 1.1 0.0 0.4 0.2 1.5 1.1 4.6 0.8 13.7 22.1 DYRK4 ENSG00000010219 "Dual specificity tyrosine phosphorylation regulated kinase 4" Q9NR20 12 4562204-4615302 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 9 "testis: 85.9" "Group enriched" "Detected in many" 7 "Early spermatids: 369.7;Late spermatids: 289.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "HPA028065, HPA056073" Enhanced Enhanced Vesicles No No Vesicles "HPA028065: AB_10601212, HPA056073: AB_2683028" "unprognostic (2.50e-1)" "unprognostic (1.55e-1)" "unprognostic (1.22e-1)" "unprognostic (3.56e-3)" "unprognostic (2.62e-1)" "unprognostic (4.07e-3)" "unprognostic (2.03e-2)" "unprognostic (4.69e-2)" "unprognostic (1.29e-1)" "unprognostic (7.13e-2)" "unprognostic (1.22e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (6.52e-6)" "unprognostic (1.86e-1)" "unprognostic (9.71e-2)" "unprognostic (1.04e-1)" "unprognostic (3.98e-2)" 1.6 2.1 2.3 2.1 1.8 1.6 2.8 1.9 2.3 2.6 2.1 2.2 2.3 1.7 2.5 9.1 1.6 2.0 1.7 1.7 1.8 1.8 1.9 2.0 2.2 2.5 1.9 2.5 2.2 2.3 2.9 2.7 2.9 2.3 2.3 2.7 2.4 2.3 3.4 1.6 1.9 2.4 2.1 2.7 4.3 1.7 85.9 2.1 1.6 4.3 1.6 2.0 2.4 1.6 7.6 2.7 1.3 5.2 1.1 1.6 1.6 1.9 3.0 3.8 4.1 5.8 7.2 4.6 2.3 4.6 5.3 5.8 0.6 3.1 5.7 0.3 6.5 3.6 4.0 2.9 4.3 4.2 4.3 6.6 4.0 0.8 3.3 16.4 3.4 3.2 4.9 9.2 3.7 12.2 9.9 7.4 6.3 1.6 6.5 4.7 4.0 3.2 8.5 5.2 1.0 1.7 0.7 2.7 2.4 6.4 1.8 0.0 1.5 0.4 2.3 3.3 8.7 1.8 3.1 0.5 6.2 4.9 0.6 2.9 1.9 2.3 3.4 3.3 5.4 3.2 0.6 2.8 1.3 1.0 2.2 1.1 7.6 1.5 1.6 2.7 5.8 1.6 1.6 0.1 1.1 5.2 1.4 1.1 1.6 2.3 1.8 1.9 2.3 1.8 1.8 1.9 2.5 2.3 2.1 11.9 14.4 11.1 13.1 7.9 20.7 19.4 5.1 12.0 13.6 15.7 9.8 12.9 26.6 22.0 369.7 9.3 4.0 0.0 23.8 10.1 17.5 12.6 17.3 9.2 41.7 12.7 5.2 9.2 15.7 289.4 14.1 15.9 15.1 18.0 47.3 16.6 22.1 15.8 29.7 28.1 17.0 6.5 15.6 20.0 31.5 6.6 8.2 17.3 15.6 9.8 DZIP3 "hRUL138, PPP1R66" ENSG00000198919 "DAZ interacting zinc finger protein 3" Q86Y13 3 108589682-108694846 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 57.4" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 183.4;Cone photoreceptor cells: 308.3;Spermatocytes: 314.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035066, HPA049232" Approved Approved Vesicles No No Vesicles "HPA035066: AB_10601549, HPA049232: AB_2680684" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (7.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (2.37e-2)" "unprognostic (3.33e-1)" "unprognostic (5.16e-2)" "unprognostic (2.74e-1)" "unprognostic (3.76e-2)" "unprognostic (2.59e-3)" "unprognostic (5.38e-2)" "prognostic favorable (3.65e-4)" "unprognostic (6.06e-2)" "unprognostic (2.78e-2)" "unprognostic (5.51e-3)" "unprognostic (3.81e-2)" 4.6 9.3 14.1 4.5 25.7 3.1 5.0 14.5 23.7 5.2 4.4 5.8 2.1 2.8 7.4 9.7 3.8 17.4 5.4 10.8 13.2 18.5 10.5 3.9 6.0 8.4 10.3 16.0 10.3 4.9 10.3 57.4 4.5 20.3 9.2 4.5 4.0 3.3 7.0 10.1 3.4 3.6 7.9 9.2 7.0 6.0 29.9 8.0 10.4 12.0 2.8 7.0 5.0 3.5 6.8 1.8 5.2 1.6 11.7 6.5 1.8 6.5 6.0 17.0 10.2 7.6 7.9 5.8 4.1 8.2 6.9 9.4 8.3 4.5 11.8 8.9 4.4 14.9 2.4 9.7 3.5 14.7 4.3 4.1 5.4 2.2 5.7 4.5 2.1 3.1 8.2 1.9 6.4 8.0 7.1 4.3 7.6 5.1 5.8 13.1 5.9 5.3 2.3 10.4 3.4 4.3 6.8 14.0 1.1 5.8 3.2 11.5 11.0 6.9 0.7 7.4 16.0 10.2 1.8 4.9 6.2 9.5 1.2 3.6 6.7 3.8 23.0 4.7 1.7 7.5 5.2 0.7 1.4 5.0 1.0 6.0 6.8 5.1 6.1 0.6 6.0 4.5 6.0 0.1 11.7 1.6 1.8 6.5 1.8 14.1 25.7 14.5 23.7 13.2 18.5 10.3 16.0 20.3 8.0 11.9 13.8 8.3 8.5 6.6 67.2 33.6 2.5 183.4 29.6 31.4 308.3 19.8 11.6 8.1 23.6 8.2 3.9 0.0 8.1 7.3 13.9 8.8 8.1 3.6 7.8 73.1 50.7 6.7 7.3 46.6 16.1 6.2 6.8 14.4 6.1 33.9 8.4 3.5 16.6 15.3 32.1 19.4 9.2 314.4 93.7 6.5 12.4 18.5 6.3 4.3 ECHDC1 dJ351K20.2 ENSG00000093144 "Ethylmalonyl-CoA decarboxylase 1" Q9NTX5 6 127288710-127343609 "Enzymes, Plasma proteins, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035445, HPA035446" Uncertain Approved Vesicles NA NA Vesicles "HPA035445: AB_10669860, HPA035446: AB_2732468" "unprognostic (9.57e-2)" "unprognostic (1.63e-2)" "unprognostic (2.46e-3)" "unprognostic (1.34e-1)" "unprognostic (4.09e-1)" "unprognostic (3.68e-2)" "unprognostic (5.03e-3)" "unprognostic (4.89e-3)" "unprognostic (4.97e-2)" "unprognostic (1.76e-1)" "unprognostic (3.99e-1)" "unprognostic (9.97e-2)" "unprognostic (8.21e-3)" "unprognostic (6.83e-2)" "unprognostic (2.86e-1)" "unprognostic (1.39e-1)" "unprognostic (1.40e-2)" 40.1 16.8 20.8 16.5 23.1 6.8 21.9 16.6 21.4 18.6 27.2 12.0 12.8 21.9 13.7 15.5 20.6 11.4 16.1 20.0 19.4 18.0 44.4 44.3 26.8 17.8 27.3 16.5 11.9 14.2 14.5 16.1 17.0 23.1 19.8 26.3 15.1 22.2 14.5 22.0 13.3 25.8 30.1 27.3 14.1 18.1 8.3 20.9 20.7 42.4 14.2 19.4 24.2 22.6 13.2 29.6 13.4 31.2 6.4 11.6 16.9 15.9 12.8 18.4 16.9 27.3 26.0 15.6 26.2 31.8 22.6 28.8 22.2 12.2 24.3 22.5 24.8 25.6 13.2 0.0 19.6 28.6 14.4 12.3 32.3 17.2 35.2 24.3 43.1 18.2 29.3 23.7 21.0 17.9 20.5 20.4 17.9 40.0 14.7 30.0 15.1 28.5 20.0 15.1 8.0 15.9 13.4 22.6 19.9 41.1 19.8 21.1 20.6 14.7 0.5 35.9 14.6 0.5 50.5 21.1 13.9 22.3 35.0 29.1 19.0 38.0 31.9 25.4 37.8 32.6 6.2 31.2 10.0 11.0 25.6 11.6 12.8 9.5 10.8 29.6 13.2 11.6 11.6 13.4 6.4 17.9 22.6 9.6 16.9 20.8 23.1 16.6 21.4 19.4 18.0 27.3 16.5 23.1 20.9 89.3 91.1 32.9 31.3 23.2 25.4 53.7 25.5 48.2 87.6 29.6 29.5 92.5 107.8 66.8 54.2 29.5 50.2 0.0 69.9 70.0 41.4 25.3 42.7 52.3 76.6 27.0 13.3 22.1 48.0 20.2 30.5 56.1 33.7 19.0 31.2 28.6 47.4 28.1 29.4 160.1 37.1 25.8 25.6 26.9 22.6 19.9 54.8 31.9 50.3 46.0 EEA1 ZFYVE2 ENSG00000102189 "Early endosome antigen 1" Q15075 12 92770637-92929331 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 173.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005861, CAB018782, HPA038158, HPA038159" Supported Supported Vesicles NA NA Vesicles "CAB005861: AB_2262056, CAB018782: AB_2277714, HPA038158: AB_10966710, HPA038159: AB_10962356" "unprognostic (5.38e-2)" "unprognostic (4.60e-1)" "unprognostic (2.00e-2)" "unprognostic (5.62e-2)" "unprognostic (1.62e-1)" "unprognostic (1.81e-2)" "unprognostic (6.75e-2)" "unprognostic (6.87e-2)" "unprognostic (1.31e-1)" "unprognostic (5.00e-2)" "unprognostic (2.81e-2)" "unprognostic (1.07e-1)" "unprognostic (2.68e-3)" "unprognostic (5.86e-2)" "unprognostic (2.85e-1)" "unprognostic (3.89e-2)" "unprognostic (1.65e-1)" 26.4 11.1 10.9 14.9 13.5 5.3 13.7 20.5 12.4 18.4 12.2 7.7 8.3 10.2 14.4 9.5 20.9 11.0 11.4 13.4 12.0 9.8 10.6 14.7 12.9 8.0 12.5 11.8 17.6 9.3 16.9 14.3 23.6 16.7 14.2 11.0 7.3 13.7 12.3 23.1 16.7 10.3 15.7 14.3 15.3 10.7 7.8 12.5 6.9 12.6 15.2 8.2 19.2 17.9 2.2 2.0 2.2 3.3 0.7 3.4 0.9 9.0 3.0 4.5 3.2 19.4 19.6 10.4 17.8 10.3 9.5 6.7 10.4 2.4 9.2 3.3 12.5 13.5 11.0 10.0 5.0 14.7 6.2 4.9 9.8 3.5 9.5 10.8 6.9 4.6 12.7 7.4 10.1 15.3 10.6 16.6 2.6 7.3 3.1 9.8 4.1 5.0 4.7 4.5 3.6 6.8 5.6 11.5 6.2 4.9 12.4 3.8 2.9 13.0 8.6 7.9 6.5 11.4 6.2 21.2 13.4 5.1 10.6 6.8 3.5 5.9 6.4 4.9 6.2 7.2 0.1 2.5 0.7 1.7 1.8 1.8 2.2 2.0 1.8 2.0 2.0 3.4 2.4 2.2 0.7 3.3 2.0 0.7 0.9 10.9 13.5 20.5 12.4 12.0 9.8 12.5 11.8 16.7 12.5 92.3 47.3 15.2 33.3 33.7 48.6 77.2 12.7 24.1 33.0 24.4 35.3 52.4 36.5 50.3 10.8 44.9 26.8 0.0 30.1 43.2 56.1 38.3 31.3 32.1 32.0 173.2 16.1 25.2 34.6 5.9 57.2 41.1 45.5 36.9 22.8 50.8 33.3 34.5 64.0 25.1 70.2 45.3 42.2 91.9 7.9 44.0 95.0 20.2 27.0 48.2 EEF2KMT "EFM3, FAM86A, MGC19636, SB153" ENSG00000118894 "Eukaryotic elongation factor 2 lysine methyltransferase" Q96G04 16 5084304-5097808 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 8 "Early spermatids: 172.8;Late spermatids: 268.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 41.8" HPA041610 Approved Uncertain Vesicles NA NA Vesicles "HPA041610: AB_2677581" "unprognostic (4.50e-2)" "unprognostic (1.53e-1)" "unprognostic (8.89e-3)" "unprognostic (3.95e-2)" "unprognostic (2.01e-2)" "unprognostic (7.70e-2)" "prognostic unfavorable (8.85e-4)" "unprognostic (3.53e-1)" "unprognostic (1.37e-1)" "unprognostic (4.03e-2)" "unprognostic (9.73e-2)" "unprognostic (1.53e-1)" "unprognostic (5.24e-3)" "unprognostic (1.82e-1)" "unprognostic (2.07e-1)" "unprognostic (2.75e-2)" "prognostic unfavorable (2.35e-4)" 4.8 6.1 4.8 4.3 15.5 0.8 11.6 4.4 7.5 5.6 4.6 4.4 2.2 6.7 6.5 4.4 5.4 5.7 3.6 5.7 5.8 4.5 4.9 8.0 8.6 3.9 4.2 4.3 5.8 13.9 10.4 5.0 2.9 7.5 4.4 4.8 2.6 5.9 6.2 7.0 4.5 3.5 7.1 3.8 4.7 4.9 27.0 4.8 3.8 6.1 5.2 4.3 5.3 3.8 9.4 7.0 6.5 11.0 7.0 13.7 5.1 2.5 6.3 3.9 6.7 4.8 3.9 5.0 4.7 3.4 6.0 3.7 4.8 6.6 6.8 3.0 6.0 6.4 4.4 7.3 7.3 4.4 7.6 5.3 3.0 3.5 7.9 6.0 7.0 4.7 4.4 5.5 6.9 12.3 2.2 5.9 8.6 5.3 6.5 5.0 16.6 2.7 4.0 6.5 14.3 3.2 6.7 4.4 41.8 6.5 3.0 4.7 3.6 6.1 8.6 3.5 3.3 5.4 2.5 2.6 8.2 5.2 24.2 4.7 4.4 4.8 4.7 2.3 4.9 7.1 6.5 5.6 0.4 7.6 10.1 12.5 9.4 7.9 8.8 7.0 7.2 5.6 9.9 0.8 7.0 11.0 1.9 13.7 5.1 4.8 15.5 4.4 7.5 5.8 4.5 4.2 4.3 7.5 4.8 3.0 3.0 5.7 6.9 0.0 2.4 0.8 2.5 13.4 4.5 5.2 0.0 5.2 26.6 15.0 172.8 5.8 2.1 0.0 16.0 10.5 5.7 7.0 1.1 10.4 13.2 6.4 3.5 4.9 1.6 268.3 7.2 2.7 0.0 6.4 5.4 4.8 13.6 0.0 3.5 15.3 2.5 0.0 0.3 5.0 17.3 0.0 3.4 4.4 6.9 6.3 EIF4ENIF1 "2610509L04Rik, 4E-T, Clast4, FLJ21601" ENSG00000184708 "Eukaryotic translation initiation factor 4E nuclear import factor 1" Q9NRA8 22 31436977-31496108 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 66.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001619, HPA002078" Enhanced Enhanced Vesicles NA NA Vesicles "HPA001619: AB_1078727, HPA002078: AB_1078728" "unprognostic (1.16e-1)" "unprognostic (1.63e-1)" "unprognostic (2.40e-2)" "unprognostic (3.01e-2)" "unprognostic (1.53e-1)" "unprognostic (6.72e-2)" "unprognostic (2.28e-3)" "unprognostic (1.30e-2)" "unprognostic (4.95e-2)" "unprognostic (9.92e-2)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" "prognostic favorable (1.57e-4)" "unprognostic (2.30e-1)" "unprognostic (1.92e-1)" "unprognostic (7.32e-2)" "unprognostic (2.45e-2)" 10.9 10.9 18.8 13.4 18.9 12.6 10.8 19.4 20.8 11.9 15.9 14.4 12.3 11.8 14.9 14.5 12.6 13.3 8.6 13.2 16.3 11.8 11.9 7.6 10.7 12.3 12.5 15.7 16.9 10.9 18.1 12.2 14.3 16.2 12.5 12.6 12.7 11.2 15.2 17.4 13.7 10.3 13.8 11.8 11.4 11.3 43.6 14.8 8.8 13.3 7.7 15.3 14.1 12.9 6.6 6.5 3.1 10.7 1.7 5.7 3.0 13.5 8.4 21.3 11.5 12.0 10.7 8.6 9.9 12.1 15.6 14.6 9.5 4.9 17.8 5.9 14.7 10.4 13.4 19.2 8.9 14.4 13.9 19.8 7.3 13.5 10.8 12.5 28.2 12.9 12.6 12.3 11.6 13.2 14.3 13.0 10.5 17.5 19.1 14.6 16.1 18.4 13.7 9.7 12.7 6.9 21.6 17.8 18.2 15.8 10.3 16.5 15.4 13.7 11.0 10.2 14.7 11.8 11.1 14.5 10.4 13.7 10.3 10.9 14.1 13.5 17.4 10.0 10.3 12.2 2.0 3.5 1.6 5.4 4.2 5.7 6.6 3.0 5.1 3.2 3.3 3.1 5.1 3.1 1.7 10.7 6.5 2.0 3.0 18.8 18.9 19.4 20.8 16.3 11.8 12.5 15.7 16.2 14.8 11.9 14.6 5.2 5.7 6.5 17.1 19.1 12.7 5.3 10.3 12.2 11.8 8.1 8.3 7.3 42.3 8.4 5.1 0.0 5.5 4.9 6.9 5.7 5.8 7.9 6.9 17.5 11.5 9.8 8.4 66.1 13.6 6.1 6.8 16.2 10.1 8.5 8.5 0.0 14.5 7.8 13.5 6.5 6.5 25.4 6.4 9.3 5.6 6.2 7.6 6.2 EIF5A2 ENSG00000163577 "Eukaryotic translation initiation factor 5A2" Q9GZV4 3 170888415-170908693 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport" "Elongation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 31.2" "Group enriched" "Detected in many" 11 "Early spermatids: 309.4;Late spermatids: 705.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029090 Approved Supported Vesicles NA NA Vesicles "HPA029090: AB_10671359" "unprognostic (2.41e-1)" "unprognostic (2.42e-1)" "unprognostic (4.05e-1)" "unprognostic (5.75e-2)" "unprognostic (1.27e-1)" "prognostic unfavorable (7.42e-4)" "unprognostic (1.11e-3)" "unprognostic (1.47e-1)" "unprognostic (3.72e-1)" "unprognostic (1.08e-1)" "unprognostic (1.06e-1)" "unprognostic (1.79e-1)" "unprognostic (2.66e-2)" "unprognostic (3.45e-2)" "unprognostic (5.92e-2)" "unprognostic (1.64e-2)" "unprognostic (4.29e-3)" 5.6 3.9 3.6 4.1 8.4 4.9 4.2 1.9 14.4 4.4 4.6 4.3 2.0 2.5 6.2 2.0 4.1 3.6 4.9 5.4 4.3 5.8 6.8 3.4 3.2 3.6 6.7 6.2 6.4 4.5 2.2 5.2 2.5 21.6 4.8 3.8 3.4 2.7 4.2 1.9 3.0 2.6 9.6 5.1 3.0 11.0 31.2 2.5 6.1 3.1 2.6 4.2 6.3 6.2 2.6 0.9 10.2 1.3 6.9 11.2 4.3 11.6 6.1 2.2 3.1 12.0 7.9 5.3 8.8 11.5 9.4 13.2 12.4 7.7 7.4 16.6 12.3 21.1 3.9 7.1 3.2 12.0 8.1 3.1 3.4 2.5 3.9 8.1 9.1 10.7 8.6 4.7 14.1 11.7 13.1 4.6 1.9 2.8 0.0 15.3 3.7 4.1 4.1 4.2 9.1 3.9 0.0 6.5 0.0 3.9 2.1 1.8 3.4 9.4 2.4 7.4 3.7 5.4 6.2 6.4 11.6 8.2 23.8 20.2 11.6 0.1 16.8 3.9 3.2 8.2 10.2 1.2 1.2 11.2 1.3 7.7 2.0 7.7 10.6 0.9 2.6 4.6 7.6 0.6 6.9 1.2 0.8 9.2 4.3 3.6 8.4 1.9 14.4 4.3 5.8 6.7 6.2 21.6 2.5 0.0 0.3 3.2 5.2 15.1 2.8 8.1 0.0 4.0 1.2 1.8 0.0 0.8 1.7 6.4 309.4 7.1 1.0 0.0 6.6 1.7 11.3 4.4 2.3 2.4 7.4 0.0 4.7 2.5 4.1 705.4 11.8 4.9 10.1 11.8 1.1 7.5 12.5 4.2 10.6 18.0 2.6 45.3 14.5 25.1 9.3 18.9 0.6 16.6 1.6 5.0 EML2 "ELP70, EMAP-2, EMAP2" ENSG00000125746 "Echinoderm microtubule associated protein like 2" O95834 19 45606994-45645629 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Rod photoreceptor cells: 151.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012757 Approved Approved Vesicles NA NA 140000 Vesicles "HPA012757: AB_1848145" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.61e-3)" "unprognostic (2.12e-1)" "unprognostic (1.81e-3)" "unprognostic (1.13e-1)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.85e-1)" "unprognostic (3.05e-3)" "unprognostic (3.72e-1)" "unprognostic (2.75e-3)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (9.44e-2)" "unprognostic (7.48e-2)" "unprognostic (7.03e-2)" 7.7 23.0 13.0 9.4 25.3 9.5 10.0 11.3 20.7 12.6 15.5 32.8 13.5 8.6 5.9 6.4 26.8 9.3 9.9 14.7 15.8 18.9 11.0 5.4 9.6 9.3 32.4 12.0 3.6 15.6 47.9 9.7 16.9 26.6 11.2 11.1 12.4 21.2 17.5 4.1 22.0 7.9 8.9 24.1 8.6 13.5 2.9 25.5 9.9 15.7 6.2 10.6 15.6 14.3 7.8 8.8 10.6 7.0 3.7 9.7 4.9 17.6 6.0 1.2 0.4 9.8 5.4 6.7 11.1 14.4 5.0 5.7 2.3 14.8 4.5 6.6 5.9 1.5 14.9 2.2 22.1 1.7 20.0 5.5 2.3 6.6 4.1 18.6 6.7 4.9 8.3 29.1 5.8 28.5 4.0 3.6 10.5 6.8 13.3 3.8 17.5 3.7 1.3 0.7 28.2 5.4 0.7 2.1 6.6 12.9 21.7 6.5 1.2 6.1 12.1 8.2 6.7 7.1 7.3 5.7 0.0 2.1 1.8 0.1 25.1 15.4 2.8 7.9 7.5 14.5 10.6 4.9 7.1 9.6 6.2 7.0 7.8 6.5 9.7 5.9 3.4 4.2 5.7 1.3 3.7 7.0 8.8 7.7 4.9 13.0 25.3 11.3 20.7 15.8 18.9 32.4 12.0 26.6 25.5 3.0 12.5 10.2 36.5 16.6 27.3 8.1 17.8 13.4 9.1 33.2 13.7 59.6 31.5 13.9 55.8 11.6 22.7 0.0 18.1 16.7 6.9 20.3 19.5 5.9 14.0 27.0 16.8 14.1 6.7 19.4 3.7 7.6 18.6 18.0 32.1 12.5 16.5 26.0 6.7 5.9 151.2 0.0 13.3 2.6 5.9 12.5 84.4 24.5 25.5 40.6 ENTPD4 "KIAA0392, LALP70, LAP70, LYSAL1, NTPDase-4, UDPase" ENSG00000197217 "Ectonucleoside triphosphate diphosphohydrolase 4" Q9Y227 8 23385783-23457695 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA017655 Supported Approved Vesicles NA NA 28000 Vesicles "HPA017655: AB_1848181" "unprognostic (2.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.23e-3)" "unprognostic (1.38e-1)" "unprognostic (5.06e-2)" "unprognostic (7.86e-3)" "unprognostic (2.00e-2)" "unprognostic (2.99e-3)" "unprognostic (2.07e-2)" "unprognostic (8.74e-2)" "unprognostic (2.82e-1)" "unprognostic (1.20e-1)" "unprognostic (4.55e-2)" "unprognostic (1.39e-1)" "unprognostic (1.11e-1)" "unprognostic (6.62e-2)" "unprognostic (3.72e-2)" 16.3 11.5 15.0 21.9 19.8 25.7 15.3 20.3 27.4 15.2 18.5 14.7 15.7 17.0 18.8 17.9 13.3 12.7 14.4 21.0 14.5 12.8 13.0 14.4 19.9 26.0 16.2 12.2 14.7 26.5 30.4 25.2 19.3 20.6 17.6 20.2 18.0 19.5 13.7 14.9 12.2 26.1 16.1 14.5 26.9 19.1 18.7 15.8 17.0 15.8 9.3 30.7 16.7 16.7 9.7 8.0 15.9 9.5 4.4 10.7 6.8 9.3 12.9 16.3 11.2 14.2 18.1 16.6 15.0 14.3 10.2 16.0 18.5 12.5 15.9 10.9 15.1 15.7 11.4 7.3 13.6 19.6 3.8 5.1 8.4 8.0 6.4 11.6 4.4 16.7 11.1 16.6 13.5 14.5 24.9 14.6 12.4 5.8 14.6 17.2 4.2 6.4 5.4 9.5 12.0 4.7 6.4 16.3 4.8 13.0 11.1 13.0 12.4 5.6 8.2 11.0 33.9 6.0 6.3 18.0 18.6 18.4 20.8 11.0 11.7 4.9 20.7 24.9 5.3 18.6 14.9 6.0 13.7 8.5 9.5 10.0 9.7 8.3 9.1 8.0 6.7 10.7 8.3 15.9 4.4 6.9 7.3 6.5 6.8 15.0 19.8 20.3 27.4 14.5 12.8 16.2 12.2 20.6 15.8 17.9 34.6 17.1 9.5 5.8 30.2 20.4 7.6 14.7 28.4 14.0 13.7 12.6 0.0 13.8 6.9 13.7 17.8 23.3 14.7 13.0 12.7 14.2 16.3 10.5 10.5 44.5 16.6 11.1 11.0 15.7 6.6 15.2 11.8 12.6 15.2 18.9 18.1 11.9 8.1 3.7 34.2 12.9 12.3 20.7 21.1 4.8 16.9 15.0 10.5 13.9 EPHX4 "ABHD7, EPHXRP, FLJ90341" ENSG00000172031 "Epoxide hydrolase 4" Q8IUS5 1 92029982-92063536 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 13.3;brain: 20.7" "Cell type enhanced" "Detected in some" 11 "Endothelial cells: 2.9;Melanocytes: 3.3;Muller glia cells: 8.1;Pancreatic endocrine cells: 3.0;Spermatocytes: 3.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 13.3" "Lineage enriched" "Detected in single" 24 "T-cells: 13.3" "Cell line enhanced" "Detected in some" "A-431: 10.0;CAPAN-2: 8.8;EFO-21: 17.9;RPTEC TERT1: 24.8;U-251 MG: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035067 Uncertain Approved Vesicles NA NA Vesicles "HPA035067: AB_10601465" "unprognostic (1.27e-1)" "unprognostic (4.17e-2)" "unprognostic (6.76e-3)" "unprognostic (6.10e-8)" "prognostic unfavorable (9.43e-4)" "unprognostic (5.36e-3)" "unprognostic (2.72e-4)" "unprognostic (4.85e-2)" "unprognostic (9.44e-3)" "unprognostic (7.93e-2)" "prognostic unfavorable (2.00e-4)" "unprognostic (2.53e-1)" "unprognostic (6.36e-6)" "unprognostic (6.93e-3)" "unprognostic (1.02e-1)" "unprognostic (1.67e-1)" "unprognostic (1.25e-1)" 1.0 1.3 5.8 1.3 14.1 0.3 3.2 1.7 20.7 2.4 1.0 0.3 0.1 1.6 1.7 1.3 2.1 1.3 1.2 1.2 3.3 2.4 0.9 0.4 1.5 0.7 3.1 9.8 0.6 0.3 0.5 1.3 1.9 4.4 2.2 1.4 1.5 0.4 4.1 0.4 0.6 0.9 2.5 1.1 0.4 0.5 2.6 2.1 0.0 3.9 0.0 0.7 1.9 0.4 0.1 0.0 0.0 0.0 0.5 13.3 1.4 10.0 0.3 2.0 0.0 0.0 0.0 0.5 0.2 3.7 0.3 0.2 0.0 8.8 0.0 17.9 0.0 2.7 0.1 0.3 0.8 0.3 0.0 5.4 0.0 0.0 0.0 0.1 0.7 0.0 0.6 0.4 0.0 0.0 6.5 3.1 0.0 0.0 0.0 0.3 0.6 1.4 0.3 1.9 0.0 3.5 0.3 0.2 0.0 24.8 2.0 1.2 1.5 6.1 0.0 1.8 0.1 0.0 1.4 0.1 0.0 0.0 0.0 7.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 13.3 0.0 2.3 0.1 1.7 3.3 0.0 0.0 0.4 3.4 0.0 0.5 0.0 0.0 0.0 1.4 5.8 14.1 1.7 20.7 3.3 2.4 3.1 9.8 4.4 2.1 0.0 0.0 0.0 0.1 0.1 0.8 1.2 0.0 0.0 1.2 0.0 2.0 0.4 0.0 0.3 1.3 2.9 0.0 0.0 0.7 0.6 0.5 0.2 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 8.1 3.0 0.0 0.0 0.0 1.8 0.0 0.8 3.8 0.7 0.4 0.0 0.0 0.0 0.3 EPN2 "EHB21, KIAA1065" ENSG00000072134 "Epsin 2" O95208 17 19215615-19336715 "Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 34.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 19.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 19.9" "Cell line enhanced" "Detected in many" "SuSa: 53.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049809, HPA053360" Approved Supported Vesicles NA NA Vesicles "HPA049809: AB_2680893, HPA053360: AB_2682126" "unprognostic (1.38e-2)" "unprognostic (2.54e-2)" "unprognostic (2.58e-2)" "unprognostic (2.09e-1)" "unprognostic (1.94e-1)" "unprognostic (8.12e-3)" "unprognostic (6.73e-3)" "unprognostic (1.43e-1)" "unprognostic (8.89e-2)" "unprognostic (4.58e-3)" "unprognostic (3.42e-2)" "unprognostic (1.57e-1)" "prognostic favorable (9.13e-5)" "unprognostic (1.32e-1)" "unprognostic (9.40e-2)" "unprognostic (2.23e-2)" "prognostic unfavorable (8.15e-5)" 6.5 5.1 16.3 6.2 11.8 3.4 4.4 9.9 34.8 7.0 5.2 4.3 3.6 2.9 9.9 7.0 13.9 7.7 4.8 10.7 16.7 10.5 4.5 3.6 6.1 3.6 14.9 13.1 7.2 4.3 8.4 3.6 7.7 8.5 7.3 3.0 5.6 5.0 9.2 9.8 18.4 3.6 8.7 14.7 4.5 3.2 6.7 10.6 3.6 4.4 8.1 3.6 5.4 6.9 2.9 0.7 19.9 1.1 0.6 1.5 0.4 11.8 11.9 17.4 7.6 9.2 14.8 13.7 11.4 7.4 7.1 6.2 7.7 3.6 1.8 11.2 11.3 6.6 11.2 7.7 8.5 8.7 8.8 8.6 1.2 7.5 3.8 9.6 0.5 5.2 8.3 7.7 11.2 9.1 9.4 15.1 2.6 3.3 1.6 6.2 8.6 0.5 0.8 4.5 15.8 7.8 2.7 7.4 3.1 8.3 3.3 5.1 11.6 8.1 5.4 5.9 53.3 8.2 1.5 13.8 7.9 9.1 12.3 4.9 2.6 1.6 1.5 21.5 0.2 12.1 7.1 1.1 19.9 1.5 0.7 1.0 2.3 1.1 1.2 0.5 2.9 1.3 1.2 7.3 0.6 0.8 0.7 0.9 0.4 16.3 11.8 9.9 34.8 16.7 10.5 14.9 13.1 8.5 10.6 50.6 24.8 8.0 24.9 21.4 65.7 28.8 28.1 48.2 27.3 36.6 45.2 23.3 23.2 18.4 30.4 27.0 5.3 0.0 7.3 34.8 19.7 26.8 13.9 7.3 7.0 33.4 5.8 14.7 4.7 54.7 43.1 5.7 5.0 1.0 14.8 42.7 16.8 14.0 37.1 7.8 80.3 25.8 29.9 37.7 38.9 42.8 18.3 5.0 8.3 28.7 EPS15L1 eps15R ENSG00000127527 "Epidermal growth factor receptor pathway substrate 15 like 1" Q9UBC2 19 16355239-16472085 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 71.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019237, HPA055309" Uncertain Approved Vesicles NA NA 8900 Vesicles "HPA019237: AB_1848223, HPA055309: AB_2682780" "unprognostic (3.06e-2)" "unprognostic (3.33e-3)" "unprognostic (2.19e-1)" "unprognostic (6.45e-3)" "unprognostic (1.35e-1)" "unprognostic (8.64e-2)" "unprognostic (2.58e-3)" "unprognostic (5.12e-2)" "unprognostic (1.07e-3)" "unprognostic (7.54e-2)" "unprognostic (5.21e-2)" "unprognostic (1.81e-2)" "prognostic favorable (8.10e-5)" "unprognostic (2.47e-1)" "unprognostic (9.59e-2)" "unprognostic (2.14e-1)" "unprognostic (3.32e-1)" 14.1 12.2 16.4 12.4 22.9 22.7 10.2 34.2 31.6 15.3 10.8 19.9 11.4 8.7 14.1 7.4 18.5 15.4 11.0 26.4 16.8 15.5 13.0 11.5 10.8 14.1 15.4 17.2 16.1 12.8 19.8 18.2 15.6 20.5 13.9 11.1 16.4 14.4 16.0 44.0 20.6 11.2 16.7 11.8 14.3 11.9 14.7 15.2 14.2 12.9 13.9 16.5 11.6 14.4 11.1 4.4 26.4 6.2 8.7 5.9 4.2 13.6 6.5 14.2 9.3 15.3 11.9 21.0 9.1 8.0 15.9 13.9 7.1 9.8 14.8 16.6 13.9 12.6 13.8 19.9 11.1 13.9 7.3 18.7 12.6 9.0 15.1 15.5 11.0 13.7 9.7 11.4 17.5 12.2 15.9 12.8 13.3 9.8 16.3 13.3 27.7 12.5 16.3 8.9 19.1 22.5 16.2 6.0 12.6 10.9 14.8 12.6 7.8 9.9 8.8 9.4 11.1 30.4 10.8 13.2 9.7 6.2 31.0 15.3 4.5 9.2 14.2 10.3 16.4 13.3 23.5 5.8 16.1 5.8 5.7 5.5 11.1 5.0 5.9 4.4 9.7 5.6 4.1 26.4 8.7 6.2 4.2 4.9 4.2 16.4 22.9 34.2 31.6 16.8 15.5 15.4 17.2 20.5 15.2 8.9 9.8 16.8 11.5 14.7 27.1 15.9 5.1 12.0 5.7 8.7 47.1 17.3 8.3 9.8 71.6 9.0 7.9 0.0 5.0 17.2 17.2 12.1 11.5 7.3 16.6 11.1 10.9 10.4 11.0 13.6 17.3 12.0 3.3 8.2 10.3 11.5 7.1 9.3 19.1 11.0 24.7 19.4 12.3 18.6 16.9 21.3 9.2 15.3 8.5 19.3 EPS8L3 "FLJ21522, MGC16817" ENSG00000198758 "EPS8 like 3" Q8TE67 1 109750080-109764027 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "gallbladder: 30.0;intestine: 115.1" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 255.7;Late spermatids: 82.4;Mucus-secreting cells: 88.8;Paneth cells: 126.3;Undifferentiated cells: 82.1" "Group enriched" "Detected in many" 6 "colorectal cancer: 52.5;pancreatic cancer: 29.7;stomach cancer: 26.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 22 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 22 "NK-cells: 2.1" "Cell line enhanced" "Detected in some" "CACO-2: 8.6;CAPAN-2: 8.2;Hep G2: 19.4;OE19: 36.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030998 Approved Approved Vesicles NA NA Vesicles "HPA030998: AB_2673691" "unprognostic (1.73e-3)" "unprognostic (1.80e-1)" "unprognostic (1.24e-1)" "unprognostic (2.76e-2)" "unprognostic (2.48e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (4.13e-5)" "unprognostic (5.55e-3)" "unprognostic (3.71e-2)" "unprognostic (2.09e-1)" "unprognostic (2.33e-1)" "prognostic unfavorable (2.52e-5)" "unprognostic (5.87e-3)" "unprognostic (3.89e-1)" "prognostic favorable (1.82e-4)" 0.2 0.1 0.2 11.0 0.2 0.0 0.2 0.2 0.2 0.5 88.2 0.2 0.2 41.3 0.2 0.2 0.3 0.2 30.0 0.2 0.2 0.1 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.3 22.1 0.2 0.2 0.3 0.2 0.1 115.1 0.5 0.2 0.2 15.1 1.2 0.2 0.2 0.2 0.2 0.2 0.5 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.6 8.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 36.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 10.2 0.0 0.0 0.0 0.0 0.0 0.0 4.9 28.5 0.0 255.7 0.0 21.7 0.0 0.0 0.0 4.6 0.0 0.0 0.0 49.3 0.0 0.0 82.4 0.6 0.0 0.0 0.0 88.8 0.0 26.8 126.3 0.4 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 82.1 0.5 EREG ER ENSG00000124882 Epiregulin O14944 4 74365143-74388751 "Predicted membrane proteins, Predicted secreted proteins" "Angiogenesis, Differentiation" "Developmental protein, Growth factor, Mitogen" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 52.1;tongue: 44.0" "Cell type enhanced" "Detected in many" 13 "Enterocytes: 44.2;Kupffer cells: 56.9;Macrophages: 122.8" "Cancer enhanced" "Detected in many" "colorectal cancer: 11.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 60.3;CAPAN-2: 17.1;hTEC/SVTERT24-B: 19.0;U-2197: 41.1;U-87 MG: 70.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA054373 Approved Vesicles "Secreted to blood" NA NA 46000 Vesicles "HPA054373: " "unprognostic (1.26e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (4.56e-3)" "unprognostic (3.94e-2)" "unprognostic (2.24e-3)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "prognostic unfavorable (1.45e-5)" "unprognostic (1.07e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (6.57e-5)" "unprognostic (2.94e-1)" "unprognostic (1.70e-6)" "unprognostic (2.42e-2)" "unprognostic (1.13e-2)" "unprognostic (6.59e-3)" "unprognostic (3.16e-3)" 2.2 0.0 0.1 4.6 0.3 52.1 1.2 0.0 0.1 5.0 1.2 0.1 0.0 0.0 0.1 0.5 15.3 1.2 7.3 0.8 0.0 0.0 0.4 0.2 6.7 1.1 0.0 0.2 0.5 0.1 0.0 0.0 2.0 0.3 0.2 1.6 0.1 1.6 0.0 0.5 10.7 1.0 1.3 0.1 1.9 0.3 0.3 0.0 0.2 0.0 44.0 7.2 4.1 4.6 0.6 1.3 2.6 1.2 0.4 0.3 0.3 0.3 9.1 0.0 0.0 0.9 1.5 0.0 2.0 60.3 0.6 0.3 7.1 17.1 0.0 10.1 0.0 4.6 0.5 0.0 13.1 0.6 0.0 0.0 0.2 0.3 0.2 0.2 0.0 0.0 0.9 4.6 19.0 10.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 41.1 0.0 0.0 0.0 0.0 70.5 0.0 0.0 1.9 1.2 2.6 0.3 1.0 0.2 0.2 0.2 0.2 1.3 0.6 0.3 0.2 1.0 0.4 0.2 0.4 0.2 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.2 0.3 0.0 6.0 11.1 1.9 4.9 4.7 0.0 15.7 2.5 4.0 29.6 0.0 0.0 0.5 0.0 0.0 3.1 2.2 44.2 0.0 0.2 0.7 6.1 2.0 6.9 0.0 28.2 0.0 3.5 0.6 56.9 0.4 0.3 122.8 6.8 29.7 24.7 0.0 0.4 17.5 0.0 0.1 0.0 0.0 2.2 0.5 0.2 8.2 0.6 1.0 27.7 6.7 ERV3-1 "envR, ERV-R, ERV3, H-PLK, HERV-R" ENSG00000213462 "Endogenous retrovirus group 3 member 1, envelope" Q14264 7 64990809-65006743 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 10.1" "Group enriched" "Detected in many" 4 "granulocytes: 10.1;monocytes: 2.5" "Cell line enhanced" "Detected in many" "AN3-CA: 19.5" "HPA017209, HPA046508" Enhanced Approved Vesicles NA NA Vesicles "HPA017209: AB_2732419, HPA046508: AB_2732525" "unprognostic (2.74e-2)" "unprognostic (1.84e-1)" "unprognostic (2.11e-1)" "unprognostic (1.27e-2)" "unprognostic (4.48e-1)" "unprognostic (2.03e-1)" "unprognostic (7.00e-2)" "unprognostic (1.79e-1)" "unprognostic (4.05e-3)" "unprognostic (3.55e-1)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "unprognostic (4.27e-3)" "unprognostic (2.11e-1)" "unprognostic (2.19e-1)" "unprognostic (9.39e-2)" "unprognostic (1.88e-2)" 27.2 41.3 9.9 9.0 11.7 8.6 18.3 13.8 11.6 9.4 7.1 8.7 5.6 3.9 11.2 31.9 18.9 9.0 17.9 8.4 10.1 7.2 7.3 4.0 10.7 5.6 11.2 9.2 10.6 7.6 9.6 19.3 21.2 11.7 8.1 6.5 9.3 14.9 13.1 5.1 14.2 5.8 8.5 13.2 7.0 6.9 9.4 12.7 12.6 10.2 6.2 10.2 10.5 13.8 0.9 1.2 10.1 2.5 1.4 1.5 1.1 2.1 0.7 12.7 19.5 8.0 3.3 8.6 4.0 4.5 1.4 3.3 0.7 14.2 3.5 3.7 1.5 2.7 2.5 1.7 0.9 2.2 2.6 0.9 1.9 0.6 6.8 0.6 5.2 2.5 3.9 1.1 1.3 0.3 7.5 8.1 4.1 8.4 7.0 5.3 5.3 3.3 3.2 3.6 6.8 0.8 7.7 0.5 2.5 2.2 4.4 2.4 12.3 4.3 1.2 0.4 14.1 3.2 11.5 6.6 4.9 0.6 3.6 2.0 2.2 5.1 1.1 3.9 15.1 2.9 0.1 1.5 3.4 0.9 2.5 0.8 0.7 0.2 0.7 1.2 0.9 0.6 0.6 10.1 1.4 0.8 0.7 1.5 1.1 9.9 11.7 13.8 11.6 10.1 7.2 11.2 9.2 11.7 12.7 3.0 9.6 34.1 15.5 3.8 26.4 1.8 15.3 10.7 11.4 15.7 27.5 14.5 8.3 12.4 5.5 11.3 6.7 23.3 15.3 9.4 6.9 10.3 8.1 2.1 8.2 17.5 13.3 15.4 15.4 4.1 10.6 15.5 10.1 13.6 7.2 14.0 14.3 7.0 9.2 2.2 18.2 6.5 7.1 9.8 9.5 5.0 33.6 25.8 6.0 22.2 ESPN DFNB36 ENSG00000187017 Espin B1AK53 1 6424776-6461367 "Disease related genes, Predicted intracellular proteins" Hearing Actin-binding "Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 70.4;liver: 54.9" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 302.8;Late spermatids: 360.4;Muller glia cells: 292.0;Paneth cells: 221.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 6 "cerebellum: 6.0" "Group enriched" "Detected in some" 4 "MAIT T-cell: 3.6;memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 37 "T-cells: 3.6" "Cell line enhanced" "Detected in some" "BEWO: 17.0;Hep G2: 27.1;SK-BR-3: 55.6;T-47d: 18.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA028674, HPA060220" Enhanced Approved Vesicles NA NA Vesicles "HPA028674: AB_10601316, HPA060220: AB_2684224" "unprognostic (5.06e-2)" "unprognostic (1.18e-2)" "unprognostic (2.69e-1)" "unprognostic (1.28e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.28e-1)" "unprognostic (1.16e-1)" "unprognostic (5.71e-2)" "unprognostic (7.48e-3)" "unprognostic (5.53e-2)" "unprognostic (6.26e-3)" "unprognostic (5.51e-2)" "unprognostic (1.16e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-2)" 0.6 1.4 0.6 2.5 0.8 6.7 2.9 6.0 0.7 13.3 44.8 0.6 9.2 27.1 1.2 19.7 9.9 6.3 1.2 0.6 1.0 0.1 14.3 54.9 1.6 0.6 0.6 0.6 2.4 0.6 12.9 12.1 1.3 0.6 2.6 1.7 19.5 2.9 4.7 0.6 27.1 70.4 1.0 0.6 0.6 0.4 37.7 0.6 1.2 0.7 2.4 3.2 0.8 5.9 0.0 0.0 0.0 0.0 0.0 3.6 0.3 4.6 0.2 0.2 0.0 0.0 0.0 17.0 0.0 0.0 0.0 0.0 10.1 0.5 0.1 2.3 0.0 0.0 11.1 0.8 0.0 0.0 0.6 0.2 0.1 0.2 27.1 0.0 0.2 0.9 0.0 0.2 0.0 0.0 0.0 0.0 0.3 5.7 0.0 0.0 9.4 0.0 0.3 0.2 1.2 4.2 0.0 0.1 3.6 0.0 0.0 7.3 0.3 1.3 55.6 1.7 0.1 18.5 2.4 5.3 0.0 0.2 0.2 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.6 0.0 1.2 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.6 0.8 6.0 0.7 1.0 0.1 0.6 0.6 0.6 0.6 0.0 1.1 1.4 1.7 6.9 5.5 1.1 5.1 1.4 1.2 8.7 64.8 2.2 11.6 0.3 114.4 0.6 302.8 23.3 2.9 0.4 0.4 1.4 0.0 99.9 0.2 0.0 5.8 3.1 2.9 360.4 3.4 0.3 0.0 0.0 16.1 292.0 0.1 221.0 2.1 91.6 68.8 0.0 0.0 2.6 2.5 19.8 5.5 0.8 19.0 3.2 EXOC2 "FLJ11026, SEC5L1, Sec5p" ENSG00000112685 "Exocyst complex component 2" Q96KP1 6 485133-693111 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032093 Approved Vesicles NA NA 5300 Vesicles "HPA032093: AB_10611964" "unprognostic (1.61e-1)" "unprognostic (4.69e-1)" "unprognostic (1.52e-1)" "unprognostic (9.32e-2)" "unprognostic (1.91e-2)" "unprognostic (2.48e-1)" "unprognostic (1.82e-3)" "unprognostic (1.34e-1)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "unprognostic (5.32e-2)" "unprognostic (2.02e-1)" "unprognostic (8.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (2.20e-1)" 15.9 13.8 16.6 18.2 19.9 8.8 16.7 17.0 20.8 16.4 13.5 22.2 9.3 12.8 14.3 12.5 18.7 10.5 13.6 16.7 17.0 19.0 14.5 15.3 16.8 18.2 19.7 11.6 12.6 11.0 22.8 22.0 26.4 22.4 12.5 15.5 24.4 13.4 12.9 15.7 17.5 14.5 14.1 22.2 18.4 13.4 25.7 17.1 24.8 21.5 12.2 20.2 16.5 14.5 12.5 12.1 8.9 13.6 12.2 18.8 11.4 10.3 8.0 13.4 14.6 12.3 11.1 8.2 9.4 11.0 11.3 13.5 10.2 5.6 7.7 23.2 11.2 17.0 9.1 15.0 16.4 13.5 24.1 16.0 9.8 9.7 10.1 15.4 10.4 9.9 9.6 13.4 8.0 9.4 11.2 18.9 15.3 19.2 5.7 14.0 9.0 13.9 10.2 13.6 9.3 7.7 13.2 11.6 15.5 10.1 11.3 13.2 7.7 7.5 4.6 14.8 26.3 11.9 6.4 27.4 10.2 7.6 12.7 8.7 14.1 28.1 8.2 10.4 8.7 31.3 8.9 7.8 8.6 15.7 9.5 18.8 12.5 15.9 16.4 12.1 12.0 15.2 14.5 2.5 12.2 13.6 9.9 17.2 11.4 16.6 19.9 17.0 20.8 17.0 19.0 19.7 11.6 22.4 17.1 3.0 16.4 4.4 3.0 4.2 8.1 7.6 0.0 6.7 5.7 5.2 7.9 11.8 6.6 5.8 8.8 8.4 4.0 0.0 4.4 5.8 4.5 4.9 4.7 8.3 8.7 7.9 2.4 9.8 9.8 2.7 6.4 5.6 5.0 8.2 5.9 4.8 6.2 4.9 8.5 6.9 9.0 0.0 6.2 17.2 17.9 6.8 10.8 15.2 5.1 6.0 F11 FXI ENSG00000088926 "Coagulation factor XI" P03951 4 186265945-186288806 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Heparin-binding, Hydrolase, Protease, Serine protease" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 88.9" "Cell type enhanced" "Detected in some" 27 "Alveolar cells type 2: 19.3;Distal tubular cells: 10.0;Hepatocytes: 59.9" "Cancer enriched" "Detected in some" 13 "liver cancer: 16.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "Hep G2: 14.0" "Not detected" "Not detected" HPA039808 Approved Vesicles "Secreted to blood" NA NA 4400000000 Vesicles "HPA039808: AB_2676693" "unprognostic (1.28e-1)" "unprognostic (3.15e-1)" "prognostic favorable (3.29e-5)" "unprognostic (1.88e-1)" "unprognostic (2.08e-1)" "unprognostic (2.11e-1)" "unprognostic (1.85e-3)" "unprognostic (2.91e-2)" "unprognostic (7.65e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 2.7 0.1 0.1 5.5 0.2 0.3 0.1 0.1 4.8 0.1 0.1 0.1 10.2 88.9 2.8 0.1 0.1 0.1 0.1 19.0 0.0 0.2 0.1 0.3 0.1 0.0 0.4 0.1 0.1 0.1 0.1 6.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.0 19.3 0.0 0.0 0.0 0.0 0.3 2.5 0.0 4.5 1.8 0.0 0.0 10.0 0.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 59.9 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.3 0.0 0.0 4.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 F3 "CD142, TF" ENSG00000117525 "Coagulation factor III, tissue factor" P13726 1 94529225-94541800 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Blood coagulation, Hemostasis" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Basal glandular cells: 636.0;Exocrine glandular cells: 410.4;Muller glia cells: 389.7;Pancreatic endocrine cells: 1078.7;Peritubular cells: 498.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 117.4;HaCaT: 55.6;HBEC3-KT: 144.4;U-2197: 54.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009438, HPA049292, HPA069132" Uncertain Approved Vesicles "Secreted to blood" NA NA 603000 Vesicles "CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092" "unprognostic (3.86e-2)" "unprognostic (1.19e-1)" "unprognostic (8.04e-2)" "unprognostic (1.64e-1)" "unprognostic (2.69e-2)" "unprognostic (1.23e-3)" "unprognostic (4.93e-2)" "unprognostic (8.00e-2)" "unprognostic (5.88e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (2.02e-8)" "unprognostic (4.84e-2)" "unprognostic (4.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.08e-1)" 45.5 9.8 27.0 14.1 42.9 2.1 55.1 3.4 27.9 14.8 18.7 20.9 18.7 18.3 30.5 23.7 21.3 25.4 30.9 18.8 26.9 14.5 6.6 2.8 31.4 5.8 14.1 20.3 41.6 35.0 6.1 28.8 65.4 39.2 29.7 22.2 49.9 29.2 33.0 2.4 17.7 19.2 5.9 46.3 2.9 18.2 16.4 16.0 0.0 21.8 17.3 11.9 24.7 22.3 0.5 0.9 2.8 0.8 0.7 0.4 0.2 117.4 0.2 0.2 0.0 12.8 6.3 6.6 16.7 10.0 18.1 19.7 2.1 25.2 0.0 8.6 20.7 3.9 55.6 1.5 144.4 29.9 0.1 0.1 0.0 3.6 0.3 4.2 0.0 0.0 10.9 3.2 8.5 41.9 34.4 0.1 0.1 0.1 0.1 12.6 0.2 0.1 2.4 1.1 0.7 0.2 0.1 1.2 0.0 2.2 0.3 0.1 0.3 13.3 5.5 0.4 3.6 0.1 1.6 0.0 11.0 0.3 54.8 5.0 0.1 0.1 0.1 8.4 0.6 0.4 1.7 0.8 0.1 0.3 0.3 0.4 0.2 0.3 0.2 0.2 0.5 0.3 0.3 2.8 0.7 0.2 0.9 0.2 0.2 27.0 42.9 3.4 27.1 26.9 14.5 14.1 20.3 39.2 16.0 122.1 188.9 0.5 636.0 14.4 1.5 21.1 7.6 72.3 238.8 14.0 0.0 13.6 0.0 120.9 5.6 10.5 10.3 0.0 410.4 4.8 48.3 85.3 2.3 0.6 5.4 3.2 12.6 12.3 4.0 9.8 260.4 4.9 3.3 3.6 40.9 389.7 1078.7 11.0 498.9 0.3 13.3 6.5 7.2 1.1 3.4 6.6 6.4 0.8 9.5 358.5 FAM114A2 "133K02, C5orf3" ENSG00000055147 "Family with sequence similarity 114 member A2" Q9NRY5 5 153990128-154038936 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Spermatocytes: 100.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035869, HPA035870" Approved Approved Vesicles NA NA Vesicles "HPA035869: AB_10669534, HPA035870: AB_10673222" "unprognostic (1.81e-1)" "unprognostic (2.65e-1)" "unprognostic (3.45e-2)" "unprognostic (3.27e-1)" "unprognostic (7.99e-2)" "unprognostic (8.21e-2)" "unprognostic (5.18e-3)" "unprognostic (6.70e-2)" "unprognostic (1.92e-2)" "unprognostic (2.66e-1)" "unprognostic (9.70e-3)" "unprognostic (4.37e-1)" "unprognostic (7.80e-2)" "unprognostic (1.38e-3)" "unprognostic (4.17e-2)" "unprognostic (5.90e-3)" "unprognostic (2.85e-2)" 15.7 16.1 10.3 11.1 10.4 6.9 13.6 7.2 10.5 10.5 10.6 8.5 15.9 10.3 12.8 15.1 14.0 10.9 9.7 16.5 12.7 9.5 13.7 18.3 12.0 16.7 10.1 9.8 14.0 26.4 22.3 18.9 11.4 11.5 13.0 9.7 12.5 16.0 12.5 20.7 10.2 13.4 17.4 8.9 14.3 13.0 30.7 9.9 16.6 14.6 11.5 14.3 13.1 11.1 12.4 10.9 25.9 15.8 12.1 14.5 8.7 8.4 11.2 12.0 18.8 17.0 15.9 10.9 20.4 14.3 15.2 21.2 8.2 12.5 10.7 19.6 15.0 10.6 7.2 10.4 19.9 18.5 11.9 11.6 13.6 6.8 5.9 20.0 11.9 14.1 14.2 12.4 13.6 24.7 11.2 21.2 14.1 8.5 16.8 19.6 8.1 13.5 4.9 5.2 9.0 5.5 11.7 16.6 16.2 11.6 5.9 2.8 10.1 14.8 16.0 20.7 13.3 21.5 8.7 19.6 14.1 10.1 12.9 12.2 25.6 20.6 15.1 16.8 16.5 15.1 20.0 10.9 25.9 12.4 13.8 14.2 12.4 10.4 14.5 10.9 11.7 13.0 12.7 5.5 12.1 15.8 9.9 11.6 8.7 10.3 10.4 7.2 10.5 12.7 9.5 10.1 9.8 11.5 9.9 8.9 8.6 14.3 5.5 5.6 8.9 24.0 2.5 13.4 5.7 10.4 3.9 19.1 6.6 10.8 31.5 17.9 5.4 0.0 10.8 13.2 13.0 4.3 17.3 16.8 15.3 9.5 5.2 6.7 17.0 9.8 10.3 12.3 13.5 10.8 6.9 23.6 8.9 3.5 9.2 12.3 16.2 6.5 10.3 100.0 36.0 5.9 15.3 10.7 5.2 2.7 FAM198A "C3orf41, DKFZP434B172" ENSG00000144649 "Family with sequence similarity 198 member A" Q9UFP1 3 42979267-43060211 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 11.9;Leydig cells: 9.2;Muller glia cells: 17.2;Peritubular cells: 18.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 5.9;RPMI-8226: 6.2;SK-BR-3: 4.2;T-47d: 11.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047726 Approved Supported Vesicles "Secreted - unknown location" NA NA 440000 Vesicles "HPA047726: AB_10960554" "unprognostic (2.16e-3)" "unprognostic (2.19e-1)" "unprognostic (1.04e-1)" "unprognostic (2.93e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.65e-2)" "unprognostic (5.79e-2)" "unprognostic (2.69e-1)" "unprognostic (6.21e-2)" "unprognostic (2.02e-1)" "unprognostic (1.50e-1)" "unprognostic (1.57e-4)" "unprognostic (4.45e-2)" "unprognostic (2.09e-2)" "unprognostic (3.49e-2)" "unprognostic (3.81e-1)" 8.9 3.5 6.2 3.7 8.3 0.1 5.4 4.1 6.8 10.8 3.5 6.1 2.4 1.3 11.7 9.4 4.0 13.8 13.0 2.0 7.2 2.6 1.3 12.1 3.8 1.1 5.1 5.5 9.4 3.0 0.3 2.6 3.2 11.2 2.7 1.8 4.0 4.1 3.8 1.4 1.8 2.5 9.2 5.2 1.2 4.3 3.1 6.8 0.0 2.0 1.1 0.6 3.8 4.2 0.0 1.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 5.9 0.2 0.0 1.7 0.3 0.6 0.0 0.0 0.2 1.8 0.0 1.8 0.0 2.8 0.0 0.7 0.0 0.0 0.0 2.5 0.9 0.0 0.0 1.3 0.5 2.1 1.2 0.0 0.6 1.4 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.4 0.0 3.4 0.0 0.0 0.0 0.0 6.2 0.0 0.8 0.1 0.4 0.0 4.2 0.0 0.3 11.9 1.4 0.0 0.8 1.2 2.4 0.0 0.4 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.2 1.2 0.0 0.0 6.2 8.3 4.1 6.8 7.2 2.6 5.1 5.5 11.2 6.8 0.0 0.0 0.0 0.1 0.1 1.2 0.6 0.0 0.0 0.0 1.8 0.0 1.2 0.0 0.1 0.6 0.3 0.0 0.0 0.2 1.9 3.1 0.2 0.0 11.9 3.1 3.2 0.0 1.8 0.3 0.0 9.2 0.0 0.0 1.0 0.0 17.2 0.3 0.0 18.7 0.3 1.6 6.5 1.4 0.9 0.9 0.5 2.3 0.0 0.0 0.0 FAM220A "ACPIN1, C7orf70, MGC12966, SIPAR" ENSG00000178397 "Family with sequence similarity 220 member A" Q7Z4H9 7 6329409-6348981 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "skeletal muscle: 56.7;testis: 40.9" "Group enriched" "Detected in many" 14 "Early spermatids: 230.4;Late spermatids: 278.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA055050 Approved Vesicles NA NA Vesicles "HPA055050: AB_2682684" "unprognostic (3.49e-2)" "unprognostic (3.53e-1)" "unprognostic (2.69e-2)" "unprognostic (9.79e-2)" "unprognostic (3.26e-2)" "unprognostic (4.02e-2)" "prognostic unfavorable (5.17e-6)" "unprognostic (2.78e-1)" "unprognostic (1.43e-2)" "unprognostic (2.36e-1)" "unprognostic (1.98e-1)" "unprognostic (1.51e-2)" "unprognostic (1.30e-1)" "unprognostic (8.84e-3)" "unprognostic (1.14e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (3.71e-2)" 5.8 6.9 10.5 5.1 9.3 2.3 7.7 14.0 16.6 7.5 6.1 6.8 3.8 4.3 8.1 6.1 8.9 6.2 5.9 12.6 10.3 9.7 6.5 5.1 4.9 6.8 8.3 11.6 8.7 10.5 15.3 7.2 6.0 7.9 6.6 4.4 5.6 7.2 6.9 56.7 7.7 4.6 7.3 7.9 5.8 5.3 40.9 5.4 9.7 9.1 11.8 7.7 7.5 6.3 11.1 9.6 9.5 5.5 16.2 10.2 3.8 15.9 10.1 7.4 17.3 17.2 14.6 8.2 8.2 10.2 9.9 11.7 6.7 8.9 13.3 9.5 9.7 19.9 11.8 11.2 6.9 13.0 9.2 7.2 4.4 8.1 7.5 18.7 8.0 6.7 8.1 23.4 7.4 18.0 9.6 9.2 10.1 8.6 12.8 8.5 12.5 4.9 14.7 17.3 8.4 13.2 12.8 11.1 11.1 9.1 5.8 7.6 13.1 11.5 14.2 17.1 15.6 13.6 21.0 6.9 7.9 18.1 15.3 10.4 13.8 21.3 14.5 9.2 14.5 24.1 6.7 5.5 9.5 5.5 4.5 5.7 11.1 6.6 8.5 9.6 10.6 10.2 8.4 2.4 16.2 4.7 7.7 8.3 3.8 10.5 9.3 14.0 16.6 10.3 9.7 8.3 11.6 7.9 5.4 3.0 1.4 4.4 4.7 6.9 2.7 8.5 0.0 1.4 9.1 1.8 5.9 5.4 1.7 4.8 230.4 3.3 2.5 0.0 4.1 6.2 5.2 3.7 1.1 3.4 5.7 0.0 5.8 5.5 5.9 278.7 7.8 5.7 3.3 6.4 4.0 3.7 5.0 2.3 12.4 2.2 1.8 0.0 4.2 17.9 10.4 8.8 6.9 3.3 3.2 5.9 FAM3B "2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44" ENSG00000183844 "Family with sequence similarity 3 member B" P58499 21 41304212-41357431 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Apoptosis Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.8;pancreas: 120.3;salivary gland: 67.9" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 242.6;Exocrine glandular cells: 349.6;Pancreatic endocrine cells: 184.9;Syncytiotrophoblasts: 134.9" "Cancer enhanced" "Detected in many" "prostate cancer: 40.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "eosinophil: 3.0;neutrophil: 6.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.9" "Cell line enhanced" "Detected in some" "CACO-2: 9.3;CAPAN-2: 6.0;Hep G2: 15.3;OE19: 13.2;RPMI-8226: 42.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015885, HPA029777, CAB034131" Enhanced Approved Vesicles "Secreted to blood" NA NA 2080000 57000 Vesicles "CAB034131: AB_2231472, HPA015885: AB_1848396, HPA029777: AB_2673194" "unprognostic (2.88e-1)" "unprognostic (3.31e-3)" "unprognostic (5.13e-2)" "unprognostic (1.27e-1)" "unprognostic (2.62e-1)" "unprognostic (6.32e-3)" "unprognostic (1.41e-1)" "unprognostic (8.79e-3)" "unprognostic (9.38e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "unprognostic (3.78e-1)" "unprognostic (5.60e-3)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (1.78e-1)" "unprognostic (1.55e-3)" 0.6 0.2 0.2 4.5 0.4 0.0 4.3 0.2 0.3 1.8 38.5 0.4 29.9 38.2 0.2 8.8 17.4 4.5 6.9 0.4 0.2 0.2 5.2 0.6 2.0 0.7 0.3 0.2 0.7 120.3 0.0 1.9 7.9 0.4 10.0 0.0 0.2 67.9 36.0 0.2 0.9 83.8 2.0 0.3 0.5 30.8 2.0 0.2 2.3 3.9 7.4 17.6 17.5 4.7 0.2 1.3 6.9 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.3 6.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.4 13.2 0.0 0.0 0.0 42.4 0.0 2.8 0.2 0.2 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 3.0 0.0 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 6.9 0.0 0.6 1.3 0.0 0.0 0.2 0.4 0.2 0.3 0.2 0.2 0.3 0.2 0.4 0.2 20.8 18.8 0.0 11.2 1.1 0.0 0.1 81.5 22.7 50.0 62.8 0.0 242.6 21.6 113.7 19.2 1.0 0.0 0.0 349.6 6.2 5.7 99.4 1.1 0.0 23.0 0.0 0.0 0.0 2.5 7.0 0.6 8.1 5.0 3.6 0.9 0.0 184.9 0.0 0.4 0.4 0.0 0.0 0.9 26.7 7.2 1.1 134.9 0.0 0.0 104.8 FAM43A FLJ90022 ENSG00000185112 "Family with sequence similarity 43 member A" Q8N2R8 3 194686544-194689037 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 61.8;Extravillous trophoblasts: 69.8;Ito cells: 78.5;Syncytiotrophoblasts: 135.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 47.9;NB-4: 28.5;PC-3: 22.6;TIME: 24.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048345 Uncertain Approved Vesicles NA NA Vesicles "HPA048345: AB_2680367" "unprognostic (1.61e-1)" "unprognostic (1.11e-1)" "unprognostic (9.18e-2)" "unprognostic (1.90e-2)" "unprognostic (5.71e-3)" "unprognostic (5.13e-3)" "unprognostic (9.80e-2)" "unprognostic (8.28e-2)" "unprognostic (4.96e-2)" "unprognostic (1.38e-1)" "unprognostic (3.92e-3)" "unprognostic (1.74e-1)" "unprognostic (2.14e-1)" "unprognostic (1.15e-1)" "unprognostic (1.45e-1)" "unprognostic (2.91e-3)" "prognostic unfavorable (9.96e-4)" 10.7 1.8 1.6 3.5 1.6 2.4 10.4 2.7 4.2 5.2 4.2 2.1 1.6 0.8 4.8 2.7 5.3 6.0 4.2 7.0 2.7 1.6 4.6 23.5 5.6 8.0 2.5 3.6 3.5 7.0 0.5 2.7 9.3 4.1 7.9 1.7 3.3 6.7 2.1 5.5 8.6 3.8 2.9 1.6 20.6 2.7 6.1 2.3 2.6 2.6 5.8 5.2 5.7 8.9 5.0 8.7 3.6 1.3 2.8 1.4 0.4 0.1 0.7 0.6 0.4 9.7 4.7 3.9 1.2 3.3 0.0 0.0 0.2 0.1 0.5 13.7 4.5 3.1 1.4 0.8 0.3 0.0 0.3 2.5 1.7 3.8 0.5 0.8 0.4 5.0 1.2 2.0 0.2 0.0 0.2 47.9 0.0 1.0 0.9 0.1 0.7 0.0 28.5 2.2 4.8 22.6 2.1 0.1 0.2 0.0 0.0 13.3 1.1 0.9 0.9 2.8 1.0 0.5 5.9 24.0 0.5 0.7 0.6 0.3 0.0 0.5 1.2 0.2 13.0 9.0 3.6 1.3 1.5 1.0 1.1 1.4 2.3 0.6 0.9 1.3 5.0 0.1 0.3 1.6 2.8 0.7 8.7 0.4 0.4 1.6 1.6 2.7 4.2 2.7 1.6 2.5 3.6 4.1 2.3 0.0 4.5 27.4 20.1 3.5 14.8 31.3 0.0 0.0 0.0 1.8 7.9 18.7 6.6 4.5 0.1 61.8 15.4 0.0 1.5 69.8 14.0 21.7 15.0 0.5 5.1 0.0 6.3 78.5 9.7 0.8 15.3 3.1 11.8 0.0 2.5 2.1 4.4 17.5 9.2 0.5 1.7 25.8 17.6 0.5 5.9 3.4 135.8 15.2 7.3 11.2 FAM86B1 MGC16279 ENSG00000186523 "Family with sequence similarity 86 member B1" Q8N7N1 8 12182096-12194133 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 7.5" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 10.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 5.8" "HPA041610, HPA055718" Uncertain Uncertain Vesicles NA NA Vesicles "HPA041610: AB_2677581, HPA055718: AB_2682895" "unprognostic (1.90e-2)" "unprognostic (8.67e-2)" "unprognostic (2.79e-1)" "unprognostic (3.74e-2)" "unprognostic (3.13e-3)" "unprognostic (1.05e-1)" "unprognostic (1.94e-1)" "unprognostic (1.74e-1)" "unprognostic (5.68e-2)" "unprognostic (1.91e-2)" "unprognostic (1.32e-1)" "unprognostic (6.69e-2)" "unprognostic (8.00e-3)" "unprognostic (2.66e-2)" "unprognostic (1.58e-1)" "unprognostic (7.02e-2)" "unprognostic (2.58e-2)" 0.9 2.0 3.2 1.0 6.9 1.2 0.7 4.8 7.5 0.8 0.5 2.2 4.0 1.3 1.2 2.8 1.3 1.1 3.3 4.1 1.3 0.1 1.2 0.7 2.8 5.0 0.9 2.0 5.4 0.3 2.6 0.0 2.4 1.0 2.0 3.0 0.7 0.1 2.3 1.4 0.3 0.6 2.6 0.0 0.8 1.1 0.2 0.6 0.9 0.1 0.0 0.8 0.2 0.5 2.9 0.0 5.8 0.0 0.7 2.5 4.7 0.3 1.1 0.7 1.6 1.3 1.0 0.2 0.2 1.1 4.9 1.0 0.8 0.8 0.5 0.8 0.2 0.7 0.8 3.1 2.0 2.2 0.3 0.5 0.5 1.4 1.3 0.2 2.4 1.6 1.6 0.2 2.7 0.0 1.3 1.9 0.6 0.5 1.5 1.0 0.7 0.3 1.3 4.7 1.0 0.9 0.5 0.6 0.4 2.2 0.0 0.0 1.0 0.9 4.0 1.6 0.6 1.4 0.6 0.8 0.1 0.8 0.8 0.1 0.7 0.1 0.0 0.7 0.2 0.8 0.5 0.3 0.0 0.6 0.7 0.9 0.0 0.0 0.6 0.4 0.2 3.0 2.6 0.8 2.5 1.0 2.6 0.4 5.1 10.7 4.5 1.8 2.0 1.3 5.0 3.9 4.4 1.1 0.5 0.0 1.6 1.2 2.9 2.2 1.1 0.8 1.9 1.6 4.1 1.8 1.9 4.0 1.7 1.1 3.3 0.0 1.2 2.3 2.9 0.0 2.5 6.8 1.2 0.0 2.1 0.9 0.7 1.1 0.9 0.0 2.0 1.3 FAM86B2 ENSG00000145002 "Family with sequence similarity 86 member B2" P0C5J1 8 12425614-12436343 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 4.6" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 3.0;Early spermatids: 1.2;Late spermatids: 3.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "hTERT-HME1: 6.3;RPMI-8226: 18.5" "HPA041610, HPA055718" Uncertain Uncertain Vesicles NA NA Vesicles "HPA041610: AB_2677581, HPA055718: AB_2682895" "unprognostic (3.75e-2)" "unprognostic (1.87e-1)" "unprognostic (6.57e-2)" "unprognostic (1.01e-1)" "unprognostic (3.26e-2)" "unprognostic (2.48e-1)" "unprognostic (2.26e-1)" "unprognostic (1.48e-1)" "unprognostic (3.82e-1)" "unprognostic (3.24e-1)" "unprognostic (6.04e-4)" "unprognostic (9.37e-2)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (2.62e-1)" "unprognostic (1.37e-1)" "unprognostic (2.13e-2)" 0.4 0.9 0.2 0.4 0.7 0.0 0.8 0.2 0.3 0.8 0.8 0.4 1.0 0.0 3.9 4.6 0.7 0.1 0.2 0.5 1.1 0.5 0.6 0.1 0.2 1.3 1.1 0.6 2.2 0.1 0.6 0.6 0.5 1.8 0.3 1.2 0.0 0.6 0.0 0.0 0.4 0.1 3.4 0.1 1.0 0.6 0.4 1.3 0.0 0.9 0.6 2.1 0.3 0.2 1.3 0.2 0.0 0.3 1.5 1.5 0.3 0.7 0.5 1.3 0.5 1.3 0.8 0.0 1.5 0.3 0.2 1.1 1.8 0.0 0.0 0.0 0.2 1.8 0.0 1.2 0.0 0.0 0.4 1.5 1.4 6.3 0.1 0.0 0.0 1.3 0.2 0.1 0.4 0.0 0.4 1.2 2.2 0.4 0.2 0.7 18.5 0.0 1.2 1.9 0.0 0.5 1.4 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.7 1.5 0.4 0.9 1.1 1.3 0.4 0.4 0.3 0.0 0.6 0.9 0.0 2.1 0.3 3.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 FAM98A DKFZP564F0522 ENSG00000119812 "Family with sequence similarity 98 member A" Q8NCA5 2 33583658-33599382 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036250, HPA036251" Uncertain Approved Vesicles NA NA Vesicles "HPA036250: AB_2675020, HPA036251: AB_10673124" "unprognostic (7.25e-2)" "unprognostic (9.92e-2)" "unprognostic (1.59e-2)" "unprognostic (1.40e-1)" "unprognostic (1.51e-1)" "unprognostic (2.42e-2)" "prognostic unfavorable (4.86e-7)" "unprognostic (1.07e-1)" "unprognostic (2.29e-1)" "unprognostic (2.78e-2)" "unprognostic (1.01e-1)" "unprognostic (3.51e-1)" "unprognostic (2.02e-2)" "unprognostic (2.38e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (8.18e-5)" "unprognostic (6.01e-2)" 19.5 18.5 17.6 13.5 19.7 4.5 11.6 15.0 27.1 16.4 13.8 23.5 9.3 9.6 16.1 14.0 16.4 9.6 11.7 26.6 22.5 16.3 19.2 19.1 9.6 11.6 20.9 17.9 13.8 11.8 57.7 26.4 26.6 26.0 16.8 12.3 8.4 24.8 12.4 38.4 11.5 9.9 24.8 23.4 11.5 13.5 36.3 16.5 8.2 14.8 17.7 14.8 12.6 10.1 12.0 6.8 3.0 8.9 4.4 10.0 4.6 25.6 12.8 7.4 12.4 29.3 32.0 11.7 63.8 22.9 17.5 23.0 13.4 5.3 39.5 11.8 27.8 16.1 11.6 23.4 17.5 23.9 18.2 15.8 32.8 13.7 18.7 14.1 26.1 12.7 16.9 11.9 23.7 15.3 18.4 23.0 4.3 22.4 12.2 30.7 12.5 14.4 7.6 18.3 23.3 17.1 11.4 23.9 14.1 18.3 19.7 13.1 7.4 16.6 25.8 7.5 12.3 10.7 4.2 38.5 11.2 19.2 23.8 25.0 23.3 28.0 39.2 26.7 19.0 15.8 1.3 4.9 3.0 8.0 8.9 8.3 12.0 6.6 6.8 6.8 7.2 8.8 6.9 0.1 4.4 4.8 4.2 10.0 4.6 17.6 19.7 15.0 27.1 22.5 16.3 20.9 17.9 26.0 16.5 20.8 7.8 18.6 10.5 18.1 16.4 65.5 15.3 17.4 22.7 7.0 2.0 22.5 21.6 19.1 11.3 17.8 6.0 0.0 25.2 27.8 19.2 13.5 2.3 20.3 14.5 44.5 5.2 20.3 8.9 11.4 20.8 10.3 8.5 2.8 11.1 17.0 21.8 10.4 20.5 32.6 14.2 0.0 19.8 31.5 44.9 17.9 33.4 8.7 9.1 21.7 FANCD2OS "C3orf24, MGC40179" ENSG00000163705 "FANCD2 opposite strand" Q96PS1 3 10081317-10108231 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 6 "testis: 53.0" "Group enriched" "Detected in some" 88 "Early spermatids: 499.8;Late spermatids: 668.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "neutrophil: 8.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.4" "Cell line enhanced" "Detected in some" "CACO-2: 4.8;Daudi: 1.5;HEL: 2.5;MCF7: 2.3" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA076166 Approved Vesicles NA NA Vesicles "HPA076166: " "unprognostic (5.99e-2)" "unprognostic (4.33e-3)" "unprognostic (8.04e-2)" "unprognostic (1.11e-3)" "unprognostic (3.51e-1)" "unprognostic (2.63e-2)" "unprognostic (4.78e-2)" "unprognostic (3.49e-1)" "unprognostic (2.53e-3)" "unprognostic (3.91e-2)" "unprognostic (9.45e-2)" "unprognostic (2.11e-7)" "unprognostic (2.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.15e-1)" "unprognostic (1.80e-1)" 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 8.4 1.6 0.4 0.4 0.1 0.3 0.4 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.8 0.6 1.5 0.7 0.0 0.3 1.1 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 2.3 1.3 0.0 0.1 0.0 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.8 0.2 0.1 0.0 1.2 0.6 0.3 0.9 0.6 0.4 0.5 0.3 0.3 0.4 0.2 0.4 0.2 0.1 0.8 0.3 0.3 8.4 0.4 1.6 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 499.8 0.0 0.0 0.0 0.6 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 668.2 6.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 3.9 0.0 0.0 0.0 0.0 5.1 2.4 0.0 0.0 0.0 0.0 0.0 FERMT3 "KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2" ENSG00000149781 "Fermitin family member 3" Q86UX7 11 64206678-64223886 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 59.4;bone marrow: 57.6;lymphoid tissue: 52.7" "Cell type enhanced" "Detected in many" 10 "granulocytes: 94.6;Hofbauer cells: 174.8;Kupffer cells: 81.3;Macrophages: 95.8;monocytes: 155.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 62.7;HL-60: 27.4;HMC-1: 67.1;Karpas-707: 27.0;NB-4: 35.3;U-937: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065231 Approved Vesicles NA NA 450000000 Vesicles "HPA065231: AB_2685439" "unprognostic (1.96e-2)" "unprognostic (1.07e-2)" "unprognostic (3.38e-3)" "prognostic favorable (9.89e-4)" "unprognostic (8.77e-2)" "unprognostic (1.83e-2)" "unprognostic (3.56e-2)" "unprognostic (2.46e-1)" "unprognostic (4.20e-1)" "unprognostic (3.98e-1)" "unprognostic (2.70e-1)" "unprognostic (3.88e-1)" "prognostic unfavorable (2.12e-5)" "unprognostic (3.08e-3)" "unprognostic (5.25e-2)" "unprognostic (4.97e-2)" "unprognostic (1.75e-1)" 20.0 5.6 3.1 29.4 5.5 57.6 5.6 0.9 3.2 3.4 8.8 3.4 0.7 8.1 3.4 6.0 3.6 5.8 6.5 7.2 2.2 2.4 5.3 5.5 17.8 39.1 6.3 0.8 4.9 2.8 0.2 2.6 7.5 3.7 4.2 3.0 5.6 8.9 2.9 3.2 2.8 12.4 3.3 4.8 52.7 10.6 2.5 4.3 51.2 4.0 2.4 29.6 6.2 2.9 13.7 47.3 54.7 49.5 22.6 30.6 59.4 0.2 0.3 0.1 0.1 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.5 0.4 6.6 0.6 1.3 0.1 0.5 0.2 0.1 0.1 17.0 0.1 62.7 0.2 0.0 2.3 27.4 67.1 0.2 0.2 1.1 0.0 0.1 17.0 16.0 1.4 27.0 1.8 0.7 24.4 35.3 0.2 0.2 0.4 14.7 1.8 0.1 0.0 0.1 0.4 0.1 0.1 0.9 0.3 0.1 0.4 19.1 1.6 0.2 0.5 0.4 0.1 0.3 0.6 12.0 4.1 28.4 18.1 40.6 49.5 54.7 30.6 46.3 29.4 13.7 24.4 28.4 39.0 13.4 16.1 21.1 45.0 22.6 33.5 47.3 28.3 59.4 3.1 5.5 0.9 3.2 2.2 2.4 6.3 0.8 3.7 4.3 8.9 17.1 42.2 0.6 4.1 0.6 2.0 5.1 1.4 6.8 0.0 0.0 0.9 0.0 0.6 0.1 3.6 5.9 23.3 2.2 1.1 5.3 0.9 94.6 1.7 174.8 0.0 0.0 17.2 81.3 0.8 0.9 95.8 16.9 155.9 22.4 0.1 2.8 10.5 2.5 0.2 0.2 6.5 6.1 1.1 0.7 4.0 2.2 69.2 13.9 0.7 FETUB ENSG00000090512 "Fetuin B" Q9UGM5 3 186635969-186653141 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Fertilization "Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 76.1" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 37.1" "Cancer enriched" "Detected in some" 12 "liver cancer: 44.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 1.5;Hep G2: 4.5;HSkMC: 1.0;NTERA-2: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035132, HPA035133" Supported Approved Vesicles "Secreted to blood" NA NA 47500000000 4500000000 Vesicles "HPA035132: AB_10601650, HPA035133: " "unprognostic (9.01e-2)" "unprognostic (1.95e-1)" "unprognostic (4.62e-1)" "unprognostic (8.74e-2)" "unprognostic (6.28e-3)" "unprognostic (1.24e-2)" "unprognostic (7.55e-2)" "unprognostic (9.78e-2)" "unprognostic (1.73e-2)" "unprognostic (9.18e-2)" "unprognostic (1.79e-1)" "unprognostic (8.39e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.0 0.1 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 76.1 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.3 0.0 2.6 11.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 4.5 0.0 0.5 0.0 1.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.7 0.4 0.2 0.0 0.4 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 5.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 37.1 0.0 0.0 0.0 1.3 2.4 4.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 FGD6 "FLJ11183, ZFYVE24" ENSG00000180263 "FYVE, RhoGEF and PH domain containing 6" Q6ZV73 12 95076749-95217482 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Pancreatic endocrine cells: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 5.5" "Group enriched" "Detected in many" 6 "B-cells: 2.0;dendritic cells: 1.9;monocytes: 5.5" "Cell line enhanced" "Detected in many" "Daudi: 15.8;hTERT-HME1: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007974 Approved Approved Vesicles NA NA Vesicles "HPA007974: AB_1848520" "unprognostic (1.28e-2)" "unprognostic (2.67e-3)" "unprognostic (6.06e-2)" "unprognostic (5.56e-2)" "unprognostic (1.65e-1)" "unprognostic (4.70e-2)" "unprognostic (4.66e-2)" "unprognostic (1.35e-3)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.62e-5)" "prognostic unfavorable (9.83e-4)" "prognostic unfavorable (5.46e-6)" "unprognostic (1.01e-2)" "unprognostic (1.38e-1)" "unprognostic (3.33e-2)" "unprognostic (1.92e-1)" 4.6 8.6 7.8 31.4 9.1 2.6 6.4 5.3 8.5 7.2 10.0 3.9 14.5 2.7 6.6 2.6 9.2 5.1 9.3 8.2 7.4 3.4 6.5 6.0 9.9 9.5 3.7 5.2 9.0 10.2 4.2 3.8 13.1 4.3 7.4 8.1 6.2 4.8 17.2 4.2 14.3 8.7 9.8 6.3 5.9 5.2 5.6 5.4 5.0 9.9 5.1 17.1 7.2 11.1 2.0 1.9 0.5 5.5 0.3 0.2 0.9 14.8 13.6 12.6 1.4 1.3 1.2 6.6 2.1 3.0 0.8 1.2 5.2 10.3 15.8 3.6 1.3 0.9 6.0 2.2 12.7 1.8 1.6 1.4 0.7 2.2 2.5 1.8 1.6 0.1 5.3 5.8 1.5 15.6 5.1 8.1 2.2 3.3 0.3 0.4 0.8 1.3 0.3 5.2 1.9 4.7 3.6 2.5 1.2 9.0 4.8 2.1 3.4 6.1 3.2 0.3 6.6 1.4 0.1 11.1 0.5 1.4 0.6 1.6 1.5 3.4 4.5 0.6 1.0 1.0 0.5 3.3 0.0 0.1 5.5 0.0 1.3 0.0 0.0 1.9 2.0 0.2 0.0 0.2 0.3 3.8 0.0 0.0 0.9 7.8 9.1 5.3 8.5 7.4 3.4 3.7 5.2 4.3 5.4 14.9 13.4 0.9 19.4 43.0 4.5 20.5 5.1 9.4 12.5 8.7 3.9 3.7 0.0 20.4 1.1 15.7 13.1 0.0 19.3 7.2 3.3 17.0 1.1 5.0 9.9 1.6 12.0 15.4 13.4 1.5 11.5 7.8 1.7 5.4 9.4 2.0 51.0 10.5 9.9 4.4 8.1 0.0 3.4 1.5 16.8 21.8 36.6 0.0 4.6 26.3 FGFRL1 ENSG00000127418 "Fibroblast growth factor receptor like 1" Q8N441 4 1009936-1026897 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 51.1" "Cell type enhanced" "Detected in many" 14 "Hepatocytes: 29.6;Muller glia cells: 87.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.5;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 5 "granulocytes: 1.2;monocytes: 3.6;T-cells: 1.2" "Cell line enhanced" "Detected in many" "U-251 MG: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB026019, HPA068828" Approved Supported Vesicles No No Vesicles "CAB026019: , HPA068828: AB_2686043" "unprognostic (1.30e-2)" "unprognostic (2.54e-2)" "unprognostic (6.27e-2)" "unprognostic (2.80e-2)" "unprognostic (1.23e-2)" "unprognostic (1.48e-1)" "unprognostic (2.62e-2)" "unprognostic (9.79e-2)" "unprognostic (4.87e-3)" "unprognostic (8.46e-2)" "unprognostic (2.01e-2)" "unprognostic (1.51e-1)" "unprognostic (2.36e-3)" "unprognostic (1.49e-1)" "unprognostic (7.80e-2)" "unprognostic (1.06e-2)" "unprognostic (1.96e-2)" 21.8 22.9 16.0 6.1 20.5 5.8 21.5 13.8 20.6 8.1 6.6 9.1 5.3 6.6 6.6 5.0 4.7 19.7 9.8 12.2 16.6 3.6 11.5 25.1 6.4 4.0 8.8 8.4 14.0 51.1 12.6 9.0 3.1 17.0 7.6 4.8 12.7 29.3 3.1 9.6 3.7 6.0 4.1 14.0 5.3 15.0 3.2 11.1 1.0 33.8 3.9 3.6 6.2 11.5 0.4 0.3 1.2 3.6 0.1 1.2 0.4 8.5 11.6 4.2 12.8 4.5 4.7 1.1 15.2 2.3 4.9 3.2 8.4 17.7 0.9 19.8 23.2 22.0 2.2 8.1 5.1 4.5 3.2 7.9 0.1 15.2 22.1 9.2 4.9 2.1 9.9 4.4 8.4 3.6 18.3 4.6 3.4 9.3 3.3 2.9 11.1 5.7 13.5 5.3 14.4 31.6 9.4 6.2 6.0 8.5 1.3 0.4 0.8 14.1 0.3 5.6 5.3 8.4 4.3 9.9 26.2 10.7 13.2 36.8 3.6 4.8 1.3 6.9 5.7 8.4 1.2 0.1 0.0 0.7 3.5 0.1 0.4 1.2 0.2 0.3 0.1 0.2 0.5 0.0 0.1 3.6 0.3 0.1 0.4 16.0 20.5 13.8 20.6 16.6 3.6 8.8 8.4 17.0 11.1 3.0 5.5 0.5 2.9 5.8 4.7 7.5 7.6 9.4 4.5 7.0 0.0 1.2 0.0 8.0 0.2 2.2 3.2 0.0 8.9 16.2 4.6 8.6 1.1 29.6 2.6 0.0 1.7 4.9 2.1 1.0 4.0 2.9 6.8 1.0 8.1 87.5 15.6 3.5 3.2 6.2 5.1 0.0 4.2 0.2 2.2 4.1 1.3 2.5 3.2 5.1 FJX1 "FLJ22416, FLJ25593" ENSG00000179431 "Four jointed box 1" Q86VR8 11 35618419-35620868 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 15.5;Cytotrophoblasts: 18.7;Extravillous trophoblasts: 14.0;Ito cells: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-251 MG: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059220 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA059220: AB_2683950" "unprognostic (8.99e-2)" "unprognostic (1.90e-1)" "unprognostic (1.65e-3)" "unprognostic (5.20e-2)" "unprognostic (5.72e-2)" "unprognostic (9.56e-3)" "unprognostic (5.16e-2)" "unprognostic (1.06e-2)" "unprognostic (1.74e-1)" "unprognostic (4.39e-3)" "unprognostic (5.28e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (9.24e-9)" "unprognostic (1.64e-2)" "unprognostic (9.64e-2)" "unprognostic (8.35e-2)" "prognostic unfavorable (6.56e-4)" 6.0 3.5 7.8 3.5 10.3 0.7 3.6 6.6 25.4 8.8 1.4 7.9 0.0 1.1 10.1 3.4 3.1 6.1 4.5 2.4 8.0 4.9 3.8 4.9 2.2 2.3 5.7 5.7 12.2 17.0 1.7 1.8 6.6 7.7 4.1 1.1 2.7 2.6 4.7 1.1 10.3 1.1 3.4 5.1 7.8 1.7 1.2 3.3 1.7 2.2 3.0 3.4 3.7 2.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 9.8 4.9 5.2 1.6 1.8 5.8 1.6 11.1 7.5 10.6 7.7 6.2 3.1 0.0 2.5 4.3 22.0 10.5 1.8 18.3 9.1 0.1 14.5 0.9 1.9 0.2 4.4 1.1 0.0 2.1 14.0 5.5 16.9 1.7 4.8 0.5 5.2 0.0 10.2 2.3 0.3 0.0 7.2 0.0 14.7 0.6 11.7 2.2 8.1 12.2 5.0 2.8 1.2 0.9 3.1 4.0 21.1 0.2 9.4 8.5 15.7 1.6 26.1 0.0 0.0 0.0 15.2 0.4 12.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 10.3 6.6 12.3 8.0 4.9 5.7 5.7 7.7 3.3 0.0 0.0 0.0 9.3 15.5 0.4 1.0 0.0 4.0 3.4 0.0 11.8 18.7 1.7 7.9 0.0 5.6 0.0 0.0 0.2 14.0 4.5 1.5 0.0 0.0 3.1 0.0 0.0 16.0 0.6 0.0 0.6 1.5 0.0 0.0 0.0 10.3 1.1 0.0 0.7 6.7 0.3 0.0 5.3 0.4 1.1 8.3 10.0 0.0 0.0 2.6 FKBP1B "FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase" ENSG00000119782 "FK506 binding protein 1B" P68106 2 24049701-24063681 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 31.1;intestine: 24.9" "Cell type enhanced" "Detected in many" 4 "Pancreatic endocrine cells: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 21.9;NTERA-2: 21.3;SH-SY5Y: 15.5;SuSa: 23.9;TIME: 18.6" "Low region specificity" "Detected in all" "HPA045572, HPA051798" Uncertain Approved Vesicles NA NA Vesicles "HPA045572: AB_2732521, HPA051798: AB_2681615" "unprognostic (3.01e-3)" "unprognostic (3.35e-1)" "unprognostic (7.05e-2)" "unprognostic (9.89e-3)" "unprognostic (1.47e-2)" "unprognostic (2.10e-1)" "unprognostic (2.23e-2)" "unprognostic (9.19e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-1)" "unprognostic (9.55e-2)" "unprognostic (1.08e-1)" "unprognostic (1.12e-1)" "unprognostic (7.53e-2)" "unprognostic (3.43e-2)" "unprognostic (2.85e-2)" "unprognostic (1.45e-1)" 2.9 5.9 25.0 2.8 30.7 1.9 5.9 15.7 23.1 5.1 7.2 1.6 7.4 24.9 3.6 4.2 4.5 4.5 7.1 3.4 31.1 14.0 4.4 4.6 9.0 2.2 13.0 19.7 4.6 4.9 6.4 2.8 5.6 7.9 5.1 4.6 2.4 3.3 9.2 1.1 3.6 6.7 4.0 5.2 1.8 13.3 1.6 4.4 0.6 5.0 1.1 3.2 7.1 3.5 1.5 2.2 4.4 0.8 0.3 5.4 1.1 0.1 0.9 8.5 0.0 5.4 2.1 3.0 2.8 2.9 1.2 1.8 0.5 1.0 0.0 2.1 5.0 7.7 3.3 12.5 9.8 0.8 1.4 8.0 2.9 0.1 21.9 2.0 0.0 7.0 2.0 2.3 2.9 0.6 7.3 7.9 3.3 0.7 0.0 2.8 0.0 0.9 0.0 21.3 0.7 1.5 1.5 0.7 0.0 0.9 0.5 2.1 15.5 0.1 0.0 2.7 23.9 0.5 1.0 18.6 0.0 2.6 0.1 0.6 0.5 0.2 0.0 3.1 0.0 0.6 1.3 0.8 4.4 0.3 0.7 0.0 0.3 0.6 0.5 2.2 1.5 0.0 0.2 0.1 0.3 0.0 0.4 5.4 1.1 25.0 30.7 15.7 23.1 31.1 14.0 13.0 19.7 7.9 4.4 0.0 5.0 0.0 11.5 8.1 1.2 0.4 28.1 1.4 0.0 7.0 0.0 4.5 11.6 24.5 0.4 9.3 9.3 0.0 33.8 22.1 7.8 15.8 1.1 9.8 6.2 1.6 9.1 11.1 3.4 1.8 2.6 9.4 27.0 19.8 7.9 12.1 37.4 28.1 3.9 4.1 2.5 25.8 11.2 1.4 3.0 6.5 4.3 0.0 3.4 14.5 FO393400.1 ENSG00000285382 20 32632183-32743567 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in single" 31 "HEL: 13.2" HPA054119 Approved Vesicles NA NA Vesicles "HPA054119: AB_2682388" 3.3 2.9 2.8 2.4 3.0 3.1 3.3 3.8 5.1 2.2 2.2 2.6 4.2 1.9 3.3 4.4 2.4 3.6 2.5 4.4 2.2 3.7 4.6 3.2 2.1 1.4 4.2 3.5 4.3 2.6 1.6 5.4 2.3 3.0 2.0 3.2 3.5 3.1 3.1 3.9 2.6 4.0 0.8 2.5 3.0 3.3 2.0 1.3 6.5 2.0 2.9 3.9 1.7 1.0 0.8 1.6 0.3 0.6 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.6 0.3 0.8 0.4 0.2 0.3 0.4 0.3 0.3 0.1 1.0 0.3 0.6 0.5 0.6 0.2 0.8 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FPGT GFPP ENSG00000254685 "Fucose-1-phosphate guanylyltransferase" O14772 1 74198212-74234086 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072331 Uncertain Vesicles NA NA Vesicles "HPA072331: " "unprognostic (1.53e-1)" "unprognostic (1.94e-1)" "unprognostic (8.18e-3)" "unprognostic (4.32e-2)" "unprognostic (5.14e-2)" "unprognostic (2.46e-1)" "prognostic unfavorable (2.30e-4)" "unprognostic (1.86e-1)" "unprognostic (5.14e-2)" "unprognostic (2.58e-1)" "unprognostic (7.59e-2)" "unprognostic (1.33e-1)" "unprognostic (3.59e-3)" "unprognostic (1.44e-1)" "unprognostic (7.88e-2)" "unprognostic (3.53e-2)" "unprognostic (1.91e-1)" 14.6 11.6 10.9 9.1 12.6 3.4 13.0 19.0 15.8 15.9 11.7 13.0 7.5 11.5 17.7 11.1 15.7 15.4 13.3 12.8 10.9 7.1 15.9 13.7 10.8 8.0 15.5 10.6 14.1 10.2 14.2 27.7 10.6 14.4 11.1 11.3 10.6 11.7 9.1 15.7 12.0 12.0 11.8 16.3 11.0 12.3 8.7 13.9 6.6 20.0 6.8 9.2 17.9 12.9 4.3 9.2 15.2 14.9 3.8 5.4 7.4 9.3 7.7 5.8 8.5 13.5 12.7 8.7 12.2 8.2 8.5 10.0 4.3 7.0 5.7 15.1 7.2 9.6 7.8 10.4 11.2 13.5 11.5 4.4 12.9 9.4 7.3 11.3 9.8 10.0 10.4 14.5 8.4 4.0 5.8 8.7 8.0 13.3 6.9 13.2 2.5 5.4 2.0 6.3 12.0 7.0 5.8 13.7 8.0 7.4 6.8 6.1 6.1 9.0 13.3 14.0 1.9 16.0 11.2 7.8 3.7 7.1 20.2 9.2 7.5 5.4 7.6 15.0 9.7 12.5 12.0 14.9 15.2 4.3 14.5 5.0 3.6 4.4 3.9 9.2 4.3 4.9 4.4 4.4 3.8 12.5 0.9 5.4 7.4 10.9 12.6 19.0 15.8 10.9 7.1 15.5 10.6 14.4 13.9 6.0 2.7 0.5 3.7 6.1 7.0 8.7 10.2 9.4 2.3 10.4 2.0 11.0 16.6 5.0 6.1 5.2 9.3 0.0 6.3 9.1 5.8 2.7 4.7 7.9 13.3 3.2 5.8 6.7 9.8 5.7 9.5 10.6 5.0 3.6 7.6 8.4 5.6 7.0 5.3 12.4 4.5 25.8 5.2 8.1 10.6 5.6 5.1 1.8 7.2 1.7 FPGT-TNNI3K ENSG00000259030 "FPGT-TNNI3K readthrough" 1 74198235-74543982 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 28.0" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 7.9;Cone photoreceptor cells: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 5.0;CAPAN-2: 4.6;SiHa: 6.5" HPA072331 Approved Vesicles NA NA Vesicles "HPA072331: " "unprognostic (6.29e-2)" "unprognostic (4.96e-2)" "unprognostic (1.99e-1)" "unprognostic (1.46e-1)" "unprognostic (1.24e-1)" "unprognostic (3.44e-3)" "unprognostic (8.37e-2)" "unprognostic (1.70e-2)" "unprognostic (6.63e-2)" "unprognostic (6.85e-2)" "unprognostic (1.04e-1)" "unprognostic (8.37e-2)" "unprognostic (6.76e-3)" "unprognostic (3.20e-2)" "unprognostic (2.75e-1)" "unprognostic (1.11e-2)" "unprognostic (7.87e-3)" 8.5 5.5 5.4 3.1 6.3 2.7 6.1 16.1 8.2 6.4 6.3 6.6 3.4 2.5 9.3 4.2 6.0 5.7 4.2 28.0 5.4 4.9 6.3 3.7 6.1 3.5 8.0 5.2 5.6 3.1 4.7 15.0 3.8 7.4 5.5 3.7 5.2 5.4 6.0 11.2 8.0 5.1 6.3 8.5 5.9 4.9 4.1 7.1 2.9 5.1 3.0 3.5 5.5 4.9 2.4 2.4 4.9 4.7 0.8 4.9 3.5 0.0 1.1 0.7 1.5 0.8 5.0 0.1 2.1 1.0 0.2 0.4 1.1 4.6 0.1 3.3 0.2 0.0 0.0 0.3 3.1 0.4 0.1 0.2 1.7 0.1 0.1 0.8 0.4 0.3 2.1 2.1 0.2 0.2 0.6 0.2 0.2 0.0 1.7 1.0 0.0 0.1 0.2 0.1 1.7 0.9 2.3 3.9 0.0 0.4 0.0 1.1 3.4 6.5 0.3 0.3 0.0 0.0 2.3 0.1 0.7 0.2 0.2 0.8 0.2 0.1 1.7 1.0 1.0 1.1 3.6 4.1 3.5 1.1 4.7 3.5 2.1 3.9 2.2 2.4 2.4 4.9 2.5 4.9 0.8 1.2 2.1 3.8 3.5 5.4 6.3 16.1 8.2 5.4 4.9 8.0 5.2 7.4 7.1 3.0 0.6 0.0 0.4 0.1 4.9 7.9 2.5 1.4 1.2 0.0 9.8 0.1 0.0 0.1 0.9 0.5 0.0 0.0 0.9 0.1 0.5 0.3 2.3 0.4 0.2 4.8 2.9 2.5 1.9 0.2 2.6 0.1 1.7 0.0 0.0 1.2 0.9 1.4 0.7 0.5 2.7 0.0 0.5 1.8 1.4 0.1 0.0 0.0 0.2 0.2 FST FS ENSG00000134363 Follistatin P19883 5 53480409-53487134 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.7" "Cell type enhanced" "Detected in many" 16 "Fibroblasts: 85.9;Hepatocytes: 22.9;Urothelial cells: 26.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "memory CD4 T-cell: 1.0;naive CD4 T-cell: 2.0;non-classical monocyte: 1.0" "Group enriched" "Detected in many" 5 "monocytes: 1.0;T-cells: 2.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 59.4;HaCaT: 50.3;HBEC3-KT: 32.1;HMC-1: 36.1;PC-3: 97.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA016612, CAB026025" Approved Approved Vesicles "Secreted to blood" NA NA 1800000 Vesicles "CAB026025: , HPA016612: " "unprognostic (1.43e-1)" "unprognostic (6.50e-2)" "unprognostic (1.44e-1)" "unprognostic (7.73e-3)" "unprognostic (2.30e-1)" "unprognostic (1.50e-3)" "unprognostic (8.02e-2)" "unprognostic (2.32e-2)" "unprognostic (3.06e-1)" "unprognostic (1.57e-1)" "unprognostic (1.93e-1)" "unprognostic (1.94e-1)" "prognostic unfavorable (4.44e-5)" "unprognostic (1.21e-3)" "unprognostic (2.48e-1)" "unprognostic (2.07e-2)" "unprognostic (2.18e-1)" 12.4 3.2 2.0 3.1 0.8 0.1 7.1 0.2 0.7 3.5 5.2 0.3 1.1 0.9 2.3 9.5 3.6 4.9 4.1 5.6 1.0 1.0 1.7 42.7 4.3 0.8 0.4 0.6 20.7 19.4 0.0 2.9 13.5 1.0 9.3 1.7 5.7 5.5 6.5 12.6 9.0 4.3 3.7 0.4 0.2 4.8 4.9 0.5 1.2 2.0 6.7 7.1 6.2 13.8 0.1 0.2 0.0 1.0 0.0 2.0 0.1 3.3 0.3 5.9 0.0 6.7 2.3 9.8 13.0 59.4 8.0 7.8 0.0 0.0 0.0 0.1 3.4 0.4 50.3 0.0 32.1 5.7 0.1 0.0 0.6 0.2 5.3 3.6 0.0 36.1 5.5 0.0 14.7 9.6 5.5 6.8 0.0 0.0 0.1 5.0 0.0 0.0 0.2 9.0 0.0 97.2 0.6 7.5 0.0 0.0 5.5 0.0 0.0 0.5 0.0 0.3 15.8 0.0 0.0 0.0 22.0 6.3 2.2 1.9 0.0 0.0 0.0 2.5 0.7 20.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.2 0.1 2.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 2.0 0.8 0.2 0.7 1.0 1.0 0.4 0.6 1.0 0.5 0.0 1.4 0.0 12.8 17.7 0.0 7.3 0.0 0.0 12.5 0.0 0.0 0.6 0.0 0.6 0.3 1.6 0.0 0.0 3.8 7.6 85.9 5.3 0.0 22.9 1.6 0.0 0.0 1.3 0.3 0.9 2.8 0.4 5.0 0.0 0.0 0.0 10.0 0.0 10.6 0.0 0.0 12.9 12.5 0.3 0.7 4.1 5.0 0.0 0.0 26.0 FTCDNL1 FONG ENSG00000226124 "Formiminotransferase cyclodeaminase N-terminal like" E5RQL4 2 199760544-199851173 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Proximal tubular cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA065748 Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA065748: " "unprognostic (1.78e-1)" "unprognostic (1.70e-1)" "unprognostic (1.27e-2)" "unprognostic (9.80e-2)" "unprognostic (3.09e-1)" "unprognostic (7.21e-2)" "unprognostic (1.54e-3)" "unprognostic (1.59e-1)" "unprognostic (1.03e-1)" "unprognostic (4.82e-2)" "unprognostic (5.37e-2)" "unprognostic (9.86e-2)" "prognostic favorable (3.31e-4)" "unprognostic (3.92e-2)" "unprognostic (4.63e-2)" "prognostic unfavorable (5.74e-4)" "unprognostic (1.21e-2)" 4.5 9.4 5.5 1.8 19.0 4.0 4.2 1.6 12.0 1.7 2.3 9.7 2.6 2.1 1.2 3.9 2.9 3.9 2.0 5.3 5.8 4.8 8.0 17.9 2.8 3.5 7.6 7.5 2.4 4.3 1.9 2.0 1.5 7.9 2.8 2.5 2.7 4.8 1.7 13.1 2.4 1.8 3.4 9.1 8.0 2.1 2.8 4.0 0.1 11.0 2.4 1.8 1.6 1.9 3.8 10.6 2.0 6.2 1.2 2.4 1.9 0.7 2.4 0.1 0.1 2.5 1.5 1.8 0.9 0.9 1.2 0.5 0.0 4.3 2.4 0.3 1.0 7.2 0.0 1.1 6.4 1.5 2.9 0.8 1.8 1.0 2.0 0.9 6.4 8.1 1.1 0.2 0.5 0.1 0.9 0.0 6.1 3.4 0.1 0.9 7.4 2.4 2.6 2.0 0.6 5.1 0.4 0.2 0.1 0.5 0.0 2.9 0.0 4.2 3.9 4.0 1.8 6.0 8.5 0.7 3.5 0.0 2.2 1.5 6.5 3.5 1.4 6.5 3.3 1.7 0.0 5.3 2.0 0.6 6.2 2.3 3.8 2.2 0.8 6.9 2.1 1.5 2.4 0.0 1.2 5.6 10.6 0.0 1.9 5.5 19.0 1.6 12.0 5.8 4.8 7.6 7.5 7.9 4.0 0.0 0.0 0.5 2.3 2.4 3.3 4.5 5.1 0.0 2.3 3.5 3.9 1.1 1.7 0.2 1.6 1.1 0.0 0.0 0.6 1.2 1.4 1.8 0.0 5.8 7.0 1.6 0.0 2.5 6.2 0.8 0.3 4.3 6.8 1.0 0.6 0.9 0.5 0.0 0.4 8.7 5.4 0.0 3.6 0.5 0.7 1.9 0.2 0.0 0.9 0.7 FUK FLJ39408 ENSG00000157353 Fucokinase Q8N0W3 16 70454421-70480274 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041971 Approved Approved Vesicles NA NA Vesicles "HPA041971: AB_10795648" "unprognostic (4.55e-1)" "unprognostic (3.21e-1)" "unprognostic (1.73e-2)" "unprognostic (3.95e-2)" "unprognostic (3.79e-2)" "unprognostic (2.64e-2)" "unprognostic (8.79e-3)" "unprognostic (1.26e-1)" "unprognostic (1.49e-1)" "unprognostic (1.57e-1)" "unprognostic (4.82e-3)" "unprognostic (4.85e-2)" "prognostic favorable (8.91e-4)" "unprognostic (2.49e-2)" "unprognostic (9.68e-2)" "unprognostic (8.89e-2)" "prognostic favorable (8.38e-4)" 6.7 11.3 11.5 9.8 13.2 8.5 7.3 13.9 13.5 7.5 12.1 15.5 15.1 18.5 8.3 11.5 8.2 10.8 9.4 7.2 9.4 7.4 13.1 11.9 8.1 9.1 12.5 12.4 10.5 12.2 17.1 16.4 11.0 9.8 9.1 7.7 12.9 10.8 9.4 9.0 13.0 13.1 6.3 9.3 9.7 12.2 6.1 12.5 7.2 12.0 4.2 11.1 7.6 6.8 4.3 3.2 3.9 4.4 2.9 6.7 2.5 3.1 4.4 2.6 5.7 1.5 1.8 9.9 1.8 2.9 2.4 3.1 3.9 10.3 2.2 8.8 1.7 0.7 4.5 1.8 4.5 1.5 4.2 6.3 2.9 8.0 4.5 3.8 3.7 2.2 3.0 5.3 1.8 4.5 3.6 4.5 4.3 5.4 2.7 1.8 9.8 4.4 8.5 1.6 5.1 2.5 6.5 0.6 9.7 6.1 5.5 4.2 5.1 10.2 3.5 5.2 2.1 15.0 7.2 4.7 1.9 2.5 4.1 2.1 9.6 4.5 4.5 3.4 3.5 4.2 0.6 4.4 1.8 4.8 2.5 4.1 1.9 4.8 4.8 2.7 4.3 6.7 3.1 3.9 2.9 2.8 3.2 3.2 2.5 11.5 13.2 13.9 13.5 9.4 7.4 12.5 12.4 9.8 12.5 3.0 8.1 1.5 1.7 1.0 5.0 4.5 2.5 0.0 3.4 15.7 3.9 4.7 1.7 4.5 0.8 3.6 15.4 0.0 6.3 2.2 2.5 2.6 0.0 5.8 4.2 9.5 4.1 7.4 3.8 1.1 2.8 2.1 1.7 3.6 10.7 4.5 4.5 11.5 6.0 5.5 7.3 0.0 1.7 4.2 2.0 2.4 4.3 2.9 13.6 1.3 FUT4 "CD15, ELFT, FCT3A, FUC-TIV" ENSG00000196371 "Fucosyltransferase 4" P22083 11 94543840-94549898 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "bone marrow: 71.3" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 20.4;Mucus-secreting cells: 20.8;Pancreatic endocrine cells: 18.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HL-60: 20.8;NB-4: 13.5;THP-1: 26.3;U-937: 18.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "CAB000014, CAB016129" Enhanced Approved Vesicles NA NA Vesicles "CAB000014: , CAB016129: AB_626918" "unprognostic (6.36e-2)" "unprognostic (7.53e-2)" "unprognostic (4.70e-3)" "unprognostic (2.46e-3)" "unprognostic (1.46e-2)" "unprognostic (2.29e-2)" "unprognostic (1.66e-2)" "prognostic unfavorable (3.64e-4)" "unprognostic (7.26e-2)" "unprognostic (4.14e-1)" "unprognostic (4.81e-3)" "unprognostic (1.27e-1)" "unprognostic (9.08e-3)" "unprognostic (8.17e-2)" "unprognostic (1.37e-1)" "unprognostic (4.04e-1)" "unprognostic (3.10e-3)" 5.5 2.4 5.5 6.1 6.2 71.3 6.3 3.0 6.0 4.4 8.3 6.7 4.7 10.9 5.9 2.5 3.0 4.6 7.5 3.7 6.2 2.2 4.1 3.0 6.0 5.4 8.1 2.5 4.9 11.4 1.4 2.9 3.4 4.8 3.4 8.3 3.8 6.3 2.9 1.7 1.9 10.1 5.8 5.7 6.5 9.7 2.9 4.5 10.4 2.9 1.9 3.1 4.4 3.0 0.7 1.9 2.5 3.9 0.8 1.9 0.8 1.6 0.8 1.0 0.0 3.2 2.9 5.3 1.5 0.7 1.3 1.5 7.1 2.3 0.0 3.6 2.5 0.7 0.8 1.7 0.1 1.3 10.7 1.7 5.3 1.2 0.1 1.6 20.8 4.7 2.5 0.0 1.7 0.0 0.3 2.1 4.8 5.3 0.0 1.6 0.8 4.3 13.5 2.0 6.5 2.0 3.9 0.0 0.0 1.4 1.1 1.4 0.5 0.9 2.1 0.8 3.1 1.2 26.3 1.9 1.1 2.9 0.0 0.5 0.6 0.3 0.0 0.9 18.7 0.6 2.0 3.1 2.5 1.1 1.5 0.7 0.6 1.0 1.3 1.8 0.7 1.1 0.7 1.7 0.8 3.9 1.9 1.9 0.8 5.5 6.2 3.0 6.0 6.2 2.2 8.1 2.5 4.8 4.5 0.0 0.0 0.0 2.3 1.4 0.6 0.8 20.4 2.7 2.3 1.8 3.9 12.9 0.0 12.8 0.2 1.3 12.1 0.0 15.5 2.0 4.6 1.6 0.0 0.8 7.7 0.0 9.8 2.5 10.6 0.2 4.0 3.3 3.3 10.0 20.8 0.5 18.4 3.5 1.1 1.9 8.8 0.0 1.4 0.9 3.2 0.5 1.8 2.5 14.4 1.2 FYCO1 "FLJ13335, ZFYVE7" ENSG00000163820 "FYVE and coiled-coil domain containing 1" Q9BQS8 3 45917899-45995824 "Disease related genes, Predicted intracellular proteins" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 105.8" "Cell type enhanced" "Detected in many" 8 "Cardiomyocytes: 78.1;Rod photoreceptor cells: 38.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035526, HPA057966" Uncertain Enhanced Vesicles NA NA Vesicles "HPA035526: AB_10672867, HPA057966: AB_2683567" "unprognostic (2.45e-1)" "unprognostic (6.62e-2)" "unprognostic (6.97e-3)" "unprognostic (1.14e-3)" "unprognostic (7.65e-2)" "unprognostic (1.23e-2)" "unprognostic (1.57e-2)" "unprognostic (4.53e-3)" "unprognostic (5.85e-2)" "unprognostic (8.85e-2)" "unprognostic (2.36e-1)" "unprognostic (2.98e-1)" "prognostic favorable (3.33e-11)" "unprognostic (2.90e-1)" "unprognostic (1.42e-1)" "unprognostic (2.89e-2)" "unprognostic (6.99e-2)" 11.6 7.8 4.1 11.4 4.7 3.1 11.6 1.4 3.5 13.5 20.2 7.3 11.4 4.2 19.8 11.1 12.6 7.9 22.0 29.1 4.2 2.7 5.7 6.2 7.9 5.0 4.7 3.5 14.8 15.9 11.4 4.9 4.3 6.1 14.5 5.6 16.2 9.5 11.6 105.8 9.9 7.7 39.9 6.4 6.4 11.6 5.0 5.3 8.5 10.4 25.5 9.5 23.3 27.0 0.6 2.8 1.1 1.1 3.0 6.0 1.3 6.4 6.3 1.8 8.1 17.9 14.1 3.1 6.2 14.7 8.4 9.3 3.4 5.7 4.8 3.6 8.8 8.0 4.9 5.3 10.5 9.9 2.0 5.6 6.8 5.2 3.8 12.2 5.2 5.0 15.6 10.5 13.2 13.1 12.8 16.5 8.3 4.4 7.0 5.9 4.0 5.3 3.2 2.8 5.3 6.0 1.8 5.2 2.6 10.0 22.8 1.4 2.1 3.9 12.4 10.9 2.9 6.0 3.5 12.7 3.1 3.7 10.7 3.4 4.0 2.5 1.6 10.9 6.7 5.9 1.1 1.0 0.6 4.4 1.1 6.0 0.6 2.6 4.6 0.4 0.6 1.1 1.8 0.9 3.0 0.7 2.8 2.6 1.3 4.1 4.7 1.4 3.5 4.2 2.7 4.7 3.5 6.1 5.3 26.8 10.7 3.0 4.1 3.7 10.8 78.1 7.6 14.7 11.4 15.7 33.4 3.6 3.3 6.9 0.0 7.5 6.3 0.0 7.1 2.0 6.1 11.8 2.3 9.5 3.6 0.0 9.2 12.3 5.9 0.4 11.8 3.2 10.1 0.0 7.9 16.2 9.8 0.0 16.6 4.4 38.5 6.5 9.8 2.6 0.7 3.6 2.4 6.9 5.7 5.2 FZD7 FzE3 ENSG00000155760 "Frizzled class receptor 7" O75084 2 202034587-202038445 "G-protein coupled receptors, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 17.3;Fibroblasts: 22.1;Smooth muscle cells: 12.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 15 "eosinophil: 1.5" "Lineage enriched" "Detected in single" 15 "granulocytes: 1.5" "Cell line enhanced" "Detected in many" "BJ hTERT+: 25.5;CAPAN-2: 31.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059979, HPA069165, HPA076183" Approved Supported Vesicles NA NA Vesicles "HPA059979: , HPA069165: AB_2686096, HPA076183: " "unprognostic (3.44e-2)" "unprognostic (6.89e-2)" "unprognostic (9.30e-3)" "unprognostic (2.44e-3)" "unprognostic (4.92e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (7.71e-5)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" "unprognostic (8.22e-2)" "unprognostic (2.73e-2)" "unprognostic (1.10e-1)" "unprognostic (1.87e-3)" "unprognostic (8.16e-3)" "unprognostic (1.43e-1)" "unprognostic (4.16e-2)" "unprognostic (2.05e-3)" 4.8 1.6 3.2 4.7 6.5 0.0 9.9 23.3 4.5 8.5 17.8 2.0 3.3 3.9 9.7 9.4 9.1 8.6 3.7 8.7 10.8 0.7 4.1 0.8 3.0 4.0 0.8 6.2 17.4 0.8 0.0 4.9 3.2 3.8 12.4 3.4 6.1 13.4 16.2 13.5 5.3 5.6 17.3 3.0 2.0 3.1 3.2 3.0 0.8 2.6 4.3 3.2 13.1 8.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 4.6 2.6 17.3 5.5 5.8 4.3 7.4 19.8 25.5 6.4 7.4 16.3 31.8 0.0 11.8 13.6 4.1 5.1 3.1 0.7 7.4 2.3 4.1 0.5 1.1 1.3 3.9 0.9 1.0 4.1 0.5 3.4 2.0 5.1 0.0 0.3 1.3 1.3 5.1 2.1 0.0 2.8 18.1 1.0 1.7 1.9 3.2 0.5 1.0 3.1 2.8 6.2 2.6 0.2 3.2 14.9 1.8 1.2 0.0 12.4 4.4 7.5 2.5 1.2 0.9 0.0 2.5 0.2 8.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 6.5 23.3 4.5 10.8 0.7 0.8 6.2 3.8 3.0 0.0 7.2 0.0 7.2 9.2 0.0 17.3 2.5 1.4 0.0 1.8 0.0 0.4 1.7 0.8 0.1 0.6 7.8 0.0 0.2 0.7 22.1 3.8 1.1 0.0 1.2 0.0 1.2 1.3 0.6 0.0 4.9 1.4 3.3 0.0 6.4 6.1 0.4 2.3 4.6 0.0 0.4 6.5 12.6 1.1 0.5 8.5 0.7 0.0 3.8 1.6 GAA ENSG00000171298 "Glucosidase alpha, acid" P10253 17 80101556-80119879 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, FDA approved drug targets, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Extravillous trophoblasts: 125.7;Syncytiotrophoblasts: 139.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 23.8;eosinophil: 8.4;intermediate monocyte: 20.0;myeloid DC: 15.6;neutrophil: 10.8;non-classical monocyte: 24.7" "Group enriched" "Detected in all" 9 "dendritic cells: 15.6;granulocytes: 10.8;monocytes: 24.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026970, HPA029126" Enhanced Approved Vesicles NA NA 3000000 Vesicles "HPA026970: AB_2672065, HPA029126: AB_2672918" "unprognostic (1.13e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (7.66e-4)" "unprognostic (2.94e-2)" "unprognostic (1.14e-2)" "unprognostic (7.96e-2)" "unprognostic (2.05e-2)" "unprognostic (1.19e-1)" "unprognostic (2.90e-1)" "unprognostic (1.43e-1)" "unprognostic (1.29e-2)" "unprognostic (2.76e-1)" "unprognostic (1.46e-1)" "unprognostic (7.02e-2)" "unprognostic (2.38e-1)" "unprognostic (1.78e-2)" "unprognostic (1.18e-1)" 27.5 19.6 13.8 17.0 14.8 11.3 18.6 14.3 23.0 14.9 16.5 23.4 21.7 19.4 20.1 50.9 13.9 18.2 23.5 21.4 13.5 17.6 27.9 44.2 34.0 30.2 18.1 16.1 14.6 29.4 28.8 24.7 84.1 14.9 22.3 7.2 21.9 27.5 22.1 26.3 18.3 15.4 17.2 16.6 35.8 17.4 30.7 14.6 13.9 21.9 14.9 13.5 24.0 13.4 1.4 15.6 10.8 24.7 1.1 1.8 9.8 11.4 22.4 4.4 14.5 13.9 14.0 28.9 7.2 13.3 5.5 4.5 6.6 18.7 4.1 19.2 5.6 4.7 4.9 1.4 8.3 1.3 5.3 16.7 0.0 3.8 23.7 24.2 0.5 13.7 30.1 12.0 10.3 3.6 11.2 9.7 11.2 4.1 17.3 4.1 26.5 1.9 2.7 9.2 2.8 15.7 10.0 15.2 7.0 4.4 12.0 5.1 14.7 9.4 10.5 12.9 2.8 30.0 16.4 6.2 20.4 11.0 14.7 2.6 41.4 11.5 1.2 6.5 10.7 12.8 0.1 23.8 8.4 1.5 20.0 1.8 1.3 1.2 1.6 15.6 1.4 1.4 0.9 10.8 1.1 24.7 3.8 0.8 9.8 13.8 14.8 14.3 23.0 13.5 17.6 18.1 16.1 14.9 14.6 17.9 45.3 3.9 14.4 10.0 15.6 14.3 30.6 5.3 17.0 14.0 7.9 106.8 5.0 23.0 42.5 17.4 18.6 0.0 13.8 125.7 30.3 19.9 8.1 23.1 92.2 11.1 5.8 29.4 107.0 25.5 22.2 64.5 23.6 31.5 14.3 28.7 9.4 17.5 18.0 18.2 16.5 6.5 10.3 18.4 26.8 7.3 139.0 7.7 15.5 10.8 GABARAP "ATG8A, MM46" ENSG00000170296 "GABA type A receptor-associated protein" O95166 17 7240014-7242770 "Predicted intracellular proteins, Transporters" "Apoptosis, Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Intestinal endocrine cells: 381.1;monocytes: 547.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065883 Approved Vesicles NA NA Vesicles "HPA065883: AB_2685574" "unprognostic (2.58e-1)" "unprognostic (4.55e-3)" "unprognostic (1.92e-1)" "unprognostic (9.08e-2)" "unprognostic (1.19e-1)" "unprognostic (4.30e-2)" "unprognostic (1.36e-1)" "unprognostic (2.57e-1)" "unprognostic (1.01e-1)" "unprognostic (1.58e-1)" "prognostic favorable (9.52e-5)" "unprognostic (1.85e-1)" "unprognostic (1.45e-2)" "unprognostic (2.09e-1)" "unprognostic (2.85e-2)" "unprognostic (1.22e-2)" "unprognostic (1.58e-1)" 104.5 120.3 103.9 69.9 94.9 90.9 108.6 54.9 127.8 105.0 89.0 125.1 77.0 63.3 84.0 136.8 103.0 94.1 86.2 94.1 91.8 97.8 113.0 191.6 99.8 87.9 112.1 68.9 139.6 109.2 82.0 118.8 112.4 85.7 108.8 86.6 98.2 126.9 96.9 152.5 85.6 114.5 80.8 119.8 116.5 83.7 142.8 61.4 109.4 148.8 100.7 90.7 98.9 88.7 54.9 138.6 314.7 174.9 30.4 47.9 162.9 25.1 39.7 67.6 46.0 109.6 126.8 26.7 41.3 79.8 41.4 62.0 16.4 22.7 26.5 26.4 77.4 49.3 22.9 49.2 38.4 54.9 46.3 53.6 20.2 36.0 41.4 104.1 12.8 41.7 125.0 54.1 49.4 45.2 107.4 75.0 39.3 15.7 29.3 70.4 18.1 30.5 29.6 26.9 47.0 37.6 42.4 31.6 35.2 79.7 26.9 30.3 80.0 32.2 29.7 42.3 53.4 38.2 25.4 63.1 42.6 24.2 41.0 34.3 31.4 30.4 16.5 67.9 33.4 43.6 107.9 174.9 157.5 35.9 155.4 37.2 54.9 42.8 37.6 138.6 50.7 38.9 36.5 314.7 30.4 130.2 105.9 47.9 162.9 103.9 94.9 54.9 127.8 91.8 97.8 112.1 68.9 85.7 61.4 83.4 111.1 36.6 3.4 18.4 2.4 0.3 43.3 279.7 127.4 26.2 0.0 20.6 36.5 370.8 18.5 15.3 263.7 0.0 269.7 25.6 28.6 6.9 143.5 38.2 69.9 1.6 381.1 46.1 163.5 56.9 19.5 71.9 32.1 547.4 268.5 7.7 357.3 340.1 13.1 66.3 2.5 6.5 18.4 18.5 5.3 20.3 44.3 34.6 223.3 2.3 GABARAPL1 "APG8L, ATG8B, ATG8L, gec1" ENSG00000139112 "GABA type A receptor associated protein like 1" Q9H0R8 12 10212458-10223130 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 9 "Distal tubular cells: 366.4;Syncytiotrophoblasts: 776.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 27.1" "Group enriched" "Detected in many" 6 "granulocytes: 27.1;NK-cells: 9.1;T-cells: 12.1" "Cell line enhanced" "Detected in many" "HHSteC: 44.0;SiHa: 40.4;SuSa: 113.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051386, HPA065883" Approved Approved Vesicles NA NA Vesicles "HPA051386: AB_2681463, HPA065883: AB_2685574" "unprognostic (9.58e-3)" "unprognostic (1.16e-1)" "unprognostic (4.23e-2)" "unprognostic (1.06e-1)" "unprognostic (8.46e-2)" "unprognostic (1.85e-3)" "prognostic favorable (2.36e-4)" "unprognostic (2.90e-1)" "unprognostic (6.38e-2)" "unprognostic (2.79e-2)" "unprognostic (9.25e-3)" "unprognostic (1.72e-1)" "prognostic favorable (8.19e-8)" "unprognostic (5.42e-2)" "unprognostic (2.57e-2)" "unprognostic (1.10e-1)" "unprognostic (1.77e-1)" 41.7 34.7 35.9 11.3 61.8 48.5 24.8 39.9 95.5 16.5 15.9 18.6 17.7 13.9 23.1 46.3 13.2 13.0 26.8 78.5 35.5 42.3 88.0 68.7 25.5 5.2 35.8 48.3 27.9 31.9 42.0 41.1 65.7 52.6 24.9 14.7 27.5 35.6 27.3 63.0 12.0 12.2 24.1 19.8 10.3 22.4 10.1 20.3 2.2 21.6 14.0 5.5 23.7 24.0 0.1 1.2 27.1 2.7 9.1 12.1 2.5 1.4 2.9 6.3 5.6 38.1 10.2 4.9 33.7 15.6 5.8 7.7 12.6 4.8 0.3 2.7 38.5 14.7 9.1 5.9 4.0 5.3 0.9 5.1 1.9 18.4 3.4 44.0 2.3 2.2 17.8 8.9 4.5 4.0 18.3 14.0 4.0 2.3 0.1 2.4 0.1 1.9 2.3 14.7 0.3 2.9 0.1 11.6 0.1 25.3 3.5 0.6 1.2 40.4 6.2 11.4 113.2 2.8 1.4 18.9 1.9 6.2 2.9 1.5 5.9 9.4 9.5 6.4 1.1 2.6 17.0 1.9 17.2 12.1 1.1 3.9 0.1 1.6 7.2 1.2 0.0 1.6 6.6 27.1 9.1 2.7 0.5 2.4 2.5 35.9 61.8 39.9 74.7 35.5 42.3 35.8 48.3 52.6 20.3 56.6 39.0 18.2 194.1 55.8 119.9 178.4 53.5 9.4 21.6 55.8 145.3 239.1 366.4 47.0 234.0 94.1 36.0 23.3 50.1 25.6 92.0 152.5 16.3 86.4 67.4 84.2 68.1 43.0 59.4 49.7 23.9 59.4 70.9 27.9 31.8 94.0 50.5 28.1 23.0 147.8 196.5 19.4 42.1 7.5 6.3 36.9 776.9 64.8 8.0 135.8 GALNT9 GALNAC-T9 ENSG00000182870 "Polypeptide N-acetylgalactosaminyltransferase 9" Q9HCQ5 12 132196372-132329349 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 52.4" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 7.3;Collecting duct cells: 26.2;Proximal tubular cells: 5.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "memory B-cell: 2.6;naive B-cell: 1.5" "Lineage enriched" "Detected in single" 9 "B-cells: 2.6" "Cell line enriched" "Detected in some" 4 "U-87 MG: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075016 Approved Vesicles NA NA Vesicles "HPA075016: AB_2686729" "unprognostic (1.13e-1)" "unprognostic (3.47e-2)" "unprognostic (1.47e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (6.53e-2)" "unprognostic (2.65e-1)" "unprognostic (1.32e-2)" "unprognostic (2.03e-1)" "unprognostic (1.64e-3)" "unprognostic (2.85e-1)" "unprognostic (6.62e-2)" "unprognostic (5.17e-2)" "unprognostic (1.89e-1)" "unprognostic (1.71e-1)" "unprognostic (3.89e-2)" "unprognostic (5.69e-2)" 2.6 2.2 9.3 1.0 6.7 0.6 0.5 52.4 27.9 1.1 0.8 0.8 0.0 1.1 1.8 7.7 0.5 1.9 0.7 0.6 12.9 6.8 3.2 0.5 0.9 1.3 4.3 10.8 1.3 0.4 1.9 2.7 0.5 6.9 1.0 0.6 0.3 1.2 1.7 0.5 0.9 1.0 0.6 1.7 1.2 0.7 0.9 1.1 0.0 6.1 0.0 0.4 0.7 0.1 2.6 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.6 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.7 0.0 6.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 26.6 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 2.6 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 9.3 6.7 52.4 20.2 12.9 6.8 4.3 10.8 6.9 1.1 0.0 1.1 0.0 0.4 0.0 7.3 0.8 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.4 1.1 0.0 0.2 3.2 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.1 0.0 1.8 5.0 2.1 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.8 GCM1 "GCMA, hGCMa" ENSG00000137270 "Glial cells missing homolog 1" Q9NP62 6 53126964-53148829 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "placenta: 102.4" "Group enriched" "Detected in some" 7 "Extravillous trophoblasts: 166.4;Syncytiotrophoblasts: 222.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.5" "Group enriched" "Detected in many" 8 "B-cells: 1.8;granulocytes: 4.5" "Cell line enriched" "Detected in some" 5 "BEWO: 30.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA011343, HPA073469" Enhanced Approved Vesicles NA NA Vesicles "HPA011343: AB_2668489, HPA073469: " "unprognostic (2.81e-2)" "unprognostic (4.09e-2)" "unprognostic (1.89e-2)" "unprognostic (1.53e-1)" "unprognostic (3.17e-1)" "unprognostic (7.68e-2)" "unprognostic (8.47e-3)" "unprognostic (2.83e-2)" "unprognostic (2.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.42e-1)" "unprognostic (5.98e-2)" "unprognostic (1.29e-4)" "unprognostic (1.86e-1)" "unprognostic (7.42e-2)" "unprognostic (2.96e-2)" 0.3 0.3 0.1 0.1 0.1 0.3 0.5 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.0 1.5 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.0 0.2 102.4 0.1 0.2 0.0 0.1 0.1 0.1 3.1 0.0 0.4 0.1 0.1 2.2 0.0 2.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.8 0.2 4.5 0.3 0.4 0.3 0.1 0.1 0.1 0.1 0.2 0.0 0.0 30.1 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.2 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.2 0.0 0.1 0.0 6.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.2 0.1 0.0 0.1 0.1 0.6 0.3 2.2 0.2 0.1 0.2 0.7 0.1 0.1 0.2 1.8 0.2 0.2 4.5 0.4 0.3 0.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.3 1.9 0.0 0.0 0.0 0.2 166.4 0.0 0.1 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.7 0.0 0.0 0.2 0.0 0.0 0.0 222.5 0.0 0.0 0.0 GCSH ENSG00000140905 "Glycine cleavage system protein H" P23434 16 81081938-81096425 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 55.9" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 501.6;Extravillous trophoblasts: 1237.6;Proximal tubular cells: 489.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041368, HPA057079" Supported Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA041368: AB_10804001, HPA057079: " "unprognostic (4.09e-2)" "unprognostic (2.98e-2)" "unprognostic (2.29e-1)" "unprognostic (2.47e-3)" "unprognostic (2.55e-3)" "unprognostic (4.87e-2)" "unprognostic (1.38e-1)" "unprognostic (1.67e-1)" "unprognostic (2.75e-1)" "unprognostic (1.96e-2)" "unprognostic (6.92e-2)" "unprognostic (2.80e-2)" "prognostic favorable (6.26e-6)" "unprognostic (1.12e-2)" "unprognostic (2.59e-1)" "unprognostic (6.31e-2)" "unprognostic (6.47e-2)" 10.9 10.0 28.9 3.7 26.8 3.0 11.4 8.1 21.8 9.9 6.4 15.0 14.2 3.8 9.4 35.9 6.0 10.4 6.3 11.7 23.5 20.6 37.3 55.9 4.0 5.8 30.8 15.8 8.9 10.2 19.4 7.2 12.9 18.7 9.9 7.0 10.4 9.4 9.3 18.1 4.3 3.1 6.9 27.6 2.6 5.2 3.5 17.9 6.7 48.7 5.9 4.8 6.6 4.9 4.4 12.2 2.8 2.6 7.9 7.3 2.9 18.1 8.0 25.3 11.0 12.4 9.6 51.7 10.6 7.9 12.9 6.3 10.7 17.0 4.8 9.6 4.6 9.8 9.3 19.3 10.7 21.6 1.3 25.2 6.2 10.7 33.0 14.1 20.0 7.2 9.8 14.4 8.0 16.5 4.0 6.5 13.5 24.0 1.0 12.8 19.2 13.0 40.6 33.4 14.6 16.8 20.4 13.3 7.2 29.2 16.7 13.1 13.6 15.2 9.9 20.0 20.4 14.5 9.6 5.7 8.4 14.7 13.3 10.9 4.1 8.7 29.0 5.6 12.0 6.7 2.8 1.7 1.7 3.4 2.6 5.7 4.4 3.3 4.9 4.5 3.3 5.8 7.3 2.2 7.9 2.0 12.2 2.6 2.9 28.9 26.8 8.1 21.8 23.5 20.6 30.8 15.8 18.7 17.9 3.0 5.1 31.8 74.7 25.8 44.4 11.8 33.1 20.1 13.6 76.8 35.3 501.6 250.4 57.2 25.7 29.8 9.8 0.0 37.0 1237.6 66.3 92.3 36.8 317.5 102.2 36.5 25.3 31.3 17.6 15.2 130.3 25.7 81.0 24.4 29.9 130.3 38.6 14.0 132.6 489.6 42.3 32.3 58.7 20.0 68.6 23.7 191.3 21.0 48.6 56.2 GDE1 MIR16 ENSG00000006007 "Glycerophosphodiester phosphodiesterase 1" Q9NZC3 16 19501689-19522145 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 226.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077420 Approved Vesicles NA NA Vesicles "HPA077420: " "unprognostic (1.69e-1)" "unprognostic (5.13e-2)" "prognostic favorable (3.12e-4)" "unprognostic (1.47e-1)" "unprognostic (1.83e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (7.52e-5)" "unprognostic (2.10e-2)" "unprognostic (1.40e-2)" "unprognostic (4.31e-2)" "unprognostic (2.60e-3)" "unprognostic (9.92e-2)" "prognostic favorable (3.12e-5)" "unprognostic (8.36e-2)" "unprognostic (9.69e-3)" "unprognostic (1.88e-1)" "unprognostic (3.36e-2)" 20.3 18.5 30.6 11.7 34.3 17.5 23.9 13.5 32.2 18.1 31.0 24.5 23.0 22.7 15.0 22.6 19.0 13.4 17.5 40.7 31.1 17.5 21.1 21.3 22.1 13.1 29.2 20.6 9.9 28.3 35.3 13.9 15.5 20.8 21.4 32.5 12.5 20.4 24.9 42.4 18.5 20.8 27.2 25.3 10.1 22.8 14.8 23.8 9.6 17.9 21.7 12.7 22.8 12.4 4.6 7.4 23.9 12.4 3.7 7.4 4.6 14.8 17.9 9.8 11.7 47.6 17.6 14.2 15.4 26.4 12.0 14.9 10.2 26.6 11.1 19.8 22.3 13.2 12.9 13.7 18.1 14.6 12.1 21.2 9.3 17.6 21.9 28.9 12.2 8.7 18.5 29.4 12.8 15.0 22.3 16.1 14.5 5.1 11.6 13.0 26.8 10.7 11.3 11.5 23.3 13.9 15.4 18.1 16.1 29.7 22.8 11.5 10.5 14.9 17.9 14.2 15.9 18.3 14.7 16.9 10.2 9.1 13.4 9.4 10.9 10.2 7.8 15.6 18.2 9.0 23.9 11.8 6.4 5.7 10.5 7.3 4.6 6.8 6.6 7.4 3.7 3.6 5.7 19.8 3.7 12.4 4.6 7.4 4.6 30.6 34.3 13.5 32.2 31.1 17.5 29.2 20.6 20.8 23.8 35.7 72.1 27.9 29.4 20.8 14.8 63.5 35.7 26.8 26.1 8.7 25.5 63.8 19.9 79.5 27.6 16.8 94.2 23.3 143.1 66.0 28.2 77.4 3.5 20.0 53.4 30.2 32.1 17.8 30.7 51.5 26.4 32.5 23.6 22.6 50.6 19.8 66.9 87.7 35.7 39.2 21.5 12.9 25.5 71.0 39.2 25.7 226.1 21.8 61.0 49.4 GDF10 BMP-3b ENSG00000266524 "Growth differentiation factor 10" P55107 10 47300386-47313547 "Plasma proteins, Predicted secreted proteins" Osteogenesis "Cytokine, Growth factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.8;tongue: 14.8" "Group enriched" "Detected in some" 5 "Bipolar cells: 17.8;Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 34.3" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5" "Lineage enriched" "Detected in single" 16 "T-cells: 1.5" "Cell line enhanced" "Detected in some" "AF22: 17.7;MOLT-4: 3.8;SH-SY5Y: 7.2" "Region enriched" "Detected in many" 8 "cerebellum: 47.7" "Low region specificity" "Detected in all" HPA015498 Uncertain Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA015498: AB_1849584" "unprognostic (4.34e-2)" "unprognostic (3.10e-1)" "unprognostic (1.41e-1)" "unprognostic (5.09e-1)" "unprognostic (3.17e-1)" "unprognostic (9.84e-3)" "unprognostic (1.37e-2)" "unprognostic (2.26e-2)" "unprognostic (1.55e-1)" "unprognostic (4.08e-2)" "unprognostic (1.15e-1)" "unprognostic (2.54e-1)" "unprognostic (1.72e-7)" "unprognostic (3.49e-2)" "unprognostic (1.48e-1)" "unprognostic (2.59e-3)" "unprognostic (2.63e-1)" 6.8 4.4 1.4 0.3 2.8 0.0 10.8 7.6 5.2 1.9 0.4 1.7 0.0 0.0 2.3 2.4 5.4 0.5 2.9 2.1 3.0 0.0 0.0 15.8 0.9 0.0 5.0 0.1 11.6 0.2 0.0 0.0 0.9 2.8 0.3 6.8 3.0 0.3 2.5 0.3 0.1 0.6 0.8 0.1 0.1 10.5 0.8 0.0 3.7 14.8 2.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 17.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.3 17.8 0.6 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.0 4.7 0.0 1.1 0.0 0.1 1.6 0.0 0.0 0.0 0.2 0.9 0.0 1.7 0.0 0.0 4.3 0.0 0.0 0.0 0.0 34.3 0.0 0.1 0.2 0.5 0.6 0.0 0.0 0.0 0.0 GDF11 BMP-11 ENSG00000135414 "Growth differentiation factor 11" O95390 12 55743280-55757278 "Predicted secreted proteins" "Cytokine, Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 35.4" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 71.9;Cone photoreceptor cells: 72.6;Horizontal cells: 54.0;Rod photoreceptor cells: 49.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 54.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060985, HPA069609" Approved Approved Vesicles "Secreted to blood" No No 46400 270000 Vesicles "HPA060985: AB_2684403, HPA069609: AB_2686159" "unprognostic (5.21e-2)" "unprognostic (1.62e-1)" "unprognostic (3.20e-2)" "unprognostic (2.41e-2)" "unprognostic (2.78e-2)" "unprognostic (3.39e-1)" "unprognostic (2.13e-1)" "unprognostic (2.62e-2)" "unprognostic (8.96e-3)" "unprognostic (1.23e-2)" "prognostic favorable (1.08e-4)" "unprognostic (2.69e-1)" "unprognostic (1.62e-2)" "unprognostic (1.27e-1)" "unprognostic (3.13e-1)" "unprognostic (1.01e-3)" "unprognostic (9.48e-2)" 4.6 4.9 15.9 5.6 13.9 2.6 1.9 10.7 13.3 10.3 4.5 9.2 6.6 2.7 10.0 3.5 4.0 6.9 7.4 11.4 13.3 12.9 3.2 1.6 3.1 4.1 13.9 7.3 7.5 4.7 4.6 4.6 3.3 9.3 7.7 2.8 35.4 7.0 16.0 1.9 2.1 3.6 7.3 13.1 5.7 3.5 1.7 9.5 5.7 4.6 1.6 2.9 7.5 2.9 2.4 2.3 1.4 1.2 0.8 3.9 0.5 1.9 3.1 13.8 7.7 10.5 7.7 3.5 4.1 3.9 5.3 4.5 10.6 0.9 3.8 5.5 4.3 2.5 1.9 10.4 7.4 1.8 7.3 9.4 4.7 5.2 1.6 2.1 3.9 54.1 7.4 0.4 7.7 2.2 5.9 6.8 5.2 5.2 12.6 6.7 3.7 6.3 3.4 11.1 0.1 7.8 10.1 3.8 2.4 3.2 2.7 9.4 5.7 2.5 1.2 1.1 5.9 4.4 4.3 4.1 6.4 9.9 5.0 3.0 3.4 1.0 1.9 3.4 3.9 4.4 0.7 0.7 1.4 3.9 0.5 3.6 2.3 2.4 2.5 0.6 2.4 2.2 3.0 1.2 0.8 1.2 2.3 1.7 0.5 15.9 13.9 10.7 10.0 13.3 12.9 13.9 7.3 9.3 9.5 0.0 0.6 5.4 8.5 0.5 71.9 23.4 0.0 0.0 1.2 0.0 72.6 2.9 0.0 4.3 0.4 4.5 1.3 0.0 1.2 3.9 5.8 4.5 5.7 0.0 1.4 54.0 10.3 3.7 0.6 0.4 8.3 0.3 3.3 2.8 1.3 28.4 3.1 2.9 5.3 0.4 49.9 12.9 5.7 1.2 3.5 0.6 3.9 17.3 2.0 5.3 GDI1 "FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4" ENSG00000203879 "GDP dissociation inhibitor 1" P31150 X 154436913-154443467 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "brain: 122.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012979, HPA049290, HPA057668" Enhanced Approved Vesicles NA NA 70000000 Vesicles "CAB012979: AB_2533970, HPA049290: AB_2680700, HPA057668: AB_2683498" "prognostic unfavorable (6.84e-4)" "unprognostic (1.13e-2)" "prognostic unfavorable (3.83e-5)" "unprognostic (3.53e-1)" "unprognostic (1.22e-1)" "unprognostic (1.92e-3)" "unprognostic (1.31e-3)" "unprognostic (1.36e-1)" "unprognostic (1.46e-2)" "unprognostic (1.30e-1)" "unprognostic (2.98e-3)" "unprognostic (3.86e-2)" "unprognostic (3.88e-3)" "unprognostic (1.70e-1)" "unprognostic (8.12e-2)" "unprognostic (1.92e-2)" "unprognostic (1.72e-1)" 19.8 27.1 51.7 16.2 65.3 10.5 12.0 61.3 122.3 16.7 13.6 46.2 6.5 11.5 20.1 15.7 14.4 23.0 15.2 25.7 53.7 54.3 13.7 10.3 16.9 15.1 45.1 49.6 27.7 16.2 18.8 26.9 19.0 65.3 19.6 13.9 13.8 13.6 24.0 14.3 17.2 13.1 25.6 46.4 17.1 13.5 12.9 31.3 6.8 12.7 6.2 15.7 13.9 11.8 7.6 8.3 20.6 13.4 5.6 13.0 4.9 20.3 18.9 42.6 35.2 17.5 20.7 13.4 29.5 19.8 31.1 32.5 10.9 10.8 16.3 30.9 29.9 47.4 16.1 37.4 18.0 21.6 29.4 18.4 5.1 27.7 7.3 25.7 4.9 18.6 21.2 22.3 36.0 22.1 34.0 20.0 20.6 6.2 25.9 36.9 20.6 15.6 12.3 11.3 22.7 34.4 15.6 11.1 9.3 21.7 9.5 59.0 45.7 14.2 18.5 22.3 34.6 11.0 8.9 22.5 28.7 24.9 29.6 43.1 36.7 38.8 25.9 31.1 11.1 35.2 14.9 5.7 17.2 8.9 8.6 13.0 7.3 9.6 8.6 4.7 7.6 7.6 7.5 20.6 5.6 13.4 8.3 10.8 4.9 51.7 65.3 61.3 96.6 53.7 54.3 45.1 49.6 65.3 31.3 14.9 33.8 24.4 21.0 24.2 64.9 56.8 22.9 44.2 18.2 26.2 23.6 18.6 26.6 37.0 2.2 31.8 21.6 0.0 27.5 30.2 32.7 23.2 33.4 12.1 31.9 57.2 87.1 27.6 30.7 4.0 34.8 27.8 16.9 88.4 21.4 35.7 37.8 21.0 37.4 22.4 28.6 51.8 45.7 19.7 64.1 26.5 41.4 39.9 13.3 20.3 GFPT2 GFAT2 ENSG00000131459 "Glutamine-fructose-6-phosphate transaminase 2" O94808 5 180300690-180353387 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 65.6" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 28.9;Peritubular cells: 17.7;Smooth muscle cells: 16.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 7.1" "Lineage enriched" "Detected in single" 49 "T-cells: 7.1" "Cell line enhanced" "Detected in many" "ASC diff: 24.3;ASC TERT1: 41.6;GAMG: 30.6;HSkMC: 26.7;hTEC/SVTERT24-B: 49.5;U-87 MG: 86.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056892, HPA059910" Uncertain Approved Vesicles NA NA Vesicles "HPA056892: AB_2683266, HPA059910: AB_2684157" "unprognostic (3.48e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (1.91e-2)" "unprognostic (1.08e-2)" "unprognostic (6.28e-2)" "unprognostic (3.39e-3)" "unprognostic (3.05e-1)" "prognostic unfavorable (2.95e-4)" "unprognostic (7.65e-2)" "unprognostic (2.73e-2)" "unprognostic (4.50e-2)" "unprognostic (2.94e-2)" "prognostic unfavorable (2.58e-14)" "unprognostic (3.67e-3)" "unprognostic (1.23e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (1.52e-3)" 65.6 3.9 4.5 15.8 5.6 0.9 11.0 17.0 9.2 10.0 9.2 9.3 5.4 2.1 9.0 16.7 5.9 15.9 14.6 16.4 7.1 3.8 2.8 2.6 11.0 3.1 6.2 6.8 17.5 11.1 3.5 2.5 6.0 8.4 7.7 3.6 2.9 4.0 8.0 6.0 4.0 5.0 10.0 17.2 1.7 6.6 6.3 7.7 0.0 5.6 5.4 3.5 14.3 14.6 0.0 0.1 0.0 0.0 0.1 7.1 0.2 0.0 5.4 4.2 5.5 24.3 41.6 0.4 0.6 0.1 0.4 0.1 0.1 0.0 0.0 0.3 4.5 30.6 0.0 2.3 0.0 0.2 0.5 0.8 0.0 2.6 0.0 10.1 0.0 0.0 26.7 0.2 49.5 0.1 8.4 8.0 0.2 0.0 0.0 21.2 0.7 0.0 0.0 9.1 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.2 0.3 8.3 0.1 0.3 5.2 0.3 0.0 3.8 13.7 2.1 8.8 10.0 0.0 0.0 0.0 86.1 0.0 0.3 0.0 0.0 0.0 1.4 0.0 7.1 0.0 0.8 2.4 0.1 0.0 0.8 1.1 0.0 0.1 0.0 0.1 0.0 0.2 4.5 5.6 17.0 9.2 7.1 3.8 6.2 6.8 8.4 7.7 3.0 4.5 0.0 0.3 6.5 0.0 2.2 0.0 2.7 5.7 1.8 0.0 0.9 1.7 0.8 4.5 0.6 0.0 0.0 0.7 0.4 28.9 0.9 1.1 0.0 0.4 0.0 0.0 1.8 0.8 2.0 9.5 1.8 8.5 0.0 0.0 5.2 0.5 0.0 17.7 0.3 0.0 0.0 16.5 9.1 5.3 3.8 2.3 3.8 0.0 0.4 GFRA2 "GDNFRB, NTNRA, RETL2, TRNR2" ENSG00000168546 "GDNF family receptor alpha 2" O00451 8 21690403-21812357 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.2;thyroid gland: 17.4" "Group enriched" "Detected in many" 5 "Horizontal cells: 208.2;Late spermatids: 217.5" "Cancer enriched" "Detected in some" 5 "thyroid cancer: 6.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 10.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.1;monocytes: 10.9" "Cell line enhanced" "Detected in some" "HEL: 9.0;HMC-1: 20.6;WM-115: 3.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024704, CAB032791" Uncertain Uncertain Vesicles "Intracellular and membrane" NA NA 3300000 Vesicles "CAB032791: AB_2110428, HPA024704: AB_1849629" "unprognostic (4.24e-2)" "unprognostic (1.11e-2)" "unprognostic (4.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.93e-2)" "unprognostic (1.08e-2)" "unprognostic (7.48e-4)" "unprognostic (2.87e-1)" "unprognostic (6.11e-2)" "unprognostic (4.40e-3)" "unprognostic (2.11e-3)" "unprognostic (7.82e-2)" "unprognostic (1.50e-4)" "unprognostic (8.45e-4)" "unprognostic (1.74e-1)" "unprognostic (4.68e-2)" "unprognostic (9.63e-3)" 4.2 3.4 2.6 3.4 6.7 1.2 1.4 2.1 19.2 4.9 3.6 0.7 2.6 3.4 1.3 4.0 3.0 4.3 1.2 3.2 6.8 8.9 1.1 1.9 2.2 4.3 4.3 7.1 1.0 0.9 0.2 2.0 11.5 3.2 1.3 2.0 3.7 2.0 4.9 0.4 1.2 3.2 3.5 1.9 12.2 2.2 6.7 0.2 1.0 17.4 0.0 1.5 2.4 2.6 0.1 3.1 0.9 10.9 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 2.4 0.9 0.0 10.9 0.0 0.0 0.0 0.0 3.1 0.1 0.2 0.0 0.5 0.0 1.4 0.0 0.0 0.9 2.6 6.7 2.1 19.2 6.8 8.9 4.3 7.1 3.2 0.2 0.0 2.6 0.0 0.1 1.5 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 39.8 0.0 0.0 0.0 0.0 0.1 1.0 0.1 1.1 0.0 0.5 208.2 0.0 1.3 25.5 217.5 0.6 6.0 0.0 0.0 0.0 1.5 0.0 0.0 1.8 0.0 1.7 6.5 2.1 1.2 1.9 0.6 0.2 0.0 0.0 0.1 GGT1 "CD224, D22S672, D22S732, GGT" ENSG00000100031 "Gamma-glutamyltransferase 1" P19440 22 24583750-24629005 "Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glutathione biosynthesis" "Acyltransferase, Hydrolase, Protease, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 54.1;seminal vesicle: 41.7" "Group enriched" "Detected in many" 6 "Alveolar cells type 1: 74.5;Alveolar cells type 2: 21.4;Cholangiocytes: 40.8;Ductal cells: 54.8;Enterocytes: 80.7;Hepatocytes: 34.1;Pancreatic endocrine cells: 33.5;Paneth cells: 23.0;Proximal tubular cells: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 35.6;Karpas-707: 52.5;OE19: 37.9;RPMI-8226: 51.6;RPTEC TERT1: 48.0" "HPA045635, HPA047534, HPA065444" Supported Uncertain Vesicles "Intracellular and membrane" NA NA 4600000 Vesicles "HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491" "unprognostic (8.13e-3)" "unprognostic (4.76e-1)" "unprognostic (8.29e-2)" "unprognostic (1.28e-2)" "unprognostic (3.70e-2)" "unprognostic (1.43e-2)" "unprognostic (5.60e-3)" "unprognostic (1.68e-1)" "unprognostic (2.21e-1)" "prognostic favorable (7.44e-4)" "unprognostic (4.55e-2)" "unprognostic (2.55e-2)" "prognostic favorable (4.83e-4)" "unprognostic (1.44e-2)" "unprognostic (5.37e-2)" "unprognostic (1.74e-1)" "unprognostic (6.10e-2)" 1.6 0.5 1.7 1.7 2.2 2.7 8.2 2.3 2.6 7.3 7.9 1.6 23.7 22.3 1.4 19.9 1.2 0.8 12.2 2.0 1.8 1.2 54.1 29.2 14.3 3.2 1.7 1.6 1.3 17.3 0.0 1.6 1.4 2.2 14.7 2.4 1.4 8.7 41.7 0.9 1.1 20.9 1.7 1.9 4.7 6.6 5.0 2.1 2.4 4.8 1.6 5.5 2.1 1.1 3.3 7.5 15.9 14.6 6.6 8.6 6.6 0.2 19.3 0.2 0.0 0.0 0.1 0.5 0.1 0.6 0.2 0.2 2.6 4.2 0.2 4.3 0.0 3.8 2.8 1.4 0.2 0.1 35.6 2.9 0.1 8.6 14.0 1.5 0.3 11.9 0.4 0.2 0.6 0.4 0.3 0.1 5.3 2.0 52.5 0.2 0.4 0.3 14.6 1.4 37.9 0.2 0.2 2.2 51.6 48.0 0.6 0.2 0.3 0.1 9.3 0.2 5.5 9.3 11.1 2.2 3.5 2.3 10.8 0.3 15.8 5.9 0.2 7.4 15.0 0.1 5.2 14.6 0.4 1.4 6.8 5.2 3.3 7.7 3.4 7.5 0.3 1.0 1.9 15.9 6.6 5.5 0.1 8.6 6.6 1.7 2.2 2.3 2.6 1.8 1.2 1.7 1.6 2.2 2.1 74.5 21.4 3.4 0.1 0.7 0.4 0.4 40.8 2.7 7.9 1.8 0.0 0.9 1.7 54.8 1.1 0.1 80.7 0.0 7.2 0.3 1.3 3.0 5.7 34.1 4.7 0.0 1.2 2.5 3.0 4.1 0.0 2.9 1.7 5.4 2.5 2.0 33.5 23.0 0.4 32.7 0.0 0.0 0.2 0.6 0.7 0.4 0.7 3.2 4.2 0.0 GGT2 GGT ENSG00000133475 "Gamma-glutamyltransferase 2" P36268 22 21207973-21227637 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 5.6;salivary gland: 5.5;thyroid gland: 8.4" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 7.4;Early spermatids: 3.8;Late spermatids: 14.7" "Cancer enhanced" "Detected in single" "thyroid cancer: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.4;HeLa: 4.6;Karpas-707: 2.0;U-2197: 13.9" "HPA045635, HPA047534, HPA065444" Supported Uncertain Vesicles NA NA Vesicles "HPA045635: AB_2679400, HPA047534: AB_2680079, HPA065444: AB_2685491" "unprognostic (4.27e-1)" "unprognostic (6.91e-2)" "unprognostic (7.03e-2)" "unprognostic (8.13e-2)" "unprognostic (1.01e-2)" "unprognostic (2.38e-5)" "unprognostic (1.05e-3)" "unprognostic (5.85e-4)" "unprognostic (7.97e-3)" "unprognostic (8.84e-2)" "unprognostic (1.16e-1)" "unprognostic (6.39e-2)" "unprognostic (2.39e-1)" "unprognostic (1.48e-2)" "unprognostic (3.46e-3)" 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.1 0.2 0.0 1.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.1 2.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 5.5 0.0 0.0 0.5 1.2 0.0 0.0 0.0 0.3 1.0 8.4 0.0 0.0 0.0 0.1 0.2 0.4 0.4 0.4 0.5 0.3 0.0 0.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.1 0.0 0.0 1.0 0.0 1.5 0.0 0.0 0.1 0.5 0.6 13.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.3 0.1 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.5 0.3 3.0 7.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.5 0.2 0.0 0.1 0.0 0.0 0.0 GLTPD2 ENSG00000182327 "Glycolipid transfer protein domain containing 2" A6NH11 17 4788959-4790390 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 13.0;kidney: 9.8;liver: 44.4" "Group enriched" "Detected in some" 6 "Hepatocytes: 65.2;Proximal tubular cells: 128.9" "Cancer enriched" "Detected in many" 5 "liver cancer: 25.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "non-classical monocyte: 3.2" "Lineage enriched" "Detected in single" 6 "monocytes: 3.2" "Cell line enhanced" "Detected in some" "BEWO: 4.7;CACO-2: 11.8;Hep G2: 15.5;MCF7: 5.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA058295, HPA065267" Uncertain Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA058295: AB_2683671, HPA065267: AB_2685451" "unprognostic (4.00e-1)" "unprognostic (1.93e-1)" "unprognostic (1.95e-3)" "unprognostic (1.70e-1)" "unprognostic (3.03e-2)" "unprognostic (1.79e-4)" "unprognostic (1.40e-1)" "unprognostic (1.45e-2)" "unprognostic (4.16e-3)" "unprognostic (2.33e-2)" "unprognostic (5.62e-4)" "unprognostic (7.80e-2)" "unprognostic (2.62e-1)" "unprognostic (4.25e-1)" "unprognostic (4.79e-1)" "unprognostic (1.71e-4)" "unprognostic (7.59e-3)" 0.2 0.3 0.5 0.2 0.7 0.8 0.2 0.8 1.8 0.2 8.0 0.3 0.2 8.6 0.3 0.2 0.4 0.3 0.2 0.2 0.5 0.7 9.8 44.4 0.6 0.2 0.5 0.4 0.2 0.5 0.2 0.5 0.2 0.4 0.2 0.0 0.5 0.8 0.2 0.8 1.4 13.0 0.2 0.4 0.8 0.9 0.2 0.2 0.4 0.2 1.6 0.3 0.4 0.3 0.0 0.5 0.0 3.2 0.0 0.2 0.2 0.6 2.5 0.2 2.1 0.0 0.0 4.7 0.4 0.0 0.0 0.0 11.8 0.9 1.2 1.3 0.0 0.4 2.3 0.0 0.1 0.0 2.2 1.8 0.1 1.0 15.5 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.7 0.6 0.0 5.4 0.2 0.2 0.3 0.6 1.0 0.9 0.6 0.3 0.0 0.9 1.6 1.0 2.2 0.4 0.6 0.1 1.4 0.1 2.5 0.8 1.0 0.5 0.4 0.2 0.6 0.1 0.3 0.7 0.9 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.2 0.5 0.7 0.8 0.7 0.5 0.7 0.5 0.4 0.4 0.2 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.3 0.0 65.2 0.1 0.0 0.0 1.8 1.3 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 128.9 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.1 0.5 GNAZ ENSG00000128266 "G protein subunit alpha z" P19086 22 23070361-23125037 "Predicted intracellular proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 34.4" "Group enriched" "Detected in many" 6 "Horizontal cells: 117.6;Rod photoreceptor cells: 32.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 25.1;SH-SY5Y: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003011 Enhanced Approved Vesicles NA NA 6900000 Vesicles "HPA003011: AB_1078918" "unprognostic (7.61e-2)" "unprognostic (1.63e-2)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.85e-4)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.51e-3)" "unprognostic (3.45e-2)" "unprognostic (1.30e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-3)" "unprognostic (1.68e-2)" "unprognostic (9.69e-2)" "unprognostic (2.29e-1)" "unprognostic (6.63e-2)" "unprognostic (2.82e-1)" "unprognostic (1.30e-1)" 8.8 6.9 15.4 3.2 13.4 1.8 3.2 17.8 34.4 2.2 6.0 11.1 6.9 2.3 6.2 3.7 5.9 6.9 12.1 2.0 17.7 14.7 2.2 0.6 1.7 2.2 16.4 13.0 9.9 2.2 4.7 11.1 0.9 13.5 7.8 2.3 6.8 2.4 19.5 1.9 1.2 2.4 12.9 19.0 5.1 5.3 4.3 7.7 0.0 1.9 0.0 1.7 3.6 1.5 1.3 0.1 1.7 1.4 0.2 0.6 5.3 0.0 1.2 4.2 9.0 0.0 0.0 0.2 5.7 11.4 5.6 3.8 0.0 0.0 10.9 0.4 0.5 7.7 0.2 5.3 0.2 4.1 1.4 4.4 0.7 6.4 7.9 0.4 0.0 0.9 0.0 0.2 0.1 0.3 1.4 0.1 0.6 0.1 3.4 0.1 3.9 0.0 0.0 2.6 0.3 3.5 0.0 4.3 1.7 0.1 0.1 25.1 15.5 1.3 2.8 1.1 0.5 1.2 0.1 0.0 4.7 5.4 1.2 0.1 4.3 7.3 5.7 2.3 0.4 1.7 1.7 0.3 0.5 0.2 0.0 0.0 0.3 0.0 0.0 0.1 1.3 0.0 0.6 0.9 0.2 1.4 0.0 0.0 5.3 15.4 13.4 17.8 19.4 17.7 14.7 16.4 13.0 13.5 7.7 3.0 0.0 0.0 0.3 0.2 11.7 1.0 7.6 1.4 1.2 3.5 7.9 0.0 0.0 1.7 1.2 2.1 0.0 0.0 1.5 0.0 0.9 0.3 0.0 0.0 0.1 117.6 4.6 3.7 0.0 2.1 3.7 0.4 1.7 0.0 0.2 12.8 0.7 0.0 3.9 0.5 32.2 0.0 4.2 1.6 3.2 0.4 0.0 0.0 0.0 0.1 GNL1 HSR1 ENSG00000204590 "G protein nucleolar 1 (putative)" P36915 6 30541377-30557174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033575, HPA043338, HPA050455" Uncertain Supported Vesicles NA NA Vesicles "CAB033575: AB_2109945, HPA043338: AB_2678437, HPA050455: AB_2681132" "unprognostic (2.76e-2)" "unprognostic (3.68e-2)" "unprognostic (2.21e-1)" "unprognostic (3.53e-2)" "unprognostic (3.30e-2)" "unprognostic (2.75e-1)" "unprognostic (4.22e-2)" "unprognostic (8.33e-2)" "unprognostic (1.03e-1)" "unprognostic (3.84e-2)" "unprognostic (3.95e-3)" "unprognostic (7.32e-2)" "unprognostic (5.67e-3)" "unprognostic (4.42e-2)" "unprognostic (2.10e-1)" "unprognostic (4.15e-1)" "unprognostic (1.78e-1)" 14.2 9.2 15.6 12.9 18.6 7.7 13.4 18.8 29.2 13.3 7.9 12.1 7.6 4.3 15.2 15.1 8.4 17.4 10.6 6.9 14.6 14.1 13.5 9.3 12.8 9.7 13.1 17.3 25.9 13.0 40.3 11.6 11.1 14.3 9.0 13.2 9.3 10.1 15.3 8.0 13.8 7.8 16.9 13.9 8.8 8.8 31.7 12.5 12.8 13.5 7.6 16.7 11.1 10.6 1.4 0.3 0.8 0.7 1.2 3.6 1.7 7.4 1.5 4.3 12.4 8.2 9.7 0.3 2.3 4.6 1.9 3.0 10.7 4.6 3.4 4.4 7.4 19.0 5.0 11.1 9.1 3.2 1.2 6.5 5.5 5.3 1.0 0.0 1.0 3.6 8.3 7.3 14.9 5.0 0.0 0.8 13.4 9.6 0.4 4.7 1.7 2.6 0.2 2.4 5.9 1.2 5.7 2.7 3.7 6.4 3.2 3.7 3.6 3.0 2.2 1.3 1.5 2.1 3.4 4.4 7.8 2.2 1.4 2.6 5.8 6.3 6.8 0.2 4.7 9.4 0.8 0.5 0.7 2.7 0.7 3.6 1.4 2.9 3.4 0.3 1.2 0.6 1.1 0.7 1.2 0.7 0.3 1.7 1.7 15.6 18.6 18.8 29.2 14.6 14.1 13.1 17.3 14.3 12.5 41.7 42.8 28.9 84.1 52.7 40.0 11.2 33.1 8.1 21.6 24.4 39.3 59.0 19.9 34.2 92.0 43.0 23.2 23.3 30.7 56.3 42.9 42.6 31.1 14.1 25.3 15.9 44.2 40.5 18.7 144.9 33.6 17.8 27.0 12.6 21.6 29.3 24.9 22.6 30.1 23.0 31.9 38.8 46.4 86.6 45.5 35.5 133.9 30.5 23.4 49.4 GPHA2 "A2, GPA2, MGC126572, ZSIG51" ENSG00000149735 "Glycoprotein hormone alpha 2" Q96T91 11 64934471-64935888 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "pancreas: 98.0" "Cell type enhanced" "Detected in some" 28 "Exocrine glandular cells: 15.7;Pancreatic endocrine cells: 3.7;Spermatocytes: 4.7;Spermatogonia: 2.5" "Cancer enriched" "Detected in some" 7 "testis cancer: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "Hep G2: 21.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA067068 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA067068: " "unprognostic (1.13e-1)" "unprognostic (8.31e-3)" "unprognostic (1.51e-2)" "unprognostic (9.22e-4)" "unprognostic (7.88e-3)" "unprognostic (2.62e-1)" "unprognostic (1.45e-1)" "unprognostic (3.20e-2)" "unprognostic (1.82e-1)" "unprognostic (1.75e-1)" "unprognostic (5.03e-2)" "unprognostic (9.86e-3)" "unprognostic (1.70e-1)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.2 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 6.7 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.1 0.1 0.7 98.0 0.0 15.1 0.1 0.2 0.7 0.0 0.7 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 4.2 0.1 0.1 0.2 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 21.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.3 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 15.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.4 0.0 0.0 0.0 4.7 2.5 0.0 0.0 0.0 0.0 0.1 GPR137C "DKFZp762F0713, TM7SF1L2" ENSG00000180998 "G protein-coupled receptor 137C" Q8N3F9 14 52553148-52637713 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.1;epididymis: 16.6" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 19.6;Rod photoreceptor cells: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 3.9;T-cells: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003640, HPA030763" Uncertain Approved Vesicles NA NA Vesicles "HPA003640: AB_2667025, HPA030763: AB_10602352" "unprognostic (1.39e-1)" "unprognostic (1.45e-1)" "unprognostic (1.23e-1)" "unprognostic (6.84e-2)" "unprognostic (8.50e-3)" "unprognostic (7.34e-3)" "unprognostic (5.95e-3)" "unprognostic (2.32e-2)" "unprognostic (4.41e-2)" "unprognostic (8.42e-4)" "unprognostic (2.20e-2)" "unprognostic (1.04e-1)" "unprognostic (7.88e-2)" "unprognostic (4.08e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (2.60e-1)" 1.4 2.2 7.1 1.0 11.0 3.3 1.9 31.1 20.2 1.4 1.2 7.5 0.2 2.0 2.5 16.6 1.7 1.2 2.8 2.4 5.9 10.6 1.2 1.3 1.7 2.1 6.3 7.5 1.6 0.7 2.3 1.8 1.8 13.3 1.6 1.5 3.2 1.7 1.5 1.3 1.8 1.2 1.5 7.0 2.5 1.4 6.5 8.3 0.0 2.1 0.0 1.2 2.1 0.7 0.7 0.5 2.4 0.5 3.9 4.1 0.8 0.8 0.3 8.2 7.5 2.4 0.7 3.3 3.4 2.3 3.6 8.6 1.5 1.6 0.8 2.5 2.8 7.6 1.9 2.7 0.5 5.3 1.2 1.9 0.9 2.3 0.9 0.3 0.5 1.9 0.4 0.0 3.3 0.2 0.8 1.8 1.8 1.2 3.6 5.1 4.0 0.3 1.1 2.0 1.5 4.8 1.8 5.1 0.3 1.1 5.7 8.3 10.5 1.7 0.5 0.2 3.6 5.1 0.0 0.3 8.2 8.7 5.9 2.8 0.8 2.0 1.8 2.0 0.4 2.4 1.2 0.5 0.5 3.1 0.1 4.1 0.3 2.0 3.9 0.2 0.7 1.5 1.8 2.4 3.9 0.4 0.5 1.4 0.8 7.1 11.0 31.1 14.1 5.9 10.6 6.3 7.5 13.3 8.3 0.0 2.2 0.0 0.7 0.6 19.6 2.2 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 1.3 3.0 0.0 0.0 0.2 0.2 1.5 2.4 0.0 0.4 0.4 6.4 1.2 3.7 1.0 1.5 0.6 0.6 1.7 0.0 0.5 5.1 0.0 0.0 0.7 0.1 19.2 0.0 2.1 4.1 2.8 0.6 0.1 0.0 0.0 0.3 GPR17 ENSG00000144230 "G protein-coupled receptor 17" Q13304 2 127645864-127652639 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 43.8" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 32 "glioma: 16.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "naive B-cell: 4.0" "Lineage enriched" "Detected in single" 11 "B-cells: 4.0" "Cell line enhanced" "Detected in some" "HeLa: 4.6;REH: 7.7;TIME: 7.6;U-2 OS: 3.2;U-2197: 3.6;U-251 MG: 4.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029766 Enhanced Supported Approved Vesicles NA NA Vesicles "HPA029766: AB_10612114" "unprognostic (8.10e-2)" "unprognostic (1.73e-1)" "unprognostic (2.61e-1)" "unprognostic (1.42e-2)" "unprognostic (1.54e-1)" "unprognostic (5.19e-2)" "unprognostic (2.77e-5)" "unprognostic (8.40e-3)" "unprognostic (2.92e-1)" "unprognostic (3.25e-2)" "unprognostic (1.61e-3)" "unprognostic (6.60e-2)" "unprognostic (2.11e-3)" "unprognostic (3.33e-2)" "unprognostic (2.19e-1)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" 7.0 2.2 23.7 6.8 21.3 0.8 5.4 4.1 25.6 2.4 16.4 43.8 0.0 3.3 11.2 3.3 5.0 4.0 4.3 12.5 20.6 1.2 2.3 1.6 9.3 2.4 9.1 9.9 1.4 4.6 0.5 0.4 2.7 18.8 3.9 0.8 0.1 1.7 0.5 13.1 6.7 3.8 0.5 6.3 12.6 5.0 1.8 22.6 0.0 2.8 0.0 0.5 6.1 3.9 4.0 0.3 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.3 0.6 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.6 0.9 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.4 0.0 0.3 0.0 0.0 0.6 0.3 0.1 0.0 0.2 7.7 0.2 0.0 0.0 0.0 0.0 0.3 0.2 0.4 0.0 2.3 0.3 0.0 7.6 0.0 3.2 3.6 4.5 0.2 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 4.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.7 21.3 4.1 25.6 20.6 1.2 9.1 9.9 18.8 22.6 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPR174 FKSG79 ENSG00000147138 "G protein-coupled receptor 174" Q9BXC1 X 79144663-79175315 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 8 "lymphoid tissue: 73.8" "Group enriched" "Detected in some" 20 "Alveolar cells type 2: 3.7;Club cells: 1.2;Collecting duct cells: 1.8;T-cells: 2.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "JURKAT: 24.1;MOLT-4: 39.8" "Low region specificity" "Detected in single" "Low region specificity" "Detected in some" HPA041025 Enhanced Uncertain Vesicles NA NA Vesicles "HPA041025: AB_10794260" "unprognostic (6.38e-3)" "unprognostic (9.87e-3)" "unprognostic (4.36e-2)" "unprognostic (1.18e-2)" "unprognostic (1.84e-1)" "unprognostic (8.48e-4)" "unprognostic (7.12e-2)" "unprognostic (1.05e-2)" "unprognostic (1.75e-1)" "unprognostic (2.02e-1)" "unprognostic (2.46e-1)" "unprognostic (1.05e-1)" "unprognostic (6.53e-5)" "unprognostic (2.27e-1)" "unprognostic (2.64e-2)" "unprognostic (1.21e-1)" "unprognostic (1.78e-2)" 2.2 0.5 0.4 20.3 0.4 2.6 1.3 0.3 0.4 2.4 5.1 0.0 0.5 2.1 1.6 0.9 2.6 0.9 1.9 1.0 0.4 0.4 1.9 1.7 8.2 16.6 0.5 0.0 1.0 0.7 0.0 1.1 0.3 0.2 1.7 2.0 1.6 3.8 0.1 0.5 0.7 9.1 0.2 1.0 21.0 2.2 0.5 0.0 73.8 2.5 1.6 28.1 5.1 1.8 4.0 1.8 6.0 9.1 6.5 8.6 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.0 0.7 0.0 0.0 39.8 0.0 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.1 0.0 0.0 0.0 6.0 0.0 4.7 5.7 3.4 1.7 4.0 7.5 8.6 0.1 3.9 6.1 6.8 0.4 6.5 9.1 1.8 7.6 2.7 0.4 0.4 0.3 0.4 0.4 0.4 0.5 0.0 0.2 0.0 0.0 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 GPR180 ITR ENSG00000152749 "G protein-coupled receptor 180" Q86V85 13 94601903-94634645 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047250 Approved Approved Vesicles NA NA Vesicles "HPA047250: AB_2679998" "unprognostic (3.91e-3)" "unprognostic (3.28e-1)" "unprognostic (4.16e-3)" "unprognostic (2.95e-1)" "unprognostic (1.17e-2)" "unprognostic (1.40e-1)" "unprognostic (3.75e-3)" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (6.71e-2)" "unprognostic (1.47e-1)" "unprognostic (2.86e-2)" "prognostic unfavorable (3.18e-5)" "unprognostic (2.49e-2)" "unprognostic (1.10e-1)" "unprognostic (8.47e-2)" "unprognostic (2.80e-2)" 14.6 6.8 7.6 6.6 11.4 2.7 15.9 14.7 13.1 8.3 6.1 7.6 5.2 5.7 7.1 5.8 5.3 7.3 5.3 7.6 7.9 8.8 7.5 18.7 6.8 6.3 8.8 7.8 7.3 10.6 7.5 18.8 9.9 10.8 7.6 7.4 12.3 7.5 7.2 5.6 5.7 5.1 8.1 12.1 6.0 7.7 3.5 8.8 8.6 10.2 3.9 7.3 6.4 6.9 1.5 2.5 0.3 1.5 1.5 4.3 1.3 13.2 3.4 4.8 5.1 10.3 11.2 2.0 9.1 7.2 8.9 11.9 4.1 9.2 4.4 4.0 7.8 6.2 8.5 6.8 6.4 12.3 11.5 4.3 8.6 4.6 0.0 8.1 12.3 7.0 6.4 5.5 5.4 7.4 8.0 9.0 6.4 2.4 2.2 8.8 2.0 6.1 2.7 3.2 9.5 3.8 7.1 6.5 1.8 10.0 4.0 7.1 5.1 4.2 9.4 11.1 6.4 6.6 5.1 8.1 5.5 4.4 6.5 7.5 3.6 3.7 2.1 9.1 10.1 7.4 0.3 1.5 0.3 2.4 1.0 4.3 1.5 2.9 1.7 2.5 1.5 3.5 2.9 0.0 1.5 1.1 1.8 3.4 1.3 7.6 11.4 14.7 13.1 7.9 8.8 8.8 7.8 10.8 8.8 3.0 2.6 9.3 5.8 5.4 12.8 4.1 5.1 10.7 2.3 12.2 29.5 8.1 5.0 7.7 0.6 6.7 3.1 0.0 8.9 23.3 9.7 9.6 4.7 27.1 9.6 17.5 9.9 8.6 4.4 0.0 8.9 4.6 6.8 3.6 8.7 14.0 10.3 3.5 5.3 6.3 22.2 6.5 8.2 1.2 10.8 4.1 3.4 5.7 5.2 4.2 GRB10 ENSG00000106070 "Growth factor receptor bound protein 10" Q13322 7 50590063-50793462 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 65.8" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 82.5;Early spermatids: 134.4;Late spermatids: 152.5;Rod photoreceptor cells: 83.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 12 "basophil: 11.4;eosinophil: 3.5" "Lineage enriched" "Detected in single" 26 "granulocytes: 11.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019423, HPA027502, HPA031818" Enhanced Supported Vesicles NA NA Vesicles "CAB019423: AB_2112883, HPA027502: AB_10602325, HPA031818: AB_2674057" "unprognostic (2.82e-2)" "unprognostic (1.69e-3)" "unprognostic (1.25e-2)" "unprognostic (1.45e-2)" "unprognostic (3.68e-2)" "unprognostic (1.60e-1)" "unprognostic (6.83e-2)" "unprognostic (5.91e-3)" "unprognostic (1.67e-2)" "unprognostic (2.31e-3)" "unprognostic (4.44e-1)" "unprognostic (2.07e-1)" "unprognostic (1.23e-3)" "unprognostic (1.73e-3)" "unprognostic (8.16e-3)" "unprognostic (2.63e-2)" "unprognostic (8.50e-2)" 14.3 14.6 14.7 4.9 26.7 6.5 18.8 22.0 20.9 9.7 10.5 14.6 2.0 12.3 8.9 8.0 7.3 9.0 15.6 19.1 13.8 14.8 19.8 15.6 8.3 4.3 19.8 10.7 6.5 65.8 6.0 21.5 10.6 20.9 10.6 5.1 16.5 7.0 11.7 35.7 3.7 8.4 13.0 9.9 15.9 7.2 11.4 16.9 0.4 18.3 4.2 3.2 12.7 17.3 0.0 0.1 11.4 0.2 0.0 0.4 0.1 0.1 10.6 17.6 7.1 8.2 6.3 9.3 4.3 3.7 8.4 10.1 6.4 0.1 0.2 7.7 5.4 24.3 1.0 18.1 4.6 4.1 0.1 7.3 18.4 10.9 4.6 17.5 11.5 28.6 16.5 7.2 12.9 12.8 8.3 21.4 1.3 34.8 0.2 6.3 1.2 2.0 15.5 19.1 8.9 18.6 5.4 0.0 0.1 5.6 4.2 7.7 0.0 0.5 2.7 22.9 11.9 9.3 23.4 26.1 7.4 10.2 15.2 16.4 0.7 0.2 0.1 23.6 10.5 25.1 11.4 0.1 3.5 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.1 0.0 0.1 14.7 26.7 22.0 20.9 13.8 14.8 19.8 10.7 20.9 16.9 6.0 8.8 0.9 5.6 6.6 11.0 12.2 58.6 1.4 3.4 5.2 82.5 3.7 1.7 16.5 134.4 28.6 8.6 23.3 21.0 11.9 11.5 17.1 0.0 22.5 1.4 4.8 0.0 52.2 11.4 152.5 1.7 2.3 6.8 1.0 2.2 18.0 30.3 2.9 0.4 14.7 83.0 0.0 12.7 1.4 19.2 3.8 2.2 0.9 3.3 5.6 GRK2 "ADRBK1, BARK1" ENSG00000173020 "G protein-coupled receptor kinase 2" P25098 11 67266410-67286556 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 78.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 26.5;granulocytes: 19.8;Hofbauer cells: 31.0;monocytes: 15.4;Pancreatic endocrine cells: 22.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 56.3;REH: 74.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005021, CAB037248, HPA048330" Enhanced Approved Vesicles NA NA Vesicles "CAB005021: AB_562360, CAB037248: AB_1078280, HPA048330: AB_2680361" "unprognostic (5.58e-2)" "unprognostic (1.75e-1)" "unprognostic (2.01e-2)" "unprognostic (5.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.29e-3)" "unprognostic (3.31e-2)" "unprognostic (6.17e-2)" "unprognostic (1.11e-1)" "unprognostic (6.35e-2)" "unprognostic (2.22e-1)" "unprognostic (2.55e-2)" "prognostic unfavorable (1.25e-4)" "unprognostic (3.66e-1)" "unprognostic (2.40e-1)" "unprognostic (4.04e-2)" "unprognostic (5.19e-3)" 13.1 10.7 24.5 35.8 17.0 78.2 17.0 32.9 35.3 12.8 17.2 12.2 12.6 17.5 11.4 9.9 20.2 12.6 17.6 13.6 21.9 17.4 13.0 14.1 19.1 42.8 13.4 19.0 9.8 10.4 9.7 12.2 12.7 15.7 17.8 16.2 9.3 17.4 20.8 20.8 23.5 26.3 12.2 12.5 59.6 17.4 6.8 11.1 35.9 10.1 13.6 37.5 17.1 15.5 4.1 6.0 21.0 18.3 3.8 5.3 7.4 7.6 5.4 5.3 8.9 4.3 3.9 5.3 4.6 4.4 6.3 5.2 12.0 12.8 39.5 7.4 4.2 8.4 10.4 7.7 6.2 3.3 48.1 4.8 22.4 6.2 5.4 5.3 47.0 45.0 3.5 7.3 5.0 6.7 4.7 8.0 16.2 8.1 20.3 5.4 14.3 26.1 56.3 6.6 23.1 8.2 74.7 10.5 11.7 6.4 10.1 10.7 5.8 6.8 10.0 16.3 3.4 9.2 51.1 4.4 5.0 6.6 6.3 5.1 12.9 11.9 35.4 6.5 27.9 4.5 6.9 10.3 10.5 5.3 15.9 4.0 3.8 4.0 4.3 6.0 4.1 3.2 3.1 21.0 3.8 18.3 5.3 2.6 7.4 24.5 17.0 32.9 35.3 21.9 17.4 13.4 19.0 15.7 11.1 3.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 1.4 7.9 5.2 0.0 7.8 1.7 9.4 0.0 0.0 0.0 0.0 10.9 5.1 0.0 0.0 19.8 0.0 31.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 15.4 0.0 0.0 22.7 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 GRM1 "GPRC1A, mGlu1, MGLUR1, PPP1R85" ENSG00000152822 "Glutamate metabotropic receptor 1" Q13255 6 146027646-146437598 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 39.9" "Cell type enriched" "Detected in some" 7 "Rod photoreceptor cells: 113.7" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 39.9" "Cell type enriched" "Detected in single" 4 "NK-cell: 1.1" "Lineage enriched" "Detected in single" 4 "NK-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 1.4;GAMG: 2.5;HeLa: 1.2;hTERT-RPE1: 1.5;Karpas-707: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015701 Approved Supported Approved Vesicles NA NA Vesicles "HPA015701: AB_1853917" "unprognostic (1.04e-2)" "unprognostic (7.33e-2)" "unprognostic (3.73e-3)" "unprognostic (9.77e-3)" "unprognostic (6.75e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" "unprognostic (5.78e-2)" "unprognostic (4.31e-2)" "unprognostic (2.93e-2)" "unprognostic (9.48e-3)" "unprognostic (7.92e-2)" "unprognostic (1.84e-2)" "unprognostic (1.03e-1)" "unprognostic (3.50e-2)" "unprognostic (8.33e-3)" "unprognostic (9.76e-2)" 0.5 0.5 6.6 0.4 6.0 0.4 0.5 39.9 13.0 0.5 0.5 0.9 0.0 0.4 0.5 0.7 0.5 0.7 0.5 7.7 6.0 2.7 2.7 0.5 0.6 0.5 2.6 4.1 0.5 0.5 0.4 0.2 0.5 3.6 0.5 0.4 2.6 0.5 0.8 0.4 0.5 0.5 0.5 1.0 0.6 0.5 1.3 0.9 0.0 0.8 0.0 0.4 0.5 0.1 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.1 1.4 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.1 2.5 0.0 0.0 0.0 0.1 0.1 0.0 0.3 1.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 1.5 0.6 0.0 0.0 1.2 0.1 0.0 0.0 0.3 0.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.9 0.5 0.1 0.1 0.4 0.1 0.0 0.4 0.1 0.0 0.1 0.6 0.2 0.2 0.0 0.1 0.4 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.0 6.6 6.0 39.9 10.5 6.0 2.7 2.6 4.1 3.6 0.9 0.0 0.0 0.0 0.0 0.0 13.4 3.9 0.0 0.0 0.0 1.8 15.7 0.0 1.7 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 113.7 0.0 0.0 0.7 0.7 0.0 0.0 0.0 0.0 0.0 GSAP "LOC54103, PION" ENSG00000186088 "Gamma-secretase activating protein" A4D1B5 7 77310751-77416400 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lung: 33.1" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 71.5;Alveolar cells type 2: 50.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 11.2;U-937: 14.7" "Low region specificity" "Detected in many" HPA023994 Approved Vesicles NA NA Vesicles "HPA023994: AB_1855386" "prognostic favorable (3.36e-4)" "unprognostic (3.70e-1)" "unprognostic (8.55e-3)" "unprognostic (4.53e-3)" "unprognostic (6.80e-3)" "unprognostic (3.52e-3)" "unprognostic (4.36e-2)" "unprognostic (7.18e-3)" "unprognostic (1.09e-1)" "unprognostic (9.98e-3)" "unprognostic (2.07e-3)" "unprognostic (2.41e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (3.61e-1)" "unprognostic (1.82e-2)" "unprognostic (9.49e-2)" "prognostic favorable (4.15e-5)" 5.7 6.3 3.8 19.9 3.9 7.0 5.7 1.7 6.6 3.5 6.4 4.4 2.8 2.0 3.9 6.7 5.0 5.7 8.0 7.3 4.2 5.4 6.2 13.9 33.1 24.0 4.5 2.2 4.0 5.4 9.4 14.0 3.6 4.2 5.8 4.1 5.6 5.6 5.3 2.5 3.7 10.1 8.0 5.5 21.5 6.9 1.9 3.3 3.8 9.4 3.4 14.8 5.5 3.4 13.7 11.7 1.3 9.7 11.2 6.6 5.7 3.2 1.7 0.0 0.0 0.5 2.2 0.3 2.0 6.8 1.1 2.9 0.5 4.7 0.7 0.2 0.0 3.9 1.6 0.1 1.6 3.0 2.1 1.4 3.5 0.2 9.0 3.0 0.3 0.0 0.8 6.2 5.5 11.2 8.2 0.5 0.0 0.0 0.3 9.2 1.8 0.0 7.0 0.5 5.1 2.4 0.0 0.1 0.1 6.2 2.7 0.2 5.2 2.2 1.1 5.3 0.4 2.0 2.9 0.0 1.7 1.2 0.2 6.1 1.3 0.0 1.2 7.9 14.7 1.4 0.0 9.7 0.9 6.6 8.9 3.9 13.7 2.2 4.5 11.7 12.3 2.9 4.8 1.3 11.2 6.4 0.3 0.1 5.7 3.8 3.9 1.7 6.6 4.2 5.4 4.5 2.2 4.2 3.3 71.5 50.8 31.3 9.0 4.6 16.8 7.3 5.1 12.0 29.6 3.5 15.7 2.4 21.6 6.2 0.0 9.9 0.9 0.0 5.3 0.7 2.6 10.5 12.7 13.2 9.6 19.1 5.2 3.7 33.4 0.0 4.9 31.0 8.5 13.6 5.3 37.9 6.0 5.7 3.5 6.8 21.3 6.5 3.1 1.1 0.4 4.0 1.4 15.9 4.3 15.9 GTPBP2 ENSG00000172432 "GTP binding protein 2" Q9BX10 6 43605316-43629162 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Late spermatids: 36.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTERT-HME1: 56.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031418, HPA031419" Approved Approved Vesicles NA Yes Vesicles "HPA031418: AB_2673872, HPA031419: AB_10600709" "unprognostic (1.35e-1)" "unprognostic (1.01e-1)" "unprognostic (8.94e-2)" "unprognostic (1.08e-3)" "unprognostic (2.56e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (1.08e-6)" "unprognostic (4.71e-2)" "unprognostic (2.58e-3)" "unprognostic (6.47e-2)" "unprognostic (8.31e-2)" "unprognostic (6.15e-3)" "prognostic unfavorable (1.44e-15)" "unprognostic (1.13e-1)" "unprognostic (3.36e-1)" "unprognostic (1.06e-1)" "unprognostic (2.89e-3)" 26.8 19.8 21.4 28.0 19.7 27.9 23.5 27.5 26.1 20.1 22.4 19.9 29.6 22.7 19.0 20.5 38.2 14.5 18.6 20.5 19.1 10.8 20.5 22.5 29.1 21.4 15.0 17.4 20.4 26.2 30.9 26.8 24.1 17.9 20.7 20.7 19.9 29.0 25.3 19.2 19.8 21.9 21.0 17.0 28.8 23.8 17.2 20.1 28.2 30.0 13.3 29.6 25.7 25.2 3.0 2.8 7.0 2.5 1.2 3.4 4.4 17.8 4.7 12.6 8.5 9.7 10.5 14.4 17.0 18.4 20.0 22.9 5.4 7.6 6.5 7.3 9.1 16.9 9.7 4.7 6.9 13.8 17.6 10.2 16.0 12.0 4.8 38.8 10.3 17.8 12.3 48.4 22.1 56.8 13.2 10.3 9.1 22.2 33.2 9.9 6.2 7.6 14.9 3.8 19.3 5.5 6.6 9.1 7.2 9.3 10.9 10.8 11.2 5.8 5.3 21.7 7.8 10.2 16.0 11.4 10.1 11.3 6.4 11.3 22.6 10.7 8.7 14.5 9.5 10.5 7.0 2.5 5.0 3.4 1.4 2.0 1.7 0.9 3.0 1.3 3.0 2.4 2.8 3.7 1.2 2.0 2.8 1.5 4.4 21.4 19.7 27.5 26.1 19.1 10.8 15.0 17.4 17.9 20.1 3.0 5.6 5.1 1.9 4.6 6.1 9.2 7.6 0.0 2.3 1.8 7.9 2.1 0.0 8.2 14.5 6.7 9.2 0.0 8.7 9.0 4.9 4.4 1.1 4.0 7.0 1.6 1.2 8.0 13.6 36.8 4.9 5.7 6.8 8.2 7.0 2.2 17.0 6.2 3.9 1.1 8.1 12.9 3.8 7.7 9.1 4.5 2.1 2.1 5.0 9.5 GUCY2C "GUC2C, STAR" ENSG00000070019 "Guanylate cyclase 2C" P25092 12 14612632-14696585 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters" "cGMP biosynthesis" "Lyase, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "intestine: 85.1" "Cell type enhanced" "Detected in some" 21 "Enterocytes: 37.2;Intestinal endocrine cells: 169.6;Mucus-secreting cells: 61.9;Paneth cells: 99.3;Undifferentiated cells: 41.2" "Group enriched" "Detected in many" 5 "colorectal cancer: 23.9;stomach cancer: 9.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 4.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.2;CAPAN-2: 4.6;SiHa: 4.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA037655, HPA073759" Uncertain Uncertain Vesicles NA NA Vesicles "HPA037655: AB_10672388, HPA073759: " "unprognostic (1.08e-1)" "unprognostic (2.12e-1)" "unprognostic (3.58e-2)" "unprognostic (2.11e-2)" "unprognostic (1.60e-2)" "unprognostic (5.67e-3)" "prognostic unfavorable (1.37e-5)" "unprognostic (9.14e-2)" "unprognostic (1.49e-2)" "unprognostic (2.95e-1)" "unprognostic (1.58e-1)" "unprognostic (5.40e-2)" "unprognostic (2.35e-4)" "unprognostic (8.02e-2)" "unprognostic (1.64e-1)" "unprognostic (1.33e-1)" "unprognostic (1.98e-1)" 0.2 0.1 0.2 3.4 0.2 0.0 0.2 0.2 0.2 0.2 38.8 0.2 0.2 28.0 0.3 0.2 0.4 0.2 0.3 0.4 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.2 0.2 0.2 0.2 17.5 0.2 0.5 0.2 0.2 1.0 85.1 0.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.3 4.3 0.7 2.7 1.7 0.0 0.0 0.6 1.1 0.1 0.0 3.7 0.0 0.0 2.2 0.2 0.0 0.0 0.0 3.2 4.6 0.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.5 0.1 0.6 0.0 0.6 4.2 0.3 0.0 1.1 0.4 0.1 0.0 0.0 0.0 0.9 0.1 1.3 0.8 1.3 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.5 0.0 4.3 0.0 0.0 0.7 2.3 0.0 0.0 2.7 0.0 0.0 0.7 0.0 0.6 0.2 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.0 1.5 0.0 0.5 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 61.9 0.0 0.3 99.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 41.2 0.0 GULP1 "CED-6, CED6, GULP" ENSG00000144366 "GULP, engulfment adaptor PTB domain containing 1" Q9UBP9 2 188291669-188595931 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Lipid transport, Phagocytosis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 86.0" "Cell type enhanced" "Detected in many" 7 "Intestinal endocrine cells: 131.2;Muller glia cells: 100.6;Syncytiotrophoblasts: 170.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 32.7;WM-115: 71.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020587 Enhanced Approved Vesicles NA NA Vesicles "HPA020587: AB_1850452" "unprognostic (1.95e-1)" "unprognostic (3.32e-1)" "unprognostic (3.80e-2)" "unprognostic (5.19e-2)" "unprognostic (2.12e-2)" "unprognostic (2.41e-1)" "unprognostic (8.69e-4)" "unprognostic (3.86e-2)" "unprognostic (1.06e-1)" "unprognostic (9.28e-2)" "unprognostic (8.25e-3)" "unprognostic (2.23e-1)" "prognostic favorable (4.25e-6)" "prognostic unfavorable (6.17e-4)" "unprognostic (1.29e-1)" "unprognostic (7.33e-2)" "unprognostic (3.04e-4)" 8.0 15.0 3.1 7.6 9.8 0.0 9.7 0.7 8.0 22.6 11.8 2.2 14.4 6.5 23.3 40.6 11.5 10.4 8.9 5.1 2.5 4.8 11.4 1.0 9.0 1.2 2.4 4.5 17.9 32.3 23.9 3.7 86.0 14.3 14.3 3.8 19.4 10.7 16.1 5.9 5.0 10.5 15.1 2.8 3.2 11.9 17.0 2.2 0.3 8.0 6.1 3.1 11.3 20.2 0.6 0.4 1.5 1.9 0.6 0.2 0.3 3.8 9.4 32.7 7.3 5.1 5.0 6.1 5.3 9.0 8.7 7.0 5.9 18.9 0.0 4.0 4.2 8.4 2.5 6.5 0.4 6.3 0.0 4.3 8.0 7.1 0.0 4.7 0.0 0.0 3.0 1.2 4.1 4.4 13.3 4.0 0.0 6.7 0.1 5.9 0.5 0.0 0.1 8.3 5.5 14.6 0.0 7.7 3.8 17.3 1.6 0.1 24.6 0.0 4.4 11.3 14.7 1.5 0.0 1.9 2.6 1.2 8.8 2.9 0.0 0.0 0.0 1.4 0.0 71.2 1.3 1.9 0.4 0.2 1.1 0.1 0.3 0.1 0.1 0.4 0.6 0.2 0.2 1.5 0.6 0.7 0.2 0.1 0.3 3.1 9.8 0.7 8.0 2.5 4.8 2.4 4.5 14.3 2.2 14.9 12.0 0.8 22.6 14.0 1.2 1.2 50.9 49.5 37.5 22.7 0.0 32.9 38.1 25.9 3.4 21.5 13.4 0.0 33.1 5.1 35.1 61.3 0.0 0.2 2.8 1.6 131.2 5.5 0.6 4.7 19.0 3.6 33.7 1.8 2.0 100.6 43.4 5.8 57.7 30.0 1.5 6.5 40.6 35.4 22.8 24.1 170.9 0.0 0.8 15.0 GUSB ENSG00000169919 "Glucuronidase beta" P08236 7 65960684-65982314 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Cancer-related genes, Disease mutation, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 56.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036322, HPA036323" Approved Supported Vesicles "Intracellular and membrane" NA NA 48000 Vesicles "HPA036322: AB_10670796, HPA036323: AB_2675059" "unprognostic (1.54e-2)" "unprognostic (6.49e-2)" "unprognostic (1.18e-2)" "unprognostic (3.50e-1)" "unprognostic (2.58e-2)" "unprognostic (4.46e-2)" "unprognostic (2.89e-1)" "unprognostic (1.56e-3)" "unprognostic (1.32e-1)" "unprognostic (2.32e-1)" "unprognostic (7.00e-3)" "unprognostic (1.91e-1)" "unprognostic (3.34e-2)" "unprognostic (8.83e-3)" "unprognostic (1.98e-1)" "unprognostic (5.06e-1)" "unprognostic (1.45e-1)" 23.5 12.0 3.7 7.9 5.5 20.7 25.4 5.7 4.4 10.4 14.6 7.7 22.0 10.0 10.4 12.2 9.3 7.6 11.1 8.0 3.7 2.9 11.8 50.4 15.3 12.3 6.3 3.1 8.6 17.1 9.0 7.3 30.0 4.5 12.1 11.4 9.9 17.2 11.8 5.9 10.0 16.1 8.3 3.9 17.5 11.0 7.9 5.8 14.7 17.7 5.9 13.0 9.2 7.4 9.7 27.7 22.1 36.0 15.2 11.5 15.8 17.0 6.6 6.5 14.5 22.1 13.2 9.4 5.4 15.1 11.9 11.0 9.5 17.6 7.8 8.5 6.9 6.2 6.9 4.2 6.5 7.1 7.3 8.5 10.6 10.0 6.4 10.8 22.7 17.7 9.1 7.0 6.9 9.0 14.2 10.4 4.5 16.1 56.5 7.7 12.4 8.3 24.4 4.3 26.0 5.5 8.6 15.0 44.2 7.5 10.3 9.5 8.4 14.5 33.9 18.9 7.6 18.9 22.6 7.3 14.6 13.2 5.5 13.5 32.1 38.5 13.1 10.9 30.2 17.7 7.4 28.1 22.1 11.5 36.0 10.3 9.7 9.0 10.2 27.7 7.8 6.2 7.3 4.5 15.2 30.0 11.3 11.3 15.8 3.7 5.5 5.7 4.4 3.7 2.9 6.3 3.1 4.5 5.8 47.6 56.2 18.6 26.4 16.0 13.7 8.3 25.5 48.2 37.5 27.9 7.9 72.3 5.0 32.4 47.6 31.3 41.1 23.3 26.7 48.8 48.3 25.5 35.8 64.7 114.3 15.9 41.2 39.9 74.2 36.8 40.0 72.1 37.1 43.3 42.3 27.3 25.9 48.9 26.9 19.2 17.7 25.8 22.6 41.3 28.8 12.9 56.0 34.6 40.6 25.3 GYG1 GYG ENSG00000163754 "Glycogenin 1" P46976 3 148991341-149027668 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" Transferase "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 113.0" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 202.8;Early spermatids: 172.2;Late spermatids: 292.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030497, HPA073229" Supported Approved Vesicles NA NA Vesicles "HPA030497: AB_10602326, HPA073229: " "unprognostic (2.68e-2)" "unprognostic (6.31e-3)" "unprognostic (3.21e-1)" "unprognostic (1.81e-1)" "unprognostic (6.19e-2)" "unprognostic (1.49e-2)" "prognostic unfavorable (6.15e-5)" "unprognostic (2.55e-2)" "unprognostic (2.71e-1)" "unprognostic (1.10e-1)" "unprognostic (7.75e-3)" "unprognostic (1.29e-1)" "unprognostic (3.56e-2)" "unprognostic (1.27e-2)" "unprognostic (1.96e-1)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" 10.8 7.9 7.0 8.5 8.5 55.7 10.0 9.2 7.5 10.6 31.0 6.0 11.9 4.8 15.6 15.4 18.1 11.1 12.0 32.0 8.0 9.0 8.5 6.3 9.1 14.7 11.6 7.1 13.3 14.3 6.5 7.8 6.5 10.0 16.3 7.6 7.7 11.3 19.4 113.0 4.7 8.4 32.5 8.1 13.6 12.8 47.3 7.4 4.2 9.4 39.6 8.5 28.7 14.6 7.0 26.7 16.8 26.7 17.7 32.5 17.5 18.8 12.2 9.1 10.2 25.3 26.5 12.4 27.8 23.2 40.6 38.1 15.9 19.3 0.0 13.8 32.2 21.7 5.8 23.9 12.3 41.1 6.3 10.3 14.4 5.8 18.0 22.9 14.6 21.8 14.5 20.1 13.4 17.0 21.2 23.3 9.5 8.8 34.3 23.3 33.2 2.8 11.7 10.9 14.6 10.0 8.0 13.8 27.0 11.2 17.7 7.5 3.5 14.7 20.3 15.8 9.0 20.1 15.6 19.3 20.8 6.2 14.9 20.3 31.2 17.3 13.4 17.6 22.6 6.7 7.2 23.4 16.8 17.4 24.5 32.5 7.0 11.6 18.1 26.7 5.1 6.3 10.7 11.6 17.7 26.7 10.7 15.9 17.5 7.0 8.5 9.2 7.5 8.0 9.0 11.6 7.1 10.0 7.4 11.9 12.0 15.2 20.5 10.8 7.4 202.8 10.2 16.0 11.4 31.4 17.7 31.4 23.2 37.5 172.2 32.3 12.4 0.0 67.2 38.6 32.6 36.2 17.4 13.9 84.7 6.4 13.8 43.0 102.9 292.0 49.2 51.1 38.8 27.9 13.4 81.1 32.6 13.3 72.2 12.2 4.9 64.7 60.5 46.6 19.8 13.0 24.5 62.3 12.1 16.9 HAPLN1 CRTL1 ENSG00000145681 "Hyaluronan and proteoglycan link protein 1" P10915 5 83637805-83721613 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "placenta: 41.8" "Cell type enhanced" "Detected in some" 20 "Cytotrophoblasts: 7.6;Extravillous trophoblasts: 9.6;Fibroblasts: 4.4;Hofbauer cells: 9.4;Syncytiotrophoblasts: 19.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 33 "PC-3: 44.7;SuSa: 23.1;TIME: 28.3;U-2 OS: 46.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019105, HPA019482, HPA025238" Enhanced Approved Supported Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA019105: AB_1850496, HPA019482: AB_1850498, HPA025238: " "unprognostic (5.74e-4)" "unprognostic (2.94e-2)" "unprognostic (6.58e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (2.76e-3)" "unprognostic (6.01e-4)" "unprognostic (2.52e-2)" "unprognostic (1.70e-1)" "unprognostic (9.04e-3)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "prognostic unfavorable (4.81e-9)" "unprognostic (6.87e-2)" "unprognostic (2.04e-1)" "unprognostic (8.62e-2)" "unprognostic (3.91e-2)" 0.1 0.0 5.4 1.5 3.9 0.0 0.1 0.6 4.7 0.1 4.7 0.1 0.1 3.8 0.5 0.1 1.2 0.0 0.5 1.8 3.4 1.3 0.4 0.1 0.9 0.1 1.7 0.7 0.2 0.2 0.0 0.1 41.8 1.5 4.9 5.8 1.5 0.9 0.1 0.1 0.5 9.3 0.3 0.6 0.1 2.4 0.1 0.1 0.1 0.3 0.5 0.3 0.9 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 44.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.1 0.0 0.0 28.3 0.0 46.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 5.4 3.9 0.6 4.4 3.4 1.3 1.7 0.7 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 4.4 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 HAVCR1 "CD365, HAVCR, HAVCR-1, KIM1, TIM-1, TIM1, TIMD1" ENSG00000113249 "Hepatitis A virus cellular receptor 1" Q96D42 5 157029413-157059119 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "kidney: 37.6" "Not detected" "Not detected" "Cancer enriched" "Detected in many" 12 "renal cancer: 26.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "A549: 36.6;CACO-2: 44.0;RPTEC TERT1: 17.5" "HPA007173, CAB075697" Uncertain Approved Vesicles NA NA 155000 Vesicles "CAB075697: , HPA007173: AB_1080282" "unprognostic (1.24e-1)" "unprognostic (1.66e-1)" "unprognostic (5.76e-2)" "unprognostic (2.00e-1)" "unprognostic (6.99e-2)" "unprognostic (2.46e-3)" "unprognostic (4.75e-3)" "unprognostic (3.20e-2)" "unprognostic (3.21e-1)" "unprognostic (8.70e-4)" "unprognostic (3.81e-3)" "unprognostic (7.10e-3)" "prognostic unfavorable (7.81e-4)" "unprognostic (1.38e-1)" "unprognostic (1.57e-1)" "prognostic favorable (1.32e-4)" 0.4 0.1 0.2 1.0 0.2 0.9 0.2 0.2 0.2 0.2 6.7 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.5 0.2 0.3 0.2 37.6 0.5 0.6 0.6 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 5.3 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.5 0.5 0.2 1.1 0.2 0.2 0.2 0.2 0.2 0.3 0.2 1.3 1.2 2.0 1.8 2.1 3.4 2.3 0.0 36.6 0.1 0.0 0.1 0.0 5.7 0.0 0.0 0.0 0.0 44.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 1.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 2.0 1.8 0.5 0.7 1.1 1.0 0.8 1.8 0.9 1.2 1.3 3.4 2.5 1.3 2.1 0.8 0.8 2.8 2.3 0.2 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 HDHD2 DKFZP564D1378 ENSG00000167220 "Haloacid dehalogenase like hydrolase domain containing 2" Q9H0R4 18 47107403-47150520 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040697, CAB045978, HPA059818" Approved Approved Vesicles NA NA 170000 Vesicles "CAB045978: AB_11124418, HPA040697: AB_2677084, HPA059818: AB_2684132" "unprognostic (3.22e-1)" "unprognostic (6.32e-2)" "unprognostic (9.95e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.58e-1)" "unprognostic (3.11e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-2)" "unprognostic (5.35e-3)" "unprognostic (1.82e-2)" "unprognostic (8.64e-3)" "prognostic favorable (3.52e-5)" "unprognostic (1.95e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (1.17e-1)" 11.0 23.7 29.3 9.1 24.9 8.5 15.8 34.7 29.0 10.3 14.9 22.2 10.5 11.0 12.6 14.6 12.7 14.5 10.6 23.7 25.6 27.3 20.3 25.2 11.6 15.3 32.1 23.1 13.1 19.3 21.0 15.6 10.3 37.5 15.9 14.7 12.0 12.5 16.8 12.6 10.5 11.9 12.3 30.4 11.3 13.2 9.9 22.2 15.3 23.6 7.9 18.1 11.4 9.4 20.3 18.0 13.5 18.5 21.2 22.1 14.8 7.5 5.1 19.7 9.6 12.1 17.3 5.8 8.4 8.3 14.2 14.5 2.3 6.0 13.5 7.5 10.0 6.6 6.9 10.5 12.2 20.6 10.1 10.6 12.1 10.2 13.3 16.7 17.4 10.9 14.4 15.2 8.3 18.5 15.7 11.8 21.6 12.3 14.6 18.5 10.1 15.4 9.9 19.3 6.4 5.3 14.9 12.3 16.5 17.9 11.6 17.9 14.5 8.4 5.8 10.6 14.1 8.5 23.0 8.2 11.0 8.4 3.2 6.0 19.2 8.7 11.2 13.4 17.6 10.4 12.0 18.5 13.5 16.5 16.8 16.8 20.3 17.1 15.7 18.0 19.8 22.1 17.5 1.8 21.2 16.1 11.7 16.8 14.8 29.3 24.9 34.7 29.0 25.6 27.3 32.1 23.1 37.5 22.2 14.9 15.6 12.8 9.5 6.4 20.3 10.8 10.2 17.4 14.8 10.4 13.7 20.2 61.3 15.2 1.6 9.0 10.2 0.0 15.7 12.3 8.7 18.4 7.0 22.9 19.1 42.9 13.3 10.4 14.0 1.5 16.4 10.8 15.1 21.6 16.3 40.1 15.4 22.6 22.3 41.6 27.6 19.4 11.4 16.1 39.2 5.3 16.5 14.9 21.3 11.9 HEPACAM "FLJ25530, GLIALCAM, hepaCAM" ENSG00000165478 "Hepatic and glial cell adhesion molecule" Q14CZ8 11 124919193-124936412 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Cell cycle, Growth arrest, Growth regulation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 11 "adipose tissue: 17.3;brain: 64.7;liver: 19.6" "Group enriched" "Detected in some" 7 "Hepatocytes: 9.3;Muller glia cells: 13.0" "Cancer enriched" "Detected in some" 12 "glioma: 29.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in single" 31 "Hep G2: 24.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017613, CAB025486" Enhanced Approved Vesicles NA NA Vesicles "CAB025486: , HPA017613: AB_1850595" "unprognostic (3.22e-3)" "unprognostic (1.06e-2)" "unprognostic (1.64e-1)" "unprognostic (6.41e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (2.25e-1)" "unprognostic (7.58e-2)" "unprognostic (1.33e-2)" "unprognostic (1.06e-6)" "unprognostic (2.62e-1)" "unprognostic (3.21e-1)" 17.3 1.8 25.6 1.7 25.7 1.5 2.6 8.5 64.7 1.6 1.8 55.4 0.0 1.6 1.6 1.7 1.6 1.6 1.6 1.7 31.0 10.8 1.6 19.6 1.6 1.7 30.3 22.4 1.5 1.6 1.5 0.6 1.5 27.9 1.6 1.8 0.0 1.7 2.1 1.6 1.6 1.6 1.6 21.5 1.5 1.6 1.7 35.5 0.0 1.6 0.0 2.3 1.5 0.3 1.5 1.2 3.0 1.4 2.0 1.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 24.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.0 1.1 1.2 1.1 1.2 1.5 1.5 1.4 1.0 1.2 1.3 1.7 1.5 1.3 2.0 1.4 1.0 1.1 1.5 25.6 25.7 8.5 29.7 31.0 10.8 30.3 22.4 27.9 35.5 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 HIP1 ILWEQ ENSG00000127946 "Huntingtin interacting protein 1" O00291 7 75533300-75738962 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Apoptosis, Differentiation, Endocytosis, Transcription, Transcription regulation" "Actin-binding, Activator" "Cancer-related genes, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 1171.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 27.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013606, CAB015334, CAB016402, HPA017964" Enhanced Supported Vesicles NA NA Vesicles "CAB015334: AB_2117565, CAB016402: AB_627725, HPA013606: AB_1850717, HPA017964: AB_1850719" "unprognostic (8.23e-2)" "unprognostic (1.22e-1)" "unprognostic (2.20e-2)" "unprognostic (1.64e-1)" "unprognostic (1.04e-1)" "unprognostic (2.59e-1)" "unprognostic (2.73e-3)" "unprognostic (1.03e-2)" "unprognostic (1.11e-2)" "unprognostic (2.02e-2)" "unprognostic (2.70e-2)" "unprognostic (7.98e-2)" "unprognostic (1.73e-3)" "unprognostic (9.67e-2)" "unprognostic (1.75e-1)" "unprognostic (1.00e-2)" "unprognostic (1.09e-1)" 16.5 8.7 14.6 7.2 25.9 5.1 13.5 13.2 20.8 13.2 5.3 34.4 4.9 2.9 13.4 10.1 5.7 13.8 8.7 9.2 17.5 11.9 14.6 9.6 17.7 4.6 27.2 11.8 8.1 4.0 4.9 3.6 20.0 16.1 6.8 4.5 9.9 4.0 12.4 3.9 10.8 4.6 12.6 24.8 10.8 4.6 18.5 29.7 1.6 15.8 5.7 4.6 9.7 8.8 0.5 4.0 8.8 1.1 3.3 1.5 0.3 2.5 27.3 18.6 17.5 7.9 10.7 5.6 4.8 3.1 3.1 2.3 1.5 2.4 1.8 5.6 11.8 10.9 3.1 18.8 3.9 4.2 1.5 3.5 1.4 3.2 2.5 7.8 0.4 7.4 8.2 2.4 10.2 2.1 5.8 13.0 2.0 1.9 1.8 5.0 10.4 1.2 10.6 20.2 0.2 3.3 2.1 7.8 0.1 2.4 9.7 0.9 8.2 4.4 2.8 6.3 17.3 17.2 6.7 4.6 9.2 7.1 3.1 6.6 2.0 0.2 4.4 9.2 3.9 6.2 8.8 1.1 7.6 1.1 1.1 1.0 0.4 0.2 0.9 1.6 0.5 0.1 0.7 7.7 3.3 0.8 4.0 1.5 0.3 14.6 25.9 13.2 16.9 17.5 11.9 27.2 11.8 16.1 29.7 56.6 35.7 6.0 6.3 15.7 7.1 12.5 5.1 0.0 17.0 26.2 11.8 1.3 11.6 10.2 240.8 40.7 0.7 0.0 5.3 7.5 15.4 4.0 13.9 20.2 11.7 22.3 4.6 30.1 15.1 1171.7 20.8 22.9 10.1 1.0 1.4 18.6 2.6 8.5 23.3 2.2 8.2 84.1 37.2 9.3 4.1 8.0 0.7 17.0 2.6 3.1 HLA-DMA "D6S222E, RING6" ENSG00000204257 "Major histocompatibility complex, class II, DM alpha" P28067 6 32948613-32969094 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "B-cells: 394.3;Hofbauer cells: 370.5;Kupffer cells: 264.8;Macrophages: 648.8;monocytes: 269.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 4.1;intermediate monocyte: 4.0;memory B-cell: 6.8;myeloid DC: 7.9;naive B-cell: 7.0;plasmacytoid DC: 5.7" "Group enriched" "Detected in many" 12 "B-cells: 7.0;dendritic cells: 7.9;monocytes: 4.1" "Group enriched" "Detected in some" 4 "U-266/70: 15.7;U-698: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012750, HPA017295" Enhanced Approved Vesicles NA NA Vesicles "HPA012750: AB_1853926, HPA017295: AB_2669575" "unprognostic (1.69e-3)" "unprognostic (3.52e-2)" "unprognostic (8.03e-2)" "prognostic favorable (4.64e-5)" "unprognostic (3.99e-1)" "unprognostic (3.90e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.59e-4)" "unprognostic (7.01e-2)" "unprognostic (9.69e-2)" "unprognostic (6.66e-2)" "unprognostic (1.89e-1)" "unprognostic (2.12e-3)" "unprognostic (1.41e-1)" "unprognostic (4.95e-2)" "unprognostic (3.80e-1)" "unprognostic (2.14e-2)" 22.9 20.5 5.1 27.2 7.9 18.9 17.4 1.0 5.0 11.3 18.4 9.8 5.7 3.2 8.0 25.3 6.7 32.1 11.1 13.1 4.6 5.2 19.3 12.4 50.7 24.5 10.1 2.0 14.9 20.2 2.1 5.0 3.2 9.7 7.6 14.3 8.4 17.3 10.1 4.3 7.3 28.4 4.3 15.2 38.5 23.1 3.5 7.9 17.3 10.0 11.9 42.1 5.9 6.0 7.0 7.9 0.5 4.1 0.3 0.4 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.2 0.1 0.0 1.3 0.2 0.0 0.0 0.2 1.9 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 15.7 6.9 40.0 0.3 0.0 0.0 0.0 4.1 0.4 0.2 4.0 0.0 6.8 0.1 0.3 7.9 7.0 0.1 0.2 0.5 0.3 1.1 5.7 0.4 3.1 5.1 7.9 1.0 5.0 4.6 5.2 10.1 2.0 9.7 7.9 68.5 147.1 394.3 13.3 42.8 1.6 3.6 50.9 37.5 51.2 50.6 2.0 3.8 14.9 38.3 2.8 85.6 22.0 23.3 46.1 3.5 19.8 18.9 40.4 2.9 370.5 0.0 2.9 32.5 264.8 4.3 15.0 648.8 75.9 269.7 18.9 4.1 34.9 15.3 17.7 36.3 0.8 19.4 18.6 3.6 4.4 36.6 3.3 44.0 22.6 27.6 HLA-DMB "D6S221E, RING7" ENSG00000242574 "Major histocompatibility complex, class II, DM beta" P28068 6 32934629-32941070 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "B-cells: 222.5;Hofbauer cells: 281.2;Kupffer cells: 131.2;Macrophages: 353.4;monocytes: 112.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 6 "B-cells: 19.9;dendritic cells: 11.5;monocytes: 11.9" "Group enriched" "Detected in some" 13 "CAPAN-2: 7.3;Daudi: 10.3;EFO-21: 4.9;U-266/70: 3.9;U-698: 12.6" "HPA012298, HPA077524" Supported Supported Vesicles NA NA Vesicles "HPA012298: AB_1853927, HPA077524: " "unprognostic (5.34e-2)" "unprognostic (1.63e-2)" "unprognostic (2.45e-2)" "prognostic favorable (3.89e-5)" "unprognostic (3.07e-1)" "unprognostic (7.64e-3)" "unprognostic (4.00e-1)" "unprognostic (3.46e-3)" "unprognostic (6.99e-2)" "unprognostic (8.76e-2)" "unprognostic (8.93e-2)" "unprognostic (2.73e-1)" "unprognostic (6.82e-3)" "unprognostic (2.03e-1)" "unprognostic (4.14e-2)" "unprognostic (8.35e-2)" "unprognostic (5.60e-2)" 12.0 13.0 5.9 20.2 7.5 4.3 7.9 0.4 4.9 8.1 9.7 8.8 2.1 1.2 6.2 10.2 3.3 12.6 6.0 8.0 5.7 4.2 13.1 5.4 20.8 24.0 10.2 2.3 7.4 5.0 1.2 3.2 6.2 8.1 6.3 10.5 6.3 7.8 3.2 2.9 4.5 31.8 1.9 14.5 35.6 6.1 2.1 7.3 10.5 33.7 3.8 34.5 10.6 3.2 19.9 11.5 2.2 11.9 2.2 1.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 10.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.9 0.3 12.6 0.0 0.0 0.0 0.0 11.9 2.2 0.3 10.1 0.4 15.1 0.2 0.5 11.1 19.9 0.1 0.5 0.5 2.2 3.5 11.5 1.0 10.3 5.9 7.5 0.4 4.9 5.7 4.2 10.2 2.3 8.1 7.3 8.9 53.6 222.5 0.9 10.6 0.1 2.2 7.6 10.7 6.8 15.7 0.0 1.4 10.0 10.4 0.5 31.8 3.1 0.0 4.0 1.2 4.7 1.4 14.0 0.6 281.2 0.0 4.1 3.7 131.2 0.7 3.1 353.4 15.1 112.8 1.5 0.5 3.9 0.9 1.8 6.0 1.2 6.5 4.1 0.4 0.5 9.5 2.3 15.0 1.7 2.4 HLA-DPA1 HLA-DP1A ENSG00000231389 "Major histocompatibility complex, class II, DP alpha 1" P20036 6 33064569-33080775 "Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 59.5" "Cell type enhanced" "Detected in many" 18 "B-cells: 1100.8;Hofbauer cells: 1218.6;Kupffer cells: 965.1;Macrophages: 2476.0;monocytes: 4193.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 16.3;intermediate monocyte: 37.8;memory B-cell: 30.0;myeloid DC: 59.5;naive B-cell: 26.7;non-classical monocyte: 23.2;plasmacytoid DC: 17.1" "Group enriched" "Detected in all" 8 "B-cells: 30.0;dendritic cells: 59.5;monocytes: 37.8" "Cell line enhanced" "Detected in some" "Daudi: 15.8;HDLM-2: 48.6;REH: 12.4;U-698: 11.4" HPA017967 Enhanced Supported Vesicles NA NA 92000 Vesicles "HPA017967: AB_1853929" "unprognostic (8.93e-3)" "unprognostic (3.15e-2)" "unprognostic (3.64e-2)" "unprognostic (9.40e-3)" "unprognostic (9.07e-2)" "unprognostic (2.80e-2)" "unprognostic (5.69e-2)" "unprognostic (1.82e-2)" "unprognostic (7.28e-2)" "unprognostic (1.39e-1)" "unprognostic (1.93e-1)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.17e-1)" "unprognostic (4.69e-2)" "unprognostic (8.11e-2)" "unprognostic (1.06e-1)" 25.2 12.8 3.3 13.3 3.6 4.7 16.3 3.5 3.3 11.8 6.8 3.1 4.3 8.6 8.5 15.9 8.5 5.7 14.7 11.1 4.2 6.2 12.4 9.7 35.9 20.2 6.2 3.8 3.8 5.4 3.8 5.2 6.5 4.8 7.4 7.3 7.5 7.4 15.7 4.1 5.8 14.7 6.4 20.4 37.6 5.6 8.6 4.1 10.9 14.2 9.5 21.5 8.5 17.8 30.0 59.5 1.3 37.8 4.0 5.6 20.3 0.0 0.0 0.0 0.0 0.3 0.6 0.5 0.2 0.1 0.2 0.0 0.0 2.1 15.8 2.2 0.3 3.1 0.0 0.0 0.0 0.0 48.6 1.0 2.6 0.0 0.0 0.0 0.0 5.1 0.7 0.0 1.0 0.0 0.0 0.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 12.4 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 1.1 3.5 0.0 0.0 0.0 2.4 0.3 11.4 5.5 0.1 1.9 0.3 16.3 1.3 4.6 37.8 1.2 30.0 2.1 5.0 59.5 26.7 0.7 3.4 0.6 4.0 23.2 17.1 5.6 20.3 3.3 3.6 3.5 3.3 4.2 6.2 6.2 3.8 4.8 4.1 77.4 317.2 1100.8 5.1 183.6 2.5 10.5 76.5 80.3 113.7 22.7 0.0 4.2 8.3 15.4 2.1 188.1 6.1 0.0 15.8 5.3 55.4 10.4 62.4 4.5 1218.6 4.8 9.8 60.2 965.1 4.3 16.7 2476.0 286.8 4193.1 9.2 4.8 4.8 4.5 25.8 32.7 3.1 51.8 21.8 0.9 2.9 153.2 5.7 100.5 4.1 8.9 HLA-E ENSG00000204592 "Major histocompatibility complex, class I, E" 6 30489467-30494205 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Endothelial cells: 1478.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 25.2;U-266/70: 35.8" "CAB024589, HPA031454" Enhanced Approved Vesicles NA NA Vesicles "CAB024589: AB_324025, HPA031454: AB_2673891" "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (9.20e-2)" "unprognostic (2.47e-3)" "unprognostic (2.06e-1)" "unprognostic (3.63e-1)" "unprognostic (1.14e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-2)" "unprognostic (1.35e-2)" "unprognostic (5.57e-2)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (2.90e-1)" "unprognostic (4.14e-2)" "unprognostic (1.75e-3)" "unprognostic (1.42e-3)" 81.4 19.4 12.6 42.9 16.9 81.7 49.9 6.5 14.9 37.6 32.7 23.2 15.5 2.1 41.2 30.6 40.1 28.2 44.0 36.7 15.1 13.3 34.8 56.5 129.7 76.7 19.9 10.5 29.1 14.6 33.9 11.6 33.1 24.9 32.2 28.6 33.9 23.1 27.5 34.8 97.2 36.8 22.9 21.7 97.1 50.5 18.1 14.6 35.0 45.7 36.4 72.4 45.9 33.3 23.0 7.8 90.2 28.9 23.2 37.1 56.3 11.3 1.8 0.7 6.7 25.2 20.0 0.0 0.0 0.0 0.0 0.0 4.7 23.1 7.4 11.5 10.1 19.8 14.0 1.5 5.8 0.0 7.5 4.8 8.8 2.2 0.0 0.0 0.0 3.2 15.7 10.9 8.0 0.0 0.0 0.0 4.8 1.1 0.1 6.0 0.0 0.0 0.0 0.0 3.8 0.0 1.6 0.0 9.7 10.2 6.4 0.0 0.5 7.8 6.2 0.0 0.1 0.0 15.1 11.2 7.1 0.0 0.0 1.4 35.8 20.4 2.9 0.0 6.7 18.6 56.6 14.0 52.5 37.0 24.6 31.5 23.0 28.1 37.1 7.8 22.5 28.5 28.4 90.2 23.2 28.9 6.6 29.4 56.3 12.6 16.9 6.5 14.9 15.1 13.3 19.9 10.5 24.9 14.6 288.8 451.7 691.8 327.5 430.6 2.0 80.3 247.1 216.8 225.2 116.9 5.9 69.1 14.9 371.5 3.5 1478.5 407.9 46.7 585.9 231.5 281.0 321.3 504.0 75.0 648.8 4.8 207.4 1236.3 939.1 5.9 122.3 661.4 442.1 534.8 437.5 90.5 562.6 382.2 71.8 70.5 5.3 174.6 453.2 9.2 3.3 372.8 300.2 1180.5 194.8 500.2 HMCN2 "DKFZp434P0216, FLJ23816" ENSG00000148357 "Hemicentin 2" Q8NDA2 9 130265882-130434123 "Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 15.6;Enterocytes: 21.5" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 8.2;RH-30: 19.2;SCLC-21H: 2.8;SH-SY5Y: 4.5;U-138 MG: 3.2;U-87 MG: 4.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA053903, HPA070647" Enhanced Approved Vesicles "Secreted to extracellular matrix" NA NA 7700000 Vesicles "HPA053903: AB_2682301, HPA070647: AB_2686290" "unprognostic (1.61e-1)" "unprognostic (8.05e-3)" "unprognostic (1.69e-1)" "unprognostic (5.53e-4)" "unprognostic (1.05e-1)" "unprognostic (1.12e-2)" "unprognostic (1.10e-1)" "unprognostic (8.78e-3)" "unprognostic (3.23e-1)" "unprognostic (3.97e-4)" "unprognostic (3.36e-2)" "unprognostic (3.93e-1)" "unprognostic (1.04e-3)" "unprognostic (1.53e-2)" "unprognostic (3.62e-2)" "unprognostic (8.96e-3)" "unprognostic (8.63e-2)" 7.4 1.7 0.2 10.2 0.2 0.1 3.8 0.1 0.4 18.3 25.0 0.0 1.0 5.9 21.9 25.1 4.9 5.1 5.0 8.7 0.4 0.4 1.4 0.4 2.7 2.3 0.0 0.0 8.9 0.8 0.2 0.1 0.3 0.8 5.1 2.3 0.1 1.7 3.4 24.3 2.8 11.2 20.8 0.5 0.3 2.3 6.3 0.0 1.8 2.6 10.9 1.5 12.1 7.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.4 0.2 0.5 0.0 19.2 0.1 0.0 0.1 2.8 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.4 0.4 0.4 0.0 0.0 0.8 0.0 3.0 6.9 0.5 0.2 0.8 0.5 3.6 0.0 6.7 6.8 0.0 0.0 0.0 1.7 0.0 15.6 1.3 21.5 0.0 0.0 0.1 2.4 0.7 7.0 1.1 0.3 1.6 0.0 0.6 0.3 8.0 0.0 0.9 1.7 0.0 1.9 0.0 0.1 7.0 0.0 1.1 0.6 0.0 3.8 0.2 0.7 0.5 0.2 0.0 2.9 3.3 HP ENSG00000257017 Haptoglobin P00738 16 72054592-72061055 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Immunity" "Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "liver: 1156.9" "Cell type enriched" "Detected in many" 51 "Hepatocytes: 52541.7" "Cancer enriched" "Detected in many" 81 "liver cancer: 1297.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "classical monocyte: 20.0;eosinophil: 30.9" "Group enriched" "Detected in many" 7 "granulocytes: 30.9;monocytes: 20.0" "Group enriched" "Detected in some" 5 "Hep G2: 66.2;HSkMC: 37.9" "CAB003787, HPA047750" Enhanced Approved Vesicles "Secreted to blood" NA NA 998000000000 140000000000 Vesicles "CAB003787: , HPA047750: AB_2680146" "unprognostic (6.38e-3)" "unprognostic (7.73e-3)" "unprognostic (1.23e-1)" "unprognostic (2.41e-2)" "unprognostic (2.34e-3)" "unprognostic (2.07e-1)" "unprognostic (7.79e-3)" "unprognostic (1.37e-1)" "unprognostic (2.31e-1)" "unprognostic (1.84e-1)" "unprognostic (6.30e-2)" "unprognostic (8.18e-2)" "prognostic unfavorable (6.94e-13)" "unprognostic (4.34e-4)" "unprognostic (1.80e-1)" "unprognostic (6.61e-2)" "unprognostic (2.49e-2)" 9.8 0.0 0.3 0.4 0.3 4.4 0.3 0.3 0.3 1.5 0.4 0.3 0.3 0.0 0.3 0.5 0.3 1.1 0.3 3.0 0.3 0.0 0.4 1156.9 1.4 0.4 0.3 0.3 0.3 0.5 0.0 0.5 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 1.4 0.0 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.5 0.0 3.5 30.9 20.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.5 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.4 0.0 66.2 0.1 9.5 1.8 37.9 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.6 0.1 0.8 0.0 0.0 0.3 7.1 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 2.1 1.4 0.0 0.2 0.0 0.0 1.2 0.0 4.5 0.0 3.7 0.0 2.6 20.0 30.9 0.0 0.8 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 5.8 0.0 0.9 0.0 0.0 5.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 17.9 220.1 295.8 0.8 0.1 0.2 72.5 853.5 10.7 10.3 0.0 0.0 0.0 0.0 0.0 0.1 6.8 0.0 864.3 9.6 0.0 0.2 0.2 3.5 52541.7 2.4 0.0 0.0 971.0 1021.7 0.0 9.5 0.0 1.7 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.1 0.0 0.9 0.0 0.0 0.3 0.1 23.0 0.0 0.0 HPR ENSG00000261701 "Haptoglobin-related protein" P00739 16 72063224-72077246 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Serine protease homolog" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "liver: 151.4" "Cell type enriched" "Detected in some" 18 "Hepatocytes: 430.8" "Cancer enriched" "Detected in some" 53 "liver cancer: 185.1" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 14 "Hep G2: 33.6" HPA047750 Supported Approved Vesicles "Secreted to blood" NA NA 49000000000 77000000000 Vesicles "HPA047750: AB_2680146" "unprognostic (2.43e-1)" "unprognostic (4.69e-2)" "unprognostic (5.97e-3)" "unprognostic (2.42e-1)" "unprognostic (2.32e-3)" "unprognostic (2.36e-1)" "unprognostic (1.66e-1)" "unprognostic (8.21e-2)" "unprognostic (2.30e-1)" "unprognostic (3.44e-6)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.29e-1)" 0.2 0.0 1.3 0.0 1.6 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1 15.2 0.7 0.8 0.1 151.4 0.0 0.1 2.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 2.9 1.1 1.0 0.4 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.6 1.6 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 1.1 1.3 1.0 0.1 0.5 0.4 0.4 0.3 1.1 2.0 1.1 0.3 0.4 0.3 2.9 2.3 0.3 0.0 9.8 0.0 0.0 0.1 0.0 14.9 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 23.3 0.2 0.0 0.2 0.0 0.0 430.8 0.0 0.0 0.0 9.8 7.3 2.1 9.2 0.0 0.0 0.0 0.0 5.2 0.0 0.0 4.9 4.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HS3ST1 3OST1 ENSG00000002587 "Heparan sulfate-glucosamine 3-sulfotransferase 1" O14792 4 11393150-11429765 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.4;gallbladder: 31.9;ovary: 30.3" "Cell type enhanced" "Detected in many" 6 "Ciliated cells: 64.3;Club cells: 83.0;granulocytes: 93.6;Peritubular cells: 84.8;Urothelial cells: 90.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 8 "cerebellum: 27.4;cerebral cortex: 9.0" "Group enriched" "Detected in some" 39 "memory B-cell: 7.3;naive B-cell: 15.8;plasmacytoid DC: 22.3" "Group enriched" "Detected in many" 99 "B-cells: 15.8;dendritic cells: 22.3" "Cell line enhanced" "Detected in some" "A-431: 4.5;CAPAN-2: 14.4;HaCaT: 4.3;RPTEC TERT1: 12.6;RT4: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002237 Approved Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA002237: AB_1079085" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (4.01e-2)" "prognostic favorable (7.73e-4)" "unprognostic (3.32e-2)" "unprognostic (8.90e-3)" "unprognostic (4.21e-1)" "unprognostic (2.08e-1)" "unprognostic (2.22e-1)" "unprognostic (1.32e-1)" "unprognostic (1.77e-2)" "unprognostic (1.08e-1)" "prognostic favorable (5.99e-8)" "unprognostic (9.99e-2)" "unprognostic (1.42e-1)" "unprognostic (1.57e-1)" "prognostic favorable (8.67e-4)" 2.3 2.9 1.6 2.8 2.2 2.8 2.0 27.4 9.0 3.3 2.7 1.1 3.6 3.5 4.3 5.0 10.2 4.3 31.9 2.2 1.7 1.8 10.4 0.9 3.4 2.1 1.9 1.5 30.3 1.1 0.7 8.9 1.0 2.4 3.2 1.7 1.7 3.7 2.4 0.7 0.8 2.9 1.7 2.2 3.0 7.0 3.0 0.3 3.8 1.8 7.0 7.4 7.3 2.4 15.8 22.3 0.1 0.1 0.0 0.1 0.6 4.5 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 14.4 0.0 0.4 0.0 0.0 4.3 0.0 2.5 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.7 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.9 1.2 1.0 0.0 0.0 12.6 10.3 3.8 0.0 0.0 0.1 0.5 0.2 0.0 0.0 2.0 0.7 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.1 7.3 0.0 0.0 0.3 15.8 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.6 1.6 2.2 27.4 9.0 1.7 1.8 1.9 1.5 2.4 0.3 3.0 8.0 2.2 9.8 8.0 1.5 2.4 15.3 64.3 83.0 19.2 3.9 0.5 0.0 17.1 0.8 23.4 3.0 0.0 1.8 31.9 5.0 4.1 93.6 0.0 37.3 1.6 2.4 9.2 2.7 0.8 8.1 9.0 1.7 7.2 5.6 39.8 32.0 2.6 84.8 3.7 2.2 0.0 6.4 6.0 5.5 7.0 1.1 0.9 3.7 90.2 HS3ST3B1 "30ST3B1, 3OST3B1" ENSG00000125430 "Heparan sulfate-glucosamine 3-sulfotransferase 3B1" Q9Y662 17 14301083-14349404 "Enzymes, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 20.6;liver: 29.1;lymphoid tissue: 26.6;placenta: 33.5;salivary gland: 12.6" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 37.3;Hepatocytes: 32.1;Ito cells: 34.4;Syncytiotrophoblasts: 30.3" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 4 "cerebral cortex: 2.7;pons and medulla: 6.0" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 20.6" "Group enriched" "Detected in many" 5 "dendritic cells: 20.6;T-cells: 14.7" "Cell line enhanced" "Detected in many" "AF22: 15.5;BEWO: 11.1;Hep G2: 13.5;HSkMC: 15.4;U-251 MG: 14.2" HPA064126 Approved Vesicles NA NA Vesicles "HPA064126: AB_2685194" "unprognostic (1.74e-1)" "unprognostic (1.13e-1)" "unprognostic (2.29e-2)" "unprognostic (5.55e-3)" "unprognostic (2.85e-3)" "unprognostic (5.22e-2)" "unprognostic (5.03e-3)" "unprognostic (1.79e-1)" "unprognostic (2.93e-1)" "unprognostic (8.13e-3)" "unprognostic (8.80e-2)" "unprognostic (1.13e-1)" "unprognostic (1.02e-3)" "unprognostic (7.77e-3)" "unprognostic (9.46e-2)" "unprognostic (1.91e-1)" "unprognostic (1.54e-3)" 1.4 1.4 0.6 8.7 0.8 1.3 3.0 0.9 2.7 3.8 1.8 0.0 0.8 1.4 1.0 0.3 2.8 1.7 2.6 2.0 0.6 0.7 3.6 29.1 3.7 26.6 0.6 0.0 4.7 1.3 0.4 1.4 33.5 6.0 2.4 1.9 5.3 12.6 2.5 1.8 2.2 2.5 0.6 2.9 4.9 1.4 0.7 0.0 13.2 1.5 2.5 5.9 1.5 5.3 0.4 20.6 0.5 0.4 3.8 14.7 2.7 0.0 0.3 15.5 0.0 4.7 5.3 11.1 4.4 6.4 4.0 4.2 0.0 0.1 0.0 0.0 6.0 0.0 0.0 0.4 2.4 2.0 1.3 3.2 0.3 2.0 13.5 6.2 0.5 2.3 15.4 0.8 1.4 3.7 0.9 0.0 0.8 4.6 0.0 3.2 0.8 0.7 0.6 0.5 0.1 0.4 2.7 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.3 0.4 0.0 3.9 0.0 0.0 14.2 0.0 0.0 0.0 3.0 0.0 0.9 0.1 0.2 0.0 6.3 0.4 5.0 0.4 7.6 4.9 0.4 0.4 7.7 7.5 0.5 3.8 0.4 20.6 14.7 2.7 0.6 0.8 0.9 2.7 0.6 0.7 0.6 0.0 6.0 0.0 0.0 0.6 1.4 0.2 10.2 2.0 2.2 2.5 4.0 1.2 7.0 37.3 5.1 0.0 0.6 11.1 2.5 0.0 0.0 0.2 10.4 9.0 0.7 0.0 32.1 1.4 7.9 0.0 34.4 3.7 1.4 2.6 4.3 1.7 1.8 0.0 6.0 0.1 0.0 1.1 0.0 15.2 12.9 2.7 0.6 0.4 12.9 30.3 11.7 0.0 0.1 HSD11B1L "SCDR10, SDR26C2" ENSG00000167733 "Hydroxysteroid 11-beta dehydrogenase 1 like" Q7Z5J1 19 5680604-5688523 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 34.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SH-SY5Y: 17.2" "Low region specificity" "Detected in all" HPA049078 Supported Vesicles "Secreted in brain" NA NA Vesicles "HPA049078: AB_2680622" "unprognostic (2.34e-2)" "unprognostic (1.10e-1)" "unprognostic (4.73e-3)" "unprognostic (5.26e-2)" "unprognostic (9.37e-2)" "prognostic favorable (4.38e-4)" "unprognostic (4.81e-3)" "unprognostic (6.63e-3)" "unprognostic (2.63e-1)" "unprognostic (2.47e-1)" "unprognostic (1.18e-3)" "unprognostic (1.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.75e-1)" "unprognostic (5.77e-2)" "unprognostic (4.52e-1)" "unprognostic (1.73e-2)" 3.9 8.8 34.4 2.1 19.2 4.7 5.0 10.3 29.7 3.9 2.9 5.4 3.7 2.6 3.6 8.5 2.2 7.6 4.8 3.8 25.4 16.1 6.7 3.5 4.4 2.3 11.7 20.4 6.1 6.2 5.8 8.5 2.5 10.7 4.0 1.9 3.2 9.1 6.9 15.0 6.9 2.9 2.7 6.0 2.6 3.3 4.3 7.5 0.0 6.6 1.3 1.8 2.5 2.2 2.5 4.8 2.5 5.8 1.4 4.5 1.7 2.9 2.8 10.4 1.9 4.9 5.3 2.1 2.2 4.5 1.0 4.5 1.3 2.9 0.7 4.9 1.9 0.8 1.5 1.2 1.6 1.0 2.4 3.1 1.9 2.5 1.8 3.4 0.7 7.1 5.2 3.5 1.6 1.5 9.6 1.6 4.4 1.9 2.8 4.2 0.4 1.8 2.0 2.8 12.5 3.3 3.3 0.4 2.5 8.7 0.7 2.8 17.2 0.5 1.5 11.0 3.8 2.4 0.6 2.8 2.6 4.6 4.4 1.8 6.9 2.3 0.8 7.2 1.1 2.0 1.7 2.5 0.2 1.2 5.8 1.6 1.2 3.2 3.6 2.3 2.5 4.5 3.9 2.5 1.4 2.9 4.8 0.9 1.7 34.4 19.2 10.3 29.7 25.4 16.1 11.7 20.4 10.7 7.5 0.0 1.6 0.8 7.6 7.2 11.2 2.0 5.1 13.4 4.5 22.7 13.7 4.0 13.3 8.9 6.8 3.8 3.8 0.0 4.1 3.9 8.9 8.0 10.3 3.2 4.2 7.9 24.6 8.0 2.8 9.6 6.6 3.6 5.0 2.8 4.3 17.0 4.8 2.8 12.0 23.7 11.7 0.0 9.9 10.3 10.6 8.9 2.4 3.3 3.5 7.5 HSD17B3 SDR12C2 ENSG00000130948 "Hydroxysteroid 17-beta dehydrogenase 3" P37058 9 96235306-96302152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Disease mutation, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 41.9" "Cell type enriched" "Detected in some" 8 "Leydig cells: 100.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HBEC3-KT: 5.0;HEL: 4.4;U-2 OS: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA056833 Enhanced Approved Vesicles NA NA Vesicles "HPA056833: AB_2683252" "unprognostic (2.78e-1)" "unprognostic (6.61e-3)" "unprognostic (1.03e-1)" "unprognostic (5.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (3.08e-2)" "unprognostic (6.15e-2)" "unprognostic (1.74e-1)" "unprognostic (5.13e-2)" "unprognostic (3.26e-4)" "unprognostic (3.45e-1)" "unprognostic (5.48e-8)" "unprognostic (8.47e-3)" "unprognostic (1.15e-1)" "unprognostic (7.24e-2)" "unprognostic (3.11e-2)" 0.5 0.4 1.0 0.5 1.0 0.4 0.5 0.5 0.9 0.8 0.5 0.5 0.5 0.4 0.5 0.5 0.5 1.3 0.5 0.5 1.7 0.5 1.0 6.3 0.5 0.5 1.6 0.5 0.5 1.3 0.4 0.5 0.5 0.5 0.8 0.4 0.5 0.5 0.5 0.5 0.5 1.1 0.5 1.9 0.5 0.4 41.9 0.5 0.5 4.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.0 1.0 0.5 0.9 1.7 0.5 1.6 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.4 0.3 0.0 0.4 0.0 0.2 0.1 0.0 1.6 0.0 0.0 1.7 0.0 0.0 7.8 100.1 0.0 0.0 0.0 0.2 0.5 0.1 0.0 12.0 0.0 0.2 0.0 0.5 0.3 1.9 0.3 0.1 0.0 0.2 0.0 HTRA3 "Prsp, Tasp" ENSG00000170801 "HtrA serine peptidase 3" P83110 4 8269765-8307111 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 57.9" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 14.0;Fibroblasts: 45.9;Leydig cells: 40.3;Peritubular cells: 40.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in single" 9 "basal ganglia: 8.2" "Cell type enhanced" "Detected in single" "neutrophil: 1.3" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 5 "U-2197: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021187, HPA063810" Approved Approved Vesicles "Secreted in female reproductive system" NA NA Vesicles "HPA021187: AB_1851311, HPA063810: AB_2685129" "unprognostic (5.87e-2)" "unprognostic (1.40e-2)" "unprognostic (2.89e-2)" "unprognostic (9.32e-2)" "unprognostic (1.84e-1)" "unprognostic (3.09e-2)" "unprognostic (1.12e-3)" "unprognostic (5.29e-2)" "unprognostic (3.81e-2)" "unprognostic (1.15e-1)" "unprognostic (1.95e-2)" "unprognostic (2.79e-1)" "prognostic unfavorable (1.61e-9)" "unprognostic (1.65e-3)" "unprognostic (2.56e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.34e-2)" 23.7 1.8 0.6 7.3 8.2 5.3 35.6 0.7 0.9 12.3 9.4 0.8 5.4 3.7 19.6 26.6 14.4 7.9 19.8 57.9 0.7 0.3 1.7 1.6 15.4 4.3 0.8 0.9 30.7 2.8 0.0 5.1 9.6 0.9 15.4 2.0 8.6 6.6 3.0 12.9 9.0 6.7 50.1 0.8 1.8 6.8 7.2 0.6 1.3 9.3 11.6 3.0 28.7 12.7 0.0 0.4 1.3 0.3 0.0 0.0 0.1 0.0 0.3 0.4 0.0 2.1 3.9 0.1 0.8 0.0 1.0 0.2 0.0 0.0 0.0 4.8 2.1 0.5 0.0 0.4 0.0 0.3 0.0 0.8 0.4 5.0 0.0 2.2 0.0 0.2 0.4 0.0 1.4 0.0 0.6 3.4 0.0 0.1 0.0 3.5 0.0 0.0 12.2 2.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 5.6 0.1 9.1 0.1 0.0 10.6 0.0 0.4 2.7 0.5 1.7 64.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.1 0.6 8.2 0.7 0.9 0.7 0.3 0.8 0.9 0.9 0.6 0.0 0.0 0.0 0.3 4.6 0.0 14.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.6 3.1 0.0 0.0 0.0 3.7 45.9 0.1 0.0 0.0 1.1 0.0 0.0 4.3 0.0 0.5 40.3 0.9 0.0 0.0 0.0 0.0 0.2 0.0 40.3 0.0 0.0 0.0 5.1 0.2 0.9 4.5 1.1 0.0 0.0 0.1 IDI2 IPPI2 ENSG00000148377 "Isopentenyl-diphosphate delta isomerase 2" Q9BXS1 10 1018907-1025859 "Enzymes, Predicted intracellular proteins" "Cholesterol biosynthesis, Cholesterol metabolism, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 125 "skeletal muscle: 141.6" "Cell type enhanced" "Detected in some" 13 "Club cells: 1.2;Horizontal cells: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 1.4;NB-4: 2.7;NTERA-2: 1.5;SK-MEL-30: 3.4" HPA041254 Uncertain Vesicles NA NA Vesicles "HPA041254: AB_10794270" "unprognostic (6.69e-3)" "unprognostic (4.05e-2)" "unprognostic (1.64e-1)" 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 141.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.7 0.5 0.1 0.0 0.7 0.0 0.8 0.1 0.0 1.0 0.0 0.0 0.4 0.4 0.8 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.7 0.0 0.5 0.0 0.3 0.9 1.4 0.2 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.2 0.3 2.7 1.5 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.1 0.0 0.0 0.0 3.4 0.2 1.0 0.1 0.0 0.1 0.1 0.4 0.0 0.2 0.4 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.1 1.0 0.1 0.1 0.1 0.0 0.7 0.1 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 IDUA MPS1 ENSG00000127415 "Iduronidase, alpha-L-" P35475 4 986997-1004506 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Disease mutation, Mucopolysaccharidosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Leydig cells: 18.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 32.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025901, HPA046979, HPA054254" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 130000 Vesicles "CAB025901: , HPA046979: AB_2679888, HPA054254: AB_2682429" "unprognostic (3.62e-2)" "unprognostic (9.08e-2)" "prognostic unfavorable (3.13e-4)" "unprognostic (7.23e-2)" "unprognostic (1.45e-1)" "unprognostic (2.31e-2)" "unprognostic (1.83e-1)" "unprognostic (1.67e-1)" "unprognostic (1.43e-2)" "unprognostic (1.89e-3)" "unprognostic (2.64e-2)" "unprognostic (4.61e-3)" "prognostic unfavorable (7.87e-5)" "unprognostic (2.24e-1)" "unprognostic (1.55e-1)" "unprognostic (2.46e-2)" "prognostic favorable (8.04e-5)" 11.0 15.0 14.7 12.0 15.3 10.8 12.9 36.5 15.7 12.4 9.2 10.9 16.9 17.1 13.0 13.4 7.7 12.1 15.9 8.9 13.4 6.5 13.4 10.7 12.8 11.2 11.6 10.0 14.6 22.6 13.0 15.2 4.0 12.8 14.5 6.0 14.1 20.2 15.8 6.2 16.8 11.8 7.3 9.0 15.3 21.3 4.7 12.6 7.6 14.0 3.4 10.0 10.4 11.2 0.8 4.1 0.0 3.8 3.1 4.5 1.1 3.1 5.8 0.0 2.4 13.4 4.8 8.8 8.4 7.4 2.9 1.7 2.0 9.9 1.3 9.5 5.7 2.9 1.9 0.3 1.1 0.6 8.4 0.4 5.0 6.0 0.7 5.6 4.0 13.5 9.2 4.2 2.3 0.0 4.2 2.0 3.2 2.5 0.1 2.8 3.4 2.8 4.2 1.9 9.7 5.5 7.6 0.0 1.4 4.7 6.2 0.1 3.8 0.9 0.0 4.8 1.3 6.8 3.4 8.8 15.7 1.7 8.8 2.3 32.6 3.7 1.6 7.6 5.5 3.8 0.0 3.5 0.0 3.3 2.7 4.5 0.6 2.7 2.6 4.1 0.8 3.4 2.0 0.0 3.1 3.8 2.5 1.3 1.1 14.7 15.3 36.5 15.7 13.4 6.5 11.6 10.0 12.8 12.6 6.0 5.3 0.5 8.6 3.2 1.9 2.4 0.0 0.0 1.2 7.0 3.9 0.4 0.0 1.6 0.7 3.7 4.2 0.0 2.1 1.4 5.1 7.4 2.3 2.4 5.8 0.0 10.3 6.2 4.6 0.2 18.1 3.5 5.0 0.0 3.6 1.9 1.6 6.0 9.9 1.3 2.2 0.0 3.9 1.4 1.5 1.6 0.3 5.0 3.5 5.8 IFIT2 "cig42, G10P2, GARG-39, IFI-54, IFI54, ISG-54K" ENSG00000119922 "Interferon induced protein with tetratricopeptide repeats 2" P09913 10 89283694-89309276 "Predicted intracellular proteins" "Antiviral defense, Apoptosis, Immunity, Innate immunity" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 93.4" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 93.4" "Lineage enriched" "Detected in all" 5 "granulocytes: 93.4" "Group enriched" "Detected in many" 4 "BJ hTERT+ SV40 Large T+: 50.6;BJ hTERT+ SV40 Large T+ RasG12V: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003408 Approved Approved Vesicles NA NA Vesicles "HPA003408: AB_1079100" "unprognostic (1.77e-1)" "unprognostic (2.10e-1)" "unprognostic (2.42e-2)" "unprognostic (2.25e-3)" "unprognostic (1.75e-2)" "unprognostic (9.28e-2)" "unprognostic (6.71e-3)" "unprognostic (2.22e-1)" "unprognostic (5.40e-1)" "unprognostic (1.36e-1)" "unprognostic (7.03e-3)" "unprognostic (1.27e-1)" "prognostic unfavorable (6.99e-4)" "unprognostic (2.92e-2)" "unprognostic (1.03e-2)" "unprognostic (5.33e-3)" "unprognostic (6.46e-2)" 15.5 7.7 10.2 8.9 11.9 31.9 5.5 8.1 10.5 4.5 3.7 15.6 2.1 4.7 3.5 7.4 2.3 6.7 9.7 4.8 10.4 9.2 10.5 14.9 14.4 6.5 23.7 6.7 6.9 2.4 4.5 3.3 11.3 20.4 3.9 3.1 5.2 5.8 4.7 1.8 2.5 4.1 4.6 29.4 18.0 2.6 1.3 17.9 3.9 4.2 0.4 3.7 7.3 3.5 4.0 2.9 93.4 17.0 1.7 2.2 3.4 10.0 0.4 0.1 4.7 4.8 5.3 1.4 3.8 10.6 50.6 40.3 0.0 7.4 1.1 2.2 2.6 7.6 10.6 0.2 0.5 5.4 4.2 0.0 1.8 5.4 0.0 8.3 0.2 0.8 3.0 0.2 3.8 0.5 3.1 0.2 1.0 0.0 0.2 0.7 0.0 1.2 2.3 0.1 0.0 2.0 0.7 1.3 0.2 1.7 2.0 0.0 0.0 1.1 0.3 9.1 0.3 0.2 0.5 0.3 0.5 0.1 1.4 0.3 0.4 1.7 0.1 0.8 0.9 1.0 17.9 7.0 21.8 2.2 15.1 1.2 4.0 1.7 1.5 2.3 3.5 1.8 1.6 93.4 1.7 17.0 2.9 0.9 3.4 10.2 11.9 8.1 10.5 10.4 9.2 23.7 6.7 20.4 17.9 38.7 4.1 7.5 5.0 1.3 1.0 5.7 5.1 5.3 12.5 12.2 0.0 1.8 8.3 25.1 0.1 18.3 9.6 0.0 3.7 1.0 5.0 15.4 4.7 5.5 25.2 23.8 3.4 14.1 17.2 0.0 7.5 16.8 6.8 8.2 5.2 12.8 7.5 5.8 11.0 8.4 0.6 0.0 3.1 0.0 0.0 0.5 1.1 11.7 1.5 3.9 IGIP "C5orf53, LOC492311" ENSG00000182700 "IgA inducing protein" A6NJ69 5 140125935-140129392 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Horizontal cells: 27.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 14.4;ASC TERT1: 13.9" "Low region specificity" "Detected in all" "HPA041877, HPA048615" Uncertain Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA041877: AB_2677721, HPA048615: AB_2680462" "unprognostic (1.15e-1)" "unprognostic (1.12e-1)" "unprognostic (5.85e-2)" "unprognostic (2.00e-2)" "unprognostic (2.46e-1)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (1.10e-1)" "unprognostic (2.38e-1)" "unprognostic (5.05e-2)" "prognostic favorable (3.94e-4)" "unprognostic (1.94e-1)" "prognostic favorable (6.25e-6)" "unprognostic (2.93e-3)" "unprognostic (1.70e-1)" "unprognostic (5.98e-2)" "unprognostic (7.77e-2)" 5.1 7.6 13.9 2.0 13.1 0.0 5.3 16.0 13.7 7.3 3.8 3.4 1.6 2.8 3.8 8.0 2.5 3.5 3.8 4.6 13.4 13.7 7.6 6.2 3.8 3.1 17.8 3.3 5.3 3.6 16.2 6.1 3.7 9.8 5.8 3.1 3.7 4.3 7.3 7.7 7.5 3.7 8.2 14.4 3.8 3.4 1.9 9.4 2.0 7.1 2.8 3.0 3.7 3.4 0.6 0.1 1.0 0.5 0.5 2.2 0.1 2.0 0.6 1.0 2.9 14.4 13.9 1.3 5.1 5.1 1.2 1.5 2.0 1.6 3.8 5.5 6.9 0.7 2.1 1.1 3.1 2.3 3.3 1.9 0.8 2.8 1.5 3.4 1.0 1.4 4.7 7.9 2.3 4.4 8.9 1.5 2.8 0.6 1.5 4.4 1.7 1.1 2.5 0.2 1.6 1.6 1.2 2.4 1.7 6.8 1.8 1.0 1.5 2.8 1.8 2.9 1.1 1.4 3.0 8.9 3.6 0.3 1.2 2.8 3.7 2.4 1.3 3.8 2.6 2.6 0.0 0.2 1.0 0.7 0.1 1.9 0.6 1.0 0.8 0.1 0.5 2.2 1.8 0.0 0.5 0.5 0.1 1.1 0.1 13.9 13.1 16.0 12.9 13.4 13.7 17.8 3.3 9.8 9.4 11.9 3.2 0.5 1.7 1.8 19.0 13.8 10.2 2.7 5.7 3.5 13.7 1.9 0.0 2.5 1.5 3.7 3.9 0.0 1.6 1.1 2.9 3.5 8.1 4.7 0.9 27.0 8.6 4.3 2.6 0.5 6.1 2.2 6.8 1.8 4.4 5.6 2.5 5.1 15.9 2.2 9.4 0.0 5.0 2.3 0.9 3.4 1.5 0.8 3.4 1.7 IGSF10 "CMF608, FLJ25972" ENSG00000152580 "Immunoglobulin superfamily member 10" Q6WRI0 3 151425384-151458709 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Osteogenesis" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 17.8" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 118.2;Horizontal cells: 57.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 4 "dendritic cells: 1.5" "Group enriched" "Detected in some" 5 "HeLa: 25.6;HL-60: 12.4;REH: 9.2;RPMI-8226: 29.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "HPA012655, HPA012921" Uncertain Approved Vesicles "Secreted - unknown location" NA NA 280000 Vesicles "HPA012655: , HPA012921: AB_1851526" "unprognostic (1.78e-3)" "unprognostic (2.48e-2)" "unprognostic (1.71e-1)" "unprognostic (3.47e-7)" "unprognostic (1.68e-1)" "unprognostic (2.12e-1)" "unprognostic (9.82e-2)" "unprognostic (8.84e-4)" "unprognostic (9.38e-3)" "unprognostic (1.96e-1)" "unprognostic (5.70e-2)" "unprognostic (2.04e-1)" "unprognostic (7.52e-4)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (4.59e-3)" "unprognostic (7.57e-4)" 2.5 2.9 0.6 0.1 0.4 0.0 4.5 0.0 0.2 0.3 0.5 0.0 0.7 0.8 2.0 3.4 7.3 4.1 0.7 0.8 0.0 0.0 6.7 0.5 0.3 17.8 0.1 0.7 1.5 0.0 0.0 0.6 3.7 0.0 0.0 1.2 0.7 0.7 0.3 0.2 0.4 0.3 1.3 1.6 1.5 0.1 0.2 1.5 0.2 0.3 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.0 0.2 0.2 4.0 25.6 0.0 0.9 12.4 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 29.6 0.0 0.0 0.5 0.0 3.2 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.1 3.7 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.5 1.2 2.2 14.0 1.1 2.5 13.4 10.3 1.8 3.9 18.9 0.0 0.2 118.2 0.7 0.0 0.0 1.2 2.6 5.4 0.9 0.0 0.0 1.2 57.2 5.8 0.0 0.3 22.0 6.4 1.6 3.3 1.0 0.4 23.5 0.3 0.0 1.1 0.3 2.2 0.0 0.9 6.7 2.4 2.0 25.9 0.0 0.0 0.0 IGSF8 "CD316, CD81P3, EWI2, PGRL" ENSG00000162729 "Immunoglobulin superfamily member 8" Q969P0 1 160091340-160098943 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.2" "Cell type enhanced" "Detected in many" 7 "Extravillous trophoblasts: 187.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-MEL-30: 58.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011917, HPA075970" Approved Supported Vesicles NA NA 190000 Vesicles "HPA011917: AB_1851536, HPA075970: " "unprognostic (4.08e-1)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.46e-1)" "unprognostic (1.20e-1)" "unprognostic (1.71e-1)" "unprognostic (1.01e-3)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (2.31e-1)" "unprognostic (2.60e-2)" "unprognostic (2.35e-1)" "unprognostic (3.74e-3)" "unprognostic (1.75e-3)" 9.9 10.4 25.2 9.0 30.3 2.4 11.1 40.9 54.2 9.6 11.8 53.5 6.4 18.2 8.6 16.6 7.0 13.9 8.5 11.6 32.4 24.1 10.4 19.3 10.1 10.3 32.2 29.9 15.1 19.1 9.0 8.7 7.8 25.9 13.8 7.4 11.2 21.0 14.0 6.0 34.0 14.4 5.1 42.6 10.6 9.8 11.5 25.3 6.2 10.0 5.9 6.2 6.0 6.9 14.3 5.6 1.2 4.0 4.7 15.6 6.4 8.9 5.4 7.0 17.9 4.1 2.6 14.8 4.4 5.8 9.5 8.9 6.1 6.2 13.2 16.6 6.4 8.2 17.3 2.8 6.5 1.3 15.7 5.1 1.7 6.0 10.4 6.9 4.5 14.7 3.2 13.2 6.1 2.0 6.7 1.9 14.6 2.3 7.6 2.2 8.5 11.2 10.5 14.8 18.8 8.6 6.4 3.6 9.5 8.6 9.3 2.9 12.8 5.0 16.5 58.9 6.4 11.7 5.8 1.9 4.2 9.1 7.5 3.5 21.0 23.2 5.9 14.8 1.8 10.9 0.0 2.9 1.2 13.3 4.0 11.7 12.2 11.0 15.4 3.3 14.3 14.8 15.6 0.8 4.7 2.4 5.6 14.9 6.4 25.2 30.3 40.9 54.2 32.4 24.1 32.2 29.9 25.9 25.3 8.9 3.5 22.5 26.4 38.8 54.6 3.2 12.7 0.0 1.2 36.6 9.8 28.1 5.0 30.1 3.1 7.9 34.9 0.0 10.8 187.6 24.7 18.9 10.3 26.8 13.7 62.0 19.1 9.8 3.2 0.5 15.5 8.0 40.5 85.6 23.2 90.2 17.8 37.4 14.9 13.3 11.7 6.5 16.3 1.7 5.8 54.5 58.0 14.4 27.4 24.0 IL27RA "CRL1, IL-27R, TCCR, WSX-1, WSX1, zcytor1" ENSG00000104998 "Interleukin 27 receptor subunit alpha" Q6UWB1 19 14031748-14053216 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 25.2;lymphoid tissue: 32.3" "Cell type enhanced" "Detected in many" 9 "B-cells: 31.8;Kupffer cells: 33.3;T-cells: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA073441 Approved Vesicles NA NA 4100000 Vesicles "HPA073441: " "prognostic favorable (1.74e-6)" "unprognostic (1.99e-1)" "unprognostic (1.55e-1)" "unprognostic (6.09e-2)" "unprognostic (2.03e-3)" "unprognostic (2.28e-1)" "unprognostic (2.05e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.40e-3)" "unprognostic (9.92e-2)" "unprognostic (3.35e-2)" "prognostic unfavorable (2.58e-10)" "unprognostic (5.45e-3)" "unprognostic (3.91e-2)" "unprognostic (1.76e-1)" "unprognostic (1.87e-3)" 8.4 2.1 2.8 26.0 2.7 3.5 20.6 3.0 3.5 3.5 3.9 1.1 2.7 3.6 3.6 2.0 3.4 4.2 4.1 5.8 3.8 3.6 4.8 2.1 11.8 25.3 2.6 2.3 2.3 3.5 8.1 1.1 2.0 2.5 5.0 3.4 1.2 7.4 2.1 2.8 2.6 9.0 3.0 2.5 18.0 4.1 2.4 1.6 32.3 4.9 2.2 28.3 6.0 6.8 14.6 18.2 5.3 19.7 19.1 25.2 16.9 8.3 3.6 3.7 4.9 0.3 1.9 1.5 3.9 8.2 7.2 10.4 1.7 6.8 0.1 4.2 3.5 3.3 1.6 5.7 2.3 5.6 16.0 3.9 20.3 0.8 3.0 0.6 9.7 0.3 1.9 0.9 3.4 0.7 5.8 2.8 5.1 14.0 15.2 0.3 11.7 7.2 21.1 4.8 5.0 2.5 6.4 2.1 7.7 4.4 2.0 3.2 1.7 5.0 0.3 5.7 2.0 6.4 6.0 4.5 0.7 9.0 7.3 4.2 15.8 7.6 7.4 0.7 19.8 4.7 5.3 19.7 0.5 22.9 16.3 20.2 14.6 22.7 18.9 18.2 12.8 25.2 19.4 1.5 19.1 7.5 6.8 19.9 16.9 2.8 2.7 3.0 3.5 3.8 3.6 2.6 2.3 2.5 1.6 0.0 10.6 31.8 10.6 1.6 0.0 1.2 5.1 0.0 7.9 3.5 0.0 0.5 0.0 9.0 0.3 16.3 0.0 0.0 2.3 1.6 3.0 6.3 17.3 0.8 20.7 1.6 2.4 20.9 33.3 0.0 3.1 26.0 5.0 4.6 0.9 0.2 4.1 0.0 3.2 0.7 0.0 0.0 1.7 0.1 13.4 1.1 0.1 61.2 1.1 3.1 IL2RG "CD132, CIDX, IMD4, SCIDX1" ENSG00000147168 "Interleukin 2 receptor subunit gamma" P31785 X 71107404-71112108 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 115.3;lymphoid tissue: 169.3" "Cell type enhanced" "Detected in many" 12 "B-cells: 121.6;Enterocytes: 82.5;monocytes: 130.8;T-cells: 235.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 6 "Karpas-707: 225.6" "HPA046641, HPA049691" Enhanced Approved Vesicles NA NA Vesicles "HPA046641: AB_2679733, HPA049691: AB_2680851" "unprognostic (2.97e-3)" "unprognostic (4.24e-2)" "unprognostic (1.23e-1)" "prognostic favorable (1.73e-4)" "unprognostic (8.25e-2)" "unprognostic (1.93e-3)" "unprognostic (1.37e-1)" "unprognostic (1.53e-1)" "unprognostic (1.91e-3)" "unprognostic (1.23e-2)" "unprognostic (4.36e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (2.28e-7)" "unprognostic (1.73e-1)" "unprognostic (4.69e-2)" "unprognostic (4.89e-2)" "unprognostic (9.54e-2)" 5.8 1.3 1.4 39.5 1.4 12.8 3.6 0.8 0.9 2.9 16.6 0.9 0.9 8.2 3.0 2.1 5.3 3.1 5.3 2.6 1.4 1.5 3.7 4.7 13.6 70.4 1.8 0.6 2.9 1.5 0.0 1.2 5.3 1.5 3.2 20.8 2.9 10.4 1.8 1.6 2.7 28.6 1.5 2.9 58.7 6.0 2.0 0.9 169.3 3.3 4.2 61.4 7.6 3.1 51.9 30.6 65.6 19.7 94.6 115.3 99.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 17.6 1.3 0.0 0.0 0.1 0.0 0.0 0.0 14.8 0.0 2.3 0.0 0.0 0.0 9.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 21.0 3.9 225.6 0.0 0.0 32.6 17.8 0.0 0.0 0.0 7.5 0.0 1.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 12.9 22.7 11.3 0.2 37.8 0.0 35.2 8.5 13.4 107.2 19.7 105.6 51.9 97.7 110.4 20.3 51.6 68.0 84.9 65.6 94.6 13.5 30.6 115.3 99.0 1.4 1.4 0.8 0.9 1.4 1.5 1.8 0.6 1.5 0.9 3.0 15.7 121.6 6.6 7.2 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.3 0.0 1.0 0.0 4.5 82.5 0.0 2.0 0.2 3.3 3.6 38.1 1.5 32.3 0.0 74.7 6.7 21.7 0.0 0.0 41.4 40.5 130.8 19.5 0.0 16.5 58.8 0.4 1.1 0.2 0.0 4.1 0.0 0.0 5.9 0.2 235.1 18.0 6.8 IL6 "BSF2, HGF, HSF, IFNB2, IL-6" ENSG00000136244 "Interleukin 6" P05231 7 22725884-22732002 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Cytokine, Growth factor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 60.1;lymphoid tissue: 48.0" "Cell type enriched" "Detected in many" 9 "Smooth muscle cells: 589.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 10.0;cerebral cortex: 4.4;hippocampal formation: 3.9;pons and medulla: 12.8" "Group enriched" "Detected in some" 70 "memory B-cell: 6.1;naive B-cell: 7.7" "Lineage enriched" "Detected in single" 77 "B-cells: 7.7" "Group enriched" "Detected in some" 4 "BJ hTERT+: 208.4;GAMG: 141.1" "Low region specificity" "Detected in single" "CAB023406, CAB072821" Supported Approved Vesicles "Secreted to blood" NA NA 5700 Vesicles "CAB023406: AB_617317, CAB072821: " "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (1.47e-1)" "unprognostic (1.35e-1)" "unprognostic (3.59e-2)" "unprognostic (9.88e-3)" "unprognostic (1.35e-1)" "unprognostic (3.07e-3)" "unprognostic (3.25e-1)" "unprognostic (2.17e-1)" "unprognostic (2.48e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (1.10e-11)" "unprognostic (2.45e-3)" "unprognostic (2.10e-1)" "unprognostic (4.31e-2)" "unprognostic (7.80e-2)" 60.1 5.6 1.4 48.0 10.0 15.3 11.5 0.7 4.4 2.9 8.1 1.2 0.4 0.7 2.1 4.6 14.3 7.8 16.1 21.6 3.9 1.5 1.3 5.2 34.9 3.0 1.8 0.2 5.3 8.3 5.7 14.2 4.5 12.8 6.5 7.5 3.3 3.1 0.8 6.9 2.8 4.5 8.2 7.0 3.5 6.5 3.2 1.2 0.1 4.5 12.7 3.5 34.9 8.4 7.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.8 208.4 3.9 13.4 0.0 0.0 0.0 6.8 1.3 141.1 0.1 0.0 0.0 5.3 8.2 0.0 0.0 0.3 0.0 4.4 0.0 0.0 0.5 0.0 39.8 5.7 3.8 1.4 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 13.5 0.0 0.0 0.7 0.0 0.0 1.2 1.3 0.1 2.4 0.4 0.0 2.3 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 10.0 0.7 4.4 3.9 1.5 1.8 0.2 12.8 1.2 6.0 27.2 7.2 1.9 39.6 0.0 0.9 0.0 13.4 20.5 3.5 0.0 0.5 0.0 5.8 0.3 40.7 0.0 0.0 2.4 3.1 63.9 7.3 5.8 0.0 4.2 0.0 0.0 3.1 6.1 0.0 0.0 46.2 38.8 7.2 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 589.1 0.0 0.0 29.2 1.1 0.0 0.0 9.0 INHBE "activin, MGC4638" ENSG00000139269 "Inhibin beta E subunit" P58166 12 57452323-57459280 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Hormone" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 40 "liver: 127.6" "Cell type enriched" "Detected in single" 51 "Hepatocytes: 32.6" "Cancer enriched" "Detected in some" 27 "liver cancer: 34.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HHSteC: 15.2;Karpas-707: 22.8;RH-30: 10.7;U-266/70: 76.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016843, CAB034017" Enhanced Supported Vesicles "Secreted to blood" NA NA 1400000 Vesicles "CAB034017: AB_2233745, HPA016843: AB_1851796" "unprognostic (7.34e-2)" "unprognostic (6.73e-2)" "unprognostic (3.45e-1)" "unprognostic (4.69e-5)" "unprognostic (2.61e-1)" "unprognostic (2.50e-1)" "unprognostic (3.13e-1)" "unprognostic (1.24e-1)" "unprognostic (8.79e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-1)" "unprognostic (2.70e-1)" "prognostic unfavorable (5.66e-8)" "unprognostic (4.09e-3)" "unprognostic (1.56e-1)" "unprognostic (3.57e-2)" "unprognostic (7.52e-3)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 127.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.1 0.0 1.0 0.9 3.1 0.6 0.6 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.8 2.2 0.0 2.7 0.1 0.0 1.1 0.5 0.2 0.0 0.1 0.5 0.0 0.3 5.1 0.0 0.0 0.0 3.3 15.2 0.6 0.7 1.4 1.5 0.3 3.3 0.1 0.0 0.5 1.3 22.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 2.3 0.0 0.0 5.7 0.2 0.0 0.0 2.1 0.1 0.1 2.4 0.0 0.0 1.2 0.0 0.1 76.9 2.4 1.0 0.4 0.1 0.1 1.9 0.5 0.5 0.3 0.4 0.4 0.9 0.1 0.2 0.1 1.0 0.2 0.5 3.1 0.6 0.6 0.9 0.2 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 INPP5F "hSac2, KIAA0966, SAC2" ENSG00000198825 "Inositol polyphosphate-5-phosphatase F" Q9Y2H2 10 119726097-119829278 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 69.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 30.5;SH-SY5Y: 24.2;SK-MEL-30: 46.0;SuSa: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042605 Supported Vesicles NA NA Vesicles "HPA042605: AB_10793886" "unprognostic (2.65e-2)" "unprognostic (3.23e-1)" "unprognostic (3.42e-2)" "unprognostic (5.84e-2)" "unprognostic (1.87e-2)" "unprognostic (1.57e-3)" "unprognostic (2.46e-3)" "unprognostic (2.21e-1)" "unprognostic (1.12e-1)" "unprognostic (8.09e-2)" "unprognostic (2.09e-1)" "unprognostic (6.46e-2)" "unprognostic (7.78e-2)" "unprognostic (1.02e-1)" "unprognostic (9.91e-2)" "unprognostic (2.96e-2)" "unprognostic (6.21e-2)" 4.6 12.3 17.5 5.9 50.4 3.2 5.7 37.0 52.9 10.9 5.0 5.5 2.2 3.1 11.8 18.0 4.5 4.2 5.5 4.1 24.6 53.1 7.3 2.0 4.2 7.6 23.7 29.1 9.8 4.6 8.9 34.0 8.2 69.7 8.3 6.1 3.4 7.1 8.4 7.5 10.4 3.8 10.8 19.2 4.1 3.8 10.1 7.3 1.4 8.4 1.4 9.3 5.3 4.5 12.2 7.4 1.5 4.5 3.8 6.7 2.2 3.9 2.7 30.5 4.4 3.3 3.4 2.7 5.5 3.0 2.6 2.6 4.0 5.0 2.5 2.1 6.9 3.6 4.4 3.3 3.2 4.0 1.6 3.0 1.7 1.4 4.1 4.6 1.1 5.6 4.1 3.0 5.2 5.2 5.4 8.8 2.0 1.5 4.1 6.2 2.2 1.5 4.6 2.9 3.6 3.5 2.1 5.4 0.6 4.4 2.0 2.2 24.2 6.1 1.9 46.0 63.8 1.3 1.2 5.8 2.6 3.4 3.4 5.3 4.6 2.0 1.1 3.3 3.9 10.7 1.1 4.0 1.5 1.3 3.5 1.6 8.1 2.8 1.9 7.4 12.2 3.2 1.4 1.0 3.8 4.5 1.8 6.7 2.2 17.5 50.4 37.0 50.5 24.6 53.1 23.7 29.1 69.7 7.3 6.0 4.5 10.0 9.8 8.0 24.8 5.3 0.0 2.7 5.7 12.2 15.7 7.7 10.0 3.1 28.7 7.4 6.4 0.0 3.9 7.2 6.7 8.4 2.3 2.8 8.6 39.7 1.2 4.9 5.7 18.7 4.9 11.5 18.6 21.6 5.8 18.8 5.5 5.5 3.5 16.7 21.0 6.5 7.5 10.3 40.3 9.2 11.1 4.3 6.0 10.2 INSIG1 "CL-6, MGC1405" ENSG00000186480 "Insulin induced gene 1" O15503 7 155297776-155310235 "Plasma proteins, Predicted membrane proteins" "Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 81.4;liver: 143.2" "Cell type enhanced" "Detected in many" 8 "Hepatocytes: 494.0" "Cancer enhanced" "Detected in all" "liver cancer: 142.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "intermediate monocyte: 45.7;non-classical monocyte: 81.4" "Lineage enriched" "Detected in all" 6 "monocytes: 81.4" "Cell line enhanced" "Detected in many" "Karpas-707: 155.1;RPMI-8226: 72.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071524 Uncertain Vesicles NA NA Vesicles "HPA071524: " "unprognostic (8.11e-2)" "unprognostic (3.22e-1)" "unprognostic (2.91e-1)" "unprognostic (1.47e-1)" "unprognostic (9.23e-2)" "unprognostic (3.83e-2)" "unprognostic (2.05e-2)" "unprognostic (3.06e-1)" "unprognostic (1.60e-2)" "unprognostic (1.52e-1)" "unprognostic (4.64e-2)" "unprognostic (2.12e-1)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "unprognostic (1.91e-1)" "prognostic unfavorable (9.62e-4)" "unprognostic (4.97e-2)" 18.4 9.2 8.5 8.3 8.8 9.7 14.1 10.1 14.3 6.0 7.4 21.8 7.5 12.5 5.2 8.3 15.6 4.6 8.0 5.6 10.8 11.6 6.4 143.2 18.5 6.9 8.6 8.3 16.4 27.2 4.6 5.2 17.5 23.9 15.9 6.7 11.9 31.4 3.1 2.4 10.5 14.2 5.1 19.2 4.5 13.4 8.2 8.3 10.7 3.3 6.1 6.9 11.2 5.6 10.0 13.6 10.7 81.4 4.0 12.7 12.5 19.2 3.6 9.6 6.0 25.4 34.0 5.2 1.5 22.0 4.6 30.7 2.2 28.0 12.6 4.5 11.9 35.9 10.4 6.5 11.4 5.5 3.8 19.2 3.4 6.6 0.0 12.5 5.8 57.0 21.1 6.3 35.5 3.3 3.4 6.1 25.1 6.3 155.1 5.9 10.0 28.5 15.4 10.0 3.6 2.2 5.3 0.0 72.7 36.3 9.6 7.2 5.6 5.1 3.7 8.1 3.7 3.6 19.6 6.9 5.1 1.5 9.6 4.0 37.8 6.6 11.2 22.6 22.8 4.7 3.1 4.9 2.1 8.7 45.7 4.4 7.7 6.0 7.4 13.6 10.0 5.9 6.7 10.7 4.0 81.4 7.7 12.7 12.5 8.5 8.8 10.1 14.3 10.8 11.6 8.6 8.3 23.9 8.3 38.7 98.0 59.2 52.4 124.6 12.6 22.7 28.1 48.2 35.2 38.4 9.8 43.4 14.9 38.4 16.5 50.6 41.6 0.0 120.7 153.6 37.0 96.2 61.0 494.0 42.6 36.5 121.5 36.2 57.7 5.6 14.7 90.2 234.5 28.9 44.4 73.4 47.8 10.5 17.3 8.4 17.2 19.4 86.4 38.0 53.2 135.8 109.0 47.3 19.0 105.7 INSL4 EPIL ENSG00000120211 "Insulin like 4" Q14641 9 5231419-5235304 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "placenta: 88.0" "Cell type enriched" "Detected in some" 11 "Syncytiotrophoblasts: 2990.3" "Cancer enhanced" "Detected in some" "lung cancer: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "A549: 23.6" HPA065145 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA065145: " "unprognostic (9.77e-2)" "unprognostic (2.02e-1)" "unprognostic (4.66e-1)" "unprognostic (7.74e-2)" 0.1 0.1 0.0 0.0 0.1 0.3 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.2 1.8 0.1 0.0 0.0 0.2 0.0 0.1 0.8 0.1 0.2 0.0 0.1 0.0 0.1 0.1 0.0 0.0 88.0 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.0 0.1 0.2 0.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.0 0.0 23.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 269.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 19.9 0.0 0.0 0.0 0.0 34.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2990.3 0.0 0.0 0.0 IQCC FLJ10547 ENSG00000160051 "IQ motif containing C" Q4KMZ1 1 32205661-32208687 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 26.6" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 23.3;Spermatocytes: 18.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028602, HPA028686" Approved Approved Vesicles NA NA Vesicles "HPA028602: AB_10600298, HPA028686: AB_10601985" "unprognostic (1.45e-3)" "unprognostic (4.25e-3)" "unprognostic (2.07e-1)" "unprognostic (1.76e-1)" "unprognostic (2.56e-1)" "unprognostic (4.00e-3)" "unprognostic (7.81e-6)" "prognostic favorable (5.65e-4)" "unprognostic (4.97e-2)" "unprognostic (2.97e-2)" "prognostic favorable (8.23e-5)" "unprognostic (2.00e-1)" "unprognostic (3.28e-1)" "unprognostic (3.12e-3)" "prognostic favorable (3.79e-4)" "unprognostic (4.22e-2)" "unprognostic (1.66e-1)" 2.2 4.2 5.0 3.3 8.2 4.4 5.0 9.7 11.7 3.8 3.5 5.1 4.4 2.5 5.5 10.2 3.1 8.3 3.4 2.8 4.0 4.3 4.3 1.9 2.9 3.5 3.1 5.9 5.4 8.1 5.6 9.5 2.7 3.4 4.3 3.5 4.7 4.8 5.7 4.1 4.9 3.1 3.0 3.1 3.2 4.4 26.6 4.6 4.4 8.3 1.0 3.7 2.8 2.9 5.1 2.8 3.4 1.1 3.9 3.8 1.2 7.5 2.5 6.2 5.8 1.1 2.3 3.9 4.3 5.0 9.1 8.5 6.1 6.8 2.7 4.8 1.3 1.6 6.4 6.2 3.8 7.7 4.1 7.0 4.8 5.8 2.6 1.5 5.1 3.3 1.6 4.0 8.1 3.6 3.7 1.9 10.5 8.4 0.7 4.1 5.2 8.4 5.3 3.9 4.1 5.7 11.9 3.7 6.2 3.4 2.9 8.7 3.4 8.6 5.0 4.6 5.9 6.0 5.4 2.6 3.4 6.3 4.9 7.3 3.4 2.4 2.4 4.8 4.9 6.9 1.6 1.0 0.4 3.3 1.0 3.1 5.1 3.4 2.5 1.8 2.5 3.8 2.2 3.4 3.9 1.1 2.8 3.7 1.2 5.0 8.2 9.7 11.7 4.0 4.3 3.1 5.9 3.4 4.6 0.0 2.9 0.0 0.8 0.2 4.8 1.6 2.5 4.0 0.0 3.5 5.9 1.4 3.3 1.2 0.6 1.1 0.9 23.3 1.2 1.6 1.6 0.5 1.1 0.5 0.8 6.4 2.9 0.0 0.0 1.1 1.1 0.2 0.0 1.8 2.7 2.3 1.0 1.5 2.5 0.4 8.4 0.0 0.5 18.9 9.8 0.6 0.8 1.9 1.7 0.2 IRAK1BP1 "AIP70, SIMPL" ENSG00000146243 "Interleukin 1 receptor associated kinase 1 binding protein 1" Q5VVH5 6 78867472-78946440 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "bone marrow: 79.6" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 31.4;Early spermatids: 52.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035742, HPA035743" Uncertain Approved Vesicles NA NA Vesicles "HPA035742: AB_10670119, HPA035743: AB_2674764" "unprognostic (2.62e-1)" "unprognostic (1.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-1)" "unprognostic (5.82e-2)" "unprognostic (2.12e-1)" "unprognostic (2.38e-3)" "unprognostic (3.93e-2)" "unprognostic (6.55e-2)" "unprognostic (2.34e-2)" "unprognostic (1.32e-2)" "unprognostic (9.88e-2)" "unprognostic (2.81e-2)" "unprognostic (4.64e-2)" "unprognostic (1.82e-1)" "unprognostic (3.39e-2)" "unprognostic (2.58e-1)" 2.8 4.0 6.9 3.4 12.4 79.6 3.9 8.8 8.1 6.4 4.1 3.4 6.2 3.5 7.2 7.7 3.2 7.3 5.3 3.6 5.6 4.1 7.0 2.6 4.4 6.0 3.0 6.5 7.0 8.1 4.2 17.9 2.8 4.3 5.2 2.7 5.1 4.2 6.5 2.3 5.7 4.7 4.1 3.6 4.7 5.5 15.4 5.7 8.8 7.6 1.9 2.3 4.5 4.0 1.4 1.6 3.9 1.4 1.3 2.0 0.4 1.6 3.2 5.2 4.7 2.2 4.8 4.5 1.1 2.7 1.1 1.9 3.8 3.0 3.2 1.4 2.5 2.7 3.0 9.4 4.4 1.9 4.8 3.8 4.0 4.7 2.0 2.8 9.7 3.7 4.2 4.5 2.0 2.5 3.6 3.5 6.6 5.1 7.8 1.7 0.8 2.9 6.5 2.4 0.7 2.7 1.1 3.0 2.3 4.8 6.5 6.9 8.3 1.5 1.7 1.2 3.4 3.8 6.5 3.2 2.8 2.6 1.5 4.0 7.8 4.6 4.8 0.8 0.7 3.1 3.9 0.3 0.4 1.5 0.2 1.1 1.4 1.4 0.8 0.6 0.9 1.9 2.0 2.5 1.3 1.4 1.6 1.6 0.4 6.9 12.4 8.8 8.1 5.6 4.1 3.0 6.5 4.3 5.7 17.9 5.6 0.5 4.8 2.3 7.8 13.2 7.6 28.1 14.8 3.5 31.4 3.0 8.3 4.4 52.1 5.8 0.4 0.0 5.2 0.6 2.4 1.2 0.0 2.1 1.4 4.8 6.3 2.5 1.8 27.4 9.8 1.2 0.0 1.0 2.6 12.8 3.7 0.0 7.8 10.2 17.4 12.9 2.1 25.8 14.7 2.3 0.7 1.0 3.5 1.7 IRAK2 ENSG00000134070 "Interleukin 1 receptor associated kinase 2" O43187 3 10164865-10243743 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 28.7" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 18.1;Glandular cells: 20.2;Urothelial cells: 22.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 16.2;BJ hTERT+: 16.9;CAPAN-2: 17.1;GAMG: 30.8;RT4: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013483, HPA050520" Uncertain Approved Vesicles NA NA Vesicles "CAB013483: , HPA050520: AB_2681154" "unprognostic (1.31e-1)" "unprognostic (2.04e-2)" "unprognostic (1.46e-2)" "unprognostic (4.61e-3)" "unprognostic (8.71e-2)" "unprognostic (9.55e-2)" "prognostic unfavorable (8.35e-4)" "unprognostic (1.89e-2)" "unprognostic (8.01e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (2.26e-4)" "unprognostic (2.24e-1)" "unprognostic (3.10e-2)" "unprognostic (7.22e-2)" "unprognostic (4.38e-2)" "unprognostic (3.91e-2)" "prognostic favorable (6.60e-5)" 12.1 5.8 3.6 8.6 5.9 28.7 5.4 4.5 7.0 3.3 4.0 12.2 2.3 3.3 3.5 2.6 8.4 2.4 6.8 2.7 3.6 5.2 4.3 15.4 12.7 5.3 10.4 3.7 1.9 3.2 2.4 1.8 3.5 7.8 6.4 3.1 2.1 4.8 3.4 19.6 6.2 6.7 3.4 6.1 5.9 5.2 1.7 8.6 3.9 4.1 2.7 16.7 14.3 7.2 5.0 1.3 2.5 1.2 8.4 7.9 2.5 1.2 3.7 0.1 0.5 4.0 3.4 16.2 1.3 16.9 2.3 2.2 1.7 17.1 0.0 0.4 2.0 30.8 0.4 0.4 4.3 3.1 1.0 1.2 0.3 0.8 4.7 2.0 0.0 0.5 2.1 0.7 8.5 11.0 6.1 4.7 0.1 0.8 5.2 2.7 0.0 0.0 0.8 0.1 2.0 3.6 0.8 0.0 0.2 5.1 23.4 0.2 0.1 1.6 0.0 0.1 0.4 0.4 0.8 4.8 5.3 0.4 3.2 3.3 1.7 5.1 1.0 11.3 2.2 0.9 0.2 1.2 0.1 7.5 0.7 7.9 5.0 2.2 4.1 1.3 4.5 1.6 3.9 2.5 8.4 0.2 0.1 0.9 2.5 3.6 5.9 4.5 7.0 3.6 5.2 10.4 3.7 7.8 8.6 0.0 5.5 0.9 18.1 7.1 0.6 1.6 0.0 0.0 2.3 0.0 0.0 0.1 0.0 8.5 3.3 2.1 1.1 0.0 3.5 0.4 1.0 20.2 0.0 4.7 2.9 0.0 0.0 1.3 2.5 1.1 0.9 4.3 5.0 2.8 0.1 1.7 10.4 0.0 0.0 1.0 0.0 0.0 3.1 0.4 0.4 6.5 0.8 1.5 0.4 22.1 IRAK3 IRAK-M ENSG00000090376 "Interleukin 1 receptor associated kinase 3" Q9Y616 12 66188879-66254622 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 58.0" "Cell type enhanced" "Detected in many" 14 "Ito cells: 36.2;Kupffer cells: 118.3;Macrophages: 66.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 5.6;classical monocyte: 13.1;intermediate monocyte: 13.2;myeloid DC: 6.2;neutrophil: 7.2;non-classical monocyte: 20.6" "Group enriched" "Detected in many" 12 "dendritic cells: 6.2;granulocytes: 7.2;monocytes: 20.6" "Cell line enhanced" "Detected in some" "ASC diff: 15.0;ASC TERT1: 12.4;HEL: 12.8;HL-60: 17.0;NB-4: 13.6;THP-1: 20.6;U-937: 14.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA043097 Approved Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA043097: AB_10795612" "unprognostic (7.12e-2)" "unprognostic (1.06e-1)" "unprognostic (2.90e-1)" "unprognostic (1.28e-1)" "unprognostic (1.90e-1)" "unprognostic (7.56e-3)" "unprognostic (1.49e-1)" "unprognostic (2.46e-1)" "unprognostic (7.82e-2)" "unprognostic (1.33e-1)" "unprognostic (2.95e-2)" "unprognostic (8.52e-2)" "prognostic unfavorable (6.23e-4)" "unprognostic (5.58e-2)" "unprognostic (4.64e-2)" "unprognostic (3.41e-2)" "unprognostic (3.23e-2)" 21.8 3.7 2.1 10.6 3.6 58.0 13.4 1.0 2.4 8.7 6.5 2.3 5.5 1.7 6.2 8.6 4.9 7.0 7.6 16.0 2.9 2.1 3.6 2.9 22.1 25.6 4.6 0.3 5.9 2.7 1.3 17.9 6.1 3.7 7.0 3.0 5.5 6.0 5.5 5.5 3.3 4.9 6.4 5.9 25.3 6.2 5.1 2.8 1.0 4.9 4.5 5.4 9.5 11.4 0.4 6.2 7.2 20.6 0.9 0.3 3.6 0.0 0.0 0.2 0.0 15.0 12.4 0.0 1.6 0.0 0.9 1.3 0.0 1.2 0.0 0.8 3.0 0.0 0.0 1.8 0.0 0.7 0.0 0.0 12.8 0.7 0.0 7.8 17.0 2.4 7.8 0.0 0.7 0.0 0.0 4.4 0.0 0.0 0.0 0.5 0.0 0.0 13.6 0.7 0.0 0.0 0.0 3.7 0.0 0.1 1.9 0.1 0.0 6.7 0.0 0.7 0.0 0.0 20.6 4.7 0.0 0.0 0.0 0.0 0.5 0.1 1.2 0.0 14.9 0.0 5.6 13.1 2.2 0.0 13.2 0.0 0.0 0.0 0.0 6.2 0.4 0.0 0.0 7.2 0.9 20.6 0.0 0.3 3.6 2.1 3.6 1.0 2.4 2.9 2.1 4.6 0.3 3.7 2.8 8.9 20.8 0.8 4.1 1.3 0.3 2.2 0.0 6.7 20.5 3.5 0.0 0.2 0.0 0.6 3.6 29.3 0.0 0.0 1.0 0.1 17.3 1.4 26.5 0.0 8.9 0.0 0.0 36.2 118.3 3.0 6.6 66.9 5.0 2.8 1.0 0.2 2.8 0.0 10.6 0.2 0.0 0.0 7.2 0.7 0.9 1.1 0.2 2.5 0.2 2.2 IRGQ "FKSG27, IRGQ1" ENSG00000167378 "Immunity related GTPase Q" Q8WZA9 19 43584369-43596135 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043254, HPA050338" Approved Approved Vesicles NA NA 18000 Vesicles "HPA043254: AB_10794178, HPA050338: AB_2681094" "unprognostic (1.98e-1)" "prognostic favorable (5.17e-4)" "unprognostic (2.55e-1)" "unprognostic (2.07e-3)" "unprognostic (9.87e-2)" "unprognostic (3.20e-3)" "prognostic unfavorable (9.60e-4)" "unprognostic (1.96e-2)" "unprognostic (3.98e-1)" "unprognostic (7.48e-2)" "prognostic favorable (3.57e-5)" "unprognostic (9.24e-2)" "prognostic favorable (3.92e-4)" "unprognostic (2.82e-1)" "unprognostic (7.91e-2)" "unprognostic (5.18e-2)" "unprognostic (4.65e-2)" 5.1 6.1 9.0 4.9 8.7 17.4 4.5 17.2 16.0 6.4 4.9 6.5 9.4 5.0 6.7 6.0 5.2 5.7 6.3 9.2 8.2 8.4 9.5 8.9 6.5 3.3 6.7 13.0 8.5 5.8 10.8 7.9 5.4 9.2 6.6 4.6 5.6 5.9 5.8 15.4 5.5 4.7 5.5 6.1 6.6 6.6 4.7 6.5 2.7 5.2 4.5 4.9 5.5 5.4 1.1 1.6 5.4 1.7 1.1 1.2 0.8 3.3 5.5 4.6 9.2 5.1 3.6 4.7 3.0 1.9 3.4 3.5 4.2 2.1 2.1 4.8 3.6 3.4 4.8 4.3 2.4 2.1 3.9 3.1 2.9 6.7 4.1 3.1 3.9 4.3 3.6 4.7 4.5 2.5 3.8 4.3 3.5 4.2 4.4 3.3 2.7 4.8 2.8 2.4 1.0 3.0 8.9 4.3 1.7 2.9 6.9 8.8 7.9 8.0 8.4 2.5 5.2 5.4 3.6 6.8 11.5 8.5 2.9 4.1 4.5 3.8 3.6 7.0 1.7 9.1 5.4 1.7 0.9 0.9 1.4 0.6 0.8 0.7 0.8 1.0 1.1 1.2 0.7 3.5 1.1 1.4 1.6 0.8 0.8 9.0 8.7 17.2 16.0 8.2 8.4 6.7 13.0 9.2 6.5 11.9 17.8 12.0 9.6 5.8 16.3 24.6 25.5 2.7 6.8 3.5 25.5 4.8 1.7 10.8 7.3 7.7 11.8 0.0 11.1 3.1 7.1 14.9 12.7 12.3 7.2 19.1 34.5 9.8 11.8 2.3 2.8 7.0 5.0 6.4 13.6 13.0 14.7 5.8 9.9 9.3 20.2 0.0 6.2 2.1 2.2 5.8 6.4 3.8 9.9 12.2 IRX3 IRX-1 ENSG00000177508 "Iroquois homeobox 3" P78415 16 54283304-54286763 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "seminal vesicle: 87.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 59.7;Basal glandular cells: 41.5;Ciliated cells: 72.3;Club cells: 48.9;Suprabasal keratinocytes: 36.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 29.1;NB-4: 48.3;RPTEC TERT1: 58.2;T-47d: 30.1;THP-1: 48.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA062522 Approved Vesicles NA NA Vesicles "HPA062522: AB_2797268" "unprognostic (4.21e-3)" "unprognostic (4.50e-2)" "unprognostic (2.34e-2)" "unprognostic (1.04e-1)" "unprognostic (3.34e-2)" "unprognostic (2.35e-1)" "unprognostic (1.39e-1)" "unprognostic (1.35e-2)" "unprognostic (1.52e-1)" "unprognostic (9.75e-2)" "unprognostic (2.92e-1)" "unprognostic (1.07e-1)" "unprognostic (3.15e-2)" "unprognostic (5.40e-2)" "unprognostic (2.39e-1)" "unprognostic (8.20e-2)" "unprognostic (1.25e-1)" 4.4 2.5 1.8 0.1 2.1 0.0 38.3 3.8 0.7 15.3 0.5 1.5 46.8 0.1 4.0 18.1 14.1 5.3 0.2 46.9 3.2 3.6 9.8 1.0 46.8 1.9 4.6 0.3 1.6 2.1 15.4 3.4 1.0 7.8 10.0 0.0 5.9 20.5 87.8 9.1 33.8 0.2 0.6 8.2 0.2 7.7 1.4 3.2 0.4 8.9 9.1 6.5 2.6 6.6 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.2 0.2 3.8 3.7 2.1 0.8 0.4 1.6 3.5 3.4 0.8 1.0 1.6 0.0 0.5 2.4 1.3 7.1 3.0 0.8 4.6 3.4 2.4 0.0 5.1 3.5 0.1 3.9 1.0 0.6 14.8 6.5 3.0 2.4 0.0 4.6 0.0 0.0 29.1 1.8 7.2 48.3 0.2 0.0 0.0 5.5 4.7 0.0 58.2 1.5 2.6 0.4 4.9 12.6 0.5 0.4 30.1 48.1 0.8 14.4 1.6 2.6 1.2 0.0 0.0 0.0 9.4 12.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.8 1.8 2.1 3.8 0.3 3.2 3.6 4.6 0.3 7.8 3.2 17.9 59.7 0.0 41.5 22.1 0.3 10.6 0.0 72.3 48.9 5.2 0.0 0.0 1.7 4.6 0.0 5.1 0.0 0.0 0.2 0.1 14.7 23.1 0.0 2.9 0.3 0.0 0.0 6.2 1.2 0.0 0.0 2.3 10.1 0.0 0.0 10.6 0.2 0.0 0.0 2.2 0.9 0.0 4.2 0.5 0.4 36.1 0.0 0.0 0.0 31.4 IST1 KIAA0174 ENSG00000182149 "IST1, ESCRT-III associated factor" P53990 16 71845996-71931199 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041802, HPA054532" Approved Supported Vesicles NA NA 45000 Vesicles "HPA041802: AB_10794491, HPA054532: AB_2682517" "unprognostic (2.15e-1)" "unprognostic (2.80e-1)" "unprognostic (1.22e-1)" "unprognostic (1.67e-3)" "unprognostic (2.04e-2)" "unprognostic (3.13e-3)" "unprognostic (2.11e-2)" "unprognostic (4.49e-2)" "unprognostic (3.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" "unprognostic (1.02e-1)" "prognostic favorable (4.55e-4)" "unprognostic (1.64e-2)" "unprognostic (7.88e-3)" "unprognostic (8.43e-3)" "prognostic favorable (8.88e-4)" 43.9 41.2 40.4 36.4 48.5 54.9 43.2 42.4 50.8 41.5 51.7 63.2 36.6 39.9 48.1 35.4 44.9 49.6 37.1 40.0 39.9 38.6 54.9 36.4 43.9 45.4 53.4 36.8 49.6 49.8 91.6 55.5 52.1 41.7 40.2 50.0 45.1 39.2 38.4 64.6 45.7 46.5 48.4 56.4 55.8 40.5 45.9 48.9 50.6 47.3 32.8 60.6 44.6 42.6 52.4 52.1 87.3 56.5 52.7 67.6 71.8 16.9 25.0 35.3 22.7 35.5 25.1 29.9 21.2 26.9 29.8 31.3 27.1 23.7 24.2 26.5 24.6 21.3 25.7 34.4 22.6 38.1 16.0 16.7 20.3 15.0 43.6 26.9 19.8 28.9 29.6 31.6 26.7 25.8 29.9 37.2 22.9 27.8 8.9 30.6 28.3 25.6 16.6 40.3 27.8 15.6 40.6 19.3 29.5 24.9 24.8 26.6 19.9 23.6 12.5 19.3 45.3 22.8 24.7 18.5 22.6 22.4 13.8 16.8 23.5 41.6 66.5 19.2 17.8 27.1 55.5 56.5 67.7 49.0 53.0 53.0 52.4 47.0 51.2 52.1 51.8 50.7 47.4 87.3 52.7 49.6 36.2 67.6 71.8 40.4 48.5 42.4 50.8 39.9 38.6 53.4 36.8 41.7 48.9 44.7 53.3 37.3 35.4 62.3 26.4 36.4 68.8 52.2 44.3 43.6 23.6 49.1 29.9 40.1 13.5 48.8 83.5 0.0 36.6 37.1 53.1 37.5 59.0 37.7 46.2 20.6 72.4 50.3 73.9 15.0 38.0 52.9 40.5 66.7 69.5 21.7 47.6 73.7 44.9 42.6 29.3 58.2 42.6 47.8 54.0 61.2 54.9 56.4 51.0 50.3 ITIH1 "H1P, IATIH, ITIH" ENSG00000055957 "Inter-alpha-trypsin inhibitor heavy chain 1" P19827 3 52777592-52792068 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 95 "liver: 321.2" "Cell type enriched" "Detected in some" 23 "Hepatocytes: 864.9" "Cancer enriched" "Detected in some" 598 "liver cancer: 329.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 10.9;Hep G2: 3.3;HL-60: 2.5;RH-30: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA041639, HPA042049" Approved Approved Vesicles "Secreted to blood" NA NA 4490000 31000000000 Vesicles "HPA041639: AB_10796349, HPA042049: AB_10797379" "unprognostic (1.87e-4)" "unprognostic (1.31e-3)" "unprognostic (2.38e-1)" "unprognostic (8.55e-2)" "unprognostic (1.03e-1)" "unprognostic (2.64e-3)" "prognostic favorable (1.89e-5)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.30e-1)" "unprognostic (2.91e-2)" "unprognostic (8.45e-2)" "unprognostic (4.53e-4)" "unprognostic (4.02e-3)" "unprognostic (5.70e-3)" "unprognostic (2.08e-1)" "unprognostic (2.24e-2)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 321.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.3 0.8 0.0 0.9 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 0.0 2.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.7 0.0 0.0 3.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 38.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 864.9 0.1 0.0 0.0 18.4 14.8 1.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.1 0.5 0.0 0.0 ITIH4 "H4P, IHRP, ITIHL1" ENSG00000055955 "Inter-alpha-trypsin inhibitor heavy chain family member 4" Q14624 3 52812975-52831479 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 461.4" "Group enriched" "Detected in many" 4 "Early spermatids: 104.1;Hepatocytes: 95.7;Late spermatids: 94.2" "Cancer enriched" "Detected in single" 27 "liver cancer: 7.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 5.3;JURKAT: 4.5;U-266/70: 6.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA001835, HPA003948, CAB072872" Enhanced Approved Vesicles "Secreted to blood" NA NA 3060000 53000000000 Vesicles "CAB072872: AB_2665724, HPA001835: AB_1079432, HPA003948: AB_1079433" "unprognostic (6.08e-2)" "unprognostic (4.45e-2)" "unprognostic (1.67e-1)" "unprognostic (2.69e-1)" "unprognostic (2.64e-1)" "unprognostic (1.96e-1)" "unprognostic (5.86e-2)" "unprognostic (1.98e-2)" "unprognostic (5.64e-2)" "unprognostic (1.02e-1)" "unprognostic (2.47e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-14)" "unprognostic (1.71e-3)" "unprognostic (2.96e-2)" "unprognostic (1.52e-1)" "unprognostic (4.21e-5)" 0.5 1.8 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.4 0.2 0.1 0.1 0.1 0.1 1.3 0.2 0.1 0.1 0.6 0.1 0.0 0.2 461.4 0.2 0.1 0.1 0.2 0.2 22.8 0.0 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.2 4.1 0.1 0.1 0.2 0.1 0.5 0.1 0.3 0.1 0.1 0.2 0.1 0.2 0.2 0.2 0.3 0.3 0.6 0.6 2.6 0.8 0.0 0.0 0.4 1.0 2.1 1.1 0.0 0.4 0.1 0.0 0.0 0.2 0.3 0.2 1.3 0.0 0.5 0.2 1.1 0.0 0.0 0.5 5.3 0.2 2.2 0.0 2.8 0.9 2.4 0.2 0.3 0.3 0.0 0.1 0.0 0.0 4.5 0.6 1.8 0.0 0.2 0.5 0.7 1.0 0.2 0.0 1.8 1.0 0.0 0.8 0.7 0.1 1.0 0.7 0.0 0.4 1.1 1.1 0.7 0.2 0.0 0.9 1.0 0.0 6.5 3.0 0.5 0.1 0.7 1.2 0.0 0.6 0.0 0.1 0.1 0.1 0.3 0.7 0.0 0.0 0.2 0.0 0.8 0.6 2.6 0.1 0.3 0.4 0.0 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.2 0.1 0.0 0.6 1.9 0.2 0.7 10.2 0.4 5.1 0.0 1.2 0.0 11.8 0.0 0.0 0.3 104.1 0.6 0.0 23.3 2.3 0.0 0.4 0.3 0.0 95.7 0.4 4.8 0.0 3.1 2.6 94.2 1.1 1.6 0.0 1.0 0.0 1.7 3.5 0.0 1.8 0.0 5.6 6.5 2.1 0.9 1.4 0.3 0.2 1.3 0.0 0.1 ITPR1 "ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29" ENSG00000150995 "Inositol 1,4,5-trisphosphate receptor type 1" Q14643 3 4493348-4847840 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Apoptosis, Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 46.6" "Cell type enhanced" "Detected in many" 5 "Peritubular cells: 49.5;Sertoli cells: 38.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 35.0;HeLa: 25.5;HMC-1: 16.9;U-87 MG: 20.8" "Region enhanced" "Detected in all" "cerebellum: 782.1" "Low region specificity" "Detected in all" "HPA014765, HPA016487" Approved Approved Vesicles NA NA 37000 Vesicles "HPA014765: AB_1851843, HPA016487: AB_1851842" "unprognostic (1.92e-1)" "unprognostic (5.04e-2)" "unprognostic (1.34e-1)" "unprognostic (1.75e-1)" "unprognostic (2.16e-2)" "unprognostic (3.61e-2)" "unprognostic (1.60e-1)" "unprognostic (1.12e-1)" "unprognostic (1.12e-1)" "unprognostic (3.17e-2)" "unprognostic (1.92e-2)" "unprognostic (2.08e-1)" "unprognostic (2.77e-2)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (3.43e-4)" "unprognostic (2.40e-1)" 4.8 8.2 6.1 7.4 18.6 3.2 11.9 39.5 30.2 10.2 7.4 1.7 21.5 2.4 18.4 13.2 7.8 10.1 11.8 5.3 8.7 5.1 8.7 2.5 6.4 7.1 4.8 10.4 14.2 2.7 46.6 7.3 4.6 3.8 15.0 3.7 12.5 9.6 27.4 3.2 3.2 5.0 17.4 3.7 6.0 5.5 3.0 4.3 7.0 19.3 0.6 8.6 14.1 10.6 8.9 3.6 5.4 1.6 1.2 2.2 1.2 0.0 1.3 0.2 0.6 10.0 0.4 3.2 0.2 0.2 0.3 0.3 0.3 0.3 4.4 0.4 0.4 1.8 0.0 0.9 1.1 0.5 35.0 1.4 12.7 25.5 1.6 13.8 5.4 16.9 2.6 0.7 1.7 0.5 3.6 1.4 3.4 1.4 5.1 1.3 0.5 2.4 1.8 0.9 0.2 3.9 1.4 0.2 0.3 1.1 1.1 0.1 8.5 2.3 1.4 2.3 0.3 0.9 7.7 1.7 0.8 1.4 1.1 1.0 7.8 3.7 2.9 20.8 5.8 1.8 5.4 1.6 1.9 1.5 1.0 1.9 6.6 1.7 1.5 2.1 8.9 2.2 1.9 0.8 1.2 0.7 3.6 1.3 1.2 6.1 18.6 39.5 30.2 8.7 5.1 4.8 10.4 3.8 4.3 0.0 31.8 25.3 4.8 3.4 1.6 4.8 5.1 21.4 14.8 8.7 0.0 0.5 3.3 1.5 4.4 22.4 0.0 0.0 4.5 0.4 13.0 6.1 24.4 1.8 4.7 1.6 3.4 22.1 13.3 5.7 27.9 15.3 6.8 6.4 0.8 3.9 1.5 0.3 49.5 3.5 1.0 38.8 26.4 1.4 2.6 2.8 0.8 19.5 0.6 3.1 ITPR3 IP3R3 ENSG00000096433 "Inositol 1,4,5-trisphosphate receptor type 3" Q14573 6 33620365-33696574 "Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Early spermatids: 129.4;Late spermatids: 168.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "basophil: 1.8;gdT-cell: 2.8;MAIT T-cell: 2.1;memory B-cell: 1.5;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.0;naive B-cell: 2.0;naive CD4 T-cell: 1.4;naive CD8 T-cell: 1.7;T-reg: 2.4" "Group enriched" "Detected in many" 10 "B-cells: 2.0;granulocytes: 1.8;T-cells: 2.8" "Cell line enhanced" "Detected in many" "hTERT-HME1: 52.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA003915, HPA064704" Approved Uncertain Vesicles No No Vesicles "HPA003915: AB_1851845, HPA064704: " "unprognostic (2.57e-1)" "unprognostic (2.81e-2)" "unprognostic (1.52e-2)" "unprognostic (2.30e-1)" "unprognostic (5.40e-2)" "unprognostic (1.24e-1)" "unprognostic (2.08e-2)" "unprognostic (6.14e-2)" "unprognostic (3.35e-1)" "unprognostic (3.08e-2)" "unprognostic (4.14e-3)" "unprognostic (1.88e-1)" "unprognostic (6.44e-3)" "unprognostic (5.01e-2)" "unprognostic (1.74e-1)" "unprognostic (8.89e-2)" "unprognostic (2.43e-2)" 7.8 6.0 2.0 17.8 2.4 2.6 9.0 1.7 2.3 6.5 39.6 1.0 35.1 14.8 7.7 15.6 10.0 6.7 28.9 7.2 1.8 1.4 8.6 1.2 21.0 9.7 4.4 1.2 7.3 11.0 1.3 3.9 3.9 4.0 7.2 9.5 5.4 12.7 26.0 2.7 27.9 44.0 6.6 3.5 20.0 21.4 20.1 1.9 10.6 28.4 9.7 18.1 5.2 16.5 2.0 0.2 1.8 0.0 0.1 2.8 0.7 21.8 10.3 1.9 0.1 1.9 6.2 12.8 7.5 19.4 9.5 8.6 14.1 17.1 18.7 8.2 5.4 23.9 21.7 8.8 20.4 4.9 10.9 7.3 0.0 29.3 15.5 4.5 3.3 2.4 4.4 18.5 23.9 52.0 20.9 16.0 7.5 7.3 6.1 10.2 10.4 5.6 1.9 1.9 16.7 15.2 8.6 0.0 11.0 33.8 15.4 17.9 0.6 13.0 19.1 18.7 2.2 6.5 1.8 21.8 12.9 6.4 16.5 16.5 4.2 4.1 8.9 10.3 5.0 7.4 1.8 0.0 0.0 2.8 0.0 2.1 1.5 1.7 2.0 0.2 2.0 1.4 1.7 0.0 0.1 0.0 0.0 2.4 0.7 2.0 2.4 1.7 2.3 1.8 1.4 4.4 1.2 4.0 1.9 44.7 47.5 4.3 10.4 23.6 0.6 1.6 7.6 8.1 18.2 29.6 0.0 0.2 0.0 25.3 129.4 13.2 36.8 0.0 26.2 5.4 5.0 12.7 0.0 0.2 0.5 0.0 23.0 15.4 0.6 168.6 21.6 3.3 11.8 4.6 35.8 0.2 62.5 35.1 13.1 0.0 1.2 6.5 2.0 1.1 3.0 22.2 0.5 10.0 30.7 15.4 ITPRIP "bA127L20.2, DANGER, KIAA1754" ENSG00000148841 "Inositol 1,4,5-trisphosphate receptor interacting protein" Q8IWB1 10 104309698-104338404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 81.5" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 42.1;Ito cells: 85.3;Suprabasal keratinocytes: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 24.1" "Lineage enriched" "Detected in all" 4 "granulocytes: 24.1" "Cell line enhanced" "Detected in many" "hTCEpi: 38.6" "Low region specificity" "Detected in all" HPA043626 Uncertain Vesicles NA NA Vesicles "HPA043626: AB_10963078" "unprognostic (2.45e-2)" "unprognostic (3.06e-1)" "unprognostic (1.59e-2)" "unprognostic (3.22e-2)" "unprognostic (1.08e-2)" "unprognostic (4.20e-1)" "unprognostic (7.87e-2)" "prognostic unfavorable (3.59e-4)" "unprognostic (9.74e-2)" "unprognostic (1.87e-1)" "unprognostic (2.64e-2)" "unprognostic (4.00e-2)" "unprognostic (5.37e-3)" "unprognostic (1.01e-3)" "unprognostic (2.65e-1)" "unprognostic (2.75e-1)" "unprognostic (2.11e-3)" 23.7 5.8 3.5 7.4 3.8 81.5 20.8 0.5 4.3 13.5 5.5 4.5 6.8 1.6 8.5 6.0 29.5 5.6 9.8 33.8 3.0 1.5 6.9 7.2 20.2 9.8 4.4 1.5 19.9 4.4 4.4 7.3 24.4 4.7 8.6 2.5 21.7 6.7 7.3 7.6 26.4 3.8 8.4 3.4 8.8 5.6 8.4 5.2 12.9 14.0 14.6 14.2 13.6 17.3 2.4 4.4 24.1 5.7 3.2 3.4 9.7 2.3 5.8 7.1 3.2 12.4 12.0 4.1 13.2 27.9 9.6 12.0 0.4 1.0 4.1 3.0 8.1 19.2 7.7 2.3 6.3 10.0 3.6 2.9 2.4 9.3 1.7 24.5 5.5 4.6 11.1 38.6 20.0 16.1 11.2 17.9 4.2 10.3 7.9 11.7 0.9 1.1 6.0 5.3 0.8 6.9 5.1 3.7 2.4 3.9 1.0 4.0 2.7 2.4 2.9 5.7 4.5 0.2 4.2 30.9 19.5 5.1 12.8 12.5 3.0 3.5 2.7 14.3 10.0 9.1 3.5 5.7 9.9 3.4 4.1 3.3 1.9 1.9 1.9 4.4 2.4 2.3 2.0 24.1 3.2 3.7 3.1 1.5 9.7 3.5 3.8 0.5 4.3 3.0 1.5 4.4 1.5 4.7 5.2 3.0 8.8 7.2 17.3 33.7 0.0 5.3 0.0 2.7 5.7 3.5 0.0 5.0 0.0 3.4 4.5 42.1 0.7 23.3 2.1 16.6 10.8 4.5 20.7 1.8 9.8 0.0 0.0 85.3 15.5 0.4 4.6 14.4 8.5 1.0 2.6 2.7 2.5 0.0 5.3 0.6 0.6 12.9 13.0 2.2 1.4 63.6 4.2 13.1 1.6 16.1 JAGN1 "FLJ14602, GL009" ENSG00000171135 "Jagunal homolog 1" Q8N5M9 3 9890554-9894349 "Disease related genes, Predicted membrane proteins" "Immunity, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067610 Approved Vesicles NA NA Vesicles "HPA067610: " "unprognostic (1.05e-1)" "unprognostic (1.76e-1)" "unprognostic (1.86e-3)" "unprognostic (1.97e-2)" "unprognostic (1.77e-1)" "unprognostic (1.95e-1)" "unprognostic (2.92e-3)" "unprognostic (1.57e-1)" "unprognostic (2.37e-2)" "unprognostic (6.36e-3)" "unprognostic (9.93e-3)" "unprognostic (2.70e-1)" "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.65e-2)" "unprognostic (2.49e-1)" 19.7 31.6 9.8 12.7 11.5 6.8 18.4 10.5 15.4 15.8 27.1 14.1 15.7 16.8 16.9 25.7 13.2 16.8 16.6 13.7 9.7 11.6 21.4 39.6 12.1 18.2 10.8 10.7 18.1 42.3 17.0 12.5 19.6 12.6 17.3 19.1 14.3 21.3 14.2 23.2 17.7 29.4 13.3 11.0 12.8 19.3 12.8 9.7 24.1 27.3 13.7 15.0 16.6 21.7 24.8 26.0 39.0 27.9 21.4 25.1 28.4 9.7 17.2 12.0 7.0 36.8 38.7 40.1 13.6 20.2 15.3 15.6 12.3 12.9 15.6 6.1 13.5 16.6 8.5 19.0 18.2 15.0 11.4 20.6 19.0 17.7 21.3 31.5 13.7 11.9 36.9 27.4 19.9 22.9 15.3 14.5 13.9 20.5 10.5 17.4 28.8 11.2 23.6 15.9 19.0 22.3 9.5 10.0 19.0 21.7 14.0 7.6 14.7 8.9 9.3 16.8 11.3 15.4 17.1 12.3 8.2 8.9 8.9 10.8 19.4 27.2 18.1 10.8 16.3 13.6 39.0 27.9 13.5 22.9 21.2 24.3 24.1 22.7 22.0 25.6 24.8 25.1 23.1 11.2 21.4 15.8 26.0 23.9 28.4 9.8 11.5 10.5 15.4 9.7 11.6 10.8 10.7 12.6 9.7 29.8 13.7 44.5 40.0 24.5 28.0 12.1 38.2 28.1 22.7 36.6 9.8 65.9 18.3 67.2 2.3 32.2 60.0 0.0 85.4 70.3 33.6 53.3 8.1 50.5 49.2 22.3 24.8 27.6 35.9 5.3 36.5 26.2 35.4 82.0 47.9 47.2 66.6 49.1 36.4 48.8 15.8 45.3 21.7 60.6 36.4 32.1 44.3 31.0 53.6 30.1 KCNG1 "K13, KCNG, kH2, Kv6.1" ENSG00000026559 "Potassium voltage-gated channel modifier subfamily G member 1" Q9UIX4 20 51003656-51023129 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 25.8;endometrium 1: 48.3" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 45.1;Syncytiotrophoblasts: 81.1" "Cancer enhanced" "Detected in many" "urothelial cancer: 8.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 27 "naive B-cell: 10.8" "Lineage enriched" "Detected in single" 87 "B-cells: 10.8" "Cell line enhanced" "Detected in many" "hTCEpi: 26.7;U-138 MG: 20.3;WM-115: 17.0" "Group enriched" "Detected in many" 5 "amygdala: 21.4;basal ganglia: 17.0;cerebral cortex: 15.2;hippocampal formation: 19.7" "Group enriched" "Detected in all" 4 "amygdala: 16.3;basal ganglia: 12.0;cerebral cortex: 22.5;hippocampal formation: 21.1" "HPA039530, HPA040024" Approved Approved Vesicles NA NA Vesicles "HPA039530: AB_10795144, HPA040024: AB_10796338" "unprognostic (1.19e-1)" "unprognostic (4.47e-2)" "unprognostic (8.70e-2)" "unprognostic (3.49e-2)" "unprognostic (4.07e-2)" "unprognostic (5.05e-4)" "unprognostic (2.53e-2)" "unprognostic (3.89e-3)" "unprognostic (3.64e-2)" "unprognostic (3.43e-2)" "unprognostic (8.74e-2)" "unprognostic (8.89e-2)" "unprognostic (1.83e-9)" "unprognostic (1.52e-1)" "unprognostic (7.42e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-2)" 0.5 4.5 13.3 2.9 7.0 0.3 0.7 2.3 11.9 9.6 2.4 1.6 25.8 0.6 48.3 2.8 3.7 11.9 1.9 1.0 7.9 2.9 0.5 0.4 0.5 3.0 2.0 9.5 0.9 3.7 1.3 0.8 9.3 6.7 5.6 1.3 0.7 1.4 18.3 0.3 0.5 7.2 5.8 1.0 3.5 0.8 5.4 2.6 0.0 0.5 0.0 1.4 2.8 3.4 10.8 0.0 0.0 0.1 0.0 0.0 0.1 0.4 1.7 1.3 6.5 0.7 1.7 0.1 5.7 0.0 3.4 2.6 0.1 0.1 0.0 3.5 1.7 9.4 1.6 0.8 1.7 3.4 0.2 2.2 0.0 6.3 0.0 11.9 0.0 0.2 3.4 26.7 12.8 13.1 0.6 0.9 0.0 0.1 0.0 0.3 6.3 0.0 0.1 6.8 0.0 11.8 0.0 0.0 0.0 0.0 2.0 2.0 7.4 12.4 14.5 9.3 2.2 1.0 0.9 0.3 20.3 12.0 0.1 1.6 0.0 0.0 0.0 6.0 0.4 17.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 13.3 7.0 2.3 11.9 7.9 2.9 2.0 9.5 6.7 2.6 3.0 1.4 1.5 9.3 1.0 0.3 0.8 0.0 1.4 1.2 0.0 0.0 45.1 0.0 2.9 14.5 0.3 3.5 0.0 0.0 2.4 1.0 5.6 0.0 0.0 2.9 1.6 0.0 0.0 0.0 14.4 1.4 0.0 0.0 0.0 0.2 0.2 0.3 3.5 3.9 0.0 0.1 0.0 1.0 1.2 0.9 0.3 81.1 0.0 0.3 7.9 KCNH1 "eag, eag1, h-eag, Kv10.1" ENSG00000143473 "Potassium voltage-gated channel subfamily H member 1" O95259 1 210676823-211134180 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 20.2" "Group enriched" "Detected in some" 6 "Early spermatids: 9.0;Late spermatids: 13.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "LHCN-M2: 4.3;RH-30: 7.2;RPTEC TERT1: 4.2;SH-SY5Y: 9.2;SK-MEL-30: 8.6;T-47d: 6.5" "Low region specificity" "Detected in all" "HPA014551, HPA019445, HPA076421" Enhanced Supported Vesicles NA NA Vesicles "HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: " "unprognostic (9.12e-2)" "unprognostic (4.82e-3)" "unprognostic (2.63e-1)" "unprognostic (6.70e-2)" "unprognostic (3.56e-1)" "unprognostic (3.63e-2)" "unprognostic (1.73e-1)" "unprognostic (9.36e-2)" "unprognostic (1.41e-1)" "unprognostic (1.98e-1)" "unprognostic (1.46e-2)" "unprognostic (2.77e-2)" "unprognostic (1.42e-3)" "unprognostic (1.17e-1)" "unprognostic (8.89e-2)" "unprognostic (1.36e-1)" "unprognostic (9.70e-2)" 0.9 2.3 6.3 1.3 13.3 0.7 0.6 19.1 20.2 1.0 1.3 3.3 0.2 1.2 1.5 1.0 0.9 1.2 1.0 0.7 3.8 1.7 1.0 0.7 0.7 0.7 1.1 7.5 0.8 0.9 0.9 0.8 1.1 1.7 1.3 1.3 0.0 0.8 0.9 0.7 0.9 1.0 1.0 2.1 0.6 1.5 2.4 1.5 0.0 0.8 0.0 0.7 0.9 0.7 0.1 0.7 0.7 0.1 0.1 0.3 0.0 0.0 1.4 0.3 0.0 0.0 0.0 0.1 0.7 0.1 1.5 1.7 0.0 0.0 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 4.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 7.2 0.0 4.2 0.0 0.3 9.2 1.6 0.1 8.6 1.2 6.5 0.0 0.0 1.1 0.1 1.4 0.8 0.0 0.0 0.0 0.2 0.0 0.6 0.7 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.0 0.7 0.1 0.0 6.3 13.3 19.1 20.2 3.8 1.7 1.1 7.5 1.7 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 KCNIP1 KCHIP1 ENSG00000182132 "Potassium voltage-gated channel interacting protein 1" Q9NZI2 5 170353487-170736632 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.2;epididymis: 27.8" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 47.7" "Cancer enriched" "Detected in some" 18 "glioma: 22.8" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 23 "RPTEC TERT1: 36.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022864, HPA066717" Uncertain Approved Vesicles NA NA Vesicles "HPA022864: AB_1858712, HPA066717: " "unprognostic (7.75e-5)" "unprognostic (2.66e-2)" "unprognostic (6.78e-2)" "unprognostic (3.22e-4)" "unprognostic (4.51e-2)" "unprognostic (3.49e-1)" "unprognostic (1.25e-2)" "unprognostic (2.69e-1)" "unprognostic (5.46e-2)" "unprognostic (6.62e-3)" "unprognostic (4.74e-2)" "unprognostic (7.52e-2)" "unprognostic (2.55e-1)" "unprognostic (2.58e-2)" "unprognostic (1.63e-1)" "unprognostic (2.39e-1)" "unprognostic (6.05e-2)" 1.1 5.9 20.6 1.2 27.9 0.6 1.9 6.4 31.2 4.0 1.0 6.0 5.2 0.9 2.7 27.8 1.0 2.8 2.9 1.2 11.7 20.5 4.9 0.8 1.9 1.2 12.9 7.3 0.9 2.4 5.1 0.7 2.1 11.1 2.3 1.3 0.8 1.3 7.9 0.8 0.7 1.1 2.1 6.9 2.2 1.1 5.2 5.3 0.0 1.2 0.0 1.2 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 27.9 6.4 14.6 11.7 20.5 12.9 7.3 11.1 5.3 0.0 0.0 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 47.7 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 11.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KCNIP2 KCHIP2 ENSG00000120049 "Potassium voltage-gated channel interacting protein 2" Q9NS61 10 101825974-101843920 "Predicted intracellular proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "adipose tissue: 86.5;brain: 54.5;heart muscle: 74.8" "Cell type enhanced" "Detected in some" 22 "Bipolar cells: 37.5;Cardiomyocytes: 109.6;Cone photoreceptor cells: 23.6;Horizontal cells: 46.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 1.9;intermediate monocyte: 1.2;memory B-cell: 2.9;naive B-cell: 4.6" "Group enriched" "Detected in many" 5 "B-cells: 4.6;granulocytes: 1.9;monocytes: 1.2" "Cell line enhanced" "Detected in many" "HEL: 20.1;HMC-1: 12.5" "Group enriched" "Detected in many" 5 "amygdala: 96.2;basal ganglia: 204.2;cerebral cortex: 97.2;hippocampal formation: 151.4;olfactory region: 172.7" "Low region specificity" "Detected in all" HPA066717 Approved Vesicles NA NA Vesicles "HPA066717: " "unprognostic (5.92e-2)" "unprognostic (2.16e-1)" "unprognostic (3.48e-3)" "unprognostic (5.77e-4)" "unprognostic (1.34e-1)" "unprognostic (1.31e-3)" "unprognostic (8.80e-2)" "unprognostic (9.11e-3)" "unprognostic (1.14e-1)" "unprognostic (5.34e-2)" "unprognostic (3.18e-2)" "unprognostic (7.20e-2)" "unprognostic (1.49e-9)" "unprognostic (9.85e-2)" "unprognostic (1.81e-1)" "unprognostic (3.27e-1)" "unprognostic (8.37e-4)" 86.5 3.5 15.5 2.0 54.5 0.9 10.4 8.3 26.1 1.8 2.4 2.6 0.0 1.4 2.3 2.4 1.2 2.2 1.9 74.8 19.6 5.0 1.0 1.0 1.4 3.7 4.2 11.3 5.7 1.6 1.2 3.3 1.8 4.3 1.6 2.7 1.7 4.6 2.1 3.8 3.0 1.6 1.8 2.1 2.8 1.6 4.1 9.8 0.0 1.3 0.8 3.9 1.6 0.7 4.6 0.5 1.9 1.2 0.0 0.4 0.4 1.6 2.5 2.5 3.1 1.0 1.1 0.6 1.1 1.0 0.6 0.9 3.6 3.2 1.6 1.0 0.7 0.6 1.7 0.8 0.4 0.6 2.2 1.9 20.1 2.4 1.9 0.9 1.3 12.5 2.6 1.7 1.0 1.3 3.6 1.0 4.5 5.8 1.8 1.0 1.1 0.7 3.9 0.8 0.7 0.6 0.9 0.2 1.2 1.0 1.0 7.3 1.2 0.8 0.5 2.4 1.6 2.1 0.8 2.2 1.4 2.1 0.6 1.1 1.7 1.7 1.7 1.5 5.1 0.2 0.0 0.1 1.9 0.1 1.2 0.4 2.9 0.3 0.0 0.4 4.6 0.0 0.1 0.0 0.0 0.5 0.5 0.3 0.4 15.5 54.5 8.3 26.1 19.6 5.0 4.2 11.3 4.3 9.8 0.0 0.0 1.3 0.1 0.3 37.5 109.6 0.0 0.0 0.0 1.8 23.6 0.2 0.0 0.1 5.6 0.0 0.4 0.0 0.0 0.1 0.2 0.2 0.0 0.0 1.8 46.1 0.0 0.6 0.6 5.3 1.7 0.3 0.0 0.0 0.1 6.3 0.2 0.0 0.7 0.0 4.8 0.0 0.4 1.4 5.3 0.0 0.2 0.0 0.3 0.0 KCNIP3 "CSEN, DREAM, KCHIP3" ENSG00000115041 "Potassium voltage-gated channel interacting protein 3" Q9Y2W7 2 95297304-95386083 "Predicted intracellular proteins, Transporters" "Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport" "Ion channel, Potassium channel, Repressor, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.8;parathyroid gland: 32.5" "Group enriched" "Detected in some" 5 "Leydig cells: 23.6;Peritubular cells: 40.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ hTERT+: 12.1;hTERT-RPE1: 15.9;RPTEC TERT1: 23.8;U-138 MG: 11.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066717, HPA069797" Enhanced Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA066717: , HPA069797: AB_2686199" "unprognostic (1.05e-2)" "unprognostic (5.76e-2)" "unprognostic (3.33e-3)" "prognostic unfavorable (1.58e-5)" "unprognostic (2.67e-1)" "unprognostic (6.73e-2)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (2.73e-1)" "unprognostic (7.42e-2)" "unprognostic (2.32e-1)" "unprognostic (4.09e-1)" "unprognostic (1.44e-3)" "unprognostic (8.90e-2)" "unprognostic (6.51e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-1)" 4.2 1.8 19.8 1.5 20.1 0.7 2.8 3.7 39.8 6.0 4.6 12.9 0.6 2.1 5.8 4.9 3.5 5.3 2.4 3.4 16.7 7.8 4.6 1.2 1.5 1.1 9.1 19.5 8.8 2.5 32.5 5.6 6.5 8.2 5.7 1.8 1.4 6.9 18.6 2.2 3.9 1.9 6.4 6.3 2.2 2.9 9.2 15.9 5.4 19.5 0.0 1.3 4.5 5.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.9 0.0 0.5 4.1 3.6 2.9 0.0 4.2 12.1 6.9 6.4 0.0 0.0 0.0 0.4 5.5 3.7 0.1 2.7 0.7 2.9 0.0 0.9 0.0 1.1 0.0 1.5 0.0 0.0 2.0 2.4 1.5 6.8 15.9 0.0 0.7 0.0 0.0 0.5 5.2 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 23.8 0.0 0.4 0.1 0.2 0.2 4.6 0.0 0.2 0.0 0.2 11.2 2.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 20.1 3.7 39.8 16.7 7.8 9.1 19.5 8.2 15.9 0.0 0.6 0.0 0.7 0.3 0.6 0.9 0.0 0.0 0.0 1.8 0.0 0.0 6.6 0.3 0.3 0.6 0.2 0.0 0.0 0.0 3.3 0.4 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 23.6 0.0 6.8 1.0 0.0 0.7 0.3 0.0 40.3 0.6 0.0 0.0 2.3 0.0 0.9 0.6 0.0 0.0 0.1 0.0 KCNIP4 "CALP, KCHIP4, MGC44947" ENSG00000185774 "Potassium voltage-gated channel interacting protein 4" Q6PIL6 4 20728616-21948799 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.9" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 32.3;Distal tubular cells: 53.0;Muller glia cells: 43.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 10.1;SCLC-21H: 7.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022862, HPA066717" Supported Approved Vesicles NA NA Vesicles "HPA022862: AB_1852654, HPA066717: " "unprognostic (8.08e-2)" "unprognostic (1.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.14e-2)" "unprognostic (9.26e-2)" "unprognostic (1.49e-1)" "unprognostic (2.53e-1)" "unprognostic (2.99e-2)" "unprognostic (1.18e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (2.13e-1)" "unprognostic (3.11e-1)" "unprognostic (1.03e-2)" "unprognostic (2.69e-1)" "unprognostic (4.59e-2)" "unprognostic (2.10e-2)" 1.1 3.6 15.8 2.2 28.3 1.0 0.9 22.4 38.9 15.0 4.2 1.8 0.0 2.4 9.6 1.1 5.6 3.9 2.6 1.8 11.9 16.2 7.8 0.7 1.1 1.1 11.6 19.3 1.9 1.0 0.5 5.1 1.8 16.9 1.0 5.2 3.5 1.4 0.8 1.3 2.3 5.5 7.8 3.9 1.1 1.3 1.3 3.5 0.0 8.9 0.0 0.5 2.7 1.1 0.3 0.7 0.0 0.7 0.8 0.7 0.3 1.7 1.5 2.2 2.2 0.0 0.0 1.1 1.3 0.0 0.0 0.0 1.9 1.7 3.4 1.4 0.5 1.7 0.9 0.0 0.1 0.0 0.4 2.3 1.2 2.5 1.2 0.0 3.2 0.5 0.0 0.8 0.0 1.4 2.9 0.6 1.3 2.0 1.1 0.0 0.6 2.8 1.9 2.8 1.3 1.4 0.8 4.2 1.3 10.1 1.0 7.9 4.7 1.4 1.7 2.2 2.7 0.9 1.2 2.2 1.1 1.5 2.4 3.2 1.0 0.1 1.2 3.7 2.7 1.7 0.0 0.3 0.0 0.2 0.7 0.7 0.2 0.1 0.2 0.7 0.3 0.5 0.5 0.0 0.8 0.5 0.3 0.2 0.3 15.8 28.3 22.4 33.0 11.9 16.2 11.6 19.3 16.9 3.5 0.0 0.0 0.0 0.0 0.0 32.3 0.4 0.0 0.0 0.0 14.0 0.0 0.0 53.0 0.0 6.9 0.3 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 3.2 0.0 0.0 3.3 1.0 0.0 43.9 0.0 7.0 0.0 4.7 11.8 0.0 0.0 0.1 0.7 0.1 0.1 0.0 0.3 0.0 KCNJ16 "BIR9, Kir5.1" ENSG00000153822 "Potassium voltage-gated channel subfamily J member 16" Q9NPI9 17 70053429-70135608 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4" "Cell type enhanced" "Detected in some" 27 "Cholangiocytes: 43.3;Collecting duct cells: 232.1;Distal tubular cells: 34.9;Proximal tubular cells: 89.7" "Group enriched" "Detected in many" 10 "renal cancer: 37.2;thyroid cancer: 80.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 5.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.1" "Cell line enriched" "Detected in some" 23 "RPTEC TERT1: 80.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059563 Approved Uncertain Vesicles NA NA Vesicles "HPA059563: AB_2684065" "unprognostic (2.81e-3)" "unprognostic (2.10e-1)" "unprognostic (6.06e-2)" "unprognostic (1.20e-3)" "unprognostic (1.16e-1)" "unprognostic (7.53e-2)" "unprognostic (4.38e-4)" "unprognostic (1.02e-1)" "unprognostic (1.23e-1)" "unprognostic (1.52e-2)" "unprognostic (3.35e-1)" "unprognostic (1.34e-1)" "prognostic favorable (9.61e-7)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "prognostic favorable (6.58e-4)" "unprognostic (3.88e-1)" 0.4 0.3 4.1 0.3 4.4 0.4 1.5 22.6 6.1 0.3 0.4 1.7 12.6 0.4 0.4 6.4 0.3 2.0 6.5 0.4 6.0 7.2 96.5 0.9 0.5 0.4 8.3 3.4 0.4 15.8 59.4 0.8 0.5 25.5 1.0 0.3 0.0 4.1 14.3 0.4 0.5 1.2 0.2 7.5 1.1 7.4 0.8 5.3 0.0 60.4 0.0 0.2 0.3 0.3 1.1 0.5 5.1 0.2 0.9 1.2 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.5 0.0 0.0 80.8 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.6 0.9 0.1 1.2 1.0 1.0 0.5 0.1 1.1 0.7 0.6 5.1 0.9 0.1 0.5 1.1 0.3 4.1 4.4 22.6 6.1 6.0 7.2 8.3 3.4 25.5 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 43.3 17.4 4.5 232.1 0.0 0.0 34.9 6.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 89.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 KCNK1 "DPK, K2p1.1, TWIK-1" ENSG00000135750 "Potassium two pore domain channel subfamily K member 1" O00180 1 233614004-233672512 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 75.3" "Cell type enhanced" "Detected in many" 9 "Basal glandular cells: 117.0;Glandular cells: 169.9;Horizontal cells: 189.1;Urothelial cells: 247.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "cerebellum: 75.3" "Cell type enriched" "Detected in single" 98 "plasmacytoid DC: 9.7" "Lineage enriched" "Detected in single" 98 "dendritic cells: 9.7" "Cell line enhanced" "Detected in many" "HeLa: 21.0;SCLC-21H: 19.8;U-266/70: 45.5;U-266/84: 41.0" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 236.2" "HPA016049, CAB022588" Approved Approved Vesicles NA NA Vesicles "CAB022588: , HPA016049: AB_1855571" "unprognostic (7.06e-3)" "unprognostic (1.76e-1)" "unprognostic (4.64e-2)" "unprognostic (7.46e-2)" "unprognostic (9.15e-2)" "unprognostic (1.27e-1)" "prognostic favorable (3.84e-4)" "unprognostic (4.32e-2)" "unprognostic (6.15e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (7.29e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (8.69e-8)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.97e-1)" 1.9 3.3 15.2 2.2 12.7 0.3 4.5 75.3 22.8 5.5 11.5 7.9 5.1 12.5 4.5 22.9 12.0 8.4 9.3 20.8 10.3 5.2 7.2 10.8 3.4 0.8 8.9 11.1 3.8 4.4 2.5 11.3 5.0 22.3 4.6 10.6 2.6 7.2 9.3 0.5 8.7 9.6 3.2 12.3 0.8 28.0 0.7 7.8 0.0 5.6 1.6 3.2 4.3 6.5 0.0 9.7 0.0 0.0 0.0 0.0 0.0 10.3 5.6 0.0 0.0 0.0 0.0 15.8 2.8 0.0 0.0 0.0 0.0 17.0 0.0 6.7 2.0 2.3 15.0 2.8 4.9 0.0 0.0 4.9 0.0 21.0 0.0 0.1 0.0 0.5 1.2 5.3 0.0 3.9 0.3 0.0 5.7 2.4 4.5 0.0 3.8 3.7 0.0 3.4 12.1 12.8 0.0 0.8 1.1 4.9 8.6 19.8 3.9 10.3 4.5 0.0 0.3 1.3 0.0 0.0 0.0 8.4 0.0 0.3 45.5 41.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 15.2 12.7 75.3 17.1 10.3 5.2 8.9 11.1 22.3 7.8 8.9 15.6 0.0 117.0 56.2 1.2 37.7 5.1 28.1 33.0 17.4 3.9 0.2 1.7 19.6 0.9 0.7 34.8 0.0 42.5 13.5 15.3 169.9 0.0 8.2 0.6 189.1 28.2 0.0 0.8 0.0 1.4 0.8 10.1 0.0 45.4 65.8 61.4 22.8 0.0 11.3 5.0 0.0 3.4 0.4 0.7 41.7 0.7 1.5 21.1 247.4 KCNQ5 Kv7.5 ENSG00000185760 "Potassium voltage-gated channel subfamily Q member 5" Q9NR82 6 72621792-73198851 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 6.6;brain: 23.0;skeletal muscle: 26.1;thyroid gland: 6.9" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 3.2;Cardiomyocytes: 2.0;Horizontal cells: 1.6;Melanocytes: 1.7;Smooth muscle cells: 1.4;T-cells: 2.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 20.4;HEL: 13.3;HL-60: 17.9;U-251 MG: 13.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016655 Enhanced Approved Vesicles NA NA Vesicles "HPA016655: AB_1855557" "unprognostic (4.91e-2)" "unprognostic (1.42e-1)" "unprognostic (4.96e-2)" "unprognostic (3.78e-2)" "unprognostic (2.69e-1)" "unprognostic (2.18e-2)" "unprognostic (3.57e-2)" "unprognostic (1.43e-1)" "unprognostic (6.09e-2)" "unprognostic (8.55e-2)" "unprognostic (7.96e-2)" "unprognostic (1.05e-1)" "unprognostic (6.77e-2)" "unprognostic (1.08e-2)" "unprognostic (2.62e-1)" "unprognostic (8.16e-2)" "unprognostic (1.39e-3)" 0.7 2.8 4.2 3.0 14.9 6.6 1.1 0.6 19.6 0.6 0.9 0.0 0.0 0.8 0.7 0.6 1.7 1.0 0.9 0.6 6.9 2.7 0.6 0.8 0.8 3.4 3.0 7.5 0.7 0.6 0.6 0.5 1.0 23.0 2.4 0.9 2.2 2.1 1.9 26.1 0.6 0.9 1.7 0.9 2.0 0.8 2.0 0.7 1.6 6.9 0.4 3.1 1.2 0.7 2.7 0.5 1.2 0.0 2.2 1.7 0.2 2.5 0.6 0.0 0.1 0.0 0.9 0.0 20.4 3.0 3.0 2.6 0.0 0.0 12.2 0.0 6.9 0.3 0.4 0.1 1.2 3.6 0.1 4.3 13.3 0.0 0.0 0.5 17.9 0.0 0.2 0.5 8.7 9.1 2.0 0.0 0.0 0.7 8.4 6.0 0.1 0.0 7.7 0.8 0.0 4.3 0.0 0.7 8.4 1.2 0.0 3.4 1.6 0.0 0.0 8.3 0.1 2.5 1.3 0.0 12.7 5.6 0.1 13.5 8.8 0.2 5.6 0.1 8.6 0.7 1.2 0.0 0.0 0.2 0.0 1.1 2.7 0.5 1.5 0.5 1.4 1.7 1.2 0.0 2.2 0.0 0.0 0.0 0.2 4.2 14.9 0.6 19.6 6.9 2.7 3.0 7.5 23.0 0.7 0.0 0.0 0.8 3.2 0.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.7 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.2 0.3 0.2 2.2 0.0 0.3 KCNRG ENSG00000198553 "Potassium channel regulator" Q8N5I3 13 50015254-50020922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 27.7;ovary: 17.1" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 92.3" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001027 Uncertain Vesicles NA NA Vesicles "HPA001027: " "unprognostic (1.85e-3)" "unprognostic (1.66e-2)" "unprognostic (1.08e-2)" "prognostic favorable (2.61e-5)" "unprognostic (3.15e-1)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (5.39e-3)" "unprognostic (1.26e-1)" "unprognostic (1.09e-1)" "unprognostic (1.71e-1)" "unprognostic (5.91e-1)" "unprognostic (1.65e-2)" "unprognostic (4.98e-2)" "unprognostic (4.69e-2)" "unprognostic (1.52e-1)" "unprognostic (9.16e-2)" 0.4 0.2 0.3 0.3 0.3 1.1 0.6 0.9 0.3 1.8 0.3 0.5 0.3 0.3 1.0 4.8 0.6 27.7 0.3 1.0 0.3 0.5 0.6 0.3 9.1 0.3 0.3 0.3 17.1 0.3 0.4 0.4 0.3 0.5 0.5 0.8 0.3 0.3 1.7 0.4 0.8 0.4 0.4 0.3 0.4 0.3 1.7 0.3 0.3 0.4 0.3 0.6 0.3 0.3 2.7 1.2 4.4 1.1 1.3 1.4 0.4 0.9 0.9 2.9 0.9 0.9 1.4 0.4 0.1 2.3 1.9 0.1 3.4 0.9 1.8 0.6 2.8 1.2 1.2 2.2 0.8 1.4 1.3 1.4 3.8 1.4 1.6 2.7 3.1 1.1 1.9 2.1 1.4 3.5 1.6 3.7 6.8 1.5 0.4 2.3 1.1 3.4 3.1 2.0 2.3 1.3 2.5 0.0 0.0 1.7 2.4 2.5 5.3 1.0 1.8 1.7 1.5 1.4 1.0 1.2 1.7 0.7 1.1 0.7 0.2 0.4 2.0 0.6 1.3 0.4 3.2 1.1 0.7 0.5 1.1 0.7 1.5 0.7 1.0 0.9 2.7 0.8 0.9 4.4 1.3 0.8 1.2 1.4 0.4 0.3 0.3 0.9 0.3 0.3 0.5 0.3 0.3 0.5 0.3 0.0 2.4 0.0 0.7 0.1 0.6 0.5 0.0 92.3 6.8 0.0 2.0 0.6 0.0 0.5 11.5 0.1 0.5 0.0 1.2 0.4 0.8 0.6 0.0 0.2 0.5 3.2 4.1 0.0 0.0 8.9 0.6 0.0 0.0 1.0 1.1 0.8 0.4 0.0 0.7 1.5 1.0 0.0 0.3 3.4 1.5 0.1 0.6 0.0 0.6 1.0 KCNT2 "KCa4.2, SLICK, SLO2.1" ENSG00000162687 "Potassium sodium-activated channel subfamily T member 2" Q6UVM3 1 196225779-196609225 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 38.7;Early spermatids: 12.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HHSteC: 4.3;hTERT-RPE1: 12.4;SCLC-21H: 9.3;SH-SY5Y: 8.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051218 Uncertain Approved Vesicles NA NA Vesicles "HPA051218: AB_2681392" "unprognostic (5.06e-2)" "unprognostic (2.94e-2)" "unprognostic (8.01e-2)" "unprognostic (5.10e-6)" "unprognostic (1.22e-3)" "unprognostic (1.30e-2)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (5.90e-2)" "unprognostic (2.18e-1)" "unprognostic (9.56e-3)" "unprognostic (2.61e-1)" "prognostic unfavorable (1.67e-5)" "unprognostic (3.30e-4)" "unprognostic (2.95e-2)" "unprognostic (4.75e-1)" "unprognostic (1.72e-3)" 3.9 2.8 4.8 1.3 5.5 0.6 2.2 1.4 8.3 1.8 2.3 0.6 0.0 2.1 2.2 1.7 4.0 2.7 5.9 6.8 9.4 3.1 1.8 10.5 5.5 1.3 1.8 5.2 14.9 1.1 0.9 14.1 1.8 3.7 4.2 2.5 2.9 2.6 2.5 1.2 1.9 2.1 2.6 5.2 1.4 2.6 3.3 1.0 0.0 4.5 3.4 1.2 3.3 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.1 0.3 0.0 0.0 1.3 0.3 2.7 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 1.6 0.0 4.3 0.0 0.0 1.0 0.0 0.4 0.1 12.4 0.5 0.0 0.0 0.0 0.3 0.0 0.2 0.0 3.3 0.0 0.2 0.0 0.3 0.0 0.0 0.7 9.3 8.4 0.0 0.0 0.2 3.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.3 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 5.5 1.4 8.3 9.4 3.1 1.8 5.2 3.7 1.0 38.7 0.6 0.0 0.3 0.3 0.0 1.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 5.9 0.0 0.0 0.0 2.5 0.0 2.3 6.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 KCTD8 ENSG00000183783 "Potassium channel tetramerization domain containing 8" Q6ZWB6 4 44173909-44448807 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 19.5" "Cell type enhanced" "Detected in some" 20 "Cholangiocytes: 7.6;Collecting duct cells: 3.5;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 16.2" "Cancer enhanced" "Detected in some" "glioma: 0.9;thyroid cancer: 0.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 4.1;NTERA-2: 2.9;PC-3: 1.8;SCLC-21H: 10.9;U-2 OS: 3.3" "Low region specificity" "Detected in all" HPA031562 Enhanced Approved Vesicles NA NA Vesicles "HPA031562: AB_10602609" "unprognostic (1.49e-2)" "unprognostic (7.70e-3)" "unprognostic (1.53e-1)" "unprognostic (4.15e-1)" "unprognostic (1.77e-2)" "unprognostic (1.48e-1)" "unprognostic (7.85e-2)" "unprognostic (2.62e-3)" "unprognostic (1.33e-1)" "unprognostic (4.58e-3)" "unprognostic (2.57e-3)" "unprognostic (8.72e-2)" "unprognostic (3.55e-2)" "unprognostic (2.44e-1)" 2.0 1.4 5.4 0.9 12.2 0.7 0.9 19.5 18.9 2.2 1.0 8.5 3.5 0.8 4.2 1.3 0.8 1.1 1.5 1.1 4.8 5.2 2.8 0.7 1.0 0.7 8.9 4.0 4.3 2.4 0.7 0.2 0.7 6.8 1.5 1.1 2.3 1.7 3.1 2.6 0.8 0.9 2.3 8.0 0.7 2.6 3.8 8.3 0.0 8.6 0.4 0.7 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 1.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 12.2 19.5 8.5 4.8 5.2 8.9 4.0 6.8 8.3 0.0 0.0 0.0 0.6 0.0 2.7 0.2 7.6 0.0 0.0 3.5 3.9 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.2 0.0 0.0 1.0 16.2 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.0 0.0 KIAA0319 NMIG ENSG00000137261 KIAA0319 Q5VV43 6 24544104-24646155 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" Neurogenesis "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 23.5" "Group enriched" "Detected in some" 5 "Early spermatids: 57.8;Late spermatids: 47.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 1.4;neutrophil: 5.0" "Group enriched" "Detected in many" 32 "B-cells: 1.4;granulocytes: 5.0" "Cell line enhanced" "Detected in some" "A549: 4.1;GAMG: 4.3;HDLM-2: 4.8;SCLC-21H: 7.8;U-266/84: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA015607, HPA076313" Enhanced Supported Approved Vesicles "Secreted in brain" NA NA Vesicles "HPA015607: AB_1852299, HPA076313: AB_2732308" "unprognostic (1.64e-1)" "unprognostic (2.81e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-1)" "unprognostic (1.08e-1)" "unprognostic (1.77e-1)" "unprognostic (1.72e-2)" "unprognostic (4.65e-2)" "unprognostic (9.70e-2)" "unprognostic (2.21e-5)" "unprognostic (7.88e-4)" "unprognostic (9.53e-4)" "unprognostic (1.44e-6)" "unprognostic (1.20e-1)" "unprognostic (6.97e-2)" "unprognostic (3.13e-1)" "unprognostic (3.41e-2)" 0.9 1.9 9.9 1.3 10.2 0.9 1.1 10.7 23.5 0.9 1.6 4.0 0.0 0.9 0.9 0.9 0.8 4.8 1.4 0.8 9.7 7.7 0.9 0.8 2.2 0.9 5.8 12.1 0.8 3.0 0.8 3.8 1.1 10.2 1.7 1.7 0.0 0.8 0.9 0.8 2.4 1.1 1.1 1.4 1.1 3.2 3.5 2.3 0.0 0.8 0.0 1.1 0.9 0.1 1.4 0.0 5.0 0.0 0.0 0.0 0.0 3.6 4.1 0.2 2.6 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.2 1.5 1.1 2.0 0.0 4.3 1.7 0.7 0.0 0.0 4.8 1.8 0.0 3.5 0.2 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.3 0.0 1.9 0.0 0.2 0.0 1.2 0.1 0.0 0.5 0.2 0.3 0.2 0.0 0.8 0.1 0.2 7.8 0.5 0.1 2.2 0.0 0.1 0.8 0.0 0.0 0.0 0.6 0.4 0.8 0.6 6.3 0.3 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 9.9 10.2 10.7 14.9 9.7 7.7 5.8 12.1 10.2 2.3 3.0 0.3 0.0 0.0 0.0 1.8 1.2 0.0 10.7 2.3 0.0 0.0 0.0 0.0 0.2 57.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.8 0.0 0.0 47.2 0.6 0.0 0.0 1.0 0.7 0.2 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.9 1.4 0.0 0.6 0.0 0.3 0.2 KIF5C ENSG00000168280 "Kinesin family member 5C" O60282 2 148875250-149026759 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Transport "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 95.8" "Cell type enhanced" "Detected in many" 15 "Bipolar cells: 265.2;Early spermatids: 558.1;Late spermatids: 572.0" "Cancer enhanced" "Detected in many" "prostate cancer: 19.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "MAIT T-cell: 5.9" "Lineage enriched" "Detected in single" 7 "T-cells: 5.9" "Cell line enriched" "Detected in some" 4 "SCLC-21H: 66.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035210, HPA062272" Enhanced Approved Vesicles NA NA Vesicles "HPA035210: AB_10671931, HPA062272: AB_2732678" "unprognostic (1.95e-1)" "unprognostic (2.39e-1)" "unprognostic (2.54e-1)" "unprognostic (4.70e-4)" "unprognostic (1.89e-1)" "unprognostic (3.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.90e-2)" "unprognostic (2.86e-1)" "unprognostic (1.41e-2)" "unprognostic (6.61e-3)" "unprognostic (1.56e-1)" "unprognostic (6.55e-6)" "unprognostic (8.34e-3)" "unprognostic (3.69e-1)" "unprognostic (3.63e-2)" "unprognostic (4.46e-2)" 1.8 10.5 32.0 2.3 31.8 1.3 1.6 33.8 95.8 2.2 2.5 21.7 0.0 1.6 1.8 11.0 1.4 1.6 1.7 1.6 25.4 13.7 1.6 1.2 1.5 1.8 15.8 25.5 3.3 2.5 1.5 12.6 1.3 27.1 21.9 3.2 0.4 1.4 7.5 1.3 1.4 2.3 2.0 20.1 1.6 2.4 13.5 18.3 0.0 3.6 0.0 1.7 2.4 1.0 0.8 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 12.9 2.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.1 0.6 0.0 0.1 2.8 0.0 7.5 0.0 1.5 3.8 1.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.4 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.0 13.0 0.0 4.0 0.0 0.1 0.0 0.0 2.7 66.9 15.4 0.0 0.3 0.2 2.7 0.0 0.0 0.0 0.0 1.1 0.0 1.9 1.3 0.2 0.0 4.7 0.2 0.4 0.0 0.0 0.0 0.3 0.0 5.9 0.5 1.1 1.4 0.0 0.8 0.2 0.3 0.0 0.0 0.0 0.0 0.7 0.0 32.0 31.8 33.8 40.3 25.4 13.7 15.8 25.5 27.1 18.3 0.0 0.0 1.3 5.9 1.1 265.2 12.9 7.6 0.0 0.0 17.4 102.1 0.0 0.0 0.2 558.1 2.2 0.0 0.0 0.0 0.1 2.1 48.5 0.0 0.0 0.2 93.8 124.7 1.3 0.8 572.0 7.5 0.6 5.0 1.0 1.3 6.8 1.5 2.9 12.0 0.0 12.9 6.5 8.5 11.8 9.7 0.4 0.0 5.7 0.6 1.7 KISS1 ENSG00000170498 "KiSS-1 metastasis suppressor" Q15726 1 204190341-204196486 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "placenta: 267.2" "Cell type enriched" "Detected in many" 41 "Syncytiotrophoblasts: 1117.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 9.2" "Group enriched" "Detected in some" 8 "basal ganglia: 11.3;hypothalamus: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 22 "BJ: 55.9;U-2 OS: 22.8" "Low region specificity" "Detected in all" "CAB017775, HPA035542" Enhanced Approved Vesicles "Secreted in female reproductive system" NA NA Vesicles "CAB017775: , HPA035542: AB_2674677" "unprognostic (9.64e-2)" "unprognostic (1.78e-2)" "unprognostic (1.86e-2)" "unprognostic (1.18e-2)" "unprognostic (3.89e-1)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (3.28e-2)" "unprognostic (1.28e-2)" "unprognostic (4.51e-2)" "unprognostic (1.63e-1)" "unprognostic (8.98e-12)" "unprognostic (2.25e-1)" "unprognostic (2.91e-2)" "unprognostic (1.76e-1)" "prognostic favorable (6.29e-6)" 0.2 0.0 0.2 0.2 11.3 0.0 0.2 1.0 0.2 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.2 0.0 0.2 0.2 0.2 4.2 1.1 2.7 0.5 0.2 0.2 0.2 0.2 0.4 0.1 2.5 267.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.5 0.2 0.2 0.7 1.4 3.6 0.2 0.2 0.2 0.2 0.2 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 55.9 0.7 1.0 0.2 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.3 0.1 0.1 0.0 0.0 22.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 11.3 1.0 0.2 0.2 4.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 4.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 3.3 27.0 0.3 5.1 0.0 4.0 4.1 0.4 1.8 0.0 2.9 14.5 0.0 0.0 1.3 0.0 3.1 0.3 0.0 0.0 0.0 0.6 0.0 2.9 0.8 0.0 1.2 0.0 0.0 0.1 0.1 0.4 0.0 1117.8 0.0 1.9 2.2 KITLG "DFNA69, FPH2, Kitl, KL-1, MGF, SCF, SF, SLF" ENSG00000049130 "KIT ligand" P21583 12 88492793-88580851 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Cell adhesion" "Growth factor" "Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 66.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 83.5;SK-BR-3: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070395 Approved Approved Vesicles "Intracellular and membrane" NA NA 150000 Vesicles "HPA070395: AB_2686264" "unprognostic (7.13e-2)" "unprognostic (1.90e-1)" "unprognostic (5.00e-2)" "unprognostic (2.05e-1)" "unprognostic (2.70e-1)" "unprognostic (1.93e-2)" "prognostic unfavorable (4.01e-4)" "unprognostic (2.22e-3)" "unprognostic (5.61e-3)" "unprognostic (7.89e-2)" "unprognostic (5.47e-3)" "unprognostic (5.03e-2)" "prognostic favorable (5.81e-7)" "unprognostic (7.15e-2)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (1.54e-2)" 10.1 3.8 7.8 8.0 6.4 0.0 11.2 4.8 11.5 9.6 16.1 2.9 8.5 6.2 11.7 8.7 16.7 4.7 13.9 5.6 8.4 3.9 21.9 2.8 22.9 6.1 3.3 7.7 4.4 5.0 1.9 3.2 10.1 4.0 17.9 15.9 7.8 11.8 14.8 4.8 5.3 9.5 21.0 3.7 2.6 13.0 5.8 2.9 0.7 6.5 5.8 6.6 17.5 17.8 0.0 0.2 0.0 0.5 0.0 0.0 0.0 3.5 1.9 1.8 0.2 7.3 15.6 0.0 21.4 15.4 3.7 1.7 83.5 3.3 0.0 0.6 18.0 4.4 12.9 2.7 4.8 3.5 0.0 2.4 0.0 2.9 0.6 1.1 0.4 0.0 13.5 5.1 11.6 7.0 1.5 4.4 0.0 0.0 0.0 1.6 0.6 0.0 0.0 1.3 4.2 4.8 0.0 3.4 0.0 6.2 1.7 0.5 1.2 5.2 29.2 0.5 1.7 15.0 1.0 2.9 16.9 2.4 19.7 1.7 0.0 0.0 0.0 2.1 0.0 1.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 6.4 4.8 11.5 8.4 3.9 3.3 7.7 4.0 2.9 17.9 28.1 0.0 11.7 11.9 2.2 3.2 2.5 12.0 25.0 66.3 0.0 0.0 1.7 2.6 0.5 19.6 4.5 0.0 15.9 0.1 14.1 7.5 0.0 0.2 0.9 20.6 9.1 3.1 2.9 0.0 13.0 1.8 11.8 0.0 7.5 0.2 9.2 0.0 3.5 1.4 1.1 12.9 20.5 0.0 0.2 4.5 0.0 0.0 9.3 2.6 KLK8 "HNP, neuropsin, ovasin, PRSS19, TADG14" ENSG00000129455 "Kallikrein related peptidase 8" O60259 19 50996007-51002711 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 43.6;skin 1: 40.4;tongue: 46.9" "Group enriched" "Detected in some" 13 "Basal keratinocytes: 58.6;Suprabasal keratinocytes: 157.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 29.9;ovarian cancer: 30.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A-431: 32.2;CAPAN-2: 42.3;HaCaT: 31.2" "Region enriched" "Detected in many" 5 "hippocampal formation: 39.6" "CAB019393, HPA035761" Enhanced Approved Vesicles "Secreted in other tissues" NA NA 950000 Vesicles "CAB019393: , HPA035761: AB_2674769" "unprognostic (4.27e-3)" "unprognostic (2.59e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (5.46e-2)" "prognostic unfavorable (5.72e-4)" "unprognostic (2.95e-1)" "unprognostic (9.02e-2)" "prognostic unfavorable (1.10e-4)" "unprognostic (4.29e-2)" "unprognostic (4.66e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (6.17e-4)" 1.6 0.0 0.1 0.4 0.1 0.0 4.5 1.0 0.3 8.1 0.7 0.1 0.1 0.0 1.1 0.7 43.6 6.7 0.3 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.0 0.1 0.4 0.6 0.3 0.0 0.3 6.0 0.1 0.3 40.4 0.1 0.1 0.6 0.3 0.0 0.7 0.1 0.5 0.3 46.9 11.1 0.3 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.2 0.0 0.0 0.2 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.6 42.3 0.0 0.8 0.0 0.0 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 3.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.3 0.1 0.0 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.0 58.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 1.7 0.0 8.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 3.4 157.5 0.0 0.0 0.0 0.1 KLRC3 NKG2-E ENSG00000205810 "Killer cell lectin like receptor C3" Q07444 12 10412312-10420595 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 28.5;brain: 9.7;lymphoid tissue: 6.9" "Cell type enhanced" "Detected in some" 19 "Club cells: 1.2;Intestinal endocrine cells: 1.7;T-cells: 1.3" "Cancer enriched" "Detected in single" 9 "glioma: 0.6" "Cell type enriched" "Detected in some" 5 "NK-cell: 28.5" "Lineage enriched" "Detected in many" 5 "NK-cells: 28.5" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.5;GAMG: 5.1;HEL: 2.2;HeLa: 11.6;HSkMC: 2.2;SuSa: 2.8;U-698: 3.2" "HPA039910, HPA062570" Approved Uncertain Vesicles NA NA Vesicles "HPA039910: , HPA062570: AB_2684795" "unprognostic (8.92e-4)" "unprognostic (4.47e-2)" "unprognostic (2.03e-2)" "unprognostic (1.32e-1)" "unprognostic (5.07e-3)" "unprognostic (2.48e-1)" "unprognostic (3.22e-1)" "unprognostic (9.12e-2)" "unprognostic (3.52e-3)" "unprognostic (3.09e-1)" "unprognostic (1.08e-1)" "unprognostic (3.15e-1)" 0.1 0.0 4.6 0.2 2.4 2.5 0.0 0.2 9.7 0.0 0.6 1.2 0.7 0.0 0.1 0.3 0.9 0.0 3.7 2.9 0.0 0.6 0.8 2.7 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 0.0 2.1 6.9 0.7 0.1 0.1 1.0 0.1 0.0 0.0 0.0 0.3 0.0 28.5 5.6 1.5 0.0 0.0 0.1 0.7 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.1 0.1 0.0 1.0 0.0 0.0 0.0 2.2 11.6 0.1 0.0 0.2 0.0 2.2 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.1 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.9 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 4.4 0.3 28.5 0.0 0.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 KLRG1 "2F1, CLEC15A, MAFA, MAFA-L" ENSG00000139187 "Killer cell lectin like receptor G1" Q96E93 12 8950044-9010760 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 83.1" "Cell type enhanced" "Detected in many" 20 "Erythroid cells: 23.3;granulocytes: 113.5;T-cells: 58.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 71.3;MAIT T-cell: 83.1" "Lineage enriched" "Detected in many" 28 "T-cells: 83.1" "Group enriched" "Detected in many" 5 "HEL: 23.6;HUVEC TERT2: 8.3;NTERA-2: 16.2;U-937: 14.8" "Low region specificity" "Detected in some" "HPA051403, HPA076494" Approved Enhanced Vesicles NA NA Vesicles "HPA051403: , HPA076494: AB_2686800" "unprognostic (1.54e-2)" "unprognostic (8.42e-4)" "unprognostic (1.06e-1)" "unprognostic (1.28e-1)" "unprognostic (2.94e-1)" "unprognostic (1.53e-4)" "unprognostic (3.05e-1)" "unprognostic (2.27e-3)" "unprognostic (2.23e-2)" "unprognostic (1.01e-2)" "unprognostic (3.45e-3)" "unprognostic (6.88e-2)" "unprognostic (1.71e-2)" "unprognostic (2.05e-2)" "unprognostic (4.17e-2)" "unprognostic (4.96e-2)" "unprognostic (7.86e-2)" 15.4 3.9 4.4 7.3 5.8 5.6 5.7 12.3 5.0 3.2 3.5 7.1 0.8 1.7 5.6 4.2 2.2 2.6 7.7 5.1 4.4 5.8 3.2 6.4 5.5 17.3 8.3 3.4 2.7 1.9 1.5 5.6 1.5 5.5 4.8 4.7 5.6 3.5 1.8 3.1 2.2 5.0 3.9 5.5 19.0 3.6 2.2 6.8 6.8 2.9 2.3 11.1 8.3 2.6 0.5 1.3 2.4 0.6 2.9 83.1 14.0 0.1 2.2 1.2 1.7 2.0 0.4 1.1 0.3 0.3 0.2 0.7 0.8 0.7 3.1 0.1 0.3 1.6 0.2 2.9 0.3 0.3 2.3 1.5 23.6 0.3 1.2 0.6 0.8 1.2 1.4 0.3 0.4 0.0 0.4 8.3 1.8 1.0 0.3 0.2 0.5 0.5 1.6 16.2 0.8 1.5 0.9 0.7 0.0 0.3 0.3 0.4 3.2 0.7 0.4 0.9 3.1 0.2 1.1 0.6 0.5 0.7 0.4 1.0 1.0 2.8 1.8 1.4 14.8 0.2 2.4 0.3 0.2 71.3 0.4 83.1 0.5 15.8 43.4 1.3 0.5 4.3 29.9 0.9 2.9 0.6 0.5 1.2 14.0 4.4 5.8 12.3 5.0 4.4 5.8 8.3 3.4 5.5 6.8 0.0 7.0 4.7 0.4 0.3 4.1 2.5 0.0 0.0 0.0 0.0 7.9 0.8 1.7 0.5 1.7 1.6 0.0 23.3 0.2 0.3 0.4 0.2 113.5 1.8 3.0 4.8 1.2 16.0 5.9 2.0 0.6 1.7 1.7 1.0 0.0 1.5 0.2 0.0 0.0 2.2 3.5 0.0 0.5 1.6 4.3 0.0 0.2 58.9 0.6 0.0 KRIT1 "CAM, CCM1" ENSG00000001631 "KRIT1, ankyrin repeat containing" O00522 7 92198969-92246166 "Disease related genes, Predicted intracellular proteins" Angiogenesis "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Spermatocytes: 177.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049606 Supported Uncertain Vesicles NA NA Vesicles "HPA049606: AB_2680832" "unprognostic (8.12e-2)" "unprognostic (1.11e-2)" "unprognostic (1.83e-2)" "unprognostic (3.75e-2)" "unprognostic (1.94e-1)" "unprognostic (8.93e-2)" "unprognostic (4.10e-3)" "unprognostic (1.06e-2)" "unprognostic (2.30e-3)" "unprognostic (2.18e-1)" "unprognostic (7.24e-2)" "unprognostic (1.04e-1)" "unprognostic (1.19e-1)" "unprognostic (2.82e-1)" "unprognostic (2.61e-1)" "unprognostic (6.18e-2)" "unprognostic (1.04e-1)" 16.7 16.2 18.0 15.6 22.4 7.1 15.8 32.7 32.0 18.7 16.3 11.7 16.8 14.8 19.3 16.1 15.4 16.2 17.1 19.5 14.7 13.5 17.5 14.0 13.5 14.4 22.1 15.9 23.1 16.6 26.2 46.0 16.3 17.2 17.5 13.5 12.8 17.2 19.6 23.0 13.3 14.6 16.7 20.3 14.7 16.2 23.7 19.9 19.1 25.0 12.6 17.2 19.4 19.8 11.8 8.2 11.7 5.8 12.7 11.4 3.6 19.0 13.1 16.4 17.6 14.7 14.5 15.4 17.9 13.1 12.0 11.6 11.1 20.0 17.1 17.8 10.4 16.6 15.9 16.0 10.6 16.6 18.1 19.1 17.4 16.8 7.6 11.5 22.3 21.3 13.6 14.2 11.7 13.5 13.3 12.1 14.4 34.2 24.0 13.8 17.7 24.3 13.2 17.1 14.2 13.6 16.6 24.0 21.6 7.8 17.2 17.9 22.0 21.6 23.0 14.3 21.2 13.7 12.1 17.0 23.3 20.7 32.0 13.1 18.8 21.4 32.1 13.2 18.3 21.9 11.7 5.8 5.9 7.8 4.3 8.1 11.8 8.8 10.5 6.0 10.0 11.4 9.9 2.4 12.7 3.2 8.2 8.2 3.6 18.0 22.4 32.7 32.0 14.7 13.5 22.1 15.9 17.2 19.9 14.9 30.1 23.0 24.1 17.6 42.8 24.6 20.4 44.2 27.3 40.1 31.4 30.9 39.7 19.8 19.6 33.8 18.6 0.0 21.0 25.7 28.6 21.5 34.8 24.5 16.6 27.0 19.5 43.6 20.6 12.2 47.5 20.7 6.8 19.0 19.9 38.9 19.6 28.1 50.9 24.8 49.3 38.8 20.2 177.4 82.6 22.0 23.5 29.4 22.9 16.3 KRT25 KRT25A ENSG00000204897 "Keratin 25" Q7Z3Z0 17 40748021-40755332 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 44.5" "Group enriched" "Detected in some" 9 "Early spermatids: 8.0;Late spermatids: 6.8" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebral cortex: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RPTEC TERT1: 5.6" "Region enriched" "Detected in single" 7 "cerebellum: 9.7" "Group enriched" "Detected in some" 5 "cerebral cortex: 8.3;hippocampal formation: 6.1" "HPA053977, HPA058943" Enhanced Approved Vesicles NA NA Vesicles "HPA053977: AB_2682329, HPA058943: AB_2683859" "unprognostic (8.19e-2)" "unprognostic (5.89e-8)" "unprognostic (1.79e-1)" 1.6 0.0 0.0 0.0 0.9 0.0 8.6 0.0 3.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 44.5 0.1 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 L1TD1 "ECAT11, FLJ10884" ENSG00000240563 "LINE1 type transposase domain containing 1" Q5T7N2 1 62194831-62212328 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 18.2;placenta: 34.0" "Cell type enhanced" "Detected in many" 16 "Cytotrophoblasts: 82.1;Syncytiotrophoblasts: 23.6" "Cancer enriched" "Detected in some" 14 "testis cancer: 120.2" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "non-classical monocyte: 8.1" "Lineage enriched" "Detected in single" 17 "monocytes: 8.1" "Group enriched" "Detected in some" 22 "NTERA-2: 68.4;SuSa: 53.8" "HPA028501, HPA030064" Enhanced Vesicles NA NA Vesicles "HPA028501: AB_10599287, HPA030064: AB_10600538" "unprognostic (2.03e-2)" "unprognostic (7.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.86e-1)" "unprognostic (3.51e-1)" "unprognostic (2.29e-1)" "unprognostic (2.46e-1)" "unprognostic (4.03e-1)" "unprognostic (1.09e-1)" "unprognostic (9.23e-2)" "unprognostic (4.04e-2)" "unprognostic (4.61e-2)" "unprognostic (1.52e-5)" "unprognostic (3.49e-2)" "unprognostic (2.43e-1)" "unprognostic (5.75e-2)" "unprognostic (1.95e-1)" 0.6 0.8 0.2 18.2 0.4 0.0 0.7 0.4 0.2 1.6 6.9 0.0 0.3 0.1 0.3 0.4 0.4 0.4 0.3 0.3 0.2 0.2 0.4 0.2 3.1 1.6 0.2 0.1 1.3 0.3 0.0 0.4 34.0 0.7 2.4 1.6 1.5 0.7 0.1 0.6 0.3 0.6 0.5 0.2 2.9 0.4 8.5 0.0 0.4 2.4 0.1 0.1 1.6 1.3 0.4 0.3 0.1 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 8.1 0.0 0.0 0.0 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.1 0.7 0.0 6.0 15.4 0.0 0.5 0.3 2.5 0.3 0.0 10.7 13.6 0.0 5.9 82.1 0.0 0.0 0.3 0.7 0.2 0.0 0.3 20.0 2.1 0.3 1.1 0.0 6.6 3.2 10.2 0.0 0.8 0.4 1.7 2.0 0.0 0.0 4.4 0.3 0.4 0.9 17.3 0.0 3.9 0.0 0.9 0.7 13.2 0.1 23.6 1.9 0.6 0.2 L3HYPDH "C14orf149, FLJ25436" ENSG00000126790 "Trans-L-3-hydroxyproline dehydratase" Q96EM0 14 59460363-59484430 "Enzymes, Predicted intracellular proteins" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 26.8;Proximal tubular cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056694 Approved Uncertain Vesicles NA NA 16000 Vesicles "HPA056694: AB_2683210" "unprognostic (3.39e-2)" "unprognostic (5.55e-3)" "unprognostic (3.81e-2)" "unprognostic (5.86e-2)" "unprognostic (1.10e-1)" "unprognostic (5.06e-2)" "unprognostic (8.34e-2)" "unprognostic (1.16e-1)" "unprognostic (7.24e-2)" "unprognostic (9.50e-2)" "unprognostic (1.26e-3)" "unprognostic (6.60e-2)" "prognostic unfavorable (1.72e-9)" "unprognostic (1.16e-1)" "unprognostic (2.22e-1)" "unprognostic (1.05e-1)" "unprognostic (1.14e-1)" 17.9 15.4 13.5 13.5 17.1 4.9 22.8 10.4 16.5 12.6 9.9 18.5 10.9 12.3 17.6 10.3 9.8 16.3 13.2 15.9 13.6 7.2 20.2 17.4 11.5 18.5 22.7 9.6 20.1 12.8 23.1 22.5 11.9 18.2 15.5 12.0 12.9 13.6 15.5 8.7 11.0 13.7 14.0 18.4 14.3 11.0 18.9 17.4 6.6 17.9 9.9 15.0 12.7 18.7 2.3 7.9 0.8 7.0 7.0 5.1 2.5 6.0 16.6 3.6 8.5 7.8 20.7 5.0 16.5 13.2 9.6 9.4 3.3 11.1 2.1 7.0 9.1 17.0 16.6 5.8 8.9 9.5 3.5 7.5 5.7 14.5 12.0 8.8 5.0 4.0 14.9 6.1 9.6 14.9 15.0 11.7 5.9 7.4 9.7 9.9 7.3 1.9 8.3 5.8 2.4 15.0 2.8 5.8 8.4 15.3 3.5 3.7 5.3 15.6 6.5 5.9 3.1 6.8 3.3 16.3 11.2 13.7 8.7 19.3 2.5 1.1 2.0 19.3 4.3 21.9 0.0 5.0 0.8 5.1 7.0 3.4 2.3 2.5 3.0 7.9 2.2 3.9 1.4 0.0 7.0 3.2 4.3 1.1 2.5 13.5 17.1 10.4 16.5 13.6 7.2 22.7 9.6 18.2 17.4 3.0 6.7 3.2 5.1 4.6 3.0 7.5 5.1 26.8 5.7 3.5 2.0 10.8 6.6 6.2 6.8 6.7 2.0 0.0 2.1 9.5 9.7 2.6 13.9 13.1 7.1 1.6 2.9 11.1 3.5 6.8 17.8 3.0 3.3 0.0 3.6 4.0 4.2 0.0 11.3 31.2 2.1 12.9 9.2 13.4 5.1 3.0 4.1 3.9 3.1 0.9 LAMB3 "BM600-125kDa, kalinin-140kDa, LAMNB1, nicein-125kDa" ENSG00000196878 "Laminin subunit beta 3" Q13751 1 209614870-209652466 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Amelogenesis imperfecta, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 1: 205.4;Basal glandular cells: 278.5;Pancreatic endocrine cells: 523.1;Urothelial cells: 285.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "myeloid DC: 1.9;neutrophil: 3.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.9;granulocytes: 3.4" "Cell line enhanced" "Detected in many" "CAPAN-2: 43.5;HaCaT: 66.0;HBEC3-KT: 161.1;hTCEpi: 51.6;hTERT-HME1: 32.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA007584, HPA008069, CAB078183" Enhanced Approved Vesicles "Secreted to extracellular matrix" NA NA 15000 Vesicles "CAB078183: AB_2665825, HPA007584: , HPA008069: AB_1079228" "prognostic favorable (8.43e-4)" "unprognostic (3.08e-2)" "unprognostic (1.46e-2)" "unprognostic (2.88e-2)" "unprognostic (8.00e-2)" "unprognostic (1.60e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.62e-5)" "unprognostic (1.95e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (2.55e-4)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.43e-5)" "unprognostic (1.02e-1)" "unprognostic (2.38e-1)" "unprognostic (6.01e-2)" "unprognostic (4.92e-3)" 24.5 8.4 1.2 5.5 1.7 3.3 11.7 0.8 4.1 10.2 9.9 0.9 3.2 12.1 7.0 3.1 22.1 6.3 8.4 8.9 1.1 0.8 4.7 4.7 11.0 1.6 1.2 2.2 1.4 2.1 0.0 1.1 16.1 1.1 11.9 6.3 0.8 19.1 10.3 1.9 17.9 22.8 2.7 1.4 2.1 28.7 1.7 0.8 4.9 1.1 35.8 30.2 16.2 13.3 0.1 1.9 3.4 0.5 0.4 0.4 0.1 21.1 3.1 0.0 0.0 2.3 1.5 0.1 0.6 1.9 0.7 1.1 8.3 43.5 0.0 1.8 0.4 1.1 66.0 0.0 161.1 1.1 1.5 0.1 0.1 11.2 0.1 0.3 0.1 0.1 0.3 51.6 2.4 32.1 1.4 0.7 0.0 0.3 0.8 0.2 0.0 0.0 0.1 0.0 9.7 9.1 0.0 2.1 19.3 8.9 13.2 0.0 0.0 9.0 1.0 1.8 0.1 0.2 1.1 16.8 3.6 7.8 0.1 12.6 0.2 0.4 0.0 5.3 0.0 0.2 0.0 0.3 0.0 0.0 0.5 0.0 0.0 0.4 0.0 1.9 0.1 0.4 0.0 3.4 0.4 0.0 0.0 0.0 0.1 1.2 1.7 0.8 4.1 1.1 0.8 1.2 2.2 1.1 0.8 205.4 75.6 2.2 278.5 97.4 0.2 6.9 2.5 44.2 151.2 45.4 0.0 0.1 0.0 174.0 4.1 1.1 142.2 0.0 132.9 1.1 4.3 108.8 18.4 3.9 2.1 3.2 7.5 0.0 0.0 7.4 1.7 10.1 8.5 3.6 43.8 0.8 523.1 80.7 0.7 1.9 0.3 0.0 4.2 0.3 0.7 22.7 0.5 0.0 20.5 285.9 LAMP3 "CD208, DC-LAMP, DCLAMP, LAMP, TSC403" ENSG00000078081 "Lysosomal associated membrane protein 3" Q9UQV4 3 183122213-183163839 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "lung: 123.9" "Group enriched" "Detected in many" 7 "Alveolar cells type 2: 374.8;monocytes: 592.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "eosinophil: 7.6" "Group enriched" "Detected in many" 8 "granulocytes: 7.6;T-cells: 6.6" "Cell line enhanced" "Detected in some" "EFO-21: 57.7;HDLM-2: 14.6;HHSteC: 21.4;hTCEpi: 19.5;JURKAT: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB025133, HPA051467" Enhanced Enhanced Vesicles NA NA 47000 Vesicles "CAB025133: , HPA051467: AB_2681495" "unprognostic (1.43e-3)" "unprognostic (2.06e-2)" "unprognostic (1.70e-1)" "unprognostic (2.99e-3)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (7.67e-2)" "unprognostic (8.64e-2)" "unprognostic (4.95e-2)" "prognostic favorable (9.90e-4)" "unprognostic (1.80e-3)" "unprognostic (5.80e-2)" "prognostic unfavorable (1.89e-7)" "unprognostic (3.12e-1)" "unprognostic (4.13e-2)" "unprognostic (8.35e-2)" "unprognostic (1.29e-1)" 0.5 0.7 0.4 14.1 0.4 0.0 0.5 0.3 0.4 1.0 0.6 0.1 0.6 0.4 0.4 1.0 2.5 0.5 0.8 0.4 0.4 0.4 0.8 0.6 123.9 11.2 0.4 0.1 0.4 8.3 0.0 0.6 1.0 0.6 1.0 1.7 0.2 6.8 1.9 0.4 1.9 1.4 0.8 0.5 2.0 0.8 8.4 0.0 21.3 8.3 3.1 11.3 3.3 0.9 0.4 0.0 7.6 0.1 0.8 6.6 1.1 3.5 0.1 0.0 0.5 0.0 0.0 2.8 0.0 0.9 0.6 0.1 0.8 1.8 0.0 57.7 0.3 6.5 0.5 1.2 2.2 0.1 14.6 1.7 0.0 0.1 0.1 21.4 0.0 0.5 0.3 19.5 0.0 2.6 0.0 2.6 17.7 0.1 3.4 0.1 0.0 0.8 0.1 0.1 0.3 0.8 0.0 0.0 0.2 0.0 1.1 0.2 0.1 0.2 0.1 1.5 0.7 1.1 0.1 2.7 0.0 1.0 0.1 0.0 1.2 4.3 0.1 0.0 0.0 0.0 0.4 0.1 7.6 0.4 0.0 3.2 0.1 2.7 1.7 0.0 0.4 3.5 2.0 1.9 0.8 0.1 0.0 6.6 1.1 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.1 0.6 0.0 59.6 374.8 0.5 3.2 5.4 0.0 1.2 2.5 9.4 15.9 1.8 0.0 1.9 0.0 0.6 26.0 0.5 0.0 0.0 5.3 0.2 0.2 1.2 17.4 0.0 1.3 0.0 0.0 0.0 0.0 69.6 0.6 3.1 1.7 592.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.5 5.0 1.0 0.5 0.3 2.0 LAMTOR4 C7orf59 ENSG00000188186 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4" Q0VGL1 7 100148907-100155944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 206.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 206.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020998 Enhanced Supported Vesicles NA NA Vesicles "HPA020998: AB_1845762" "prognostic favorable (2.48e-4)" "prognostic favorable (6.08e-4)" "unprognostic (1.29e-2)" "unprognostic (1.14e-1)" "unprognostic (8.21e-3)" "unprognostic (6.11e-2)" "unprognostic (1.10e-2)" "unprognostic (1.32e-2)" "unprognostic (6.17e-2)" "unprognostic (1.57e-1)" "unprognostic (2.42e-3)" "unprognostic (8.83e-2)" "unprognostic (1.11e-1)" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.45e-1)" "unprognostic (1.68e-2)" 31.0 30.7 43.8 36.0 40.2 54.7 43.2 20.9 70.6 28.5 41.8 27.9 26.5 28.6 25.0 35.3 32.9 35.9 36.0 42.2 39.5 35.1 36.3 24.9 32.0 44.7 49.5 30.7 30.0 36.9 19.3 28.5 26.8 38.7 30.8 34.5 31.2 35.4 27.5 44.4 84.7 27.2 31.3 47.8 41.5 29.7 21.3 35.2 15.7 37.3 33.1 26.6 31.3 39.6 31.4 35.1 206.0 53.2 17.6 26.5 46.2 19.2 46.9 24.8 31.3 26.4 30.5 20.2 11.6 28.6 21.6 26.8 21.6 31.1 31.1 39.3 17.5 39.5 20.4 23.5 29.9 9.3 31.4 66.4 24.8 44.4 37.2 24.9 19.2 35.9 36.5 29.6 22.6 28.0 24.2 33.0 29.2 23.3 50.2 29.4 91.9 18.6 77.5 26.3 53.5 37.7 19.6 20.4 55.4 24.5 23.6 17.5 32.4 21.4 50.4 38.4 19.8 20.2 38.2 22.0 20.7 30.8 42.6 18.6 30.5 40.6 57.6 33.0 54.0 29.3 52.0 53.2 183.0 19.6 46.9 16.3 31.4 24.8 20.2 35.1 27.7 25.5 20.5 206.0 17.6 43.4 29.7 26.5 46.2 43.8 40.2 20.9 70.6 39.5 35.1 49.5 30.7 38.7 35.2 86.4 157.1 194.3 153.1 244.3 54.7 157.4 145.2 139.2 85.3 207.6 11.8 217.7 452.6 149.0 26.3 183.1 559.6 0.0 283.4 159.4 191.6 159.9 180.0 212.1 461.4 55.6 287.5 220.4 484.9 36.2 135.4 342.4 411.7 182.1 346.6 148.8 173.2 634.8 113.1 406.9 51.3 142.3 219.3 71.5 128.6 579.4 168.4 176.8 418.7 161.9 LBH ENSG00000213626 "Limb bud and heart development" Q53QV2 2 30231531-30323730 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 198.3;Pancreatic endocrine cells: 178.1;Smooth muscle cells: 316.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 6 "gdT-cell: 28.5;MAIT T-cell: 28.5;memory B-cell: 22.8;memory CD4 T-cell: 21.5;memory CD8 T-cell: 21.6;naive B-cell: 33.4;naive CD4 T-cell: 36.7;naive CD8 T-cell: 31.3;T-reg: 20.7" "Group enriched" "Detected in many" 8 "B-cells: 33.4;T-cells: 36.7" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 75.0;hTERT-RPE1: 38.7;U-2 OS: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA034669 Approved Approved Vesicles NA NA Vesicles "HPA034669: AB_10600820" "unprognostic (2.13e-2)" "unprognostic (2.34e-2)" "unprognostic (1.78e-1)" "unprognostic (4.77e-3)" "unprognostic (1.23e-3)" "unprognostic (1.57e-1)" "unprognostic (2.69e-1)" "unprognostic (3.65e-3)" "unprognostic (1.93e-1)" "unprognostic (3.24e-2)" "unprognostic (2.54e-1)" "unprognostic (1.60e-1)" "unprognostic (2.32e-2)" "prognostic unfavorable (8.24e-4)" "unprognostic (2.25e-2)" "unprognostic (7.91e-3)" "unprognostic (1.67e-1)" 13.7 3.8 3.7 25.5 5.3 6.7 29.8 1.8 9.2 22.1 10.1 2.7 7.6 3.8 36.4 17.2 12.3 18.2 21.0 59.3 4.5 11.5 15.4 6.0 66.1 53.6 6.2 5.0 44.3 4.5 21.4 6.6 15.9 9.4 10.2 5.1 32.0 45.8 12.0 7.0 11.8 15.1 14.0 3.4 33.5 8.9 8.1 0.8 78.1 48.6 9.5 32.7 13.1 9.5 33.4 2.9 0.9 0.7 4.2 36.7 21.2 0.0 2.8 3.5 0.6 0.9 0.5 0.3 3.6 4.8 0.9 0.1 14.6 3.8 7.0 8.5 75.0 0.9 4.8 20.3 0.2 0.1 10.0 0.8 1.1 3.1 0.0 2.8 0.1 1.0 3.4 0.2 1.2 0.0 38.7 0.1 4.7 3.5 0.0 3.5 0.0 7.7 0.0 21.5 0.6 0.1 8.0 19.1 2.4 0.6 1.2 1.0 2.5 5.9 0.5 0.2 13.3 0.0 0.3 4.7 6.9 25.3 13.2 0.4 13.7 0.7 0.6 3.0 0.4 2.1 0.1 0.1 0.2 28.5 0.3 28.5 22.8 21.5 21.6 0.2 33.4 36.7 31.3 0.9 4.2 0.7 2.9 20.7 21.2 3.7 5.3 1.8 9.2 4.5 11.5 6.2 5.0 9.4 0.8 101.3 24.8 81.5 50.3 11.0 17.2 59.8 7.6 105.7 53.4 24.4 198.3 15.6 11.6 68.7 24.4 39.6 1.6 23.3 51.4 10.7 31.9 45.3 15.1 1.5 25.3 7.9 22.8 29.4 9.8 84.4 9.8 5.6 21.9 1.8 0.7 12.8 178.1 8.6 25.1 15.3 44.9 174.6 316.5 0.9 2.1 9.4 7.8 117.0 1.7 51.8 LDLRAD4 C18orf1 ENSG00000168675 "Low density lipoprotein receptor class A domain containing 4" O15165 18 13217498-13652755 "Predicted intracellular proteins, Predicted membrane proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.4;lymphoid tissue: 49.2" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 112.3;Late spermatids: 181.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 15.6;JURKAT: 15.5;MOLT-4: 47.7;REH: 14.4;U-698: 12.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047633, HPA065246" Approved Supported Vesicles NA NA Vesicles "HPA047633: , HPA065246: AB_2685444" "unprognostic (2.52e-1)" "unprognostic (4.31e-3)" "unprognostic (5.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.64e-1)" "unprognostic (3.94e-3)" "unprognostic (9.73e-2)" "unprognostic (2.26e-2)" "unprognostic (2.21e-2)" "unprognostic (2.92e-2)" "unprognostic (2.30e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (4.58e-4)" "unprognostic (2.51e-2)" "unprognostic (4.38e-2)" "unprognostic (6.58e-2)" "unprognostic (8.18e-2)" 8.3 6.6 9.6 11.5 22.0 11.9 7.5 10.3 22.9 8.6 6.1 45.4 4.3 9.8 12.9 5.2 5.6 11.0 7.8 17.8 14.6 10.7 3.9 10.4 5.9 11.6 19.9 12.5 3.6 6.2 4.6 8.3 8.0 23.5 10.4 3.3 3.7 4.8 8.3 19.0 4.8 10.9 7.5 30.7 8.9 7.6 8.9 21.2 49.2 5.2 2.5 8.5 7.9 6.7 8.2 8.2 17.2 11.0 12.5 14.5 6.2 0.1 0.2 0.9 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.5 0.4 0.2 0.0 0.0 0.0 7.8 0.8 15.6 3.2 0.2 0.0 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 15.5 0.2 0.6 0.0 1.2 47.7 0.6 1.2 0.2 5.5 14.4 0.1 0.6 0.0 0.8 1.1 1.6 0.2 1.1 0.0 0.7 2.1 4.8 1.4 0.8 5.6 0.1 1.0 2.2 0.2 12.0 0.0 3.5 3.2 12.7 10.3 3.4 10.2 10.3 8.9 7.2 9.7 8.8 5.1 8.2 14.5 12.6 17.2 12.5 11.0 8.2 5.2 6.2 9.6 22.0 10.3 20.6 14.6 10.7 19.9 12.5 23.5 21.2 3.0 6.6 34.6 2.1 9.3 4.2 15.4 0.0 6.7 7.9 1.8 66.8 0.6 1.7 5.0 112.3 18.0 7.1 0.0 3.3 0.4 27.0 21.2 23.1 21.7 18.5 0.0 56.4 18.4 18.9 181.4 10.3 35.0 13.5 6.4 7.9 4.3 0.5 3.5 23.0 2.1 17.0 6.5 9.2 2.3 5.3 6.8 1.4 16.6 6.7 3.0 LHFPL3 LHFPL4 ENSG00000187416 "LHFPL tetraspan subfamily member 3" Q86UP9 7 104328656-104907232 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 8 "brain: 36.5" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 7.0" "Cancer enriched" "Detected in some" 12 "glioma: 27.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.5;K-562: 2.2;SCLC-21H: 4.1;SH-SY5Y: 5.5;SK-BR-3: 4.6;SK-MEL-30: 2.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069691 Approved Vesicles No NA Vesicles "HPA069691: AB_2686171" "unprognostic (1.20e-2)" "unprognostic (6.91e-2)" "unprognostic (4.59e-3)" "unprognostic (5.03e-2)" "unprognostic (2.27e-2)" "unprognostic (2.22e-1)" "unprognostic (1.07e-1)" "unprognostic (6.96e-2)" "unprognostic (5.81e-2)" "unprognostic (5.99e-3)" "unprognostic (8.50e-3)" "unprognostic (3.07e-1)" "unprognostic (1.33e-1)" 0.5 0.6 6.4 0.6 7.7 0.5 0.5 2.3 36.5 4.3 0.8 6.1 0.0 2.0 0.7 0.5 0.5 0.9 0.5 0.5 4.9 5.6 1.4 0.5 2.2 0.5 4.8 4.2 0.7 1.5 0.5 0.1 0.5 5.6 0.7 0.6 3.8 0.5 0.5 0.5 0.7 1.4 0.5 6.0 0.9 0.8 0.7 6.7 0.0 0.5 0.0 0.6 0.5 0.2 0.5 0.0 0.0 0.5 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.2 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 4.1 5.5 0.0 4.6 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.0 0.4 0.0 0.1 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 7.7 2.3 7.1 4.9 5.6 4.8 4.2 5.6 6.7 0.0 0.3 0.0 0.0 0.0 0.7 0.2 0.0 1.4 0.0 0.0 7.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 LMBRD1 "bA810I22.1, C6orf209, cblF, FLJ11240" ENSG00000168216 "LMBR1 domain containing 1" Q9NUN5 6 69675802-69797111 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Host-virus interaction, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016491, HPA019547" Uncertain Supported Vesicles NA NA Vesicles "HPA016491: , HPA019547: AB_2281256" "unprognostic (1.44e-1)" "unprognostic (3.84e-2)" "unprognostic (7.67e-2)" "unprognostic (7.64e-2)" "unprognostic (2.41e-1)" "unprognostic (5.37e-2)" "unprognostic (2.26e-1)" "unprognostic (4.39e-2)" "unprognostic (2.19e-1)" "unprognostic (1.97e-1)" "unprognostic (2.22e-1)" "unprognostic (1.47e-1)" "prognostic favorable (1.07e-7)" "unprognostic (7.99e-2)" "unprognostic (1.67e-1)" "unprognostic (2.60e-2)" "unprognostic (2.68e-2)" 21.3 44.1 34.1 14.2 32.5 5.4 29.1 32.9 34.1 23.7 20.9 38.1 20.0 23.1 18.4 32.1 20.6 25.5 23.9 19.8 35.8 32.7 53.1 38.9 24.7 21.9 37.9 22.8 29.0 36.8 58.9 23.6 25.0 32.5 19.0 21.8 26.5 22.4 24.6 17.9 18.6 30.2 17.2 57.8 19.9 19.9 11.9 30.6 17.8 41.8 13.2 18.7 22.7 19.4 24.4 9.9 37.8 18.5 7.8 14.4 11.5 6.7 3.2 7.6 10.3 22.9 24.5 11.4 5.4 19.8 4.5 9.5 5.3 14.0 9.0 15.4 14.2 7.0 10.8 8.4 8.0 8.1 17.6 10.8 8.7 6.3 7.7 14.0 5.3 11.8 17.3 17.0 5.2 7.3 21.7 8.0 7.3 15.9 13.5 14.4 4.6 3.6 5.6 3.9 12.7 3.4 4.1 18.7 25.3 31.0 11.2 4.9 8.1 6.8 9.3 9.9 6.1 9.9 19.0 12.2 6.3 4.0 5.9 5.4 8.1 7.0 3.4 7.8 8.6 11.9 25.2 10.6 19.0 8.4 13.2 8.6 24.4 11.2 9.5 9.9 21.7 12.8 9.0 37.8 7.8 18.5 9.6 14.4 11.5 34.1 32.5 32.9 34.1 35.8 32.7 37.9 22.8 32.5 30.6 59.6 34.7 34.6 36.9 25.8 68.6 35.2 45.9 52.2 50.0 55.8 104.1 65.0 16.6 37.2 15.4 36.2 60.6 23.3 43.3 52.5 48.2 25.5 39.3 51.4 37.9 52.4 18.0 36.8 63.3 3.2 32.8 46.1 30.4 39.7 38.1 48.7 36.8 42.1 31.8 49.4 81.3 25.8 22.8 17.0 15.9 33.2 64.8 31.0 27.5 33.1 LOXL4 "FLJ21889, LOXC" ENSG00000138131 "Lysyl oxidase like 4" Q96JB6 10 98247690-98268250 "Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 29.1" "Cell type enhanced" "Detected in many" 15 "Club cells: 9.1;Collecting duct cells: 29.6;Ductal cells: 8.6" "Cancer enhanced" "Detected in all" "melanoma: 44.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.3;plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "BJ hTERT+: 60.1;CAPAN-2: 72.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB033876, HPA037609" Approved Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "CAB033876: AB_2135101, HPA037609: AB_2675579" "unprognostic (9.91e-3)" "unprognostic (3.97e-2)" "unprognostic (1.81e-2)" "unprognostic (1.43e-2)" "prognostic unfavorable (6.49e-4)" "unprognostic (7.71e-2)" "unprognostic (1.75e-2)" "unprognostic (8.38e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (9.57e-4)" "unprognostic (2.51e-1)" "unprognostic (4.97e-2)" "unprognostic (5.25e-2)" "unprognostic (5.77e-3)" "unprognostic (1.28e-1)" "unprognostic (6.10e-2)" "unprognostic (7.40e-3)" 6.3 1.8 1.1 1.1 4.2 0.1 10.7 1.0 1.7 20.7 7.3 4.6 1.4 1.4 8.0 4.6 2.3 7.4 4.6 1.8 1.6 0.3 4.4 29.1 3.1 0.6 1.1 1.2 6.1 14.5 1.7 1.4 5.1 8.2 5.1 1.5 3.2 15.7 10.7 14.7 3.1 2.5 7.1 3.0 1.8 2.3 10.8 1.0 1.4 5.7 1.9 1.7 3.1 6.0 0.8 1.2 0.1 0.2 2.3 0.0 0.0 0.0 0.4 0.0 0.0 1.7 7.4 0.2 7.6 60.1 0.6 6.5 1.2 72.2 0.0 6.9 5.9 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.0 3.1 1.6 0.0 0.0 0.8 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.0 0.1 0.1 0.0 13.6 0.8 0.2 0.0 0.0 0.0 0.1 0.0 8.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 2.3 0.0 1.2 0.0 0.0 1.1 4.2 1.0 1.7 1.6 0.3 1.1 1.2 8.2 1.0 6.0 1.0 0.0 1.9 0.8 0.2 1.1 5.1 4.0 9.1 29.6 0.0 0.2 0.0 8.6 0.2 0.6 0.0 0.0 0.5 0.3 5.1 2.0 1.1 0.2 0.2 0.0 0.0 3.7 0.0 0.0 3.7 0.0 0.0 0.0 0.0 4.9 3.3 0.0 1.4 0.5 0.0 0.0 1.6 0.0 0.2 0.6 0.3 0.0 0.0 1.6 LPL LIPD ENSG00000175445 "Lipoprotein lipase" P06858 8 19901717-19967258 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Lipid degradation, Lipid metabolism" "Heparin-binding, Hydrolase" "Disease mutation, FDA approved drug targets, Hyperlipidemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4" "Cell type enhanced" "Detected in many" 20 "Cardiomyocytes: 482.3;Hofbauer cells: 114.1;Horizontal cells: 195.5;Sertoli cells: 232.8" "Cancer enhanced" "Detected in all" "glioma: 39.2" "Region enhanced" "Detected in many" "basal ganglia: 16.3" "Cell type enhanced" "Detected in some" "non-classical monocyte: 7.1" "Lineage enriched" "Detected in many" 5 "monocytes: 7.1" "Cell line enriched" "Detected in some" 5 "AF22: 91.4" "Region enhanced" "Detected in many" "basal ganglia: 40.6" "Region enriched" "Detected in many" 4 "basal ganglia: 64.0" HPA048749 Supported Vesicles "Secreted to blood" NA NA 880000 Vesicles "HPA048749: AB_2680511" "unprognostic (5.52e-2)" "unprognostic (3.16e-1)" "unprognostic (6.41e-2)" "unprognostic (3.03e-1)" "unprognostic (4.14e-2)" "unprognostic (1.01e-2)" "unprognostic (1.88e-4)" "unprognostic (1.05e-1)" "unprognostic (6.78e-2)" "unprognostic (8.20e-2)" "unprognostic (2.54e-2)" "unprognostic (5.28e-1)" "unprognostic (1.18e-1)" "unprognostic (4.20e-3)" "unprognostic (4.16e-3)" "unprognostic (1.19e-1)" "prognostic unfavorable (6.07e-4)" 178.6 4.3 2.0 11.4 16.3 0.6 146.2 3.9 8.0 1.0 16.9 0.3 27.3 0.8 1.3 1.1 1.1 0.7 8.2 121.4 2.8 2.3 4.8 0.6 20.7 7.0 4.5 0.7 2.7 1.8 32.6 0.9 7.1 1.7 0.9 1.8 8.4 9.2 85.1 53.8 1.8 3.1 1.3 2.8 0.8 1.8 0.7 3.4 0.0 2.7 9.7 1.0 3.2 6.1 0.0 0.7 1.3 7.1 0.0 0.1 0.4 0.0 0.0 91.4 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.0 14.5 0.0 0.0 1.8 0.0 0.0 0.0 0.0 3.5 0.0 0.4 0.0 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.0 0.0 7.4 0.0 1.6 1.3 0.0 2.8 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.4 2.0 16.3 3.9 2.3 2.8 2.3 4.5 0.7 1.7 3.4 11.9 93.6 0.0 0.1 1.3 1.0 482.3 0.0 5.3 1.2 0.0 2.0 0.3 13.3 0.0 0.6 5.4 0.0 0.0 0.0 0.6 3.1 0.3 5.8 0.0 114.1 195.5 0.0 4.3 13.4 1.0 1.1 23.8 13.5 2.8 0.0 1.7 0.0 0.0 0.0 0.0 2.2 232.8 19.1 0.3 0.2 0.5 0.3 0.0 0.0 0.1 LRFN2 "FIGLER2, KIAA1246, SALM1" ENSG00000156564 "Leucine rich repeat and fibronectin type III domain containing 2" Q9ULH4 6 40391586-40587465 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 21.7" "Cell type enriched" "Detected in some" 5 "Cone photoreceptor cells: 58.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 1.8;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 4 "dendritic cells: 1.3;T-cells: 1.8" "Group enriched" "Detected in some" 5 "REH: 3.5;SH-SY5Y: 10.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA076660 Enhanced Supported Vesicles NA NA Vesicles "HPA076660: AB_2686812" "unprognostic (1.93e-2)" "unprognostic (2.04e-1)" "unprognostic (3.61e-2)" "unprognostic (4.58e-4)" "unprognostic (3.10e-1)" "unprognostic (1.21e-1)" "unprognostic (2.69e-1)" "unprognostic (5.75e-3)" "unprognostic (4.94e-2)" "unprognostic (1.80e-1)" "unprognostic (9.05e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (1.64e-1)" "unprognostic (2.98e-1)" "unprognostic (1.16e-1)" "unprognostic (2.66e-4)" 0.5 1.4 5.9 0.5 7.6 1.3 0.6 4.5 21.7 0.5 0.8 0.0 0.0 0.5 0.6 0.4 1.8 0.6 0.6 0.4 5.0 5.2 0.5 0.4 0.4 0.5 2.3 7.4 2.1 0.7 0.4 0.6 0.5 0.9 0.5 0.7 2.7 0.4 0.4 0.4 0.5 0.5 0.5 0.8 3.1 0.7 2.5 0.5 0.0 0.7 0.0 0.6 0.5 0.2 0.0 1.3 0.0 0.0 0.3 1.8 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.2 0.0 3.5 0.0 0.0 0.0 0.3 1.4 10.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.0 0.4 0.0 0.3 0.0 1.3 0.0 0.2 5.9 7.6 4.5 21.7 5.0 5.2 2.3 7.4 0.9 0.5 0.0 0.0 0.0 0.0 0.0 11.6 0.6 0.0 0.0 0.0 0.0 58.9 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.0 LRG1 LRG ENSG00000171236 "Leucine rich alpha-2-glycoprotein 1" P02750 19 4536409-4540474 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "liver: 636.5" "Cell type enriched" "Detected in many" 9 "Hepatocytes: 728.6" "Cancer enriched" "Detected in many" 9 "liver cancer: 160.9" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 19 "neutrophil: 58.9" "Lineage enriched" "Detected in many" 42 "granulocytes: 58.9" "Cell line enhanced" "Detected in some" "Hep G2: 8.2;HMC-1: 8.3;SK-BR-3: 8.8;THP-1: 14.8;U-937: 27.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA001888, HPA001889" Enhanced Approved Vesicles "Secreted to blood" NA NA 21000000000 74000000000 Vesicles "HPA001888: AB_1079276, HPA001889: AB_1079275" "unprognostic (5.54e-3)" "unprognostic (1.78e-1)" "unprognostic (1.78e-1)" "unprognostic (1.42e-1)" "unprognostic (2.64e-2)" "unprognostic (1.05e-1)" "unprognostic (1.88e-1)" "unprognostic (1.13e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-2)" "unprognostic (1.46e-3)" "unprognostic (9.83e-2)" "prognostic unfavorable (3.66e-6)" "unprognostic (4.06e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.49e-4)" "unprognostic (2.60e-2)" 1.7 0.9 0.2 3.3 0.4 5.4 0.9 0.2 0.3 1.7 1.3 0.2 2.2 1.1 0.3 1.1 4.5 1.9 3.0 0.9 0.4 0.2 3.5 636.5 2.2 5.7 0.7 0.1 1.5 8.1 0.0 0.7 0.4 0.4 1.1 0.8 0.3 4.1 3.0 0.5 0.8 0.6 0.2 0.3 4.3 2.3 0.5 0.3 0.3 0.9 1.7 3.4 1.4 1.3 0.1 0.3 58.9 1.4 0.0 0.2 0.4 5.9 0.1 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.6 4.3 2.1 7.7 0.0 0.3 0.8 0.0 1.0 0.0 7.7 0.2 0.1 0.1 8.2 0.0 0.2 8.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.3 0.0 6.0 0.1 4.7 0.0 0.0 0.1 6.2 0.6 1.1 0.0 0.0 0.0 8.8 0.1 0.8 2.6 14.8 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.0 27.4 0.0 0.5 1.4 3.0 0.0 0.4 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 58.9 0.0 0.2 0.0 0.2 0.4 0.2 0.4 0.2 0.3 0.4 0.2 0.7 0.1 0.4 0.3 11.9 51.2 16.5 26.9 7.1 0.0 0.4 58.6 78.9 39.8 14.0 0.0 0.5 1.7 54.6 0.0 8.3 25.4 0.0 54.4 10.6 1.4 2.9 11.5 728.6 5.4 1.6 4.7 42.4 17.4 0.0 0.0 7.6 1.7 10.0 20.0 0.0 55.9 7.0 0.0 3.6 0.0 0.0 2.1 0.0 0.2 5.1 1.1 2.9 16.7 29.6 LRP1B "LRP-DIT, LRPDIT" ENSG00000168702 "LDL receptor related protein 1B" Q9NZR2 2 140231423-142131701 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Endocytosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.7;thyroid gland: 14.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 15.8;Early spermatids: 4.6;Late spermatids: 4.3" "Cancer enhanced" "Detected in some" "glioma: 1.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "myeloid DC: 1.4;plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Cell line enhanced" "Detected in some" "ASC diff: 4.2;HEK 293: 4.5;HeLa: 2.3;HSkMC: 2.2;U-138 MG: 4.9;U-87 MG: 2.6" "Low region specificity" "Detected in all" "HPA069094, HPA074788" Approved Approved Vesicles NA NA 63000 Vesicles "HPA069094: AB_2686082, HPA074788: AB_2797273" "unprognostic (5.31e-4)" "unprognostic (3.68e-2)" "unprognostic (2.61e-1)" "unprognostic (7.36e-4)" "unprognostic (5.19e-2)" "unprognostic (1.26e-1)" "unprognostic (2.00e-2)" "unprognostic (3.49e-1)" "unprognostic (3.75e-1)" "unprognostic (7.02e-3)" "unprognostic (1.64e-3)" "unprognostic (1.05e-1)" "unprognostic (2.94e-3)" "unprognostic (4.85e-3)" "unprognostic (1.52e-1)" "unprognostic (1.66e-2)" "unprognostic (1.36e-1)" 4.8 4.5 17.6 1.3 14.1 1.2 2.6 23.2 25.7 1.4 1.3 6.5 0.0 1.2 1.3 6.8 1.3 1.9 1.4 1.6 18.3 9.3 2.2 1.6 1.4 1.2 10.8 16.7 3.0 1.2 1.1 12.7 1.2 12.8 3.5 1.3 0.1 2.5 3.8 10.5 1.7 1.3 1.3 8.2 1.2 1.5 1.9 10.6 0.0 14.9 0.0 1.3 1.2 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 4.2 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 1.0 0.2 0.2 0.6 4.5 0.0 2.3 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.4 1.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.2 0.0 0.0 0.4 0.0 0.0 0.0 4.9 0.1 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 17.6 14.1 23.2 21.3 18.3 9.3 10.8 16.7 12.8 10.6 0.0 0.0 0.0 0.3 0.2 15.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.7 0.0 0.8 0.0 0.3 0.1 0.1 0.3 0.0 0.0 0.0 0.6 LRRC24 LRRC14OS ENSG00000254402 "Leucine rich repeat containing 24" Q50LG9 8 144522377-144527032 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.9" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 100.1;Cone photoreceptor cells: 68.7;Late spermatids: 50.7;Rod photoreceptor cells: 63.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 4.2;SCLC-21H: 4.5;SH-SY5Y: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028171, HPA052250" Enhanced Approved Vesicles NA NA Vesicles "HPA028171: AB_2672504, HPA052250: AB_2681774" "unprognostic (1.75e-1)" "unprognostic (5.76e-2)" "unprognostic (2.33e-3)" "unprognostic (3.63e-2)" 2.5 4.0 5.1 1.4 9.3 1.7 1.5 12.3 16.9 2.3 2.1 1.6 0.6 2.0 2.5 1.7 1.7 2.8 1.3 1.5 4.5 7.9 2.2 1.6 2.0 1.4 4.5 8.4 4.5 3.2 9.3 8.4 1.5 5.9 11.4 1.1 10.3 2.8 3.2 2.3 1.7 2.0 1.6 2.1 2.2 1.9 1.5 1.3 0.6 1.6 1.0 1.1 1.4 1.6 0.0 0.5 0.0 0.1 0.1 0.5 0.0 0.4 0.8 0.6 1.6 0.8 0.5 1.8 0.5 0.6 0.7 0.6 0.2 1.6 0.8 3.5 0.2 0.3 0.1 0.0 0.0 0.1 1.2 2.3 0.5 1.0 0.3 0.6 0.0 1.0 0.7 0.4 0.5 0.1 0.4 0.3 0.9 0.9 0.1 0.1 4.2 1.2 1.7 0.2 0.2 0.8 1.8 0.1 0.6 0.1 0.5 4.5 12.4 0.4 0.1 0.4 0.0 3.8 1.3 0.0 0.1 1.2 0.5 0.2 1.0 0.1 0.1 0.6 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.1 9.3 12.3 16.9 4.5 7.9 4.5 8.4 5.9 1.3 0.0 2.9 0.0 0.5 0.8 100.1 0.0 2.5 0.0 1.2 1.8 68.7 0.4 3.3 0.2 19.3 0.0 1.8 0.0 0.2 0.4 0.8 1.5 0.0 2.4 0.4 28.6 10.3 0.0 1.5 50.7 2.6 0.8 5.0 0.0 1.7 12.1 0.4 1.9 2.8 3.0 63.8 0.0 1.4 4.8 2.9 0.4 0.3 0.0 1.6 0.5 LRRC37A KIAA0563 ENSG00000176681 "Leucine rich repeat containing 37A" A6NMS7 17 46292733-46337794 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 9.4;testis: 15.2" "Cell type enriched" "Detected in some" 5 "Early spermatids: 18.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 8.0" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.22e-2)" "unprognostic (3.75e-2)" "unprognostic (6.02e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-1)" "unprognostic (3.06e-2)" "unprognostic (5.23e-2)" "unprognostic (5.20e-2)" "unprognostic (8.22e-2)" "unprognostic (2.05e-1)" "unprognostic (2.65e-3)" "unprognostic (3.37e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-2)" "unprognostic (4.30e-2)" 0.9 0.4 1.4 2.0 1.8 1.4 1.7 2.6 1.7 0.7 0.9 0.5 1.1 0.4 1.1 1.0 0.5 1.1 1.5 1.2 0.9 0.6 0.9 1.5 0.6 1.2 0.9 0.5 2.1 0.7 1.3 1.0 1.0 0.9 9.4 1.8 1.3 0.6 0.8 1.2 0.8 15.2 1.2 0.9 1.1 1.1 1.4 1.7 2.1 1.4 2.1 1.5 0.2 0.2 0.2 1.6 0.2 0.3 0.0 0.5 0.1 0.4 0.1 0.2 3.6 0.3 8.0 0.3 0.3 2.5 0.3 0.0 0.0 0.0 0.5 1.2 0.4 4.0 2.7 0.6 0.0 0.2 0.0 1.0 0.0 0.0 0.2 0.5 0.3 0.2 0.6 0.9 0.0 0.3 0.7 1.2 0.0 0.0 2.7 2.9 1.8 0.0 1.9 0.5 1.1 0.2 0.6 0.1 0.0 0.5 3.6 1.2 1.4 2.4 0.4 0.2 3.6 2.5 0.5 1.3 2.4 2.3 2.1 1.1 1.0 1.0 1.0 0.9 0.8 0.8 1.5 1.1 1.4 1.3 1.1 1.9 2.1 1.4 1.7 1.0 0.2 3.0 0.3 0.0 0.3 0.1 0.6 3.6 0.0 1.4 0.0 0.0 0.0 0.1 1.7 0.2 18.2 0.0 1.3 0.0 0.4 0.0 0.2 0.1 1.1 0.0 0.3 0.0 1.2 0.0 2.7 1.0 0.0 0.4 0.0 0.0 1.1 0.0 0.2 0.0 0.4 0.0 0.5 0.0 0.0 0.7 0.2 0.1 0.1 0.5 1.0 0.0 LRRC37A2 FLJ45049 ENSG00000238083 "Leucine rich repeat containing 37 member A2" A6NM11 17 46511511-46555650 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 13.5" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 20.8;Early spermatids: 32.7" "Low cancer specificity" "Detected in many" "Cell type enriched" "Detected in single" 7 "eosinophil: 2.9" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.9" "Cell line enhanced" "Detected in some" "Daudi: 4.0;THP-1: 4.3;U-138 MG: 2.5" "HPA042121, HPA043056, HPA045090, HPA049080" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211, HPA049080: AB_2680624" "unprognostic (1.59e-2)" "unprognostic (3.75e-2)" "unprognostic (8.96e-2)" "unprognostic (6.35e-2)" "unprognostic (2.53e-1)" "unprognostic (2.97e-3)" "unprognostic (4.61e-3)" "unprognostic (1.63e-1)" "unprognostic (6.47e-2)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (8.00e-2)" "unprognostic (3.02e-7)" "unprognostic (8.40e-2)" "unprognostic (2.82e-1)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" 0.5 0.0 0.3 0.4 0.7 0.9 0.8 0.9 0.4 0.1 0.4 0.0 0.2 0.1 0.5 0.3 0.0 0.1 0.4 0.4 0.5 0.4 0.7 0.5 0.1 0.3 0.1 0.1 1.2 0.1 0.4 0.9 0.4 0.7 0.6 0.9 0.4 0.5 0.2 0.0 0.5 13.5 0.4 0.5 0.6 0.3 0.2 0.3 2.9 0.1 0.1 0.4 0.0 0.5 0.7 0.4 0.3 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.9 0.0 4.0 0.1 0.3 0.8 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.9 0.5 0.7 0.0 0.0 0.0 0.8 0.0 0.3 0.0 2.0 0.1 0.0 0.8 2.0 0.0 0.3 0.1 0.2 0.0 0.1 1.8 0.8 0.4 0.0 1.4 0.2 0.4 0.3 0.0 0.3 0.0 1.4 4.3 0.8 2.5 1.9 0.0 0.8 1.4 1.1 0.5 0.2 1.0 1.6 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.1 0.4 0.1 0.2 0.1 0.1 0.0 0.1 0.1 0.3 0.2 0.0 20.8 10.5 0.8 3.8 1.3 7.1 2.0 2.5 14.7 7.9 0.0 11.8 1.0 0.0 1.9 32.7 1.9 1.0 0.0 0.8 0.8 1.9 1.9 10.5 0.4 1.2 12.7 1.7 1.3 1.5 7.5 3.1 3.2 0.0 0.0 1.7 2.8 0.9 1.4 1.8 0.3 8.4 12.9 2.0 6.8 2.5 1.9 0.6 4.4 1.0 2.7 LRRC37A3 "FLJ34306, KIAA0563" ENSG00000176809 "Leucine rich repeat containing 37 member A3" O60309 17 64854312-64919480 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 23.2;Horizontal cells: 23.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA042121, HPA043056, HPA045090" Supported Approved Vesicles NA NA Vesicles "HPA042121: AB_2677858, HPA043056: AB_2678294, HPA045090: AB_2679211" "unprognostic (2.28e-1)" "unprognostic (1.68e-1)" "unprognostic (1.39e-1)" "unprognostic (4.73e-2)" "unprognostic (2.92e-2)" "unprognostic (3.38e-1)" "unprognostic (1.84e-2)" "unprognostic (2.27e-1)" "unprognostic (3.29e-1)" "unprognostic (1.80e-2)" "unprognostic (5.31e-6)" "unprognostic (1.83e-1)" "prognostic unfavorable (3.25e-6)" "unprognostic (2.26e-1)" "unprognostic (4.89e-2)" "unprognostic (5.18e-2)" "unprognostic (7.43e-3)" 4.4 6.6 14.8 5.5 14.0 6.2 8.8 27.9 16.0 4.3 3.6 7.4 5.4 3.2 6.9 16.0 3.9 7.8 6.8 3.8 15.1 15.0 15.7 3.4 4.8 4.3 12.8 7.2 8.4 5.2 5.7 18.8 4.6 12.1 6.7 4.0 8.3 4.3 6.2 6.4 7.1 4.0 4.2 6.6 4.6 4.2 25.8 12.6 7.3 14.3 0.3 3.1 4.6 10.0 2.3 2.3 5.3 1.0 3.1 1.2 0.3 2.3 4.5 4.4 9.8 4.9 3.1 3.1 3.2 2.6 2.4 2.5 2.0 3.4 2.3 1.5 1.6 3.9 1.9 1.2 0.9 1.0 3.0 4.4 7.1 2.7 1.4 2.0 2.7 1.8 2.1 1.7 1.6 0.7 9.9 1.6 3.0 1.4 1.3 1.6 6.1 1.3 4.6 3.4 0.5 1.3 1.5 2.3 1.0 5.0 2.1 2.9 11.0 1.2 5.6 1.3 13.1 2.5 4.9 5.3 4.0 1.3 1.6 1.7 1.9 1.8 1.8 2.8 11.3 6.8 5.3 0.4 0.7 0.7 0.7 0.8 0.6 1.0 0.4 0.6 2.3 1.2 1.1 2.0 3.1 1.0 2.3 0.9 0.3 14.8 14.0 27.9 16.0 15.1 15.0 12.8 7.2 12.1 12.6 0.0 2.1 1.4 1.8 1.5 10.2 2.1 0.0 9.4 2.3 1.8 3.9 1.1 1.7 1.8 23.2 2.6 1.2 0.0 1.2 0.1 1.6 1.7 2.3 0.8 1.4 23.8 1.2 3.7 1.9 5.6 2.0 0.8 1.7 1.8 0.8 4.3 0.7 1.4 2.8 5.1 3.6 6.5 1.2 6.0 1.7 0.9 0.8 1.3 0.6 1.4 LRRK2 "DKFZp434H2111, FLJ45829, PARK8, RIPK7, ROCO2" ENSG00000188906 "Leucine rich repeat kinase 2" Q5S007 12 40196744-40369285 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Differentiation" "GTPase activation, Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "blood: 40.4;lung: 50.4" "Cell type enriched" "Detected in many" 5 "Alveolar cells type 2: 391.0" "Group enriched" "Detected in many" 7 "lung cancer: 5.3;renal cancer: 17.1;thyroid cancer: 22.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 40.4" "Lineage enriched" "Detected in many" 7 "granulocytes: 40.4" "Cell line enhanced" "Detected in some" "A549: 9.9;ASC TERT1: 10.2;BJ hTERT+: 5.7;RPTEC TERT1: 10.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA014293, CAB037160" Approved Supported Vesicles NA NA Vesicles "CAB037160: AB_1840989, HPA014293: AB_1853353" "unprognostic (2.67e-1)" "unprognostic (1.75e-1)" "unprognostic (6.45e-3)" "unprognostic (1.06e-1)" "unprognostic (3.00e-2)" "unprognostic (6.10e-3)" "unprognostic (2.71e-1)" "unprognostic (3.14e-1)" "unprognostic (2.25e-1)" "unprognostic (9.07e-2)" "unprognostic (2.76e-1)" "unprognostic (1.23e-1)" "prognostic favorable (3.02e-6)" "unprognostic (2.55e-2)" "unprognostic (3.43e-2)" "unprognostic (2.01e-3)" "unprognostic (5.21e-3)" 3.7 3.4 2.3 7.0 3.9 8.6 3.0 1.7 5.0 5.1 4.5 1.7 2.6 0.7 5.3 2.9 5.3 3.8 4.5 4.0 1.8 1.4 10.6 4.5 50.4 6.8 2.2 3.6 5.8 3.3 10.9 2.5 1.0 1.9 3.6 1.6 3.3 4.2 2.0 5.6 2.6 3.4 6.7 4.9 8.6 2.7 1.2 2.4 0.5 3.9 2.7 4.9 4.6 6.8 0.9 1.5 40.4 5.8 0.0 0.0 0.8 0.0 9.9 0.1 0.0 3.9 10.2 0.1 2.1 5.7 0.4 0.3 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.3 0.0 0.4 0.0 0.8 0.3 0.2 0.0 0.7 0.5 0.1 2.5 0.7 0.0 0.2 3.8 0.6 0.0 0.0 0.0 0.7 0.0 0.0 1.2 0.2 0.0 0.1 0.0 0.0 0.0 10.9 0.0 0.1 0.6 0.0 0.2 2.8 0.3 2.8 2.2 1.4 1.2 1.1 1.2 0.7 0.0 0.0 0.0 2.4 0.0 0.5 0.0 5.8 1.2 0.0 3.1 0.0 0.9 0.0 0.0 1.5 0.9 0.0 0.0 40.4 0.0 3.0 0.2 0.0 0.8 2.3 3.9 1.7 5.0 1.8 1.4 2.2 3.6 1.9 2.4 29.8 391.0 17.5 1.5 2.2 7.5 6.9 5.1 5.3 30.7 26.2 0.0 0.0 1.7 0.8 0.4 4.5 0.0 0.0 2.3 0.1 9.4 0.6 12.8 7.8 4.6 44.5 0.0 9.2 74.8 0.0 17.5 19.9 11.8 10.8 0.0 11.0 1.1 0.0 11.3 15.2 0.9 0.0 3.9 0.2 0.4 2.8 0.3 0.8 0.0 0.5 LSM4 YER112W ENSG00000130520 "LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated" Q9Y4Z0 19 18306230-18323274 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 551.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040932 Uncertain Approved Vesicles NA NA Vesicles "HPA040932: AB_10795529" "unprognostic (2.71e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (7.42e-3)" "unprognostic (1.98e-1)" "unprognostic (4.09e-2)" "unprognostic (1.10e-3)" "unprognostic (9.80e-2)" "unprognostic (1.57e-1)" "prognostic favorable (1.34e-4)" "unprognostic (8.31e-3)" "unprognostic (1.25e-1)" "prognostic favorable (2.22e-4)" "unprognostic (2.51e-2)" "unprognostic (7.23e-2)" "unprognostic (8.08e-2)" "unprognostic (1.34e-1)" 19.0 41.0 42.7 22.3 37.8 35.8 31.5 23.9 40.7 25.0 41.2 16.4 29.6 38.6 17.9 26.5 31.4 26.6 28.2 33.3 35.1 35.4 37.9 37.9 22.2 41.0 38.6 34.0 20.1 34.2 18.4 25.2 29.4 25.5 21.0 31.9 25.3 21.3 29.7 55.5 21.1 35.6 21.9 24.1 24.3 34.2 50.9 19.2 40.3 27.4 37.5 25.3 18.2 18.6 35.4 77.8 34.5 54.2 42.3 40.6 52.0 47.8 25.5 43.8 39.2 17.4 16.4 49.7 22.1 20.0 29.3 28.1 22.8 51.8 28.3 47.2 23.8 26.5 32.4 48.6 46.8 22.5 32.9 85.0 25.5 40.7 27.2 17.1 24.2 15.3 14.9 28.5 27.2 32.4 17.0 24.2 42.3 53.4 29.9 30.7 78.6 66.4 52.4 56.2 70.2 79.9 37.6 19.1 52.6 36.9 17.1 48.9 45.2 18.9 24.2 32.6 32.5 23.9 26.3 13.4 17.1 19.6 41.9 41.2 27.6 23.3 32.8 23.0 47.8 29.1 27.8 49.7 34.5 33.8 54.2 40.6 34.6 36.4 34.8 54.8 35.4 39.2 39.2 4.1 42.3 41.8 77.8 34.3 52.0 42.7 37.8 23.9 40.7 35.1 35.4 38.6 34.0 25.5 19.2 26.8 35.0 96.1 78.8 59.9 70.0 43.9 81.5 57.6 35.2 109.9 13.7 223.3 253.7 181.2 231.0 66.1 189.6 0.0 160.4 388.0 70.2 118.7 116.4 95.1 248.7 55.6 119.5 44.2 87.6 551.5 57.8 137.7 99.5 329.2 138.8 71.0 136.3 192.9 44.6 260.5 52.1 45.3 61.8 169.2 334.8 62.9 142.6 79.8 214.2 95.3 LTK TYK1 ENSG00000062524 "Leukocyte receptor tyrosine kinase" P29376 15 41503638-41513887 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Systemic lupus erythematosus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 15.1" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 13.4;Ito cells: 14.7;Mucus-secreting cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 5 "MAIT T-cell: 8.3;plasmacytoid DC: 7.0" "Group enriched" "Detected in many" 10 "dendritic cells: 7.0;T-cells: 8.3" "Cell line enhanced" "Detected in some" "HEL: 5.4;NB-4: 10.5;RH-30: 5.1;THP-1: 16.1" "Low region specificity" "Detected in many" HPA059545 Approved Vesicles NA NA Vesicles "HPA059545: AB_2684057" "unprognostic (9.47e-4)" "unprognostic (5.52e-4)" "unprognostic (1.51e-1)" "unprognostic (2.49e-1)" "unprognostic (4.12e-1)" "unprognostic (5.65e-3)" "unprognostic (1.74e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "unprognostic (2.81e-3)" "unprognostic (9.36e-3)" "unprognostic (5.36e-2)" "unprognostic (4.68e-2)" "unprognostic (5.78e-2)" "unprognostic (1.52e-1)" "unprognostic (1.10e-1)" "unprognostic (1.90e-1)" 1.0 0.5 0.5 5.1 1.6 3.1 0.5 2.0 3.2 0.6 8.2 0.5 1.9 10.6 1.3 1.1 1.2 0.3 2.0 2.2 0.5 0.1 3.5 4.3 15.1 0.6 0.5 0.5 1.0 0.5 1.0 0.7 8.9 0.5 0.7 4.8 4.3 11.7 0.5 2.0 0.9 10.7 0.5 0.5 5.5 8.3 2.4 0.8 0.5 0.7 0.5 2.2 0.6 0.7 0.7 7.0 0.0 0.0 0.0 8.3 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.6 0.1 0.6 1.0 1.3 2.4 0.0 0.0 0.1 0.7 0.0 0.0 2.9 0.0 0.4 0.2 1.4 5.4 0.0 0.0 2.4 0.0 0.0 0.4 0.4 0.0 0.1 0.0 0.0 0.0 2.0 0.0 2.1 0.0 0.0 10.5 0.4 2.0 0.2 0.2 5.1 0.2 0.0 0.0 0.5 3.4 0.1 0.2 0.0 3.0 0.2 16.1 0.0 0.0 0.2 0.2 0.1 0.4 0.2 0.2 0.0 0.5 0.9 0.0 0.0 0.0 0.6 0.0 8.3 0.7 0.5 1.4 0.1 0.1 0.0 0.1 0.0 0.0 0.0 7.0 0.0 0.2 0.5 1.6 2.0 3.2 0.5 0.1 0.5 0.5 0.5 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 5.1 4.0 1.2 0.0 0.0 0.2 0.0 0.0 2.1 0.1 13.4 0.0 0.2 1.1 0.2 0.0 0.0 0.2 0.1 0.0 1.7 14.7 3.2 1.7 0.0 0.0 3.3 0.0 7.8 0.0 0.5 3.5 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.1 0.3 1.3 2.8 0.0 LY96 MD-2 ENSG00000154589 "Lymphocyte antigen 96" Q9Y6Y9 8 73991352-74029087 "Predicted secreted proteins" "Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 92.6" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 473.5;Kupffer cells: 449.9;Macrophages: 173.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 92.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 92.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 21.0;GAMG: 21.8;Karpas-707: 52.3;RPMI-8226: 25.2;U-87 MG: 27.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053060 Approved Vesicles "Secreted to blood" NA NA 95000 Vesicles "HPA053060: AB_2682029" "unprognostic (2.96e-1)" "unprognostic (2.64e-2)" "unprognostic (2.11e-1)" "unprognostic (1.85e-1)" "unprognostic (1.64e-2)" "unprognostic (2.87e-1)" "unprognostic (2.12e-3)" "unprognostic (1.42e-1)" "unprognostic (8.29e-2)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (6.38e-11)" "unprognostic (2.87e-2)" "unprognostic (1.29e-2)" "unprognostic (1.60e-2)" "unprognostic (5.90e-2)" 23.4 9.6 5.7 20.9 9.6 7.3 12.6 1.6 7.8 7.5 10.3 2.5 2.7 6.0 6.2 12.3 9.6 7.6 17.1 18.8 11.2 5.8 7.4 10.9 17.3 36.3 11.6 1.9 12.7 3.2 0.7 7.2 21.8 9.2 9.6 7.4 3.9 9.0 3.4 6.0 3.5 7.0 10.0 19.6 47.3 4.9 7.2 6.6 5.3 6.5 5.2 18.4 15.3 16.1 4.0 6.8 92.6 14.2 0.0 3.1 4.6 0.4 0.0 0.1 0.0 10.1 21.0 0.0 14.0 17.0 3.7 8.8 0.0 0.1 4.3 4.8 8.9 21.8 0.1 0.0 0.2 9.8 4.6 0.1 0.1 0.0 0.5 5.0 0.7 0.2 6.1 0.1 6.1 1.2 0.6 18.6 2.7 0.0 52.3 13.4 0.0 1.7 0.6 0.0 0.0 0.3 1.7 0.0 25.2 0.7 0.0 0.1 0.0 0.0 0.0 1.7 0.1 0.0 0.9 14.4 9.7 0.7 5.1 3.3 13.8 6.4 2.6 27.0 0.2 4.1 1.6 14.2 0.0 0.0 12.3 0.2 4.0 2.0 0.3 6.8 1.8 1.3 0.4 92.6 0.0 9.8 5.6 3.1 4.6 5.7 9.6 1.6 7.8 11.2 5.8 11.6 1.9 9.2 6.6 14.9 15.4 42.6 1.0 12.2 0.1 0.7 0.0 4.0 13.6 3.5 0.0 2.4 0.0 3.2 22.0 45.8 0.0 0.0 6.3 2.6 16.0 0.6 3.5 2.0 473.5 0.0 0.0 102.5 449.9 2.0 13.3 173.5 72.6 46.9 0.0 0.0 13.2 0.0 6.3 0.6 0.1 6.5 14.7 0.5 0.1 10.2 5.4 15.9 0.0 1.0 LZTS3 "KIAA0552, ProSAPiP1" ENSG00000088899 "Leucine zipper tumor suppressor family member 3" O60299 20 3162617-3173592 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 51.9;salivary gland: 36.2" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 17.9;Alveolar cells type 2: 9.3;Cardiomyocytes: 12.0;Club cells: 11.4;Collecting duct cells: 10.4;Distal tubular cells: 10.0;Proximal tubular cells: 9.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031008, HPA031009" Approved Approved Vesicles NA NA Vesicles "HPA031008: AB_10601610, HPA031009: AB_10670162" "unprognostic (4.09e-2)" "unprognostic (4.10e-2)" "unprognostic (1.55e-2)" "prognostic unfavorable (7.26e-4)" "unprognostic (1.15e-1)" "unprognostic (6.19e-3)" "unprognostic (2.14e-1)" "prognostic favorable (7.98e-4)" "unprognostic (3.31e-1)" "unprognostic (1.08e-1)" "unprognostic (4.57e-2)" "unprognostic (9.69e-3)" "prognostic favorable (5.92e-8)" "unprognostic (4.63e-2)" "unprognostic (1.85e-1)" "unprognostic (8.47e-2)" "unprognostic (1.38e-1)" 2.4 5.3 17.6 1.4 31.1 1.7 3.5 51.9 45.7 11.5 2.4 4.2 2.1 8.6 4.6 3.7 1.7 6.4 6.8 5.4 16.4 10.7 11.9 2.7 5.6 1.2 7.1 17.4 9.0 17.0 11.8 4.1 2.2 10.5 5.0 2.2 7.4 36.2 7.9 5.1 1.4 6.5 2.7 4.5 1.7 7.7 1.9 6.0 0.0 7.1 0.4 1.0 2.6 1.5 0.2 0.8 0.0 0.0 0.0 0.9 0.0 2.8 2.7 3.8 4.2 5.3 1.5 2.6 2.8 6.1 4.8 7.1 15.3 8.0 4.8 1.6 5.5 6.3 1.4 2.1 3.0 3.7 0.1 2.7 0.2 0.5 12.5 12.0 0.2 1.3 1.9 6.6 6.7 2.6 1.8 0.7 4.5 2.7 1.5 2.3 1.2 0.3 0.6 8.5 6.5 2.6 1.3 1.3 5.1 6.0 1.0 15.0 4.6 2.3 3.3 2.3 5.8 7.7 0.1 4.3 5.2 9.8 2.0 0.8 3.0 0.4 1.4 2.5 0.8 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.2 0.2 0.9 0.0 0.0 0.0 0.8 0.5 0.0 17.6 31.1 51.9 45.7 16.4 10.7 7.1 17.4 10.5 6.0 17.9 9.3 2.2 0.0 1.3 0.0 12.0 0.0 4.0 11.4 10.4 0.0 1.1 10.0 4.9 0.0 0.7 0.0 0.0 4.3 0.3 0.7 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 8.1 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.9 1.4 0.0 0.0 0.0 MAN1B1 "ERManI, MANA-ER, MRT15" ENSG00000177239 "Mannosidase alpha class 1B member 1" Q9UKM7 9 137086927-137109187 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051516 Approved Uncertain Vesicles NA NA 540000 Vesicles "HPA051516: AB_2681518" "unprognostic (1.21e-2)" "unprognostic (4.66e-1)" "unprognostic (1.25e-3)" "unprognostic (4.67e-3)" "unprognostic (2.27e-1)" "unprognostic (3.70e-3)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.59e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-2)" "unprognostic (5.93e-3)" "unprognostic (1.75e-1)" "unprognostic (3.55e-2)" "unprognostic (2.28e-1)" "unprognostic (5.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.44e-3)" 20.4 25.4 19.7 13.5 23.7 9.8 18.6 21.6 36.1 24.3 21.6 24.5 20.6 19.8 22.7 28.1 23.1 28.9 25.9 19.5 20.5 21.5 24.3 32.7 20.4 19.9 18.6 25.2 24.2 32.6 23.6 25.1 30.8 18.0 21.2 12.0 22.0 32.7 23.1 12.2 25.4 17.8 18.5 16.4 22.2 21.8 30.3 18.2 19.9 25.1 12.7 19.3 21.0 16.0 13.0 23.0 16.3 24.4 18.0 21.9 18.5 7.2 17.1 6.0 16.9 22.5 19.4 19.8 12.4 26.2 16.5 14.7 8.4 22.9 6.6 41.5 20.6 23.3 25.1 3.6 12.0 3.0 9.1 6.0 2.9 15.4 9.6 21.3 5.1 11.4 22.9 22.7 9.6 8.1 22.1 10.9 8.9 8.0 10.9 11.7 14.7 5.4 12.1 8.0 21.4 17.3 3.1 10.0 20.9 13.2 3.6 6.9 6.2 18.3 19.4 12.6 3.2 21.6 10.9 15.3 24.5 9.1 18.0 14.4 4.4 3.6 4.4 29.4 6.5 21.0 7.9 20.1 16.3 21.9 21.8 20.5 13.0 17.3 20.6 23.0 11.0 17.0 17.0 5.9 18.0 24.4 16.1 21.5 18.5 19.7 23.7 21.6 36.1 20.5 21.5 18.6 25.2 18.0 18.2 17.9 33.0 15.9 12.9 10.3 17.8 9.3 15.3 16.0 7.9 24.4 15.7 44.1 6.6 27.3 4.5 16.8 31.6 0.0 27.7 61.8 26.8 11.6 20.7 17.9 29.2 28.6 29.2 17.8 16.4 4.3 19.5 16.3 21.9 33.3 26.3 17.7 26.2 24.6 20.5 13.0 18.2 12.9 16.0 15.6 26.2 14.2 38.0 24.5 21.3 6.8 MANBA ENSG00000109323 "Mannosidase beta" O00462 4 102630770-102760994 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053478 Approved Supported Vesicles "Intracellular and membrane" NA NA 12000000 Vesicles "HPA053478: AB_2682165" "unprognostic (2.29e-2)" "unprognostic (1.40e-1)" "unprognostic (3.80e-1)" "unprognostic (1.70e-1)" "prognostic unfavorable (7.56e-5)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.74e-6)" "unprognostic (1.32e-1)" "unprognostic (2.19e-1)" "unprognostic (4.87e-2)" "unprognostic (7.78e-2)" "unprognostic (1.44e-2)" "unprognostic (1.33e-1)" "unprognostic (1.75e-2)" "unprognostic (7.12e-2)" "unprognostic (4.81e-2)" "unprognostic (2.13e-1)" 12.7 23.5 8.5 12.2 11.9 8.6 17.1 13.4 8.4 12.1 9.9 12.9 11.7 8.1 11.6 13.6 9.3 11.0 15.5 12.1 8.7 8.6 11.8 10.3 17.7 20.2 15.1 6.2 16.7 18.1 25.1 18.4 25.0 10.8 12.0 10.8 12.4 27.4 11.4 5.4 7.8 14.0 14.2 15.3 21.3 14.4 4.6 13.5 9.4 19.2 3.6 12.8 17.9 12.6 3.9 9.5 25.2 11.6 3.6 3.1 3.9 7.0 3.9 1.9 1.9 37.5 17.4 4.9 4.9 9.7 2.1 4.2 5.1 8.2 7.6 6.6 6.8 6.8 3.3 5.0 10.8 1.7 5.3 2.1 4.3 4.5 7.8 11.4 8.0 19.6 14.8 18.5 9.1 7.6 27.8 3.9 3.3 7.2 7.8 7.7 3.2 1.9 7.7 2.7 8.7 3.2 3.9 4.5 2.1 6.1 8.3 1.2 0.9 5.8 10.1 7.6 20.0 14.4 5.5 3.0 5.8 2.8 13.0 2.6 4.2 8.7 0.7 10.5 3.6 4.2 6.2 11.5 25.2 1.8 10.6 1.4 3.8 3.1 2.0 9.5 3.9 3.0 2.0 10.1 3.6 11.6 2.3 1.6 3.9 8.5 11.9 13.4 8.4 8.7 8.6 15.1 6.2 10.8 13.5 29.8 35.2 25.3 8.3 5.3 5.4 10.4 12.7 4.0 12.5 8.7 5.9 32.0 1.7 5.7 1.9 7.2 4.6 0.0 2.4 6.3 10.6 7.4 33.5 15.8 38.4 6.4 1.7 9.2 46.4 1.1 8.3 42.8 0.0 29.7 10.9 4.3 5.7 21.0 18.7 7.6 7.1 0.0 8.3 0.2 1.1 4.0 18.9 10.9 10.5 8.3 MAP1LC3A "ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3" ENSG00000101460 "Microtubule associated protein 1 light chain 3 alpha" Q9H492 20 34546854-34560345 "Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 529.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "neutrophil: 30.6" "Lineage enriched" "Detected in all" 8 "granulocytes: 30.6" "Cell line enhanced" "Detected in many" "HHSteC: 19.7;HSkMC: 29.8;SCLC-21H: 19.0;SK-BR-3: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007649, CAB037174, HPA042824, HPA052474, HPA052484" Enhanced Approved Vesicles NA NA Vesicles "CAB037174: AB_1079382, HPA007649: AB_1853943, HPA042824: , HPA052474: AB_2681844, HPA052484: AB_2681846" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.02e-1)" "unprognostic (1.99e-2)" "unprognostic (4.56e-3)" "unprognostic (1.06e-2)" "unprognostic (1.55e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-2)" "unprognostic (1.98e-1)" "prognostic favorable (5.31e-5)" "unprognostic (2.82e-2)" "unprognostic (1.59e-3)" "unprognostic (3.84e-1)" "unprognostic (1.35e-1)" "unprognostic (7.90e-2)" "unprognostic (2.76e-1)" 29.8 15.1 38.3 10.3 33.6 10.7 16.8 45.6 59.8 15.8 22.7 17.8 9.6 24.2 16.1 15.8 13.6 16.1 18.7 30.3 39.0 46.8 15.3 31.9 11.8 20.4 41.6 46.7 11.9 20.7 17.8 26.6 9.7 38.3 16.9 16.2 13.6 14.2 15.4 29.7 23.3 26.8 18.8 29.0 12.1 13.5 15.7 18.2 1.1 17.6 10.2 24.5 13.0 13.5 3.4 1.4 30.6 1.6 1.1 4.0 1.0 0.0 1.6 1.9 0.0 12.8 17.9 0.0 9.4 9.0 7.0 6.7 0.0 0.1 0.0 0.1 9.5 14.6 1.9 0.0 3.5 1.4 2.1 0.7 0.0 6.8 0.0 19.7 0.0 4.2 29.8 0.4 4.7 1.7 0.0 4.2 0.0 0.0 0.0 7.5 0.0 0.0 0.2 0.6 1.3 1.8 0.0 0.0 0.0 0.0 0.0 19.0 10.9 10.7 26.4 0.0 8.1 0.1 7.8 7.2 15.0 0.1 3.0 4.0 0.0 2.0 0.0 9.9 0.0 6.2 1.3 1.3 3.6 1.9 1.6 1.4 3.4 2.0 2.0 0.4 1.6 0.6 1.2 30.6 1.1 0.6 1.4 4.0 1.0 38.3 33.6 45.6 59.3 39.0 46.8 41.6 46.7 38.3 18.2 0.0 10.0 22.9 100.3 51.3 101.3 26.0 38.2 0.0 4.5 43.6 80.5 21.4 96.2 37.2 114.7 50.7 91.8 0.0 21.1 13.1 62.2 110.0 18.4 30.0 30.5 66.7 158.5 72.4 15.0 529.1 88.1 21.5 59.1 34.3 62.1 64.8 36.7 74.8 102.2 83.7 109.6 135.8 103.0 48.2 14.0 44.9 177.1 20.3 71.0 69.8 MAP3K15 "ASK3, bA723P2.3, FLJ16518" ENSG00000180815 "Mitogen-activated protein kinase kinase kinase 15" Q6ZN16 X 19360056-19515261 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 17.3;brain: 13.2" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 1.9;Cardiomyocytes: 2.5;Collecting duct cells: 5.2;Cone photoreceptor cells: 3.9;Distal tubular cells: 3.3" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in some" 6 "pons and medulla: 13.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.2;HAP1: 7.9;HEK 293: 6.7;JURKAT: 3.9;REH: 4.1;SuSa: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA004006 Approved Vesicles NA NA Vesicles "HPA004006: AB_1079358" "unprognostic (2.87e-1)" "unprognostic (7.09e-2)" "unprognostic (3.21e-2)" "unprognostic (6.56e-8)" "unprognostic (3.47e-2)" "unprognostic (1.42e-2)" "unprognostic (2.19e-3)" "unprognostic (2.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.87e-2)" "unprognostic (1.30e-2)" "unprognostic (8.95e-2)" "unprognostic (2.77e-3)" "unprognostic (4.00e-1)" "unprognostic (2.37e-1)" "unprognostic (3.98e-2)" "unprognostic (8.20e-2)" 0.1 17.3 0.5 0.4 0.3 0.5 0.1 2.3 0.1 0.1 0.1 5.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.4 0.5 3.6 0.1 0.5 0.0 0.1 0.0 1.3 4.1 0.4 5.7 0.0 13.2 0.1 0.0 4.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 2.6 0.1 2.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.2 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.4 0.0 7.9 0.0 0.0 1.3 6.7 2.7 0.0 0.7 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.5 0.0 0.0 0.2 0.0 2.1 2.0 0.0 0.8 4.1 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.3 2.3 0.1 0.4 0.5 0.1 0.0 13.2 0.0 0.0 1.9 0.0 0.6 0.1 0.6 2.5 0.0 0.0 0.0 5.2 3.9 0.0 3.3 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 1.1 0.0 0.6 0.0 0.0 0.2 1.2 0.0 0.1 0.0 0.0 0.0 MAP4K2 "BL44, GCK, RAB8IP" ENSG00000168067 "Mitogen-activated protein kinase kinase kinase kinase 2" Q12851 11 64784914-64803241 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Stress response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007330 Enhanced Approved Vesicles NA NA Vesicles "HPA007330: AB_1079361" "unprognostic (1.66e-1)" "unprognostic (2.83e-1)" "unprognostic (3.07e-3)" "unprognostic (4.37e-3)" "unprognostic (2.67e-1)" "unprognostic (9.23e-2)" "prognostic unfavorable (3.10e-5)" "unprognostic (4.51e-2)" "unprognostic (3.65e-1)" "unprognostic (5.28e-2)" "unprognostic (1.24e-2)" "unprognostic (1.41e-1)" "unprognostic (2.47e-2)" "unprognostic (2.97e-1)" "unprognostic (1.57e-2)" "unprognostic (1.82e-1)" "unprognostic (1.95e-2)" 6.9 6.2 9.4 15.2 10.0 19.1 5.8 12.1 15.6 5.2 5.8 10.1 6.9 4.9 6.2 4.0 4.3 4.4 6.3 5.5 9.4 9.2 6.2 3.1 12.0 22.3 8.3 7.3 4.2 7.2 5.2 8.0 12.3 12.5 6.1 4.7 6.7 9.0 8.9 3.4 5.0 9.9 5.6 6.7 22.6 7.1 5.5 6.6 11.5 8.7 3.9 18.8 6.1 5.1 10.8 5.0 8.2 14.8 2.3 9.6 7.1 6.0 5.5 3.6 6.4 3.2 2.0 8.5 4.5 4.3 5.5 3.9 2.4 2.8 10.5 8.4 5.2 9.7 1.8 4.3 4.4 3.3 13.7 2.1 18.5 7.6 5.0 3.9 9.7 7.0 1.9 2.2 4.3 2.7 3.8 13.4 18.4 1.5 1.0 1.6 7.5 5.7 9.7 2.4 3.6 7.4 12.0 0.4 12.1 3.1 3.0 4.3 6.2 3.9 5.1 4.0 4.3 10.3 15.0 10.3 4.6 10.3 4.2 1.9 1.2 2.3 11.4 4.1 14.7 3.4 2.2 4.2 5.6 5.2 12.2 5.3 10.8 7.0 4.7 4.4 7.6 8.6 6.3 8.2 2.3 14.8 5.0 9.6 7.1 9.4 10.0 12.1 15.6 9.4 9.2 8.3 7.3 12.5 6.6 3.0 4.5 18.1 3.3 1.1 19.5 3.6 2.5 1.4 2.3 1.8 23.6 6.4 3.3 1.3 29.3 15.5 1.8 0.0 1.5 10.2 2.8 2.6 1.1 1.8 9.1 11.1 5.8 20.3 8.5 25.2 3.7 8.3 1.7 8.2 2.0 7.0 0.9 11.5 6.7 2.8 13.8 6.5 2.5 1.8 11.1 1.3 4.2 10.0 1.9 1.6 MAPK8IP3 "JIP3, JSAP1, KIAA1066, syd" ENSG00000138834 "Mitogen-activated protein kinase 8 interacting protein 3" Q9UPT6 16 1706183-1770317 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005580, HPA041785, HPA069311" Approved Approved Vesicles NA NA Vesicles "CAB005580: AB_627840, HPA041785: AB_2677671, HPA069311: AB_2686116" "unprognostic (1.49e-1)" "unprognostic (2.22e-1)" "unprognostic (8.28e-3)" "unprognostic (8.32e-2)" "unprognostic (3.90e-1)" "unprognostic (6.83e-3)" "unprognostic (3.66e-2)" "unprognostic (2.41e-2)" "unprognostic (1.55e-1)" "unprognostic (8.67e-2)" "unprognostic (1.57e-2)" "unprognostic (6.91e-3)" "prognostic unfavorable (5.25e-5)" "unprognostic (2.84e-1)" "unprognostic (1.85e-1)" "unprognostic (2.45e-1)" "prognostic favorable (3.95e-4)" 9.6 13.8 29.3 14.0 35.7 24.7 6.7 54.9 56.8 8.4 7.7 25.8 5.7 14.9 10.4 5.4 5.5 7.2 9.2 15.1 24.4 19.4 9.1 7.5 8.5 16.4 20.3 35.7 14.6 21.8 12.0 21.3 9.8 32.9 11.1 5.1 8.8 18.1 9.5 12.8 25.1 13.8 8.0 15.3 20.6 13.8 11.1 22.0 4.6 10.0 2.4 7.7 9.8 7.6 1.5 1.6 2.4 1.3 0.0 1.4 0.4 3.7 7.3 7.7 6.9 3.8 6.5 6.1 6.3 2.4 3.2 2.8 10.2 12.6 4.4 4.0 4.0 2.2 7.2 1.9 4.2 1.0 6.9 8.5 5.8 16.6 7.8 5.3 3.8 10.3 12.9 5.6 4.6 2.3 14.1 4.2 8.5 4.9 8.5 3.3 9.6 5.9 16.6 5.2 1.8 4.1 25.8 3.8 7.4 3.9 5.0 16.2 12.9 7.6 7.2 3.0 3.7 3.8 5.4 13.0 13.5 7.5 5.7 5.0 19.2 3.3 5.7 3.5 4.0 6.7 0.0 1.3 2.4 1.4 0.3 0.8 1.5 0.3 0.5 0.4 1.4 0.4 0.4 1.1 0.0 0.3 1.6 0.8 0.4 29.3 35.7 54.9 53.1 24.4 19.4 20.3 35.7 32.9 22.0 3.0 8.5 6.2 4.0 8.8 36.3 5.9 10.2 4.0 7.9 3.5 35.3 4.4 1.7 4.2 19.9 6.3 12.0 0.0 3.2 4.9 6.4 4.9 1.1 7.8 6.1 82.6 9.8 8.0 11.3 15.6 7.2 7.5 6.8 8.2 9.6 7.2 6.0 10.4 8.5 0.7 17.5 6.5 2.1 14.2 3.1 8.4 4.7 6.1 8.9 5.1 MARCH3 "MARCH-III, MGC48332, RNF173" ENSG00000173926 "Membrane associated ring-CH-type finger 3" Q86UD3 5 126867714-127030808 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Muller glia cells: 52.5;Spermatocytes: 61.1;Syncytiotrophoblasts: 82.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 8.8;naive B-cell: 13.1" "Lineage enriched" "Detected in many" 5 "B-cells: 13.1" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 25.1;HUVEC TERT2: 16.7;TIME: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043406 Uncertain Supported Vesicles NA NA Vesicles "HPA043406: AB_10793947" "unprognostic (5.96e-3)" "unprognostic (1.46e-2)" "unprognostic (1.91e-2)" "unprognostic (4.21e-2)" "unprognostic (9.00e-3)" "unprognostic (1.17e-2)" "unprognostic (7.75e-3)" "unprognostic (9.41e-2)" "unprognostic (8.93e-2)" "unprognostic (2.05e-3)" "unprognostic (3.15e-2)" "unprognostic (1.82e-1)" "unprognostic (5.60e-6)" "unprognostic (7.74e-2)" "unprognostic (7.64e-2)" "unprognostic (1.05e-1)" "unprognostic (3.64e-1)" 11.3 6.0 5.6 11.0 9.4 6.6 6.2 5.3 4.8 2.0 10.8 8.2 0.5 2.4 3.7 3.6 3.4 3.2 10.4 15.2 7.8 6.8 2.0 1.9 5.2 5.2 9.5 2.3 4.0 5.0 1.7 10.8 4.0 12.3 2.9 11.8 9.7 11.2 1.1 11.9 11.5 5.2 6.5 16.0 3.7 5.5 14.2 7.6 2.1 3.6 3.4 5.8 6.5 6.7 13.1 0.7 2.5 0.4 1.9 2.6 0.7 0.3 1.2 2.4 1.3 2.1 2.1 0.8 8.5 3.6 6.9 10.2 1.1 0.5 2.3 0.8 1.3 1.5 0.7 3.0 1.5 9.8 0.5 2.7 7.2 2.0 1.1 3.5 2.9 1.8 1.5 0.5 25.1 3.0 1.6 16.7 0.3 3.0 0.4 5.7 0.8 0.3 1.3 2.0 1.8 2.8 0.9 9.6 0.6 0.5 1.2 0.7 0.5 2.0 0.3 1.0 1.2 1.7 3.0 20.3 1.3 1.1 7.9 0.9 1.1 1.3 1.3 5.1 2.3 1.2 0.0 0.2 2.5 0.5 0.4 0.1 8.8 0.6 0.3 0.1 13.1 2.4 0.5 0.8 1.9 0.3 0.7 2.6 0.7 5.6 9.4 5.3 4.8 7.8 6.8 9.5 2.3 12.3 7.6 3.0 3.4 18.2 0.0 5.4 18.3 12.9 17.8 1.4 3.4 0.0 2.0 33.6 0.0 0.0 33.1 6.0 15.5 23.3 0.0 3.1 6.7 0.0 24.3 0.8 7.7 35.0 14.3 11.6 3.5 9.8 0.3 2.0 3.3 0.0 23.4 52.5 0.0 44.4 1.8 0.2 25.6 0.0 0.9 61.1 12.7 7.8 82.5 5.1 21.9 0.0 MBOAT2 "FLJ14415, FLJ90298, OACT2" ENSG00000143797 "Membrane bound O-acyltransferase domain containing 2" Q6ZWT7 2 8852690-9003813 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 34.7" "Cell type enhanced" "Detected in many" 8 "Horizontal cells: 133.5;Muller glia cells: 95.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "basophil: 6.3;eosinophil: 2.8;neutrophil: 6.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 6.7" "Cell line enhanced" "Detected in many" "SK-BR-3: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014836 Uncertain Approved Vesicles NA NA Vesicles "HPA014836: AB_1854745" "unprognostic (2.49e-1)" "unprognostic (2.17e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (2.13e-9)" "unprognostic (1.30e-1)" "unprognostic (2.32e-2)" "unprognostic (2.38e-1)" "unprognostic (3.97e-3)" "unprognostic (3.09e-1)" "unprognostic (3.00e-1)" "unprognostic (1.03e-3)" "unprognostic (1.70e-1)" "unprognostic (5.90e-2)" "unprognostic (2.23e-1)" "unprognostic (3.04e-2)" "unprognostic (6.66e-2)" "prognostic unfavorable (5.32e-4)" 2.3 2.9 12.8 2.9 18.0 24.2 10.1 10.1 20.2 6.0 8.2 16.6 1.2 3.1 5.3 3.5 14.2 3.7 4.3 5.1 14.7 12.4 8.0 1.3 10.9 2.9 23.3 10.3 6.8 2.1 34.7 5.5 3.8 16.2 16.1 9.3 6.4 5.6 4.1 1.2 12.3 4.3 4.6 18.5 2.5 6.9 2.7 17.8 1.9 5.3 16.1 10.3 4.4 7.5 0.0 0.8 6.7 0.7 0.0 0.2 0.3 8.4 2.6 7.9 3.4 3.6 8.0 4.6 4.1 1.5 5.3 3.5 0.7 13.5 2.4 4.9 9.7 4.2 6.5 7.0 8.2 8.0 7.5 12.1 10.1 3.7 0.0 4.4 0.0 3.2 5.8 4.9 5.0 3.5 11.7 2.8 3.5 8.6 1.9 4.6 2.2 3.0 0.2 3.1 3.8 10.0 4.5 12.5 0.1 7.8 1.2 4.7 14.5 4.2 25.5 4.0 4.1 4.8 2.9 1.5 9.4 5.0 7.2 11.6 0.7 0.2 2.7 14.7 1.4 3.1 6.3 0.7 2.8 0.0 0.2 0.0 0.0 0.2 0.1 0.8 0.0 0.2 0.1 6.7 0.0 0.2 0.1 0.0 0.3 12.8 18.0 10.1 15.8 14.7 12.4 23.3 10.3 16.2 17.8 17.9 10.1 4.5 2.9 3.0 18.3 10.6 5.1 16.0 19.4 38.4 7.9 2.5 5.0 4.5 7.3 8.8 10.3 46.7 1.4 1.3 9.8 21.0 8.1 0.0 1.7 133.5 36.0 4.3 2.1 7.8 4.9 4.3 13.5 44.1 49.8 95.3 52.2 20.4 7.1 8.4 7.2 6.5 12.0 10.7 23.7 4.4 1.6 2.1 11.9 29.8 MDK "FLJ27379, MK, NEGF2" ENSG00000110492 Midkine P21741 11 46380756-46383837 "Cancer-related genes, Predicted secreted proteins" Differentiation "Developmental protein, Growth factor, Heparin-binding, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 115.9" "Cell type enhanced" "Detected in many" 11 "Intestinal endocrine cells: 971.2;Paneth cells: 1226.4;Urothelial cells: 439.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.6;neutrophil: 4.9" "Group enriched" "Detected in many" 5 "B-cells: 3.6;granulocytes: 4.9;T-cells: 2.0" "Cell line enhanced" "Detected in many" "NTERA-2: 89.4;REH: 130.0;SH-SY5Y: 111.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010055, HPA057126" Uncertain Approved Vesicles "Secreted to blood" NA NA 158000 1200000 Vesicles "CAB010055: AB_627949, HPA057126: AB_2683344" "unprognostic (8.87e-3)" "unprognostic (6.65e-2)" "unprognostic (4.02e-2)" "unprognostic (7.24e-2)" "prognostic unfavorable (5.48e-4)" "unprognostic (1.90e-1)" "unprognostic (5.67e-3)" "unprognostic (1.02e-1)" "unprognostic (3.66e-2)" "unprognostic (1.11e-2)" "unprognostic (4.01e-2)" "unprognostic (4.15e-1)" "prognostic unfavorable (3.06e-6)" "unprognostic (8.78e-2)" "unprognostic (1.31e-1)" "unprognostic (3.48e-1)" "unprognostic (1.12e-2)" 8.0 16.2 4.7 11.9 5.6 1.7 13.5 5.3 5.9 62.5 36.3 5.3 13.9 50.6 41.0 33.9 6.5 34.6 35.0 6.4 4.0 5.9 6.1 2.0 8.0 3.6 4.9 4.4 115.9 13.1 8.9 64.8 11.5 5.5 47.7 7.4 59.0 22.2 24.5 4.7 4.1 58.4 16.6 4.0 13.9 21.0 9.3 2.1 22.5 5.2 5.5 12.4 15.3 23.0 3.6 0.2 4.9 0.6 0.2 2.0 1.5 4.9 6.5 76.3 0.2 0.5 6.4 1.8 3.8 7.7 14.7 13.1 49.5 21.8 0.3 53.8 5.6 0.6 42.5 43.0 0.0 1.3 15.1 9.0 2.1 0.6 67.8 34.8 0.1 0.3 10.3 1.3 8.9 0.0 3.1 21.4 2.9 36.6 0.3 8.2 33.8 1.8 0.9 89.4 26.7 38.8 130.0 2.9 0.4 0.1 0.1 42.4 111.0 12.7 1.1 1.0 70.5 34.8 34.3 5.8 22.6 54.3 0.3 2.6 0.2 1.0 0.4 0.6 1.3 19.6 0.0 0.1 0.0 0.3 0.5 0.0 3.6 0.2 0.5 0.1 1.1 0.2 0.0 4.9 0.2 0.6 0.2 2.0 1.5 4.7 5.6 5.3 5.9 4.0 5.9 4.9 4.4 5.5 2.1 0.0 4.8 2.4 142.7 9.8 0.1 5.8 40.8 41.5 46.6 45.4 0.0 140.1 1.7 217.8 16.4 56.2 413.9 0.0 92.4 97.9 99.4 135.8 4.6 5.9 43.2 0.0 971.2 77.3 4.0 90.5 101.5 7.1 35.4 16.2 245.7 23.8 203.6 1226.4 17.7 13.5 0.7 84.1 56.5 14.9 29.0 7.0 128.0 3.2 126.6 439.7 MEMO1 "C2orf4, CGI-27, MEMO" ENSG00000162959 "Mediator of cell motility 1" Q9Y316 2 31865060-32011230 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042603, HPA057952" Approved Approved Vesicles NA NA Vesicles "HPA042603: AB_10806243, HPA057952: AB_2683562" "unprognostic (1.33e-1)" "unprognostic (1.28e-3)" "unprognostic (1.81e-1)" "unprognostic (2.94e-5)" "unprognostic (1.02e-2)" "unprognostic (3.96e-2)" "unprognostic (2.24e-4)" "unprognostic (1.70e-2)" "unprognostic (6.73e-2)" "unprognostic (8.37e-3)" "unprognostic (1.18e-1)" "unprognostic (1.34e-1)" "unprognostic (5.95e-9)" "unprognostic (6.57e-2)" "unprognostic (2.26e-1)" "unprognostic (3.77e-2)" "unprognostic (4.23e-2)" 9.3 14.9 11.5 12.1 24.2 22.4 8.3 23.5 21.5 9.1 9.5 9.4 12.5 9.4 8.9 9.8 19.6 7.8 7.6 19.8 12.9 10.1 9.2 20.0 8.2 16.2 10.2 13.8 6.7 10.2 9.3 13.0 11.4 12.1 11.4 12.0 11.6 9.9 10.5 31.3 11.0 8.9 11.0 9.8 12.4 9.8 33.0 9.1 32.4 8.2 3.9 18.4 14.2 10.6 6.9 17.0 11.4 18.2 8.7 12.0 6.8 32.0 14.0 15.5 14.4 13.8 19.6 27.8 27.5 17.4 15.9 12.4 18.9 18.3 34.2 8.9 19.0 20.8 16.3 18.3 24.2 21.2 22.6 10.0 24.6 9.2 23.0 19.2 24.7 20.6 14.6 15.9 15.6 16.0 18.1 24.9 8.2 17.7 15.8 27.5 14.1 29.4 50.6 22.9 27.7 17.6 20.0 17.7 26.4 31.4 31.6 13.1 24.3 14.2 34.7 21.8 13.7 14.5 29.7 22.7 22.2 24.4 17.6 30.2 16.6 24.9 29.2 20.2 35.5 17.3 1.2 11.8 11.4 5.6 16.3 4.3 6.9 7.0 6.8 17.0 5.3 5.0 5.1 9.7 8.7 18.2 6.5 12.0 6.8 11.5 24.2 23.5 21.5 12.9 10.1 10.2 13.8 12.1 9.1 6.0 14.1 7.7 13.6 24.6 14.2 3.9 7.6 8.1 7.9 10.4 15.7 10.5 1.7 4.2 2.7 11.3 5.4 0.0 2.1 8.7 11.3 12.0 9.3 11.1 8.7 11.1 12.6 15.4 21.6 1.7 12.0 16.6 11.8 12.6 5.0 6.7 6.3 9.3 8.1 1.3 9.7 6.5 8.2 8.1 6.1 14.4 13.8 9.2 8.9 16.5 METAP1D "MAP1D, Metap1l" ENSG00000172878 "Methionyl aminopeptidase type 1D, mitochondrial" Q6UB28 2 171999583-172082430 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Leydig cells: 31.1;Peritubular cells: 24.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030298, HPA030299" Uncertain Uncertain Vesicles NA NA Vesicles "HPA030298: AB_2673419, HPA030299: AB_10602421" "unprognostic (5.31e-2)" "unprognostic (1.07e-1)" "unprognostic (1.88e-1)" "unprognostic (5.83e-2)" "unprognostic (2.54e-2)" "unprognostic (7.90e-3)" "unprognostic (1.92e-3)" "unprognostic (1.07e-2)" "unprognostic (4.55e-1)" "unprognostic (7.07e-2)" "unprognostic (2.64e-2)" "unprognostic (8.19e-2)" "unprognostic (2.53e-3)" "unprognostic (3.44e-3)" "unprognostic (3.06e-2)" "unprognostic (5.48e-3)" "unprognostic (2.92e-2)" 7.1 7.5 7.2 8.0 8.4 6.3 8.2 6.7 9.2 6.5 6.1 9.6 6.5 5.0 9.0 6.4 5.2 10.3 4.5 6.4 6.0 4.9 5.4 8.3 3.6 8.1 9.3 7.1 18.9 23.8 5.5 13.8 4.1 8.6 8.3 7.1 7.3 9.7 10.3 13.8 7.1 5.9 10.0 7.2 8.6 6.3 5.9 9.5 2.1 5.6 6.3 6.7 5.4 5.7 2.5 0.5 0.2 1.2 1.2 3.6 0.7 3.3 2.7 3.9 13.2 5.8 7.6 8.1 3.9 3.9 6.2 4.0 6.1 4.5 1.7 7.1 4.1 6.4 6.2 8.6 6.8 6.4 6.0 10.3 9.5 7.0 8.1 6.2 5.6 2.5 5.8 10.7 6.2 10.0 5.4 3.5 6.6 13.7 4.9 4.7 4.1 3.2 7.6 7.2 9.6 3.3 7.2 3.4 3.0 4.4 4.7 8.2 3.2 2.7 5.6 9.6 3.6 6.5 7.6 4.1 8.0 6.3 4.8 3.7 6.1 5.5 3.8 5.7 11.2 7.6 0.0 0.2 0.0 1.3 1.2 0.6 1.2 1.9 0.7 0.5 2.5 1.9 3.6 0.2 1.2 0.2 0.0 1.4 0.7 7.2 8.4 6.7 9.2 6.0 4.9 9.3 7.1 8.6 9.5 0.0 5.8 5.8 8.8 4.9 4.9 3.4 5.1 1.4 1.2 3.5 2.0 3.9 6.6 2.1 0.6 3.8 0.4 0.0 2.9 3.9 8.0 4.7 4.6 6.0 3.4 4.8 0.0 6.2 2.8 0.9 31.1 1.3 5.0 0.0 2.6 3.2 1.8 0.0 24.8 3.8 4.9 12.9 5.6 6.9 10.6 5.0 1.6 6.9 5.2 4.1 METTL23 "C17orf95, LOC124512" ENSG00000181038 "Methyltransferase like 23" Q86XA0 17 76726830-76733936 "Disease related genes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA022889 Approved Vesicles No No Vesicles "HPA022889: " "unprognostic (5.45e-3)" "unprognostic (1.22e-1)" "unprognostic (1.35e-1)" "unprognostic (1.35e-1)" "unprognostic (7.70e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (4.18e-6)" "unprognostic (5.22e-2)" "unprognostic (1.76e-1)" "unprognostic (1.73e-2)" "unprognostic (1.03e-3)" "unprognostic (3.21e-2)" "prognostic unfavorable (3.93e-7)" "unprognostic (1.13e-2)" "unprognostic (1.82e-1)" "unprognostic (3.79e-1)" "unprognostic (3.65e-1)" 19.6 21.9 13.4 20.8 14.3 16.3 25.8 12.1 16.2 19.2 19.5 20.6 24.6 15.1 18.8 25.3 22.5 18.5 22.7 17.5 12.6 12.2 25.3 35.1 18.6 32.8 17.8 12.9 23.3 28.3 28.7 23.0 14.1 15.8 22.6 19.2 21.5 21.6 23.7 20.8 18.7 19.6 16.2 14.5 32.3 18.9 43.7 19.5 29.4 38.8 29.5 27.0 19.5 16.4 24.6 22.5 15.2 13.7 23.8 26.7 14.8 25.0 21.9 12.6 11.4 31.3 26.3 12.0 12.8 25.9 16.8 16.3 10.9 17.8 14.2 12.5 16.0 22.0 14.1 8.9 22.9 19.0 7.0 21.0 18.2 14.3 20.8 30.8 12.9 16.1 25.2 22.0 20.8 29.0 26.7 26.3 17.5 17.3 17.7 20.2 14.1 16.0 11.0 9.3 28.0 24.8 11.0 21.0 39.1 24.0 12.7 12.0 17.3 12.7 19.7 44.0 32.0 27.6 16.3 9.6 19.3 9.7 18.8 22.3 24.4 9.2 14.2 18.5 9.2 17.5 9.2 13.5 15.2 24.0 13.7 26.6 24.6 26.7 26.4 15.1 21.5 26.1 25.7 4.5 23.8 12.0 22.5 26.3 14.8 13.4 14.3 12.1 16.2 12.6 12.2 17.8 12.9 15.8 19.5 26.8 12.6 49.6 37.7 14.5 13.6 16.1 33.1 20.1 22.7 19.2 9.8 36.8 101.2 34.8 122.2 29.8 14.7 0.0 34.4 34.4 20.7 30.5 31.1 47.9 49.9 6.4 21.9 26.4 30.4 28.4 30.2 34.1 23.6 50.5 22.8 30.1 30.6 34.5 24.4 66.3 19.1 51.8 27.7 117.2 44.1 14.2 14.4 52.3 31.0 31.0 METTL6 MGC24132 ENSG00000206562 "Methyltransferase like 6" Q8TCB7 3 15381275-15440566 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 171.3;Late spermatids: 95.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035166 Uncertain Approved Vesicles No No Vesicles "HPA035166: AB_10602709" "unprognostic (2.73e-1)" "unprognostic (3.53e-1)" "unprognostic (2.60e-1)" "unprognostic (1.29e-2)" "unprognostic (6.60e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.66e-6)" "unprognostic (3.98e-1)" "unprognostic (1.82e-1)" "unprognostic (1.13e-1)" "unprognostic (1.45e-1)" "unprognostic (2.19e-2)" "unprognostic (1.68e-2)" "unprognostic (1.27e-2)" "unprognostic (2.81e-1)" "unprognostic (3.77e-2)" "unprognostic (2.46e-1)" 8.6 9.6 19.4 8.6 19.3 5.0 11.7 18.4 18.9 11.7 7.1 16.8 6.2 7.1 10.7 10.6 10.0 11.5 7.7 9.3 13.1 14.3 8.4 7.9 7.8 10.3 13.3 9.6 14.8 10.7 12.5 17.9 11.0 13.7 10.6 8.7 12.0 7.5 11.3 7.8 8.8 6.4 12.4 14.2 8.7 7.8 20.2 11.3 11.8 11.8 3.8 12.0 9.0 8.3 14.1 16.5 15.7 14.0 14.2 14.5 9.4 8.0 13.4 14.6 12.6 13.1 15.4 39.1 14.8 16.2 19.8 19.8 8.5 10.9 13.7 9.6 14.4 15.1 6.8 15.1 12.9 20.3 9.6 16.9 13.3 13.2 12.0 26.4 12.6 11.5 13.5 16.6 23.3 10.7 14.7 16.9 13.9 13.7 14.0 19.3 18.1 13.2 9.9 16.2 8.9 17.0 10.2 18.8 13.5 11.3 11.6 6.5 11.7 12.6 12.5 12.0 11.1 18.1 11.0 10.9 14.2 9.1 13.8 13.3 15.0 25.3 16.7 14.9 12.3 13.3 9.0 11.1 15.7 13.8 14.0 13.4 10.6 13.1 13.5 12.3 14.1 13.4 14.5 6.7 14.2 13.0 16.5 11.9 9.4 19.4 19.3 18.4 18.9 13.1 14.3 13.3 9.6 13.7 11.3 3.0 5.6 0.8 6.7 3.5 16.3 5.2 2.5 10.7 4.5 8.7 5.9 7.9 5.0 9.2 171.3 6.8 1.7 0.0 11.8 16.3 5.4 4.1 4.7 1.9 8.0 19.1 1.7 4.9 5.4 95.3 8.3 6.6 5.0 7.2 2.2 11.0 7.0 3.5 8.5 5.0 14.0 6.5 5.3 30.2 13.8 2.5 9.7 8.5 3.9 5.3 MEX3C "FLJ38871, RKHD2, RNF194" ENSG00000176624 "Mex-3 RNA binding family member C" Q5U5Q3 18 51174550-51218304 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 11 "Early spermatids: 519.8;Late spermatids: 374.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040603 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA040603: AB_10805714" "unprognostic (1.09e-1)" "unprognostic (2.90e-2)" "unprognostic (8.88e-2)" "unprognostic (8.88e-3)" "unprognostic (2.04e-1)" "unprognostic (7.30e-2)" "prognostic unfavorable (8.49e-5)" "unprognostic (4.34e-2)" "unprognostic (4.43e-1)" "unprognostic (1.05e-2)" "unprognostic (1.03e-2)" "unprognostic (6.75e-2)" "unprognostic (7.99e-2)" "unprognostic (1.82e-1)" "unprognostic (1.48e-1)" "unprognostic (8.01e-2)" "unprognostic (3.17e-1)" 12.6 12.2 13.8 14.5 13.5 27.5 19.4 21.7 13.7 14.7 11.3 10.7 8.8 8.7 13.4 9.5 11.7 11.1 13.0 11.3 15.1 9.1 9.3 10.3 12.0 19.8 16.3 8.3 14.5 10.1 16.6 9.5 11.7 12.3 10.3 9.8 7.6 12.4 10.1 9.0 10.2 12.7 13.6 12.6 16.3 10.5 43.7 12.7 40.0 13.6 9.3 18.4 13.0 17.5 2.8 2.0 10.3 1.3 5.8 3.8 1.5 7.6 4.5 22.1 8.3 12.3 15.1 17.2 10.9 14.3 6.3 7.8 7.3 5.8 15.6 3.8 14.5 10.2 14.0 9.5 15.6 12.3 11.4 4.2 3.3 4.6 9.5 19.8 21.2 6.3 12.8 22.0 8.9 28.0 18.5 16.4 12.5 3.5 27.3 16.4 5.6 15.8 10.5 10.6 4.8 4.6 16.0 11.5 16.0 14.7 2.5 9.8 13.4 8.2 4.5 43.0 21.6 4.4 11.8 12.2 15.4 10.3 4.6 9.3 19.8 2.9 24.9 10.6 10.8 34.7 10.3 1.3 1.5 3.6 1.3 3.1 2.8 3.8 3.7 2.0 2.1 1.6 3.8 0.7 5.8 0.9 2.0 3.1 1.5 13.8 13.5 21.7 13.7 15.1 9.1 16.3 8.3 12.3 12.7 17.9 5.3 9.3 8.7 34.0 12.9 11.1 17.8 2.7 9.1 3.5 19.6 4.1 5.0 9.9 519.8 25.3 7.3 0.0 7.5 6.3 17.5 10.6 12.7 6.8 6.7 11.1 6.4 8.6 12.6 374.0 15.0 4.4 18.6 3.6 8.4 8.0 12.4 0.0 14.2 6.2 13.8 0.0 10.3 13.0 12.4 40.1 3.5 21.7 11.2 17.0 MFNG ENSG00000100060 "MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" O00587 22 37469063-37486401 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 72.7;lymphoid tissue: 42.1" "Group enriched" "Detected in many" 5 "B-cells: 44.1;Endothelial cells: 25.5;granulocytes: 30.1;Hofbauer cells: 28.8;Ito cells: 45.4;Kupffer cells: 36.8;Macrophages: 23.4;monocytes: 20.8;T-cells: 53.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 32.8;HEL: 25.3;HL-60: 41.3;HMC-1: 54.8;HUVEC TERT2: 44.2;U-698: 31.7;U-937: 37.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048936, HPA056479" Approved Approved Vesicles "Intracellular and membrane" NA NA 28000 Vesicles "HPA048936: AB_2680564, HPA056479: " "unprognostic (1.21e-1)" "unprognostic (4.17e-3)" "prognostic unfavorable (5.12e-4)" "prognostic favorable (1.65e-4)" "unprognostic (6.41e-3)" "unprognostic (1.00e-2)" "unprognostic (2.64e-1)" "unprognostic (2.36e-2)" "unprognostic (4.64e-2)" "unprognostic (2.91e-2)" "unprognostic (5.44e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (2.67e-1)" "unprognostic (4.03e-2)" "unprognostic (3.86e-2)" "unprognostic (1.43e-1)" 10.0 4.5 2.6 16.6 5.1 14.4 13.4 1.0 3.3 6.0 6.5 3.0 2.0 3.7 6.5 3.5 4.4 7.1 6.3 6.7 2.8 2.6 6.1 5.6 14.9 42.1 5.6 1.2 3.6 3.7 0.8 2.2 14.0 8.3 5.6 3.7 4.4 5.7 2.5 3.4 3.0 14.1 5.1 4.4 37.6 4.1 2.6 3.6 33.9 6.3 4.5 19.3 8.8 4.2 24.1 40.5 72.7 40.8 40.9 53.3 53.2 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.6 32.8 0.1 0.0 0.1 2.3 9.6 1.9 0.0 12.9 0.2 25.3 0.1 0.3 0.1 41.3 54.8 0.0 0.5 0.3 0.7 0.2 44.2 11.4 0.1 15.7 0.0 0.1 4.7 0.5 0.1 1.2 0.1 12.1 0.4 24.7 0.1 0.0 19.8 0.2 0.1 0.0 0.0 0.2 0.3 2.8 24.6 0.0 1.2 4.9 0.1 0.0 0.1 31.7 0.2 37.2 0.5 36.8 40.1 72.7 41.3 38.8 45.1 21.8 48.0 43.3 40.5 24.1 52.9 45.5 25.5 40.9 40.8 10.1 53.3 53.2 2.6 5.1 1.0 3.3 2.8 2.6 5.6 1.2 8.3 3.6 0.0 6.7 44.1 0.2 3.3 0.6 1.4 5.1 0.0 5.7 0.0 0.0 0.3 0.0 3.0 0.1 25.5 1.1 0.0 0.8 0.2 1.1 0.4 30.1 1.0 28.8 0.0 1.2 45.4 36.8 0.0 0.0 23.4 3.3 20.8 2.2 0.0 2.1 0.6 0.0 0.3 0.3 0.0 1.0 0.0 0.5 2.0 0.6 53.8 0.6 0.3 MFSD14A "DKFZP564L0864, HIAT1" ENSG00000156875 "Major facilitator superfamily domain containing 14A" Q96MC6 1 100038097-100083377 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 248.4;Late spermatids: 274.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA073127, HPA073681" Approved Approved Vesicles NA NA Vesicles "HPA073127: , HPA073681: AB_2686625" "unprognostic (1.37e-1)" "unprognostic (3.49e-2)" "unprognostic (2.51e-3)" "unprognostic (1.54e-1)" "unprognostic (2.18e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.08e-4)" "unprognostic (2.16e-1)" "unprognostic (7.75e-2)" "unprognostic (2.39e-1)" "unprognostic (1.11e-2)" "unprognostic (1.14e-1)" "unprognostic (1.18e-1)" "unprognostic (2.41e-1)" "unprognostic (3.84e-1)" "unprognostic (1.05e-1)" "unprognostic (5.15e-2)" 24.3 23.7 21.8 23.9 23.5 55.7 34.7 16.3 28.3 22.0 23.5 30.2 21.2 14.7 29.4 20.6 24.5 22.9 19.3 17.0 19.9 20.8 22.7 21.7 27.1 24.1 24.5 16.8 27.0 29.2 92.6 19.4 25.0 23.6 26.0 17.1 20.5 23.0 32.0 18.8 22.4 18.5 29.3 33.9 20.6 21.7 28.3 22.3 24.4 21.3 15.9 21.0 23.0 22.9 24.1 27.0 47.1 28.1 26.9 29.8 30.8 23.5 9.8 22.2 11.4 26.0 24.7 18.7 17.3 29.6 23.5 27.5 8.3 16.5 17.7 28.3 22.4 15.5 22.7 19.7 19.0 22.6 15.4 15.6 17.4 15.0 12.4 23.0 28.0 22.9 20.1 29.2 20.7 26.6 20.8 18.0 20.1 21.3 34.8 21.6 6.9 21.0 16.5 25.5 11.5 14.5 14.8 27.1 17.3 25.1 20.7 23.1 20.6 19.5 28.5 28.5 14.7 11.0 28.6 19.7 19.4 13.7 20.3 17.8 33.2 34.9 24.7 21.1 20.5 8.3 32.8 28.1 26.1 25.9 25.2 29.2 24.1 26.5 28.3 27.0 19.4 29.8 27.6 47.1 26.9 20.7 12.6 28.6 30.8 21.8 23.5 16.3 28.3 19.9 20.8 24.5 16.8 23.6 22.3 6.0 8.6 16.2 37.8 0.0 16.3 0.0 25.5 10.7 6.8 3.5 9.8 31.3 1.7 8.7 248.4 19.6 4.3 46.7 6.2 26.8 8.2 35.5 2.3 14.3 20.0 12.7 12.9 17.2 28.9 274.7 21.0 4.2 0.0 7.2 13.2 20.5 5.7 19.3 28.7 0.6 10.5 12.9 0.0 16.3 20.7 0.0 48.7 13.8 13.6 47.7 MFSD3 ENSG00000167700 "Major facilitator superfamily domain containing 3" Q96ES6 8 144509074-144511213 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Proximal tubular cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056013 Uncertain Approved Vesicles NA NA Vesicles "HPA056013: AB_2683009" "unprognostic (7.92e-2)" "prognostic unfavorable (5.08e-4)" "unprognostic (2.00e-1)" "unprognostic (5.18e-2)" "unprognostic (6.50e-2)" "unprognostic (3.74e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (9.41e-2)" "unprognostic (1.06e-1)" "unprognostic (5.49e-2)" "unprognostic (5.29e-2)" "prognostic favorable (5.44e-7)" "unprognostic (4.08e-3)" "unprognostic (2.37e-1)" "unprognostic (1.50e-1)" "unprognostic (9.81e-2)" 7.7 12.3 12.5 7.4 12.5 3.0 7.2 12.0 17.3 5.6 12.7 5.6 19.6 19.8 4.3 12.5 8.0 6.3 10.3 10.2 8.8 9.2 17.7 21.2 8.0 6.4 10.0 15.3 3.5 19.2 14.3 9.7 4.8 10.4 10.5 5.5 5.0 24.0 9.4 23.5 11.3 13.1 3.0 4.6 6.4 12.7 4.1 9.1 4.2 12.8 8.7 5.5 5.8 4.9 4.7 17.2 3.4 6.6 3.2 4.0 3.2 7.8 10.9 2.7 2.3 3.0 2.3 9.0 2.5 2.7 1.4 2.1 3.6 5.6 11.5 8.9 2.4 2.9 7.7 1.3 6.0 0.2 5.4 22.2 3.6 9.7 8.9 5.8 1.7 5.1 3.4 11.4 0.9 4.0 6.3 3.7 8.1 6.8 3.1 3.4 26.3 4.3 9.2 7.3 11.3 18.7 4.9 1.5 20.1 6.7 4.7 20.1 10.1 6.5 16.1 5.4 1.8 16.8 2.5 3.9 1.9 5.1 2.1 3.5 3.1 1.2 3.9 4.1 5.6 3.3 1.6 6.6 3.4 3.7 5.6 3.5 4.7 3.6 3.8 9.9 2.4 3.5 3.5 0.4 3.2 3.1 17.2 4.0 3.2 12.5 12.5 12.0 17.3 8.8 9.2 10.0 15.3 10.4 9.1 3.0 3.0 13.7 9.1 5.4 8.0 8.5 25.5 0.0 3.4 26.2 9.8 13.2 31.5 15.6 0.4 3.7 33.3 23.3 18.4 11.6 4.1 11.3 0.0 16.3 13.7 15.9 19.0 2.5 2.8 0.2 4.0 6.8 8.5 4.6 15.9 14.3 14.0 17.8 4.6 53.6 9.1 0.0 2.3 3.2 12.6 6.1 7.8 2.9 24.5 6.7 MIA3 "FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077" ENSG00000154305 "MIA family member 3, ER export factor" Q5JRA6 1 222618086-222668012 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055922, HPA056816" Supported Enhanced Vesicles "Intracellular and membrane" NA NA 750000 Vesicles "HPA055922: AB_2682971, HPA056816: AB_2683243" "unprognostic (1.24e-1)" "unprognostic (7.42e-2)" "unprognostic (1.43e-1)" "unprognostic (6.60e-2)" "unprognostic (1.86e-2)" "unprognostic (8.57e-2)" "unprognostic (1.28e-3)" "unprognostic (5.41e-2)" "unprognostic (2.56e-1)" "unprognostic (5.65e-2)" "unprognostic (6.73e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (3.57e-2)" "unprognostic (1.83e-1)" "unprognostic (8.62e-3)" "unprognostic (3.26e-1)" 20.5 24.1 21.4 17.4 23.7 25.8 25.0 32.8 25.0 23.3 19.3 10.0 26.2 18.7 23.5 24.4 15.7 18.1 18.5 19.5 18.4 17.4 19.5 63.7 18.4 19.0 17.0 18.8 23.4 34.1 30.2 34.7 22.7 25.6 30.1 23.1 9.9 32.8 31.7 25.5 16.5 23.2 21.3 22.9 23.0 36.6 29.3 19.6 19.5 25.6 19.5 19.3 26.8 19.8 18.6 14.9 29.4 20.1 22.0 18.3 11.1 11.7 8.9 13.9 21.1 44.1 22.2 23.3 16.9 25.3 18.7 22.3 9.2 12.2 9.7 16.1 19.1 11.3 20.1 14.8 15.6 19.2 16.6 9.2 13.3 9.2 14.4 40.5 22.8 16.1 20.3 15.0 17.9 31.7 21.9 19.6 14.6 17.0 23.7 14.1 7.1 17.8 14.7 15.3 36.8 12.8 12.1 37.7 23.3 9.6 11.7 15.0 15.8 17.4 15.8 14.0 20.4 16.9 15.0 14.2 12.7 9.8 21.4 17.9 27.1 17.2 12.1 15.9 11.0 16.6 23.6 14.6 29.4 17.4 19.5 18.3 18.3 15.0 17.0 10.4 18.6 17.8 17.4 24.8 22.0 20.1 14.9 16.0 11.1 21.4 23.7 32.8 25.0 18.4 17.4 17.0 18.8 25.6 19.6 65.5 44.7 27.0 22.7 16.7 55.5 55.8 28.1 60.2 58.0 5.2 29.5 23.4 0.0 21.4 25.4 21.9 30.2 23.3 30.0 14.2 25.4 40.1 16.3 52.3 18.5 42.9 58.0 17.8 17.4 18.1 34.2 23.7 18.6 13.6 83.2 42.1 26.6 22.0 46.0 21.6 37.6 19.4 25.6 49.2 40.6 14.1 30.0 34.1 22.9 26.0 MITD1 LOC129531 ENSG00000158411 "Microtubule interacting and trafficking domain containing 1" Q8WV92 2 99161427-99181058 "Predicted intracellular proteins" "Cell cycle, Cell division, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036162, HPA036163" Approved Enhanced Vesicles NA NA Vesicles "HPA036162: AB_10672236, HPA036163: AB_2674978" "prognostic favorable (5.96e-4)" "unprognostic (1.67e-2)" "unprognostic (3.09e-1)" "unprognostic (2.79e-1)" "unprognostic (2.02e-1)" "unprognostic (8.96e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (1.39e-1)" "unprognostic (5.35e-2)" "unprognostic (1.01e-2)" "unprognostic (1.09e-1)" "unprognostic (6.31e-3)" "prognostic unfavorable (1.32e-11)" "unprognostic (2.38e-1)" "unprognostic (2.40e-1)" "unprognostic (6.91e-2)" "prognostic favorable (5.46e-8)" 18.8 19.1 19.6 26.3 34.2 11.7 18.8 20.6 30.2 16.6 17.6 13.5 14.4 15.6 17.7 15.5 20.0 16.6 14.2 13.6 21.1 12.5 17.9 17.1 15.2 33.6 29.0 12.5 18.4 13.8 6.6 28.9 16.8 21.6 14.9 21.0 12.7 15.5 13.4 12.8 15.9 18.9 17.8 30.2 25.9 17.4 7.0 33.1 20.2 17.7 14.0 28.4 16.5 26.7 25.0 24.0 22.9 20.8 19.2 21.5 10.3 23.8 6.4 13.1 5.0 15.5 20.2 18.1 11.4 16.1 16.1 22.0 7.9 20.2 16.7 13.3 9.3 36.9 18.2 12.8 12.7 27.0 23.7 8.8 14.7 9.6 16.6 23.1 24.6 8.7 15.9 10.9 14.1 13.6 14.9 18.1 16.0 12.0 10.3 14.5 5.7 23.5 36.6 11.0 15.5 12.8 13.3 18.9 14.3 20.2 13.5 4.3 6.4 11.2 10.4 14.2 24.0 5.4 19.7 13.5 10.0 13.1 10.4 14.1 12.2 9.5 22.7 18.2 20.9 9.9 12.9 20.8 14.3 15.2 18.1 17.0 25.0 21.5 18.0 17.6 24.9 20.9 16.7 22.9 19.2 16.2 24.0 18.2 10.3 19.6 34.2 20.6 30.2 21.1 12.5 29.0 12.5 21.6 33.1 23.8 14.5 44.4 24.8 16.8 11.8 9.5 20.4 24.1 26.1 33.2 13.7 40.8 38.1 40.3 15.6 29.2 22.3 0.0 53.0 27.8 25.8 17.8 30.0 29.7 44.5 11.1 15.1 28.3 17.2 4.0 47.2 30.9 21.9 47.7 23.5 18.0 46.0 32.6 37.1 41.5 51.2 38.8 18.9 14.9 12.8 15.3 18.9 41.5 24.7 16.3 MMD "MMA, PAQR11" ENSG00000108960 "Monocyte to macrophage differentiation associated" Q15546 17 55392613-55421992 "Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 61.1;brain: 40.5;breast: 46.0" "Cell type enhanced" "Detected in many" 6 "monocytes: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 32.8;HSkMC: 59.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026978 Approved Vesicles NA NA Vesicles "HPA026978: AB_2672068" "unprognostic (1.33e-1)" "unprognostic (2.92e-2)" "prognostic favorable (3.52e-5)" "prognostic unfavorable (3.88e-4)" "unprognostic (2.48e-1)" "unprognostic (4.16e-2)" "prognostic unfavorable (6.39e-5)" "unprognostic (8.07e-3)" "unprognostic (6.67e-2)" "unprognostic (2.15e-1)" "unprognostic (1.30e-1)" "unprognostic (1.06e-3)" "prognostic unfavorable (2.85e-4)" "unprognostic (3.71e-3)" "unprognostic (7.93e-2)" "prognostic unfavorable (8.62e-4)" "unprognostic (1.12e-2)" 61.1 6.6 33.4 7.1 40.5 5.3 46.0 2.0 23.7 2.6 5.6 4.1 1.7 5.0 3.2 4.9 3.6 1.8 4.7 5.0 26.9 7.5 3.2 6.0 4.7 9.0 11.2 5.1 1.5 1.6 0.9 2.1 13.4 4.6 3.2 6.5 3.2 2.2 4.1 2.5 2.5 4.7 5.4 6.5 8.7 2.4 7.8 5.0 1.4 3.3 1.2 5.6 5.7 4.1 4.1 3.6 9.6 1.6 2.2 4.2 15.9 5.1 13.2 19.5 3.8 32.8 25.9 9.6 3.2 1.5 2.0 3.0 2.0 15.3 7.4 9.4 1.1 5.8 0.3 5.4 4.1 4.3 9.7 1.9 2.7 0.7 23.9 8.8 2.6 0.8 59.3 1.3 2.9 3.3 4.6 2.6 7.2 0.9 5.9 4.3 0.7 7.3 1.9 5.3 0.9 3.4 2.9 12.6 2.7 5.7 1.4 1.8 18.6 1.1 2.0 2.9 12.7 4.3 4.7 2.4 5.4 6.5 4.3 3.6 2.6 1.3 10.4 7.8 2.2 4.3 9.6 1.3 1.5 1.4 1.6 4.2 3.6 1.6 2.9 3.6 4.1 2.7 2.9 3.8 2.2 1.5 1.1 1.7 15.9 33.4 40.5 2.0 16.9 26.9 7.5 11.2 5.1 4.6 5.0 3.0 1.1 10.5 17.0 4.7 24.9 4.3 7.6 0.0 1.2 7.0 3.9 8.1 13.3 22.9 2.1 11.3 2.6 46.7 1.2 13.7 8.0 18.3 0.0 17.0 32.6 15.9 7.5 10.4 35.9 2.5 1.7 28.4 6.8 74.9 5.8 11.5 12.0 0.0 3.2 7.1 9.3 19.4 5.2 15.6 16.0 15.3 16.7 12.5 7.9 4.0 MMP1 CLG ENSG00000196611 "Matrix metallopeptidase 1" P03956 11 102789920-102798160 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Collagen degradation, Host-virus interaction" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 62.4;stomach 1: 27.2" "Cell type enriched" "Detected in some" 7 "Pancreatic endocrine cells: 1303.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 344.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 90.2;HBF TERT88: 89.3;HUVEC TERT2: 234.8;WM-115: 115.7" HPA004920 Approved Vesicles "Secreted to extracellular matrix" NA NA 7730000 430000 Vesicles "HPA004920: AB_2667293" "unprognostic (4.11e-3)" "prognostic unfavorable (4.66e-4)" "unprognostic (4.20e-3)" "unprognostic (1.19e-3)" "unprognostic (6.46e-2)" "unprognostic (6.50e-2)" "prognostic unfavorable (4.22e-6)" "unprognostic (7.83e-3)" "unprognostic (2.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.11e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (9.86e-10)" "unprognostic (1.67e-2)" "unprognostic (1.49e-1)" "unprognostic (1.26e-2)" "unprognostic (5.11e-2)" 0.2 0.1 0.3 12.3 0.3 0.0 0.9 0.3 0.3 0.3 2.7 0.3 0.2 3.2 4.8 0.2 3.3 0.1 62.4 0.4 0.2 0.1 0.7 1.3 4.7 0.2 0.2 0.2 0.2 1.6 0.0 0.2 8.6 0.5 0.7 3.0 0.3 2.0 0.2 0.2 0.3 8.8 0.2 0.4 1.8 27.2 2.2 0.2 0.4 0.3 1.3 0.9 11.0 0.2 0.0 0.0 0.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 90.2 36.9 9.6 0.7 0.0 0.0 0.4 21.6 14.2 0.3 0.0 12.6 89.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 37.9 3.2 0.0 234.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.7 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 12.1 30.6 0.0 1.3 0.1 0.0 0.0 0.0 0.7 0.0 115.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.9 0.3 0.3 0.3 0.3 0.2 0.1 0.2 0.2 0.5 0.2 3.0 1.6 0.0 14.4 2.1 0.0 0.0 35.7 0.0 23.9 3.5 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 184.0 0.0 0.2 5.4 0.0 0.0 0.3 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 7.2 0.0 0.0 1303.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.3 0.1 0.0 0.0 25.0 MMP2 "CLG4, CLG4A, TBE-1" ENSG00000087245 "Matrix metallopeptidase 2" P08253 16 55389700-55506691 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Angiogenesis, Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 217.4;Fibroblasts: 249.9;Leydig cells: 315.0;Peritubular cells: 393.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 292.5;ASC TERT1: 85.2;hTERT-RPE1: 329.2;U-87 MG: 93.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001939, CAB002788" Approved Approved Vesicles "Secreted to extracellular matrix" NA NA 1600000000 160000000 Vesicles "CAB002788: , HPA001939: AB_1079395" "unprognostic (7.26e-2)" "unprognostic (1.36e-3)" "unprognostic (1.66e-1)" "unprognostic (2.14e-3)" "unprognostic (5.03e-2)" "unprognostic (1.20e-1)" "unprognostic (1.74e-1)" "unprognostic (9.36e-3)" "unprognostic (4.81e-3)" "unprognostic (3.79e-2)" "unprognostic (4.59e-3)" "unprognostic (6.12e-2)" "unprognostic (1.28e-3)" "unprognostic (1.59e-2)" "unprognostic (8.00e-2)" "unprognostic (8.98e-2)" "unprognostic (4.63e-2)" 197.5 9.0 1.2 13.2 1.6 0.0 136.4 0.8 1.4 74.3 74.4 2.4 36.9 5.6 85.0 123.0 52.3 25.7 115.4 54.0 0.9 0.5 9.4 3.5 38.9 3.9 1.5 1.1 71.0 6.5 0.7 2.2 58.9 2.2 66.8 18.7 36.4 18.6 20.4 68.6 68.2 22.6 57.1 1.8 12.4 20.5 57.0 1.1 1.3 20.6 31.8 9.1 84.1 105.3 0.0 0.0 0.9 0.7 0.0 0.0 0.0 0.3 0.1 9.7 0.1 292.5 85.2 15.9 25.0 57.5 5.0 4.0 0.0 0.1 0.0 20.1 44.1 1.9 2.7 0.0 0.2 2.9 0.0 0.0 0.0 0.6 0.1 27.7 0.0 0.7 72.6 0.0 26.0 0.2 329.2 32.7 0.0 0.0 0.1 16.8 0.0 0.0 0.3 7.7 0.0 0.0 0.0 2.3 0.0 0.8 0.3 0.1 17.6 4.6 0.0 0.1 45.4 0.0 1.7 45.9 79.6 7.6 15.2 3.2 0.0 0.0 0.0 93.1 1.3 14.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.2 0.0 0.0 0.0 1.2 1.6 0.8 1.4 0.9 0.5 1.5 1.1 2.2 1.1 0.0 0.3 0.0 13.0 108.4 5.2 3.1 0.0 0.0 3.4 10.4 0.0 5.4 0.0 1.7 11.5 11.9 0.0 0.0 0.3 217.4 249.9 2.7 0.0 0.0 25.6 1.6 27.1 15.4 0.0 26.9 315.0 5.3 121.4 0.0 0.0 5.0 6.9 0.0 393.8 0.0 1.8 12.9 70.0 1.2 2.1 89.5 14.4 0.0 0.0 3.8 MMP3 "STMY, STMY1" ENSG00000149968 "Matrix metallopeptidase 3" P08254 11 102835801-102843803 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "epididymis: 177.5;salivary gland: 73.4" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 11.5;Basal keratinocytes: 7.4;Club cells: 11.4;Early spermatids: 14.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 59.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "BJ: 101.3;BJ hTERT+: 275.6;fHDF/TERT166: 119.3" "Low region specificity" "Detected in many" HPA007875 Uncertain Supported Vesicles "Secreted to extracellular matrix" NA NA 2540000 170000 Vesicles "HPA007875: AB_1079396" "unprognostic (2.27e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (1.63e-3)" "unprognostic (5.11e-3)" "unprognostic (3.78e-1)" "unprognostic (5.11e-2)" "unprognostic (5.26e-6)" "unprognostic (3.46e-2)" "unprognostic (7.14e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (4.09e-4)" "unprognostic (3.26e-2)" "unprognostic (1.22e-15)" "unprognostic (3.17e-1)" "unprognostic (1.55e-1)" "unprognostic (3.43e-2)" "unprognostic (2.34e-1)" 19.1 0.0 0.2 14.4 0.3 0.0 6.9 0.2 0.5 0.2 1.5 0.3 0.2 1.8 28.3 177.5 0.2 0.0 1.4 0.2 0.2 0.0 0.3 0.5 0.4 0.2 0.2 0.2 0.3 0.2 0.0 0.2 0.2 0.2 1.2 1.7 0.2 73.4 1.5 7.3 12.6 0.7 5.9 0.2 0.2 2.8 1.4 0.2 0.2 0.6 1.5 0.9 7.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 101.3 275.6 1.8 0.5 0.0 0.0 0.0 0.0 119.3 6.8 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 8.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.8 0.1 0.0 0.0 0.0 0.0 3.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 0.5 0.2 0.0 0.2 0.2 0.2 0.2 3.0 0.0 0.0 11.5 7.4 0.0 0.2 5.1 0.0 11.4 0.0 0.0 0.1 0.0 0.7 14.6 0.0 0.0 0.0 1.2 2.2 1.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.3 0.6 0.0 0.0 0.0 0.0 1.0 0.0 0.9 3.0 0.2 0.0 0.1 5.2 MMRN2 "EMILIN3, EndoGlyx-1, FLJ13465" ENSG00000173269 "Multimerin 2" Q9H8L6 10 86935540-86969481 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 12 "Endothelial cells: 80.1;Ito cells: 127.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 3.1" "Lineage enriched" "Detected in single" 6 "T-cells: 3.1" "Group enriched" "Detected in many" 4 "CAPAN-2: 24.6;HUVEC TERT2: 51.7;TIME: 61.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA020741 Approved Vesicles "Secreted to extracellular matrix" NA NA 86000000 Vesicles "HPA020741: AB_1848154" "unprognostic (4.17e-1)" "unprognostic (7.87e-2)" "unprognostic (6.67e-3)" "unprognostic (3.30e-1)" "unprognostic (1.73e-1)" "unprognostic (2.08e-2)" "unprognostic (1.75e-3)" "unprognostic (1.43e-1)" "unprognostic (2.09e-2)" "unprognostic (3.11e-2)" "unprognostic (1.81e-2)" "unprognostic (1.34e-1)" "unprognostic (6.17e-3)" "unprognostic (1.54e-3)" "unprognostic (1.25e-1)" "unprognostic (6.44e-2)" "unprognostic (1.66e-1)" 61.0 8.0 5.4 5.7 6.5 0.4 63.6 4.1 6.8 17.2 10.1 3.5 9.5 5.0 19.0 12.0 12.5 12.5 10.2 51.0 8.2 4.9 11.1 11.1 26.1 7.5 5.9 2.5 12.2 5.4 6.7 5.2 41.9 7.4 13.1 4.4 13.8 12.8 15.2 20.2 19.5 8.1 13.9 6.3 30.8 7.5 10.5 6.0 2.0 16.2 17.6 6.2 23.4 42.2 0.5 0.1 0.1 0.3 0.0 3.1 0.1 3.0 0.8 0.1 0.0 0.3 1.8 2.0 1.1 3.0 1.3 1.9 1.7 24.6 0.0 10.6 2.0 3.3 6.0 0.0 1.4 1.8 2.2 0.0 0.6 2.4 0.0 0.2 0.0 1.3 0.4 7.4 1.6 10.9 3.7 51.7 0.6 0.5 9.8 0.5 1.9 0.1 1.1 0.5 0.1 1.3 0.0 0.0 0.0 0.5 4.7 1.3 0.0 0.8 1.0 0.3 0.2 4.1 0.3 61.7 0.5 3.2 0.5 0.0 0.7 1.0 0.0 1.6 0.0 0.7 0.1 0.3 0.0 0.3 0.0 3.1 0.5 0.9 0.7 0.1 0.2 0.3 0.1 0.1 0.0 0.1 0.0 0.9 0.1 5.4 6.5 4.1 6.8 8.2 4.9 5.9 2.5 7.4 6.0 0.0 8.0 0.0 0.9 8.4 0.0 8.3 5.1 0.0 1.2 1.8 0.0 0.6 0.0 0.0 0.9 80.1 0.0 0.0 0.0 0.1 3.6 0.5 0.0 3.4 1.3 0.0 0.0 127.1 8.1 1.5 2.3 0.5 3.3 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.5 6.5 4.7 1.5 1.8 6.8 0.2 0.0 0.0 0.9 MPV17L "FLJ39599, MLPH1, MLPH2, MPV17L1" ENSG00000156968 "MPV17 mitochondrial inner membrane protein like" Q2QL34 16 15395754-15413268 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 33.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 4 "HMC-1: 30.3" HPA041180 Approved Supported Vesicles NA NA Vesicles "HPA041180: AB_10794266" "unprognostic (9.65e-2)" "unprognostic (8.74e-2)" "unprognostic (4.16e-1)" "unprognostic (1.35e-3)" "unprognostic (6.68e-2)" "unprognostic (2.84e-1)" "unprognostic (2.73e-1)" "unprognostic (4.38e-3)" "unprognostic (8.41e-2)" "unprognostic (8.99e-3)" "unprognostic (8.70e-2)" "unprognostic (6.36e-3)" "prognostic favorable (1.48e-11)" "unprognostic (2.84e-1)" "unprognostic (7.60e-2)" "unprognostic (6.61e-3)" "unprognostic (3.87e-2)" 3.1 4.9 6.2 3.7 8.7 8.3 16.0 6.8 8.0 7.1 4.5 10.5 1.6 7.1 4.5 3.1 2.5 3.3 5.7 3.7 7.4 5.4 8.2 12.2 2.3 4.7 5.8 6.1 4.8 33.1 10.6 11.7 1.4 6.3 3.7 2.9 9.7 10.1 5.0 16.0 9.1 5.6 9.4 7.2 3.7 4.1 2.7 7.0 0.0 5.2 1.3 1.6 4.8 2.4 4.0 2.2 5.7 3.6 3.6 2.5 1.2 0.8 1.6 0.6 0.6 0.1 0.1 1.0 0.4 0.0 0.0 0.0 1.5 2.9 1.2 1.2 0.5 0.4 1.2 2.9 0.0 0.0 0.9 0.8 5.9 3.6 3.0 0.3 2.8 30.3 0.2 0.3 0.1 0.2 0.4 0.0 1.2 1.8 2.7 0.0 1.6 0.9 1.7 1.5 0.2 1.0 1.5 0.5 1.1 0.5 0.6 4.8 1.7 2.5 7.0 0.2 0.7 1.5 2.0 2.0 1.1 0.6 0.9 0.8 1.1 0.4 1.3 0.6 1.3 0.4 3.9 3.6 0.6 2.3 2.7 1.9 2.1 1.5 2.4 1.2 4.0 1.5 2.5 5.7 3.6 1.0 2.2 1.2 1.2 6.2 8.7 6.8 8.0 7.4 5.4 5.8 6.1 6.3 7.0 6.0 9.1 2.9 11.2 7.0 12.3 5.0 10.2 22.7 14.8 0.0 9.8 0.4 13.3 6.8 2.5 4.5 2.6 0.0 11.2 0.4 10.3 5.6 5.8 26.3 0.9 7.9 1.2 5.5 8.3 0.4 6.6 6.9 20.3 0.0 6.2 5.7 8.5 14.8 13.4 14.6 14.8 0.0 11.3 4.1 2.1 10.0 0.5 3.1 10.5 8.4 MREG "DSU, FLJ10116, WDT2" ENSG00000118242 Melanoregulin Q8N565 2 215942805-216034096 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 56.9;monocytes: 36.9;Rod photoreceptor cells: 37.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 24.4" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 42.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068583 Approved Vesicles NA NA Vesicles "HPA068583: AB_2686009" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-1)" "unprognostic (1.20e-2)" "unprognostic (3.24e-1)" "unprognostic (1.13e-2)" "unprognostic (3.70e-1)" "unprognostic (7.37e-2)" "unprognostic (2.39e-1)" "unprognostic (5.85e-3)" "unprognostic (8.11e-3)" "unprognostic (8.93e-2)" "unprognostic (6.38e-3)" "unprognostic (6.62e-3)" "unprognostic (6.92e-2)" "prognostic favorable (4.20e-4)" "unprognostic (9.99e-2)" 5.6 5.8 3.1 4.3 4.5 3.4 16.0 24.4 6.6 6.1 3.6 0.9 11.8 4.2 2.2 5.6 25.8 4.0 1.8 1.7 2.9 3.7 3.8 12.1 12.4 8.3 4.1 2.4 1.6 4.1 6.1 10.6 10.0 6.4 1.8 4.0 18.6 5.0 4.9 1.0 14.3 3.4 1.1 3.0 2.7 4.7 1.6 1.7 9.6 4.6 11.9 18.5 3.5 11.3 2.8 4.9 2.0 0.2 2.0 3.5 0.3 9.6 2.4 2.7 1.6 2.0 1.2 6.5 3.4 2.7 2.4 4.4 12.7 7.6 3.4 3.1 1.9 5.4 6.2 8.6 12.6 5.1 6.8 7.3 4.7 2.5 19.4 1.1 2.8 1.8 1.8 5.6 2.6 3.4 2.1 1.9 7.2 2.6 8.2 1.5 42.6 8.1 2.6 11.3 5.9 2.3 4.5 6.6 5.0 5.6 14.3 7.7 4.1 2.0 17.3 17.7 6.9 9.6 1.2 0.2 4.5 1.3 2.3 4.9 11.5 6.9 8.0 3.0 10.2 3.4 2.0 0.1 0.2 1.9 0.0 3.5 2.8 1.7 2.8 0.3 1.3 0.8 1.2 0.8 2.0 0.2 4.9 2.9 0.3 3.1 4.5 24.4 6.6 2.9 3.7 4.1 2.4 6.4 1.7 3.0 11.2 4.2 8.7 2.4 10.8 0.7 2.5 5.3 15.9 7.0 56.9 16.3 3.3 2.6 0.3 1.0 2.9 0.0 2.1 3.4 1.6 6.0 1.1 6.8 13.8 1.6 1.7 1.3 0.6 0.0 2.3 3.6 5.0 36.9 2.2 3.9 5.1 3.5 7.1 1.0 37.7 6.5 0.4 0.7 3.2 1.4 21.6 2.9 2.4 19.5 MS4A6A "CD20L3, MS4A6" ENSG00000110077 "Membrane spanning 4-domains A6A" Q9H2W1 11 60172014-60184666 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 112.4;lymphoid tissue: 89.5" "Group enriched" "Detected in many" 14 "Hofbauer cells: 335.3;Ito cells: 767.3;Kupffer cells: 1329.9;Macrophages: 569.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "basophil: 32.4;classical monocyte: 112.4;intermediate monocyte: 35.6;myeloid DC: 65.3;plasmacytoid DC: 46.3" "Group enriched" "Detected in many" 96 "dendritic cells: 65.3;granulocytes: 32.4;monocytes: 112.4" "Cell line enriched" "Detected in some" 9 "THP-1: 32.6" "HPA011391, HPA076623" Approved Approved Vesicles NA NA Vesicles "HPA011391: AB_10603876, HPA076623: AB_2686809" "unprognostic (1.17e-1)" "prognostic favorable (6.33e-4)" "unprognostic (2.35e-2)" "unprognostic (1.21e-2)" "unprognostic (1.00e-1)" "unprognostic (8.51e-2)" "unprognostic (2.33e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-1)" "unprognostic (1.76e-1)" "unprognostic (1.91e-1)" "unprognostic (3.20e-1)" "unprognostic (4.75e-3)" "unprognostic (1.06e-1)" "unprognostic (4.66e-2)" "unprognostic (3.94e-2)" "unprognostic (2.97e-2)" 29.3 17.8 12.3 18.3 26.7 9.1 18.1 2.8 14.6 10.2 14.9 4.7 4.0 9.0 7.0 28.3 8.7 11.3 21.0 23.1 10.7 6.9 18.0 35.6 23.0 89.5 22.2 2.4 7.7 6.0 2.4 8.8 21.5 20.5 9.6 19.0 10.2 11.8 6.3 6.0 5.1 20.4 17.2 32.0 78.1 8.5 8.3 19.4 8.5 7.0 6.7 15.4 21.5 6.3 0.7 65.3 32.4 112.4 0.2 0.3 61.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 2.8 0.0 3.8 0.0 0.0 0.0 0.0 2.9 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 32.4 112.4 0.7 0.1 35.6 0.3 0.7 0.2 0.1 65.3 0.1 0.1 0.1 7.4 0.2 2.3 46.3 0.1 61.3 12.3 26.7 2.8 14.6 10.7 6.9 22.2 2.4 20.5 19.4 6.0 31.7 53.0 0.4 8.2 0.0 2.4 30.6 2.7 4.5 3.5 0.0 1.6 0.0 0.0 2.0 8.5 0.0 0.0 0.0 1.7 7.3 0.2 12.8 6.0 335.3 0.0 0.0 767.3 1329.9 1.1 1.4 569.3 13.5 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 45.3 7.2 0.3 1.0 6.9 1.7 27.7 0.0 0.1 MS4A6E ENSG00000166926 "Membrane spanning 4-domains A6E" Q96DS6 11 60334831-60396596 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 9 "testis: 28.2" "Cell type enriched" "Detected in some" 21 "Early spermatids: 1123.1" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 5 "intermediate monocyte: 1.2" "Lineage enriched" "Detected in single" 6 "monocytes: 1.2" "Group enriched" "Detected in some" 7 "K-562: 2.1;SuSa: 4.2" HPA076623 Approved Vesicles NA NA Vesicles "HPA076623: AB_2686809" "unprognostic (2.58e-1)" "unprognostic (3.35e-1)" "unprognostic (3.47e-1)" "unprognostic (6.81e-3)" "unprognostic (4.55e-4)" "unprognostic (1.08e-1)" "unprognostic (1.71e-1)" "unprognostic (1.76e-1)" 2.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 28.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1123.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 53.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 5.1 2.5 0.0 0.0 0.0 0.0 0.0 MTFR2 "DUFD1, FAM54A" ENSG00000146410 "Mitochondrial fission regulator 2" Q6P444 6 136231024-136250335 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 15.2;lymphoid tissue: 16.8;testis: 13.5" "Cell type enhanced" "Detected in many" 10 "Erythroid cells: 23.3;Extravillous trophoblasts: 18.8;Spermatocytes: 11.8;Spermatogonia: 9.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029792, HPA029794" Approved Uncertain Vesicles NA Yes Vesicles "HPA029792: AB_10600210, HPA029794: AB_10600535" "unprognostic (6.49e-3)" "unprognostic (6.29e-2)" "unprognostic (1.65e-1)" "prognostic unfavorable (9.64e-4)" "unprognostic (3.93e-1)" "unprognostic (1.75e-2)" "unprognostic (4.60e-6)" "prognostic unfavorable (8.28e-4)" "unprognostic (3.77e-2)" "unprognostic (1.22e-1)" "unprognostic (6.27e-2)" "unprognostic (6.54e-2)" "unprognostic (1.11e-16)" "unprognostic (8.82e-3)" "unprognostic (1.55e-1)" "unprognostic (4.10e-2)" "unprognostic (3.64e-2)" 1.7 0.9 0.6 5.1 1.5 15.2 0.9 0.9 1.1 0.8 2.9 0.8 0.4 2.8 0.7 0.9 4.5 0.5 1.7 1.0 0.6 0.6 2.5 0.7 1.5 6.4 0.8 0.4 0.9 0.7 0.0 0.7 3.2 1.2 0.7 4.1 0.6 1.3 0.4 1.4 1.9 3.2 0.9 1.1 3.8 1.9 13.5 0.4 16.8 0.4 3.2 5.8 1.1 1.4 1.6 3.0 0.1 2.9 0.0 2.6 1.1 7.2 5.6 4.8 9.0 0.8 1.4 8.6 9.6 6.7 11.4 15.9 9.9 5.9 18.8 5.9 3.8 15.1 11.3 10.9 7.1 17.0 10.5 8.4 14.8 4.1 9.0 0.5 27.1 14.0 1.1 1.5 12.6 8.1 1.3 6.1 16.5 15.9 14.6 8.5 9.6 15.2 22.7 4.8 9.7 6.9 14.0 7.7 9.4 4.9 5.6 3.8 3.8 6.0 10.6 5.5 6.2 4.5 18.7 3.3 5.7 5.9 19.9 14.6 5.6 13.1 12.4 3.3 18.5 8.6 0.0 0.6 0.0 1.2 2.9 0.4 1.6 1.6 2.6 3.0 1.3 0.2 1.3 0.1 0.0 2.3 2.2 2.2 1.1 0.6 1.5 0.9 1.1 0.6 0.6 0.8 0.4 1.2 0.4 0.0 0.6 6.2 0.3 0.9 0.0 0.3 0.0 1.4 1.2 0.0 0.0 4.9 0.0 0.8 6.5 0.3 0.9 23.3 2.2 18.8 0.4 0.8 1.1 0.5 5.6 0.0 0.0 1.3 4.3 4.2 0.3 1.8 0.0 2.8 1.0 0.0 0.8 0.0 0.0 1.3 0.0 0.0 0.3 11.8 9.9 0.3 2.5 1.5 1.4 0.9 MTMR2 "CMT4B, KIAA1073" ENSG00000087053 "Myotubularin related protein 2" Q13614 11 95832882-95925315 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Hydrolase "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 87.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049831 Approved Supported Vesicles NA NA Vesicles "HPA049831: AB_2680904" "unprognostic (1.71e-2)" "unprognostic (2.55e-3)" "unprognostic (7.81e-3)" "unprognostic (4.16e-1)" "unprognostic (4.18e-3)" "unprognostic (5.36e-2)" "prognostic unfavorable (1.61e-8)" "unprognostic (3.23e-3)" "unprognostic (3.42e-2)" "unprognostic (1.77e-2)" "prognostic unfavorable (3.60e-4)" "unprognostic (1.12e-1)" "unprognostic (2.34e-2)" "unprognostic (1.54e-1)" "unprognostic (1.50e-1)" "unprognostic (1.14e-1)" "unprognostic (8.03e-3)" 16.4 10.4 14.2 12.1 19.9 5.3 15.4 14.9 23.3 14.1 13.5 22.6 4.9 8.0 14.1 7.5 15.5 13.3 15.4 13.8 18.1 13.9 16.9 4.5 14.3 13.6 27.5 13.6 14.5 11.0 15.9 8.2 25.1 21.3 17.6 14.5 19.6 18.8 12.3 6.8 9.7 9.5 18.2 30.0 10.5 13.6 29.0 21.8 12.2 11.3 7.7 11.7 13.4 14.3 5.4 6.6 9.7 4.9 11.8 14.2 6.6 9.4 10.1 23.3 16.9 8.2 12.7 19.5 17.7 15.8 17.6 15.9 23.9 19.2 6.8 21.2 18.6 14.9 13.1 19.0 19.3 15.9 12.4 9.2 14.1 25.3 13.4 18.8 23.9 11.7 10.6 12.9 23.1 23.2 18.0 26.5 15.3 17.4 6.5 16.5 7.0 11.9 11.1 18.9 22.8 14.3 10.0 13.6 6.4 18.1 50.8 14.9 17.4 17.5 14.8 7.9 15.3 11.7 10.2 27.1 20.6 18.9 15.0 16.3 6.1 16.8 6.2 8.6 6.6 20.8 9.7 3.3 1.4 11.4 3.9 12.3 5.4 7.7 14.2 6.6 4.8 4.1 11.0 0.9 11.8 4.9 3.4 6.9 6.6 14.2 19.9 14.9 23.3 18.1 13.9 27.5 13.6 21.3 21.8 3.0 7.5 5.1 13.3 9.2 0.0 14.0 0.0 9.4 12.5 8.7 0.0 8.0 8.3 15.9 48.9 19.5 7.3 0.0 14.6 26.0 14.0 13.2 18.5 0.9 11.0 0.0 15.5 10.4 9.1 87.8 10.3 7.5 3.3 9.0 9.1 0.0 14.2 2.9 11.3 20.7 0.0 32.3 20.0 34.6 16.4 5.3 7.6 7.9 8.4 13.2 MUC5B "MG1, MUC5" ENSG00000117983 "Mucin 5B, oligomeric mucus/gel-forming" Q9HC84 11 1223066-1262172 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 301.7;lymphoid tissue: 155.1;salivary gland: 192.8" "Cell type enriched" "Detected in some" 4 "Cholangiocytes: 591.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "OE19: 41.8;PC-3: 45.1" "HPA008246, CAB009396" Enhanced Supported Vesicles "Secreted in other tissues" NA NA 590000 Vesicles "CAB009396: AB_2282256, HPA008246: AB_1854203" "unprognostic (2.01e-2)" "unprognostic (1.46e-1)" "unprognostic (9.39e-2)" "unprognostic (2.76e-3)" "unprognostic (5.46e-2)" "unprognostic (1.22e-1)" "unprognostic (4.89e-2)" "unprognostic (7.80e-3)" "unprognostic (3.75e-1)" "unprognostic (1.11e-1)" "unprognostic (4.18e-2)" "unprognostic (8.95e-2)" "unprognostic (2.57e-7)" "unprognostic (2.71e-1)" "unprognostic (1.61e-1)" "unprognostic (1.07e-1)" "unprognostic (8.13e-2)" 0.1 0.1 0.1 0.7 0.1 0.0 0.2 0.1 0.1 67.4 8.4 0.0 0.0 0.0 1.9 0.0 11.6 0.2 301.7 0.1 0.1 0.1 0.1 0.6 2.0 0.0 0.1 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.1 4.6 0.0 192.8 0.0 0.7 0.1 0.3 0.1 0.1 0.1 1.5 0.1 0.0 0.0 0.1 31.6 155.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 41.8 45.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 32.8 0.9 0.0 0.0 0.0 10.5 591.1 34.8 46.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 14.6 0.0 0.0 0.1 0.0 1.2 4.6 0.0 0.2 0.0 23.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.1 0.0 0.5 48.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 131.5 0.3 MYBPHL ENSG00000221986 "Myosin binding protein H like" A2RUH7 1 109292365-109307041 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "heart muscle: 64.6" "Cell type enriched" "Detected in some" 14 "Cardiomyocytes: 139.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 2.4;Daudi: 1.5;Hep G2: 6.7;K-562: 1.7;RH-30: 3.9;THP-1: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA077633 Approved Vesicles NA NA Vesicles "HPA077633: " "unprognostic (6.07e-3)" "unprognostic (1.43e-1)" "unprognostic (2.78e-1)" "unprognostic (1.17e-2)" "unprognostic (1.47e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-2)" "unprognostic (1.24e-2)" "unprognostic (5.53e-2)" "unprognostic (5.89e-1)" "unprognostic (5.22e-3)" "unprognostic (4.10e-1)" "unprognostic (7.05e-9)" "unprognostic (6.01e-2)" "unprognostic (1.53e-1)" "unprognostic (5.81e-2)" "unprognostic (2.64e-1)" 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.4 0.3 1.3 0.0 64.6 0.4 0.1 0.0 0.0 0.7 0.0 1.4 0.1 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.3 0.4 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.4 0.1 0.0 0.3 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 6.7 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.8 0.5 0.0 1.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.5 0.1 0.6 0.4 0.1 1.4 0.1 0.4 0.9 0.0 3.2 0.0 0.1 0.0 1.1 139.3 0.0 0.0 1.2 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.7 0.0 9.8 0.0 0.3 0.3 0.3 0.1 0.0 0.0 0.0 0.5 MYCBPAP "AMAP-1, DKFZp434N1415" ENSG00000136449 "MYCBP associated protein" Q8TBZ2 17 50508384-50531501 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "testis: 81.2" "Group enriched" "Detected in some" 8 "Ciliated cells: 56.2;Early spermatids: 173.4;Late spermatids: 100.2;Spermatocytes: 52.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 7.5;JURKAT: 7.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023257, HPA024405" Enhanced Approved Vesicles NA NA Vesicles "HPA023257: AB_2671126, HPA024405: " "unprognostic (2.05e-2)" "unprognostic (1.79e-2)" "unprognostic (9.13e-3)" "unprognostic (3.98e-5)" "unprognostic (8.62e-4)" "unprognostic (3.65e-2)" "unprognostic (1.52e-3)" "unprognostic (1.61e-1)" "unprognostic (2.38e-3)" "unprognostic (1.11e-1)" "unprognostic (7.32e-4)" "unprognostic (2.52e-1)" "unprognostic (1.39e-4)" "unprognostic (7.15e-2)" "unprognostic (1.97e-1)" "unprognostic (7.37e-2)" "unprognostic (2.02e-2)" 0.5 0.6 1.1 0.4 1.6 0.9 0.4 1.3 1.4 0.9 0.4 1.6 0.8 0.1 1.3 2.2 0.6 3.5 1.0 0.4 1.2 0.8 0.4 0.2 1.1 0.6 0.4 0.9 1.9 0.2 0.4 0.7 0.2 3.5 0.8 0.2 0.6 0.7 1.2 0.6 0.8 0.3 0.7 0.9 0.5 0.3 81.2 0.4 0.3 0.6 0.0 0.4 0.4 0.5 0.3 0.2 2.8 0.4 1.0 1.0 0.3 0.3 1.5 0.8 0.6 1.9 1.2 1.5 0.7 0.4 0.5 0.7 1.3 3.2 0.5 0.2 0.3 1.6 0.8 0.4 2.3 0.3 7.5 0.7 2.6 2.5 0.7 1.7 0.1 0.6 2.7 0.6 1.2 4.0 1.9 1.4 7.1 0.9 0.8 1.5 0.9 0.3 0.7 0.2 0.2 1.1 0.4 0.7 0.4 0.1 0.8 1.5 3.3 0.9 0.5 0.5 1.2 0.7 1.5 4.1 0.9 1.2 0.3 0.2 4.6 1.5 0.4 1.1 0.5 2.3 1.2 0.4 0.7 0.3 0.3 0.4 0.1 0.4 0.3 0.1 0.3 0.9 0.4 2.8 1.0 0.1 0.2 1.0 0.3 1.1 1.6 1.3 1.4 1.2 0.8 0.4 0.9 3.5 0.4 0.0 1.7 0.0 1.4 0.1 3.6 0.5 0.0 56.2 11.4 1.8 0.0 1.4 0.0 0.0 173.4 0.6 0.4 0.0 0.3 0.2 0.6 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.6 100.2 6.4 0.6 0.0 0.0 1.5 6.5 0.1 0.0 3.5 0.0 0.4 0.0 0.3 52.0 5.5 0.4 0.1 0.9 0.1 0.9 MYL6B MLC1SA ENSG00000196465 "Myosin light chain 6B" P14649 12 56152256-56159647 "Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 129.0" "Cell type enhanced" "Detected in many" 13 "Late spermatids: 863.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.6" "Group enriched" "Detected in all" 5 "B-cells: 5.3;dendritic cells: 15.6;T-cells: 12.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038887, HPA046859, HPA063034" Enhanced Approved Vesicles NA NA Vesicles "HPA038887: AB_10674842, HPA046859: AB_2679842, HPA063034: AB_2684927" "unprognostic (5.25e-2)" "unprognostic (3.18e-1)" "unprognostic (6.29e-3)" "unprognostic (7.39e-2)" "unprognostic (5.37e-1)" "unprognostic (1.55e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (4.66e-2)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (1.02e-3)" "unprognostic (3.48e-1)" "unprognostic (1.53e-1)" "unprognostic (3.56e-3)" "unprognostic (3.42e-2)" "unprognostic (3.00e-1)" "unprognostic (3.83e-2)" 5.6 10.0 32.0 4.8 33.1 5.4 8.7 11.9 26.7 13.9 4.1 8.0 8.5 3.0 9.8 12.8 8.4 13.2 9.7 13.6 24.1 21.8 9.3 6.2 4.5 6.9 20.7 21.6 20.0 4.8 17.4 14.1 5.1 13.4 12.6 4.0 11.0 7.3 8.3 129.0 5.1 4.1 8.4 10.7 3.9 5.1 24.9 10.2 11.5 9.9 10.7 8.8 5.6 5.0 5.3 15.6 1.8 2.3 2.0 12.0 3.1 7.5 13.0 35.4 33.8 7.5 27.0 24.7 8.8 39.1 35.3 34.5 9.3 12.6 12.7 19.6 19.0 13.5 4.3 16.6 21.5 19.1 22.9 24.1 13.3 13.4 16.3 23.8 9.7 9.3 45.2 8.7 32.6 12.7 75.2 38.1 30.9 14.0 13.1 29.0 9.9 26.5 32.2 29.7 7.2 22.5 28.0 21.9 16.7 26.8 5.1 32.6 47.9 9.8 12.0 17.8 27.1 9.9 16.6 21.1 20.8 17.8 10.7 18.9 18.6 10.6 10.5 22.2 9.8 22.7 0.7 2.3 0.7 1.8 2.2 1.0 5.3 3.7 3.0 5.4 3.5 2.7 2.2 1.8 2.0 0.9 15.6 12.0 3.1 32.0 33.1 11.9 26.7 24.1 21.8 20.7 21.6 13.4 10.2 62.5 29.6 26.0 41.8 29.5 53.0 14.1 30.6 21.4 20.5 104.7 23.6 31.3 127.6 41.5 257.0 40.5 19.3 0.0 17.8 53.4 50.7 40.2 12.7 25.5 36.1 31.8 151.1 46.1 17.2 863.2 74.8 25.0 38.8 73.9 31.3 69.7 27.9 20.1 62.6 129.3 46.7 51.8 46.7 90.0 52.8 22.2 18.9 13.8 36.0 36.2 MYO16 "KIAA0865, Myo16b, MYR8, NYAP3, PPP1R107" ENSG00000041515 "Myosin XVI" Q9Y6X6 13 108596152-109208007 "Predicted intracellular proteins" "Actin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 8.0;Hepatocytes: 4.7;Late spermatids: 8.9;Muller glia cells: 3.9;Spermatocytes: 4.2;Spermatogonia: 6.8" "Cancer enhanced" "Detected in some" "glioma: 1.0" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 10 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "AF22: 1.6;SH-SY5Y: 6.7;U-2197: 4.0" "Group enriched" "Detected in all" 4 "basal ganglia: 21.9;olfactory region: 88.9" "Low region specificity" "Detected in all" "HPA040110, HPA058769, HPA071948" Uncertain Approved Vesicles NA NA Vesicles "HPA040110: AB_10796339, HPA058769: AB_2683814, HPA071948: AB_2686475" "unprognostic (7.55e-3)" "unprognostic (7.74e-3)" "unprognostic (4.52e-4)" "unprognostic (5.12e-3)" "unprognostic (1.38e-1)" "unprognostic (5.81e-2)" "unprognostic (1.20e-2)" "unprognostic (2.16e-1)" "unprognostic (2.53e-1)" "unprognostic (6.50e-2)" "unprognostic (9.01e-3)" "unprognostic (5.29e-2)" "unprognostic (4.68e-4)" "unprognostic (4.26e-2)" "unprognostic (3.21e-2)" "unprognostic (7.06e-2)" "unprognostic (2.34e-2)" 3.4 2.2 4.0 0.9 3.7 0.4 0.8 2.4 9.2 0.9 0.6 1.5 0.0 0.6 0.5 0.5 1.0 0.5 0.5 2.4 7.5 3.2 0.6 4.8 0.8 0.9 1.8 4.5 0.5 0.7 0.3 5.7 0.6 5.7 1.1 0.6 0.7 0.6 2.0 0.4 0.7 0.5 1.4 5.1 0.5 0.6 3.0 0.0 0.0 0.5 0.0 1.1 0.5 1.2 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.8 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.0 6.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.0 4.0 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.0 3.7 2.4 9.2 7.5 3.2 1.8 4.5 5.7 0.0 0.0 1.1 0.0 0.0 0.2 3.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 8.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 1.1 4.7 0.1 0.0 0.0 0.0 0.0 8.9 0.9 0.0 1.7 0.0 0.0 3.9 0.2 0.0 0.0 0.0 0.2 0.0 0.0 4.2 6.8 0.0 0.2 0.0 0.0 0.0 MYT1L "KIAA1106, NZF1, ZC2H2C2, ZC2HC4B" ENSG00000186487 "Myelin transcription factor 1 like" Q9UL68 2 1789113-2331348 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Autism spectrum disorder, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 50.2" "Cell type enhanced" "Detected in many" 20 "Bipolar cells: 49.9;Horizontal cells: 111.2;Spermatocytes: 36.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.3;naive CD8 T-cell: 1.6" "Group enriched" "Detected in many" 8 "granulocytes: 2.3;T-cells: 1.6" "Group enriched" "Detected in some" 9 "SCLC-21H: 11.3;SH-SY5Y: 8.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060245 Approved Vesicles NA NA Vesicles "HPA060245: AB_2732643" "unprognostic (9.90e-3)" "unprognostic (3.74e-1)" "unprognostic (1.30e-1)" "unprognostic (9.61e-3)" "unprognostic (7.17e-2)" "unprognostic (3.73e-2)" "unprognostic (2.44e-1)" "unprognostic (2.36e-2)" "unprognostic (3.21e-2)" "unprognostic (1.93e-2)" "unprognostic (2.46e-1)" "unprognostic (7.96e-2)" "unprognostic (1.21e-2)" "unprognostic (1.04e-2)" 1.2 3.4 11.0 1.4 20.0 1.1 1.1 19.5 50.2 1.1 1.2 0.5 0.0 1.1 1.2 1.1 1.3 1.1 1.1 1.1 15.6 10.3 1.1 1.1 1.1 1.2 5.1 14.5 1.1 1.5 1.0 10.7 1.1 6.8 1.3 1.3 0.4 1.1 1.1 1.1 1.1 1.2 1.1 1.5 1.0 1.1 4.6 2.0 0.0 1.1 0.0 1.1 1.1 0.0 0.0 0.2 2.3 0.0 0.0 1.6 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.3 0.6 0.1 0.0 0.0 11.3 8.4 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.2 0.0 0.6 11.0 20.0 19.5 26.7 15.6 10.3 5.1 14.5 6.8 2.0 6.0 6.7 0.0 0.5 1.5 49.9 3.6 0.0 2.7 5.7 1.8 2.0 0.1 0.0 0.0 3.4 0.8 0.0 0.0 0.0 0.1 0.8 0.2 5.8 0.4 0.1 111.2 0.0 1.3 0.3 2.9 0.0 0.4 0.0 0.0 0.0 1.0 0.2 0.0 1.4 0.0 6.8 6.5 0.3 36.2 17.4 0.9 0.2 0.0 0.0 0.5 NAP1L3 "MB20, MGC26312, NPL3" ENSG00000186310 "Nucleosome assembly protein 1 like 3" Q99457 X 93670930-93673568 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.2" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 38.8;Horizontal cells: 58.8;Peritubular cells: 18.4" "Cancer enhanced" "Detected in many" "glioma: 12.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 6.9" "Group enriched" "Detected in many" 24 "NK-cells: 4.5;T-cells: 6.9" "Cell line enhanced" "Detected in some" "AF22: 9.9;HAP1: 9.5;NTERA-2: 17.4;SuSa: 15.8;U-2197: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026075 Approved Vesicles NA NA Vesicles "HPA026075: AB_1854301" "unprognostic (7.18e-2)" "unprognostic (1.81e-2)" "unprognostic (9.26e-2)" "unprognostic (4.83e-4)" "unprognostic (3.06e-1)" "unprognostic (1.28e-2)" "unprognostic (5.10e-2)" "unprognostic (1.76e-1)" "unprognostic (3.31e-2)" "unprognostic (9.29e-2)" "unprognostic (2.75e-3)" "unprognostic (5.01e-2)" "unprognostic (2.75e-3)" "unprognostic (5.78e-3)" "unprognostic (1.19e-1)" "unprognostic (1.75e-1)" "unprognostic (5.23e-4)" 2.3 10.4 24.4 2.4 25.7 1.2 2.4 44.9 60.2 16.0 2.4 5.3 0.0 1.6 9.5 4.7 1.5 8.1 4.4 8.4 22.0 42.3 2.9 1.4 1.8 2.1 18.5 31.0 13.1 1.5 1.1 7.9 1.6 20.9 3.9 2.3 2.4 1.6 4.6 0.8 1.7 2.0 6.5 13.1 3.6 1.4 11.9 7.0 0.0 4.6 0.0 1.5 3.3 1.2 0.0 0.0 0.2 0.0 4.5 6.9 1.6 0.0 0.1 9.9 7.2 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 5.4 0.2 0.0 9.5 0.0 0.0 0.0 0.2 4.5 0.0 0.1 0.5 0.0 0.3 4.5 0.0 0.5 4.6 0.0 0.0 4.9 0.0 0.0 0.5 0.0 0.0 0.0 17.4 0.0 4.1 0.0 7.7 0.0 0.3 0.0 0.1 1.0 0.0 0.0 0.1 15.8 0.0 0.5 0.0 5.5 8.0 11.7 0.4 7.5 3.1 0.0 3.1 0.0 0.0 0.0 0.0 0.0 3.0 0.0 1.1 0.0 4.3 1.6 0.0 0.0 6.9 4.8 0.2 4.5 0.0 0.0 1.3 1.6 24.4 25.7 44.9 60.2 22.0 42.3 18.5 31.0 20.9 7.0 0.0 0.0 0.0 0.2 0.6 38.8 7.3 0.0 2.7 1.2 0.0 5.9 0.2 14.9 0.0 0.8 0.7 0.0 0.0 0.0 0.1 6.6 0.0 5.7 0.0 0.3 58.8 0.0 1.8 0.0 1.7 10.9 0.0 5.0 0.0 0.0 14.5 0.3 0.0 18.4 0.3 11.1 0.0 3.4 2.2 6.9 0.4 0.2 0.0 0.0 0.0 NDFIP2 "KIAA1165, N4wbp5a" ENSG00000102471 "Nedd4 family interacting protein 2" Q9NV92 13 79481124-79556075 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 304.4;Suprabasal keratinocytes: 321.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 17.3" "Group enriched" "Detected in many" 18 "granulocytes: 17.3;T-cells: 5.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009160 Uncertain Supported Vesicles NA NA Vesicles "HPA009160: AB_1079456" "unprognostic (2.56e-1)" "unprognostic (5.51e-3)" "unprognostic (1.95e-3)" "unprognostic (9.61e-2)" "unprognostic (2.60e-1)" "prognostic unfavorable (5.99e-4)" "unprognostic (1.50e-1)" "unprognostic (5.53e-2)" "unprognostic (2.30e-1)" "unprognostic (3.12e-1)" "unprognostic (1.52e-2)" "unprognostic (2.63e-2)" "prognostic favorable (4.18e-5)" "unprognostic (1.32e-1)" "unprognostic (1.31e-1)" "unprognostic (6.47e-2)" "unprognostic (1.02e-1)" 8.0 13.0 15.3 6.7 28.4 1.2 12.8 8.7 39.6 11.8 24.0 12.0 10.5 27.9 5.8 12.9 36.4 9.4 11.1 13.9 23.6 9.6 25.2 24.7 9.5 6.4 11.6 27.3 4.8 16.9 8.8 7.5 29.7 20.4 12.8 25.8 4.8 15.8 9.3 18.2 39.4 36.1 5.0 12.7 6.1 13.7 9.4 13.8 7.3 10.7 15.7 10.7 16.8 18.8 0.3 0.1 17.3 0.0 0.6 5.0 2.1 36.3 6.2 6.5 8.3 8.0 14.8 12.4 13.4 18.8 14.2 23.8 13.6 40.8 1.5 9.3 17.6 8.1 49.8 5.7 23.6 21.6 18.8 15.9 1.7 20.7 7.4 14.7 28.6 5.0 11.7 31.1 9.5 15.1 15.9 6.7 2.9 7.3 2.8 15.9 5.2 2.3 6.5 4.8 30.0 6.3 0.1 13.0 6.8 34.9 21.3 6.7 9.5 15.2 14.8 10.6 11.2 12.3 24.1 5.7 4.6 5.8 8.8 9.0 10.7 11.7 5.7 18.8 0.1 18.3 9.7 0.0 17.3 2.6 0.0 2.2 0.2 2.4 2.1 0.0 0.3 5.0 2.8 0.1 0.6 0.0 0.1 2.4 2.1 15.3 28.4 8.7 39.6 23.6 9.6 11.6 27.3 20.4 13.8 38.7 28.2 13.7 104.5 304.4 31.6 25.7 66.2 52.2 45.5 45.4 5.9 82.8 19.9 74.5 207.3 20.9 161.3 0.0 62.9 127.6 41.2 71.9 87.6 57.0 12.8 15.9 66.7 22.7 13.6 210.2 16.1 6.1 32.1 4.6 78.3 18.6 82.7 70.2 12.0 89.2 13.9 12.9 22.7 38.1 46.6 321.3 91.8 11.5 62.9 132.4 NDNF "C4orf31, FLJ23191" ENSG00000173376 "Neuron derived neurotrophic factor" Q8TB73 4 121035613-121073021 "Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 91.6;retina: 41.0" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 229.3;Early spermatids: 225.6;Late spermatids: 164.5" "Cancer enhanced" "Detected in many" "lung cancer: 12.6" "Region enriched" "Detected in many" 4 "pons and medulla: 7.6" "Cell type enriched" "Detected in single" 11 "naive CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 23.2;U-266/70: 10.3;U-266/84: 39.6" "Group enriched" "Detected in many" 4 "basal ganglia: 11.4;olfactory region: 41.7" "Low region specificity" "Detected in all" HPA048881 Supported Vesicles "Secreted in other tissues" NA NA Vesicles "HPA048881: " "unprognostic (2.84e-1)" "unprognostic (1.75e-1)" "unprognostic (1.98e-1)" "unprognostic (1.04e-1)" "unprognostic (3.94e-1)" "unprognostic (6.26e-2)" "unprognostic (2.22e-1)" "unprognostic (2.93e-2)" "unprognostic (6.65e-4)" "unprognostic (2.18e-3)" "unprognostic (6.27e-2)" "unprognostic (3.44e-2)" "prognostic unfavorable (3.26e-4)" "unprognostic (2.38e-3)" "unprognostic (1.20e-1)" "unprognostic (1.18e-4)" "unprognostic (1.74e-1)" 3.8 1.3 1.2 0.4 1.0 0.0 14.2 0.6 1.5 7.2 3.5 1.2 1.7 1.3 3.1 2.2 5.7 10.0 6.9 4.9 1.2 1.5 12.5 0.5 91.6 0.1 1.8 1.2 21.3 0.6 0.4 8.2 28.0 7.6 26.1 4.0 41.0 2.1 2.2 7.5 1.8 3.9 2.6 5.5 0.4 2.2 8.0 0.8 7.0 1.6 9.0 1.4 8.9 11.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 5.2 0.0 7.0 5.7 0.1 0.1 0.2 0.1 0.2 0.7 0.0 0.0 0.0 23.2 0.4 0.0 0.0 0.0 0.5 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.3 0.0 0.0 0.0 6.9 0.4 0.0 0.0 0.0 0.4 3.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 1.3 0.1 0.0 0.0 5.7 0.0 0.1 0.2 10.3 39.6 0.0 1.9 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.0 0.6 1.5 1.2 1.5 1.8 1.2 7.6 0.8 229.3 38.7 0.0 0.0 1.0 69.0 1.6 15.3 22.7 52.4 12.2 17.7 0.2 0.0 0.0 225.6 11.7 0.0 0.0 0.2 0.0 3.1 0.0 2.3 0.0 0.1 1.6 1.7 4.3 0.0 164.5 3.1 0.4 5.0 0.0 0.2 15.1 0.1 0.0 0.7 0.0 18.7 0.0 3.3 7.5 4.7 0.6 0.5 0.0 1.2 0.0 NELL2 NRP2 ENSG00000184613 "Neural EGFL like 2" Q99435 12 44508275-44921848 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 36.8;brain: 73.3;fallopian tube: 35.1" "Group enriched" "Detected in many" 6 "Bipolar cells: 38.4;Ciliated cells: 40.2;Club cells: 11.4;Cone photoreceptor cells: 31.4;Rod photoreceptor cells: 43.8" "Cancer enhanced" "Detected in many" "thyroid cancer: 33.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8" "Lineage enriched" "Detected in many" 11 "T-cells: 36.8" "Cell line enhanced" "Detected in some" "AF22: 41.8;HEK 293: 10.9;NTERA-2: 16.4;SCLC-21H: 30.4;U-266/70: 11.1;U-266/84: 11.1;U-698: 15.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035714, HPA035715" Uncertain Approved Vesicles "Secreted to blood" NA NA 4700000 Vesicles "HPA035714: AB_2674746, HPA035715: AB_10669602" "unprognostic (4.25e-3)" "unprognostic (4.27e-2)" "unprognostic (1.06e-1)" "unprognostic (3.10e-2)" "unprognostic (3.01e-2)" "unprognostic (7.18e-2)" "unprognostic (5.85e-2)" "unprognostic (2.59e-2)" "unprognostic (4.85e-2)" "unprognostic (2.80e-1)" "prognostic favorable (5.56e-4)" "unprognostic (1.19e-1)" "unprognostic (1.71e-5)" "unprognostic (8.45e-2)" "unprognostic (2.92e-1)" "unprognostic (3.60e-3)" "unprognostic (3.75e-2)" 2.0 10.5 22.4 6.1 24.8 4.2 1.6 15.7 73.3 14.9 2.9 3.6 0.0 15.3 1.9 0.8 1.3 35.1 1.7 0.8 40.2 20.4 1.2 1.1 3.4 11.2 6.6 27.0 1.0 1.1 0.6 18.4 0.8 7.5 18.8 1.8 9.3 1.5 1.8 0.7 5.0 8.6 2.2 2.6 3.8 2.1 2.2 2.4 0.4 4.4 0.0 9.1 2.3 2.0 0.0 0.0 0.1 0.0 3.3 36.8 8.5 0.1 0.0 41.8 1.4 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 5.0 0.0 0.0 0.1 9.9 0.0 0.0 0.0 10.9 0.1 3.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.1 0.0 0.1 16.4 0.0 5.4 0.0 5.0 0.0 0.0 0.0 30.4 0.7 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.2 1.5 0.0 0.7 11.1 11.1 15.1 0.1 0.1 0.2 0.0 0.0 0.0 1.6 0.0 8.5 0.0 10.3 18.1 0.0 0.0 24.5 36.8 0.1 3.3 0.0 0.0 0.1 8.5 22.4 24.8 15.7 50.4 40.2 20.4 6.6 27.0 7.5 2.4 0.0 2.2 0.0 0.0 1.0 38.4 0.4 0.0 40.2 11.4 0.0 31.4 0.1 0.0 0.0 0.2 0.5 5.4 0.0 0.2 0.2 1.4 0.2 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 5.2 0.3 0.0 0.4 0.1 43.8 0.0 1.4 1.5 3.4 1.0 0.1 5.3 0.6 0.0 NEURL2 "C20orf163, dJ337O18.6, FLJ30259, Ozz, Ozz-E3" ENSG00000124257 "Neuralized E3 ubiquitin protein ligase 2" Q9BR09 20 45888625-45891287 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hofbauer cells: 10.0;Proximal tubular cells: 11.1;Sertoli cells: 12.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043402, HPA059842" Approved Approved Vesicles NA NA Vesicles "HPA043402: AB_2678464, HPA059842: AB_2684139" "unprognostic (6.26e-2)" "unprognostic (1.77e-2)" "unprognostic (1.92e-1)" "unprognostic (1.48e-2)" "unprognostic (1.50e-1)" "unprognostic (1.18e-1)" "unprognostic (3.23e-3)" "unprognostic (1.07e-1)" "unprognostic (8.04e-2)" "unprognostic (2.90e-1)" "unprognostic (1.73e-3)" "unprognostic (5.58e-2)" "unprognostic (1.99e-2)" "unprognostic (6.94e-2)" "unprognostic (1.97e-1)" "unprognostic (8.12e-2)" "unprognostic (1.58e-1)" 7.9 6.3 2.8 3.0 2.6 1.3 4.8 5.5 3.3 4.6 7.6 2.9 4.5 5.2 5.7 6.0 3.3 5.2 9.0 7.6 1.9 1.6 8.8 12.3 2.4 1.5 1.5 2.3 8.7 2.8 6.2 4.2 3.7 2.7 5.7 2.7 5.9 4.0 3.7 21.6 4.3 10.3 10.2 2.3 4.5 3.3 3.2 1.1 1.1 4.0 21.5 2.1 6.6 2.8 5.4 0.8 3.6 1.3 2.3 3.8 0.9 1.0 0.9 2.5 1.9 4.0 1.7 2.3 1.5 2.1 1.7 0.8 10.0 6.5 1.5 2.2 1.1 3.1 3.4 2.0 0.2 1.1 0.8 1.8 0.8 7.2 9.9 5.6 0.7 1.7 3.9 1.4 1.7 0.7 2.6 1.6 2.1 0.6 2.6 0.9 4.0 1.2 0.7 1.6 0.6 3.6 2.0 1.8 0.7 1.0 0.9 5.7 4.7 2.0 5.2 6.2 0.6 4.2 2.1 2.5 2.0 1.6 1.4 1.3 8.2 1.5 0.3 2.1 1.0 1.7 0.0 1.3 3.6 0.9 0.7 0.5 5.4 1.8 1.6 0.4 2.6 3.8 3.5 0.7 2.3 0.4 0.8 1.0 0.9 2.8 2.6 5.5 3.0 1.9 1.6 1.5 2.3 2.7 1.1 0.0 0.0 1.3 1.9 0.1 3.6 4.8 0.0 0.0 0.0 0.0 3.9 0.6 6.6 2.5 2.0 1.9 4.2 0.0 1.8 0.6 1.7 2.0 0.0 3.8 10.0 0.0 2.9 6.7 3.7 6.5 4.9 0.1 0.0 1.8 1.7 2.5 3.1 0.0 3.5 11.1 2.8 12.9 3.4 0.0 0.3 1.0 0.5 0.0 2.1 1.6 NHLRC1 "bA204B7.2, EPM2B" ENSG00000187566 "NHL repeat containing E3 ubiquitin protein ligase 1" Q6VVB1 6 18120440-18122687 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Autophagy, Ubl conjugation pathway" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 5 "Exocrine glandular cells: 3.2;Intestinal endocrine cells: 3.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 9.2;K-562: 7.8;SCLC-21H: 8.2" "Low region specificity" "Detected in all" HPA066030 Uncertain Vesicles NA NA Vesicles "HPA066030: " "unprognostic (1.61e-1)" "unprognostic (1.39e-1)" "unprognostic (7.95e-2)" "prognostic unfavorable (9.01e-4)" "unprognostic (6.95e-3)" "unprognostic (2.45e-1)" "unprognostic (1.09e-1)" "unprognostic (3.69e-1)" "unprognostic (2.39e-1)" "unprognostic (7.17e-2)" "unprognostic (5.07e-3)" "unprognostic (1.28e-1)" "unprognostic (2.32e-2)" "unprognostic (3.19e-1)" "unprognostic (2.33e-1)" "unprognostic (2.77e-2)" "prognostic favorable (5.30e-4)" 2.5 3.6 5.0 1.8 6.5 2.1 4.6 2.6 8.5 1.9 3.3 7.1 1.7 3.2 2.0 6.1 2.4 3.5 2.7 3.9 5.0 5.1 1.9 9.0 5.1 4.7 5.4 3.9 3.5 12.2 2.4 2.8 1.0 5.2 3.4 3.0 3.3 5.1 2.8 5.2 8.5 4.3 1.8 5.4 2.4 3.0 2.1 3.8 2.4 3.6 0.9 1.8 2.5 1.8 3.3 7.2 0.6 7.2 2.2 2.5 2.6 3.3 2.0 0.8 0.1 1.8 1.7 0.0 3.5 1.1 1.3 0.7 0.1 2.8 0.1 9.2 2.5 0.2 4.0 0.0 2.2 1.0 0.1 1.2 0.5 1.1 0.2 2.8 0.0 2.2 2.9 3.4 1.3 1.2 0.8 2.8 0.0 7.8 0.1 2.8 3.6 0.0 0.0 0.0 0.4 2.0 0.0 0.0 0.1 1.9 3.6 8.2 0.1 6.9 5.8 2.0 0.8 4.2 2.2 0.5 0.2 1.8 2.4 0.0 0.1 0.0 0.1 0.1 0.0 3.5 0.5 6.6 0.6 1.1 7.2 1.2 3.3 1.7 0.8 7.2 2.3 2.5 1.6 0.5 2.2 3.2 0.9 1.8 2.6 5.0 6.5 2.6 8.5 5.0 5.1 5.4 3.9 5.2 3.8 0.0 2.1 0.0 1.0 1.6 0.1 0.4 0.0 0.0 2.3 0.0 0.0 0.3 0.0 2.0 0.0 0.0 0.3 0.0 3.2 0.0 0.2 0.1 1.1 1.0 1.1 0.0 3.4 0.0 0.6 0.0 0.6 0.9 1.7 0.0 0.0 0.5 1.7 0.0 0.0 1.1 1.1 0.0 0.4 0.2 0.0 1.6 0.3 0.0 0.4 0.3 NIF3L1 "ALS2CR1, CALS-7, MDS015" ENSG00000196290 "NGG1 interacting factor 3 like 1" Q9GZT8 2 200889327-200903930 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036335, HPA036336, HPA061466" Supported Approved Vesicles NA NA 8700000 Vesicles "HPA036335: AB_10696654, HPA036336: AB_2675068, HPA061466: AB_2684532" "unprognostic (6.61e-2)" "unprognostic (1.16e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (9.52e-5)" "unprognostic (2.48e-2)" "unprognostic (5.92e-2)" "prognostic unfavorable (2.51e-6)" "unprognostic (1.94e-1)" "unprognostic (8.53e-3)" "unprognostic (6.75e-3)" "unprognostic (3.12e-2)" "unprognostic (2.65e-2)" "unprognostic (6.09e-2)" "unprognostic (1.16e-1)" "unprognostic (2.83e-1)" "unprognostic (6.04e-3)" "unprognostic (8.61e-2)" 12.8 21.6 14.4 17.8 29.1 7.2 19.6 21.1 31.0 14.9 16.9 19.3 10.0 12.9 16.0 21.8 17.2 18.4 11.5 16.5 19.6 14.2 19.5 17.6 12.1 19.0 15.1 13.4 17.8 15.6 20.8 12.0 18.0 25.6 14.3 22.9 16.3 16.5 17.0 21.4 16.8 15.2 15.2 17.9 18.7 16.2 15.2 13.2 20.8 16.3 15.8 24.8 15.1 12.4 20.3 18.5 32.6 21.3 20.2 23.9 14.4 15.0 16.3 26.7 16.3 12.2 15.4 18.3 16.6 17.8 35.4 28.7 25.5 17.5 12.1 16.1 14.1 25.6 16.7 37.8 21.8 38.2 16.1 35.9 18.2 29.0 27.1 11.0 21.4 12.6 12.9 21.2 23.3 22.4 16.1 11.7 25.7 26.5 12.4 20.8 19.8 26.1 26.8 31.3 17.2 29.0 15.7 14.9 23.7 18.7 15.8 16.9 20.0 14.2 14.6 19.6 39.5 14.4 19.6 6.0 17.2 16.1 15.2 14.9 11.4 21.5 26.4 16.6 17.6 16.3 32.6 14.5 18.4 18.3 21.3 19.2 20.3 21.1 23.2 17.8 15.6 23.9 19.7 4.9 20.2 17.8 18.5 19.2 14.4 14.4 29.1 21.1 31.0 19.6 14.2 15.1 13.4 25.6 13.2 0.0 6.5 13.7 7.4 3.3 24.4 11.8 2.5 24.1 15.9 5.2 13.7 27.3 13.3 17.0 6.8 5.0 6.4 0.0 16.0 31.4 5.1 4.9 9.2 8.6 15.1 17.5 1.7 7.4 6.3 4.5 15.0 9.6 5.0 20.8 10.2 17.8 11.7 10.5 18.0 14.0 24.0 6.5 6.7 27.0 21.8 7.2 18.9 6.7 11.0 4.3 NKG7 "GIG1, GMP-17" ENSG00000105374 "Natural killer cell granule protein 7" Q16617 19 51371606-51372715 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 270.6;bone marrow: 108.2" "Cell type enriched" "Detected in many" 16 "T-cells: 1698.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 270.6;MAIT T-cell: 113.5;memory CD8 T-cell: 168.7;naive CD8 T-cell: 130.3;NK-cell: 166.7" "Group enriched" "Detected in all" 46 "NK-cells: 166.7;T-cells: 270.6" "Group enriched" "Detected in some" 5 "NB-4: 60.2;THP-1: 17.9;U-937: 15.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA071454 Approved Vesicles NA NA Vesicles "HPA071454: AB_2686399" "unprognostic (1.56e-2)" "unprognostic (1.05e-2)" "unprognostic (6.54e-2)" "prognostic favorable (7.42e-6)" "unprognostic (1.27e-2)" "unprognostic (3.25e-3)" "unprognostic (2.96e-3)" "unprognostic (2.14e-1)" "unprognostic (3.22e-3)" "unprognostic (3.89e-3)" "unprognostic (3.39e-1)" "unprognostic (9.93e-2)" "prognostic unfavorable (3.32e-6)" "unprognostic (7.62e-3)" "unprognostic (2.61e-1)" "unprognostic (1.30e-2)" "unprognostic (6.44e-3)" 7.4 1.8 1.3 11.2 1.7 108.2 3.3 0.7 1.0 2.9 2.2 0.8 0.4 2.2 5.4 6.3 3.8 1.8 10.6 6.0 1.2 1.2 3.2 9.4 26.1 31.0 2.3 0.7 4.1 2.6 0.0 1.8 9.3 1.3 6.8 1.6 6.2 3.5 0.9 5.6 1.0 7.6 2.5 2.8 63.3 2.5 1.9 0.2 7.3 3.1 2.0 16.0 5.1 2.3 1.1 3.2 4.5 4.7 166.7 270.6 141.5 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.6 0.2 0.0 0.0 6.4 1.2 0.0 0.0 0.1 0.0 0.1 0.0 0.8 0.1 0.2 0.0 0.0 0.7 60.2 0.0 0.0 0.1 1.4 3.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 17.9 0.1 0.0 0.0 0.2 0.0 0.9 0.2 0.3 0.0 15.6 0.0 2.2 1.3 0.5 270.6 4.7 113.5 1.1 34.1 168.7 3.2 0.5 11.5 130.3 4.5 166.7 3.6 2.5 0.6 141.5 1.3 1.7 0.7 1.0 1.2 1.2 2.3 0.7 1.3 0.2 3.0 10.1 16.0 0.0 4.4 0.0 0.4 10.2 1.4 2.3 5.2 0.0 0.4 3.3 0.0 0.0 2.8 0.3 0.0 0.0 0.4 2.3 0.0 24.2 3.4 12.4 0.0 0.0 45.4 103.5 0.0 0.0 26.0 16.9 1.8 0.0 0.0 0.0 0.3 0.0 6.9 0.0 0.0 0.5 0.0 0.2 5.6 0.9 1698.3 0.0 0.1 NME6 "IPIA-ALPHA, NM23-H6" ENSG00000172113 "NME/NM23 nucleoside diphosphate kinase 6" O75414 3 48290722-48301685 "Enzymes, Predicted intracellular proteins" "Apoptosis, Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017909 Approved Approved Vesicles NA NA Vesicles "HPA017909: AB_1854530" "unprognostic (7.31e-3)" "unprognostic (1.87e-1)" "unprognostic (8.19e-3)" "unprognostic (2.09e-2)" "unprognostic (8.52e-2)" "unprognostic (2.20e-1)" "prognostic unfavorable (2.17e-7)" "unprognostic (1.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.00e-3)" "unprognostic (1.32e-1)" "unprognostic (2.98e-1)" "prognostic favorable (3.18e-5)" "unprognostic (1.98e-2)" "unprognostic (1.57e-2)" "unprognostic (1.23e-1)" "unprognostic (9.50e-2)" 11.7 12.2 7.0 14.4 11.0 7.7 13.5 9.2 10.9 12.2 12.0 11.9 14.6 13.5 16.1 13.2 16.1 16.3 8.8 13.7 9.9 6.8 18.0 17.5 11.1 12.9 9.2 10.3 14.5 20.6 12.1 13.3 22.1 8.8 13.2 12.7 13.5 20.8 17.6 20.1 10.3 13.4 13.3 7.1 14.2 13.4 9.0 8.2 12.6 17.5 14.3 15.1 13.9 15.7 26.4 23.5 43.3 22.7 23.0 25.8 14.3 17.9 11.2 15.3 11.1 12.5 16.8 13.7 17.6 13.6 25.9 19.7 18.7 15.8 18.1 9.2 13.7 24.3 6.3 13.7 19.4 15.4 21.6 13.3 11.8 15.0 15.2 16.7 14.9 12.7 13.7 21.3 23.0 27.4 12.4 13.9 13.7 19.7 14.0 9.7 8.5 12.5 6.4 12.9 12.7 14.7 7.4 13.4 15.2 13.0 15.5 4.7 8.1 12.0 13.2 15.7 12.4 14.8 13.9 12.4 5.1 20.4 12.7 25.0 16.6 22.4 16.3 9.7 19.8 11.3 22.0 20.1 43.3 25.8 20.7 23.6 26.4 24.2 21.9 23.5 24.4 18.7 17.7 22.5 23.0 22.7 21.1 19.4 14.3 7.0 11.0 9.2 10.9 9.9 6.8 9.2 10.3 8.8 8.2 26.8 20.2 17.6 7.9 4.4 12.2 9.2 20.4 44.2 21.6 8.7 13.7 42.3 33.2 22.4 1.9 8.3 11.2 0.0 26.1 34.3 7.8 7.3 9.3 8.3 29.6 9.5 4.1 6.7 6.7 1.5 10.9 12.4 15.1 29.7 8.8 14.6 25.4 7.0 6.7 12.8 12.2 12.9 7.4 9.1 13.2 3.6 16.5 13.8 12.8 5.9 NOV "CCN3, IGFBP9" ENSG00000136999 "Nephroblastoma overexpressed" P48745 8 119416306-119424353 "Plasma proteins, Predicted secreted proteins, Transporters" "Growth factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "adrenal gland: 236.7" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 36.6;granulocytes: 23.1;Melanocytes: 74.2" "Cancer enhanced" "Detected in all" "melanoma: 62.7" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 113 "eosinophil: 28.1;neutrophil: 14.0" "Lineage enriched" "Detected in single" 151 "granulocytes: 28.1" "Cell line enhanced" "Detected in many" "BJ hTERT+: 43.7;hTERT-RPE1: 13.6;U-2197: 45.2" "Group enriched" "Detected in many" 7 "amygdala: 134.6;basal ganglia: 51.6;cerebral cortex: 101.0;hippocampal formation: 166.1" "Low region specificity" "Detected in many" "HPA018449, HPA019684, CAB034423" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 269000000 2900000 Vesicles "CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190" "unprognostic (5.04e-2)" "unprognostic (1.01e-1)" "unprognostic (7.36e-3)" "unprognostic (1.30e-3)" "unprognostic (9.35e-3)" "unprognostic (4.92e-1)" "unprognostic (8.10e-2)" "unprognostic (6.04e-2)" "unprognostic (1.79e-2)" "unprognostic (9.17e-2)" "unprognostic (1.67e-1)" "unprognostic (3.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.74e-3)" "unprognostic (1.51e-1)" "unprognostic (1.98e-1)" "unprognostic (2.72e-2)" 6.3 236.7 2.2 1.4 7.9 1.0 5.6 3.1 12.3 5.0 2.0 3.6 3.6 1.5 5.8 2.9 1.9 3.0 2.0 5.7 3.5 1.9 4.9 0.9 2.9 1.1 2.1 15.1 1.8 2.7 2.1 13.4 0.8 7.4 5.6 2.2 1.2 1.2 5.0 1.6 3.6 1.5 2.5 2.5 1.0 1.6 2.6 0.0 0.0 6.9 4.8 1.1 3.3 2.5 0.0 0.1 28.1 0.1 0.0 0.0 0.0 0.0 1.0 0.6 0.0 4.0 1.0 0.0 5.8 43.7 5.3 3.0 0.0 0.1 0.0 4.6 7.3 4.1 3.6 0.2 0.0 1.8 0.0 0.1 0.0 3.4 0.0 0.1 0.0 0.0 0.2 0.0 2.0 0.2 13.6 0.1 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 8.7 0.0 0.0 0.0 5.6 0.0 1.3 0.0 2.1 0.0 8.1 0.0 0.0 0.0 0.0 3.8 5.8 45.2 1.2 0.0 0.0 0.0 6.0 1.8 4.3 0.0 0.1 28.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 2.2 7.9 3.1 12.3 3.5 1.9 2.1 15.1 7.4 0.0 0.0 1.1 0.0 0.6 16.7 0.0 1.2 0.0 2.7 2.3 36.6 0.0 0.0 0.0 7.2 0.0 12.6 0.3 0.0 1.0 0.0 15.4 14.0 23.1 0.0 1.4 3.2 9.2 0.6 1.2 0.0 2.8 0.4 74.2 0.0 1.3 0.0 0.6 2.9 0.7 0.0 0.2 0.0 20.8 0.0 0.0 14.8 0.1 0.0 9.8 0.9 NOX3 GP91-3 ENSG00000074771 "NADPH oxidase 3" Q9HBY0 6 155395370-155455903 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "adrenal gland: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "MCF7: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA073837 Uncertain Vesicles NA NA Vesicles "HPA073837: " "unprognostic (3.42e-1)" 0.0 1.8 0.4 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.6 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NOXA1 "FLJ25475, NY-CO-31, SDCCAG31" ENSG00000188747 "NADPH oxidase activator 1" Q86UR1 9 137423350-137434406 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 34.1;Paneth cells: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 10.6;EFO-21: 9.8;MCF7: 16.2;T-47d: 15.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA044781 Uncertain Approved Vesicles NA NA Vesicles "HPA044781: AB_10960532" "unprognostic (2.15e-1)" "unprognostic (2.86e-1)" "unprognostic (1.55e-3)" "unprognostic (1.42e-3)" "unprognostic (4.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.79e-1)" "unprognostic (3.99e-3)" "unprognostic (2.72e-1)" "unprognostic (1.69e-1)" "unprognostic (5.45e-3)" "unprognostic (1.97e-3)" "prognostic favorable (2.65e-4)" "unprognostic (4.97e-3)" "unprognostic (2.67e-1)" "unprognostic (1.74e-1)" "unprognostic (3.10e-2)" 5.1 7.1 8.5 13.9 13.0 3.8 5.9 9.9 11.8 8.9 16.0 7.5 14.5 23.2 8.4 15.7 11.9 8.2 19.7 3.8 7.5 9.7 11.0 9.2 8.6 4.7 5.1 10.1 9.0 17.4 10.4 13.4 2.1 5.2 8.4 5.2 10.0 25.2 11.3 11.6 21.8 22.6 3.9 4.2 7.8 21.1 3.4 4.0 2.5 10.8 8.1 11.3 5.9 6.5 0.4 1.7 0.1 5.5 1.6 1.0 0.4 1.6 4.2 0.1 3.3 0.4 0.0 2.2 0.3 0.5 0.1 0.2 0.7 10.6 0.0 9.8 0.1 0.6 7.1 0.1 0.2 0.0 4.5 3.6 0.0 2.5 1.5 1.0 0.1 2.1 0.3 2.3 0.0 0.1 1.9 0.2 0.0 0.6 0.7 0.0 16.2 0.0 0.9 0.2 4.3 1.4 0.1 0.0 6.2 2.8 3.6 0.9 0.3 0.2 1.7 1.7 0.2 15.9 1.4 1.1 0.2 2.3 2.4 0.3 0.7 0.0 0.0 0.3 0.6 0.5 0.0 1.2 0.1 0.1 1.8 0.5 0.4 0.1 0.0 1.7 0.2 0.4 1.0 0.0 1.6 5.5 0.0 0.0 0.4 8.5 13.0 9.9 11.8 7.5 9.7 5.1 10.1 5.2 4.0 0.0 4.8 0.8 6.7 3.1 8.6 1.0 10.2 4.0 4.5 12.2 7.9 0.2 6.6 6.1 0.0 1.5 34.1 23.3 9.7 0.4 1.0 5.5 2.3 5.7 4.7 3.2 6.4 1.3 3.3 0.0 1.1 5.0 8.5 2.8 19.0 9.6 6.6 28.1 0.7 15.9 7.8 6.5 2.0 4.3 3.6 3.6 0.2 3.2 19.7 5.8 NPHP1 "JBTS4, NPH1, SLSN1" ENSG00000144061 "Nephrocystin 1" O15259 2 110122311-110205066 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Differentiation, Spermatogenesis" "Ciliopathy, Disease mutation, Joubert syndrome, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 36.7" "Cell type enhanced" "Detected in many" 10 "Ciliated cells: 172.6;Early spermatids: 98.9;Rod photoreceptor cells: 72.4;Spermatocytes: 129.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046093, HPA074071" Approved Uncertain Vesicles NA NA Vesicles "HPA046093: AB_2679535, HPA074071: " "unprognostic (2.10e-2)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "unprognostic (1.38e-1)" "unprognostic (5.58e-2)" "unprognostic (4.63e-2)" "unprognostic (1.56e-3)" "unprognostic (4.66e-2)" "unprognostic (1.64e-2)" "unprognostic (1.16e-1)" "unprognostic (1.66e-2)" "unprognostic (1.29e-2)" "unprognostic (1.08e-1)" "unprognostic (2.93e-3)" "unprognostic (3.35e-2)" "unprognostic (1.82e-1)" "unprognostic (8.64e-2)" 3.1 4.3 8.5 1.8 13.7 0.8 5.1 2.1 7.2 5.6 4.7 4.9 8.8 1.7 7.2 11.3 2.1 19.3 4.3 4.4 9.0 7.5 8.7 1.5 5.7 1.5 3.8 6.2 5.4 3.5 17.7 28.1 2.1 20.3 4.4 2.6 4.6 2.8 8.9 36.7 1.7 1.8 7.2 5.4 1.9 3.7 25.0 7.2 0.0 8.9 3.2 1.3 4.1 3.7 3.5 1.0 1.0 0.3 3.2 1.8 0.7 8.5 2.7 5.7 4.2 3.2 6.8 1.2 2.2 7.1 7.7 7.6 2.8 6.4 0.5 5.7 5.1 7.3 4.2 2.7 6.9 9.2 1.6 3.4 0.2 1.6 1.9 4.5 1.3 0.0 4.6 4.2 12.0 3.8 11.6 4.8 1.8 0.1 0.8 4.6 1.7 0.8 2.1 2.5 0.2 4.5 0.0 5.9 0.2 13.0 0.7 3.0 3.1 3.2 3.9 7.8 2.9 4.6 1.0 3.1 4.5 3.8 4.9 7.0 2.4 2.5 0.6 13.1 0.2 3.2 0.7 0.1 0.1 1.2 0.3 1.8 2.7 0.9 0.6 1.0 3.5 1.8 1.4 1.0 3.2 0.1 0.1 0.1 0.7 8.5 13.7 2.1 7.2 9.0 7.5 3.8 6.2 20.3 7.2 6.0 6.2 0.9 7.4 4.6 11.8 11.8 7.6 172.6 30.7 8.7 45.2 1.5 16.6 12.1 98.9 6.7 0.0 0.0 4.4 0.4 4.6 3.5 0.0 2.4 1.3 20.6 0.0 7.4 1.0 44.3 6.9 2.3 6.8 0.0 0.5 10.9 6.3 0.2 9.2 21.1 72.4 12.9 3.9 129.6 24.9 3.4 0.2 1.0 1.8 4.7 NREP "C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17" ENSG00000134986 "Neuronal regeneration related protein" Q16612 5 111662621-111997464 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 149.5" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 82.5;Cytotrophoblasts: 84.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 149.5" "Group enriched" "Detected in many" 5 "myeloid DC: 16.0;NK-cell: 4.1;plasmacytoid DC: 16.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 70.3;SH-SY5Y: 76.1" HPA000545 Approved Approved Vesicles NA NA Vesicles "HPA000545: AB_1845721" "unprognostic (2.85e-2)" "unprognostic (1.00e-2)" "unprognostic (2.30e-1)" "unprognostic (1.48e-3)" "unprognostic (4.37e-1)" "unprognostic (2.26e-1)" "unprognostic (8.16e-3)" "unprognostic (1.58e-1)" "unprognostic (6.45e-3)" "unprognostic (1.32e-1)" "unprognostic (3.76e-2)" "unprognostic (2.02e-1)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.84e-2)" "unprognostic (3.47e-3)" "unprognostic (5.76e-3)" 4.2 14.4 14.1 5.0 21.9 7.1 6.4 149.5 45.5 8.2 8.5 6.7 4.3 3.5 21.7 4.1 5.2 4.6 16.0 17.2 15.7 10.5 11.7 11.7 6.3 3.3 11.0 21.5 10.4 2.9 1.7 5.0 28.2 27.8 13.1 5.9 16.1 8.3 18.2 39.6 4.7 3.9 13.1 8.0 8.3 5.6 3.0 4.3 34.1 4.7 8.6 3.8 7.4 6.4 0.9 16.2 0.0 2.6 4.1 1.1 1.4 0.1 1.1 70.3 14.9 3.3 7.9 3.3 23.4 13.9 22.2 36.9 0.1 0.4 11.5 7.3 11.3 3.1 0.0 14.6 0.8 11.5 4.6 2.1 9.0 5.9 12.4 4.7 11.9 0.1 7.6 3.7 21.5 7.4 52.5 25.1 13.1 0.1 1.2 23.1 0.2 47.4 8.4 39.8 0.0 5.4 51.0 28.4 3.1 8.5 0.2 16.0 76.1 5.1 0.3 0.5 38.6 2.9 33.1 4.9 27.1 9.1 13.2 2.5 5.6 4.5 14.6 6.0 25.3 5.3 0.0 2.6 0.0 0.0 1.3 0.0 0.9 0.1 0.1 16.0 0.8 0.8 1.1 0.0 4.1 0.6 16.2 0.0 1.4 14.1 21.9 149.5 45.5 15.7 10.5 11.0 21.5 27.8 4.3 6.0 25.0 2.7 1.4 16.1 66.2 29.9 10.2 0.0 9.1 12.2 82.5 84.9 28.2 13.3 2.0 15.7 1.1 0.0 4.9 16.2 34.0 0.8 4.7 8.5 30.5 19.1 20.7 33.7 14.5 0.8 7.8 6.9 13.5 1.8 7.6 12.1 7.6 0.0 21.9 42.5 28.6 12.9 22.3 0.9 11.3 11.0 26.3 4.9 10.7 0.1 NRG3 ENSG00000185737 "Neuregulin 3" P56975 10 81875314-82987179 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.6" "Group enriched" "Detected in some" 5 "Bipolar cells: 13.7;Cholangiocytes: 5.1;Early spermatids: 17.6;Ito cells: 7.4;Late spermatids: 7.9;Muller glia cells: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.5;HEK 293: 3.4;HUVEC TERT2: 1.7;SK-MEL-30: 7.3;U-2 OS: 6.4" "Low region specificity" "Detected in all" HPA075789 Uncertain Vesicles "Secreted in brain" NA NA Vesicles "HPA075789: " "unprognostic (6.15e-3)" "unprognostic (2.43e-2)" "unprognostic (1.65e-5)" "unprognostic (1.89e-1)" "unprognostic (7.03e-4)" "unprognostic (1.85e-2)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" "unprognostic (9.33e-2)" "unprognostic (1.82e-1)" "unprognostic (1.21e-1)" "unprognostic (3.75e-2)" "unprognostic (3.31e-4)" "unprognostic (1.04e-1)" "unprognostic (7.68e-3)" "unprognostic (7.27e-4)" 0.9 1.5 15.6 1.2 8.2 0.6 2.8 1.9 30.6 0.8 0.9 4.8 0.0 0.8 0.7 0.7 0.9 8.0 5.3 0.9 14.5 6.2 1.2 1.5 1.6 0.8 4.9 8.0 0.7 0.9 0.7 1.6 1.2 6.5 0.9 0.9 3.1 5.0 1.1 0.7 0.8 0.9 0.9 5.6 0.8 0.8 3.3 6.0 0.0 0.9 0.0 0.8 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 0.0 7.3 0.5 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.6 8.2 1.9 12.8 14.5 6.2 4.9 8.0 6.5 6.0 0.0 0.0 0.0 0.0 0.0 13.7 0.8 5.1 0.0 0.0 0.0 2.0 0.0 0.0 0.9 17.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 7.9 0.6 0.0 0.0 0.0 0.0 5.4 0.1 0.0 0.7 0.0 1.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.1 NSUN7 FLJ14001 ENSG00000179299 "NOP2/Sun RNA methyltransferase family member 7" Q8NE18 4 40749897-40809985 "Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.5" "Cell type enhanced" "Detected in many" 9 "Ciliated cells: 48.2;Early spermatids: 34.5;Late spermatids: 53.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 5 "neutrophil: 6.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 6.1" "Cell line enhanced" "Detected in some" "A-431: 3.9;CAPAN-2: 8.6;Karpas-707: 6.3;MCF7: 4.1;RPTEC TERT1: 4.2;SuSa: 5.1;T-47d: 6.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA020653 Uncertain Approved Vesicles NA NA Vesicles "HPA020653: AB_1848710" "unprognostic (2.32e-1)" "unprognostic (4.22e-1)" "unprognostic (4.77e-2)" "unprognostic (1.50e-1)" "unprognostic (2.79e-2)" "unprognostic (1.47e-1)" "unprognostic (1.63e-1)" "unprognostic (4.01e-3)" "unprognostic (4.37e-2)" "unprognostic (3.06e-1)" "unprognostic (2.24e-1)" "unprognostic (8.42e-2)" "prognostic favorable (2.76e-8)" "unprognostic (3.69e-2)" "unprognostic (1.15e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-2)" 0.7 1.2 0.9 2.8 2.0 0.7 5.1 0.2 1.0 3.2 7.0 2.4 7.3 2.3 5.9 9.7 4.5 9.1 5.4 5.5 1.0 1.9 6.6 0.7 8.1 4.2 1.0 0.5 4.6 14.1 7.7 7.5 2.8 2.6 5.7 3.2 4.3 15.2 10.3 0.1 1.9 6.7 2.6 1.8 3.6 3.8 39.5 0.2 2.4 11.9 1.5 5.3 3.7 1.5 1.1 0.0 6.1 0.1 0.0 0.0 0.0 3.9 0.4 1.9 0.0 0.0 0.0 2.9 0.0 0.3 0.2 0.2 1.5 8.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 6.3 0.0 4.1 0.1 0.0 2.3 0.0 0.5 0.1 0.1 0.0 4.2 1.1 1.0 2.3 0.6 2.7 0.0 5.1 6.3 0.0 0.2 0.0 3.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.1 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.9 2.0 0.2 1.0 1.0 1.9 1.0 0.5 2.6 0.2 8.9 5.6 0.0 3.3 1.0 0.0 3.7 0.0 48.2 15.9 8.7 0.0 7.5 8.3 4.4 34.5 0.3 2.1 0.0 4.7 2.8 0.5 4.2 0.0 0.0 3.0 0.0 7.9 0.6 0.3 53.6 1.4 0.7 0.0 1.8 5.8 2.0 5.3 0.0 0.0 5.2 0.0 0.0 0.3 22.8 12.4 0.9 3.8 0.5 7.5 4.3 NTF3 NGF2 ENSG00000185652 "Neurotrophin 3" P20783 12 5432112-5521536 "Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.2" "Cell type enhanced" "Detected in some" 10 "Basal glandular cells: 26.7;Basal keratinocytes: 16.5;Sertoli cells: 32.3;Smooth muscle cells: 32.7" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 16 "cerebellum: 29.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 9.2;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 16.2;HBF TERT88: 15.0;RT4: 6.8" "Group enriched" "Detected in many" 5 "amygdala: 4.1;basal ganglia: 7.4;cerebellum: 12.3;hippocampal formation: 12.3" "Low region specificity" "Detected in all" HPA032001 Uncertain Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA032001: AB_2674106" "unprognostic (3.04e-2)" "unprognostic (7.46e-2)" "unprognostic (7.33e-3)" "unprognostic (4.66e-3)" "unprognostic (8.89e-2)" "unprognostic (1.08e-2)" "unprognostic (1.36e-3)" "unprognostic (7.68e-2)" "unprognostic (1.35e-1)" "unprognostic (2.14e-1)" "unprognostic (1.86e-1)" "unprognostic (2.20e-1)" "unprognostic (7.77e-4)" "unprognostic (4.02e-3)" "unprognostic (1.92e-1)" "unprognostic (8.06e-3)" "unprognostic (4.51e-3)" 4.9 2.7 0.5 2.4 0.5 0.0 5.4 29.2 0.6 12.9 4.7 0.3 5.6 2.7 9.2 6.8 5.0 2.2 5.3 4.1 1.7 0.2 4.3 10.4 2.5 1.0 0.7 0.2 16.8 0.4 0.1 1.3 2.7 1.2 8.9 1.5 8.9 4.6 3.7 3.6 3.7 6.6 11.5 0.4 8.5 3.0 3.5 0.0 0.2 1.2 3.9 2.0 10.4 9.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.5 0.0 0.0 0.0 0.0 3.4 9.2 12.1 16.2 0.1 0.2 0.0 5.5 5.7 0.0 2.0 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 3.6 3.8 6.8 0.2 0.0 0.0 0.1 0.0 3.4 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 29.2 0.6 1.7 0.2 0.7 0.2 1.2 0.0 0.0 0.0 0.0 26.7 16.5 0.0 0.6 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.1 5.2 4.7 0.0 2.4 0.0 0.0 0.0 8.0 0.0 0.0 7.8 0.9 6.8 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 32.3 32.7 0.6 0.7 2.9 0.1 0.0 0.0 3.9 NTS ENSG00000133636 Neurotensin P30990 12 85874295-85882992 "Predicted secreted proteins" Vasoactive "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "intestine: 115.3" "Cell type enhanced" "Detected in some" 19 "Club cells: 27.3;Collecting duct cells: 8.7;Ito cells: 11.1" "Cancer enhanced" "Detected in many" "lung cancer: 155.1" "Group enriched" "Detected in many" 4 "hippocampal formation: 10.3;hypothalamus: 22.1;midbrain: 6.3;pons and medulla: 25.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 70.4" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "basal ganglia: 81.8" "HPA026664, HPA071012" Enhanced Supported Vesicles "Secreted to digestive system" NA NA 120000 Vesicles "HPA026664: AB_2671936, HPA071012: " "unprognostic (3.63e-1)" "prognostic favorable (9.94e-5)" "unprognostic (8.18e-2)" "prognostic unfavorable (5.10e-4)" "unprognostic (1.99e-2)" "unprognostic (3.04e-1)" "unprognostic (7.62e-2)" "unprognostic (2.43e-1)" "unprognostic (1.53e-3)" "unprognostic (8.83e-2)" "unprognostic (1.74e-2)" "unprognostic (3.76e-2)" "unprognostic (1.30e-6)" "unprognostic (2.94e-2)" "unprognostic (2.25e-1)" "unprognostic (2.17e-1)" "unprognostic (7.48e-2)" 2.9 0.6 3.9 1.4 3.2 0.1 2.5 0.3 0.4 0.5 5.2 2.5 0.0 2.8 0.2 1.6 2.5 0.5 0.8 0.8 10.3 22.1 0.9 0.7 2.0 15.1 6.3 0.1 0.7 0.4 0.1 15.0 0.3 25.0 0.4 0.7 0.0 1.6 0.5 0.1 0.1 115.3 0.5 2.7 0.2 18.8 0.3 0.4 0.1 0.9 0.8 1.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 1.3 0.0 0.5 0.0 0.0 0.0 1.7 0.5 0.0 0.0 0.0 70.4 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 3.2 0.3 0.4 10.3 22.1 6.3 0.1 25.0 0.4 0.0 0.3 0.0 0.4 1.1 0.0 0.3 0.0 5.3 27.3 8.7 0.0 0.2 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.2 0.2 2.8 0.0 0.0 0.2 0.0 2.4 11.1 0.8 0.0 0.0 0.0 1.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.5 0.0 1.9 0.1 0.0 0.0 1.1 OLFM3 NOE3 ENSG00000118733 "Olfactomedin 3" Q96PB7 1 101802574-101997030 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "brain: 30.0" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 25.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "AF22: 9.5;HAP1: 6.6;HEL: 5.8;SCLC-21H: 3.8;SH-SY5Y: 3.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050297 Uncertain Vesicles "Secreted in brain" NA NA Vesicles "HPA050297: " "unprognostic (4.19e-1)" "unprognostic (4.19e-4)" "unprognostic (1.26e-1)" "unprognostic (4.61e-2)" "unprognostic (2.93e-1)" "unprognostic (1.47e-2)" "unprognostic (3.58e-4)" "unprognostic (2.48e-1)" "unprognostic (5.68e-2)" 0.7 3.2 5.0 1.4 13.7 0.7 0.8 24.2 30.0 0.9 1.8 0.4 0.0 1.0 0.9 1.2 0.7 0.8 0.8 0.7 4.8 7.4 1.5 0.8 0.7 0.7 6.0 11.9 0.8 0.7 0.7 2.4 0.8 16.6 0.7 1.7 0.3 0.8 0.7 0.7 0.7 2.1 1.3 1.5 0.9 1.0 0.9 0.7 0.0 1.2 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.3 0.0 0.0 3.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 13.7 24.2 26.7 4.8 7.4 6.0 11.9 16.6 0.7 0.0 0.0 0.0 0.0 0.0 25.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OLFML3 "HNOEL-iso, OLF44" ENSG00000116774 "Olfactomedin like 3" Q9NRN5 1 113979391-114035572 "Predicted intracellular proteins, Predicted secreted proteins" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 18 "Fibroblasts: 177.9;Ito cells: 73.6;Leydig cells: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "myeloid DC: 5.4" "Lineage enriched" "Detected in single" 11 "dendritic cells: 5.4" "Cell line enhanced" "Detected in many" "ASC diff: 84.8;ASC TERT1: 46.4;BJ hTERT+: 52.9;HSkMC: 84.8;LHCN-M2: 84.6" "Low region specificity" "Detected in many" HPA027991 Supported Vesicles "Secreted to extracellular matrix" NA NA 1500000 Vesicles "HPA027991: AB_2732440" "unprognostic (1.04e-1)" "unprognostic (8.06e-2)" "unprognostic (1.87e-1)" "unprognostic (1.50e-2)" "unprognostic (1.41e-1)" "unprognostic (1.50e-1)" "unprognostic (2.02e-1)" "unprognostic (3.72e-1)" "unprognostic (1.67e-1)" "unprognostic (3.04e-2)" "unprognostic (1.43e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (3.45e-5)" "unprognostic (6.80e-3)" "unprognostic (1.88e-1)" "unprognostic (2.61e-1)" "unprognostic (4.41e-3)" 25.8 11.8 3.9 9.7 6.6 0.0 25.6 1.4 7.9 75.3 22.7 16.2 17.9 3.9 57.7 41.8 13.8 33.9 31.5 20.3 3.0 2.3 9.7 9.4 18.4 5.7 7.1 4.0 52.6 11.7 1.0 6.6 29.1 8.9 33.1 9.6 41.4 6.1 21.9 5.8 13.5 10.8 29.4 5.1 2.5 19.1 13.3 4.6 0.6 7.8 15.0 7.0 28.0 37.6 0.0 5.4 0.0 0.4 0.0 0.0 0.2 0.0 2.7 1.4 0.0 84.8 46.4 0.0 10.8 52.9 3.7 12.3 3.5 0.0 0.0 0.6 31.0 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.0 0.0 2.6 22.0 0.0 0.0 84.8 0.0 5.3 0.0 1.5 0.3 0.0 0.0 0.0 84.6 0.0 0.0 0.0 6.4 0.0 0.1 0.0 20.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.4 21.4 31.4 0.1 0.2 2.1 4.0 0.8 0.0 0.0 0.0 0.0 1.0 0.0 13.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 3.9 6.6 1.4 7.9 3.0 2.3 7.1 4.0 8.9 4.6 0.0 5.9 0.5 0.1 11.6 0.0 1.4 2.5 0.0 1.2 1.8 0.0 5.6 0.0 0.6 1.5 3.5 0.0 0.0 0.0 5.0 177.9 1.1 1.1 0.2 33.4 0.0 5.8 73.6 5.0 1.1 67.9 3.6 11.8 1.0 0.2 0.0 0.4 0.0 31.1 0.5 0.0 0.0 37.3 0.2 0.4 10.0 10.4 0.7 0.0 0.3 OSBPL5 "KIAA1534, ORP5" ENSG00000021762 "Oxysterol binding protein like 5" Q9H0X9 11 3087116-3166739 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Horizontal cells: 58.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 3.1;gdT-cell: 9.3;intermediate monocyte: 4.4;memory CD8 T-cell: 3.4;myeloid DC: 2.7;naive CD8 T-cell: 3.6;NK-cell: 10.0;non-classical monocyte: 10.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "NB-4: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038335, HPA038712, HPA058727" Approved Enhanced Vesicles NA NA Vesicles "HPA038335: AB_2675963, HPA038712: AB_10675949, HPA058727: AB_2683799" "unprognostic (6.02e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (3.69e-2)" "unprognostic (8.22e-3)" "unprognostic (1.71e-1)" "unprognostic (1.25e-1)" "unprognostic (4.03e-3)" "unprognostic (1.29e-1)" "unprognostic (3.49e-3)" "unprognostic (2.16e-3)" "unprognostic (9.44e-2)" "unprognostic (2.78e-2)" "unprognostic (1.22e-1)" "unprognostic (6.50e-2)" "unprognostic (7.67e-2)" "unprognostic (2.60e-1)" 17.6 7.0 4.2 10.3 6.2 17.8 20.7 4.4 8.8 24.7 15.6 7.5 24.0 9.0 17.1 15.9 8.1 12.6 13.8 10.0 4.6 6.5 8.1 2.7 12.9 10.5 6.9 6.4 9.6 8.4 2.4 6.5 7.8 9.8 15.9 5.2 9.0 17.1 17.5 28.0 17.8 9.6 20.1 11.9 20.3 10.2 4.4 6.3 36.5 9.3 9.6 3.8 14.3 17.7 0.0 2.7 1.0 10.1 10.0 9.3 3.9 1.7 2.7 3.3 3.8 9.9 4.6 0.0 8.9 4.3 3.6 2.5 0.0 5.1 0.0 2.7 5.0 2.5 6.6 0.6 2.5 0.5 1.7 2.5 7.4 8.8 0.0 8.0 6.6 1.1 7.1 2.9 1.3 1.3 2.7 2.4 13.4 2.6 0.0 1.8 4.9 14.4 36.7 2.4 1.1 5.8 7.5 4.5 1.0 1.4 1.6 5.5 0.6 3.6 13.1 3.4 2.0 5.4 17.5 8.1 4.5 6.2 10.7 1.5 1.8 0.0 0.2 4.8 12.4 5.7 0.2 3.1 1.0 9.3 4.4 1.2 0.0 1.0 3.4 2.7 0.0 0.6 3.6 0.4 10.0 10.1 1.2 0.1 3.9 4.2 6.2 4.4 8.8 4.6 6.5 6.9 6.4 9.8 6.3 0.0 5.6 0.5 2.3 4.2 12.7 2.8 2.5 5.3 3.4 3.5 7.9 0.3 1.7 2.9 0.0 7.5 7.7 0.0 1.7 0.4 7.8 2.9 1.1 0.0 1.7 58.8 0.0 3.7 5.9 1.0 8.3 2.5 3.3 0.0 5.4 3.5 2.4 7.0 15.9 1.7 0.6 12.9 8.5 0.0 0.6 5.9 0.0 7.7 6.8 2.2 OXR1 TLDC3 ENSG00000164830 "Oxidation resistance 1" Q8N573 8 106359476-106752694 "Predicted intracellular proteins" "Stress response" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 193.0;Late spermatids: 328.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027375, HPA027380, HPA027395" Enhanced Approved Vesicles NA NA Vesicles "HPA027375: AB_10600087, HPA027380: AB_10601569, HPA027395: AB_10601554" "unprognostic (8.16e-3)" "unprognostic (1.39e-1)" "unprognostic (5.52e-2)" "unprognostic (3.12e-1)" "unprognostic (4.84e-2)" "unprognostic (2.84e-2)" "unprognostic (1.17e-1)" "unprognostic (3.67e-1)" "unprognostic (2.82e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.85e-4)" "unprognostic (6.59e-2)" "prognostic favorable (5.82e-5)" "unprognostic (1.89e-1)" "unprognostic (1.32e-1)" "unprognostic (2.58e-1)" "unprognostic (2.86e-1)" 18.3 34.2 20.5 14.1 14.6 9.3 16.8 31.2 50.2 19.0 13.9 7.3 34.8 7.9 16.2 33.4 22.0 13.0 12.6 21.4 23.6 23.0 17.9 21.4 15.0 11.4 22.6 18.8 15.9 10.0 15.0 45.7 9.9 25.9 17.5 12.6 7.2 25.3 30.3 26.4 16.1 10.4 12.7 22.8 15.3 15.2 29.1 14.6 15.5 15.2 17.3 10.5 24.1 21.2 8.7 8.1 20.8 13.3 7.8 12.6 5.5 12.3 4.7 14.0 2.8 20.6 24.9 6.5 10.2 12.0 9.5 12.3 4.1 14.9 12.2 11.8 10.8 5.8 8.8 7.7 8.8 16.1 10.5 8.8 16.8 6.8 7.6 11.1 5.1 9.8 13.8 13.6 10.2 15.3 13.3 10.3 10.4 8.4 46.1 10.6 11.0 15.2 7.2 1.8 17.7 8.4 4.2 11.3 22.8 10.7 15.6 8.4 2.6 4.5 3.1 10.6 6.3 14.8 8.8 7.9 10.7 7.6 9.6 6.4 8.7 5.5 5.2 12.7 1.6 13.0 20.8 6.5 12.4 3.0 12.4 5.0 8.7 5.2 4.7 8.1 5.8 12.6 5.5 3.4 7.8 13.3 5.8 3.7 5.5 20.5 14.6 31.2 50.2 23.6 23.0 22.6 18.8 25.9 14.6 62.5 21.0 29.0 51.7 60.0 77.0 51.5 17.8 56.2 31.8 33.2 55.0 25.1 28.2 13.9 193.0 42.2 23.1 0.0 14.9 16.8 31.9 52.5 30.0 30.4 16.9 25.4 26.4 41.7 33.5 328.3 31.7 33.5 23.6 13.6 28.7 52.4 19.1 31.7 46.0 9.1 123.6 19.4 39.2 143.6 50.3 66.0 59.5 20.8 23.6 78.5 PAIP2 PAIP2A ENSG00000120727 "Poly(A) binding protein interacting protein 2" Q9BPZ3 5 139341587-139369720 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 720.9;Late spermatids: 1930.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035945, CAB037212, HPA056766" Approved Supported Vesicles NA NA Vesicles "CAB037212: AB_1841072, HPA035945: AB_10672996, HPA056766: AB_2683231" "unprognostic (1.07e-1)" "unprognostic (1.44e-1)" "unprognostic (1.19e-1)" "unprognostic (5.86e-2)" "unprognostic (7.40e-2)" "unprognostic (3.80e-3)" "unprognostic (7.70e-3)" "unprognostic (8.91e-2)" "unprognostic (4.64e-2)" "unprognostic (2.36e-2)" "unprognostic (2.67e-2)" "unprognostic (3.27e-1)" "unprognostic (2.01e-3)" "unprognostic (2.01e-1)" "unprognostic (2.21e-1)" "unprognostic (3.36e-1)" "unprognostic (6.92e-2)" 36.2 57.4 50.8 27.0 46.7 36.3 34.4 64.5 59.9 31.0 27.6 32.0 25.7 16.1 36.0 33.3 26.0 35.2 24.9 62.9 49.7 57.8 39.0 41.8 26.8 36.1 58.4 51.7 44.2 23.7 20.5 47.2 34.2 61.8 32.6 20.6 23.0 32.2 33.0 56.1 17.7 18.2 31.3 57.0 32.0 23.0 59.2 41.0 45.8 30.4 27.0 38.2 30.9 28.2 54.9 45.2 122.8 53.3 49.4 65.5 74.8 20.5 23.4 46.1 27.5 34.5 19.7 22.4 18.8 26.2 24.5 38.6 31.2 20.0 36.4 40.4 14.2 28.4 20.5 40.1 25.8 32.6 34.9 31.4 33.5 34.9 27.9 22.3 20.7 24.8 22.3 21.6 18.4 21.1 26.7 25.0 39.9 31.8 32.3 22.1 27.1 56.1 50.6 27.8 29.3 17.0 31.4 58.3 39.5 19.5 36.8 21.4 38.9 27.9 25.8 55.0 60.9 49.9 43.5 15.4 13.2 16.2 14.3 15.2 47.3 57.2 37.9 23.3 36.6 13.5 69.9 45.3 107.8 46.7 48.8 51.0 54.9 52.0 53.3 44.1 48.5 60.9 59.5 122.8 49.4 53.3 45.2 65.5 74.8 50.8 46.7 64.5 59.9 49.7 57.8 58.4 51.7 61.8 41.0 68.5 77.0 138.7 140.5 142.0 96.6 57.4 86.6 155.2 71.7 94.2 55.0 174.3 144.2 98.1 720.9 118.2 51.9 116.8 100.1 119.9 128.8 187.4 106.2 93.6 125.9 92.2 93.1 106.8 139.3 1930.3 149.0 168.1 128.2 247.1 49.3 108.0 109.4 53.2 146.0 189.5 80.1 168.1 120.5 352.6 211.4 182.2 401.2 199.3 51.7 127.6 PAK3 "bPAK, hPAK3, MRX30, MRX47" ENSG00000077264 "P21 (RAC1) activated kinase 3" O75914 X 110944285-111227361 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Allosteric enzyme, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 26.2;pancreas: 46.5;pituitary gland: 37.2" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 81.5;Leydig cells: 31.7;Peritubular cells: 76.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "MAIT T-cell: 4.3" "Lineage enriched" "Detected in single" 7 "T-cells: 4.3" "Cell line enhanced" "Detected in some" "EFO-21: 9.8;HAP1: 8.8;HDLM-2: 11.0;NTERA-2: 8.6;SCLC-21H: 11.2;SH-SY5Y: 7.0;U-2197: 6.8;U-251 MG: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044791, HPA060219" Approved Approved Vesicles NA NA Vesicles "HPA044791: , HPA060219: AB_2684223" "unprognostic (1.80e-2)" "unprognostic (1.54e-1)" "unprognostic (1.80e-2)" "unprognostic (3.27e-4)" "unprognostic (2.46e-1)" "unprognostic (5.63e-3)" "unprognostic (7.29e-2)" "unprognostic (3.23e-2)" "unprognostic (1.27e-2)" "unprognostic (3.01e-1)" "unprognostic (6.80e-3)" "unprognostic (1.66e-1)" "unprognostic (1.89e-4)" "unprognostic (5.71e-3)" "unprognostic (6.81e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" 2.0 6.8 17.6 2.5 17.5 1.0 6.4 1.8 24.6 3.7 1.6 0.9 9.1 1.0 6.8 7.6 1.7 3.7 2.6 1.2 26.2 20.8 1.6 1.1 1.8 2.5 7.9 21.9 7.9 46.5 0.9 37.2 1.6 12.9 4.8 1.7 1.4 3.0 7.1 2.4 2.0 1.4 6.1 5.8 2.9 3.0 3.6 1.9 0.0 7.7 0.0 1.7 2.0 1.5 0.1 0.1 0.6 0.1 0.2 4.3 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.0 0.2 0.3 0.9 0.0 0.0 0.0 0.0 9.8 1.0 1.4 0.0 8.8 0.5 1.2 11.0 0.3 0.0 1.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 2.0 5.2 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.1 8.6 0.0 1.9 0.1 4.0 0.0 0.8 0.0 11.2 7.0 0.0 0.4 0.0 6.2 0.0 0.0 0.0 0.6 4.3 6.8 11.7 0.0 0.1 0.1 1.2 0.0 0.1 0.6 0.1 0.1 0.1 0.0 4.3 0.0 0.7 0.4 0.0 0.1 0.1 0.1 0.5 0.2 0.1 0.1 0.3 0.0 17.6 17.5 1.8 18.5 26.2 20.8 7.9 21.9 12.9 1.9 3.0 1.4 0.0 14.1 0.2 81.5 0.8 12.7 0.0 1.2 0.0 0.0 0.3 0.0 3.0 3.4 2.4 0.0 0.0 11.6 0.3 5.8 1.3 1.1 0.0 0.2 6.4 3.5 0.6 0.3 4.7 31.7 2.0 0.0 1.0 0.0 19.0 7.3 0.0 76.4 0.5 5.5 0.0 0.4 1.1 0.6 1.0 5.6 2.2 0.0 0.9 PAQR4 FLJ30002 ENSG00000162073 "Progestin and adipoQ receptor family member 4" Q8N4S7 16 2969245-2973489 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 54.4;parathyroid gland: 32.8" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 145.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "non-classical monocyte: 6.7" "Lineage enriched" "Detected in single" 8 "monocytes: 6.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068394 Approved Vesicles NA Yes Vesicles "HPA068394: AB_2685980" "unprognostic (1.93e-1)" "unprognostic (2.75e-1)" "unprognostic (6.73e-2)" "unprognostic (1.30e-3)" "unprognostic (8.39e-2)" "unprognostic (3.00e-2)" "prognostic unfavorable (6.86e-4)" "unprognostic (2.62e-2)" "unprognostic (7.59e-2)" "unprognostic (9.65e-3)" "unprognostic (5.21e-2)" "unprognostic (8.59e-2)" "prognostic unfavorable (3.01e-6)" "prognostic favorable (1.70e-4)" "unprognostic (1.36e-1)" "unprognostic (3.79e-2)" "unprognostic (6.06e-3)" 3.1 3.2 14.1 5.2 19.2 10.3 2.3 8.0 26.3 2.4 4.8 49.6 1.3 4.9 1.8 1.0 4.2 3.0 5.5 4.2 24.1 11.7 1.7 1.6 3.9 6.3 30.6 11.1 0.4 6.6 32.8 0.9 2.2 19.1 9.6 4.5 16.8 17.0 1.3 12.3 12.3 4.9 2.8 54.4 3.2 7.4 1.6 20.3 3.6 1.5 3.5 7.8 2.1 1.7 0.5 0.9 0.1 6.7 0.0 0.4 0.5 12.9 11.0 12.5 18.0 2.0 3.7 4.2 4.9 5.9 9.1 8.6 6.6 13.8 12.9 6.7 5.6 6.4 18.2 12.9 7.7 3.8 13.7 5.6 3.9 21.6 8.9 0.2 8.4 14.4 0.9 4.1 4.9 1.3 4.6 5.9 11.0 7.7 35.1 7.7 25.9 12.1 9.0 10.5 19.4 7.5 24.1 16.4 41.6 6.2 4.5 28.6 13.3 18.2 17.6 13.2 1.7 18.9 13.1 3.6 16.0 9.8 7.3 6.9 15.3 10.6 17.2 7.0 11.4 17.5 0.0 1.0 0.1 0.4 0.5 0.0 0.5 0.2 0.1 0.9 0.1 0.0 0.3 0.1 0.0 6.7 0.5 0.1 0.5 14.1 19.2 8.0 21.2 24.1 11.7 30.6 11.1 19.1 20.3 0.0 0.0 2.9 1.4 2.7 14.6 0.8 12.7 10.7 6.8 0.0 55.0 0.7 0.0 4.4 0.5 1.0 2.0 0.0 9.9 7.2 0.8 7.5 2.3 0.0 11.5 6.4 4.1 3.7 9.5 3.0 0.6 4.5 5.0 1.0 5.3 15.7 6.5 2.9 0.0 0.3 145.7 0.0 1.2 1.6 5.2 4.4 0.5 0.0 9.3 0.8 PAQR5 "FLJ20190, MPRG" ENSG00000137819 "Progestin and adipoQ receptor family member 5" Q9NXK6 15 69298947-69407780 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 41.4" "Cell type enhanced" "Detected in many" 10 "Distal tubular cells: 39.7;Early spermatids: 33.3;granulocytes: 65.8;Late spermatids: 86.2;Proximal tubular cells: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.5" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.5" "Cell line enhanced" "Detected in many" "A549: 17.5;CAPAN-2: 21.1;fHDF/TERT166: 14.9;HMC-1: 37.0;U-87 MG: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA076729 Approved Vesicles NA NA Vesicles "HPA076729: AB_2686813" "unprognostic (4.47e-2)" "unprognostic (3.11e-2)" "unprognostic (1.46e-1)" "unprognostic (4.05e-4)" "unprognostic (1.53e-1)" "unprognostic (8.28e-2)" "unprognostic (3.58e-3)" "unprognostic (6.12e-3)" "unprognostic (1.47e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (2.00e-1)" "prognostic favorable (1.47e-14)" "unprognostic (5.64e-2)" "unprognostic (1.73e-1)" "unprognostic (4.16e-4)" "unprognostic (4.94e-2)" 1.8 15.4 1.9 4.1 2.6 0.7 1.2 1.5 3.1 1.6 12.3 3.0 1.7 1.5 1.1 1.6 9.0 1.0 1.7 1.9 1.8 1.5 41.4 1.0 10.4 0.3 2.0 1.0 0.5 4.8 5.8 0.9 1.0 3.5 1.1 10.8 3.6 1.8 4.2 0.4 3.2 5.2 3.2 3.8 0.2 4.5 1.5 2.2 0.0 0.6 5.7 4.9 2.3 2.6 0.2 0.2 3.5 0.3 0.4 0.7 0.0 5.1 17.5 0.3 0.3 0.7 2.0 0.1 1.6 10.1 2.0 4.3 1.0 21.1 0.0 2.7 14.9 1.7 0.3 5.0 0.2 3.5 0.0 0.7 3.0 2.7 0.3 1.3 0.1 37.0 1.0 0.8 9.0 9.7 2.6 0.0 0.1 0.0 0.3 8.4 0.7 0.0 0.1 1.2 2.7 1.5 0.0 0.3 0.9 7.7 0.4 1.5 0.3 2.7 1.0 1.4 1.0 0.4 1.2 0.2 6.1 2.0 0.5 0.2 0.1 0.1 0.0 15.4 0.0 1.7 3.5 0.3 0.1 0.3 0.1 0.2 0.1 0.2 0.2 0.1 0.2 0.3 0.7 1.3 0.4 0.2 0.2 0.1 0.0 1.9 2.6 1.5 3.1 1.8 1.5 2.0 1.0 3.5 2.2 11.9 21.8 0.0 1.1 0.8 0.5 0.8 22.9 1.4 1.2 19.2 0.0 0.0 39.7 16.0 33.3 0.4 18.4 0.0 0.4 0.0 0.2 0.5 65.8 0.0 3.5 0.0 0.0 0.0 0.3 86.2 0.9 0.9 0.0 0.0 4.8 5.7 1.8 3.5 1.1 33.2 0.0 6.5 0.4 0.3 0.5 1.6 0.1 0.5 11.5 0.7 PBLD "FLJ14767, MAWBP, MAWDBP" ENSG00000108187 "Phenazine biosynthesis like protein domain containing" P30039 10 68282660-68333049 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 47.3;kidney: 74.5;liver: 91.4" "Cell type enhanced" "Detected in many" 16 "Distal tubular cells: 92.9;Enterocytes: 114.6;Hepatocytes: 159.6;Proximal tubular cells: 362.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038035, HPA038036" Enhanced Approved Vesicles NA NA 420000 Vesicles "HPA038035: AB_10672470, HPA038036: AB_10675625" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (6.14e-2)" "unprognostic (8.83e-3)" "unprognostic (1.14e-1)" "unprognostic (2.78e-1)" "prognostic favorable (1.44e-4)" "unprognostic (8.25e-2)" "unprognostic (3.62e-2)" "unprognostic (3.36e-3)" "unprognostic (1.19e-1)" "unprognostic (6.26e-3)" "unprognostic (3.40e-2)" "unprognostic (1.17e-1)" "unprognostic (2.07e-2)" "unprognostic (8.28e-2)" "unprognostic (6.68e-2)" 5.0 5.9 3.6 2.4 6.4 2.5 2.9 2.3 8.0 4.1 9.4 11.8 6.8 47.3 4.5 5.1 1.5 2.3 2.9 3.3 3.9 3.1 74.5 91.4 2.3 2.8 6.7 5.6 2.3 17.9 2.4 2.4 7.0 8.4 2.6 8.0 9.4 2.2 6.2 2.3 1.8 39.3 6.5 4.9 1.6 15.0 2.1 6.2 2.5 1.9 4.3 1.6 4.1 1.6 1.7 5.6 6.4 5.8 3.3 2.3 2.5 3.4 6.9 6.7 4.6 6.1 3.5 3.1 13.9 8.8 5.3 5.6 6.3 8.8 3.9 5.4 9.7 2.2 5.3 3.1 3.6 4.6 1.8 5.1 3.1 7.5 5.7 3.0 4.5 3.1 6.2 4.3 3.2 4.0 9.6 3.2 3.7 2.7 8.6 8.3 5.3 4.1 7.9 1.9 2.7 3.0 7.2 8.8 6.4 10.6 5.0 3.9 5.2 9.3 5.4 6.4 1.9 18.7 5.4 10.0 5.3 3.8 2.5 2.2 5.2 3.7 5.7 6.3 2.5 1.3 4.2 5.8 2.9 0.9 2.9 1.8 1.7 1.4 0.9 5.6 1.6 2.3 1.6 6.4 3.3 1.7 2.4 2.3 2.5 3.6 6.4 2.3 8.0 3.9 3.1 6.7 5.6 8.4 6.2 3.0 3.4 6.1 1.7 1.6 4.7 2.8 25.5 17.4 5.7 52.4 9.8 3.1 92.9 5.7 0.8 2.9 114.6 0.0 28.7 2.1 3.3 2.4 1.1 159.6 2.6 9.5 6.9 7.4 7.8 0.0 3.7 4.2 1.7 4.6 34.2 5.0 16.3 35.1 2.8 362.3 16.5 0.0 5.6 1.2 1.4 0.5 2.6 2.2 34.0 3.1 PBX4 ENSG00000105717 "PBX homeobox 4" Q9BYU1 19 19561707-19618916 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 16.9;thyroid gland: 14.4" "Cell type enhanced" "Detected in many" 12 "Spermatocytes: 23.3;Spermatogonia: 8.7;T-cells: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 8 "gdT-cell: 2.8;MAIT T-cell: 3.3;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.9;naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.7;T-reg: 5.4" "Lineage enriched" "Detected in single" 14 "T-cells: 5.4" "Cell line enhanced" "Detected in many" "A-431: 4.0;PC-3: 4.3;RT4: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA049859, HPA056469" Enhanced Approved Vesicles NA NA Vesicles "HPA049859: AB_2680918, HPA056469: AB_2797256" "unprognostic (5.36e-3)" "prognostic favorable (8.69e-6)" "unprognostic (9.39e-3)" "unprognostic (1.03e-1)" "unprognostic (1.81e-2)" "unprognostic (1.07e-4)" "unprognostic (2.87e-2)" "unprognostic (1.18e-1)" "unprognostic (1.26e-1)" "unprognostic (3.86e-2)" "unprognostic (3.17e-1)" "unprognostic (1.13e-2)" "unprognostic (1.44e-6)" "unprognostic (2.20e-2)" "unprognostic (1.45e-1)" "unprognostic (5.89e-2)" "prognostic favorable (5.94e-7)" 1.0 0.5 2.2 4.5 3.4 1.7 1.0 1.2 1.9 0.9 1.6 0.0 4.6 1.1 0.6 1.3 0.8 1.0 7.1 0.6 2.3 2.5 1.0 0.5 1.8 3.6 0.8 1.2 1.2 0.5 0.7 1.7 1.2 1.5 1.1 1.1 0.7 1.4 2.7 0.5 2.0 1.7 0.5 0.7 1.8 1.7 16.9 0.6 6.1 14.4 0.5 9.6 1.4 0.8 0.3 0.0 0.0 0.1 0.0 5.4 0.8 4.0 0.2 1.9 0.0 0.0 0.0 2.1 0.0 1.6 1.7 1.7 0.0 1.4 0.4 0.9 1.0 1.6 1.6 2.7 0.0 0.7 0.3 0.8 0.0 0.9 0.1 0.3 0.0 1.3 0.5 0.0 0.3 0.0 0.0 0.0 1.8 0.1 0.0 0.3 0.8 1.4 0.1 0.3 2.2 4.3 0.8 0.0 0.0 1.1 5.3 1.2 2.3 1.5 0.2 0.9 0.2 0.8 0.0 0.0 0.0 1.0 2.1 0.8 0.0 1.8 0.3 0.1 0.2 0.0 0.0 0.0 0.0 2.8 0.0 3.3 0.3 2.0 2.9 0.0 0.0 1.8 1.7 0.0 0.0 0.1 0.0 5.4 0.8 2.2 3.4 1.2 1.9 2.3 2.5 0.8 1.2 1.5 0.6 0.0 2.6 0.5 2.2 4.2 0.4 0.4 0.0 2.7 2.3 0.0 0.0 0.0 1.7 0.8 1.6 0.0 0.5 0.0 0.0 1.0 2.6 2.1 0.0 0.0 0.4 0.0 0.0 0.6 0.8 1.1 0.3 0.3 1.7 1.8 2.1 1.1 1.5 0.0 0.7 0.0 0.0 6.5 1.2 23.3 8.7 2.3 0.0 15.0 0.6 2.6 PCDHA6 "CNR2, CNRS2, CRNR2, PCDH-ALPHA6" ENSG00000081842 "Protocadherin alpha 6" Q9UN73 5 140827958-141012344 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.7;pituitary gland: 11.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.0;EFO-21: 12.6;hTERT-RPE1: 3.3;U-2 OS: 5.2;WM-115: 7.5" "HPA059326, HPA078110" Enhanced Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA059326: AB_2683980, HPA078110: AB_2732371" "unprognostic (1.15e-1)" "unprognostic (7.00e-2)" "unprognostic (5.07e-1)" "unprognostic (2.79e-1)" "unprognostic (4.39e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-4)" "unprognostic (4.23e-3)" "unprognostic (8.38e-2)" "unprognostic (2.55e-1)" "unprognostic (1.23e-3)" "unprognostic (3.44e-1)" "unprognostic (1.03e-2)" "unprognostic (2.66e-3)" "unprognostic (2.56e-1)" "unprognostic (5.66e-3)" "unprognostic (3.55e-2)" 1.1 1.8 2.9 0.8 7.1 0.4 1.6 10.2 10.7 1.9 0.7 2.3 0.0 1.2 2.9 2.3 0.4 1.6 1.6 0.5 3.8 3.8 2.3 0.4 1.1 0.7 4.6 4.1 2.1 3.7 4.7 11.2 0.4 3.6 1.3 0.7 1.6 0.7 0.5 0.4 0.6 1.3 1.4 3.4 0.8 0.7 1.4 3.2 0.0 0.9 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 2.1 1.3 0.2 0.6 0.0 2.0 0.0 5.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 7.1 10.2 9.6 3.8 3.8 4.6 4.1 3.6 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHB14 PCDH-BETA14 ENSG00000120327 "Protocadherin beta 14" Q9Y5E9 5 141222932-141227759 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 12.7;Horizontal cells: 12.7;Muller glia cells: 8.3;Peritubular cells: 8.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "SH-SY5Y: 14.2;SiHa: 11.4;U-2197: 8.2" "Low region specificity" "Detected in all" "HPA007692, HPA045248" Uncertain Approved Vesicles NA NA Vesicles "HPA007692: AB_2667896, HPA045248: AB_10959599" "unprognostic (2.57e-3)" "unprognostic (1.96e-1)" "unprognostic (1.34e-1)" "unprognostic (8.97e-2)" "unprognostic (2.03e-2)" "unprognostic (6.64e-2)" "unprognostic (2.11e-2)" "unprognostic (2.38e-2)" "unprognostic (6.60e-2)" "unprognostic (2.57e-2)" "unprognostic (1.13e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (6.09e-4)" "unprognostic (2.58e-1)" "unprognostic (3.12e-2)" "unprognostic (3.77e-2)" "unprognostic (3.90e-2)" 5.3 5.5 6.6 2.7 9.4 0.9 5.7 9.3 13.9 8.7 5.7 6.8 0.8 1.7 11.5 7.6 5.2 5.3 5.9 6.0 6.8 4.7 3.8 2.9 4.0 1.6 3.8 6.6 6.9 6.0 14.2 14.2 3.7 6.1 6.7 3.2 5.4 4.8 6.3 3.2 10.3 2.2 7.8 4.3 3.1 3.3 3.2 4.0 0.0 3.0 4.3 1.6 7.1 4.9 0.3 0.0 0.7 0.1 0.0 0.3 0.0 0.0 0.0 3.3 6.0 5.4 6.4 0.4 0.5 5.3 0.5 1.6 0.1 1.0 0.2 4.4 1.4 2.8 0.3 0.7 1.0 0.5 0.0 0.1 0.0 1.3 0.1 0.2 0.2 0.2 1.1 4.7 0.1 0.2 4.7 0.6 0.1 0.0 5.7 2.3 0.5 0.4 0.0 0.4 0.0 1.1 3.5 4.0 0.0 0.1 0.2 7.4 14.2 11.4 0.3 1.2 0.5 6.1 0.4 1.7 2.1 1.9 8.2 2.1 0.0 0.1 0.1 4.4 0.1 3.5 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.2 0.1 0.0 0.3 0.2 0.3 0.7 0.0 0.0 0.0 0.1 0.0 6.6 9.4 9.3 13.9 6.8 4.7 3.8 6.6 6.1 4.0 0.0 3.7 0.0 0.9 0.3 12.7 2.5 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 4.4 2.2 0.0 0.0 2.1 0.0 3.5 0.9 0.0 0.9 0.1 12.7 3.4 3.1 0.0 0.5 3.1 0.0 0.0 0.0 0.4 8.3 2.1 0.0 8.1 0.6 1.0 0.0 3.1 1.5 0.1 2.5 0.0 0.0 0.0 0.7 PCDHB3 PCDH-BETA3 ENSG00000113205 "Protocadherin beta 3" Q9Y5E6 5 141100473-141103827 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.3" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 12.4;HAP1: 3.8;SH-SY5Y: 16.5;U-138 MG: 5.8" "Low region specificity" "Detected in all" HPA050296 Uncertain Supported Vesicles NA NA Vesicles "HPA050296: AB_2681078" "unprognostic (2.72e-2)" "unprognostic (7.47e-4)" "unprognostic (1.22e-1)" "unprognostic (1.95e-4)" "unprognostic (9.34e-3)" "unprognostic (3.42e-2)" "unprognostic (2.29e-2)" "unprognostic (3.17e-1)" "unprognostic (1.37e-1)" "unprognostic (3.34e-1)" "unprognostic (8.52e-3)" "unprognostic (3.45e-2)" "unprognostic (1.82e-2)" "unprognostic (2.37e-3)" "unprognostic (1.24e-1)" "unprognostic (1.82e-2)" "unprognostic (5.18e-4)" 5.7 4.6 3.1 2.6 9.3 0.4 5.9 3.8 6.2 4.8 2.5 2.2 1.3 1.4 8.0 3.0 1.3 3.1 3.1 3.6 3.8 3.0 4.9 0.8 3.3 1.0 3.0 3.8 5.6 3.9 4.4 17.3 1.8 4.0 5.4 2.1 3.4 2.4 2.4 1.9 2.0 2.1 3.8 3.0 1.5 1.8 11.6 2.0 0.0 2.1 2.3 0.7 2.4 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 3.4 2.1 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.2 1.8 0.0 3.8 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 1.3 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.6 16.5 0.0 0.2 0.0 0.6 2.1 0.1 0.0 5.8 0.8 0.6 0.3 0.3 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 9.3 3.8 6.2 3.8 3.0 3.0 3.8 4.0 2.0 0.0 0.0 0.0 0.1 0.0 1.1 0.4 0.0 0.0 0.0 0.0 2.0 0.0 1.7 0.3 0.7 0.6 0.0 0.0 0.2 0.0 0.5 0.6 0.0 0.0 0.0 7.9 0.0 0.6 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.8 0.5 0.0 0.7 0.0 0.2 0.0 0.5 1.4 0.9 0.3 0.0 0.0 0.0 0.3 PCSK1N "BigLEN, PEN, proSAAS, SAAS, SCG8, SgVIII" ENSG00000102109 "Proprotein convertase subtilisin/kexin type 1 inhibitor" Q9UHG2 X 48831094-48835633 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 74.9;kidney: 72.9;pituitary gland: 127.7" "Group enriched" "Detected in many" 5 "Intestinal endocrine cells: 2932.5;Proximal tubular cells: 1024.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "MAIT T-cell: 3.0;memory CD4 T-cell: 6.5;memory CD8 T-cell: 6.3;naive CD4 T-cell: 2.7;naive CD8 T-cell: 8.2;T-reg: 2.1" "Lineage enriched" "Detected in single" 77 "T-cells: 8.2" "Cell line enhanced" "Detected in some" "HEK 293: 20.0;PC-3: 50.7;SCLC-21H: 20.1;SH-SY5Y: 18.6;SiHa: 17.6;U-266/84: 23.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003925, HPA064734" Enhanced Supported Approved Vesicles "Secreted to blood" NA NA 5300000 Vesicles "HPA003925: AB_1079582, HPA064734: AB_2685339" "unprognostic (2.44e-3)" "unprognostic (5.86e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (3.36e-1)" "unprognostic (4.76e-3)" "unprognostic (1.49e-2)" "unprognostic (3.34e-1)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (1.50e-3)" "unprognostic (2.79e-3)" "prognostic favorable (1.36e-4)" "unprognostic (3.34e-2)" "unprognostic (2.91e-2)" "unprognostic (1.91e-1)" "unprognostic (2.14e-1)" 4.1 27.5 49.1 2.6 72.7 2.1 2.2 15.6 70.3 3.2 9.8 10.8 1.5 12.4 4.4 10.9 2.1 2.3 2.8 2.7 38.5 74.9 72.9 2.1 2.6 2.2 33.5 29.0 2.2 20.0 12.4 127.7 2.3 32.9 4.6 2.7 6.6 2.8 3.1 2.2 2.8 8.5 2.7 18.3 2.4 26.0 3.8 9.8 0.0 2.2 0.0 2.1 2.1 0.5 0.1 0.0 0.0 0.0 0.0 8.2 0.8 0.0 1.8 0.0 5.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 3.6 0.0 1.4 0.2 0.0 0.3 0.0 0.0 20.0 0.0 0.0 3.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.1 2.7 0.0 50.7 0.0 0.0 0.1 0.4 0.0 20.1 18.6 17.6 0.0 1.4 0.2 0.0 0.0 0.0 0.0 7.8 0.0 1.6 4.6 23.4 0.1 0.1 0.0 0.5 0.0 0.0 0.0 1.1 0.0 3.0 0.0 6.5 6.3 0.0 0.1 2.7 8.2 0.0 0.0 0.0 0.0 2.1 0.8 49.1 72.7 15.6 70.3 38.5 74.9 33.5 29.0 32.9 9.8 0.0 0.0 2.2 1.5 14.1 134.7 1.0 5.1 1.4 0.0 369.9 49.1 0.5 235.4 7.5 11.6 0.5 12.9 0.0 0.6 43.5 6.2 36.6 0.0 0.0 1.5 413.2 2932.5 0.0 0.0 41.9 3.1 2.7 54.0 0.0 16.6 54.9 36.6 411.7 6.7 1024.2 101.7 0.0 16.5 18.2 20.6 10.0 1.6 3.2 10.1 2.6 PCSK2 "NEC2, PC2, SPC2" ENSG00000125851 "Proprotein convertase subtilisin/kexin type 2" P16519 20 17226107-17484578 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 35.0;thyroid gland: 79.5" "Cell type enhanced" "Detected in many" 26 "Horizontal cells: 125.5;Melanocytes: 199.1;Muller glia cells: 518.9" "Group enriched" "Detected in many" 6 "pancreatic cancer: 14.6;thyroid cancer: 65.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "basophil: 2.2" "Lineage enriched" "Detected in single" 22 "granulocytes: 2.2" "Group enriched" "Detected in some" 5 "AF22: 36.7;SCLC-21H: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049627 Approved Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA049627: AB_2680835" "unprognostic (2.03e-3)" "unprognostic (1.61e-1)" "unprognostic (3.13e-1)" "unprognostic (2.18e-1)" "unprognostic (2.13e-1)" "unprognostic (6.84e-2)" "unprognostic (3.07e-3)" "unprognostic (4.31e-1)" "unprognostic (5.88e-2)" "unprognostic (2.50e-3)" "unprognostic (2.14e-1)" "unprognostic (7.26e-5)" "unprognostic (2.29e-1)" "unprognostic (1.57e-1)" "unprognostic (2.35e-1)" "unprognostic (1.14e-1)" 1.6 35.0 16.3 1.7 20.5 1.3 1.3 7.7 27.8 2.9 4.2 1.6 0.0 6.2 0.9 1.2 2.1 2.0 1.4 3.1 18.0 11.1 1.1 1.0 2.2 0.8 4.1 16.2 11.6 23.7 0.9 1.7 1.5 9.0 1.3 2.8 16.6 2.7 2.3 1.0 16.6 3.3 1.3 5.4 0.9 11.9 4.7 3.8 0.0 79.5 0.0 0.9 1.9 1.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.1 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 20.5 7.7 27.8 18.0 11.1 4.1 16.2 9.0 3.8 0.0 5.3 0.0 0.0 7.2 27.6 0.9 0.0 0.0 1.2 0.0 5.9 0.0 0.0 0.0 76.9 0.6 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 125.5 0.0 8.0 0.0 2.7 2.6 0.2 199.1 0.0 0.0 518.9 4.6 0.0 0.0 0.0 11.5 0.0 1.0 0.5 0.2 1.3 0.0 0.0 0.0 0.1 PDCD6IP "AIP1, Alix, Hp95" ENSG00000170248 "Programmed cell death 6 interacting protein" Q8WUM4 3 33798352-33869707 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011905, CAB016212, HPA051604" Approved Enhanced Vesicles "Intracellular and membrane" NA NA 6200000 Vesicles "CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: " "unprognostic (1.53e-1)" "unprognostic (2.63e-1)" "prognostic favorable (1.16e-4)" "unprognostic (2.17e-1)" "unprognostic (2.75e-1)" "unprognostic (5.12e-2)" "unprognostic (7.76e-3)" "unprognostic (1.23e-2)" "unprognostic (3.29e-1)" "unprognostic (2.86e-1)" "unprognostic (3.88e-3)" "unprognostic (4.49e-2)" "prognostic favorable (3.90e-9)" "unprognostic (9.61e-2)" "unprognostic (1.89e-1)" "unprognostic (4.78e-1)" "unprognostic (1.11e-1)" 39.1 26.8 18.6 26.2 27.2 16.0 27.0 24.0 31.5 33.8 36.8 26.3 16.5 28.6 33.7 22.7 45.2 27.1 26.2 29.6 20.7 19.7 42.8 41.5 29.9 24.8 22.7 18.1 33.0 21.2 34.9 26.3 43.2 48.9 26.6 34.0 23.0 27.4 20.4 29.5 31.7 57.9 25.9 24.8 32.2 29.1 24.2 16.8 35.9 35.1 25.6 37.3 28.6 31.6 11.8 12.3 10.8 18.2 12.0 9.7 8.9 17.9 18.8 12.2 10.2 31.9 32.9 13.4 23.1 22.1 20.6 21.5 13.0 17.7 25.8 14.4 30.3 13.4 16.0 18.8 24.2 23.5 10.8 15.7 22.1 15.5 10.7 21.3 22.0 22.9 25.6 28.1 23.2 27.8 24.7 30.5 12.0 19.8 10.7 29.8 9.4 13.5 13.2 11.7 16.5 23.4 12.9 15.0 16.7 25.7 15.4 6.0 10.8 22.6 27.1 12.2 20.6 26.2 21.2 37.7 24.4 12.3 20.2 19.1 10.9 14.5 21.6 23.0 24.2 12.0 6.3 13.4 10.8 8.7 18.2 9.3 11.8 9.6 8.6 12.3 10.1 8.5 8.2 8.1 12.0 17.2 5.7 9.7 8.9 18.6 27.2 24.0 31.5 20.7 19.7 22.7 18.1 48.9 16.8 80.4 77.5 41.0 48.9 37.1 29.4 46.6 76.5 112.4 72.8 61.1 49.1 43.5 31.5 60.9 71.2 58.2 165.2 0.0 68.3 44.1 40.1 52.8 51.0 50.4 54.7 23.8 34.7 52.8 89.1 35.9 68.4 71.9 27.0 31.5 82.0 25.1 88.6 90.8 75.7 55.1 45.5 45.3 38.7 87.4 42.1 37.8 80.8 39.2 56.8 62.1 PDE6G "PDEG, RP57" ENSG00000185527 "Phosphodiesterase 6G" P18545 17 81650459-81663112 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 260.3" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 2889.5" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 29.7;NK-cell: 57.8" "Group enriched" "Detected in all" 5 "granulocytes: 29.7;NK-cells: 57.8" "Cell line enhanced" "Detected in some" "Hep G2: 6.3;NB-4: 6.7;NTERA-2: 11.6;REH: 13.5;SuSa: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles NA NA Vesicles "HPA045118: AB_2732517" "unprognostic (6.16e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.51e-3)" "unprognostic (1.68e-1)" "unprognostic (1.46e-2)" "unprognostic (6.33e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (4.85e-2)" "unprognostic (5.01e-2)" "unprognostic (1.94e-2)" "unprognostic (5.71e-2)" "unprognostic (5.44e-2)" "unprognostic (2.73e-1)" "unprognostic (1.14e-1)" 0.9 1.3 0.4 2.9 0.5 4.7 0.7 0.5 0.6 0.4 0.8 0.5 0.4 0.0 0.4 0.5 0.6 0.3 1.6 0.5 0.5 0.7 3.8 2.6 2.0 13.8 0.6 0.5 0.5 0.4 0.0 0.5 8.6 0.5 0.5 0.5 260.3 0.5 0.4 0.6 0.8 2.8 0.4 0.8 17.9 0.7 2.2 0.5 2.5 0.6 0.4 4.6 2.1 0.4 1.3 8.6 29.7 7.7 57.8 2.4 3.7 0.2 0.3 0.5 0.0 0.3 0.0 0.0 0.3 1.1 1.2 1.3 0.1 0.8 0.6 0.2 0.7 0.6 0.1 0.2 0.2 2.8 0.2 0.0 0.9 0.1 6.3 0.9 0.1 0.2 0.0 0.2 1.2 0.0 2.4 3.3 0.4 0.1 0.3 1.3 0.8 0.1 6.7 11.6 0.0 0.4 13.5 0.1 2.0 0.0 0.0 0.1 0.3 0.0 0.3 0.5 8.6 0.1 0.8 1.3 0.4 0.1 0.2 0.3 0.1 0.6 1.0 1.6 2.7 0.2 29.7 5.1 8.6 1.2 7.7 0.4 0.8 0.3 0.6 8.6 1.3 0.7 2.4 0.7 57.8 4.2 0.8 0.0 3.7 0.4 0.5 0.5 0.6 0.5 0.7 0.6 0.5 0.5 0.5 0.0 1.1 1.4 0.0 0.8 338.0 0.0 0.0 0.0 0.0 5.2 486.9 0.2 1.7 0.4 0.6 0.0 0.0 0.0 0.2 0.3 0.2 0.1 24.1 0.0 18.8 247.9 0.0 3.1 3.8 1.6 0.0 3.2 3.3 19.8 0.0 402.2 0.3 0.0 0.0 0.3 2889.5 0.0 0.0 0.7 0.2 1.3 0.2 2.1 0.0 0.0 PDE6H ENSG00000139053 "Phosphodiesterase 6H" Q13956 12 14973022-14981865 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "retina: 67.4" "Cell type enriched" "Detected in some" 6 "Cone photoreceptor cells: 783.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.2;JURKAT: 1.0;MOLT-4: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles NA NA Vesicles "HPA045118: AB_2732517" "unprognostic (1.47e-3)" "unprognostic (1.07e-2)" 0.1 1.3 1.2 0.2 1.5 9.4 0.1 0.1 4.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 1.0 2.1 0.1 0.1 0.2 0.2 2.2 0.1 0.1 0.1 0.0 0.1 2.5 0.7 0.1 0.1 67.4 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.8 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.6 0.7 0.0 0.0 1.4 0.2 0.0 0.8 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 1.2 1.5 0.1 4.2 1.0 2.1 2.2 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 47.5 0.0 0.0 0.0 0.0 0.0 783.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 1.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.0 141.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PDGFB "SIS, SSV" ENSG00000100311 "Platelet derived growth factor subunit B" P01127 22 39223359-39244751 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 22.4;Ito cells: 20.9;Pancreatic endocrine cells: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 10.8" "Lineage enriched" "Detected in single" 12 "T-cells: 10.8" "Cell line enhanced" "Detected in many" "A-431: 13.6;EFO-21: 29.7;HUVEC TERT2: 22.9;SK-BR-3: 22.7;TIME: 28.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011604, HPA011972, CAB018341" Supported Approved Vesicles "Secreted to blood" NA NA 4390000 98000 Vesicles "CAB011604: AB_2162180, CAB018341: AB_2162187, HPA011972: AB_1855134" "unprognostic (4.96e-2)" "unprognostic (8.94e-3)" "unprognostic (8.41e-2)" "unprognostic (2.66e-1)" "unprognostic (9.84e-2)" "unprognostic (4.46e-3)" "unprognostic (4.34e-1)" "prognostic unfavorable (3.67e-5)" "unprognostic (3.22e-2)" "unprognostic (2.07e-1)" "unprognostic (1.05e-1)" "unprognostic (8.68e-2)" "unprognostic (1.84e-3)" "unprognostic (5.12e-3)" "unprognostic (7.47e-2)" "unprognostic (6.50e-2)" "unprognostic (1.03e-1)" 23.5 6.4 10.4 6.4 9.3 0.6 22.5 5.7 13.0 8.3 14.3 12.4 4.2 4.7 10.8 6.5 6.5 5.6 10.8 13.8 9.7 6.1 10.9 3.8 20.8 6.1 14.7 7.3 4.0 8.3 9.2 3.5 37.3 9.6 5.8 3.7 12.1 7.9 8.6 15.2 7.5 6.7 8.9 11.4 5.6 6.2 5.2 10.3 0.8 12.6 8.6 2.3 6.9 5.0 0.0 0.9 0.1 0.4 0.0 10.8 2.3 13.6 1.1 3.6 0.0 0.0 0.0 4.2 0.0 0.1 0.0 0.0 5.4 4.3 0.0 29.7 0.0 1.3 5.1 0.2 1.2 0.0 0.0 0.1 0.3 0.4 1.9 2.0 0.0 7.7 0.0 0.1 0.0 0.2 0.4 22.9 0.0 0.5 2.6 0.8 5.6 0.0 0.0 1.3 3.4 1.4 0.0 0.1 9.2 12.4 0.0 0.1 0.0 0.2 22.7 0.1 2.8 10.3 0.0 28.4 0.0 2.8 0.0 3.1 0.0 0.1 0.1 0.0 0.6 13.1 0.0 0.0 0.0 8.1 0.1 10.8 0.0 4.7 6.1 0.0 0.0 4.1 2.2 0.1 0.0 0.4 0.9 2.4 2.3 10.4 9.3 5.7 13.0 9.7 6.1 14.7 7.3 9.6 10.3 0.0 1.4 0.0 1.1 2.5 0.8 2.8 0.0 1.4 0.0 7.0 0.0 5.6 0.0 12.5 1.1 22.4 0.0 0.0 3.1 5.3 1.3 1.4 0.0 0.8 6.1 0.0 1.7 20.9 1.9 0.0 0.6 8.7 1.7 1.8 0.5 0.3 35.1 0.0 0.0 1.3 0.0 6.5 2.0 0.0 0.2 1.3 3.8 1.3 0.0 0.1 PEX2 "PAF-1, PMP35, PXMP3, RNF72, ZWS3" ENSG00000164751 "Peroxisomal biogenesis factor 2" P28328 8 76980258-77001044 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peroxisome biogenesis" "Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Distal tubular cells: 112.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010983, HPA011410, HPA027729" Approved Supported Vesicles NA NA Vesicles "HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416" "unprognostic (6.42e-2)" "unprognostic (2.90e-2)" "unprognostic (4.64e-2)" "unprognostic (2.35e-1)" "unprognostic (9.91e-2)" "unprognostic (2.33e-1)" "unprognostic (6.19e-2)" "unprognostic (2.22e-1)" "unprognostic (3.16e-2)" "unprognostic (1.37e-1)" "unprognostic (2.85e-2)" "unprognostic (2.07e-2)" "unprognostic (9.57e-3)" "unprognostic (2.48e-1)" "unprognostic (9.49e-2)" "unprognostic (3.06e-2)" "unprognostic (1.09e-3)" 21.3 30.9 25.4 17.9 23.8 17.3 30.7 20.7 24.6 24.3 23.8 24.1 65.7 22.5 25.7 24.3 21.6 24.1 18.0 22.1 26.9 20.7 31.3 25.3 20.4 27.8 29.8 18.3 20.5 26.4 21.2 32.6 17.4 25.9 25.8 22.9 24.9 28.7 63.6 32.4 17.4 27.2 25.7 30.5 23.1 27.0 14.7 30.9 32.2 34.4 19.0 23.4 24.2 23.5 17.3 17.1 52.4 22.9 28.3 22.3 24.2 27.3 9.3 15.1 15.2 16.1 20.3 7.9 20.6 23.5 15.9 17.6 5.8 24.6 15.6 30.7 18.4 13.0 10.6 10.3 15.6 19.4 28.8 8.5 19.0 8.6 8.9 10.9 15.7 15.1 22.8 13.3 12.0 14.4 25.0 17.3 25.3 10.4 15.0 16.6 8.2 27.6 9.4 8.9 39.2 8.4 5.1 12.0 12.9 18.4 19.4 5.3 14.0 13.2 60.2 11.2 13.5 18.8 11.4 17.2 14.6 19.2 18.8 10.2 27.9 16.1 27.2 18.6 8.4 16.1 52.4 20.3 35.8 22.3 20.8 19.9 17.3 15.6 17.9 16.9 17.2 20.6 19.6 14.1 28.3 22.9 17.1 17.4 24.2 25.4 23.8 20.7 24.6 26.9 20.7 29.8 18.3 25.9 30.9 44.7 18.5 25.9 28.0 16.1 26.4 23.8 28.1 24.1 19.4 26.2 11.8 35.4 112.7 45.9 2.4 15.7 28.0 0.0 43.3 19.6 25.8 30.4 17.4 29.7 24.1 12.7 27.7 17.2 35.1 5.9 27.3 21.5 27.0 32.5 33.2 49.5 36.5 29.1 33.6 53.7 29.7 6.5 24.8 13.5 17.6 18.3 29.1 41.1 26.4 33.0 PFAS "FGARAT, GATD8, KIAA0361, PURL" ENSG00000178921 "Phosphoribosylformylglycinamidine synthase" O15067 17 8247618-8270491 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 28.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022140, HPA022886" Enhanced Approved Vesicles NA NA 350000 Vesicles "HPA022140: AB_1855232, HPA022886: AB_1855233" "unprognostic (1.90e-1)" "unprognostic (9.21e-2)" "unprognostic (2.12e-1)" "unprognostic (5.19e-3)" "unprognostic (2.59e-1)" "unprognostic (6.40e-2)" "prognostic unfavorable (9.19e-4)" "unprognostic (3.19e-1)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "unprognostic (5.47e-3)" "unprognostic (1.08e-3)" "unprognostic (9.51e-3)" "unprognostic (3.63e-2)" "unprognostic (6.57e-2)" "unprognostic (2.88e-3)" "unprognostic (3.85e-1)" 15.4 15.3 11.4 14.8 13.0 17.5 12.8 14.6 18.5 11.2 12.4 14.0 10.0 9.8 15.1 11.2 13.2 13.5 14.3 9.7 9.0 8.0 13.0 17.0 9.5 18.5 10.7 12.6 16.6 15.7 11.5 9.2 10.7 10.7 11.5 12.2 12.0 10.6 10.6 11.6 13.6 11.5 14.3 7.9 18.0 11.4 17.2 11.1 29.5 12.8 10.8 16.2 10.4 9.5 9.2 7.1 28.2 2.9 2.7 6.5 1.1 5.9 26.5 13.6 20.4 5.0 4.1 15.7 7.7 2.9 14.2 10.8 12.9 5.4 26.5 12.5 4.5 5.0 14.0 31.3 10.0 10.6 12.0 25.6 15.5 25.0 16.1 4.3 12.5 11.5 3.9 2.5 16.4 10.4 4.0 11.7 14.5 20.8 4.0 5.7 9.0 22.1 10.9 22.6 3.3 12.1 33.3 14.1 12.7 6.5 10.0 8.3 12.9 9.5 6.1 8.8 7.6 6.0 5.8 8.2 7.9 10.3 14.4 19.0 4.8 8.5 13.0 8.7 17.8 13.3 9.1 2.9 6.5 4.0 2.5 5.2 7.8 5.2 4.6 2.4 9.2 6.5 5.1 28.2 2.7 1.9 7.1 2.7 1.1 11.4 13.0 14.6 18.5 9.0 8.0 10.7 12.6 10.7 11.1 0.0 6.4 2.2 1.5 2.2 6.5 2.8 2.5 8.1 5.7 3.5 5.9 4.2 0.0 3.0 1.6 2.1 1.0 0.0 2.6 3.2 2.3 1.8 1.1 3.8 4.0 1.6 0.0 3.1 3.0 0.4 4.9 2.2 3.3 6.4 2.0 1.5 1.9 3.6 1.4 2.4 6.4 0.0 1.7 3.9 10.3 1.8 2.6 2.5 5.3 1.3 PGBD2 ENSG00000185220 "PiggyBac transposable element derived 2" Q6P3X8 1 248906196-248919946 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3;Syncytiotrophoblasts: 23.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA029888, HPA029889, HPA029890" Uncertain Approved Vesicles NA NA Vesicles "HPA029888: AB_10600088, HPA029889: AB_10611386, HPA029890: AB_10602002" "unprognostic (1.06e-2)" "unprognostic (8.05e-2)" "unprognostic (2.56e-2)" "unprognostic (3.03e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.08e-4)" "unprognostic (1.94e-2)" "unprognostic (2.11e-2)" "unprognostic (2.71e-3)" "unprognostic (1.84e-1)" "unprognostic (2.59e-1)" "unprognostic (1.18e-2)" "prognostic unfavorable (7.86e-4)" "unprognostic (2.41e-1)" "unprognostic (7.91e-2)" "unprognostic (1.25e-1)" "prognostic favorable (2.05e-4)" 5.8 7.0 5.0 11.1 6.8 5.7 9.5 10.5 7.7 7.6 7.7 11.9 10.2 8.9 8.6 8.2 11.1 6.8 8.6 4.5 5.1 4.6 7.2 11.8 5.7 10.4 7.4 5.4 10.2 14.7 8.3 5.6 12.7 7.8 9.9 9.9 6.0 10.0 12.8 2.9 12.3 11.9 8.4 5.6 17.3 7.9 13.9 8.6 5.5 12.5 3.9 12.2 7.5 18.2 12.7 8.0 13.9 9.1 7.8 10.9 5.7 4.5 6.2 9.9 5.7 8.8 5.8 12.0 4.4 3.9 7.7 7.3 4.6 6.2 12.0 5.7 4.3 4.4 7.4 5.9 5.5 8.9 7.1 2.8 11.5 9.7 7.0 5.0 5.9 11.3 5.2 5.9 9.1 5.1 6.3 4.4 5.8 18.2 10.5 5.5 8.2 3.3 6.9 9.1 15.5 7.3 14.2 3.1 3.9 4.6 5.9 3.7 6.5 6.3 9.2 7.1 7.0 4.1 11.6 5.3 5.2 5.2 4.6 4.8 10.1 10.0 5.4 5.6 13.2 4.7 13.9 8.8 13.2 9.8 6.2 9.4 12.7 8.6 9.1 8.0 12.6 8.7 10.9 6.5 7.8 9.1 3.8 5.8 5.7 5.0 6.8 10.5 7.7 5.1 4.6 7.4 5.4 7.8 8.6 0.0 9.9 5.0 2.5 4.6 3.0 2.0 2.5 4.0 7.9 5.2 2.0 9.6 1.7 3.8 2.8 4.5 6.4 23.3 2.6 3.5 3.8 2.0 2.3 3.2 2.7 1.6 1.2 3.7 1.5 1.9 2.8 3.1 6.8 3.6 4.3 2.7 1.9 6.5 1.8 2.1 2.5 0.0 3.6 13.0 10.4 5.6 23.2 6.4 4.4 2.1 PHGR1 ENSG00000233041 "Proline, histidine and glycine rich 1" C9JFL3 15 40351033-40356434 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "intestine: 308.0;lymphoid tissue: 83.6" "Cell type enhanced" "Detected in some" 30 "Enterocytes: 27312.8;Mucus-secreting cells: 5830.8;Paneth cells: 7178.6;Undifferentiated cells: 3711.5" "Group enriched" "Detected in many" 16 "colorectal cancer: 248.3;stomach cancer: 94.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 13 "OE19: 136.7" HPA068787 Enhanced Approved Vesicles NA NA Vesicles "HPA068787: AB_2686035" "prognostic favorable (2.05e-4)" "unprognostic (1.73e-1)" "unprognostic (5.18e-2)" "unprognostic (1.18e-1)" "unprognostic (2.80e-1)" "unprognostic (1.20e-1)" "unprognostic (1.27e-2)" 0.3 0.1 0.3 83.6 0.3 0.0 0.6 0.3 0.3 0.3 245.3 0.3 0.3 77.9 0.3 0.3 0.4 0.5 4.1 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.4 32.9 0.3 0.4 0.3 0.3 0.3 308.0 1.3 0.3 0.3 15.1 0.3 0.3 0.3 0.3 0.3 0.3 0.9 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 136.7 0.0 0.0 0.0 1.7 0.0 0.2 10.5 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 193.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27312.8 0.0 0.2 0.0 0.0 1.8 220.4 0.0 0.0 0.0 1865.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5830.8 0.0 2.9 7178.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3711.5 0.9 PICALM "CALM, CLTH" ENSG00000073921 "Phosphatidylinositol binding clathrin assembly protein" Q13492 11 85957684-86069882 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Endocytosis "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 25.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019053, HPA019061" Enhanced Enhanced Vesicles NA NA 28000 Vesicles "HPA019053: AB_1855361, HPA019061: AB_1855362" "unprognostic (9.27e-3)" "unprognostic (7.29e-2)" "unprognostic (3.51e-1)" "unprognostic (6.83e-2)" "unprognostic (5.13e-2)" "unprognostic (1.93e-1)" "unprognostic (5.36e-3)" "unprognostic (9.02e-3)" "unprognostic (9.80e-2)" "unprognostic (6.27e-3)" "prognostic unfavorable (6.61e-4)" "unprognostic (4.31e-1)" "prognostic favorable (2.02e-6)" "unprognostic (1.26e-2)" "unprognostic (5.21e-3)" "unprognostic (2.52e-1)" "unprognostic (1.02e-1)" 72.9 24.2 35.6 43.1 51.4 37.1 51.3 30.2 39.7 38.7 35.9 60.0 27.7 39.6 41.6 26.0 41.3 31.5 48.1 41.4 43.7 34.2 63.9 53.8 45.1 35.2 52.0 33.5 38.2 29.7 70.6 23.8 76.7 50.7 29.9 32.0 26.7 31.8 37.0 35.5 35.0 45.3 49.9 70.7 49.5 30.7 22.9 55.1 31.0 30.8 28.5 34.8 44.0 49.2 2.1 7.1 25.8 8.5 3.9 5.3 3.1 29.2 13.9 22.1 15.5 33.9 35.7 41.7 37.7 48.9 29.8 26.3 54.9 39.9 22.8 38.9 60.3 31.2 24.2 23.1 27.5 43.1 6.7 8.3 64.7 19.0 17.4 34.6 15.2 29.2 30.9 29.8 55.8 46.5 50.6 32.2 15.4 41.4 18.8 56.0 17.2 17.7 14.0 12.1 47.2 7.9 12.3 33.4 16.2 57.8 24.7 13.4 10.9 46.2 15.6 12.4 29.0 21.2 12.3 34.9 55.1 19.2 64.9 30.0 6.7 17.7 20.9 13.0 12.0 37.1 3.6 8.5 4.2 3.9 7.2 3.3 2.1 2.9 5.3 7.1 1.4 3.0 2.7 25.8 3.9 7.2 2.5 3.8 3.1 35.6 51.4 30.2 39.7 43.7 34.2 52.0 33.5 50.7 55.1 32.8 63.6 25.0 34.9 103.0 19.5 39.7 33.1 32.1 25.0 68.0 11.8 37.0 26.6 54.1 51.3 74.2 54.8 70.0 32.6 99.4 46.2 37.9 47.3 49.9 74.3 38.1 24.1 74.3 121.6 73.1 33.1 105.1 57.3 46.9 31.2 20.9 64.7 45.6 41.1 65.4 16.5 77.6 77.5 17.1 12.0 84.3 34.6 40.6 25.2 76.6 PIGP "DCRC, DSCR5, DSRC" ENSG00000185808 "Phosphatidylinositol glycan anchor biosynthesis class P" P57054 21 37059170-37073170 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 193.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026921 Uncertain Approved Vesicles Yes No Vesicles "HPA026921: AB_1847874" "unprognostic (4.47e-3)" "unprognostic (9.45e-2)" "unprognostic (3.03e-1)" "unprognostic (2.40e-1)" "unprognostic (2.85e-2)" "unprognostic (1.92e-2)" "unprognostic (1.92e-2)" "unprognostic (5.54e-2)" "unprognostic (1.55e-1)" "unprognostic (1.22e-2)" "unprognostic (4.21e-3)" "unprognostic (1.12e-2)" "unprognostic (1.96e-2)" "unprognostic (1.93e-1)" "unprognostic (5.48e-2)" "unprognostic (1.02e-1)" "unprognostic (6.55e-2)" 20.0 30.3 12.3 7.9 13.4 4.2 18.0 6.9 14.3 13.1 13.8 15.6 23.1 9.9 11.7 60.6 12.5 13.9 15.2 27.8 12.3 15.2 19.0 27.4 14.7 9.9 16.1 9.8 15.0 45.4 23.9 28.9 16.2 17.9 21.3 14.3 16.6 22.2 17.4 25.0 7.0 12.8 24.0 24.8 10.1 14.8 19.3 8.4 16.3 20.3 17.3 9.9 17.2 9.2 18.2 16.7 1.7 11.1 8.7 19.3 8.7 9.1 4.4 9.2 5.6 16.7 10.9 6.1 7.4 13.7 6.7 7.6 5.8 19.4 12.6 16.6 11.2 30.3 7.4 7.6 8.4 7.1 13.1 13.2 28.6 5.5 8.0 10.1 8.4 6.3 9.9 16.0 12.1 15.2 15.7 11.5 28.6 17.0 22.6 14.8 6.1 11.2 9.3 7.0 26.2 10.7 11.0 4.7 13.3 16.9 5.1 19.0 11.4 20.9 15.8 28.1 12.8 13.5 18.5 6.0 5.0 2.4 5.8 6.7 30.1 32.7 14.4 14.4 10.8 16.3 0.2 7.1 1.7 11.3 10.4 14.0 18.2 14.5 12.1 11.1 15.3 19.3 16.7 1.0 8.7 11.1 16.7 10.7 8.7 12.3 13.4 6.9 14.3 12.3 15.2 16.1 9.8 17.9 8.4 26.8 36.1 32.3 46.9 29.3 19.4 74.2 43.3 56.2 26.1 41.8 9.8 49.2 76.3 48.2 68.0 32.1 27.7 0.0 62.5 46.0 37.9 46.4 16.1 77.3 60.5 15.9 43.1 32.5 40.6 54.3 63.9 44.6 35.4 37.9 52.5 26.5 65.1 55.4 32.9 92.2 26.6 64.7 43.9 193.5 109.2 23.1 43.7 28.8 53.6 46.5 PIKFYVE "FAB1, KIAA0981, MGC40423, p235, PIKfyve, PIP5K, PIP5K3, ZFYVE29" ENSG00000115020 "Phosphoinositide kinase, FYVE-type zinc finger containing" Q9Y2I7 2 208266267-208358751 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042558, HPA042604" Uncertain Supported Vesicles NA NA Vesicles "HPA042558: , HPA042604: AB_10796580" "unprognostic (1.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.88e-1)" "unprognostic (3.03e-1)" "unprognostic (2.04e-2)" "prognostic favorable (6.81e-4)" "unprognostic (6.82e-3)" "unprognostic (6.45e-2)" "unprognostic (1.85e-2)" "unprognostic (3.81e-2)" "unprognostic (1.77e-1)" "unprognostic (2.10e-2)" "unprognostic (1.32e-1)" "unprognostic (2.14e-1)" "unprognostic (3.29e-1)" "unprognostic (1.06e-1)" "unprognostic (7.05e-2)" 15.9 13.5 17.7 21.1 21.9 36.1 24.9 25.6 23.1 14.8 12.1 14.0 16.6 9.1 14.7 18.3 11.2 12.6 11.1 12.5 19.4 14.3 16.2 15.2 16.5 23.1 14.4 15.3 15.6 31.5 21.5 17.0 14.1 20.6 17.7 11.5 13.8 13.7 19.7 13.6 12.9 15.3 13.5 24.4 21.7 12.1 19.3 15.8 23.5 18.2 7.8 22.6 12.4 14.0 7.5 2.1 1.4 1.2 5.6 2.6 0.5 4.9 5.0 12.0 9.3 12.1 14.5 5.6 6.2 12.6 7.3 10.0 7.2 4.2 5.8 6.5 10.5 14.3 5.2 10.4 6.9 12.4 4.9 6.6 20.7 9.8 6.4 9.2 18.3 18.7 10.7 7.6 8.5 15.9 12.2 11.8 15.5 14.0 10.5 9.1 2.1 16.5 13.8 9.9 3.8 3.8 6.2 9.3 7.9 9.3 7.3 3.8 9.1 6.8 4.4 12.3 14.7 2.8 19.8 13.5 9.2 6.1 6.1 5.7 7.3 8.7 12.4 7.3 16.0 9.0 1.4 1.0 0.7 1.7 0.8 1.1 7.5 2.3 2.6 0.9 5.4 1.8 2.1 1.4 5.6 1.2 2.1 1.5 0.5 17.7 21.9 25.6 23.1 19.4 14.3 14.4 15.3 20.6 15.8 23.8 14.4 13.7 6.0 13.6 20.7 14.4 12.7 8.1 10.3 10.4 15.7 6.1 5.0 4.6 5.2 14.8 9.3 0.0 3.7 4.4 12.2 15.4 34.7 16.6 12.2 9.5 17.9 18.4 27.6 5.9 17.3 20.4 10.1 2.8 8.9 14.8 7.1 6.2 12.7 8.1 19.0 12.9 12.2 27.2 22.8 13.4 6.1 10.2 7.8 7.0 PINLYP ENSG00000234465 "Phospholipase A2 inhibitor and LY6/PLAUR domain containing" A6NC86 19 43576800-43583964 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 19.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 17.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HEL: 33.8;HMC-1: 22.6;JURKAT: 17.5;REH: 13.7;THP-1: 17.0" HPA061218 Uncertain Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA061218: AB_2684453" "unprognostic (6.72e-2)" "unprognostic (6.21e-2)" "unprognostic (4.72e-1)" "unprognostic (3.13e-2)" "unprognostic (2.46e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.22e-2)" "unprognostic (5.07e-2)" "unprognostic (2.00e-1)" "unprognostic (2.85e-2)" "unprognostic (1.14e-1)" "unprognostic (4.36e-3)" "unprognostic (1.95e-2)" "unprognostic (1.68e-1)" "unprognostic (1.08e-1)" "unprognostic (3.60e-2)" 3.6 2.0 5.6 1.8 6.5 1.2 4.0 3.7 2.5 7.4 3.9 0.6 6.8 7.1 5.0 13.1 6.6 4.2 4.4 4.6 7.9 0.3 2.9 2.9 4.2 13.1 0.6 0.0 5.6 1.6 4.5 2.0 2.3 8.1 0.0 2.0 1.7 8.3 2.9 3.0 2.1 1.8 4.0 3.3 2.7 4.4 3.2 17.4 6.6 1.2 0.9 3.3 1.5 0.3 0.1 0.9 0.0 1.6 2.2 0.1 0.4 0.6 0.8 2.1 0.0 0.0 0.0 0.1 8.9 0.8 2.0 0.0 0.0 0.8 0.0 0.1 33.8 0.3 0.0 5.1 0.0 22.6 5.0 0.3 5.1 0.0 2.4 1.4 17.5 0.4 0.4 0.3 0.2 4.0 0.5 0.8 0.0 0.3 13.7 0.1 0.0 0.4 0.2 0.2 0.0 0.0 0.1 0.0 0.1 0.0 17.0 0.6 2.2 0.4 0.0 1.5 0.0 0.0 2.0 7.8 0.0 0.1 6.6 1.2 0.5 2.6 0.8 3.2 1.4 0.8 2.1 1.8 3.2 0.2 3.3 0.0 0.9 0.2 17.4 1.6 1.5 11.9 2.7 1.3 8.9 3.2 5.6 2.2 12.7 17.4 7.9 8.7 5.9 0.4 19.9 1.0 4.7 4.5 0.0 0.0 0.3 0.4 6.7 3.3 0.0 0.0 4.1 6.4 0.0 6.2 0.6 4.2 10.6 1.8 5.0 5.4 0.5 5.5 0.3 0.0 9.2 14.0 3.4 0.0 5.1 2.6 0.9 2.8 0.1 0.0 0.4 6.4 PITPNM2 "NIR3, RDGB2, RDGBA2" ENSG00000090975 "Phosphatidylinositol transfer protein membrane associated 2" Q9BZ72 12 122983480-123150015 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 11 "lymphoid tissue: 169.5" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 51.1;Horizontal cells: 38.1;Late spermatids: 77.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 4.7" "Group enriched" "Detected in many" 4 "NK-cells: 4.7;T-cells: 2.3" "Cell line enhanced" "Detected in many" "HEL: 16.1;JURKAT: 20.1;MOLT-4: 29.7;WM-115: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003414, HPA003978" Approved Supported Vesicles NA NA Vesicles "HPA003414: AB_1855410, HPA003978: AB_1855411" "unprognostic (2.43e-1)" "unprognostic (9.29e-2)" "unprognostic (2.00e-1)" "unprognostic (5.39e-2)" "unprognostic (2.14e-1)" "unprognostic (6.76e-2)" "unprognostic (2.26e-2)" "unprognostic (1.08e-1)" "unprognostic (2.55e-1)" "unprognostic (6.44e-2)" "unprognostic (1.03e-1)" "unprognostic (9.28e-2)" "unprognostic (1.50e-3)" "unprognostic (7.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.19e-2)" "unprognostic (9.99e-2)" 3.4 5.9 3.3 3.2 7.9 3.5 3.1 9.3 8.0 3.9 3.5 2.4 3.2 3.5 3.6 5.2 3.7 2.5 2.2 4.6 2.8 2.2 3.7 4.3 5.1 6.1 2.4 2.6 14.0 2.5 5.3 4.2 3.0 2.3 2.7 1.6 3.7 2.7 3.1 3.3 3.0 3.6 4.5 2.5 3.3 2.7 14.8 2.2 169.5 2.3 2.2 4.3 4.7 2.7 0.8 0.0 0.1 0.1 4.7 2.3 1.6 2.4 4.9 1.6 2.3 1.1 2.2 9.6 0.4 0.6 1.3 0.7 2.1 2.1 0.0 2.1 0.8 2.7 7.1 1.3 1.2 0.4 0.1 1.5 16.1 2.8 5.7 0.8 0.6 3.4 1.0 2.1 1.7 1.3 6.2 2.5 20.1 3.6 0.2 1.6 1.6 29.7 3.3 1.8 0.7 2.2 8.6 0.1 6.1 2.3 2.6 1.4 0.5 3.5 2.9 2.3 0.9 0.6 1.7 7.4 1.9 2.1 3.1 2.8 0.5 0.5 11.4 4.7 1.2 14.3 0.0 0.0 0.1 2.3 0.0 0.2 0.4 0.6 1.7 0.0 0.8 1.5 1.4 0.0 4.7 0.1 0.0 1.1 1.6 3.3 7.9 9.3 8.0 2.8 2.2 2.4 2.6 2.3 2.2 0.0 5.3 0.8 0.5 3.2 15.9 6.1 2.5 0.0 2.3 8.7 51.1 1.0 1.7 2.8 25.0 6.7 4.3 0.0 3.9 5.0 1.9 0.6 1.1 12.9 0.4 38.1 0.0 6.2 0.8 77.8 1.7 0.6 1.7 1.0 3.7 3.7 3.7 0.0 4.6 2.2 15.5 0.0 2.8 3.6 2.3 1.4 3.1 1.0 2.3 0.4 PKN3 "PKNbeta, UTDP4-1" ENSG00000160447 "Protein kinase N3" Q6P5Z2 9 128702523-128720918 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Endothelial cells: 13.4;Extravillous trophoblasts: 5.1;Ito cells: 6.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 33.4;REH: 20.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA045390, HPA058305" Uncertain Approved Vesicles NA NA Vesicles "HPA045390: AB_2679308, HPA058305: AB_2683674" "unprognostic (4.36e-2)" "unprognostic (5.70e-2)" "unprognostic (2.68e-2)" "unprognostic (7.62e-2)" "unprognostic (2.23e-1)" "unprognostic (2.65e-2)" "unprognostic (6.10e-2)" "unprognostic (8.04e-2)" "unprognostic (1.78e-1)" "unprognostic (3.68e-1)" "unprognostic (1.48e-1)" "unprognostic (7.91e-2)" "unprognostic (8.73e-3)" "unprognostic (6.18e-3)" "unprognostic (9.99e-2)" "unprognostic (7.23e-2)" "unprognostic (2.36e-1)" 11.4 1.8 1.5 6.8 3.8 3.7 10.5 10.1 3.9 4.3 5.8 3.7 4.8 7.7 9.7 2.2 7.1 5.3 10.9 7.3 2.3 1.7 5.0 6.4 8.9 9.1 3.9 1.2 4.0 4.2 3.3 1.4 5.6 4.5 4.2 1.6 4.1 12.9 3.7 7.4 6.7 5.4 4.9 4.4 7.8 7.4 4.3 1.7 9.3 8.1 6.1 5.9 4.4 5.0 0.4 1.0 2.3 0.7 1.0 1.8 0.3 1.4 6.9 5.6 8.5 0.0 0.1 13.9 4.3 1.3 6.3 6.5 0.0 5.0 0.0 4.2 2.3 1.3 9.3 6.8 1.0 1.4 4.3 12.8 8.2 33.4 9.7 1.0 1.0 1.5 0.3 0.3 3.4 0.9 1.3 12.4 2.5 18.6 0.9 1.1 12.8 1.2 4.4 5.2 6.3 2.0 20.3 10.6 1.8 2.6 0.8 0.9 4.2 3.2 1.7 3.2 3.2 6.1 6.6 10.7 0.0 5.3 9.9 3.2 3.1 1.3 2.7 0.8 1.0 3.9 0.0 0.1 1.4 0.9 0.7 1.8 0.2 0.6 0.8 1.0 0.4 0.8 0.1 2.3 1.0 0.2 0.2 1.0 0.3 1.5 3.8 10.1 3.9 2.3 1.7 3.9 1.2 4.5 1.7 0.0 1.3 0.0 1.4 0.9 0.0 1.5 0.0 0.0 2.3 0.0 0.0 1.2 0.0 1.6 0.3 13.4 1.1 0.0 2.3 5.1 0.9 0.9 0.0 0.2 1.5 0.0 0.0 6.2 0.3 0.4 1.4 0.2 0.0 1.8 1.0 0.5 2.6 0.8 0.7 0.3 0.2 0.0 0.8 1.0 3.4 0.9 1.1 1.0 1.4 1.6 PLCH1 "DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3" ENSG00000114805 "Phospholipase C eta 1" Q4KWH8 3 155375580-155745067 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.7;testis: 15.8" "Cell type enriched" "Detected in many" 6 "Early spermatids: 148.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 8.4;AF22: 27.2;NTERA-2: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036176, HPA057978" Uncertain Enhanced Vesicles NA NA Vesicles "HPA036176: AB_10671837, HPA057978: AB_2683569" "unprognostic (1.08e-2)" "unprognostic (3.68e-1)" "unprognostic (2.17e-2)" "unprognostic (1.55e-2)" "unprognostic (3.50e-4)" "unprognostic (6.41e-2)" "unprognostic (2.94e-5)" "unprognostic (5.04e-2)" "unprognostic (2.41e-1)" "unprognostic (2.24e-3)" "unprognostic (4.84e-2)" "unprognostic (1.76e-2)" "prognostic favorable (3.03e-5)" "unprognostic (3.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.47e-1)" "unprognostic (1.37e-2)" 0.3 0.3 3.9 0.7 14.1 0.5 3.9 7.4 14.7 2.1 3.9 5.7 4.1 3.9 1.4 12.9 0.5 12.4 2.4 2.5 4.5 3.6 2.1 0.4 6.1 0.3 3.4 7.3 0.5 2.5 0.8 3.2 0.8 6.5 0.8 3.9 5.6 2.3 3.4 0.6 0.5 3.9 0.5 1.9 0.3 5.8 15.8 2.9 0.0 8.9 0.0 0.4 1.3 0.4 0.1 0.3 0.7 0.0 0.0 1.2 0.9 0.0 8.4 27.2 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.6 6.7 0.0 0.6 0.0 0.1 0.0 4.8 0.0 0.0 0.0 2.5 6.8 0.0 0.9 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.2 0.2 0.0 0.0 2.9 1.6 6.2 14.5 0.9 1.1 0.6 0.0 0.0 1.7 0.1 2.5 0.6 0.0 6.5 0.0 4.2 2.9 0.0 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.3 0.0 0.9 3.9 14.1 7.4 14.7 4.5 3.6 3.4 7.3 6.5 2.9 3.0 12.8 0.0 0.3 0.0 10.0 0.5 7.6 25.4 3.4 1.8 3.9 0.0 0.0 1.9 148.2 0.1 2.4 0.0 2.0 0.2 0.0 0.1 0.0 0.0 0.2 23.8 2.9 0.0 0.3 10.0 1.1 0.0 0.0 0.0 4.3 19.3 1.5 2.9 0.4 1.9 3.0 0.0 0.0 2.1 1.1 0.1 0.0 0.0 4.7 0.1 PLPP5 "DPPL1, HTPAP, PPAPDC1B" ENSG00000147535 "Phospholipid phosphatase 5" Q8NEB5 8 38263130-38269243 "Enzymes, Predicted membrane proteins" "Lipid metabolism" Hydrolase "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 77.8" "Cell type enhanced" "Detected in many" 4 "Glandular cells: 138.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "memory B-cell: 37.2;naive B-cell: 65.4" "Lineage enriched" "Detected in all" 5 "B-cells: 65.4" "Cell line enhanced" "Detected in many" "RPMI-8226: 51.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055777 Approved Vesicles NA NA Vesicles "HPA055777: AB_2682915" "unprognostic (4.54e-2)" "unprognostic (2.51e-3)" "unprognostic (3.66e-2)" "prognostic favorable (1.48e-5)" "unprognostic (1.80e-2)" "unprognostic (1.27e-2)" "unprognostic (5.58e-2)" "prognostic favorable (8.72e-5)" "unprognostic (9.79e-2)" "prognostic favorable (2.42e-5)" "unprognostic (1.50e-1)" "unprognostic (5.08e-2)" "prognostic unfavorable (8.33e-10)" "unprognostic (3.82e-2)" "unprognostic (1.58e-1)" "unprognostic (1.59e-3)" "unprognostic (1.57e-2)" 5.5 9.3 6.9 11.9 7.9 4.8 8.8 7.5 6.7 11.2 11.5 3.9 33.9 14.4 5.7 30.9 6.6 10.2 21.0 4.6 6.1 6.1 9.6 20.3 7.5 12.0 4.5 5.1 8.4 77.8 4.2 29.9 8.3 6.7 27.9 12.8 16.2 52.0 36.5 2.3 4.7 18.4 5.2 3.5 12.8 16.1 4.6 4.4 3.8 11.9 5.0 14.8 8.0 6.7 65.4 5.3 13.3 3.6 4.3 5.0 3.7 5.5 11.1 6.6 13.5 13.0 12.7 9.1 15.8 19.9 8.1 10.6 5.1 8.5 0.4 13.5 16.3 11.7 6.2 5.4 11.5 6.9 3.5 3.5 9.8 4.7 14.8 22.1 2.8 11.8 9.9 12.0 11.2 14.8 14.3 13.1 13.1 0.4 25.5 9.8 11.4 6.3 4.7 10.0 22.5 3.8 6.9 4.9 51.3 20.2 7.2 5.2 8.0 6.5 10.1 9.2 6.1 21.6 5.5 7.8 5.7 5.0 9.6 4.1 15.8 10.4 1.6 15.8 7.5 9.8 13.3 2.7 4.5 3.0 2.7 5.0 37.2 3.9 3.8 2.5 65.4 2.0 1.9 1.6 4.3 3.6 5.3 3.4 3.7 6.9 7.9 7.5 6.7 6.1 6.1 4.5 5.1 6.7 4.4 8.9 44.0 74.7 61.1 0.0 5.3 0.0 38.2 101.7 39.8 71.5 15.7 39.2 36.5 59.1 22.7 13.5 17.2 0.0 78.1 37.8 35.3 138.3 29.1 20.7 32.8 58.8 43.3 16.5 9.1 6.2 16.4 24.8 0.0 10.0 73.6 37.6 56.5 36.8 8.9 20.3 3.5 12.9 0.0 24.7 4.3 0.0 73.7 17.0 51.4 46.1 PMAIP1 "APR, NOXA" ENSG00000141682 "Phorbol-12-myristate-13-acetate-induced protein 1" Q13794 18 59899948-59904306 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 42.3;bone marrow: 45.5" "Cell type enhanced" "Detected in many" 9 "Basal keratinocytes: 713.3;Suprabasal keratinocytes: 604.1;Urothelial cells: 478.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "basophil: 42.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 51.8;U-138 MG: 50.1" HPA051063 Uncertain Uncertain Vesicles NA NA Vesicles "HPA051063: AB_2681330" "unprognostic (1.35e-3)" "unprognostic (5.02e-2)" "unprognostic (5.57e-2)" "unprognostic (4.88e-2)" "unprognostic (6.65e-3)" "unprognostic (3.76e-2)" "unprognostic (2.00e-3)" "unprognostic (1.26e-2)" "unprognostic (4.41e-2)" "unprognostic (6.12e-2)" "unprognostic (8.47e-3)" "unprognostic (5.56e-2)" "prognostic unfavorable (3.15e-6)" "unprognostic (2.53e-1)" "unprognostic (7.68e-2)" "unprognostic (8.74e-2)" "unprognostic (1.09e-1)" 1.9 0.4 2.2 9.4 2.4 45.5 3.1 0.9 2.5 6.0 2.8 1.6 0.1 2.2 3.3 1.7 12.4 1.7 4.8 1.3 3.3 2.3 1.3 1.3 10.9 7.8 2.6 0.8 1.6 1.3 5.6 27.3 14.7 3.3 3.0 2.0 0.6 3.9 0.8 1.8 20.2 6.4 1.1 2.3 7.6 1.7 1.7 0.8 12.7 1.3 11.7 18.7 7.3 6.8 10.6 3.7 42.3 9.2 1.9 7.4 4.1 6.2 4.2 1.3 0.4 2.2 17.3 4.8 30.1 20.5 17.6 17.6 0.4 7.8 24.7 4.2 5.6 51.8 9.3 5.0 2.8 17.4 7.9 37.4 4.5 6.3 1.0 22.0 15.5 7.0 7.1 7.6 23.1 12.0 6.4 5.8 11.3 6.1 4.3 5.8 0.6 12.4 4.7 37.0 0.6 7.9 12.7 7.0 9.0 10.2 5.8 9.8 8.0 1.5 0.8 16.7 14.5 1.2 12.9 21.7 50.1 13.3 2.5 33.4 0.7 0.0 21.6 4.1 8.9 11.7 42.3 5.1 30.5 3.5 7.8 3.1 10.6 1.6 2.2 3.7 7.8 1.4 1.9 16.3 1.9 9.2 3.0 7.4 4.1 2.2 2.4 0.9 2.5 3.3 2.3 2.6 0.8 3.3 0.8 29.8 22.6 94.8 231.2 713.3 0.2 2.8 10.2 25.4 37.5 3.5 2.0 82.2 0.0 47.6 0.3 21.1 112.8 0.0 57.4 7.9 58.2 192.2 32.2 0.0 75.3 0.0 127.9 6.7 15.8 1.0 0.9 67.5 70.9 235.4 45.1 0.2 105.0 80.7 1.1 0.2 0.7 0.0 36.8 0.2 3.6 604.1 263.6 50.7 55.5 478.7 PMEPA1 "STAG1, TMEPAI" ENSG00000124225 "Prostate transmembrane protein, androgen induced 1" Q969W9 20 57648392-57711536 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Signal transduction inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 60.4;prostate: 67.3" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 306.3;Glandular cells: 287.7;Muller glia cells: 308.1;Pancreatic endocrine cells: 506.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "naive B-cell: 5.2;plasmacytoid DC: 18.4" "Group enriched" "Detected in many" 7 "B-cells: 5.2;dendritic cells: 18.4" "Cell line enhanced" "Detected in many" "SiHa: 40.4;U-2 OS: 26.3;U-251 MG: 92.9;WM-115: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072291 Supported Vesicles "Intracellular and membrane" NA NA Vesicles "HPA072291: AB_2686509" "unprognostic (2.72e-3)" "prognostic unfavorable (2.45e-4)" "unprognostic (5.77e-2)" "unprognostic (1.73e-1)" "unprognostic (6.61e-2)" "unprognostic (2.11e-3)" "unprognostic (3.13e-2)" "prognostic unfavorable (4.73e-5)" "unprognostic (5.53e-1)" "unprognostic (1.32e-3)" "unprognostic (7.83e-3)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.87e-7)" "unprognostic (1.16e-1)" "unprognostic (2.35e-1)" "unprognostic (9.87e-3)" "prognostic unfavorable (7.60e-4)" 27.0 7.8 7.5 10.6 34.8 1.3 9.5 2.6 12.6 60.4 10.8 11.0 4.2 4.4 22.1 6.7 7.1 7.7 21.8 10.7 7.5 8.6 5.3 1.7 8.5 4.5 10.2 5.9 6.2 18.6 2.6 5.6 3.0 12.1 67.3 5.7 21.3 11.6 13.3 17.4 6.8 7.6 17.6 8.1 4.0 5.3 3.2 9.1 1.3 5.4 6.0 6.2 8.4 13.0 5.2 18.4 0.1 0.3 0.0 1.6 0.4 6.0 14.8 0.4 0.7 0.4 0.0 0.1 0.9 0.0 0.3 0.1 0.2 19.2 0.0 3.5 1.4 10.4 23.5 0.3 19.8 0.2 0.1 0.8 0.0 4.1 0.0 0.3 0.0 0.1 0.2 11.1 0.8 2.4 3.3 2.5 13.3 0.1 0.2 1.2 12.5 0.7 0.1 1.8 2.9 1.9 0.0 7.2 2.1 4.8 0.0 3.5 2.7 40.4 24.0 2.8 1.1 3.7 0.7 6.4 3.6 26.3 0.3 92.9 1.1 0.1 0.0 1.6 0.2 46.8 0.0 0.3 0.0 0.0 0.0 0.0 2.2 0.6 0.2 0.0 5.2 1.6 0.9 0.1 0.0 0.0 18.4 0.4 0.4 7.5 34.8 2.6 12.6 7.5 8.6 10.2 5.9 12.1 9.1 53.6 35.4 14.7 85.0 148.4 56.2 22.6 114.7 0.0 14.8 10.4 2.0 0.0 3.3 306.3 1.1 39.7 9.5 0.0 53.6 2.0 27.8 287.7 60.9 0.0 5.6 1.6 9.7 16.0 3.4 1.4 2.8 6.7 30.4 10.0 11.5 308.1 506.6 17.5 20.5 1.3 6.6 71.1 116.0 0.0 6.8 156.0 0.1 1.9 9.2 71.5 POLB ENSG00000070501 "DNA polymerase beta" P06746 8 42338454-42371808 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, DNA synthesis" "DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 73.6" "Group enriched" "Detected in many" 5 "Early spermatids: 173.0;Late spermatids: 102.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 73.6" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 81.2" "Low region specificity" "Detected in all" "CAB011616, HPA049104" Enhanced Uncertain Vesicles NA NA Vesicles "CAB011616: AB_731977, HPA049104: AB_2680632" "unprognostic (1.67e-1)" "unprognostic (2.68e-3)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.46e-4)" "unprognostic (8.49e-2)" "unprognostic (2.64e-2)" "unprognostic (4.24e-2)" "unprognostic (1.02e-1)" "unprognostic (2.31e-2)" "unprognostic (1.99e-1)" "unprognostic (4.57e-2)" "unprognostic (4.77e-1)" "prognostic unfavorable (2.15e-5)" "unprognostic (1.06e-2)" "unprognostic (1.40e-1)" "unprognostic (4.22e-2)" "prognostic favorable (5.65e-4)" 5.5 8.6 10.1 9.5 10.7 21.9 13.5 73.6 16.6 7.0 5.5 5.8 6.0 4.9 6.2 11.2 12.4 6.3 11.3 16.3 9.8 9.6 7.2 15.8 9.1 11.8 8.4 10.3 10.3 7.7 10.3 11.6 5.0 10.9 11.4 6.3 6.8 22.1 6.9 36.6 10.8 4.9 6.6 10.0 8.1 6.4 29.5 5.4 9.7 7.7 17.2 10.1 11.5 9.2 4.9 33.8 25.1 9.4 7.9 7.2 4.2 11.0 6.6 11.5 23.0 6.4 6.1 9.7 7.1 8.2 11.7 10.8 9.3 13.0 10.0 9.0 4.5 12.4 5.7 9.6 8.2 14.5 6.5 10.4 7.3 5.5 12.5 9.9 5.1 81.2 5.4 9.8 8.6 10.2 14.9 8.9 21.6 15.8 6.4 11.3 6.6 21.2 14.5 15.5 13.2 7.6 12.1 11.6 8.6 22.0 8.9 6.6 11.9 8.4 5.6 21.3 12.4 14.9 8.8 4.9 5.6 7.8 14.0 6.8 9.3 15.6 14.1 5.6 10.9 14.6 12.5 5.9 17.3 4.9 7.2 5.5 4.9 5.2 5.3 6.1 4.5 5.8 5.4 25.1 7.9 9.4 33.8 7.2 4.2 10.1 10.7 73.6 16.6 9.8 9.6 8.4 10.3 10.9 5.4 3.0 12.8 13.8 19.3 14.9 3.3 19.1 7.6 22.7 28.4 7.0 7.9 6.3 5.0 11.3 173.0 10.3 3.6 0.0 8.4 5.6 5.6 27.3 22.0 11.9 6.5 6.4 5.8 6.2 5.6 102.4 6.6 8.9 6.8 4.6 4.7 6.0 22.7 5.9 3.5 5.6 4.3 0.0 5.8 19.1 12.9 17.6 9.3 10.5 6.1 25.5 PORCN "DHOF, MG61, por, PORC, PPN" ENSG00000102312 "Porcupine O-acyltransferase" Q9H237 X 48508962-48520814 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Acyltransferase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Pancreatic endocrine cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 61.3;LHCN-M2: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049215, HPA058413" Enhanced Approved Vesicles NA NA Vesicles "HPA049215: , HPA058413: AB_2683711" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (4.01e-2)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (1.26e-3)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.69e-1)" "unprognostic (1.37e-1)" "unprognostic (1.37e-1)" "unprognostic (2.35e-1)" 4.6 31.4 9.1 4.4 14.1 3.6 4.4 20.0 15.4 12.6 4.6 7.2 12.2 3.4 10.1 3.2 13.9 7.0 6.2 13.4 10.9 9.2 3.3 1.7 5.0 6.6 7.1 8.8 4.9 4.6 6.9 4.1 4.0 8.4 5.0 2.5 7.6 5.8 16.4 5.9 6.8 2.9 6.3 5.5 4.8 5.4 5.4 5.9 2.6 8.5 4.7 5.9 6.5 5.4 4.1 7.2 13.7 5.8 7.8 12.0 4.7 4.4 5.3 1.3 9.3 5.7 3.4 0.5 1.3 2.7 2.0 1.4 0.6 6.8 0.3 5.6 2.8 2.3 6.0 1.9 61.3 0.6 2.8 0.6 0.7 3.2 1.3 8.5 0.7 8.0 4.4 7.2 5.9 12.8 4.8 1.8 2.2 0.3 4.2 21.3 1.2 0.7 0.9 1.7 1.3 3.6 1.3 1.6 6.9 3.4 1.7 1.5 2.3 10.7 2.0 2.0 0.9 2.3 0.3 1.1 5.3 2.8 12.8 2.3 3.7 2.0 0.5 15.3 1.6 3.0 13.7 5.8 7.1 12.0 5.2 9.4 3.7 8.0 10.0 7.2 4.1 5.4 8.1 1.2 7.8 4.2 3.9 5.2 4.7 9.1 14.1 20.0 14.4 10.9 9.2 7.1 8.8 8.4 5.9 6.0 3.2 3.0 4.4 3.5 12.7 2.7 2.5 4.0 4.5 15.7 17.7 0.0 1.7 5.2 0.2 3.5 0.0 0.0 8.6 1.1 4.1 2.3 5.7 1.0 3.1 7.9 5.8 4.9 2.8 0.0 5.2 2.9 3.3 2.8 2.0 9.3 22.6 1.5 3.9 0.7 15.7 6.5 4.7 1.0 3.4 3.3 6.9 6.5 1.2 5.6 PPA1 "IOPPP, PP, PP1, Ppase, SID6-8061" ENSG00000180817 "Pyrophosphatase (inorganic) 1" Q15181 10 70202830-70233911 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 942.2;Muller glia cells: 982.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019878, HPA020096" Supported Supported Vesicles NA NA 110000 Vesicles "HPA019878: AB_1855601, HPA020096: AB_1855600" "unprognostic (1.50e-1)" "unprognostic (2.85e-1)" "unprognostic (4.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.42e-1)" "unprognostic (4.47e-2)" "unprognostic (2.86e-2)" "unprognostic (9.43e-2)" "unprognostic (3.34e-1)" "unprognostic (1.62e-1)" "unprognostic (2.13e-2)" "unprognostic (3.60e-2)" "unprognostic (1.82e-3)" "unprognostic (5.36e-2)" "unprognostic (2.37e-1)" "unprognostic (3.53e-2)" "unprognostic (2.74e-1)" 46.6 55.5 41.3 36.8 56.0 24.2 88.7 66.8 62.2 34.8 45.7 25.2 43.7 33.2 30.4 59.6 48.6 38.1 31.5 30.0 46.7 54.2 40.7 59.0 39.1 54.6 74.3 47.5 17.9 72.6 23.3 29.5 34.6 60.7 24.4 53.4 26.1 36.8 42.1 37.0 24.6 41.0 32.8 72.7 22.4 32.5 25.1 47.2 20.4 52.0 35.8 44.4 32.7 40.2 21.5 48.9 1.0 17.7 15.5 35.6 25.3 58.1 24.1 21.6 63.7 58.8 51.9 20.3 21.8 41.1 34.2 36.1 73.5 30.9 84.3 19.9 21.7 22.3 47.1 63.2 42.5 35.0 79.2 60.1 23.0 24.4 41.9 37.2 56.7 14.6 34.0 50.9 27.4 73.1 37.6 41.4 42.8 53.7 45.5 32.2 34.1 54.8 53.2 22.5 80.7 67.0 33.6 24.8 49.3 71.4 36.6 65.0 21.9 24.0 94.1 18.6 15.8 23.5 25.5 18.7 9.5 36.2 31.2 41.3 15.0 32.8 61.8 14.7 79.6 8.3 0.0 17.7 0.4 13.3 13.8 35.6 21.5 30.8 23.1 48.9 13.8 34.2 28.9 1.0 15.5 14.5 11.3 30.1 25.3 41.3 56.0 66.8 62.2 46.7 54.2 74.3 47.5 60.7 47.2 208.4 123.3 139.4 261.1 238.0 182.7 75.4 170.7 77.6 178.6 102.9 163.0 265.6 170.8 481.5 21.2 172.8 203.5 23.3 678.8 222.3 156.3 255.5 36.8 132.9 92.5 81.0 156.1 38.1 69.1 22.2 101.5 81.2 172.1 942.2 201.5 982.7 518.3 210.2 110.3 442.0 227.9 64.7 156.5 149.9 174.8 224.7 205.5 113.0 280.4 496.2 PPIP5K2 "CFAP160, HISPPD1, KIAA0433, VIP2" ENSG00000145725 "Diphosphoinositol pentakisphosphate kinase 2" O43314 5 103120149-103212799 "Enzymes, Predicted intracellular proteins" Hearing "Kinase, Transferase" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037895, HPA038442" Approved Approved Vesicles NA NA Vesicles "HPA037895: AB_2675724, HPA038442: AB_10673173" "unprognostic (2.18e-1)" "unprognostic (1.04e-1)" "unprognostic (2.36e-2)" "unprognostic (1.93e-1)" "unprognostic (8.83e-2)" "unprognostic (1.60e-3)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "unprognostic (1.60e-2)" "unprognostic (8.59e-3)" "unprognostic (1.39e-1)" "unprognostic (2.12e-1)" "unprognostic (4.32e-2)" "unprognostic (1.29e-1)" "unprognostic (4.06e-1)" "prognostic unfavorable (1.12e-4)" "unprognostic (8.80e-2)" 21.6 20.5 12.6 18.2 18.4 37.9 22.3 30.7 24.2 26.1 23.8 9.7 16.0 14.3 22.6 20.3 17.0 18.5 17.7 16.4 13.2 17.6 21.9 22.6 14.8 20.6 19.5 18.7 26.8 25.5 22.3 40.3 21.6 37.2 18.4 22.1 10.5 17.4 21.7 5.7 16.4 20.2 16.0 19.8 27.7 18.6 13.5 16.2 38.5 20.0 12.9 20.3 16.9 18.2 12.1 15.7 24.3 18.2 10.0 11.2 6.7 9.7 9.5 18.5 21.4 15.0 19.5 16.7 20.2 14.1 12.7 17.5 8.0 16.5 22.9 19.8 20.2 17.9 6.0 16.0 12.1 20.8 18.1 8.4 29.1 17.9 12.7 11.1 25.0 26.4 13.0 9.1 17.9 16.5 11.4 14.1 15.1 30.1 21.1 18.8 8.2 21.6 17.6 20.1 4.3 22.3 20.6 16.5 31.4 13.6 11.2 10.4 13.6 13.9 14.6 13.6 13.6 11.5 17.0 14.1 18.2 8.2 20.2 15.1 13.4 30.4 31.1 10.6 39.8 17.0 23.0 13.4 24.3 8.7 13.8 10.7 12.1 8.4 9.0 15.7 11.3 11.1 11.2 13.0 10.0 18.2 9.3 7.3 6.7 12.6 18.4 30.7 24.2 13.2 17.6 19.5 18.7 37.2 16.2 44.7 17.2 18.1 11.4 12.0 34.2 42.3 20.4 29.4 37.5 15.7 43.2 10.7 5.0 9.7 3.7 21.5 17.0 0.0 14.8 16.5 16.2 12.8 41.7 17.9 26.3 15.9 15.6 14.7 40.6 4.5 27.3 34.8 11.8 16.2 21.5 15.6 13.5 21.0 22.3 17.5 25.9 6.5 14.6 28.9 11.1 13.8 21.7 17.0 25.4 11.4 PPM1J "DKFZp434P1514, FLJ35951, MGC19531, PP2Czeta, PPP2CZ" ENSG00000155367 "Protein phosphatase, Mg2+/Mn2+ dependent 1J" Q5JR12 1 112709994-112715477 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 30.9;skeletal muscle: 45.1;testis: 31.9" "Group enriched" "Detected in many" 8 "Early spermatids: 105.4;Late spermatids: 189.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 9 "plasmacytoid DC: 30.9" "Lineage enriched" "Detected in many" 17 "dendritic cells: 30.9" "Cell line enhanced" "Detected in many" "T-47d: 20.4" "Region enriched" "Detected in some" 8 "olfactory region: 33.6" "Low region specificity" "Detected in all" HPA046045 Uncertain Approved Vesicles NA NA Vesicles "HPA046045: AB_2679516" "unprognostic (8.68e-2)" "unprognostic (5.65e-2)" "unprognostic (3.29e-2)" "unprognostic (2.59e-1)" "unprognostic (2.93e-3)" "unprognostic (2.34e-2)" "unprognostic (3.55e-2)" "unprognostic (3.74e-2)" "unprognostic (2.55e-1)" "unprognostic (9.30e-3)" "unprognostic (3.36e-2)" "unprognostic (7.22e-2)" "unprognostic (1.80e-2)" "unprognostic (1.27e-2)" "unprognostic (1.46e-1)" "unprognostic (2.28e-2)" "unprognostic (9.96e-4)" 0.8 2.3 6.4 0.9 4.8 0.8 1.9 7.8 6.8 0.9 0.7 2.1 1.6 0.7 1.4 14.8 3.0 2.4 1.3 5.4 4.3 4.8 1.2 0.7 0.7 2.4 3.7 4.4 1.3 3.8 2.4 1.1 0.8 3.9 1.4 0.7 1.5 2.3 2.3 45.1 13.3 0.6 1.3 1.6 1.3 0.7 31.9 0.7 1.4 1.6 5.3 1.9 1.6 1.5 0.4 30.9 0.0 1.7 0.0 0.0 0.3 2.7 0.1 1.6 1.7 0.8 1.6 1.2 0.3 0.8 0.3 1.0 1.2 0.8 0.4 0.5 0.8 0.9 5.1 1.1 4.8 0.4 0.0 2.8 0.8 0.2 0.2 1.0 0.0 0.2 1.8 3.2 0.9 4.9 1.1 2.2 0.2 1.0 0.0 1.2 2.9 0.0 0.0 1.7 1.5 2.4 0.1 0.2 0.0 2.9 0.1 0.8 0.2 0.6 4.6 1.4 2.4 20.4 0.0 1.2 0.3 3.0 0.0 0.2 0.1 0.0 0.0 2.5 0.6 2.7 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.0 0.0 3.2 0.4 0.0 0.0 0.0 0.0 1.7 30.9 0.0 0.3 6.4 4.8 7.8 6.8 4.3 4.8 3.7 4.4 3.9 0.7 0.0 0.3 0.0 3.5 1.9 3.1 4.8 0.0 0.0 1.2 1.8 9.8 0.9 8.3 2.0 105.4 2.2 0.5 0.0 3.7 1.1 1.3 3.3 0.0 0.0 0.6 0.0 0.0 0.6 0.8 189.5 2.8 1.8 0.0 1.0 0.7 19.0 1.6 3.2 2.5 0.6 8.4 6.5 2.7 2.3 11.5 2.5 0.5 0.0 0.6 2.3 PPM1N FLJ40125 ENSG00000213889 "Protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)" Q8N819 19 45488777-45502510 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "blood: 43.7;skeletal muscle: 81.9" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 29.5;Extravillous trophoblasts: 60.2;Rod photoreceptor cells: 73.0" "Cancer enhanced" "Detected in many" "testis cancer: 11.3" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 6 "non-classical monocyte: 43.7" "Lineage enriched" "Detected in all" 10 "monocytes: 43.7" "Cell line enhanced" "Detected in many" "OE19: 16.9;RT4: 21.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043577 Supported Vesicles NA NA Vesicles "HPA043577: " "unprognostic (2.38e-2)" "unprognostic (1.11e-2)" "unprognostic (8.53e-2)" "unprognostic (6.59e-2)" "unprognostic (4.71e-1)" "unprognostic (2.64e-2)" "unprognostic (1.98e-3)" "unprognostic (1.02e-1)" "unprognostic (1.25e-1)" "unprognostic (4.45e-2)" "unprognostic (9.27e-2)" "unprognostic (2.48e-2)" "unprognostic (1.11e-16)" "unprognostic (3.42e-2)" "unprognostic (1.79e-1)" "unprognostic (3.92e-2)" "unprognostic (1.86e-3)" 1.7 0.9 5.4 1.2 4.5 1.3 1.9 0.7 4.1 1.3 1.7 0.1 0.7 0.6 1.5 1.0 2.2 0.8 1.0 0.9 3.3 2.3 1.2 1.5 1.5 1.6 2.6 2.2 0.8 0.5 1.3 1.4 2.4 2.7 2.3 1.0 10.6 1.5 1.4 81.9 2.4 1.4 2.6 3.4 15.7 1.7 2.9 3.5 2.5 0.9 0.0 2.4 4.0 1.9 1.9 4.3 2.3 43.7 1.1 2.9 1.9 1.9 5.0 0.9 3.8 4.4 5.9 11.0 1.4 2.2 0.4 1.7 1.2 11.7 7.9 2.4 1.3 3.0 5.5 2.2 1.6 0.7 7.7 3.2 6.3 2.0 1.4 1.1 0.5 13.4 2.5 2.5 2.2 1.3 2.9 0.7 3.1 7.1 7.2 0.8 1.3 2.2 3.4 3.0 16.9 1.1 1.4 1.1 2.2 2.4 21.3 4.3 5.1 0.7 8.1 6.2 6.8 2.8 1.9 1.0 6.2 3.8 3.0 1.0 1.2 3.1 1.6 4.5 1.6 5.4 1.7 1.6 1.0 2.2 7.2 2.0 1.9 1.4 2.2 4.3 1.3 1.6 2.9 2.3 1.1 43.7 0.8 1.5 1.9 5.4 4.5 0.7 4.1 3.3 2.3 2.6 2.2 2.7 3.5 0.0 2.4 10.4 8.5 3.1 9.5 1.6 2.5 0.0 1.2 3.5 29.5 2.7 0.0 2.5 12.0 1.8 5.2 0.0 1.6 60.2 3.8 5.0 6.9 0.8 16.7 1.6 2.9 4.9 10.1 4.5 0.9 14.1 1.7 1.8 3.1 8.1 3.2 2.5 0.7 0.3 73.0 0.0 0.9 1.0 9.8 3.6 7.1 6.9 2.5 7.6 PPP1R11 "CFAP255, HCG-V, HCGV, TCTE5, Tctex5" ENSG00000204619 "Protein phosphatase 1 regulatory inhibitor subunit 11" O60927 6 30066709-30070333 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Protein phosphatase inhibitor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 93.3" "Cell type enhanced" "Detected in many" 9 "Late spermatids: 578.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 18.8;AN3-CA: 25.1;HBEC3-KT: 15.7;HEL: 15.1;JURKAT: 29.4;RPTEC TERT1: 17.5;U-266/84: 16.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043266, HPA060174" Approved Approved Vesicles NA NA Vesicles "HPA043266: AB_2678400, HPA060174: AB_2684216" "unprognostic (2.00e-2)" "unprognostic (1.10e-1)" "unprognostic (8.88e-2)" "unprognostic (4.24e-2)" "unprognostic (3.45e-1)" "unprognostic (1.05e-1)" "unprognostic (1.77e-2)" "unprognostic (1.18e-1)" "unprognostic (2.81e-1)" "unprognostic (1.74e-3)" "unprognostic (3.33e-2)" "unprognostic (2.68e-1)" "unprognostic (8.36e-3)" "unprognostic (1.74e-1)" "unprognostic (3.31e-1)" "unprognostic (2.21e-1)" "unprognostic (4.69e-3)" 36.0 18.2 18.5 8.3 21.6 4.4 12.9 9.8 31.7 11.0 27.0 17.3 7.9 33.2 16.0 93.3 26.8 33.7 23.9 16.8 16.6 17.6 18.2 22.6 12.9 13.2 15.5 14.5 26.2 33.1 5.9 8.8 21.1 14.6 13.6 4.6 14.0 20.4 8.8 39.0 37.0 28.6 9.4 13.4 16.0 27.2 18.1 11.4 16.9 20.6 10.9 29.6 15.8 12.4 2.6 2.7 4.4 3.5 0.8 3.2 1.8 18.8 0.0 0.0 25.1 11.1 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 12.1 0.0 0.0 15.7 0.0 0.0 12.9 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 29.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.5 8.2 0.0 0.0 0.0 8.5 0.2 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 16.7 7.3 0.0 0.0 0.0 2.9 2.6 4.4 1.7 3.5 2.0 2.1 1.9 3.1 1.3 2.6 2.7 2.1 2.9 0.8 2.9 2.7 3.2 1.8 18.5 21.6 9.8 31.7 16.6 17.6 15.5 14.5 14.6 11.4 17.9 19.8 58.2 65.2 46.9 29.4 15.0 43.3 24.1 19.4 38.4 5.9 51.3 81.2 116.6 185.3 36.0 115.4 0.0 120.0 106.5 33.8 60.5 77.3 26.0 59.8 12.7 51.5 36.8 38.6 578.9 30.0 49.9 59.1 73.1 76.9 44.8 105.0 77.2 37.8 70.2 30.1 38.8 48.4 51.5 22.6 58.2 62.9 66.0 52.1 78.8 PPP1R15A GADD34 ENSG00000087074 "Protein phosphatase 1 regulatory subunit 15A" O75807 19 48872392-48876057 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Stress response, Translation regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 156.9" "Cell type enhanced" "Detected in all" 4 "Smooth muscle cells: 862.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 69.8" "Group enriched" "Detected in all" 5 "dendritic cells: 23.8;granulocytes: 69.8" "Cell line enhanced" "Detected in all" "HHSteC: 55.5;hTERT-HME1: 95.7" "Low region specificity" "Detected in all" "CAB018395, HPA020240" Approved Uncertain Vesicles NA NA Vesicles "CAB018395: AB_2237473, HPA020240: AB_1849404" "unprognostic (2.43e-3)" "unprognostic (3.21e-1)" "unprognostic (7.75e-2)" "unprognostic (1.17e-3)" "unprognostic (2.22e-2)" "unprognostic (6.17e-2)" "prognostic unfavorable (1.95e-4)" "unprognostic (5.46e-2)" "unprognostic (2.66e-2)" "unprognostic (7.16e-3)" "unprognostic (5.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.22e-1)" "unprognostic (6.43e-3)" "unprognostic (1.49e-1)" "unprognostic (1.29e-2)" "unprognostic (6.94e-2)" 39.8 29.1 16.2 33.6 12.9 156.9 56.3 12.1 12.8 26.3 19.7 13.6 12.0 12.0 37.8 19.5 28.2 34.0 32.3 42.0 14.6 13.9 18.6 18.6 56.5 10.6 29.5 6.3 24.5 10.9 9.8 16.2 44.7 31.5 28.2 15.6 12.4 9.2 23.6 35.2 40.0 16.0 36.2 17.7 13.3 19.8 14.5 17.8 3.4 18.6 46.7 19.0 41.1 114.7 8.1 23.8 69.8 10.3 2.5 6.1 6.6 10.1 4.4 4.7 3.9 13.9 7.9 7.5 17.8 28.0 20.4 18.6 6.7 5.2 3.5 4.8 12.8 28.1 7.3 1.7 9.3 15.5 1.9 2.7 15.9 2.5 3.3 55.5 3.6 22.9 10.8 25.9 28.1 95.7 9.2 10.6 4.0 21.3 29.6 13.1 1.1 2.0 5.1 1.1 18.5 8.0 2.3 4.4 1.1 4.2 11.9 2.7 4.6 9.2 6.3 40.3 5.2 2.2 6.6 11.3 24.4 6.1 17.0 10.9 15.9 12.6 3.3 8.9 2.5 29.2 27.4 10.3 17.7 4.9 6.3 4.3 8.1 4.8 4.0 7.3 5.5 2.7 2.4 69.8 2.5 7.1 23.8 6.1 6.6 16.2 12.9 12.1 12.8 14.6 13.9 29.5 6.3 31.5 17.8 268.0 205.4 97.6 586.8 428.3 24.0 122.8 56.0 235.5 175.1 12.2 33.4 76.9 3.3 199.0 3.9 212.9 352.3 46.7 84.3 175.7 303.2 750.2 686.4 11.0 180.2 33.4 163.8 100.7 105.3 3.6 54.4 379.2 376.2 163.3 114.7 30.7 160.5 315.6 21.5 6.2 26.9 84.1 862.1 4.9 11.1 376.8 241.2 156.6 127.8 653.4 PPP3CC "CALNA3, PP2Bgamma" ENSG00000120910 "Protein phosphatase 3 catalytic subunit gamma" P48454 8 22440819-22541142 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 88.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023396, CAB024950" Approved Approved Vesicles NA NA Vesicles "CAB024950: , HPA023396: AB_1855663" "unprognostic (7.66e-3)" "unprognostic (1.61e-2)" "unprognostic (1.55e-1)" "unprognostic (1.01e-1)" "unprognostic (1.38e-1)" "unprognostic (2.21e-2)" "unprognostic (7.71e-2)" "prognostic favorable (6.80e-5)" "unprognostic (9.25e-2)" "unprognostic (1.97e-1)" "unprognostic (8.84e-2)" "unprognostic (4.05e-2)" "unprognostic (7.16e-2)" "unprognostic (2.35e-2)" "unprognostic (4.00e-1)" "unprognostic (2.78e-2)" "unprognostic (1.64e-2)" 18.0 8.3 6.9 13.7 8.1 15.2 21.1 11.9 12.0 10.3 10.2 10.9 3.7 6.1 13.4 7.8 11.6 9.0 10.7 27.5 7.6 7.3 8.9 8.2 16.5 22.3 7.7 4.9 10.1 9.9 13.7 15.1 12.7 9.9 11.1 7.1 20.7 15.5 6.0 52.4 9.1 9.8 13.5 7.9 14.1 9.5 41.6 6.9 6.8 11.5 13.2 20.0 14.7 11.0 15.5 4.0 6.6 2.9 11.9 16.0 3.9 5.5 4.1 3.6 4.4 9.7 12.1 5.3 7.7 13.6 11.5 12.8 2.3 3.5 21.0 9.5 11.9 19.2 3.9 8.4 7.7 14.7 12.0 4.5 4.5 4.7 6.7 13.1 3.2 7.4 7.3 10.7 7.7 7.9 12.3 9.9 10.3 8.8 28.0 12.8 2.6 7.5 5.3 2.6 5.7 5.6 24.7 8.6 6.9 10.7 5.2 2.6 6.1 5.8 3.4 7.9 7.2 2.3 5.4 10.6 17.9 3.8 27.1 5.9 14.0 16.9 22.0 9.5 4.3 11.8 3.4 1.6 6.6 11.4 2.0 8.7 15.5 12.9 16.0 3.2 13.9 12.4 10.1 0.4 11.9 2.9 4.0 10.1 3.9 6.9 8.1 11.9 12.0 7.6 7.3 7.7 4.9 9.9 6.9 6.0 3.2 39.8 18.1 14.7 9.7 7.0 12.7 2.7 3.4 7.0 45.2 15.0 6.6 12.0 88.7 24.7 7.2 0.0 18.7 19.5 22.6 23.7 3.5 6.8 11.9 3.2 9.9 23.9 11.3 9.4 20.8 18.5 27.0 43.3 3.1 12.3 15.5 9.9 20.1 10.4 50.5 32.3 26.2 71.2 27.9 9.9 11.8 43.6 6.0 23.0 PPT2 ENSG00000221988 "Palmitoyl-protein thioesterase 2" Q9UMR5 6 32153441-32163680 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 15.7;Syncytiotrophoblasts: 19.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 16.0;EFO-21: 11.8;HEK 293: 20.4;MCF7: 8.7;RPTEC TERT1: 10.1;SK-MEL-30: 13.3;SuSa: 10.4" HPA000414 Supported Vesicles "Intracellular and membrane" NA NA Vesicles "HPA000414: " "unprognostic (1.90e-2)" "unprognostic (1.09e-1)" "unprognostic (2.95e-1)" "prognostic unfavorable (5.03e-5)" "unprognostic (1.62e-1)" "unprognostic (6.75e-3)" "unprognostic (2.92e-3)" "unprognostic (6.41e-3)" "unprognostic (7.12e-2)" "unprognostic (2.56e-3)" "unprognostic (5.28e-3)" "unprognostic (1.12e-2)" "unprognostic (2.75e-3)" "unprognostic (5.09e-2)" "unprognostic (2.94e-1)" "unprognostic (4.89e-2)" "unprognostic (1.24e-3)" 8.5 13.1 10.4 9.3 10.6 3.0 9.6 21.9 11.8 16.1 10.5 13.1 11.7 15.8 13.8 14.9 13.7 14.2 10.6 12.3 10.7 7.5 17.8 13.1 14.3 6.6 12.2 7.7 25.1 7.0 3.1 7.7 14.3 9.8 10.5 9.6 16.1 7.2 11.4 19.1 30.9 6.9 10.4 7.1 11.8 15.2 6.4 11.5 11.5 7.4 13.2 8.1 13.9 12.0 0.2 0.0 0.3 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 16.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.8 0.0 4.8 1.6 2.6 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.1 0.0 1.2 1.3 0.0 7.4 0.0 0.4 1.0 8.7 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.1 7.0 0.2 13.3 10.4 0.0 0.4 0.0 0.0 6.0 0.0 0.0 0.5 7.1 0.9 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.2 0.0 0.0 0.4 0.0 10.4 10.6 21.9 11.8 10.7 7.5 12.2 7.7 9.8 11.5 0.0 0.3 0.0 2.7 3.0 12.0 5.8 2.5 0.0 3.4 3.5 15.7 11.6 1.7 1.4 0.2 4.6 1.3 0.0 2.6 7.8 4.8 1.0 0.0 3.9 2.4 3.2 4.7 4.9 1.5 1.0 3.7 1.4 6.8 0.0 2.9 7.5 1.3 3.4 2.8 2.3 5.2 0.0 4.7 3.1 4.5 1.9 19.5 1.3 2.8 1.3 PQLC2 FLJ20320 ENSG00000040487 "PQ loop repeat containing 2" Q6ZP29 1 19312326-19329300 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 31.3;Syncytiotrophoblasts: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057810 Approved Supported Vesicles NA NA Vesicles "HPA057810: AB_2683535" "unprognostic (7.84e-3)" "unprognostic (6.56e-2)" "unprognostic (6.54e-2)" "prognostic favorable (3.50e-4)" "unprognostic (3.77e-3)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.64e-5)" "unprognostic (2.61e-1)" "unprognostic (4.47e-2)" "unprognostic (1.04e-1)" "unprognostic (1.42e-3)" "unprognostic (3.82e-2)" "unprognostic (4.70e-3)" "unprognostic (8.64e-2)" "unprognostic (2.07e-1)" "unprognostic (6.56e-2)" "unprognostic (4.46e-2)" 10.9 19.9 11.7 8.5 12.3 18.4 9.4 28.8 16.2 12.2 13.1 16.8 8.6 16.9 11.5 15.5 9.2 8.8 11.1 9.3 10.6 11.2 11.9 20.3 12.1 11.1 14.3 9.1 10.9 19.4 10.0 19.4 24.8 14.4 11.7 7.7 18.9 12.1 11.0 10.9 15.3 16.2 9.3 12.2 12.2 13.3 13.8 10.9 6.2 14.0 9.2 10.5 8.0 9.0 5.1 16.7 7.8 10.1 2.9 3.4 3.5 8.1 8.6 8.1 12.9 7.9 7.5 10.3 10.3 14.2 14.4 12.3 12.5 10.4 2.6 13.5 7.5 20.1 6.2 7.9 9.2 6.5 5.5 9.6 2.0 7.4 13.4 22.7 1.7 3.6 12.3 9.7 20.4 6.5 8.1 5.5 4.7 14.7 6.1 13.8 7.3 1.1 5.7 7.8 2.9 7.7 4.5 10.2 4.6 10.9 5.4 10.0 8.4 7.7 5.2 19.7 7.6 8.8 20.3 7.3 12.1 7.0 20.4 9.1 10.7 7.4 1.4 14.8 10.2 9.8 0.9 8.7 7.8 3.2 7.1 2.4 5.1 3.4 2.7 11.1 5.0 1.0 2.1 5.4 2.9 10.1 16.7 3.1 3.5 11.7 12.3 28.8 16.2 10.6 11.2 14.3 9.1 14.4 10.9 3.0 6.5 6.0 2.9 1.6 11.6 2.2 5.1 2.7 5.7 5.2 5.9 23.5 5.0 14.8 0.4 3.7 9.1 0.0 10.2 15.3 6.1 4.3 3.5 9.8 31.3 6.4 9.9 1.8 6.9 2.3 5.8 7.5 3.3 9.0 5.9 9.8 13.8 5.8 3.2 4.3 8.6 0.0 3.6 7.2 4.1 2.6 50.6 4.3 6.6 2.0 PRCP "HUMPCP, PCP" ENSG00000137509 Prolylcarboxypeptidase P42785 11 82823502-82970584 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Ito cells: 392.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 99.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017065, HPA071115" Approved Supported Vesicles "Intracellular and membrane" NA NA 34000000 Vesicles "HPA017065: AB_1855676, HPA071115: " "unprognostic (3.24e-1)" "unprognostic (2.25e-1)" "unprognostic (1.76e-1)" "unprognostic (1.51e-1)" "unprognostic (2.54e-1)" "unprognostic (1.33e-2)" "unprognostic (9.22e-2)" "unprognostic (1.42e-1)" "unprognostic (7.97e-2)" "unprognostic (2.61e-1)" "unprognostic (2.70e-1)" "unprognostic (1.88e-2)" "prognostic favorable (2.65e-6)" "unprognostic (7.16e-2)" "unprognostic (1.73e-2)" "unprognostic (3.49e-1)" "unprognostic (4.07e-1)" 32.6 45.9 25.0 21.5 22.2 13.1 69.5 19.4 23.8 38.8 17.9 17.9 27.6 11.0 30.7 35.5 32.2 24.6 25.6 66.3 25.8 18.9 52.4 52.5 38.1 95.1 27.0 14.8 27.8 23.4 30.6 19.3 59.8 34.9 25.1 18.4 25.1 38.1 34.5 10.3 26.2 15.7 32.8 45.0 25.1 16.8 17.4 17.7 9.8 27.9 24.2 31.7 39.4 30.1 13.1 50.0 31.2 27.9 12.1 6.2 14.7 7.5 8.3 12.8 25.7 99.0 36.4 15.0 16.2 28.9 15.5 22.8 20.5 15.7 10.9 23.7 23.5 17.6 12.0 11.6 10.7 18.2 9.7 8.4 7.8 11.6 12.7 18.5 7.0 28.6 26.5 8.3 16.2 15.3 38.1 51.4 6.0 8.3 15.4 15.9 3.4 1.0 25.0 7.4 18.5 7.7 5.7 22.2 13.0 21.7 14.0 5.3 11.6 22.2 12.8 9.1 19.7 15.4 9.6 13.3 18.3 18.4 15.8 7.9 14.5 24.6 9.8 7.5 8.5 9.4 15.5 26.4 17.4 5.3 27.9 6.1 9.9 5.3 5.8 50.0 13.1 4.4 6.2 31.2 12.1 21.2 8.9 5.0 14.7 25.0 22.2 19.4 23.8 25.8 18.9 27.0 14.8 34.9 17.7 17.9 14.6 43.2 35.5 27.8 10.0 19.8 43.3 5.3 12.5 59.3 2.0 49.3 24.9 28.4 24.0 120.7 4.9 0.0 10.6 99.1 49.9 26.3 12.7 56.8 72.6 15.9 18.9 392.8 149.3 39.4 40.9 76.3 67.4 54.1 18.6 57.0 10.0 7.0 43.5 76.8 4.3 64.7 26.8 23.6 5.7 30.6 44.3 25.4 19.9 33.8 PRPS1 "CMTX5, DFN2, DFNX1" ENSG00000147224 "Phosphoribosyl pyrophosphate synthetase 1" P60891 X 107628424-107651026 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Charcot-Marie-Tooth disease, Deafness, Disease mutation, Gout, Mental retardation, Neurodegeneration, Neuropathy, Non-syndromic deafness, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA043760, HPA051269" Uncertain Approved Vesicles NA NA 140000 Vesicles "HPA043760: AB_2678656, HPA051269: " "unprognostic (4.47e-2)" "unprognostic (6.18e-2)" "unprognostic (2.57e-2)" "unprognostic (4.19e-3)" "unprognostic (2.30e-3)" "unprognostic (2.56e-3)" "unprognostic (3.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.46e-1)" "unprognostic (9.73e-2)" "unprognostic (1.91e-2)" "unprognostic (4.11e-2)" "unprognostic (2.85e-2)" "unprognostic (4.57e-2)" "unprognostic (1.29e-1)" "unprognostic (1.25e-2)" "unprognostic (5.25e-2)" 16.8 19.0 18.8 18.7 22.4 33.5 13.0 27.0 30.3 13.5 12.1 20.5 7.0 7.3 16.6 10.4 11.8 17.6 9.6 19.9 19.0 26.5 18.5 45.1 14.9 25.4 21.8 17.5 21.4 17.8 20.0 18.2 10.0 26.9 14.9 12.4 15.0 11.2 12.4 31.2 8.4 10.8 20.0 19.3 19.4 10.8 11.3 13.6 32.3 29.9 11.3 28.6 16.9 10.7 18.2 8.5 12.6 8.7 14.4 22.1 11.6 20.7 30.8 13.7 15.8 7.6 6.0 4.7 61.1 12.7 34.7 29.4 13.3 8.9 34.2 26.4 22.2 24.9 8.5 40.8 12.6 35.7 16.9 25.4 18.2 30.7 17.3 7.0 33.7 13.6 6.8 7.4 21.0 13.8 23.3 11.9 24.7 29.0 41.5 16.0 11.1 22.8 18.2 49.6 17.5 26.7 26.6 22.0 27.5 13.6 11.9 22.6 12.1 30.3 18.3 12.3 26.8 8.4 14.1 7.1 22.6 10.6 24.7 24.2 14.2 23.1 37.4 11.7 36.6 14.1 4.8 5.2 12.6 15.7 8.2 17.6 17.0 19.7 19.3 6.2 18.2 22.1 18.7 3.1 14.4 8.7 8.5 20.1 11.6 18.8 22.4 27.0 30.3 19.0 26.5 21.8 17.5 26.9 13.6 6.0 10.6 39.3 13.5 27.6 29.0 9.5 12.7 30.8 12.5 15.7 3.9 8.6 21.6 12.6 0.6 12.2 1.6 0.0 17.6 10.9 22.4 16.3 25.5 52.0 30.0 14.3 15.5 10.4 11.7 2.6 13.0 19.1 25.3 34.3 5.4 18.6 15.4 3.5 15.9 23.1 12.2 0.0 40.6 3.1 9.7 19.4 1.5 49.0 6.4 8.4 PRPS1L1 "PRPS3, PRPSL" ENSG00000229937 "Phosphoribosyl pyrophosphate synthetase 1-like 1" P21108 7 18026774-18027863 "Enzymes, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 38.4" "Group enriched" "Detected in some" 8 "Early spermatids: 39.0;Spermatocytes: 72.2" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 1.3;K-562: 2.1" HPA051269 Uncertain Vesicles NA NA Vesicles "HPA051269: " "unprognostic (2.39e-2)" "unprognostic (3.18e-2)" "unprognostic (1.11e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 38.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.4 0.7 0.3 0.6 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.7 0.4 0.3 0.6 0.8 0.9 0.5 0.1 0.4 1.1 0.7 0.1 0.6 0.1 0.4 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 39.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 6.5 0.0 72.2 1.3 0.0 0.0 0.0 0.0 0.0 PRRC1 FLJ32875 ENSG00000164244 "Proline rich coiled-coil 1" Q96M27 5 127517609-127555089 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039212 Supported Approved Vesicles NA NA 80000 Vesicles "HPA039212: AB_10794634" "prognostic unfavorable (9.35e-5)" "unprognostic (9.01e-2)" "unprognostic (5.26e-3)" "unprognostic (6.36e-2)" "unprognostic (2.95e-1)" "unprognostic (4.47e-2)" "unprognostic (4.21e-2)" "unprognostic (1.39e-1)" "unprognostic (6.08e-2)" "unprognostic (1.04e-1)" "unprognostic (1.74e-3)" "unprognostic (5.53e-2)" "unprognostic (3.20e-3)" "unprognostic (1.57e-1)" "unprognostic (2.83e-1)" "unprognostic (3.45e-3)" "unprognostic (2.19e-1)" 19.1 22.3 9.2 13.3 10.2 14.3 19.3 12.7 11.0 24.0 23.3 13.0 24.5 19.5 26.5 21.9 23.0 17.6 18.0 17.2 8.5 8.5 26.5 40.0 17.1 21.1 11.3 8.3 25.2 55.7 28.0 38.6 42.3 10.8 18.2 21.9 17.2 47.6 24.5 13.1 21.3 36.7 17.8 12.5 19.4 18.4 18.0 11.9 30.4 23.4 16.7 28.3 21.7 19.7 14.3 13.3 11.5 11.6 10.1 20.7 9.7 13.3 13.7 20.5 15.5 27.8 35.6 24.0 23.6 26.6 21.2 33.5 23.4 15.7 14.9 24.7 37.5 15.9 12.2 15.9 29.3 32.8 20.6 11.1 13.0 13.7 20.2 16.0 11.9 17.1 24.3 21.6 22.4 26.2 19.5 22.5 14.3 11.1 18.4 24.4 15.1 23.4 12.9 11.7 19.3 18.0 9.0 27.1 19.3 16.7 16.9 15.0 11.6 18.5 20.3 17.3 19.6 21.6 15.7 26.5 19.5 14.6 22.6 16.5 15.5 11.5 19.6 23.0 19.2 19.1 11.5 9.9 7.7 16.8 11.6 20.7 14.3 14.0 14.5 13.3 10.2 15.6 13.8 3.0 10.1 10.8 9.0 10.9 9.7 9.2 10.2 12.7 11.0 8.5 8.5 11.3 8.3 10.8 11.9 32.8 18.0 15.6 12.5 13.1 11.7 10.9 28.1 21.4 27.3 26.2 13.7 21.1 11.6 25.8 2.7 18.0 31.5 0.0 26.8 34.3 24.7 29.7 15.1 34.6 19.3 7.9 15.0 31.9 20.9 3.1 31.9 12.0 18.6 8.2 46.4 9.5 26.7 21.0 28.3 20.2 11.7 12.9 23.7 9.8 19.9 16.3 26.4 13.1 28.3 14.2 PRSS27 "CAPH2, MPN" ENSG00000172382 "Serine protease 27" Q9BQR3 16 2712418-2720551 "Enzymes, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 94.1;lymphoid tissue: 97.2;tongue: 64.5" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 8.9;Horizontal cells: 11.1;Urothelial cells: 9.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 5.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.4;myeloid DC: 1.7" "Group enriched" "Detected in many" 5 "dendritic cells: 1.7;T-cells: 1.4" "Cell line enhanced" "Detected in some" "BEWO: 5.6;SK-BR-3: 22.3;T-47d: 13.1;U-266/70: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB024920, HPA028848" Approved Approved Vesicles "Secreted to digestive system" NA NA Vesicles "CAB024920: , HPA028848: " "unprognostic (2.10e-2)" "unprognostic (2.15e-1)" "unprognostic (3.46e-3)" "unprognostic (5.35e-2)" "unprognostic (5.25e-2)" "unprognostic (2.48e-2)" "unprognostic (2.56e-1)" "unprognostic (3.12e-1)" "unprognostic (4.66e-1)" "unprognostic (1.08e-1)" "unprognostic (3.79e-2)" "unprognostic (4.40e-3)" "unprognostic (4.03e-3)" "unprognostic (2.40e-1)" "unprognostic (2.26e-1)" "unprognostic (2.04e-2)" "unprognostic (1.28e-2)" 0.2 0.3 0.1 0.2 0.5 0.2 0.4 0.7 0.4 15.3 0.2 0.1 0.1 0.1 1.2 0.1 94.1 0.3 0.2 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.2 0.1 0.1 10.0 0.3 0.2 1.2 0.1 0.2 0.1 0.2 0.1 0.5 0.1 0.3 0.2 64.5 97.2 0.5 24.0 0.1 1.7 0.2 0.0 0.2 1.4 1.2 0.0 0.2 0.5 1.8 0.3 0.6 5.6 0.0 0.2 0.2 0.1 0.0 0.4 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.5 0.1 0.1 0.0 0.9 0.0 0.2 1.1 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.5 0.0 1.7 0.0 0.9 1.3 0.1 0.0 0.8 0.2 0.1 0.1 0.3 0.6 2.7 0.0 22.3 0.5 0.1 13.1 1.5 0.0 0.4 0.0 0.0 0.0 4.6 3.2 0.4 0.0 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.4 0.0 1.7 0.0 0.3 0.7 0.2 0.2 0.0 0.0 0.0 1.2 0.1 0.5 0.7 0.1 0.1 0.4 0.1 0.1 0.1 0.1 8.9 8.0 0.0 2.4 1.5 5.2 1.1 0.0 5.3 5.7 1.8 3.9 0.5 0.0 1.2 1.5 1.0 0.4 0.0 1.2 0.3 1.1 1.6 3.5 0.8 0.3 11.1 0.0 0.6 0.0 0.4 0.3 1.3 1.7 1.0 0.0 3.2 0.9 0.2 0.0 0.5 4.7 0.0 1.5 2.1 3.8 2.0 2.7 0.0 0.6 9.7 PSAP "GLBA, SAP1" ENSG00000197746 Prosaposin P07602 10 71816298-71851375 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Lipid metabolism, Sphingolipid metabolism" "Disease mutation, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Hofbauer cells: 2783.3;Kupffer cells: 2077.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "classical monocyte: 252.0;intermediate monocyte: 322.1;myeloid DC: 97.2;neutrophil: 80.8;non-classical monocyte: 263.2" "Group enriched" "Detected in all" 12 "dendritic cells: 97.2;granulocytes: 80.8;monocytes: 322.1" "Cell line enhanced" "Detected in all" "ASC diff: 260.8;hTERT-RPE1: 353.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004426, CAB004647" Supported Supported Vesicles "Intracellular and membrane" NA NA 86000000 Vesicles "CAB004647: AB_425625, HPA004426: AB_1079701" "unprognostic (4.43e-3)" "unprognostic (2.69e-1)" "unprognostic (1.64e-2)" "unprognostic (8.00e-2)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (8.36e-3)" "unprognostic (2.79e-1)" "unprognostic (3.31e-2)" "unprognostic (3.25e-2)" "unprognostic (2.30e-3)" "unprognostic (2.00e-2)" "unprognostic (3.62e-3)" "unprognostic (6.47e-2)" "unprognostic (4.42e-2)" "unprognostic (2.34e-1)" "unprognostic (2.06e-1)" 151.5 178.6 106.6 95.1 137.9 79.7 93.3 93.2 143.4 136.7 74.4 134.2 89.5 53.7 116.0 118.2 71.7 88.1 129.7 164.0 99.5 93.7 108.5 119.6 125.5 136.8 135.4 128.0 137.1 93.7 134.8 76.0 165.5 106.7 94.1 73.4 118.2 88.1 117.0 151.6 67.6 63.3 133.5 109.3 159.8 87.4 60.5 126.1 84.4 103.1 54.1 61.4 102.8 76.3 13.4 97.2 80.8 322.1 9.5 12.5 306.2 21.6 40.9 26.6 55.6 260.8 150.1 94.1 39.4 117.3 31.0 37.1 37.8 55.3 11.8 81.4 64.3 52.0 47.5 10.0 32.0 21.9 23.0 18.9 13.8 18.6 21.3 100.5 8.9 79.4 95.4 73.9 31.0 59.5 353.1 55.0 16.7 19.6 57.1 38.4 13.8 39.5 13.4 12.2 27.5 19.9 8.2 15.2 32.8 36.1 37.3 29.6 26.2 36.8 111.8 148.5 36.6 22.7 20.6 71.5 43.9 31.2 29.2 32.1 63.8 48.5 20.9 69.7 17.9 32.1 19.4 252.0 30.1 12.5 322.1 10.3 13.4 10.3 10.8 97.2 11.8 11.3 10.6 80.8 9.5 263.2 48.5 11.3 306.2 106.6 137.9 93.2 143.4 99.5 93.7 135.4 128.0 106.7 126.1 235.2 379.3 166.5 219.5 202.9 179.8 542.8 254.8 219.5 234.3 451.9 119.8 794.0 59.7 786.8 15.8 344.2 354.0 46.7 402.9 741.7 528.5 293.5 382.9 394.5 2783.3 314.6 251.7 411.3 2077.6 30.6 424.6 1465.0 629.3 1297.6 227.4 506.4 336.4 285.1 518.7 243.0 122.0 271.7 278.1 42.5 119.8 173.1 897.4 139.5 183.5 185.3 PTGR2 "FLJ39091, ZADH1" ENSG00000140043 "Prostaglandin reductase 2" Q8N8N7 14 73851844-73886827 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Ciliated cells: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 29.0" HPA001125 Approved Approved Vesicles NA NA 1000000 Vesicles "HPA001125: AB_2666207" "unprognostic (3.82e-2)" "unprognostic (2.79e-2)" "unprognostic (6.05e-2)" "unprognostic (3.26e-1)" "unprognostic (2.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.39e-1)" "unprognostic (1.96e-2)" "unprognostic (2.80e-1)" "unprognostic (8.10e-3)" "unprognostic (6.99e-3)" "unprognostic (5.96e-1)" "prognostic favorable (4.55e-12)" "unprognostic (4.42e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (7.24e-2)" 7.4 14.4 16.0 3.4 17.2 1.6 10.9 8.0 13.3 6.2 8.3 15.3 11.9 13.7 5.8 20.3 6.2 13.9 6.4 29.0 15.0 12.2 22.1 20.9 6.6 3.7 15.2 12.6 9.1 6.4 13.8 12.8 3.2 20.4 10.9 6.9 10.1 7.7 8.9 32.4 8.1 9.9 4.9 16.0 4.1 7.0 11.5 17.2 2.0 14.6 9.1 3.4 5.5 7.0 2.2 3.2 8.4 2.4 2.3 4.0 2.3 5.9 8.1 6.7 3.3 5.4 11.8 5.3 2.0 2.8 2.5 3.9 4.6 14.6 0.6 4.8 2.0 5.9 6.0 6.0 4.4 4.7 4.5 2.8 4.1 3.8 2.0 2.7 1.5 1.5 5.5 10.6 3.8 3.1 5.5 1.2 4.2 5.5 1.2 5.6 8.5 4.0 3.9 7.4 8.0 8.1 5.1 2.6 1.0 13.7 5.8 8.9 7.7 5.3 5.7 6.6 6.7 29.0 2.5 1.8 3.8 7.1 2.7 4.4 7.1 3.1 1.9 5.8 3.7 5.0 8.4 2.4 1.8 1.6 0.9 1.2 2.1 2.3 1.2 2.6 2.2 4.0 3.2 2.0 2.3 2.2 3.2 2.1 2.3 16.0 17.2 8.0 13.3 15.0 12.2 15.2 12.6 20.4 17.2 17.9 8.8 0.5 9.0 6.1 9.4 39.0 5.1 41.5 10.3 17.4 13.7 5.6 21.6 10.0 1.9 2.8 10.5 0.0 7.8 1.9 4.1 9.0 3.5 12.5 6.3 31.8 4.6 3.7 5.7 1.5 6.6 4.7 8.5 4.6 11.3 20.3 6.4 13.1 6.3 12.8 20.5 6.5 4.2 29.8 10.9 5.8 3.3 3.3 10.8 5.4 PTPN9 MEG2 ENSG00000169410 "Protein tyrosine phosphatase, non-receptor type 9" P43378 15 75463251-75579289 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041922 Approved Approved Vesicles NA NA Vesicles "HPA041922: AB_10795269" "unprognostic (9.58e-2)" "unprognostic (1.87e-1)" "unprognostic (1.28e-1)" "unprognostic (2.42e-1)" "unprognostic (1.54e-2)" "unprognostic (6.80e-2)" "unprognostic (7.38e-2)" "unprognostic (5.95e-2)" "unprognostic (3.93e-1)" "unprognostic (3.14e-1)" "unprognostic (9.25e-3)" "unprognostic (6.35e-2)" "prognostic favorable (2.49e-6)" "unprognostic (2.26e-1)" "unprognostic (1.05e-1)" "unprognostic (2.71e-1)" "unprognostic (2.39e-1)" 16.8 12.8 15.0 11.8 17.7 9.2 15.7 11.1 20.0 17.4 22.4 10.5 12.0 17.0 18.9 16.4 10.9 16.4 13.5 12.2 13.1 14.6 17.9 14.0 16.0 12.6 11.6 12.4 16.0 12.3 16.6 12.5 18.9 13.2 16.9 19.5 18.4 14.6 21.9 6.8 11.8 30.6 17.6 15.6 15.6 13.4 8.7 7.5 16.3 34.4 8.0 13.9 14.7 15.3 3.3 5.9 4.6 5.7 6.7 7.2 2.9 9.2 11.2 17.5 11.6 13.1 14.5 5.7 14.0 21.7 17.7 16.1 6.7 14.1 15.0 11.3 23.7 14.2 14.1 37.6 16.0 17.9 18.6 9.5 8.4 8.0 7.1 19.7 12.8 13.0 18.7 16.8 14.1 22.2 18.1 14.8 10.0 5.6 5.5 19.9 6.1 9.0 12.0 16.0 8.4 5.7 17.8 8.7 4.1 22.3 15.1 6.9 14.3 19.8 11.0 21.4 17.5 5.7 22.0 17.0 17.0 5.5 11.1 14.8 8.1 8.4 14.0 9.9 19.4 16.6 4.6 4.3 4.2 7.2 5.7 5.7 3.3 5.0 6.1 5.9 2.3 2.1 3.9 0.7 6.7 5.4 3.9 3.1 2.9 15.0 17.7 11.1 20.0 13.1 14.6 11.6 12.4 13.2 7.5 6.0 12.0 13.4 6.8 3.0 11.0 3.1 10.2 8.1 9.1 10.4 7.9 13.9 13.3 9.2 2.4 8.0 20.3 0.0 8.6 3.5 11.9 8.9 15.0 9.9 16.4 3.2 6.9 22.1 18.1 3.5 11.5 20.8 6.8 16.2 12.2 5.4 14.2 10.5 25.8 8.4 17.5 12.9 8.6 5.2 7.0 2.9 8.5 12.9 12.1 12.7 PTPRN2 "IA-2beta, ICAAR, KIAA0387, phogrin" ENSG00000155093 "Protein tyrosine phosphatase, receptor type N2" Q92932 7 157539056-158587788 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Phospholipid metabolism" "Hydrolase, Protein phosphatase, Receptor" "Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6;pancreas: 51.3" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 84.3;Intestinal endocrine cells: 126.1" "Cancer enhanced" "Detected in all" "prostate cancer: 40.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 14.8" "Lineage enriched" "Detected in all" 4 "granulocytes: 14.8" "Cell line enhanced" "Detected in some" "AF22: 15.6;HDLM-2: 22.0;NB-4: 22.6;SCLC-21H: 12.5;SH-SY5Y: 12.7;THP-1: 11.1;U-87 MG: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006900, HPA007255, HPA026656" Enhanced Approved Vesicles NA NA Vesicles "HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912" "unprognostic (2.42e-1)" "unprognostic (4.17e-2)" "unprognostic (7.82e-2)" "unprognostic (2.69e-2)" "prognostic unfavorable (9.37e-5)" "unprognostic (7.12e-3)" "unprognostic (1.04e-1)" "unprognostic (4.55e-2)" "unprognostic (4.27e-2)" "unprognostic (1.64e-1)" "unprognostic (1.20e-2)" "unprognostic (1.39e-1)" "prognostic favorable (8.68e-4)" "unprognostic (2.60e-2)" "unprognostic (1.48e-1)" "unprognostic (1.43e-3)" "unprognostic (6.16e-2)" 2.1 10.5 20.1 1.7 33.9 1.0 1.1 6.2 40.6 1.7 4.6 2.9 0.0 5.1 2.0 2.9 1.5 6.9 4.7 1.9 18.2 21.3 2.0 1.2 3.1 2.1 11.3 22.3 5.8 51.3 0.5 20.0 1.5 10.3 10.2 3.7 1.5 3.4 2.6 0.8 0.7 4.2 1.6 5.3 7.7 24.2 2.2 5.2 0.0 5.6 0.3 1.7 2.8 0.6 3.4 1.3 14.8 1.1 1.5 3.5 1.1 0.0 0.2 15.6 1.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.6 0.2 3.7 0.0 0.4 0.0 0.0 22.0 0.2 0.0 0.0 2.5 0.6 0.0 0.0 1.1 0.2 0.0 0.1 0.1 0.0 1.1 0.0 0.1 0.0 0.2 6.5 22.6 3.1 5.5 0.8 0.0 0.7 0.1 0.0 0.0 12.5 12.7 0.0 0.0 0.0 0.0 0.0 11.1 3.3 5.1 1.9 0.0 0.4 0.1 0.0 0.0 15.4 9.2 3.7 8.7 1.1 1.6 0.9 0.1 0.3 2.3 1.5 1.1 1.3 3.4 1.4 0.9 14.8 1.5 0.0 0.2 3.5 1.1 20.1 33.9 6.2 40.6 18.2 21.3 11.3 22.3 10.3 5.2 3.0 11.7 10.4 12.5 2.1 31.6 2.2 7.6 84.3 13.6 38.4 9.8 0.4 29.9 15.8 35.1 23.3 4.5 0.0 11.7 0.4 3.9 21.1 18.5 0.8 34.3 11.1 126.1 41.1 11.0 13.1 11.5 6.0 11.8 3.6 39.6 40.1 6.1 5.8 18.4 3.5 6.3 25.8 5.1 41.6 11.7 1.3 0.6 10.0 7.2 22.5 PUSL1 FLJ90811 ENSG00000169972 "Pseudouridylate synthase-like 1" Q8N0Z8 1 1308567-1311677 "Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEK 293: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032057, HPA039999" Uncertain Enhanced Vesicles NA NA Vesicles "HPA032057: AB_10601251, HPA039999: AB_2676792" "unprognostic (2.04e-2)" "unprognostic (1.60e-1)" "unprognostic (2.17e-1)" "unprognostic (1.38e-1)" "unprognostic (1.80e-1)" "unprognostic (3.91e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (7.55e-2)" "unprognostic (4.35e-2)" "unprognostic (1.47e-1)" "unprognostic (2.44e-2)" "unprognostic (3.91e-2)" "prognostic unfavorable (1.62e-5)" "unprognostic (3.05e-1)" "unprognostic (1.48e-1)" "unprognostic (1.45e-1)" "unprognostic (2.44e-1)" 7.6 11.7 8.0 8.8 6.8 8.8 9.1 9.4 9.2 13.6 9.2 9.8 15.4 9.9 11.2 14.4 17.1 9.1 10.3 9.2 7.9 6.0 9.5 16.2 7.1 7.8 12.2 6.8 11.4 19.5 6.2 13.2 8.0 6.6 12.4 5.0 9.5 23.3 13.7 11.0 17.0 9.6 7.5 6.5 8.8 11.4 8.3 7.7 9.0 10.6 16.7 11.9 10.9 9.8 9.0 11.3 5.8 16.6 8.1 13.4 7.8 10.1 4.6 4.6 7.9 2.2 3.6 6.3 9.2 5.1 9.1 6.1 15.8 6.7 6.2 7.5 4.5 3.8 8.4 5.1 8.4 1.6 6.9 33.9 8.6 8.3 9.4 8.6 10.2 8.3 3.5 4.4 5.0 3.8 2.5 4.1 8.7 11.0 2.9 4.2 8.3 9.6 13.3 6.3 8.6 20.3 8.9 3.5 14.7 7.0 3.9 21.5 7.9 7.2 21.6 7.3 2.2 6.0 6.8 4.8 5.9 6.1 9.6 8.7 11.4 3.6 26.4 7.3 9.3 3.5 3.6 12.3 5.8 10.6 16.6 10.6 8.9 11.6 8.7 11.3 9.0 7.7 7.7 4.9 8.1 14.0 7.1 13.4 7.8 8.0 6.8 9.4 9.2 7.9 6.0 12.2 6.8 6.6 7.7 0.0 4.0 8.2 8.8 19.6 7.5 1.6 10.2 6.7 6.8 7.0 5.9 21.2 10.0 20.2 7.7 6.7 10.5 0.0 20.2 34.1 10.4 13.7 6.9 8.9 18.2 3.2 5.1 3.1 9.7 11.8 8.1 8.9 6.8 5.4 10.0 3.4 20.9 8.6 10.6 14.0 7.5 0.0 9.5 17.4 16.4 16.8 28.8 12.8 11.3 16.9 QPRT QPRTase ENSG00000103485 "Quinolinate phosphoribosyltransferase" Q15274 16 29679008-29698699 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Pyridine nucleotide biosynthesis" "Glycosyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 61.2" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 349.5;Extravillous trophoblasts: 260.2;Hepatocytes: 304.1;Proximal tubular cells: 417.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.7" "Group enriched" "Detected in many" 4 "dendritic cells: 4.6;monocytes: 7.7" "Cell line enhanced" "Detected in many" "EFO-21: 98.7;Hep G2: 41.2" "HPA011887, HPA076010" Enhanced Approved Vesicles "Intracellular and membrane" NA NA 230000 Vesicles "HPA011887: AB_2668555, HPA076010: " "prognostic unfavorable (5.10e-5)" "unprognostic (2.00e-1)" "unprognostic (9.48e-2)" "unprognostic (2.88e-1)" "prognostic unfavorable (9.31e-4)" "unprognostic (1.44e-2)" "unprognostic (8.75e-2)" "unprognostic (1.22e-1)" "unprognostic (8.16e-2)" "unprognostic (1.01e-2)" "unprognostic (2.39e-1)" "unprognostic (6.81e-2)" "unprognostic (3.37e-2)" "unprognostic (1.33e-2)" "unprognostic (2.65e-1)" "unprognostic (1.63e-1)" "unprognostic (1.58e-2)" 3.2 36.4 6.1 3.0 5.2 1.1 2.4 1.6 5.8 17.9 10.8 4.4 43.3 20.0 12.7 44.3 1.3 14.9 4.9 11.3 4.9 7.5 40.1 61.2 4.7 2.9 7.9 7.5 15.3 22.9 6.1 2.6 24.3 10.0 4.4 5.2 12.6 15.0 19.4 1.5 1.6 24.1 4.7 6.4 5.3 2.7 3.1 2.6 3.7 2.2 0.3 2.1 5.9 5.1 0.1 4.6 1.2 7.7 0.5 1.4 2.2 0.1 0.2 9.4 10.3 1.6 3.9 23.1 0.9 0.9 1.5 1.9 23.6 16.8 0.4 98.7 1.8 1.5 0.1 3.2 0.1 0.8 0.1 2.1 4.8 0.3 41.2 9.0 0.7 2.0 12.3 0.2 0.8 0.0 2.3 0.0 4.6 12.1 0.5 0.0 22.9 3.0 16.8 28.7 0.5 0.0 13.3 2.8 9.3 8.6 0.7 7.6 15.4 0.0 26.8 19.8 16.1 20.0 21.5 0.1 0.4 3.9 0.1 0.0 0.3 0.7 3.1 0.7 1.7 1.5 0.0 3.7 0.4 1.3 4.7 1.4 0.1 0.9 1.0 4.6 0.1 0.1 0.7 1.2 0.5 7.7 2.6 0.8 2.2 6.1 5.2 1.6 5.8 4.9 7.5 7.9 7.5 10.0 2.6 8.9 22.7 18.6 9.6 3.2 1.5 34.8 7.6 0.0 0.0 61.1 0.0 349.5 43.1 0.9 0.0 2.8 125.5 0.0 48.0 260.2 17.5 2.9 4.7 304.1 118.1 6.4 27.2 11.1 13.0 0.0 27.0 12.3 40.5 5.4 45.2 20.3 17.4 77.2 25.5 417.3 3.5 6.5 11.3 0.5 2.5 1.8 180.3 6.4 95.6 6.4 RAB11FIP1 "FLJ22524, FLJ22622, Rab11-FIP1, RCP" ENSG00000156675 "RAB11 family interacting protein 1" Q6WKZ4 8 37858618-37899467 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 90.6" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 741.5;Urothelial cells: 458.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 39.0" "Lineage enriched" "Detected in all" 5 "granulocytes: 39.0" "Cell line enhanced" "Detected in many" "K-562: 29.7" "Low region specificity" "Detected in single" "CAB017037, HPA023904, HPA024010, HPA025960" Enhanced Enhanced Vesicles No No Vesicles "CAB017037: , HPA023904: AB_1855990, HPA024010: AB_1855991, HPA025960: AB_1855992" "unprognostic (1.62e-2)" "unprognostic (3.47e-2)" "unprognostic (3.22e-3)" "unprognostic (2.87e-1)" "unprognostic (1.06e-1)" "prognostic favorable (6.61e-4)" "unprognostic (4.32e-1)" "unprognostic (4.50e-3)" "unprognostic (1.58e-1)" "unprognostic (4.72e-2)" "unprognostic (2.82e-3)" "unprognostic (2.73e-2)" "prognostic favorable (1.14e-6)" "unprognostic (4.94e-2)" "unprognostic (8.41e-2)" "unprognostic (9.99e-2)" "unprognostic (1.50e-1)" 6.9 3.2 1.3 16.8 1.0 17.8 7.4 1.8 1.3 8.9 37.1 1.9 17.8 13.8 2.9 8.8 30.9 5.6 31.5 5.9 1.1 1.3 8.4 4.1 64.5 8.4 1.1 0.6 4.7 31.5 3.9 12.9 26.0 6.9 7.0 16.4 9.9 20.9 21.3 3.4 13.8 90.6 5.3 1.3 10.9 15.2 5.4 0.9 16.4 8.5 14.9 34.1 9.6 9.6 2.3 6.9 39.0 7.7 4.1 4.0 3.3 17.2 7.6 0.8 3.4 0.2 0.0 23.5 1.8 2.8 3.3 4.2 17.0 9.9 7.0 5.5 2.1 0.2 13.4 6.2 3.9 4.9 18.2 5.8 1.3 4.0 4.9 9.3 3.0 15.7 2.2 5.3 1.2 3.4 4.8 0.0 9.4 29.7 3.5 1.7 4.1 5.0 4.4 5.1 17.0 2.3 1.6 4.2 5.4 17.0 17.8 3.2 3.7 4.5 22.5 5.5 16.8 15.2 5.8 0.2 0.1 10.2 0.2 0.3 7.1 8.3 1.9 0.1 4.1 2.4 6.9 7.7 13.7 1.8 3.7 4.0 2.3 1.3 1.2 6.9 1.7 0.8 0.9 39.0 4.1 6.9 4.2 2.9 3.3 1.3 1.0 1.8 1.3 1.1 1.3 1.1 0.6 6.9 0.9 741.5 109.5 15.9 71.9 14.2 4.8 11.6 68.8 238.3 205.9 61.1 15.7 29.6 13.3 135.4 0.8 10.5 359.4 0.0 214.5 4.9 15.3 195.3 29.0 12.1 29.4 6.4 233.5 17.8 43.0 0.7 1.7 62.6 15.1 32.5 172.7 18.1 301.2 259.6 1.4 12.9 19.9 6.5 12.8 2.6 5.9 26.7 80.3 74.0 158.8 458.6 RAB12 ENSG00000206418 "RAB12, member RAS oncogene family" Q6IQ22 18 8609445-8639381 "Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 96.4" "Cell type enriched" "Detected in many" 4 "Cardiomyocytes: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040727 Approved Approved Vesicles NA NA Vesicles "HPA040727: AB_10794858" "unprognostic (7.92e-2)" "unprognostic (4.11e-2)" "unprognostic (1.05e-1)" "unprognostic (1.72e-2)" "unprognostic (1.53e-2)" "unprognostic (1.47e-2)" "unprognostic (1.25e-2)" "unprognostic (2.77e-2)" "unprognostic (1.11e-1)" "unprognostic (1.29e-3)" "unprognostic (2.67e-1)" "unprognostic (5.72e-2)" "unprognostic (2.02e-1)" "unprognostic (1.63e-1)" "unprognostic (1.46e-1)" "unprognostic (1.61e-1)" "unprognostic (9.11e-2)" 20.0 16.0 18.0 10.2 18.3 7.2 15.6 23.5 22.1 17.2 16.8 13.8 9.2 7.3 18.5 12.3 17.3 13.4 11.2 45.6 16.2 16.2 18.4 20.7 15.8 12.5 13.7 17.8 19.0 7.5 10.4 12.7 17.6 15.3 15.3 10.5 13.7 10.1 18.6 96.4 18.1 10.3 25.4 12.2 16.3 10.8 8.3 10.6 7.7 12.1 21.2 11.9 19.4 20.2 3.2 4.1 7.7 5.1 3.9 3.1 1.3 11.6 6.9 8.1 8.5 24.2 20.6 4.5 15.9 21.9 18.2 21.4 9.4 10.8 4.0 15.5 19.0 13.6 7.4 9.4 17.0 22.1 1.6 7.6 3.4 7.4 9.8 22.5 4.5 3.6 20.3 24.1 13.3 17.1 18.8 21.9 3.6 5.2 5.8 17.6 12.6 5.1 4.5 5.2 40.4 6.6 3.6 19.7 3.8 17.7 15.7 13.5 9.6 12.1 16.5 19.9 12.0 4.8 6.9 18.3 21.1 12.3 21.0 24.1 3.9 2.2 3.4 15.8 4.2 13.4 7.7 2.2 2.4 2.1 3.6 3.0 3.2 2.3 2.5 1.8 3.0 3.1 3.0 4.1 3.9 5.1 4.1 2.5 1.3 18.0 18.3 23.5 22.1 16.2 16.2 13.7 17.8 15.3 10.6 11.9 17.1 3.4 1.7 5.8 14.8 87.9 2.5 10.7 13.6 3.5 5.9 1.4 3.3 2.0 0.0 7.4 1.6 0.0 1.2 1.1 5.0 3.2 5.8 15.3 1.5 11.1 5.2 19.6 13.9 0.0 3.1 6.9 3.3 2.8 2.8 14.3 2.5 0.0 4.2 4.9 6.7 0.0 5.2 1.0 1.5 7.3 0.9 2.5 2.3 3.5 RAB14 "FBP, RAB-14" ENSG00000119396 "RAB14, member RAS oncogene family" P61106 9 121178137-121223014 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026419, CAB037066" Approved Supported Vesicles NA NA 9900000 Vesicles "CAB037066: AB_1841128, HPA026419: AB_1855996" "unprognostic (1.30e-3)" "unprognostic (3.12e-2)" "unprognostic (9.01e-2)" "unprognostic (7.18e-2)" "unprognostic (6.53e-2)" "unprognostic (3.00e-1)" "unprognostic (1.39e-1)" "unprognostic (1.18e-1)" "unprognostic (2.52e-1)" "unprognostic (6.90e-2)" "unprognostic (3.05e-2)" "unprognostic (9.71e-3)" "prognostic favorable (1.79e-8)" "unprognostic (1.38e-1)" "unprognostic (3.17e-2)" "unprognostic (2.13e-1)" "unprognostic (1.09e-1)" 28.4 29.2 35.7 29.7 37.3 41.4 37.2 36.5 50.2 29.9 30.3 31.4 38.2 28.5 27.9 26.1 50.1 25.6 25.5 24.3 33.3 34.1 37.0 58.7 57.5 38.0 44.5 34.8 27.5 22.7 38.6 25.2 30.7 35.0 29.5 31.5 20.0 29.2 55.5 28.2 42.4 27.4 24.7 43.0 28.1 31.3 23.5 41.4 23.9 32.4 25.8 34.3 27.7 32.3 19.0 23.3 24.0 30.9 19.2 21.5 15.7 21.6 22.1 28.1 23.5 32.8 35.9 22.2 30.9 24.8 23.9 19.1 17.4 23.6 20.8 18.1 29.5 20.8 41.4 20.0 23.0 27.1 17.9 13.2 22.5 30.7 17.7 22.7 24.0 27.0 22.8 41.6 24.5 27.0 26.5 33.8 19.5 17.0 19.1 35.7 20.5 23.2 19.3 16.7 42.6 25.0 18.5 30.5 24.3 26.3 31.2 24.9 14.6 36.7 32.6 21.0 20.8 34.3 19.0 31.2 25.6 18.8 31.6 21.5 17.2 32.4 21.2 24.1 21.1 33.5 23.4 21.9 24.0 18.0 30.9 17.9 19.0 16.9 19.5 23.3 17.0 20.4 20.2 23.7 19.2 30.2 14.3 21.5 15.7 35.7 37.3 36.5 50.2 33.3 34.1 44.5 34.8 35.0 41.4 148.9 86.3 53.6 73.4 140.4 91.2 33.9 71.4 87.0 89.9 59.3 35.3 75.8 72.9 69.8 30.5 73.0 67.3 0.0 56.3 68.7 55.1 66.3 74.1 102.0 79.3 89.0 57.9 59.5 87.7 24.1 48.1 78.2 104.6 89.2 51.7 90.0 61.8 46.0 53.0 77.8 55.5 58.2 60.8 83.2 110.1 177.0 97.1 57.5 49.0 92.9 RAB30 ENSG00000137502 "RAB30, member RAS oncogene family" Q15771 11 82973133-83071923 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 41.7;Melanocytes: 40.5;monocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 23.2;naive B-cell: 25.1" "Lineage enriched" "Detected in many" 5 "B-cells: 25.1" "Cell line enhanced" "Detected in many" "Daudi: 22.1;HDLM-2: 19.7;U-698: 59.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054514, HPA060565" Approved Enhanced Vesicles NA NA Vesicles "HPA054514: AB_2682512, HPA060565: AB_2684320" "unprognostic (3.21e-1)" "unprognostic (1.03e-1)" "unprognostic (1.82e-1)" "unprognostic (5.18e-2)" "unprognostic (7.21e-2)" "unprognostic (8.06e-2)" "unprognostic (2.91e-2)" "unprognostic (3.14e-2)" "unprognostic (4.36e-1)" "unprognostic (1.71e-2)" "unprognostic (1.53e-1)" "unprognostic (3.75e-2)" "unprognostic (1.64e-2)" "unprognostic (2.37e-1)" "unprognostic (2.42e-1)" "unprognostic (3.93e-2)" "unprognostic (1.85e-1)" 12.2 17.3 15.8 14.5 21.6 12.7 13.8 19.9 22.5 10.3 12.6 30.6 2.2 16.7 10.3 6.7 7.0 7.2 6.5 9.9 17.2 12.2 4.5 8.5 7.4 21.1 27.9 15.0 15.5 4.9 6.0 10.0 10.0 22.8 8.6 14.3 10.9 8.8 6.7 19.8 11.8 20.0 11.6 29.3 10.9 11.2 4.2 29.2 3.3 7.2 5.0 29.0 11.0 8.3 25.1 2.6 0.5 0.4 0.9 5.4 2.7 1.4 1.9 2.0 1.3 4.7 6.8 2.5 3.4 3.4 6.7 3.3 3.6 0.7 22.1 4.2 5.1 1.8 1.8 3.0 2.3 4.3 19.7 0.6 5.4 6.3 1.8 1.1 0.7 0.9 4.3 1.5 3.3 2.3 3.4 5.4 1.7 0.6 5.5 4.0 2.7 0.7 0.1 2.8 2.0 3.7 1.5 5.8 8.3 3.9 1.3 2.7 1.7 9.6 2.0 1.0 3.3 4.6 0.0 6.6 3.2 7.0 3.1 1.0 8.7 4.6 59.7 1.2 0.5 2.2 0.5 0.3 0.5 2.3 0.1 1.6 23.2 2.2 2.2 0.8 25.1 5.4 4.6 0.5 0.9 0.4 2.6 4.1 2.7 15.8 21.6 19.9 22.5 17.2 12.2 27.9 15.0 22.8 29.2 8.9 3.5 41.7 13.1 22.0 8.6 11.5 0.0 2.7 1.2 3.5 15.7 5.4 1.7 1.9 0.5 6.3 4.9 0.0 3.4 21.1 7.4 11.0 0.0 5.7 1.7 11.1 9.7 16.0 1.6 0.4 13.3 4.3 40.5 42.3 1.1 14.8 3.2 0.6 17.0 3.0 9.0 6.5 10.3 0.7 1.1 10.0 2.4 6.7 0.9 1.4 RAB33A RabS10 ENSG00000134594 "RAB33A, member RAS oncogene family" Q14088 X 130171649-130184870 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.3;brain: 32.4" "Cell type enhanced" "Detected in many" 10 "granulocytes: 23.0;Melanocytes: 11.8;T-cells: 20.3" "Group enriched" "Detected in many" 6 "glioma: 10.7;melanoma: 2.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HMC-1: 32.2;Karpas-707: 36.5;U-266/70: 26.8;U-937: 15.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059737 Uncertain Uncertain Vesicles NA NA Vesicles "HPA059737: AB_2684115" "unprognostic (5.40e-2)" "unprognostic (6.64e-3)" "unprognostic (3.48e-2)" "unprognostic (8.47e-3)" "unprognostic (4.88e-2)" "unprognostic (1.17e-2)" "unprognostic (2.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.12e-2)" "unprognostic (4.16e-2)" "unprognostic (3.03e-2)" "unprognostic (8.28e-2)" "unprognostic (7.00e-6)" "unprognostic (2.51e-1)" "unprognostic (6.35e-2)" "unprognostic (3.45e-2)" "unprognostic (1.61e-1)" 1.8 2.3 12.5 4.9 11.6 6.8 1.6 15.8 32.4 2.0 1.7 20.8 0.0 1.6 2.1 1.4 1.4 2.2 3.5 10.3 15.9 9.9 1.1 1.5 1.9 11.9 13.0 12.6 2.5 0.8 3.2 1.6 2.3 10.1 1.1 1.9 0.6 1.5 1.0 0.8 1.0 1.9 1.6 21.5 3.3 2.3 1.5 17.3 1.2 1.0 0.0 13.1 3.3 0.6 7.1 3.3 27.3 1.7 5.7 22.9 5.9 0.1 0.0 2.2 0.0 0.9 0.2 0.0 0.2 0.6 0.5 0.9 0.0 0.2 1.6 0.0 0.1 0.1 0.0 2.6 0.0 0.5 8.4 0.0 9.6 0.0 0.0 8.9 7.7 32.2 0.3 0.0 0.1 0.3 0.2 0.2 10.0 0.0 36.5 0.0 0.0 3.5 2.7 0.3 0.0 0.3 0.0 0.0 0.4 0.0 0.0 7.0 5.8 0.0 0.0 0.1 0.1 0.0 4.1 0.0 0.0 0.0 0.1 0.0 26.8 8.0 0.0 1.1 15.2 0.0 9.4 0.4 27.3 11.2 0.2 7.0 7.1 10.1 11.1 3.3 2.6 9.8 13.9 1.3 5.7 1.7 0.3 22.9 5.9 12.5 11.6 15.8 18.5 15.9 9.9 13.0 12.6 10.1 17.3 0.0 0.6 0.5 0.5 1.6 8.4 4.2 0.0 0.0 0.0 0.0 2.0 0.4 0.0 0.0 0.9 2.1 0.0 0.0 0.2 1.1 5.8 0.3 23.0 0.0 1.9 4.8 0.0 3.1 0.3 0.0 1.7 3.7 11.8 2.8 0.0 1.3 0.6 0.0 0.4 0.0 7.4 0.0 4.1 0.1 1.1 1.0 1.1 20.3 0.0 0.5 RAB36 ENSG00000100228 "RAB36, member RAS oncogene family" O95755 22 23145326-23164350 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 38.2" "Cell type enhanced" "Detected in many" 17 "Ciliated cells: 53.5;Late spermatids: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 12.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 12.7" "Cell line enhanced" "Detected in many" "RPMI-8226: 17.8;U-266/84: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059631 Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA059631: " "unprognostic (2.74e-2)" "unprognostic (1.32e-3)" "unprognostic (2.06e-2)" "unprognostic (1.23e-2)" "unprognostic (1.15e-2)" "unprognostic (6.60e-2)" "unprognostic (1.22e-1)" "unprognostic (3.46e-1)" "unprognostic (2.49e-2)" "unprognostic (7.94e-2)" "unprognostic (2.02e-3)" "unprognostic (5.56e-3)" "prognostic favorable (4.55e-4)" "unprognostic (7.08e-2)" "unprognostic (7.18e-2)" "unprognostic (1.64e-1)" "unprognostic (3.08e-1)" 2.4 5.9 7.6 2.0 11.9 1.3 3.5 2.7 14.1 6.5 2.8 6.8 9.3 1.4 5.4 12.7 3.0 38.2 6.6 1.9 7.7 8.4 8.2 0.8 6.1 1.7 4.5 9.3 8.1 4.3 1.9 16.6 7.0 5.8 5.1 1.8 4.8 4.6 11.2 1.2 1.9 1.5 4.9 2.6 1.9 2.7 12.8 3.1 0.0 20.7 1.2 1.9 3.6 2.1 1.0 0.3 12.7 0.6 1.7 0.7 0.3 5.6 6.6 5.1 7.7 1.2 2.5 2.1 3.2 6.5 7.1 2.7 0.4 0.0 0.0 3.5 4.2 4.0 7.1 0.2 3.7 2.3 0.0 3.0 0.0 0.2 0.6 3.0 0.0 0.9 3.2 1.4 6.6 1.3 4.7 1.0 0.0 0.3 5.8 0.3 4.5 0.0 0.1 0.6 3.7 1.8 0.0 0.0 17.8 9.2 1.0 12.6 5.5 0.3 2.8 1.6 0.4 0.0 0.6 0.5 0.9 2.2 2.5 4.6 12.6 17.5 0.0 6.5 0.0 4.2 0.3 0.6 0.0 0.7 0.3 0.4 1.0 0.1 0.2 0.3 0.3 0.5 0.4 12.7 1.7 0.3 0.0 0.1 0.3 7.6 11.9 2.7 14.1 7.7 8.4 4.5 9.3 5.8 3.1 0.0 2.7 0.8 0.6 0.5 0.6 0.8 5.1 53.5 9.1 1.8 5.9 5.3 5.0 2.8 10.0 0.1 0.0 0.0 0.2 0.3 1.0 0.4 1.1 0.0 0.3 1.6 6.4 0.6 1.2 16.9 3.1 0.0 1.7 0.0 0.5 3.2 0.1 0.0 2.8 7.8 0.5 0.0 0.8 1.9 1.6 0.1 2.4 0.0 0.0 0.3 RAB3D "D2-2, GOV, RAB16, RAD3D" ENSG00000105514 "RAB3D, member RAS oncogene family" O95716 19 11322046-11346270 "Plasma proteins, Predicted intracellular proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 49.1;Suprabasal keratinocytes: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 44.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 21.6;Karpas-707: 20.7;MCF7: 23.8;SK-BR-3: 31.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB018067, HPA063283" Approved Approved Vesicles NA NA Vesicles "CAB018067: AB_606903, HPA063283: AB_2684976" "unprognostic (4.71e-3)" "unprognostic (3.00e-1)" "unprognostic (1.79e-1)" "unprognostic (3.99e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (4.17e-3)" "unprognostic (7.27e-3)" "unprognostic (1.55e-1)" "unprognostic (2.80e-1)" "unprognostic (8.76e-2)" "unprognostic (9.92e-2)" "unprognostic (4.45e-2)" "unprognostic (7.60e-2)" "unprognostic (2.22e-1)" "unprognostic (1.74e-1)" "unprognostic (9.15e-2)" "unprognostic (1.34e-1)" 6.3 3.8 6.4 4.6 8.2 13.2 10.8 7.1 11.9 13.5 7.7 5.0 12.0 7.2 7.9 7.7 30.2 8.0 10.3 9.0 8.1 6.4 10.6 21.6 7.9 8.3 5.3 6.7 7.4 54.7 5.1 5.4 6.4 6.1 15.0 7.8 9.9 22.8 11.0 5.2 42.4 5.7 7.9 4.3 9.2 16.6 5.6 4.1 5.4 14.4 12.0 9.4 8.1 13.3 0.6 9.3 44.6 22.5 0.4 1.5 5.9 0.6 6.3 2.0 8.0 3.3 5.7 0.4 0.5 1.7 1.1 1.2 2.2 0.2 0.2 7.3 3.8 2.1 8.6 3.4 5.3 1.0 3.4 0.5 2.5 2.8 2.5 2.0 1.3 6.1 2.4 21.6 0.9 2.3 3.0 9.2 1.9 0.9 20.7 0.3 23.8 0.9 3.0 1.7 12.6 6.5 0.9 0.0 7.0 10.0 6.3 2.2 4.3 1.9 31.1 4.0 2.9 18.5 15.4 3.5 1.1 0.3 5.2 0.1 7.1 9.0 1.4 3.8 8.3 1.2 26.0 22.5 23.9 0.9 13.5 1.5 0.6 0.9 0.7 9.3 0.6 0.6 0.7 44.6 0.4 9.9 0.2 1.5 5.9 6.4 8.2 7.1 11.9 8.1 6.4 5.3 6.7 6.1 4.1 6.0 18.8 0.8 4.8 14.0 0.6 2.0 7.6 0.0 10.3 14.0 0.0 6.0 10.0 4.4 0.4 7.0 2.1 0.0 21.7 5.0 6.8 10.4 12.7 1.1 8.3 0.0 17.9 13.5 49.1 0.0 4.0 6.3 8.5 0.0 27.4 3.3 14.1 3.5 4.6 1.0 0.4 6.5 7.2 0.0 2.7 33.1 8.7 6.9 15.7 3.3 RAB40A "Rar-2, RAR2A" ENSG00000172476 "RAB40A, member RAS oncogene family" Q8WXH6 X 103499130-103519489 "Cancer-related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Cancer-related genes" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "epididymis: 34.0" "Cell type enriched" "Detected in single" 7 "Peritubular cells: 5.6" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 5 "basal ganglia: 4.2" "Cell type enriched" "Detected in single" 5 "memory B-cell: 1.2" "Lineage enriched" "Detected in single" 5 "B-cells: 1.2" "Cell line enhanced" "Detected in many" "AF22: 6.5;NTERA-2: 7.2" HPA076172 Uncertain Vesicles NA NA Vesicles "HPA076172: " "unprognostic (3.49e-1)" "unprognostic (6.01e-2)" "unprognostic (4.33e-2)" "unprognostic (4.49e-3)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "unprognostic (4.05e-1)" "unprognostic (3.82e-2)" "unprognostic (4.43e-1)" "unprognostic (7.36e-4)" "unprognostic (7.85e-3)" "unprognostic (9.39e-5)" "unprognostic (1.43e-1)" "unprognostic (1.11e-3)" 2.0 1.4 0.6 0.6 4.2 0.0 0.8 0.6 1.1 2.8 0.8 0.6 11.9 0.5 5.5 34.0 10.6 2.6 2.9 0.6 0.6 0.9 1.3 0.6 2.0 1.7 0.6 0.6 5.4 0.6 0.6 2.4 0.8 0.8 5.5 0.4 0.6 0.6 6.2 0.6 0.7 0.9 1.3 0.6 0.8 0.5 7.8 0.6 0.6 0.6 0.6 0.6 1.5 2.0 1.2 0.2 0.0 0.0 0.0 0.1 0.0 0.4 1.7 6.5 0.2 1.5 1.9 3.2 1.9 0.4 0.3 0.5 1.3 0.9 1.6 2.5 0.3 2.0 0.1 0.4 0.1 0.3 0.0 3.8 0.5 3.0 0.3 0.6 0.1 0.3 1.5 0.3 0.6 0.4 2.5 0.3 0.5 2.3 1.0 0.6 0.4 0.4 0.2 7.2 0.0 1.0 0.0 0.5 0.1 0.1 0.6 2.7 3.4 0.6 0.1 1.4 2.0 0.0 0.2 3.2 2.7 1.5 4.1 1.8 1.2 0.7 1.2 3.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.6 4.2 0.6 0.6 0.6 0.9 0.6 0.6 0.8 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 RAB40AL "RAR2, RLGP" ENSG00000102128 "RAB40A like" P0C0E4 X 102937272-102938300 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 2.9" "Cell type enhanced" "Detected in some" 7 "Cone photoreceptor cells: 2.0;Intestinal endocrine cells: 2.9;Ito cells: 2.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 2.3;HEK 293: 2.0" HPA076172 Uncertain Vesicles NA NA Vesicles "HPA076172: " "unprognostic (1.99e-1)" "unprognostic (3.05e-1)" "unprognostic (1.31e-1)" "unprognostic (1.11e-2)" "unprognostic (1.24e-1)" "unprognostic (1.04e-1)" "unprognostic (2.91e-1)" "unprognostic (1.39e-1)" "unprognostic (3.49e-1)" "unprognostic (1.83e-1)" "unprognostic (1.15e-1)" "unprognostic (2.18e-2)" "unprognostic (5.90e-10)" "unprognostic (4.74e-1)" "unprognostic (1.32e-1)" "unprognostic (5.02e-3)" "unprognostic (2.64e-2)" 0.3 1.0 0.2 0.2 0.3 0.7 0.4 2.1 0.4 0.3 0.4 1.0 0.8 2.9 0.2 0.3 0.7 0.3 0.3 0.3 0.2 0.5 0.5 0.0 0.2 1.0 0.2 0.0 0.9 0.6 0.8 0.1 0.2 0.5 0.0 0.2 0.1 0.6 0.4 0.2 0.1 0.3 0.8 0.2 0.0 0.5 0.0 1.2 0.0 0.3 0.0 0.7 0.0 0.5 0.6 0.8 0.2 0.0 0.0 2.3 0.0 0.2 0.0 0.5 0.0 0.5 0.0 0.6 0.0 0.8 0.0 1.2 0.0 0.6 0.2 2.0 0.0 1.5 0.0 0.0 0.5 0.0 0.0 0.3 0.3 0.4 0.4 0.3 0.1 0.4 0.0 0.0 1.4 0.6 1.0 0.6 0.0 1.6 0.0 0.3 0.0 0.2 1.0 0.0 0.2 0.7 0.0 0.2 0.1 0.0 0.0 0.0 0.3 1.4 0.5 0.5 0.3 0.0 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 0.0 0.0 0.0 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 2.0 0.8 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.1 0.6 0.0 0.8 0.3 1.6 2.9 2.5 1.5 0.7 1.4 0.0 0.0 0.0 0.0 0.9 0.1 0.0 1.4 0.0 0.4 0.0 0.0 0.3 0.3 0.0 0.6 0.0 0.5 0.3 RAB40B "RAR, SEC4L" ENSG00000141542 "RAB40B, member RAS oncogene family" Q12829 17 82654973-82698728 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 43.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.0" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 21.3;OE19: 25.4" HPA076172 Approved Vesicles NA NA Vesicles "HPA076172: " "unprognostic (2.21e-2)" "unprognostic (7.50e-2)" "unprognostic (2.45e-1)" "unprognostic (1.34e-1)" "unprognostic (1.14e-1)" "unprognostic (6.03e-2)" "unprognostic (2.34e-2)" "prognostic favorable (9.77e-4)" "unprognostic (1.74e-1)" "unprognostic (3.28e-2)" "unprognostic (1.36e-1)" "unprognostic (3.14e-2)" "prognostic favorable (2.95e-6)" "unprognostic (1.81e-2)" "unprognostic (1.38e-1)" "unprognostic (2.13e-2)" "unprognostic (9.83e-3)" 6.3 7.5 29.7 2.1 43.4 1.0 6.5 9.3 34.2 6.2 12.5 38.3 1.5 7.3 6.5 15.0 5.0 5.8 5.3 13.4 25.8 13.7 15.9 6.4 5.3 2.1 21.3 17.0 8.6 5.0 5.3 5.9 3.3 19.8 8.7 7.9 2.2 8.0 5.9 29.6 8.5 5.3 4.4 28.7 4.0 16.7 3.0 23.2 0.0 4.3 3.9 2.5 4.6 3.4 3.5 10.0 2.1 4.5 2.8 2.6 1.0 4.5 7.4 2.3 6.8 5.7 7.2 3.3 5.0 1.4 3.2 1.0 2.4 1.2 0.6 10.1 5.0 2.0 8.3 4.3 4.0 2.8 0.3 21.3 1.8 7.6 6.7 2.8 0.5 2.0 6.1 6.6 1.8 1.4 3.1 2.9 4.5 5.2 0.6 4.3 6.0 1.7 3.9 0.4 25.4 9.8 4.2 5.9 3.8 11.1 8.4 12.5 7.9 3.6 3.2 6.8 10.9 6.9 3.7 5.9 9.0 2.7 9.3 4.1 3.6 2.8 6.4 2.1 1.2 1.5 2.1 0.7 0.1 1.6 1.9 2.2 3.5 2.0 2.6 1.2 1.3 2.5 1.3 0.3 2.8 4.5 10.0 2.6 1.0 29.7 43.4 9.3 26.8 25.8 13.7 21.3 17.0 19.8 23.2 8.9 9.1 4.5 25.1 26.7 9.9 28.0 22.9 5.3 4.5 14.0 0.0 2.2 69.6 16.8 27.4 14.3 30.2 0.0 7.8 4.3 23.5 40.6 1.1 17.1 5.4 31.8 20.2 18.4 1.9 20.4 18.7 6.0 45.5 1.8 41.7 7.4 8.8 25.9 17.3 54.3 11.0 25.8 15.6 1.6 11.5 25.5 1.0 7.5 36.0 61.2 RAB40C "RARL, RASL8C" ENSG00000197562 "RAB40C, member RAS oncogene family" Q96S21 16 589357-629272 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 39.9" "Cell type enhanced" "Detected in many" 5 "Syncytiotrophoblasts: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 14.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076172 Approved Vesicles NA NA Vesicles "HPA076172: " "unprognostic (8.04e-2)" "unprognostic (3.63e-1)" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (5.38e-3)" "unprognostic (1.07e-2)" "prognostic unfavorable (1.18e-4)" "unprognostic (1.23e-1)" "unprognostic (4.61e-2)" "unprognostic (5.78e-2)" "unprognostic (3.45e-2)" "unprognostic (2.90e-1)" "unprognostic (1.37e-3)" "unprognostic (3.89e-2)" "unprognostic (6.20e-2)" "unprognostic (7.48e-2)" "unprognostic (4.00e-3)" 6.8 4.3 9.1 4.8 15.2 5.8 5.3 18.1 29.9 5.2 9.1 5.9 5.3 14.1 6.2 6.5 11.0 7.6 5.1 7.6 9.7 6.5 6.3 5.3 7.7 4.2 6.6 13.2 8.5 39.9 5.7 12.2 7.2 7.5 7.9 5.0 3.3 14.5 7.2 10.5 25.7 14.1 8.0 4.6 4.7 12.6 6.1 6.1 8.7 5.3 4.3 6.0 8.8 7.6 1.3 1.7 14.0 3.0 0.9 2.2 1.2 5.9 12.9 7.6 10.6 4.4 5.5 10.2 8.0 3.8 6.5 5.3 11.5 10.9 6.9 8.7 4.7 5.7 13.6 4.6 6.6 1.3 7.2 7.9 3.8 8.6 8.1 7.8 7.9 7.2 4.6 14.5 5.2 5.4 4.6 5.3 8.2 8.6 7.1 2.8 17.5 7.3 13.9 8.9 10.5 7.7 11.9 5.5 10.8 3.7 8.6 10.4 8.4 8.8 19.4 7.4 3.7 14.2 15.3 6.5 6.9 9.8 9.1 4.7 6.9 6.6 8.4 4.5 10.5 7.1 1.1 3.0 14.0 0.4 1.8 2.2 1.3 1.5 1.7 1.7 0.9 1.1 0.8 5.3 0.9 0.9 0.7 0.6 1.2 9.1 15.2 18.1 29.9 9.7 6.5 6.6 13.2 7.5 6.1 8.9 14.9 0.9 9.0 15.5 10.4 4.1 2.5 4.0 6.8 10.4 7.9 21.2 6.6 5.9 3.3 4.4 25.8 0.0 10.8 12.8 4.7 8.7 6.9 13.2 8.2 15.9 10.4 8.6 6.5 4.1 4.6 3.8 6.8 3.6 16.3 7.5 9.0 19.9 6.0 6.8 2.7 0.0 5.2 14.2 10.0 27.1 47.5 4.4 15.8 7.4 RAB5B ENSG00000111540 "RAB5B, member RAS oncogene family" P61020 12 55973913-55996683 "Predicted intracellular proteins, RAS pathway related proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010224, HPA068337" Approved Supported Vesicles NA NA 1000000 Vesicles "CAB010224: AB_2175453, HPA068337: AB_2685974" "prognostic unfavorable (2.24e-5)" "unprognostic (1.86e-1)" "unprognostic (1.91e-1)" "unprognostic (7.66e-3)" "unprognostic (2.09e-1)" "unprognostic (8.42e-2)" "unprognostic (9.16e-3)" "unprognostic (3.09e-1)" "unprognostic (3.13e-1)" "unprognostic (8.31e-3)" "unprognostic (8.64e-2)" "unprognostic (2.26e-1)" "unprognostic (2.27e-2)" "unprognostic (2.46e-2)" "unprognostic (2.74e-1)" "unprognostic (2.85e-1)" "unprognostic (2.49e-1)" 26.6 27.9 39.9 18.3 56.2 14.3 32.9 42.0 67.4 39.2 34.0 73.3 24.0 24.8 41.2 45.0 48.9 37.2 26.0 39.2 39.3 36.2 33.4 31.8 33.7 18.8 42.2 39.3 42.2 22.7 53.2 25.6 32.2 61.8 37.1 38.8 33.5 31.8 47.5 47.1 42.8 29.3 38.2 58.7 21.2 30.9 27.8 41.0 18.3 30.8 27.2 33.8 40.4 35.3 6.9 5.7 21.9 7.2 5.2 8.5 5.8 18.5 12.4 24.9 18.0 41.5 36.4 22.5 17.2 30.8 21.0 17.7 20.2 23.5 10.2 20.7 32.0 16.0 13.7 15.5 23.1 19.8 13.5 12.2 12.0 16.4 11.4 29.9 9.7 19.0 29.4 43.5 19.6 16.8 47.5 26.2 13.1 10.5 30.6 26.4 12.3 12.3 15.1 10.9 15.3 10.7 10.7 15.4 13.3 39.4 30.5 12.5 11.2 22.0 21.9 27.2 29.1 32.0 31.3 21.8 13.8 10.3 10.3 6.6 18.2 14.3 6.5 22.9 9.1 11.7 12.1 7.0 21.9 8.5 6.9 7.9 6.9 6.8 7.4 5.7 5.9 7.9 6.1 20.7 5.2 7.2 5.6 5.4 5.8 39.9 56.2 42.0 67.4 39.3 36.2 42.2 39.3 61.8 41.0 53.6 29.6 26.9 23.2 45.9 32.4 45.6 73.9 9.4 23.9 40.1 49.1 38.2 29.9 42.7 9.0 28.9 49.0 0.0 32.2 36.6 29.4 42.2 19.6 74.9 27.3 15.9 37.4 44.2 44.5 16.0 49.5 23.9 33.7 73.1 46.3 41.4 55.5 45.6 55.9 29.1 30.4 58.2 24.7 37.9 24.0 78.0 73.6 23.5 35.5 46.0 RABEP1 "neurocrescin, RAB5EP, rabaptin-5, RABPT5" ENSG00000029725 "Rabaptin, RAB GTPase binding effector protein 1" Q15276 17 5282265-5385812 "Cancer-related genes, Predicted intracellular proteins" "Apoptosis, Endocytosis, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004549, HPA019669, HPA024235, HPA024691" Supported Supported Vesicles NA NA Vesicles "CAB004549: AB_628192, HPA019669: AB_1856019, HPA024235: AB_1856020, HPA024691: AB_1856021" "unprognostic (3.22e-1)" "unprognostic (2.90e-2)" "unprognostic (2.45e-1)" "unprognostic (8.75e-3)" "unprognostic (1.64e-1)" "unprognostic (8.25e-2)" "unprognostic (3.71e-2)" "unprognostic (1.20e-1)" "unprognostic (1.60e-2)" "unprognostic (7.73e-2)" "prognostic favorable (6.43e-4)" "unprognostic (1.14e-1)" "unprognostic (6.09e-3)" "unprognostic (7.67e-2)" "unprognostic (2.60e-1)" "unprognostic (1.00e-1)" "unprognostic (9.00e-3)" 19.2 16.7 29.6 18.8 31.1 10.3 31.8 24.1 32.7 16.3 14.2 19.0 12.5 10.9 18.1 18.3 12.7 12.9 15.0 27.4 29.7 25.9 16.6 21.8 13.1 21.1 36.2 24.4 15.5 12.1 38.4 16.3 20.2 31.3 22.2 14.2 10.0 14.8 16.0 41.2 11.6 13.4 20.8 35.6 17.7 15.7 11.8 29.0 21.4 17.6 13.5 25.5 14.5 13.0 37.6 14.2 12.6 19.3 9.1 11.2 6.4 18.1 22.4 23.6 13.2 24.8 24.9 13.0 23.6 17.6 24.7 23.7 19.9 7.6 38.3 19.8 23.8 13.9 14.3 34.5 19.6 35.0 25.2 31.6 23.4 27.8 15.0 23.4 15.3 15.5 19.2 13.5 23.8 30.9 15.0 21.4 19.5 19.9 18.9 21.4 12.6 25.3 12.6 10.9 9.9 10.9 24.0 28.3 12.7 12.5 16.6 10.2 16.0 20.9 20.8 19.8 21.8 37.8 7.0 18.8 21.3 9.9 21.4 27.6 11.1 12.1 20.6 16.5 25.1 14.5 4.9 9.0 8.7 11.2 9.2 9.8 30.2 8.7 10.6 9.2 37.6 11.1 9.7 12.6 9.1 19.3 14.2 8.0 6.4 29.6 31.1 24.1 32.5 29.7 25.9 36.2 24.4 31.3 29.0 32.8 42.6 30.0 28.5 21.3 46.6 80.2 15.3 24.1 45.5 17.4 37.3 31.8 34.9 26.0 5.7 28.5 14.6 0.0 20.5 27.9 29.4 43.8 11.6 25.1 71.8 33.4 15.6 34.4 30.4 4.6 31.4 35.3 28.7 27.1 14.3 85.2 23.9 31.6 26.5 29.4 49.0 25.8 29.9 70.4 72.8 17.8 21.6 29.6 14.6 29.3 RABGGTB ENSG00000137955 "Rab geranylgeranyltransferase beta subunit" P53611 1 75786197-75795079 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026585, HPA027167, HPA030793" Approved Supported Approved Vesicles NA NA Vesicles "HPA026585: AB_1856026, HPA027167: AB_1856027, HPA030793: " "unprognostic (4.83e-2)" "unprognostic (3.04e-1)" "unprognostic (2.09e-2)" "unprognostic (2.45e-2)" "unprognostic (9.02e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (9.80e-5)" "unprognostic (9.62e-3)" "unprognostic (2.93e-1)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (6.05e-2)" "unprognostic (1.56e-1)" "unprognostic (6.77e-2)" "unprognostic (3.89e-1)" 19.4 31.8 20.2 25.3 20.1 8.7 23.5 25.8 24.2 19.4 18.8 16.8 14.8 18.6 20.9 14.1 15.7 15.6 12.0 27.2 19.1 20.4 40.7 35.8 17.4 13.1 26.3 14.8 18.5 33.2 12.3 26.4 17.3 20.5 15.6 16.2 13.7 25.0 15.8 33.5 9.5 14.5 13.1 29.4 19.0 14.3 11.9 18.0 21.3 17.3 21.6 34.4 12.4 13.3 10.6 12.8 7.6 11.5 6.3 10.7 4.4 17.1 9.8 17.8 6.9 22.3 25.7 10.3 23.4 17.4 22.5 18.0 22.1 4.2 14.4 23.9 12.9 38.2 10.6 43.3 18.8 31.7 14.9 11.6 12.4 16.4 37.3 27.7 16.6 7.6 17.1 42.6 20.0 23.2 33.3 18.3 15.4 20.7 15.0 25.1 7.4 14.0 19.8 14.1 12.9 16.8 11.5 26.2 6.6 17.1 9.4 9.6 9.3 5.3 30.2 54.2 15.8 5.9 17.1 17.6 14.2 16.1 33.3 44.7 10.1 29.5 10.3 16.4 13.5 6.2 7.6 7.7 4.5 8.8 11.5 10.3 10.6 8.9 8.1 12.8 7.1 10.5 10.7 1.3 6.3 8.0 12.0 8.0 4.4 20.2 20.1 25.8 24.2 19.1 20.4 26.3 14.8 20.5 18.0 32.8 40.6 61.9 46.8 113.4 22.5 59.6 66.2 22.7 33.0 26.2 19.6 39.2 87.9 38.3 1.3 35.0 39.3 0.0 44.7 50.2 57.6 54.1 71.3 68.3 56.4 30.2 86.2 29.4 47.6 3.6 30.0 61.3 55.6 48.7 49.0 26.6 40.5 35.1 31.5 127.1 22.2 6.5 65.0 15.4 14.3 125.0 44.7 48.9 56.6 68.1 RAET1G ULBP5 ENSG00000203722 "Retinoic acid early transcript 1G" Q6H3X3 6 149916878-149923121 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 21.2;tongue: 18.4" "Cell type enhanced" "Detected in some" 17 "Basal glandular cells: 4.2;Basal keratinocytes: 2.7;Melanocytes: 3.3;Urothelial cells: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 23.4;hTCEpi: 18.7;SiHa: 9.2;U-87 MG: 7.6" HPA062673 Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA062673: " "unprognostic (4.46e-3)" "unprognostic (4.92e-2)" "unprognostic (1.95e-1)" "unprognostic (1.21e-1)" "unprognostic (2.87e-3)" "unprognostic (1.49e-1)" "unprognostic (4.61e-3)" "prognostic unfavorable (5.35e-4)" "unprognostic (3.05e-1)" "unprognostic (1.57e-1)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (1.33e-1)" "unprognostic (1.49e-2)" "unprognostic (2.48e-1)" "unprognostic (8.85e-2)" "unprognostic (9.11e-2)" 2.5 10.0 0.3 0.6 0.3 0.0 2.5 0.2 1.0 5.6 0.6 0.5 1.4 0.2 0.8 4.3 21.2 0.5 1.2 0.9 0.4 0.2 2.3 0.2 1.3 0.1 0.3 0.1 1.9 0.1 0.1 1.2 0.1 0.5 2.9 0.1 0.8 3.9 2.2 0.4 4.3 0.5 1.8 0.9 0.2 0.6 0.5 0.2 0.2 0.7 18.4 10.7 2.8 5.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.8 1.0 0.0 1.3 1.9 1.8 0.0 0.6 2.4 1.1 1.5 0.0 1.2 0.0 0.5 1.3 1.1 2.0 0.7 4.1 0.8 0.2 1.3 0.4 23.4 0.0 0.5 0.0 0.0 2.7 18.7 2.8 1.3 1.3 0.4 0.6 0.2 0.2 0.4 1.0 0.0 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.8 2.5 0.3 0.2 9.2 0.4 0.0 0.1 0.3 0.3 1.3 0.5 0.4 1.1 0.6 0.0 0.0 0.0 7.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 1.0 0.4 0.2 0.3 0.1 0.5 0.2 0.0 0.0 0.0 4.2 2.7 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.0 0.0 1.2 0.0 0.7 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 3.3 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 0.1 0.0 0.0 9.5 RAMP2 ENSG00000131477 "Receptor activity modifying protein 2" O60895 17 42758447-42763041 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Transport Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Endothelial cells: 348.5;Ito cells: 252.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 18 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 18 "dendritic cells: 6.4" "Cell line enhanced" "Detected in many" "ASC diff: 47.1;EFO-21: 31.4;HUVEC TERT2: 14.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052020 Approved Vesicles NA NA Vesicles "HPA052020: AB_2681697" "unprognostic (8.64e-2)" "unprognostic (2.12e-2)" "unprognostic (8.03e-2)" "unprognostic (1.16e-2)" "unprognostic (5.24e-2)" "unprognostic (4.13e-3)" "unprognostic (2.68e-2)" "unprognostic (1.04e-1)" "unprognostic (4.50e-2)" "unprognostic (5.18e-2)" "unprognostic (1.02e-2)" "unprognostic (6.79e-2)" "unprognostic (1.28e-2)" "unprognostic (6.96e-3)" "unprognostic (4.42e-2)" "unprognostic (2.20e-1)" "unprognostic (1.25e-1)" 48.6 7.1 8.6 7.6 9.6 0.2 43.4 3.4 15.4 35.1 9.7 10.8 6.1 5.2 49.5 24.2 19.5 17.0 20.4 23.9 9.6 8.5 18.8 14.6 51.5 17.3 13.8 7.7 17.3 9.6 5.6 6.1 56.1 12.5 24.9 9.1 71.1 12.8 12.2 16.2 15.6 11.5 30.9 8.8 15.6 9.2 10.9 3.0 3.9 20.0 30.1 11.7 13.2 23.1 0.0 6.4 0.0 0.1 0.0 0.3 0.0 0.0 0.4 1.9 0.0 47.1 2.4 1.5 0.3 0.7 3.9 1.9 4.3 0.0 0.0 31.4 1.1 0.2 0.0 1.8 0.0 3.3 0.0 0.0 0.0 0.3 1.3 1.2 0.0 0.0 1.7 0.0 0.6 0.1 1.3 14.1 0.5 0.0 0.1 0.2 0.0 0.2 0.3 9.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.9 3.9 1.1 0.0 6.4 1.9 0.4 1.2 2.6 7.6 2.8 0.2 0.9 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.3 0.0 8.6 9.6 3.4 15.4 9.6 8.5 13.8 7.7 12.5 3.0 0.0 10.1 5.1 4.4 30.6 0.1 1.7 0.0 0.0 1.2 3.5 0.0 1.0 3.3 0.7 1.1 348.5 0.0 0.0 0.6 1.2 42.9 4.5 0.0 0.9 2.8 0.0 4.1 252.3 12.4 3.1 35.9 3.2 21.9 4.6 0.0 8.9 0.0 0.0 20.5 0.4 1.6 6.5 9.5 11.2 60.0 24.1 1.3 2.5 0.0 4.1 RANBP6 ENSG00000137040 "RAN binding protein 6" O60518 9 6011043-6015625 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043748, HPA052684" Approved Supported Vesicles NA NA Vesicles "HPA043748: AB_10796796, HPA052684: AB_2681913" "unprognostic (1.47e-2)" "unprognostic (8.86e-2)" "unprognostic (1.70e-1)" "unprognostic (6.01e-2)" "unprognostic (3.63e-2)" "unprognostic (1.30e-1)" "unprognostic (3.37e-1)" "unprognostic (3.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.22e-2)" "unprognostic (3.81e-2)" "unprognostic (1.89e-2)" "prognostic favorable (1.34e-7)" "unprognostic (2.42e-1)" "unprognostic (1.91e-1)" "unprognostic (3.04e-1)" "unprognostic (2.61e-1)" 10.6 14.6 11.8 12.6 18.1 27.0 11.7 23.7 27.1 8.6 7.2 8.1 8.6 7.5 9.3 7.5 9.8 8.2 7.8 13.6 12.8 15.8 14.2 15.3 8.4 15.8 19.7 17.3 10.4 10.9 16.1 16.2 15.6 32.0 10.4 7.4 5.4 10.1 9.3 15.1 10.0 11.6 10.5 16.0 14.3 10.9 6.1 15.0 22.3 12.6 9.2 16.0 9.3 7.6 4.2 5.2 7.2 11.1 4.8 8.1 4.4 10.9 6.0 12.4 10.5 10.9 8.7 6.7 14.1 9.8 12.1 9.9 3.2 3.4 14.9 3.9 10.8 6.0 6.4 10.8 12.5 13.7 35.1 6.3 38.7 22.7 6.7 6.4 14.6 8.3 9.4 6.9 7.6 7.5 9.7 14.0 13.4 2.9 12.5 11.6 3.6 10.4 23.7 5.5 3.9 5.1 11.2 7.7 7.0 12.8 7.7 6.1 9.0 6.6 5.0 3.7 10.6 7.9 10.0 16.6 11.5 6.9 5.6 13.0 7.4 11.9 14.3 6.5 8.8 4.2 7.2 7.2 6.4 4.6 11.1 4.5 4.2 6.7 4.7 4.5 3.7 7.9 7.5 2.3 4.8 7.7 5.2 8.1 4.4 11.8 18.1 23.7 27.1 12.8 15.8 19.7 17.3 32.0 15.0 8.9 7.2 4.2 5.8 9.2 17.3 22.0 2.5 5.3 19.4 10.4 2.0 7.3 6.6 7.6 1.0 9.3 2.1 0.0 9.3 3.9 5.4 4.5 10.4 11.3 3.8 11.1 9.1 12.3 12.0 0.9 6.1 6.6 1.7 1.8 2.7 14.1 6.0 3.6 6.3 10.9 21.0 0.0 5.1 6.2 7.9 8.3 5.5 7.5 4.5 5.0 RAPGEF1 "C3G, GRF2" ENSG00000107263 "Rap guanine nucleotide exchange factor 1" Q13905 9 131576770-131740074 "Plasma proteins, Predicted intracellular proteins" Neurogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 83.3" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 123.9;monocytes: 83.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006426, HPA075984" Enhanced Supported Vesicles NA NA Vesicles "HPA006426: AB_1856070, HPA075984: AB_2686771" "unprognostic (1.00e-1)" "unprognostic (8.19e-2)" "unprognostic (2.12e-2)" "unprognostic (2.43e-2)" "unprognostic (2.34e-1)" "unprognostic (2.38e-1)" "unprognostic (4.11e-2)" "unprognostic (1.74e-1)" "unprognostic (5.50e-2)" "unprognostic (6.04e-2)" "unprognostic (1.94e-2)" "unprognostic (1.62e-1)" "prognostic favorable (1.18e-5)" "unprognostic (5.66e-2)" "unprognostic (1.99e-2)" "unprognostic (1.49e-1)" "unprognostic (3.73e-2)" 16.2 10.8 18.4 21.5 28.0 19.7 18.5 21.8 19.5 9.6 11.5 13.7 6.0 10.1 11.1 6.9 10.3 11.4 10.2 21.5 17.4 16.0 9.4 9.7 16.9 21.7 13.1 10.2 7.4 24.1 9.0 7.3 28.5 13.5 9.0 10.3 16.8 8.5 10.0 83.3 9.2 13.7 13.2 13.0 16.7 12.0 6.8 11.6 12.4 9.9 8.8 25.9 11.3 12.0 9.2 2.9 5.3 3.9 2.0 6.5 2.3 10.6 12.4 12.6 12.7 12.9 14.0 48.4 9.2 18.9 10.7 7.7 15.4 7.0 19.3 11.6 18.5 23.0 19.5 14.4 12.8 5.4 44.7 5.9 5.6 20.8 8.1 10.9 23.3 26.1 10.6 23.6 14.0 16.7 10.8 19.3 22.5 15.1 38.3 13.8 11.1 16.4 8.3 12.7 10.6 11.3 16.4 29.4 26.8 4.9 12.9 10.7 10.7 13.4 12.8 13.4 13.2 12.2 19.7 20.3 28.8 12.1 18.2 14.0 12.9 11.2 38.1 13.7 10.0 6.9 5.3 2.0 2.6 6.5 3.8 3.7 9.2 4.2 4.2 2.4 5.3 1.1 2.9 2.3 2.0 3.9 2.9 3.0 2.3 18.4 28.0 21.8 18.5 17.4 16.0 13.1 10.2 13.5 11.6 6.0 17.3 13.3 8.3 16.7 18.8 12.5 22.9 20.1 14.8 5.2 13.7 16.3 5.0 6.8 2.1 30.2 16.8 0.0 15.9 28.3 7.6 9.5 19.7 11.3 25.1 123.9 11.6 22.1 24.1 1.5 8.1 48.3 30.4 83.8 12.0 19.1 15.1 14.4 11.3 7.0 13.2 6.5 7.2 4.4 10.7 9.9 43.3 23.5 10.2 10.2 RASA2 GAP1M ENSG00000155903 "RAS p21 protein activator 2" Q15283 3 141487047-141615342 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Early spermatids: 84.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035374, HPA035375" Approved Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA035374: AB_10602122, HPA035375: AB_2674596" "unprognostic (1.85e-1)" "unprognostic (8.11e-2)" "unprognostic (1.48e-1)" "unprognostic (2.38e-2)" "unprognostic (1.18e-1)" "unprognostic (3.36e-3)" "unprognostic (9.62e-3)" "unprognostic (2.57e-1)" "unprognostic (1.38e-1)" "unprognostic (9.21e-2)" "unprognostic (4.23e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (7.62e-7)" "unprognostic (1.17e-1)" "unprognostic (2.56e-1)" "unprognostic (1.61e-1)" "prognostic favorable (4.34e-5)" 12.0 7.4 11.1 25.2 10.6 26.8 14.4 20.8 12.2 13.4 12.7 7.9 7.7 7.7 19.1 11.2 11.6 11.3 9.9 7.4 8.7 9.9 9.3 7.5 14.4 27.1 8.2 7.8 16.2 8.7 9.2 15.0 12.2 8.7 10.5 10.8 11.4 13.2 9.4 6.1 15.7 12.9 12.3 11.2 21.4 8.2 6.7 7.8 25.4 10.1 7.3 23.6 11.8 14.0 10.5 3.4 14.4 5.9 11.5 17.7 5.8 16.0 3.0 6.5 4.9 7.2 8.9 9.3 11.7 23.1 7.6 9.4 6.9 5.3 10.3 8.1 10.1 7.3 6.7 4.6 5.0 13.9 5.5 4.5 5.5 2.4 2.5 3.8 10.4 14.5 5.2 4.6 6.9 8.2 9.2 9.6 8.9 4.9 13.4 7.5 2.3 13.6 8.6 7.5 5.4 2.2 5.1 11.0 12.7 7.5 5.8 2.3 4.7 9.3 8.3 8.5 7.1 4.1 7.9 8.0 9.0 4.1 12.4 5.2 21.9 6.4 13.9 7.8 7.2 4.4 7.7 3.7 3.8 11.9 3.7 11.7 7.0 10.6 11.9 3.4 10.5 17.7 13.5 14.4 11.5 5.9 2.6 9.7 5.8 11.1 10.6 20.8 12.2 8.7 9.9 8.2 7.8 8.7 7.8 41.7 23.4 14.6 30.7 19.2 15.7 6.1 10.2 12.0 21.6 12.2 35.3 15.3 1.7 15.2 84.9 16.3 12.7 23.3 14.3 6.1 14.4 45.5 30.1 8.7 10.8 28.6 15.1 15.4 26.9 4.6 12.7 26.0 11.8 7.2 16.3 17.5 21.7 16.1 13.4 7.0 56.0 6.5 21.5 14.2 13.9 24.0 11.0 50.3 15.9 49.5 RASL10B "RRP17, VTS58635" ENSG00000270885 "RAS like family 10 member B" Q96S79 17 35731649-35743521 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "ductus deferens: 24.6;skeletal muscle: 26.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 12.2;Early spermatids: 9.3;Horizontal cells: 6.4;Late spermatids: 25.1;Muller glia cells: 17.6" "Cancer enhanced" "Detected in many" "testis cancer: 14.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 14.1;HHSteC: 16.1;HSkMC: 11.7;NTERA-2: 24.1;REH: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046842, HPA057092" Enhanced Approved Vesicles NA NA Vesicles "HPA046842: AB_2679835, HPA057092: AB_2683332" "unprognostic (5.78e-2)" "unprognostic (2.15e-2)" "unprognostic (2.36e-2)" "prognostic unfavorable (6.38e-6)" "unprognostic (8.60e-2)" "unprognostic (1.24e-1)" "unprognostic (2.69e-2)" "unprognostic (4.98e-2)" "unprognostic (1.97e-2)" "unprognostic (7.13e-2)" "unprognostic (2.61e-2)" "unprognostic (3.18e-2)" "unprognostic (1.71e-6)" "unprognostic (2.41e-3)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (9.60e-3)" 12.8 0.9 6.3 0.3 9.1 0.2 2.8 0.3 12.3 1.8 0.3 1.0 24.6 0.8 1.3 0.8 0.3 3.9 0.8 10.9 4.7 1.0 1.1 0.4 0.2 0.0 2.8 2.5 4.7 2.5 1.1 2.8 6.3 0.9 0.2 1.1 12.6 15.2 26.7 0.3 0.9 0.9 0.6 0.2 0.3 1.6 2.5 0.0 0.9 0.0 0.2 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 3.6 0.0 0.6 0.4 1.1 0.7 0.4 2.5 2.1 4.6 0.0 0.0 0.4 0.1 0.0 0.0 14.1 0.0 0.8 0.0 4.6 0.0 2.3 5.2 16.1 0.0 0.0 11.7 0.9 0.8 0.0 2.0 0.0 7.6 3.0 0.0 0.2 0.2 6.4 0.0 24.1 0.0 0.0 11.7 6.5 10.4 0.0 0.0 10.8 10.5 0.7 0.2 0.9 11.0 1.3 0.7 0.0 1.2 8.7 0.0 0.3 0.0 0.0 2.9 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.1 2.9 12.2 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.9 9.3 0.0 0.0 0.0 0.0 0.0 2.1 0.2 0.0 3.0 0.2 6.4 0.0 0.0 0.3 25.1 2.0 0.0 0.0 0.0 0.0 17.6 0.5 0.0 2.8 0.0 1.1 0.0 1.0 0.2 0.2 0.0 0.2 0.0 0.0 0.1 RBMS3 ENSG00000144642 "RNA binding motif single stranded interacting protein 3" Q6XE24 3 28574791-30010391 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 110.2;Ito cells: 119.7;Leydig cells: 147.9;Peritubular cells: 104.0;Sertoli cells: 109.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 7.3" "Lineage enriched" "Detected in single" 8 "dendritic cells: 7.3" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 14.5;HHSteC: 14.2;WM-115: 14.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034719 Uncertain Approved Vesicles NA NA Vesicles "HPA034719: AB_10670172" "unprognostic (8.39e-2)" "unprognostic (2.54e-2)" "unprognostic (1.02e-1)" "unprognostic (7.08e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-1)" "unprognostic (3.13e-2)" "unprognostic (4.95e-2)" "unprognostic (1.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.90e-1)" "unprognostic (4.94e-2)" "prognostic unfavorable (1.85e-4)" "unprognostic (2.25e-3)" "unprognostic (3.81e-2)" "unprognostic (8.48e-2)" "unprognostic (3.24e-4)" 16.5 10.3 4.8 3.2 5.6 0.1 9.9 1.6 4.2 10.6 6.6 2.6 7.9 1.7 5.6 9.3 6.0 6.7 8.5 16.5 5.1 2.4 6.2 4.4 12.3 5.6 5.1 3.4 13.3 2.5 10.8 4.8 12.3 8.5 8.4 3.3 10.0 4.6 13.5 9.7 3.3 3.6 13.7 8.6 7.4 4.6 4.9 4.7 3.7 18.6 5.5 2.0 9.3 8.9 0.2 7.3 0.0 0.0 0.0 0.8 0.1 1.4 0.1 7.0 0.1 13.4 8.8 0.0 3.7 2.4 4.0 4.9 0.0 0.2 0.0 4.0 14.5 1.1 0.1 0.4 2.8 7.9 0.0 0.5 3.9 5.4 0.0 14.2 0.0 0.0 8.4 1.7 7.1 8.4 5.8 5.7 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.2 0.0 0.3 0.2 5.2 0.0 1.5 0.0 0.0 13.4 9.0 0.0 0.4 3.3 0.0 0.0 11.7 7.9 7.3 9.2 7.6 0.0 0.0 0.5 1.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 7.3 0.6 0.1 4.8 5.6 1.6 4.2 5.1 2.4 5.1 3.4 8.5 4.7 110.2 19.7 0.0 23.2 7.3 0.4 14.5 25.5 12.0 29.6 8.7 0.0 14.0 0.0 4.0 20.0 46.7 0.0 0.0 1.1 3.7 69.8 5.7 4.7 0.9 2.5 0.0 0.0 119.7 23.9 14.8 147.9 3.8 6.8 1.0 0.0 0.0 0.6 0.0 104.0 2.6 0.0 109.9 52.6 0.9 1.1 6.4 8.0 1.9 0.0 3.3 RBSN ZFYVE20 ENSG00000131381 "Rabenosyn, RAB effector" Q9H1K0 3 15070073-15099163 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044878 Approved Supported Vesicles NA NA Vesicles "HPA044878: AB_10967610" "unprognostic (6.76e-2)" "unprognostic (2.18e-1)" "unprognostic (3.00e-3)" "unprognostic (1.00e-1)" "unprognostic (8.06e-2)" "unprognostic (3.79e-3)" "unprognostic (1.09e-3)" "unprognostic (1.72e-2)" "unprognostic (3.57e-1)" "unprognostic (1.90e-2)" "unprognostic (2.00e-2)" "unprognostic (9.34e-2)" "unprognostic (2.38e-3)" "unprognostic (4.45e-2)" "unprognostic (1.41e-1)" "unprognostic (2.72e-1)" "unprognostic (1.78e-1)" 11.6 8.7 18.0 8.7 19.8 21.4 10.7 19.6 26.1 9.9 10.6 21.9 9.4 6.4 12.9 10.2 12.3 11.2 7.7 12.9 16.6 13.7 7.4 9.3 11.3 8.2 16.6 15.3 18.2 7.1 13.3 7.1 10.6 17.0 10.6 7.5 10.9 7.6 13.1 15.7 13.7 7.7 14.5 16.2 9.2 8.6 11.6 16.7 3.6 15.5 7.6 8.1 9.9 9.6 7.9 4.3 13.6 7.3 3.2 9.5 2.9 8.3 12.3 10.0 13.0 11.1 8.3 26.7 9.3 9.0 11.1 10.1 7.4 5.0 5.9 5.4 12.2 6.5 5.4 12.8 11.2 9.9 7.4 11.4 6.7 14.6 6.0 7.6 6.7 7.5 8.9 12.6 14.2 9.5 6.6 9.0 6.7 10.0 6.9 8.4 11.1 3.6 3.4 8.6 5.4 9.9 4.8 11.5 6.5 5.8 9.6 2.7 9.4 11.3 6.9 8.2 7.7 17.7 5.0 10.9 10.1 10.6 9.8 13.0 6.2 9.2 7.0 9.7 7.6 9.4 9.0 5.4 12.3 5.3 7.3 4.7 5.2 7.2 6.5 4.3 7.9 9.5 6.4 13.6 3.2 6.2 4.1 4.7 2.9 18.0 19.8 19.6 25.3 16.6 13.7 16.6 15.3 17.0 16.7 14.9 14.7 4.5 5.1 0.0 18.9 17.3 5.1 14.7 18.2 3.5 21.6 8.9 5.0 6.8 10.2 10.5 3.3 0.0 8.2 8.4 8.1 9.9 9.3 13.0 9.1 20.6 1.2 9.2 12.9 12.2 17.5 7.5 0.0 5.4 8.9 14.1 8.2 7.0 13.8 5.4 21.0 6.5 6.3 8.9 13.8 0.0 10.8 6.9 6.4 6.7 RC3H2 "FLJ20301, FLJ20713, MNAB, RNF164" ENSG00000056586 "Ring finger and CCCH-type domains 2" Q9HBD1 9 122844556-122905341 "Enzymes, Predicted intracellular proteins, Transcription factors" "Ubl conjugation pathway" "Repressor, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042863, HPA062144" Approved Enhanced Vesicles NA NA Vesicles "HPA042863: AB_2678204, HPA062144: AB_2732677" "unprognostic (6.05e-2)" "unprognostic (7.87e-2)" "unprognostic (7.24e-2)" "unprognostic (1.66e-1)" "unprognostic (4.08e-3)" "unprognostic (2.37e-1)" "unprognostic (2.43e-2)" "unprognostic (3.92e-2)" "unprognostic (1.99e-1)" "unprognostic (1.57e-1)" "unprognostic (1.80e-1)" "unprognostic (1.21e-1)" "prognostic favorable (5.50e-4)" "unprognostic (1.36e-1)" "unprognostic (1.68e-1)" "unprognostic (2.16e-1)" "unprognostic (1.26e-1)" 16.4 10.7 25.4 14.1 28.8 30.6 14.1 18.7 27.6 17.1 13.0 10.5 14.4 11.0 14.6 9.7 16.5 12.2 12.6 15.7 18.1 11.2 15.0 14.8 16.2 19.2 12.3 25.3 14.7 9.7 19.0 16.2 16.3 12.6 11.5 13.1 9.4 13.2 13.9 16.1 13.8 13.0 16.3 14.4 15.2 12.8 12.8 13.2 18.9 15.0 11.5 18.8 14.1 13.7 8.6 9.6 12.4 10.4 4.9 8.9 3.7 10.0 14.7 19.5 10.5 10.4 12.4 10.9 12.8 14.1 15.2 13.3 17.7 10.7 16.8 10.5 17.1 17.8 23.6 20.9 15.1 16.7 7.7 8.3 9.6 26.4 11.7 13.7 11.4 15.4 11.9 14.7 14.8 21.0 12.6 20.8 14.6 13.5 12.4 19.2 13.5 11.1 8.0 9.7 13.6 13.6 11.2 32.3 10.8 14.8 8.0 23.0 16.0 22.8 14.1 11.6 14.1 16.9 9.6 20.6 11.7 9.9 15.9 22.9 8.7 14.1 18.4 13.4 10.1 13.2 12.4 6.6 8.5 8.9 10.4 7.3 6.5 7.3 8.9 5.8 8.6 7.0 6.8 11.8 4.9 9.3 9.6 7.1 3.7 25.4 28.8 18.7 27.6 18.1 11.2 12.3 25.3 12.6 13.2 38.7 32.8 12.8 10.7 9.7 18.4 31.3 12.7 12.0 11.4 8.7 35.3 12.6 3.3 10.7 4.0 26.6 12.3 0.0 10.0 12.7 13.4 18.1 16.2 12.4 8.5 27.0 22.3 31.9 20.4 6.4 12.4 15.0 13.5 15.4 22.4 15.8 18.0 3.5 17.0 11.0 17.8 19.4 15.6 25.0 12.6 12.9 19.2 30.2 13.2 22.7 RDH5 "HSD17B9, RDH1, SDR9C5" ENSG00000135437 "Retinol dehydrogenase 5" Q92781 12 55720367-55724705 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Sensory transduction, Steroid metabolism, Vision" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 39.4;retina: 127.9" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 68.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 19.0;ASC TERT1: 16.4;hTEC/SVTERT24-B: 9.9;hTERT-RPE1: 16.2;LHCN-M2: 9.9;U-87 MG: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063345 Uncertain Vesicles "Intracellular and membrane" NA NA Vesicles "HPA063345: AB_2684992" "unprognostic (1.04e-2)" "unprognostic (6.45e-2)" "unprognostic (1.80e-1)" "unprognostic (2.67e-1)" "unprognostic (3.66e-2)" "unprognostic (1.48e-2)" "unprognostic (1.88e-2)" "unprognostic (1.54e-1)" "unprognostic (5.35e-2)" "unprognostic (4.04e-2)" "unprognostic (4.05e-1)" "unprognostic (1.26e-3)" "unprognostic (7.63e-2)" "unprognostic (8.79e-2)" "unprognostic (3.46e-2)" "unprognostic (2.12e-3)" "unprognostic (3.27e-2)" 39.4 0.7 0.6 2.8 0.8 0.2 14.9 0.5 0.8 1.0 7.6 1.0 1.5 8.6 1.9 4.5 2.4 2.2 4.8 3.9 1.0 0.5 3.7 27.2 0.7 1.6 0.8 0.8 1.4 1.5 0.0 0.6 0.4 1.5 1.8 1.9 127.9 3.2 1.0 3.1 1.0 9.4 8.8 1.1 0.9 2.7 0.9 1.0 0.3 1.1 2.6 0.7 2.0 2.5 0.4 2.3 2.1 0.9 1.5 2.6 0.4 0.4 0.9 0.5 0.3 19.0 16.4 0.3 2.4 2.7 0.5 0.9 0.3 5.1 0.6 0.4 1.3 0.1 0.2 0.2 0.0 0.4 0.6 0.8 0.1 1.0 1.3 0.5 0.0 0.2 7.0 0.6 9.9 0.0 16.2 0.2 0.3 0.1 0.8 9.9 0.4 0.2 0.1 0.2 2.3 1.4 0.3 0.3 0.3 0.1 0.5 0.1 0.7 0.1 0.3 2.2 0.1 0.4 0.3 0.3 1.0 1.0 0.7 0.6 0.7 0.3 0.1 17.7 0.2 0.2 0.3 0.6 2.1 0.4 0.9 0.2 0.4 1.2 2.6 1.2 0.3 1.0 0.4 0.9 1.5 0.9 2.3 0.2 0.4 0.6 0.8 0.5 0.8 1.0 0.5 0.8 0.8 1.5 1.0 8.9 2.1 6.7 4.2 1.6 22.6 2.1 5.1 5.3 1.2 1.8 58.9 1.6 1.7 1.6 0.6 4.2 28.4 0.0 2.3 1.0 3.3 2.8 0.0 17.9 0.5 15.9 11.1 1.8 2.2 1.8 12.4 4.0 5.0 4.6 8.7 10.9 2.8 17.6 6.3 8.4 68.6 12.9 4.7 3.5 6.3 1.5 1.3 10.0 11.8 2.7 RELL2 "C5orf16, FLJ90583" ENSG00000164620 "RELT like 2" Q8NC24 5 141636950-141641077 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.6;parathyroid gland: 27.6" "Cell type enhanced" "Detected in many" 16 "Horizontal cells: 62.0;Spermatocytes: 18.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 18.3;JURKAT: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077928 Uncertain Vesicles NA NA Vesicles "HPA077928: " "unprognostic (3.27e-2)" "unprognostic (8.46e-2)" "unprognostic (2.12e-1)" "unprognostic (4.95e-3)" "unprognostic (1.91e-3)" "unprognostic (7.12e-2)" "unprognostic (1.11e-2)" "unprognostic (1.05e-1)" "unprognostic (3.69e-2)" "unprognostic (2.12e-2)" "unprognostic (6.76e-4)" "unprognostic (4.17e-2)" "unprognostic (1.85e-2)" "unprognostic (7.85e-2)" "unprognostic (8.74e-3)" "unprognostic (4.31e-2)" "unprognostic (6.58e-2)" 2.0 4.5 6.9 2.4 12.3 2.2 2.3 12.5 27.6 1.4 2.3 2.3 0.0 2.5 1.3 1.8 2.7 1.2 2.4 1.6 10.8 14.5 3.3 1.8 2.7 4.7 17.8 8.4 1.1 2.2 27.6 9.4 7.4 24.9 2.2 2.1 1.7 3.7 1.8 1.0 4.2 1.8 2.2 3.8 5.4 2.3 4.6 2.5 4.6 2.8 1.7 5.0 2.9 0.9 2.5 7.8 1.2 3.5 0.1 5.4 1.9 0.8 2.8 2.8 5.2 2.2 0.7 1.3 2.3 4.4 7.7 11.5 10.3 1.0 0.1 1.1 3.5 16.3 4.2 2.5 10.0 2.0 2.5 1.6 6.3 6.0 5.1 3.6 2.0 18.3 1.4 6.3 7.1 5.2 1.6 2.1 20.3 2.2 3.3 1.7 1.3 3.7 0.7 3.2 3.7 1.4 0.2 0.6 4.3 2.4 2.5 4.6 5.0 2.1 10.1 1.7 0.4 3.5 4.7 1.8 5.9 2.6 4.7 4.0 1.9 5.2 14.8 3.2 8.8 3.7 0.0 1.4 0.0 3.0 3.5 1.1 2.5 3.2 3.0 2.3 1.5 2.9 1.6 1.2 0.1 2.5 7.8 5.4 1.9 6.9 12.3 12.5 27.6 10.8 14.5 17.8 8.4 24.9 2.5 0.0 1.1 1.4 1.1 4.0 4.8 0.2 2.5 0.0 0.0 1.8 11.8 0.2 1.7 2.5 1.3 2.2 2.6 0.0 2.3 3.3 1.0 3.0 0.0 0.2 3.7 62.0 1.2 0.6 4.9 2.7 0.6 2.8 6.8 0.0 1.5 6.4 1.9 3.5 1.4 4.7 7.0 0.0 1.4 18.6 6.0 3.8 5.1 5.9 0.6 1.8 REX1BD "C19orf60, FLJ20850, FLJ30108, FLJ34606, FLJ37391" ENSG00000006015 "Required for excision 1-B domain containing" Q96EN9 19 18588685-18592336 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 100.1" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 114.3;Distal tubular cells: 131.0;Hofbauer cells: 225.5;Proximal tubular cells: 163.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 25.6;EFO-21: 24.1;PC-3: 35.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043414 Approved Approved Vesicles NA NA Vesicles "HPA043414: AB_10797141" "unprognostic (1.12e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "unprognostic (6.78e-3)" "unprognostic (1.22e-1)" "unprognostic (4.87e-3)" "unprognostic (2.52e-2)" "unprognostic (1.45e-1)" "unprognostic (4.60e-1)" "unprognostic (3.10e-1)" "unprognostic (5.50e-3)" "unprognostic (3.24e-2)" "unprognostic (3.19e-2)" "unprognostic (4.02e-2)" "unprognostic (9.27e-2)" "unprognostic (1.48e-1)" "prognostic favorable (8.47e-4)" 29.8 12.6 21.2 15.2 18.2 13.1 9.9 20.7 21.6 9.8 18.3 10.3 17.5 13.0 10.8 13.9 8.7 8.4 11.5 17.6 18.0 16.6 17.7 25.4 11.5 8.5 16.6 18.0 11.9 15.9 5.0 8.3 8.6 14.4 15.8 4.7 8.5 22.2 14.3 100.1 9.7 17.8 8.7 12.3 25.8 24.1 5.2 11.4 7.4 7.4 14.0 8.8 8.1 9.9 44.5 51.8 50.5 55.2 32.5 57.0 49.0 6.8 8.3 0.7 1.3 1.2 1.0 25.6 7.2 1.1 1.7 2.0 1.5 7.9 7.1 24.1 1.3 0.4 5.0 0.3 1.6 0.4 7.7 17.2 4.6 3.1 3.9 1.4 4.0 11.5 2.2 1.6 0.8 0.4 0.6 2.1 3.2 5.8 2.1 0.8 11.4 7.4 6.5 11.2 3.5 35.6 8.1 2.1 18.0 2.4 6.2 3.5 13.3 3.3 3.3 8.0 0.3 1.8 3.4 7.1 0.8 7.3 9.9 4.2 20.5 6.4 4.1 6.8 7.2 3.3 28.1 55.2 50.5 55.7 47.3 56.8 44.5 57.0 49.9 51.8 34.3 52.6 49.1 31.6 32.5 43.7 44.8 45.1 49.0 21.2 18.2 20.7 21.6 18.0 16.6 16.6 18.0 14.4 11.4 26.8 38.7 0.0 0.0 0.0 0.0 0.0 0.0 36.1 38.7 73.3 0.0 114.3 131.0 66.1 0.0 0.0 0.0 0.0 99.8 112.7 0.0 0.0 38.4 0.0 225.5 0.0 0.0 0.0 0.0 0.0 0.0 41.7 0.0 101.8 0.0 0.0 75.0 0.0 0.0 163.2 0.0 0.0 0.0 0.0 0.0 0.0 55.6 0.0 0.0 0.0 RFFL "CARP-2, CARP2, fring, rififylin, RNF189, RNF34L" ENSG00000092871 "Ring finger and FYVE like domain containing E3 ubiquitin protein ligase" Q8WZ73 17 35005990-35089319 "Enzymes, Predicted intracellular proteins" "Apoptosis, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 56.8" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 81.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 41.3;Karpas-707: 38.5" "CAB008096, HPA017910, HPA019492" Approved Approved Vesicles NA NA Vesicles "CAB008096: AB_2178607, HPA017910: AB_1856189, HPA019492: AB_1856190" "unprognostic (2.59e-1)" "unprognostic (2.87e-1)" "prognostic favorable (4.92e-4)" "unprognostic (1.24e-1)" "unprognostic (1.44e-1)" "unprognostic (1.79e-1)" "unprognostic (5.73e-3)" "unprognostic (4.34e-3)" "unprognostic (2.31e-1)" "unprognostic (9.26e-3)" "unprognostic (2.39e-1)" "unprognostic (2.63e-1)" "prognostic unfavorable (2.43e-5)" "unprognostic (1.44e-1)" "unprognostic (1.97e-1)" "unprognostic (8.68e-2)" "unprognostic (1.36e-1)" 5.8 6.1 11.1 9.9 22.9 22.1 6.7 4.4 15.7 6.7 14.6 56.8 5.9 14.8 6.9 5.3 21.6 5.4 11.5 5.8 14.4 10.5 15.4 25.0 6.8 8.9 32.1 7.3 5.2 10.1 8.3 4.9 6.5 30.7 10.7 12.6 4.5 9.6 7.0 12.2 5.2 11.9 7.3 32.1 9.9 13.4 15.7 27.5 13.1 23.0 5.4 15.0 10.2 9.2 4.2 5.2 26.8 7.6 6.7 14.5 7.1 7.9 15.0 4.0 5.6 6.6 9.4 2.1 5.2 8.5 5.4 6.5 5.1 15.8 2.3 6.6 6.6 11.5 11.2 6.2 10.1 7.5 41.3 4.3 12.4 4.0 12.5 5.6 8.0 7.4 6.3 6.0 8.1 14.3 7.2 5.2 7.2 5.8 38.5 4.8 2.5 1.8 7.1 4.7 15.6 9.0 5.5 6.4 13.9 8.0 15.9 4.4 5.5 3.3 3.5 3.2 8.9 5.3 8.8 10.3 3.2 5.6 3.1 8.4 14.4 12.1 3.7 12.3 5.6 2.8 11.3 7.6 16.3 8.8 4.6 10.6 4.2 9.9 8.3 5.2 4.1 8.5 7.5 26.8 6.7 4.1 0.6 14.5 7.1 11.1 22.9 4.4 15.7 14.4 10.5 32.1 7.3 30.7 27.5 38.7 30.1 16.1 9.1 5.4 10.1 1.0 17.8 10.7 23.9 0.0 13.7 7.5 1.7 6.4 36.4 5.8 22.2 0.0 13.0 1.3 8.0 22.0 24.3 26.6 6.5 6.4 14.5 11.6 15.7 81.0 2.8 14.9 1.7 16.2 20.7 19.9 13.9 17.3 4.2 16.8 31.7 6.5 5.1 11.8 9.1 5.4 4.2 20.1 16.1 33.9 RFT1 CDG1N ENSG00000163933 "RFT1 homolog" Q96AA3 3 53088483-53130462 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA060327, HPA069022" Approved Approved Vesicles NA NA Vesicles "HPA060327: AB_2684253, HPA069022: AB_2732126" "unprognostic (5.74e-2)" "unprognostic (1.31e-1)" "unprognostic (1.35e-3)" "unprognostic (5.16e-3)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (1.09e-1)" "unprognostic (1.22e-1)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (9.26e-2)" "unprognostic (6.48e-2)" "unprognostic (1.96e-1)" "unprognostic (1.22e-1)" "unprognostic (5.06e-2)" "unprognostic (3.54e-2)" 12.9 19.1 10.8 13.8 14.7 7.2 13.2 11.0 19.2 11.9 11.7 17.0 9.6 10.2 16.2 14.0 16.9 13.0 11.0 12.4 10.2 7.4 10.1 17.7 11.6 15.3 10.5 10.5 15.5 43.7 15.4 9.4 13.8 10.6 11.0 13.8 13.4 18.6 11.3 7.0 13.4 10.5 11.6 11.5 14.5 12.8 23.8 11.1 16.8 15.2 9.1 16.3 12.5 12.1 16.5 27.5 25.9 23.1 11.7 14.5 13.6 16.2 15.4 10.6 16.9 12.5 13.3 22.1 14.8 13.9 25.9 23.7 15.2 32.1 21.5 9.3 14.2 24.4 17.5 23.9 24.2 23.0 20.2 10.5 21.2 11.2 15.0 21.9 19.3 12.5 14.0 20.5 34.8 25.2 11.5 16.4 22.6 11.1 19.7 17.0 16.5 18.1 11.4 21.2 28.4 20.3 7.5 10.2 32.6 14.3 11.0 6.0 8.2 18.3 13.5 13.3 12.0 10.1 27.6 10.8 24.1 15.6 16.4 29.0 12.5 15.0 16.3 17.2 24.8 25.1 25.9 23.1 9.9 13.3 22.4 13.4 12.2 12.5 13.6 24.1 16.5 14.5 14.5 7.7 11.7 15.5 27.5 10.9 13.6 10.8 14.7 11.0 19.2 10.2 7.4 10.5 10.5 10.6 11.1 3.0 3.0 0.8 9.0 4.4 3.9 5.9 10.2 5.3 4.5 8.7 3.9 35.2 1.7 14.2 1.0 5.8 4.3 0.0 18.4 27.2 7.5 7.0 2.3 9.5 19.8 4.8 2.4 10.4 8.7 1.4 8.1 4.7 6.8 10.8 6.7 4.9 11.3 10.2 5.6 4.8 6.1 0.0 2.8 9.3 9.6 3.8 20.3 6.4 10.0 6.4 RGS17 "RGS-17, RGSZ2" ENSG00000091844 "Regulator of G protein signaling 17" Q9UGC6 6 153004459-153131249 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.8" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 17.3;Ductal cells: 11.7;Intestinal endocrine cells: 40.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 12.9;GAMG: 11.0;hTERT-HME1: 14.0;LHCN-M2: 13.9;RH-30: 10.0;U-87 MG: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022276, HPA056493" Approved Approved Vesicles NA NA Vesicles "HPA022276: AB_10794628, HPA056493: AB_2683152" "unprognostic (2.77e-2)" "unprognostic (6.81e-2)" "unprognostic (3.11e-1)" "unprognostic (1.99e-1)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.03e-3)" "unprognostic (3.12e-1)" "unprognostic (3.79e-2)" "unprognostic (7.95e-3)" "unprognostic (1.92e-1)" "unprognostic (5.33e-2)" "unprognostic (5.96e-12)" "unprognostic (2.70e-2)" "unprognostic (2.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" 3.0 1.3 14.2 1.5 12.5 3.3 1.4 16.8 10.1 7.1 1.5 1.2 0.0 1.7 2.2 1.1 3.2 1.3 5.9 1.0 8.1 7.3 0.9 0.6 1.4 1.6 3.2 7.8 2.7 4.4 0.3 7.2 0.6 7.9 5.2 2.0 0.2 1.5 1.6 0.6 1.9 1.8 1.4 4.1 1.2 4.3 3.3 3.0 0.3 8.9 0.0 0.6 3.7 1.5 0.5 0.4 1.4 0.3 2.1 1.6 0.2 0.0 4.3 3.2 0.1 1.5 12.9 0.1 0.3 1.4 1.0 2.7 0.0 0.3 0.2 0.3 0.7 11.0 0.2 3.0 3.2 1.5 0.2 0.3 0.5 0.3 0.1 3.5 0.2 1.5 5.4 0.0 5.5 14.0 3.1 6.4 1.2 0.1 0.2 13.9 2.3 0.1 0.3 2.2 0.1 3.5 0.1 10.0 0.1 4.0 1.3 2.2 5.8 0.1 0.0 0.0 0.5 0.0 0.2 3.2 2.2 2.7 2.7 3.9 0.2 0.0 0.1 11.8 0.1 3.0 1.4 0.3 0.4 1.6 0.2 0.2 0.2 0.9 0.6 0.2 0.5 0.3 0.9 1.1 2.1 0.3 0.4 0.2 0.2 14.2 12.5 16.8 10.1 8.1 7.3 3.2 7.8 7.9 3.0 0.0 0.0 0.0 0.6 0.2 17.3 0.8 5.1 4.0 5.7 0.0 0.0 0.1 0.0 11.7 0.1 1.0 0.0 0.0 0.3 0.2 2.0 5.9 10.5 0.0 0.3 3.2 40.3 0.0 0.6 0.4 2.8 0.4 0.0 0.0 0.0 2.2 2.2 0.9 8.5 0.0 3.4 0.0 1.7 0.9 3.2 0.0 0.2 2.1 0.1 7.3 RHBDF1 "C16orf8, Dist1, EGFR-RS, FLJ2235, iRhom1" ENSG00000007384 "Rhomboid 5 homolog 1" Q96CC6 16 58059-76355 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.7" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077399 Uncertain Vesicles NA NA Vesicles "HPA077399: " "unprognostic (2.62e-1)" "unprognostic (2.86e-2)" "unprognostic (4.76e-2)" "unprognostic (4.04e-2)" "unprognostic (1.51e-2)" "unprognostic (3.69e-2)" "unprognostic (5.60e-3)" "unprognostic (4.54e-3)" "unprognostic (4.51e-2)" "unprognostic (1.02e-1)" "unprognostic (7.81e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.49e-5)" "unprognostic (4.81e-2)" "unprognostic (1.87e-1)" "unprognostic (8.36e-2)" "unprognostic (4.22e-2)" 12.7 3.7 6.2 11.5 9.3 0.3 17.7 3.5 6.2 21.8 10.8 6.1 6.7 5.6 13.0 10.4 17.5 10.6 17.2 15.9 7.0 2.8 8.2 3.8 17.8 4.1 6.9 4.9 18.8 9.6 9.8 4.3 26.5 7.3 19.6 5.5 15.9 20.1 13.5 13.4 22.4 7.5 14.6 5.8 6.1 9.2 7.1 3.1 1.2 11.2 15.7 10.1 16.0 19.4 0.0 0.5 0.0 1.7 0.0 0.4 0.0 4.3 7.0 4.0 9.3 15.9 19.7 13.3 11.9 22.5 8.4 8.1 9.5 15.2 0.2 5.0 12.7 4.3 13.8 2.0 8.0 1.4 0.1 2.2 0.1 7.0 2.6 17.8 0.1 7.7 16.4 8.5 21.8 3.6 15.0 12.8 0.0 1.6 0.2 13.3 24.2 0.0 1.4 3.6 9.1 6.0 0.1 4.8 0.3 9.4 4.4 0.1 1.0 3.4 13.2 7.4 5.2 20.4 1.5 13.3 13.4 9.4 10.3 3.2 0.1 0.2 0.1 9.3 0.2 20.9 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 6.2 9.3 3.5 6.2 7.0 2.8 6.9 4.9 7.3 3.1 17.9 3.8 0.0 8.9 6.1 0.9 8.1 20.4 1.4 6.8 8.7 62.8 14.0 0.0 19.1 0.5 9.5 5.3 0.0 6.9 14.1 18.2 19.2 0.0 2.6 1.9 0.0 0.0 6.2 0.3 0.9 18.1 0.3 15.1 0.0 8.3 5.7 19.4 7.2 13.1 2.1 4.3 12.9 12.9 0.2 2.5 4.8 25.6 0.5 2.9 9.4 RHOBTB3 KIAA0878 ENSG00000164292 "Rho related BTB domain containing 3" O94955 5 95713522-95824383 "Predicted intracellular proteins" Transport Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 86.0" "Cell type enhanced" "Detected in many" 6 "Leydig cells: 367.9;Muller glia cells: 260.1;Peritubular cells: 295.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 10.1" "Group enriched" "Detected in many" 4 "granulocytes: 10.1;T-cells: 2.9" "Cell line enhanced" "Detected in many" "EFO-21: 49.0;HaCaT: 62.3;SuSa: 64.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000265 Uncertain Vesicles NA NA Vesicles "HPA000265: " "unprognostic (1.68e-1)" "unprognostic (9.60e-2)" "unprognostic (5.62e-2)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "unprognostic (3.39e-2)" "unprognostic (7.37e-2)" "unprognostic (4.28e-1)" "unprognostic (6.00e-3)" "unprognostic (9.29e-2)" "unprognostic (9.15e-2)" "unprognostic (3.64e-1)" "unprognostic (1.56e-3)" "unprognostic (7.01e-3)" "unprognostic (1.15e-1)" "unprognostic (3.23e-1)" "unprognostic (8.21e-2)" 38.7 21.4 27.0 6.4 25.8 4.0 12.8 11.8 23.1 16.4 12.0 26.9 11.8 8.2 7.5 15.5 9.8 7.8 11.0 17.6 26.2 12.8 16.4 11.5 9.5 3.6 20.1 21.3 46.6 59.2 24.1 11.0 86.0 13.0 16.4 11.7 21.7 21.0 12.2 15.3 7.4 9.0 11.2 18.2 6.0 12.1 12.4 21.3 1.8 11.1 4.1 1.6 10.9 12.8 0.8 1.2 10.1 1.5 0.5 2.9 0.9 9.8 4.0 9.9 10.5 37.3 21.6 0.1 17.3 16.4 6.7 10.6 19.1 1.8 0.0 49.0 8.8 17.6 62.3 5.3 1.2 11.6 0.4 6.8 3.4 37.9 5.5 29.4 0.8 4.9 35.0 0.9 10.0 0.1 28.8 5.1 3.0 13.5 2.6 26.7 2.8 1.0 2.7 3.7 6.2 6.2 1.4 19.4 1.2 5.6 7.1 17.5 22.7 13.5 5.9 16.0 64.3 4.5 4.9 8.2 9.0 38.9 6.0 6.5 2.6 5.0 0.4 2.8 0.2 14.8 0.1 0.9 10.1 2.9 0.5 1.2 0.8 2.1 2.5 0.2 0.2 2.9 0.6 0.7 0.5 1.5 1.2 1.1 0.9 27.0 25.8 11.8 18.6 26.2 12.8 20.1 21.3 13.0 21.3 163.8 14.1 3.7 50.7 9.6 69.6 74.7 38.2 41.5 47.8 134.3 19.6 42.1 51.4 57.7 7.8 11.7 11.8 0.0 94.5 117.9 62.8 65.1 97.1 69.3 27.2 6.4 88.2 13.5 15.6 6.5 367.9 11.7 40.5 4.6 63.7 260.1 55.3 49.1 295.9 3.4 33.3 32.3 54.7 1.7 1.9 24.0 96.3 10.1 77.7 76.4 RNF135 MGC13061 ENSG00000181481 "Ring finger protein 135" Q8IUD6 17 30968785-30999911 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 64.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 30.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021576, HPA052404" Approved Approved Vesicles NA NA Vesicles "HPA021576: AB_1856331, HPA052404: AB_2681817" "unprognostic (1.13e-1)" "unprognostic (1.87e-2)" "unprognostic (6.24e-2)" "unprognostic (2.33e-2)" "unprognostic (2.68e-2)" "unprognostic (3.51e-3)" "unprognostic (1.57e-1)" "unprognostic (1.24e-1)" "unprognostic (4.60e-2)" "unprognostic (4.16e-1)" "unprognostic (1.35e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (7.51e-5)" "unprognostic (6.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.42e-1)" "unprognostic (4.47e-1)" 18.2 11.6 6.5 15.9 7.1 7.1 28.8 6.4 6.1 16.3 22.2 7.2 16.5 9.7 15.7 16.8 18.4 11.8 14.4 7.4 7.1 4.8 19.5 6.0 19.0 28.0 6.8 2.5 15.1 11.7 15.0 5.9 19.2 6.3 18.1 13.2 13.6 13.3 14.8 7.5 21.4 16.7 13.9 6.1 22.7 10.0 8.8 4.8 6.0 25.0 12.7 18.8 13.0 19.1 11.8 18.4 21.7 25.1 5.4 5.3 9.7 5.9 12.4 0.7 12.3 17.0 13.5 10.5 4.7 7.1 4.6 4.1 0.0 4.5 4.8 7.0 9.0 8.2 7.6 6.1 5.8 3.7 4.6 2.6 2.3 3.7 0.0 11.9 6.0 5.2 13.4 30.6 4.9 15.9 7.8 7.3 0.0 0.0 16.4 7.4 7.9 0.0 6.1 5.0 11.5 6.7 12.6 0.0 17.6 6.4 8.5 4.6 0.2 6.8 2.9 6.8 8.3 18.8 9.3 6.4 0.0 1.6 7.5 5.3 0.2 0.5 3.4 8.2 10.4 6.3 9.1 24.0 12.1 5.3 21.8 2.9 11.8 2.8 2.7 18.4 11.2 1.5 2.7 21.7 5.4 25.1 6.6 3.8 9.7 6.5 7.1 6.4 6.1 7.1 4.8 6.8 2.5 6.3 4.8 3.0 5.1 6.5 11.6 8.2 0.0 3.2 7.6 4.0 2.3 10.4 0.0 38.0 24.9 8.1 0.3 10.8 20.4 0.0 16.3 30.0 10.8 9.4 1.1 2.4 45.6 0.0 4.7 28.8 64.6 0.6 15.5 22.7 15.1 36.1 11.5 3.2 9.9 11.5 14.5 34.9 0.6 25.8 12.0 0.4 0.9 12.8 36.5 8.6 15.2 9.8 RNF144A "hUIP4, KIAA0161, RNF144, UBCE7IP4" ENSG00000151692 "Ring finger protein 144A" P50876 2 6917392-7068286 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.5" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 8.7" "Group enriched" "Detected in many" 7 "granulocytes: 8.7;T-cells: 4.1" "Cell line enhanced" "Detected in many" "HEL: 15.2;HMC-1: 51.6;SH-SY5Y: 15.7;SK-MEL-30: 15.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049939 Approved Supported Vesicles NA NA Vesicles "HPA049939: AB_2680960" "unprognostic (1.78e-1)" "unprognostic (2.53e-3)" "unprognostic (8.37e-2)" "prognostic unfavorable (6.00e-4)" "unprognostic (6.57e-2)" "prognostic favorable (6.96e-4)" "unprognostic (7.04e-6)" "unprognostic (1.20e-1)" "unprognostic (2.03e-2)" "unprognostic (5.64e-1)" "unprognostic (9.11e-2)" "unprognostic (1.92e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (7.32e-5)" "unprognostic (1.30e-2)" "unprognostic (3.01e-1)" "unprognostic (1.82e-3)" 12.9 28.8 13.3 4.2 21.2 12.1 11.1 45.5 20.7 17.3 5.2 28.7 9.0 3.0 26.0 8.3 4.7 8.4 7.5 8.0 15.6 11.6 7.5 1.8 5.7 7.9 26.5 12.2 20.0 29.7 21.5 12.5 6.2 13.2 8.7 5.7 5.9 4.0 7.4 8.7 5.7 4.1 12.2 21.8 21.1 2.8 5.0 27.1 3.4 3.2 1.2 5.8 5.8 6.5 0.1 0.2 8.7 0.1 0.8 4.1 0.6 0.3 2.2 12.0 2.4 2.7 5.6 9.2 0.0 0.0 0.4 1.1 0.0 0.2 1.1 1.3 0.1 3.5 0.2 3.9 0.0 0.0 0.6 1.0 15.2 0.1 4.5 0.1 0.3 51.6 8.9 0.0 0.8 0.0 0.0 0.0 3.9 6.5 0.2 0.0 1.9 7.8 0.6 4.4 0.3 5.4 6.1 8.7 1.0 0.4 3.9 3.9 15.7 0.2 1.6 15.4 1.6 0.7 1.0 0.0 1.6 4.1 4.2 1.7 4.1 1.3 0.0 6.0 3.4 5.6 1.5 0.1 8.7 2.1 0.0 3.0 0.1 2.1 1.5 0.2 0.1 4.1 2.8 0.4 0.8 0.0 0.0 0.8 0.6 13.3 21.2 45.5 20.3 15.6 11.6 26.5 12.2 13.2 27.1 3.0 3.4 0.5 0.7 2.2 3.6 10.6 2.5 2.7 3.4 0.0 70.7 1.7 1.7 2.7 5.7 7.0 4.2 23.3 5.0 2.7 5.3 3.5 9.2 0.8 3.8 9.5 24.5 28.3 1.0 10.4 4.0 1.0 23.6 1.0 2.5 7.2 4.5 9.1 9.9 0.0 42.2 0.0 3.8 1.6 6.0 1.4 0.9 6.4 2.9 0.2 ROS1 "c-ros-1, MCF3, ROS" ENSG00000047936 "ROS proto-oncogene 1, receptor tyrosine kinase" P08922 6 117288300-117425855 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 38.6;lung: 20.2" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 14.9;Alveolar cells type 2: 56.7" "Cancer enriched" "Detected in some" 13 "lung cancer: 6.9" "Group enriched" "Detected in some" 10 "cerebral cortex: 7.4;olfactory region: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "GAMG: 16.3;HSkMC: 8.7;hTCEpi: 18.1;LHCN-M2: 12.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049098, HPA072424" Uncertain Approved Vesicles NA NA Vesicles "HPA049098: AB_2680628, HPA072424: AB_2686519" "unprognostic (8.18e-2)" "unprognostic (4.64e-3)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (7.57e-2)" "unprognostic (2.05e-2)" "unprognostic (1.57e-1)" "unprognostic (1.79e-1)" "unprognostic (2.79e-2)" "unprognostic (1.00e-2)" "unprognostic (2.42e-1)" "unprognostic (5.20e-2)" "unprognostic (1.56e-12)" "unprognostic (1.09e-2)" "unprognostic (2.81e-1)" "unprognostic (1.91e-1)" "unprognostic (2.12e-1)" 0.3 0.2 0.2 0.0 0.4 0.0 0.2 0.2 7.4 0.2 0.4 0.0 7.9 0.0 0.2 38.6 0.2 0.2 0.0 0.2 0.2 0.2 0.4 0.2 20.2 0.0 0.2 2.5 0.2 0.2 0.0 0.3 0.7 0.0 0.2 0.3 0.0 0.2 2.3 0.2 0.7 0.3 0.0 0.2 0.2 0.3 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 8.7 18.1 0.2 1.6 0.0 0.0 0.0 0.0 0.0 12.5 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 1.6 0.0 2.2 1.4 0.1 1.7 0.0 0.0 0.0 1.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.2 7.4 0.2 0.2 0.2 2.5 0.0 0.0 14.9 56.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 RPL11 L11 ENSG00000142676 "Ribosomal protein L11" P62913 1 23691742-23696835 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Diamond-Blackfan anemia, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA002734, HPA074839" Approved Approved Vesicles NA NA 720000 Vesicles "HPA002734: AB_1079838, HPA074839: AB_2686717" "prognostic favorable (2.55e-4)" "unprognostic (3.98e-2)" "unprognostic (7.77e-2)" "unprognostic (3.30e-2)" "unprognostic (1.21e-1)" "unprognostic (6.70e-2)" "unprognostic (4.51e-3)" "unprognostic (4.94e-2)" "unprognostic (1.70e-2)" "unprognostic (1.25e-1)" "unprognostic (1.61e-1)" "unprognostic (8.92e-2)" "prognostic unfavorable (5.93e-6)" "unprognostic (8.65e-2)" "unprognostic (2.42e-3)" "unprognostic (5.41e-2)" "unprognostic (1.90e-1)" 75.0 46.8 35.1 71.4 74.9 65.8 175.9 33.4 41.1 100.3 69.1 32.9 50.5 30.3 130.0 112.0 87.8 95.9 65.4 79.9 56.0 26.2 56.2 78.8 78.7 222.2 39.5 46.6 148.2 311.5 47.6 43.4 48.3 78.6 85.2 97.7 43.2 204.8 66.6 84.2 92.1 58.0 103.4 47.0 72.3 77.5 52.9 23.2 65.5 91.9 92.2 169.3 73.7 115.4 178.7 93.6 43.4 72.4 79.3 199.1 235.2 38.0 62.3 75.1 38.3 129.0 183.1 26.4 25.6 108.5 98.3 73.5 112.5 43.0 79.4 28.5 87.3 39.9 32.6 94.3 126.9 110.1 28.1 126.3 37.1 213.7 148.6 96.6 62.4 30.5 177.8 188.0 82.8 149.5 121.0 103.9 139.6 42.8 43.0 104.1 118.0 36.2 99.8 18.8 124.7 71.4 46.1 36.5 75.5 110.8 68.1 29.7 36.2 20.1 42.0 74.2 67.9 30.9 77.7 31.1 24.1 33.0 40.5 32.3 39.6 35.8 55.6 30.4 89.3 27.5 43.4 72.4 22.0 73.6 63.2 125.4 178.7 150.1 107.5 93.6 157.3 199.1 146.6 11.6 79.3 49.8 93.2 109.4 235.2 35.1 74.9 33.4 41.1 56.0 26.2 39.5 46.6 78.6 23.2 1095.8 1949.2 5840.5 6304.6 5888.0 338.2 523.0 3003.8 1172.4 1937.0 1067.8 145.3 4113.3 4073.5 2275.3 832.2 3353.1 1873.9 1261.4 5801.9 6645.9 3301.0 4731.7 1987.6 2712.5 3407.9 195.5 2079.9 2711.8 3936.0 1676.5 4261.5 5099.8 3564.8 4184.1 3270.1 600.2 3952.7 3415.8 1958.1 3600.3 474.8 1390.5 3246.9 514.6 525.9 6987.2 3890.4 3666.1 4664.7 6181.0 RRAS R-Ras ENSG00000126458 "RAS related" P10301 19 49635292-49640201 "Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Smooth muscle cells: 123.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 13.8;non-classical monocyte: 15.9" "Lineage enriched" "Detected in many" 6 "monocytes: 15.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010160, HPA060364, CAB069439" Uncertain Approved Vesicles NA NA 23000 Vesicles "CAB010160: AB_2180086, CAB069439: AB_1622637, HPA060364: AB_2684264" "unprognostic (9.23e-2)" "unprognostic (6.37e-2)" "unprognostic (1.50e-1)" "unprognostic (9.86e-2)" "prognostic unfavorable (1.02e-4)" "unprognostic (8.54e-2)" "unprognostic (4.55e-3)" "prognostic unfavorable (5.28e-4)" "unprognostic (2.16e-2)" "unprognostic (7.58e-2)" "unprognostic (1.39e-3)" "unprognostic (2.30e-2)" "prognostic unfavorable (1.54e-9)" "unprognostic (6.13e-2)" "unprognostic (3.42e-2)" "unprognostic (7.14e-3)" "unprognostic (2.74e-2)" 40.9 14.9 6.3 16.0 7.0 1.7 35.2 2.9 7.3 45.2 48.8 7.0 50.6 14.5 55.3 27.0 53.2 35.2 44.9 56.5 6.2 4.8 24.5 13.7 37.8 12.6 7.0 8.0 28.0 9.0 1.7 6.9 39.2 8.5 62.7 8.8 24.9 19.9 62.1 19.2 11.1 29.4 72.5 6.2 25.1 28.7 23.3 5.8 3.4 26.8 19.1 13.8 79.6 39.4 1.1 2.5 0.1 15.9 0.3 1.2 1.4 15.9 19.8 2.5 5.1 44.4 49.6 0.7 21.2 30.1 10.3 13.6 2.7 27.0 1.0 11.1 31.1 15.1 10.7 1.4 21.7 4.2 6.5 1.1 1.9 6.5 1.6 41.3 0.1 4.1 34.9 19.3 13.0 10.4 44.1 26.3 0.7 1.2 7.9 18.3 6.3 0.0 1.8 0.5 13.7 16.1 1.5 6.2 2.9 22.3 3.2 0.0 2.3 8.3 7.4 1.3 6.9 10.6 1.5 37.4 30.5 12.2 5.3 6.0 5.9 2.4 0.2 31.7 1.2 9.5 0.0 3.8 0.1 0.4 13.8 0.4 1.1 1.1 0.4 2.5 0.3 1.2 0.3 0.0 0.3 15.9 0.7 0.4 1.4 6.3 7.0 2.9 7.3 6.2 4.8 7.0 8.0 8.5 5.8 35.7 6.4 6.5 44.4 26.3 1.5 49.0 38.2 2.7 11.4 48.8 2.0 3.7 8.3 56.9 0.7 46.0 50.1 0.0 48.8 30.8 57.9 44.2 10.3 4.5 28.8 4.8 9.8 62.0 27.6 3.0 55.8 15.7 25.3 39.7 19.1 33.8 104.3 13.9 71.5 8.6 1.3 77.6 123.5 0.9 4.7 16.8 5.9 7.0 13.2 46.3 RSPO1 "FLJ40906, RSPONDIN" ENSG00000169218 "R-spondin 1" Q2MKA7 1 37611350-37634923 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" Heparin-binding "Palmoplantar keratoderma" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 17.3;endometrium 1: 26.6" "Cell type enhanced" "Detected in some" 18 "Fibroblasts: 4.7;Melanocytes: 1.7;Smooth muscle cells: 4.1" "Cancer enriched" "Detected in some" 13 "ovarian cancer: 11.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HHSteC: 1.8;NTERA-2: 4.6;THP-1: 4.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA046154, HPA062923" Uncertain Approved Vesicles "Secreted in female reproductive system" NA NA Vesicles "HPA046154: AB_10964912, HPA062923: " "unprognostic (1.50e-2)" "unprognostic (1.97e-3)" "unprognostic (5.99e-3)" "unprognostic (2.22e-1)" "unprognostic (1.76e-1)" "unprognostic (3.75e-6)" "unprognostic (1.84e-2)" "unprognostic (1.48e-1)" "unprognostic (1.27e-1)" "unprognostic (2.08e-1)" "unprognostic (1.13e-2)" "unprognostic (1.93e-2)" "unprognostic (3.76e-2)" "unprognostic (3.21e-1)" "unprognostic (1.53e-2)" 5.0 0.1 0.2 1.9 0.3 0.0 5.8 0.5 0.6 17.3 2.1 0.2 0.2 0.6 26.6 3.0 1.8 15.8 12.2 0.4 0.2 0.0 0.7 0.2 4.5 1.9 0.2 0.2 7.5 1.6 0.0 0.2 1.3 0.4 3.0 0.2 2.3 1.5 1.4 0.2 4.0 3.1 10.9 0.2 0.7 2.0 1.0 0.2 0.2 0.2 1.3 6.1 1.3 8.8 0.4 0.3 0.7 0.5 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.4 0.2 4.7 0.4 0.0 0.7 0.1 0.0 0.0 0.0 0.1 0.1 0.4 0.1 0.7 0.2 0.1 0.1 0.0 0.2 0.2 0.2 0.1 0.1 0.4 0.2 0.1 0.7 0.0 0.5 0.3 0.3 0.0 0.2 0.3 0.5 0.6 0.2 0.0 0.2 0.2 0.4 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 RSU1 "FLJ31034, RSP-1" ENSG00000148484 "Ras suppressor protein 1" Q15404 10 16590611-16817528 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025927 Uncertain Approved Vesicles NA NA 210000000 Vesicles "HPA025927: AB_10610420" "unprognostic (7.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.08e-1)" "unprognostic (4.89e-1)" "unprognostic (9.56e-3)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (1.99e-1)" "unprognostic (3.83e-2)" "unprognostic (3.72e-2)" "unprognostic (3.30e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (9.32e-5)" "unprognostic (1.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.48e-1)" "unprognostic (4.53e-2)" 34.3 11.9 11.3 18.5 11.0 18.1 27.3 11.2 9.9 24.6 26.9 13.0 11.7 8.9 33.5 15.9 29.3 21.3 17.3 19.5 11.3 12.4 29.4 19.5 20.4 16.0 13.7 7.4 27.2 36.9 9.2 6.4 48.1 10.2 22.5 18.3 13.0 15.1 21.7 12.7 15.1 15.9 37.2 13.7 30.3 18.3 9.7 11.8 19.6 17.1 16.0 20.3 31.9 20.8 12.2 23.7 17.4 17.7 20.4 23.6 29.8 9.5 6.7 5.5 32.3 29.5 30.5 6.7 23.9 10.3 16.9 18.2 6.2 8.9 9.6 3.8 32.4 8.9 8.5 6.6 12.6 18.1 14.2 5.4 30.1 4.3 5.9 13.0 4.6 17.5 15.0 13.3 15.8 5.0 15.0 17.2 10.1 4.8 6.6 22.5 6.2 10.4 8.2 5.7 14.0 3.8 6.9 7.4 6.4 15.9 3.5 2.2 4.3 11.9 7.8 11.7 10.3 2.7 12.0 21.1 14.2 5.0 17.8 12.2 5.8 7.0 8.3 18.8 13.1 6.1 17.4 14.7 15.0 18.2 17.7 20.3 11.6 20.8 19.4 23.7 12.2 15.5 19.3 10.4 20.4 16.4 17.7 23.6 29.8 11.3 11.0 11.2 9.4 11.3 12.4 13.7 7.4 10.2 11.8 32.8 20.3 26.9 25.5 32.5 1.4 35.0 33.1 38.8 22.7 40.1 2.0 108.0 58.0 66.2 80.6 63.2 17.4 23.3 103.9 65.2 65.8 16.0 33.5 27.2 107.3 3.2 6.9 62.0 57.4 127.5 36.5 65.6 57.3 119.0 20.6 5.6 69.9 14.4 64.3 41.3 14.1 64.7 122.6 3.9 21.5 37.4 80.4 48.9 23.4 21.8 RUNDC3A "RAP2IP, RPIP8" ENSG00000108309 "RUN domain containing 3A" Q59EK9 17 44308413-44318671 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 92.6" "Group enriched" "Detected in many" 6 "Bipolar cells: 54.0;Early spermatids: 20.0;Horizontal cells: 30.2;Intestinal endocrine cells: 37.5;Late spermatids: 59.4;Rod photoreceptor cells: 15.2" "Cancer enhanced" "Detected in many" "glioma: 8.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 4 "T-cells: 1.3" "Group enriched" "Detected in some" 6 "SCLC-21H: 35.0;SH-SY5Y: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023548, HPA070733" Enhanced Supported Enhanced Vesicles NA NA Vesicles "HPA023548: AB_1856069, HPA070733: AB_2732162" "unprognostic (3.66e-2)" "unprognostic (3.77e-2)" "unprognostic (3.50e-3)" "unprognostic (1.58e-3)" "unprognostic (3.04e-1)" "unprognostic (2.02e-1)" "unprognostic (3.87e-3)" "unprognostic (2.29e-1)" "unprognostic (4.63e-2)" "unprognostic (3.43e-2)" "unprognostic (1.42e-3)" "unprognostic (1.34e-1)" "unprognostic (8.87e-3)" "unprognostic (1.07e-2)" "unprognostic (5.17e-2)" "unprognostic (9.39e-2)" "unprognostic (1.84e-1)" 1.4 12.9 40.5 1.6 28.5 2.8 1.5 33.0 92.6 1.3 1.8 4.8 0.0 2.2 1.6 1.5 1.5 1.5 1.6 1.8 40.9 20.6 1.7 1.3 1.5 1.4 22.0 23.2 1.7 4.3 2.4 16.1 2.5 15.6 1.5 1.8 1.6 1.4 1.6 1.3 4.1 2.2 1.8 8.0 1.5 3.3 5.2 4.4 0.0 2.4 0.0 1.4 1.5 0.0 0.3 0.1 0.0 0.2 0.1 1.3 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.4 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.0 0.2 0.2 0.2 0.0 0.0 0.6 0.1 0.0 35.0 22.3 0.2 0.0 0.2 0.0 0.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.3 1.3 0.3 0.1 0.1 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 40.5 28.5 33.0 49.2 40.9 20.6 22.0 23.2 15.6 4.4 0.0 1.1 0.0 0.2 0.2 54.0 1.1 0.0 0.0 0.0 0.0 5.9 0.0 3.3 0.9 20.0 0.0 0.0 0.0 2.8 0.0 0.2 0.4 0.0 0.0 0.2 30.2 37.5 0.0 0.0 59.4 1.4 0.5 0.0 0.0 0.0 5.0 1.4 0.3 3.2 0.5 15.2 0.0 0.5 0.9 1.3 0.4 0.1 0.0 0.0 0.3 RWDD2A "dJ747H23.2, MGC13523, RWDD2" ENSG00000013392 "RWD domain containing 2A" Q9UIY3 6 83193379-83198932 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030105, HPA030106, HPA030107" Uncertain Approved Vesicles NA NA Vesicles "HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009" "unprognostic (2.51e-3)" "unprognostic (1.25e-1)" "unprognostic (2.48e-2)" "unprognostic (1.33e-1)" "unprognostic (1.19e-3)" "unprognostic (3.99e-2)" "unprognostic (1.01e-1)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "prognostic favorable (3.82e-5)" "prognostic favorable (1.38e-4)" "unprognostic (1.26e-1)" "unprognostic (2.73e-1)" "unprognostic (1.91e-2)" "unprognostic (2.57e-2)" "unprognostic (1.85e-3)" "unprognostic (2.59e-2)" 5.0 10.1 8.5 3.4 10.4 1.0 5.4 11.8 14.6 5.6 4.0 5.9 11.6 4.2 5.7 15.9 3.1 6.5 7.6 7.2 9.4 11.0 7.5 8.1 4.8 3.9 6.5 11.7 7.0 13.4 7.4 9.8 4.2 11.6 19.2 4.3 3.7 16.4 11.3 4.1 3.4 4.0 5.5 4.8 4.1 5.3 14.5 3.9 1.7 10.4 3.1 4.4 5.2 2.8 3.7 6.8 0.7 3.9 0.8 4.6 2.1 2.2 2.0 4.7 8.9 5.7 4.2 3.3 5.0 10.7 3.8 4.6 2.9 1.2 1.7 4.1 6.1 8.7 2.2 3.9 3.0 5.9 2.0 4.0 2.0 3.0 6.4 8.8 0.5 1.6 5.4 5.0 4.8 10.0 12.5 7.0 4.8 3.1 3.0 4.6 3.1 0.7 1.5 1.6 2.0 2.0 2.5 9.7 1.0 7.9 2.5 1.7 5.8 3.0 4.9 4.5 7.1 3.0 3.0 7.4 2.7 1.7 3.7 2.2 6.7 2.7 1.0 3.1 0.8 3.1 0.5 1.8 0.0 2.4 1.6 3.9 3.7 3.6 3.6 2.0 2.2 4.6 4.5 0.7 0.8 3.9 6.8 4.0 2.1 8.5 10.4 11.8 14.6 9.4 11.0 6.5 11.7 11.6 3.9 0.0 7.9 5.2 3.2 3.3 5.6 5.0 5.1 4.0 0.0 1.8 0.0 6.8 5.0 7.7 27.1 2.9 2.6 0.0 8.0 2.7 5.8 7.9 0.0 4.4 4.3 1.6 5.2 4.3 1.3 11.7 8.3 2.3 8.5 3.6 4.7 8.4 6.2 3.4 5.6 9.3 4.1 6.5 5.0 20.7 7.2 2.0 4.8 2.5 2.6 2.1 RYR3 ENSG00000198838 "Ryanodine receptor 3" Q15413 15 33310945-33866121 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" "Calcium channel, Calmodulin-binding, Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "parathyroid gland: 28.8;skeletal muscle: 26.8" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 14.6;granulocytes: 13.9;Horizontal cells: 65.2;Late spermatids: 25.1" "Cancer enhanced" "Detected in single" "glioma: 1.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 31 "basophil: 4.0" "Lineage enriched" "Detected in single" 31 "granulocytes: 4.0" "Cell line enhanced" "Detected in some" "A549: 7.0;RH-30: 10.6;RPTEC TERT1: 5.0;SuSa: 4.8" "Low region specificity" "Detected in many" HPA062004 Approved Vesicles NA NA Vesicles "HPA062004: AB_2797267" "unprognostic (5.85e-2)" "unprognostic (1.57e-1)" "unprognostic (5.30e-2)" "unprognostic (1.35e-1)" "unprognostic (1.26e-2)" "unprognostic (8.03e-4)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (7.85e-2)" "unprognostic (7.10e-2)" "unprognostic (8.25e-3)" "unprognostic (2.36e-1)" "unprognostic (2.48e-2)" "unprognostic (1.86e-2)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" 1.8 2.0 9.9 1.1 15.4 2.5 2.9 4.9 12.4 2.8 4.5 6.0 0.2 1.5 10.2 1.0 2.7 3.9 1.6 1.0 13.3 3.5 1.2 0.9 1.2 0.9 5.6 6.9 1.7 0.8 28.8 1.2 1.0 10.7 1.8 2.9 0.6 1.4 3.9 26.8 1.2 1.3 7.4 5.9 1.4 1.6 1.6 7.9 0.0 1.1 1.5 1.4 2.1 2.6 0.1 0.0 4.0 0.0 0.0 0.1 0.0 0.3 7.0 1.5 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.6 0.1 0.4 0.6 0.0 2.3 0.2 0.0 0.0 0.0 0.4 0.2 1.4 0.2 0.0 0.0 1.0 0.7 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.4 2.6 0.0 0.4 0.2 0.3 1.1 0.4 0.1 0.5 10.6 0.2 5.0 0.5 0.1 0.5 0.8 0.0 0.2 4.8 0.1 0.3 0.9 0.2 0.1 0.0 0.7 0.3 1.2 0.7 0.5 2.3 0.0 4.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 15.4 4.9 12.4 13.3 3.5 5.6 6.9 10.7 7.9 0.0 0.6 0.0 0.0 0.3 2.4 1.7 0.0 10.7 1.2 0.0 0.0 0.5 0.0 0.0 14.6 0.7 0.0 0.0 0.0 0.6 0.3 0.0 13.9 0.0 0.8 65.2 0.0 0.0 0.0 25.1 0.3 0.4 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.3 0.7 0.0 0.3 0.0 1.0 0.5 0.1 0.0 0.0 0.0 S1PR1 "CD363, D1S3362, edg-1, EDG1" ENSG00000170989 "Sphingosine-1-phosphate receptor 1" P21453 1 101236888-101241518 "Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "Angiogenesis, Chemotaxis" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 88.9" "Group enriched" "Detected in many" 5 "Endothelial cells: 89.9;Ito cells: 114.2;Muller glia cells: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 19.4;HUVEC TERT2: 54.9;TIME: 30.5;U-251 MG: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010104, HPA075568" Supported Supported Vesicles No NA Vesicles "CAB010104: AB_2238920, HPA075568: AB_2686758" "unprognostic (1.41e-1)" "unprognostic (9.35e-2)" "unprognostic (2.46e-2)" "unprognostic (2.61e-1)" "unprognostic (9.78e-2)" "unprognostic (4.49e-3)" "unprognostic (1.34e-3)" "unprognostic (1.99e-1)" "unprognostic (1.36e-1)" "unprognostic (9.12e-2)" "unprognostic (2.34e-2)" "unprognostic (2.23e-1)" "unprognostic (5.82e-3)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" "unprognostic (3.64e-1)" "prognostic unfavorable (8.78e-4)" 72.3 8.4 24.7 16.6 26.2 9.7 46.3 21.6 21.8 13.3 10.5 9.5 2.5 5.7 12.1 5.0 14.7 11.5 17.6 43.5 22.9 15.4 8.9 20.5 35.7 24.5 23.2 14.0 7.9 11.0 13.4 4.7 29.6 21.2 8.9 7.0 9.3 7.5 5.6 21.7 8.2 9.8 19.0 11.0 35.2 8.0 5.8 13.9 4.4 17.0 8.7 15.7 15.2 18.5 27.4 0.2 88.9 0.2 33.4 49.8 30.8 3.6 0.0 3.9 0.0 0.4 9.3 0.0 19.4 3.5 11.8 4.2 0.0 0.1 0.0 4.8 6.7 0.0 0.0 0.5 0.2 7.9 1.3 0.4 1.3 0.1 0.0 1.8 0.0 0.8 12.5 0.0 0.0 0.9 0.5 54.9 1.1 0.0 4.0 3.7 0.0 4.6 0.0 1.0 0.1 1.3 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 30.5 2.0 0.7 0.4 37.6 0.3 0.0 0.2 0.2 0.0 0.1 88.9 0.1 4.9 49.8 0.1 40.2 25.1 45.3 44.1 0.2 27.4 35.7 36.2 1.4 33.4 0.2 0.2 26.8 30.8 24.7 26.2 21.6 16.8 22.9 15.4 23.2 14.0 21.2 13.9 0.0 12.8 17.1 0.1 6.8 0.0 16.9 2.5 0.0 2.3 0.0 0.0 5.5 0.0 0.0 0.0 89.9 0.0 0.0 0.0 0.3 8.4 0.5 7.0 6.0 7.6 0.0 0.0 114.2 6.9 0.0 0.9 1.5 5.0 14.4 0.0 38.0 0.0 0.0 0.0 0.0 1.0 0.0 1.4 0.4 0.7 4.4 2.2 9.2 0.0 0.4 SAMD5 dJ875H10.1 ENSG00000203727 "Sterile alpha motif domain containing 5" Q5TGI4 6 147508927-147737547 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Bipolar cells: 66.1;Hepatocytes: 23.7;Undifferentiated cells: 22.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CACO-2: 8.7;Hep G2: 33.3;K-562: 22.4;RH-30: 15.7;WM-115: 11.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067811 Uncertain Supported Vesicles No No Vesicles "HPA067811: AB_2685901" "unprognostic (4.16e-2)" "unprognostic (4.52e-2)" "unprognostic (9.65e-3)" "unprognostic (1.41e-2)" "unprognostic (1.82e-2)" "unprognostic (5.88e-2)" "prognostic unfavorable (2.23e-4)" "unprognostic (2.31e-1)" "unprognostic (1.54e-1)" "unprognostic (1.61e-2)" "unprognostic (8.55e-3)" "unprognostic (3.09e-2)" "unprognostic (5.40e-3)" "unprognostic (1.72e-1)" "unprognostic (4.51e-2)" "unprognostic (9.82e-3)" "unprognostic (1.50e-1)" 1.6 2.2 1.6 3.4 5.7 0.2 4.9 1.4 4.7 3.9 7.1 0.7 1.9 3.6 10.9 2.2 15.9 1.7 6.6 2.4 2.7 3.4 26.5 12.8 8.0 0.5 1.9 2.2 1.4 2.4 17.3 13.9 14.6 14.1 3.0 10.1 9.8 4.9 3.3 0.8 3.6 5.4 4.0 1.3 1.7 5.5 10.9 2.6 0.0 3.0 6.3 6.5 2.6 3.9 0.7 0.5 1.8 0.4 0.6 0.5 0.1 5.7 0.7 0.8 1.1 0.0 0.0 0.0 1.9 0.7 0.1 0.1 8.7 0.0 0.3 1.9 0.0 0.3 0.0 0.1 1.3 0.2 0.0 1.0 0.4 0.8 33.3 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.0 3.7 0.0 22.4 0.3 2.6 0.0 0.0 0.0 0.1 4.4 1.5 0.0 15.7 3.3 0.0 1.2 0.3 0.0 0.5 0.1 1.5 0.1 0.0 0.0 2.6 0.2 0.8 0.2 0.7 0.0 0.5 0.0 0.0 0.0 11.0 1.8 0.4 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.1 0.7 0.5 0.4 1.1 0.6 0.4 0.5 0.2 0.1 1.6 5.7 1.4 4.7 2.7 3.4 1.9 2.2 14.1 2.6 3.0 5.1 0.5 4.1 1.5 66.1 2.4 0.0 0.0 0.0 17.4 2.0 0.1 8.3 1.5 0.3 2.8 4.4 0.0 0.2 0.2 6.6 1.3 0.0 23.7 0.7 0.0 16.3 4.9 1.0 0.5 0.3 0.6 0.0 0.0 9.3 12.1 0.3 0.0 3.2 15.9 2.4 0.0 0.9 0.5 0.1 1.4 0.2 0.0 22.8 3.5 SARM1 "KIAA0524, SAMD2, SARM" ENSG00000004139 "Sterile alpha and TIR motif containing 1" Q6SZW1 17 28364356-28404049 "Predicted intracellular proteins" "Differentiation, Immunity, Innate immunity, Neurogenesis" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 25.2;Cone photoreceptor cells: 27.5;Horizontal cells: 20.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024359, HPA024759" Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA024359: AB_1856582, HPA024759: AB_1856581" "unprognostic (1.40e-4)" "unprognostic (9.00e-2)" "unprognostic (2.47e-1)" "unprognostic (2.41e-2)" "unprognostic (1.18e-1)" "unprognostic (1.08e-2)" "unprognostic (1.27e-1)" "unprognostic (1.27e-2)" "unprognostic (1.87e-2)" "unprognostic (7.01e-2)" "unprognostic (2.49e-4)" "unprognostic (6.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (4.84e-2)" "unprognostic (7.62e-4)" 4.3 14.6 9.5 6.9 8.6 2.6 6.0 14.4 9.4 5.4 4.2 6.5 11.2 15.3 7.5 8.9 3.7 7.0 4.5 4.6 6.8 4.4 4.6 8.7 6.2 12.3 4.8 7.6 6.3 13.1 8.0 11.7 2.8 5.4 6.8 4.9 6.1 5.0 11.7 4.0 4.8 9.8 7.7 6.6 7.2 5.8 3.5 4.5 0.9 5.9 2.4 4.4 4.7 5.1 1.3 1.2 0.7 2.4 1.5 2.4 0.8 0.1 2.4 3.1 4.0 2.3 1.6 0.5 1.7 3.3 3.7 2.4 26.0 0.4 0.5 0.1 2.4 2.2 1.1 2.2 0.1 3.1 5.5 1.5 0.0 3.7 0.6 1.7 0.0 1.6 1.1 0.1 1.7 0.5 3.5 0.1 0.8 0.1 2.0 1.0 2.2 0.3 0.0 2.2 0.5 0.2 0.9 2.6 0.6 1.2 1.8 8.2 7.6 7.4 1.1 2.9 1.4 0.3 0.6 0.3 3.3 0.4 1.2 2.4 3.3 2.2 0.5 3.5 0.2 1.7 0.7 0.7 0.1 1.2 1.2 1.1 0.8 1.7 1.8 1.2 1.3 1.1 1.8 0.6 1.5 2.4 0.4 2.4 0.8 9.5 8.6 14.4 7.7 6.8 4.4 4.8 7.6 5.4 4.5 3.0 3.4 0.0 1.9 0.8 25.2 0.8 7.6 5.3 6.8 3.5 27.5 0.5 3.3 3.4 5.8 1.6 4.5 0.0 9.3 0.6 2.3 2.2 4.6 2.0 1.4 20.6 9.1 2.5 8.2 2.0 3.1 2.1 3.3 1.8 3.6 4.7 3.5 2.9 1.4 4.6 16.3 6.5 1.7 0.2 0.4 0.5 0.5 3.2 3.9 0.9 SAYSD1 "C6orf64, FLJ11101" ENSG00000112167 "SAYSVFN motif domain containing 1" Q9NPB0 6 39104064-39115189 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 52.7" "Cell type enhanced" "Detected in many" 11 "Early spermatids: 85.1;Spermatocytes: 202.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007959 Approved Supported Vesicles NA NA Vesicles "HPA007959: AB_1078359" "unprognostic (2.65e-1)" "unprognostic (1.49e-2)" "unprognostic (2.03e-2)" "unprognostic (2.58e-1)" "unprognostic (3.70e-1)" "unprognostic (2.56e-1)" "unprognostic (9.90e-3)" "unprognostic (1.96e-2)" "unprognostic (6.50e-2)" "unprognostic (1.82e-3)" "unprognostic (5.08e-2)" "unprognostic (9.90e-2)" "unprognostic (2.54e-2)" "unprognostic (1.79e-1)" "unprognostic (9.78e-3)" "unprognostic (2.27e-1)" "unprognostic (2.00e-3)" 8.2 7.2 7.2 5.7 8.7 5.9 11.2 7.1 9.0 7.9 7.3 8.1 6.9 8.8 7.9 10.5 6.5 8.1 9.3 6.7 7.3 6.9 8.1 8.3 6.3 8.2 9.3 6.5 8.4 9.5 4.9 6.1 6.1 7.0 8.5 7.2 6.4 11.1 8.0 5.6 6.6 8.6 6.3 7.0 6.8 6.9 52.7 7.3 18.2 8.4 5.1 9.0 6.2 7.7 14.8 9.3 19.4 12.2 11.7 19.1 9.5 11.4 7.4 6.7 7.9 11.1 14.7 6.9 5.3 5.8 6.4 6.8 10.6 8.1 10.4 7.6 6.9 9.1 7.9 5.8 5.0 6.8 6.5 10.5 6.8 4.5 9.2 9.0 7.7 10.3 10.1 12.4 2.5 6.4 4.5 5.9 15.8 11.5 6.4 7.1 15.7 12.2 12.8 5.8 7.5 3.8 1.7 8.1 4.1 13.4 8.1 18.8 7.6 9.2 8.0 8.1 5.6 13.1 10.2 7.6 8.5 6.2 2.6 6.8 0.1 3.2 12.8 4.9 11.2 6.2 7.6 9.0 19.4 12.2 12.2 14.2 13.1 13.3 11.0 9.3 14.8 19.1 15.8 4.3 11.7 11.9 7.4 17.3 9.5 7.2 8.7 7.1 9.0 7.3 6.9 9.3 6.5 7.0 7.3 3.0 5.9 9.3 11.4 13.7 5.5 17.5 17.8 12.0 5.7 17.4 7.9 28.7 14.9 19.4 85.1 11.3 11.8 0.0 18.9 26.3 17.4 17.9 8.1 18.7 23.2 6.4 8.1 3.1 15.6 40.0 19.0 12.2 11.8 9.0 15.0 13.7 14.7 7.0 18.0 23.0 3.6 6.5 10.3 202.1 11.9 14.4 10.3 10.2 18.4 11.5 SBSN "HLAR698, UNQ698" ENSG00000189001 Suprabasin Q6UWP8 19 35523367-35528351 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 105.1;skin 1: 241.3;tongue: 338.1" "Cell type enriched" "Detected in some" 11 "Suprabasal keratinocytes: 889.6" "Group enriched" "Detected in many" 9 "cervical cancer: 76.5;head and neck cancer: 355.2;melanoma: 153.1" "Region enriched" "Detected in single" 7 "basal ganglia: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 20.2;ASC TERT1: 35.2;HSkMC: 47.6;U-2197: 16.3;U-87 MG: 38.5" "Low region specificity" "Detected in some" "HPA062568, HPA067734" Enhanced Approved Vesicles "Secreted - unknown location" NA NA 62000000 Vesicles "HPA062568: AB_2684794, HPA067734: AB_2685894" "unprognostic (1.10e-1)" "unprognostic (1.01e-1)" "unprognostic (2.02e-2)" "unprognostic (1.21e-1)" "unprognostic (1.73e-1)" "unprognostic (1.83e-2)" "unprognostic (1.23e-3)" "unprognostic (3.45e-3)" "unprognostic (2.56e-1)" "unprognostic (4.83e-4)" "unprognostic (4.31e-4)" "unprognostic (6.97e-2)" "unprognostic (9.08e-14)" "unprognostic (6.37e-2)" "unprognostic (6.51e-3)" "unprognostic (2.09e-1)" "unprognostic (1.36e-3)" 0.3 0.0 0.2 0.2 1.6 0.1 11.2 0.2 0.2 65.1 0.2 0.2 0.2 0.0 3.5 0.2 105.1 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.7 0.2 0.2 0.0 0.2 26.8 0.2 1.3 241.3 0.2 0.2 0.2 0.2 0.0 0.2 0.2 1.8 0.2 338.1 51.7 0.4 51.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 20.2 35.2 0.0 1.6 2.2 0.7 0.2 0.0 0.0 0.0 0.3 1.4 0.5 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 47.6 2.6 9.5 2.3 0.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.1 5.9 1.2 16.3 0.4 0.1 0.0 0.0 38.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 79.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.5 0.0 3.1 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 13.5 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.1 889.6 0.2 0.0 0.0 0.1 SBSPON "C8orf84, RPESP" ENSG00000164764 "Somatomedin B and thrombospondin type 1 domain containing" Q8IVN8 8 73064540-73124088 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 66.7;urinary bladder: 47.9" "Cell type enhanced" "Detected in many" 9 "Collecting duct cells: 40.1;Muller glia cells: 43.4;Peritubular cells: 25.1;Smooth muscle cells: 30.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ: 10.0;RPTEC TERT1: 18.1;SuSa: 3.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA029595 Approved Approved Vesicles "Secreted to extracellular matrix" NA NA 19000 Vesicles "HPA029595: AB_10600763" "prognostic favorable (7.18e-4)" "unprognostic (5.08e-3)" "unprognostic (3.24e-1)" "unprognostic (4.41e-2)" "unprognostic (1.75e-1)" "unprognostic (2.31e-1)" "unprognostic (2.78e-2)" "unprognostic (8.65e-2)" "unprognostic (2.92e-1)" "unprognostic (1.46e-1)" "unprognostic (9.54e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (8.82e-4)" "unprognostic (6.14e-2)" "unprognostic (3.54e-1)" "unprognostic (2.12e-2)" "unprognostic (6.25e-2)" 6.7 3.0 0.6 1.7 0.7 0.3 6.7 2.6 0.7 6.5 4.2 2.9 16.5 0.8 4.9 18.1 9.6 8.2 3.0 3.5 1.1 0.8 14.4 0.6 5.0 2.4 2.5 0.9 9.0 1.2 0.0 1.7 9.3 5.4 19.4 1.1 4.3 4.3 25.4 1.1 1.8 2.6 66.7 15.7 1.1 9.9 5.6 0.7 0.1 3.2 2.5 0.9 47.9 7.6 0.9 1.2 1.1 0.4 1.5 0.8 0.3 0.3 0.2 0.5 0.6 0.0 0.0 1.4 10.0 0.0 0.0 0.0 0.1 0.2 0.4 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.4 0.4 0.4 0.5 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 0.3 0.0 0.0 0.4 0.3 1.0 0.5 0.2 0.2 0.2 0.0 18.1 0.1 0.6 0.5 1.1 0.4 0.1 3.6 0.2 0.1 0.5 0.2 1.7 0.2 0.2 0.1 0.0 0.1 0.2 0.2 0.2 0.7 0.4 0.4 0.6 0.0 0.1 0.4 0.6 0.7 0.1 0.9 0.4 0.8 1.1 1.5 0.4 1.2 0.2 0.3 0.6 0.7 2.6 0.7 1.1 0.8 2.5 0.9 5.4 0.7 8.9 0.0 0.0 4.1 1.1 2.6 1.1 7.6 0.0 0.0 40.1 2.0 0.2 1.7 1.0 5.8 1.5 0.0 0.0 0.0 0.2 14.3 1.6 0.0 0.0 0.4 0.0 0.0 0.6 0.0 1.6 11.2 0.0 3.3 0.0 0.0 43.4 0.8 0.0 25.1 0.7 1.8 6.5 30.8 10.3 2.1 1.1 0.3 0.0 0.0 0.3 SCAMP3 C1orf3 ENSG00000116521 "Secretory carrier membrane protein 3" O14828 1 155255979-155262430 "Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071167 Supported Vesicles NA NA Vesicles "HPA071167: AB_2686352" "unprognostic (4.31e-2)" "unprognostic (1.30e-2)" "unprognostic (1.07e-2)" "unprognostic (2.17e-2)" "unprognostic (5.33e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (2.92e-5)" "unprognostic (8.78e-2)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (2.65e-1)" "unprognostic (3.74e-2)" "unprognostic (8.46e-3)" "unprognostic (1.60e-1)" "unprognostic (4.79e-1)" "unprognostic (1.07e-1)" "unprognostic (7.18e-2)" 23.6 41.8 21.0 20.8 25.6 16.8 28.8 22.5 35.5 21.9 19.0 36.1 26.8 24.1 20.7 17.8 27.1 21.9 21.5 37.8 19.8 20.2 33.3 40.8 23.4 25.5 27.1 26.3 22.6 41.5 41.5 20.0 37.0 26.2 23.0 17.3 26.0 33.0 28.1 45.3 30.0 20.9 18.9 30.4 27.0 24.4 14.5 26.4 21.6 27.3 23.6 27.3 23.9 20.8 32.2 32.5 25.6 35.0 29.9 28.7 30.0 13.9 30.0 9.1 18.1 22.2 17.4 9.3 16.8 19.9 19.0 17.9 16.4 19.9 12.9 25.1 19.5 18.6 21.8 13.1 12.7 7.0 17.7 24.0 9.1 19.6 13.3 22.2 17.1 15.5 15.3 16.3 23.8 10.9 12.6 15.8 13.3 16.2 31.4 20.5 27.9 15.8 15.9 17.5 24.0 32.9 13.6 7.4 39.8 11.3 12.5 11.8 23.8 11.7 27.4 19.4 9.0 29.6 26.8 12.9 21.4 12.1 22.0 24.8 41.8 38.8 16.1 21.0 18.4 24.6 25.6 29.0 23.2 28.7 31.1 25.6 32.2 26.6 26.8 31.6 30.5 24.6 26.3 2.6 29.9 35.0 32.5 26.6 30.0 21.0 25.6 22.5 35.5 19.8 20.2 27.1 26.3 26.2 26.4 14.9 36.2 29.6 20.5 34.0 17.4 31.9 28.1 20.1 28.4 31.4 3.9 72.8 8.3 46.2 1.4 29.2 26.9 0.0 60.3 45.7 27.2 20.1 24.3 33.4 50.8 17.5 28.9 28.8 21.0 4.3 15.8 24.5 23.6 54.1 21.9 20.0 40.9 24.3 17.7 21.2 10.5 12.9 21.7 10.7 3.4 35.0 59.6 32.4 24.2 19.7 SCCPDH "CGI-49, NET11" ENSG00000143653 "Saccharopine dehydrogenase (putative)" Q8NBX0 1 246724047-246768137 "Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 95.3" "Group enriched" "Detected in many" 5 "Early spermatids: 1022.4;Spermatocytes: 461.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 17 "basophil: 95.3" "Lineage enriched" "Detected in all" 22 "granulocytes: 95.3" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 53.5" "Low region specificity" "Detected in all" "HPA050775, HPA076030" Enhanced Approved Vesicles NA NA 2100000 Vesicles "HPA050775: AB_2681231, HPA076030: " "unprognostic (4.25e-1)" "unprognostic (3.11e-1)" "unprognostic (1.22e-1)" "unprognostic (1.75e-2)" "unprognostic (2.83e-2)" "unprognostic (6.43e-2)" "unprognostic (1.25e-1)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (5.51e-2)" "unprognostic (1.93e-1)" "unprognostic (3.60e-1)" "unprognostic (2.70e-2)" "unprognostic (9.63e-2)" "unprognostic (1.13e-1)" "unprognostic (2.24e-1)" "unprognostic (3.93e-2)" 14.1 25.8 15.7 6.4 17.5 13.4 11.3 11.3 20.5 10.9 11.7 24.7 8.5 15.1 12.0 8.5 4.8 14.4 9.7 15.8 15.6 19.8 23.0 67.3 9.3 7.3 26.1 15.0 10.6 12.7 15.0 12.7 14.1 21.7 18.1 12.2 7.3 7.4 16.7 23.9 10.7 15.3 10.8 62.1 5.1 12.4 65.1 17.5 8.5 18.2 7.3 4.8 25.0 13.2 1.4 2.3 95.3 3.2 4.2 3.0 2.1 13.1 12.8 9.4 5.6 11.3 14.2 0.1 10.3 14.4 17.4 14.6 7.8 37.0 7.0 13.5 11.8 9.7 4.3 7.9 3.0 17.9 9.7 2.9 11.8 11.7 15.6 10.6 22.9 10.2 9.5 1.4 11.8 1.2 16.5 18.6 14.7 14.7 0.0 17.3 3.1 23.8 29.1 14.1 7.1 10.2 20.1 12.1 0.0 53.5 30.9 10.7 12.0 13.9 0.6 9.1 5.2 10.4 23.9 12.1 8.1 7.2 19.6 26.5 34.7 11.9 4.1 13.8 31.3 10.6 95.3 3.2 5.5 2.5 2.8 3.0 1.4 0.7 2.1 1.3 1.1 1.0 3.0 0.8 4.2 1.8 2.3 0.5 2.1 15.7 17.5 11.3 20.5 15.6 19.8 26.1 15.0 21.7 17.5 6.0 11.5 8.0 36.7 26.8 29.6 33.1 50.9 52.2 17.0 144.8 17.7 28.0 26.6 57.2 1022.4 20.2 47.9 0.0 61.3 13.6 42.0 76.7 57.5 163.4 83.3 6.4 43.0 21.5 44.3 154.3 44.0 20.4 45.5 15.4 25.1 52.2 56.6 28.1 44.6 51.6 30.6 19.4 27.8 461.4 68.6 59.8 70.7 16.7 53.2 149.1 SCG3 "FLJ90833, SgIII" ENSG00000104112 "Secretogranin III" Q8WXD2 15 51681353-51721031 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 118.3" "Group enriched" "Detected in some" 7 "Bipolar cells: 115.1;Cone photoreceptor cells: 96.2;Horizontal cells: 139.8;Intestinal endocrine cells: 142.5;Rod photoreceptor cells: 63.1" "Group enriched" "Detected in many" 7 "glioma: 41.0;pancreatic cancer: 15.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "NTERA-2: 20.4;SCLC-21H: 48.9;SH-SY5Y: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006880, CAB033274, HPA053715" Enhanced Supported Supported Vesicles "Secreted in brain" NA NA 4800000 Vesicles "CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: AB_2682239" "unprognostic (1.38e-2)" "unprognostic (2.42e-1)" "unprognostic (1.40e-1)" "unprognostic (5.24e-5)" "unprognostic (1.59e-2)" "unprognostic (3.63e-2)" "unprognostic (1.74e-1)" "unprognostic (9.93e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.71e-2)" "unprognostic (8.17e-2)" "unprognostic (1.03e-1)" "unprognostic (2.78e-1)" "unprognostic (2.78e-1)" "unprognostic (8.88e-2)" "unprognostic (1.27e-1)" 1.7 12.9 29.6 2.1 25.4 1.7 1.7 33.4 118.3 1.5 2.4 6.5 0.0 2.9 1.5 1.6 1.6 1.6 1.6 1.5 22.6 23.5 1.5 1.5 1.8 1.7 13.6 37.7 1.5 11.5 1.4 23.7 1.5 27.1 1.6 2.8 1.3 1.5 1.4 1.5 1.8 2.6 1.7 13.2 1.5 8.7 2.9 7.3 0.0 2.1 0.0 1.5 1.6 0.1 0.9 1.2 1.9 0.5 0.3 0.8 0.2 0.0 0.0 1.8 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.0 0.0 20.4 0.0 0.0 0.1 0.0 0.1 0.0 0.2 48.9 23.1 0.1 0.1 0.0 6.6 0.0 1.4 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.3 0.1 4.3 0.4 0.4 0.6 0.8 0.2 0.5 0.9 0.6 0.4 0.4 0.7 0.5 0.6 1.9 0.3 0.5 1.2 0.2 0.2 29.6 25.4 33.4 40.6 22.6 23.5 13.6 37.7 27.1 7.3 0.0 0.0 0.0 0.0 0.2 115.1 0.2 0.0 0.0 0.0 0.0 96.2 0.0 1.7 0.4 13.3 0.6 0.0 0.0 0.9 0.0 0.2 0.5 0.0 0.0 0.4 139.8 142.5 1.8 0.0 9.2 0.0 0.0 1.7 11.8 0.2 11.7 8.7 0.0 0.4 0.0 63.1 0.0 0.1 15.8 4.9 0.0 0.0 0.0 0.2 0.0 SCGB2A1 "LPHC, MGB2, MGC71973, UGB3" ENSG00000124939 "Secretoglobin family 2A member 1" O75556 11 62208668-62213939 "Cancer-related genes, Predicted secreted proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "cervix, uterine: 191.8;epididymis: 135.9" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 61.1;Ciliated cells: 107.1;Glandular cells: 36.8;Intestinal endocrine cells: 35.6;Mucus-secreting cells: 60.0" "Group enriched" "Detected in many" 10 "endometrial cancer: 971.9;ovarian cancer: 208.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "EFO-21: 14.0" HPA034584 Enhanced Approved Vesicles "Secreted in other tissues" NA NA Vesicles "HPA034584: AB_10602221" "unprognostic (7.73e-2)" "unprognostic (3.77e-1)" "prognostic favorable (1.22e-4)" "prognostic favorable (1.54e-8)" "unprognostic (2.98e-2)" "unprognostic (1.86e-2)" "unprognostic (3.39e-1)" "unprognostic (1.95e-1)" "unprognostic (2.69e-1)" "unprognostic (6.87e-3)" "prognostic favorable (6.36e-4)" "unprognostic (5.67e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" "unprognostic (3.35e-1)" 0.2 0.0 0.2 0.5 0.2 0.0 6.8 0.2 0.3 191.8 1.0 0.3 20.8 0.0 40.8 135.9 1.0 28.7 2.5 0.4 0.2 0.3 1.2 0.4 0.9 0.2 0.2 0.3 5.6 2.2 0.0 1.5 0.7 0.5 1.2 1.3 0.2 18.8 1.4 0.2 2.3 0.3 0.2 0.2 0.2 4.3 4.5 0.2 0.3 0.8 1.1 3.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.5 0.0 0.1 0.0 1.1 0.2 0.0 2.6 0.6 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.3 0.2 0.3 0.2 0.3 0.5 0.2 0.0 3.7 0.0 4.1 0.1 0.0 0.0 61.1 107.1 11.4 15.7 0.0 0.1 3.3 4.8 0.0 0.0 2.6 0.0 4.7 0.0 0.0 36.8 0.0 0.0 3.7 0.0 35.6 0.0 0.0 0.0 0.0 0.0 5.0 0.0 60.0 0.0 14.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.4 3.9 SDF2 ENSG00000132581 "Stromal cell derived factor 2" Q99470 17 28648356-28662189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042799 Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA042799: AB_10794533" "unprognostic (3.91e-1)" "unprognostic (2.79e-1)" "unprognostic (2.03e-1)" "unprognostic (5.77e-3)" "unprognostic (3.90e-2)" "unprognostic (1.88e-2)" "prognostic unfavorable (1.16e-4)" "unprognostic (2.28e-3)" "unprognostic (3.20e-3)" "unprognostic (3.02e-1)" "unprognostic (1.04e-2)" "unprognostic (1.52e-1)" "unprognostic (1.79e-1)" "unprognostic (1.39e-3)" "unprognostic (2.21e-1)" "unprognostic (7.75e-3)" "unprognostic (6.61e-2)" 13.3 31.8 15.4 10.9 14.9 8.8 17.1 11.2 13.9 17.9 15.8 13.3 26.1 9.6 14.5 28.3 14.4 16.9 14.8 13.3 11.4 13.4 20.1 22.5 14.2 8.8 18.8 11.5 19.9 18.9 10.1 18.9 21.3 16.2 19.1 11.3 11.5 20.7 16.0 13.1 10.2 14.2 14.7 11.4 15.0 13.8 9.5 14.2 11.3 25.2 13.9 14.7 12.8 15.0 11.5 15.3 45.5 12.3 15.1 16.9 13.0 7.4 19.0 8.7 7.4 37.2 10.7 8.0 23.3 15.9 14.6 17.3 10.5 6.9 4.0 21.1 20.6 19.3 14.3 11.2 7.3 10.6 23.1 13.7 6.9 8.9 9.7 11.5 4.0 8.9 21.2 9.8 13.2 3.5 14.1 13.3 4.3 7.1 8.9 16.7 11.0 7.5 8.6 5.9 18.4 7.1 5.4 15.5 8.6 14.0 9.1 6.3 6.9 16.5 12.8 12.0 15.7 15.1 4.6 17.1 7.4 9.8 9.7 13.1 10.2 15.8 5.5 11.8 5.4 11.3 36.3 12.3 30.5 16.9 9.8 15.5 11.5 13.2 16.3 7.7 10.7 12.5 14.9 45.5 15.1 9.4 15.3 16.6 13.0 15.4 14.9 11.2 13.9 11.4 13.4 18.8 11.5 16.2 14.2 23.8 20.0 36.3 50.6 30.2 25.2 10.1 28.1 20.1 26.1 40.1 23.6 110.1 24.9 68.3 3.7 43.0 68.9 23.3 41.5 92.5 54.1 49.7 20.7 42.3 50.3 12.7 54.9 41.1 39.2 2.2 70.5 41.1 35.4 46.9 44.8 47.8 62.2 84.2 62.6 44.7 26.1 71.1 33.0 25.9 29.9 33.0 176.4 60.9 41.1 70.8 SEC23B "CDA-II, CDAII, CDAN2, HEMPAS" ENSG00000101310 "Sec23 homolog B, coat complex II component" Q15437 20 18507482-18561415 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008216, HPA069974" Uncertain Supported Vesicles NA NA Vesicles "HPA008216: AB_1079895, HPA069974: AB_2686223" "unprognostic (4.47e-2)" "unprognostic (2.67e-2)" "unprognostic (3.52e-1)" "prognostic favorable (8.25e-4)" "unprognostic (1.24e-1)" "unprognostic (1.33e-1)" "unprognostic (5.44e-3)" "unprognostic (6.01e-2)" "unprognostic (1.39e-1)" "unprognostic (8.75e-2)" "unprognostic (1.97e-1)" "unprognostic (9.97e-2)" "unprognostic (3.91e-2)" "unprognostic (1.72e-2)" "unprognostic (4.26e-2)" "unprognostic (2.81e-2)" "unprognostic (8.21e-2)" 11.8 32.9 16.5 16.5 19.0 17.2 21.3 13.5 20.0 21.8 16.9 28.8 40.9 12.8 11.2 29.2 24.0 17.4 14.3 8.2 16.2 14.8 27.1 32.8 17.4 15.3 22.3 12.3 13.2 43.1 32.8 31.8 13.1 18.0 19.4 18.9 15.6 69.5 46.3 4.4 14.9 14.9 10.8 22.0 19.7 20.5 23.4 18.3 19.2 34.3 12.7 20.8 12.8 12.5 27.5 44.1 50.8 38.4 32.9 34.1 36.6 24.7 28.0 15.9 14.7 10.7 12.0 35.6 21.0 14.4 26.4 22.8 24.3 22.9 11.5 13.9 16.1 34.2 26.7 27.8 38.6 28.6 13.8 12.6 18.7 11.1 36.3 21.8 26.1 23.9 9.1 23.0 38.3 49.1 14.9 16.2 10.3 21.7 25.4 18.0 25.6 17.9 13.8 14.7 35.8 30.2 18.6 24.1 36.0 24.4 25.1 25.1 17.9 24.7 56.7 23.1 21.1 24.9 27.7 13.3 16.6 9.0 18.5 25.7 32.2 44.3 17.7 14.1 14.1 23.1 50.8 38.4 42.1 24.7 38.4 34.1 27.5 25.3 26.4 44.1 22.2 23.0 24.1 19.6 32.9 35.9 33.4 29.1 36.6 16.5 19.0 13.5 20.0 16.2 14.8 22.3 12.3 18.0 18.3 14.9 38.7 20.8 17.5 10.2 20.2 2.8 15.3 40.2 29.6 29.6 15.7 28.9 49.7 32.6 60.6 9.5 18.6 23.3 29.3 25.0 12.1 30.3 16.1 21.9 37.1 12.7 18.9 15.4 37.0 4.5 13.3 26.2 21.9 27.1 28.0 23.0 29.5 23.0 9.9 40.7 18.8 19.4 8.2 34.1 18.3 12.4 55.0 16.0 18.8 24.3 SEC23IP p125 ENSG00000107651 "SEC23 interacting protein" Q9Y6Y8 10 119892711-119944658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038403, HPA043305" Approved Enhanced Vesicles NA NA Vesicles "HPA038403: AB_10675796, HPA043305: AB_2678416" "unprognostic (4.05e-2)" "unprognostic (5.01e-2)" "unprognostic (8.70e-2)" "unprognostic (1.35e-1)" "unprognostic (3.12e-1)" "unprognostic (1.07e-1)" "unprognostic (9.52e-3)" "unprognostic (1.78e-1)" "unprognostic (3.36e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-1)" "unprognostic (6.81e-3)" "unprognostic (3.43e-2)" 21.6 22.4 11.7 26.3 15.9 21.3 22.0 18.2 16.1 21.3 19.4 19.2 22.8 15.5 25.7 25.7 21.1 20.4 22.0 18.2 18.7 11.4 19.0 32.9 20.0 25.5 10.4 13.0 23.2 21.6 19.3 23.2 21.2 16.8 21.0 21.9 19.1 23.3 27.0 24.3 20.9 20.4 26.0 12.4 20.2 27.5 30.9 11.1 23.3 22.2 15.2 25.4 21.6 18.7 14.3 14.3 15.1 20.6 14.6 17.6 11.1 19.5 24.0 16.4 23.5 16.2 21.3 14.1 19.7 32.6 20.7 24.5 23.1 19.0 21.9 9.1 28.1 21.5 17.0 23.9 22.3 30.7 17.2 21.2 17.9 12.6 18.3 22.2 20.2 21.9 24.4 12.2 26.5 24.9 19.9 26.5 10.6 14.7 16.4 20.1 12.5 18.9 14.2 19.5 17.7 17.3 16.9 32.9 12.1 15.3 19.4 7.6 17.6 18.3 12.9 15.6 18.1 14.3 12.9 23.5 12.7 12.3 18.8 22.7 21.5 19.3 26.2 20.8 24.2 11.1 15.1 12.3 12.2 14.0 19.3 17.6 14.3 13.9 15.7 14.3 12.1 14.8 13.9 5.0 14.6 20.6 9.0 14.4 11.1 11.7 15.9 18.2 16.1 18.7 11.4 10.4 13.0 16.8 11.1 11.9 20.4 15.2 16.5 7.4 17.9 16.5 30.6 17.4 23.9 17.4 5.9 15.3 5.0 14.6 24.4 15.3 16.2 23.3 12.5 14.9 14.6 23.5 20.9 22.2 20.0 11.1 19.1 13.5 19.9 20.1 13.0 18.4 8.5 9.0 22.3 16.4 16.7 18.1 14.2 16.5 20.3 0.0 14.7 20.9 17.7 12.2 19.3 16.6 17.5 18.0 SEC24C KIAA0079 ENSG00000176986 "SEC24 homolog C, COPII coat complex component" P53992 10 73744384-73772161 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040196, HPA040213" Supported Supported Vesicles NA NA Vesicles "HPA040196: AB_10796449, HPA040213: AB_10796451" "unprognostic (5.06e-2)" "unprognostic (1.00e-2)" "unprognostic (2.17e-1)" "unprognostic (3.54e-1)" "unprognostic (8.46e-2)" "unprognostic (7.23e-2)" "unprognostic (9.06e-2)" "unprognostic (4.55e-2)" "unprognostic (1.64e-1)" "unprognostic (2.46e-2)" "unprognostic (1.02e-1)" "unprognostic (1.35e-1)" "unprognostic (7.71e-2)" "unprognostic (8.34e-3)" "unprognostic (2.11e-1)" "unprognostic (3.35e-2)" "unprognostic (1.77e-2)" 20.6 34.2 17.8 24.8 24.7 10.8 21.2 30.2 33.5 28.7 23.4 29.4 22.6 22.3 29.1 30.7 49.6 25.5 25.8 23.5 18.3 16.2 25.1 44.9 23.1 23.3 25.8 18.9 28.3 27.6 46.6 35.3 39.1 21.7 29.2 23.6 27.1 35.9 39.7 33.6 25.2 25.1 27.2 18.2 28.9 25.7 29.8 23.6 30.1 31.2 28.4 38.3 24.4 28.3 9.3 12.5 15.4 15.0 14.9 26.3 13.4 21.1 21.4 16.9 30.3 18.5 15.2 13.9 16.0 27.3 21.6 20.3 19.7 14.4 16.8 13.3 21.3 14.8 18.4 23.6 21.2 18.7 22.3 16.8 15.6 15.6 20.8 14.7 23.4 21.9 12.9 23.5 18.9 23.6 27.4 22.2 13.4 18.4 24.6 21.1 18.9 17.4 16.1 10.6 20.1 78.5 19.0 13.7 13.7 14.3 12.1 6.1 15.8 12.5 43.9 17.5 16.6 32.3 20.8 21.6 9.1 16.6 17.6 18.4 25.1 24.3 25.0 26.0 23.9 10.5 15.4 10.5 9.0 20.4 15.0 26.3 9.3 12.2 15.8 12.5 7.3 9.0 11.8 8.0 14.9 12.4 10.4 7.5 13.4 17.8 24.7 30.2 33.5 18.3 16.2 25.8 18.9 21.7 23.6 32.8 25.8 9.0 4.6 7.7 13.4 1.7 20.4 2.7 18.2 14.0 15.7 15.2 3.3 12.5 6.1 7.1 20.6 0.0 16.5 13.6 7.8 9.4 21.9 16.3 15.1 14.3 18.4 16.0 10.0 4.8 10.9 11.6 5.0 8.2 16.3 10.4 20.0 14.1 11.0 7.7 14.2 6.5 8.2 9.8 7.8 9.9 21.1 16.6 14.5 6.7 SEC24D KIAA0755 ENSG00000150961 "SEC24 homolog D, COPII coat complex component" O94855 4 118722823-118838683 "Disease related genes, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Craniosynostosis, Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041626, HPA053486" Approved Approved Vesicles NA NA Vesicles "HPA041626: AB_10796348, HPA053486: AB_2682166" "unprognostic (9.06e-2)" "unprognostic (3.11e-1)" "unprognostic (3.23e-2)" "unprognostic (8.60e-3)" "unprognostic (1.05e-1)" "unprognostic (1.92e-1)" "unprognostic (1.93e-1)" "unprognostic (2.58e-1)" "unprognostic (9.39e-2)" "unprognostic (3.23e-1)" "unprognostic (1.22e-1)" "unprognostic (6.85e-2)" "prognostic unfavorable (3.42e-6)" "unprognostic (1.09e-3)" "unprognostic (5.64e-2)" "unprognostic (4.30e-3)" "unprognostic (1.37e-1)" 14.7 10.6 3.1 12.5 4.0 7.3 13.9 6.4 6.1 26.8 25.2 2.9 27.9 18.0 25.4 24.6 11.5 16.6 18.6 16.7 4.0 4.0 11.1 65.5 17.9 11.4 3.8 4.7 21.9 32.4 6.1 37.0 33.8 3.8 16.9 16.2 10.1 23.0 38.0 6.5 8.1 41.8 20.2 4.0 19.3 14.3 9.3 2.4 7.6 21.1 8.6 17.0 24.0 15.9 1.8 5.9 15.7 7.0 5.2 6.8 2.4 7.6 4.1 9.5 7.6 27.2 36.4 6.7 32.8 36.6 16.9 20.2 4.3 5.7 6.0 4.7 52.4 8.7 2.6 5.2 10.4 18.3 5.0 2.8 6.7 6.4 18.3 27.7 17.3 12.5 21.6 5.9 14.8 24.4 30.1 27.8 4.2 1.7 18.6 26.4 5.3 8.4 5.2 8.9 17.3 6.6 5.2 6.9 10.5 15.0 3.8 5.6 11.3 4.6 23.9 3.9 14.5 3.3 14.1 30.1 13.2 4.2 18.8 7.4 14.4 5.2 10.1 28.6 11.1 18.2 5.9 5.5 15.7 3.4 6.2 6.8 1.8 3.5 4.8 5.9 1.4 2.3 2.9 5.1 5.2 7.0 3.1 4.5 2.4 3.1 4.0 6.4 6.1 4.0 4.0 3.8 4.7 3.8 2.4 3.0 11.7 11.9 13.0 18.7 3.8 3.4 20.4 10.7 18.2 14.0 0.0 20.2 0.0 8.9 73.3 15.7 24.8 0.0 22.1 49.1 54.0 27.5 8.1 60.6 24.7 1.6 39.6 27.6 37.6 64.8 42.3 20.7 16.9 8.2 58.7 1.2 15.6 14.0 36.0 3.1 2.9 25.8 43.4 10.9 6.6 15.4 37.6 10.0 13.6 16.6 SEMA7A "CD108, H-Sema-L, SEMAL" ENSG00000138623 "Semaphorin 7A (John Milton Hagen blood group)" O75326 15 74409289-74433958 "Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins" "Differentiation, Inflammatory response, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 36.4;lymphoid tissue: 34.7;placenta: 54.0" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 64.8;Extravillous trophoblasts: 51.6;monocytes: 49.5;Pancreatic endocrine cells: 55.5;Rod photoreceptor cells: 57.4;Syncytiotrophoblasts: 139.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 8.9" "Lineage enriched" "Detected in many" 5 "granulocytes: 8.9" "Cell line enhanced" "Detected in many" "HMC-1: 101.9;hTEC/SVTERT24-B: 40.0;U-251 MG: 58.8;U-87 MG: 34.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008210, HPA042273" Uncertain Uncertain Vesicles NA NA 29000000 Vesicles "HPA008210: , HPA042273: AB_10806234" "unprognostic (2.00e-1)" "unprognostic (2.72e-1)" "unprognostic (2.02e-2)" "unprognostic (5.81e-2)" "unprognostic (6.49e-2)" "unprognostic (8.61e-2)" "unprognostic (2.54e-2)" "unprognostic (4.18e-3)" "unprognostic (1.33e-1)" "unprognostic (1.39e-1)" "unprognostic (5.18e-3)" "unprognostic (1.44e-1)" "prognostic unfavorable (2.45e-11)" "unprognostic (1.32e-1)" "unprognostic (2.01e-2)" "unprognostic (6.25e-2)" "unprognostic (2.57e-2)" 2.2 1.9 5.4 10.4 13.8 12.8 1.4 22.9 27.3 1.3 1.8 19.9 1.4 2.7 4.3 1.8 3.2 1.2 3.3 1.4 10.8 5.7 1.4 1.5 4.4 19.0 28.5 5.7 5.9 0.9 6.4 1.9 54.0 28.6 1.4 1.8 7.8 1.7 3.5 1.4 4.7 6.0 2.0 36.4 34.7 3.7 23.6 15.4 9.0 1.1 0.4 19.7 4.6 1.7 1.4 1.8 8.9 0.0 0.8 0.2 0.0 5.8 0.0 1.7 0.5 2.2 7.6 14.6 27.1 10.9 5.7 8.8 2.3 9.6 0.0 1.6 12.2 4.6 1.7 0.5 1.7 5.9 0.4 0.3 10.6 0.0 2.9 0.5 0.3 101.9 5.3 0.0 40.0 2.2 14.4 0.0 0.7 6.0 3.7 18.5 0.4 1.4 3.4 1.9 0.1 4.1 0.2 1.2 1.5 2.4 2.5 0.1 0.1 0.2 4.9 2.2 1.6 0.3 2.1 1.0 10.7 7.1 5.1 58.8 0.6 0.4 0.1 34.3 1.2 0.5 3.9 0.0 8.9 0.2 0.0 0.2 1.4 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.8 0.0 1.8 0.0 0.0 5.4 13.8 22.9 27.3 10.8 5.7 28.5 5.7 28.6 15.4 3.0 0.0 2.7 0.5 0.3 10.9 0.8 0.0 0.0 2.3 1.8 64.8 20.3 0.0 17.3 0.5 2.4 0.0 0.0 12.1 51.6 0.8 1.9 8.1 0.8 6.4 1.6 0.0 0.6 0.8 1.5 3.4 1.2 8.5 49.5 0.0 4.2 55.5 0.0 1.8 0.0 57.4 0.0 0.9 0.7 0.4 1.3 139.1 2.5 0.0 25.3 SEPSECS "SLA, SLA/LP" ENSG00000109618 "Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase" Q9HD40 4 25120014-25160442 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "RNA-binding, Transferase, tRNA-binding" "Disease mutation, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 34.2" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070409 Approved Vesicles NA NA Vesicles "HPA070409: AB_2686265" "unprognostic (1.83e-1)" "unprognostic (4.09e-2)" "unprognostic (6.37e-3)" "unprognostic (5.86e-2)" "unprognostic (9.63e-2)" "unprognostic (4.61e-3)" "unprognostic (1.82e-3)" "unprognostic (6.33e-2)" "unprognostic (1.24e-1)" "unprognostic (3.34e-1)" "unprognostic (2.52e-1)" "unprognostic (3.56e-2)" "unprognostic (4.45e-3)" "unprognostic (4.64e-2)" "unprognostic (1.65e-1)" "unprognostic (1.16e-2)" "unprognostic (2.13e-3)" 7.0 6.1 3.8 8.5 6.4 11.8 7.4 5.4 6.0 5.3 13.5 7.8 8.9 11.8 6.7 9.6 5.3 6.5 8.9 5.6 4.8 3.6 10.5 34.2 9.4 9.7 7.2 4.9 8.5 11.3 7.3 5.1 4.4 5.4 4.7 7.8 5.2 6.2 9.2 5.5 10.9 15.3 3.7 7.0 7.5 7.4 8.9 6.8 12.3 7.7 4.8 8.0 6.8 5.5 5.7 5.9 3.2 4.0 3.4 5.5 2.2 2.9 1.6 6.2 3.3 5.7 7.9 5.4 3.0 4.1 3.4 3.4 1.3 7.2 5.4 3.0 3.4 3.8 3.6 4.8 3.6 3.8 2.7 1.6 6.6 5.6 2.6 6.4 5.8 8.7 7.4 5.7 2.5 5.6 5.2 3.6 12.2 10.4 5.5 2.7 1.7 9.3 16.3 2.9 2.4 6.1 4.8 7.4 4.8 4.7 3.1 4.7 4.4 2.7 2.2 5.2 4.6 4.2 5.6 3.7 5.2 2.7 1.6 2.9 8.6 9.6 6.0 3.2 9.6 3.1 2.4 4.0 2.2 3.6 3.4 3.5 3.4 4.5 4.9 3.4 5.7 4.6 5.5 3.2 3.4 2.4 5.9 2.6 2.2 3.8 6.4 5.4 6.0 4.8 3.6 7.2 4.9 5.4 6.8 0.0 7.4 4.1 1.5 2.2 2.6 3.9 25.5 9.4 3.4 15.7 0.0 4.7 6.6 4.2 17.7 6.3 8.5 0.0 4.1 3.2 4.0 2.3 3.5 35.0 5.4 4.8 5.8 6.7 6.9 13.0 3.1 5.8 3.3 6.4 6.4 3.1 4.6 7.0 6.0 17.4 2.2 0.0 1.8 13.4 18.5 2.9 4.9 4.9 7.3 1.1 SERPINA1 "A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1" ENSG00000197249 "Serpin family A member 1" P01009 14 94376747-94390693 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Acute phase, Blood coagulation, Hemostasis" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "liver: 3314.2" "Cell type enriched" "Detected in many" 7 "Hepatocytes: 29973.4" "Cancer enriched" "Detected in all" 10 "liver cancer: 3850.6" "Low region specificity" "Detected in some" "Group enriched" "Detected in many" 5 "classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0" "Group enriched" "Detected in many" 5 "granulocytes: 139.3;monocytes: 203.0" "Cell line enriched" "Detected in some" 8 "Hep G2: 326.1" "Region enriched" "Detected in many" 6 "cerebellum: 334.2" "HPA000927, HPA001292, CAB013211, CAB016648, CAB073396" Enhanced Enhanced Vesicles "Secreted to blood" NA NA 2070000000000 210000000000 Vesicles "CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762" "prognostic favorable (1.61e-5)" "unprognostic (3.37e-1)" "prognostic favorable (5.86e-4)" "unprognostic (1.38e-2)" "unprognostic (1.98e-2)" "unprognostic (5.50e-3)" "unprognostic (3.81e-2)" "unprognostic (6.78e-2)" "unprognostic (2.54e-2)" "unprognostic (7.96e-2)" "unprognostic (1.08e-1)" "unprognostic (4.54e-1)" "unprognostic (1.23e-2)" "unprognostic (1.89e-1)" "unprognostic (1.30e-2)" "unprognostic (1.17e-2)" "unprognostic (1.96e-1)" 0.9 0.4 0.7 4.9 1.4 3.0 2.4 0.2 0.7 2.6 7.5 0.5 3.1 6.3 0.8 8.6 0.4 0.7 14.2 1.0 0.4 0.5 74.1 3314.2 13.6 5.3 1.0 0.2 0.6 7.4 0.0 0.4 0.8 0.8 0.6 4.1 0.6 0.9 3.6 0.2 0.3 36.2 1.4 1.3 8.9 7.0 0.8 0.8 0.5 0.8 0.2 0.9 0.5 0.6 0.3 33.5 139.3 203.0 0.2 0.3 100.0 2.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 12.9 41.0 0.1 1.1 0.0 0.1 0.1 0.0 0.8 0.0 5.0 0.0 0.2 0.1 326.1 0.0 1.1 0.1 0.3 0.4 0.0 1.4 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.5 0.1 1.1 0.1 22.1 0.2 0.0 0.1 0.4 0.1 0.1 0.0 19.4 0.2 0.1 0.1 5.1 0.1 0.6 0.2 0.1 0.5 0.3 2.8 0.0 0.4 110.2 29.1 0.2 165.9 0.3 0.3 0.1 0.2 33.5 0.1 0.2 0.1 139.3 0.2 203.0 0.7 0.2 100.0 0.7 1.4 0.2 0.7 0.4 0.5 1.0 0.2 0.8 0.8 32.8 233.5 435.3 1.1 2.1 0.0 2.8 4603.8 45.5 60.3 143.1 0.0 1.4 58.0 1848.5 0.1 6.6 53.3 817.7 189.3 1.7 1.6 5.0 1.1 29973.4 171.4 0.0 11.6 922.6 1276.8 0.0 0.0 188.6 1.7 107.4 659.1 0.3 1376.2 37.4 0.0 447.0 0.2 0.0 5.1 0.0 0.1 1.5 5.4 46.5 24.7 7.1 SERPINB5 "maspin, PI5" ENSG00000206075 "Serpin family B member 5" P36952 18 63476761-63505085 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 99.3;skin 1: 60.7;tongue: 118.8" "Cell type enhanced" "Detected in many" 18 "Basal keratinocytes: 856.4;Suprabasal keratinocytes: 1062.2;Urothelial cells: 663.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 124.6" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 147.0;HBEC3-KT: 48.5;hTCEpi: 102.0;hTERT-HME1: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "CAB009570, HPA019025, HPA019132, HPA020136" Enhanced Supported Vesicles "Intracellular and membrane" NA NA 660000 Vesicles "CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728" "unprognostic (2.84e-3)" "unprognostic (1.05e-1)" "unprognostic (9.24e-2)" "unprognostic (1.04e-3)" "unprognostic (2.09e-2)" "prognostic unfavorable (1.54e-4)" "unprognostic (1.36e-1)" "unprognostic (3.47e-3)" "prognostic unfavorable (5.71e-6)" "unprognostic (1.28e-1)" "unprognostic (1.84e-6)" "unprognostic (2.57e-1)" "unprognostic (6.58e-2)" "unprognostic (3.14e-1)" "unprognostic (8.38e-2)" 0.2 0.1 0.1 0.9 0.1 0.0 9.7 0.1 0.1 23.6 2.7 0.1 0.7 3.9 2.1 0.5 99.3 0.1 4.3 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.2 0.1 4.1 1.0 0.1 11.1 0.3 0.1 60.7 6.8 0.9 0.1 0.1 2.2 0.4 0.1 5.1 0.1 118.8 41.2 7.1 19.7 0.6 0.5 1.2 0.4 1.0 0.5 0.1 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.4 0.0 0.0 147.0 0.0 48.5 0.0 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.0 102.0 0.0 25.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 20.2 10.7 0.0 0.0 0.0 0.0 10.7 0.1 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.4 0.3 0.4 0.2 0.1 0.2 0.2 0.4 0.2 0.6 0.5 0.3 1.2 1.0 0.2 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 229.2 856.4 0.0 0.2 0.0 16.0 20.5 3.5 0.0 0.2 0.0 0.1 7.6 0.0 5.4 0.0 0.0 0.2 8.7 51.7 0.0 0.0 0.0 0.0 3.4 0.0 0.0 15.2 0.6 0.2 59.1 0.0 3.2 0.0 9.5 46.0 0.0 0.0 0.0 0.0 14.4 2.6 0.6 1062.2 0.1 0.0 7.0 663.3 SERPIND1 "D22S673, HC-II, HC2, HCF2, HLS2" ENSG00000099937 "Serpin family D member 1" P05546 22 20773879-20787720 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Chemotaxis, Hemostasis" "Heparin-binding, Protease inhibitor, Serine protease inhibitor" "Disease mutation, FDA approved drug targets, Thrombophilia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 47 "liver: 170.8" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 223.1" "Cancer enriched" "Detected in many" 80 "liver cancer: 334.4" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "Hep G2: 64.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB008639, HPA055767" Supported Approved Vesicles "Secreted to blood" NA NA 94000000000 Vesicles "CAB008639: AB_1618010, HPA055767: AB_2682912" "unprognostic (1.68e-1)" "unprognostic (8.27e-2)" "unprognostic (4.40e-2)" "prognostic favorable (4.09e-4)" "unprognostic (5.42e-2)" "unprognostic (1.23e-1)" "unprognostic (1.12e-3)" "unprognostic (1.56e-1)" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-2)" "unprognostic (2.88e-1)" "unprognostic (3.94e-9)" "unprognostic (2.01e-1)" "unprognostic (4.66e-2)" "unprognostic (8.36e-3)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 2.3 0.0 0.2 0.6 0.9 0.3 0.0 1.4 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 170.8 0.3 0.0 0.0 0.7 0.3 0.0 3.6 0.1 0.2 2.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.1 0.1 0.5 0.0 0.1 0.0 0.0 0.0 0.1 1.9 2.7 0.7 0.4 1.3 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 64.2 0.0 0.2 0.1 0.0 0.0 0.5 0.0 0.0 6.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 5.2 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 4.4 0.0 0.4 0.0 1.0 0.2 1.7 0.4 0.5 0.6 0.1 1.9 0.9 0.7 0.7 1.3 0.2 2.7 0.7 0.1 0.0 2.3 0.6 0.9 0.0 0.0 0.0 0.7 2.6 0.5 0.0 13.7 0.0 0.0 0.0 0.0 0.8 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.7 0.0 1.1 223.1 0.1 0.0 0.0 4.9 2.9 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SERTM1 C13orf36 ENSG00000180440 "Serine rich and transmembrane domain containing 1" A2A2V5 13 36673912-36697839 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3" "Cell type enriched" "Detected in some" 5 "Alveolar cells type 1: 8.9" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.7" "Group enriched" "Detected in many" 7 "amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HAP1: 2.7;HEK 293: 3.2;NTERA-2: 8.0;SH-SY5Y: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA054814, HPA070485" Uncertain Enhanced Vesicles NA NA Vesicles "HPA054814: AB_2682611, HPA070485: AB_2686272" "unprognostic (8.71e-2)" "unprognostic (2.11e-1)" "unprognostic (5.58e-3)" "unprognostic (4.66e-3)" "unprognostic (4.05e-3)" "unprognostic (5.06e-2)" "unprognostic (2.79e-2)" "unprognostic (1.63e-2)" "unprognostic (1.00e-8)" "unprognostic (2.51e-2)" "unprognostic (5.60e-2)" "unprognostic (4.44e-2)" 5.0 1.8 13.9 0.5 10.1 0.5 1.2 0.3 30.2 16.4 0.7 1.3 1.8 0.6 30.9 13.5 0.5 25.3 0.5 0.6 26.5 2.0 0.6 0.5 5.6 0.5 1.5 11.6 14.5 0.8 1.0 11.2 0.5 2.4 0.9 0.5 8.2 0.5 1.2 0.5 0.6 0.6 17.4 0.9 0.5 0.9 1.5 0.0 0.0 9.3 0.0 0.5 1.1 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.0 3.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 10.1 0.3 21.6 26.5 2.0 1.5 11.6 2.4 0.0 8.9 0.0 0.0 0.0 0.0 1.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 SEZ6L ENSG00000100095 "Seizure related 6 homolog like" Q9BYH1 22 26169474-26383597 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 60.8" "Cell type enriched" "Detected in some" 6 "Horizontal cells: 20.6" "Group enriched" "Detected in some" 6 "glioma: 14.6;pancreatic cancer: 3.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "intermediate monocyte: 7.4;myeloid DC: 7.2;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 73 "dendritic cells: 7.2;monocytes: 7.4" "Group enriched" "Detected in some" 7 "SCLC-21H: 30.8;SH-SY5Y: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045135 Approved Vesicles NA NA 2400000 Vesicles "HPA045135: AB_2732518" "unprognostic (1.01e-2)" "unprognostic (1.03e-1)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.49e-2)" "unprognostic (6.47e-2)" "unprognostic (4.19e-1)" "unprognostic (1.09e-2)" "unprognostic (5.02e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-3)" "unprognostic (7.80e-2)" "unprognostic (2.40e-6)" "unprognostic (4.52e-2)" "unprognostic (3.89e-1)" "unprognostic (2.39e-4)" "unprognostic (3.18e-1)" 1.2 12.5 26.4 1.6 11.3 1.3 1.1 20.1 60.8 2.4 1.3 4.3 0.0 1.5 1.1 1.1 1.1 1.1 1.2 2.5 39.1 23.6 1.1 1.1 1.3 1.1 11.2 25.5 1.1 2.7 1.0 3.8 1.1 15.0 1.3 1.4 0.0 1.3 1.2 1.1 1.2 1.6 1.4 5.3 1.3 2.9 1.4 5.4 0.0 1.2 0.0 1.1 1.2 0.2 0.0 7.2 0.0 7.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.8 8.2 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 7.4 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.5 26.4 11.3 20.1 29.3 39.1 23.6 11.2 25.5 15.0 5.4 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 20.6 0.0 0.0 0.0 0.7 0.6 0.7 0.0 3.6 0.0 0.5 1.0 0.0 0.4 0.0 0.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 SH3BGRL MGC117402 ENSG00000131171 "SH3 domain binding glutamate rich protein like" O75368 X 81201943-81298547 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051248 Approved Approved Vesicles NA NA 14000000 Vesicles "HPA051248: AB_2681405" "unprognostic (3.02e-3)" "unprognostic (4.25e-2)" "unprognostic (4.89e-2)" "unprognostic (3.15e-2)" "unprognostic (1.46e-1)" "unprognostic (1.39e-1)" "unprognostic (2.25e-2)" "unprognostic (3.20e-2)" "unprognostic (1.23e-1)" "unprognostic (1.51e-1)" "unprognostic (1.78e-1)" "unprognostic (4.62e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (4.08e-4)" "unprognostic (2.12e-1)" "unprognostic (3.75e-1)" "unprognostic (1.73e-1)" 46.5 35.9 48.6 32.9 40.4 43.2 51.5 11.7 40.4 60.0 70.4 27.3 43.5 25.0 66.2 45.0 49.3 45.0 43.1 24.2 42.4 46.3 41.4 17.6 37.7 46.3 56.7 29.0 40.1 23.1 29.7 59.8 24.3 40.7 55.6 32.1 27.8 34.8 88.1 9.7 19.1 33.6 77.4 67.1 52.7 41.0 26.7 36.0 46.5 33.4 21.4 34.8 81.7 34.9 31.5 41.1 83.4 71.1 23.2 32.6 51.1 0.1 7.0 25.5 29.2 33.6 45.8 1.7 15.6 29.8 5.7 11.8 2.2 21.5 20.9 13.5 22.8 8.1 3.8 18.0 11.2 9.2 17.7 6.3 27.7 11.7 1.3 8.1 19.4 54.5 26.5 8.1 8.1 7.2 44.7 25.2 14.3 9.5 52.0 31.3 9.4 20.2 25.3 20.0 0.2 11.3 18.6 11.6 11.0 29.6 9.6 0.0 11.3 0.0 0.7 14.1 17.7 8.5 59.4 25.5 16.0 6.4 14.6 6.4 12.1 10.4 19.2 18.3 39.9 11.8 83.4 49.5 71.9 17.6 63.9 19.0 31.5 22.3 20.7 41.1 26.0 20.7 21.6 17.1 23.2 71.1 19.4 32.6 51.1 48.6 40.4 11.7 40.4 42.4 46.3 56.7 29.0 40.7 36.0 104.2 80.1 174.5 109.6 112.2 11.1 20.3 56.0 127.2 88.7 115.1 0.0 5.3 291.8 67.6 4.3 119.6 42.3 93.5 66.7 4.3 136.2 89.9 212.7 17.1 382.1 4.8 89.6 135.1 328.5 9.4 161.4 380.8 140.0 336.4 72.7 101.9 45.7 107.8 295.2 151.2 8.1 258.7 350.5 1.6 6.8 104.5 4.8 147.1 66.1 120.4 SHROOM1 "APXL2, KIAA1960" ENSG00000164403 "Shroom family member 1" Q2M3G4 5 132822141-132830898 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.7;urinary bladder: 37.8" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 81.2;Hepatocytes: 58.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "classical monocyte: 3.7" "Lineage enriched" "Detected in single" 5 "monocytes: 3.7" "Cell line enhanced" "Detected in many" "RT4: 19.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037690, HPA037691" Uncertain Approved Vesicles NA NA Vesicles "HPA037690: AB_2675613, HPA037691: AB_2675614" "unprognostic (2.50e-1)" "unprognostic (1.06e-1)" "unprognostic (4.52e-2)" "unprognostic (2.66e-1)" "unprognostic (1.45e-2)" "unprognostic (3.47e-1)" "unprognostic (9.26e-2)" "unprognostic (1.33e-2)" "unprognostic (3.74e-1)" "unprognostic (3.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.01e-2)" "prognostic unfavorable (5.72e-6)" "unprognostic (8.22e-2)" "unprognostic (2.91e-2)" "unprognostic (2.88e-2)" "unprognostic (2.26e-3)" 5.5 2.4 8.2 2.9 13.5 0.7 3.5 8.3 9.6 4.2 12.0 26.3 23.8 6.5 6.4 2.7 2.2 3.8 7.2 2.4 9.5 5.3 3.2 42.7 4.6 1.0 23.8 7.9 2.6 6.7 7.6 3.1 12.4 12.3 35.9 11.9 8.8 6.3 17.0 1.8 1.5 10.0 4.9 13.8 1.3 10.5 1.3 20.5 0.0 3.0 0.6 1.0 37.8 11.6 0.1 0.2 0.7 3.7 0.3 0.1 0.6 6.8 4.2 0.7 0.6 1.2 3.5 7.5 7.0 6.4 5.9 6.6 9.0 4.7 1.2 10.1 4.0 3.1 0.7 2.5 4.7 3.6 7.0 8.0 0.2 6.5 8.2 3.6 0.5 2.5 1.5 2.5 4.1 2.6 4.1 3.9 0.1 5.5 6.7 5.0 3.6 0.2 3.1 1.1 5.4 5.8 0.4 0.0 0.6 1.0 19.6 4.8 1.2 6.9 0.6 3.8 4.0 4.2 2.4 3.7 6.8 9.2 1.0 9.0 7.3 5.1 0.1 6.7 0.0 2.1 0.5 3.7 0.1 0.1 0.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.3 0.8 0.0 0.0 0.6 8.2 13.5 8.3 9.6 9.5 5.3 23.8 7.9 12.3 20.5 23.8 27.8 1.5 12.6 1.1 2.3 2.0 33.1 12.0 17.0 8.7 9.8 4.7 1.7 5.9 0.6 9.3 81.2 0.0 9.3 3.9 4.2 47.7 8.1 58.6 5.7 15.9 21.9 12.9 10.5 0.9 4.4 4.0 0.0 0.0 27.1 20.3 6.7 35.1 4.6 2.1 12.0 25.8 3.6 8.4 4.1 1.8 2.4 2.2 27.4 13.9 SIRPB1 "CD172b, SIRP-BETA-1" ENSG00000101307 "Signal regulatory protein beta 1" "O00241, Q5TFQ8" 20 1563521-1620061 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 137.6" "Cell type enhanced" "Detected in some" 19 "Hofbauer cells: 14.8;Kupffer cells: 35.5;Macrophages: 18.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 137.6" "Group enriched" "Detected in many" 6 "granulocytes: 137.6;monocytes: 43.6" "Group enriched" "Detected in some" 4 "HMC-1: 25.3;NB-4: 33.6;THP-1: 26.0" HPA047463 Uncertain Uncertain Vesicles NA NA 33000000 Vesicles "HPA047463: AB_2680057" "unprognostic (1.88e-2)" "unprognostic (6.19e-2)" "unprognostic (1.50e-1)" "unprognostic (2.24e-1)" "unprognostic (5.38e-2)" "unprognostic (1.60e-1)" "unprognostic (4.40e-2)" "unprognostic (7.18e-2)" "unprognostic (4.11e-3)" "unprognostic (9.12e-2)" "unprognostic (6.31e-2)" "unprognostic (4.57e-2)" "unprognostic (2.65e-3)" "unprognostic (5.76e-2)" "unprognostic (2.39e-3)" "unprognostic (5.00e-3)" "unprognostic (1.19e-2)" 23.7 1.8 2.3 18.7 5.4 31.9 1.8 2.7 3.2 1.1 1.4 1.9 0.1 1.0 1.0 0.5 0.9 2.5 7.6 7.2 2.3 1.6 1.5 7.5 19.4 19.5 6.6 0.7 1.9 0.9 0.1 1.5 3.8 3.7 1.2 1.2 1.7 1.8 0.6 0.9 0.9 2.6 2.1 7.2 28.7 1.2 1.2 3.9 2.5 0.9 0.4 2.9 4.1 1.9 0.2 15.2 137.6 43.6 0.7 1.0 19.2 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.1 3.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 25.3 0.0 0.1 0.1 0.0 3.7 0.2 0.5 0.0 0.1 0.2 0.0 0.0 33.6 0.1 0.0 1.5 0.0 0.0 0.0 5.0 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 26.0 0.7 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.5 6.1 0.1 0.5 43.6 72.5 0.6 36.3 0.9 0.2 0.6 0.5 15.2 0.2 0.8 0.5 137.6 0.7 29.5 14.5 1.0 19.2 2.3 5.4 2.7 3.2 2.3 1.6 6.6 0.7 3.7 3.9 3.0 6.9 0.5 0.0 0.0 0.2 0.4 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.9 0.0 14.8 0.0 0.0 3.1 35.5 0.0 0.0 18.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 SLAMF7 "19A, CD319, CRACC, CS1" ENSG00000026751 "SLAM family member 7" Q9NQ25 1 160739057-160754821 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.9;lymphoid tissue: 45.0" "Cell type enriched" "Detected in many" 5 "monocytes: 204.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 5 "U-266/70: 80.7" "Low region specificity" "Detected in all" "CAB015445, HPA055945, HPA061654" Enhanced Approved Vesicles NA NA 620000 Vesicles "CAB015445: AB_1121905, HPA055945: AB_2682980, HPA061654: AB_2684576" "unprognostic (5.82e-3)" "unprognostic (1.81e-2)" "unprognostic (1.84e-3)" "unprognostic (2.12e-3)" "unprognostic (2.75e-1)" "unprognostic (1.07e-2)" "unprognostic (7.87e-2)" "unprognostic (7.19e-2)" "unprognostic (2.46e-2)" "prognostic favorable (3.93e-4)" "unprognostic (1.08e-1)" "unprognostic (8.13e-2)" "prognostic unfavorable (8.57e-5)" "unprognostic (1.35e-1)" "unprognostic (3.91e-2)" "unprognostic (1.02e-1)" "unprognostic (1.50e-2)" 5.5 1.0 0.7 28.6 0.7 2.3 3.4 0.6 0.7 4.1 11.9 0.2 0.4 11.1 1.9 1.3 6.7 1.6 6.2 1.0 0.7 0.7 2.4 3.1 10.2 24.6 0.8 0.4 2.5 2.2 0.0 0.9 1.3 0.6 1.8 10.2 2.9 15.1 4.8 0.9 2.0 15.8 0.8 1.2 45.0 11.0 1.5 0.4 5.9 2.1 4.2 38.7 11.5 2.6 3.7 27.4 1.1 14.9 17.3 32.9 8.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.2 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 2.2 0.0 0.7 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.6 0.0 0.2 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 80.7 6.8 0.0 2.2 0.0 0.0 0.0 1.6 0.3 32.9 11.0 25.4 3.7 3.5 22.4 7.2 0.6 1.1 13.6 1.1 17.3 14.9 27.4 0.0 8.7 0.7 0.7 0.6 0.7 0.7 0.7 0.8 0.4 0.6 0.4 8.9 8.9 20.2 1.4 0.7 0.0 0.8 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.5 0.0 0.3 0.0 23.3 2.3 0.1 1.1 1.8 8.1 0.0 8.9 0.0 0.0 0.6 6.0 0.0 0.0 12.8 18.6 204.6 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.2 39.5 0.0 3.0 SLC15A3 "hPTR3, PHT2" ENSG00000110446 "Solute carrier family 15 member 3" Q8IY34 11 60937084-60952530 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Peptide transport, Protein transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 16 "Hofbauer cells: 82.1;monocytes: 92.8;Muller glia cells: 202.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 36.4;BJ hTERT+ SV40 Large T+ RasG12V: 44.2;HHSteC: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA047880, HPA057642" Approved Supported Vesicles NA NA Vesicles "HPA047880: AB_10959455, HPA057642: AB_2683487" "unprognostic (5.61e-2)" "prognostic favorable (4.07e-5)" "unprognostic (8.79e-2)" "unprognostic (1.67e-2)" "unprognostic (8.48e-2)" "unprognostic (9.33e-3)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (1.10e-1)" "unprognostic (1.39e-1)" "unprognostic (1.60e-1)" "unprognostic (1.46e-1)" "unprognostic (9.78e-3)" "unprognostic (6.47e-2)" "unprognostic (4.42e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 27.2 7.5 7.7 23.5 8.3 36.8 9.3 2.0 7.0 11.0 16.3 10.6 8.1 9.0 10.3 7.4 12.0 8.6 15.4 11.1 8.2 5.4 8.9 9.1 30.1 24.2 12.2 5.9 16.1 6.6 1.9 5.0 26.6 9.8 10.2 6.7 13.2 5.8 5.5 4.0 4.2 14.0 9.7 12.6 40.0 9.8 5.0 8.3 8.6 5.6 6.5 19.3 11.4 9.3 5.0 10.8 15.0 12.5 0.1 1.4 2.2 3.4 0.1 1.3 0.0 7.7 5.5 13.4 0.8 13.5 36.4 44.2 0.0 1.7 5.6 0.1 5.9 9.3 1.1 0.0 0.4 1.3 5.6 0.0 0.1 0.1 0.2 21.4 0.2 0.5 3.9 0.1 9.8 0.0 0.1 2.1 0.0 0.0 1.1 2.3 0.2 0.0 0.8 6.4 0.0 0.2 2.4 0.1 1.7 0.0 0.8 0.0 0.0 1.7 6.8 0.6 0.3 2.8 4.3 0.0 0.2 1.1 0.8 0.1 0.0 0.0 3.5 2.3 0.1 9.7 0.0 9.5 0.9 0.1 12.5 0.1 5.0 0.0 0.0 6.0 2.4 1.3 1.4 15.0 0.1 6.4 10.8 0.0 2.2 7.7 8.3 2.0 7.0 8.2 5.4 12.2 5.9 9.8 8.3 8.9 19.9 9.3 0.2 1.4 1.3 1.7 0.0 0.0 2.3 0.0 0.0 3.1 0.0 0.3 5.5 10.1 0.0 0.0 1.9 10.4 4.1 0.2 15.0 2.4 82.1 4.8 0.0 16.0 47.0 2.9 7.5 37.0 1.7 92.8 0.9 202.1 1.2 0.9 4.6 0.0 4.2 12.9 3.5 0.5 0.7 1.3 2.2 0.0 0.9 0.3 SLC16A6 "MCT6, MCT7" ENSG00000108932 "Solute carrier family 16 member 6" O15403 17 68267026-68291267 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 32.5" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 21.6;Kupffer cells: 17.4;Rod photoreceptor cells: 39.6" "Group enriched" "Detected in many" 6 "breast cancer: 10.9;melanoma: 11.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 13 "SK-MEL-30: 107.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA054459, HPA066328" Uncertain Approved Vesicles NA NA Vesicles "HPA054459: AB_2682494, HPA066328: AB_2685660" "unprognostic (2.53e-2)" "unprognostic (2.09e-3)" "unprognostic (8.41e-2)" "unprognostic (6.94e-2)" "unprognostic (3.10e-1)" "unprognostic (5.26e-3)" "unprognostic (5.08e-3)" "unprognostic (5.39e-2)" "unprognostic (1.63e-3)" "unprognostic (1.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.44e-2)" "unprognostic (8.78e-2)" "unprognostic (2.23e-1)" "unprognostic (8.16e-3)" "unprognostic (2.09e-2)" "unprognostic (9.46e-2)" 7.8 3.4 3.0 6.6 6.3 8.1 6.2 3.7 6.2 2.2 0.8 3.1 9.8 0.9 2.8 32.5 12.4 1.5 1.6 1.4 3.2 4.2 0.9 1.4 9.7 4.6 4.7 1.4 1.8 1.2 0.4 2.4 2.4 6.9 0.8 1.0 13.0 3.5 11.0 10.3 4.2 1.2 0.9 2.7 6.3 1.1 2.2 0.9 1.5 3.3 6.6 7.9 3.7 3.3 0.6 2.7 8.5 4.7 1.1 2.9 1.2 0.4 0.3 0.1 0.1 0.1 0.1 3.1 0.1 3.9 0.3 0.2 0.1 0.5 3.5 0.3 0.0 0.0 0.1 0.6 0.0 0.1 1.0 0.2 0.2 0.4 4.5 0.7 1.2 0.2 0.1 0.0 0.2 0.2 0.3 0.1 0.5 0.2 0.8 0.0 3.9 1.6 0.7 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.3 0.8 0.0 0.1 2.1 107.0 0.8 3.1 0.7 0.5 1.2 0.2 0.1 0.3 0.8 3.1 3.2 8.1 0.9 0.5 1.1 4.7 0.3 2.9 4.4 1.5 0.6 1.2 2.3 2.7 0.3 0.8 1.6 8.5 1.1 2.2 0.6 2.6 1.2 3.0 6.3 3.7 6.2 3.2 4.2 4.7 1.4 6.9 0.9 0.0 4.5 0.8 0.1 0.2 4.8 0.6 0.0 2.7 6.8 8.7 21.6 0.1 0.0 0.0 0.5 0.9 0.0 0.0 0.0 8.6 0.9 0.2 1.1 0.0 5.5 0.0 0.0 1.3 17.4 0.0 0.0 12.8 10.1 1.0 0.0 5.8 0.0 0.0 1.8 0.2 39.6 0.0 0.1 1.6 0.4 0.4 0.3 5.7 0.0 0.0 SLC26A2 "DTD, DTDST" ENSG00000155850 "Solute carrier family 26 member 2" P50443 5 149960737-149993455 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 81.9" "Cell type enriched" "Detected in many" 4 "Syncytiotrophoblasts: 676.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 24.2;RPTEC TERT1: 55.5;TIME: 28.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041957, HPA058090" Enhanced Approved Vesicles NA NA Vesicles "HPA041957: AB_10795646, HPA058090: AB_2683602" "unprognostic (6.64e-2)" "unprognostic (1.53e-1)" "unprognostic (3.03e-2)" "prognostic favorable (7.29e-4)" "unprognostic (2.59e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.59e-1)" "unprognostic (5.64e-2)" "unprognostic (1.19e-1)" "unprognostic (7.43e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.70e-1)" "unprognostic (1.77e-1)" "unprognostic (8.12e-2)" "unprognostic (1.06e-1)" 8.5 15.6 2.6 23.2 3.7 1.3 4.7 6.3 2.3 3.8 81.9 3.0 29.4 5.4 4.8 14.2 8.3 3.1 2.6 3.1 2.5 2.6 3.8 1.6 6.8 5.3 3.7 2.3 5.1 2.9 21.4 11.1 16.9 7.6 6.1 75.0 4.9 27.9 36.7 11.2 6.0 13.4 4.3 5.5 3.0 2.4 2.8 3.0 5.2 2.7 4.4 13.0 4.1 2.8 1.6 1.7 7.0 3.3 2.5 3.0 1.1 3.3 3.0 3.8 6.2 4.6 3.3 0.9 3.1 2.8 2.5 3.1 15.7 1.8 2.5 24.2 3.3 6.1 2.4 3.6 7.3 4.6 2.0 2.3 3.2 2.4 1.8 3.5 5.9 5.5 3.6 4.3 4.2 5.5 6.3 6.0 3.2 0.8 2.6 10.6 1.0 2.2 3.1 1.2 1.1 4.8 3.3 5.9 1.3 55.5 14.7 1.1 2.9 5.5 1.3 9.4 3.1 2.6 3.5 28.5 5.9 4.4 5.1 3.7 1.8 2.4 1.5 5.4 7.2 8.4 7.0 1.1 0.8 2.5 0.8 3.0 1.3 1.5 2.1 1.7 1.6 2.1 2.2 1.0 2.5 3.3 1.7 2.6 1.1 2.6 3.7 6.3 2.3 2.5 2.6 3.7 2.3 7.6 3.0 41.7 13.7 7.5 12.5 4.0 16.1 6.7 7.6 6.7 14.8 31.4 15.7 160.9 1.7 5.2 17.7 15.3 151.8 0.0 8.6 5.2 16.0 21.5 87.8 2.4 26.4 6.4 20.3 16.5 13.8 9.9 16.1 12.2 86.0 16.2 37.7 15.0 9.4 147.9 11.7 4.4 80.3 0.0 10.2 9.2 10.2 4.4 676.5 9.6 53.2 4.9 SLC27A4 "ACSVL4, FATP4" ENSG00000167114 "Solute carrier family 27 member 4" Q6P1M0 9 128340646-128361470 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport" Ligase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 56.1" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 75.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007293, CAB009771" Approved Approved Vesicles NA NA Vesicles "CAB009771: AB_2270540, HPA007293: AB_1857062" "unprognostic (7.25e-2)" "unprognostic (1.29e-1)" "unprognostic (1.60e-1)" "unprognostic (3.92e-3)" "unprognostic (3.74e-2)" "unprognostic (2.03e-1)" "unprognostic (1.85e-3)" "unprognostic (1.31e-3)" "unprognostic (4.51e-1)" "unprognostic (4.69e-2)" "unprognostic (7.72e-2)" "unprognostic (5.07e-2)" "prognostic favorable (2.61e-5)" "unprognostic (7.29e-3)" "unprognostic (2.11e-1)" "unprognostic (3.45e-2)" "unprognostic (8.01e-3)" 7.7 7.1 9.9 7.0 13.6 2.5 4.9 9.4 26.5 6.5 25.7 15.8 5.2 54.0 6.6 5.6 26.1 4.4 9.8 7.7 11.6 15.9 17.7 20.8 5.8 5.0 14.8 9.6 5.6 11.3 9.8 5.4 5.8 21.9 5.7 8.3 6.7 7.5 7.3 6.7 24.3 56.1 8.1 11.6 5.1 8.6 13.2 7.9 6.8 12.7 15.2 14.9 8.5 9.5 3.7 7.2 2.6 6.2 1.9 8.1 3.3 10.2 20.1 10.3 13.2 15.7 4.8 11.8 8.7 5.5 10.1 7.3 14.4 10.1 9.6 7.0 9.3 12.1 35.2 12.4 10.0 3.1 9.6 19.1 5.7 17.7 12.5 8.5 10.5 9.2 6.3 13.7 10.4 8.3 4.5 11.4 13.0 13.5 6.7 9.2 25.2 12.4 10.1 4.6 23.2 32.0 15.2 10.1 17.8 17.2 15.5 17.9 9.8 14.5 26.7 9.5 5.4 13.3 4.0 16.7 12.1 11.8 13.2 10.7 6.0 8.5 3.1 12.3 6.3 13.6 0.0 4.1 2.6 8.1 5.6 6.1 3.7 5.2 6.4 7.2 1.7 4.1 4.3 1.6 1.9 6.2 6.4 3.6 3.3 9.9 13.6 9.4 26.5 11.6 15.9 14.8 9.6 21.9 7.9 0.0 1.4 3.0 1.2 2.5 9.3 2.8 7.6 1.4 0.0 8.7 11.8 4.9 1.7 12.4 2.2 3.3 75.1 0.0 13.8 5.7 3.8 2.4 9.2 15.5 9.9 7.9 12.6 4.9 7.1 3.6 1.1 2.9 1.7 12.6 14.0 4.8 20.8 31.7 3.9 8.1 6.2 6.5 2.7 8.8 6.9 5.4 4.3 1.7 12.4 2.6 SLC2A8 "GLUT8, GLUTX1" ENSG00000136856 "Solute carrier family 2 member 8" Q9NY64 9 127397138-127408424 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 119.6;Late spermatids: 229.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "plasmacytoid DC: 33.8" "Lineage enriched" "Detected in all" 5 "dendritic cells: 33.8" "Cell line enhanced" "Detected in many" "CACO-2: 46.6;Hep G2: 27.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011935 Uncertain Approved Vesicles NA NA Vesicles "HPA011935: AB_1849760" "unprognostic (6.49e-2)" "prognostic favorable (2.57e-6)" "unprognostic (9.13e-2)" "unprognostic (1.85e-3)" "unprognostic (4.23e-2)" "unprognostic (9.43e-3)" "unprognostic (2.62e-1)" "unprognostic (1.30e-1)" "unprognostic (6.33e-2)" "unprognostic (1.36e-1)" "prognostic favorable (9.86e-6)" "unprognostic (1.70e-1)" "prognostic favorable (6.55e-6)" "unprognostic (4.25e-2)" "unprognostic (3.55e-1)" "unprognostic (1.59e-3)" "unprognostic (2.04e-3)" 10.9 24.5 11.4 13.3 11.3 3.5 10.4 15.0 15.2 9.0 19.8 11.7 37.0 17.7 9.5 17.4 8.7 6.0 9.4 9.8 10.4 9.3 8.7 25.7 8.1 7.3 12.5 10.2 6.7 12.1 5.7 5.5 13.2 8.7 18.5 6.5 12.5 9.4 28.3 22.6 11.6 17.0 44.1 10.3 11.3 13.1 30.6 9.3 1.2 9.1 6.9 4.3 42.4 9.1 2.4 33.8 6.9 5.6 1.2 6.3 2.0 1.8 7.2 3.2 7.2 0.0 0.0 10.2 2.8 1.9 4.5 2.7 46.6 1.7 2.8 6.4 1.5 7.2 9.7 3.9 4.5 1.1 2.6 6.2 0.4 5.7 27.5 4.2 0.0 3.0 0.1 4.2 0.4 1.8 2.2 3.5 3.9 2.9 6.3 1.8 13.1 0.0 0.0 5.2 10.2 11.3 1.0 4.5 7.8 4.2 19.3 5.4 3.7 6.7 11.5 2.5 4.3 7.4 1.6 3.0 0.0 4.7 0.3 6.2 19.5 18.2 4.2 3.1 0.0 3.4 0.0 3.0 6.9 4.9 5.6 3.5 2.3 1.6 3.3 4.6 2.4 0.3 1.2 0.2 1.2 5.1 33.8 6.3 2.0 11.4 11.3 15.0 15.2 10.4 9.3 12.5 10.2 8.7 9.3 8.9 9.6 5.4 6.1 9.8 11.1 6.1 7.6 5.3 4.5 5.2 9.8 66.2 13.3 12.0 119.6 7.4 15.1 23.3 14.7 10.8 11.6 11.0 6.9 23.6 59.6 6.4 11.6 12.9 12.4 229.4 10.0 8.2 25.3 8.2 13.3 14.9 15.9 21.5 11.0 12.2 7.7 12.9 8.1 38.0 10.9 9.3 56.3 6.9 15.6 5.5 SLC30A2 ZNT2 ENSG00000158014 "Solute carrier family 30 member 2" Q9BRI3 1 26037252-26046133 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 78.0;placenta: 20.0" "Cell type enhanced" "Detected in many" 16 "Cytotrophoblasts: 23.2;Exocrine glandular cells: 18.5;Proximal tubular cells: 27.2;Syncytiotrophoblasts: 71.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 19.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "BEWO: 4.7;RPTEC TERT1: 10.6;WM-115: 6.5" "Region enriched" "Detected in single" 5 "olfactory region: 1.5" "Not detected" "Not detected" HPA017979 Approved Vesicles NA NA Vesicles "HPA017979: AB_1857085" "unprognostic (4.87e-2)" "unprognostic (6.70e-2)" "unprognostic (3.79e-2)" "unprognostic (1.79e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-2)" "unprognostic (2.25e-2)" "unprognostic (2.59e-1)" "unprognostic (3.67e-2)" "unprognostic (1.02e-1)" "unprognostic (6.99e-2)" "unprognostic (1.10e-1)" "prognostic favorable (2.86e-6)" "unprognostic (9.38e-2)" "unprognostic (3.50e-2)" "unprognostic (1.17e-1)" "unprognostic (3.01e-2)" 0.1 0.7 0.1 0.1 0.1 0.2 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.0 1.3 1.1 0.1 0.1 4.0 2.2 0.1 0.1 10.4 0.1 0.2 0.1 0.1 0.1 0.1 78.0 0.1 0.1 20.0 0.1 0.3 0.0 2.0 1.0 1.4 1.7 0.4 0.6 0.1 0.1 0.1 0.1 0.4 0.1 0.1 12.8 0.2 0.1 0.5 0.1 1.5 1.1 3.1 1.0 1.5 0.9 0.4 0.2 0.2 0.2 1.0 0.3 0.1 4.7 0.4 0.2 0.1 0.1 0.9 1.0 0.2 0.9 0.1 0.2 0.9 0.2 0.3 0.1 0.6 0.3 0.6 0.7 0.1 0.1 0.6 0.7 0.0 0.2 0.1 0.1 0.3 0.0 0.3 0.6 1.5 0.1 0.8 0.5 0.9 0.8 0.4 0.2 0.3 0.7 0.7 10.6 0.4 0.9 0.5 0.6 1.1 0.4 1.6 0.7 0.5 0.6 0.7 1.2 0.6 0.3 1.1 0.6 0.8 0.5 0.6 6.5 3.1 1.0 0.4 0.9 0.4 0.5 0.7 0.6 0.8 0.2 1.5 0.6 0.8 3.1 1.5 0.5 1.1 0.5 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 3.0 4.0 0.0 0.7 0.3 2.4 5.1 15.3 0.0 0.0 8.7 0.0 23.2 5.0 6.8 0.0 0.5 0.4 0.0 18.5 2.4 0.6 0.6 4.6 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 3.3 1.8 0.1 0.5 5.4 0.0 0.0 27.2 1.8 6.5 0.9 0.2 0.4 0.6 71.2 0.0 0.6 0.7 SLC35B2 UGTrel4 ENSG00000157593 "Solute carrier family 35 member B2" Q8TB61 6 44254096-44257890 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029638 Approved Approved Vesicles NA NA Vesicles "HPA029638: AB_10602402" "prognostic unfavorable (7.90e-4)" "unprognostic (2.47e-3)" "unprognostic (2.30e-1)" "unprognostic (1.39e-2)" "unprognostic (2.36e-1)" "unprognostic (1.65e-2)" "prognostic unfavorable (8.59e-5)" "unprognostic (3.84e-1)" "unprognostic (2.51e-1)" "unprognostic (7.03e-3)" "unprognostic (4.27e-2)" "prognostic favorable (6.07e-4)" "unprognostic (3.60e-2)" "unprognostic (1.13e-1)" "unprognostic (4.07e-1)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" 18.0 28.2 14.8 12.6 15.0 10.7 17.7 16.2 24.8 18.3 18.9 35.8 19.0 13.0 22.6 23.4 14.3 18.6 27.1 17.7 15.2 10.9 32.3 35.5 16.1 12.9 17.1 14.6 16.7 38.1 27.4 11.1 26.1 19.8 19.0 20.2 23.8 49.6 20.4 17.5 15.6 16.4 20.5 24.7 18.4 20.6 16.3 18.7 12.2 19.3 17.8 17.6 19.6 14.3 12.9 14.4 21.8 8.6 10.8 21.1 10.2 23.1 13.3 16.7 32.0 27.5 29.1 12.2 25.4 42.1 25.0 30.8 11.7 21.6 5.2 22.9 31.4 26.9 22.1 11.4 28.6 17.6 15.3 14.7 10.4 10.5 13.9 25.7 22.2 17.0 29.8 30.1 23.0 11.3 34.6 18.3 11.9 14.9 22.4 29.9 27.2 8.2 18.6 7.4 69.9 15.5 8.2 10.8 26.4 27.0 17.2 20.8 20.0 12.5 13.9 28.6 10.9 25.8 20.4 18.1 19.7 13.1 19.6 22.1 17.3 19.7 12.1 26.3 17.7 40.0 21.8 8.6 13.2 21.1 6.5 17.8 12.9 11.9 16.1 7.7 7.7 11.0 14.2 0.7 10.8 2.3 14.4 9.6 10.2 14.8 15.0 16.2 24.8 15.2 10.9 17.1 14.6 19.8 18.7 6.0 11.5 22.3 25.5 11.9 9.7 6.7 43.3 5.3 11.4 26.2 2.0 50.8 11.6 69.2 0.4 9.8 13.7 0.0 64.7 44.1 30.6 27.0 34.6 15.3 32.9 9.5 18.9 16.0 9.9 1.2 21.6 10.0 50.6 32.5 20.3 42.2 56.9 27.4 18.7 11.5 12.5 0.0 16.7 15.2 67.3 12.2 29.4 13.1 29.9 18.4 SLC38A2 "ATA2, KIAA1382, SAT2, SNAT2" ENSG00000134294 "Solute carrier family 38 member 2" Q96QD8 12 46358189-46372867 "Predicted membrane proteins" "Amino-acid transport, Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Basal keratinocytes: 993.3;Suprabasal keratinocytes: 942.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-HME1: 135.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035180 Approved Uncertain Vesicles NA NA Vesicles "HPA035180: AB_10669901" "unprognostic (6.61e-3)" "unprognostic (2.87e-2)" "unprognostic (4.88e-2)" "unprognostic (2.51e-2)" "unprognostic (2.96e-1)" "unprognostic (1.00e-2)" "unprognostic (7.78e-2)" "unprognostic (5.50e-3)" "unprognostic (1.20e-1)" "unprognostic (3.79e-1)" "unprognostic (9.24e-3)" "unprognostic (1.75e-1)" "unprognostic (1.47e-1)" "unprognostic (5.08e-2)" "unprognostic (3.80e-1)" "unprognostic (1.83e-1)" "unprognostic (8.68e-2)" 44.7 45.4 19.9 23.3 34.5 27.0 72.0 34.5 40.6 36.2 25.5 23.6 20.0 11.6 45.2 16.2 47.1 36.6 46.8 39.2 24.2 14.0 27.4 102.9 51.9 34.5 54.4 15.2 49.3 27.3 54.3 16.2 76.6 32.6 25.7 17.8 17.7 36.6 20.3 47.8 69.5 25.1 40.4 60.0 28.6 29.2 19.7 43.8 40.7 32.0 35.6 26.2 36.0 49.3 12.1 24.7 17.9 13.5 30.0 15.3 12.7 8.4 20.0 17.4 47.6 40.5 40.9 12.6 40.1 103.1 35.2 29.1 11.9 16.1 0.0 54.0 68.5 23.5 29.2 12.1 37.3 34.5 6.8 6.8 11.0 24.4 36.6 62.3 8.9 11.7 40.9 81.3 22.2 135.9 86.7 29.8 12.4 10.8 17.1 62.4 10.6 10.9 13.1 14.8 0.0 20.9 9.9 12.9 21.0 21.5 19.1 11.5 9.9 27.1 7.6 24.4 19.7 15.4 20.9 49.0 16.9 13.4 7.2 6.3 19.7 18.6 10.4 16.3 32.4 8.3 17.9 13.5 10.5 14.3 7.8 11.1 12.1 12.0 14.2 20.8 11.9 15.2 15.3 10.5 30.0 10.1 24.7 13.9 12.7 19.9 34.5 34.5 40.6 24.2 14.0 54.4 15.2 32.6 43.8 77.4 94.1 77.1 114.9 993.3 38.3 137.9 99.3 25.4 56.9 54.1 66.8 40.9 5.0 36.4 4.2 142.4 78.6 186.9 43.6 41.4 160.4 157.7 78.7 245.9 47.8 50.9 73.5 233.9 166.5 5.0 243.7 110.6 237.8 20.8 107.5 73.3 64.3 63.0 79.9 22.3 73.5 278.1 220.9 7.2 14.7 942.6 32.2 136.8 67.6 105.8 SLC38A9 FLJ90709 ENSG00000177058 "Solute carrier family 38 member 9" Q8NBW4 5 55625845-55773194 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 44.2" "Cell type enhanced" "Detected in many" 20 "Cytotrophoblasts: 168.8;Early spermatids: 189.6;Syncytiotrophoblasts: 518.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 49.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043785, HPA061702" Uncertain Supported Vesicles NA NA Vesicles "HPA043785: AB_10961859, HPA061702: " "unprognostic (4.80e-2)" "unprognostic (1.18e-1)" "unprognostic (3.26e-2)" "prognostic unfavorable (7.24e-5)" "unprognostic (2.49e-1)" "unprognostic (8.19e-2)" "unprognostic (8.35e-2)" "unprognostic (7.95e-2)" "unprognostic (5.47e-2)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" "unprognostic (4.87e-1)" "unprognostic (4.18e-3)" "unprognostic (1.76e-1)" "unprognostic (2.25e-1)" "unprognostic (2.84e-2)" "unprognostic (1.12e-1)" 7.2 6.3 8.2 6.9 8.0 5.2 6.8 9.9 9.7 6.4 7.5 9.2 6.7 6.6 7.5 5.9 9.0 5.8 7.1 3.9 6.2 6.4 6.7 13.5 6.4 8.4 9.4 6.4 6.9 18.2 10.1 11.8 44.2 8.6 5.9 8.5 6.7 7.6 5.3 5.2 6.2 7.1 7.2 8.8 8.9 7.7 15.8 8.5 13.3 7.1 5.7 11.4 8.7 6.9 10.8 10.8 7.4 11.8 8.9 10.0 6.4 8.1 8.3 6.9 9.3 9.6 9.9 49.9 6.8 9.6 8.3 13.7 13.3 11.2 13.3 11.6 5.6 13.6 10.1 9.3 8.0 10.9 7.1 8.7 4.2 8.9 8.9 15.4 7.5 5.1 12.0 9.7 9.2 10.8 6.0 9.3 8.7 9.1 8.9 7.7 6.9 9.4 7.2 12.8 3.1 7.5 7.2 11.6 13.4 11.2 6.5 3.8 6.1 7.0 4.3 11.6 10.1 9.4 15.3 12.6 1.7 5.6 12.2 7.1 9.6 19.6 8.0 4.3 7.7 4.7 4.8 11.8 7.4 7.8 10.2 10.0 10.8 6.3 9.0 10.8 6.2 9.2 7.7 2.9 8.9 7.5 10.8 8.1 6.4 8.2 8.0 9.9 9.7 6.2 6.4 9.4 6.4 8.6 8.5 6.0 1.9 9.5 3.9 2.9 5.4 2.0 15.3 4.0 7.9 8.7 7.9 168.8 1.7 7.8 189.6 6.8 4.0 0.0 9.9 52.8 5.4 4.1 2.3 18.4 23.0 1.6 4.1 9.8 10.6 73.4 6.9 8.2 5.0 8.2 5.0 5.1 9.5 7.0 4.6 5.7 7.9 6.5 4.5 14.0 4.3 3.0 518.4 8.7 5.2 4.2 SLC39A3 ZIP3 ENSG00000141873 "Solute carrier family 39 member 3" Q9BRY0 19 2732204-2740152 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Early spermatids: 234.7;Late spermatids: 338.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-937: 90.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042139, HPA058526" Uncertain Approved Vesicles NA NA Vesicles "HPA042139: AB_10793875, HPA058526: AB_2683743" "unprognostic (1.81e-1)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "prognostic favorable (9.76e-5)" "unprognostic (2.26e-1)" "unprognostic (2.44e-2)" "unprognostic (9.88e-3)" "unprognostic (1.01e-1)" "unprognostic (6.03e-2)" "unprognostic (3.66e-2)" "unprognostic (4.37e-3)" "unprognostic (4.07e-2)" "unprognostic (1.75e-3)" "unprognostic (9.22e-3)" "unprognostic (6.58e-2)" "unprognostic (7.97e-2)" "unprognostic (1.80e-2)" 11.1 15.5 13.3 8.3 18.0 23.9 13.3 10.6 28.0 12.7 10.8 14.0 8.3 10.2 14.3 19.5 10.5 14.6 10.5 11.7 14.4 13.0 11.0 23.6 9.0 11.7 11.5 12.9 11.0 11.9 17.8 15.5 10.6 14.9 10.8 8.8 10.7 12.4 11.7 11.2 8.1 9.4 14.0 11.1 12.9 9.3 50.1 8.8 13.0 12.5 6.8 9.4 14.2 7.8 24.4 38.0 29.6 17.5 13.1 17.5 15.4 11.9 9.7 7.3 18.0 15.2 10.4 7.4 8.7 10.3 16.1 16.5 10.5 7.8 7.4 5.6 14.9 12.8 9.7 11.2 11.6 10.1 0.0 8.0 32.5 7.2 10.5 16.8 26.9 47.6 9.3 18.8 11.9 9.8 5.8 8.2 13.9 35.6 33.1 10.8 7.7 13.2 20.2 7.8 10.6 12.9 17.5 4.8 22.0 7.6 9.3 10.1 9.2 7.6 5.4 18.1 4.9 9.5 35.3 5.0 11.3 6.2 17.5 12.6 9.0 14.1 7.0 8.5 90.6 13.4 16.4 17.5 29.6 17.5 16.1 15.4 24.4 15.4 14.9 23.4 24.4 12.9 14.5 7.8 13.1 15.5 38.0 9.7 15.4 13.3 18.0 10.6 28.0 14.4 13.0 11.5 12.9 14.9 8.8 3.0 3.2 33.4 14.3 9.2 19.5 6.7 28.1 5.3 5.7 7.0 7.9 32.9 14.9 40.6 234.7 14.4 18.4 70.0 53.8 46.9 22.6 24.4 25.3 27.7 57.4 46.1 23.1 17.2 18.1 338.5 19.8 24.6 23.6 28.9 16.6 28.8 36.0 20.3 26.2 18.0 15.4 25.8 15.1 118.7 27.5 8.5 22.1 20.0 23.4 14.6 SLC48A1 "FLJ20489, hHRG-1, HRG1" ENSG00000211584 "Solute carrier family 48 member 1" Q6P1K1 12 47753916-47782753 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 90.7" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 48.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 42.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065396, HPA073994" Approved Supported Vesicles NA NA Vesicles "HPA065396: , HPA073994: " "unprognostic (9.60e-2)" "prognostic favorable (4.27e-4)" "unprognostic (1.13e-2)" "unprognostic (1.18e-2)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (9.39e-5)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (9.88e-2)" "unprognostic (1.54e-2)" "unprognostic (6.63e-3)" "prognostic favorable (1.34e-6)" "unprognostic (1.45e-1)" "unprognostic (5.96e-2)" "unprognostic (1.52e-1)" "unprognostic (2.72e-2)" 16.2 13.5 27.8 5.0 33.5 7.7 10.7 12.5 39.5 13.1 8.3 90.7 6.7 5.6 11.9 12.7 13.9 21.9 11.5 12.8 32.7 20.8 18.5 6.3 11.7 4.9 44.1 27.9 35.6 10.6 24.3 6.4 13.2 38.6 9.3 8.2 7.4 13.2 18.1 16.7 14.7 5.3 12.7 44.5 11.3 7.7 5.1 39.7 4.9 35.6 6.1 6.0 9.9 7.6 7.1 8.5 23.7 11.9 1.2 5.4 4.0 4.5 14.2 2.2 17.0 14.9 6.4 5.0 3.3 7.3 3.1 3.2 4.5 12.4 2.8 42.7 9.1 6.3 18.2 2.9 3.8 2.4 23.1 2.8 19.3 11.9 6.1 8.5 5.1 11.5 3.8 7.7 4.5 5.5 16.4 8.8 7.9 5.0 11.3 2.0 9.5 2.4 5.2 1.5 8.5 7.0 2.4 0.6 15.1 12.6 12.2 2.9 1.3 4.4 5.5 3.1 4.3 18.4 4.8 4.8 4.5 6.0 8.4 2.3 9.1 5.6 0.8 5.8 24.5 2.6 0.0 11.9 7.8 3.6 8.5 3.2 7.1 4.4 3.7 8.5 6.3 5.4 4.4 23.7 1.2 4.8 1.6 3.4 4.0 27.8 33.5 12.5 39.5 32.7 20.8 44.1 27.9 38.6 39.7 8.9 9.1 3.7 8.4 6.0 10.5 14.3 10.2 1.4 5.7 48.8 2.0 8.0 19.9 8.5 7.7 21.5 6.7 0.0 8.5 1.7 9.9 11.0 1.1 10.4 20.5 14.3 8.1 12.9 14.9 10.4 30.2 9.3 5.0 40.5 12.9 19.3 6.7 7.0 21.5 27.0 10.3 6.5 8.5 4.3 9.6 10.5 3.0 2.5 7.6 10.1 SLC6A12 BGT-1 ENSG00000111181 "Solute carrier family 6 member 12" P48065 12 190077-214570 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 22.1;liver: 59.3" "Cell type enhanced" "Detected in some" 18 "Collecting duct cells: 43.6;Hepatocytes: 17.4;monocytes: 17.2" "Cancer enhanced" "Detected in many" "renal cancer: 11.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 57 "classical monocyte: 6.6;intermediate monocyte: 6.4;myeloid DC: 2.9;neutrophil: 3.7;non-classical monocyte: 8.6" "Group enriched" "Detected in many" 51 "dendritic cells: 2.9;granulocytes: 3.7;monocytes: 8.6" "Cell line enhanced" "Detected in some" "Hep G2: 8.4;RPTEC TERT1: 17.0;SuSa: 3.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034973 Approved Approved Vesicles NA NA Vesicles "HPA034973: AB_10610427" "unprognostic (3.48e-1)" "unprognostic (4.73e-2)" "unprognostic (8.69e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (1.70e-1)" "unprognostic (1.09e-1)" "unprognostic (1.88e-2)" "unprognostic (8.30e-2)" "unprognostic (6.96e-3)" "unprognostic (2.70e-2)" "unprognostic (1.85e-2)" "unprognostic (3.68e-1)" "prognostic favorable (2.70e-6)" "unprognostic (2.30e-1)" "unprognostic (4.92e-4)" "unprognostic (3.35e-1)" "unprognostic (4.31e-4)" 0.6 0.8 6.3 1.3 12.9 0.6 0.8 6.6 14.7 0.9 1.0 4.3 0.0 3.7 1.3 5.6 0.5 3.0 1.2 0.7 7.2 4.6 22.1 59.3 2.2 0.8 8.1 4.9 0.7 1.3 0.6 0.3 0.9 9.4 0.6 1.8 0.2 0.6 0.5 0.5 0.7 1.1 1.2 3.1 0.8 2.3 1.6 8.8 0.0 4.5 0.0 0.7 0.9 0.2 0.0 2.9 3.7 8.6 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 1.0 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 8.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 17.0 0.1 0.0 0.5 0.0 0.0 0.1 3.7 0.3 0.5 0.0 0.0 0.6 0.0 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 6.6 0.0 0.0 6.4 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 3.7 0.0 8.6 0.0 0.0 1.9 6.3 12.9 6.6 14.7 7.2 4.6 8.1 4.9 9.4 8.8 0.0 0.3 0.9 0.0 0.1 0.0 0.4 0.0 0.0 0.0 43.6 0.0 0.0 1.7 0.0 3.6 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 17.4 2.4 0.0 0.0 1.3 0.3 3.4 0.6 1.8 0.0 17.2 1.2 6.3 0.0 0.0 0.0 6.8 0.2 6.5 0.0 0.5 1.7 0.4 0.7 0.0 0.8 0.0 SLC6A14 ENSG00000268104 "Solute carrier family 6 member 14" Q9UN76 X 116436622-116461458 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" Obesity "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5" "Cell type enhanced" "Detected in some" 15 "Alveolar cells type 2: 100.3;Club cells: 33.0;Exocrine glandular cells: 28.5;Pancreatic endocrine cells: 101.5" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 3.8;Hep G2: 8.2;OE19: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA003193 Uncertain Approved Vesicles NA NA Vesicles "HPA003193: AB_2190122" "unprognostic (3.06e-2)" "unprognostic (3.55e-2)" "unprognostic (8.49e-2)" "unprognostic (1.00e-3)" "unprognostic (1.30e-3)" "unprognostic (1.49e-2)" "unprognostic (7.41e-3)" "unprognostic (3.67e-3)" "unprognostic (2.66e-1)" "unprognostic (1.83e-2)" "prognostic unfavorable (9.74e-4)" "unprognostic (1.34e-2)" "unprognostic (3.89e-2)" "unprognostic (2.08e-2)" "unprognostic (1.71e-1)" "unprognostic (1.59e-1)" 0.0 0.0 0.0 1.5 0.0 0.0 5.9 0.0 0.0 6.3 0.8 0.0 11.8 0.4 0.1 0.0 1.8 0.0 1.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.2 0.5 0.3 0.0 26.3 5.8 0.0 1.1 0.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 23.5 1.2 1.0 1.0 0.4 0.2 1.1 0.4 0.3 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.1 0.0 0.1 0.0 0.0 3.8 8.2 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.2 0.0 0.5 0.0 0.5 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.2 0.0 1.4 0.5 0.0 0.0 0.1 0.0 1.1 0.4 0.5 0.4 0.1 0.3 0.4 0.2 0.2 0.1 0.4 0.3 0.3 0.4 0.3 0.2 0.2 0.1 0.0 20.8 100.3 0.0 0.1 0.1 0.0 0.2 0.0 10.7 33.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.2 0.0 28.5 0.0 0.0 5.2 3.5 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.1 0.0 101.5 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 1.0 3.2 SLC6A3 "DAT, DAT1" ENSG00000142319 "Solute carrier family 6 member 3" Q01959 5 1392790-1445430 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 48.4" "Cell type enriched" "Detected in single" 5 "Alveolar cells type 2: 2.9" "Cancer enriched" "Detected in some" 18 "renal cancer: 25.7" "Region enriched" "Detected in some" 47 "midbrain: 48.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "NTERA-2: 1.2;RPMI-8226: 2.1;SCLC-21H: 3.8" "Group enriched" "Detected in some" 8 "midbrain: 96.4;thalamus: 31.8" "Region enriched" "Detected in single" 138 "midbrain: 362.2" "HPA012763, HPA013602, CAB016249, CAB078172" Enhanced Supported Approved Vesicles NA NA Vesicles "CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484" "unprognostic (2.25e-4)" "unprognostic (2.22e-1)" "unprognostic (8.45e-2)" "unprognostic (5.24e-2)" "unprognostic (7.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.64e-5)" "unprognostic (9.31e-2)" "unprognostic (7.89e-2)" "unprognostic (4.81e-2)" "unprognostic (1.30e-1)" "unprognostic (2.12e-2)" "prognostic unfavorable (3.40e-7)" "unprognostic (6.98e-2)" "unprognostic (1.64e-1)" "unprognostic (2.22e-2)" "unprognostic (4.74e-2)" 0.2 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.7 0.0 0.0 0.0 0.3 1.1 0.8 0.1 0.8 0.6 0.1 0.0 0.6 0.3 0.0 3.4 0.0 48.4 0.0 1.5 0.0 0.0 0.0 0.1 1.0 0.7 0.0 1.7 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.8 0.0 2.4 2.2 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 0.0 0.1 3.8 0.0 0.0 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.6 48.4 0.0 1.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 SLC7A11 xCT ENSG00000151012 "Solute carrier family 7 member 11" Q9UPY5 4 138164097-138242349 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.2" "Cell type enhanced" "Detected in many" 13 "Glandular cells: 37.7;monocytes: 90.2;Muller glia cells: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 3.8" "Lineage enriched" "Detected in single" 8 "dendritic cells: 3.8" "Cell line enhanced" "Detected in many" "hTCEpi: 28.6;TIME: 31.4;WM-115: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064215 Approved Vesicles NA NA Vesicles "HPA064215: AB_2685213" "unprognostic (3.55e-3)" "unprognostic (4.64e-3)" "unprognostic (2.43e-2)" "unprognostic (7.18e-3)" "unprognostic (2.59e-1)" "unprognostic (8.80e-3)" "unprognostic (2.07e-8)" "unprognostic (1.98e-2)" "unprognostic (1.09e-2)" "prognostic favorable (1.77e-4)" "unprognostic (1.90e-2)" "unprognostic (4.07e-2)" "unprognostic (2.22e-8)" "unprognostic (3.81e-2)" "unprognostic (3.76e-2)" "unprognostic (2.29e-2)" "unprognostic (1.54e-2)" 1.1 0.9 16.3 4.7 15.8 2.2 1.5 8.2 26.0 2.4 2.0 17.9 0.0 1.5 1.3 13.4 3.3 8.9 3.8 2.5 17.4 6.9 0.9 0.9 2.3 1.5 12.6 16.8 1.7 5.4 1.0 1.2 2.1 17.2 2.0 2.8 0.3 1.6 1.0 0.8 1.9 1.4 1.0 27.2 1.4 9.2 2.2 14.0 0.0 8.9 6.0 2.2 4.0 0.8 0.1 3.8 0.4 0.0 0.1 0.0 0.0 1.6 13.8 6.2 4.8 1.3 1.7 1.7 7.6 5.3 1.7 4.0 1.5 5.8 3.1 10.0 26.5 9.4 2.2 3.3 6.5 7.4 5.9 0.7 2.2 13.1 3.4 20.6 5.8 2.1 4.1 28.6 4.9 22.1 2.6 21.6 3.2 3.0 8.2 9.1 1.2 0.8 0.5 1.2 8.1 3.9 0.9 2.0 3.6 1.0 6.6 2.5 0.5 3.3 0.9 11.7 1.4 1.5 12.4 31.4 2.3 6.5 3.4 6.0 6.9 3.1 3.2 3.9 3.2 46.1 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.0 3.8 0.0 0.0 16.3 15.8 8.2 15.9 17.4 6.9 12.6 16.8 17.2 14.0 0.0 5.9 3.7 7.0 4.0 4.0 3.6 2.5 1.4 3.4 0.0 2.0 2.2 0.0 3.6 2.1 1.6 1.1 0.0 21.4 0.5 1.0 37.7 4.6 0.4 0.5 1.6 25.9 3.7 0.0 0.4 2.3 9.0 5.0 90.2 5.4 48.4 27.4 1.1 2.1 0.0 1.9 0.0 1.0 0.7 0.7 2.8 0.9 0.0 1.3 11.1 SLC9A6 "KIAA0267, NHE6" ENSG00000198689 "Solute carrier family 9 member A6" Q92581 X 135973841-136047269 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 35.1" "Cell type enhanced" "Detected in many" 7 "Horizontal cells: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059445, HPA059590" Enhanced Supported Vesicles NA NA Vesicles "HPA059445: AB_2684021, HPA059590: AB_2684075" "unprognostic (1.35e-1)" "unprognostic (8.28e-3)" "unprognostic (4.36e-1)" "unprognostic (4.93e-2)" "unprognostic (1.84e-1)" "unprognostic (1.19e-1)" "unprognostic (2.60e-2)" "unprognostic (1.57e-1)" "unprognostic (1.15e-1)" "unprognostic (2.72e-2)" "unprognostic (7.43e-2)" "unprognostic (1.29e-1)" "unprognostic (7.07e-2)" "unprognostic (5.30e-2)" "unprognostic (1.75e-1)" "unprognostic (4.49e-2)" "unprognostic (5.06e-2)" 4.3 5.7 16.4 4.7 27.6 4.0 3.1 15.3 35.1 5.2 5.2 7.8 1.6 7.5 5.7 3.2 5.6 5.2 4.8 7.2 19.1 24.3 6.2 3.9 5.7 4.7 15.0 15.6 7.4 3.3 9.3 8.6 4.0 22.3 3.6 5.5 4.6 3.3 4.6 5.5 4.1 6.5 6.5 9.5 4.8 5.2 5.1 4.0 3.6 5.9 1.7 5.8 4.7 3.2 5.3 6.8 3.2 8.4 5.9 13.9 6.0 13.2 7.0 7.4 2.7 10.5 10.2 13.3 10.7 11.5 9.2 19.5 6.1 10.6 9.9 24.4 12.3 13.7 7.9 9.6 9.6 13.4 7.7 8.7 2.7 11.2 3.6 5.5 7.7 9.4 5.6 8.5 15.2 7.5 6.6 7.8 9.7 4.9 14.1 10.1 5.8 10.2 2.2 4.2 4.9 9.5 6.9 11.0 10.0 6.6 6.6 6.6 5.0 7.7 0.8 6.2 6.6 3.2 6.0 11.1 11.5 8.2 17.0 13.7 6.8 15.1 8.7 7.0 13.2 6.4 2.2 6.0 3.2 8.1 8.4 13.9 5.3 9.5 7.9 6.8 4.0 10.6 7.9 2.6 5.9 6.6 4.3 8.0 6.0 16.4 27.6 15.3 25.9 19.1 24.3 15.0 15.6 22.3 4.0 3.0 4.8 4.2 1.3 6.6 13.4 8.1 17.8 0.0 1.2 12.2 7.9 2.2 0.0 4.0 0.6 4.6 8.0 0.0 5.1 2.1 4.7 2.1 1.1 7.8 8.9 46.1 10.3 8.6 12.9 0.9 5.2 8.8 8.5 2.8 3.4 13.2 4.6 5.8 4.2 4.9 7.0 0.0 4.9 5.0 12.3 5.9 2.4 7.7 5.0 2.2 SLC9A7 NHE7 ENSG00000065923 "Solute carrier family 9 member A7" Q96T83 X 46599252-46759172 "Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Potassium transport, Sodium transport, Transport" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 42.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 42.0" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048938, HPA075385" Approved Supported Vesicles NA NA Vesicles "HPA048938: AB_2680565, HPA075385: AB_2686747" "unprognostic (2.77e-1)" "unprognostic (4.68e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.58e-4)" "prognostic unfavorable (8.14e-4)" "unprognostic (2.16e-2)" "unprognostic (2.73e-3)" "unprognostic (5.26e-3)" "unprognostic (1.28e-2)" "unprognostic (9.25e-2)" "unprognostic (5.30e-2)" "unprognostic (1.11e-1)" "unprognostic (2.08e-1)" "unprognostic (7.20e-2)" "unprognostic (2.62e-1)" "unprognostic (1.57e-1)" "unprognostic (1.13e-1)" 1.7 7.2 4.4 3.8 42.0 4.4 7.9 7.0 12.4 1.8 1.2 1.8 1.2 1.7 1.2 3.8 3.2 2.5 2.2 2.3 3.3 7.1 3.3 4.1 1.8 7.8 3.6 4.3 6.3 4.6 11.5 13.6 1.4 12.7 6.5 1.3 2.3 7.3 2.9 10.0 2.9 2.7 1.0 2.7 4.7 8.2 1.3 8.2 2.8 6.9 1.7 8.2 2.3 2.2 4.3 6.0 2.1 0.6 1.4 0.7 0.5 7.0 5.4 0.8 2.4 0.9 5.4 3.1 6.7 8.4 4.0 3.3 5.5 7.7 15.5 2.1 10.7 7.9 3.3 5.2 7.6 7.4 8.1 2.8 1.6 2.1 2.2 3.3 0.7 12.8 3.4 1.0 11.4 7.6 19.2 5.7 5.4 0.1 0.3 5.5 10.6 1.7 0.8 3.7 3.4 6.5 6.9 0.3 0.2 3.1 7.9 5.8 0.7 3.4 5.2 1.5 6.8 6.9 0.3 0.3 8.7 2.9 1.3 3.9 1.6 0.4 7.8 12.3 0.1 2.8 1.0 0.6 0.3 0.6 0.6 0.4 3.4 0.7 0.3 2.4 4.3 0.4 0.5 2.1 1.4 0.6 6.0 0.7 0.5 4.4 42.0 7.0 8.3 3.3 7.1 3.6 4.3 12.7 8.2 3.0 8.0 17.9 7.5 0.6 10.1 4.5 2.5 0.0 3.4 15.7 3.9 5.5 0.0 15.3 0.0 0.5 0.0 0.0 12.2 0.3 0.4 18.2 0.0 4.9 6.6 12.7 2.4 0.6 4.7 0.4 0.9 9.1 1.7 9.0 1.0 6.6 12.5 0.0 0.4 1.7 3.4 6.5 0.8 0.0 0.9 0.9 6.1 0.5 0.8 11.2 SMIM17 ENSG00000268182 "Small integral membrane protein 17" P0DL12 19 56643145-56655766 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enriched" "Detected in many" 6 "brain: 26.5" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.4" "Lineage enhanced" "Detected in single" "dendritic cells: 1.4" "Cell line enhanced" "Detected in some" "AF22: 5.4;HEK 293: 5.3;RH-30: 4.2;SCLC-21H: 4.9" "HPA071857, HPA071861" Enhanced Approved Vesicles NA NA Vesicles "HPA071857: AB_2686461, HPA071861: AB_2686462" "unprognostic (1.32e-1)" "unprognostic (2.82e-1)" "unprognostic (1.24e-1)" "unprognostic (5.67e-3)" "unprognostic (1.62e-1)" "unprognostic (4.57e-2)" "unprognostic (5.84e-2)" "unprognostic (3.00e-2)" "unprognostic (2.51e-1)" "unprognostic (6.50e-2)" "unprognostic (4.64e-2)" "unprognostic (9.02e-3)" "unprognostic (3.46e-3)" "unprognostic (6.26e-2)" "unprognostic (1.01e-1)" "unprognostic (3.71e-3)" "unprognostic (7.51e-3)" 1.8 1.2 7.0 0.6 10.4 0.8 2.4 4.5 17.3 0.9 1.1 0.9 0.0 1.0 2.2 4.8 1.2 1.5 1.0 1.7 6.0 13.8 1.3 0.8 1.3 0.7 5.9 7.7 1.8 1.2 0.5 2.2 1.1 26.5 1.7 1.2 0.4 1.3 2.6 1.1 1.9 0.7 1.4 2.7 1.0 0.7 1.6 0.1 0.0 1.1 0.0 0.8 0.5 0.5 0.0 1.4 0.0 0.4 0.0 0.0 0.1 0.3 0.0 5.4 1.5 1.2 0.9 1.1 0.7 0.6 1.3 0.3 0.0 0.2 0.4 0.8 0.3 0.5 0.3 0.1 0.4 0.7 0.0 5.3 3.1 0.6 0.8 0.8 2.5 0.4 1.7 0.7 0.0 1.5 1.1 0.5 2.9 0.1 0.0 1.1 0.0 2.8 0.4 0.0 0.0 0.6 1.5 4.2 0.1 0.7 0.0 4.9 1.0 1.3 0.1 0.8 0.9 0.0 0.8 0.8 1.9 0.2 0.5 0.5 0.3 0.8 1.3 0.6 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 7.0 10.4 4.5 17.3 6.0 13.8 5.9 7.7 26.5 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SMIM3 "C5orf62, MSTP150, NID67" ENSG00000256235 "Small integral membrane protein 3" Q9BZL3 5 150777946-150796734 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adipose tissue: 24.4;blood: 22.3;bone marrow: 11.4;pancreas: 45.7" "Cell type enhanced" "Detected in many" 8 "granulocytes: 87.8;Sertoli cells: 135.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 64.2;ASC TERT1: 31.4;LHCN-M2: 29.1;U-87 MG: 47.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075345 Approved Vesicles NA NA Vesicles "HPA075345: AB_2686744" "unprognostic (2.33e-1)" "unprognostic (4.05e-2)" "unprognostic (1.35e-2)" "unprognostic (2.70e-2)" "unprognostic (9.45e-2)" "unprognostic (5.65e-2)" "unprognostic (4.57e-3)" "unprognostic (1.47e-1)" "unprognostic (3.90e-1)" "unprognostic (2.05e-2)" "unprognostic (9.71e-3)" "unprognostic (3.46e-3)" "prognostic unfavorable (1.15e-8)" "unprognostic (3.87e-3)" "unprognostic (1.31e-2)" "unprognostic (2.16e-1)" "unprognostic (1.46e-3)" 24.4 5.4 6.1 3.3 5.6 11.4 3.9 3.3 6.2 2.2 3.1 1.8 0.7 1.3 3.0 2.9 2.2 3.0 3.3 3.4 2.6 1.2 2.9 1.1 3.6 0.7 3.0 1.0 3.2 45.7 1.2 1.8 6.4 6.2 3.2 2.3 1.3 1.8 3.3 2.5 2.2 3.9 3.7 2.6 1.9 2.9 1.7 4.3 1.8 2.7 0.7 0.7 3.8 1.8 0.3 18.4 22.3 13.3 3.6 7.2 11.6 2.0 0.6 1.1 9.4 64.2 31.4 2.4 8.0 17.2 2.9 11.9 3.1 5.4 0.0 0.4 8.2 2.0 1.6 1.8 1.7 4.4 0.0 0.5 2.9 0.4 1.4 11.4 2.9 21.2 26.3 3.6 8.3 3.8 19.3 0.9 7.2 0.8 0.0 29.1 1.5 4.1 4.0 0.5 1.6 1.9 2.3 0.1 0.0 3.1 1.5 0.2 0.7 1.1 0.1 2.3 1.3 3.9 18.1 1.5 13.2 2.4 10.3 4.1 0.0 0.0 0.0 47.7 11.1 1.6 17.9 13.3 22.3 7.2 5.3 4.3 0.3 5.1 4.9 6.2 0.0 5.0 4.3 13.9 3.6 4.8 18.4 0.7 11.6 6.1 5.6 3.3 6.2 2.6 1.2 3.0 1.0 6.2 4.3 6.0 10.4 0.5 56.6 0.0 0.7 6.6 10.2 0.0 4.5 7.0 0.0 7.7 11.6 6.6 0.6 6.7 2.3 0.0 28.1 4.8 19.3 11.1 87.8 0.4 39.0 0.0 4.6 12.9 26.7 0.6 13.0 15.3 0.0 34.3 34.3 42.1 14.9 0.0 34.6 7.1 0.7 135.8 63.1 0.0 0.5 0.0 6.8 10.2 6.2 43.2 SMIM8 "C6orf162, dJ102H19.2, DKFZP586E1923" ENSG00000111850 "Small integral membrane protein 8" Q96KF7 6 87322583-87399749 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007401, HPA067453" Approved Approved Vesicles NA NA Vesicles "HPA007401: AB_1078357, HPA067453: AB_2685844" "unprognostic (2.54e-1)" "unprognostic (5.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.90e-1)" "unprognostic (1.56e-2)" "unprognostic (3.16e-2)" "unprognostic (3.09e-2)" "unprognostic (6.17e-2)" "unprognostic (5.31e-2)" "unprognostic (6.12e-3)" "unprognostic (1.86e-5)" "unprognostic (1.98e-1)" "unprognostic (1.34e-1)" "unprognostic (2.01e-1)" "unprognostic (3.06e-2)" "unprognostic (2.86e-2)" "unprognostic (4.01e-1)" 7.8 9.0 13.3 6.3 14.6 9.0 9.1 15.6 15.6 7.4 8.3 7.6 8.5 8.8 11.4 12.2 6.5 7.1 4.7 10.3 17.9 12.5 10.4 12.0 5.6 9.1 12.0 10.8 10.5 8.0 6.1 19.2 5.8 11.9 7.9 8.1 7.8 7.2 7.3 16.2 5.4 7.9 11.3 10.2 6.5 6.3 7.4 8.0 11.0 7.5 4.7 6.5 6.5 8.7 16.0 8.9 13.4 8.4 7.7 18.7 8.5 4.3 3.9 8.0 13.8 4.7 5.3 3.5 4.9 3.8 4.2 8.0 2.7 4.1 9.0 5.9 4.9 7.2 5.5 6.3 3.7 8.0 8.0 6.9 13.1 4.4 5.3 4.4 13.6 4.8 5.0 5.1 4.2 4.5 4.7 5.9 11.6 14.7 15.2 4.6 3.3 8.2 10.9 4.9 6.5 6.0 13.2 11.9 5.1 5.3 4.3 13.7 5.7 7.2 4.3 7.8 7.7 3.9 13.8 5.7 2.2 6.3 9.3 4.7 6.8 11.0 5.9 7.1 6.6 6.5 5.2 8.1 13.1 10.7 7.7 10.6 16.0 12.6 12.8 8.9 10.4 18.7 16.2 13.4 7.7 8.4 7.5 15.5 8.5 13.3 14.6 15.6 15.6 17.9 12.5 12.0 10.8 11.9 8.0 11.9 4.3 15.9 17.9 12.2 25.0 38.9 12.7 13.4 12.5 22.7 35.3 14.8 38.1 8.8 15.3 13.4 7.7 0.0 9.1 10.5 15.1 10.1 4.7 12.1 12.7 35.0 8.2 19.0 14.6 12.1 14.7 12.8 8.5 10.8 9.5 23.3 6.9 14.0 19.4 18.3 23.0 25.8 12.5 18.9 21.6 12.9 12.5 13.1 17.6 10.7 SMU1 "BWD, FLJ10805, fSAP57, SMU-1" ENSG00000122692 "SMU1, DNA replication regulator and spliceosomal factor" Q2TAY7 9 33041764-33076659 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019708 Supported Approved Vesicles NA NA 16000 Vesicles "HPA019708: AB_1857300" "unprognostic (2.20e-2)" "prognostic favorable (2.66e-4)" "unprognostic (1.17e-1)" "unprognostic (1.58e-1)" "unprognostic (1.80e-2)" "unprognostic (8.44e-2)" "unprognostic (2.59e-3)" "unprognostic (5.06e-2)" "unprognostic (3.04e-2)" "prognostic favorable (1.25e-4)" "unprognostic (4.98e-3)" "unprognostic (3.15e-1)" "prognostic favorable (1.67e-5)" "unprognostic (1.09e-2)" "unprognostic (7.04e-2)" "unprognostic (8.71e-2)" "unprognostic (5.96e-2)" 25.0 20.0 21.7 17.0 22.2 23.3 20.7 29.6 24.5 22.2 18.0 28.3 17.4 14.5 28.3 21.2 18.1 20.6 15.0 17.1 21.3 21.2 19.5 21.9 17.0 19.7 22.1 18.1 26.3 18.7 30.3 26.6 18.2 24.2 21.1 19.1 20.2 20.5 21.0 22.9 21.9 19.6 23.6 23.5 21.0 16.9 16.0 19.5 31.1 24.1 16.5 24.6 20.8 17.7 14.4 21.2 20.7 17.5 12.9 16.5 10.4 16.0 12.7 15.3 13.3 16.7 12.8 12.0 12.6 11.4 17.3 17.2 12.9 6.8 20.4 9.3 15.6 9.4 9.9 19.6 15.1 19.3 23.3 9.4 15.3 22.0 15.0 14.5 26.4 14.5 13.3 17.3 15.9 11.4 13.0 14.4 14.3 14.1 13.1 14.4 7.4 20.6 28.3 21.1 12.1 13.6 17.7 12.7 11.0 13.1 12.1 13.1 11.4 17.0 12.3 7.9 12.5 11.9 9.7 15.4 11.1 12.4 16.1 14.6 5.9 10.8 24.1 12.4 12.5 7.9 20.7 14.9 11.6 14.1 16.0 15.0 14.4 16.0 13.2 16.6 13.7 16.3 16.5 8.7 12.9 17.5 21.2 13.2 10.4 21.7 22.2 29.6 24.5 21.3 21.2 22.1 18.1 24.2 19.5 23.8 28.9 28.1 39.6 47.7 26.6 25.4 28.1 54.9 39.8 19.2 35.3 29.5 18.3 29.2 19.4 33.7 15.9 0.0 21.2 30.4 26.9 27.7 37.1 26.6 27.4 22.3 27.0 23.4 26.4 4.7 30.0 32.1 21.9 31.5 18.7 36.8 23.2 18.4 24.4 25.3 37.1 19.4 32.4 27.7 31.8 50.3 48.3 29.4 20.4 33.1 SNX16 ENSG00000104497 "Sorting nexin 16" P57768 8 81799581-81842866 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 68.5;Horizontal cells: 52.4;Late spermatids: 97.8;Spermatocytes: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024730, HPA024731, HPA024817" Approved Supported Vesicles NA NA Vesicles "HPA024730: AB_10600220, HPA024731: AB_1857346, HPA024817: AB_10602313" "unprognostic (5.50e-2)" "unprognostic (3.20e-2)" "unprognostic (1.40e-1)" "unprognostic (8.41e-3)" "unprognostic (3.21e-3)" "unprognostic (7.54e-3)" "unprognostic (1.24e-3)" "unprognostic (1.33e-1)" "unprognostic (2.12e-1)" "unprognostic (2.18e-1)" "unprognostic (3.94e-2)" "unprognostic (1.43e-1)" "unprognostic (5.73e-3)" "unprognostic (7.60e-3)" "unprognostic (2.30e-1)" "unprognostic (1.35e-1)" "unprognostic (3.65e-1)" 11.7 5.9 6.6 5.8 10.0 9.5 16.2 13.1 14.8 13.7 9.8 3.0 4.2 6.9 10.7 8.1 18.8 7.2 11.9 8.3 7.3 9.6 14.8 7.6 12.1 6.2 11.2 11.4 10.8 4.9 7.9 12.1 5.7 10.2 13.2 7.3 3.8 8.8 8.6 6.6 11.7 11.8 11.7 11.4 17.1 9.4 15.6 8.7 15.3 18.7 7.5 6.5 10.0 15.9 4.5 5.0 11.6 6.1 3.2 6.5 2.6 8.3 2.8 4.3 4.1 14.5 9.3 5.1 10.6 13.4 9.3 13.9 2.1 6.8 1.4 6.1 7.4 11.3 7.3 3.8 4.7 15.1 10.9 2.1 4.4 3.6 4.2 11.2 1.8 7.9 7.1 8.0 4.2 8.5 10.9 7.6 5.3 2.7 16.5 22.9 4.9 9.3 3.4 1.6 8.5 4.2 3.9 6.1 1.5 9.4 4.2 6.9 5.6 2.0 2.8 5.5 7.7 7.4 3.7 4.3 13.0 9.6 9.3 4.8 10.1 7.5 3.5 5.6 5.7 10.4 11.6 6.1 7.1 2.9 3.8 2.7 2.3 3.7 2.4 5.0 4.5 4.3 3.8 8.3 3.2 3.1 4.0 6.5 2.6 6.6 10.0 13.1 14.8 7.3 9.6 11.2 11.4 10.2 8.7 6.0 6.5 2.7 10.9 22.3 4.0 7.0 5.1 12.0 11.4 5.2 3.9 1.6 5.0 5.2 68.5 9.0 4.2 0.0 5.4 3.2 6.7 11.0 8.1 2.9 5.2 52.4 2.9 12.9 8.5 97.8 21.6 8.4 3.3 1.0 5.0 4.5 5.8 5.7 15.2 5.6 5.0 19.4 10.3 55.1 10.9 28.0 8.2 5.3 4.6 18.2 SNX24 SBBI31 ENSG00000064652 "Sorting nexin 24" Q9Y343 5 122843439-123029354 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 70.2;Late spermatids: 69.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044566, HPA073934" Approved Approved Vesicles NA NA Vesicles "HPA044566: AB_10797034, HPA073934: AB_2686644" "unprognostic (2.63e-1)" "unprognostic (2.50e-1)" "unprognostic (2.73e-1)" "prognostic unfavorable (7.93e-6)" "unprognostic (2.31e-2)" "unprognostic (1.73e-1)" "prognostic unfavorable (8.88e-4)" "unprognostic (1.37e-1)" "unprognostic (1.61e-1)" "unprognostic (3.42e-1)" "unprognostic (5.77e-2)" "unprognostic (3.69e-2)" "prognostic favorable (1.28e-4)" "unprognostic (2.03e-1)" "unprognostic (1.10e-1)" "unprognostic (6.94e-2)" "unprognostic (1.50e-2)" 6.7 7.2 10.7 5.2 13.8 3.3 6.5 6.2 14.9 7.3 9.0 20.4 5.9 12.6 9.5 10.4 31.2 6.5 8.9 9.7 11.5 11.1 17.1 11.4 14.2 4.6 25.1 8.9 5.9 8.9 20.9 15.8 24.2 19.7 5.5 10.7 8.2 11.0 5.8 7.2 13.5 14.5 9.5 38.3 6.4 13.1 6.9 16.4 1.0 15.4 12.9 8.2 8.1 11.3 0.7 1.3 0.1 5.9 2.5 2.5 1.2 13.1 6.1 9.6 6.5 3.6 9.4 19.7 11.8 11.1 13.8 17.8 8.3 12.4 0.0 10.1 11.6 13.5 2.7 6.1 15.0 21.0 7.2 3.7 1.9 5.6 11.8 18.2 0.1 2.3 7.8 22.3 6.9 26.9 11.9 6.7 2.2 2.4 11.1 10.3 11.7 0.3 0.4 3.9 2.4 3.7 1.6 15.4 6.7 19.8 8.1 5.9 7.0 11.2 8.3 12.4 13.0 14.9 4.2 5.5 14.9 11.6 5.8 18.8 3.9 5.1 1.9 12.6 0.2 30.2 0.0 2.8 0.0 1.2 5.4 0.7 0.7 1.3 1.0 1.3 0.6 0.5 0.3 0.1 2.5 5.9 0.3 2.5 1.2 10.7 13.8 6.2 14.9 11.5 11.1 25.1 8.9 19.7 16.4 41.7 21.1 0.0 6.8 9.3 15.5 13.0 17.8 9.4 1.2 19.2 5.9 40.1 29.9 12.8 70.2 6.0 22.2 0.0 10.3 47.6 9.4 7.1 0.0 10.4 57.5 11.1 1.2 8.0 37.6 69.6 8.3 11.0 3.3 18.0 6.0 9.6 16.8 2.9 8.9 30.6 16.5 12.9 6.6 4.4 7.5 14.6 33.2 2.9 6.9 8.0 SNX25 SBBI31 ENSG00000109762 "Sorting nexin 25" Q9H3E2 4 185204237-185370185 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Alveolar cells type 2: 113.6" "Low cancer specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 3.6" "Group enriched" "Detected in many" 4 "B-cells: 3.6;T-cells: 1.5" "Cell line enhanced" "Detected in many" "HDLM-2: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036928 Supported Vesicles NA NA Vesicles "HPA036928: AB_10669720" "unprognostic (9.20e-2)" "unprognostic (1.31e-1)" "unprognostic (2.26e-1)" "unprognostic (4.29e-3)" "unprognostic (8.89e-2)" "unprognostic (5.63e-2)" "unprognostic (1.43e-2)" "unprognostic (6.41e-2)" "unprognostic (5.35e-2)" "unprognostic (2.99e-2)" "unprognostic (4.03e-3)" "unprognostic (1.87e-1)" "unprognostic (3.33e-1)" "unprognostic (1.13e-1)" "unprognostic (1.57e-1)" "unprognostic (1.32e-2)" "unprognostic (8.55e-3)" 3.0 3.7 2.6 2.9 5.3 0.1 4.6 11.9 4.2 2.7 5.6 1.1 3.3 2.8 3.1 4.7 3.9 4.4 3.3 5.6 5.6 4.1 15.1 4.9 4.6 3.4 4.6 7.2 5.7 5.6 7.9 3.0 2.8 4.3 4.8 2.5 3.5 3.1 2.1 4.2 2.6 5.9 8.5 6.0 3.8 2.2 3.6 0.2 0.0 0.2 0.6 1.5 0.2 5.8 3.1 3.9 5.6 10.6 7.9 5.9 18.0 8.6 9.1 7.6 2.6 4.1 16.8 2.0 12.8 6.3 2.3 4.5 3.9 10.3 27.8 7.5 2.8 3.8 6.1 6.2 1.9 4.1 5.4 4.3 7.9 4.4 18.4 7.9 3.1 5.9 16.9 12.0 1.7 0.7 3.3 3.2 0.8 3.0 2.4 4.5 4.2 22.1 2.2 8.5 6.2 3.7 1.0 14.7 5.9 2.1 2.4 15.2 5.2 3.4 5.0 7.8 15.3 6.2 3.6 8.6 1.4 6.5 0.0 0.0 0.0 0.6 0.2 1.0 2.5 1.3 1.5 0.0 3.6 0.4 0.9 0.0 0.6 0.0 0.2 0.8 0.2 23.8 113.6 3.7 3.4 4.2 14.7 6.0 0.0 6.7 10.3 5.2 29.5 3.4 0.0 5.2 5.6 8.9 4.5 0.0 2.2 4.0 3.3 8.0 1.1 7.3 1.6 6.4 0.0 9.2 3.5 3.4 8.9 2.2 20.3 1.0 4.7 5.8 3.5 0.0 9.2 2.1 15.9 0.0 5.1 3.7 17.6 5.4 4.7 5.0 2.4 3.8 SNX8 Mvp1 ENSG00000106266 "Sorting nexin 8" Q9Y5X2 7 2251770-2354318 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 87.3;Late spermatids: 250.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 42.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057296, HPA060194" Approved Supported Vesicles NA NA Vesicles "HPA057296: AB_2683401, HPA060194: AB_2684219" "unprognostic (2.22e-2)" "unprognostic (3.38e-1)" "unprognostic (9.85e-3)" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (9.32e-2)" "prognostic unfavorable (8.47e-6)" "unprognostic (5.23e-2)" "unprognostic (1.91e-3)" "unprognostic (1.54e-2)" "unprognostic (3.06e-1)" "unprognostic (6.01e-2)" "unprognostic (1.54e-1)" "unprognostic (5.10e-2)" "unprognostic (4.83e-2)" "unprognostic (1.12e-2)" "unprognostic (1.35e-1)" 14.3 7.3 11.7 13.9 12.8 10.1 15.6 11.1 14.2 6.8 8.4 11.4 4.8 11.7 7.3 9.9 11.3 7.7 11.0 14.0 12.0 9.6 8.2 9.1 10.7 24.1 12.7 9.6 9.1 10.8 4.7 7.9 15.4 10.9 4.7 7.8 12.9 8.5 3.9 9.9 9.9 9.6 6.5 17.0 33.1 7.7 20.5 12.5 4.9 9.5 6.9 18.9 9.5 8.5 18.2 13.1 4.5 10.2 1.2 2.0 4.8 15.9 15.6 6.4 8.9 9.0 8.8 15.2 7.8 11.6 13.2 16.4 11.0 12.5 9.3 3.2 9.2 42.0 4.3 5.5 4.2 6.7 2.3 5.2 5.2 6.3 9.0 22.9 5.0 8.6 17.5 5.0 16.1 6.3 3.6 4.9 7.4 10.2 11.0 10.7 10.4 1.7 5.3 11.6 8.9 7.8 8.2 13.3 4.2 3.1 7.5 3.1 8.2 7.1 19.6 11.1 7.4 14.6 10.9 7.4 11.1 29.7 18.2 10.1 7.2 8.8 8.6 11.0 6.8 30.0 4.5 9.4 3.0 1.8 10.2 1.4 15.5 1.4 1.9 13.1 18.2 1.4 1.6 1.6 1.2 9.6 3.4 2.0 4.8 11.7 12.8 11.1 14.2 12.0 9.6 12.7 9.6 10.9 12.5 6.0 10.3 18.0 6.1 4.6 10.0 9.2 10.2 1.4 0.0 3.5 7.9 14.2 11.6 12.1 87.3 8.4 9.1 0.0 26.0 13.0 10.4 5.5 11.6 6.4 65.1 20.6 5.8 61.4 32.7 250.8 11.2 46.6 13.5 65.9 9.6 6.1 20.3 8.6 12.4 11.5 11.6 0.0 2.8 10.4 27.9 5.4 36.3 5.3 8.0 8.2 SOHLH2 "bHLHe81, FLJ20449, SPATA28, TEB1" ENSG00000120669 "Spermatogenesis and oogenesis specific basic helix-loop-helix 2" Q9NX45 13 36168208-36214615 "Predicted intracellular proteins, Transcription factors" "Differentiation, Oogenesis, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 23.6" "Group enriched" "Detected in some" 8 "Early spermatids: 52.6;Extravillous trophoblasts: 15.9;Late spermatids: 58.0;Spermatocytes: 19.1;Spermatogonia: 40.2" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 7.2;HL-60: 9.5;Karpas-707: 10.9;NB-4: 13.9;U-266/84: 13.9" HPA029182 Uncertain Vesicles NA NA Vesicles "HPA029182: AB_10602409" "unprognostic (1.00e-1)" "unprognostic (1.65e-1)" "unprognostic (1.99e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-2)" "unprognostic (3.01e-2)" "unprognostic (2.95e-1)" "unprognostic (7.88e-2)" "unprognostic (2.12e-1)" "unprognostic (1.39e-1)" "unprognostic (5.53e-3)" "unprognostic (2.10e-1)" "unprognostic (8.56e-2)" "unprognostic (7.44e-2)" "unprognostic (5.93e-2)" 0.3 0.3 0.9 0.3 2.1 0.5 0.4 0.3 3.5 0.3 1.8 0.3 0.3 0.2 0.3 2.0 0.3 0.2 0.3 0.9 1.2 1.2 0.6 0.3 0.3 0.3 1.2 0.3 0.3 0.3 0.2 0.3 3.5 0.3 1.8 0.0 0.3 0.3 1.2 0.4 0.2 0.3 0.4 0.6 0.3 0.1 23.6 0.3 0.3 0.4 0.3 0.3 1.3 0.3 1.0 0.3 0.5 0.3 0.0 0.5 0.0 7.2 0.2 0.8 0.0 0.6 1.2 4.3 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.1 0.0 0.1 1.6 0.0 0.0 0.1 9.5 0.0 2.1 0.6 0.0 0.0 0.4 0.9 0.2 0.4 10.9 2.2 0.1 0.0 13.9 0.2 0.0 0.0 0.2 0.2 0.8 1.0 0.7 0.1 1.3 0.0 0.0 0.0 2.7 0.1 0.6 0.0 0.0 0.8 0.5 0.5 1.4 13.9 0.2 0.8 5.1 0.5 0.0 0.3 0.5 0.2 0.0 0.1 0.1 0.1 0.1 0.0 1.0 0.2 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.9 2.1 0.3 3.5 1.2 1.2 1.2 0.3 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 52.6 0.0 0.0 0.0 0.0 15.9 0.3 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 58.0 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 1.1 0.3 0.0 0.0 19.1 40.2 0.1 2.9 0.0 0.0 0.1 SPA17 "CT22, SP17" ENSG00000064199 "Sperm autoantigenic protein 17" Q15506 11 124673798-124697518 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 28.2;testis: 82.1" "Cell type enhanced" "Detected in many" 22 "Ciliated cells: 459.0;Early spermatids: 1302.0;Late spermatids: 1861.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 40.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA037568 Enhanced Approved Vesicles NA NA Vesicles "HPA037568: AB_10672905" "unprognostic (1.41e-2)" "unprognostic (3.49e-1)" "unprognostic (2.39e-3)" "prognostic favorable (1.03e-4)" "unprognostic (2.85e-1)" "unprognostic (1.56e-1)" "unprognostic (1.01e-4)" "unprognostic (2.64e-1)" "unprognostic (3.80e-2)" "unprognostic (4.56e-2)" "unprognostic (6.47e-2)" "unprognostic (8.54e-2)" "unprognostic (1.71e-3)" "unprognostic (6.78e-2)" "unprognostic (9.78e-3)" "unprognostic (8.52e-2)" "unprognostic (2.71e-1)" 1.3 2.2 5.6 1.3 6.0 2.3 3.5 1.0 5.8 3.5 3.5 4.3 2.8 1.9 2.7 13.7 2.1 28.2 2.8 2.0 5.6 6.8 5.9 1.1 4.5 1.3 3.9 4.3 3.2 1.8 4.4 8.1 1.4 20.1 2.2 3.9 0.8 1.6 2.7 0.7 1.3 1.6 1.9 3.6 1.0 2.2 82.1 2.7 2.6 7.6 1.6 1.7 1.8 1.3 0.5 3.7 4.2 6.0 0.4 1.3 1.8 11.6 8.7 20.0 8.3 6.4 9.6 10.4 8.6 13.1 8.8 7.5 2.8 24.6 5.3 5.8 12.3 10.1 8.3 8.3 14.6 13.9 5.7 6.0 8.3 1.6 5.3 4.6 1.8 3.6 3.9 7.8 15.7 8.1 7.9 8.8 10.9 11.6 4.8 19.6 10.1 1.2 0.4 9.2 14.7 8.3 6.8 3.1 0.0 21.0 5.4 13.3 8.9 19.1 6.4 5.3 10.0 40.0 8.7 8.5 10.2 9.3 4.9 10.9 2.1 1.7 3.3 8.9 1.7 10.8 4.2 4.5 0.8 0.7 3.5 0.6 0.4 1.3 0.8 3.7 0.5 1.1 0.8 0.2 0.4 6.0 1.7 1.2 1.8 5.6 6.0 1.0 5.8 5.6 6.8 3.9 4.3 20.1 2.7 3.0 9.3 0.0 4.4 2.4 2.6 1.9 15.3 459.0 71.7 19.2 3.9 5.3 16.6 24.9 1302.0 4.5 10.5 0.0 13.6 8.5 3.0 3.1 0.0 1.1 10.2 0.0 6.9 2.5 4.0 1861.1 25.9 7.1 1.7 1.8 7.9 8.2 12.0 10.5 17.0 38.2 0.9 12.9 3.4 239.9 61.1 1.9 2.3 1.8 9.4 5.1 SPARC ON ENSG00000113140 "Secreted protein acidic and cysteine rich" P09486 5 151661096-151687165 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Fibroblasts: 896.1;Ito cells: 958.1;Peritubular cells: 1044.4;Sertoli cells: 2315.4;Smooth muscle cells: 1190.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 9.3" "Group enriched" "Detected in many" 7 "granulocytes: 9.3;monocytes: 3.0" "Cell line enhanced" "Detected in many" "ASC diff: 234.0;BJ: 191.0;fHDF/TERT166: 302.0;WM-115: 222.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002306, HPA002989, HPA003020" Supported Approved Vesicles "Secreted to blood" NA NA 190000000 Vesicles "CAB002306: AB_563919, HPA002989: AB_1079532, HPA003020: AB_1079531" "unprognostic (3.34e-2)" "unprognostic (8.57e-2)" "unprognostic (1.31e-1)" "unprognostic (3.97e-1)" "unprognostic (7.01e-2)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (8.36e-3)" "unprognostic (5.27e-2)" "unprognostic (1.22e-1)" "unprognostic (4.09e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (3.53e-5)" "unprognostic (2.59e-3)" "unprognostic (1.17e-2)" "unprognostic (3.53e-1)" "unprognostic (4.93e-3)" 178.3 58.3 50.2 47.4 93.3 3.4 68.6 33.8 131.3 115.6 42.8 92.3 22.9 13.2 89.0 65.9 36.9 38.5 177.8 65.5 68.3 100.3 46.3 25.0 66.8 25.4 124.7 18.0 55.1 14.1 36.7 16.8 249.1 153.5 46.3 22.4 47.5 15.8 45.3 31.2 40.2 20.6 144.0 202.0 43.8 20.4 75.2 68.8 7.4 38.6 39.4 14.8 104.6 35.9 0.0 0.8 9.3 3.0 0.0 0.3 40.6 0.2 0.2 56.5 2.6 234.0 79.4 5.3 191.0 63.0 79.1 81.6 0.2 0.1 0.0 45.3 302.0 12.9 2.6 7.1 14.5 27.3 0.2 2.6 2.5 0.0 5.2 70.1 0.1 0.2 123.9 20.9 58.2 8.1 93.3 108.6 0.6 2.3 2.0 44.9 0.0 0.2 1.6 26.1 0.0 0.2 0.1 56.1 0.1 0.0 0.0 2.1 4.2 0.1 0.0 25.4 95.1 0.2 6.2 128.2 37.0 57.1 16.7 59.9 0.1 0.2 0.2 32.3 0.1 222.0 2.2 3.0 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 9.3 0.0 0.0 0.7 0.0 40.6 50.2 93.3 33.8 24.6 68.3 100.3 124.7 18.0 153.5 68.8 77.4 37.5 11.1 26.9 146.3 50.1 28.0 7.6 9.4 30.7 15.7 2.0 100.4 0.0 4.6 11.1 490.8 0.0 23.3 0.3 315.9 896.1 5.2 11.5 5.5 99.3 1.6 0.0 958.1 70.8 28.8 295.7 31.0 222.7 5.4 0.0 10.6 8.6 0.0 1044.4 35.4 63.7 2315.4 1190.8 7.0 6.8 94.6 123.1 5.1 0.0 4.4 SPEG "APEG1, BPEG, KIAA1297, MGC12676, SPEGalpha, SPEGbeta" ENSG00000072195 "SPEG complex locus" Q15772 2 219434846-219498287 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Differentiation "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 88.7" "Cell type enhanced" "Detected in many" 9 "Cardiomyocytes: 55.0;Late spermatids: 30.8;Sertoli cells: 45.3;Smooth muscle cells: 36.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 27.9;U-87 MG: 14.6" "Low region specificity" "Detected in all" HPA018904 Enhanced Approved Vesicles NA NA Vesicles "HPA018904: AB_1844924" "unprognostic (3.70e-1)" "unprognostic (1.23e-2)" "unprognostic (5.05e-3)" "unprognostic (2.45e-4)" "unprognostic (2.04e-2)" "unprognostic (4.65e-3)" "unprognostic (2.41e-2)" "unprognostic (1.12e-1)" "unprognostic (8.92e-3)" "unprognostic (2.29e-2)" "unprognostic (8.66e-4)" "unprognostic (1.06e-1)" "unprognostic (3.47e-9)" "unprognostic (1.14e-1)" "unprognostic (7.01e-2)" "unprognostic (5.95e-4)" "unprognostic (1.28e-3)" 7.7 7.1 10.1 9.1 7.7 1.2 4.2 10.4 9.8 19.2 45.1 4.1 10.5 5.7 31.6 14.1 13.5 19.0 17.4 17.8 8.7 5.3 2.0 1.4 3.0 1.7 4.0 8.0 7.0 2.9 4.7 10.5 4.8 5.5 16.7 4.5 6.7 7.8 23.0 88.7 2.2 9.2 45.2 9.1 1.9 16.1 3.0 3.9 0.0 2.0 16.8 1.6 22.5 12.6 0.0 0.3 0.0 0.0 0.0 0.5 0.7 3.6 0.3 1.8 3.1 0.9 2.9 1.2 7.7 5.2 5.2 3.9 2.8 1.3 0.0 2.8 5.6 2.9 4.5 1.5 1.8 2.0 0.4 1.2 0.4 3.3 0.1 1.3 0.0 0.6 8.2 2.7 4.7 1.1 27.9 0.0 2.0 2.7 0.0 3.7 1.0 0.0 11.0 3.9 0.1 1.4 1.8 4.2 0.6 5.0 0.0 2.1 9.6 0.5 0.0 0.1 9.2 0.3 0.1 0.1 13.0 13.2 1.5 12.1 0.4 0.0 0.1 14.6 0.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.7 10.1 7.7 10.4 9.8 8.7 5.3 4.0 8.0 5.5 3.9 0.0 2.1 0.0 5.6 2.9 1.1 55.0 5.1 0.0 0.0 1.8 2.0 0.8 0.0 1.2 17.7 1.4 5.9 0.0 1.0 0.7 8.5 2.7 0.0 2.4 1.0 4.8 6.4 3.7 6.6 30.8 9.8 1.7 3.3 1.8 3.3 6.5 0.3 2.9 17.7 2.3 0.8 45.3 36.2 1.1 2.6 1.3 1.1 0.0 2.4 3.5 SPINK5 "DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI" ENSG00000133710 "Serine peptidase inhibitor, Kazal type 5" Q9NQ38 5 148025683-148137289 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Hypotrichosis, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 101.6;esophagus: 313.0;tongue: 97.4" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 45.0;Basal keratinocytes: 47.7;Cholangiocytes: 58.6;Mucus-secreting cells: 32.9;Paneth cells: 66.2;Suprabasal keratinocytes: 56.2" "Cancer enhanced" "Detected in many" "head and neck cancer: 45.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 12.3;HeLa: 18.1;Karpas-707: 16.0;SuSa: 5.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009067, HPA011351, CAB015347" Enhanced Enhanced Vesicles "Secreted in other tissues" NA NA 28000000 Vesicles "CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447" "unprognostic (9.66e-3)" "unprognostic (1.42e-2)" "unprognostic (2.41e-1)" "unprognostic (1.17e-1)" "unprognostic (3.25e-2)" "unprognostic (1.42e-3)" "unprognostic (2.45e-2)" "unprognostic (6.85e-2)" "unprognostic (1.16e-1)" "unprognostic (2.28e-2)" "unprognostic (4.92e-3)" "unprognostic (4.56e-1)" "unprognostic (2.44e-1)" "unprognostic (7.91e-2)" "unprognostic (2.82e-1)" "unprognostic (6.87e-2)" "unprognostic (2.59e-1)" 0.1 0.0 0.2 0.1 0.1 0.0 2.8 0.1 0.2 101.6 0.7 0.2 0.1 0.0 3.2 0.2 313.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.3 0.1 0.2 1.7 0.2 18.1 0.1 0.2 48.6 0.1 0.1 0.1 0.1 0.7 0.2 0.1 3.6 0.3 97.4 65.3 0.3 64.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.2 1.5 0.0 0.0 12.3 0.0 1.1 0.0 0.0 0.0 0.0 18.1 0.0 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.2 0.0 0.7 16.0 0.0 1.7 0.0 0.0 2.2 1.6 0.2 0.0 0.0 0.0 0.0 4.7 2.4 0.0 0.5 0.0 0.0 5.9 3.8 0.0 0.0 0.0 0.1 0.0 0.0 4.2 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 8.9 45.0 0.0 1.4 47.7 0.0 0.8 58.6 6.7 9.1 0.0 0.0 1.7 0.0 0.0 9.3 6.4 13.4 0.0 1.1 1.6 1.0 0.6 1.1 0.0 0.1 0.0 4.1 1.3 0.6 2.7 0.6 0.6 3.3 0.0 32.9 0.0 4.6 66.2 0.0 0.0 0.0 0.0 0.9 0.6 1.9 56.2 1.3 0.0 20.3 2.3 SPOCK1 "SPOCK, testican-1, TIC1" ENSG00000152377 "SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1" Q08629 5 136975298-137598379 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 92.2" "Cell type enhanced" "Detected in many" 19 "Cardiomyocytes: 54.3;Muller glia cells: 252.1;Peritubular cells: 141.1" "Cancer enriched" "Detected in all" 7 "prostate cancer: 83.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "classical monocyte: 2.5;myeloid DC: 1.6" "Group enriched" "Detected in many" 4 "dendritic cells: 1.6;monocytes: 2.5" "Cell line enhanced" "Detected in many" "ASC diff: 75.8;hTERT-RPE1: 144.5;HUVEC TERT2: 75.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007450, HPA026770" Uncertain Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA007450: AB_10603116, HPA026770: " "unprognostic (1.05e-1)" "unprognostic (9.25e-2)" "prognostic unfavorable (1.93e-4)" "unprognostic (1.58e-1)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (5.83e-3)" "prognostic unfavorable (9.08e-4)" "unprognostic (1.00e-2)" "prognostic unfavorable (4.72e-4)" "unprognostic (9.09e-3)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.77e-5)" "prognostic unfavorable (9.40e-4)" "unprognostic (1.26e-1)" "unprognostic (2.21e-1)" "unprognostic (1.90e-2)" 11.3 31.0 20.6 4.0 30.4 1.5 9.3 68.2 92.2 20.5 7.4 36.0 5.1 2.1 20.5 26.1 5.6 6.8 14.3 38.6 29.9 16.6 18.0 1.4 1.9 1.7 35.5 29.0 3.2 3.7 1.4 3.7 7.6 19.6 48.9 3.6 5.2 2.9 20.7 5.6 3.2 2.6 23.2 21.7 6.8 3.7 15.9 36.0 0.1 3.3 0.0 1.6 8.1 11.5 0.0 1.6 0.4 2.5 0.0 0.0 0.6 0.5 0.1 38.2 0.0 75.8 15.5 0.0 12.4 11.5 27.0 15.2 0.0 0.0 0.0 0.0 25.9 6.8 0.5 0.1 8.9 8.4 2.1 0.0 0.0 2.3 0.0 0.5 0.0 0.0 27.0 3.6 16.6 2.9 144.5 75.8 0.0 0.0 0.0 7.7 0.0 0.0 0.0 2.4 0.0 3.5 0.0 0.0 0.0 18.0 1.2 0.4 1.8 6.1 0.1 0.0 4.8 0.0 0.1 12.1 38.5 1.3 13.1 3.5 0.0 0.0 0.0 20.9 0.5 17.4 0.0 2.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 20.6 30.4 68.2 28.5 29.9 16.6 35.5 29.0 19.6 36.0 0.0 0.0 0.0 1.7 1.5 5.0 54.3 0.0 0.0 0.0 21.0 2.0 0.4 1.7 0.7 8.2 2.1 0.0 0.0 1.2 0.4 9.5 48.4 0.0 0.0 0.8 7.9 33.7 1.3 2.4 8.9 16.1 1.1 6.8 1.0 0.0 252.1 1.5 0.0 141.1 1.7 3.2 12.9 12.8 7.5 5.9 1.3 0.1 0.0 0.1 2.1 SPON2 DIL1 ENSG00000159674 "Spondin 2" Q9BUD6 4 1166932-1208962 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 238.3;Fibroblasts: 91.2;T-cells: 101.5" "Cancer enriched" "Detected in all" 7 "prostate cancer: 243.7" "Region enhanced" "Detected in many" "cerebellum: 10.7" "Cell type enhanced" "Detected in many" "gdT-cell: 54.2" "Lineage enriched" "Detected in many" 5 "T-cells: 54.2" "Group enriched" "Detected in some" 6 "HHSteC: 55.2;HSkMC: 97.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA040170, HPA066095" Approved Approved Vesicles "Secreted to blood" NA NA 1600000 Vesicles "HPA040170: AB_2676868, HPA066095: AB_2685615" "unprognostic (1.22e-1)" "unprognostic (3.56e-1)" "unprognostic (3.07e-2)" "prognostic favorable (2.03e-4)" "unprognostic (7.64e-2)" "unprognostic (6.28e-2)" "unprognostic (2.70e-3)" "unprognostic (2.28e-3)" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.82e-1)" "unprognostic (1.40e-1)" "unprognostic (1.23e-2)" "unprognostic (2.74e-3)" "unprognostic (1.22e-1)" "unprognostic (2.01e-2)" "prognostic unfavorable (9.22e-4)" 18.5 10.2 0.9 11.7 4.2 7.2 27.9 10.7 3.4 63.7 18.0 1.0 6.4 8.5 46.7 25.7 13.9 11.6 26.6 14.4 1.8 0.0 19.3 35.7 13.9 1.6 0.5 1.5 24.2 4.8 0.1 3.2 44.9 1.9 39.4 3.2 3.4 6.3 7.6 8.9 9.1 14.2 23.1 0.6 6.7 9.6 10.6 0.9 1.1 3.5 21.0 3.0 20.1 22.8 0.2 8.7 2.1 0.4 10.0 54.2 22.7 0.0 0.1 0.0 0.0 1.8 13.2 0.5 1.1 0.7 0.1 0.2 0.0 0.0 0.3 1.9 4.5 0.1 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.0 55.2 0.0 0.3 97.3 0.0 0.1 0.0 0.0 0.0 0.7 0.0 1.7 0.0 0.0 0.9 2.5 0.6 1.7 0.1 0.1 0.6 1.4 0.0 0.0 0.3 0.1 0.1 0.0 0.5 0.2 0.0 0.3 0.0 0.0 0.1 4.0 0.0 0.2 0.4 0.1 0.0 1.3 0.0 0.8 0.1 0.1 54.2 0.2 1.1 0.1 7.6 22.3 0.1 0.2 3.4 22.0 2.1 10.0 0.4 8.7 0.0 22.7 0.9 4.2 10.7 3.4 1.8 0.0 0.5 1.5 1.9 0.9 0.0 6.4 5.2 1.9 32.6 1.7 4.2 12.7 13.4 2.3 1.8 0.0 3.1 1.7 3.0 0.2 4.5 10.7 0.0 1.2 238.3 91.2 11.8 5.8 32.1 11.2 0.0 13.3 20.3 2.4 0.0 27.6 6.6 25.3 8.2 8.5 0.9 1.4 3.5 8.9 15.1 0.2 6.5 7.1 0.2 0.4 18.7 32.5 101.5 5.8 11.2 SPOPL BTBD33 ENSG00000144228 "Speckle type BTB/POZ protein like" Q6IQ16 2 138501801-138573547 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034687 Uncertain Approved Vesicles NA NA Vesicles "HPA034687: AB_10670573" "unprognostic (1.39e-3)" "unprognostic (1.24e-1)" "unprognostic (2.48e-2)" "unprognostic (3.02e-2)" "unprognostic (3.37e-1)" "unprognostic (3.12e-2)" "unprognostic (4.42e-2)" "unprognostic (2.41e-1)" "unprognostic (1.40e-1)" "unprognostic (2.04e-1)" "unprognostic (2.75e-2)" "unprognostic (8.90e-2)" "prognostic favorable (3.63e-4)" "unprognostic (2.25e-2)" "unprognostic (1.15e-1)" "unprognostic (9.09e-2)" "unprognostic (1.91e-3)" 13.6 8.8 17.3 14.9 20.0 17.5 18.8 14.5 17.5 11.1 13.1 10.7 10.1 11.1 15.7 6.3 9.9 9.9 10.7 9.8 13.4 11.3 12.9 13.2 13.7 14.7 16.1 13.1 16.2 9.9 13.2 16.7 9.5 16.0 14.1 13.0 9.3 15.1 19.3 9.0 13.5 13.9 17.8 19.4 15.0 13.0 5.7 17.2 5.7 12.4 6.6 13.4 12.7 13.3 1.8 3.5 9.0 2.6 0.6 0.7 0.9 10.0 3.1 5.7 5.5 4.7 7.9 11.0 7.5 5.7 4.7 5.7 11.3 8.3 10.8 7.2 6.4 4.2 4.0 7.4 6.6 10.0 8.4 6.0 6.9 7.3 17.7 4.9 7.5 9.7 5.2 9.8 9.3 8.7 9.6 7.5 2.6 2.2 15.2 7.9 9.8 0.7 7.1 5.1 7.1 5.4 3.8 10.0 6.2 7.4 14.4 6.7 8.3 11.4 10.9 5.5 7.1 6.0 8.3 7.4 7.6 6.5 9.5 11.3 22.0 16.0 8.0 12.8 7.1 6.9 0.6 2.6 4.2 0.6 2.4 0.5 1.7 0.5 0.5 3.5 1.8 0.3 0.3 9.0 0.6 1.9 1.5 0.7 0.9 17.3 20.0 14.5 17.5 13.4 11.3 16.1 13.1 16.0 17.2 11.9 9.9 13.7 9.8 49.3 8.2 10.6 10.2 12.0 28.4 3.5 3.9 5.0 6.6 8.4 1.6 9.8 12.5 0.0 11.6 6.0 8.2 18.4 8.1 10.4 8.4 17.5 18.4 6.2 36.5 2.1 15.8 22.6 11.8 7.2 18.6 6.6 15.9 11.5 14.9 13.9 16.3 6.5 17.8 9.3 22.2 39.1 5.1 7.4 10.2 15.7 SPPL2A "IMP3, PSL2" ENSG00000138600 "Signal peptide peptidase like 2A" Q8TCT8 15 50702266-50765808 "Enzymes, Plasma proteins, Predicted membrane proteins, Transporters" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036062, HPA067304" Enhanced Supported Vesicles NA NA Vesicles "HPA036062: AB_10611670, HPA067304: AB_2685820" "unprognostic (1.66e-1)" "unprognostic (1.03e-1)" "unprognostic (2.70e-1)" "unprognostic (5.82e-3)" "unprognostic (3.71e-1)" "unprognostic (1.70e-1)" "unprognostic (2.15e-1)" "unprognostic (1.88e-1)" "unprognostic (2.22e-2)" "unprognostic (6.36e-2)" "unprognostic (2.04e-2)" "unprognostic (4.00e-2)" "unprognostic (3.11e-2)" "unprognostic (2.26e-2)" "unprognostic (1.44e-2)" "unprognostic (6.96e-2)" "unprognostic (3.66e-1)" 20.5 23.5 6.9 18.0 8.6 15.0 23.3 6.2 8.1 16.4 29.3 10.8 15.3 24.9 14.5 17.9 18.7 13.0 14.9 37.6 7.8 5.3 23.3 44.8 19.2 23.9 8.3 6.1 13.2 32.7 61.0 11.8 32.2 14.4 14.7 26.9 14.9 21.7 15.5 63.1 15.8 39.2 20.5 8.5 21.2 18.3 10.2 7.4 21.6 15.6 17.4 17.7 19.7 13.9 9.8 19.4 24.0 27.3 11.9 15.4 22.4 15.4 26.9 10.5 13.8 41.4 24.7 16.5 24.9 41.8 22.9 32.7 31.1 17.9 9.6 18.6 48.7 34.4 23.3 12.6 15.1 25.6 19.6 7.7 18.2 18.4 16.0 34.2 11.3 29.8 21.4 27.8 18.9 30.6 17.0 22.5 10.5 13.7 37.8 30.2 35.6 5.3 4.3 4.5 24.8 6.1 6.5 16.2 21.1 31.4 36.0 8.4 9.5 15.0 29.0 16.8 22.0 20.6 22.4 27.4 37.0 14.9 23.7 29.3 15.4 26.3 10.6 16.7 19.0 25.3 21.2 26.9 24.0 15.4 24.6 9.7 9.8 12.6 13.9 19.4 9.3 7.2 11.5 19.4 11.9 27.3 17.1 15.4 22.4 6.9 8.6 6.2 8.1 7.8 5.3 8.3 6.1 14.4 7.4 44.7 34.7 37.5 70.0 38.2 14.8 64.5 58.6 29.4 37.5 64.6 19.6 118.1 19.9 75.9 11.3 46.7 152.1 0.0 145.2 68.6 45.2 72.3 45.0 111.7 79.3 7.9 36.9 43.0 60.6 5.6 41.4 67.0 30.4 170.5 66.7 31.2 103.1 123.8 34.3 42.8 17.0 25.8 39.1 30.5 14.8 33.9 171.1 48.4 59.7 82.4 SPRYD7 "C13orf1, CLLD6" ENSG00000123178 "SPRY domain containing 7" Q5W111 13 49912706-49936490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 122.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043934 Approved Approved Vesicles NA NA Vesicles "HPA043934: AB_10960545" "unprognostic (1.83e-2)" "prognostic unfavorable (8.48e-6)" "unprognostic (2.57e-1)" "unprognostic (4.95e-2)" "unprognostic (4.45e-1)" "unprognostic (1.87e-3)" "unprognostic (3.54e-2)" "unprognostic (1.12e-1)" "unprognostic (4.05e-1)" "unprognostic (3.12e-3)" "unprognostic (3.34e-3)" "unprognostic (1.17e-1)" "unprognostic (1.01e-1)" "unprognostic (6.53e-2)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.06e-2)" 7.5 13.2 17.1 5.6 15.5 4.5 8.7 14.9 21.0 6.1 11.0 8.9 4.9 9.2 6.8 8.5 10.4 7.4 6.2 16.2 17.2 20.6 12.5 15.3 14.8 4.6 15.8 14.2 8.5 9.4 11.4 10.7 12.3 13.2 10.0 10.0 6.3 7.6 8.1 30.3 8.7 10.3 10.5 12.9 5.8 10.0 17.0 9.6 1.1 10.2 11.9 5.4 8.2 8.0 7.6 3.6 2.4 5.9 9.2 6.4 2.6 6.9 6.0 3.9 4.3 4.7 6.8 8.8 13.7 6.5 9.7 5.6 10.8 5.7 6.8 4.4 10.1 8.0 6.0 8.6 12.7 13.6 11.2 7.7 7.2 4.7 7.5 16.3 17.3 5.2 5.8 14.4 8.5 16.7 6.1 5.9 3.9 8.1 6.2 22.4 4.2 0.7 8.2 1.5 10.6 6.8 3.3 6.5 4.1 10.1 5.3 3.2 4.0 4.1 9.1 6.7 5.2 8.5 10.8 7.5 8.9 4.9 8.1 13.6 3.8 5.9 5.2 6.9 7.0 9.9 0.8 3.0 2.4 3.1 3.4 6.4 7.6 3.0 4.1 3.6 6.6 2.5 3.7 0.7 9.2 5.9 2.5 4.3 2.6 17.1 15.5 14.9 21.0 17.2 20.6 15.8 14.2 13.2 9.6 122.1 29.1 12.0 20.1 18.0 28.8 56.8 17.8 26.8 29.6 12.2 7.9 32.9 44.7 32.5 87.7 18.4 30.0 0.0 22.5 37.7 18.2 18.3 16.3 38.9 24.2 22.3 22.4 17.8 7.5 10.6 19.5 15.9 21.9 17.2 18.0 18.0 29.5 23.0 19.1 63.2 26.2 6.5 19.6 112.6 46.6 27.0 33.3 12.9 20.8 8.2 SRR "ILV1, ISO1" ENSG00000167720 "Serine racemase" Q9GZT4 17 2303383-2325260 "Enzymes, Predicted intracellular proteins" "Allosteric enzyme, Isomerase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007529, CAB015343" Approved Approved Vesicles NA NA Vesicles "CAB015343: AB_2195009, HPA007529: AB_2667853" "unprognostic (2.96e-1)" "unprognostic (7.86e-2)" "unprognostic (6.01e-2)" "prognostic favorable (6.20e-5)" "unprognostic (3.05e-1)" "unprognostic (1.57e-2)" "unprognostic (4.32e-2)" "unprognostic (9.97e-2)" "unprognostic (9.09e-2)" "unprognostic (4.85e-2)" "prognostic favorable (8.16e-4)" "unprognostic (5.17e-2)" "prognostic favorable (2.45e-6)" "unprognostic (6.14e-2)" "unprognostic (1.99e-1)" "unprognostic (1.89e-1)" "unprognostic (5.84e-2)" 11.6 12.6 17.1 7.7 14.7 13.9 16.7 12.2 24.9 8.4 10.4 13.9 11.4 7.9 10.9 11.3 12.9 10.0 9.6 12.6 15.2 13.0 10.3 9.0 10.9 7.0 12.6 15.6 9.8 14.8 11.0 9.7 6.5 12.4 9.6 8.8 10.6 11.9 9.3 16.9 13.4 7.5 15.0 13.2 7.3 9.2 13.8 9.0 13.4 13.8 6.1 6.0 12.1 7.3 9.7 15.5 5.2 12.6 13.9 13.5 8.7 7.3 13.5 24.4 9.1 13.3 14.1 11.9 15.7 9.8 10.4 10.8 12.4 9.3 13.9 2.1 16.2 7.7 15.6 6.7 5.8 13.3 16.1 13.1 7.2 9.9 4.7 13.4 2.0 4.0 11.9 5.9 23.2 11.2 12.1 15.2 14.8 7.4 10.2 23.1 4.3 14.2 2.7 5.1 7.0 10.1 23.5 27.7 6.4 12.0 3.4 4.8 12.3 13.6 1.7 7.1 8.3 10.7 5.0 11.9 11.2 7.9 12.7 9.3 9.0 12.2 2.5 20.0 6.7 15.2 2.4 8.2 5.2 9.5 8.7 9.9 9.7 12.3 10.1 15.5 8.9 10.4 13.5 1.0 13.9 12.6 10.4 8.9 8.7 17.1 14.7 12.2 24.9 15.2 13.0 12.6 15.6 12.4 9.0 3.0 3.0 1.4 3.9 2.6 7.6 3.6 0.0 5.3 3.4 1.8 0.0 4.2 11.6 8.3 1.1 3.2 2.2 0.0 6.0 3.1 4.6 2.4 0.0 2.6 8.0 15.9 1.7 8.0 3.2 1.0 3.7 3.6 5.0 13.6 2.8 10.8 5.8 0.0 4.9 4.9 5.3 0.0 3.8 14.0 4.7 2.0 2.9 2.5 3.1 2.0 ST3GAL2 "SIAT4B, ST3GalA.2, ST3GALII" ENSG00000157350 "ST3 beta-galactoside alpha-2,3-sialyltransferase 2" Q16842 16 70375978-70439237 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 28.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017270 Approved Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA017270: AB_1857523" "unprognostic (2.76e-2)" "unprognostic (6.33e-2)" "unprognostic (3.41e-1)" "unprognostic (1.35e-1)" "unprognostic (4.99e-1)" "unprognostic (1.01e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (1.14e-2)" "unprognostic (2.21e-1)" "unprognostic (1.91e-2)" "prognostic favorable (2.33e-4)" "unprognostic (9.54e-2)" "prognostic unfavorable (3.34e-6)" "unprognostic (7.42e-2)" "unprognostic (8.83e-3)" "unprognostic (4.64e-2)" "unprognostic (5.20e-2)" 12.6 9.1 9.3 17.2 11.9 14.3 8.9 24.1 10.6 11.3 8.8 5.1 9.3 9.2 13.9 5.6 5.8 9.0 6.8 9.2 10.4 6.0 8.8 12.9 9.3 14.9 5.1 4.7 13.6 4.2 8.8 7.2 8.8 6.8 7.5 4.7 9.9 4.9 9.0 33.3 6.0 10.5 12.0 4.0 17.7 5.4 9.6 5.9 16.0 6.6 4.9 12.6 9.1 12.0 3.2 14.3 11.2 2.2 2.8 4.2 1.1 1.4 8.5 7.4 9.8 4.0 5.4 1.7 6.0 6.4 6.7 3.3 5.1 3.3 4.1 10.8 6.5 6.0 1.0 2.9 2.5 3.2 9.7 4.7 17.5 3.5 7.6 4.9 6.4 28.9 4.1 1.4 6.8 1.2 8.2 9.2 7.1 23.9 4.0 3.7 0.7 6.7 17.5 10.0 2.8 4.6 12.9 2.8 5.5 4.5 1.1 3.3 9.7 15.1 0.3 6.6 8.0 1.6 7.1 9.8 8.5 10.2 3.6 4.4 8.4 3.3 8.4 9.3 5.4 11.9 2.7 2.0 5.7 2.0 2.2 1.9 1.7 2.4 2.2 1.0 3.2 4.2 3.3 11.2 2.8 1.3 14.3 2.7 1.1 9.3 11.9 24.1 10.6 10.4 6.0 5.1 4.7 6.8 5.9 8.9 6.9 13.0 3.6 3.0 15.1 5.6 10.2 1.4 2.3 8.7 13.7 3.7 0.0 5.4 14.0 13.1 5.1 46.7 3.8 1.6 10.6 2.2 17.3 11.5 11.6 17.5 12.7 14.7 10.0 25.8 10.9 14.4 1.7 23.4 4.0 5.1 2.4 0.0 7.8 5.0 10.2 6.5 7.1 5.4 8.1 2.0 1.5 8.6 5.2 1.8 ST3GAL5 "SIAT9, SIATGM3S, ST3GalV" ENSG00000115525 "ST3 beta-galactoside alpha-2,3-sialyltransferase 5" Q9UNP4 2 85837120-85905199 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 40.1" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 80.4;Alveolar cells type 2: 105.8" "Cancer enhanced" "Detected in all" "thyroid cancer: 41.7" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AN3-CA: 26.2;RT4: 22.2;SK-MEL-30: 18.4;U-266/84: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034708, HPA040425, HPA068928" Uncertain Approved Vesicles NA NA Vesicles "HPA034708: AB_10601594, HPA040425: AB_2676978, HPA068928: AB_2686060" "unprognostic (7.90e-2)" "unprognostic (1.61e-2)" "unprognostic (3.84e-2)" "unprognostic (2.93e-2)" "unprognostic (1.27e-1)" "unprognostic (1.75e-1)" "unprognostic (1.12e-2)" "unprognostic (5.81e-3)" "unprognostic (1.38e-1)" "unprognostic (6.45e-2)" "unprognostic (5.03e-3)" "unprognostic (3.43e-2)" "prognostic unfavorable (2.25e-7)" "unprognostic (2.22e-1)" "unprognostic (5.74e-2)" "prognostic favorable (4.99e-4)" "prognostic favorable (4.48e-4)" 8.0 40.1 15.3 7.2 18.5 4.1 4.2 9.9 34.9 3.3 3.8 18.8 0.0 2.7 8.0 2.9 2.9 4.9 11.8 2.1 14.8 12.0 2.4 7.0 18.0 11.5 14.0 13.4 7.2 2.9 1.5 7.4 24.1 18.1 4.8 5.0 18.7 4.8 2.2 9.5 5.0 3.4 6.2 18.0 11.1 4.1 9.0 13.4 5.5 36.7 0.4 6.9 30.9 7.8 2.5 1.1 1.3 6.1 1.4 1.8 0.5 0.1 12.8 1.2 26.2 10.9 5.9 3.9 2.8 8.6 2.7 2.4 0.2 9.3 0.3 0.1 4.8 1.2 0.5 1.7 3.0 3.4 0.1 1.5 0.2 0.5 0.4 8.7 0.1 3.8 3.3 0.4 1.0 0.4 4.9 6.5 3.5 0.3 14.5 8.8 0.8 0.8 1.4 0.1 4.4 0.0 1.6 8.3 5.1 1.4 22.2 1.8 1.8 0.1 0.0 18.4 2.7 0.1 0.5 2.1 0.0 1.3 0.0 0.2 14.6 19.3 0.2 2.1 2.6 13.2 0.9 1.8 0.1 1.4 6.1 1.8 2.5 0.8 0.9 1.1 1.5 0.7 0.8 1.3 1.4 5.1 0.4 0.3 0.5 15.3 18.5 9.9 21.9 14.8 12.0 14.0 13.4 18.1 13.4 80.4 105.8 40.9 24.7 4.9 49.5 1.6 30.6 14.7 50.0 3.5 55.0 0.3 3.3 8.1 9.5 5.2 0.0 0.0 14.5 0.5 10.3 8.0 33.5 15.5 30.3 68.3 6.4 33.2 46.9 8.7 7.5 25.6 30.4 12.6 0.0 52.2 6.7 0.0 1.8 2.9 41.0 0.0 5.0 6.9 20.0 3.3 0.2 19.7 0.0 5.1 ST6GALNAC5 "MGC3184, SIAT7E, ST6GalNAcV" ENSG00000117069 "ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5" Q9BVH7 1 76867441-77065711 "Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 29.4" "Cell type enriched" "Detected in some" 7 "Alveolar cells type 1: 50.6" "Cancer enhanced" "Detected in many" "ovarian cancer: 10.9" "Group enriched" "Detected in many" 4 "amygdala: 22.1;basal ganglia: 22.3;cerebral cortex: 12.7;hippocampal formation: 29.4;olfactory region: 14.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 9.1;fHDF/TERT166: 10.9;HaCaT: 5.2;SH-SY5Y: 7.9;U-2 OS: 9.0;U-251 MG: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA065593, HPA070354" Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA065593: AB_2685515, HPA070354: AB_2686260" "unprognostic (1.32e-1)" "unprognostic (5.96e-2)" "unprognostic (1.72e-1)" "unprognostic (1.49e-2)" "unprognostic (2.82e-2)" "unprognostic (2.04e-2)" "unprognostic (4.67e-2)" "unprognostic (2.72e-2)" "unprognostic (3.60e-2)" "unprognostic (1.99e-1)" "unprognostic (1.61e-2)" "unprognostic (1.58e-1)" "unprognostic (2.10e-2)" "unprognostic (5.90e-3)" "unprognostic (9.66e-2)" "unprognostic (6.88e-2)" "unprognostic (1.69e-2)" 0.7 10.1 22.1 5.2 22.3 0.4 4.2 0.6 12.7 2.9 3.4 0.3 0.0 1.4 0.9 0.7 3.7 6.9 12.6 1.4 29.4 2.7 0.7 0.6 12.1 1.6 3.0 14.2 6.5 0.8 0.4 8.5 0.9 4.7 4.2 2.7 5.8 1.5 1.6 0.6 1.0 2.1 10.2 0.8 1.0 3.7 1.2 0.2 0.0 0.6 0.0 1.4 4.2 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.4 2.4 0.0 9.1 0.0 0.0 0.0 0.0 0.8 3.2 2.6 0.8 0.0 0.2 0.0 0.0 10.9 0.0 5.2 0.0 0.1 2.8 0.0 0.2 0.0 0.0 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.7 0.6 0.0 0.1 2.5 7.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.3 9.0 0.0 5.0 0.0 0.2 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.1 22.3 0.6 12.7 29.4 2.7 3.0 14.2 4.7 0.2 50.6 0.3 0.0 0.0 0.0 7.3 0.4 0.0 1.4 1.2 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.1 0.6 0.1 1.1 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.0 0.5 0.0 0.1 0.0 0.0 0.1 STAM STAM1 ENSG00000136738 "Signal transducing adaptor molecule" Q92783 10 17644125-17715914 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "T-reg: 33.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034399, HPA043882" Supported Supported Vesicles NA NA Vesicles "CAB034399: AB_2197486, HPA043882: AB_2678713" "unprognostic (1.09e-2)" "unprognostic (8.32e-2)" "unprognostic (1.10e-1)" "unprognostic (3.95e-2)" "unprognostic (9.11e-3)" "unprognostic (1.04e-1)" "prognostic unfavorable (3.44e-6)" "unprognostic (1.39e-1)" "unprognostic (8.53e-2)" "unprognostic (8.58e-2)" "unprognostic (1.37e-2)" "unprognostic (8.39e-2)" "unprognostic (1.02e-3)" "unprognostic (1.39e-1)" "unprognostic (2.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.02e-1)" 13.5 16.7 16.8 9.3 21.8 58.5 10.8 23.2 25.4 12.9 9.4 22.7 6.3 11.4 15.0 8.9 14.5 9.6 12.2 23.7 18.4 18.4 14.3 9.5 14.6 10.3 18.6 16.1 15.5 17.2 14.4 13.4 11.7 24.5 12.8 11.0 16.1 12.7 9.4 26.0 11.5 9.7 12.3 20.7 8.8 13.3 10.8 15.0 25.1 15.2 12.5 13.0 13.7 10.6 2.4 4.3 17.2 3.6 7.2 33.4 2.9 14.9 9.6 13.5 6.8 16.5 12.2 5.4 20.8 10.0 21.2 17.2 12.7 15.0 4.1 3.1 17.4 15.7 8.3 13.3 11.1 17.3 4.8 6.8 39.2 8.6 22.7 18.1 2.9 21.0 11.3 14.6 17.3 14.9 14.9 10.8 28.8 13.5 5.6 23.4 5.6 15.7 2.9 7.3 10.6 4.8 8.4 12.5 5.5 9.8 6.1 6.2 10.5 11.8 9.0 18.7 12.7 13.4 4.8 12.2 11.9 11.8 19.8 9.3 3.6 4.9 7.0 13.7 4.8 7.6 17.2 3.5 5.4 2.9 3.6 2.7 2.4 6.2 3.0 4.3 1.7 4.5 3.6 2.9 7.2 3.2 2.6 33.4 2.9 16.8 21.8 23.2 25.4 18.4 18.4 18.6 16.1 24.5 15.0 11.9 18.9 7.8 5.2 20.4 16.1 23.4 7.6 14.7 14.8 15.7 9.8 8.7 5.0 13.1 2.8 9.0 5.4 0.0 11.5 8.5 16.9 8.8 30.1 6.2 13.1 9.5 10.9 9.8 10.3 2.7 8.9 11.9 18.6 5.4 7.3 13.3 22.5 5.8 5.6 12.1 14.2 25.8 10.0 12.9 10.9 18.3 20.6 12.5 7.4 5.5 STARD3NL "MENTHO, MGC3251" ENSG00000010270 "STARD3 N-terminal like" O95772 7 38178222-38230671 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019204 Enhanced Supported Vesicles NA NA Vesicles "HPA019204: AB_2197800" "unprognostic (1.55e-3)" "unprognostic (2.80e-3)" "unprognostic (2.22e-1)" "unprognostic (2.58e-1)" "unprognostic (4.37e-2)" "prognostic unfavorable (2.20e-4)" "prognostic unfavorable (1.44e-5)" "unprognostic (9.64e-2)" "unprognostic (1.89e-1)" "unprognostic (5.37e-2)" "prognostic favorable (8.48e-4)" "unprognostic (1.07e-1)" "unprognostic (2.97e-1)" "unprognostic (2.41e-2)" "unprognostic (8.09e-3)" "unprognostic (2.65e-1)" "unprognostic (8.71e-2)" 18.3 15.6 28.9 15.3 26.5 23.4 20.3 16.1 37.7 23.2 14.6 22.5 11.8 12.7 23.3 19.8 9.6 19.4 15.5 18.2 27.9 36.7 23.8 11.8 22.4 15.8 34.6 19.4 17.8 11.1 9.5 19.7 33.7 29.8 29.3 16.7 16.4 10.0 16.1 10.6 4.5 13.7 22.9 33.1 17.6 11.8 21.7 15.3 13.4 23.2 5.9 10.2 17.3 16.0 14.4 21.0 27.0 23.4 34.2 27.8 20.8 11.5 12.4 27.5 17.8 19.0 19.0 9.6 19.0 19.7 18.8 24.8 9.8 18.4 9.1 19.2 17.3 57.6 12.6 15.1 14.4 28.6 8.2 13.1 18.5 6.9 13.4 16.8 20.3 21.7 17.8 7.1 19.9 15.9 21.6 34.1 25.2 21.0 16.0 28.8 7.1 11.4 32.7 19.4 9.7 9.9 14.1 25.6 4.2 26.3 10.9 11.1 25.9 6.5 17.3 17.9 39.7 12.1 26.9 23.2 12.9 18.5 20.1 26.7 17.1 17.2 3.4 26.2 36.2 41.9 14.4 23.4 27.0 27.8 20.0 12.7 14.4 11.7 20.5 21.0 14.1 9.9 19.4 26.3 34.2 21.5 14.9 11.6 20.8 28.9 26.5 16.1 37.7 27.9 36.7 34.6 19.4 29.8 15.3 17.9 38.9 35.0 46.4 18.4 8.0 15.9 12.7 17.4 15.9 29.6 11.8 43.7 26.6 28.6 97.7 36.8 10.2 0.0 30.1 76.6 25.5 61.8 23.1 10.5 57.9 4.8 20.6 48.5 50.4 71.1 17.0 44.7 25.3 13.6 20.3 25.1 30.1 22.9 24.4 41.1 11.2 12.9 41.8 40.2 33.6 14.2 35.4 46.8 21.1 42.2 STEAP2 "IPCA-1, PCANAP1, STAMP1, STMP" ENSG00000157214 "STEAP2 metalloreductase" Q8NFT2 7 90167590-90238137 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "prostate: 100.2" "Cell type enriched" "Detected in many" 4 "Glandular cells: 110.4" "Cancer enriched" "Detected in many" 12 "prostate cancer: 88.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 13.4;CAPAN-2: 28.9;U-138 MG: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029115, HPA055603" Uncertain Supported Vesicles NA NA Vesicles "HPA029115: AB_10603894, HPA055603: " "unprognostic (6.26e-3)" "unprognostic (2.48e-1)" "unprognostic (2.55e-1)" "unprognostic (1.65e-1)" "unprognostic (8.20e-4)" "unprognostic (2.34e-1)" "unprognostic (1.13e-1)" "unprognostic (3.67e-3)" "unprognostic (7.91e-2)" "unprognostic (1.70e-1)" "unprognostic (9.92e-2)" "unprognostic (1.34e-1)" "unprognostic (2.71e-2)" "unprognostic (9.73e-2)" "unprognostic (6.11e-2)" "unprognostic (9.86e-5)" "unprognostic (3.69e-2)" 10.7 4.1 6.2 9.7 14.5 1.3 13.6 8.7 18.2 7.0 8.3 2.3 2.2 5.7 5.4 3.6 9.1 7.5 8.8 9.4 5.1 5.2 6.5 3.6 10.8 1.6 3.2 11.1 19.5 6.4 10.3 17.6 1.4 6.0 100.2 7.0 3.8 6.8 6.7 2.3 3.5 5.9 9.0 2.9 3.0 9.2 2.3 1.6 1.6 5.8 1.2 2.5 10.4 19.9 1.1 0.4 1.3 0.4 0.3 0.2 0.0 1.8 13.4 0.3 3.8 7.2 7.0 0.2 1.6 3.5 0.2 0.5 2.5 28.9 0.0 0.2 4.4 5.4 1.1 2.9 2.1 0.5 0.0 2.9 0.0 0.0 0.7 0.6 0.0 0.0 5.1 0.4 7.0 1.4 5.8 3.6 0.0 0.0 0.2 4.0 0.0 0.0 0.4 5.5 0.0 1.5 0.0 0.0 0.1 6.3 3.9 0.3 1.3 2.1 0.0 0.1 0.6 10.2 0.0 3.0 16.8 3.8 2.3 1.4 0.0 0.0 0.0 7.3 0.0 0.7 1.3 0.4 0.5 0.2 0.2 0.1 1.1 0.1 0.1 0.0 0.4 0.2 0.2 1.2 0.3 0.2 0.4 0.0 0.0 6.2 14.5 8.7 18.2 5.1 5.2 3.2 11.1 6.0 1.6 0.0 0.6 0.0 20.8 4.2 5.1 11.6 17.8 16.0 13.6 12.2 2.0 0.0 0.0 0.6 0.4 1.8 11.8 0.0 6.6 0.0 17.5 110.4 0.0 4.9 0.0 1.6 15.1 2.5 0.0 0.4 14.4 1.7 0.0 0.0 12.5 26.2 8.6 25.8 14.5 8.6 1.2 0.0 6.2 1.0 3.4 4.6 0.0 0.0 12.7 19.6 STK11IP "KIAA1898, LIP1, LKB1IP, STK11IP1" ENSG00000144589 "Serine/threonine kinase 11 interacting protein" 2 219597860-219616451 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 14.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036837, HPA036838, HPA053192" Approved Enhanced Vesicles NA NA Vesicles "HPA036837: AB_10969754, HPA036838: AB_10672100, HPA053192: AB_2682075" "unprognostic (3.37e-1)" "unprognostic (1.33e-1)" "unprognostic (3.51e-1)" "unprognostic (1.97e-1)" "unprognostic (2.15e-1)" "unprognostic (3.33e-3)" "unprognostic (1.22e-3)" "unprognostic (8.36e-2)" "unprognostic (9.36e-2)" "unprognostic (1.87e-2)" "prognostic favorable (1.63e-4)" "unprognostic (9.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.80e-3)" "unprognostic (9.44e-2)" "unprognostic (1.02e-1)" "unprognostic (2.51e-2)" 5.7 8.4 10.1 11.9 10.7 15.2 6.4 15.0 9.5 5.8 8.2 6.7 6.7 8.1 9.2 14.3 8.2 9.1 9.5 6.2 7.0 6.5 7.2 5.6 7.4 11.4 5.1 7.5 17.0 9.9 7.0 21.2 12.1 7.0 8.2 7.2 6.2 5.8 6.3 5.1 16.3 7.9 7.5 5.9 10.6 6.4 27.7 6.4 26.5 8.9 7.1 9.6 5.9 6.3 1.7 14.8 5.0 6.1 3.4 2.7 2.1 7.0 11.0 11.8 8.0 4.2 7.5 12.1 6.3 5.5 10.2 8.7 10.1 12.0 4.1 6.4 6.0 9.3 17.5 5.6 13.4 7.6 6.0 8.5 10.6 11.2 8.1 5.5 11.0 28.1 7.2 12.0 8.6 4.3 10.5 6.2 7.0 7.9 6.2 5.7 13.8 6.4 13.7 11.8 3.3 6.1 12.2 4.3 3.2 10.2 11.1 7.8 12.3 4.0 10.0 8.2 9.9 6.4 10.8 4.7 11.1 9.5 10.6 6.0 6.9 3.0 7.3 8.4 6.1 6.9 1.5 3.9 5.0 2.7 5.7 2.4 1.7 1.3 2.2 7.6 1.5 1.1 1.1 1.3 3.4 6.1 14.8 2.1 2.1 10.1 10.7 15.0 9.5 7.0 6.5 5.1 7.5 7.0 6.4 6.0 7.0 0.5 1.9 2.1 7.8 3.2 2.5 10.7 6.8 7.0 17.7 8.6 1.7 4.8 11.5 3.7 8.4 0.0 5.6 4.7 4.1 2.4 12.7 3.0 7.6 11.1 12.6 5.5 8.4 24.5 23.6 6.0 3.3 1.8 8.5 6.0 3.5 3.5 13.8 2.2 11.7 12.9 4.0 17.2 11.5 2.4 13.5 4.1 5.6 2.5 STPG3 "C9orf173, FLJ40246" ENSG00000197768 "Sperm-tail PG-rich repeat containing 3" Q8N7X2 9 137251261-137253483 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "testis: 55.3" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 7.3;RPMI-8226: 3.0;SK-BR-3: 3.0;T-47d: 4.6;U-266/70: 2.9" HPA044352 Uncertain Vesicles NA NA Vesicles "HPA044352: AB_10965328" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (4.32e-3)" "unprognostic (4.72e-4)" "unprognostic (2.56e-1)" "unprognostic (1.22e-2)" "unprognostic (1.08e-2)" "unprognostic (2.77e-3)" "unprognostic (1.29e-1)" "unprognostic (3.93e-2)" "unprognostic (8.59e-4)" "unprognostic (2.09e-1)" "unprognostic (7.25e-2)" "unprognostic (2.65e-1)" "unprognostic (1.58e-1)" "unprognostic (1.29e-1)" "unprognostic (7.95e-2)" 0.8 0.4 0.2 0.2 0.2 0.1 0.4 0.2 0.2 0.3 0.2 0.2 0.2 4.4 0.2 1.2 0.2 0.3 0.2 0.2 0.2 0.0 1.1 1.7 0.2 0.2 0.2 0.2 0.2 1.4 0.0 1.1 0.2 0.2 0.2 0.0 0.2 1.5 0.2 0.2 0.5 3.2 0.2 0.2 0.2 0.5 55.3 0.2 0.2 1.4 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.3 0.9 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.6 2.0 1.2 0.3 0.0 0.0 1.0 0.0 0.0 0.0 7.3 0.0 0.1 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.0 0.3 0.0 0.5 1.3 1.1 0.0 1.7 0.0 0.2 0.0 0.5 0.4 0.0 0.0 3.0 0.0 0.0 0.9 0.6 0.4 3.0 0.0 0.6 4.6 0.0 0.0 0.8 1.4 0.2 0.0 2.9 1.5 1.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 STX16 "hsyn16, SYN16" ENSG00000124222 "Syntaxin 16" O14662 20 58651253-58679526 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA041019, HPA042033" Uncertain Enhanced Vesicles NA NA Vesicles "HPA041019: AB_10964273, HPA042033: AB_10963935" "unprognostic (7.52e-2)" "unprognostic (1.91e-1)" "unprognostic (7.96e-2)" "unprognostic (1.35e-2)" "unprognostic (1.51e-1)" "unprognostic (2.12e-1)" "prognostic unfavorable (4.18e-4)" "unprognostic (7.32e-2)" "unprognostic (5.11e-2)" "unprognostic (3.51e-2)" "unprognostic (2.80e-3)" "unprognostic (2.41e-2)" "prognostic unfavorable (1.11e-16)" "unprognostic (3.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.56e-1)" "unprognostic (5.89e-2)" 22.1 24.5 41.9 25.3 46.7 36.7 22.3 54.5 43.2 21.9 23.3 35.0 35.9 20.3 30.3 36.9 18.8 26.7 23.4 17.3 36.8 22.4 18.6 20.0 20.5 32.8 43.0 32.8 29.2 23.1 18.5 33.0 20.5 34.0 24.6 21.1 20.9 27.9 28.5 25.9 41.5 23.6 29.4 33.0 31.0 21.7 22.2 42.9 16.6 23.7 15.7 24.7 24.2 24.3 4.7 4.3 14.1 6.2 5.6 6.1 4.0 14.3 8.4 11.1 10.8 20.5 22.0 15.5 17.8 12.1 18.3 11.4 16.4 21.1 16.5 25.0 12.7 23.0 21.4 10.2 21.2 15.3 7.8 10.8 10.3 22.1 19.8 20.4 14.7 23.4 24.3 32.6 12.3 18.8 34.5 18.5 19.6 11.9 14.8 14.7 33.6 11.3 17.8 4.5 11.7 14.4 10.5 10.4 11.4 14.0 10.7 7.4 11.3 18.9 33.3 32.1 19.7 13.3 19.5 19.5 30.3 14.7 11.5 19.6 30.7 14.2 9.2 22.3 11.4 12.6 14.1 6.2 5.2 5.0 5.6 5.6 2.6 4.5 3.5 4.1 4.7 6.1 5.5 14.0 5.6 4.1 4.3 4.8 4.0 41.9 46.7 54.5 43.2 36.8 22.4 43.0 32.8 34.0 42.9 20.8 40.6 22.8 18.7 23.9 60.9 17.1 43.3 45.5 31.8 27.9 80.5 20.1 5.0 13.1 3.2 32.4 21.5 23.3 11.7 13.5 17.7 20.1 18.5 25.2 19.3 39.7 44.3 32.5 32.9 6.5 21.0 31.3 20.3 14.4 28.0 32.0 16.7 27.1 27.3 8.4 50.6 12.9 21.7 39.8 20.2 36.9 14.6 34.6 25.0 16.6 SULT2B1 HSST2 ENSG00000088002 "Sulfotransferase family 2B member 1" O00204 19 48552075-48599425 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Transferase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 91.8;lymphoid tissue: 78.6;tongue: 79.6" "Cell type enhanced" "Detected in many" 13 "Glandular cells: 53.7;Suprabasal keratinocytes: 120.1;Urothelial cells: 113.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "CAPAN-2: 27.6;MCF7: 16.9;OE19: 44.8;T-47d: 13.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA041724, HPA043539, HPA076510" Enhanced Supported Vesicles NA NA Vesicles "HPA041724: AB_2677638, HPA043539: AB_2678540, HPA076510: " "unprognostic (6.55e-2)" "unprognostic (1.47e-1)" "unprognostic (5.28e-3)" "unprognostic (8.74e-2)" "unprognostic (5.00e-2)" "unprognostic (5.97e-2)" "unprognostic (4.43e-2)" "unprognostic (3.29e-3)" "unprognostic (1.62e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-2)" "unprognostic (4.42e-2)" "unprognostic (5.01e-6)" "unprognostic (7.96e-3)" "unprognostic (1.32e-1)" "unprognostic (8.04e-2)" "unprognostic (2.77e-2)" 0.1 0.1 0.1 0.3 0.1 0.0 4.0 0.1 0.2 28.7 0.8 0.0 9.2 2.9 2.2 5.2 91.8 0.3 2.3 0.0 0.1 0.1 2.5 0.1 6.5 0.0 0.2 0.0 0.1 0.2 0.8 0.1 11.4 0.0 6.9 0.0 0.0 12.4 6.9 0.2 45.7 13.4 0.0 0.1 0.0 0.7 0.2 0.0 0.5 1.1 79.6 78.6 0.6 32.0 0.7 1.5 2.5 1.0 1.1 3.1 0.9 4.5 5.8 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 27.6 0.0 0.0 0.0 0.2 1.4 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.2 0.0 0.0 2.5 0.0 0.8 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 16.9 0.0 0.2 0.0 44.8 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 2.3 0.1 0.0 13.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 2.5 0.8 0.4 2.1 0.9 3.1 0.4 1.8 1.4 0.7 0.7 0.6 1.2 1.4 1.1 1.0 1.5 1.1 0.9 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.0 17.9 0.3 0.0 28.4 21.4 0.0 0.6 2.5 4.0 13.6 8.7 0.0 2.8 0.0 11.1 0.0 0.3 8.6 0.0 1.0 2.7 2.0 53.7 0.0 0.0 0.6 0.0 4.6 0.0 0.0 0.2 0.3 0.2 11.8 0.0 7.1 1.2 10.8 7.0 0.0 0.8 0.6 0.0 2.8 0.2 7.5 120.1 1.6 0.0 2.6 113.8 SUSD4 FLJ10052 ENSG00000143502 "Sushi domain containing 4" Q5VX71 1 223220819-223364202 "Predicted intracellular proteins, Predicted membrane proteins" "Complement pathway, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 33.0;esophagus: 33.8" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 26.6;Horizontal cells: 20.6;Leydig cells: 19.0;Urothelial cells: 26.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD4 T-cell: 7.4;naive CD4 T-cell: 11.7" "Lineage enriched" "Detected in single" 66 "T-cells: 11.7" "Cell line enhanced" "Detected in some" "HaCaT: 7.1;RPTEC TERT1: 8.4;SCLC-21H: 29.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058296 Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA058296: AB_2683672" "unprognostic (2.90e-1)" "unprognostic (2.90e-3)" "unprognostic (1.27e-3)" "prognostic unfavorable (4.28e-4)" "unprognostic (2.12e-1)" "unprognostic (7.01e-2)" "unprognostic (7.53e-3)" "unprognostic (1.82e-3)" "unprognostic (7.94e-2)" "unprognostic (1.57e-1)" "unprognostic (1.27e-3)" "unprognostic (1.36e-1)" "unprognostic (6.51e-6)" "unprognostic (3.64e-2)" "unprognostic (5.11e-2)" "unprognostic (3.03e-1)" "unprognostic (7.11e-2)" 0.8 5.2 15.9 1.5 33.0 0.9 8.1 9.9 21.3 3.4 0.9 4.0 4.7 1.5 0.9 24.3 33.8 3.6 1.3 9.6 30.6 14.6 13.7 4.0 3.2 1.9 6.8 12.8 27.8 7.6 8.3 16.5 1.0 6.6 4.4 0.8 1.2 13.2 5.7 1.2 3.5 0.9 0.9 2.4 0.8 7.6 5.1 3.8 0.3 1.5 8.1 13.8 2.7 9.1 0.0 0.0 0.0 0.1 0.1 11.7 1.8 4.3 0.4 0.1 0.0 0.0 0.0 0.1 0.6 0.3 0.7 0.5 4.5 1.3 0.0 1.4 0.1 0.0 7.1 0.2 1.1 0.7 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.5 0.1 0.0 5.0 0.4 0.0 0.3 3.2 3.1 0.0 0.1 2.1 0.9 0.0 0.1 0.0 8.4 2.0 29.0 0.3 0.0 2.4 0.0 0.6 1.8 0.2 0.0 1.3 5.2 0.0 2.6 0.5 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.1 6.0 0.0 7.4 1.9 0.0 0.0 11.7 2.1 0.0 0.1 0.0 0.0 1.0 1.8 15.9 33.0 9.9 17.9 30.6 14.6 6.8 12.8 6.6 3.8 0.0 4.5 0.0 5.3 0.6 15.9 9.1 0.0 8.1 12.5 15.7 9.8 0.0 26.6 0.6 2.5 0.4 0.0 0.0 6.3 0.0 0.7 6.8 0.0 1.5 2.1 20.6 1.2 0.0 0.0 2.8 19.0 0.1 5.0 0.0 0.0 1.1 2.7 0.0 11.7 0.2 6.1 0.0 1.0 0.5 5.9 1.5 0.0 1.3 0.0 26.8 SYBU "FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL" ENSG00000147642 Syntabulin Q9NX95 8 109573978-109691791 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 82.7" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 47.0;Horizontal cells: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "memory B-cell: 9.4;naive B-cell: 4.4" "Lineage enriched" "Detected in single" 29 "B-cells: 9.4" "Cell line enhanced" "Detected in many" "HaCaT: 13.5;PC-3: 15.2;SK-BR-3: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053057 Uncertain Supported Vesicles NA NA Vesicles "HPA053057: AB_2682028" "unprognostic (4.69e-2)" "unprognostic (1.40e-1)" "unprognostic (2.46e-1)" "unprognostic (1.31e-1)" "unprognostic (1.18e-1)" "unprognostic (4.27e-1)" "prognostic favorable (7.74e-4)" "unprognostic (1.22e-2)" "unprognostic (1.37e-1)" "unprognostic (2.16e-1)" "unprognostic (3.13e-1)" "unprognostic (5.52e-2)" "unprognostic (1.87e-3)" "unprognostic (1.68e-1)" "unprognostic (6.05e-3)" "unprognostic (6.89e-2)" "unprognostic (4.27e-2)" 17.6 19.7 18.2 2.5 25.5 0.8 13.3 36.8 31.3 7.7 8.7 4.0 11.5 7.1 3.4 7.9 4.1 12.8 6.9 2.6 15.2 23.0 3.3 26.6 5.2 3.1 13.5 17.9 5.5 82.7 1.6 12.4 2.1 14.7 5.1 12.5 3.5 12.6 10.0 2.5 5.3 7.4 5.1 7.2 1.2 8.7 1.7 5.1 0.3 7.6 1.1 5.1 2.9 3.8 9.4 0.1 0.0 0.0 0.0 0.3 0.1 5.2 2.6 2.1 0.0 0.3 0.3 1.5 1.8 0.0 0.0 0.0 4.7 3.1 0.4 0.3 1.4 0.7 13.5 0.4 3.6 0.0 0.0 7.3 0.0 7.9 4.7 3.5 0.0 0.0 1.3 4.6 0.0 4.4 0.2 1.9 0.3 0.2 0.9 2.0 0.1 0.1 0.0 0.4 4.6 15.2 0.0 0.0 0.0 5.8 1.2 10.2 1.1 4.8 31.0 1.0 1.6 3.9 0.2 2.7 0.2 1.1 0.0 0.8 0.9 0.0 0.3 6.4 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 9.4 0.1 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 18.2 25.5 36.8 31.3 15.2 23.0 13.5 17.9 14.7 5.1 8.9 4.8 2.0 1.9 5.0 47.0 2.0 22.9 14.7 15.9 10.4 7.9 2.9 3.3 4.2 0.7 5.8 4.1 0.0 8.1 1.0 4.1 14.5 0.0 33.1 0.3 90.6 33.2 3.7 1.5 0.0 2.0 0.2 1.7 1.0 22.2 1.6 4.6 13.1 0.4 0.0 6.3 0.0 4.4 0.1 0.4 2.9 0.6 0.0 11.7 2.6 SYNDIG1 "C20orf39, FLJ14220, IFITMD5, SynDIG1, TMEM90B" ENSG00000101463 "Synapse differentiation inducing 1" Q9H7V2 20 24469199-24666616 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.3;heart muscle: 28.2" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 5.0;Cardiomyocytes: 12.1;Distal tubular cells: 5.0;Peritubular cells: 6.7;Proximal tubular cells: 5.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Karpas-707: 8.2;RH-30: 23.3;RPMI-8226: 22.1;SCLC-21H: 5.4;U-87 MG: 14.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044271, HPA059267" Enhanced Vesicles NA NA Vesicles "HPA044271: AB_2732515, HPA059267: AB_2683961" "unprognostic (9.33e-2)" "unprognostic (1.83e-2)" "unprognostic (2.17e-1)" "unprognostic (9.56e-2)" "unprognostic (5.03e-2)" "unprognostic (1.27e-1)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (1.62e-1)" "unprognostic (4.69e-2)" "unprognostic (4.23e-1)" "unprognostic (3.71e-2)" "unprognostic (1.94e-2)" "unprognostic (7.75e-3)" "unprognostic (2.21e-1)" "prognostic unfavorable (6.16e-6)" "unprognostic (1.40e-3)" 2.6 1.7 12.5 2.1 12.0 0.7 0.8 21.3 22.7 4.5 1.5 23.3 0.3 1.9 2.6 1.5 0.9 5.1 10.0 28.2 12.8 8.8 6.2 0.7 1.1 2.5 14.5 12.9 1.3 1.4 0.9 0.6 0.9 11.5 3.2 1.6 0.5 0.8 14.8 0.6 0.8 2.8 3.1 22.4 1.4 2.2 1.3 16.6 0.1 5.1 0.0 3.1 2.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.4 0.0 0.4 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 8.2 0.0 0.4 0.0 0.0 1.4 0.0 0.0 0.0 23.3 22.1 0.0 0.0 5.4 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 12.0 21.3 19.7 12.8 8.8 14.5 12.9 11.5 16.6 0.0 0.0 0.0 0.0 0.0 5.0 12.1 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.9 0.0 6.7 5.4 0.4 0.0 0.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 SYT13 KIAA1427 ENSG00000019505 "Synaptotagmin 13" Q7L8C5 11 45240301-45286319 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.1;gallbladder: 18.8" "Cell type enriched" "Detected in many" 8 "Intestinal endocrine cells: 323.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.4" "Lineage enriched" "Detected in single" 6 "granulocytes: 1.4" "Cell line enhanced" "Detected in some" "A549: 11.5;NTERA-2: 5.4;RPTEC TERT1: 35.1;SCLC-21H: 9.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046224, HPA056602" Uncertain Supported Vesicles NA NA Vesicles "HPA046224: AB_10961288, HPA056602: AB_2683185" "unprognostic (4.96e-2)" "unprognostic (1.06e-2)" "unprognostic (9.92e-2)" "prognostic unfavorable (7.79e-5)" "unprognostic (1.00e-2)" "unprognostic (4.17e-2)" "unprognostic (3.75e-2)" "unprognostic (9.83e-3)" "unprognostic (2.19e-1)" "unprognostic (7.58e-2)" "unprognostic (1.21e-1)" "unprognostic (2.47e-1)" "unprognostic (5.66e-3)" "unprognostic (2.94e-2)" "unprognostic (1.76e-1)" "unprognostic (8.70e-2)" "unprognostic (5.13e-2)" 0.4 4.5 15.8 1.5 15.1 0.4 0.5 19.0 38.1 0.3 10.6 1.2 0.0 10.9 0.6 0.3 0.4 0.5 18.8 4.5 11.8 19.5 8.0 0.6 0.8 0.4 10.6 15.1 0.4 6.4 0.4 9.4 0.4 27.9 2.0 11.2 0.9 1.4 0.4 0.5 0.5 11.1 1.1 2.2 0.5 9.2 1.8 0.3 0.0 1.8 0.0 0.3 0.4 0.2 0.2 0.0 1.4 0.0 0.2 0.2 0.0 0.0 11.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 5.4 0.0 0.1 0.0 0.0 0.0 35.1 0.0 9.3 0.4 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.1 1.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.2 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.0 15.8 15.1 19.0 31.1 11.8 19.5 10.6 15.1 27.9 0.3 0.0 0.0 0.0 0.2 0.0 1.1 8.1 15.3 0.0 0.0 3.5 23.6 0.0 5.0 1.2 3.1 0.0 10.0 0.0 0.5 0.0 0.0 4.2 0.0 0.0 0.0 1.6 323.7 0.0 0.0 8.2 0.3 0.0 0.0 0.0 30.8 0.5 5.3 17.5 0.0 0.3 1.5 0.0 0.0 1.9 0.2 0.0 0.0 0.0 38.3 0.1 SYT14 "FLJ34198, sytXIV" ENSG00000143469 "Synaptotagmin 14" Q8NB59 1 209938174-210171389 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 17.4;pituitary gland: 31.1;testis: 9.5;thyroid gland: 15.9" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 28.8;Cone photoreceptor cells: 25.5;Horizontal cells: 49.3;Rod photoreceptor cells: 28.8;Spermatogonia: 19.3" "Cancer enhanced" "Detected in some" "thyroid cancer: 1.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 13.0;GAMG: 8.8;SCLC-21H: 6.8;TIME: 10.8;U-138 MG: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036963 Supported Vesicles NA NA Vesicles "HPA036963: AB_10670378" "unprognostic (1.38e-4)" "unprognostic (8.62e-3)" "unprognostic (1.93e-1)" "unprognostic (3.90e-4)" "unprognostic (1.97e-1)" "unprognostic (4.43e-5)" "unprognostic (1.92e-1)" "unprognostic (1.88e-2)" "unprognostic (6.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.81e-1)" "unprognostic (4.85e-3)" "unprognostic (2.30e-4)" "unprognostic (1.61e-1)" "unprognostic (1.76e-1)" "unprognostic (3.33e-3)" 0.7 3.2 5.9 0.8 7.4 0.8 0.6 17.4 10.2 0.6 0.7 3.8 0.0 0.7 1.4 0.8 0.6 0.6 0.6 0.6 4.5 2.6 0.9 0.6 0.7 0.7 3.3 5.9 0.8 1.2 0.6 31.1 0.6 5.0 0.8 0.8 1.1 0.6 0.6 0.7 0.7 0.7 0.7 2.4 0.7 0.9 9.5 3.0 0.0 15.9 0.0 0.6 0.6 0.4 2.0 0.8 2.1 0.5 1.1 0.8 0.1 3.3 0.1 0.0 0.0 0.3 0.0 0.0 2.7 13.0 2.7 1.4 0.0 0.2 0.0 0.1 0.3 8.8 4.1 0.0 0.0 3.3 0.5 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.1 1.9 5.7 1.7 0.5 0.0 0.0 0.0 4.9 0.0 0.0 0.0 4.5 0.0 1.8 0.0 0.1 0.1 0.2 3.0 6.8 3.1 0.0 0.0 5.6 1.0 0.0 0.1 10.8 8.2 3.9 0.7 1.4 0.1 0.1 0.0 0.7 0.0 1.9 2.1 0.4 0.6 0.8 0.2 0.4 0.6 0.5 0.4 0.3 2.0 0.4 0.6 1.8 1.1 0.5 0.8 0.4 0.1 5.9 7.4 17.4 10.2 4.5 2.6 3.3 5.9 5.0 3.0 0.0 0.0 0.0 0.1 0.0 28.8 1.6 0.0 0.0 0.0 0.0 25.5 0.0 3.3 0.1 12.0 0.0 0.0 0.0 0.5 0.0 0.0 0.4 0.0 0.0 0.0 49.3 0.0 0.0 0.0 3.2 0.6 0.0 0.0 0.0 0.0 1.5 0.5 0.0 0.0 0.3 28.8 0.0 0.0 4.9 19.3 0.0 0.0 0.0 0.0 0.1 SYT6 ENSG00000134207 "Synaptotagmin 6" Q5T7P8 1 114089291-114153919 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 14.9;kidney: 3.7;pancreas: 11.1" "Cell type enhanced" "Detected in some" 18 "Early spermatids: 5.6;Late spermatids: 9.2;Melanocytes: 3.3;Proximal tubular cells: 2.4" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "NTERA-2: 21.1;WM-115: 14.9" "Group enriched" "Detected in many" 7 "basal ganglia: 27.9;olfactory region: 87.2" "Low region specificity" "Detected in many" HPA058362 Approved Vesicles NA NA Vesicles "HPA058362: " "unprognostic (7.12e-2)" "unprognostic (2.03e-2)" "unprognostic (3.26e-3)" "unprognostic (1.04e-1)" "unprognostic (9.37e-2)" "unprognostic (2.49e-1)" "unprognostic (4.11e-2)" "unprognostic (3.60e-3)" "unprognostic (1.19e-1)" "unprognostic (4.71e-1)" "unprognostic (5.50e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-1)" "unprognostic (2.11e-3)" "unprognostic (1.48e-1)" "unprognostic (1.48e-2)" "unprognostic (1.18e-1)" 0.3 2.2 2.6 0.8 6.5 0.3 2.1 0.2 10.4 0.4 0.3 5.1 0.0 0.9 0.4 0.2 0.2 0.3 0.5 0.3 2.3 14.9 3.7 0.3 0.4 0.3 2.8 1.3 2.3 11.1 0.7 0.3 1.4 3.9 1.5 0.6 0.9 1.1 0.2 0.4 0.4 0.5 0.3 4.2 0.3 0.3 0.9 3.3 0.0 0.3 0.0 0.3 0.3 0.0 0.0 0.0 0.5 0.0 0.1 0.3 0.1 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 21.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.6 6.5 0.2 9.3 2.3 14.9 2.8 1.3 3.9 3.3 0.0 0.0 0.0 0.0 0.0 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 9.2 0.0 0.0 3.3 0.0 0.0 0.2 0.0 0.0 0.0 2.4 0.7 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.0 SYTL4 ENSG00000102362 "Synaptotagmin like 4" Q96C24 X 100674491-100732123 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 36.2;ovary: 47.3;pituitary gland: 41.9" "Cell type enhanced" "Detected in many" 8 "Leydig cells: 67.3;Peritubular cells: 39.3;Sertoli cells: 51.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 5.1" "Lineage enriched" "Detected in single" 9 "granulocytes: 5.1" "Cell line enhanced" "Detected in many" "HAP1: 15.1;HMC-1: 31.3;RT4: 20.6;TIME: 17.7" "Region enriched" "Detected in single" 5 "hypothalamus: 35.1" "Low region specificity" "Detected in some" "HPA001475, HPA001589, HPA075138" Approved Approved Vesicles NA Yes 6100000 Vesicles "HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: " "unprognostic (7.82e-3)" "unprognostic (1.52e-1)" "unprognostic (3.43e-2)" "unprognostic (6.16e-2)" "unprognostic (1.04e-1)" "unprognostic (1.14e-1)" "unprognostic (5.78e-2)" "unprognostic (1.32e-1)" "unprognostic (3.35e-2)" "unprognostic (2.81e-1)" "unprognostic (1.07e-3)" "unprognostic (5.62e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.30e-1)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "unprognostic (1.60e-2)" 3.8 3.1 9.1 2.8 9.5 1.6 4.4 4.3 8.4 18.1 5.3 6.6 4.8 1.7 36.2 5.4 2.6 10.0 2.9 2.1 11.9 6.0 4.2 7.1 3.0 0.7 9.8 2.7 47.3 8.8 1.3 41.9 2.6 9.4 9.2 6.8 1.3 3.8 6.0 4.5 1.4 3.0 22.5 7.8 2.3 5.3 7.8 9.5 0.0 6.2 1.1 1.4 4.3 9.4 0.5 0.3 5.1 0.3 0.5 0.4 2.3 0.1 3.0 0.8 0.0 4.5 2.5 0.0 3.9 2.5 4.2 7.5 0.3 3.9 0.0 1.0 2.7 3.6 3.5 15.1 1.3 4.4 0.0 1.3 0.0 5.1 0.2 1.1 0.0 31.3 0.9 0.3 3.8 0.2 1.6 10.5 0.0 1.4 0.0 1.9 1.0 0.0 0.0 0.6 10.6 0.0 0.0 1.2 0.0 3.7 20.6 7.6 0.3 1.5 5.9 0.8 1.6 3.7 0.3 17.7 2.2 4.7 10.8 0.9 0.0 0.0 0.0 2.7 0.0 2.4 1.1 0.3 0.5 0.2 0.2 0.2 0.3 0.2 0.2 0.0 0.5 0.4 0.2 5.1 0.5 0.2 0.3 0.1 2.3 9.1 9.5 4.3 8.4 11.9 6.0 9.8 2.7 9.4 9.5 26.8 1.7 0.0 6.9 0.1 0.1 3.6 22.9 6.7 6.8 3.5 0.0 0.2 3.3 5.5 1.6 9.5 15.8 0.0 2.0 0.2 6.3 15.5 3.5 32.1 1.0 0.0 0.0 12.3 1.6 2.0 67.3 0.9 3.3 0.0 18.0 4.6 5.4 25.4 39.3 1.6 0.4 51.8 6.2 1.4 4.6 0.6 0.0 0.7 8.1 7.6 TAC3 "NKB, NKNB, ZNEUROK1" ENSG00000166863 "Tachykinin 3" Q9UHF0 12 57010000-57028883 "Disease related genes, Predicted secreted proteins" Neuropeptide "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "placenta: 133.5" "Group enriched" "Detected in some" 4 "Cytotrophoblasts: 6.9;Extravillous trophoblasts: 8.1;Syncytiotrophoblasts: 15.3" "Cancer enriched" "Detected in many" 7 "urothelial cancer: 40.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "K-562: 15.0;SuSa: 15.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045919 Supported Supported Approved Vesicles "Secreted in female reproductive system" NA NA Vesicles "HPA045919: AB_10960533" "unprognostic (4.53e-2)" "unprognostic (1.97e-2)" "unprognostic (8.41e-2)" "unprognostic (3.00e-2)" "unprognostic (3.61e-2)" "unprognostic (1.76e-2)" "unprognostic (5.99e-2)" "unprognostic (8.41e-2)" "unprognostic (1.34e-1)" "unprognostic (2.03e-1)" "unprognostic (5.28e-2)" "unprognostic (4.71e-14)" "unprognostic (1.58e-2)" "unprognostic (1.76e-1)" "unprognostic (1.01e-1)" "unprognostic (2.39e-1)" 0.5 0.6 3.9 1.5 20.0 0.8 0.5 0.0 11.0 0.5 1.2 0.1 0.0 1.5 0.6 0.5 0.5 0.5 0.6 0.5 4.4 9.5 0.5 0.5 0.5 0.5 0.8 2.1 0.5 0.7 0.5 0.0 133.5 1.5 0.5 1.0 0.3 0.5 0.5 0.5 0.7 3.2 2.0 9.4 0.5 8.1 0.8 0.2 0.0 0.5 0.0 0.6 2.2 0.5 0.0 0.1 0.0 0.1 0.0 0.7 0.0 0.0 0.1 0.0 0.5 0.0 0.0 1.4 0.0 1.1 0.3 0.0 2.9 0.0 0.8 0.0 0.1 0.0 0.0 0.2 0.0 0.4 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.3 15.0 0.4 0.0 0.0 0.0 0.2 2.0 0.6 0.0 0.0 0.0 0.0 0.0 1.5 2.5 0.7 0.0 0.9 0.0 15.3 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.9 20.0 0.0 11.0 4.4 9.5 0.8 2.1 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 8.1 0.0 0.0 0.0 0.0 2.0 0.0 1.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.6 0.0 15.3 0.0 1.7 0.0 TAOK1 "FLJ14314, KIAA1361, MAP3K16, MARKK, PSK2, TAO1" ENSG00000160551 "TAO kinase 1" Q7L7X3 17 29390464-29551904 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA repair" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007669 Approved Uncertain Vesicles NA NA 13000 Vesicles "HPA007669: AB_1080201" "unprognostic (1.46e-1)" "unprognostic (7.15e-3)" "unprognostic (2.70e-2)" "unprognostic (1.52e-1)" "unprognostic (1.81e-2)" "unprognostic (4.85e-2)" "unprognostic (1.28e-2)" "unprognostic (4.31e-2)" "unprognostic (1.15e-1)" "unprognostic (6.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.36e-1)" "unprognostic (2.85e-2)" "unprognostic (5.53e-3)" "unprognostic (3.57e-1)" "unprognostic (1.66e-1)" "unprognostic (2.62e-1)" 17.2 11.5 19.1 11.9 25.0 12.7 13.3 20.1 24.4 15.8 11.9 22.2 7.9 7.1 14.9 10.8 12.7 11.0 11.6 15.3 18.7 15.5 13.6 10.6 13.2 11.1 30.0 17.6 13.5 9.3 31.7 13.7 14.3 21.8 12.0 10.7 10.9 11.1 13.3 15.0 13.8 9.8 17.7 21.0 13.0 10.8 14.3 23.5 11.7 17.7 6.0 11.2 14.5 17.1 2.4 4.8 5.5 2.1 1.4 3.0 0.9 13.7 24.5 19.3 8.2 14.4 18.3 8.1 13.0 13.9 11.9 12.6 13.2 4.8 8.5 12.7 21.1 12.8 10.8 17.6 9.0 21.6 17.8 13.0 13.6 14.1 7.0 10.5 15.0 12.6 12.0 11.6 17.6 18.1 12.6 16.3 8.7 13.9 7.8 15.6 9.2 11.8 5.6 8.2 7.6 6.3 10.9 27.2 5.9 11.3 19.9 10.7 13.1 22.3 20.9 13.4 20.4 15.1 13.9 23.6 18.3 14.9 16.0 18.2 7.2 15.4 9.9 13.4 9.4 16.5 1.7 1.9 1.5 2.0 2.1 1.6 1.6 2.0 2.4 1.7 2.4 3.0 2.2 5.5 1.4 1.9 4.8 1.2 0.9 19.1 25.0 20.1 22.7 18.7 15.5 30.0 17.6 21.8 23.5 44.7 47.4 18.4 23.0 39.5 53.4 78.7 30.6 24.1 38.7 43.6 92.3 15.2 13.3 23.9 10.7 41.3 21.4 0.0 20.9 13.5 47.9 34.5 27.7 23.6 25.9 49.3 36.1 51.5 65.2 12.5 36.8 44.8 38.8 23.4 20.1 35.6 30.2 21.2 50.9 15.9 48.3 25.8 36.8 55.4 33.6 40.1 31.5 19.8 18.0 38.2 TAPT1 FLJ90013 ENSG00000169762 "Transmembrane anterior posterior transformation 1" Q6NXT6 4 16160505-16227410 "Disease related genes, Predicted membrane proteins" "Chondrogenesis, Cilium biogenesis/degradation, Differentiation, Host-virus interaction, Osteogenesis" "Developmental protein, Receptor" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 108.0;Late spermatids: 117.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "REH: 27.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042567, HPA048658" Approved Uncertain Vesicles NA NA Vesicles "HPA042567: AB_2678055, HPA048658: AB_2680482" "unprognostic (2.34e-1)" "unprognostic (5.84e-2)" "unprognostic (1.41e-2)" "prognostic favorable (9.75e-4)" "unprognostic (2.43e-1)" "unprognostic (2.56e-2)" "unprognostic (2.32e-3)" "unprognostic (3.15e-3)" "unprognostic (1.54e-1)" "unprognostic (6.30e-2)" "prognostic favorable (5.34e-4)" "unprognostic (7.07e-2)" "prognostic favorable (8.52e-4)" "unprognostic (9.00e-2)" "unprognostic (8.52e-2)" "unprognostic (7.25e-3)" "prognostic favorable (4.18e-4)" 10.2 19.2 18.6 7.4 18.0 26.2 13.1 15.0 17.3 10.2 10.1 20.2 8.2 8.3 15.1 12.2 8.2 10.7 10.8 14.4 17.5 13.5 15.8 35.9 14.7 11.0 20.1 10.8 10.8 9.8 14.4 14.5 17.2 13.5 10.2 10.7 11.3 9.4 11.0 38.0 9.8 12.8 12.0 18.5 11.2 9.2 13.1 19.1 15.3 17.8 7.8 9.9 10.1 16.8 6.5 1.8 2.6 0.7 0.9 2.4 0.7 3.0 2.2 3.8 4.4 5.7 4.4 1.6 5.0 3.7 4.7 5.2 3.0 5.3 19.4 5.4 3.1 6.9 2.5 3.2 2.5 6.0 1.8 4.0 3.8 3.2 3.2 5.5 7.6 4.0 2.7 4.9 4.6 3.4 5.8 2.3 12.1 5.8 9.1 4.5 2.1 11.2 6.2 2.5 5.7 5.3 27.4 5.3 3.5 7.6 3.1 6.3 5.1 4.6 3.9 5.7 2.7 7.2 7.5 4.4 3.9 2.6 2.6 6.3 8.9 7.3 14.8 8.0 19.0 4.5 2.6 0.7 0.2 0.6 0.6 0.2 2.1 1.8 1.0 1.1 6.5 2.4 1.7 1.6 0.9 0.7 1.8 1.3 0.7 18.6 18.0 15.0 16.2 17.5 13.5 20.1 10.8 13.5 19.1 29.8 50.5 7.1 5.3 8.0 20.4 13.4 12.7 17.4 10.3 7.0 108.0 3.6 3.3 6.4 69.0 8.4 8.4 0.0 7.0 2.3 6.6 5.8 2.3 37.6 3.6 66.7 13.8 6.2 7.5 117.7 9.2 11.5 15.1 2.8 10.1 28.6 7.9 8.6 14.2 7.9 54.9 6.5 7.2 23.1 5.5 6.9 5.8 5.9 7.3 5.6 TBC1D3 "DKFZp434P2235, PRC17, TBC1D3A" ENSG00000274611 "TBC1 domain family member 3" Q8IZP1 17 38181659-38192541 "Predicted membrane proteins" "GTPase activation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "endometrium 1: 3.4;intestine: 5.5;lymphoid tissue: 3.5;testis: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Cell line enhanced" "Detected in some" "AF22: 9.1;REH: 5.7;U-138 MG: 7.9;U-266/70: 12.4;U-266/84: 4.8;U-698: 6.2" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.5 0.0 3.4 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.0 2.9 1.9 0.0 0.0 0.0 0.2 5.5 0.0 0.0 0.0 5.5 0.0 3.5 0.0 0.0 0.0 2.2 0.0 0.0 0.9 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.7 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.9 0.0 0.0 0.0 12.4 4.8 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3B "PRC17, TBC1D3I" ENSG00000274808 "TBC1 domain family member 3B" A6NDS4 17 36165681-36176636 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 6.6;testis: 3.5" "Cell type enriched" "Detected in some" 11 "Early spermatids: 11.6" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 11.5;HeLa: 9.8;T-47d: 8.0" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.94e-2)" "unprognostic (1.49e-1)" "unprognostic (1.67e-1)" "unprognostic (4.13e-2)" "unprognostic (1.11e-1)" "unprognostic (2.83e-1)" "unprognostic (2.51e-1)" "unprognostic (1.17e-1)" "unprognostic (7.15e-2)" "unprognostic (9.96e-3)" "unprognostic (1.05e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-1)" "unprognostic (3.56e-1)" "unprognostic (1.34e-1)" 0.0 0.1 1.0 0.4 0.4 0.1 0.0 0.1 1.2 0.0 0.0 1.0 0.4 0.2 0.0 0.0 0.0 0.2 0.6 0.1 1.3 0.0 0.0 0.2 0.0 0.8 0.8 1.2 6.6 0.5 0.0 2.0 1.9 3.5 0.0 0.1 0.4 0.0 0.0 0.7 0.0 1.0 0.4 0.1 1.5 2.5 1.5 1.8 1.5 1.8 4.9 1.2 0.7 1.3 2.1 0.5 11.5 0.2 1.0 0.7 0.6 5.0 0.7 1.1 0.5 2.0 3.9 0.8 9.8 0.7 0.9 0.3 1.4 1.5 2.3 1.6 0.2 3.3 1.0 1.2 0.7 1.1 0.5 0.1 1.0 4.4 0.5 0.4 0.5 1.5 0.4 0.2 1.6 1.5 1.0 1.3 1.1 0.7 0.9 2.0 8.0 1.0 2.7 0.5 0.4 4.0 0.5 1.6 1.2 0.5 1.5 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TBC1D3C MGC44903 ENSG00000278299 "TBC1 domain family member 3C" Q6IPX1 17 38057693-38068592 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.3;skin 1: 3.5;testis: 3.4" "Cell type enriched" "Detected in single" 8 "Early spermatids: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "CAPAN-2: 27.5" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.5 1.2 0.5 0.1 0.0 1.8 1.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.3 3.5 0.0 0.1 0.0 1.5 3.4 0.0 0.9 0.0 0.0 0.0 0.8 0.3 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 5.3 0.1 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.2 0.0 1.0 0.0 0.0 2.8 5.6 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3D ENSG00000274419 "TBC1 domain family member 3D" A0A087WVF3 17 38003976-38014902 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "intestine: 7.9;skin 1: 4.2" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 2.4;Cholangiocytes: 2.5;Club cells: 2.3;Cone photoreceptor cells: 5.9;Pancreatic endocrine cells: 2.5;Syncytiotrophoblasts: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 3.8;CAPAN-2: 11.6;HaCaT: 8.4;HeLa: 9.4;RPMI-8226: 5.0;RT4: 5.6" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 1.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.8 1.5 0.8 0.0 0.0 0.8 4.2 7.9 0.0 0.0 0.0 2.6 0.0 0.5 0.0 0.0 0.0 0.7 0.2 0.0 0.3 0.0 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.0 0.0 1.1 8.4 0.0 0.0 0.0 0.0 0.0 2.2 9.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.2 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 1.2 0.0 5.0 0.0 5.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 2.9 1.0 0.0 3.5 1.5 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 2.4 2.5 0.0 2.3 0.0 5.9 0.3 0.0 1.0 0.4 0.0 0.0 0.0 1.6 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 2.5 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 TBC1D3E ENSG00000278599 "TBC1 domain family member 3E" A0A087X179 17 38127951-38138862 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "bone marrow: 3.9;gallbladder: 3.0;pancreas: 4.3;testis: 4.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HHSteC: 9.8" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (1.18e-1)" "unprognostic (3.35e-1)" "unprognostic (3.51e-1)" "unprognostic (4.22e-2)" "unprognostic (6.28e-2)" "unprognostic (1.87e-2)" "unprognostic (5.07e-3)" "unprognostic (1.32e-3)" 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 1.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 9.8 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3F ENSG00000275954 "TBC1 domain family member 3F" 17 36428618-36439566 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 1.3" HPA046969 Uncertain Vesicles NA NA Vesicles "HPA046969: " 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3G ENSG00000260287 "TBC1 domain family member 3G" Q6DHY5 17 36323884-36334759 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 10 "testis: 8.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 36 "SiHa: 5.5;U-2197: 1.6" "HPA046969, HPA047745, HPA052553" Supported Approved Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (4.41e-1)" "unprognostic (1.17e-2)" "unprognostic (5.01e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3H ENSG00000274226 "TBC1 domain family member 3H" P0C7X1 17 36377531-36388423 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "cervix, uterine: 1.6;testis: 5.0;urinary bladder: 3.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "CAPAN-2: 11.5" "HPA046969, HPA047745, HPA052553" Approved Approved Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 3.3 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3I ENSG00000274933 "TBC1 domain family member 3I" A0A087WXS9 17 36253456-36264553 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "skin 1: 1.3;testis: 3.0" "Cell type enriched" "Detected in some" 23 "Early spermatids: 30.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "CAPAN-2: 11.1" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 0.2 0.0 0.9 0.5 0.0 1.3 0.9 0.0 0.3 0.1 3.0 0.0 0.1 0.2 0.1 0.2 0.7 0.2 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.2 0.0 0.6 0.0 0.1 0.1 0.2 0.1 11.1 0.1 0.6 0.0 0.0 1.7 0.0 0.1 0.0 0.1 0.7 0.7 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.1 0.4 0.2 0.1 0.9 0.0 0.0 0.2 0.2 0.1 0.0 0.1 0.1 0.2 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.7 0.1 0.2 0.2 0.2 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 TBC1D3K ENSG00000273513 "TBC1 domain family member 3K" A0A087X1G2 17 37924415-37935365 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "lymphoid tissue: 1.3;skeletal muscle: 1.1;testis: 4.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "SiHa: 2.2;T-47d: 5.4" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D3L ENSG00000274512 "TBC1 domain family member 3L" B9A6J9 17 37977972-37989048 "Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skin 1: 10.8" "Cell type enhanced" "Detected in some" 15 "Collecting duct cells: 1.8;Early spermatids: 2.1" "Low cancer specificity" "Detected in single" "Cell type enhanced" "Detected in some" "neutrophil: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 22.7;hTERT-RPE1: 24.9" "HPA046969, HPA047745, HPA052553" Approved Uncertain Vesicles NA NA Vesicles "HPA046969: , HPA047745: AB_2680144, HPA052553: AB_2681869" "unprognostic (5.14e-2)" "unprognostic (8.71e-2)" "unprognostic (8.44e-2)" "unprognostic (1.28e-1)" "unprognostic (3.61e-2)" "unprognostic (6.34e-2)" "unprognostic (3.19e-1)" "unprognostic (9.50e-2)" "unprognostic (1.76e-1)" "unprognostic (1.04e-1)" "unprognostic (1.80e-2)" "unprognostic (6.63e-6)" "unprognostic (2.90e-1)" "unprognostic (2.21e-1)" "unprognostic (1.66e-1)" "unprognostic (1.28e-3)" 0.5 2.4 1.8 0.6 1.8 1.3 0.2 1.2 2.4 0.0 2.9 2.4 1.2 0.8 0.0 0.0 0.6 1.0 1.8 0.5 0.3 0.1 0.3 1.4 1.1 3.3 1.3 4.1 10.8 1.0 0.2 2.7 1.8 0.9 0.0 0.3 1.2 0.6 0.3 3.8 0.8 1.0 1.0 0.4 7.0 9.3 3.8 5.7 7.2 6.6 22.7 3.2 2.2 2.9 3.4 5.1 0.1 2.4 0.1 4.1 2.6 11.6 3.4 3.1 1.9 7.0 8.8 0.0 15.1 2.2 5.1 0.9 8.9 5.5 7.6 3.8 2.2 24.9 3.9 4.6 1.8 8.4 4.8 3.8 4.2 21.0 3.6 5.4 2.1 2.8 4.4 0.0 9.2 9.7 5.2 7.2 0.0 3.8 4.2 9.3 5.5 1.5 8.9 0.0 5.1 3.9 4.4 5.9 2.6 0.0 5.9 3.0 3.3 0.0 0.8 0.9 0.3 0.6 0.0 0.1 0.3 0.9 0.1 0.6 0.6 1.0 3.8 1.0 0.8 0.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 0.0 0.4 0.0 TBX4 ENSG00000121075 "T-box 4" P57082 17 61452404-61485110 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "lung: 31.1;placenta: 17.0;prostate: 15.0;smooth muscle: 26.0;urinary bladder: 18.6" "Group enriched" "Detected in some" 7 "Early spermatids: 5.7;Late spermatids: 11.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 5.4;Hep G2: 2.2;OE19: 2.2;THP-1: 10.7" "Low region specificity" "Detected in single" "Region enhanced" "Detected in single" "basal ganglia: 1.6" "CAB032413, HPA044457" Uncertain Approved Vesicles NA NA Vesicles "CAB032413: AB_2200705, HPA044457: AB_2678948" "unprognostic (1.03e-2)" "unprognostic (2.05e-2)" "unprognostic (1.43e-1)" "unprognostic (1.63e-3)" "unprognostic (6.07e-2)" "unprognostic (3.80e-2)" "unprognostic (1.25e-2)" "unprognostic (4.14e-2)" "unprognostic (7.77e-3)" "unprognostic (7.41e-2)" "unprognostic (6.83e-2)" "unprognostic (1.38e-1)" "unprognostic (1.46e-8)" "unprognostic (1.92e-1)" "unprognostic (4.41e-2)" "unprognostic (6.15e-2)" "unprognostic (5.39e-2)" 0.5 0.1 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.0 0.0 31.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 17.0 0.6 15.0 0.0 0.0 0.1 0.0 0.1 0.3 0.1 26.0 0.0 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 18.6 4.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.9 0.1 0.0 0.1 5.4 0.5 0.4 0.5 1.9 0.0 0.0 0.0 0.5 0.1 0.1 0.0 0.0 0.3 0.0 0.8 0.0 0.0 2.2 0.5 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 1.2 0.1 0.0 0.2 2.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.0 0.5 0.2 0.0 10.7 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 TCTE1 "D6S46, DRC5, FAP155, MGC33600" ENSG00000146221 "T-complex-associated-testis-expressed 1" Q5JU00 6 44278743-44297688 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "fallopian tube: 17.3;testis: 48.6" "Group enriched" "Detected in some" 11 "Early spermatids: 137.7;Late spermatids: 222.1" "Cancer enhanced" "Detected in some" "endometrial cancer: 1.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTERT-HME1: 2.6;Karpas-707: 3.8;SCLC-21H: 3.2;U-266/70: 1.8;U-266/84: 3.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA031739 Uncertain Vesicles NA NA Vesicles "HPA031739: AB_10601269" "unprognostic (3.27e-2)" "unprognostic (1.86e-1)" "unprognostic (2.04e-2)" "unprognostic (5.27e-3)" "unprognostic (1.55e-1)" "unprognostic (1.57e-2)" "unprognostic (7.06e-2)" "unprognostic (1.42e-2)" "unprognostic (3.46e-1)" "unprognostic (3.49e-2)" "unprognostic (1.17e-2)" "unprognostic (7.05e-2)" "unprognostic (2.23e-5)" "unprognostic (7.68e-2)" "unprognostic (3.13e-2)" "unprognostic (1.37e-3)" "unprognostic (2.68e-1)" 0.2 0.2 2.2 0.2 2.2 1.1 0.2 5.8 1.8 0.7 0.2 1.1 0.0 0.2 0.6 3.0 0.2 17.3 0.3 0.2 2.8 2.0 0.2 0.2 2.1 0.2 0.8 1.0 2.2 0.3 0.2 0.2 0.2 3.2 0.4 0.2 0.0 0.4 0.4 0.2 0.6 0.3 0.3 0.6 0.3 0.2 48.6 0.3 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.9 0.0 0.1 0.0 0.2 0.1 0.3 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.4 0.3 0.1 0.2 0.1 0.6 0.3 0.0 0.0 2.6 0.3 0.0 0.4 0.1 3.8 0.0 0.3 0.2 0.5 0.2 0.2 0.0 0.9 0.4 0.0 0.0 0.1 3.2 1.1 0.0 0.2 1.2 0.1 0.1 0.2 0.1 0.0 0.2 0.0 0.0 1.8 3.2 0.3 0.1 0.4 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.1 0.2 0.0 2.2 2.2 5.8 1.8 2.8 2.0 0.8 1.0 3.2 0.3 0.0 0.0 0.0 0.1 0.1 0.6 0.3 0.0 16.0 2.3 0.0 0.0 0.0 0.0 0.0 137.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 10.7 1.9 0.0 0.1 0.0 0.0 0.0 TDRD10 DKFZp434M202 ENSG00000163239 "Tudor domain containing 10" Q5VZ19 1 154502219-154548147 "Cancer-related genes, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "testis: 48.4" "Group enriched" "Detected in some" 5 "Early spermatids: 47.9;Late spermatids: 66.1;Spermatocytes: 133.2" "Cancer enhanced" "Detected in many" "testis cancer: 5.9" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 2.2;HUVEC TERT2: 7.7;RPMI-8226: 2.1;TIME: 4.1" "Low region specificity" "Detected in all" HPA054327 Approved Vesicles NA NA Vesicles "HPA054327: AB_2682452" "unprognostic (1.30e-1)" "unprognostic (6.33e-2)" "unprognostic (1.78e-1)" "unprognostic (5.33e-3)" "unprognostic (9.69e-3)" "unprognostic (5.80e-3)" "unprognostic (2.99e-1)" "unprognostic (5.97e-3)" "unprognostic (2.44e-2)" "unprognostic (2.06e-1)" "unprognostic (1.00e-3)" "unprognostic (1.61e-1)" "unprognostic (1.34e-3)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "prognostic favorable (8.04e-5)" "unprognostic (1.62e-1)" 4.1 1.4 0.7 1.1 0.9 0.0 2.6 0.7 1.4 1.3 0.8 0.9 1.4 0.5 2.1 2.0 1.0 2.1 1.2 2.3 0.7 0.0 1.0 1.5 3.3 1.6 0.9 1.2 4.6 0.7 0.8 0.8 1.4 1.2 1.1 1.1 0.7 0.7 1.0 1.1 0.7 1.0 1.4 1.2 3.5 0.5 48.4 0.8 0.7 4.9 1.5 1.0 1.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.8 0.0 0.1 4.1 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.9 0.7 1.4 0.7 0.0 0.9 1.2 1.2 0.8 3.0 7.9 0.0 0.0 0.6 0.0 1.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 47.9 4.7 0.0 0.0 0.0 0.0 0.7 0.0 1.1 0.0 0.3 0.0 0.0 6.2 3.5 66.1 2.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 133.2 17.2 0.3 0.0 0.0 0.0 0.0 TECPR1 "DKFZP434B0335, FLJ23419, FLJ90593, KIAA1358" ENSG00000205356 "Tectonin beta-propeller repeat containing 1" Q7Z6L1 7 98214624-98252251 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 63.9" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021061 Approved Supported Vesicles NA NA Vesicles "HPA021061: AB_1847687" "unprognostic (8.10e-3)" "unprognostic (7.89e-2)" "unprognostic (9.05e-3)" "unprognostic (5.00e-3)" "unprognostic (2.03e-1)" "unprognostic (1.11e-2)" "unprognostic (2.49e-2)" "unprognostic (1.45e-2)" "unprognostic (1.72e-1)" "unprognostic (1.88e-1)" "prognostic favorable (8.12e-4)" "unprognostic (2.48e-1)" "unprognostic (2.54e-1)" "unprognostic (1.38e-1)" "unprognostic (3.24e-1)" "unprognostic (9.46e-2)" "unprognostic (6.12e-2)" 6.5 4.7 11.5 8.9 10.6 5.2 6.3 9.0 15.8 4.1 5.9 6.2 5.1 8.4 4.5 5.5 5.8 4.8 7.6 5.9 10.4 9.0 4.6 5.4 9.0 11.0 6.8 12.8 4.0 63.9 4.2 10.2 7.7 9.8 6.9 4.9 8.0 29.5 5.0 6.9 5.4 8.1 4.6 8.5 11.2 9.3 3.3 7.0 6.4 5.9 5.9 6.4 5.1 5.4 3.4 4.1 6.1 7.4 1.6 8.7 3.1 3.0 4.2 5.9 12.8 5.1 3.1 4.4 6.3 3.5 5.0 6.2 4.0 3.8 2.5 10.2 7.2 6.2 1.9 4.0 2.9 2.1 5.9 5.7 3.6 5.9 4.2 6.1 4.3 7.0 5.4 2.4 4.8 3.8 4.7 17.5 10.5 2.3 14.1 3.8 4.9 6.2 4.5 2.3 6.0 4.1 5.2 6.0 17.6 3.8 3.3 10.7 11.9 3.7 11.2 5.9 4.5 3.4 6.2 17.9 4.8 8.2 12.2 5.2 18.0 6.4 1.2 9.9 3.8 8.9 2.6 4.7 1.4 3.9 5.2 2.4 3.4 5.1 3.1 2.9 3.2 8.7 7.2 6.1 1.6 7.4 4.1 5.1 3.1 11.5 10.6 9.0 15.8 10.4 9.0 6.8 12.8 9.8 7.0 8.9 17.3 10.5 1.9 2.1 33.6 8.2 7.6 5.3 6.8 5.2 100.1 4.4 1.7 5.7 2.0 17.9 11.8 0.0 11.4 7.4 4.1 5.1 8.1 6.7 11.2 30.2 28.2 18.4 21.9 1.6 6.6 7.6 1.7 10.8 20.9 10.0 9.0 11.4 3.2 2.9 66.4 0.0 4.4 4.2 3.8 1.6 2.9 10.2 6.0 2.5 TEX38 "ATPAF1-AS1, C1orf223, LOC374973, THEG4" ENSG00000186118 "Testis expressed 38" Q6PEX7 1 46668855-46673594 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 43 "testis: 109.8" "Group enriched" "Detected in some" 114 "Early spermatids: 1833.7;Late spermatids: 4115.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "SCLC-21H: 2.0;SK-BR-3: 2.2;TIME: 2.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA073711 Uncertain Vesicles NA NA Vesicles "HPA073711: " "unprognostic (8.46e-2)" "unprognostic (1.99e-1)" "unprognostic (3.14e-2)" "unprognostic (8.86e-2)" "unprognostic (6.81e-3)" "unprognostic (3.50e-1)" "unprognostic (1.99e-1)" "unprognostic (9.21e-2)" "unprognostic (5.39e-2)" "unprognostic (4.15e-3)" "unprognostic (4.93e-4)" "unprognostic (2.64e-1)" "unprognostic (5.28e-2)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (7.84e-2)" "unprognostic (3.48e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 2.5 0.3 0.1 1.6 0.0 0.1 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.7 0.2 0.2 0.0 1.3 0.6 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.8 0.3 0.3 0.8 0.3 0.0 0.5 0.4 0.0 0.6 0.6 0.5 0.1 0.0 0.4 0.1 0.9 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.9 0.0 0.6 0.6 2.0 1.4 1.0 2.2 0.0 1.8 0.8 0.0 2.5 0.3 0.0 1.0 0.2 0.9 0.3 0.6 0.2 0.0 0.2 0.0 0.3 2.5 1.2 0.2 1.6 0.9 0.1 0.9 0.4 0.4 0.9 0.2 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1833.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4115.3 26.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.4 6.5 0.0 24.7 13.3 0.0 0.0 0.0 0.0 0.0 TGFA ENSG00000163235 "Transforming growth factor alpha" P01135 2 70447280-70554193 "Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 36.6;Pancreatic endocrine cells: 47.6;Urothelial cells: 56.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "basophil: 6.3;eosinophil: 14.0;neutrophil: 14.7" "Lineage enriched" "Detected in many" 5 "granulocytes: 14.7" "Cell line enhanced" "Detected in many" "A-431: 24.0;CAPAN-2: 29.7;HBEC3-KT: 25.9;OE19: 19.0;RPTEC TERT1: 26.1;U-87 MG: 24.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042297 Approved Approved Vesicles "Secreted to blood" No No 57900 Vesicles "HPA042297: AB_10793878" "unprognostic (1.23e-1)" "unprognostic (1.06e-3)" "unprognostic (3.57e-3)" "unprognostic (6.39e-2)" "unprognostic (1.41e-1)" "unprognostic (8.49e-3)" "unprognostic (1.52e-1)" "unprognostic (3.00e-3)" "unprognostic (6.69e-2)" "unprognostic (9.21e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (7.74e-2)" "unprognostic (3.70e-2)" "unprognostic (1.60e-1)" "unprognostic (9.21e-2)" "prognostic favorable (1.52e-4)" "unprognostic (9.19e-2)" 2.0 0.5 8.4 4.3 10.7 1.2 6.2 3.5 7.9 5.7 9.4 21.4 0.3 7.4 1.2 2.8 23.8 5.7 14.6 0.8 10.7 6.9 12.4 4.0 3.5 4.2 10.9 5.2 0.5 12.0 1.0 0.8 1.7 9.4 2.2 7.3 9.7 6.3 1.2 0.4 10.8 13.7 1.3 22.5 5.1 7.6 2.3 12.8 0.2 7.4 17.4 12.1 5.4 10.8 0.0 0.6 14.7 0.4 0.2 2.7 0.4 24.0 3.8 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 29.7 0.0 15.3 0.1 4.1 12.9 0.2 25.9 0.0 0.0 0.6 0.0 0.6 2.0 0.0 0.3 0.0 0.0 10.4 0.0 10.2 1.2 0.0 1.9 0.0 0.1 0.0 0.9 0.0 0.5 0.4 19.0 7.3 0.0 0.1 6.3 26.1 9.3 0.2 0.0 2.0 0.0 0.0 0.0 3.3 0.2 0.2 0.1 1.8 0.0 5.3 0.1 0.1 0.0 24.6 0.8 8.9 6.3 0.4 14.0 1.0 0.1 2.7 0.0 0.6 0.6 0.6 0.0 0.3 0.2 14.7 0.2 0.0 0.0 0.0 0.4 8.4 10.7 3.5 7.9 10.7 6.9 10.9 5.2 9.4 12.8 6.0 2.4 0.0 6.5 14.3 1.4 1.4 28.1 12.0 6.8 24.4 0.0 0.0 1.7 36.6 14.8 1.2 14.9 0.0 8.8 0.0 0.5 11.0 5.7 1.5 3.0 0.0 1.2 0.0 2.2 1.4 0.3 3.1 0.0 30.7 5.8 8.6 47.6 8.5 0.0 6.1 0.7 0.0 0.9 0.0 0.2 21.8 0.0 2.2 4.7 56.3 TGFB3 "ARVD, ARVD1" ENSG00000119699 "Transforming growth factor beta 3" P10600 14 75958099-75982991 "Cancer-related genes, Disease related genes, Predicted secreted proteins" "Growth factor, Mitogen" "Cancer-related genes, Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 31.7;Glandular cells: 27.5;Late spermatids: 36.7;Leydig cells: 25.0;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.8" "Lineage enhanced" "Detected in single" "T-cells: 1.8" "Group enriched" "Detected in many" 5 "SK-BR-3: 50.4;T-47d: 35.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA063582 Approved Vesicles "Secreted to blood" NA NA 44800 Vesicles "HPA063582: AB_2685049" "unprognostic (7.84e-2)" "unprognostic (1.89e-1)" "unprognostic (4.32e-3)" "unprognostic (1.29e-1)" "unprognostic (3.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.24e-1)" "unprognostic (9.79e-2)" "unprognostic (2.83e-2)" "unprognostic (1.51e-2)" "unprognostic (5.63e-2)" "unprognostic (4.10e-1)" "prognostic unfavorable (4.01e-7)" "unprognostic (6.38e-3)" "unprognostic (1.10e-1)" "unprognostic (1.22e-2)" "unprognostic (3.27e-3)" 6.9 4.7 10.6 8.4 14.0 0.4 7.8 3.2 8.6 29.2 4.1 6.7 13.1 2.3 10.4 21.4 4.4 4.9 21.5 17.9 11.9 6.6 4.8 12.2 8.6 4.2 16.8 7.0 3.1 11.1 6.8 4.6 31.0 8.4 25.8 3.2 10.0 5.0 12.0 13.3 1.5 2.9 20.7 13.0 2.2 4.5 3.8 8.8 4.2 4.4 5.7 8.2 11.6 6.4 0.4 0.1 0.0 0.0 0.0 1.8 0.2 0.4 0.1 0.5 5.5 1.0 1.3 0.1 0.2 0.4 0.2 0.2 0.3 1.3 0.0 0.4 1.0 0.1 0.3 1.1 0.1 0.1 0.3 0.5 0.0 1.1 0.6 1.3 0.2 0.3 4.6 0.1 0.4 0.1 1.0 1.3 1.1 0.5 2.5 0.3 2.5 0.2 0.2 0.1 0.3 1.9 1.2 1.6 0.2 0.5 0.2 9.1 2.1 1.6 50.4 0.3 0.7 35.3 0.0 0.3 0.8 1.8 0.8 2.2 0.2 0.2 0.1 1.4 0.3 1.3 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.1 0.6 0.0 0.4 1.8 0.5 0.0 0.0 0.0 0.1 0.3 0.2 10.6 14.0 3.2 8.6 11.9 6.6 16.8 7.0 8.4 8.8 0.0 3.2 0.0 1.2 3.9 0.7 3.4 0.0 6.7 2.3 1.8 3.9 0.5 0.0 0.4 17.1 7.5 1.1 0.0 1.2 0.3 31.7 27.5 0.0 0.2 0.8 0.0 0.0 8.0 0.6 36.7 25.0 1.2 10.1 1.0 0.6 1.7 0.4 0.0 12.0 0.3 2.9 32.3 20.6 0.2 1.0 2.8 1.1 1.3 0.4 0.7 TGFBR3L ENSG00000260001 "Transforming growth factor beta receptor 3 like" H3BV60 19 7916145-7919097 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "pituitary gland: 56.6" "Cell type enhanced" "Detected in many" 10 "Sertoli cells: 12.9;T-cells: 6.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 2.9" "Lineage enriched" "Detected in single" 8 "T-cells: 2.9" "Cell line enhanced" "Detected in some" "PC-3: 5.7;REH: 13.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA074356 Enhanced Approved Vesicles NA NA Vesicles "HPA074356: AB_2686681" "unprognostic (1.57e-1)" "unprognostic (6.92e-2)" "unprognostic (3.07e-3)" "unprognostic (2.01e-2)" "unprognostic (2.63e-1)" "unprognostic (7.65e-2)" "unprognostic (9.51e-3)" "unprognostic (1.09e-1)" "unprognostic (6.96e-2)" "unprognostic (3.41e-2)" "unprognostic (2.81e-1)" "unprognostic (2.04e-1)" "unprognostic (3.50e-3)" "unprognostic (1.31e-1)" "unprognostic (2.66e-1)" "unprognostic (1.06e-1)" "unprognostic (8.62e-3)" 0.3 2.0 1.6 0.2 2.8 0.6 0.3 1.9 6.4 5.0 0.6 0.0 0.3 6.0 2.8 0.5 0.3 0.7 0.2 2.1 0.7 0.8 3.7 4.0 0.3 0.1 0.5 1.7 0.3 0.3 0.9 56.6 0.4 1.9 2.5 0.1 0.6 0.8 0.7 0.3 0.5 5.7 2.0 0.6 0.3 0.4 0.5 0.0 0.0 0.3 0.0 0.1 1.1 0.8 0.1 0.3 0.0 0.1 0.0 2.9 0.1 0.1 0.2 0.1 0.5 0.1 0.0 3.3 2.7 0.0 0.2 0.0 0.5 0.0 0.1 3.0 0.1 0.0 2.0 0.0 0.0 0.0 3.4 1.1 0.5 0.2 0.6 0.2 1.7 0.4 0.2 0.1 0.0 0.0 0.3 0.0 3.0 0.7 0.5 0.0 1.5 1.2 0.2 0.6 0.2 5.7 13.8 0.0 3.1 0.2 0.0 1.0 2.5 0.3 0.0 0.7 0.0 0.9 0.6 0.2 1.8 2.9 2.0 0.9 0.8 0.9 0.8 0.4 0.0 0.7 0.0 0.0 0.0 2.9 0.0 0.6 0.1 0.9 1.9 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.3 0.0 0.1 1.6 2.8 1.9 6.4 0.7 0.8 0.5 1.7 1.9 0.0 0.0 0.0 0.8 3.2 1.3 1.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.5 0.0 0.0 0.0 0.2 0.5 1.7 0.6 0.0 2.8 0.2 0.0 0.0 2.5 0.0 3.3 1.1 0.5 5.0 0.0 0.0 2.7 0.4 0.0 1.1 4.4 2.4 12.9 4.2 0.2 0.9 1.3 0.3 6.9 0.0 0.4 TGFBRAP1 "TRAP-1, TRAP1, VPS3" ENSG00000135966 "Transforming growth factor beta receptor associated protein 1" Q8WUH2 2 105264391-105330034 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037672, HPA038397" Approved Approved Vesicles NA NA Vesicles "HPA037672: AB_2675597, HPA038397: AB_10669782" "unprognostic (1.66e-1)" "unprognostic (1.58e-2)" "unprognostic (8.99e-2)" "unprognostic (4.49e-3)" "unprognostic (3.02e-2)" "unprognostic (6.77e-2)" "unprognostic (5.63e-3)" "unprognostic (9.15e-2)" "unprognostic (2.25e-1)" "unprognostic (2.98e-2)" "unprognostic (2.29e-1)" "unprognostic (8.30e-2)" "unprognostic (8.82e-2)" "unprognostic (3.89e-1)" "unprognostic (1.07e-1)" "unprognostic (1.01e-1)" "unprognostic (1.62e-2)" 12.7 11.8 9.4 8.9 12.5 23.4 13.6 14.1 18.3 8.3 10.1 15.2 11.1 8.4 11.8 8.4 10.1 9.4 7.1 7.7 9.2 7.2 9.3 6.9 8.8 12.9 11.2 9.9 10.0 11.7 16.4 7.5 12.4 10.9 10.5 10.0 15.5 10.9 13.7 15.3 14.5 10.0 11.2 10.4 11.9 17.1 3.0 11.8 10.3 13.3 9.2 10.5 11.5 12.9 3.3 3.0 3.1 2.5 2.6 5.5 2.0 14.3 11.4 8.3 10.3 9.1 7.2 17.0 10.5 14.4 17.9 17.1 16.7 8.9 14.6 11.4 11.8 18.2 8.8 14.8 24.9 14.8 15.5 15.7 19.6 9.1 13.2 8.3 18.1 15.0 8.7 15.0 14.8 13.2 9.5 18.9 12.9 17.6 7.2 21.5 9.6 12.8 11.7 10.6 9.9 9.6 14.6 13.2 21.1 11.1 17.7 16.5 11.0 8.6 17.4 16.9 6.3 8.6 11.2 13.5 11.3 17.3 9.4 10.6 7.6 9.2 16.1 8.0 12.7 23.3 1.2 2.5 3.1 5.5 2.0 4.8 2.0 3.7 3.1 1.9 3.3 2.3 3.6 1.0 2.6 1.7 3.0 2.6 2.0 9.4 12.5 14.1 18.3 9.2 7.2 11.2 9.9 10.9 11.8 6.0 7.4 5.1 3.0 7.1 12.0 5.5 0.0 1.4 9.1 5.2 15.7 9.0 1.7 5.2 0.1 7.5 4.2 0.0 9.3 4.4 5.6 6.1 2.3 5.4 10.7 14.3 10.9 15.4 12.7 0.0 6.9 5.5 3.3 3.6 9.4 8.9 7.1 0.0 7.8 5.1 6.2 25.8 5.7 0.3 1.1 11.4 6.2 8.6 9.3 2.6 THBS3 ENSG00000169231 "Thrombospondin 3" P49746 1 155195588-155209051 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 23 "Early spermatids: 241.6;Late spermatids: 766.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 36.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA006293, HPA073242" Approved Approved Vesicles "Secreted to extracellular matrix" NA NA 4100000 Vesicles "HPA006293: AB_10602898, HPA073242: AB_2732223" "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "prognostic unfavorable (2.43e-4)" "prognostic unfavorable (1.44e-4)" "unprognostic (2.63e-1)" "unprognostic (1.30e-1)" "unprognostic (3.62e-2)" "unprognostic (4.23e-1)" "unprognostic (4.54e-2)" "unprognostic (1.20e-1)" "unprognostic (1.88e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.38e-12)" "unprognostic (2.06e-2)" "unprognostic (9.41e-2)" "unprognostic (8.50e-3)" "unprognostic (2.26e-1)" 10.5 5.5 6.2 12.2 19.5 5.4 15.4 4.7 10.0 20.7 12.6 8.5 8.2 3.4 34.4 24.7 15.1 13.8 19.2 14.4 5.8 3.3 10.1 8.1 8.5 3.2 9.5 6.1 17.5 11.4 12.8 9.5 8.6 7.0 11.4 7.5 8.1 7.5 11.4 5.7 12.9 8.0 24.5 6.1 6.4 8.1 8.3 4.2 1.1 14.3 23.5 7.4 14.4 11.4 1.7 3.5 2.2 4.1 0.9 4.3 2.0 1.4 3.6 13.3 13.5 7.3 8.5 0.8 6.1 9.1 2.8 5.2 0.4 11.0 1.0 6.9 13.4 0.8 3.6 0.3 2.3 2.1 2.4 0.8 0.8 3.9 0.5 7.8 0.7 1.8 14.6 8.1 4.2 5.8 36.1 5.1 2.2 0.7 2.1 2.5 5.3 0.5 1.3 3.0 3.1 1.8 11.8 0.5 2.3 5.9 3.7 19.7 11.2 1.5 3.0 3.1 20.1 8.9 1.8 3.9 9.5 2.2 1.7 2.1 5.2 0.6 0.2 8.6 0.7 0.8 0.0 4.1 1.6 1.8 2.2 1.1 1.7 2.7 2.2 3.5 0.9 3.0 1.0 2.2 0.9 0.7 0.5 4.3 2.0 6.2 19.5 4.7 10.0 5.8 3.3 9.5 6.1 7.0 4.2 0.0 14.7 0.0 2.1 7.0 2.7 1.2 2.5 2.7 1.2 0.0 0.0 1.1 1.7 3.7 241.6 6.3 2.6 0.0 2.3 1.5 11.7 2.2 0.0 3.9 10.0 7.9 4.6 1.8 4.8 766.9 21.6 4.9 10.1 1.0 4.8 1.7 4.0 2.9 9.6 2.8 2.7 0.0 8.1 21.2 2.5 4.5 1.1 0.7 3.1 1.3 THBS4 ENSG00000113296 "Thrombospondin 4" P35443 5 79991311-80083287 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion, Tissue remodeling, Unfolded protein response" "Growth factor, Mitogen" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 69.8;heart muscle: 59.0;skeletal muscle: 61.7;smooth muscle: 94.0" "Cell type enriched" "Detected in many" 9 "Sertoli cells: 485.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 51 "eosinophil: 8.0" "Lineage enriched" "Detected in single" 51 "granulocytes: 8.0" "Cell line enhanced" "Detected in some" "AF22: 5.1;SCLC-21H: 4.0;THP-1: 10.9;U-2 OS: 4.7;U-266/70: 4.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" "CAB004597, HPA042426" Approved Approved Vesicles "Secreted to extracellular matrix" NA NA 420000000 Vesicles "CAB004597: AB_628352, HPA042426: AB_2677992" "unprognostic (1.41e-1)" "unprognostic (5.33e-2)" "unprognostic (4.26e-3)" "unprognostic (3.64e-2)" "unprognostic (9.94e-2)" "unprognostic (8.10e-2)" "unprognostic (5.64e-2)" "unprognostic (7.12e-2)" "unprognostic (1.66e-1)" "unprognostic (2.25e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (1.96e-3)" "unprognostic (2.74e-2)" "unprognostic (3.98e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (3.33e-4)" 69.8 1.0 7.6 2.1 8.3 3.7 9.7 0.8 4.6 1.1 21.4 2.6 1.2 1.3 12.2 13.6 6.5 1.4 4.1 59.0 6.4 6.4 0.8 0.6 1.0 0.9 8.5 1.9 2.1 23.0 5.5 7.8 0.6 10.7 3.7 3.7 4.9 19.8 2.6 61.7 1.5 1.4 94.0 11.5 0.6 4.0 5.5 2.6 2.0 9.9 39.3 4.1 3.4 2.7 0.1 0.0 8.0 0.0 0.0 0.1 0.0 0.2 0.0 5.1 0.3 0.4 2.2 0.5 0.1 0.2 1.5 0.5 0.1 0.6 0.2 0.2 0.4 1.3 0.2 0.2 0.6 1.3 0.2 0.7 0.5 0.0 0.3 2.8 0.0 0.1 1.6 0.3 0.1 0.3 0.5 0.0 0.1 0.0 0.3 0.3 0.7 0.1 0.1 3.9 0.0 0.1 0.0 1.6 0.0 0.4 0.1 4.0 1.2 0.1 0.0 0.4 2.3 0.0 10.9 0.0 0.1 4.7 0.3 0.3 4.2 0.1 0.7 1.8 3.5 0.9 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 7.6 8.3 0.8 4.6 6.4 6.4 8.5 1.9 10.7 2.6 0.0 0.6 0.0 0.0 0.2 1.2 5.0 0.0 0.0 1.2 3.5 53.0 0.0 0.0 0.1 28.0 2.2 0.0 0.0 0.0 0.0 2.7 0.8 0.0 0.0 0.1 1.6 8.6 0.6 0.0 3.2 0.9 0.0 1.7 0.0 0.0 1.9 0.0 0.0 41.1 0.6 1.9 485.0 2.2 16.9 1.4 0.9 0.0 0.0 0.0 0.0 TLL1 ENSG00000038295 "Tolloid like 1" O43897 4 165873258-166103895 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" Differentiation "Developmental protein, Hydrolase, Metalloprotease, Protease" "Atrial septal defect, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.6" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 15.1;Endothelial cells: 11.3;Horizontal cells: 7.9" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "cerebellum: 40.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "HeLa: 8.7;Karpas-707: 13.6;PC-3: 4.9" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 10 "cerebellum: 132.6" HPA060767 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA060767: AB_2684357" "unprognostic (2.17e-1)" "unprognostic (6.45e-4)" "unprognostic (8.60e-2)" "unprognostic (2.65e-5)" "unprognostic (9.85e-2)" "unprognostic (2.51e-4)" "unprognostic (3.37e-2)" "unprognostic (3.61e-2)" "unprognostic (1.56e-1)" "unprognostic (5.07e-4)" "unprognostic (2.86e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (2.13e-3)" "unprognostic (7.76e-2)" "unprognostic (6.91e-3)" "unprognostic (1.21e-5)" 10.1 1.3 1.2 2.6 2.8 0.0 7.9 40.6 2.9 5.0 5.4 0.2 4.2 1.4 3.0 2.7 2.5 2.4 5.4 2.4 2.2 1.7 3.3 0.5 3.1 3.0 1.1 0.6 1.6 4.6 1.1 2.2 13.8 8.5 3.1 2.2 3.3 1.9 1.9 1.6 2.7 4.4 3.3 0.9 0.4 1.7 1.5 0.1 0.0 3.2 1.4 1.6 3.6 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 2.0 0.5 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.2 0.0 0.1 0.0 8.7 0.0 0.0 0.0 0.0 0.6 1.5 0.0 1.8 0.0 1.4 0.0 0.0 13.6 0.0 0.0 0.0 0.2 1.2 0.0 4.9 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.0 0.3 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.8 40.6 2.9 2.2 1.7 1.1 0.6 8.5 0.1 0.0 1.1 0.0 0.2 1.5 15.1 4.1 0.0 1.4 1.2 0.0 0.0 3.9 0.0 1.5 0.0 11.3 0.0 0.0 1.9 0.9 1.6 0.8 0.0 0.0 0.2 7.9 0.0 1.8 0.0 0.0 2.8 0.0 1.7 0.0 0.0 0.0 0.1 0.0 4.2 0.8 0.5 0.0 0.3 0.1 0.0 1.5 1.6 0.0 0.0 0.1 TMBIM1 "LFG3, PP1201, RECS1" ENSG00000135926 "Transmembrane BAX inhibitor motif containing 1" Q969X1 2 218274192-218292586 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 85.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012093, HPA070824" Approved Supported Vesicles NA NA Vesicles "HPA012093: AB_1858056, HPA070824: AB_2686317" "unprognostic (4.36e-2)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (1.73e-3)" "unprognostic (2.34e-3)" "unprognostic (3.81e-3)" "unprognostic (8.91e-3)" "unprognostic (5.58e-3)" "unprognostic (9.85e-2)" "unprognostic (3.76e-3)" "prognostic unfavorable (4.22e-4)" "unprognostic (1.69e-1)" "prognostic favorable (3.38e-4)" "unprognostic (1.22e-1)" "unprognostic (4.63e-2)" "unprognostic (2.75e-2)" "unprognostic (4.50e-1)" 64.3 34.6 26.5 22.1 45.0 23.0 84.3 11.0 38.3 35.7 42.2 43.1 33.7 41.8 35.0 30.0 86.8 25.1 50.3 34.6 21.0 17.2 50.7 69.3 46.7 34.3 37.5 13.7 27.9 87.6 31.3 15.0 92.7 40.9 31.6 40.1 23.9 40.1 43.7 53.2 49.5 70.6 41.2 50.3 22.7 57.8 13.2 32.5 9.4 66.4 42.1 36.3 57.7 54.5 17.0 19.6 60.3 43.5 13.0 24.0 33.6 26.9 9.7 0.5 7.2 63.1 26.6 29.0 26.5 32.7 15.7 18.1 24.8 66.9 6.2 19.3 38.9 29.9 46.1 9.0 59.4 15.5 22.2 3.7 39.0 6.7 29.8 28.6 0.5 38.5 25.2 55.8 32.1 41.0 16.8 16.6 1.0 24.3 11.6 27.3 1.1 0.4 6.7 0.4 55.7 8.8 0.9 4.3 4.8 21.1 85.0 0.5 0.5 8.7 32.5 18.4 6.0 8.7 5.9 25.1 28.2 7.8 13.0 9.6 5.6 6.5 2.7 27.8 6.2 15.9 60.3 27.7 59.9 24.0 36.2 20.5 17.0 22.0 19.5 19.6 14.0 14.7 15.8 35.5 13.0 43.5 5.3 23.5 33.6 26.5 45.0 11.0 38.3 21.0 17.2 37.5 13.7 40.9 32.5 68.5 24.6 28.7 69.9 72.6 1.9 23.1 86.6 8.1 29.6 66.3 0.0 126.2 11.6 144.8 0.6 46.0 183.5 23.3 245.6 121.5 63.2 108.4 48.5 40.1 94.3 0.0 21.8 25.2 35.2 1.9 50.0 57.9 43.9 14.4 54.8 22.4 239.0 105.2 55.9 32.3 1.7 12.9 47.2 0.7 12.3 88.3 235.9 34.8 41.2 229.1 TMC4 ENSG00000167608 "Transmembrane channel like 4" 19 54160108-54173250 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 45.8;seminal vesicle: 49.1" "Cell type enhanced" "Detected in many" 8 "Enterocytes: 180.2;Paneth cells: 96.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.4;neutrophil: 1.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 4 "OE19: 13.2;T-47d: 24.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA048635 Approved Approved Vesicles NA NA Vesicles "HPA048635: AB_2680470" "unprognostic (7.55e-2)" "unprognostic (1.66e-1)" "unprognostic (4.20e-2)" "unprognostic (1.49e-1)" "unprognostic (7.04e-2)" "unprognostic (1.68e-1)" "unprognostic (4.82e-2)" "unprognostic (2.19e-2)" "unprognostic (1.03e-1)" "unprognostic (2.68e-3)" "unprognostic (7.59e-2)" "unprognostic (3.09e-1)" "prognostic favorable (1.54e-8)" "unprognostic (6.70e-2)" "unprognostic (2.48e-1)" "unprognostic (8.94e-2)" "unprognostic (1.79e-2)" 1.2 0.4 0.8 4.7 1.2 0.0 6.5 0.5 0.7 3.7 31.0 0.0 32.0 19.7 2.0 16.2 2.9 8.7 21.8 1.7 0.9 0.8 11.8 0.8 9.6 0.0 0.8 0.0 3.8 25.0 0.3 11.1 6.9 0.0 8.6 7.5 0.0 34.5 49.1 0.8 1.3 45.8 0.8 0.6 0.3 8.2 0.6 0.0 1.0 17.1 2.8 5.6 6.7 2.7 0.0 0.0 1.5 1.4 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.0 0.0 0.8 1.2 0.5 0.7 0.9 0.8 0.8 0.0 0.0 0.0 26.8 25.9 0.5 19.7 2.2 0.3 1.6 58.6 71.0 25.0 43.6 0.0 19.8 11.6 62.6 0.0 1.3 180.2 0.0 57.0 5.4 1.9 25.5 5.7 1.0 3.3 0.0 40.0 1.8 2.2 0.0 1.1 2.8 1.7 1.8 82.2 0.1 44.7 96.5 0.7 21.6 0.2 25.8 9.9 0.1 2.3 1.5 19.6 2.1 71.7 32.6 TMC7 FLJ21240 ENSG00000170537 "Transmembrane channel like 7" Q7Z402 16 18983934-19063942 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 24.8;testis: 14.9" "Cell type enriched" "Detected in many" 4 "Early spermatids: 117.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "OE19: 12.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029465 Uncertain Approved Vesicles NA NA Vesicles "HPA029465: AB_10600914" "unprognostic (1.80e-4)" "unprognostic (6.13e-2)" "unprognostic (1.82e-1)" "unprognostic (2.07e-3)" "unprognostic (1.25e-1)" "unprognostic (1.19e-3)" "unprognostic (7.60e-5)" "prognostic unfavorable (3.20e-4)" "unprognostic (7.60e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (7.64e-4)" "unprognostic (3.39e-1)" "unprognostic (1.00e-1)" "unprognostic (1.75e-1)" "unprognostic (1.94e-1)" "unprognostic (5.66e-2)" "prognostic favorable (9.20e-4)" 3.6 0.7 6.2 1.9 11.4 0.7 2.0 8.5 11.1 1.1 6.7 24.8 0.0 4.4 1.5 1.3 0.9 1.0 2.6 1.6 9.7 5.3 1.0 0.7 5.2 0.7 15.7 6.6 0.7 0.9 1.4 0.7 7.7 12.8 2.8 8.2 0.6 0.7 1.9 1.6 2.0 4.9 2.2 15.7 1.1 5.4 14.9 12.8 0.0 1.6 0.0 0.6 9.6 1.3 1.6 1.2 2.9 0.8 1.6 1.0 0.2 1.9 4.0 1.2 2.0 0.2 1.7 5.3 0.7 1.1 0.7 1.8 1.3 9.3 0.2 8.9 0.7 2.0 7.3 3.2 3.1 0.9 0.1 2.3 0.2 3.2 5.7 0.2 0.2 0.1 0.4 4.5 7.2 8.1 2.4 3.0 4.1 2.2 0.7 3.2 4.5 0.3 0.3 3.4 12.1 5.9 0.2 3.5 0.3 1.3 9.7 0.7 2.0 2.2 6.1 0.6 5.6 1.8 0.7 2.6 1.2 2.0 1.4 3.5 0.5 1.0 0.3 6.2 0.3 1.0 2.5 0.8 0.8 0.9 0.6 0.5 0.9 0.9 0.7 0.3 1.6 0.9 1.0 2.9 1.6 0.4 1.2 0.5 0.2 6.2 11.4 8.5 8.3 9.7 5.3 15.7 6.6 12.8 12.8 3.0 3.8 0.0 2.5 0.3 0.6 0.8 2.5 0.0 1.2 0.0 0.0 0.1 0.0 2.8 117.6 3.0 3.9 0.0 10.0 1.5 0.4 2.0 0.0 0.2 0.2 0.0 1.2 4.3 0.0 29.3 1.1 1.2 0.0 0.0 5.4 0.2 9.6 6.8 0.4 0.0 2.5 0.0 1.0 5.4 10.0 0.9 0.2 0.0 3.3 15.2 TMED2 "P24A, p24b1, p24beta1, RNP24" ENSG00000086598 "Transmembrane p24 trafficking protein 2" Q15363 12 123584531-123598577 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014060 Approved Supported Vesicles NA NA Vesicles "HPA014060: AB_1856389" "unprognostic (6.36e-2)" "unprognostic (3.38e-3)" "unprognostic (5.41e-3)" "unprognostic (1.75e-2)" "unprognostic (2.98e-2)" "prognostic unfavorable (3.36e-6)" "unprognostic (3.57e-3)" "unprognostic (2.20e-2)" "unprognostic (4.31e-2)" "unprognostic (9.76e-3)" "unprognostic (1.03e-2)" "unprognostic (3.94e-2)" "prognostic unfavorable (2.35e-7)" "unprognostic (2.97e-1)" "unprognostic (1.63e-1)" "unprognostic (1.51e-1)" "unprognostic (9.87e-2)" 31.3 31.9 15.7 21.8 21.2 23.5 32.0 13.2 21.5 38.5 31.6 20.4 41.1 27.6 33.4 49.0 41.3 27.4 28.9 41.7 15.7 17.1 32.6 120.1 28.1 29.4 18.2 16.7 37.4 135.4 18.1 36.3 40.0 18.9 33.3 32.8 23.8 90.2 38.0 46.3 27.4 34.2 30.5 22.5 25.6 32.4 17.8 15.0 24.0 49.2 23.8 30.0 34.0 27.8 32.4 69.3 58.9 40.9 39.5 61.2 36.2 41.9 37.4 24.9 43.0 56.8 50.4 59.3 73.0 59.0 46.5 36.9 37.3 36.6 36.0 39.2 72.7 31.9 42.1 33.6 39.3 48.9 27.0 29.0 38.8 22.7 48.1 107.9 52.8 33.5 42.3 65.7 39.9 54.3 66.7 43.4 24.6 39.1 24.7 47.4 31.1 28.0 43.4 35.9 36.3 33.7 29.1 40.6 41.8 56.7 63.6 31.0 26.8 48.9 49.1 48.3 31.5 83.3 42.9 41.1 39.7 25.1 38.3 40.8 54.7 50.7 30.5 46.9 35.0 46.8 58.9 39.8 39.6 46.8 40.9 61.2 32.4 42.4 44.1 44.2 27.2 34.6 40.3 31.5 39.5 37.8 69.3 38.3 36.2 15.7 21.2 13.2 21.5 15.7 17.1 18.2 16.7 18.9 15.0 44.7 63.4 116.9 242.8 370.8 48.2 119.4 201.2 64.3 75.1 146.5 19.6 243.2 99.5 277.5 9.2 101.5 131.7 0.0 218.6 589.4 362.9 393.4 91.1 470.6 200.1 46.1 163.9 139.3 120.4 10.9 168.0 156.4 359.4 130.8 234.1 92.4 213.4 161.4 144.2 138.8 38.3 161.7 234.9 97.7 158.0 436.1 377.9 163.0 207.2 283.9 TMEM102 "CBAP, FLJ36878" ENSG00000181284 "Transmembrane protein 102" Q8N9M5 17 7435443-7437679 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Late spermatids: 49.0;Pancreatic endocrine cells: 27.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 7.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HaCaT: 11.3;HMC-1: 13.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA024433 Uncertain Approved Vesicles NA NA Vesicles "HPA024433: AB_1858071" "unprognostic (2.42e-2)" "unprognostic (2.52e-2)" "unprognostic (1.54e-2)" "unprognostic (1.64e-1)" "unprognostic (1.10e-2)" "unprognostic (9.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.61e-1)" "unprognostic (2.91e-2)" "unprognostic (2.69e-2)" "unprognostic (2.69e-1)" "unprognostic (4.95e-2)" "prognostic favorable (9.90e-4)" "unprognostic (1.10e-3)" "unprognostic (8.40e-2)" "unprognostic (1.67e-1)" "unprognostic (1.42e-3)" 6.6 8.6 1.6 5.8 6.0 3.7 8.2 0.9 3.5 3.5 8.0 2.9 7.4 7.1 2.3 3.1 11.7 2.9 6.5 4.1 2.2 0.9 9.1 7.1 6.0 11.9 7.3 0.1 1.9 7.6 3.8 1.5 6.1 3.2 4.8 2.8 2.0 8.3 3.0 4.1 9.6 10.9 1.0 3.7 7.9 6.3 6.9 3.5 17.8 9.1 4.1 13.2 4.8 4.6 1.5 1.2 7.4 2.1 1.9 2.1 0.8 5.5 3.9 0.4 0.0 1.5 0.7 3.2 1.2 1.6 0.8 1.7 2.1 5.9 5.6 5.3 0.6 0.8 11.3 1.0 6.2 0.2 5.0 7.0 5.2 2.4 2.0 0.7 3.0 13.0 0.4 5.9 0.4 1.1 2.0 2.6 4.9 1.9 0.3 0.0 3.3 3.4 5.4 0.2 5.4 3.3 5.6 0.4 1.9 5.5 3.7 0.2 3.8 0.6 5.1 1.5 1.1 2.7 1.2 3.4 0.3 0.3 0.6 0.1 1.1 1.5 0.8 1.7 2.7 2.6 0.0 0.9 7.4 1.7 1.9 1.0 1.5 1.8 2.1 1.1 1.4 1.4 1.5 0.1 1.9 2.1 1.2 1.6 0.8 1.6 6.0 0.9 3.5 2.2 0.9 7.3 0.1 3.2 3.5 0.0 0.0 9.3 3.6 3.3 0.0 0.8 7.6 0.0 0.0 1.8 0.0 8.3 6.6 17.2 14.6 1.4 15.3 0.0 19.1 5.1 0.9 2.0 0.0 3.2 6.8 1.6 1.2 2.5 9.1 49.0 0.9 6.9 1.7 12.6 7.0 1.6 27.1 14.0 0.7 7.4 0.6 0.0 1.4 0.9 1.9 6.1 4.2 6.5 6.3 13.7 TMEM135 FLJ22104 ENSG00000166575 "Transmembrane protein 135" Q86UB9 11 87037844-87323758 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 42.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056685, HPA069473" Uncertain Supported Vesicles NA NA Vesicles "HPA056685: AB_2683208, HPA069473: AB_2686139" "unprognostic (1.55e-2)" "unprognostic (1.11e-1)" "unprognostic (2.70e-2)" "unprognostic (6.51e-2)" "unprognostic (3.10e-2)" "unprognostic (4.42e-1)" "unprognostic (1.45e-2)" "unprognostic (2.63e-1)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.26e-1)" "unprognostic (1.65e-1)" "prognostic favorable (9.02e-4)" "unprognostic (3.48e-2)" "unprognostic (7.34e-2)" "unprognostic (1.35e-2)" "unprognostic (1.80e-1)" 31.6 28.9 10.5 9.5 12.0 5.9 23.3 11.4 14.8 8.3 14.3 12.8 18.9 21.8 15.1 7.8 7.4 8.4 12.6 12.6 9.9 11.3 16.5 31.2 11.7 9.8 13.8 10.2 14.1 9.2 14.7 24.4 13.5 12.9 15.4 12.1 12.8 16.9 17.8 14.9 7.5 20.1 11.1 11.2 8.3 10.1 15.7 11.4 14.1 15.0 6.4 7.0 10.7 9.9 5.9 7.0 2.2 6.0 8.4 10.4 4.5 4.2 6.9 4.9 6.7 15.8 15.2 6.2 3.3 8.5 4.0 8.4 12.2 19.2 12.0 8.5 4.2 9.2 4.1 6.6 8.0 4.2 10.5 4.1 9.6 7.3 42.3 8.8 5.2 5.0 17.4 4.8 5.2 3.6 5.0 9.9 11.9 8.8 16.5 4.2 3.4 12.8 6.1 5.8 22.0 5.9 6.7 3.9 9.5 8.8 13.2 2.5 6.3 5.1 14.6 7.0 9.5 20.9 5.8 5.2 4.3 5.3 14.8 2.5 6.9 12.4 13.0 3.0 5.9 7.8 0.9 5.8 1.7 9.7 6.0 8.5 5.9 6.3 10.4 6.6 5.2 7.1 6.8 2.2 8.4 2.7 7.0 6.5 4.5 10.5 12.0 11.4 14.8 9.9 11.3 13.8 10.2 12.9 11.4 8.9 6.9 1.5 3.9 3.8 5.8 4.6 0.0 1.4 6.8 1.8 3.9 1.7 5.0 2.6 2.2 6.3 12.6 0.0 2.9 7.1 7.5 9.3 9.2 14.7 4.3 1.6 3.5 8.6 6.3 5.2 6.6 4.2 5.0 3.6 6.5 5.0 2.9 6.2 6.7 8.4 4.2 32.3 5.3 2.1 3.6 4.3 1.3 3.2 7.8 3.7 TMEM145 FLJ90805 ENSG00000167619 "Transmembrane protein 145" Q8NBT3 19 42313325-42325062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 5 "brain: 74.5" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 57.8;Cone photoreceptor cells: 27.5;Horizontal cells: 65.2;Rod photoreceptor cells: 30.8" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Region enriched" "Detected in all" 4 "cerebellum: 74.5" "Group enriched" "Detected in some" 8 "basophil: 4.5;neutrophil: 15.5" "Lineage enriched" "Detected in many" 12 "granulocytes: 15.5" "Cell line enhanced" "Detected in many" "HMC-1: 11.9;PC-3: 8.8;SCLC-21H: 22.7;SH-SY5Y: 10.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060462 Enhanced Approved Approved Vesicles NA NA Vesicles "HPA060462: AB_2684285" "unprognostic (9.56e-3)" "unprognostic (8.61e-2)" "unprognostic (6.65e-2)" "unprognostic (1.19e-1)" "unprognostic (2.96e-1)" "unprognostic (3.02e-1)" "unprognostic (1.47e-1)" "unprognostic (6.62e-2)" "unprognostic (2.14e-1)" "unprognostic (4.27e-3)" "unprognostic (1.53e-2)" "unprognostic (9.85e-2)" "unprognostic (4.20e-4)" "unprognostic (7.35e-2)" "unprognostic (7.64e-2)" "unprognostic (2.30e-1)" "unprognostic (6.31e-2)" 1.6 6.2 8.0 1.2 7.7 2.5 1.3 74.5 30.5 0.6 1.2 3.8 0.0 1.7 1.1 1.6 1.0 1.1 1.4 1.3 5.8 8.5 0.9 1.4 0.8 1.5 5.1 7.6 1.2 3.7 3.0 6.4 0.6 9.3 1.2 1.2 2.8 1.1 0.9 2.3 3.3 1.1 1.2 3.9 1.5 2.0 3.3 3.2 0.0 1.3 0.0 1.1 1.0 0.3 1.3 0.8 15.5 0.9 0.6 0.9 0.8 0.5 2.8 2.1 6.5 0.2 0.2 0.9 0.2 0.1 1.0 2.6 0.5 0.7 1.5 0.3 0.7 0.6 0.2 1.5 0.4 1.2 6.8 1.7 2.8 2.6 2.4 0.2 1.7 11.9 0.6 0.5 0.4 0.6 0.2 1.1 0.8 1.5 5.6 0.1 0.6 0.4 1.9 1.3 2.0 8.8 0.2 0.6 5.3 0.1 1.0 22.7 10.8 1.0 0.7 1.4 0.1 2.0 1.9 0.3 1.9 1.9 1.3 0.7 1.2 3.1 1.4 0.7 1.1 5.2 4.5 0.9 0.9 0.6 0.8 0.3 1.0 0.6 0.4 0.2 1.3 0.6 0.9 15.5 0.6 0.7 0.8 0.4 0.8 8.0 7.7 74.5 18.1 5.8 8.5 5.1 7.6 9.3 3.2 0.0 0.0 0.0 0.4 0.2 57.8 0.4 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.1 0.3 0.6 0.0 0.0 0.2 0.0 0.0 0.3 1.1 0.0 0.3 65.2 0.0 1.8 1.2 0.0 0.0 0.0 5.0 0.0 0.0 11.9 0.1 0.0 0.4 0.0 30.8 0.0 0.0 5.1 17.9 0.1 0.0 0.0 0.0 0.0 TMEM159 promethin ENSG00000011638 "Transmembrane protein 159" Q96B96 16 21158377-21180616 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 107.6;Suprabasal keratinocytes: 131.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basal ganglia: 14.6;cerebellum: 13.7" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 29.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018033, HPA063509" Approved Approved Vesicles NA NA Vesicles "HPA018033: AB_2204762, HPA063509: AB_2685026" "unprognostic (7.62e-3)" "unprognostic (2.42e-1)" "unprognostic (1.99e-2)" "unprognostic (1.06e-1)" "unprognostic (8.68e-2)" "unprognostic (6.80e-2)" "unprognostic (3.32e-1)" "unprognostic (2.93e-1)" "unprognostic (3.35e-1)" "unprognostic (2.93e-3)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.03e-1)" "prognostic favorable (8.11e-5)" "unprognostic (8.28e-2)" "unprognostic (1.28e-1)" "unprognostic (1.84e-2)" "unprognostic (1.57e-2)" 35.6 12.7 2.2 6.0 14.6 1.8 27.4 13.7 2.8 25.3 13.5 1.0 10.1 2.7 28.3 9.8 37.1 8.4 23.9 32.4 1.4 1.6 11.3 1.2 10.7 7.6 1.2 1.6 22.0 6.1 5.6 1.2 5.3 1.7 29.7 6.4 10.9 35.2 7.9 57.5 32.5 7.3 45.5 1.5 3.6 7.9 10.9 1.4 6.1 17.4 35.5 21.9 43.7 21.1 11.4 11.3 12.2 8.6 7.5 13.1 7.3 5.9 2.8 3.1 11.3 29.4 18.9 1.6 2.7 12.0 1.2 2.3 2.1 8.2 7.8 3.2 9.0 5.5 9.0 5.1 4.6 1.3 3.5 1.8 3.6 1.0 4.0 6.8 2.8 9.6 7.0 24.0 6.6 21.3 4.8 6.7 4.4 2.5 2.4 2.1 10.5 2.1 2.1 2.7 5.0 1.7 11.2 1.6 2.9 14.8 17.9 0.4 0.4 7.6 10.4 3.5 6.1 17.2 2.1 4.7 1.7 2.2 9.5 0.7 0.2 0.6 2.5 8.5 2.5 1.9 12.2 8.6 8.0 10.1 5.9 8.7 11.4 13.1 8.6 5.0 9.2 9.6 8.8 3.9 7.5 7.1 11.3 13.0 7.3 2.2 14.6 13.7 2.8 1.4 1.6 1.2 1.6 1.7 1.4 8.9 18.1 0.5 34.8 107.6 0.5 54.1 12.7 4.0 22.7 21.0 0.0 3.4 6.6 16.7 0.5 15.3 21.3 0.0 18.5 1.9 18.8 41.3 15.1 0.0 9.7 1.6 13.9 9.2 11.9 0.0 62.5 15.3 28.7 26.2 28.8 23.3 18.9 40.7 35.0 16.3 1.8 32.3 32.3 2.2 6.1 131.2 1.6 10.1 27.2 56.7 TMEM167A "FLJ30508, MGC23909, TMEM167" ENSG00000174695 "Transmembrane protein 167A" Q8TBQ9 5 83052846-83077863 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077278 Approved Vesicles NA NA Vesicles "HPA077278: " "unprognostic (5.38e-3)" "unprognostic (2.84e-3)" "unprognostic (3.78e-2)" "unprognostic (4.40e-2)" "unprognostic (1.66e-1)" "unprognostic (3.34e-1)" "unprognostic (4.06e-3)" "unprognostic (7.74e-2)" "unprognostic (9.94e-3)" "unprognostic (3.99e-3)" "unprognostic (2.72e-1)" "unprognostic (4.09e-2)" "unprognostic (2.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.51e-1)" "unprognostic (1.13e-3)" "unprognostic (1.29e-2)" 22.9 38.0 29.3 20.9 31.3 19.8 23.2 24.2 32.8 24.9 18.8 21.8 12.2 20.5 16.9 20.6 16.7 13.1 21.2 21.8 27.8 28.4 26.2 25.3 21.4 16.3 32.9 20.9 12.9 23.6 22.2 32.9 26.1 35.5 18.0 22.8 15.2 21.3 15.9 15.6 16.1 19.7 17.3 26.7 18.2 17.5 9.7 25.3 22.8 22.2 16.1 17.5 18.4 14.3 2.9 8.4 13.2 15.6 3.9 4.3 6.8 13.1 8.0 30.2 26.8 44.6 31.2 27.7 20.8 16.3 13.5 17.8 12.1 17.1 8.4 13.1 24.6 18.2 11.1 20.1 27.0 22.5 11.6 12.4 22.7 15.0 18.6 17.5 11.6 14.9 24.3 19.1 17.4 16.4 22.1 16.6 12.7 12.5 17.1 19.8 11.5 14.2 12.8 31.2 6.9 13.7 12.7 19.4 23.2 19.0 10.5 14.3 18.7 13.9 14.7 20.6 28.9 26.5 27.5 22.5 8.5 8.4 24.5 18.6 10.0 27.8 8.5 15.7 21.1 20.1 13.2 15.0 6.8 2.6 14.2 3.0 2.9 3.6 3.2 8.4 2.4 3.9 3.0 8.8 3.9 15.6 4.0 4.3 6.8 29.3 31.3 24.2 32.8 27.8 28.4 32.9 20.9 35.5 25.3 32.8 22.1 57.6 46.9 42.6 42.8 42.8 76.5 28.1 26.1 47.1 39.3 88.2 144.2 76.0 12.3 56.7 80.5 0.0 105.9 256.8 99.2 99.3 32.3 96.2 144.4 31.8 48.8 49.7 208.1 14.6 43.7 117.7 89.4 108.2 77.1 46.8 108.0 74.8 46.7 173.3 28.5 32.3 52.7 47.3 64.5 58.7 150.0 55.8 58.1 92.4 TMEM198 "MGC99813, TMEM198A" ENSG00000188760 "Transmembrane protein 198" Q66K66 2 219543663-219550595 "Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.0" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 20.6;Intestinal endocrine cells: 18.4;Muller glia cells: 9.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SCLC-21H: 17.3;SH-SY5Y: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042385, HPA062897" Enhanced Approved Vesicles NA NA Vesicles "HPA042385: AB_2677972, HPA062897: " "unprognostic (2.59e-2)" "unprognostic (8.51e-2)" "unprognostic (5.97e-3)" "unprognostic (2.77e-1)" "unprognostic (4.43e-2)" "unprognostic (8.09e-2)" "unprognostic (1.83e-1)" "unprognostic (1.03e-1)" "unprognostic (4.28e-1)" "unprognostic (2.06e-1)" "prognostic favorable (6.89e-4)" "unprognostic (6.39e-2)" "unprognostic (7.91e-3)" "unprognostic (3.41e-3)" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" 3.0 9.4 14.4 3.1 10.3 0.9 2.3 14.2 22.0 3.3 2.6 4.1 1.4 16.1 4.0 2.5 2.7 2.5 3.9 3.4 16.5 5.2 3.0 2.6 2.4 1.8 4.1 11.9 10.9 20.0 5.2 13.0 2.6 6.2 4.0 1.8 3.0 7.0 4.3 3.5 2.2 6.4 3.5 7.5 1.8 4.7 5.0 4.9 0.0 4.0 0.5 1.9 3.8 1.2 0.2 2.6 0.1 0.0 0.8 0.4 0.4 0.5 0.1 4.8 8.2 1.0 0.9 4.3 2.5 1.3 2.0 1.7 10.5 1.4 2.1 2.4 1.5 5.0 2.9 1.7 1.2 0.4 7.1 2.0 1.7 2.1 8.6 1.5 0.6 4.0 2.1 0.7 0.9 2.3 2.2 0.0 1.5 6.2 7.0 1.2 1.0 0.1 0.5 6.2 0.8 0.7 0.2 2.9 2.4 1.2 1.1 17.3 15.0 0.6 1.7 4.1 0.9 0.2 3.3 0.1 2.2 0.9 2.0 1.0 6.7 1.9 2.2 2.0 0.1 3.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 2.6 0.0 0.4 14.4 10.3 14.2 22.0 16.5 5.2 4.1 11.9 6.2 4.9 0.0 1.4 0.0 1.1 0.1 8.1 1.6 0.0 0.0 0.0 0.0 2.0 0.8 1.7 2.7 0.7 0.0 1.0 0.0 7.0 0.6 2.2 0.8 0.0 1.5 0.2 20.6 18.4 0.0 0.3 1.3 2.6 0.0 1.7 1.0 0.9 9.8 1.8 0.8 4.6 1.6 6.5 0.0 2.8 9.2 3.1 0.1 2.4 0.5 0.1 0.3 TMEM231 "ALYE870, FLJ22167, JBTS20, MKS11, PRO1886" ENSG00000205084 "Transmembrane protein 231" Q9H6L2 16 75536744-75556286 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 58.4" "Cell type enhanced" "Detected in many" 16 "Ciliated cells: 119.1;Cone photoreceptor cells: 49.1;Rod photoreceptor cells: 33.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA042081 Enhanced Approved Vesicles NA NA Vesicles "HPA042081: AB_10795391" "unprognostic (4.29e-2)" "unprognostic (9.84e-2)" "unprognostic (8.07e-2)" "unprognostic (2.71e-3)" "unprognostic (1.03e-1)" "unprognostic (9.34e-2)" "unprognostic (2.90e-2)" "unprognostic (2.81e-1)" "unprognostic (2.92e-1)" "unprognostic (1.69e-2)" "unprognostic (3.34e-3)" "unprognostic (7.84e-2)" "unprognostic (3.73e-2)" "unprognostic (1.22e-1)" "unprognostic (1.66e-1)" "unprognostic (1.12e-1)" "unprognostic (1.28e-1)" 3.7 5.3 7.9 2.8 14.7 2.5 4.1 5.0 12.4 7.1 4.1 16.6 3.6 4.0 6.4 10.1 3.1 58.4 4.8 7.9 9.1 9.9 4.7 2.5 7.3 2.7 6.5 9.9 14.3 4.7 6.6 7.7 3.6 14.3 5.4 3.5 6.6 3.1 5.6 1.9 3.3 4.2 7.7 6.2 2.7 3.2 8.5 6.6 0.2 8.0 1.0 2.2 3.5 3.0 5.0 3.2 6.2 0.9 1.0 3.5 1.3 3.9 2.4 6.3 10.5 6.1 15.1 3.5 4.3 5.6 5.4 6.6 1.5 6.3 4.3 6.1 6.2 4.6 9.5 0.7 5.0 3.3 0.8 2.6 0.2 3.2 1.4 5.4 2.4 1.9 3.3 6.2 5.5 13.4 9.8 3.8 4.1 4.2 0.2 1.6 10.1 1.5 4.7 3.8 0.6 2.2 0.8 0.9 9.6 7.0 1.4 5.3 3.5 8.7 2.2 4.0 2.2 2.0 2.7 5.6 4.2 3.6 2.7 2.3 8.2 7.2 1.3 10.6 1.2 4.2 3.0 0.9 0.6 1.7 0.9 3.5 5.0 1.8 2.9 2.5 2.4 1.6 2.4 6.2 1.0 0.5 3.2 0.5 1.3 7.9 14.7 5.0 12.4 9.1 9.9 6.5 9.9 14.3 6.6 3.0 4.6 0.0 4.2 0.9 15.3 4.0 0.0 119.1 19.4 7.0 49.1 1.0 0.0 2.5 14.1 4.9 4.6 0.0 2.0 0.9 3.1 3.9 1.1 1.1 0.8 12.7 2.9 3.7 0.8 3.3 1.7 1.8 0.0 4.6 5.9 6.0 1.5 4.5 3.5 1.4 33.5 0.0 3.7 10.8 9.0 0.9 0.2 1.0 5.0 2.2 TMEM234 "C1orf91, dJ622L5.7, FLJ90779, RP4-622L5" ENSG00000160055 "Transmembrane protein 234" Q8WY98 1 32214472-32222359 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015049 Uncertain Approved Vesicles NA NA Vesicles "HPA015049: AB_1856409" "unprognostic (1.39e-2)" "unprognostic (1.36e-1)" "unprognostic (1.52e-1)" "unprognostic (1.26e-1)" "unprognostic (2.44e-3)" "unprognostic (3.09e-1)" "prognostic unfavorable (2.35e-5)" "unprognostic (2.67e-1)" "unprognostic (1.07e-2)" "unprognostic (6.49e-2)" "unprognostic (2.66e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.12e-5)" "unprognostic (1.95e-1)" "unprognostic (2.44e-1)" "unprognostic (7.92e-2)" "unprognostic (2.37e-2)" 7.9 9.2 7.0 9.5 9.2 5.7 8.6 9.5 12.2 9.4 9.4 9.9 21.9 5.0 9.6 22.2 10.4 11.8 12.3 11.0 7.4 8.4 11.5 7.3 9.8 9.9 6.0 7.6 12.6 10.8 14.5 14.9 12.5 6.6 10.2 9.3 14.8 8.8 25.0 6.3 5.3 7.4 9.6 5.8 9.0 9.4 15.9 4.7 8.6 15.3 4.0 9.4 6.8 9.0 5.2 7.5 23.2 8.3 7.0 6.4 4.1 8.2 6.8 3.6 3.9 10.5 8.3 4.0 12.2 9.0 6.3 4.8 4.5 8.8 2.5 14.2 11.6 4.9 6.9 4.6 9.0 5.6 5.3 5.4 5.2 10.0 5.1 8.0 6.1 3.5 10.7 9.6 6.8 5.0 11.7 9.3 2.7 4.7 1.8 11.0 2.4 2.4 4.9 6.9 2.1 5.0 3.3 2.9 2.9 14.3 4.0 4.7 4.8 9.2 5.2 4.0 12.3 2.4 2.0 11.0 2.4 3.8 9.1 8.7 3.1 1.5 1.2 7.2 2.3 8.4 11.7 8.0 11.9 4.1 8.3 6.4 4.5 3.3 4.4 7.5 5.2 2.4 3.0 23.2 7.0 5.9 5.6 1.9 4.1 7.0 9.2 9.5 12.2 7.4 8.4 6.0 7.6 6.6 4.7 8.9 1.0 5.8 6.2 2.4 5.6 2.8 2.5 22.7 6.8 22.7 2.0 22.7 1.7 18.9 18.4 7.7 12.9 0.0 13.5 19.1 7.5 6.4 3.5 5.8 16.7 1.6 5.8 9.2 7.5 41.2 8.6 6.3 13.5 15.4 10.8 8.0 15.1 11.5 7.4 9.8 11.5 6.5 6.9 26.5 15.3 2.8 17.8 5.7 8.4 5.8 TMEM248 "C7orf42, FLJ10099, FLJ13090" ENSG00000106609 "Transmembrane protein 248" Q9NWD8 7 66921225-66958551 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016495 Uncertain Approved Vesicles NA NA 1200000 Vesicles "HPA016495: AB_1848643" "unprognostic (6.74e-2)" "unprognostic (1.73e-2)" "unprognostic (4.86e-2)" "unprognostic (4.64e-2)" "unprognostic (6.67e-3)" "unprognostic (9.36e-2)" "unprognostic (1.39e-2)" "unprognostic (4.14e-2)" "unprognostic (2.32e-1)" "unprognostic (4.54e-2)" "unprognostic (9.18e-2)" "unprognostic (2.80e-3)" "unprognostic (1.30e-1)" "unprognostic (8.96e-2)" "unprognostic (5.11e-2)" "unprognostic (8.28e-2)" "unprognostic (5.57e-2)" 32.2 33.0 23.8 30.2 30.6 11.9 44.6 28.0 28.4 38.7 32.8 23.8 39.0 32.1 40.6 32.9 26.0 36.1 40.7 28.2 24.6 30.4 30.9 46.3 31.6 38.3 20.9 21.3 40.8 58.4 47.2 28.9 35.6 21.0 34.7 32.4 39.4 36.9 36.8 19.1 23.7 44.8 34.7 23.8 32.6 33.7 33.3 20.6 40.1 37.7 24.0 35.9 33.2 40.7 10.7 10.1 8.6 5.2 9.0 9.3 2.3 18.2 21.5 18.2 25.9 41.5 32.0 16.0 22.5 38.8 21.5 23.3 15.5 24.0 18.6 27.5 30.3 29.4 16.6 15.6 18.6 26.8 17.0 11.5 13.6 15.4 17.9 26.9 22.5 18.9 28.7 21.6 18.0 15.0 31.4 27.9 14.6 25.9 12.5 34.0 11.1 21.1 27.8 27.0 18.9 14.7 15.5 21.2 31.4 29.1 14.1 12.7 27.2 19.8 36.5 19.9 28.4 18.3 20.8 25.7 30.3 14.9 19.7 24.6 15.4 17.3 20.9 25.3 25.2 28.7 2.3 5.0 8.6 7.9 5.2 9.3 9.6 8.5 8.1 3.9 10.7 8.4 8.8 7.4 9.0 3.1 10.1 5.6 2.3 23.8 30.6 28.0 28.4 24.6 30.4 20.9 21.3 21.0 20.6 47.6 36.0 52.8 43.6 57.4 17.6 20.0 56.0 26.8 22.7 50.6 5.9 43.1 10.0 31.7 90.3 43.5 63.0 23.3 40.8 69.9 58.2 82.8 27.7 96.6 46.4 17.5 26.6 55.9 54.2 141.2 59.0 47.5 47.2 24.4 75.1 91.8 47.7 67.4 61.9 30.6 12.3 32.3 48.4 79.2 60.9 64.5 73.7 59.8 53.0 69.4 TMEM256 "C17orf61, MGC40107" ENSG00000205544 "Transmembrane protein 256" Q8N2U0 17 7402975-7404137 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 456.8;Proximal tubular cells: 475.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA062732 Approved Vesicles NA NA Vesicles "HPA062732: AB_2684852" "unprognostic (3.82e-2)" "unprognostic (1.93e-1)" "unprognostic (2.91e-1)" "unprognostic (2.77e-2)" "unprognostic (1.05e-1)" "unprognostic (1.74e-3)" "unprognostic (3.69e-2)" "unprognostic (5.73e-2)" "unprognostic (7.45e-2)" "unprognostic (2.12e-2)" "unprognostic (3.22e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (9.36e-4)" "unprognostic (1.12e-2)" "unprognostic (1.60e-1)" "unprognostic (1.03e-1)" "unprognostic (1.19e-2)" 28.7 23.5 23.4 20.7 31.8 19.8 48.2 15.0 32.9 18.7 40.7 12.1 32.8 48.6 18.7 30.7 19.9 22.1 26.1 54.0 20.2 15.8 32.6 54.8 25.3 54.0 25.0 20.1 21.8 73.8 13.0 12.9 9.4 28.4 22.4 16.2 16.8 38.5 39.7 26.3 16.1 42.4 23.6 37.5 18.9 23.0 7.4 16.3 11.1 16.7 24.4 17.1 20.5 18.0 28.2 30.2 5.0 23.5 13.8 19.5 27.3 22.1 28.9 15.5 21.6 26.5 33.2 14.7 10.2 14.2 16.2 15.3 11.5 12.6 19.2 18.8 10.0 13.4 18.9 9.7 30.3 11.6 10.1 32.6 12.2 11.0 29.7 18.3 4.2 16.8 29.3 14.3 21.3 17.7 22.4 23.4 21.2 9.1 13.2 20.5 11.4 14.2 13.8 7.2 9.5 19.2 22.8 14.1 22.1 38.9 9.2 1.8 13.1 15.9 12.4 16.7 16.2 22.5 7.8 14.5 7.8 14.9 15.8 13.0 11.2 13.7 9.7 20.6 5.7 14.9 3.8 23.5 5.0 14.0 16.9 17.1 28.2 16.8 16.1 21.7 26.3 19.5 17.9 1.4 13.8 12.2 30.2 16.5 27.3 23.4 31.8 15.0 32.9 20.2 15.8 25.0 20.1 28.4 16.3 41.7 45.6 142.1 74.5 77.6 24.2 55.1 117.2 103.1 53.4 125.6 7.9 74.7 252.0 108.1 4.3 65.3 317.0 46.7 166.5 182.0 82.7 95.4 66.9 456.8 174.6 19.1 120.3 103.7 156.8 4.0 127.1 107.5 136.7 150.5 165.7 71.2 171.2 198.6 66.8 475.2 32.2 58.2 87.2 6.6 42.6 117.1 39.0 86.3 181.5 71.4 TMEM263 "C12orf23, MGC17943" ENSG00000151135 "Transmembrane protein 263" Q8WUH6 12 106955719-106978778 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014453, HPA042339" Uncertain Approved Vesicles NA NA Vesicles "HPA014453: , HPA042339: AB_10795503" "unprognostic (2.56e-2)" "unprognostic (1.41e-1)" "unprognostic (8.99e-2)" "unprognostic (5.65e-2)" "unprognostic (3.90e-1)" "unprognostic (3.46e-2)" "prognostic unfavorable (7.84e-4)" "unprognostic (4.66e-2)" "unprognostic (6.01e-2)" "unprognostic (3.11e-2)" "unprognostic (7.07e-2)" "unprognostic (1.19e-1)" "unprognostic (3.05e-3)" "unprognostic (3.49e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.53e-1)" 14.5 17.6 13.7 15.1 14.7 4.0 25.9 10.6 12.4 29.0 13.9 5.2 26.7 10.8 22.6 27.9 13.2 12.8 19.6 25.3 10.9 16.0 24.4 44.8 12.9 18.2 11.3 10.4 24.0 28.1 12.8 65.3 40.9 11.6 21.1 12.3 10.0 25.2 26.8 10.1 5.6 15.0 18.9 10.4 15.0 18.9 12.4 6.9 32.1 32.8 7.0 12.1 21.2 23.2 11.9 9.1 5.9 0.9 11.5 17.9 8.3 8.9 8.0 15.4 10.3 36.1 40.9 6.4 33.9 31.8 16.8 21.3 8.5 3.9 0.8 10.5 48.3 9.4 4.1 9.6 13.5 23.3 16.0 9.8 12.4 12.6 17.7 18.5 0.6 7.9 28.4 6.4 18.3 15.2 39.0 20.4 9.6 5.8 3.4 22.9 7.3 9.3 5.6 4.9 5.6 15.4 20.7 11.4 2.0 16.7 7.6 7.9 10.7 18.1 8.6 13.4 12.4 10.1 3.6 23.7 14.2 8.7 18.6 8.6 14.2 8.1 8.3 11.2 2.1 22.3 5.9 0.8 0.9 10.2 0.9 12.0 9.2 9.9 8.7 2.6 11.9 17.9 16.0 0.7 11.5 0.3 9.1 10.2 8.3 13.7 14.7 10.6 11.0 10.9 16.0 11.3 10.4 11.6 6.9 8.9 17.6 20.1 43.8 0.0 24.3 46.6 12.7 22.7 20.5 22.7 29.5 34.9 77.9 16.2 24.1 20.3 13.5 0.0 28.5 63.2 46.3 43.7 29.9 42.7 11.8 11.1 27.6 28.8 5.0 29.3 43.7 6.9 0.0 12.6 48.2 31.2 18.5 8.6 41.1 34.0 18.5 25.8 39.5 31.2 23.2 0.0 30.1 14.6 17.4 23.5 TMEM270 "MGC26719, WBSCR28" ENSG00000175877 "Transmembrane protein 270" Q6UE05 7 73861159-73865893 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 35.0" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "T-reg: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.1;GAMG: 1.5;MCF7: 5.3;PC-3: 1.8;RPMI-8226: 1.4;U-2197: 1.4;U-87 MG: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA077196 Approved Vesicles NA NA Vesicles "HPA077196: AB_2732334" "unprognostic (3.84e-2)" "unprognostic (6.91e-2)" "unprognostic (6.87e-5)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (2.81e-3)" "unprognostic (1.34e-1)" "unprognostic (8.31e-3)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-1)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.26e-1)" "unprognostic (1.44e-1)" "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 2.1 0.2 0.0 0.4 1.5 0.9 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.4 0.0 0.3 1.8 0.0 0.0 1.4 0.3 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.3 0.1 1.4 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM39B FLJ10315 ENSG00000121775 "Transmembrane protein 39B" Q9GZU3 1 32072031-32102866 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040191, HPA040224" Approved Approved Vesicles NA NA Vesicles "HPA040191: AB_10805706, HPA040224: AB_10795274" "unprognostic (1.74e-2)" "unprognostic (2.20e-2)" "unprognostic (4.38e-2)" "prognostic unfavorable (3.00e-4)" "unprognostic (1.06e-1)" "unprognostic (1.14e-2)" "prognostic unfavorable (2.82e-6)" "unprognostic (1.10e-2)" "unprognostic (3.37e-2)" "unprognostic (1.74e-1)" "unprognostic (3.63e-2)" "unprognostic (4.47e-2)" "prognostic unfavorable (5.11e-9)" "unprognostic (2.20e-1)" "unprognostic (5.80e-2)" "unprognostic (4.45e-2)" "unprognostic (2.10e-1)" 13.4 10.2 6.2 7.4 10.1 6.1 10.8 6.2 14.3 18.2 10.7 11.5 8.2 7.1 18.8 11.9 8.2 11.8 9.4 10.0 5.8 7.9 6.7 13.7 9.3 13.5 7.2 11.7 16.1 6.6 7.8 9.9 16.9 8.3 9.7 8.1 10.8 8.5 13.7 9.9 13.0 8.4 12.6 7.0 9.5 9.0 18.3 7.1 22.9 10.8 10.3 13.1 12.7 11.3 11.5 21.6 5.1 14.1 4.4 10.6 8.3 8.1 2.4 2.9 7.8 10.0 6.0 4.1 7.7 11.8 9.3 9.0 4.2 12.0 8.7 11.6 5.3 5.7 9.3 2.3 11.4 2.6 4.8 7.5 5.7 5.2 2.2 12.1 10.1 5.8 8.8 4.2 14.2 10.3 5.1 5.6 5.0 7.4 7.8 8.0 3.8 6.5 3.0 10.4 9.2 5.8 12.0 11.2 12.3 4.1 4.4 7.2 4.3 10.5 5.4 8.2 1.1 4.2 4.8 8.4 14.6 9.7 5.3 7.5 3.9 5.9 9.5 8.9 8.7 11.1 2.5 14.1 5.1 5.3 12.0 7.2 11.5 7.9 6.6 14.4 11.5 10.6 8.6 3.7 4.4 8.7 21.6 8.2 8.3 6.2 10.1 6.2 14.3 5.8 7.9 7.2 11.7 8.3 7.1 8.9 0.6 14.5 14.4 9.8 7.7 2.2 7.6 2.7 7.9 3.5 17.7 28.7 1.7 7.4 2.4 17.5 4.7 0.0 13.8 18.0 17.0 4.9 15.0 5.5 13.5 6.4 5.2 12.3 15.7 0.9 11.2 12.6 10.1 19.8 7.6 4.3 5.3 2.9 13.1 3.4 5.6 6.5 12.2 10.3 15.1 8.9 34.1 10.1 9.3 3.5 TMEM54 CAC-1 ENSG00000121900 "Transmembrane protein 54" Q969K7 1 32894594-32901438 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 76.7" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 673.9;Mucus-secreting cells: 310.3;Paneth cells: 422.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CAPAN-2: 48.3;OE19: 57.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA061992 Approved Vesicles NA NA Vesicles "HPA061992: AB_2684652" "unprognostic (2.67e-1)" "unprognostic (2.57e-2)" "unprognostic (2.55e-1)" "unprognostic (4.98e-2)" "unprognostic (3.70e-2)" "unprognostic (3.85e-2)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (2.42e-2)" "unprognostic (3.48e-2)" "unprognostic (9.43e-2)" "unprognostic (6.82e-3)" "unprognostic (2.13e-2)" "unprognostic (9.06e-2)" "unprognostic (3.12e-2)" "unprognostic (3.40e-2)" 3.2 3.3 16.1 21.5 10.7 0.0 8.5 2.7 10.6 10.0 70.0 8.2 7.0 37.9 8.5 9.4 28.8 5.0 24.2 4.5 9.7 9.4 11.4 4.4 7.2 2.4 10.9 5.7 6.2 12.4 9.0 4.7 47.3 6.8 14.7 37.4 7.4 11.8 8.4 1.9 26.9 76.7 7.3 7.3 3.1 35.0 3.7 6.0 1.1 23.6 16.9 14.2 12.5 15.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 29.9 8.1 0.0 7.8 14.9 9.0 29.3 4.4 7.2 10.7 13.8 20.2 48.3 0.0 13.1 5.9 13.6 18.4 7.0 25.9 3.2 34.8 1.4 0.0 2.9 1.0 10.8 0.1 0.4 7.7 23.7 16.3 4.5 7.2 4.7 3.1 4.1 0.0 5.5 32.1 0.0 0.6 2.5 57.6 14.1 4.0 12.2 0.1 3.9 38.5 0.4 4.0 3.1 20.1 10.1 5.0 21.8 5.8 8.9 10.5 11.2 23.5 9.4 1.1 2.5 3.5 7.5 0.7 14.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 10.7 2.7 10.6 9.7 9.4 10.9 5.7 6.8 6.0 17.9 25.1 9.7 74.9 18.1 5.9 2.8 76.5 6.7 6.8 45.4 3.9 34.8 23.2 128.9 43.4 11.3 673.9 0.0 180.9 127.1 10.8 130.2 5.7 1.5 7.4 0.0 58.3 12.9 1.8 20.3 18.4 3.7 13.5 5.4 310.3 13.7 137.0 422.1 23.0 38.7 8.7 6.5 11.3 11.1 8.9 55.7 53.8 0.0 231.5 148.6 TMEM68 FLJ32370 ENSG00000167904 "Transmembrane protein 68" Q96MH6 8 55696424-55773407 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018216, HPA019173" Uncertain Approved Vesicles NA NA Vesicles "HPA018216: AB_2205185, HPA019173: AB_1858129" "unprognostic (4.43e-2)" "unprognostic (3.10e-2)" "unprognostic (8.04e-2)" "unprognostic (2.40e-1)" "unprognostic (4.61e-2)" "unprognostic (1.15e-1)" "unprognostic (3.46e-3)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" "unprognostic (3.37e-2)" "unprognostic (3.28e-2)" "unprognostic (1.03e-1)" "unprognostic (3.92e-2)" "unprognostic (1.48e-2)" "unprognostic (1.64e-1)" "unprognostic (4.41e-2)" "unprognostic (1.63e-1)" 10.4 18.3 14.0 8.4 18.0 10.6 14.6 18.9 20.5 13.0 15.1 16.3 16.0 14.6 15.4 17.9 16.1 25.4 12.5 7.4 13.8 13.2 20.6 14.6 11.3 10.5 12.7 10.2 15.7 13.5 15.9 18.5 15.6 13.2 15.8 16.6 13.1 14.0 12.2 7.8 17.6 18.3 14.4 13.3 12.9 12.0 9.8 11.7 22.7 18.8 13.4 12.3 17.1 13.0 9.2 7.2 21.7 7.7 8.2 10.5 3.9 12.4 7.5 12.8 7.7 10.8 12.5 22.4 11.0 8.5 10.7 10.4 10.6 23.5 13.7 13.1 7.3 13.7 15.8 9.9 14.7 11.9 18.7 11.2 16.5 6.8 11.1 11.9 7.0 9.2 8.4 22.7 10.8 25.5 15.8 9.7 14.9 15.8 13.8 15.6 6.5 17.4 9.6 13.8 27.2 3.9 12.8 5.3 8.8 17.7 9.7 10.6 9.4 7.4 12.1 21.7 17.4 17.8 9.1 7.6 8.2 10.3 14.0 9.0 11.9 14.9 17.2 11.1 11.7 12.6 21.7 7.1 5.0 7.2 4.4 10.5 9.2 8.6 7.6 7.2 9.2 7.2 10.1 7.9 8.2 7.7 6.4 6.3 3.9 14.0 18.0 18.9 20.5 13.8 13.2 12.7 10.2 13.2 11.7 11.9 10.1 7.5 25.1 30.3 17.3 4.1 20.4 56.2 21.6 24.4 13.7 26.7 11.6 14.9 1.3 9.5 14.5 0.0 7.0 17.4 11.9 20.6 5.7 11.0 11.5 20.6 14.5 10.4 14.9 1.1 12.0 10.1 6.8 13.6 23.7 17.2 12.5 19.2 13.1 17.7 15.2 25.8 9.5 15.8 12.3 31.0 18.5 11.5 14.1 24.8 TMEM8B "C9orf127, NAG-5, NGX6" ENSG00000137103 "Transmembrane protein 8B" A6NDV4 9 35814451-35865518 "Predicted membrane proteins, Transporters" "Cell adhesion, Growth regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cytotrophoblasts: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "plasmacytoid DC: 27.2" "Lineage enriched" "Detected in many" 18 "dendritic cells: 27.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052130, HPA062701" Approved Approved Vesicles NA NA Vesicles "HPA052130: AB_2681740, HPA062701: AB_2684839" "unprognostic (5.54e-2)" "unprognostic (3.32e-1)" "unprognostic (3.96e-1)" "unprognostic (3.53e-2)" "unprognostic (3.81e-1)" "unprognostic (1.42e-1)" "unprognostic (4.09e-2)" "unprognostic (2.67e-2)" "unprognostic (2.97e-1)" "unprognostic (1.62e-1)" "prognostic favorable (3.14e-4)" "unprognostic (5.93e-2)" "prognostic favorable (1.89e-15)" "unprognostic (8.00e-2)" "unprognostic (1.26e-1)" "unprognostic (1.68e-2)" "unprognostic (3.29e-2)" 9.7 19.5 28.2 5.7 30.4 3.4 9.4 22.9 34.4 15.5 13.0 16.9 14.9 8.7 18.4 11.5 9.3 18.3 12.1 17.8 25.3 14.1 11.3 4.7 10.4 5.9 12.9 21.2 33.3 14.6 28.4 23.6 7.7 18.3 19.3 9.4 17.5 19.9 24.0 19.1 9.2 8.4 18.1 13.0 8.7 13.1 13.6 15.4 5.6 17.3 5.1 4.9 14.2 11.9 0.9 27.2 0.6 1.5 0.5 0.6 1.1 2.9 3.1 11.0 8.6 12.4 10.4 1.3 2.6 5.1 2.9 3.6 1.3 0.8 2.3 6.3 7.1 8.5 1.1 2.9 4.3 2.4 1.8 4.9 0.7 2.2 3.1 8.8 0.2 0.3 9.7 5.6 3.0 3.2 9.4 1.6 10.7 1.0 6.5 5.1 1.1 6.0 1.3 1.6 2.4 4.3 6.7 2.2 5.7 3.0 1.3 2.6 7.7 4.0 1.9 3.9 3.8 3.0 1.1 2.6 6.9 2.2 6.7 1.0 8.7 2.6 2.6 6.3 1.1 4.2 0.4 1.5 0.1 0.6 0.3 0.5 0.9 0.6 0.6 4.7 0.9 0.6 0.5 0.6 0.5 0.3 27.2 0.4 1.1 28.2 30.4 22.9 34.4 25.3 14.1 12.9 21.2 18.3 15.4 11.9 13.5 0.9 7.2 3.9 3.9 10.1 10.2 4.0 7.9 14.0 2.0 29.0 1.7 4.4 20.2 2.9 3.9 0.0 3.4 5.3 7.2 9.2 1.1 2.9 2.9 1.6 6.4 1.3 1.9 9.9 13.6 3.3 10.1 0.0 5.6 8.2 3.2 8.6 18.4 4.1 5.0 6.5 6.1 8.0 4.4 1.4 10.9 3.8 6.3 8.2 TMTC4 "FLJ14624, FLJ22153" ENSG00000125247 "Transmembrane and tetratricopeptide repeat containing 4" Q5T4D3 13 100603927-100675093 "Predicted intracellular proteins, Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 45.7" "Cell type enhanced" "Detected in many" 6 "Ito cells: 52.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016489, HPA057056" Approved Approved Vesicles NA NA Vesicles "HPA016489: AB_1858157, HPA057056: " "unprognostic (1.49e-1)" "unprognostic (1.87e-1)" "unprognostic (8.34e-2)" "unprognostic (1.35e-1)" "unprognostic (2.43e-2)" "unprognostic (1.96e-1)" "unprognostic (1.50e-2)" "unprognostic (1.96e-1)" "unprognostic (1.88e-2)" "unprognostic (1.09e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.41e-1)" "unprognostic (1.99e-1)" "unprognostic (6.04e-2)" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" 4.1 4.4 11.4 4.4 13.7 1.9 5.7 10.6 21.8 6.6 7.0 45.7 8.3 8.5 8.7 7.5 4.8 13.2 4.9 3.2 16.9 8.7 11.5 9.8 3.5 3.6 16.9 10.0 5.3 12.8 7.5 3.3 4.0 29.6 7.9 7.6 4.6 6.9 5.6 9.4 6.5 7.3 6.0 25.2 3.9 7.9 9.7 11.3 4.2 7.2 3.9 4.6 7.7 4.3 2.4 6.4 0.2 3.3 1.3 4.4 1.4 5.0 4.3 22.2 11.7 2.9 6.0 24.9 2.9 2.5 2.7 2.2 4.3 9.3 15.0 9.6 2.4 5.2 3.6 6.9 3.0 3.3 8.5 4.9 6.3 8.0 6.7 3.1 8.2 0.1 8.4 5.9 1.0 5.0 7.6 12.1 8.2 4.7 1.9 3.2 4.4 5.9 4.7 6.0 14.8 4.2 6.5 3.9 3.3 11.2 3.9 11.4 11.9 5.5 10.8 2.8 14.0 7.9 23.2 18.9 2.4 4.2 2.2 4.9 5.0 4.1 2.9 11.9 5.4 7.1 0.0 2.0 0.2 2.7 2.1 2.4 2.0 2.6 4.4 6.4 2.4 3.0 1.1 0.0 1.3 3.3 4.2 3.8 1.4 11.4 13.7 10.6 21.8 16.9 8.7 16.9 10.0 29.6 11.3 6.0 3.8 4.6 6.6 2.7 17.6 9.0 17.8 6.7 6.8 5.2 7.9 9.1 1.7 9.8 4.1 4.6 7.9 0.0 16.4 15.9 5.7 9.1 0.0 12.4 3.8 25.4 10.3 52.2 8.7 4.7 3.7 4.1 3.3 0.0 11.2 9.6 12.0 7.0 6.3 12.4 7.5 6.5 4.2 8.8 31.8 5.1 2.6 2.6 12.6 4.7 TNFAIP8L2 FLJ23467 ENSG00000163154 "TNF alpha induced protein 8 like 2" Q6P589 1 151156629-151159749 "Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 63.1;lymphoid tissue: 38.7" "Cell type enhanced" "Detected in some" 14 "Hofbauer cells: 59.6;Kupffer cells: 56.1;Macrophages: 47.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 12.8;HL-60: 7.5;HMC-1: 19.9;NB-4: 10.8;THP-1: 41.5;U-937: 16.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062742 Approved Vesicles NA NA Vesicles "HPA062742: " "unprognostic (3.19e-3)" "unprognostic (1.02e-2)" "unprognostic (6.63e-3)" "unprognostic (2.27e-2)" "unprognostic (1.29e-1)" "unprognostic (6.49e-3)" "unprognostic (1.05e-1)" "unprognostic (9.15e-3)" "prognostic favorable (3.64e-4)" "unprognostic (9.54e-2)" "unprognostic (3.32e-2)" "unprognostic (9.03e-2)" "prognostic unfavorable (3.53e-7)" "unprognostic (1.78e-1)" "unprognostic (3.91e-2)" "unprognostic (4.87e-2)" "unprognostic (2.23e-1)" 8.5 4.2 5.7 13.8 8.8 4.1 2.7 1.3 4.5 2.0 3.2 4.0 0.0 3.9 2.0 2.6 2.1 3.0 4.1 2.8 4.1 3.3 2.9 6.0 8.2 20.9 8.2 2.2 1.8 2.0 0.3 1.9 7.0 7.2 2.6 4.6 1.8 6.4 1.4 1.0 2.7 6.9 3.9 8.0 38.7 2.5 1.0 6.9 21.0 1.8 1.2 12.8 7.2 1.9 17.7 56.4 63.1 50.6 47.1 43.9 44.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.8 0.1 0.0 0.0 7.5 19.9 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.1 10.8 0.0 0.0 0.0 2.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 41.5 1.1 0.1 0.0 0.0 0.1 0.1 0.0 0.8 0.0 16.3 0.0 53.4 50.6 50.0 23.3 45.4 22.9 15.6 28.8 23.5 56.4 17.7 43.9 31.5 63.1 47.1 41.2 13.3 31.6 44.8 5.7 8.8 1.3 4.5 4.1 3.3 8.2 2.2 7.2 6.9 0.0 1.7 16.4 0.0 0.2 0.2 0.0 5.1 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 4.7 0.2 59.6 0.0 0.0 1.3 56.1 0.0 0.3 47.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.3 0.3 13.8 0.0 0.0 TNFSF12 "APO3L, DR3LG, TWEAK" ENSG00000239697 "TNF superfamily member 12" O43508 17 7548891-7557890 "Predicted secreted proteins" "Angiogenesis, Apoptosis, Differentiation" "Cytokine, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 11.8;BJ hTERT+: 11.2;fHDF/TERT166: 9.7;HDLM-2: 9.9;HSkMC: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035984, HPA052967" Uncertain Approved Vesicles "Secreted to blood" NA NA 853000 150000 Vesicles "HPA035984: , HPA052967: AB_2682000" "unprognostic (2.96e-3)" "unprognostic (2.96e-1)" "unprognostic (4.71e-2)" "prognostic favorable (5.70e-5)" "unprognostic (5.31e-2)" "unprognostic (7.91e-2)" "unprognostic (6.45e-2)" "unprognostic (2.38e-2)" "unprognostic (4.48e-2)" "unprognostic (6.09e-2)" "unprognostic (6.20e-2)" "unprognostic (8.62e-2)" "unprognostic (3.29e-2)" "unprognostic (4.11e-2)" "unprognostic (3.15e-2)" "unprognostic (8.74e-2)" "unprognostic (2.38e-1)" 32.9 16.7 23.0 14.0 16.9 2.9 20.4 15.7 21.8 22.1 27.4 9.5 18.0 9.5 17.6 18.6 24.5 19.8 30.1 23.3 16.3 13.3 15.0 8.8 23.8 16.8 14.8 13.9 31.3 20.6 9.0 8.4 13.4 7.8 27.8 6.2 19.7 26.7 32.7 12.8 8.2 11.3 24.2 9.1 21.6 18.0 7.4 8.5 2.6 11.3 9.6 11.0 26.0 37.7 2.6 2.4 10.5 5.7 2.4 6.9 0.8 0.0 0.0 0.5 0.0 9.1 11.8 2.5 4.0 11.2 4.5 2.7 0.0 1.4 0.0 3.5 9.7 0.4 0.9 0.4 0.4 0.4 9.9 1.7 0.6 0.3 0.8 8.9 0.0 0.0 10.3 1.1 1.5 0.1 2.1 7.3 0.0 0.1 0.0 3.9 0.0 0.0 0.3 0.4 0.0 5.0 0.1 0.0 0.1 7.2 0.0 0.0 4.7 1.3 0.0 3.8 0.1 0.7 0.4 7.0 6.1 0.5 0.0 2.1 0.0 0.0 0.0 1.1 0.0 5.4 4.0 3.1 10.5 5.2 5.7 6.9 2.6 3.8 2.8 1.8 2.5 4.4 4.1 2.2 2.4 1.4 2.4 4.1 0.8 23.0 16.9 15.7 21.8 16.3 13.3 14.8 13.9 7.8 8.5 8.9 9.8 8.7 9.8 5.5 7.7 3.8 12.7 0.0 4.5 15.7 0.0 1.2 6.6 12.4 0.4 20.4 1.1 0.0 10.6 0.8 13.3 9.0 34.5 2.9 40.2 19.1 1.2 28.8 42.6 0.0 46.9 42.4 18.6 28.9 1.7 29.4 7.9 0.0 47.4 29.4 2.2 58.2 36.0 0.2 1.2 6.6 0.7 21.4 3.7 4.6 TNFSF12-TNFSF13 TWE-PRIL ENSG00000248871 "TNFSF12-TNFSF13 readthrough" 17 7549099-7561601 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 40 "Alveolar cells type 2: 3.0;Ciliated cells: 2.7;Club cells: 6.8;granulocytes: 3.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 3.9;eosinophil: 10.5;intermediate monocyte: 6.5;myeloid DC: 2.7" "Group enriched" "Detected in many" 5 "dendritic cells: 2.7;granulocytes: 10.5;monocytes: 6.5" "Cell line enhanced" "Detected in some" "BJ hTERT+: 4.5;fHDF/TERT166: 3.2;HUVEC TERT2: 2.9;U-138 MG: 4.6;U-251 MG: 4.7" "Low region specificity" "Detected in many" "HPA004863, HPA035984, HPA052967" Uncertain Approved Vesicles "Intracellular and membrane" NA NA Vesicles "HPA004863: AB_1078187, HPA035984: , HPA052967: AB_2682000" "unprognostic (1.59e-1)" "unprognostic (1.48e-1)" "unprognostic (2.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (3.04e-1)" "unprognostic (2.19e-1)" "unprognostic (1.05e-2)" "unprognostic (1.40e-1)" "unprognostic (8.96e-3)" "unprognostic (1.38e-2)" "unprognostic (2.05e-1)" "unprognostic (8.23e-2)" 10.0 8.6 3.2 6.1 3.1 5.6 5.6 3.2 6.1 5.9 3.5 1.9 4.8 2.7 3.8 5.0 7.0 3.1 8.9 4.3 3.1 3.1 3.1 3.1 6.6 7.1 3.1 3.4 5.9 3.3 2.0 3.1 2.4 1.3 8.2 1.7 5.4 4.4 4.4 3.1 3.1 3.6 6.9 3.1 5.6 5.7 3.1 1.6 0.0 3.1 1.9 4.8 7.5 11.5 1.2 2.7 10.5 6.5 0.4 1.1 1.6 0.0 0.4 0.0 0.0 0.0 0.6 0.4 1.3 4.5 1.6 2.5 0.0 0.2 0.0 0.8 3.2 0.0 0.0 1.4 0.0 0.9 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.2 0.5 1.0 0.9 0.0 0.0 2.9 0.0 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.4 0.9 0.0 0.0 0.0 1.7 0.0 0.0 2.2 0.4 0.0 1.1 0.0 0.0 0.0 1.3 4.6 0.3 0.0 4.7 0.0 0.0 0.0 1.0 0.0 0.6 0.8 3.9 10.5 0.4 6.5 0.5 0.8 0.7 0.4 2.7 1.2 0.4 0.3 0.5 0.4 0.5 1.4 1.1 1.6 3.2 3.1 3.2 6.1 3.1 3.1 3.1 3.4 1.3 1.6 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TNPO3 "IPO12, LGMD1F, MTR10A, TRN-SR, TRN-SR2" ENSG00000064419 "Transportin 3" Q9Y5L0 7 128954180-129055173 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039555, HPA041537" Approved Enhanced Vesicles NA NA Vesicles "HPA039555: AB_10672000, HPA041537: AB_2677539" "unprognostic (5.76e-2)" "unprognostic (1.72e-2)" "unprognostic (1.97e-1)" "unprognostic (5.49e-3)" "unprognostic (1.05e-1)" "unprognostic (1.74e-1)" "prognostic unfavorable (3.29e-5)" "unprognostic (1.86e-2)" "unprognostic (1.24e-1)" "unprognostic (1.93e-2)" "unprognostic (2.27e-2)" "unprognostic (2.34e-2)" "unprognostic (3.26e-2)" "unprognostic (4.70e-2)" "unprognostic (2.93e-1)" "unprognostic (2.04e-1)" "unprognostic (4.24e-2)" 17.8 24.0 22.6 23.8 20.5 28.9 16.2 29.6 21.4 15.2 18.4 15.8 30.1 15.5 19.7 17.9 26.3 16.1 12.9 16.1 16.6 17.7 19.1 21.6 15.4 20.5 17.7 15.5 20.7 19.8 21.7 19.2 13.9 18.4 16.7 19.7 15.6 19.0 20.4 41.4 19.2 17.8 18.9 16.2 17.2 21.9 36.3 15.1 29.5 22.3 15.9 26.4 22.6 18.1 16.6 15.9 20.9 21.7 14.4 17.4 10.5 20.3 23.1 18.0 30.3 17.5 15.1 15.3 18.4 16.1 17.2 20.4 18.8 18.9 25.6 8.6 19.6 32.7 15.1 36.3 17.7 24.8 21.2 16.1 18.8 19.2 14.7 16.7 34.3 16.1 14.1 18.1 21.0 18.8 15.1 21.4 21.2 42.6 18.4 21.9 15.1 29.6 25.4 51.4 22.5 21.4 21.2 16.7 20.8 17.4 19.2 22.4 17.7 19.6 9.2 20.6 27.2 10.4 21.4 16.0 21.9 10.9 25.7 25.0 23.7 18.4 35.5 31.6 35.3 37.9 20.6 13.6 20.9 17.4 17.2 15.5 16.6 14.2 15.4 15.9 15.5 14.1 16.1 15.9 14.4 21.7 7.7 14.5 10.5 22.6 20.5 29.6 21.4 16.6 17.7 17.7 15.5 18.4 15.1 14.9 14.7 29.0 13.4 6.1 22.0 17.3 17.8 12.0 13.6 17.4 21.6 21.1 6.6 20.5 30.3 15.5 17.6 23.3 21.6 30.1 13.4 15.7 10.4 23.2 24.5 35.0 11.1 15.4 23.5 19.0 15.5 20.1 8.5 44.1 20.5 14.0 25.4 17.5 16.6 15.2 20.6 12.9 12.7 72.0 30.2 7.2 29.3 15.3 22.6 23.5 TP53I3 PIG3 ENSG00000115129 "Tumor protein p53 inducible protein 3" Q53FA7 2 24077433-24085861 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 55.0" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 190.0;Paneth cells: 164.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 6 "T-47d: 115.8" "Low region specificity" "Detected in all" "CAB017479, HPA022012, HPA028742" Enhanced Supported Vesicles NA NA 200000 Vesicles "CAB017479: AB_2303667, HPA022012: AB_1858202, HPA028742: AB_10603456" "unprognostic (3.66e-2)" "unprognostic (1.41e-3)" "unprognostic (5.55e-2)" "unprognostic (8.04e-2)" "unprognostic (7.10e-3)" "unprognostic (4.47e-1)" "unprognostic (1.09e-2)" "unprognostic (1.53e-3)" "unprognostic (1.17e-1)" "unprognostic (2.83e-2)" "unprognostic (3.52e-2)" "unprognostic (1.75e-1)" "unprognostic (9.89e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-1)" "unprognostic (3.67e-2)" "unprognostic (8.57e-3)" 10.3 9.5 2.7 11.7 2.7 6.3 6.3 2.5 3.6 12.0 42.1 3.6 10.5 18.4 8.5 7.0 43.2 6.1 17.8 5.0 1.6 3.2 28.2 11.5 15.7 5.3 2.1 2.0 4.7 20.3 4.0 4.6 13.0 3.3 6.6 15.5 6.7 11.3 6.9 4.9 2.8 55.0 6.1 2.3 5.6 9.0 41.3 1.9 8.6 9.0 10.6 9.0 8.2 21.8 3.6 11.1 11.4 13.4 0.2 0.4 4.0 5.0 16.6 9.7 4.0 7.7 17.2 7.1 5.0 6.2 4.4 6.1 4.2 9.1 0.6 2.9 8.3 1.2 1.5 2.5 8.9 2.7 3.8 0.3 1.4 5.8 10.8 5.0 0.6 2.9 18.6 14.2 11.8 2.9 9.1 19.8 3.0 1.2 4.3 18.5 3.3 0.9 0.1 7.4 5.7 6.8 1.8 8.6 0.1 7.4 7.9 1.4 6.2 6.6 1.5 1.0 8.2 115.8 1.0 14.5 5.0 12.3 3.4 2.5 2.0 1.2 0.5 1.7 0.0 1.3 7.3 13.4 11.4 0.2 8.5 0.1 3.6 0.2 0.4 11.1 2.6 0.0 0.3 2.8 0.2 3.8 4.8 0.3 4.0 2.7 2.7 2.5 3.6 1.6 3.2 2.1 2.0 3.3 1.9 26.8 28.9 12.6 28.1 4.1 0.7 9.6 53.5 5.3 19.4 40.1 0.0 37.7 92.9 83.6 104.8 14.5 144.3 0.0 119.0 24.8 16.4 11.1 12.7 11.0 42.3 0.0 76.2 22.7 23.6 190.0 7.2 21.7 13.5 27.1 44.3 6.7 79.6 164.1 8.5 62.2 1.9 19.4 12.5 18.5 8.9 6.0 24.1 3.8 54.0 39.6 TPK1 "HTPK1, PP20" ENSG00000196511 "Thiamin pyrophosphokinase 1" Q9H3S4 7 144451941-144836395 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 70.4;Late spermatids: 75.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AN3-CA: 27.3;CACO-2: 6.5;EFO-21: 8.3;TIME: 6.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021545, HPA021849" Approved Approved Vesicles NA NA 78000 Vesicles "HPA021545: AB_1858209, HPA021849: AB_1858210" "unprognostic (4.05e-2)" "unprognostic (3.28e-2)" "unprognostic (2.38e-2)" "unprognostic (3.32e-2)" "unprognostic (2.42e-1)" "unprognostic (1.63e-1)" "unprognostic (7.62e-2)" "unprognostic (6.08e-2)" "unprognostic (2.37e-1)" "unprognostic (1.68e-1)" "unprognostic (3.76e-2)" "unprognostic (6.06e-2)" "unprognostic (1.45e-3)" "unprognostic (3.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.59e-1)" "unprognostic (9.22e-3)" 12.2 7.4 5.1 9.6 4.7 3.6 7.6 4.0 7.2 4.3 8.4 4.2 2.4 18.2 5.1 5.0 3.3 3.9 5.4 6.4 5.6 6.6 6.0 6.2 8.8 23.3 4.9 3.1 4.4 3.3 3.6 4.6 7.0 4.4 3.7 8.5 8.9 7.1 4.1 3.0 2.9 13.9 5.1 6.0 15.1 4.0 5.9 2.0 5.1 4.9 4.1 14.2 5.5 3.3 5.4 9.6 3.4 7.4 4.0 5.5 3.8 0.2 0.2 0.3 27.3 0.2 0.2 2.2 0.1 0.1 0.0 0.0 6.5 1.1 0.4 8.3 0.4 0.5 0.0 0.5 0.3 0.2 1.6 0.4 0.1 0.1 0.1 0.7 2.0 0.6 0.5 0.5 0.3 0.4 0.7 5.2 1.0 0.5 1.2 0.1 0.8 0.6 3.0 0.7 0.8 2.3 0.2 0.6 0.9 4.2 2.4 0.2 0.0 0.4 0.0 0.5 0.5 0.3 3.9 6.2 0.3 0.7 0.5 0.3 0.6 1.5 0.6 0.9 5.2 0.2 0.3 7.3 0.2 3.9 5.3 4.0 5.0 4.4 3.5 9.6 5.4 5.2 4.2 3.4 4.0 7.4 2.3 5.5 3.8 5.1 4.7 4.0 7.2 5.6 6.6 4.9 3.1 4.4 2.0 8.9 3.2 15.9 2.3 2.1 3.2 4.5 10.2 2.7 0.0 3.5 7.9 35.1 16.6 4.2 70.4 7.7 15.5 0.0 5.7 11.9 5.3 2.4 7.0 3.9 14.8 1.6 1.2 6.7 13.9 75.1 4.6 16.2 8.5 7.2 4.3 2.4 6.9 7.4 1.1 6.9 4.5 0.0 3.4 7.9 11.8 1.5 26.8 6.4 6.3 3.6 TPRA1 "FLJ32197, GPR175, TMEM227, TPRA40" ENSG00000163870 "Transmembrane protein adipocyte associated 1" Q86W33 3 127573069-127598251 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 81.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019784 Approved Approved Vesicles NA NA Vesicles "HPA019784: AB_2670266" "unprognostic (1.52e-1)" "unprognostic (1.33e-2)" "unprognostic (9.41e-3)" "unprognostic (1.66e-2)" "unprognostic (6.91e-3)" "unprognostic (9.74e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (3.46e-1)" "unprognostic (2.32e-1)" "unprognostic (1.91e-1)" "unprognostic (1.17e-1)" "unprognostic (1.11e-1)" "unprognostic (2.02e-2)" "unprognostic (1.73e-2)" "unprognostic (4.42e-2)" "unprognostic (2.09e-1)" "unprognostic (4.28e-2)" 17.6 21.0 14.6 11.4 13.5 22.4 22.1 20.3 16.7 22.6 25.8 15.9 26.9 17.1 21.5 16.7 19.5 21.9 18.2 15.4 14.9 12.4 18.1 23.5 20.4 13.1 16.3 11.6 21.9 30.4 24.0 15.9 35.7 14.0 19.5 11.1 21.0 24.3 19.5 31.3 28.7 18.2 16.9 10.7 17.7 16.8 18.3 12.5 13.9 30.2 15.8 14.5 19.5 19.8 9.5 19.2 13.7 16.3 6.5 14.1 7.3 21.5 15.5 6.2 12.3 24.0 13.3 23.3 13.5 15.2 11.2 10.2 10.0 14.1 18.9 24.6 16.6 36.9 22.8 10.2 15.5 5.9 11.9 9.1 12.4 21.1 9.6 26.3 7.8 24.3 13.2 13.1 7.7 19.1 23.4 8.4 13.0 7.5 17.6 13.7 17.9 8.7 21.2 10.5 11.3 12.0 16.3 9.4 16.8 13.1 8.8 12.5 4.8 21.0 25.8 17.1 5.1 13.0 18.3 15.4 13.7 8.3 29.4 7.4 15.1 11.2 18.2 15.2 18.8 10.4 3.6 16.3 13.7 10.2 11.0 12.9 9.5 12.4 14.1 19.2 8.2 9.9 10.0 10.3 6.5 9.6 13.4 8.7 7.3 14.6 13.5 20.3 16.7 14.9 12.4 16.3 11.6 14.0 12.5 20.8 6.5 13.8 19.1 44.4 7.0 11.1 10.2 4.0 9.1 24.4 3.9 48.5 5.0 23.8 2.4 25.4 18.2 0.0 17.0 37.2 30.5 18.2 18.4 17.9 30.0 4.8 16.7 19.6 16.2 1.1 31.1 22.0 28.7 81.2 16.1 11.2 24.3 15.9 18.4 12.3 8.6 12.9 24.4 7.7 18.1 47.6 57.0 12.1 19.6 17.8 TRAF3IP3 T3JAM ENSG00000009790 "TRAF3 interacting protein 3" Q9Y228 1 209756032-209782320 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 86.5;lymphoid tissue: 69.5" "Cell type enhanced" "Detected in many" 20 "B-cells: 61.1;granulocytes: 55.6;T-cells: 188.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 39.7;JURKAT: 22.7;Karpas-707: 16.5;MOLT-4: 20.5;NB-4: 23.6;THP-1: 22.3;U-266/70: 24.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA040796 Enhanced Approved Vesicles NA NA Vesicles "HPA040796: AB_10794861" "prognostic favorable (4.11e-4)" "unprognostic (1.11e-1)" "unprognostic (1.51e-3)" "unprognostic (1.36e-4)" "unprognostic (2.67e-1)" "unprognostic (1.91e-5)" "unprognostic (3.83e-3)" "prognostic favorable (8.15e-4)" "unprognostic (5.30e-2)" "unprognostic (3.72e-2)" "unprognostic (5.00e-2)" "unprognostic (2.39e-1)" "unprognostic (1.38e-4)" "unprognostic (3.08e-1)" "unprognostic (2.93e-2)" "unprognostic (3.16e-2)" "unprognostic (4.21e-2)" 2.2 0.8 1.7 30.6 2.1 9.8 1.3 0.6 1.5 1.5 3.8 2.2 0.3 2.3 1.5 1.4 2.5 1.7 4.6 1.2 1.7 1.4 3.4 2.4 5.8 32.6 3.8 0.6 1.2 1.3 0.0 1.0 1.0 2.7 2.2 3.6 1.7 8.4 1.3 0.7 1.1 19.8 1.0 3.8 38.3 4.1 1.4 2.6 69.5 2.4 1.5 33.6 5.7 1.9 43.9 25.3 54.9 29.5 50.1 86.5 56.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 39.7 0.0 3.7 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.7 0.0 16.5 0.0 0.0 20.5 23.6 0.0 0.0 0.0 2.4 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 24.5 8.5 1.5 0.0 11.1 0.0 54.9 24.1 24.8 48.9 25.7 51.8 43.9 67.8 55.9 25.3 41.4 76.9 60.8 6.5 50.1 29.5 18.6 86.5 56.3 1.7 2.1 0.6 1.5 1.7 1.4 3.8 0.6 2.7 2.6 3.0 14.8 61.1 3.6 2.1 1.5 0.6 2.5 1.4 0.0 0.0 0.0 0.3 10.0 0.1 8.9 0.7 0.2 0.0 0.2 0.3 1.1 0.4 55.6 3.2 22.1 0.0 0.0 4.3 27.4 5.7 0.3 22.8 10.1 5.4 0.2 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.3 0.5 0.2 1.9 0.3 188.4 0.4 2.0 TRAPPC5 "MGC52424, TRS31" ENSG00000181029 "Trafficking protein particle complex 5" Q8IUR0 19 7680843-7687703 "Predicted intracellular proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 33.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 74.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042221, HPA049064" Uncertain Approved Vesicles NA NA Vesicles "HPA042221: AB_2677907, HPA049064: AB_2680618" "unprognostic (3.10e-2)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.12e-2)" "unprognostic (1.14e-1)" "unprognostic (3.21e-3)" "unprognostic (1.80e-1)" "unprognostic (2.86e-1)" "unprognostic (6.28e-2)" "unprognostic (2.55e-2)" "unprognostic (2.12e-2)" "unprognostic (6.82e-2)" "unprognostic (4.86e-8)" "unprognostic (3.09e-1)" "unprognostic (1.11e-1)" "unprognostic (6.08e-2)" "unprognostic (1.51e-1)" 23.1 35.3 30.1 23.4 31.6 50.9 24.1 18.8 44.9 18.7 24.2 17.7 19.6 27.3 18.4 23.7 31.8 16.0 22.3 27.5 27.8 25.2 32.0 47.9 17.5 32.3 24.1 25.7 21.7 39.1 12.2 19.4 26.7 20.7 21.6 9.4 22.3 42.5 22.4 83.5 26.7 28.1 16.0 17.8 31.2 28.6 46.1 14.8 23.1 27.6 28.3 26.8 20.1 17.0 46.7 70.9 85.7 61.8 14.4 34.1 44.6 13.9 30.5 4.9 13.5 4.0 6.0 14.9 11.1 8.1 10.9 11.2 18.0 9.7 14.6 22.4 7.6 6.2 13.0 3.1 11.1 2.1 11.1 47.3 5.4 20.5 37.6 14.0 9.6 11.0 9.8 14.9 8.3 3.8 3.7 13.7 15.3 7.7 21.4 5.3 43.9 16.4 34.2 15.8 6.2 74.7 10.7 6.9 21.0 11.8 33.5 13.0 11.3 9.4 17.9 15.4 1.8 14.3 10.4 13.8 13.2 10.9 24.8 11.0 19.5 9.7 9.6 18.3 11.9 17.6 28.9 61.8 23.1 20.0 60.9 19.2 46.7 25.1 22.0 70.9 45.7 25.0 21.7 85.7 14.4 54.3 30.3 34.1 44.6 30.1 31.6 18.8 44.9 27.8 25.2 24.1 25.7 20.7 14.8 3.0 2.2 8.4 1.0 1.6 4.9 0.8 2.5 2.7 6.8 5.2 2.0 2.8 0.0 20.8 9.9 0.9 26.4 0.0 16.7 4.1 1.7 1.7 1.1 13.4 8.5 7.9 10.9 11.1 22.2 33.1 1.4 8.5 1.7 16.2 14.0 1.1 21.0 24.6 3.2 9.3 4.6 0.0 1.4 2.3 0.5 1.5 2.9 5.0 14.0 1.1 TRIM17 "RBCC, RNF16, terf" ENSG00000162931 "Tripartite motif containing 17" Q9Y577 1 228407940-228416861 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.8;testis: 18.3" "Group enriched" "Detected in some" 56 "Early spermatids: 233.3;Late spermatids: 64.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 7.8;HEL: 3.5;NTERA-2: 3.3;SH-SY5Y: 4.1;T-47d: 9.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA054908 Uncertain Approved Vesicles NA NA Vesicles "HPA054908: AB_2682638" "prognostic favorable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (3.06e-2)" "unprognostic (5.45e-2)" "unprognostic (1.25e-1)" "unprognostic (7.74e-3)" "unprognostic (7.42e-3)" "unprognostic (2.02e-1)" "unprognostic (1.17e-2)" "unprognostic (8.91e-2)" "unprognostic (2.23e-1)" "unprognostic (2.04e-1)" "unprognostic (5.96e-4)" "unprognostic (3.88e-1)" "unprognostic (4.88e-2)" "unprognostic (6.33e-2)" "unprognostic (3.64e-1)" 1.3 0.8 14.4 1.5 19.1 1.1 1.9 25.8 11.8 1.5 0.9 0.6 1.7 1.4 3.6 1.7 1.3 3.9 1.7 1.5 8.9 3.4 1.2 0.6 1.7 2.0 0.7 9.2 2.2 1.1 0.8 1.0 1.3 2.7 2.0 0.8 1.9 5.9 3.8 0.8 3.5 1.6 1.1 0.9 5.3 1.4 18.3 4.7 0.0 2.9 0.1 1.2 2.5 1.3 1.7 0.6 0.7 0.3 0.0 1.0 0.1 0.3 0.7 0.5 0.4 0.0 0.0 7.8 0.5 0.0 0.0 0.1 1.7 0.9 0.1 1.9 0.0 0.2 1.7 0.0 0.0 0.1 0.3 0.8 3.5 1.0 0.2 1.6 0.1 0.3 0.2 0.2 0.1 0.0 0.1 0.0 0.5 0.2 0.5 0.1 0.1 0.3 0.0 3.3 0.1 0.2 0.1 0.1 0.0 0.0 0.8 0.5 4.1 0.0 0.4 0.0 0.8 9.6 0.2 0.0 0.4 1.7 0.3 0.1 0.1 0.0 0.2 0.2 0.1 0.3 0.0 0.3 0.7 0.9 0.1 1.0 0.6 0.2 1.0 0.0 1.7 1.0 0.8 0.2 0.0 0.2 0.6 0.0 0.1 14.4 19.1 25.8 11.8 8.9 3.4 0.7 9.2 2.7 4.7 0.0 0.3 0.0 1.1 0.2 1.1 0.6 0.0 2.7 2.3 1.8 0.0 0.0 0.0 0.7 233.3 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 64.0 1.1 0.0 0.0 0.0 0.0 0.5 0.9 0.0 0.4 0.0 0.0 0.0 0.0 1.2 1.6 0.3 0.7 0.5 0.0 0.6 TRPC1 HTRP-1 ENSG00000144935 "Transient receptor potential cation channel subfamily C member 1" P48995 3 142724074-142807888 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 18.1;Cone photoreceptor cells: 15.7;Horizontal cells: 12.7;Rod photoreceptor cells: 15.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC TERT1: 18.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009387, HPA021130" Supported Approved Vesicles NA NA Vesicles "CAB009387: AB_2240941, HPA021130: AB_1858361" "unprognostic (1.66e-1)" "unprognostic (7.38e-2)" "unprognostic (1.56e-2)" "unprognostic (4.37e-5)" "unprognostic (5.53e-1)" "unprognostic (1.40e-2)" "unprognostic (5.90e-3)" "unprognostic (1.59e-2)" "unprognostic (1.36e-1)" "unprognostic (2.17e-1)" "unprognostic (8.46e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (2.72e-5)" "unprognostic (1.44e-3)" "unprognostic (1.57e-1)" "unprognostic (1.61e-1)" "unprognostic (2.49e-2)" 6.8 8.3 8.5 3.5 13.4 1.2 6.8 23.0 15.9 17.7 8.3 11.4 4.3 2.6 20.4 9.2 6.5 10.1 9.1 15.9 10.0 11.4 6.0 2.0 5.4 3.3 9.4 12.2 24.5 3.0 12.2 14.4 6.1 14.7 12.3 4.9 13.0 3.7 13.6 2.4 6.2 4.7 17.6 11.4 5.0 4.4 8.0 7.9 0.4 8.9 3.9 2.3 9.3 8.9 0.6 0.0 0.0 0.0 0.3 1.3 0.3 3.2 4.6 8.4 1.0 7.6 18.7 3.8 5.1 8.1 6.5 9.6 1.4 0.9 0.0 1.7 5.3 11.4 0.3 2.3 2.4 9.4 0.8 3.4 5.1 1.9 2.2 3.1 0.2 0.0 9.0 2.4 6.0 7.3 11.0 3.7 0.0 0.2 0.0 9.1 2.0 0.3 0.4 4.7 0.0 2.4 0.0 4.0 0.0 4.5 0.1 5.4 4.0 6.3 0.0 1.1 8.0 2.6 0.0 3.4 8.2 1.3 11.0 6.9 3.4 1.4 1.6 6.2 0.1 2.4 0.0 0.0 0.0 0.2 0.0 1.2 0.6 1.3 0.6 0.0 0.3 1.2 1.3 0.0 0.3 0.0 0.0 0.0 0.3 8.5 13.4 23.0 15.9 10.0 11.4 9.4 12.2 14.7 7.9 3.0 0.3 0.0 2.2 2.6 18.1 10.1 0.0 2.7 0.0 5.2 15.7 0.1 0.0 0.2 2.1 2.9 0.0 0.0 0.2 0.2 7.2 0.8 0.0 0.0 0.1 12.7 1.7 4.3 0.0 1.7 7.8 0.0 1.7 0.0 0.0 6.8 0.1 0.0 10.3 0.3 15.0 0.0 9.0 10.3 2.1 1.0 0.2 0.0 0.0 0.2 TRPM3 "GON-2, KIAA1616, LTRPC3" ENSG00000083067 "Transient receptor potential cation channel subfamily M member 3" Q9HCF6 9 70529063-71446904 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 36.6;kidney: 28.0;retina: 105.2" "Cell type enriched" "Detected in many" 4 "Muller glia cells: 278.6" "Cancer enhanced" "Detected in single" "renal cancer: 0.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 16 "NK-cell: 2.1" "Lineage enriched" "Detected in single" 16 "NK-cells: 2.1" "Cell line enriched" "Detected in some" 4 "HAP1: 19.4" "Low region specificity" "Detected in all" "HPA072650, HPA074393" Enhanced Approved Vesicles NA NA Vesicles "HPA072650: , HPA074393: " "unprognostic (3.74e-1)" "unprognostic (6.30e-2)" "unprognostic (4.79e-2)" "unprognostic (4.81e-2)" "unprognostic (1.38e-2)" "unprognostic (8.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.19e-2)" "unprognostic (1.11e-1)" "unprognostic (1.89e-2)" "unprognostic (6.10e-2)" "unprognostic (1.15e-2)" "unprognostic (1.82e-7)" "unprognostic (3.51e-2)" "unprognostic (5.64e-2)" "unprognostic (1.74e-2)" "unprognostic (1.50e-2)" 0.9 1.7 6.0 0.7 4.5 1.1 0.8 36.6 5.1 0.8 0.7 9.6 2.1 1.8 2.4 3.0 0.7 1.3 1.3 1.4 9.4 6.0 28.0 0.9 0.8 0.7 8.3 3.5 5.3 1.5 0.7 6.8 0.8 34.8 1.4 0.7 105.2 0.8 5.0 1.1 0.8 0.7 1.0 8.1 1.1 1.6 5.3 5.9 0.0 2.1 0.0 0.6 0.8 0.5 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.0 0.0 1.1 0.1 1.3 3.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 19.4 0.0 0.1 0.0 0.1 0.1 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 2.7 0.2 0.0 0.0 1.2 4.5 0.0 0.0 0.0 1.4 0.0 0.1 0.0 0.2 0.0 1.0 0.0 1.3 0.0 0.2 0.0 0.4 0.2 0.0 0.0 3.6 0.0 0.1 3.5 0.0 0.0 0.0 0.0 0.5 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 6.0 4.5 36.6 3.8 9.4 6.0 8.3 3.5 34.8 5.9 3.0 4.0 0.0 0.9 0.3 9.5 4.8 2.5 1.4 4.5 15.7 62.8 0.0 5.0 0.0 3.9 1.3 0.0 0.0 0.2 0.0 1.5 0.4 0.0 0.0 0.2 1.6 14.8 0.6 0.0 1.7 5.2 1.1 0.0 0.0 0.0 278.6 0.1 0.0 8.5 25.8 4.7 0.0 1.0 1.5 0.4 0.6 0.2 0.8 0.0 0.3 TRUB1 PUS4 ENSG00000165832 "TruB pseudouridine synthase family member 1" Q8WWH5 10 114938193-114977676 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 43.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037914, HPA057552" Approved Approved Vesicles NA NA Vesicles "HPA037914: AB_10672399, HPA057552: AB_2683465" "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (1.27e-2)" "unprognostic (2.93e-2)" "unprognostic (3.20e-3)" "unprognostic (9.79e-2)" "unprognostic (9.26e-2)" "unprognostic (4.89e-2)" "unprognostic (6.87e-2)" "unprognostic (2.51e-2)" "unprognostic (2.26e-2)" "unprognostic (1.56e-1)" "unprognostic (1.50e-3)" "unprognostic (7.54e-2)" "unprognostic (2.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-1)" 7.2 29.0 14.7 7.7 19.5 3.3 10.9 11.5 22.0 10.0 8.9 9.2 7.8 8.4 12.6 9.4 9.9 9.6 8.1 20.2 14.7 15.8 15.4 13.0 6.2 8.7 11.0 10.9 16.8 8.3 13.1 9.6 7.0 18.1 11.7 10.2 7.7 9.5 11.3 8.2 6.6 7.6 10.8 10.2 9.6 7.9 17.9 8.0 12.7 11.9 9.2 9.2 8.7 8.3 9.2 6.0 4.0 8.2 10.2 8.5 6.0 13.8 10.8 10.7 26.5 7.7 10.4 14.4 11.9 13.5 16.2 18.5 8.8 14.3 17.2 13.9 9.3 7.1 11.9 14.3 14.8 24.1 13.0 15.4 7.9 5.4 15.7 13.3 14.7 11.8 10.6 20.4 11.5 22.8 17.3 9.1 13.9 8.1 7.0 19.2 6.6 13.7 11.7 10.0 9.3 10.7 13.8 27.0 10.4 21.4 7.0 10.0 11.0 10.0 14.9 26.1 12.0 11.9 9.1 8.1 7.5 7.5 11.8 14.5 13.4 10.8 14.4 10.5 18.8 6.7 4.0 3.3 1.1 6.0 5.1 8.5 9.2 6.4 6.3 6.0 7.1 8.5 7.8 0.3 10.2 8.2 5.4 7.6 6.0 14.7 19.5 11.5 22.0 14.7 15.8 11.0 10.9 18.1 8.0 11.9 5.9 10.9 3.2 4.9 14.1 12.6 7.6 8.1 11.4 8.7 2.0 7.4 18.3 7.2 43.0 6.0 5.4 0.0 4.3 5.4 8.7 3.1 10.3 18.5 6.5 23.8 7.5 15.4 7.6 5.4 7.8 4.0 3.3 2.8 7.7 10.9 5.9 0.0 9.6 21.4 5.5 6.5 7.6 13.4 19.0 6.0 5.1 4.4 11.0 5.0 TSPAN11 ENSG00000110900 "Tetraspanin 11" A1L157 12 30926428-30996599 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 25.6" "Cell type enhanced" "Detected in some" 10 "Ito cells: 7.4;Late spermatids: 8.4;Leydig cells: 4.4;Muller glia cells: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 18.6;HSkMC: 18.4;NTERA-2: 14.8;SCLC-21H: 7.1;SH-SY5Y: 14.2;SuSa: 9.1" "Low region specificity" "Detected in many" HPA066789 Approved Vesicles NA NA Vesicles "HPA066789: AB_2685723" "unprognostic (4.10e-2)" "unprognostic (4.27e-2)" "unprognostic (4.38e-3)" "unprognostic (1.18e-2)" "unprognostic (4.51e-1)" "prognostic favorable (5.28e-4)" "unprognostic (4.28e-2)" "prognostic favorable (3.43e-4)" "unprognostic (7.89e-3)" "unprognostic (8.05e-2)" "unprognostic (1.51e-2)" "unprognostic (3.03e-2)" "unprognostic (5.77e-3)" "unprognostic (2.04e-2)" "unprognostic (5.81e-2)" "unprognostic (2.90e-3)" "unprognostic (1.79e-1)" 3.1 2.5 6.4 16.0 3.8 0.0 2.5 15.2 12.7 9.0 25.6 9.0 3.0 4.4 6.4 7.8 8.8 2.4 12.2 8.8 5.0 4.7 1.6 1.0 8.5 2.6 4.1 3.8 1.9 1.4 0.3 1.5 0.8 3.8 5.4 11.0 12.2 3.8 6.8 0.8 6.5 10.9 8.3 2.6 2.6 4.5 1.6 3.7 0.0 4.0 12.3 8.9 6.6 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 18.6 0.0 0.0 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.5 0.0 1.1 1.6 0.0 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 18.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 14.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 7.1 14.2 0.1 0.0 0.0 9.1 0.0 0.0 0.0 0.1 0.9 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 3.8 15.2 4.3 5.0 4.7 4.1 3.8 3.8 3.7 0.0 0.0 0.0 0.0 0.7 1.5 0.8 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 3.0 0.7 0.0 0.0 0.0 0.0 2.1 0.4 0.0 0.0 0.1 0.0 0.0 7.4 0.0 8.4 4.4 1.1 1.7 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.2 0.0 1.1 0.2 0.2 1.0 0.0 0.0 0.0 0.0 TSPAN14 "DC-TM4F2, MGC11352, TM4SF14" ENSG00000108219 "Tetraspanin 14" Q8NG11 10 80454166-80533123 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ito cells: 166.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "TIME: 64.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014773, HPA057174" Uncertain Supported Vesicles NA NA 170000 Vesicles "HPA014773: AB_2208670, HPA057174: " "unprognostic (7.52e-2)" "prognostic favorable (3.56e-4)" "unprognostic (6.55e-3)" "unprognostic (1.56e-1)" "unprognostic (4.40e-2)" "unprognostic (1.18e-1)" "unprognostic (2.11e-2)" "unprognostic (8.90e-2)" "unprognostic (5.21e-2)" "unprognostic (3.13e-1)" "unprognostic (5.15e-3)" "unprognostic (4.12e-3)" "prognostic favorable (4.20e-4)" "unprognostic (2.52e-2)" "unprognostic (1.53e-1)" "unprognostic (2.99e-1)" "unprognostic (2.57e-3)" 56.8 10.3 15.4 17.2 14.1 22.0 45.1 5.2 16.8 30.0 14.1 15.1 28.1 13.3 18.9 22.4 44.6 22.2 15.1 15.2 13.4 7.7 22.9 16.0 32.9 47.4 18.8 10.8 21.7 14.4 12.3 7.4 39.0 13.0 20.0 12.3 22.7 24.8 16.5 11.3 33.3 17.3 15.3 16.5 28.2 12.6 12.9 14.5 16.0 26.2 19.1 26.7 30.5 28.4 4.4 10.1 16.2 47.7 26.1 29.0 21.3 21.9 32.5 30.2 10.4 46.5 14.9 14.2 11.3 21.7 12.3 9.0 31.3 12.8 7.1 21.8 6.1 4.4 22.9 8.4 20.5 10.1 12.5 3.2 20.1 3.8 26.8 15.6 7.5 4.9 14.3 18.2 12.4 22.7 22.4 45.9 7.3 11.1 5.2 3.5 18.8 10.8 5.3 6.9 13.7 0.0 37.5 3.5 1.1 48.3 31.5 6.5 9.9 4.5 31.5 34.8 10.8 12.7 18.0 64.7 3.1 12.9 3.0 7.9 2.5 9.3 2.5 10.2 15.1 13.6 3.8 14.8 16.0 29.0 30.4 13.2 4.4 22.7 25.7 10.1 4.2 27.1 25.2 16.2 26.1 47.7 4.0 17.9 21.3 15.4 14.1 5.2 16.8 13.4 7.7 18.8 10.8 13.0 14.5 14.9 59.8 19.7 37.8 31.0 1.9 11.8 35.7 9.4 17.0 31.4 72.6 5.4 6.6 35.7 1.9 70.2 22.1 0.0 21.7 57.5 18.8 31.3 7.0 17.9 43.6 3.2 61.8 166.3 95.3 1.7 36.2 45.9 13.5 14.4 32.7 26.6 48.5 11.5 38.5 7.2 7.0 97.0 20.8 3.9 20.0 31.9 6.4 40.7 24.8 62.8 TSPAN8 "CO-029, TM4SF3" ENSG00000127324 "Tetraspanin 8" P19075 12 71125085-71441898 "Cancer-related genes, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 235.3" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 1761.5;Mucus-secreting cells: 790.5;Paneth cells: 2064.2;Undifferentiated cells: 1231.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 283.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 12 "OE19: 211.9" "Low region specificity" "Detected in many" "HPA022273, CAB026009, HPA044337" Enhanced Approved Vesicles NA NA Vesicles "CAB026009: , HPA022273: , HPA044337: AB_2678899" "unprognostic (1.64e-1)" "unprognostic (2.18e-2)" "unprognostic (1.64e-1)" "unprognostic (6.40e-2)" "unprognostic (6.81e-2)" "unprognostic (7.29e-3)" "unprognostic (1.90e-1)" "unprognostic (1.15e-1)" "unprognostic (5.62e-2)" "unprognostic (1.06e-1)" "unprognostic (4.01e-3)" "unprognostic (2.93e-1)" "prognostic unfavorable (9.66e-5)" "unprognostic (1.88e-2)" "unprognostic (1.00e-1)" "unprognostic (2.97e-2)" "prognostic favorable (7.36e-5)" 1.9 0.8 0.7 24.1 2.3 0.0 1.1 0.6 1.3 2.0 139.5 2.8 1.5 83.2 1.2 1.5 1.1 1.3 30.8 1.0 0.7 0.7 7.6 3.7 5.1 1.0 4.7 1.0 6.9 9.9 0.0 0.8 0.7 3.5 14.2 79.5 2.6 11.7 1.0 12.5 2.4 235.3 3.4 9.7 0.6 55.5 1.6 2.7 0.6 1.8 3.1 5.0 3.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.0 4.6 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 211.9 17.7 0.0 0.0 0.4 3.4 4.1 0.4 0.8 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.3 0.6 1.3 0.7 0.7 4.7 1.0 3.5 2.7 0.0 2.1 2.7 36.6 18.4 0.2 0.4 346.5 45.5 54.6 41.8 0.0 0.8 107.8 562.4 25.2 2.2 1761.5 0.0 594.9 0.6 38.2 601.4 4.6 21.3 0.2 0.0 167.5 1.8 2.1 10.6 40.9 3.5 60.8 13.6 790.5 7.2 214.1 2064.2 30.1 2.1 0.4 0.0 20.6 0.5 0.9 11.8 0.9 1.5 1231.3 12.4 TUFT1 ENSG00000143367 "Tuftelin 1" Q9NNX1 1 151540305-151583583 "Predicted intracellular proteins, Predicted secreted proteins" Biomineralization "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 54.9" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 61.5;Suprabasal keratinocytes: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 8 "cerebellum: 72.2" "HPA028112, HPA054301" Approved Approved Approved Vesicles "Secreted - unknown location" NA NA Vesicles "HPA028112: AB_10603224, HPA054301: AB_2682442" "unprognostic (6.16e-2)" "unprognostic (3.76e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (4.83e-4)" "unprognostic (4.49e-3)" "unprognostic (1.12e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-2)" "unprognostic (8.29e-3)" "unprognostic (9.06e-2)" "unprognostic (6.70e-3)" "unprognostic (7.88e-2)" "unprognostic (2.58e-3)" "unprognostic (1.41e-1)" "unprognostic (1.32e-1)" "unprognostic (1.82e-3)" "unprognostic (4.53e-2)" 3.4 4.0 2.7 3.3 2.5 3.8 11.6 8.5 4.5 13.3 8.1 1.1 6.7 4.6 5.9 6.9 23.4 3.1 9.7 3.0 2.0 4.0 9.4 3.9 5.3 2.2 1.9 3.9 5.4 9.3 7.8 5.7 33.1 3.3 7.5 8.3 3.3 18.8 9.4 1.7 54.9 9.8 9.6 1.8 1.1 7.4 5.0 1.5 0.5 3.6 12.0 14.4 11.9 12.2 1.2 1.6 6.5 1.1 0.2 6.0 0.9 14.6 5.0 3.7 4.3 0.8 0.7 23.9 3.9 3.5 15.7 15.1 15.9 11.7 1.3 24.6 4.6 7.4 17.2 6.5 6.0 11.5 9.7 3.2 0.8 8.5 2.4 12.5 0.3 1.8 2.5 7.1 12.3 27.4 9.3 1.2 1.8 1.3 10.1 4.8 6.0 0.7 0.2 4.4 10.8 4.3 0.0 10.6 5.0 13.0 22.7 7.4 3.0 25.2 17.2 3.0 11.7 13.7 0.7 3.2 2.8 19.8 17.4 26.1 2.5 4.8 0.1 2.4 0.3 1.7 6.5 1.1 1.1 0.7 0.3 1.4 1.2 1.9 1.0 1.6 0.6 1.7 0.6 4.5 0.2 0.6 0.2 6.0 0.9 2.7 2.5 8.5 4.5 2.0 4.0 1.9 3.9 3.3 1.5 23.8 1.3 0.0 41.3 61.5 1.8 8.9 7.6 1.4 9.1 14.0 0.0 22.2 11.6 15.0 2.1 0.7 37.6 0.0 13.3 12.0 7.4 24.8 4.6 9.3 3.5 0.0 30.9 1.8 0.0 1.9 2.3 2.6 8.5 2.8 21.4 2.0 31.3 21.6 4.9 9.1 0.5 6.5 5.6 0.7 3.4 58.2 47.5 3.2 17.0 26.9 TVP23A "FAM18A, YDR084C" ENSG00000166676 "Trans-golgi network vesicle protein 23 homolog A" A6NH52 16 10760919-10818794 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 13.3" "Cell type enriched" "Detected in many" 8 "monocytes: 50.5" "Cancer enhanced" "Detected in some" "glioma: 2.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 3.6;SH-SY5Y: 6.1;U-266/70: 3.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060582 Uncertain Approved Vesicles NA NA Vesicles "HPA060582: AB_2684326" "unprognostic (6.70e-4)" "unprognostic (1.64e-3)" "unprognostic (2.38e-2)" "unprognostic (8.24e-3)" "unprognostic (2.72e-2)" "unprognostic (4.39e-5)" "unprognostic (4.96e-2)" "unprognostic (4.68e-2)" "unprognostic (4.42e-2)" "unprognostic (9.22e-2)" "unprognostic (1.73e-2)" "unprognostic (2.42e-1)" "unprognostic (8.78e-7)" "unprognostic (1.20e-3)" "unprognostic (1.14e-1)" "unprognostic (1.87e-2)" "unprognostic (2.87e-4)" 1.9 4.3 10.1 3.3 11.0 5.5 1.1 5.6 13.3 1.7 1.4 2.3 1.6 2.4 2.4 2.3 1.2 2.3 3.2 2.5 9.4 8.0 1.3 1.5 2.3 6.1 6.6 11.8 8.7 2.0 0.5 3.6 0.8 5.7 4.6 1.4 3.1 2.1 3.7 1.9 2.5 2.6 2.8 2.9 3.2 2.1 2.8 3.1 1.3 1.5 0.0 2.6 2.4 1.4 1.6 3.8 0.8 0.8 0.5 0.8 0.4 0.4 0.8 0.9 1.0 0.0 0.3 0.8 0.2 0.0 0.0 0.1 0.2 0.8 1.3 0.5 0.2 0.7 1.2 0.0 0.0 0.0 2.8 0.6 0.4 1.7 1.2 0.0 0.3 1.6 0.4 0.0 0.4 0.0 0.6 0.0 0.7 0.4 1.2 0.0 0.8 0.8 1.1 3.6 0.3 0.1 2.0 0.3 0.3 0.1 1.3 0.6 6.1 0.2 0.6 0.1 0.7 0.6 0.5 0.9 1.0 0.8 1.2 0.5 3.2 0.5 0.9 0.9 1.1 0.5 0.6 0.8 0.2 0.6 0.6 0.4 0.9 0.8 0.2 3.8 1.6 0.4 0.4 0.8 0.5 0.6 0.8 0.2 0.4 10.1 11.0 5.6 13.3 9.4 8.0 6.6 11.8 5.7 3.1 0.0 2.6 0.0 0.0 1.0 6.4 0.5 0.0 0.0 0.0 0.0 2.0 0.2 0.0 0.0 0.6 0.6 0.0 0.0 0.5 0.2 1.5 0.0 0.0 0.0 0.8 1.6 0.0 0.0 1.3 0.0 2.6 5.0 1.7 50.5 0.0 4.8 0.2 0.0 1.4 1.0 0.9 0.0 0.8 1.4 2.7 0.9 1.1 0.0 0.0 0.1 TXK "BTKL, PSCTK5, PTK4, RLK, TKL" ENSG00000074966 "TXK tyrosine kinase" P42681 4 48066393-48134256 "Enzymes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Transcription, Transcription regulation" "DNA-binding, Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 43.5;lymphoid tissue: 49.1;placenta: 28.4" "Cell type enriched" "Detected in some" 9 "T-cells: 43.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "NK-cell: 43.5" "Group enriched" "Detected in many" 26 "NK-cells: 43.5;T-cells: 17.5" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.8;HMC-1: 11.3;U-266/70: 5.5;U-266/84: 6.8;WM-115: 25.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA062482 Approved Vesicles NA NA Vesicles "HPA062482: AB_2684778" "unprognostic (1.04e-2)" "unprognostic (2.21e-2)" "unprognostic (4.13e-2)" "unprognostic (9.24e-3)" "unprognostic (1.09e-2)" "unprognostic (2.58e-4)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (1.50e-1)" "unprognostic (6.39e-3)" "unprognostic (8.13e-2)" "unprognostic (4.06e-1)" "unprognostic (1.33e-1)" "unprognostic (1.37e-1)" "unprognostic (1.61e-1)" "unprognostic (2.59e-1)" "unprognostic (2.04e-2)" 1.8 1.5 0.3 15.3 0.4 3.9 1.5 0.2 0.6 0.8 2.1 0.3 0.2 1.3 1.3 11.6 2.4 2.6 1.7 0.7 0.2 0.4 2.1 2.8 4.0 49.1 0.5 0.5 0.5 1.0 0.4 1.3 28.4 0.6 0.9 1.0 1.0 6.1 0.2 0.5 1.7 7.9 0.4 0.4 17.8 1.0 1.7 0.2 14.0 1.9 0.2 19.3 2.4 1.4 0.0 0.1 1.1 0.0 43.5 17.5 10.6 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 4.8 0.0 1.4 0.0 0.2 0.2 0.0 0.0 0.4 0.2 0.1 2.4 0.0 0.0 0.0 0.3 11.3 0.0 0.0 0.1 0.0 0.8 0.1 0.4 0.2 0.0 0.7 0.0 0.0 2.1 0.0 0.6 0.8 0.3 0.0 0.0 1.4 1.3 0.0 0.2 0.0 0.0 1.1 0.1 0.0 0.2 0.4 0.0 0.0 0.3 0.1 5.5 6.8 0.4 0.0 0.4 25.4 1.1 0.0 0.3 13.2 0.0 17.4 0.0 6.8 6.4 0.0 0.0 17.5 11.9 0.8 43.5 0.0 0.1 5.1 10.6 0.3 0.4 0.2 0.6 0.2 0.4 0.5 0.5 0.6 0.2 0.0 2.6 0.8 0.5 0.3 0.0 0.2 2.5 0.0 0.0 0.0 3.9 0.2 1.7 1.3 4.3 0.1 0.0 0.0 0.0 0.1 0.5 0.4 1.1 1.0 1.2 0.0 0.0 4.3 5.1 1.3 0.3 0.5 1.7 0.0 0.0 2.3 0.2 0.0 0.0 0.6 0.4 0.0 0.0 0.4 0.2 1.0 0.5 43.1 0.2 0.6 TYR "OCA1, OCA1A, OCAIA" ENSG00000077498 Tyrosinase P14679 11 89177452-89295759 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase, Tumor antigen" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 70 "retina: 82.0;skin 1: 25.2" "Cell type enriched" "Detected in some" 8 "Melanocytes: 175.5" "Cancer enriched" "Detected in single" 1755 "melanoma: 351.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 864 "SK-MEL-30: 86.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000079, HPA043241, HPA050889, HPA064583" Enhanced Enhanced Vesicles NA NA Vesicles "CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: " "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (1.85e-3)" "unprognostic (9.75e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 82.0 0.7 0.0 0.0 25.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.3 0.0 175.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.8 0.0 0.0 0.0 0.0 TYRP1 "b-PROTEIN, CAS2, CATB, GP75, OCA3, TRP, TYRP" ENSG00000107165 "Tyrosinase related protein 1" P17643 9 12685439-12710290 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase" "Albinism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 277.3" "Cell type enriched" "Detected in some" 19 "Melanocytes: 2358.5" "Cancer enriched" "Detected in some" 262 "melanoma: 313.2" "Region enriched" "Detected in some" 5 "pons and medulla: 5.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 52 "SK-MEL-30: 177.7" "Group enriched" "Detected in some" 5 "olfactory region: 5.6;thalamus: 2.0" "Low region specificity" "Detected in all" "HPA000937, CAB002520" Enhanced Approved Vesicles NA NA 16000 Vesicles "CAB002520: AB_564153, HPA000937: AB_1080437" "unprognostic (7.48e-2)" "unprognostic (1.10e-3)" "unprognostic (2.28e-1)" "unprognostic (3.16e-3)" "unprognostic (8.10e-2)" "unprognostic (3.82e-3)" "unprognostic (1.53e-1)" "unprognostic (2.25e-3)" "unprognostic (4.46e-1)" "unprognostic (8.71e-2)" "unprognostic (6.17e-2)" "unprognostic (2.42e-1)" "unprognostic (2.68e-6)" "unprognostic (1.27e-1)" "unprognostic (5.99e-2)" "unprognostic (1.95e-2)" 0.2 0.0 0.2 0.2 0.3 0.0 1.7 0.2 1.0 0.2 0.5 1.3 0.2 1.6 0.2 0.3 3.6 0.2 1.4 21.5 0.9 0.1 5.7 0.2 2.1 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 5.0 0.2 1.8 277.3 1.1 0.2 1.3 51.1 1.4 0.4 1.1 0.2 0.6 0.5 0.2 0.2 0.2 0.9 0.3 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 177.7 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.2 1.0 0.9 0.1 0.2 0.3 5.0 0.2 0.0 0.0 0.0 0.0 82.0 0.6 39.7 0.0 0.0 0.0 3.5 2.0 0.0 122.7 0.2 2.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.3 0.3 0.0 2358.5 0.0 0.0 15.4 0.0 0.0 0.0 0.8 1.3 0.0 3.1 0.5 0.7 14.6 0.0 0.0 0.0 0.1 UBIAD1 "SCCD, TERE1" ENSG00000120942 "UbiA prenyltransferase domain containing 1" Q9Y5Z9 1 11273206-11296049 "Disease related genes, Predicted membrane proteins" "Menaquinone biosynthesis, Ubiquinone biosynthesis" "Prenyltransferase, Transferase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044862 Approved Vesicles NA NA Vesicles "HPA044862: AB_2679117" "unprognostic (1.79e-2)" "unprognostic (2.26e-1)" "unprognostic (5.06e-2)" "unprognostic (1.74e-1)" "unprognostic (7.95e-3)" "unprognostic (7.55e-2)" "unprognostic (1.16e-2)" "unprognostic (2.01e-1)" "unprognostic (1.61e-1)" "unprognostic (2.55e-1)" "unprognostic (1.20e-1)" "unprognostic (1.63e-1)" "prognostic favorable (6.80e-5)" "unprognostic (3.00e-1)" "unprognostic (3.89e-1)" "unprognostic (2.03e-2)" "unprognostic (1.25e-1)" 12.1 11.8 9.2 10.2 11.8 9.2 12.0 10.2 13.1 9.6 9.8 17.6 5.0 7.8 13.0 9.7 8.8 14.4 11.9 11.6 9.0 8.3 9.9 38.1 8.7 18.6 14.1 6.1 17.5 23.4 14.6 10.0 9.1 11.0 10.6 10.0 11.9 11.2 10.2 24.8 11.3 9.5 11.5 15.5 12.9 10.7 17.7 13.6 17.9 12.2 9.6 17.5 11.7 8.7 22.0 10.7 9.5 8.7 9.6 27.0 11.4 8.5 8.5 6.8 13.0 5.0 4.7 9.1 9.4 7.7 10.2 9.3 9.8 7.9 16.9 9.7 6.7 9.6 11.8 17.1 11.3 12.5 11.8 14.7 11.3 9.1 13.0 9.2 17.2 9.9 7.1 15.4 13.7 16.4 5.4 7.4 15.7 13.4 14.1 6.8 8.7 11.1 8.7 8.1 16.1 12.6 10.6 15.1 20.5 7.8 5.7 8.4 9.0 10.0 10.0 12.7 2.9 7.4 9.1 6.1 9.0 9.7 9.3 12.2 11.5 15.9 31.5 5.7 22.9 11.1 4.8 6.5 9.5 13.1 8.7 14.6 22.0 17.8 13.3 8.6 20.7 27.0 18.3 2.0 9.6 7.3 10.7 16.6 11.4 9.2 11.8 10.2 13.1 9.0 8.3 14.1 6.1 11.0 13.6 8.9 13.4 15.8 11.6 13.7 11.1 8.4 7.6 10.7 23.9 5.2 7.9 8.9 10.0 8.9 26.6 8.4 5.1 23.3 11.2 12.1 10.3 9.4 6.9 18.6 7.9 12.7 4.7 4.3 6.9 17.6 11.5 11.3 5.0 5.4 9.7 9.8 9.3 3.5 10.3 7.9 13.9 0.0 10.3 16.1 13.8 11.0 15.8 12.1 13.1 8.9 UCN2 "SRP, UCN-II, UCNI, URP" ENSG00000145040 "Urocortin 2" Q96RP3 3 48561727-48563773 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 18.6;vagina: 6.3" "Cell type enriched" "Detected in single" 5 "Basal keratinocytes: 2.6" "Cancer enhanced" "Detected in many" "melanoma: 18.9" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTCEpi: 15.7;hTEC/SVTERT24-B: 12.4;SiHa: 10.8;U-251 MG: 11.4;WM-115: 31.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA066841 Uncertain Approved Vesicles "Secreted to blood" NA NA 98600 Vesicles "HPA066841: AB_2685735" "unprognostic (7.98e-2)" "unprognostic (1.35e-1)" "unprognostic (4.80e-2)" "unprognostic (1.96e-2)" "unprognostic (2.39e-2)" "unprognostic (4.26e-2)" "unprognostic (1.92e-3)" "unprognostic (2.02e-3)" "unprognostic (1.62e-1)" "unprognostic (2.93e-3)" "unprognostic (2.52e-3)" "unprognostic (1.09e-1)" "unprognostic (3.34e-14)" "unprognostic (4.39e-2)" "unprognostic (2.75e-1)" "unprognostic (1.36e-1)" "unprognostic (2.88e-2)" 1.7 0.0 0.3 0.5 0.9 0.1 0.6 0.3 0.3 2.0 0.3 0.3 0.3 0.1 1.8 1.1 3.7 0.1 0.6 0.3 0.3 0.5 0.9 0.3 0.3 0.3 1.6 0.3 0.3 0.3 0.0 0.3 0.3 0.9 3.3 0.1 0.3 1.6 0.7 0.3 18.6 0.3 0.4 0.3 0.5 0.1 1.1 0.3 0.3 0.3 0.3 0.3 0.3 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 1.0 0.6 1.5 5.4 6.8 3.4 2.5 0.0 0.0 0.0 0.2 1.3 4.1 1.0 0.0 6.5 1.8 5.0 0.1 0.1 8.9 0.8 1.1 0.0 0.3 0.7 15.7 12.4 2.5 2.4 0.0 0.1 0.0 0.1 0.5 0.0 0.0 1.0 0.4 0.0 0.1 0.1 0.1 0.0 1.0 0.0 0.0 0.0 10.8 0.0 8.1 1.0 0.1 0.2 0.0 1.5 1.0 0.1 11.4 0.0 0.1 0.0 5.1 0.0 31.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 0.3 0.3 0.3 0.5 1.6 0.3 0.9 0.3 0.0 0.0 0.0 0.3 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 USP6 "HRP1, Tre-2, TRE17, Tre2, TRESMCR" ENSG00000129204 "Ubiquitin specific peptidase 6" P35125 17 5116438-5175034 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Calmodulin-binding, Hydrolase, Protease, Thiol protease" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "skeletal muscle: 18.2;testis: 29.0" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 19.3;Erythroid cells: 23.3;Spermatocytes: 19.2" "Cancer enriched" "Detected in single" 14 "testis cancer: 2.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA046969 Uncertain Vesicles NA NA Vesicles "HPA046969: " "unprognostic (3.89e-2)" "unprognostic (3.79e-3)" "unprognostic (2.50e-1)" "unprognostic (1.85e-1)" "unprognostic (9.32e-2)" "unprognostic (3.50e-3)" "unprognostic (1.29e-1)" "unprognostic (1.67e-2)" "unprognostic (3.45e-2)" "unprognostic (2.46e-2)" "unprognostic (7.91e-4)" "unprognostic (6.28e-3)" "unprognostic (3.24e-4)" "unprognostic (3.75e-2)" "unprognostic (3.13e-1)" "unprognostic (2.71e-1)" "unprognostic (7.09e-4)" 0.3 0.3 0.3 0.3 0.6 0.2 0.4 0.5 0.5 0.3 0.5 0.3 1.2 0.0 0.6 0.6 0.3 0.5 0.4 0.3 0.3 0.1 0.3 0.3 0.3 0.3 0.3 0.3 2.6 0.3 0.0 0.4 0.4 0.3 0.4 0.1 0.3 0.3 0.3 18.2 0.6 0.7 0.9 0.3 0.3 0.0 29.0 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.9 1.2 1.9 1.0 0.2 0.4 0.1 2.2 0.9 2.2 1.6 0.4 0.2 2.3 1.9 0.1 0.6 0.4 0.8 1.0 2.2 1.6 1.2 1.9 1.0 0.7 0.8 0.5 1.5 1.3 1.7 1.3 0.9 1.2 0.5 2.8 1.1 0.5 0.1 0.2 2.5 0.3 1.8 0.5 0.3 0.5 2.5 1.8 0.7 1.5 0.7 0.1 1.4 1.9 0.2 0.5 0.7 0.9 2.1 1.0 0.1 3.3 3.7 2.1 2.2 1.2 0.9 3.2 2.0 1.4 2.0 1.6 1.5 0.0 0.1 2.6 0.1 0.4 0.9 0.4 0.3 0.2 0.6 0.3 0.3 0.3 0.9 0.3 0.4 1.9 0.2 1.0 1.2 0.1 0.1 0.3 0.6 0.5 0.3 0.3 0.1 0.3 0.3 0.3 0.3 6.0 9.6 0.5 0.9 9.6 7.9 1.6 7.6 5.3 5.7 3.5 11.8 0.5 3.3 0.0 19.3 2.9 0.0 23.3 0.0 0.8 1.5 2.4 0.0 2.6 2.3 1.6 0.0 4.9 4.9 9.4 1.7 5.7 3.3 0.0 0.0 4.7 0.1 0.0 2.5 2.8 9.8 6.5 0.6 19.2 5.5 9.2 0.6 0.7 0.0 0.9 USP9X "DFFRX, FAF, MRX99" ENSG00000124486 "Ubiquitin specific peptidase 9, X-linked" Q93008 X 41085635-41236579 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Cell division, Chromosome partition, Mitosis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011618, HPA047417, CAB070164" Approved Uncertain Vesicles NA NA Vesicles "CAB011618: AB_470860, CAB070164: AB_10011071, HPA047417: " "unprognostic (5.42e-3)" "unprognostic (6.42e-2)" "unprognostic (3.19e-3)" "unprognostic (2.94e-2)" "unprognostic (5.99e-2)" "unprognostic (4.76e-1)" "unprognostic (1.82e-2)" "unprognostic (4.07e-1)" "unprognostic (1.90e-1)" "unprognostic (1.72e-1)" "unprognostic (7.07e-2)" "unprognostic (1.09e-1)" "unprognostic (5.82e-2)" "unprognostic (1.59e-1)" "unprognostic (4.19e-2)" "unprognostic (2.78e-1)" "unprognostic (1.33e-1)" 18.0 21.8 17.7 14.0 15.9 15.5 16.8 16.6 16.7 18.4 20.6 11.4 25.4 13.2 19.6 19.0 17.3 17.0 17.1 20.9 14.2 14.2 18.5 34.2 16.7 23.1 15.2 15.4 15.7 16.5 45.8 17.0 41.1 12.9 13.4 14.4 13.9 14.2 25.2 42.8 14.8 22.0 17.3 14.0 16.7 16.9 16.9 14.0 21.1 20.3 17.6 16.5 20.3 19.9 6.4 5.5 13.0 5.0 4.9 7.8 3.1 18.2 21.6 19.2 19.6 16.1 16.9 4.4 10.5 14.1 12.0 13.9 9.9 8.5 12.3 5.9 23.9 35.9 12.4 32.9 19.1 20.1 15.4 23.6 14.2 20.9 8.9 13.6 12.3 10.4 14.6 8.6 28.7 27.2 17.2 18.5 8.3 17.2 10.0 18.5 13.3 8.8 4.9 20.3 6.5 11.9 9.7 26.2 7.9 11.4 15.1 10.9 10.2 44.2 12.2 12.0 36.0 11.8 6.9 19.7 18.3 14.2 17.3 11.3 9.2 10.7 15.7 13.1 5.5 9.1 3.3 4.7 6.0 5.6 4.2 7.8 6.4 6.6 6.2 5.5 4.7 6.7 6.0 13.0 4.9 5.0 4.2 5.6 3.1 17.7 15.9 16.6 16.7 14.2 14.2 15.2 15.4 12.9 14.0 38.7 32.0 23.8 26.8 42.8 35.0 73.6 43.3 30.8 36.4 26.2 35.3 31.0 6.6 26.8 13.0 39.8 39.2 70.0 22.8 21.8 35.1 30.2 24.4 55.5 29.3 35.0 25.8 52.8 43.4 13.1 30.8 38.0 32.1 33.3 42.5 32.0 27.0 35.7 46.3 20.3 29.3 32.3 39.6 31.4 69.2 48.3 39.0 26.1 36.7 34.3 USP9Y DFFRY ENSG00000114374 "Ubiquitin specific peptidase 9, Y-linked" O00507 Y 12701231-12860839 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 60.9" "Cancer enhanced" "Detected in many" "prostate cancer: 5.7" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 2.4;dendritic cells: 2.0;T-cells: 2.7" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 16.2;RT4: 8.7" "Not detected" "Not detected" HPA057687 Uncertain Vesicles NA NA Vesicles "HPA057687: " "unprognostic (2.63e-1)" "unprognostic (8.97e-2)" "unprognostic (1.10e-5)" "unprognostic (8.46e-3)" "unprognostic (4.93e-2)" "unprognostic (2.53e-2)" "unprognostic (2.77e-1)" "unprognostic (3.17e-2)" "unprognostic (1.71e-1)" "unprognostic (4.05e-2)" "unprognostic (1.41e-4)" "unprognostic (2.28e-1)" "unprognostic (1.19e-2)" "unprognostic (1.42e-1)" 1.2 2.2 1.4 0.9 3.1 1.7 1.1 9.6 4.0 0.0 1.6 1.4 0.0 8.6 4.4 0.0 3.8 2.4 1.8 3.4 2.9 2.2 2.2 1.4 2.1 0.0 2.7 0.0 4.8 1.7 9.3 4.8 2.3 7.6 2.8 2.0 1.8 0.0 1.5 2.2 1.5 2.9 2.8 4.5 3.2 0.0 2.4 2.0 0.1 0.2 0.5 2.7 0.2 0.0 2.3 0.0 0.0 0.0 0.0 2.5 7.2 7.2 3.6 3.9 0.0 0.0 4.1 0.0 6.0 0.0 0.0 0.0 0.0 3.3 2.3 0.0 2.6 0.0 7.1 4.0 0.0 0.0 6.0 5.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 6.5 0.0 4.0 0.0 1.5 0.0 0.0 0.0 2.0 0.9 16.2 8.7 2.8 0.0 0.0 0.0 2.1 5.4 0.0 0.0 5.5 4.4 0.0 0.0 3.2 0.0 3.8 7.1 0.1 0.0 0.0 0.0 0.1 0.0 1.9 0.2 2.7 1.2 2.2 1.5 0.3 2.4 2.2 1.3 0.1 0.5 0.0 2.0 1.6 0.2 23.8 19.7 0.8 7.4 10.4 22.1 24.6 2.5 21.4 15.9 19.2 60.9 4.3 1.7 4.1 0.4 5.8 0.0 0.0 0.0 1.1 9.3 11.2 2.3 0.2 2.5 25.4 0.0 5.5 6.9 0.0 11.5 7.3 3.3 2.8 0.3 8.1 3.7 0.0 14.5 5.4 24.9 0.0 7.6 3.2 1.7 10.2 2.9 10.0 0.0 9.9 VAMP7 "SYBL1, TI-VAMP, VAMP-7" ENSG00000124333 "Vesicle associated membrane protein 7" P51809 X 155881293-155943769 "Predicted intracellular proteins, Predicted membrane proteins" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036733 Approved Supported Vesicles NA NA 14000 Vesicles "HPA036733: AB_10672228" "unprognostic (7.54e-3)" "unprognostic (1.35e-2)" "unprognostic (2.07e-1)" "unprognostic (1.04e-1)" "unprognostic (6.15e-3)" "unprognostic (2.70e-2)" "unprognostic (5.77e-2)" "unprognostic (7.95e-2)" "unprognostic (7.18e-2)" "unprognostic (3.38e-3)" "unprognostic (1.02e-1)" "unprognostic (1.15e-1)" "prognostic favorable (2.83e-4)" "unprognostic (1.29e-1)" "unprognostic (3.42e-1)" "unprognostic (2.47e-1)" "unprognostic (2.97e-1)" 11.9 12.7 43.9 9.5 51.2 13.4 51.9 21.2 41.1 38.4 9.3 2.5 2.5 9.6 36.5 6.6 10.4 8.5 9.3 26.9 46.8 12.5 61.4 20.5 10.3 9.8 50.6 44.8 34.5 7.9 12.8 35.0 68.7 58.5 9.4 10.5 2.5 8.3 9.0 12.0 9.3 11.3 12.0 63.0 8.4 8.4 5.6 47.6 2.5 10.4 2.5 11.6 10.2 26.1 6.6 13.5 34.8 13.8 11.2 11.0 10.6 22.4 9.8 6.8 14.0 18.8 18.1 18.2 17.5 15.6 15.9 32.2 10.6 14.8 31.3 32.6 21.0 18.0 8.1 15.2 12.3 21.1 13.0 13.3 13.0 14.6 7.5 21.1 26.6 20.4 16.8 12.3 17.7 16.3 13.9 17.6 13.8 27.7 17.4 17.9 11.3 10.3 15.2 4.8 16.8 14.5 7.9 13.3 23.2 21.0 11.3 5.1 14.9 10.3 10.5 15.3 18.6 10.2 22.4 18.5 14.6 15.3 20.9 24.8 40.1 50.6 43.8 12.8 32.7 16.2 34.8 12.9 19.7 8.3 13.8 10.5 6.5 9.9 10.2 13.5 6.6 9.2 9.8 11.2 11.2 12.8 7.7 11.0 10.6 43.9 51.2 21.2 41.1 46.8 12.5 50.6 44.8 58.5 47.6 3.0 8.6 21.6 11.9 17.4 6.6 9.9 7.6 4.0 9.1 7.0 5.9 42.4 34.9 22.9 5.2 19.6 15.5 46.7 22.8 35.9 25.1 14.3 31.1 21.3 28.1 6.4 12.7 19.6 24.4 4.9 16.4 30.8 18.6 24.4 14.5 10.4 23.3 14.0 18.4 39.8 4.1 25.8 22.8 23.4 25.8 16.9 58.4 26.6 14.5 14.2 VAV2 ENSG00000160293 "Vav guanine nucleotide exchange factor 2" P52735 9 133761894-133992604 "Plasma proteins, Predicted intracellular proteins" Angiogenesis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Collecting duct cells: 34.9;Hepatocytes: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 6.4" "Group enriched" "Detected in many" 36 "B-cells: 6.4;dendritic cells: 2.0;monocytes: 3.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003224 Uncertain Approved Vesicles NA NA Vesicles "HPA003224: AB_1080554" "unprognostic (1.56e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-2)" "unprognostic (1.09e-1)" "unprognostic (3.43e-1)" "unprognostic (1.19e-1)" "unprognostic (6.57e-2)" "unprognostic (1.16e-3)" "unprognostic (1.83e-2)" "unprognostic (3.74e-3)" "unprognostic (4.73e-2)" "unprognostic (9.16e-2)" "prognostic favorable (7.39e-7)" "unprognostic (8.64e-3)" "unprognostic (3.00e-2)" "prognostic unfavorable (4.33e-4)" "unprognostic (3.97e-2)" 6.3 19.2 6.8 13.3 5.6 1.9 8.1 2.8 7.3 7.7 16.6 5.8 9.3 15.5 9.8 9.2 5.4 9.5 21.3 5.7 5.4 6.9 16.0 30.3 17.2 12.5 7.7 5.5 6.1 44.1 8.8 6.5 9.6 9.6 7.8 7.3 9.4 12.1 11.0 1.7 4.6 28.1 7.6 4.7 13.8 7.0 3.5 4.0 3.1 11.6 3.9 13.3 8.6 17.3 6.4 2.0 0.0 3.6 0.0 0.1 0.7 4.8 8.6 13.5 5.4 3.7 6.3 34.9 9.8 5.4 8.3 5.0 13.0 7.6 1.4 8.0 9.7 10.7 29.0 12.7 21.1 4.3 8.2 2.9 1.6 10.8 14.5 13.9 3.9 0.6 6.2 13.6 7.3 10.4 5.5 9.2 2.9 2.8 2.4 5.7 24.7 0.3 2.0 6.6 21.2 8.2 13.2 11.4 4.7 18.8 8.8 15.0 10.2 25.7 17.2 3.5 9.1 10.4 5.7 7.4 11.8 6.6 11.6 13.4 0.1 0.1 2.7 7.8 3.5 7.2 0.0 1.4 0.0 0.1 3.6 0.0 6.4 0.0 0.1 2.0 4.5 0.0 0.0 0.0 0.0 2.4 1.2 0.0 0.7 6.8 5.6 2.8 7.3 5.4 6.9 7.7 5.5 9.6 4.0 0.0 4.8 11.3 2.4 4.5 1.0 3.2 30.6 1.4 7.9 34.9 0.0 0.6 3.3 8.1 2.6 4.2 29.3 0.0 10.8 14.7 5.4 4.7 0.0 35.0 5.2 0.0 27.1 9.8 4.5 5.8 6.6 5.5 1.7 10.8 6.3 5.3 18.4 11.4 5.6 11.7 1.4 12.9 8.5 0.1 1.9 2.4 0.8 0.0 11.6 2.0 VCAN "CSPG2, PG-M" ENSG00000038427 Versican P13611 5 83471465-83582303 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Fibroblasts: 557.1;Kupffer cells: 784.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 55.5;myeloid DC: 21.3" "Group enriched" "Detected in many" 31 "dendritic cells: 21.3;monocytes: 55.5" "Cell line enhanced" "Detected in some" "AF22: 43.6;HSkMC: 29.6;hTERT-RPE1: 140.3;RPTEC TERT1: 55.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004726, CAB008979" Supported Approved Vesicles "Secreted to blood" NA NA 5200000 Vesicles "CAB008979: , HPA004726: AB_1080561" "unprognostic (7.90e-2)" "unprognostic (9.03e-3)" "unprognostic (7.09e-2)" "unprognostic (6.06e-3)" "unprognostic (1.87e-1)" "unprognostic (4.49e-2)" "unprognostic (1.23e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (7.59e-4)" "unprognostic (4.36e-3)" "unprognostic (2.68e-3)" "unprognostic (2.05e-1)" "prognostic unfavorable (5.17e-4)" "prognostic unfavorable (1.41e-4)" "unprognostic (1.15e-1)" "unprognostic (4.44e-2)" "unprognostic (5.30e-3)" 33.3 18.3 14.8 53.2 10.3 20.1 12.3 4.8 16.2 25.2 8.4 17.9 1.7 3.6 14.5 23.5 9.0 7.6 23.2 35.7 19.8 8.9 8.5 3.1 25.8 21.2 13.9 9.8 5.3 3.2 3.7 2.0 52.0 14.4 8.9 8.9 3.3 6.5 4.1 9.0 9.3 4.7 33.9 18.2 18.4 6.2 8.7 19.4 1.1 5.7 6.5 2.3 24.4 9.8 0.0 21.3 1.2 55.5 0.1 0.1 17.7 0.0 0.8 43.6 0.0 17.7 12.2 0.0 0.3 0.8 0.3 0.2 0.4 0.0 0.0 6.7 15.7 0.5 0.0 0.0 0.0 0.2 0.0 1.3 0.3 0.0 0.3 0.8 0.0 0.0 29.6 0.0 18.5 0.1 140.3 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 7.4 0.0 1.4 0.0 9.1 0.0 55.4 0.0 0.5 2.2 0.0 0.0 0.0 5.0 0.0 0.0 16.8 13.3 0.0 24.4 25.0 0.0 0.0 0.0 6.1 0.0 2.3 1.2 55.5 0.1 0.1 7.7 0.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 0.9 0.1 0.8 0.4 0.0 17.7 14.8 10.3 4.8 9.8 19.8 8.9 13.9 9.8 14.4 19.4 17.9 29.9 3.0 4.4 34.3 0.0 6.8 30.6 25.4 30.7 24.4 0.0 7.1 0.0 1.6 0.8 12.1 0.0 0.0 0.6 5.1 557.1 1.5 11.6 2.1 24.5 0.0 0.0 23.4 784.4 0.7 17.3 132.2 42.2 5.4 0.0 0.0 19.5 0.0 110.7 1.2 0.0 0.0 33.9 0.3 0.4 25.1 9.6 4.4 0.0 0.8 VDAC1 "MGC111064, PORIN" ENSG00000213585 "Voltage dependent anion channel 1" P21796 5 133971915-134005133 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 189.4" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB005885, HPA030780, CAB072343" Supported Uncertain Vesicles NA NA 4800000 Vesicles "CAB005885: AB_2214787, CAB072343: , HPA030780: AB_2673608" "prognostic unfavorable (5.30e-4)" "unprognostic (7.63e-3)" "unprognostic (3.07e-3)" "unprognostic (2.01e-1)" "unprognostic (5.11e-3)" "prognostic unfavorable (4.90e-4)" "prognostic unfavorable (8.49e-4)" "prognostic unfavorable (2.87e-5)" "unprognostic (1.81e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (2.64e-1)" "unprognostic (3.19e-2)" "unprognostic (8.98e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" 22.4 27.0 32.2 18.9 36.6 9.8 22.6 24.4 46.4 13.8 31.3 15.6 20.4 54.0 12.1 42.8 35.2 13.3 25.8 79.0 31.0 32.3 44.9 52.5 16.3 17.3 30.6 29.5 14.6 27.5 31.6 14.1 22.8 41.8 17.9 35.3 23.3 26.6 17.9 189.4 21.9 39.9 18.9 20.7 18.3 32.5 8.3 14.7 16.3 17.3 66.6 25.5 18.9 21.3 18.9 44.7 9.2 36.5 26.5 23.3 20.0 55.6 49.5 45.4 47.0 45.6 63.9 64.1 62.7 46.4 62.4 64.3 101.2 44.8 77.0 47.2 65.3 83.3 43.9 64.0 110.4 78.3 45.4 52.7 44.3 53.0 80.9 46.6 40.6 44.1 58.1 59.3 48.4 54.1 62.5 60.4 39.2 39.4 31.6 81.4 62.1 49.4 40.5 31.7 86.1 42.0 45.6 45.4 73.1 96.9 70.5 50.8 28.7 39.9 48.8 62.5 65.2 23.4 39.9 48.9 58.8 39.2 53.8 81.9 42.4 41.8 48.3 87.3 54.6 66.7 6.4 26.2 9.2 18.5 36.5 20.4 18.9 19.1 19.3 44.7 13.4 13.7 15.1 2.2 26.5 31.2 13.1 23.3 20.0 32.2 36.6 24.4 46.4 31.0 32.3 30.6 29.5 41.8 14.7 98.3 53.8 114.9 202.6 182.0 420.0 257.9 188.5 124.5 83.0 120.4 76.6 339.7 618.4 271.3 51.9 101.8 313.3 0.0 265.3 390.2 136.0 191.2 120.0 170.9 298.9 491.0 99.9 56.4 90.4 40.4 88.6 191.3 236.2 427.4 159.8 195.2 250.0 193.2 105.4 471.4 182.7 84.1 306.0 8.8 29.6 203.5 272.3 89.7 280.1 214.3 VPS37D "MGC35352, WBSCR24" ENSG00000176428 "VPS37D, ESCRT-I subunit" Q86XT2 7 73667825-73672112 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 10.7;Collecting duct cells: 10.4;Distal tubular cells: 8.3;Muller glia cells: 7.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.0" "Lineage enriched" "Detected in single" 10 "T-cells: 1.0" "Cell line enhanced" "Detected in many" "SH-SY5Y: 15.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040978 Uncertain Approved Vesicles NA NA Vesicles "HPA040978: AB_10805833" "unprognostic (2.98e-2)" "unprognostic (2.17e-1)" "unprognostic (1.13e-2)" "unprognostic (7.85e-2)" "unprognostic (1.93e-1)" "unprognostic (3.85e-2)" "unprognostic (2.54e-1)" "unprognostic (3.94e-1)" "unprognostic (8.80e-2)" "unprognostic (1.97e-1)" "prognostic favorable (2.07e-5)" "unprognostic (4.19e-2)" "prognostic favorable (5.80e-9)" "unprognostic (9.63e-2)" "unprognostic (1.67e-1)" "unprognostic (1.25e-2)" "unprognostic (1.43e-1)" 2.6 1.7 7.2 0.8 8.3 0.6 2.9 7.5 9.2 4.7 1.9 3.8 1.7 4.1 3.9 6.9 0.9 6.4 3.2 3.9 6.0 7.6 8.8 6.2 1.8 0.7 5.1 2.6 6.0 5.3 3.8 2.4 1.0 5.3 4.5 0.7 2.2 7.2 5.0 2.8 2.3 2.4 1.9 3.8 1.2 1.9 5.5 3.3 0.8 7.4 0.2 0.5 3.6 5.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.7 2.9 2.3 4.8 1.6 3.2 1.4 1.2 2.0 1.0 1.2 0.3 0.8 1.0 1.1 1.6 2.7 0.3 2.5 1.1 0.3 0.4 2.5 0.0 0.2 3.2 4.2 0.0 1.4 2.5 0.7 1.4 0.5 4.6 1.1 4.1 1.3 0.2 1.4 3.5 0.7 0.1 1.6 0.8 4.2 0.1 0.1 0.2 3.9 0.3 4.7 15.0 0.0 2.0 2.7 0.4 4.8 0.2 1.7 2.9 4.0 1.7 1.0 1.9 0.2 1.3 6.5 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 7.2 8.3 7.5 7.2 6.0 7.6 5.1 2.6 5.3 3.3 0.0 0.0 0.0 0.5 0.9 10.7 1.6 0.0 0.0 0.0 10.4 0.0 0.1 8.3 3.3 0.7 0.5 0.0 0.0 0.7 0.3 0.9 1.4 0.0 5.1 0.1 0.0 4.7 1.8 0.0 0.7 1.7 0.0 5.0 1.0 0.0 7.7 1.8 0.6 2.5 6.3 4.9 0.0 1.4 0.5 5.7 1.0 0.2 0.0 0.2 0.3 VSTM1 UNQ3033 ENSG00000189068 "V-set and transmembrane domain containing 1" Q6UX27 19 54040825-54063953 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Immunity Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "blood: 53.5;bone marrow: 39.4" "Cell type enriched" "Detected in some" 5 "Late spermatids: 15.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enriched" "Detected in many" 15 "eosinophil: 53.5" "Lineage enriched" "Detected in many" 15 "granulocytes: 53.5" "Group enriched" "Detected in some" 7 "EFO-21: 1.0;HMC-1: 2.5;hTERT-HME1: 4.0;U-2 OS: 3.6" HPA059365 Approved Vesicles "Secreted to blood" NA NA Vesicles "HPA059365: " "unprognostic (5.13e-2)" "unprognostic (5.31e-2)" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (1.36e-3)" "unprognostic (1.30e-1)" "unprognostic (1.09e-1)" "unprognostic (3.80e-1)" "unprognostic (1.09e-1)" "unprognostic (1.59e-1)" "unprognostic (9.47e-2)" "unprognostic (1.31e-5)" "unprognostic (3.73e-1)" "unprognostic (1.14e-1)" "unprognostic (9.74e-2)" "unprognostic (4.67e-2)" 0.9 0.2 0.7 0.1 0.2 39.4 0.1 0.0 0.5 0.2 0.1 1.3 0.0 0.1 0.3 0.1 0.1 0.6 0.1 4.2 0.7 0.2 0.5 1.2 4.0 7.2 0.6 0.0 0.2 1.1 0.1 8.7 2.0 0.2 0.1 0.1 0.2 0.1 0.1 2.1 0.1 0.8 0.3 0.1 7.9 0.1 0.5 0.3 3.0 0.4 0.0 0.1 0.8 0.0 0.0 0.0 53.5 3.6 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 3.0 53.5 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 3.6 0.0 0.0 2.1 0.7 0.2 0.0 0.5 0.7 0.2 0.6 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 2.2 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 WASHC1 "FAM39E, FLJ00038, WASH1" ENSG00000181404 "WASH complex subunit 1" A8K0Z3 9 14521-73865 "Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Collecting duct cells: 57.6;Cytotrophoblasts: 30.8;Distal tubular cells: 43.1;Proximal tubular cells: 37.7;Syncytiotrophoblasts: 35.8" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002689 Uncertain Supported Vesicles NA NA Vesicles "HPA002689: AB_1078803" "unprognostic (9.43e-2)" "unprognostic (1.62e-2)" "unprognostic (3.16e-2)" "unprognostic (1.30e-1)" "unprognostic (1.43e-1)" "unprognostic (2.33e-2)" "unprognostic (3.22e-3)" "unprognostic (2.06e-2)" "unprognostic (5.00e-1)" "unprognostic (5.40e-3)" "unprognostic (3.37e-3)" "unprognostic (6.95e-2)" "unprognostic (3.90e-2)" "unprognostic (1.88e-1)" "unprognostic (3.38e-1)" "unprognostic (2.31e-2)" "unprognostic (1.02e-1)" 1.7 1.5 0.8 2.4 0.4 0.5 0.4 1.1 1.9 4.1 5.4 3.3 3.3 1.2 2.5 1.5 0.0 1.4 2.1 2.5 0.8 0.0 0.6 3.2 0.0 1.2 5.0 4.2 3.7 1.3 3.8 2.1 1.3 0.3 0.3 0.3 0.2 3.5 5.7 4.9 8.7 5.0 5.0 3.4 11.5 7.0 4.3 9.0 7.5 5.1 10.7 10.8 9.6 5.9 5.0 6.7 7.1 4.7 5.8 4.1 5.6 14.2 6.3 4.9 2.3 4.9 11.6 4.6 5.0 7.0 4.2 9.3 8.5 3.8 3.7 3.0 4.1 15.3 1.8 4.3 10.3 18.1 1.8 3.4 9.5 7.7 7.9 7.6 14.8 6.5 5.8 6.0 4.3 8.1 4.8 13.1 5.8 13.1 6.9 5.6 7.4 8.9 7.1 8.0 8.3 3.5 9.1 8.2 6.4 3.7 7.5 10.1 7.4 2.4 5.9 4.9 5.0 6.2 3.9 3.5 4.0 4.1 5.7 3.3 4.2 3.4 3.6 5.0 8.7 5.1 4.2 3.4 20.8 22.7 0.0 0.0 0.0 0.0 0.0 0.0 14.7 13.6 57.6 0.0 30.8 43.1 11.8 0.0 0.0 0.0 0.0 13.6 21.5 0.0 0.0 15.1 0.0 23.3 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 8.2 0.0 0.0 11.1 0.0 0.0 37.7 0.0 0.0 0.0 0.0 0.0 0.0 35.8 0.0 0.0 0.0 WASHC3 "CCDC53, CGI-116" ENSG00000120860 "WASH complex subunit 3" Q9Y3C0 12 102012927-102062149 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 106.1;Hofbauer cells: 63.8;monocytes: 81.2;Proximal tubular cells: 75.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038339 Uncertain Approved Vesicles NA NA Vesicles "HPA038339: AB_2675966" "unprognostic (4.25e-2)" "unprognostic (1.61e-2)" "unprognostic (2.28e-1)" "unprognostic (3.45e-3)" "unprognostic (1.21e-2)" "unprognostic (2.42e-1)" "unprognostic (2.11e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.63e-2)" "unprognostic (7.54e-2)" "unprognostic (4.98e-2)" "unprognostic (7.81e-2)" "unprognostic (7.41e-2)" "unprognostic (1.74e-1)" "unprognostic (1.08e-1)" "unprognostic (1.08e-1)" 15.1 22.4 25.3 11.1 24.2 8.4 18.4 11.1 22.0 19.8 17.3 18.6 17.5 10.0 20.5 27.9 17.2 13.5 14.8 23.7 23.3 24.2 29.0 29.1 14.4 13.9 24.6 18.9 13.9 10.3 25.1 22.5 14.7 22.5 19.4 16.6 15.3 13.2 26.9 17.8 12.3 12.3 23.1 27.6 13.6 15.4 61.7 20.0 17.2 18.8 19.3 19.5 17.1 13.9 25.3 22.5 40.2 26.0 21.5 44.5 19.8 6.0 8.3 7.5 4.4 26.8 35.2 7.1 8.5 16.6 12.7 13.7 7.5 5.6 6.5 6.1 18.4 14.0 10.9 7.9 20.4 16.4 15.6 4.7 9.0 6.2 10.2 24.9 7.3 5.2 20.5 27.7 16.4 16.5 34.6 17.1 16.1 5.2 6.7 32.5 8.1 7.6 13.6 2.2 12.7 15.2 4.1 10.8 9.5 20.9 10.0 7.0 3.8 11.4 7.8 17.2 14.8 10.0 4.8 8.0 14.5 3.7 7.9 5.9 16.9 10.9 7.9 20.1 5.6 6.0 40.2 17.0 35.8 16.0 25.4 18.4 25.3 23.5 20.5 22.5 21.7 17.7 20.6 7.1 21.5 26.0 21.6 44.5 19.8 25.3 24.2 11.1 22.0 23.3 24.2 24.6 18.9 22.5 20.0 26.8 37.4 0.0 0.0 0.0 0.0 0.0 0.0 41.5 26.1 31.4 0.0 49.8 106.1 40.5 0.0 0.0 0.0 0.0 34.1 41.5 0.0 0.0 37.2 0.0 63.8 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.0 81.2 0.0 0.0 34.2 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 0.0 33.0 0.0 0.0 0.0 WDFY2 ZFYVE22 ENSG00000139668 "WD repeat and FYVE domain containing 2" Q96P53 13 51584455-51767707 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 119.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050094 Supported Vesicles NA NA Vesicles "HPA050094: " "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-3)" "unprognostic (1.59e-1)" "unprognostic (2.41e-1)" "unprognostic (1.39e-2)" "unprognostic (9.58e-2)" "unprognostic (2.28e-1)" "unprognostic (2.59e-2)" "unprognostic (3.87e-2)" "unprognostic (1.14e-1)" "unprognostic (7.49e-4)" "unprognostic (1.47e-1)" "unprognostic (7.04e-2)" "unprognostic (6.36e-2)" "unprognostic (2.48e-1)" 9.0 16.5 11.0 9.9 11.6 21.9 12.8 6.3 9.6 9.3 4.7 20.2 11.1 3.9 9.0 15.2 16.1 8.9 8.6 6.6 11.0 7.0 7.8 12.5 9.1 9.0 17.1 7.5 10.9 26.4 23.1 11.7 9.6 11.0 7.1 4.7 6.7 8.5 16.7 3.1 29.4 5.7 6.9 11.2 10.6 8.4 14.4 16.7 9.6 10.4 13.3 10.1 6.4 12.0 4.5 13.1 5.4 8.8 3.8 3.3 3.3 1.1 2.1 9.3 3.7 4.6 9.6 3.1 9.0 5.7 4.7 3.7 1.3 1.3 3.6 0.9 6.1 3.0 4.0 5.1 16.0 8.9 2.9 2.8 7.7 2.9 10.8 3.6 5.2 3.6 7.7 7.7 10.4 11.9 7.6 2.0 3.9 2.1 1.9 7.6 2.4 3.5 11.8 11.1 2.5 3.1 4.7 3.7 2.4 5.9 3.0 2.6 6.3 2.6 4.0 4.1 8.1 1.9 12.4 7.6 8.9 1.7 4.3 6.2 1.2 2.0 2.6 10.2 5.4 10.9 4.8 8.1 3.9 2.4 8.7 3.3 4.0 2.6 2.0 13.1 4.5 2.3 2.9 5.4 3.8 8.8 12.0 3.3 3.3 11.0 11.6 6.3 9.3 11.0 7.0 17.1 7.5 11.0 16.7 14.9 18.7 15.4 17.7 20.7 30.2 5.9 2.5 17.4 26.1 27.9 119.8 23.9 23.2 14.6 33.4 9.2 6.2 0.0 20.7 28.3 13.3 9.6 27.8 17.0 23.6 35.0 13.2 30.1 52.3 15.7 36.5 30.9 11.8 10.8 5.2 37.4 18.7 3.4 20.5 5.0 53.1 25.8 11.7 28.4 14.9 23.7 11.7 16.6 6.8 14.4 WDR38 ENSG00000136918 "WD repeat domain 38" Q5JTN6 9 124853417-124857890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "fallopian tube: 51.4" "Group enriched" "Detected in some" 7 "Ciliated cells: 83.0;Early spermatids: 23.2;Late spermatids: 80.7" "Cancer enhanced" "Detected in some" "endometrial cancer: 12.2" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.5;HDLM-2: 3.0;HeLa: 2.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA056607 Approved Vesicles NA NA Vesicles "HPA056607: AB_2683188" "unprognostic (5.66e-3)" "unprognostic (2.15e-3)" "unprognostic (1.51e-2)" "prognostic favorable (3.97e-4)" "unprognostic (1.14e-1)" "unprognostic (2.17e-3)" "unprognostic (4.29e-3)" "unprognostic (7.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.82e-1)" "unprognostic (1.38e-1)" "unprognostic (5.90e-2)" "unprognostic (7.75e-5)" "unprognostic (1.01e-1)" "unprognostic (3.25e-2)" "unprognostic (6.36e-2)" "unprognostic (4.42e-2)" 0.2 0.2 2.0 0.2 3.1 0.2 0.2 0.2 0.5 2.9 0.2 10.6 0.0 0.2 0.7 11.9 0.2 51.4 0.2 0.3 2.8 3.3 0.2 0.2 10.8 0.2 0.3 0.4 6.0 0.2 0.2 1.0 0.2 8.8 0.2 0.2 0.0 0.2 0.3 0.3 0.3 0.2 0.3 0.7 0.2 0.2 7.0 1.3 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.3 0.5 0.2 0.0 0.3 0.2 0.0 0.2 0.1 0.1 0.4 2.5 0.1 0.1 0.3 1.1 0.1 0.2 0.0 0.0 3.0 0.3 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.1 0.5 0.0 0.0 0.0 0.7 0.1 0.3 0.6 0.1 0.1 0.0 0.2 0.2 0.1 0.0 0.0 0.7 0.0 0.2 1.3 0.0 0.0 0.0 0.5 0.5 0.2 0.4 0.5 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 3.1 0.2 0.5 2.8 3.3 0.3 0.4 8.8 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 83.0 9.1 0.0 0.0 0.0 0.0 0.2 23.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 80.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 WDR48 "KIAA1449, P80, SPG60" ENSG00000114742 "WD repeat domain 48" Q8TAF3 3 39051998-39096671 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Spermatocytes: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038421, HPA058015" Approved Supported Vesicles NA NA Vesicles "HPA038421: AB_10670780, HPA058015: AB_2683580" "unprognostic (1.95e-1)" "unprognostic (2.14e-1)" "unprognostic (2.99e-2)" "unprognostic (3.78e-1)" "unprognostic (7.68e-2)" "unprognostic (2.34e-3)" "unprognostic (6.14e-3)" "unprognostic (9.87e-3)" "unprognostic (8.02e-2)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (2.14e-2)" "prognostic favorable (1.63e-7)" "unprognostic (2.41e-1)" "unprognostic (2.94e-2)" "unprognostic (1.43e-1)" "unprognostic (1.69e-2)" 16.0 15.0 16.3 9.2 22.0 22.3 13.9 22.3 24.2 15.4 14.0 15.4 19.0 10.1 19.9 9.1 11.9 14.1 10.5 11.8 16.4 14.0 16.5 11.9 10.5 12.1 17.3 16.3 17.0 12.1 21.1 20.2 16.0 20.4 14.5 12.4 9.4 14.0 17.4 14.7 11.3 12.0 14.4 17.4 10.9 11.9 36.8 18.0 21.9 20.4 7.0 15.2 22.6 11.9 12.2 10.1 16.7 12.8 14.9 13.2 9.7 4.9 8.0 17.1 9.9 11.4 13.4 6.5 7.6 10.6 10.0 12.4 5.6 5.4 14.7 4.6 10.2 7.5 5.9 15.4 9.7 10.5 35.6 17.6 13.2 12.1 7.4 4.5 9.8 5.9 8.8 8.9 11.1 11.8 14.6 10.7 9.1 14.9 12.7 7.1 4.5 10.1 3.7 15.8 6.3 9.9 4.1 8.7 10.1 8.5 11.4 11.9 13.4 6.5 12.1 9.3 14.4 6.9 9.8 9.1 7.6 5.3 7.3 7.2 12.9 22.2 10.6 8.1 7.3 6.6 16.7 6.6 7.2 11.2 9.6 10.5 10.9 11.5 12.4 10.1 12.2 12.4 10.7 9.3 14.9 12.8 6.7 13.2 9.7 16.3 22.0 22.3 24.2 16.4 14.0 17.3 16.3 20.4 18.0 14.9 22.4 9.9 11.9 15.7 19.1 21.5 5.1 22.7 18.2 10.4 15.7 13.4 14.9 13.6 57.2 18.3 15.5 0.0 10.5 10.2 15.3 15.7 23.1 9.0 7.4 20.6 21.2 11.1 9.2 48.4 17.3 14.3 13.5 19.0 13.7 21.8 11.2 12.4 15.6 11.6 16.9 25.8 17.3 76.5 57.7 18.4 18.0 13.8 11.2 13.1 WDR72 FLJ38736 ENSG00000166415 "WD repeat domain 72" Q3MJ13 15 53513741-53762878 "Disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "kidney: 64.1;thyroid gland: 36.3" "Group enriched" "Detected in some" 5 "Collecting duct cells: 21.0;Hepatocytes: 38.9;Proximal tubular cells: 75.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 8.1;OE19: 14.9;RPMI-8226: 13.9;RPTEC TERT1: 9.1;SuSa: 13.6;U-266/70: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048212, HPA057410, HPA059819" Uncertain Approved Vesicles NA NA Vesicles "HPA048212: AB_2680315, HPA057410: AB_2683430, HPA059819: AB_2684133" "unprognostic (6.39e-4)" "unprognostic (1.41e-1)" "unprognostic (3.19e-2)" "unprognostic (1.79e-2)" "unprognostic (2.63e-2)" "unprognostic (3.37e-2)" "unprognostic (5.54e-2)" "unprognostic (2.20e-1)" "unprognostic (1.13e-1)" "unprognostic (1.26e-1)" "unprognostic (2.78e-2)" "unprognostic (1.09e-2)" "prognostic favorable (3.33e-16)" "unprognostic (2.83e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.80e-4)" "unprognostic (7.67e-2)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 2.7 0.2 0.1 3.0 0.8 0.6 4.9 0.3 0.8 4.6 0.2 0.1 0.1 64.1 13.1 0.8 0.1 0.1 0.1 0.5 1.3 1.5 0.9 0.8 0.1 0.2 0.1 0.3 11.2 0.4 0.1 1.1 0.6 0.1 0.1 0.1 0.2 1.1 0.1 0.1 36.3 0.4 0.5 0.6 0.1 0.2 0.0 0.1 0.0 0.2 0.8 0.1 0.0 8.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 2.6 0.1 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.9 14.9 0.1 0.0 0.1 13.9 9.1 2.9 1.6 0.0 0.0 0.1 0.0 13.6 2.0 0.0 0.1 0.3 0.4 0.0 0.1 6.4 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.5 0.2 0.3 0.5 0.0 0.1 0.3 0.2 0.0 0.2 0.0 0.0 0.8 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 6.0 5.1 0.0 0.8 0.1 0.4 0.4 7.6 0.0 0.0 21.0 0.0 0.3 8.3 1.0 0.9 0.0 0.0 0.0 0.5 1.0 0.2 0.2 0.0 38.9 0.1 3.2 0.0 0.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 75.4 0.0 0.0 0.0 1.1 0.9 0.4 0.1 0.0 0.3 4.9 WNK3 PRKWNK3 ENSG00000196632 "WNK lysine deficient protein kinase 3" Q9BYP7 X 54192823-54358642 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 31.6;testis: 26.7" "Cell type enhanced" "Detected in many" 15 "Cardiomyocytes: 178.0;Spermatogonia: 48.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.9" "Group enriched" "Detected in many" 10 "B-cells: 1.1;T-cells: 1.9" "Cell line enhanced" "Detected in some" "AF22: 5.9;AN3-CA: 4.5;HAP1: 6.8;NTERA-2: 11.9;SiHa: 5.8;SuSa: 5.3;U-2 OS: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077678 Approved Approved Vesicles NA NA Vesicles "HPA077678: AB_2686850" "unprognostic (1.86e-1)" "unprognostic (1.68e-3)" "unprognostic (2.44e-1)" "unprognostic (7.87e-5)" "unprognostic (4.82e-3)" "unprognostic (1.85e-3)" "unprognostic (1.85e-2)" "unprognostic (3.32e-2)" "unprognostic (3.38e-1)" "unprognostic (3.03e-2)" "unprognostic (5.78e-4)" "unprognostic (2.22e-1)" "unprognostic (2.64e-2)" "unprognostic (5.61e-2)" "unprognostic (9.99e-2)" "unprognostic (7.63e-2)" "unprognostic (8.74e-2)" 0.9 5.0 3.9 0.9 4.3 0.8 1.7 3.0 3.6 1.5 0.7 1.7 13.9 1.0 1.3 31.6 1.1 1.8 1.1 1.5 3.9 3.4 2.8 8.7 0.9 1.0 2.3 3.0 5.7 0.9 2.2 14.0 1.2 3.9 2.2 0.7 1.3 1.2 4.8 0.7 0.9 0.7 1.5 3.3 1.0 1.2 26.7 3.5 0.0 1.7 0.0 0.8 1.3 1.9 1.1 0.0 0.1 0.0 0.1 1.9 0.1 0.0 0.0 5.9 4.5 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.5 0.0 6.8 0.1 0.2 0.0 1.2 0.0 0.0 0.1 0.2 0.0 0.2 0.4 0.0 0.2 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 2.8 0.8 0.0 1.2 0.2 1.9 1.8 5.8 0.0 0.7 5.3 0.5 0.0 0.3 0.0 5.2 0.0 1.2 0.0 4.0 0.0 1.6 0.0 2.6 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 1.1 1.9 0.4 0.1 0.1 0.0 0.0 0.0 0.1 3.9 4.3 3.0 3.6 3.9 3.4 2.3 3.0 3.9 3.5 0.0 2.9 0.8 4.6 3.3 24.5 178.0 2.5 0.0 5.7 7.0 13.7 0.2 5.0 1.4 4.2 3.1 0.0 0.0 0.0 0.3 3.1 4.8 5.8 41.5 0.1 33.4 0.0 17.8 0.6 14.6 14.7 0.5 0.0 0.0 0.0 20.7 0.3 0.0 41.1 3.1 40.9 6.5 3.3 30.2 48.2 1.0 0.1 0.0 0.0 1.1 WNT2 "INT1L1, IRP" ENSG00000105989 "Wnt family member 2" P09544 7 117276631-117323289 "Cancer-related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 10.4;lung: 10.9;placenta: 40.9" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 24.8;Fibroblasts: 9.4;Hofbauer cells: 6.8;Ito cells: 11.1;Late spermatids: 7.0;Syncytiotrophoblasts: 7.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "U-2197: 21.6" "Region enhanced" "Detected in many" "basal ganglia: 12.6" "Low region specificity" "Detected in all" HPA020920 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA020920: AB_1858850" "unprognostic (1.90e-1)" "unprognostic (6.97e-2)" "unprognostic (2.88e-2)" "unprognostic (4.11e-3)" "unprognostic (9.14e-2)" "unprognostic (2.47e-1)" "unprognostic (2.54e-2)" "unprognostic (2.75e-1)" "unprognostic (2.74e-1)" "unprognostic (5.70e-2)" "unprognostic (1.36e-2)" "unprognostic (1.41e-1)" "unprognostic (3.43e-1)" "unprognostic (4.05e-2)" "unprognostic (2.50e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-1)" 1.8 0.0 0.2 0.1 1.1 0.0 1.4 0.3 2.3 3.0 0.2 0.4 0.4 0.0 10.4 2.7 0.4 1.0 0.2 0.7 0.9 0.9 0.3 0.8 10.9 0.0 0.1 0.5 0.8 0.1 0.0 0.2 40.9 0.5 7.6 0.0 0.9 0.1 0.5 0.0 1.1 0.2 1.2 0.2 1.5 0.1 0.7 0.0 0.0 0.2 0.0 0.1 1.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 2.1 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.3 2.3 0.9 0.9 0.1 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 2.3 0.0 0.0 3.8 0.0 0.0 24.8 0.4 0.0 0.0 0.0 2.9 9.4 0.2 0.0 0.0 6.8 0.0 0.0 11.1 1.0 7.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.0 0.0 0.3 1.6 0.1 2.4 7.6 0.0 0.0 0.1 WNT3 "INT4, MGC131950, MGC138321, MGC138323" ENSG00000108379 "Wnt family member 3" P56703 17 46762506-46833154 "Disease related genes, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" Proto-oncogene "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "liver: 7.8;skin 1: 17.2" "Group enriched" "Detected in some" 4 "Basal keratinocytes: 39.5;Early spermatids: 27.0;Late spermatids: 45.9;Suprabasal keratinocytes: 15.4" "Cancer enriched" "Detected in many" 6 "testis cancer: 13.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 10.3;U-698: 11.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA066281 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA066281: AB_2685647" "unprognostic (1.84e-1)" "unprognostic (2.90e-2)" "unprognostic (2.35e-1)" "unprognostic (6.41e-4)" "unprognostic (4.73e-2)" "unprognostic (5.26e-2)" "unprognostic (1.33e-1)" "unprognostic (1.26e-1)" "unprognostic (4.97e-2)" "unprognostic (2.20e-2)" "unprognostic (2.16e-1)" "unprognostic (2.66e-1)" "unprognostic (1.10e-8)" "unprognostic (1.77e-1)" "unprognostic (2.08e-1)" "unprognostic (1.61e-1)" "unprognostic (1.38e-1)" 0.5 0.6 1.0 0.6 3.9 0.4 0.4 1.4 4.7 0.2 0.2 3.8 0.1 4.7 0.3 0.4 0.6 0.4 0.4 0.6 1.4 2.9 0.6 7.8 0.3 2.9 2.1 3.5 0.6 0.3 6.0 0.9 0.7 4.1 0.8 0.6 0.1 1.2 0.3 0.5 17.2 1.4 0.5 1.6 0.5 0.4 2.4 2.3 0.1 0.6 1.4 0.5 0.2 0.3 1.0 1.4 0.2 0.3 0.0 1.2 0.1 2.6 0.0 10.3 0.0 0.0 0.0 0.9 0.8 0.6 1.8 0.0 2.6 2.0 1.9 1.1 0.4 2.0 1.2 0.4 0.0 2.3 0.0 0.2 0.0 0.5 2.3 0.0 0.0 0.3 0.0 1.4 0.3 0.6 1.7 0.5 0.2 1.6 0.0 0.3 0.4 0.0 1.6 0.1 1.0 1.2 1.1 1.9 0.1 0.1 0.0 0.2 0.7 1.4 0.0 0.5 0.8 0.0 2.5 0.0 3.2 1.4 0.5 0.7 0.3 0.2 11.3 0.5 0.0 1.0 0.2 0.1 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.4 0.1 0.3 0.0 0.0 0.3 1.4 1.2 0.1 1.0 3.9 1.4 4.7 1.4 2.9 2.1 3.5 4.1 2.3 0.0 1.0 0.0 0.5 39.5 1.1 0.9 0.0 0.0 0.0 0.0 0.0 1.8 1.7 0.7 27.0 0.1 1.0 0.0 2.1 0.1 0.9 1.1 0.0 3.9 0.2 7.9 0.0 0.0 0.0 45.9 0.3 0.0 1.7 1.0 0.5 0.2 1.9 0.6 0.4 0.3 0.6 0.0 0.6 0.4 1.1 15.4 0.2 0.0 0.6 0.3 WNT3A ENSG00000154342 "Wnt family member 3A" P56704 1 228007051-228061260 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "lung: 7.4;placenta: 19.9" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 1: 11.9;Basal glandular cells: 2.4;Basal keratinocytes: 3.1;Syncytiotrophoblasts: 2.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "HEK 293: 2.8;U-2 OS: 9.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA066281 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA066281: AB_2685647" "unprognostic (9.84e-3)" "prognostic favorable (6.11e-5)" "unprognostic (2.40e-1)" "unprognostic (3.37e-1)" "unprognostic (7.82e-2)" "unprognostic (4.94e-2)" "unprognostic (2.19e-1)" "unprognostic (1.96e-1)" "unprognostic (4.22e-2)" "unprognostic (4.12e-2)" "unprognostic (2.16e-1)" "unprognostic (4.80e-3)" "unprognostic (1.99e-1)" "unprognostic (7.26e-2)" "unprognostic (5.43e-3)" "unprognostic (1.54e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.6 0.1 0.1 0.1 0.0 0.1 0.1 2.0 0.2 0.1 0.1 0.1 0.0 0.2 0.1 7.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 19.9 0.1 2.4 0.0 0.1 1.7 0.1 0.1 3.0 0.1 0.1 0.6 0.1 0.0 1.0 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.0 2.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.1 0.1 0.1 11.9 0.0 0.0 2.4 3.1 0.0 1.4 0.0 0.0 1.2 1.8 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.9 2.4 0.0 0.0 0.5 WNT4 WNT-4 ENSG00000162552 "Wnt family member 4" P56705 1 22117305-22143969 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 34.3;skin 1: 28.6" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 14.8;Intestinal endocrine cells: 28.3;Mucus-secreting cells: 10.2;Suprabasal keratinocytes: 9.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "eosinophil: 2.8" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.8" "Cell line enhanced" "Detected in some" "HaCaT: 10.2;SCLC-21H: 12.5;SK-BR-3: 10.6;T-47d: 4.2" "Low region specificity" "Detected in many" HPA011397 Uncertain Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA011397: AB_1858854" "unprognostic (1.85e-1)" "unprognostic (9.08e-2)" "unprognostic (6.67e-3)" "unprognostic (1.75e-2)" "unprognostic (7.17e-2)" "unprognostic (4.30e-3)" "unprognostic (2.77e-2)" "unprognostic (2.15e-1)" "prognostic unfavorable (5.34e-4)" "unprognostic (2.14e-2)" "prognostic favorable (4.90e-4)" "unprognostic (1.01e-1)" "unprognostic (2.95e-2)" "unprognostic (4.21e-1)" "unprognostic (2.32e-1)" "unprognostic (4.74e-2)" "unprognostic (9.49e-2)" 0.5 6.5 1.0 0.3 1.0 0.0 1.4 0.6 1.7 4.3 1.7 1.1 1.0 2.0 3.1 6.6 6.9 6.4 6.4 0.6 1.5 3.1 1.1 1.2 1.4 0.3 1.0 1.7 34.3 1.9 0.0 3.7 11.8 1.7 7.7 1.0 1.7 3.0 1.8 2.7 28.6 4.1 1.2 1.5 0.3 2.8 0.9 0.8 1.4 2.2 5.4 2.8 2.0 3.5 0.0 0.0 2.8 0.0 0.0 0.4 0.0 1.5 0.1 3.1 0.1 0.1 0.0 2.7 0.6 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.1 0.3 10.2 0.0 0.8 0.0 0.3 0.3 0.3 0.3 0.0 0.2 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.1 1.4 0.2 0.4 0.0 0.0 0.0 1.9 12.5 0.0 0.1 10.6 0.7 0.8 4.2 0.0 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.0 1.0 0.6 1.7 1.5 3.1 1.0 1.7 1.7 0.8 3.0 7.5 0.0 3.4 14.8 0.0 0.6 0.0 2.7 6.8 0.0 0.0 0.6 0.0 2.2 0.0 0.0 0.3 0.0 0.5 0.1 0.9 3.8 0.0 0.4 0.1 0.0 28.3 1.3 0.0 0.0 0.0 0.0 5.0 0.0 10.2 0.0 0.9 0.0 3.5 0.0 0.0 0.0 0.2 0.0 0.0 9.2 0.2 0.0 0.5 2.6 WNT5B ENSG00000111186 "Wnt family member 5B" Q9H1J7 12 1529891-1647243 "Predicted secreted proteins" "Wnt signaling pathway" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 14 "Muller glia cells: 42.4;Urothelial cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 8 "classical monocyte: 4.6;eosinophil: 3.5;intermediate monocyte: 2.1;myeloid DC: 2.1" "Group enriched" "Detected in many" 13 "dendritic cells: 2.1;granulocytes: 3.5;monocytes: 4.6" "Cell line enhanced" "Detected in many" "BJ: 51.9;BJ hTERT+: 32.6;BJ hTERT+ SV40 Large T+: 38.0;BJ hTERT+ SV40 Large T+ RasG12V: 31.6;fHDF/TERT166: 36.2;HBF TERT88: 33.4;hTEC/SVTERT24-B: 33.2;U-138 MG: 33.0" "Low region specificity" "Detected in many" HPA061991 Approved Vesicles "Secreted to extracellular matrix" NA NA Vesicles "HPA061991: " "unprognostic (7.44e-2)" "unprognostic (5.59e-2)" "unprognostic (8.14e-2)" "unprognostic (3.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.45e-1)" "unprognostic (5.53e-3)" "unprognostic (1.26e-1)" "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (4.08e-2)" "unprognostic (2.16e-2)" "unprognostic (1.49e-3)" "unprognostic (1.90e-1)" "unprognostic (2.93e-2)" "unprognostic (2.77e-1)" "unprognostic (2.71e-2)" 4.1 1.7 1.6 6.5 3.4 0.1 4.1 1.0 1.7 8.0 14.1 1.3 19.4 3.0 6.3 6.2 11.9 4.8 3.6 2.9 1.4 3.0 2.7 3.3 2.7 4.0 1.8 0.5 5.3 0.7 13.6 7.1 2.7 2.3 23.4 4.4 5.8 14.2 16.5 0.7 3.4 5.2 17.8 1.4 4.3 4.0 1.7 1.0 2.9 1.2 5.1 5.0 23.3 14.3 0.0 2.1 3.5 4.6 0.0 0.2 1.3 0.0 0.0 0.3 0.0 8.1 14.4 0.0 51.9 32.6 38.0 31.6 1.9 0.2 0.6 0.1 36.2 25.6 0.7 0.7 0.0 33.4 12.0 1.7 2.8 0.0 0.0 2.0 0.0 0.0 12.0 0.7 33.2 9.5 15.4 0.0 0.0 2.0 11.8 8.9 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.5 0.8 0.4 0.0 0.2 0.7 1.1 0.1 0.0 4.2 0.0 0.2 0.0 33.0 1.3 12.9 26.4 3.2 0.4 0.1 3.2 0.0 0.3 0.0 4.6 3.5 0.0 2.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 1.3 1.6 3.4 1.0 1.7 1.4 3.0 1.8 0.5 2.3 1.0 0.0 1.1 0.0 10.4 0.8 1.1 1.6 0.0 4.0 3.4 0.0 0.0 0.8 0.0 0.8 0.1 0.5 1.0 0.0 0.6 0.7 3.3 9.8 0.0 1.5 4.1 0.0 0.0 0.6 1.9 0.2 2.0 1.3 3.3 5.4 2.2 42.4 1.7 4.8 2.5 0.0 2.8 6.5 2.3 0.5 5.3 1.1 0.6 0.0 1.9 15.0 XKR4 KIAA1889 ENSG00000206579 "XK related 4" Q5GH76 8 55102389-55542054 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.7" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 2: 25.5;Club cells: 17.0;Cone photoreceptor cells: 33.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "REH: 3.7;RPTEC TERT1: 15.0" "Low region specificity" "Detected in all" "HPA025072, HPA028083" Uncertain Approved Vesicles NA NA Vesicles "HPA025072: AB_1858886, HPA028083: AB_10601025" "unprognostic (7.15e-4)" "unprognostic (1.28e-3)" "unprognostic (6.98e-2)" "unprognostic (5.63e-3)" "unprognostic (7.39e-2)" "unprognostic (5.68e-3)" "unprognostic (6.33e-2)" "unprognostic (5.14e-2)" "unprognostic (1.88e-1)" "unprognostic (2.63e-1)" "unprognostic (2.38e-3)" "unprognostic (6.63e-2)" "unprognostic (3.46e-4)" "unprognostic (2.08e-2)" "unprognostic (2.39e-2)" "unprognostic (7.36e-2)" "unprognostic (4.96e-2)" 1.2 1.4 18.7 4.3 5.6 0.8 0.7 4.4 12.1 2.1 5.1 0.6 0.3 1.5 1.0 1.4 2.5 1.1 1.4 2.6 8.6 4.5 0.9 0.7 0.7 2.0 2.0 8.8 0.9 1.1 0.5 5.3 0.6 2.0 1.2 2.2 2.5 2.0 2.9 0.8 1.4 2.0 3.5 1.2 0.9 1.5 0.9 3.4 0.6 0.7 0.6 2.3 1.0 1.6 0.8 0.3 2.2 0.2 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 3.7 0.0 0.0 15.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.2 0.3 0.2 0.1 0.1 0.6 0.2 0.1 0.0 0.8 0.2 0.3 1.2 0.7 0.1 0.3 0.1 0.1 18.7 5.6 4.4 11.5 8.6 4.5 2.0 8.8 2.0 3.4 8.9 25.5 0.0 0.5 0.3 6.5 1.4 0.0 9.4 17.0 3.5 33.4 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.1 0.7 0.5 0.0 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 1.1 8.5 2.8 0.0 0.6 0.7 0.0 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.6 0.1 0.0 0.0 0.7 YIPF6 "FinGER6, MGC21416" ENSG00000181704 "Yip1 domain family member 6" Q96EC8 X 68498323-68537285 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Syncytiotrophoblasts: 233.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003720 Uncertain Approved Vesicles NA NA Vesicles "HPA003720: AB_1080626" "unprognostic (5.07e-3)" "unprognostic (2.13e-1)" "unprognostic (1.53e-1)" "unprognostic (1.72e-1)" "unprognostic (7.17e-2)" "unprognostic (5.90e-3)" "unprognostic (1.64e-1)" "unprognostic (1.28e-1)" "unprognostic (1.75e-1)" "unprognostic (2.15e-1)" "unprognostic (1.33e-2)" "unprognostic (3.15e-1)" "unprognostic (8.85e-3)" "unprognostic (8.48e-2)" "unprognostic (2.90e-2)" "unprognostic (3.25e-1)" "unprognostic (6.32e-2)" 13.3 15.6 16.5 7.2 17.7 4.9 15.8 12.9 17.1 16.0 12.3 17.3 11.6 11.5 14.0 16.2 13.6 13.7 11.2 11.9 14.9 14.4 19.6 28.3 12.7 6.2 17.6 13.1 11.5 26.8 18.0 32.9 32.4 16.1 21.1 14.6 11.7 16.0 16.1 18.1 10.9 14.4 16.9 17.1 8.8 14.9 6.9 15.3 4.3 22.4 7.4 10.9 13.4 11.4 4.0 3.8 12.4 4.6 3.1 2.7 3.1 11.5 9.5 12.2 4.0 16.9 10.7 11.6 9.4 12.1 7.5 9.5 9.7 12.4 0.1 16.4 8.2 11.6 9.4 16.0 6.6 13.2 3.4 9.4 4.7 11.2 9.3 15.3 5.6 7.6 10.2 12.7 11.0 14.5 13.7 7.6 6.6 7.8 10.8 10.8 10.2 3.3 5.0 12.9 18.1 12.2 3.2 14.9 6.5 13.3 11.3 12.8 14.1 15.0 11.2 11.2 11.9 7.0 5.7 9.1 7.5 6.6 27.4 17.6 6.3 7.5 2.5 13.0 8.9 13.3 5.4 4.6 5.2 2.7 4.6 1.8 4.0 2.7 2.3 3.3 2.5 2.7 2.4 12.4 3.1 4.2 3.8 2.6 3.1 16.5 17.7 12.9 15.6 14.9 14.4 17.6 13.1 16.1 15.3 65.5 102.0 29.5 53.1 31.0 52.2 31.9 35.7 56.2 60.3 54.1 45.2 87.0 29.9 37.4 20.1 38.0 36.0 23.3 38.3 78.0 44.1 79.2 51.0 53.4 38.8 42.9 52.2 41.1 19.9 45.3 39.4 40.2 33.7 17.2 48.8 63.4 44.2 31.6 44.6 57.6 50.2 25.8 43.8 21.3 29.6 37.9 233.2 30.6 31.6 72.1 ZBTB39 "KIAA0352, ZNF922" ENSG00000166860 "Zinc finger and BTB domain containing 39" O15060 12 56998834-57006446 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 19.2;Horizontal cells: 20.6;Spermatogonia: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016866, HPA020306" Uncertain Approved Vesicles NA NA Vesicles "HPA016866: AB_2669470, HPA020306: AB_2670406" "unprognostic (2.06e-2)" "unprognostic (1.61e-1)" "unprognostic (8.92e-2)" "unprognostic (2.90e-2)" "unprognostic (3.07e-1)" "unprognostic (2.68e-2)" "unprognostic (4.10e-3)" "unprognostic (1.69e-1)" "unprognostic (1.70e-2)" "unprognostic (1.59e-1)" "unprognostic (1.22e-3)" "unprognostic (1.76e-1)" "unprognostic (2.34e-1)" "unprognostic (5.74e-2)" "unprognostic (3.46e-1)" "unprognostic (2.54e-2)" "unprognostic (7.00e-2)" 5.5 5.2 6.9 8.5 9.0 10.5 9.6 9.9 10.1 6.0 6.7 11.9 5.5 4.7 9.0 5.9 6.6 7.7 4.5 4.8 6.2 4.8 5.2 9.5 6.3 7.8 7.1 6.7 10.1 8.8 8.4 4.0 8.0 6.9 6.1 5.3 6.5 6.5 7.9 6.0 6.5 8.3 8.2 8.1 12.5 7.5 18.0 7.8 6.4 6.0 5.3 8.9 7.1 6.1 1.8 2.1 2.9 1.3 2.5 2.7 0.9 2.2 3.7 10.5 5.3 2.4 2.6 6.9 2.2 2.7 3.6 2.6 3.8 1.6 7.2 2.9 2.2 2.3 3.0 8.0 3.4 3.5 3.3 5.6 7.9 2.2 3.0 2.2 6.0 6.6 1.9 3.3 2.8 4.6 3.9 4.1 8.2 9.8 6.6 2.6 2.6 8.8 5.1 10.4 2.3 3.1 8.5 32.2 3.4 1.6 4.5 5.2 6.7 3.1 4.1 3.1 10.2 3.4 6.7 3.2 3.0 6.6 1.4 2.7 8.6 5.6 7.7 1.9 3.4 1.8 2.9 1.3 0.0 1.9 0.9 1.9 1.5 1.9 2.6 1.5 1.8 1.4 2.7 0.0 2.5 0.3 2.1 0.6 0.9 6.9 9.0 9.9 10.1 6.2 4.8 7.1 6.7 6.9 7.8 0.0 1.1 0.9 1.6 1.3 9.6 2.8 5.1 4.0 2.3 0.0 15.7 2.3 0.0 1.4 19.2 3.4 0.8 0.0 1.5 1.5 1.8 2.7 1.1 2.4 1.6 20.6 1.2 8.0 2.7 12.4 1.7 1.8 1.7 3.6 2.2 2.0 2.2 1.9 5.3 1.1 7.4 6.5 0.4 11.6 17.4 1.4 1.8 2.6 2.3 1.0 ZC3H10 "FLJ14451, ZC3HDC10" ENSG00000135482 "Zinc finger CCCH-type containing 10" Q96K80 12 56118159-56127514 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 36.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039236, HPA062265" Uncertain Approved Vesicles NA NA Vesicles "HPA039236: AB_10795463, HPA062265: AB_2684730" "unprognostic (1.19e-1)" "unprognostic (1.53e-1)" "unprognostic (2.97e-1)" "unprognostic (7.39e-2)" "unprognostic (2.27e-1)" "unprognostic (3.35e-2)" "unprognostic (2.95e-2)" "unprognostic (1.53e-2)" "unprognostic (2.07e-2)" "unprognostic (2.80e-1)" "unprognostic (1.31e-5)" "unprognostic (4.42e-2)" "unprognostic (2.69e-2)" "unprognostic (6.45e-2)" "unprognostic (1.40e-1)" "unprognostic (2.58e-2)" "unprognostic (1.21e-1)" 11.3 10.1 7.9 9.0 11.8 4.1 8.6 11.2 10.4 10.9 10.4 12.9 6.5 5.4 13.2 7.3 7.1 8.9 8.9 7.7 7.3 4.7 7.9 8.1 7.7 8.3 11.1 5.9 13.3 11.2 8.2 9.4 7.9 9.2 13.5 4.6 9.0 8.7 9.8 13.6 7.7 7.0 7.4 6.8 11.5 7.7 24.6 12.0 13.3 10.0 5.2 7.2 10.5 9.7 6.2 7.1 7.6 12.7 10.9 7.1 4.7 4.5 8.1 6.4 5.1 8.0 5.4 5.0 5.5 3.6 3.3 2.6 2.1 2.7 4.8 9.0 3.9 1.8 6.1 3.3 1.9 2.1 8.6 8.5 7.4 7.6 2.3 4.8 6.6 4.7 3.4 4.4 3.8 4.4 6.1 4.9 5.8 3.8 9.2 4.3 2.8 7.5 2.9 4.4 2.6 6.7 7.5 6.9 4.5 2.8 2.2 6.3 6.1 3.1 4.8 4.9 5.1 7.8 6.1 7.0 3.1 7.3 6.1 4.0 7.7 4.8 2.8 4.1 3.3 7.6 3.6 7.0 7.6 6.9 7.9 7.1 5.2 5.5 5.9 7.1 6.2 5.4 5.3 4.9 10.9 12.7 3.3 2.7 4.7 7.9 11.8 11.2 10.4 7.3 4.7 11.1 5.9 9.2 12.0 0.0 3.4 6.0 2.5 0.7 8.2 2.4 5.1 4.0 0.0 7.0 19.6 5.1 13.3 4.1 36.2 3.2 4.2 0.0 2.6 2.4 3.1 1.9 2.3 2.4 4.6 12.7 1.2 6.2 5.1 9.8 4.9 2.9 3.3 9.0 2.3 9.7 2.8 2.8 4.9 3.5 15.5 0.0 4.7 15.0 11.6 1.5 5.4 2.5 1.9 1.2 ZCCHC18 "PNMA7B, SIZN2" ENSG00000166707 "Zinc finger CCHC-type containing 18" P0CG32 X 104112131-104115846 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "brain: 9.6;ovary: 9.4" "Cell type enhanced" "Detected in some" 8 "Intestinal endocrine cells: 4.1;Muller glia cells: 3.2;Sertoli cells: 6.5;T-cells: 6.1" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 19 "B-cells: 3.0;T-cells: 2.2" "Cell line enhanced" "Detected in some" "Daudi: 4.6;Karpas-707: 8.6;SH-SY5Y: 5.8" "Low region specificity" "Detected in all" "HPA034940, HPA078516" Uncertain Approved Vesicles NA NA Vesicles "HPA034940: AB_10671098, HPA078516: " "unprognostic (7.20e-2)" "unprognostic (7.71e-4)" "unprognostic (8.29e-2)" "unprognostic (4.21e-2)" "unprognostic (1.04e-1)" "unprognostic (1.89e-3)" "unprognostic (2.20e-2)" "unprognostic (3.22e-2)" "unprognostic (7.59e-2)" "unprognostic (3.34e-1)" "unprognostic (4.44e-6)" "unprognostic (4.05e-2)" "unprognostic (1.02e-6)" "unprognostic (3.82e-2)" "unprognostic (4.02e-1)" "unprognostic (3.91e-2)" "unprognostic (4.14e-3)" 0.9 2.3 3.4 3.3 9.4 1.1 2.6 9.6 9.2 1.7 0.9 1.2 0.5 1.1 3.6 1.1 1.0 1.6 1.4 1.2 3.1 7.7 0.5 0.3 1.0 4.9 3.8 4.9 9.4 2.6 0.3 2.3 0.7 4.7 1.5 1.1 1.2 0.5 1.8 1.0 0.5 2.6 1.9 2.5 3.4 1.4 2.2 2.2 0.0 0.4 0.2 5.1 2.0 1.1 3.0 0.0 0.0 0.0 0.1 2.2 0.3 0.0 0.2 3.5 2.5 0.3 0.0 0.2 0.7 0.1 0.6 0.6 0.1 0.0 4.6 0.1 0.2 0.8 0.0 2.1 0.0 0.3 1.3 1.7 0.8 0.2 0.0 0.4 2.6 0.8 0.2 0.0 0.4 0.0 2.1 0.7 0.3 0.0 8.6 0.2 0.0 0.0 0.1 2.0 0.0 0.6 3.1 0.9 0.0 0.5 0.3 2.5 5.8 0.2 0.0 0.0 0.4 0.0 0.3 1.6 0.2 1.1 0.2 1.0 0.2 0.0 2.2 0.1 2.5 0.7 0.0 0.0 0.0 1.4 0.0 2.2 2.5 1.1 1.7 0.0 3.0 1.2 1.6 0.0 0.1 0.0 0.0 0.8 0.3 3.4 9.4 9.6 7.2 3.1 7.7 3.8 4.9 4.7 2.2 0.0 1.1 0.0 0.1 0.1 0.6 0.6 0.0 2.7 2.3 1.8 0.0 0.0 0.0 0.2 0.1 1.0 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.0 0.0 1.6 4.1 0.0 0.3 0.0 1.4 0.0 1.7 0.0 0.0 3.2 0.0 0.0 1.1 0.1 0.8 6.5 2.1 0.0 0.2 0.0 0.0 6.1 0.0 0.0 ZCCHC3 "C20orf99, dJ1103G7.7" ENSG00000247315 "Zinc finger CCHC-type containing 3" Q9NUD5 20 296968-300321 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042972 Approved Vesicles NA NA Vesicles "HPA042972: AB_10959663" "unprognostic (5.98e-3)" "unprognostic (1.38e-1)" "unprognostic (1.26e-2)" "unprognostic (1.01e-3)" "unprognostic (2.13e-1)" "unprognostic (3.04e-1)" "unprognostic (1.30e-2)" "unprognostic (1.90e-1)" "unprognostic (3.29e-1)" "unprognostic (6.55e-2)" "prognostic favorable (1.29e-4)" "unprognostic (4.30e-1)" "unprognostic (3.34e-3)" "unprognostic (6.33e-2)" "unprognostic (1.88e-1)" "unprognostic (3.67e-1)" "unprognostic (1.74e-2)" 1.5 2.1 1.8 3.1 1.1 1.2 2.1 1.2 1.5 2.0 2.5 0.6 2.6 1.0 1.4 1.4 1.4 1.1 3.3 4.4 1.8 1.5 4.5 1.5 0.9 1.2 2.0 1.2 0.4 1.4 1.0 2.7 1.6 1.4 1.3 3.1 0.9 4.5 4.8 6.1 2.9 2.1 3.7 1.6 8.4 6.6 20.8 10.3 6.8 7.0 12.3 5.3 5.8 5.9 6.1 10.0 5.0 7.6 3.5 3.3 6.2 11.7 10.5 5.9 5.6 4.1 9.7 15.5 3.1 31.3 7.9 17.6 4.3 6.7 7.0 3.6 4.3 6.2 9.4 8.8 19.1 7.8 4.5 3.7 13.4 21.7 18.5 8.2 7.0 19.8 9.9 9.8 5.2 5.4 8.8 12.8 6.3 12.8 16.1 9.3 5.9 33.1 4.1 6.1 6.1 2.4 6.3 14.4 18.3 15.0 2.2 11.5 5.9 6.1 2.9 4.5 3.4 1.4 3.3 3.2 3.0 2.9 2.0 4.5 3.7 3.5 0.8 2.1 1.3 4.8 2.7 1.6 0.0 7.8 13.0 19.4 14.1 26.8 7.0 20.4 8.1 5.7 8.7 7.9 19.5 3.3 5.8 0.4 13.4 10.7 0.0 4.7 10.9 14.8 13.5 0.0 9.2 9.1 35.0 20.2 18.4 10.5 0.0 16.1 6.7 11.8 2.8 14.5 17.7 4.9 10.5 9.9 5.7 20.6 6.5 7.3 3.9 9.7 5.0 17.3 7.5 12.4 14.0 ZNF37A "KOX21, ZNF37" ENSG00000075407 "Zinc finger protein 37A" P17032 10 38094334-38150293 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA003172 Approved Approved Vesicles NA NA Vesicles "HPA003172: AB_1080709" "unprognostic (8.64e-2)" "unprognostic (1.24e-1)" "unprognostic (3.22e-1)" "unprognostic (6.87e-2)" "unprognostic (1.17e-2)" "unprognostic (2.31e-2)" "prognostic unfavorable (2.83e-4)" "unprognostic (7.65e-3)" "unprognostic (2.47e-1)" "unprognostic (3.54e-2)" "unprognostic (1.02e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (2.31e-4)" "unprognostic (4.39e-2)" "unprognostic (1.29e-1)" "unprognostic (3.43e-2)" "unprognostic (3.09e-2)" 8.2 10.1 11.9 9.9 15.3 4.9 9.9 23.2 13.9 11.8 9.9 11.0 6.6 8.0 12.5 10.5 6.9 10.1 8.7 7.8 11.5 9.9 10.4 9.1 10.2 9.2 16.3 10.7 13.5 16.7 20.0 25.0 8.2 12.8 10.3 8.5 9.0 12.7 15.4 6.7 10.7 9.0 16.3 12.0 9.7 10.1 4.1 16.2 8.2 14.0 3.9 9.8 8.5 8.4 5.6 2.9 2.5 4.7 6.4 5.4 1.7 11.7 6.1 5.4 10.2 8.3 8.2 5.9 9.1 3.4 4.2 5.7 4.8 3.5 17.3 2.8 5.0 5.8 4.8 10.1 7.6 6.6 11.1 9.6 17.4 6.9 6.8 7.2 18.2 11.3 6.2 12.8 7.2 6.1 8.5 5.5 8.3 11.3 12.3 9.0 2.7 10.2 2.8 4.8 4.1 10.0 7.4 14.8 3.5 4.5 4.6 4.4 7.6 6.3 5.1 5.1 6.0 9.3 5.7 9.4 8.0 8.6 7.6 8.7 13.9 14.9 6.8 5.3 13.1 5.0 2.5 2.4 2.2 3.9 1.9 5.1 3.5 4.5 3.9 2.3 5.6 5.4 4.5 2.0 6.4 4.7 2.9 2.4 1.7 11.9 15.3 23.2 13.9 11.5 9.9 16.3 10.7 12.8 16.2 23.8 35.8 21.7 11.7 7.2 60.7 27.9 2.5 13.4 25.0 10.4 51.1 8.7 1.7 15.7 2.6 20.2 5.6 0.0 10.3 5.5 13.1 13.0 39.3 9.3 6.2 39.7 40.2 22.1 10.2 1.1 26.2 10.8 5.0 9.0 9.8 28.9 11.0 7.0 26.5 6.3 50.9 12.9 18.4 18.0 12.4 5.3 3.2 16.6 13.3 8.1 ZNF469 KIAA1858 ENSG00000225614 "Zinc finger protein 469" Q96JG9 16 88427471-88440757 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 8 "Cardiomyocytes: 5.0;Ito cells: 3.7;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.5" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.5" "Cell line enhanced" "Detected in many" "A549: 5.7;BJ hTERT+: 6.3;HeLa: 5.6;SiHa: 6.7;THP-1: 8.6" "Low region specificity" "Detected in many" HPA069784 Approved Vesicles NA NA Vesicles "HPA069784: AB_2686196" "unprognostic (1.80e-1)" "unprognostic (7.79e-3)" "unprognostic (7.71e-2)" "unprognostic (7.01e-2)" "unprognostic (2.97e-1)" "unprognostic (2.30e-1)" "unprognostic (9.17e-3)" "unprognostic (7.08e-3)" "unprognostic (5.04e-2)" "unprognostic (5.02e-2)" "unprognostic (6.92e-2)" "unprognostic (1.01e-1)" "unprognostic (8.71e-7)" "unprognostic (2.24e-2)" "unprognostic (1.83e-2)" "unprognostic (2.20e-2)" "unprognostic (3.34e-2)" 1.8 0.8 2.5 2.3 2.2 0.1 0.7 0.0 2.2 4.3 0.2 0.4 2.9 0.0 0.2 1.3 2.6 0.4 2.5 1.6 0.0 0.1 0.5 1.3 1.6 4.3 0.8 0.0 0.0 0.5 1.3 0.0 0.6 0.8 1.5 0.2 0.8 2.1 1.6 1.9 0.9 0.3 0.0 0.5 1.7 0.4 0.1 1.5 0.0 0.3 0.0 0.2 0.0 0.0 5.7 0.2 0.0 0.9 1.3 0.0 3.6 6.3 0.8 0.1 0.0 0.2 0.0 0.1 4.8 1.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 5.6 0.0 4.1 0.2 0.1 1.4 0.0 1.4 0.0 1.0 3.7 0.0 0.0 0.0 1.0 0.5 0.0 0.9 0.7 0.1 4.7 0.4 0.0 0.0 0.0 0.0 0.0 2.9 6.7 0.0 0.0 0.1 1.2 8.6 4.5 5.1 1.3 2.8 0.9 0.0 0.0 0.0 0.0 1.2 0.5 0.0 0.0 0.0 0.1 0.3 0.2 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 2.6 0.0 0.5 0.2 0.0 5.0 0.0 1.4 2.3 0.0 0.0 0.0 0.0 1.9 0.2 0.4 0.0 0.0 0.0 0.0 3.0 0.3 0.0 0.0 2.5 3.2 0.0 3.7 0.3 0.0 0.0 1.3 0.0 1.0 0.0 0.3 0.5 0.0 1.4 0.0 0.0 6.5 3.1 0.0 0.2 0.1 0.1 0.0 0.0 0.3 ZNF530 KIAA1508 ENSG00000183647 "Zinc finger protein 530" Q6P9A1 19 57599885-57612722 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 7.3;Sertoli cells: 6.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HEK 293: 37.8;U-266/84: 27.5" HPA045868 Uncertain Approved Vesicles NA NA Vesicles "HPA045868: AB_2679478" "unprognostic (1.57e-1)" "unprognostic (3.02e-3)" "unprognostic (5.65e-2)" "unprognostic (2.90e-2)" "unprognostic (3.58e-2)" "unprognostic (1.06e-1)" "unprognostic (1.54e-2)" "unprognostic (6.80e-2)" "unprognostic (9.69e-3)" "unprognostic (4.98e-3)" "unprognostic (3.19e-2)" "unprognostic (7.84e-3)" "unprognostic (1.47e-1)" "unprognostic (1.70e-1)" "unprognostic (3.11e-1)" "unprognostic (1.86e-2)" "unprognostic (1.06e-1)" 3.2 3.5 6.3 4.7 6.9 7.0 4.4 12.4 7.1 2.5 2.6 2.6 1.4 2.7 2.9 5.3 2.3 2.0 3.1 11.0 5.1 4.4 3.2 2.3 4.6 7.6 5.8 4.0 2.4 4.1 3.2 2.0 3.4 3.3 4.0 2.3 4.5 3.7 3.9 14.6 4.7 2.6 2.1 4.1 5.4 4.6 3.6 3.5 7.2 2.5 2.7 5.6 3.6 2.5 6.5 3.6 3.5 3.1 5.6 6.5 3.4 3.2 3.0 2.2 1.8 0.1 1.0 3.4 2.0 0.8 3.4 2.0 2.1 0.5 0.4 1.7 0.7 2.1 1.1 1.8 1.5 3.7 0.1 37.8 6.5 5.5 1.2 0.3 2.3 3.1 0.7 0.8 3.2 0.9 1.0 0.7 2.4 0.8 1.6 1.1 1.2 3.3 1.8 3.3 0.2 7.2 0.4 6.9 3.2 0.6 5.6 2.5 2.3 2.4 0.6 0.6 2.0 1.5 3.7 1.0 4.4 2.7 0.9 4.1 7.5 27.5 4.5 2.7 2.6 3.0 1.9 3.1 1.8 6.3 1.9 5.0 6.5 4.3 6.5 3.6 5.8 5.9 4.8 3.5 5.6 2.1 3.5 5.6 3.4 6.3 6.9 12.4 7.1 5.1 4.4 5.8 4.0 3.3 3.5 6.0 1.0 0.0 0.5 1.5 2.9 7.3 2.5 0.0 0.0 0.0 0.0 1.4 1.7 1.7 0.2 2.2 0.4 0.0 2.5 1.1 1.2 1.2 2.3 0.6 1.6 0.0 0.0 1.3 0.3 0.0 0.9 1.1 5.0 1.0 0.0 5.8 1.0 1.1 1.4 0.5 4.3 6.5 1.4 2.3 2.9 1.5 1.1 1.5 0.8 0.8 ZNF563 FLJ34797 ENSG00000188868 "Zinc finger protein 563" Q8TA94 19 12317477-12333720 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "Early spermatids: 144.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in all" 5 "B-cells: 5.5;T-cells: 11.6" "Cell line enhanced" "Detected in many" "Hep G2: 12.0" HPA042136 Uncertain Approved Vesicles NA NA Vesicles "HPA042136: AB_10795395" "unprognostic (1.40e-1)" "unprognostic (3.61e-1)" "unprognostic (1.02e-1)" "unprognostic (8.81e-2)" "unprognostic (9.88e-2)" "unprognostic (2.49e-1)" "unprognostic (1.20e-1)" "unprognostic (9.16e-4)" "unprognostic (1.02e-2)" "unprognostic (5.38e-2)" "unprognostic (3.36e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-3)" "unprognostic (9.90e-2)" "unprognostic (2.12e-1)" "unprognostic (1.27e-3)" "unprognostic (1.18e-2)" 4.6 5.4 5.6 7.7 7.9 2.1 6.9 7.5 6.0 5.5 3.7 3.6 6.2 2.5 4.5 6.2 4.7 5.7 4.1 7.3 6.4 2.2 8.7 17.2 3.6 4.6 4.8 4.8 6.4 4.0 4.9 9.3 2.2 5.4 8.5 4.0 3.8 4.9 7.1 3.5 6.8 4.0 4.3 4.6 4.4 3.2 22.6 7.2 6.1 9.1 2.0 5.1 5.8 6.4 5.5 1.7 1.1 1.4 1.6 11.6 2.6 2.4 0.3 0.9 3.5 3.5 2.3 0.3 2.9 5.5 3.5 5.5 3.0 0.9 5.6 3.0 3.6 4.1 2.0 2.8 6.8 3.3 0.1 0.5 0.8 0.5 12.0 3.1 0.5 3.7 3.9 5.0 3.6 2.4 2.7 0.1 3.1 1.1 1.3 3.2 1.6 3.2 1.2 1.5 1.3 2.3 0.2 2.6 0.2 4.0 3.5 0.9 1.6 0.3 0.7 0.4 4.2 2.3 0.3 0.4 5.5 1.1 6.5 1.8 5.7 4.4 0.4 1.1 0.5 2.0 0.7 1.3 0.8 3.4 1.3 2.0 3.8 5.8 3.1 1.6 5.5 11.6 6.5 1.1 1.6 1.4 1.7 4.5 2.6 5.6 7.9 7.5 6.0 6.4 2.2 4.8 4.8 5.4 7.2 3.0 1.7 2.0 1.6 1.1 7.6 5.2 5.1 5.3 2.3 1.8 0.0 0.4 1.7 4.1 144.2 3.4 1.3 0.0 4.4 0.1 1.3 2.1 0.0 6.7 1.9 4.8 0.0 4.3 2.1 17.6 7.2 1.5 5.0 1.8 2.6 14.3 2.5 3.5 5.3 6.3 3.3 12.9 3.1 12.8 4.3 1.8 0.1 2.1 2.6 0.6 ZNF624 KIAA1349 ENSG00000197566 "Zinc finger protein 624" Q9P2J8 17 16620737-16653856 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Horizontal cells: 7.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SuSa: 15.3" "HPA023157, HPA023244" Uncertain Approved Vesicles NA NA Vesicles "HPA023157: AB_2671094, HPA023244: AB_2671117" "unprognostic (2.47e-1)" "unprognostic (8.75e-2)" "unprognostic (3.51e-2)" "unprognostic (3.97e-3)" "unprognostic (1.64e-1)" "unprognostic (3.77e-2)" "unprognostic (1.24e-1)" "unprognostic (2.18e-1)" "unprognostic (1.10e-2)" "unprognostic (4.76e-2)" "unprognostic (1.40e-1)" "unprognostic (1.62e-1)" "unprognostic (1.75e-2)" "unprognostic (1.52e-1)" "unprognostic (7.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.97e-1)" 6.1 3.7 5.6 3.6 10.5 2.6 4.9 4.4 7.1 6.2 4.4 7.5 2.0 3.4 6.5 3.0 3.8 5.3 3.2 3.6 5.9 4.6 4.9 2.1 4.9 5.4 14.5 5.8 9.4 2.7 7.0 2.3 7.3 7.6 4.2 4.6 4.1 4.3 4.1 2.2 5.5 3.9 5.2 11.6 8.0 4.7 11.6 11.9 8.9 5.8 2.2 5.2 5.9 4.3 5.6 3.8 3.8 6.9 5.1 5.5 2.1 1.3 2.1 6.4 2.2 3.2 3.8 1.6 2.2 3.6 4.1 3.8 1.1 1.2 3.2 1.9 2.8 1.3 1.8 1.8 2.3 4.5 3.4 2.2 3.5 1.3 0.9 3.1 2.4 3.5 4.3 5.4 2.2 4.7 2.2 3.7 4.0 2.2 0.8 5.3 1.8 5.9 1.0 1.1 4.3 1.0 6.3 10.9 1.0 2.7 2.6 1.9 3.8 2.4 1.7 2.6 15.3 1.4 1.0 5.2 3.9 1.5 1.5 1.6 1.5 1.0 0.0 1.8 0.0 3.3 2.0 2.2 3.8 3.9 6.9 5.5 3.5 4.2 4.2 3.8 5.6 4.7 2.8 0.5 5.1 2.8 1.1 3.0 2.1 5.6 10.5 4.4 7.1 5.9 4.6 14.5 5.8 7.6 11.9 0.0 0.0 0.0 0.4 0.5 3.6 1.4 2.5 5.3 2.3 0.0 2.0 1.2 3.3 1.1 6.3 1.6 0.9 0.0 0.9 1.3 1.8 0.5 3.5 0.0 2.1 7.9 0.0 6.7 4.5 1.1 1.4 1.9 0.0 0.0 1.4 2.3 1.6 0.0 2.5 1.3 2.8 0.0 1.4 6.2 7.3 0.6 1.3 1.8 0.7 0.9 ZNF644 "BM-005, KIAA1221, MGC60165, MGC70410" ENSG00000122482 "Zinc finger protein 644" Q9H582 1 90915298-91022272 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057795 Uncertain Uncertain Vesicles NA NA Vesicles "HPA057795: AB_2683529" "unprognostic (8.20e-2)" "unprognostic (5.86e-3)" "prognostic favorable (4.27e-4)" "prognostic unfavorable (8.39e-4)" "unprognostic (3.19e-3)" "unprognostic (4.62e-3)" "unprognostic (8.04e-2)" "unprognostic (7.01e-2)" "unprognostic (2.44e-2)" "unprognostic (6.32e-2)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (2.61e-2)" "unprognostic (3.03e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (3.07e-1)" 22.2 14.1 20.7 19.0 20.0 19.4 23.9 34.9 25.1 24.7 17.6 17.8 17.1 11.2 23.8 16.7 17.6 14.4 14.2 14.9 21.7 16.6 15.2 26.2 15.1 19.5 23.7 18.9 21.3 14.4 22.4 24.2 18.2 23.3 18.3 18.7 12.0 20.6 15.3 20.3 14.4 19.1 19.2 25.3 21.6 14.6 17.1 26.5 35.3 26.1 14.9 19.7 19.9 18.3 8.1 7.0 5.0 4.8 12.5 8.6 3.2 13.0 6.3 18.4 10.1 8.6 10.1 10.6 11.4 12.1 13.1 14.0 8.3 4.8 16.0 12.7 8.7 17.2 10.4 18.3 13.3 19.4 11.4 10.3 20.7 12.4 11.9 12.3 18.7 6.9 9.5 15.7 12.9 17.6 12.1 13.6 12.0 14.4 18.5 13.6 4.7 15.3 16.7 16.7 6.9 11.8 15.1 30.1 9.0 13.5 12.1 15.1 11.8 14.1 11.0 29.2 13.1 7.2 19.0 10.7 14.4 11.9 11.7 17.5 13.2 8.9 21.4 5.8 14.4 7.4 5.0 4.5 5.0 6.2 4.8 7.0 8.1 7.0 7.0 5.8 7.2 8.6 7.5 1.3 12.5 4.7 7.0 5.5 3.2 20.7 20.0 34.9 25.1 21.7 16.6 23.7 18.9 23.3 26.5 65.5 23.0 38.4 82.6 48.1 32.9 41.2 22.9 36.1 45.5 10.4 23.6 21.1 26.6 28.4 7.0 36.5 26.5 0.0 19.7 15.1 32.9 51.0 43.7 23.2 19.0 52.4 52.8 20.3 24.0 11.7 43.1 27.4 33.7 20.8 24.3 37.9 25.0 28.1 32.5 22.1 34.8 51.8 64.6 45.3 49.0 41.5 10.1 34.6 31.0 62.6 ZNF813 FLJ16542 ENSG00000198346 "Zinc finger protein 813" Q6ZN06 19 53467735-53496255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ito cells: 16.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 17.7" HPA056406 Uncertain Approved Vesicles NA NA Vesicles "HPA056406: AB_2683119" "unprognostic (1.20e-1)" "unprognostic (3.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.98e-3)" "unprognostic (2.28e-1)" "unprognostic (3.61e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-3)" "unprognostic (3.39e-3)" "unprognostic (1.74e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-2)" "unprognostic (1.25e-3)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (6.56e-2)" 5.9 3.7 4.0 5.0 4.3 2.5 4.8 3.2 3.6 5.8 4.3 2.5 1.7 3.8 4.1 8.7 4.0 4.1 3.0 2.4 2.5 2.3 5.0 2.5 4.7 4.1 4.6 1.6 4.8 4.1 5.2 3.5 12.7 4.7 10.7 3.7 2.0 4.8 3.3 1.6 4.0 6.3 4.5 6.3 6.5 4.0 4.2 5.2 10.2 5.8 2.8 4.3 6.4 9.5 4.8 2.5 2.4 5.5 6.8 6.8 2.6 0.8 0.8 2.6 4.4 2.2 2.7 6.1 2.3 2.4 1.6 2.3 4.5 2.6 6.6 2.3 2.2 3.0 1.4 6.2 2.7 3.1 0.0 9.8 6.7 1.8 5.1 1.2 0.0 7.2 2.3 2.2 1.8 1.4 0.9 1.4 4.9 3.6 0.1 2.6 1.2 8.7 3.7 3.3 0.8 2.3 5.3 5.7 3.2 1.6 17.7 1.1 2.5 0.0 4.5 1.6 5.9 1.8 3.3 2.4 0.9 3.3 0.1 2.2 3.6 5.3 7.5 0.0 0.0 4.6 2.4 2.2 1.7 3.7 3.2 3.7 3.4 3.5 4.1 2.5 4.8 6.8 5.2 1.1 6.8 5.5 2.4 2.6 2.6 4.0 4.3 3.2 3.6 2.5 2.3 4.6 1.6 4.7 5.2 6.0 2.6 1.4 3.1 1.5 0.6 1.6 2.5 1.4 3.4 0.0 0.0 4.4 1.7 1.8 1.1 3.6 1.1 0.0 1.0 5.9 2.7 5.1 0.0 0.8 2.4 3.2 0.0 16.0 3.1 0.0 2.3 1.5 3.3 2.8 4.1 1.1 1.3 3.5 2.1 0.7 0.4 0.0 1.9 0.6 5.1 1.4 7.4 1.3 3.7 2.2 ZPR1 ZNF259 ENSG00000109917 "ZPR1 zinc finger" O75312 11 116773799-116788050 "Predicted intracellular proteins" "Differentiation, mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 178.4;Late spermatids: 307.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022596, HPA030979" Uncertain Approved Vesicles NA NA Vesicles "CAB022596: , HPA030979: AB_2673684" "unprognostic (2.12e-2)" "unprognostic (3.55e-1)" "unprognostic (6.22e-2)" "unprognostic (1.44e-1)" "unprognostic (2.32e-1)" "prognostic unfavorable (8.01e-4)" "prognostic unfavorable (5.87e-6)" "unprognostic (1.04e-1)" "unprognostic (1.09e-1)" "unprognostic (9.42e-2)" "unprognostic (4.96e-3)" "unprognostic (4.79e-2)" "unprognostic (2.17e-2)" "unprognostic (1.48e-1)" "unprognostic (1.73e-1)" "unprognostic (1.71e-2)" "unprognostic (6.66e-2)" 19.5 13.2 20.2 15.9 20.5 34.9 17.3 12.0 23.3 13.7 14.0 17.1 11.5 12.4 16.4 16.2 18.0 14.4 14.2 14.7 17.6 14.0 14.2 26.3 15.8 16.5 25.9 18.2 17.6 24.4 12.6 13.2 14.8 19.1 14.3 15.3 9.1 14.1 15.5 28.7 15.5 14.9 18.5 15.8 15.7 17.1 32.4 19.1 13.0 16.9 13.8 20.9 15.9 18.5 20.4 17.7 12.4 16.7 19.0 18.1 14.5 8.6 12.6 7.5 14.2 11.5 12.1 10.0 14.9 11.7 13.4 14.4 31.6 15.7 19.9 26.4 14.8 24.2 11.8 20.7 13.6 19.1 12.9 10.2 42.1 6.8 17.0 22.9 19.0 17.7 11.4 19.2 25.5 41.6 9.0 14.8 12.9 19.9 13.6 19.5 10.7 15.5 23.8 13.7 24.0 19.2 12.2 11.5 21.9 12.9 15.2 9.9 17.1 12.2 16.3 10.3 13.5 11.0 13.1 12.6 17.4 8.6 10.2 20.9 9.6 7.2 24.5 9.5 34.0 16.7 8.7 16.0 12.4 13.2 16.7 15.6 20.4 18.1 17.1 17.7 17.0 17.9 16.2 2.4 19.0 13.7 12.8 17.6 14.5 20.2 20.5 12.0 23.3 17.6 14.0 25.9 18.2 19.1 19.1 8.9 12.8 32.6 49.6 0.0 9.5 10.1 17.8 5.3 18.2 19.2 0.0 29.5 38.1 45.7 178.4 15.6 17.9 0.0 34.7 46.1 16.2 32.9 28.7 17.8 32.8 4.8 22.4 14.1 13.6 307.9 17.5 21.0 0.0 45.9 17.8 6.7 47.9 17.3 11.7 19.2 5.7 6.5 15.6 63.0 30.3 0.0 38.3 21.3 23.5 82.7